PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Ferrari, RG; Panzenhagen, PHN; Conte, CA				Ferrari, Rafaela G.; Panzenhagen, Pedro H. N.; Conte-Junior, Carlos A.			Phenotypic and Genotypic Eligible Methods for Salmonella Typhimurium Source Tracking	FRONTIERS IN MICROBIOLOGY			English	Review						phage typing; antimicrobial resistance profile; PFGE; MLVA; MLST; CRISPR; Ribotyping; WGS	ENTERICA SEROVAR TYPHIMURIUM; FIELD GEL-ELECTROPHORESIS; TANDEM-REPEAT ANALYSIS; MEDIATED QUINOLONE RESISTANCE; FRAGMENT LENGTH POLYMORPHISM; MOLECULAR TYPING METHODS; DIFFERENT PHAGE TYPES; VARIABLE-NUMBER; ANTIMICROBIAL RESISTANCE; SEROTYPE TYPHIMURIUM	Salmonellosis is one of the most common causes of foodborne infection and a leading cause of human gastroenteritis. Throughout the last decade, Salmonella enterica serotype Typhimurium (ST) has shown an increase report with the simultaneous emergence of multidrug-resistant isolates, as phage type DT104. Therefore, to successfully control this microorganism, it is important to attribute salmonellosis to the exact source. Studies of Salmonella source attribution have been performed to determine the main food/food-production animals involved, toward which, control efforts should be correctly directed. Hence, the election of a ST subtyping method depends on the particular problem that efforts must be directed, the resources and the data available. Generally, before choosing a molecular subtyping, phenotyping approaches such as serotyping, phage typing, and antimicrobial resistance profiling are implemented as a screening of an investigation, and the results are computed using frequency-matching models (i.e., Dutch, Hald and Asymmetric Island models). Actually, due to the advancement of molecular tools as PFGE, MLVA, MLST, CRISPR, and WGS more precise results have been obtained, but even with these technologies, there are still gaps to be elucidated. To address this issue, an important question needs to be answered: what are the currently suitable subtyping methods to source attribute ST. This review presents the most frequently applied subtyping methods used to characterize ST, analyses the major available microbial subtyping attribution models and ponders the use of conventional phenotyping methods, as well as, the most applied genotypic tools in the context of their potential applicability to investigates ST source tracking.	[Ferrari, Rafaela G.; Panzenhagen, Pedro H. N.; Conte-Junior, Carlos A.] Univ Fed Fluminense, Fac Vet, Dept Food Technol, Mol & Analyt Lab Ctr, Niteroi, RJ, Brazil; [Ferrari, Rafaela G.; Panzenhagen, Pedro H. N.; Conte-Junior, Carlos A.] Univ Fed Rio de Janeiro, Chem Inst, Food Sci Program, Rio De Janeiro, Brazil; [Conte-Junior, Carlos A.] Fundacao Oswaldo Cruz, Natl Inst Hlth Qual Control, Rio De Janeiro, Brazil	Conte, CA (reprint author), Univ Fed Fluminense, Fac Vet, Dept Food Technol, Mol & Analyt Lab Ctr, Niteroi, RJ, Brazil.; Conte, CA (reprint author), Univ Fed Rio de Janeiro, Chem Inst, Food Sci Program, Rio De Janeiro, Brazil.; Conte, CA (reprint author), Fundacao Oswaldo Cruz, Natl Inst Hlth Qual Control, Rio De Janeiro, Brazil.	carlosconte@id.uff.br			Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil) [E-26/201.185/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [311422/2016-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Embrapa, CAPES, Brazil) [125]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (process no. E-26/201.185/2014, FAPERJ, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (process no. 311422/2016-0, CNPq, Brazil), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (process no. 125, CAPES/Embrapa 2014, CAPES, Brazil).	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Adaska JM, 2006, APPL ENVIRON MICROB, V72, P6632, DOI 10.1128/AEM.01038-06; Ahrenfeldt J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3407-6; Alcocer Iliana, 2003, Food Sci. Technol (Campinas), V23, P401, DOI 10.1590/S0101-20612003000300019; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Almeida F, 2016, J APPL MICROBIOL, V120, P1677, DOI 10.1111/jam.13110; Almeida F, 2017, INFECT GENET EVOL, V51, P41, DOI 10.1016/j.meegid.2017.03.009; Almeida F, 2015, J MED MICROBIOL, V64, P1395, DOI 10.1099/jmm.0.000158; Almeida F, 2013, INFECT GENET EVOL, V19, P145, DOI 10.1016/j.meegid.2013.07.004; Alt K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128349; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187                                                       ; Andoh LA, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0043-z; Andreoletti O, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.764; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3502; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Arnedo-Pena A, 2016, ENFERM INFEC MICR CL, V34, P544, DOI 10.1016/j.eimc.2015.11.016; Aslam M, 2012, FOOD MICROBIOL, V32, P110, DOI 10.1016/j.fm.2012.04.017; Baggesen DL, 2010, EUROSURVEILLANCE, V15, P12; Bailey JS, 2002, J FOOD PROTECT, V65, P1005, DOI 10.4315/0362-028X-65.6.1005                                                     ; Barco L, 2012, ZOONOSES PUBLIC HLTH, V59, P505, DOI 10.1111/j.1863-2378.2012.01487.x; Barco L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00301; Barco L, 2013, INT J FOOD MICROBIOL, V163, P193, DOI 10.1016/j.ijfoodmicro.2013.03.005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Best EL, 2007, J APPL MICROBIOL, V103, P565, DOI 10.1111/j.1365-2672.2007.03278.x; Best EL, 2009, MICROB DRUG RESIST, V15, P133, DOI 10.1089/mdr.2009.0911; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Brichta-Harhay DM, 2011, APPL ENVIRON MICROB, V77, P1783, DOI 10.1128/AEM.01885-10; Cai YQ, 2016, INT J FOOD MICROBIOL, V222, P56, DOI 10.1016/j.ijfoodmicro.2016.01.020; CALLOW B R, 1959, J Hyg (Lond), V57, P346; Campioni F, 2015, APMIS, V123, P422, DOI 10.1111/apm.12367; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chiou CS, 2010, INT J FOOD MICROBIOL, V142, P67, DOI 10.1016/j.ijfoodmicro.2010.06.001; Cho S, 2007, FEMS MICROBIOL LETT, V275, P16, DOI 10.1111/j.1574-6968.2007.00875.x; Christensen H, 2000, J APPL MICROBIOL, V89, P130, DOI 10.1046/j.1365-2672.2000.01095.x; Clark CG, 2003, J CLIN MICROBIOL, V41, P27, DOI [10.1128/JCM.41.1.27-33.2003, 10.1128/JCM>41.1.27-33.2003]; Cloeckaert A, 2001, VET RES, V32, P301, DOI 10.1051/vetres:2001126; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Cui MQ, 2016, FOOD CONTROL, V62, P270, DOI 10.1016/j.foodcont.2015.10.036; David JM, 2013, PREV VET MED, V110, P12, DOI 10.1016/j.prevetmed.2013.02.002; De Cesare A, 2001, J APPL MICROBIOL, V91, P780, DOI 10.1046/j.1365-2672.2001.01441.x; den Bakker HC, 2011, APPL ENVIRON MICROB, V77, P8648, DOI 10.1128/AEM.06538-11; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; DiMarzio M, 2013, ANTIMICROB AGENTS CH, V57, P4282, DOI 10.1128/AAC.00913-13; Dimovski K, 2014, J BACTERIOL, V196, P3036, DOI 10.1128/JB.01820-14; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Dyet KH, 2011, EPIDEMIOL INFECT, V139, P1050, DOI 10.1017/S0950268810002025; EFSA, 2009, EFSA J, V7; European Food Safety Authority, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4329, 10.2903/j.efsa.2016.4469]; EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4375; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1                                                   ; Eriksson J, 2005, INT J FOOD MICROBIOL, V104, P93, DOI 10.1016/j.ijfoodmicro.2005.01.011; Fabre L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002671; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Fakhr MK, 2005, J CLIN MICROBIOL, V43, P2215, DOI 10.1128/JCM.43.5.2215-2219.2005; Fang H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S4; FELIX A, 1956, J GEN MICROBIOL, V14, P208, DOI 10.1099/00221287-14-1-208                                                       ; Ferrari R, 2013, BRAZ J MICROBIOL, V44, P657, DOI 10.1590/S1517-83822013000200046; Ferrari R, 2011, J INFECT DEV COUNTR, V5, P496; Ferrari R, 2011, CURR MICROBIOL, V62, P628, DOI 10.1007/s00284-010-9754-7; Ferrari RG, 2013, BRAZ J INFECT DIS, V17, P125, DOI 10.1016/j.bjid.2012.09.011; Foley SL, 2006, J CLIN MICROBIOL, V44, P3569, DOI 10.1128/JCM.00745-06; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Fontana J, 2003, EMERG INFECT DIS, V9, P496, DOI 10.3201/eid0904.020423                                                          ; Foxman Betsy, 2005, Epidemiol Perspect Innov, V2, P10, DOI 10.1186/1742-5573-2-10; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Fu SZ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02002; Galiana A, 2014, REV ESP QUIM, V27, P239; Garcia P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00680; Garcia P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089635; Garcia P, 2013, J CLIN MICROBIOL, V51, P973, DOI 10.1128/JCM.02777-12; Gebreyes WA, 2006, EPIDEMIOL INFECT, V134, P187, DOI 10.1017/S0950268805004723; Gebreyes WA, 2009, J CLIN MICROBIOL, V47, P777, DOI 10.1128/JCM.01660-08; Ghilardi ACR, 2006, MEM I OSWALDO CRUZ, V101, P281, DOI 10.1590/S0074-02762006000300010; Gilbert D, 2004, BRIEF BIOINFORM, V5, P300, DOI 10.1093/bib/5.3.300; Giraud E, 2003, J MED MICROBIOL, V52, P697, DOI 10.1099/jmm.0.05178-0; Gorman R, 2004, J CLIN MICROBIOL, V42, P2314, DOI 10.1128/JCM.42.5.2314-2316.2004; Greig J, 2015, ZOONOSES PUBLIC HLTH, V62, P269, DOI 10.1111/zph.12147; Guillier L, 2013, INT J FOOD MICROBIOL, V166, P471, DOI 10.1016/j.ijfoodmicro.2013.08.006; Hald T., 2012, EFSA SUPPORT PUBL, V9, p259E, DOI [10.2903/sp.efsa.2012.EN-259, DOI 10.2903/SP.EFSA.2012.EN-259]; Harvey SP, 2005, FEMS IMMUNOL MED MIC, V44, P91, DOI 10.1016/j.femsim.2004.12.002; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Hoelzer K, 2010, APPL ENVIRON MICROB, V76, P5947, DOI 10.1128/AEM.00377-10; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Hopkins KL, 2011, EUROSURVEILLANCE, V16, P2; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Hyytia-Trees EK, 2007, FUTURE MICROBIOL, V2, P175, DOI 10.2217/17460913.2.2.175; Ido N, 2015, J VET MED SCI, V77, P609, DOI 10.1292/jvms.14-0465; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jensen MBF, 2017, EUR J CLIN MICROBIOL, V36, P1923, DOI 10.1007/s10096-017-3015-7; Jeoffreys NJ, 2001, PATHOLOGY, V33, P66; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kariuki S, 2015, CLIN INFECT DIS, V61, pS317, DOI 10.1093/cid/civ711; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kotetishvili M, 2002, J CLIN MICROBIOL, V40, P1626, DOI 10.1128/JCM.40.5.1626-1635.2002; Kottwitz LBM, 2013, BRAZ J MICROBIOL, V44, P367, DOI 10.1590/S1517-83822013005000036; Kurosawa A, 2012, VET MICROBIOL, V160, P264, DOI 10.1016/j.vetmic.2012.05.023; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; Lagatolla C, 1996, J CLIN MICROBIOL, V34, P2440; Lan RT, 2003, MICROBES INFECT, V5, P841, DOI 10.1016/S1286-4579(03)00174-6; Landeras E, 1996, J CLIN MICROBIOL, V34, P2294; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103                                                      ; Larsson JT, 2013, EUROSURVEILLANCE, V18, P20, DOI 10.2807/1560-7917.ES2013.18.35.20566; LEEKITCHAROENPHON, 2012, BMC GENOMICS S7, V13, DOI DOI 10.1186/1471-2164-13-S7-S6; LEEKITCHAROENPHON, 2012, BMC GENOMICS, V13, DOI DOI 10.1186/1471-2164-13-88; Leekitcharoenphon P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156212; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Li F, 2011, J NANOMATER, DOI 10.1155/2011/484589; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Liebana E, 2004, VET MICROBIOL, V100, P189, DOI 10.1016/j.vetmic.2004.01.020; Liebana E, 2002, J APPL MICROBIOL, V93, P732, DOI 10.1046/j.1365-2672.2002.01737.x; Liebana E, 2002, J CLIN MICROBIOL, V40, P4450, DOI 10.1128/JCM.40.12.4450-4456.2002; Liebana E, 2001, J CLIN MICROBIOL, V39, P3609, DOI 10.1128/JCM.39.10.3609-3616.2001; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Lienemann T, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0467-8; Lindqvist N, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-15; Lindstedt BA, 2013, EUROSURVEILLANCE, V18, P7; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Litrup E, 2010, J APPL MICROBIOL, V109, P2032, DOI 10.1111/j.1365-2672.2010.04833.x; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Liu WB, 2011, FOOD MICROBIOL, V28, P1182, DOI 10.1016/j.fm.2011.04.001; Liu Y, 2016, GASTROENT RES PRACT, V15, P2016, DOI DOI 10.1177/1533034615587616; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Malorny B, 2001, VET RES, V32, P119, DOI 10.1051/vetres:2001116; McDermott P. F., 2016, SALMONELLA ANTIMICRO, V60, P5515, DOI DOI 10.1128/AAC.01030-16; Medalla F, 2013, FOODBORNE PATHOG DIS, V10, P302, DOI 10.1089/fpd.2012.1336; Miriagou V, 2006, MICROBES INFECT, V8, P1923, DOI 10.1016/j.micinf.2005.12.027; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Mughini-Gras L, 2014, INFECT GENET EVOL, V28, P251, DOI 10.1016/j.meegid.2014.10.003; Mughini-Gras L, 2014, INT J FOOD MICROBIOL, V191, P109, DOI 10.1016/j.ijfoodmicro.2014.09.010; Mughini-Gras L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087933; Mughini-Gras L., FOOD MICROBIOL, DOI [10.1016/j.fm.2017.03.002, DOI 10.1016/J.FM.2017.03.002]; NARMS, 2014, NARMS INT REP; NARMS, 2014, HUM IS SURV REP 2014; Ngoi ST, 2015, BIOMED ENVIRON SCI, V28, P751, DOI 10.3967/bes2015.105; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nillian E., 2011, FOOD NUTR SCI, V2, P1077, DOI [10.4236/fns.2011.210144, DOI 10.4236/FNS.2011.210144]; Norton S, 2012, WEST PAC SURVEILL RE, V3, P16, DOI [10.5365/wpsar.2012.3.1.001, 10.5365/WPSAR.2012.3.1.001]; Octavia S, 2015, J CLIN MICROBIOL, V53, P3507, DOI 10.1128/JCM.01733-15; Octavia S, 2015, J CLIN MICROBIOL, V53, P1063, DOI 10.1128/JCM.03235-14; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; OLSEN JE, 1993, VET QUART, V15, P125, DOI 10.1080/01652176.1993.9694390                                                   ; Olsen SJ, 2004, EMERG INFECT DIS, V10, P932, DOI 10.3201/eid1005.030484                                                          ; Paranthaman K, 2013, FOODBORNE PATHOG DIS, V10, P850, DOI 10.1089/fpd.2013.1513; Pavlic M, 2009, FOODBORNE PATHOG DIS, V6, P1047, DOI 10.1089/fpd.2009.0264; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Petersen RF, 2011, FOODBORNE PATHOG DIS, V8, P655, DOI 10.1089/fpd.2010.0683; Petrovska L, 2016, EMERG INFECT DIS, V22, P617, DOI 10.3201/eid2204.150531; Phillips A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0831-3; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P143, DOI 10.1089/fpd.2009.0369; Prendergast DM, 2011, FOOD MICROBIOL, V28, P1087, DOI 10.1016/j.fm.2011.02.013; Pui CF, 2011, FOOD CONTROL, V22, P337, DOI 10.1016/j.foodcont.2010.05.021; Pulsenet MLVA, 2013, APPL BIOSYSTEMS GENE; Rabsch Wolfgang, 2007, V394, P177, DOI 10.1007/978-1-59745-512-1_10; Ranieri ML, 2013, J CLIN MICROBIOL, V51, P1786, DOI 10.1128/JCM.03201-12; Ribot EM, 2002, EMERG INFECT DIS, V8, P387, DOI 10.3201/eid0804.010202                                                          ; Rivoal K, 2009, INT J FOOD MICROBIOL, V129, P180, DOI 10.1016/j.ijfoodmicro.2008.11.021; Ross IL, 2011, CURR MICROBIOL, V62, P1034, DOI 10.1007/s00284-010-9820-1; Ross IL, 2009, INT J MED MICROBIOL, V299, P37, DOI 10.1016/j.ijmm.2008.05.009; Ross IL, 2005, J CLIN MICROBIOL, V43, P1604, DOI 10.1128/JCM.43.4.1604-1611.2005; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schjorring S, 2016, EUROSURVEILLANCE, V21, P5, DOI [10.2807/1560-7917.ES.2016.21.50.30429, 10.2807/1560-7917.ES.2016.21.50.304292]; Schmieger H, 1999, J BACTERIOL, V181, P1630; Schulman LS, 2017, J THEOR BIOL, V417, P61, DOI 10.1016/j.jtbi.2017.01.022; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shariat N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-254; Silley P, 2011, INT J ANTIMICROB AG, V37, P504, DOI 10.1016/j.ijantimicag.2010.12.002; Sona I, 2013, INFECT GENET EVOL, V16, P226, DOI 10.1016/j.meegid.2013.01.020; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P36, DOI 10.1089/fpd.2006.3.36                                                           ; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Tankouo-Sandjong B, 2007, J MICROBIOL METH, V69, P23, DOI 10.1016/j.mimet.2006.11.013; Tavechio A., 2006, COMPARACAO FENOTIPIC; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; THRELFALL EJ, 1990, J APPL BACTERIOL, V68, P5, DOI 10.1111/j.1365-2672.1990.tb02542.x; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; Torpdahl M, 2007, EMERG INFECT DIS, V13, P388, DOI 10.3201/eid1303.060460                                                          ; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x                                                ; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275; vanBelkum A, 1997, INFECT IMMUN, V65, P5017; Wang Y, 2015, FOOD CONTROL, V47, P420, DOI 10.1016/j.foodcont.2014.07.031; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Weill F., 2014, MOL TYPING SUBTYPING; Weymann D, 2017, MOL GENET GENOM MED, V5, P251, DOI 10.1002/mgg3.281; WHO, 2015, EST GLOB BURD FOODB; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Wise MG, 2009, J MICROBIOL METH, V76, P18, DOI 10.1016/j.mimet.2008.09.006; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zheng J, 2011, J CLIN MICROBIOL, V49, P85, DOI 10.1128/JCM.00120-10; Zou W, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S15; Zou W, 2010, J CLIN MICROBIOL, V48, P3122, DOI 10.1128/JCM.00645-10	209	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	DEC 22	2017	8								2587	10.3389/fmicb.2017.02587				21	Microbiology	Microbiology	FQ8EC	WOS:000418594700004		gold			2018-01-05	
J	Frias-Lasserre, D; Villagra, CA				Frias-Lasserre, Daniel; Villagra, Cristian A.			The Importance of ncRNAs as Epigenetic Mechanisms in Phenotypic Variation and Organic Evolution	FRONTIERS IN MICROBIOLOGY			English	Review						non-codingRNAs; phenotypic plasticity; biodiversity; adaptation; evolution	LONG NONCODING RNAS; PROTEIN-CODING DNA; TRANSGENERATIONAL INHERITANCE; CENTRAL DOGMA; HAMMERHEAD RIBOZYMES; ADAPTIVE EVOLUTION; GENE-EXPRESSION; MESSENGER-RNA; HUMAN GENOME; FUNCTIONAL DIVERSIFICATION	Neo-Darwinian explanations of organic evolution have settled on mutation as the principal factor in producing evolutionary novelty. Mechanistic characterizations have been also biased by the classic dogma of molecular biology, where only proteins regulate gene expression. This together with the rearrangement of genetic information, in terms of genes and chromosomes, was considered the cornerstone of evolution at the level of natural populations. This predominant view excluded both alternative explanations and phenomenologies that did not fit its paradigm. With the discovery of non-coding RNAs (ncRNAs) and their role in the control of genetic expression, new mechanisms arose providing heuristic power to complementary explanations to evolutionary processes overwhelmed by mainstream genocentric views. Viruses, epimutation, paramutation, splicing, and RNA editing have been revealed as paramount functions in genetic variations, phenotypic plasticity, and diversity. This article discusses how current epigenetic advances on ncRNAs have changed the vision of the mechanisms that generate variation, how organism-environment interaction can no longer be underestimated as a driver of organic evolution, and how it is now part of the transgenerational inheritance and evolution of species.	[Frias-Lasserre, Daniel; Villagra, Cristian A.] Univ Metropolitana Ciencias Educ, Inst Entomol, Santiago, Chile	Frias-Lasserre, D (reprint author), Univ Metropolitana Ciencias Educ, Inst Entomol, Santiago, Chile.	daniel.frias@umce.cl			Research Direction of Metropolitan University of Educational Sciences (DIUMCE)	Financed by Research Direction of Metropolitan University of Educational Sciences (DIUMCE).	Adam M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-52; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Baldwin J M, 1897, Science, V5, P634, DOI 10.1126/science.5.121.634; Baldwin J. Mark, 1896, American Naturalist, Vxxx, P441; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Jablonka E., 2005, J CLIN INVEST, V115, P2961, DOI 10.1172/JCI27017; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; Berk AJ, 2016, P NATL ACAD SCI USA, V113, P801, DOI 10.1073/pnas.1525084113; Bidarimath M, 2014, CELL MOL IMMUNOL, V11, P538, DOI 10.1038/cmi.2014.45; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blignaut M., 2012, EPIGENETICS, V7, P664, DOI DOI 10.4161/EPI.20170; Bongiorni S, 1999, GENETICS, V151, P1471; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; BROWN SW, 1964, SCIENCE, V145, P130, DOI 10.1126/science.145.3628.130; BROWN SW, 1966, SCIENCE, V151, P417, DOI 10.1126/science.151.3709.417; Burggren Warren, 2016, Biology-Basel, V5, P24, DOI 10.3390/biology5020024; Bush SJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0474; Cao JN, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-11; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047998; Choudhuri S, 2010, J BIOCHEM MOL TOXIC, V24, P195, DOI 10.1002/jbt.20325; CHOW LT, 1977, CELL, V11, P819, DOI 10.1016/0092-8674(77)90294-X; COE EH, 1966, GENETICS, V53, P1035; Creevey CJ, 2003, BIOINFORMATICS, V19, P1726, DOI 10.1093/bioinformatics/btg225; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CROUSE HV, 1960, GENETICS, V45, P1429; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; D'Urso A, 2014, TRENDS GENET, V30, P230, DOI 10.1016/j.tig.2014.04.004; Daniel FL, 2010, BIOL RES, V43, P299, DOI [/S0716-97602010000300006, 10.4067/S0716-97602010000300006]; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; de la Pena M, 2010, EMBO REP, V11, P711, DOI 10.1038/embor.2010.100; De Lucia F, 2011, CURR OPIN PLANT BIOL, V14, P168, DOI 10.1016/j.pbi.2010.11.006; Denhardt D. T., 2017, J CELL PHYSL, V233, P1975, DOI 10.1002/jcp.25837; Dietrich MR, 2003, NAT REV GENET, V4, P68, DOI 10.1038/nrg979; Dietrich MR, 2000, AM ZOOL, V40, P738, DOI 10.1668/0003-1569(2000)040[0738:FHMTHE]2.0.CO;2                                 ; Dobzhansky T., 1940, SCIENCE, V98, P356; Dulcis D, 2017, NEURON, V95, P1319, DOI 10.1016/j.neuron.2017.08.023; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Feinberg AP, 2000, CURR TOP MICROBIOL, V249, P87; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flanagan James M, 2007, Genome Biol, V8, P307, DOI 10.1186/gb-2007-8-6-307; Frias-Lasserre D, 2012, INT J MOL SCI, V13, P477, DOI 10.3390/ijms13010477; Fried C, 2004, J EXP ZOOL PART B, V302B, P165, DOI 10.1002/jez.b.20007; Furrow RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101559; Gaiti F, 2017, DEV BIOL, V427, P193, DOI 10.1016/j.ydbio.2016.11.013; Gann A, 2010, CURR BIOL, V20, pR718, DOI 10.1016/j.cub.2010.06.027; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0                                                                ; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0                                                                ; Gillings MR, 2014, TRENDS ECOL EVOL, V29, P1, DOI 10.1016/j.tree.2013.10.001; Goldschmidt R., 1940, MAT BASIS EVOLUTION; Goldschmidt R. B., 1945, PAN PACIFIC ENT, V21, P41; GOLDSCHMIDT RB, 1945, SCIENCE, V101, P389, DOI 10.1126/science.101.2624.389; Gommans WM, 2009, BIOESSAYS, V31, P1137, DOI 10.1002/bies.200900045; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4                                                   ; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Gu TJ, 2016, GENETICS, V202, P787, DOI 10.1534/genetics.115.179481; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hanson M.A., 2016, EUROPEAN J HUMAN GEN, V2, P1; Harjanto D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12145; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Herbert A, 1999, NAT GENET, V21, P265, DOI 10.1038/6780; Hollick JB, 2010, ANNU REV CELL DEV BI, V26, P557, DOI 10.1146/annurev.cellbio.042308.113400; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; HOUSSA M, 2014, SPRINGER THESES-RECO, P1, DOI DOI 10.1007/978-3-319-07182-4_1; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822                                                                  ; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jacob F., 1963, CYTODIFFERENTIATION, P30; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Joh RI, 2014, BBA-GENE REGUL MECH, V1839, P1385, DOI 10.1016/j.bbagrm.2014.06.006; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670                                                         ; Keller C, 2013, CHROMOSOME RES, V21, P627, DOI 10.1007/s10577-013-9390-8; Khosla S, 1996, CHROMOSOMA, V104, P386, DOI 10.1007/BF00337228; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kosten T., 2014, TRANSGENERATIONAL EP, P197; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Kurokawa R., 2015, STRUCTURES FUNCTIONS, DOI [10.1007/978-4-431-55576-6, DOI 10.1007/978-4-431-55576-6]; LAKE JA, 1988, P NATL ACAD SCI USA, V85, P4779, DOI 10.1073/pnas.85.13.4779; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANDWEBER LF, 1993, NATURE, V363, P179, DOI 10.1038/363179a0                                                                ; Larriba E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040452; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lei Q, 2016, GENOME BIOL EVOL, V8, P562, DOI 10.1093/gbe/evw025; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li L, 2015, PLANT BIOTECHNOL J, V13, P177, DOI 10.1111/pbi.12238; Li YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08790; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu F, 2012, INSECT MOL BIOL, V21, P297, DOI 10.1111/j.1365-2583.2012.01135.x; Liu S, 2015, J EXP BIOL, V218, P100, DOI 10.1242/jeb.107243; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; MacDonald WA, 2012, GENET RES INT, DOI 10.1155/2012/585024; Mahfouz MM, 2010, PLANT SIGNAL BEHAV, V5, P806, DOI 10.4161/psb.5.7.11695; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; Mashoodh R., 2014, TRANSGENERATIONAL EP, P221; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Maturana-Romesin H, 2000, REV CHIL HIST NAT, V73, P261; Matylla-Kulinska K, 2014, WIRES RNA, V5, P591, DOI 10.1002/wrna.1243; Mayr E., 1949, P281; MAYR E, 1985, J HIST BIOL, V18, P295, DOI 10.1007/BF00138928; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N                                                    ; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; MOSS L, 2001, LIFE MIND, P85; Mouillet JF, 2014, INT J DEV BIOL, V58, P281, DOI 10.1387/ijdb.130349ys; Mulder R. H., 2017, PARENTAL STRESS EARL, P157; Muniz L, 2013, NUCLEIC ACIDS RES, V41, P4686, DOI 10.1093/nar/gkt159; Nei M., 2013, MUTATION DRIVEN EVOL; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Penn AC, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00061; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pluskota WE, 2011, RNA TECHNOL, P339, DOI 10.1007/978-3-642-19454-2_21; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Przybilski R, 2005, PLANT CELL, V17, P1877, DOI 10.1105/tpc.105.032730; Pulukuri SMK, 2009, MOL CANCER RES, V7, P1285, DOI 10.1158/1541-7786.MCR-08-0508; Qu Zhipeng, 2012, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00205; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rangwala SH, 2004, CURR OPIN GENET DEV, V14, P686, DOI 10.1016/j.gde.2004.09.009; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Riddle N., 2014, TRANSGENERATIONAL EP, P105; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rivera C, 2014, BBA-GENE REGUL MECH, V1839, P1433, DOI 10.1016/j.bbagrm.2014.03.009; Rubio MAT, 2007, P NATL ACAD SCI USA, V104, P7821, DOI 10.1073/pnas.0702394104; Ruden DM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00060; Sabin LR, 2013, MOL CELL, V49, P783, DOI 10.1016/j.molcel.2013.02.010; SAKAGUCHI K, 1990, MICROBIOL REV, V54, P66; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; SCHUBERT FR, 1993, P NATL ACAD SCI USA, V90, P143, DOI 10.1073/pnas.90.1.143; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4                                                    ; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Shapiro JA, 2009, ANN NY ACAD SCI, V1178, P6, DOI 10.1111/j.1749-6632.2009.04990.x; Sharp PA, 2005, TRENDS BIOCHEM SCI, V30, P279, DOI 10.1016/j.tibs.2005.04.002; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Singh Minati, 2013, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00326; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Slack JMW, 2002, NAT REV GENET, V3, P889, DOI 10.1038/nrg933; Steele E. J., 1998, FRONTIERS SCI SERIES; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Swati D., 2017, BIOCOMMUNICATION ARC, P277; Sweatt JD, 2016, DIALOGUES CLIN NEURO, V18, P289; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; THODAY JM, 1953, SYM SOC EXP BIOL, V7, P96; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tollefsbol T. O., 2014, TRANSGENERATIONAL EP, P1; Tollefsbol TO, 2011, HANDBOOK OF EPIGENETICS: THE NEW MOLECULAR AND MEDICAL GENETICS, P1, DOI 10.1016/B978-0-12-375709-8.00001-0; van Otterdijk SD, 2016, FASEB J, V30, P2457, DOI 10.1096/fj.201500083; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Vella Monica C, 2005, WormBook, P1; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Watson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105338; Weber M, 2006, HIST PHIL LIFE SCI, V28, P595; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Woltereck R., 1909, ZOOL GESELLSCHAFT, V19, P110; Wright Mathew W., 2011, Human Genomics, V5, P90; Yan W, 2014, MOL CELL ENDOCRINOL, V398, P24, DOI 10.1016/j.mce.2014.09.008; Yang L, 2015, WIRES RNA, V6, P651, DOI 10.1002/wrna.1307; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yohn NL, 2015, PROG BIOPHYS MOL BIO, V118, P21, DOI 10.1016/j.pbiomolbio.2015.03.002; Yu CX, 2015, TUMOR BIOL, V36, P81, DOI 10.1007/s13277-014-2875-z; Yuan SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09266; Zhao Y, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0109-3; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92	213	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	DEC 22	2017	8								2483	10.3389/fmicb.2017.02483				13	Microbiology	Microbiology	FQ8CZ	WOS:000418591800001		gold			2018-01-05	
J	Ye, Y; Li, P; Xu, TQ; Zeng, LT; Cheng, D; Yang, M; Luo, J; Lian, XM				Ye, Ying; Li, Peng; Xu, Tangqian; Zeng, Liting; Cheng, Deng; Yang, Meng; Luo, Jie; Lian, Xingming			OsPT4 Contributes to Arsenate Uptake and Transport in Rice	FRONTIERS IN PLANT SCIENCE			English	Article						OsPT4; rice; arsenate; phosphate transporter; uptake	ORYZA-SATIVA L.; PHOSPHATE TRANSPORTER; ARSENITE UPTAKE; AQUAPORIN LSI1; ACCUMULATION; ARABIDOPSIS; TOLERANCE; TRANSLOCATION; ACQUISITION; CONSUMPTION	Arsenic (As) is toxic to organisms, and elevated As accumulation in rice (Oryza sativa) grain may pose a significant health risk to humans. The predominant form of As in soil under aerobic conditions is As(V), which has a chemical structure similar to that of PO43-. Rice roots take up As(V) by phosphate (Pi) transporters, such as OsPT1 and OsPT8. In the present study, we investigated the contribution of OsPT4, belonging to the Pht1 family, on rice As(V) uptake and transport. We determined the mRNA amounts of OsPTs in rice seedlings, and expressions of OsPT1, OsPT4, and OsPT8 were up-regulated under As(V) conditions. OsPT4-overexpressing plants were obtained to examine the As (V) transport activity of OsPT4 in rice. When transgenic rice grew in hydroponic culture with 25 and 50 mu M As(V), the plants showed sensitivity to As(V) stress with aboveground parts showing delayed growth and the roots stunted. The OsPT4 CRISPR lines showed the opposite phenotype. When plants were grown in 5 mu M As(V) solution for 7 days, the As accumulation of OsPT4-overexpressing plants increased up to twice in roots and shoots. Furthermore, the arsenate uptake rates of OsPT4-overexpressing lines were higher compared with wild type. The V-max of As(V) uptake in OsPT4-overexpressing plants increased 23-45% compared with Nipponbare. In the flooded soil, the As accumulation of OsPT4-overexpressing plants increased 40-66% and 22-30% in straw and grain, respectively. While in OsPT4-cr plants As accumulation in roots decreased 17-30% compared with Nipponbare. Therefore, the present study indicates that OsPT4 is involved in As(V) uptake and transport and could be a good candidate gene to generate low As-accumulating rice.	[Lian, Xingming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Hubei, Peoples R China	Lian, XM (reprint author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	xmlian@mail.hzau.edu.cn			National High Technology Research and Development Program of China [2014AA10A603]; Special Fund for Agro-Scientific Research in the Public Interest [201403015]; National Natural Science Foundation of China [31520103914, 31471932]	This work was supported by grants from the National High Technology Research and Development Program of China (2014AA10A603), Special Fund for Agro-Scientific Research in the Public Interest (201403015), the National Natural Science Foundation of China (31520103914 and 31471932).	Abedin MJ, 2002, PLANT SOIL, V240, P311, DOI 10.1023/A:1015792723288                                                         ; Abernathy CO, 2003, J NUTR, V133, p1536S; Alamdar A, 2017, CHEMOSPHERE, V168, P1004, DOI 10.1016/j.chemosphere.2016.10.110; Anawar HM, 2002, ENVIRON INT, V27, P597, DOI 10.1016/S0160-4120(01)00116-7; Begum MC, 2016, PLANT PHYSIOL BIOCH, V104, P266, DOI 10.1016/j.plaphy.2016.03.034; Cao Y, 2017, ENVIRON SCI TECHNOL, V51, P12131, DOI 10.1021/acs.est.7b03028; Catarecha P, 2007, PLANT CELL, V19, P1123, DOI 10.1105/tpc.106.041871; Chen Y, 2015, J EXP BOT, V66, P3717, DOI 10.1093/jxb/erv164; Cozzolino V, 2010, APPL SOIL ECOL, V45, P262, DOI 10.1016/j.apsoil.2010.05.001; Das HK, 2004, ENVIRON INT, V30, P383, DOI 10.1016/j.envint.2003.09.005; De la Rosa G, 2006, ENVIRON SCI TECHNOL, V40, P1991, DOI 10.1021/es051526s; Duan GL, 2007, NEW PHYTOL, V174, P311, DOI 10.1111/j.1469-8137.2007.02009.x; Finnegan PM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00182; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hartley-Whitaker J, 2001, PLANT PHYSIOL, V126, P299, DOI 10.1104/pp.126.1.299; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Kamiya T, 2013, SOIL SCI PLANT NUTR, V59, P580, DOI 10.1080/00380768.2013.804390; Li RY, 2009, PLANT PHYSIOL, V150, P2071, DOI 10.1104/pp.109.140350; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Meharg AA, 2002, NEW PHYTOL, V154, P29, DOI 10.1046/j.1469-8137.2002.00363.x; Meharg AA, 2004, TRENDS PLANT SCI, V9, P415, DOI 10.1016/j.tplants.2004.07.002; Meharg AA, 2003, ENVIRON SCI TECHNOL, V37, P229, DOI 10.1021/es0259842; Mehra P, 2017, PLANT BIOTECHNOL J, V15, P1054, DOI 10.1111/pbi.12699; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Moore KL, 2014, NEW PHYTOL, V201, P104, DOI 10.1111/nph.12497; Okkenhaug G, 2012, ENVIRON SCI TECHNOL, V46, P3155, DOI 10.1021/es2022472; Pandey BK, 2017, PLANT PHYSIOL, V174, P2316, DOI 10.1104/pp.17.00571; Raab A, 2005, NEW PHYTOL, V168, P551, DOI 10.1111/j.1469-8137.2005.01519.x; Seyfferth AL, 2010, ENVIRON SCI TECHNOL, V44, P8108, DOI 10.1021/es101139z; Shi SL, 2016, PLANT PHYSIOL, V172, P1708, DOI 10.1104/pp.16.01332; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896                                                         ; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Su YH, 2010, PLANT SOIL, V328, P27, DOI 10.1007/s11104-009-0074-2; Wang PT, 2016, J EXP BOT, V67, P6051, DOI 10.1093/jxb/erw362; Williams PN, 2009, ENVIRON SCI TECHNOL, V43, P637, DOI 10.1021/es802412r; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Wu P, 2013, CURR OPIN PLANT BIOL, V16, P205, DOI 10.1016/j.pbi.2013.03.002; Wu ZC, 2011, PLANT PHYSIOL, V157, P498, DOI 10.1104/pp.111.178921; Xu WZ, 2015, MOL PLANT, V8, P722, DOI 10.1016/j.molp.2015.01.005; Xu XY, 2007, NEW PHYTOL, V176, P590, DOI 10.1111/j.1469-8137.2007.02195.x; Ye Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126186; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang F, 2015, PLANT J, V82, P556, DOI 10.1111/tpj.12804; Zhao FJ, 2010, NEW PHYTOL, V186, P392, DOI 10.1111/j.1469-8137.2010.03192.x; Zhu YG, 2008, ENVIRON SCI TECHNOL, V42, P5008, DOI 10.1021/es8001103	52	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	DEC 22	2017	8								2197	10.3389/fpls.2017.02197				12	Plant Sciences	Plant Sciences	FQ8AU	WOS:000418585800002		gold			2018-01-05	
J	Covarrubias, S; Robinson, EK; Shapleigh, B; Vollmers, A; Katzman, S; Hanley, N; Fong, N; McManus, MT; Carpenter, S				Covarrubias, Sergio; Robinson, Elektra K.; Shapleigh, Barbara; Vollmers, Apple; Katzman, Sol; Hanley, Nicole; Fong, Nicholas; McManus, Michael T.; Carpenter, Susan			CRISPR/Cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-kappa B reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION; ACTIVATION; TRANSCRIPTION; INFLAMMATION; REPRESSION; CANCER; ASSAY	The innate immune system protects against infections by initiating an inducible inflammatory response. NF-kappa B is one of the critical transcription factors controlling this complex response, but some aspects of its regulation remain unclear. For example, although long non-coding RNAs (lncRNAs) have been shown to critically regulate gene expression, only a fraction of these have been functionally characterized, and the extent to which lncRNAs control NF-kappa B expression is unknown. Here, we describe the generation of a GFP-based NF-kappa B reporter system in immortalized murine bone marrow-derived macrophages (iBMDM). Activation of this reporter, using Toll-like receptor ligands, resulted in GFP expression, which could be monitored by flow cytometry. We also established a CRISPR/Cas9 gene deletion system in this NF-kappa B reporter line, enabling us to screen for genes that regulate NF-kappa B signaling. Our deletion-based approach identified two long intergenic non-coding (linc) RNAs, lincRNA-Cox2 and lincRNA-AK170409, that control NF-kappa B signaling. We demonstrate a potential novel role for lincRNA-Cox2 in promoting I kappa B alpha degradation in the cytoplasm. For lincRNA-AK170409, we provide evidence that this nuclearly-localized lincRNA regulates a number of inflammation-related genes. In conclusion, we have established an NF-kappa B-GFP iBMDM reporter cell line and a line that stably expresses Cas9. Our approach enabled the identification of lincRNA-Cox2 and lincRNA-AK170409 as NF-kappa B regulators, and this tool will be useful for identifying additional genes involved in regulating this transcription factor critical for immune function.	[Covarrubias, Sergio; Robinson, Elektra K.; Shapleigh, Barbara; Vollmers, Apple; Hanley, Nicole; Fong, Nicholas; Carpenter, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [McManus, Michael T.] Univ Calif Santa Cruz, Diabet Ctr, Dept Microbiol & Immunol, Santa Cruz, CA 95064 USA	Carpenter, S (reprint author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	sucarpen@ucsc.edu			National Institutes of Health [R03AI131019]	This work was supported by National Institutes of Health Grant R03AI131019 (to S. Carpenter).	Beamer CA, 2013, SEMIN IMMUNOPATHOL, V35, P693, DOI 10.1007/s00281-013-0391-7; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20                                          ; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Burger-Kentischer A, 2010, J IMMUNOL METHODS, V358, P93, DOI 10.1016/j.jim.2010.03.020; Carpenter S, 2016, VIRUS RES, V212, P137, DOI 10.1016/j.virusres.2015.08.019; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chen PH, 2012, ONCOGENE, V31, P2555, DOI 10.1038/onc.2011.438; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Hellweg CE, 2003, J BIOMOL SCREEN, V8, P511, DOI 10.1177/1087057103257204; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615                                                       ; Sakai J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01600-y; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266                                                           ; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	29	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20911	20920		10.1074/jbc.M117.799155				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FQ6DG	WOS:000418453400009					2018-01-05	
J	Elewa, A; Wang, H; Talavera-Lopez, C; Joven, A; Brito, G; Kumar, A; Hameed, LS; Penrad-Mobayed, M; Yao, ZY; Zamani, N; Abbas, Y; Abdullayev, I; Sandberg, R; Grabherr, M; Andersson, B; Simon, A				Elewa, Ahmed; Wang, Heng; Talavera-Lopez, Carlos; Joven, Alberto; Brito, Goncalo; Kumar, Anoop; Hameed, L. Shahul; Penrad-Mobayed, May; Yao, Zeyu; Zamani, Neda; Abbas, Yamen; Abdullayev, Ilgar; Sandberg, Rickard; Grabherr, Manfred; Andersson, Bjorn; Simon, Andras			Reading and editing the Pleurodeles waltl genome reveals novel features of tetrapod regeneration	NATURE COMMUNICATIONS			English	Article							LIMB REGENERATION; HARBINGER TRANSPOSONS; RETINAL REGENERATION; SEQUENCE ALIGNMENT; XENOPUS-LAEVIS; FLOW-CYTOMETRY; DNA CONTENT; MICRORNAS; SALAMANDERS; ZEBRAFISH	Salamanders exhibit an extraordinary ability among vertebrates to regenerate complex body parts. However, scarce genomic resources have limited our understanding of regeneration in adult salamanders. Here, we present the similar to 20 Gb genome and transcriptome of the Iberian ribbed newt Pleurodeles waltl, a tractable species suitable for laboratory research. We find that embryonic stem cell-specific miRNAs mir-93b and mir-427/430/302, as well as Harbinger DNA transposons carrying the Myb-like proto-oncogene have expanded dramatically in the Pleurodeles waltl genome and are co-expressed during limb regeneration. Moreover, we find that a family of salamander methyltransferases is expressed specifically in adult appendages. Using CRISPR/Cas9 technology to perturb transcription factors, we demonstrate that, unlike the axolotl, Pax3 is present and necessary for development and that contrary to mammals, muscle regeneration is normal without functional Pax7 gene. Our data provide a foundation for comparative genomic studies that generate models for the uneven distribution of regenerative capacities among vertebrates.	[Elewa, Ahmed; Talavera-Lopez, Carlos; Joven, Alberto; Brito, Goncalo; Kumar, Anoop; Hameed, L. Shahul; Yao, Zeyu; Abdullayev, Ilgar; Sandberg, Rickard; Andersson, Bjorn; Simon, Andras] Karolinska Inst, Dept Cell & Mol Biol, SE-17165 Stockholm, Sweden; [Wang, Heng] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Penrad-Mobayed, May] CNRS, Inst Jacques Monod, F-75205 Paris, France; [Penrad-Mobayed, May] Univ Paris Diderot, F-75205 Paris, France; [Zamani, Neda; Grabherr, Manfred] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Abbas, Yamen] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Abdullayev, Ilgar; Sandberg, Rickard] Ludwig Inst Canc Res, SE-17165 Stockholm, Sweden; [Talavera-Lopez, Carlos] Francis Crick Inst, London NW1 1AT, England	Elewa, A; Simon, A (reprint author), Karolinska Inst, Dept Cell & Mol Biol, SE-17165 Stockholm, Sweden.	ahmed.elewa@ki.se; andras.simon@ki.se			Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2015079, b2015188, b2016417, SNIC 2016/1-20, SNIC 2016/1-251]; NIH [F32GM117806]; National Natural Science Foundation of China [31771617]; European Research Council; Swedish Research Council; Wenner-Gren Foundation; Cancerfonden	We thank Elly Tanaka and colleagues for sharing the axolotl genome assembly prior to publication. We acknowledge continuous support from members of the Frisen Lab (KI/CMB), Science for Life Laboratory, the National Genomics Infrastructure (NGI) the Swedish National Infrastructure for Computing (SNIC) and Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) for providing assistance in massive parallel sequencing and computational infrastructure (projects b2015079, b2015188, b2016417, SNIC 2016/1-20 and SNIC 2016/1-251). We thank Agustin Gonzalez and his lab (UCM, Madrid) for facilitating the embryos from which our initial colony was established. Mihaela Martis (BILS - SciLifeLab) is acknowledged for assistance concerning transcriptome assembly, Sarantis Giatrellis (CMB - KI) for assistance measuring nuclear DNA content and Karen Echeverri for facilitating miRNA in situ hybridization experiments. We thank Marc Friedlander for advice regarding miRNA prediction. A.E. is supported by NIH Ruth Kirschstein postdoctoral fellowship F32GM117806. This work was supported by grants from the National Natural Science Foundation of China (31771617) to H.W., the European Research Council, the Swedish Research Council, Wenner-Gren Foundation and Cancerfonden to A.S.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Baddar NWA, 2015, METHODS MOL BIOL, V1290, P321, DOI 10.1007/978-1-4939-2495-0_25; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Berghoff BA, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0150-8; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Buckingham M, 2015, SEMIN CELL DEV BIOL, V44, P115, DOI 10.1016/j.semcdb.2015.09.017; Che RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087940; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein JA, 2000, METH MOL B, V137, P459; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941                                                    ; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Friedli M, 2014, GENOME RES, V24, P1251, DOI 10.1101/gr.172809.114; Frobisch NB, 2011, DEV DYNAM, V240, P1087, DOI 10.1002/dvdy.22629; GALLIEN CL, 1966, CR ACAD SCI D NAT, V262, P122; Galliot B, 2010, TRENDS CELL BIOL, V20, P514, DOI 10.1016/j.tcb.2010.05.006; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grabherr MG, 2010, BIOINFORMATICS, V26, P1145, DOI 10.1093/bioinformatics/btq102; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayashi T, 2015, METHODS MOL BIOL, V1290, P297, DOI 10.1007/978-1-4939-2495-0_23; Hayashi T, 2013, DEV GROWTH DIFFER, V55, P229, DOI 10.1111/dgd.12019; JAYLET A, 1971, CHROMOSOMA, V35, P288, DOI 10.1007/BF00326279                                                              ; Joven A, 2015, METHODS MOL BIOL, V1290, P47, DOI 10.1007/978-1-4939-2495-0_4; Joven A, 2013, J COMP NEUROL, V521, P3913, DOI 10.1002/cne.23385; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Katsura Y, 2017, MOL BIOL EVOL, V34, P718, DOI 10.1093/molbev/msw272; Keinath MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16413; Kirkham M, 2014, STEM CELL REP, V2, P507, DOI 10.1016/j.stemcr.2014.01.018; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lacroix J. C., 1968, Annls Embryol Morph, V1, P179; Li RQ, 2005, PLOS COMPUT BIOL, V1, P313, DOI 10.1371/journal.pcbi.0010043; LICHT LE, 1991, COMP BIOCHEM PHYS B, V100, P83, DOI 10.1016/0305-0491(91)90089-V; Liew WC, 2014, BRIEF FUNCT GENOMICS, V13, P172, DOI 10.1093/bfgp/elt041; Lizana M, 2000, AMPHIBIA-REPTILIA, V21, P411, DOI 10.1163/156853800300059304; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Lozito TP, 2016, DEVELOPMENT, V143, P2946, DOI 10.1242/dev.129585; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Miyake A, 2014, DEV NEUROBIOL, V74, P739, DOI 10.1002/dneu.22169; Monsoro-Burq A. H., 2007, CSH PROT; MORESCALCHI A, 1974, EXPERIENTIA, V30, P491; Morgan GT, 2002, CHROMOSOME RES, V10, P177, DOI 10.1023/A:1015227020652                                                         ; Nakamura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109831; Penrad-Mobayed M, 2010, METHODS, V51, P37, DOI 10.1016/j.ymeth.2010.01.014; Roberts-Galbraith RH, 2015, CURR OPIN GENET DEV, V32, P37, DOI 10.1016/j.gde.2015.01.009; Roco AS, 2015, P NATL ACAD SCI USA, V112, pE4752, DOI 10.1073/pnas.1505291112; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Sessions SK, 2008, CHROMOSOME RES, V16, P183, DOI 10.1007/s10577-007-1205-3; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Simon A, 2013, WIRES DEV BIOL, V2, P291, DOI 10.1002/wdev.73; Sinzelle L, 2008, P NATL ACAD SCI USA, V105, P4715, DOI 10.1073/pnas.0707746105; Smith JJ, 2012, MOL BIOL EVOL, V29, P985, DOI 10.1093/molbev/msr267; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Sun C, 2012, GENOME BIOL EVOL, V4, P168, DOI 10.1093/gbe/evr139; Tanaka EM, 2016, CELL, V165, P1598, DOI 10.1016/j.cell.2016.05.038; Tang GQ, 2008, GENOME RES, V18, P104, DOI 10.1101/gr.6539108; Wang H, 2016, CURR OPIN GENET DEV, V40, P108, DOI 10.1016/j.gde.2016.06.013; Wang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8916; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoshii C, 2007, DEV BIOL, V303, P45, DOI 10.1016/j.ydbio.2006.11.024	74	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 22	2017	8								2286	10.1038/s41467-017-01964-9				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ7VG	WOS:000418570700001		gold			2018-01-05	
J	Fu, R; Ding, Y; Luo, J; Yu, L; Li, CL; Li, DS; Guo, SW				Fu, Rui; Ding, Yan; Luo, Jie; Yu, Li; Li, Cheng Lin; Li, Dong Sheng; Guo, Shi Wen			TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells	BIOSCIENCE REPORTS			English	Article							PATHWAY; CANCER; 5-HYDROXYMETHYLCYTOSINE; GLIOBLASTOMA; PATTERNS; INVASION; THERAPY; EMT	DNA methylation and demethylation play a critical role in the regulation of the molecular pathogenesis of gliomas. Tet methylcytosine dioxygenase 1 (TET1) catalyses the sequential oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, (5hmC) leading to eventual DNA demethylation. It has been reported that TET1 is a tumour suppressor in several cancers. However, whether TET1 plays a role in glioma development is largely unclear. Different glioma specimens and corresponding normal controls were collected to analyse the expression of TET1. At the same time, TET1 of glioma U251 cells was knocked down or over-expressed to observe its effect on glioma cell proliferation and invasion as well as autophagy level. Here, we reported that the expression of TET1 in glioma tissue was significantly lower than the corresponding non-tumour normal tissues, and the concentration of TET1 is negatively correlated with the glioma WHO classification. When TET1 gene in glioma U251 cells was knocked down by CRISPR/Caspase-9 system, the proliferation and invasive ability of U251 increased remarkably. But when TET1 was overexpressed in U251 cells, the proliferation and invasion were impaired. Following the down-expression of TET1, the level of autophagy in U251 cells decreased accordingly. However, when TET1 was overexpressed in U251 cells, the level of autophagy incraesed. Furthermore, bafilomycin A1 (Baf-A1) but not 3-methyladenine (3-MA) could decrease the autophagy level of TET1(-/-) U251 cells as the wild-type controls. It suggests that the tumour suppressor effect of TET1 seems to be mediated by regulating the level of autophagy, and the regulation of TET1 on autophagy is at an early stage.	[Fu, Rui; Luo, Jie; Guo, Shi Wen] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Taihe Hosp, Dept Neurosurg, Shiyan, Hubei, Peoples R China; [Ding, Yan; Yu, Li; Li, Cheng Lin; Li, Dong Sheng] Hubei Univ Med, Taihe Hosp, Hubei Key Lab Embryon Stem Cell Res, Shiyan 442000, Hubei, Peoples R China	Guo, SW (reprint author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Taihe Hosp, Dept Neurosurg, Shiyan, Hubei, Peoples R China.	gsw1962@126.com			National Natural Science Foundation of China [81602297]; Science and Technology Department of Hubei Province [2016CFB11, 2017CFB562]	This work was supported by the National Natural Science Foundation of China [grant number 81602297]; and the Science and Technology Department of Hubei Province [grant number 2016CFB11 and 2017CFB562].	Ahsan S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-59; Catalano M, 2015, MOL ONCOL, V9, P1612, DOI 10.1016/j.molonc.2015.04.016; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Codo P, 2014, ONCOTARGET, V5, P7651, DOI 10.18632/oncotarget.2287                                                        ; Coulter JB, 2013, J BIOL CHEM, V288, P28792, DOI 10.1074/jbc.M113.491365; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x; Ding Y, 2014, ONCOTARGET, V5, P8393, DOI 10.18632/oncotarget.2298                                                        ; Fu HL, 2014, J BIOMED NANOTECHNOL, V10, P1217, DOI 10.1166/jbn.2014.1861; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; Giatromanolaki A, 2014, CANCER BIOL THER, V15, P1468, DOI 10.4161/15384047.2014.955719; Hadjipanayis CG, 2009, J MOL MED, V87, P363, DOI 10.1007/s00109-009-0440-9; Koukourakis MI, 2010, BRIT J CANCER, V103, P1209, DOI 10.1038/sj.bjc.6605904; Li LF, 2016, ACTA BIOCH BIOPH SIN, V48, P491, DOI 10.1093/abbs/gmw025; Macintosh RL, 2012, CELL CYCLE, V11, P2022, DOI 10.4161/cc.20424; McBride SM, 2010, J NEURO-ONCOL, V97, P33, DOI 10.1007/s11060-009-0004-4; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Muller T, 2012, AM J PATHOL, V181, P675, DOI 10.1016/j.ajpath.2012.04.017; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; Song CX, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-173, 10.1186/gb-2012-13-10-2012]; Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910; Turei D, 2015, AUTOPHAGY, V11, P155, DOI 10.4161/15548627.2014.994346; Yang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133896; Zeng JX, 2016, CELL CYCLE, V15, P1602, DOI 10.1080/15384101.2016.1181234	25	0	0	18	18	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	DEC 22	2017	37		6						BSR20160523	10.1042/BSR20160523				9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FN2ON	WOS:000415833300004					2018-01-05	
J	Lino, MM; Simoes, S; Pinho, S; Ferreira, L				Lino, Miguel M.; Simoes, Susana; Pinho, Sonia; Ferreira, Lino			Intracellular delivery of more than one protein with spatio-temporal control	NANOSCALE			English	Article							GOLD NANORODS; ENERGY-TRANSFER; CYTOSOLIC DELIVERY; TRIGGERED RELEASE; DRUG-DELIVERY; NANOPARTICLES; LIGHT; DNA; CELLS; SIRNA	Transient, non-integrative modulation of cell function by intracellular delivery of proteins has high potential in cellular reprogramming, gene editing and therapeutic medicine applications. Unfortunately, the capacity to deliver multiple proteins intracellularly with temporal and spatial control has not been demonstrated. Here, we report a near infrared (NIR) laser-activatable nanomaterial that allows for precise control over the release of two proteins from a single nanomaterial. The nanomaterial is formed by gold nanorods (AuNRs) modified with single stranded DNA (ssDNA) to which complementary DNA-conjugated proteins are hybridized. Using DNA strands with distinct melting temperatures we are able to control independently the release of each protein with a laser using the same wavelength but with different powers. Studies in mammalian cells show that AuNRs conjugated with proteins are internalized by endocytosis and NIR laser irradiation promotes endosomal escape and the release of the proteins from the AuNRs simultaneously. Our results further demonstrate the feasibility of protein release from a carrier that has been accumulated within the cell up to 1 day while maintaining its activity.	[Lino, Miguel M.; Simoes, Susana; Pinho, Sonia; Ferreira, Lino] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Ferreira, Lino] Univ Coimbra, Fac Med, P-3000548 Coimbra, Portugal	Ferreira, L (reprint author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.; Ferreira, L (reprint author), Univ Coimbra, Fac Med, P-3000548 Coimbra, Portugal.	lino@uc-biotech.pt			FCT [SFRH/BD/81705/2011, SFRH/BPD/105327/2014, SFRH/BPD/96048/2013]; EC (ERC) [307384]; ERA Chair project ERA@UC through European Union [669088]	The authors would like to acknowledge financial support from FCT (SFRH/BD/81705/2011 to ML; SFRH/BPD/105327/2014 to SS and SFRH/BPD/96048/2013 to SP) and EC (ERC project no. 307384, "Nanotrigger") and ERA Chair project ERA@UC (ref: 669088) through European Union's Horizon 2020 program.	Braun GB, 2009, ACS NANO, V3, P2007, DOI 10.1021/nn900469q; Brzostowski J. A., 2009, CURR PROTOC PROTEIN, V56; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Choi CHJ, 2013, P NATL ACAD SCI USA, V110, P7625, DOI 10.1073/pnas.1305804110; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Diaz JA, 2013, SMALL, V9, P2862, DOI 10.1002/smll.201202278; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/nmeth.2998, 10.1038/NMETH.2998]; Febvay S, 2010, NANO LETT, V10, P2211, DOI 10.1021/nl101157z; Fleischer CC, 2014, J PHYS CHEM B, V118, P14017, DOI 10.1021/jp502624n; Forbes N, 2014, PART PART SYST CHAR, V31, P1158, DOI 10.1002/ppsc.201400035; Foster AA, 2015, ADV HEALTHC MATER, V4, P760, DOI 10.1002/adhm.201400671; Ghosh P, 2010, J AM CHEM SOC, V132, P2642, DOI 10.1021/ja907887z; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e; Hu Y, 2007, NANO LETT, V7, P3056, DOI 10.1021/nl071542i; Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w; Huschka R, 2011, J AM CHEM SOC, V133, P12247, DOI 10.1021/ja204578e; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jain PK, 2006, J AM CHEM SOC, V128, P2426, DOI 10.1021/ja056769z; Jiang ZQ, 2015, J BIOMED MATER RES A, V103, P65, DOI 10.1002/jbm.a.35158; Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Krpetic Z, 2010, NANO LETT, V10, P4549, DOI 10.1021/nl103142t; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lee SE, 2009, NANO LETT, V9, P562, DOI 10.1021/nl802689k; Levitsky KL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02937; Liu Y, 2011, ANGEW CHEM INT EDIT, V50, P3058, DOI 10.1002/anie.201005740; Morales DP, 2015, MOL PHARMACEUT, V12, P600, DOI 10.1021/mp500675p; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Paulo CSO, 2013, BIOMATERIALS, V34, P5281, DOI 10.1016/j.biomaterials.2013.03.048; Perez-Juste J, 2005, COORDIN CHEM REV, V249, P1870, DOI 10.1016/j.ccr.2005.01.030; Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000; Rwei AY, 2015, NANO TODAY, V10, P451, DOI 10.1016/j.nantod.2015.06.004; Singh MP, 2010, J AM CHEM SOC, V132, P9383, DOI 10.1021/ja1022128; Storhofff JJ, 2002, LANGMUIR, V18, P6666, DOI 10.1021/la0202428; Tong R, 2012, J AM CHEM SOC, V134, P8848, DOI 10.1021/ja211888a; Vankayala R, 2014, SMALL, V10, P1612, DOI 10.1002/smll.201302719; Vasdekis AE, 2012, ACS NANO, V6, P7850, DOI 10.1021/nn302122h; Wang FH, 2014, J CONTROL RELEASE, V196, P37, DOI 10.1016/j.jconrel.2014.09.026; Wang LM, 2013, NANOSCALE, V5, P8384, DOI 10.1039/c3nr01626a; Wijaya A, 2008, LANGMUIR, V24, P9966, DOI 10.1021/la8019205; Wu J, 2014, ANGEW CHEM INT EDIT, V53, P8975, DOI 10.1002/anie.201404766; Yun CS, 2005, J AM CHEM SOC, V127, P3115, DOI 10.1021/ja043940i; Zhou L, 2014, ADV MATER, V26, P2424, DOI 10.1002/adma.201304437; Zhu SW, 2015, ADV MATER, V27, P3620, DOI 10.1002/adma.201500417	46	0	0	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale	DEC 21	2017	9	47					18668	18680		10.1039/c7nr02414b				13	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	FP2YD	WOS:000417485000015	29165472				2018-01-05	
J	Lopacinska-Jorgensen, JM; Pedersen, JN; Bak, M; Mehrjouy, MM; Sorensen, KT; Ostergaard, PF; Bilenberg, B; Kristensen, A; Taboryski, RJ; Flyvbjerg, H; Marie, R; Tommerup, N; Silahtaroglu, A				Lopacinska-Jorgensen, Joanna M.; Pedersen, Jonas N.; Bak, Mads; Mehrjouy, Mana M.; Sorensen, Kristian T.; Ostergaard, Peter F.; Bilenberg, Brian; Kristensen, Anders; Taboryski, Rafael J.; Flyvbjerg, Henrik; Marie, Rodolphe; Tommerup, Niels; Silahtaroglu, Asli			Enrichment of megabase-sized DNA molecules for single-molecule optical mapping and next-generation sequencing	SCIENTIFIC REPORTS			English	Article							FIELD GEL-ELECTROPHORESIS; HUMAN GENOME; GENE DESERTS; TECHNOLOGIES; IMPROVEMENT; RESOLUTION; EVOLUTION; DISEASE; IMPACT; BEADS	Next-generation sequencing (NGS) has caused a revolution, yet left a gap: long-range genetic information from native, non-amplified DNA fragments is unavailable. It might be obtained by optical mapping of megabase-sized DNA molecules. Frequently only a specific genomic region is of interest, so here we introduce a method for selection and enrichment of megabase-sized DNA molecules intended for single-molecule optical mapping: DNA from a human cell line is digested by the NotI rare-cutting enzyme and size-selected by pulsed-field gel electrophoresis. For demonstration, more than 600 sub-megabase-to megabase-sized DNA molecules were recovered from the gel and analysed by denaturation-renaturation optical mapping. Size-selected molecules from the same gel were sequenced by NGS. The optically mapped molecules and the NGS reads showed enrichment from regions defined by NotI restriction sites. We demonstrate that the unannotated genome can be characterized in a locus-specific manner via molecules partially overlapping with the annotated genome. The method is a promising tool for investigation of structural variants in enriched human genomic regions for both research and diagnostic purposes. Our enrichment method could potentially work with other genomes or target specified regions by applying other genomic editing tools, such as the CRISPR/Cas9 system.	[Lopacinska-Jorgensen, Joanna M.; Bak, Mads; Mehrjouy, Mana M.; Tommerup, Niels; Silahtaroglu, Asli] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Norre Alle 14, DK-2200 Copenhagen, Denmark; [Pedersen, Jonas N.; Sorensen, Kristian T.; Ostergaard, Peter F.; Kristensen, Anders; Taboryski, Rafael J.; Flyvbjerg, Henrik; Marie, Rodolphe] Tech Univ Denmark, Dept Micro & Nanotechnol, Orsteds Plads 345a, DK-2800 Lyngby, Denmark; [Bilenberg, Brian] NIL Technol ApS, Diplomvej 381, DK-2800 Lyngby, Denmark	Silahtaroglu, A (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Norre Alle 14, DK-2200 Copenhagen, Denmark.	asli@sund.ku.dk		Pedersen, Jonas Nyvold/0000-0001-7642-8212	Danish Council for Strategic Research through the Strategic Research Center PolyNano [10-092322/DSF]	This work was supported by the Danish Council for Strategic Research through the Strategic Research Center PolyNano (grant no. 10-092322/DSF). The authors would like to thank Dr Hocine W. Mankouri and Dr Wai Kit Chu from Nordea Center for Healthy Aging and Department of Cellular and Molecular Medicine, University of Copenhagen for help with pulsed field-gel electrophoresis and Dr Marion Cremer from Department Biology II, Ludwig-Maximilians-University of Munich for comments that improved the manuscript.	Altemose N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003628; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8                                                   ; Basseville M., 1993, CHANGE, V2; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; CAI WW, 1995, P NATL ACAD SCI USA, V92, P5164, DOI 10.1073/pnas.92.11.5164                                                         ; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948; Good JM, 2011, METHODS MOL BIOL, V772, P85, DOI 10.1007/978-1-61779-228-1_5; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Harewood L, 2014, HUM MOL GENET, V23, pR76, DOI 10.1093/hmg/ddu278; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Howe K, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0052-y; Kantor RM, 1999, BIOCHEM BIOPH RES CO, V258, P102, DOI 10.1006/bbrc.1999.0592                                                          ; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Khan SR, 2013, ANAL BIOCHEM, V443, P269, DOI 10.1016/j.ab.2013.06.001; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Klee EW, 2011, EXPERT REV MOL DIAGN, V11, P703, DOI [10.1586/ERM.11.58, 10.1586/erm.11.58]; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Konig K, 2015, J THORAC ONCOL, V10, P1049, DOI 10.1097/JTO.0000000000000570; Kozarewa I., 2015, CURR PROTOC MOL BIOL; Larsen S, 2010, BIOCHEM BIOPH RES CO, V392, P252, DOI 10.1016/j.bbrc.2009.12.010; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Mak ACY, 2016, GENETICS, V202, P351, DOI 10.1534/genetics.115.183483; Marie R, 2013, P NATL ACAD SCI USA, V110, P4893, DOI 10.1073/pnas.1214570110; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Neely RK, 2010, CHEM SCI, V1, P453, DOI 10.1039/c0sc00277a; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328                                                         ; Ostergaard PF, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/10/105002; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Park Jong, 2005, Cancer Biomarkers, V1, P193; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Raillon C, 2012, NANOSCALE, V4, P4916, DOI 10.1039/c2nr30951c; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARTZ DC, 1982, COLD SPRING HARB SYM, V47, P189; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Sorensen KT, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4922068; Tanzi S, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/115008; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Tostesen E, 2003, BIOPOLYMERS, V70, P364, DOI 10.1002/bip.10495; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; WANG YK, 1993, NUCLEIC ACIDS RES, V21, P2528, DOI 10.1093/nar/21.10.2528; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Weissensteiner M. H., 2017, GENOME RES PUBLISHED; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Zhang MP, 2012, NAT PROTOC, V7, P467, DOI 10.1038/nprot.2011.455; Zlatanova J, 2000, PROG BIOPHYS MOL BIO, V74, P37, DOI 10.1016/S0079-6107(00)00014-6	60	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 20	2017	7								17893	10.1038/s41598-017-18091-6				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ5HE	WOS:000418388700013		gold			2018-01-05	
J	Zdralevic, M; Marchiq, I; de Padua, MMC; Parks, SK; Pouyssegur, J				Zdralevic, Masa; Marchiq, Ibtissam; Cunha de Padua, Monique M.; Parks, Scott K.; Pouyssegur, Jacques			Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs	FRONTIERS IN ONCOLOGY			English	Review						cancer; CRISPR-Cas9; glycolysis; immune response; lactic acid; metabolism; oxidative phosphorylation; pentose phosphate pathway	LACTATE-DEHYDROGENASE-B; AUTOCRINE MOTILITY FACTOR; LACTIC-ACID PRODUCTION; CELL LUNG-CANCER; OXIDATIVE STRESS; HEXOSE-TRANSPORT; POOR-PROGNOSIS; TUMOR-CELLS; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM	Research on cancer metabolism has recently re-surfaced as a major focal point in cancer field with a reprogrammed metabolism no longer being considered as a mere consequence of oncogenic transformation, but as a hallmark of cancer. Reprogramming metabolic pathways and nutrient sensing is an elaborate way by which cancer cells respond to high bioenergetic and anabolic demands during tumorigenesis. Thus, inhibiting specific metabolic pathways at defined steps should provide potent ways of arresting tumor growth. However, both animal models and clinical observations have revealed that this approach is seriously limited by an extraordinary cellular metabolic plasticity. The classical example of cancer metabolic reprogramming is the preference for aerobic glycolysis, or Warburg effect, where cancers increase their glycolytic flux and produce lactate regardless of the presence of the oxygen. This allows cancer cells to meet the metabolic requirements for high rates of proliferation. Here, we discuss the benefits and limitations of disrupting fermentative glycolysis for impeding tumor growth at three levels of the pathway: (i) an upstream block at the level of the glucose-6-phosphate isomerase (GPI), (ii) a downstream block at the level of lactate dehydrogenases (LDH, isoforms A and B), and (iii) the endpoint block preventing lactic acid export (MCT1/4). Using these examples of genetic disruption targeting glycolysis studied in our lab, we will discuss the responses of different cancer cell lines in terms of metabolic rewiring, growth arrest, and tumor escape and compare it with the broader literature.	[Zdralevic, Masa; Marchiq, Ibtissam; Cunha de Padua, Monique M.; Pouyssegur, Jacques] Univ Cote Azur, Ctr A Lacassagne, INSERM, CNRS,IRCAN, Nice, France; [Parks, Scott K.; Pouyssegur, Jacques] CSM, Med Biol Dept, Monaco, Monaco; [Marchiq, Ibtissam; Cunha de Padua, Monique M.] Inst Recherches Servier, Oncol R&D Unit, Croissy Sur Seine, France; [Marchiq, Ibtissam; Cunha de Padua, Monique M.] Univ Fed Parana, Jardim Amer, Curitiba, Parana, Brazil	Zdralevic, M; Pouyssegur, J (reprint author), Univ Cote Azur, Ctr A Lacassagne, INSERM, CNRS,IRCAN, Nice, France.; Pouyssegur, J (reprint author), CSM, Med Biol Dept, Monaco, Monaco.	masa.zdralevic@unice.fr; pouysseg@unice.fr			Fondation ARC on Cancer Research [PDF20151203643]; Federal University of Parana, Brazil; LNCC; Servier-CNRS contract; Centre Scientifique de Monaco; LNCC (Equipe Labellisee); EU-Metoxia; GEMLUC	MZ was supported by a post-doctoral fellowship from the Fondation ARC on Cancer Research (grant no. PDF20151203643), MP was awarded a 1-year CNPq Fellowship from the Federal University of Parana, Brazil, IM was funded by LNCC and Servier-CNRS contract, SP was supported by the Centre Scientifique de Monaco, and JP was funded by LNCC (Equipe Labellisee), EU-Metoxia, the Centre Scientifique de Monaco and a Grant from GEMLUC.	Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Baldini N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00411; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BISSELL MJ, 1973, P NATL ACAD SCI USA, V70, P2951, DOI 10.1073/pnas.70.10.2951; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; BROWN J, 1962, METABOLISM, V11, P1098; CHEN W, 1992, BIOCHIMIE, V74, P867, DOI 10.1016/0300-9084(92)90070-U; De Bari L, 2010, INT J ONCOL, V37, P1607, DOI 10.3892/ijo_00000815; de Padua MC, 2017, ONCOTARGET, V8, P87623, DOI 10.18632/oncotarget.21007; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902                                                      ; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Funasaka T, 2005, FASEB J, V19, P1422, DOI 10.1096/fj.05-3699com; GOLDBERG E, 1971, P NATL ACAD SCI USA, V68, P349, DOI 10.1073/pnas.68.2.349; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Granja S, 2014, ONCOTARGET, V6, P1; GROSSE F, 1986, EUR J BIOCHEM, V160, P459, DOI 10.1111/j.1432-1033.1986.tb10062.x; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; KEENOY BMY, 1992, BIOCHEM J, V288, P433; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kinoshita T, 2012, INT J ONCOL, V40, P185, DOI 10.3892/ijo.2011.1196; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; KOEN AL, 1969, BIOCHEM GENET, V3, P457, DOI 10.1007/BF00485606                                                              ; Koh YW, 2017, PATHOL RES PRACT, V213, P1134, DOI 10.1016/j.prp.2017.07.006; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Leiblich A, 2006, ONCOGENE, V25, P2953, DOI 10.1038/sj.onc.1209262; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li C, 2016, AM J TRANSL RES, V8, P4831; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; Mack N, 2017, ANTICANCER RES, V37, P1205, DOI 10.21873/anticanres.11435; Marchiq I, 2016, J MOL MED, V94, P155, DOI 10.1007/s00109-015-1307-x; Marchiq I, 2015, CANCER RES, V75, P171, DOI 10.1158/0008-5472.CAN-14-2260; McCleland ML, 2013, CLIN CANCER RES, V19, P773, DOI 10.1158/1078-0432.CCR-12-2638; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreno-Sanchez R, 2009, BIOFACTORS, V35, P209, DOI 10.1002/biof.31; Ngo DC, 2015, MOL BIOL REP, V42, P819, DOI 10.1007/s11033-015-3857-y; Niizeki H, 2002, BRIT J CANCER, V86, P1914, DOI 10.1038/sj.bjc.6600331; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Passarella S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00407; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pertega-Gomes N, 2015, J PATHOL, V236, P517, DOI 10.1002/path.4547; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Pizzuto R, 2012, BBA-BIOENERGETICS, V1817, P1679, DOI 10.1016/j.bbabio.2012.05.010; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; POUYSSEGUR J, 1980, P NATL ACAD SCI-BIOL, V77, P2698, DOI 10.1073/pnas.77.5.2698; Pusapati RV, 2016, CANCER CELL, V29, P548, DOI 10.1016/j.ccell.2016.02.018; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Salway J.G., 2004, METABOLISM GLANCE; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stine ZE, 2013, CRIT REV BIOCHEM MOL, V48, P609, DOI 10.3109/10409238.2013.844093; Stoltzman CA, 2011, J BIOL CHEM, V286, P38027, DOI 10.1074/jbc.M111.275503; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; de Oliveira ATT, 2012, J BIOENERG BIOMEMBR, V44, P171, DOI 10.1007/s10863-012-9408-5; ULLREY DB, 1982, P NATL ACAD SCI-BIOL, V79, P3777, DOI 10.1073/pnas.79.12.3777; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; WICK AN, 1957, J BIOL CHEM, V224, P963; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Woodward GE, 1952, J FRANKLIN I, V254, P259, DOI 10.1016/0016-0032(52)90482-1; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003	87	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2234-943X			FRONT ONCOL	Front. Oncol.	DEC 20	2017	7								313	10.3389/fonc.2017.00313				8	Oncology	Oncology	FQ4YA	WOS:000418363800001		gold			2018-01-05	
J	Ferenczi, A; Pyott, DE; Xipnitou, A; Molnar, A				Ferenczi, Aron; Pyott, Douglas Euan; Xipnitou, Andromachi; Molnar, Attila			Efficient targeted DNA editing and replacement in Chlamydomonas reinhardtii using Cpf1 ribonucleoproteins and single-stranded DNA	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Chlamydomonas reinhardtii; CRISPR/Cpf1; RNP; ssODN; editing	STABLE NUCLEAR TRANSFORMATION; ZINC-FINGER NUCLEASES; HOMOLOGOUS RECOMBINATION; TRIACYLGLYCEROL ACCUMULATION; CONCENTRATING MECHANISM; CHLOROPHYLL ANTENNA; SGRNA DESIGN; GENE; GENOME; REVEALS	The green alga Chlamydomonas reinhardtii is an invaluable reference organism to research fields including algal, plant, and ciliary biology. Accordingly, decades-long standing inefficiencies in targeted nuclear gene editing broadly hinder Chlamydomonas research. Here we report that single-step codelivery of CRISPR/Cpf1 ribonucleoproteins with single-stranded DNA repair templates results in precise and targeted DNA replacement with as much as similar to 10% efficiency in C. reinhardtii. We demonstrate its use in transgene-and selection-free generation of sequence-specific mutations and epitope tagging at an endogenous locus. As the direct delivery of gene-editing reagents bypasses the use of transgenes, this method is potentially applicable to a wider range of species without the need to develop methods for stable transformation.	[Ferenczi, Aron; Pyott, Douglas Euan; Xipnitou, Andromachi; Molnar, Attila] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3BF, Midlothian, Scotland	Molnar, A (reprint author), Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3BF, Midlothian, Scotland.	attila.molnar@ed.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) PHYCONET Proof of Concept Fund [PHYCPoC-31]; BBSRC East of Scotland BioScience (EASTBIO) National Productivity Investment Fund (NPIF) Industrial Cooperative Awards in Science & Technology (CASE) studentship [BB/R505493/1]; BBSRC EASTBIO [BB/J01446X/1]	We thank Dr. Martin Wear, Dr. Sophie Kneeshaw, and Dr. Cihan Makbul for suggestions in protein purification, Kwangryul Baek for advising on Chlamydomonas electroporation, and Prof. Andrew Hudson for critically reading the manuscript. A.M. is a Chancellor's Fellow at the University of Edinburgh. This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) PHYCONET Proof of Concept Fund, Grant PHYCPoC-31. A.F. acknowledges support of BBSRC East of Scotland BioScience (EASTBIO) National Productivity Investment Fund (NPIF) Industrial Cooperative Awards in Science & Technology (CASE) studentship BB/R505493/1. D.E.P. was supported by BBSRC EASTBIO Grant BB/J01446X/1.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Benning C, 2015, PLANT J, V82, P363, DOI 10.1111/tpj.12831; Bothmer A., 2017, LOCUS, V8, P13905; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen FQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14958; Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847; DEBUCHY R, 1989, EMBO J, V8, P2803; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Goodenough U, 2015, PLANT J, V82, P365, DOI 10.1111/tpj.12794; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Greiner A, 2017, PLANT CELL, V29, P2498, DOI 10.1105/tpc.17.00659; GUMPEL NJ, 1994, CURR GENET, V26, P438, DOI 10.1007/BF00309931; Harris CJ, 2015, NUCLEIC ACIDS RES, V43, P7590, DOI 10.1093/nar/gkv604; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363                                                ; Harris EH, 2009, CHLAMYDOMONAS SOURCE; Hough Soren H, 2016, Per Med, V13, P517, DOI 10.2217/pme-2016-0068; Hu XX, 2017, J GENET GENOMICS, V44, P71, DOI 10.1016/j.jgg.2016.12.001; Jiang WZ, 2017, PLANT CELL REP, V36, P1001, DOI 10.1007/s00299-017-2138-8; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Juergens MT, 2015, PLANT PHYSIOL, V167, P558, DOI 10.1104/pp.114.250530; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101018; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228                                                          ; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Kirst H, 2012, PLANT PHYSIOL, V158, P930, DOI 10.1104/pp.111.189910; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li-Beisson Y, 2015, PLANT J, V82, P504, DOI 10.1111/tpj.12787; Lohr M, 2005, PLANT PHYSIOL, V138, P490, DOI 10.1104/pp.104.056069; Mages W, 2007, PROTIST, V158, P435, DOI 10.1016/j.protis.2007.05.001; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MAYFIELD SP, 1990, P NATL ACAD SCI USA, V87, P2087, DOI 10.1073/pnas.87.6.2087; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Philipps G, 2012, PLANTA, V235, P729, DOI 10.1007/s00425-011-1537-2; Richardson CD, 2017, BIORXIV101101136028; Ruiz MT, 1998, PLANT CELL, V10, P937; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scranton MA, 2015, PLANT J, V82, P523, DOI 10.1111/tpj.12780; Shimogawara K, 1998, GENETICS, V148, P1821; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; Slaninova M, 2008, BIOLOGIA, V63, P941, DOI 10.2478/s11756-008-0146-4; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Tu MJ, 2017, NUCLEIC ACIDS RES, V45, P11295, DOI 10.1093/nar/gkx783; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Wang YJ, 2015, PLANT J, V82, P429, DOI 10.1111/tpj.12829; Wang YJ, 2011, PHOTOSYNTH RES, V109, P115, DOI 10.1007/s11120-011-9643-3; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075                                                           ; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099; Zorin B, 2005, EUKARYOT CELL, V4, P1264, DOI 10.1128/EC.4.7.1264-1272.2005; Zorin B, 2009, GENE, V432, P91, DOI 10.1016/j.gene.2008.11.028	68	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 19	2017	114	51					13567	13572		10.1073/pnas.1710597114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ4IT	WOS:000418321600075	29208717				2018-01-05	
J	Ikeda, M; Matsuyama, S; Akagi, S; Ohkoshi, K; Nakamura, S; Minabe, S; Kimura, K; Hosoe, M				Ikeda, Mitsumi; Matsuyama, Shuichi; Akagi, Satoshi; Ohkoshi, Katsuhiro; Nakamura, Sho; Minabe, Shiori; Kimura, Koji; Hosoe, Misa			Correction of a Disease Mutation using CRISPR/Cas9-assisted Genome Editing in Japanese Black Cattle	SCIENTIFIC REPORTS			English	Article							CUMULUS CELL-NUCLEI; PLURIPOTENT STEM-CELLS; IN-VITRO; CLONED MICE; MOUSE; GENE; RNA; RECONSTITUTION; GENERATION; ENZYMES	Isoleucyl-tRNA synthetase (IARS) syndrome is a recessive disease of Japanese Black cattle caused by a single nucleotide substitution. To repair the mutated IARS gene, we designed clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) to create a double-strand break near the mutation site. CRISPR/Cas9 and donor DNA that contained a synonymous codon for the correct amino acid and an Aequorea coerulescens Green Fluorescent Protein (AcGFP) cassette with a piggyBac transposase recognition site at both ends were introduced into bovine fetal fibroblast (BFF) cells isolated from a homozygous mutant calf. Recombinant cells were enriched on the basis of expression of AcGFP, and two cell lines that contained the repaired allele were subcloned. We generated somatic cell nuclear transfer (SCNT) embryos from the repaired cells and transferred 22 blastocysts to recipient cows. In total, five viable fetuses were retrieved at Days 34 and 36. PiggyBac transposase mRNA was introduced into BFF cells isolated from cloned foetuses and AcGFP-negative cells were used for second round of cloning. We transferred nine SCNT embryos to recipient cows and retrieved two fetuses at Day 34. Fetal genomic DNA analysis showed correct repair of the IARS mutation without any additional DNA footprint.	[Ikeda, Mitsumi; Ohkoshi, Katsuhiro; Hosoe, Misa] NARO, Inst Agrobiol Sci, Ikenodai 2, Tsukuba, Ibaraki 3058602, Japan; [Matsuyama, Shuichi; Nakamura, Sho; Minabe, Shiori] NARO, Inst Livestock & Grassland Sci, Senbonmatsu 768, Nasushiobara, Tochigi 3292793, Japan; [Akagi, Satoshi] NARO, Inst Livestock & Grassland Sci, Ikenodai 2, Tsukuba, Ibaraki 3050901, Japan; [Kimura, Koji] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Tsushima Naka 1-1-1, Okayama 7008530, Japan	Hosoe, M (reprint author), NARO, Inst Agrobiol Sci, Ikenodai 2, Tsukuba, Ibaraki 3058602, Japan.	hosoe@affrc.go.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [27010]	We thank Dr. S. Takahashi and Dr. S. Mizuno (Laboratory Animal Resource Center, Tsukuba Univ., Japan) for providing a p2color vector. This work was supported by a Grant-in-Aid 27010 A from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	Akagi S, 2003, CLONING STEM CELLS, V5, P101, DOI 10.1089/153623003322234696; Akagi S, 2008, CLONING STEM CELLS, V10, P173, DOI 10.1089/clo.2007.0047; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Dochi O, 1998, THERIOGENOLOGY, V49, P1051, DOI 10.1016/S0093-691X(98)00053-3; Ezashi T, 2012, REPROD DOMEST ANIM, V47, P92, DOI 10.1111/j.1439-0531.2012.02061.x; Fu Y., 2014, NATURE BIOTECHNOLOGY; Furusawa T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106641; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Ge HT, 2016, TRANSGENIC RES, V25, P721, DOI 10.1007/s11248-016-9967-z; Hasegawa Y, 2016, EXP ANIM TOKYO, V65, P319, DOI 10.1538/expanim.16-0016; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hikabe O, 2016, NATURE, V539, P299, DOI 10.1038/nature20104; Hirano T, 2016, ANIM SCI J, V87, P1178, DOI 10.1111/asj.12639; Hirano T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064036; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kimura K, 2007, THERIOGENOLOGY, V68, P633, DOI 10.1016/j.theriogenology.2007.02.016; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Liu X, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3368; Liu X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3565; Luo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20657; Menchaca A, 2016, THERIOGENOLOGY, V86, P160, DOI 10.1016/j.theriogenology.2016.04.028; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Ribas R, 2005, CLONING STEM CELLS, V7, P126, DOI 10.1089/clo.2005.7.126; Rosenkrans C. F., 1991, CULTURE BOVINE ZYGOT; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tan W, 2012, ADV GENET, V80, P37, DOI 10.1016/B978-0-12-404742-6.00002-8; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; VIENKEN J, 1982, FEBS LETT, V137, P11, DOI 10.1016/0014-5793(82)80304-9; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wei JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11735; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	41	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 19	2017	7								17827	10.1038/s41598-017-17968-w				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ4WQ	WOS:000418359600077	29259316	gold			2018-01-05	
J	Kanda, N; Ichikawa, M; Ono, A; Toyoda, A; Fujiyama, A; Abe, J; Tsuchikane, Y; Nishiyama, T; Sekimoto, H				Kanda, Naho; Ichikawa, Machiko; Ono, Ayaka; Toyoda, Atsushi; Fujiyama, Asao; Abe, Jun; Tsuchikane, Yuki; Nishiyama, Tomoaki; Sekimoto, Hiroyuki			CRISPR/Cas9-based knockouts reveal that CpRLP1 is a negative regulator of the sex pheromone PR-IP in the &ITClosterium peracerosum-strigosum-littorale&IT complex	SCIENTIFIC REPORTS			English	Article							UNICELLULAR CHAROPHYCEAN ALGA; RECEPTOR-LIKE PROTEINS; PROTOPLAST-RELEASE; LAND PLANTS; CLOSTERIUM; REPRODUCTION; BINDING; ARABIDOPSIS; EXPRESSION; PEPTIDES	Heterothallic strains of the Closterium peracerosum-strigosum-littorale (C. psl.) complex have two sexes, mating-type plus (mt(+)) and mating-type minus (mt(-)). Conjugation between these two sexes is regulated by two sex pheromones, protoplast-release-inducing protein (PR-IP) and PR-IP Inducer,which are produced by mt(+) and mt(-) cells, respectively. PR-IP mediates the release of protoplasts from mt(-) cells during mating. In this study, we examined the mechanism of action of CpRLP1 (receptor-like protein 1), which was previously identified in a cDNA microarray analysis as one of the PR-IP-inducible genes. Using CRISPR/Cas9 technology, we generated CpRLP1 knockout mutants in mt cells of the C. psl. complex. When the knockout mt(-) cells were mixed with wild-type mt(+) cells, conjugation was severely reduced. Many cells released protoplasts without pairing, suggesting a loss of synchronization between the two mating partners. Furthermore, the knockout mutants were hypersensitive to PR-IP. We conclude that CpRLP1 is a negative regulator of PR-IP that regulates the timing of protoplast release in conjugating C. psl. cells. As the first report of successful gene knockout in the class Charophyceae, this study provides a basis for research aimed at understanding the ancestral roles of genes that are indispensable for the development of land plants.	[Kanda, Naho; Ichikawa, Machiko; Sekimoto, Hiroyuki] Japan Womens Univ, Grad Sch Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan; [Ono, Ayaka; Abe, Jun; Tsuchikane, Yuki; Sekimoto, Hiroyuki] Japan Womens Univ, Fac Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, 1111 Yata, Mishima, Shizuoka 4118540, Japan; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Takaramachi 13-1, Kanazawa, Ishikawa 9200934, Japan	Sekimoto, H (reprint author), Japan Womens Univ, Grad Sch Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.; Sekimoto, H (reprint author), Japan Womens Univ, Fac Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	sekimoto@fc.jwu.ac.jp			KAKENHI for Innovative Areas "Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; Japan Society for the Promotion of Science [24370038, 26650147, 15H05237, 16H02518, 16H06378, 16H06279, 16H04836, 26440223]	We thank Drs Wenzhi Jiang and Donald P. Weeks for providing us with the Chlamydomonas codon-optimized Cas9 vector. We also thank Satoko Akatsuka, Mie Haduki, Makiko Hanasato, Tomomi Nakagawa, and Yuka Marukawa for their help in conducting preliminary experiments. This work was supported by Grants-in-Aid for Scientific Research (Nos 24370038, 26650147, 15H05237, 16H02518, 16H06378, 16H06279, and 16H04836 to H.S. and 26440223 to Y.T.) from the Japan Society for the Promotion of Science. This work was also supported in part by a KAKENHI (Grant-in-Aid for Scientific Research) for Innovative Areas "Genome Science" (No. 221S0002 to A.T. and A.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe J, 2016, BIOPROTOCOL, V6, pe1813; Abe J, 2008, PLANT CELL PHYSIOL, V49, P625, DOI 10.1093/pcp/pcn039; Abe J, 2011, PLANT CELL PHYSIOL, V52, P1676, DOI 10.1093/pcp/pcr103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Delaux PM, 2015, P NATL ACAD SCI USA, V112, P13390, DOI 10.1073/pnas.1515426112; Graham L. E., 2009, ALGAE; Higashiyama T, 2017, PLANT PHYSIOL, V173, P112, DOI 10.1104/pp.16.01571; Hirano N, 2015, PLANT CELL PHYSIOL, V56, P1456, DOI 10.1093/pcp/pcv065; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Ichimura T, 1971, P 7 INT SEAW S, P208; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jorda L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00897; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.4, 10.1038/nplants.2014.4]; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Lee JS, 2015, NATURE, V522, P435, DOI 10.1038/nature14561; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Li HJ, 2016, SCI CHINA LIFE SCI, V59, P867, DOI 10.1007/s11427-016-0118-x; Lv YT, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1197469; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; R Core Team, 2016, R LANG ENV STAT COMP; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; SEKIMOTO H, 1992, J PHYCOL, V28, P615, DOI 10.1111/j.0022-3646.1992.00615.x; SEKIMOTO H, 1990, PLANTA, V182, P348, DOI 10.1007/BF02411384; SEKIMOTO H, 1993, PLANTA, V189, P468, DOI 10.1007/BF00194447; Sekimoto H, 2006, PLANT PHYSIOL, V141, P271, DOI 10.1104/pp.106.078048; Sekimoto H, 2014, SEXUAL REPROD ANIMAL, P345; Sekimoto H, 2017, J PLANT RES, V130, P423, DOI 10.1007/s10265-017-0908-6; Sekimoto H, 2012, INT REV CEL MOL BIO, V297, P309, DOI 10.1016/B978-0-12-394308-8.00014-5; Shinohara H, 2015, PLANT J, V82, P328, DOI 10.1111/tpj.12817; Timme RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029696; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wang GD, 2010, PLANT SIGNAL BEHAV, V5, P540, DOI [10.1104/pp.109.148197, 10.4161/psb.11030]; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x	35	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 19	2017	7								17873	10.1038/s41598-017-18251-8				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ4WQ	WOS:000418359600123	29259295	gold			2018-01-05	
J	Phan, QV; Contzen, J; Seemann, P; Gossen, M				Phan, Quang Vinh; Contzen, Joerg; Seemann, Petra; Gossen, Manfred			Site-specific chromosomal gene insertion: Flp recombinase&IT versus &ITCas9 nuclease	SCIENTIFIC REPORTS			English	Article							MEDIATED CASSETTE EXCHANGE; BONE MORPHOGENETIC PROTEIN-2; ONE-STEP GENERATION; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; CRE RECOMBINASE; CHO-CELLS; GENOME; EXPRESSION; MICE	Site-specific recombination systems like those based on the Flp recombinase proved themselves as efficient tools for cell line engineering. The recent emergence of designer nucleases, especially RNA guided endonucleases like Cas9, has considerably broadened the available toolbox for applications like targeted transgene insertions. Here we established a recombinase-mediated cassette exchange (RMCE) protocol for the fast and effective, drug-free isolation of recombinant cells. Distinct fluorescent protein patterns identified the recombination status of individual cells. In derivatives of a CHO master cell line the expression of the introduced transgene of interest could be dramatically increased almost 20-fold by subsequent deletion of the fluorescent protein gene that provided the initial isolation principle. The same master cell line was employed in a comparative analysis using CRISPR/Cas9 for transgene integration in identical loci. Even though the overall targeting efficacy was comparable, multi-loci targeting was considerably more effective for Cas9-mediated transgene insertion when compared to RMCE. While Cas9 is inherently more flexible, our results also alert to the risk of aberrant recombination events around the cut site. Together, this study points at the individual strengths in performance of both systems and provides guidance for their appropriate use.	[Phan, Quang Vinh; Contzen, Joerg; Seemann, Petra; Gossen, Manfred] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Fohrer Str 15, D-13353 Berlin, Germany; [Seemann, Petra] Charite, Augustenburger Pl 1, D-13353 Berlin, Germany; [Phan, Quang Vinh; Contzen, Joerg; Gossen, Manfred] HZG, Inst Biomat Sci, D-14513 Teltow, Germany; [Phan, Quang Vinh] Charite, Lab Padiatr Mol Biol, Berlin, Germany	Gossen, M (reprint author), Berlin Brandenburg Ctr Regenerat Therapies BCRT, Fohrer Str 15, D-13353 Berlin, Germany.; Gossen, M (reprint author), HZG, Inst Biomat Sci, D-14513 Teltow, Germany.	manfred.gossen@charite.de			Helmholtz Association; Impuls- und Vernetzungsfond [SO-036]; Federal Ministry of Education and Research (BMBF), Germany (KMU Innovativ grants) [031A191G, 031A522B]	All members of our laboratory are acknowledged for stimulating discussion. We are grateful to Andreas Kurtz for his support, Marten Jager for his advice on the NGS data and Elisa Degenkolbe for her technical assistance in the detection of BMP-2. We thank the BCRT Flow Cytometry Lab and the BCRT Next Generation Sequencing Lab for assistance. This work was financially supported by the Helmholtz Association through programme oriented funding (POF) as well as its Impuls- und Vernetzungsfond (SO-036), and the Federal Ministry of Education and Research (BMBF), Germany (KMU Innovativ grants 031A191G und 031A522B).	Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Bodalia PN, 2016, BONE JOINT RES, V5, P145, DOI 10.1302/2046-3758.54.2000418; Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Bouhassira EE, 1997, BLOOD, V90, P3332; Boyne PJ, 2001, J BONE JOINT SURG AM, V83A, pS146; BROSIUS J, 1984, GENE, V27, P151, DOI 10.1016/0378-1119(84)90136-7; Calos MP, 2017, CLIN PHARMACOL THER, V101, P42, DOI 10.1002/cpt.542; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen SX, 2011, DIS MODEL MECH, V4, P537, DOI 10.1242/dmm.006569; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K                         ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coroadinha AS, 2006, J BIOTECHNOL, V124, P457, DOI 10.1016/j.jbiotec.2006.01.037; EGGERMONT J, 1993, EMBO J, V12, P2539; Fernandes F, 2012, BIOTECHNOL BIOENG, V109, P2836, DOI 10.1002/bit.24542; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; Fischer S, 2015, BIOTECHNOL ADV, V33, P1878, DOI 10.1016/j.biotechadv.2015.10.015; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Goetze S, 2005, MOL CELL BIOL, V25, P2260, DOI 10.1128/MCB.25.6.2260-2272.2005; Gu MB, 1995, CYTOTECHNOLOGY, V18, P159, DOI 10.1007/BF00767763; Hampf M, 2007, J MOL BIOL, V365, P911, DOI 10.1016/j.jmb.2006.10.009; HOLMES KL, 1986, J EXP MED, V164, P443, DOI 10.1084/jem.164.2.443; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Karpinski J, 2016, NAT BIOTECHNOL, V34, P401, DOI 10.1038/nbt.3467; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755                                                          ; Kaufman WL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn508; KROMENAKER SJ, 1994, BIOTECHNOL PROGR, V10, P299, DOI 10.1021/bp00027a010; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mayrhofer P, 2014, APPL MICROBIOL BIOT, V98, P9723, DOI 10.1007/s00253-014-6011-1; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Mitta B, 2005, METAB ENG, V7, P426, DOI 10.1016/j.ymben.2005.06.006; Mussolino C, 2015, CURR OPIN PHARMACOL, V24, P105, DOI 10.1016/j.coph.2015.08.008; Nehlsen K, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-100; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Olorunniji FJ, 2016, BIOCHEM J, V473, P673, DOI 10.1042/BJ20151112; Pichler J, 2009, J BIOTECHNOL, V141, P80, DOI 10.1016/j.jbiotec.2009.03.001; Poitevin Y, 2017, J IMMUNOL METHODS, V444, P1, DOI 10.1016/j.jim.2017.02.004; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Quadros RM, 2015, FEBS OPEN BIO, V5, P191, DOI 10.1016/j.fob.2015.03.003; Salmon P., 2007, CURR PROTOC HUM GENE; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schebelle L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq044; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Sorrell DA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq192; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vidigal J, 2013, J BIOTECHNOL, V168, P436, DOI 10.1016/j.jbiotec.2013.10.020; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wei SJ, 2012, ORTHOPEDICS, V35, pE847, DOI 10.3928/01477447-20120525-23; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Werner J, 2014, NUCLEIC ACIDS RES, V42, P13061, DOI 10.1093/nar/gku1124; Whitelaw E, 2001, Methods Mol Biol, V158, P351; Yallop CA, 2001, CYTOTECHNOLOGY, V35, P101, DOI 10.1023/A:1017550902771; YAMAGUCHI K, 1988, ANAL BIOCHEM, V172, P104, DOI 10.1016/0003-2697(88)90417-4; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564                                                                	60	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 19	2017	7								17771	10.1038/s41598-017-17651-0				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ4WQ	WOS:000418359600021	29259215	gold			2018-01-05	
J	Dudek, NK; Sun, CL; Burstein, D; Kantor, RS; Goltsman, DSA; Bik, EM; Thomas, BC; Banfield, JF; Relman, DA				Dudek, Natasha K.; Sun, Christine L.; Burstein, David; Kantor, Rose S.; Goltsman, Daniela S. Aliaga; Bik, Elisabeth M.; Thomas, Brian C.; Banfield, Jillian F.; Relman, David A.			Novel Microbial Diversity and Functional Potential in the Marine Mammal Oral Microbiome	CURRENT BIOLOGY			English	Article							CRISPR-CAS SYSTEMS; MULTIPLE SEQUENCE ALIGNMENT; BIOSYNTHETIC GENE CLUSTERS; LARGE PHYLOGENIES; GENOMIC SEQUENCE; ONLINE RESOURCE; HIGH-THROUGHPUT; RNA GENES; CD-HIT; BACTERIAL	The vast majority of bacterial diversity lies within phylum-level lineages called "candidate phyla,'' which lack isolated representatives and are poorly understood. These bacteria are surprisingly abundant in the oral cavity of marine mammals. We employed a genome-resolved metagenomic approach to recover and characterize genomes and functional potential from microbes in the oral gingival sulcus of two bottlenose dolphins (Tursiops truncatus). We detected organisms from 24 known bacterial phyla and one archaeal phylum. We also recovered genomes from two deep-branching, previously uncharacterized phylum-level lineages (here named "Candidatus Delphibacteria'' and "Candidatus Fertabacteria''). The Delphibacteria lineage is found in both managed and wild dolphins; its metabolic profile suggests a capacity for denitrification and a possible role in dolphin health. We uncovered a rich diversity of predicted Cas9 proteins, including the two longest predicted Cas9 proteins to date. Notably, we identified the first type II CRISPR-Cas systems encoded by members of the Candidate Phyla Radiation. Using their spacer sequences, we subsequently identified and assembled a complete Saccharibacteria phage genome. These findings underscore the immense microbial diversity and functional potential that await discovery in previously unexplored environments.	[Dudek, Natasha K.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Sun, Christine L.; Goltsman, Daniela S. Aliaga; Bik, Elisabeth M.; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Sun, Christine L.; Goltsman, Daniela S. Aliaga; Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Burstein, David; Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Kantor, Rose S.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Lawrence Berkeley Natl Lab, Earth & Environm Sci, Berkeley, CA 94720 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Bik, Elisabeth M.] uBiome, San Francisco, CA 94105 USA	Relman, DA (reprint author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Relman, DA (reprint author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Relman, DA (reprint author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	relman@stanford.edu			B1 fellowship from the Fonds de Recherche du Quebec-Nature et Technologie; long-term EMBO fellowship; Frontiers in Science award from the Allen Institute; U.S. Department of Energy; Office of Naval Research [00014-07-1-0287]; Thomas C. and Joan M. Merigan Endowment at Stanford University	We thank Mohamed Donia (Princeton University) for guidance in the analysis of the Actinobacteria biosynthetic gene cluster. We thank Stephanie Venn-Watson, Kevin Carlin, and Eric D. Jensen from the U.S. Navy Marine Mammal Program (San Diego, CA, USA) for providing the dolphin oral samples, Alix Switzer (Stanford University) for the contribution of DNA prepared from a harbor seal oral sample, and Frances Gulland and coworkers at The Marine Mammal Center (Sausalito, CA, USA) for collection of the harbor seal oral sample. We thank Beth Shapiro (University of California, Santa Cruz) for her support of this research, as well as members of the Relman laboratory for helpful comments and discussion, especially Elizabeth Costello. Funding was provided by a B1 fellowship from the Fonds de Recherche du Quebec-Nature et Technologie (to N.K.D.), a long-term EMBO fellowship (to D.B.), a Frontiers in Science award from the Allen Institute (to J.F.B.), a cycle grant from the U.S. Department of Energy (to J.F.B.), Office of Naval Research grant 00014-07-1-0287 (to D.A.R.), and the Thomas C. and Joan M. Merigan Endowment at Stanford University (to D.A.R.). B.C.T. and J.F.B. are shareholders of Metagenomi.co. E.M.B. is an employee and shareholder of uBiome.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Bik EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10516; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eloe-Fadrosh EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10476; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hug LA, 2016, ENVIRON MICROBIOL, V18, P159, DOI 10.1111/1462-2920.12930; Hug LA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-22; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joshi NA, 2011, SICKLE SLIDING WINDO; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI 10.1038/nrd2466; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; O'Leary Nuala A, 2016, Nucleic Acids Res, V44, pD733, DOI 10.1093/nar/gkv1189; Paez-Espino D, 2017, NUCLEIC ACIDS RES, V45, pD457, DOI 10.1093/nar/gkw1030; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Sato Y, 2013, ENVIRON MICROBIOL, V15, P2994, DOI 10.1111/1462-2920.12256; Schreiber F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-24; Sekiguchi Y, 2015, PEERJ, V3, DOI 10.7717/peerj.740; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Skennerton CT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt183; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Ultsch A, 2005, ESOM MAPS TOOLS CLUS, V46, P1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209	77	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	DEC 18	2017	27	24					3752	+		10.1016/j.cub.2017.10.040				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FQ3VF	WOS:000418285000019	29153320				2018-01-05	
J	Hosaka, A; Saito, R; Takashima, K; Sasaki, T; Fu, Y; Kawabe, A; Ito, T; Toyoda, A; Fujiyama, A; Tarutani, Y; Kakutani, T				Hosaka, Aoi; Saito, Raku; Takashima, Kazuya; Sasaki, Taku; Fu, Yu; Kawabe, Akira; Ito, Tasuku; Toyoda, Atsushi; Fujiyama, Asao; Tarutani, Yoshiaki; Kakutani, Tetsuji			Evolution of sequence-specific anti-silencing systems in Arabidopsis	NATURE COMMUNICATIONS			English	Article							DIRECTED DNA METHYLATION; RNA INTERFERENCE; TANDEM REPEATS; THALIANA; PATTERNS; HISTONE; PLANTS; SUPPRESSORS; BIOGENESIS; TRANSPOSON	The arms race between parasitic sequences and their hosts is a major driving force for evolution of gene control systems. Since transposable elements (TEs) are potentially deleterious, eukaryotes silence them by epigenetic mechanisms such as DNA methylation. Little is known about how TEs counteract silencing to propagate during evolution. Here, we report behavior of sequence-specific anti-silencing proteins used by Arabidopsis TEs and evolution of those proteins and their target sequences. We show that VANC, a TE-encoded anti-silencing protein, induces extensive DNA methylation loss throughout TEs. Related VANC proteins have evolved to hypomethylate TEs of completely different spectra. Targets for VANC proteins often form tandem repeats, which vary considerably between related TEs. We propose that evolution of VANC proteins and their targets allow propagation of TEs while causing minimal host damage. Our findings provide insight into the evolutionary dynamics of these apparently "selfish" sequences. They also provide potential tools to edit epigenomes in a sequence-specific manner.	[Hosaka, Aoi; Saito, Raku; Takashima, Kazuya; Sasaki, Taku; Fu, Yu; Ito, Tasuku; Tarutani, Yoshiaki; Kakutani, Tetsuji] Natl Inst Genet, Dept Integrated Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan; [Hosaka, Aoi; Saito, Raku; Fu, Yu; Tarutani, Yoshiaki; Kakutani, Tetsuji] SOKENDAI, Sch Life Sci, Dept Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan; [Sasaki, Taku; Ito, Tasuku; Kakutani, Tetsuji] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kawabe, Akira] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 6068555, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Yata 1111, Mishima, Shizuoka 4118540, Japan	Hosaka, A; Kakutani, T (reprint author), Natl Inst Genet, Dept Integrated Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan.; Hosaka, A; Kakutani, T (reprint author), SOKENDAI, Sch Life Sci, Dept Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan.; Kakutani, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	ahosaka@nig.ac.jp; tkakutan@nig.ac.jp		Kawabe, Akira/0000-0001-5770-412X	NIH [S10 OD018174]; Mitsubishi Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology [26221105, 15H05963]; JST CREST Grant, Japan [JPMJCR15O1]; Systems Functional Genetics Project of the Transdisciplinary Research Integration Center, ROIS, Japan	We thank Kae Kato and Akiko Terui for technical assistance, Hiroyuki Araki, Kenichi Nonomura, Naruya Saito, and Taiko To for technical advice, Yasushi Hiromi, Hideki Innan, Damon Lisch, and Eric Richards for comments on the manuscript. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. Computations were partially performed on the NIG supercomputer at NIG, Japan. Supported by grants from Mitsubishi Foundation (to T.K.), Japanese Ministry of Education, Culture, Sports, Science and Technology (26221105 and 15H05963, to T.K.), JST CREST Grant, Japan (JPMJCR15O1 to T.K.), and Systems Functional Genetics Project of the Transdisciplinary Research Integration Center, ROIS, Japan (to A.T., A.F., Y.T., and T.K.).	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573                                                            ; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Drinnenberg IA, 2016, TRENDS CELL BIOL, V26, P498, DOI 10.1016/j.tcb.2016.01.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Baidouri M, 2014, GENOME RES, V24, P831, DOI 10.1101/gr.164400.113; Fu Y, 2013, EMBO J, V32, P2407, DOI 10.1038/emboj.2013.169; Fujimoto R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000048; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Henikoff S, 2002, NATURE, V417, P227, DOI 10.1038/417227a                                                                 ; Ito H, 2014, CHROMOSOME RES, V22, P217, DOI 10.1007/s10577-014-9417-9; Ito T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005154; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Kamthan A, 2016, THEOR APPL GENET, V129, P1639, DOI 10.1007/s00122-016-2747-6; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MY, 2014, TRENDS PLANT SCI, V19, P320, DOI 10.1016/j.tplants.2014.01.014; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299                                                          ; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Martienssen R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019323; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Molaro A, 2016, CURR OPIN GENET DEV, V37, P51, DOI 10.1016/j.gde.2015.12.001; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Peccoud J, 2017, P NATL ACAD SCI USA, V114, P4721, DOI 10.1073/pnas.1621178114; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajeevkumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00693; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Wendte JM, 2017, BBA-GENE REGUL MECH, V1860, P140, DOI 10.1016/j.bbagrm.2016.08.004; Weng KF, 2015, MICROBES INFECT, V17, P557, DOI 10.1016/j.micinf.2015.04.005; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204                                           ; Yu ZH, 2000, GENETICS, V156, P2019; Zamore PD, 2004, CURR BIOL, V14, pR198, DOI 10.1016/j.cub.2004.02.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JH, 2016, CURR OPIN VIROL, V17, P39, DOI 10.1016/j.coviro.2015.12.002	52	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 18	2017	8								2161	10.1038/s41467-017-02150-7				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ3HC	WOS:000418247100010	29255196	gold			2018-01-05	
J	le Sage, C; Lawo, S; Panicker, P; Scales, TME; Rahman, SA; Little, AS; McCarthy, NJ; Moore, JD; Cross, BCS				le Sage, Carlos; Lawo, Steffen; Panicker, Prince; Scales, Tim M. E.; Rahman, Syed Asad; Little, Annette S.; McCarthy, Nicola J.; Moore, Jonathan D.; Cross, Benedict C. S.			Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance	SCIENTIFIC REPORTS			English	Article							SEQUENCE-SPECIFIC CONTROL; HUMAN-CELLS; ACTIVATION; SYSTEM; EXPRESSION; REPRESSION; VULNERABILITIES; KNOCKOUT; BACTERIA; ARCHAEA	Pooled CRISPR-Cas9 knock out screens provide a valuable addition to the methods available for novel drug target identification and validation. However, where gene editing is targeted to amplified loci, the resulting multiple DNA cleavage events can be a cause of false positive hit identification. The generation of nuclease deficient versions of Cas9 has enabled the development of two additional techniques -CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) - that enable the repression or overexpression, respectively, of target genes. Here we report the first direct combination of all three approaches (CRISPRko, CRISPRi and CRISPRa) in the context of genome-wide screens to identify components that influence resistance and sensitivity to the BRAF inhibitor, vemurafenib. The pairing of both loss-and gain-of-function datasets reveals complex gene networks which control drug response and illustrates how such data can add substantial confidence to target identification and validation analyses.	[le Sage, Carlos; Lawo, Steffen; Panicker, Prince; Scales, Tim M. E.; Rahman, Syed Asad; Little, Annette S.; McCarthy, Nicola J.; Moore, Jonathan D.; Cross, Benedict C. S.] Horizon Discovery, 8100 Cambridge Res Pk, Cambridge CB25 9TL, England	Cross, BCS (reprint author), Horizon Discovery, 8100 Cambridge Res Pk, Cambridge CB25 9TL, England.	Benedict.Cross@horizondiscovery.com					Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cross BCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31782; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hart T., 2015, BIORXIV33068; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Horlbeck M. A., 2016, ELIFE, V5; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Ji WY, 2014, ACS SYNTH BIOL, V3, P929, DOI 10.1021/sb500036q; Jost M, 2017, MOL CELL, V68, P210, DOI 10.1016/j.molcel.2017.09.012; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Meyers R. M., 2017, BIORXIV, P1; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	31	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 18	2017	7								17693	10.1038/s41598-017-18172-6				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ4JP	WOS:000418323900005	29255251	gold			2018-01-05	
J	Huang, GP; Liu, XY; Duszynski, DW; Tang, XL; El-Ashram, S; Liu, ZZ; Suo, X; Li, QY				Huang, Guangping; Liu, Xianyong; Duszynski, Donal W.; Tang, Xiaoli; El-Ashram, Saeed; Liu, Zhengzhu; Suo, Xun; Li, Qiuyan			Improved Cytotoxic T Lymphocyte Responses to Vaccination with Porcine Reproductive and Respiratory Syndrome Virus in 4-1BB Transgenic Pigs	FRONTIERS IN IMMUNOLOGY			English	Article						immune response; viral infection; 4-1BB; co-stimulation; transgenic pig	MONONUCLEAR-CELLS PBMC; EMBRYONIC STEM-CELLS; INFECTIOUS-DISEASES; CO-STIMULATION; IMMUNE-SYSTEM; ROSA26 LOCUS; COSTIMULATION; PRRSV; LIGAND; FUTURE	Vaccination is the most reliable measure to prevent infectious diseases in domestic animals. Development of novel vaccines demands extensive studies with new technologies, such as using novel adjuvants and immunomodulatory molecules. The co-stimulatory molecule 4-1BB provides a key signal that directs the fate of T cells during activation, and thus is important to their function in immune protection. To determine whether host immune responses to viral infection could be promoted by enhancing 4-1BB co-stimulation, in this study, we produced transgenic pig clones expressing an extra copy of the 4-1BB gene by clustered regularly interspaced short palindromic repeats/CRISPR-associated gene 9-mediated homologous recombination at the Rosa26 locus. The immune responses of transgenic pigs to porcine reproductive and respiratory syndrome virus (PRRSV) vaccine were determined on day 14. We show that peripheral blood lymphocytes of transgenic pigs expressed around twice the level of 4-1BB mRNA than those of control pigs. We also found IL-2, TNF-alpha, and granzyme B mRNA levels as well as PRRSV-specific IFN-gamma response were significantly upregulated in 4-1BB transgenic pigs, leading to more efficient cytotoxic T lymphocyte (CTL) killing, whereas the expressions of IL-4, IL-17, and Foxp3 were not affected. These results indicate that higher levels of 4-1BB expression involve in promoting Th1 differentiation and enhancing specific CTL responses to PRRSV, and provide a novel approach to increase the efficacy of current vaccines to control the infectious diseases.	[Huang, Guangping; Liu, Xianyong; Tang, Xiaoli; El-Ashram, Saeed; Suo, Xun] China Agr Univ, Coll Vet Med, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Huang, Guangping; Liu, Xianyong; Tang, Xiaoli; El-Ashram, Saeed; Suo, Xun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China; [Duszynski, Donal W.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Liu, Zhengzhu] Hebei Normal Univ Sci & Technol, Dept Anim Sci & Vet Med, Qinhuangdao, Hebei, Peoples R China; [Li, Qiuyan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [El-Ashram, Saeed] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China	Li, QY (reprint author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	liqiuyan@cau.edu.cn			National Transgenic Breeding Program of China [2014ZX0800603B, 2016ZX08006003]	This study was supported by the National Transgenic Breeding Program of China (No. 2014ZX0800603B and 2016ZX08006003).	ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; Appleman LJ, 2003, IMMUNOL REV, V192, P161, DOI 10.1034/j.1600-065X.2003.00009.x                                                ; Arnold C, 2013, ENVIRON HEALTH PERSP, V121, pA256, DOI [10.1289/ehp.121-a256, 10.1289/ehp.121-A256]; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777                                                     ; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Clark J, 2003, NAT REV GENET, V4, P825, DOI 10.1038/nrg1183; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Das PB, 2010, J VIROL, V84, P1731, DOI 10.1128/JVI.01774-09; Dione MM, 2014, PREV VET MED, V117, P565, DOI 10.1016/j.prevetmed.2014.10.012; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Dwivedi V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-45; Eun SY, 2015, J IMMUNOL, V194, P134, DOI 10.4049/jimmunol.1401383; Ferrari L, 2013, VET IMMUNOL IMMUNOP, V151, P193, DOI 10.1016/j.vetimm.2012.11.006; Galliher-Beckley A, 2015, VACCINE, V33, P3518, DOI 10.1016/j.vaccine.2015.05.058; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Gun G, 2014, BIORESEARCH OPEN ACC, V3, P255, DOI 10.1089/biores.2014.0039; Halachmi I, 2016, ANIMAL, V10, P1482, DOI 10.1017/S1751731116001142; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcalls.2005-0475; Huang GP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01110; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Laderach D, 2002, INT IMMUNOL, V14, P1155, DOI 10.1093/intimm/dxf080; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; Li XJ, 2012, J GENET GENOMICS, V39, P237, DOI 10.1016/j.jgg.2012.05.006; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015639; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Mokhtar H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00040; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; POLLOK KE, 1993, J IMMUNOL, V150, P771; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renukaradhya GJ, 2015, VACCINE, V33, P4069, DOI 10.1016/j.vaccine.2015.06.092; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Sanchez-Paulete AR, 2016, EUR J IMMUNOL, V46, P513, DOI 10.1002/eji.201445388; Skern R, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-10; Sundstrom J, 2014, FOOD SECUR, V6, P201, DOI 10.1007/s12571-014-0331-y; Tan JT, 2000, J IMMUNOL, V164, P2320, DOI 10.4049/jimmunol.164.5.2320                                                     ; ULMER AJ, 1984, IMMUNOBIOLOGY, V166, P238, DOI 10.1016/S0171-2985(84)80042-X                                                   ; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Vinay DS, 2011, CELL MOL IMMUNOL, V8, P281, DOI 10.1038/cmi.2010.82; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang ZF, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00060; Wen T, 2002, J IMMUNOL, V168, P4897, DOI 10.4049/jimmunol.168.10.4897                                                    ; Whitelaw CBA, 2005, REV SCI TECH OIE, V24, P275, DOI 10.20506/rst.24.1.1569                                                          ; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Xiao ZG, 2004, J VIROL, V78, P5923, DOI 10.1128/JVI.78.11.5923-5933.2004; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910                                                     ; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619; Zhao XX, 2011, VET IMMUNOL IMMUNOP, V144, P179, DOI 10.1016/j.vetimm.2011.10.003; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	59	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	DEC 18	2017	8								1846	10.3389/fimmu.2017.01846				13	Immunology	Immunology	FQ1WQ	WOS:000418148700001		gold			2018-01-05	
J	Pratama, AA; Haq, IU; Nazir, R; De Mares, MC; van Elsas, JD				Pratama, Akbar Adjie; Haq, Irshad Ul; Nazir, Rashid; De Mares, Maryam Chaib; van Elsas, Jan Dirk			Draft genome sequences of three fungal-interactive Paraburkholderia terrae strains, BS007, BS110 and BS437	STANDARDS IN GENOMIC SCIENCES			English	Article						Paraburkholderia terrae; Mycosphere; Fungal-interactive; Genome	BURKHOLDERIA; MYCOSPHERE; DIVERSITY; EVOLUTION; BACTERIA; PROPOSAL; ARCHAEA; SYSTEM; PHAGES; GENUS	Here, we report the draft genome sequences of three fungal-interactive Paraburkholderia terrae strains, denoted BS110, BS007 and BS437. Phylogenetic analyses showed that the three strains belong to clade II of the genus Burkholderia, which was recently renamed Paraburkholderia. This novel genus primarily contains environmental species, encompassing non-pathogenic plant-as well as fungal-interactive species. The genome of strain BS007 consists of 11,025,273 bp, whereas those of strains BS110 and BS437 have 11,178,081 and 11,303,071 bp, respectively. Analyses of the three annotated genomes revealed the presence of (1) a large suite of substrate capture systems, and (2) a suite of genetic systems required for adaptation to microenvironments in soil and the mycosphere. Thus, genes encoding traits that potentially confer fungal interactivity were found, such as type 4 pili, type 1, 2, 3, 4 and 6 secretion systems, and biofilm formation (PGA, alginate and pel) and glycerol uptake systems. Furthermore, the three genomes also revealed the presence of a highly conserved five-gene cluster that had previously been shown to be upregulated upon contact with fungal hyphae. Moreover, a considerable number of prophage-like and CRISPR spacer sequences was found, next to genetic systems responsible for secondary metabolite production. Overall, the three P. terrae strains possess the genetic repertoire necessary for adaptation to diverse soil niches, including those influenced by soil fungi.	[Pratama, Akbar Adjie; Haq, Irshad Ul; De Mares, Maryam Chaib; van Elsas, Jan Dirk] Univ Groningen, Groningen Inst Evolutionary Life Sci, Microbial Ecol, Dept Microbial Ecol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Nazir, Rashid] COMSATS Inst Informat Technol, Dept Environm Sci, Univ Rd, Abbottabad 22060, Pakistan	Pratama, AA; van Elsas, JD (reprint author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Microbial Ecol, Dept Microbial Ecol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	A.A.P.Pratama@rug.nl; j.d.van.elsas@rug.nl			Indonesia Endowment Fund for Education (LPDP-Lembaga Pengelolaan Dana Pendidikan, Departemen Keuangan, Republik Indonesia); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [607,786]	A scholarship of the Indonesia Endowment Fund for Education (LPDP-Lembaga Pengelolaan Dana Pendidikan, Departemen Keuangan, Republik Indonesia) to A.A.P. Funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no 607,786, BluePharmTrain to M. C. D. M.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Estrada-de los Santos P, 2013, CURR MICROBIOL, V67, P51, DOI 10.1007/s00284-013-0330-9; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Garrity GM, 2005, BERGEYS MAN SYST BAC, V2; Garrity GM, 2005, BERGEYS MANUAL SYSTE, V2, P575; Garrity GM, 2005, BERGEYS MAN SYSTEMAT, V2; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haq I. U., 2016, FEMS MICROBIOL ECOL, V92, P1; Lackner G, 2011, ISME J, V5, P252, DOI 10.1038/ismej.2010.126; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Nazir R, 2012, J BACTERIOL, V194, P4480, DOI 10.1128/JB.00725-12; Nazir R, 2012, SOIL BIOL BIOCHEM, V50, P221, DOI 10.1016/j.soilbio.2012.03.015; Obeng N, 2016, TRENDS MICROBIOL, V24, P440, DOI 10.1016/j.tim.2015.12.009; Pratama AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09317-8; Sahl J. W., 2015, PLOS ONE, V10, P1; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Sawana A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00429; Schurr MJ, 2013, J BACTERIOL, V195, P1623, DOI 10.1128/JB.00173-13; Shi WY, 2002, INFECT IMMUN, V70, P1, DOI 10.1128/IAI.70.1.1-4.2002; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Ul Haq I, 2017, MICROB ECOL, V73, P236, DOI 10.1007/s00248-016-0885-7; Ul Haq I, 2014, GENOME BIOL EVOL, V6, P1652, DOI 10.1093/gbe/evu126; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; Warmink JA, 2008, ISME J, V2, P887, DOI 10.1038/ismej.2008.41; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x                                              ; Yakandawala N, 2011, APPL ENVIRON MICROB, V77, P8303, DOI 10.1128/AEM.05814-11; Yang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02959-8; Yang P, 2016, BIOL FERT SOILS, V52, P1037, DOI 10.1007/s00374-016-1140-6	33	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1944-3277			STAND GENOMIC SCI	Stand. Genomic Sci.	DEC 18	2017	12								81	10.1186/s40793-017-0293-8				14	Genetics & Heredity; Microbiology	Genetics & Heredity; Microbiology	FQ2JS	WOS:000418183300001		gold			2018-01-05	
J	Ma, F; Hu, YC; Ju, Y; Jiang, QR; Cheng, ZJ; Zhang, Q; Sodmergen				Ma, Fei; Hu, Yingchun; Ju, Yan; Jiang, Qianru; Cheng, Zhijun; Zhang, Quan; Sodmergen			A novel tetratricopeptide repeat protein, WHITE TO GREEN1, is required for early chloroplast development and affects RNA editing in chloroplasts	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Arabidopsis thaliana; chloroplast; early development; MORFs; plastid gene; PPR; RNA editing; TPR; virescent	PLASTID GENE-EXPRESSION; MOTIF-CONTAINING PROTEIN; NUCLEUS-ENCODED FACTOR; PRE-MESSENGER-RNA; ARABIDOPSIS-THALIANA; PEPTIDE REPEAT; SIGNAL-TRANSDUCTION; PLANT-MITOCHONDRIA; PHOTOSYSTEM-I; PPR PROTEINS	The chloroplast is essential for plant photosynthesis and production, but the regulatory mechanism of chloroplast development is still elusive. Here, a novel gene, WHITE TO GREEN1 (WTG1), was identified to have a function in chloroplast development and plastid gene expression by screening Arabidopsis leaf coloration mutants. WTG1 encodes a chloroplast-localized tetratricopeptide repeat protein that is expressed widely in Arabidopsis cells. Disruption of WTG1 suppresses plant growth, retards leaf greening and chloroplast development, and represses photosynthetic gene expression, but complemented expression of WTG1 restored a normal phenotype. Moreover, WTG1 protein is associated with the organelle RNA editing factors MORF8 and MORF9, and RNA editing of the plastid petL-5 and ndhG-50 transcripts was affected in wtg1 mutants. These results indicate that WTG1 affects both transcriptional and posttranscriptional regulation of plastid gene expression, and provide evidence for the involvement of a tetratricopeptide repeat protein in chloroplast RNA editing in Arabidopsis.	[Ma, Fei; Hu, Yingchun; Ju, Yan; Jiang, Qianru; Zhang, Quan; Sodmergen] Peking Univ, Coll Life Sci, Minist Educ Cell Proliferat & Differentiat, Key Lab, Beijing 100871, Peoples R China; [Cheng, Zhijun] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Zhang, Q; Sodmergen (reprint author), Peking Univ, Coll Life Sci, Minist Educ Cell Proliferat & Differentiat, Key Lab, Beijing 100871, Peoples R China.	zhang.q@water.pku.edu.cn; sodmergn@pku.edu.cn			National Basic Research Program of China [2013CB126905]; Ministry of Agriculture of China for Transgenic Research [2014ZX0800938B]	We thank the TOLOBIO company for performing the REMSA experiments; Zhang Chao for providing the method to analyze RNA-seq data; and Professor Li Yi (Peking University) and Professor W. Sakamoto for providing the pWM101 and pGreen0029-DUO1-DIPS-GFP-NOS plasmids, respectively. This work was supported by grant 2013CB126905 from the National Basic Research Program of China (S) and grant 2014ZX0800938B from the Ministry of Agriculture of China for Transgenic Research (ZC).	Alag R, 2009, PROTEIN SCI, V18, P2115, DOI 10.1002/pro.226; Alonso JM, 2003, METH MOL B, V236, P177; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chaudhuri S, 1996, EMBO J, V15, P5958; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Chi W, 2010, PLANT J, V64, P14, DOI 10.1111/j.1365-313X.2010.04304.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0                                                                ; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hattori M, 2007, J BIOL CHEM, V282, P10773, DOI 10.1074/jbc.M608034200; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; Heinnickel M, 2016, P NATL ACAD SCI USA, V113, P2774, DOI 10.1073/pnas.1524040113; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644                                                         ; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Hu ZH, 2014, J EXP BOT, V65, P1111, DOI 10.1093/jxb/ert463; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IBA K, 1991, DEV GENET, V12, P342, DOI 10.1002/dvg.1020120503; Ichinose M, 2012, PLANT J, V70, P271, DOI 10.1111/j.1365-313X.2011.04869.x; Ishizaki Y, 2005, PLANT J, V42, P133, DOI 10.1111/j.1365-313X.2005.02362.x; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; Kim CH, 2013, MOL PLANT, V6, P1580, DOI 10.1093/mp/sst020; Kindgren P, 2015, PLANT CELL, V27, P403, DOI 10.1105/tpc.114.134189; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4                                                   ; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Lichtenthaler H. K., 1983, BIOCHEM SOC T, V11, P591, DOI DOI 10.1042/BST0110591; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU BW, 1992, NUCLEIC ACIDS RES, V20, P5699, DOI 10.1093/nar/20.21.5699                                                          ; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mach J, 2009, PLANT CELL, V21, P17, DOI 10.1105/tpc.109.210114; MALIGA P, 1988, MOL GEN GENET, V214, P456, DOI 10.1007/BF00330480; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OELMULLER R, 1989, PHOTOCHEM PHOTOBIOL, V49, P229, DOI 10.1111/j.1751-1097.1989.tb04101.x; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Park S, 2007, PLANT PHYSIOL, V143, P1547, DOI [10.1104/pp.106.096396, 10.1104/pp.107.096396]; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Pfalz J, 2013, TRENDS PLANT SCI, V18, P186, DOI 10.1016/j.tplants.2012.11.003; Pogson BJ, 2011, PLANT PHYSIOL, V155, P1545, DOI 10.1104/pp.110.170365; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Rudowska L, 2012, BBA-BIOENERGETICS, V1817, P1380, DOI 10.1016/j.bbabio.2012.03.013; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Shi XW, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1167299; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Shikanai T, 2013, RNA BIOL, V10, P1446, DOI 10.4161/rna.25207; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tavares-Carreon F, 2008, J BIOL CHEM, V283, P1472, DOI 10.1074/jbc.M708437200; Terzi LC, 2009, PLANT J, V59, P163, DOI 10.1111/j.1365-313X.2009.03859.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Waadt R, 2008, CSH PROTOC, V2008, DOI [10.1101/pdb.prot4995, DOI 10.1101/PDB.PROT4995]; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wang ML, 2016, PLANT CELL PHYSIOL, V57, P2586, DOI 10.1093/pcp/pcw172; Wang YL, 2016, PLANT PHYSIOL, V170, P2110, DOI 10.1104/pp.15.01949; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Yagi Y, 2012, P NATL ACAD SCI USA, V109, P7541, DOI 10.1073/pnas.1119403109; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x; Yang ZP, 2015, PHOTOSYNTH RES, V126, P285, DOI 10.1007/s11120-015-0131-z; Yap A, 2015, PLANT J, V81, P661, DOI 10.1111/tpj.12756; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zhang M, 2015, PLANT J, V83, P582, DOI 10.1111/tpj.12911; Zhang ZM, 2016, PLANT PHYSIOL, V171, P1182, DOI 10.1104/pp.16.00325; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	107	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	DEC 16	2017	68	21-22					5829	5843		10.1093/jxb/erx383				15	Plant Sciences	Plant Sciences	FQ4YR	WOS:000418365600013					2018-01-05	
J	Birkeland, NK; Schonheit, P; Poghosyan, L; Fiebig, A; Klenk, HP				Birkeland, Nils-Kare; Schoenheit, Peter; Poghosyan, Lianna; Fiebig, Anne; Klenk, Hans-Peter			Complete genome sequence analysis of Archaeoglobus fulgidus strain 7324 (DSM 8774), a hyperthermophilic archaeal sulfate reducer from a North Sea oil field	STANDARDS IN GENOMIC SCIENCES			English	Article						Anaerobic; Hyperthermophile; Sulfate reduction; SRB; Petroleum; Oil-field	SP NOV.; GLUTAMATE-DEHYDROGENASE; STARCH DEGRADATION; RNA GENES; ANNOTATION; ARCHAEBACTERIA; BACTERIA; PATHWAY; SYSTEM	Archaeoglobus fulgidus is the type species of genus Archaeoglobus Stetter 1998, a hyperthermophilic sulfate reducing group within the Archaeoglobi class of the euryarchaeota phylum. Members of this genus grow heterotrophically or chemolithoautotrophically with sulfate or thiosulfate as electron acceptors. Except for A. fulgidus strain 7324 and the candidate species "Archaeoglobus lithotrophicus", which both originate from deep oil-fields, the other members of this genus have been recovered from marine hydrothermal systems. Here we describe the features of the A. fulgidus strain 7324 genome as compared to the A. fulgidus VC16 type strain. The 2.3 Mbp genome sequence of strain 7324 shares about 93.5% sequence identity with that of strain VC16(T) but is about 138 Kbp longer, which is mostly due to two large 'insertions' carrying one extra cdc6 (cell-cycle control protein 6) gene, extra CRISPR elements and mobile genetic elements, a high-GC ncRNA gene (hgcC) and a large number of hypothetical gene functions. A comparison with four other Archaeoglobus spp. genomes identified 1001 core Archaeoglobus genes and more than 2900 pan-genome orthologous genes.	[Birkeland, Nils-Kare; Poghosyan, Lianna] Univ Bergen, Dept Biol, POB 7803, NO-5020 Bergen, Norway; [Schoenheit, Peter] Christian Albrechts Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany; [Fiebig, Anne; Klenk, Hans-Peter] DSMZ German Collect Microorganisms & Cell Culture, Leibniz Inst, Inhoffenstr 7b, D-38124 Braunschweig, Germany; [Fiebig, Anne] IPK Gatersleben, Corrensstr 3, D-06466 Gatersleben, Germany; [Klenk, Hans-Peter] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Birkeland, NK (reprint author), Univ Bergen, Dept Biol, POB 7803, NO-5020 Bergen, Norway.	nils.birkeland@uib.no					Aalen N, 1997, ARCH MICROBIOL, V168, P536, DOI 10.1007/s002030050533; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Bardou P, 2014, BMV BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-293, DOI 10.1186/1471-2105-15-293.]; BEEDER J, 1994, APPL ENVIRON MICROB, V60, P1227; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bland C, 2007, BMC BIOINFORMATICS, DOI DOI 10.1186/1471-2105-8-209.; BURGGRAF S, 1990, SYST APPL MICROBIOL, V13, P24, DOI 10.1016/S0723-2020(11)80176-1                                                   ; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Garrity GM, 2001, BERGEYS MANUAL SYSTE, V1, P211; Garrity GM, 2001, BERGEYS MANUAL SYSTE, V1, P349; Hafenbradl D, 1996, ARCH MICROBIOL, V166, P308, DOI 10.1007/s002030050388; Hansen T, 2004, EXTREMOPHILES, V8, P29, DOI 10.1007/s00792-003-0356-1; Huber H, 1997, SYST APPL MICROBIOL, V20, P374, DOI 10.1016/S0723-2020(97)80005-7                                                   ; Huber H, 2001, BERGEYS MANUAL SYSTE, V1, P349; Huber H, 2001, BERGEYS MANUAL SYSTE, V1, P349; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hyatt D, 2010, BMC BIOINFORMATICS, DOI DOI 10.1186/1471-2105-11-119.; Johnsen U, 2003, J BIOL CHEM, V278, P25417, DOI 10.1074/jbc.M210288200; Kashefi K, 2002, INT J SYST EVOL MICR, V52, P719, DOI 10.1099/ijs.0.01953-0; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052                                                                   ; Kostyukova AS, 1999, EXTREMOPHILES, V3, P239, DOI 10.1007/s007920050122; Labes A, 2003, ARCH MICROBIOL, V180, P69, DOI 10.1007/s00203-003-0563-2; Labes A, 2001, ARCH MICROBIOL, V176, P329, DOI 10.1007/s002030100330                                                           ; Labes A, 2007, J BACTERIOL, V189, P8901, DOI 10.1128/JB.01136-07; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lien T, 1998, INT J SYST BACTERIOL, V48, P1007, DOI 10.1099/00207713-48-3-1007                                                      ; Maisnier-Patin S, 2002, MOL MICROBIOL, V45, P1443, DOI 10.1046/j.1365-2958.2002.03111.x                                                ; Maisnier-Patin S, 2002, MOL MICROBIOL, V46, P599, DOI 10.1046/j.1365-2958.2002.02955.x-i1                                             ; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, DOI DOI 10.1186/1471-2105-14-60.; Mori K, 2008, INT J SYST EVOL MICR, V58, P810, DOI 10.1099/ijs.0.65422-0; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Parey K, 2013, METALLOMICS, V5, P302, DOI 10.1039/c2mt20225e; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Slobodkina GB, 2009, INT J SYST EVOL MICR, V59, P2880, DOI 10.1099/ijs.0.011080-0; Steen IH, 2001, METHOD ENZYMOL, V331, P13; Steinsbu BO, 2010, INT J SYST EVOL MICR, V60, P2745, DOI 10.1099/ijs.0.016105-0; STETTER KO, 1988, SYST APPL MICROBIOL, V10, P172, DOI 10.1016/S0723-2020(88)80032-8                                                   ; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tindall BJ, 2008, INT J SYST EVOL MICR, V58, P1755, DOI 10.1099/ijs.0.2008/005264-0; von Jan M, 2010, STAND GENOMIC SCI, V2, P327, DOI 10.4056/sigs.942153; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZELLNER G, 1989, SYST APPL MICROBIOL, V11, P151, DOI 10.1016/S0723-2020(89)80055-4                                                   	47	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1944-3277			STAND GENOMIC SCI	Stand. Genomic Sci.	DEC 16	2017	12								79	10.1186/s40793-017-0296-5				9	Genetics & Heredity; Microbiology	Genetics & Heredity; Microbiology	FQ2JR	WOS:000418183200001		gold			2018-01-05	
J	Schimmel, J; Kool, H; van Schendel, R; Tijsterman, M				Schimmel, Joost; Kool, Hanneke; van Schendel, Robin; Tijsterman, Marcel			Mutational signatures of non-homologous and polymerase theta-mediated end-joining in embryonic stem cells	EMBO JOURNAL			English	Article						cNHEJ; CRISPR/Cas9; double-strand break repair; embryonic stem cells; polymerase theta-mediated end joining	DOUBLE-STRAND BREAK; HOMOLOGOUS-RECOMBINATION; DNA-REPAIR; TANDEM DUPLICATIONS; MAMMALIAN-CELLS; POL-THETA; GENOME; CANCER; PATHWAY; NHEJ	Cells employ potentially mutagenic DNA repair mechanisms to avoid the detrimental effects of chromosome breaks on cell survival. While classical non-homologous end-joining (cNHEJ) is largely error-free, alternative end-joining pathways have been described that are intrinsically mutagenic. Which end-joining mechanisms operate in germ and embryonic cells and thus contribute to heritable mutations found in congenital diseases is, however, still largely elusive. Here, we determined the genetic requirements for the repair of CRISPR/Cas9-induced chromosomal breaks of different configurations, and establish the mutational consequences. We find that cNHEJ and polymerase theta-mediated end-joining (TMEJ) act both parallel and redundant in mouse embryonic stem cells and account for virtually all end-joining activity. Surprisingly, mutagenic repair by polymerase theta (Pol theta, encoded by the Polq gene) is most prevalent for blunt double-strand breaks (DSBs), while cNHEJ dictates mutagenic repair of DSBs with protruding ends, in which the cNHEJ polymerases lambda and mu play minor roles. We conclude that cNHEJ-dependent repair of DSBs with protruding ends can explain de novo formation of tandem duplications in mammalian genomes.	[Schimmel, Joost; Kool, Hanneke; van Schendel, Robin; Tijsterman, Marcel] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands	Tijsterman, M (reprint author), Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands.	m.tijsterman@lumc.nl			European Commission (DDResponse); ZonMW/NGI-horizon; Dutch STW Open Technology Program; VENI grant from NWO-Life Sciences	We thank Dr. Sjef Verbeek for experimental advice on CRISPR/Cas9 and mouse embryonic stem cells. M.T. is supported by grants from the European Commission (DDResponse) and ZonMW/NGI-horizon. J.S. received support from the Dutch STW Open Technology Program and is funded by a VENI grant from NWO-Life Sciences.	Ahrabi S, 2016, NUCLEIC ACIDS RES, V44, P5743, DOI 10.1093/nar/gkw326; Beagan K, 2016, CELL MOL LIFE SCI, V73, P603, DOI 10.1007/s00018-015-2078-9; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Bothmer A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13905; Boulton SJ, 1996, EMBO J, V15, P5093; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Dai CH, 2016, ONCOTARGET, V7, P65157, DOI 10.18632/oncotarget.11214; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Geisinger JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1542; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Higgins GS, 2010, ONCOTARGET, V1, P175, DOI 10.18632/oncotarget.124                                                         ; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Killock D, 2015, NAT REV CLIN ONCOL, V12, DOI 10.1038/nrclinonc.2015.166; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Lemmens B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9909; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Lucas D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000389; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Messer PW, 2007, MOL BIOL EVOL, V24, P1190, DOI 10.1093/molbev/msm035; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pryor JM, 2015, P NATL ACAD SCI USA, V112, pE4537, DOI 10.1073/pnas.1505805112; Ramsden DA, 2012, ENVIRON MOL MUTAGEN, V53, P741, DOI 10.1002/em.21725; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ristic D, 2003, NUCLEIC ACIDS RES, V31, P5229, DOI 10.1093/nar/gkg729; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295                                                           ; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Savatier P, 2002, Methods Mol Biol, V185, P27; Schiml S, 2016, P NATL ACAD SCI USA, V113, P7266, DOI 10.1073/pnas.1603823113; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Soulier J, 2005, BLOOD, V105, P1329, DOI 10.1182/blood-2004-05-1852; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Thomas EE, 2005, CURR OPIN GENET DEV, V15, P640, DOI 10.1016/j.gde.2005.09.008; Thyme SB, 2016, CELL REP, V15, P1611, DOI 10.1016/j.celrep.2016.04.089; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; van Kregten M, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.164, 10.1038/NPLANTS.2016.164]; van Kregten M, 2014, EXP CELL RES, V329, P178, DOI 10.1016/j.yexcr.2014.08.038; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; van Schendel R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006368; van Schendel R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8394; Vaughn JN, 2014, P NATL ACAD SCI USA, V111, P6684, DOI 10.1073/pnas.1321854111; Vermeulen C, 2007, RADIAT RES, V168, P683, DOI 10.1667/RR1057R.1; Vriend LEM, 2016, NUCLEIC ACIDS RES, V44, P5204, DOI 10.1093/nar/gkw179; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Waters CA, 2014, DNA REPAIR, V17, P39, DOI 10.1016/j.dnarep.2014.02.008; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Wood RD, 2016, DNA REPAIR, V44, P22, DOI 10.1016/j.dnarep.2016.05.003; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zahn KE, 2015, NAT STRUCT MOL BIOL, V22, P304, DOI 10.1038/nsmb.2993; Zelensky AN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00124-3	73	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-4189	1460-2075		EMBO J	Embo J.	DEC 15	2017	36	24					3634	3649		10.15252/embj.201796948				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FQ3AU	WOS:000418230000007	29079701				2018-01-05	
J	Holmgaard, A; Askou, AL; Benckendorff, JNE; Thomsen, EA; Cai, YJ; Bek, T; Mikkelsen, JG; Corydon, TJ				Holmgaard, Andreas; Askou, Anne Louise; Benckendorff, Josephine Natalia Esther; Thomsen, Emil Aagaard; Cai, Yujia; Bek, Toke; Mikkelsen, Jacob Giehm; Corydon, Thomas J.			In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; CRISPR-CAS9 SYSTEM; ANIMAL-MODELS; GENOME; THERAPY; CAS9; VECTORS; EXPRESSION; MUTATIONS	Virus-based gene therapy by CRISPR/Cas9-mediated genome editing and knockout may provide a new option for treatment of inherited and acquired ocular diseases of the retina. In support of this notion, we show that Streptococcus pyogenes (Sp) Cas9, delivered by lentiviral vectors (LVs), can be used in vivo to selectively ablate the vascular endothelial growth factor A (Vegfa) gene in mice. By generating LVs encoding SpCas9 targeted to Vegfa, and in parallel the fluorescent eGFP marker protein, we demonstrate robust knockout of Vegfa that leads to a significant reduction of VEGFA protein in transduced cells. Three of the designed single-guide RNAs (sgRNAs) induce in vitro indel formation at high frequencies (44%-93%). A single unilateral subretinal injection facilitates RPE-specific localization of the vector and disruption of Vegfa in isolated eGFP(+) RPE cells obtained from mice five weeks after LV administration. Notably, sgRNA delivery results in the disruption of Vegfa with an in vivo indel formation efficacy of up to 84%. Sequencing of Vegfa-specific amplicons reveals formation of indels, including 4-bp deletions and 2-bp insertions. Taken together, our data demonstrate the capacity of lentivirus-delivered SpCas9 and sgRNAs as a developing therapeutic path in the treatment of ocular diseases, including age-related macular degeneration.	[Holmgaard, Andreas; Askou, Anne Louise; Benckendorff, Josephine Natalia Esther; Thomsen, Emil Aagaard; Cai, Yujia; Mikkelsen, Jacob Giehm; Corydon, Thomas J.] Aarhus Univ, Dept Biomed, Bartholin Alle 6, DK-8000 Aarhus C, Denmark; [Bek, Toke; Corydon, Thomas J.] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus C, Denmark	Corydon, TJ (reprint author), Aarhus Univ, Dept Biomed, Bartholin Alle 6, DK-8000 Aarhus C, Denmark.	corydon@biomed.au.dk		Mikkelsen, Jacob Giehm/0000-0002-1322-3209; Corydon, Thomas Juhl/0000-0003-3588-6350	Faculty of Health Sciences; Danish Council for Independent Research [4183-00017B]; Gene Therapy Initiative Aarhus (GTI-Aarhus) - Lundbeck Foundation [R126-2012-12456]; Danish Eye Foundation; Aase og Ejnar Danielsen's Foundation; Knud and Edith Eriksen's Foundation; Maskinfabrikant Jochum Jensen og hustru Mette Marie Jensen f. Poulsens Mindelegat; Riisfort Foundation; Svend Helge Schroder og hustru Ketty Lydia Larsen Schroders fund	The authors would like to thank Tina Hindkjaer, Kamilla Zahll Hornbek, Christian Knudsen, and Karen Kathrine Brondum for their excellent technical support. Cell sorting was performed at the FACS Core Facility, Aarhus University, Denmark. This work was supported by the Faculty of Health Sciences (PhD scholarship to A.H.), the Danish Council for Independent Research (4183-00017B to T.J.C.), the Gene Therapy Initiative Aarhus (GTI-Aarhus) funded by the Lundbeck Foundation (R126-2012-12456 to T.J.C. and J.G.M.), the Danish Eye Foundation (to T.J.C.), Aase og Ejnar Danielsen's Foundation (to T.J.C.), Knud and Edith Eriksen's Foundation (to T.J.C.), Maskinfabrikant Jochum Jensen og hustru Mette Marie Jensen f. Poulsens Mindelegat (to T.J.C.), the Riisfort Foundation (to T.J.C.), and Svend Helge Schroder og hustru Ketty Lydia Larsen Schroders fund (to T.J.C.).	Askou AL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.64; Askou AL, 2014, ACTA OPHTHALMOL, V92, P1, DOI 10.1111/aos.12452; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Balaggan KS, 2012, GENE THER, V19, P145, DOI 10.1038/gt.2011.153; Bemelmans AP, 2006, PLOS MED, V3, P1892, DOI 10.1371/journal.pmed.0030347; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corydon TJ, 2015, HUM GENE THER, V26, P525, DOI 10.1089/hum.2015.064; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Latella MC, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.92; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MILLER JW, 1994, AM J PATHOL, V145, P574; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pihlmann M, 2012, J GENE MED, V14, P328, DOI 10.1002/jgm.2623; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rossmiller B, 2012, MOL VIS, V18, P2479; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Trapani I, 2015, HUM MOL GENET, V24, P6811, DOI 10.1093/hmg/ddv386; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yiu G, 2016, INVEST OPHTH VIS SCI, V57, P5490, DOI 10.1167/iovs.16-20296; Zhao L.-L., 2009, J BIOMED SCI ENG, V2, P363, DOI [10.4236/jbise.2009.25052, DOI 10.4236/JBISE.2009.25052]; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	42	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	DEC 15	2017	9						89	99		10.1016/j.omtn.2017.08.016				11	Medicine, Research & Experimental	Research & Experimental Medicine	FQ6SJ	WOS:000418494000009	29246327	gold			2018-01-05	
J	Zhang, Z; Zhang, YL; Gao, F; Han, S; Cheah, KS; Tse, HF; Lian, QZ				Zhang, Zhao; Zhang, Yuelin; Gao, Fei; Han, Shuo; Cheah, Kathryn S.; Tse, Hung-Fat; Lian, Qizhou			CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Review							HOMOLOGY-DIRECTED REPAIR; DUCHENNE MUSCULAR-DYSTROPHY; SEQUENCE-SPECIFIC CONTROL; HUMAN HEMATOPOIETIC STEM; STRAND BREAK REPAIR; OFF-TARGET SITES; IN-VIVO; MAMMALIAN-CELLS; GENE-THERAPY; CRISPR-CAS9 NUCLEASES	Genome-editing involves the insertion, deletion, or replacement of DNA in the genome of a living organism using "molecular scissors." Traditional genome editing with engineered nucleases for human stem cells is limited by its low efficiency, high cost, and poor specificity. The CRISPR system has recently emerged as a powerful gene manipulation technique with advantages of high editing efficiency and low cost. Although this technique offers huge potential for gene manipulation in various organisms ranging from prokaryotes to higher mammals, there remain many challenges in human stem cell research. In this review, we highlight the basic biology and application of the CRISPR/Cas9 system in current human stem cell research, discuss its advantages and challenges, and debate the future prospects for human stem cells in regenerative medicine.	[Zhang, Zhao; Zhang, Yuelin; Gao, Fei; Han, Shuo; Tse, Hung-Fat; Lian, Qizhou] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat; Lian, Qizhou] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Cheah, Kathryn S.; Lian, Qizhou] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Lian, QZ (reprint author), Univ Hong Kong, Dept Med, Cardiol Div, Hong Kong 000000, Hong Kong, Peoples R China.	qzlian@hku.hk			NSFC [31270967, 31571407]; Shenzhen seed grant [JCYJ20140828163633995]; Hong Kong TRS [T12-708/12-N]; Hong Kong RGC GRF [HKU17113816, HKU17120517]	This research was supported in part by the NSFC (grants 31270967 and 31571407 to Q.L.), a Shenzhen seed grant (JCYJ20140828163633995), Hong Kong TRS (grant T12-708/12-N), and Hong Kong RGC GRF (grants HKU17113816 and HKU17120517 to Q.L.).	Adkar SS, 2016, MOL THER, V24, pS128, DOI 10.1016/S1525-0016(16)33127-6                                                   ; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Avior Y, 2017, STEM CELL REP, V8, P1354, DOI 10.1016/j.stemcr.2017.03.005; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Blum R, 2016, BLOOD, V128; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Buchschacher GL, 2000, BLOOD, V95, P2499; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chang CJ, 2016, BLOOD, V128; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fessler E, 2016, EMBO MOL MED, V8, P745, DOI 10.15252/emmm.201606184; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gerace D, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0511-8; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Guo DS, 2017, STEM CELL RES, V18, P67, DOI 10.1016/j.scr.2016.12.007; Guo JY, 2017, PROTEIN CELL, V8, P379, DOI 10.1007/s13238-016-0360-8; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hunt CPJ, 2017, NEUROCHEM INT, V106, P3, DOI 10.1016/j.neuint.2017.01.003; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Luo Y., 2016, STEM CELLS INT, V2016; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Pan A, 2014, MED HYPOTHESES, V83, P702, DOI 10.1016/j.mehy.2014.09.022; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Sohn EH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11791; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Stuckey DW, 2014, NAT REV CANCER, V14, P683, DOI 10.1038/nrc3798; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Upadhyay SK, 2014, BIOMED RES INT, DOI 10.1155/2014/742482; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Wang G, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.152; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Woo DH, 2016, CELL STEM CELL, V19, P397, DOI 10.1016/j.stem.2016.05.024; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao X, 1998, J VIROL, V72, P2224; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xu L, 2017, MOL THER, V25, P1782, DOI 10.1016/j.ymthe.2017.04.027; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1047/jbc.M200748200; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zlotorynski Eytan, 2016, Nat Rev Mol Cell Biol, V18, P4, DOI 10.1038/nrm.2016.169; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zufferey R, 1998, J VIROL, V72, P9873	147	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	DEC 15	2017	9						230	241		10.1016/j.omtn.2017.09.009				12	Medicine, Research & Experimental	Research & Experimental Medicine	FQ6SJ	WOS:000418494000022	29246302	gold			2018-01-05	
J	Gautron, AS; Juillerat, A; Guyot, V; Filhol, JM; Dessez, E; Duclert, A; Duchateau, P; Poirot, L				Gautron, Anne-Sophie; Juillerat, Alexandre; Guyot, Valerie; Filhol, Jean-Marie; Dessez, Emilie; Duclert, Aymeric; Duchateau, Philippe; Poirot, Laurent			Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							TUMOR MICROENVIRONMENT; EFFECTOR NUCLEASES; CRYSTAL-STRUCTURE; DNA RECOGNITION; BLOCKADE; BINDING; PD-1; SPECIFICITY; THERAPY; CANCER	Using a TALEN-mediated gene-editing approach, we have previously described a process for the large-scale manufacturing of "off-the-shelf" CAR T cells from third-party donor T cells by disrupting the gene encoding TCR alpha constant chain (TRAC). Taking advantage of a previously described strategy to control TALEN targeting based on the exclusion capacities of non-conventional RVDs, we have developed highly efficient and specific nucleases targeting a key T cell immune checkpoint, PD-1, to improve engineered CAR T cells' functionalities. Here, we demonstrate that this approach allows combined TRAC and PDCD1 TALEN processing at the desired locus while eliminating low-frequency off-site processing. Thus, by replacing few RVDs, we provide here an easy and rapid redesign of optimal TALEN combinations. We anticipate that this method can greatly benefit multiplex editing, which is of key importance especially for therapeutic applications where high editing efficiencies need to be associated with maximal specificity and safety.	[Gautron, Anne-Sophie; Guyot, Valerie; Filhol, Jean-Marie; Dessez, Emilie; Duclert, Aymeric; Duchateau, Philippe; Poirot, Laurent] Cellectis SA, 8 Rue Croix Jarry, F-75013 Paris, France; [Juillerat, Alexandre] Cellectis Inc, 430E 29th St, New York, NY 10016 USA	Gautron, AS; Duchateau, P (reprint author), Cellectis SA, 8 Rue Croix Jarry, F-75013 Paris, France.	anne-sophie.gautron@cellectis.com; philippe.duchateau@cellectis.com					Beatty GL, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28327; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945                                                      ; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Flade S, 2017, ACS CHEM BIOL, V12, P1719, DOI 10.1021/acschembio.7b00324; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Gersbach CA, 2014, EXPERT OPIN THER TAR, V18, P835, DOI 10.1517/14728222.2014.913572; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jadus MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/160724; Juillerat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08150; Juillerat A, 2014, NUCLEIC ACIDS RES, V42, P5390, DOI 10.1093/nar/gku155; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Liu XJ, 2016, CANCER RES, V76, P1578, DOI 10.1158/0008-5472.CAN-15-2524; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Menger L, 2016, CANCER RES, V76, P2087, DOI 10.1158/0008-5472.CAN-15-3352; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Niu JW, 2014, MOL BIOTECHNOL, V56, P681, DOI 10.1007/s12033-014-9771-z; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pen JJ, 2014, GENE THER, V21, P262, DOI 10.1038/gt.2013.80; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Ren JT, 2017, ONCOTARGET, V8, P17002, DOI 10.18632/oncotarget.15218; Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8; Scharenberg AM, 2013, CURR GENE THER, V13, P291; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Valton J, 2015, MOL THER, V23, P1507, DOI 10.1038/mt.2015.104; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2; Yang JJ, 2014, CELL RES, V24, P628, DOI 10.1038/cr.2014.19; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	46	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	DEC 15	2017	9						312	321		10.1016/j.omtn.2017.10.005				10	Medicine, Research & Experimental	Research & Experimental Medicine	FQ6SJ	WOS:000418494000029	29246309	gold			2018-01-05	
J	Provenzano, C; Cappella, M; Valaperta, R; Cardani, R; Meola, G; Martelli, F; Cardinali, B; Falcone, G				Provenzano, Claudia; Cappella, Marisa; Valaperta, Rea; Cardani, Rosanna; Meola, Giovanni; Martelli, Fabio; Cardinali, Beatrice; Falcone, Germana			CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TYPE-1 MUSCLE-CELLS; MOUSE MODEL; CAS9 NUCLEASES; RNA; REPEAT; GENE; CRISPR-CAS9; INSTABILITY; THERAPY	Myotonic dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy, characterized by progressive myopathy, myotonia, and multi-organ involvement. This dystrophy is an inherited autosomal dominant disease caused by a (CTG)n expansion within the 30 untranslated region of the DMPK gene. Expression of the mutated gene results in production of toxic transcripts that aggregate as nuclear foci and sequester RNA-binding proteins, resulting in mis-splicing of several transcripts, defective translation, and microRNA dysregulation. No effective therapy is yet available for treatment of the disease. In this study, myogenic cell models were generated from myotonic dystrophy patient-derived fibroblasts. These cells exhibit typical disease-associated ribonuclear aggregates, containing CUG repeats and muscleblind-like 1 protein, and alternative splicing alterations. We exploited these cell models to develop new gene therapy strategies aimed at eliminating the toxic mutant repeats. Using the CRISPR/Cas9 gene-editing system, the repeat expansions were removed, therefore preventing nuclear foci formation and splicing alterations. Compared with the previously reported strategies of inhibition/degradation of CUG expanded transcripts by various techniques, the advantage of this approach is that affected cells can be permanently reverted to a normal phenotype.	[Provenzano, Claudia; Cappella, Marisa; Cardinali, Beatrice; Falcone, Germana] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Cappella, Marisa] Sapienza Univ Rome, DAHFMO Unit Histol & Med Embryol, Rome, Italy; [Valaperta, Rea] Policlin San Donato IRCCS, Mol Biol Lab, Milan, Italy; [Cardani, Rosanna] Policlin San Donato IRCCS, Muscle Histopathol & Mol Biol Lab, Milan, Italy; [Meola, Giovanni] IRCCS Policlin San Donato, Dept Neurol, Milan, Italy; [Meola, Giovanni] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Martelli, Fabio] Policlin San Donato IRCCS, Mol Cardiol Lab, Milan, Italy	Cardinali, B; Falcone, G (reprint author), CNR, Inst Cell Biol & Neurobiol, Rome, Italy.	beatrice.cardinali@cnr.it; germana.falcone@cnr.it			Telethon-Italy [GGP14092]; AFM-Telethon [18477]; Ministero della Salute; Telethon-Italy	We thank Cora Chadick for cell sorting at the EMBL flow cytometry facility in Monterotondo, Italy, and James Sawitzke, EMBL Monterotondo, Italy, for proofreading the manuscript. We gratefully acknowledge the financial support of Telethon-Italy (grant no. GGP14092 to F.M. and G.F.), AFM-Telethon (grant no. 18477 to F.M. and G.F.), and Ministero della Salute (to F.M.). M.C. is a recipient of a fellowship from Telethon-Italy.	Arandel L, 2017, DIS MODEL MECH, V10, P487, DOI 10.1242/dmm.027367; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Bisset DR, 2015, HUM MOL GENET, V24, P4971, DOI 10.1093/hmg/ddv219; Botta A, 2013, GENES-BASEL, V4, P275, DOI 10.3390/genes4020275; Brouwer J.R., 2013, J NUCL ACIDS, V2013, DOI DOI 10.1155/2013/567435; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Falcone G, 2014, BIOMED RES INT, DOI 10.1155/2014/503634; Falcone G, 2013, AGING CELL, V12, P312, DOI 10.1111/acel.12034; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao YZ, 2016, MOL THER, V24, P1378, DOI 10.1038/mt.2016.97; Gomes-Pereira M, 2011, TRENDS MOL MED, V17, P506, DOI 10.1016/j.molmed.2011.05.004; Groh WJ, 2011, MUSCLE NERVE, V43, P648, DOI 10.1002/mus.21934; Harper P.S, 2001, DISORDERS VOLUNTARY, P541; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lam LT, 2000, HUM MOL GENET, V9, P2167, DOI 10.1093/hmg/9.14.2167; Larsen Jan, 2011, BMC Res Notes, V4, P490, DOI 10.1186/1756-0500-4-490; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Loro E, 2010, CELL DEATH DIFFER, V17, P1315, DOI 10.1038/cdd.2010.33; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769                                                   ; Meola G, 2015, BBA-MOL BASIS DIS, V1852, P594, DOI 10.1016/j.bbadis.2014.05.019; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pantic B, 2016, EXP CELL RES, V342, P39, DOI 10.1016/j.yexcr.2016.02.013; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Santoro M, 2014, NEUROPATH APPL NEURO, V40, P464, DOI 10.1111/nan.12076; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704                                                                   ; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Turner C, 2014, CURR OPIN NEUROL, V27, P599, DOI 10.1097/WCO.0000000000000128; Valaperta R, 2013, BIOMED RES INT, DOI 10.1155/2013/958510; van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014; Wahbi K, 2017, EUR HEART J, V38, P751, DOI 10.1093/eurheartj/ehw569; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wojtkowiak-Szlachcic A, 2015, NUCLEIC ACIDS RES, V43, P3318, DOI 10.1093/nar/gkv163; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	55	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	DEC 15	2017	9						337	348		10.1016/j.omtn.2017.10.006				12	Medicine, Research & Experimental	Research & Experimental Medicine	FQ6SJ	WOS:000418494000032	29246312	gold			2018-01-05	
J	Aquino-Jarquin, G				Aquino-Jarquin, Guillermo			Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research	CANCER RESEARCH			English	Review							RENAL-CELL CARCINOMA; OVARIAN-CANCER; CRISPR-CAS9 SYSTEM; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; IN-VIVO; GENOME; EXPRESSION; GENE; DELIVERY	MicroRNAs (miRNA) are small, noncoding RNA molecules with a master role in the regulation of important tasks in different critical processes of cancer pathogenesis. Because there are different miRNAs implicated in all the stages of cancer, for example, functioning as oncogenes, this makes these small molecules suitable targets for cancer diagnosis and therapy. RNA-mediated interference has been one major approach for sequence-specific regulation of gene expression in eukaryotic organisms. Recently, the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 system, first identified in bacteria and archaea as an adaptive immune response to invading genetic material, has been explored as a sequence-specific molecular tool for editing genomic sequences for basic research in life sciences and for therapeutic purposes. There is growing evidence that small noncoding RNAs, including miRNAs, can be targeted by the CRISPR/Cas9 system despite their lacking an open reading frame to evaluate functional loss. Thus, CRISPR/Cas9 technology represents a novel gene-editing strategy with compelling robustness, specificity, and stability for the modification of miRNA expression. Here, I summarize key features of current knowledge of genomic editing by CRISPR/Cas9 technology as a feasible strategy for globally interrogating miRNA gene function and miRNA-based therapeutic intervention. Alternative emerging strategies for nonviral delivery of CRISPR/Cas9 core components into human cells in a clinical context are also analyzed critically. (C) 2017 AACR.	[Aquino-Jarquin, Guillermo] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Gen Genet & Bioinformat, Torre Hemato Oncol,4to Piso,Secc 2, Mexico City, Cdmx, Mexico	Aquino-Jarquin, G (reprint author), Hosp Infantil Mexico Dr Federico Gomez, Doctor Marquez 162, Mexico City 06720, Cdmx, Mexico.	guillaqui@himfg.edu.mx			Mexican Federal Funds [HIM/2017/043-SSA-1326]	G. Aquino-Jarquin is supported by grant HIM/2017/043-SSA-1326 from Mexican Federal Funds.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175                                                      ; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Aquino-Jarquin G, 2011, INT J MOL SCI, V12, P9155, DOI 10.3390/ijms12129155; Arya D, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.471; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Burke JM, 2014, RNA, V20, P1068, DOI 10.1261/rna.044537.114; Chang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22312; Chira S, 2017, MOL THER-NUCL ACIDS, V7, P211, DOI 10.1016/j.omtn.2017.04.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Solis CA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00070; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guernet A, 2017, METHODS, V121, P130, DOI 10.1016/j.ymeth.2017.03.007; 하대유, 2011, Immune Network, V11, P135; Hao J, 2011, FEBS LETT, V585, P207, DOI 10.1016/j.febslet.2010.11.039; He D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112930; Hirosawa M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx309; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huo WY, 2017, J CANCER, V8, P57, DOI 10.7150/jca.16723; Jiang Q, 2014, RNA BIOL, V11, P1243, DOI 10.1080/15476286.2014.996067; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kunej T, 2012, CANCER J, V18, P223, DOI 10.1097/PPO.0b013e318258b771; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li XD, 2017, BRIT J CANCER, V116, P66, DOI 10.1038/bjc.2016.379; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maher ER, 2013, SEMIN CANCER BIOL, V23, P10, DOI 10.1016/j.semcancer.2012.06.003; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rapti Irene, 2015, World J Hepatol, V7, P1064, DOI 10.4254/wjh.v7.i8.1064; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seth K, 2016, BIOCHEM BIOPH RES CO, V480, P499, DOI 10.1016/j.bbrc.2016.10.130; Shao Ming, 2016, [Zoological Research, 动物学研究], V37, P191, DOI 10.13918/j.issn.2095-8137.2016.4.191; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song PP, 2016, WORLD J GASTROENTERO, V22, P262, DOI 10.3748/wjg.v22.i1.262; Su ZM, 2015, EXP THER MED, V9, P961, DOI 10.3892/etm.2015.2199; Toscano-Garibay JD, 2012, DNA CELL BIOL, V31, P1358, DOI 10.1089/dna.2012.1703; Vorvis C, 2016, AM J PHYSIOL-GASTR L, V310, pG1124, DOI 10.1152/ajpgi.00035.2016; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang DY, 2017, ONCOL LETT, V13, P2053, DOI 10.3892/ol.2017.5690; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YX, 2012, REGUL PEPTIDES, V178, P36, DOI 10.1016/j.regpep.2012.06.005; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xu L, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1048; Yoshino H, 2017, ONCOTARGET, V8, P20881, DOI 10.18632/oncotarget.14930; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhao YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03943; Zhen S, 2017, ONCOTARGET, V8, P9375, DOI 10.18632/oncotarget.14072; Zhou SJ, 2017, CELL DEATH DIFFER, V24, P1577, DOI 10.1038/cdd.2017.87	60	0	0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	DEC 15	2017	77	24					6812	6817		10.1158/0008-5472.CAN-17-2142				6	Oncology	Oncology	FQ2ME	WOS:000418189800002	29208606				2018-01-05	
J	Caculitan, NG; Chuh, JD; Ma, Y; Zhang, DL; Kozak, KR; Liu, YC; Pillow, TH; Sadowsky, J; Cheung, TK; Phung, Q; Haley, B; Lee, BC; Akita, RW; Sliwkowski, MX; Polson, AG				Caculitan, Nina G.; Chuh, Josefa dela Cruz; Ma, Yong; Zhang, Donglu; Kozak, Katherine R.; Liu, Yichin; Pillow, Thomas H.; Sadowsky, Jack; Cheung, Tommy K.; Phung, Qui; Haley, Benjamin; Lee, Byoung-Chul; Akita, Robert W.; Sliwkowski, Mark X.; Polson, Andrew G.			Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates	CANCER RESEARCH			English	Article							SITE-SPECIFIC CONJUGATION; NON-HODGKINS-LYMPHOMA; ANTICANCER ACTIVITY; CYSTEINE PROTEASES; CANCER; LINKER; POTENT; TRASTUZUMAB; PROGRESSION; CALICHEAMICIN	Antibody-drug conjugates (ADC) are designed to selectively bind to tumor antigens via the antibody and release their cytotoxic payload upon internalization. Controllable payload release through judicious design of the linker has been an early technological milestone. Here, we examine the effect of the protease-cleavable valine-citrulline [VC(S)] linker on ADC efficacy. The VC(S) linker was designed to be cleaved by cathepsin B, a lysosomal cysteine protease. Surprisingly, suppression of cathepsin B expression via CRISPR-Cas9 gene deletion or shRNA knockdown had no effect on the efficacy of ADCs with VC(S) linkers armed with a monomethyl auristatin E (MMAE) payload. Mass spectrometry studies of payload release suggested that other cysteine cathepsins can cleave the VC(S) linker. Also, ADCs with a nonprotease-cleavable enantiomer, the VC(R) isomer, mediated effective cell killing with a cysteine-VC(R)-MMAE catabolite generated by lysosomal catabolism. Based on these observations, we altered the payload to a pyrrolo[2,1-c][1,4] benzodiazepine dimer (PBD) conjugate that requires linker cleavage in order to bind its DNA target. Unlike the VC-MMAE ADCs, the VC(S)-PBD ADC is at least 20-fold more cytotoxic than the VC(R)-PBD ADC. Our findings reveal that the VC(S) linker has multiple paths to produce active catabolites and that antibody and intracellular targets are more critical to ADC efficacy. These results suggest that protease-cleavable linkers are unlikely to increase the therapeutic index of ADCs and that resistance based on linker processing is improbable. (C) 2017 AACR.	[Caculitan, Nina G.; Chuh, Josefa dela Cruz; Ma, Yong; Zhang, Donglu; Kozak, Katherine R.; Liu, Yichin; Pillow, Thomas H.; Sadowsky, Jack; Cheung, Tommy K.; Phung, Qui; Haley, Benjamin; Akita, Robert W.; Sliwkowski, Mark X.; Polson, Andrew G.] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Lee, Byoung-Chul] 23andMe, San Francisco, CA USA; [Ma, Yong] Calithera Biosci, San Francisco, CA USA	Polson, AG (reprint author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	polson@gene.com					Allan ERO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128945; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; Dal Corso A, 2017, BIOCONJUGATE CHEM, V28, P1826, DOI 10.1021/acs.bioconjchem.7b00304; de Groot FMH, 2001, CURR MED CHEM, V8, P1093; DiJoseph JF, 2004, BLOOD, V103, P1807, DOI 10.1182/blood-2003-07-2466; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dorywalska M, 2016, MOL CANCER THER, V15, P958, DOI 10.1158/1535-7163.MCT-15-1004; Dubowchik GM, 2002, BIOCONJUGATE CHEM, V13, P855, DOI 10.1021/bc025536j; Erickson HK, 2012, MOL CANCER THER, V11, P1133, DOI 10.1158/1535-7163.MCT-11-0727; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Hamann PR, 2002, BIOCONJUGATE CHEM, V13, P47, DOI 10.1021/bc010021y; Jain N, 2015, PHARM RES-DORDR, V32, P3526, DOI 10.1007/s11095-015-1657-7; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Lehar SM, 2015, NATURE, V527, P323, DOI 10.1038/nature16057; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Mariathasan S, 2017, TRENDS MOL MED, V23, P135, DOI 10.1016/j.molmed.2016.12.008; Miller ML, 2016, MOL CANCER THER, V15, P1870, DOI 10.1158/1535-7163.MCT-16-0184; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u                                                               ; Polson AG, 2010, LEUKEMIA, V24, P1566, DOI 10.1038/leu.2010.141; Polson AG, 2009, CANCER RES, V69, P2358, DOI 10.1158/0008-5472.CAN-08-2250; POOLE AR, 1978, NATURE, V273, P545, DOI 10.1038/273545a0; Rodriguez-Franco EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036571; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757                                                         ; Rudin CM, 2017, LANCET ONCOL, V18, P42, DOI [10.1016/S1470-2045(16)30565-4, 10.1016/s1470-2045(16)30565-4]; Saunders LR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9459; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Zhang DL, 2016, ACS MED CHEM LETT, V7, P988, DOI 10.1021/acsmedchemlett.6b00233	38	0	0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	DEC 15	2017	77	24					7027	7037		10.1158/0008-5472.CAN-17-2391				11	Oncology	Oncology	FQ2ME	WOS:000418189800020	29046337				2018-01-05	
J	Bettembourg, M; Dal-Soglio, M; Bureau, C; Vernet, A; Dardoux, A; Portefaix, M; Bes, M; Meynard, D; Mieulet, D; Cayrol, B; Perin, C; Courtois, B; Ma, JF; Dievart, A				Bettembourg, M.; Dal-Soglio, M.; Bureau, C.; Vernet, A.; Dardoux, A.; Portefaix, M.; Bes, M.; Meynard, D.; Mieulet, D.; Cayrol, B.; Perin, C.; Courtois, B.; Ma, J. F.; Dievart, A.			Root cone angle is enlarged in docs1 LRR-RLK mutants in rice	RICE			English	Article						Rice; Root cap; Angle; Gravitropism; docs1; Lrr; Rlk; GSA; RCA; RGA	OUTER CELL-LAYERS; AUXIN TRANSPORT; REVERSE GENETICS; GROWTH ANGLE; DEEPER-ROOTING-1; SPECIFICATION; GRAVITROPISM; ARCHITECTURE; MUTAGENESIS; MECHANISM	The DEFECTIVE IN OUTER CELL LAYER SPECIFICATION 1 (DOCS1) gene belongs to the Leucine-Rich Repeat Receptor-Like Kinase (LRR-RLK) subfamily. It has been discovered few years ago in Oryza sativa (rice) in a screen to isolate mutants with defects in sensitivity to aluminum. The c68 (docs1-1) mutant possessed a nonsense mutation in the C-terminal part of the DOCS1 kinase domain. We have generated a new loss-of-function mutation in the DOCS1 gene (docs1-2) using the CRISPR-Cas9 technology. This new loss-of-function mutant and docs1-1 present similar phenotypes suggesting the original docs1-1 was a null allele. Besides the aluminum sensitivity phenotype, both docs1 mutants shared also several root phenotypes described previously: less root hairs and mixed identities of the outer cell layers. Moreover, our new results suggest that DOCS1 could also play a role in root cap development. We hypothesized these docs1 root phenotypes may affect gravity responses. As expected, in seedlings, the early gravitropic response was delayed. Furthermore, at adult stage, the root gravitropic set angle of docs1 mutants was also affected since docs1 mutant plants displayed larger root cone angles. All these observations add new insights into the DOCS1 gene function in gravitropic responses at several stages of plant development.	[Bettembourg, M.; Dal-Soglio, M.; Bureau, C.; Vernet, A.; Dardoux, A.; Portefaix, M.; Bes, M.; Meynard, D.; Mieulet, D.; Cayrol, B.; Perin, C.; Courtois, B.; Dievart, A.] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Bettembourg, M.; Dal-Soglio, M.; Bureau, C.; Vernet, A.; Dardoux, A.; Portefaix, M.; Bes, M.; Meynard, D.; Mieulet, D.; Cayrol, B.; Perin, C.; Courtois, B.; Dievart, A.] Univ Montpellier, AGAP, CIRAD, INRA,Montpellier SupAgro, Montpellier, France; [Ma, J. F.] Okayama Univ, Inst Plant Sci & Resources, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan; [Dievart, A.] SJTU, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Dievart, A (reprint author), CIRAD, UMR AGAP, F-34398 Montpellier, France.; Dievart, A (reprint author), Univ Montpellier, AGAP, CIRAD, INRA,Montpellier SupAgro, Montpellier, France.; Dievart, A (reprint author), SJTU, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.	mathilde_bettembourg@hotmail.com; marinadalsoglio29@gmail.com; charlotte.bureau@cirad.fr; aurore.vernet@cirad.fr; audrey.dardou@cirad.fr; murielle.portefaix@cirad.fr; martine.bes@cirad.fr; donaldo.meynard@cirad.fr; delphine.mieulet@cirad.fr; bastien.cayrol@inra.fr; christophe.perin@cirad.fr; brigitte.courtois@cirad.fr; maj@rib.okayama-u.ac.jp; anne.dievart@cirad.fr			Centre de cooperation Internationale de Recherche en Agronomie pour le Developpement (CIRAD) PhD fellowship	This work was supported by the Centre de cooperation Internationale de Recherche en Agronomie pour le Developpement (CIRAD) PhD fellowship to MBet.	Adamowski M, 2015, PLANT CELL, V27, P20, DOI 10.1105/tpc.114.134874; Armengot L, 2016, J EXP BOT, V67, P4015, DOI 10.1093/jxb/erw216; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Bettembourg M, 2017, RICE, V10, DOI 10.1186/s12284-017-0184-z; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Digby J, 1995, PLANT CELL ENVIRON, V18, P1434, DOI 10.1111/j.1365-3040.1995.tb00205.x; Dufayard JF, 2017, FRONT PLANT SCI, V8, DOI [10.3389/fpls.2017.00381, 10.3389/fpls.2017.00916]; Firn RD, 1997, PLANTA, V203, pS159, DOI 10.1007/PL00008104; Hanzawa E, 2013, RICE, V6, DOI 10.1186/1939-8433-6-30; Huang CF, 2012, PLANT J, V69, P565, DOI 10.1111/j.1365-313X.2011.04824.x; Huang CF, 2009, PLANT CELL PHYSIOL, V50, P976, DOI 10.1093/pcp/pcp050; Kitomi Y, 2015, RICE, V8, DOI 10.1186/s12284-015-0049-2; Lartaud M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00790; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Ma XY, 2016, TRENDS PLANT SCI, V21, P1017, DOI [10.1016/j.tplants.2016.06.014, 10.1016/j.tplants.2016.08.014]; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mieulet D, 2013, METHODS MOL BIOL, V1057, P205, DOI 10.1007/978-1-62703-568-2_15; Rosquete MR, 2013, CURR BIOL, V23, P817, DOI 10.1016/j.cub.2013.03.064; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Sato EM, 2015, J EXP BOT, V66, P2155, DOI [10.1093/jxb/eru515, 10.1093/jxb/er]; Uga Y, 2015, BREEDING SCI, V65, P111, DOI 10.1270/jsbbs.65.111; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Wu YZ, 2016, MOL PLANT, V9, P289, DOI 10.1016/j.molp.2015.12.011	24	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1939-8425	1939-8433		RICE	Rice	DEC 15	2017	10								50	10.1186/s12284-017-0190-1				8	Agronomy	Agriculture	FQ4NJ	WOS:000418334000001	29247303	gold			2018-01-05	
J	Sheth, RU; Yim, SS; Wu, FL; Wang, HH				Sheth, Ravi U.; Yim, Sung Sun; Wu, Felix L.; Wang, Harris H.			Multiplex recording of cellular events over time on CRISPR biological tape	SCIENCE			English	Article							IMMUNE-RESPONSE; LIVING BACTERIA; CAS SYSTEMS; ACQUISITION; ADAPTATION; GENOME; CELLS; DNA; PROKARYOTES; INTEGRATION	Although dynamics underlie many biological processes, our ability to robustly and accurately profile time-varying biological signals and regulatory programs remains limited. Here we describe a framework for storing temporal biological information directly in the genomes of a cell population. We developed a "biological tape recorder" in which biological signals trigger intracellular DNA production that is then recorded by the CRISPR-Cas adaptation system. This approach enables stable recording over multiple days and accurate reconstruction of temporal and lineage information by sequencing CRISPR arrays. We further demonstrate a multiplexing strategy to simultaneously record the temporal availability of three metabolites (copper, trehalose, and fucose) in the environment of a cell population over time. This work enables the temporal measurement of dynamic cellular states and environmental changes and suggests new applications for chronicling biological events on a large scale.	[Sheth, Ravi U.; Yim, Sung Sun; Wu, Felix L.; Wang, Harris H.] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Sheth, Ravi U.; Wu, Felix L.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY USA; [Wang, Harris H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA	Wang, HH (reprint author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Wang, HH (reprint author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	hw2429@columbia.edu			Department of Defense Office of Naval Research [N00014-17-1-2353, N00014-15-1-2704]; NIH Director's Early Independence Award [DP50D009172-02]; Sloan Foundation [FR-2015-65795]; Fannie and John Hertz Foundation; NSF [DGE 16-44869]; NIH [T32GM008224]	We thank T. Blazejewski, C. Munck, and members of the Wang laboratory for advice and comments on the manuscript. Sequencing data associated with this study are available in the National Center for Biotechnology Information Sequence Read Archive under PRJNA417866 and plasmids are available through Addgene. H.H.W. acknowledges specific funding support from the Department of Defense Office of Naval Research (N00014-17-1-2353 and N00014-15-1-2704), an NIH Director's Early Independence Award DP50D009172-02), and the Sloan Foundation (FR-2015-65795) for this work. R.U.S. is supported by a Fannie and John Hertz Foundation Graduate Fellowship and an NSF Graduate Research Fellowship (DGE 16-44869). F.L.W. is supported by an NIH training grant (T32GM008224). R.U.S., S.S.Y., and H.H.W. developed the initial concept; R.U.S., S.SY. and FUN. performed experiments; R.U.S. and F.L.W. analyzed the sequencing data: R.U.S. and H.H.W. wrote the manuscript; and. all authors discussed results and commented on and approved the manuscript. H.H.W. and R.U.S. are inventors or, a provisional patent application, filed by the Trustees of Columbia University in the City of New York regarding this work.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Elbaz J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11179; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Heler R, 2017, MOL CELL, V65, P168, DOI 10.1016/j.molcel.2016.11.031; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/NMETH.4108, 10.1038/nmeth.4108]; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Pei W., 2011, NATURE, V548, P456; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Schmidt ST, 2017, ACS SYNTH BIOL, V6, P936, DOI 10.1021/acssynbio.6b00309; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/NMETH.3147, 10.1038/nmeth.3147]; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	30	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1457	+		10.1126/science.aao0958				5	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8TH	WOS:000417918500047	29170279				2018-01-05	
J	Chung, EJ; Efstathiou, NE; Konstantinou, EK; Maidana, DE; Miller, JW; Young, LH; Vavvas, DG				Chung, Eun Jee; Efstathiou, Nikolaos E.; Konstantinou, Eleni K.; Maidana, Daniel E.; Miller, Joan W.; Young, Lucy H.; Vavvas, Demetrios G.			AICAR suppresses TNF-alpha-induced complement factor B in RPE cells	SCIENTIFIC REPORTS			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; PIGMENT EPITHELIAL-CELLS; INDUCED CHOROIDAL NEOVASCULARIZATION; CARBOXAMIDE RIBONUCLEOTIDE AICAR; FACTOR-H POLYMORPHISM; AMP-DEPENDENT KINASE; MACULAR DEGENERATION; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; ENDOTHELIAL-CELLS	Age related macular degeneration is the leading cause of blindness in the developed world. Although its precise cause remains elusive, dysfunction of the retinal pigment epithelium (RPE) and dysregulation of complement have been implicated in its pathogenesis. The goal of this study was to evaluate the role of an AMP-dependent kinase (AMPK) activator, 5-aminoimidazole-4-carboxamide riboside (AICAR), on tumor necrosis factor alpha (TNF-alpha) induction of complement factor B (CFB) in RPE cells. We found that AICAR inhibited TNF-alpha-induced CFB expression in ARPE-19 and human primary RPE cells in a dose-dependent fashion. Treatment of cells with dipyridamole, which blocks AICAR cellular uptake abolished these effects. In contrast, the adenosine kinase inhibitor, 5-iodotubericidin, which inhibits the conversion of AICAR to the direct activator of AMPK, ZMP, did not reverse the effects on TNF-alpha-induced CFB expression, suggesting AMPK-independent effects. Indeed, knockout of AMPK in RPE cells using Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 did not abolish the inhibitory effects of AICAR on RPE CFB expression. Collectively, our results suggest that AICAR can suppress TNF-alpha-induced CFB expression in RPE cells in an AMPK-independent mechanism, and could be used as a therapeutic target in certain complement over-activation scenarios.	[Chung, Eun Jee; Efstathiou, Nikolaos E.; Konstantinou, Eleni K.; Maidana, Daniel E.; Miller, Joan W.; Young, Lucy H.; Vavvas, Demetrios G.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Retina Serv,Angiogenesis Lab, Boston, MA 02114 USA; [Chung, Eun Jee] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Ophthalmol, Gyeonggi Do, South Korea	Vavvas, DG (reprint author), Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Retina Serv,Angiogenesis Lab, Boston, MA 02114 USA.	Demetrios_Vavvas@meei.harvard.edu			Yeatts Family Foundation; Loefflers Family Fund; Macula Society Research Grant award; RPB; Alcon Research Institute Young Investigator Award; Research to Prevent Blindness foundation; STAMATIOU foundation scholarship; NEI [EY014104];  [NEI R21EY023079-01A1];  [R01-EY025362-01]	This work was supported by: NEI R21EY023079-01A1, R01-EY025362-01 (DGV); the Yeatts Family Foundation (DGV, JWM); the Loefflers Family Fund (DGV, JWM); the 2013 Macula Society Research Grant award (DGV); a Physician Scientist Award from RPB and the Alcon Research Institute Young Investigator Award (DGV), an unrestricted grant (JWM) from the Research to Prevent Blindness foundation; NEI grant EY014104 (MEEI Core Grant) and the STAMATIOU foundation scholarship (NEE).	ANDOH A, 1993, J IMMUNOL, V151, P4239; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872                                                     ; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491                                                      ; Boss M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32111; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; CIRCOLO A, 1990, J BIOL CHEM, V265, P5066; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; COLTEN HR, 1982, MOL IMMUNOL, V19, P1279, DOI 10.1016/0161-5890(82)90294-2; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; COULPIER M, 1995, CLIN EXP IMMUNOL, V101, P142; DASILVA XG, 2000, P NATL ACAD SCI USA, V97, P4023, DOI DOI 10.1073/PNAS.97.8.4023); DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189                                                         ; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; HA J, 1994, J BIOL CHEM, V269, P22162; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627                                                     ; Jang TC, 2011, INT J CANCER, V128, P2230, DOI 10.1002/ijc.25558; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kawakami Y, 1997, CANCER LETT, V116, P21, DOI 10.1016/S0304-3835(97)04737-X; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6                                                   ; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Luo C, 2011, MOL VIS, V17, P1588; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Qin SF, 2008, INVEST OPHTH VIS SCI, V49, P1274, DOI 10.1167/iovs.07-1109; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177                                                               ; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Schnabolk G, 2015, INVEST OPHTH VIS SCI, V56, P1850, DOI 10.1167/iovs.14-15910; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Takeuchi K, 2013, J BIOL CHEM, V288, P20581, DOI 10.1074/jbc.M113.460832; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; TIMMERMAN JJ, 1995, HUM IMMUNOL, V43, P19, DOI 10.1016/0198-8859(94)00122-7; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x                                               ; Wang JY, 2008, J IMMUNOL, V181, P712, DOI 10.4049/jimmunol.181.1.712                                                      ; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618                                                            	52	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 15	2017	7								17651	10.1038/s41598-017-17744-w				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ3IM	WOS:000418250800036	29247196	gold			2018-01-05	
J	Hummer, BH; de Leeuw, NF; Burns, C; Chen, L; Joens, MS; Hosford, B; Fitzpatrick, JAJ; Asensio, CS				Hummer, Blake H.; de Leeuw, Noah F.; Burns, Christian; Chen, Lan; Joens, Matthew S.; Hosford, Bethany; Fitzpatrick, James A. J.; Asensio, Cedric S.			HID-1 controls formation of large dense core vesicles by influencing cargo sorting and trans-Golgi network acidification	MOLECULAR BIOLOGY OF THE CELL			English	Article							REGULATED SECRETORY PATHWAY; VESICULAR MONOAMINE TRANSPORTER-2; AP-1 ADAPTER COMPLEX; CAENORHABDITIS-ELEGANS; H+-ATPASE; GRANULE BIOGENESIS; VACUOLAR ATPASES; PC12 CELLS; PROTEIN; PH	Large dense core vesicles (LDCVs) mediate the regulated release of neuropeptides and peptide hormones. They form at the trans-Golgi network (TGN), where their soluble content aggregates to form a dense core, but the mechanisms controlling biogenesis are still not completely understood. Recent studies have implicated the peripheral membrane protein HID-1 in neuropeptide sorting and insulin secretion. Using CRISPR/Cas9, we generated HID-1 KO rat neuroendocrine cells, and we show that the absence of HID-1 results in specific defects in peptide hormone and monoamine storage and regulated secretion. Loss of HID-1 causes a reduction in the number of LDCVs and affects their morphology and biochemical properties, due to impaired cargo sorting and dense core formation. HID-1 KO cells also exhibit defects in TGN acidification together with mislocalization of the Golgi-enriched vacuolar H+-ATPase subunit isoform a2. We propose that HID-1 influences early steps in LDCV formation by controlling dense core formation at the TGN.	[Hummer, Blake H.; de Leeuw, Noah F.; Burns, Christian; Chen, Lan; Hosford, Bethany; Asensio, Cedric S.] Univ Denver, Dept Biol Sci, Denver, CO 80210 USA; [Joens, Matthew S.; Fitzpatrick, James A. J.] Washington Univ, Sch Med, Ctr Cellular Imaging, St Louis, MO 63110 USA	Asensio, CS (reprint author), Univ Denver, Dept Biol Sci, Denver, CO 80210 USA.	Cedric.Asensio@du.edu			National Institutes of Health [GM116096]; American Heart Association [16BGIA27780049]; American Diabetes Association [1-17-JDF-064]; Washington University Center for Cellular Imaging; Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; Foundation for Barnes Jewish Hospital	We thank Emmanuel Boucrot and Dan Sirkis for critical reading of the manuscript, Dinah Loerke for help with image analysis, the Angleson lab for access to their microscope, members of the Asensio lab for thoughtful discussions, Josh Loomis and Shirley Sobus for help with cell sorting and analysis at the National Jewish Health Center flow cytometry core facility (Denver), Xiao-Song Xie for the a2 antibody, and the National Institutes of Health (GM116096), the American Heart Association (# 16BGIA27780049), and the American Diabetes Association (1-17-JDF-064) for support to C.S.A. M.S.J. and J.A.J.F. gratefully acknowledge support from the Washington University Center for Cellular Imaging, which is supported by the Washington University School of Medicine, the Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505), and the Foundation for Barnes Jewish Hospital.	Ailion M, 2014, NEURON, V82, P167, DOI 10.1016/j.neuron.2014.02.017; ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Argiolas A, 2013, PROG NEUROBIOL, V108, P80, DOI 10.1016/j.pneurobio.2013.06.006; Arvan P, 2004, TRAFFIC, V5, P53, DOI 10.1046/j.1600-0854.2003.00152.x; Asensio CS, 2013, DEV CELL, V27, P425, DOI [10.1016/j.devce1.2013.10.007, 10.1016/j.devcel.2013.10.007]; Asensio CS, 2010, J CELL BIOL, V191, P1173, DOI 10.1083/jcb.201006131; Cao MA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001541; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Dittie AS, 1996, J CELL BIOL, V132, P523, DOI 10.1083/jcb.132.4.523; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859                                                        ; Du W, 2016, ELIFE, V5, DOI 10.7554/eLife.18134; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Erickson JD, 1995, J MOL NEUROSCI, V6, P277, DOI 10.1007/BF02736786; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Hannemann M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002722; Holst B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001542; Hu G, 2013, ACS CHEM BIOL, V8, P1947, DOI 10.1021/cb400259n; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kakhlon O, 2006, EMBO J, V25, P1590, DOI 10.1038/sj.emboj.7601067; Kogel T, 2010, TRAFFIC, V11, P637, DOI 10.1111/j.1600-0854.2010.01048.x; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803                                                         ; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Mesa R, 2011, GENETICS, V187, P467, DOI 10.1534/genetics.110.121996; MOORE HP, 1983, NATURE, V302, P434, DOI 10.1038/302434a0; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222                                                            ; Pinheiro PS, 2014, J NEUROSCI, V34, P10688, DOI 10.1523/JNEUROSCI.5132-13.2014; Richter C, 2014, ANNU REV NEUROSCI, V37, P503, DOI 10.1146/annurev-neuro-062111-150447; Sasidharan N, 2012, P NATL ACAD SCI USA, V109, P18944, DOI 10.1073/pnas.1203306109; Saw NMN, 2011, MOL BIOL CELL, V22, P3394, DOI 10.1091/mbc.E11-02-0155; Sirkis DW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003812; Sohn JW, 2013, TRENDS NEUROSCI, V36, P504, DOI 10.1016/j.tins.2013.05.003; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Topalidou I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006074; Wang LF, 2011, PROTEIN CELL, V2, P74, DOI 10.1007/s13238-011-1008-3; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245                                                           ; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200                                                          ; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu Y, 2011, BIOCHEM J, V434, P383, DOI 10.1042/BJ20110027	53	0	0	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	DEC 15	2017	28	26					3870	3880		10.1091/mbc.E17-08-0491				11	Cell Biology	Cell Biology	FP7TY	WOS:000417843200012	29074564				2018-01-05	
J	DiStasio, A; Driver, A; Sund, K; Donlin, M; Muraleedharan, RM; Pooya, S; Kline-Fath, B; Kaufman, KM; Prows, CA; Schorry, E; Dasgupta, B; Stottmann, RW				DiStasio, Andrew; Driver, Ashley; Sund, Kristen; Donlin, Milene; Muraleedharan, Ranjith M.; Pooya, Shabnam; Kline-Fath, Beth; Kaufman, Kenneth M.; Prows, Cynthia A.; Schorry, Elizabeth; Dasgupta, Biplab; Stottmann, Rolf W.			Copb2 is essential for embryogenesis and hypomorphic mutations cause human microcephaly	HUMAN MOLECULAR GENETICS			English	Article							CORTICAL DEVELOPMENT; SEQUENCING DATA; PROTEIN; COATOMER; BRAIN; GENE; SIZE; TRANSPORT; MALFORMATIONS; GENERATION	Primary microcephaly is a congenital brain malformation characterized by a head circumference less than three standard deviations below the mean for age and sex and results in moderate to severe mental deficiencies and decreased lifespan. We recently studied two children with primary microcephaly in an otherwise unaffected family. Exome sequencing identified an autosomal recessive mutation leading to an amino acid substitution in a WD40 domain of the highly conserved Coatomer Protein Complex, Subunit Beta 2 (COPB2). To study the role of Copb2 in neural development, we utilized genome-editing technology to generate an allelic series in the mouse. Two independent null alleles revealed that Copb2 is essential for early stages of embryogenesis. Mice homozygous for the patient variant (Copb2(R254C/R254C)) appear to have a grossly normal phenotype, likely due to differences in corticogenesis between the two species. Strikingly, mice heterozygous for the patient mutation and a null allele (Copb2(R254C/Zfn)) show a severe perinatal phenotype including low neonatal weight, significantly increased apoptosis in the brain, and death within the first week of life. Immunostaining of the Copb2(R254C/Zfn) brain revealed a reduction in layer V (CTIP2(+)) neurons, while the overall cell density of the cortex is unchanged. Moreover, neurospheres derived from animals with Copb2 variants grew less than control. These results identify a general requirement for COPB2 in embryogenesis and a specific role in corticogenesis. We further demonstrate the utility of CRISPR-Cas9 generated mouse models in the study of potential pathogenicity of variants of potential clinical interest.	[DiStasio, Andrew; Driver, Ashley; Sund, Kristen; Donlin, Milene; Prows, Cynthia A.; Schorry, Elizabeth; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Muraleedharan, Ranjith M.; Pooya, Shabnam; Dasgupta, Biplab] Cincinnati Childrens Hosp Med Ctr, Div Hematol & Oncol, Cincinnati, OH 45229 USA; [Kline-Fath, Beth] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; [Kaufman, Kenneth M.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [Kaufman, Kenneth M.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Prows, Cynthia A.] Cincinnati Childrens Hosp Med Ctr, Div Patient Serv, Cincinnati, OH 45229 USA; [Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA	Stottmann, RW (reprint author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 7016, Cincinnati, OH 45229 USA.	rolf.stottmann@cchmc.org			Cincinnati Children's Research Foundation; National Institutes of Health [R01NS085023]	Cincinnati Children's Research Foundation and National Institutes of Health (R01NS085023 to R.W.S.)	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Basel-Vanagaite L, 2010, PEDIATR NEUROL, V43, P7, DOI 10.1016/j.pediatrneurol.2010.02.015; Bettayeb K, 2016, P NATL ACAD SCI USA, V113, P5418, DOI 10.1073/pnas.1604176113; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; Claerhout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039400; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396                                                   ; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; GARRETT WJ, 1980, RADIOLOGY, V136, P711, DOI 10.1148/radiology.136.3.7403552                                                 ; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Haack TB, 2013, INT REV NEUROBIOL, V110, P85, DOI 10.1016/B978-0-12-410502-7.00005-3; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429                                                                   ; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283                                                                  ; Jackson LP, 2014, CURR OPIN CELL BIOL, V29, P67, DOI 10.1016/j.ceb.2014.04.009; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; Patel ZH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00016; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sgourdou P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43708; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stottmann RW, 2013, HUM MOL GENET, V22, P4053, DOI 10.1093/hmg/ddt255; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Vece TJ, 2016, J CLIN IMMUNOL, V36, P377, DOI 10.1007/s10875-016-0271-8; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0                                                                ; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043	51	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	DEC 15	2017	26	24					4836	4848		10.1093/hmg/ddx362				13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FO2YW	WOS:000416671100007	29036432				2018-01-05	
J	Shi, L; Meng, TY; Zhao, ZL; Han, JS; Zhang, W; Gao, F; Cai, JH				Shi, Long; Meng, Tongyu; Zhao, Zhilong; Han, Jinsheng; Zhang, Wei; Gao, Fei; Cai, Jianhui			CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes	GENE			English	Article						CRISPR; CTLA-4; cytotoxic T lymphocytes; T cell-mediated antitumor immunity; Cancer immunotherapy	OVERCOMING IMMUNOLOGICAL-TOLERANCE; MELANOMA TARGETING CTLA-4; CELL-ACTIVATION; TUMOR-IMMUNITY; CANCER-IMMUNOTHERAPY; BREAST-CANCER; CD28 RECEPTOR; MOUSE MODEL; BLOCKADE; ANTIGEN	T cell-mediated anti-tumor immunity plays a pivotal role in cancer immune surveillance. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a protein receptor mainly expressed in activated T cells and regulatory T cells. CTLA-4 competes with CD28 for ligand binding and generates inhibitory signals to attenuate T cell activation. The blockade of CTLA-4 mediated immune inhibitory checkpoint has been associated with enhanced anti-tumor immunity. In this study, we use CRISPR-Cas9 system to knock out (KO) CTLA-4 from cytotoxic T lymphocytes (CTLs) and evaluate its effect on the anti-tumor activity of the CTLs. CTLA-4 KO CTLs robustly enhanced tumor cell death by 40% compared to the control and facilitated apoptosis and caspase activities in tumor cells. The knockout of CTLA-4 also increased TNF-alpha and IFN-gamma secretion of the CTLs by approximately 2 fold. The effectiveness of CTLA-4 KO in enhancing anti-tumor activity of the CTLs was verified in vivo using mouse xenograft model. The xenografted mice treated with CTLA-4 KO CTLs demonstrated repressed tumor growth and prolonged survival compared to the control group. Our data suggest that CRISPR targeting CTLA-4 immune checkpoint could significantly improve the anti-tumor activity of CTLs.	[Shi, Long] Hebei Med Univ, Hosp 2, Dept Oncol, Shijiazhuang 050000, Hebei, Peoples R China; [Cai, Jianhui] Hebei Med Univ, Dept Surg, Shijiazhuang 050000, Hebei, Peoples R China; [Gao, Fei; Cai, Jianhui] Hebei Gen Hosp, Dept Surg & Oncol, Shijiazhuang 050000, Hebei, Peoples R China; [Meng, Tongyu] First Hosp SJZ, Dept Gynecol Oncol, Shijiazhuang 050000, Hebei, Peoples R China; [Zhao, Zhilong] Jinzhou Med Univ, Affiliated Hosp 3, Dept Surg, Jinzhou 121000, Liaoning, Peoples R China; [Han, Jinsheng] Cangzhou Hosp Tradit Chinese Med & Western Med In, Dept Surg, Cangzhou 601000, Hebei, Peoples R China; [Zhang, Wei] Handan Cent Hosp, Dept Surg, Handan 056001, Hebei, Peoples R China	Cai, JH (reprint author), Hebei Med Univ, Dept Surg, Shijiazhuang 050000, Hebei, Peoples R China.	jianhuicai2002@163.com					BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BRETSCHER P, 1992, IMMUNOL TODAY, V13, P74, DOI 10.1016/0167-5699(92)90138-W                                                    ; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X                                                   ; DAMLE NK, 1988, J IMMUNOL, V140, P1753; Demaria S, 2005, CLIN CANCER RES, V11, P728; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991                                                              ; Espenschied J, 2003, J IMMUNOL, V170, P3401, DOI 10.4049/jimmunol.170.6.3401                                                     ; Fevery S, 2007, LEUKEMIA, V21, P1451, DOI 10.1038/sj.leu.2404720; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027                                                          ; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Grosso Joseph F, 2013, Cancer Immun, V13, P5; HARA T, 1985, J EXP MED, V161, P1513, DOI 10.1084/jem.161.6.1513; ISHIDA Y, 1992, EMBO J, V11, P3887; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N                                                    ; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 1999, P NATL ACAD SCI USA, V96, P15074, DOI 10.1073/pnas.96.26.15074; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; LEDBETTER JA, 1990, BLOOD, V75, P1531; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233                                                ; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Lute KD, 2005, BLOOD, V106, P3127, DOI 10.1182/blood-2005-06-2298; Mangsbo SM, 2010, J IMMUNOTHER, V33, P225, DOI 10.1097/CJI.0b013e3181c01fcb; MARTIN PJ, 1986, J IMMUNOL, V136, P3282; Mocellin S, 2013, BBA-REV CANCER, V1836, P187, DOI 10.1016/j.bbcan.2013.05.003; Pilones KA, 2009, CLIN CANCER RES, V15, P597, DOI 10.1158/1078-0432.CCR-08-1277; Ribas A, 2008, ONCOLOGIST, V13, P10, DOI 10.1634/theoncologist.13-S4-10; Saha A, 2010, SCAND J IMMUNOL, V71, P70, DOI 10.1111/j.1365-3083.2009.02355.x; Salama AKS, 2011, CLIN CANCER RES, V17, P4622, DOI 10.1158/1078-0432.CCR-10-2232; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; VANLIER RAW, 1991, EUR J IMMUNOL, V21, P1775, DOI 10.1002/eji.1830210731                                                          ; Waitz R, 2012, CANCER RES, V72, P430, DOI 10.1158/0008-5472.CAN-11-1782; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Weber J, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.13-S4-16; Yang YF, 1997, CANCER RES, V57, P4036; Yin LM, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-75	44	0	0	59	59	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	DEC 15	2017	636						36	41		10.1016/j.gene.2017.09.010				6	Genetics & Heredity	Genetics & Heredity	FL3HP	WOS:000414113800005	28888577				2018-01-05	
J	Jeong, JE; Rhee, JK; Kim, TM; Kwak, SM; Bang, SH; Cho, H; Cheon, YH; Min, JA; Yoo, GS; Kim, K; Choi, JS; Choi, SW; Kim, DJ				Jeong, Jo-Eun; Rhee, Je-Keun; Kim, Tae-Min; Kwak, Su-Min; Bang, Sol-hee; Cho, Hyun; Cheon, Young-Hoon; Min, Jung Ah; Yoo, Gil Sang; Kim, Kyudong; Choi, Jung-Seok; Choi, Sam-Wook; Kim, Dai-Jin			The association between the nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults	PLOS ONE			English	Article							VIDEO GAME ADDICTION; ALCOHOL DEPENDENCE; GENDER-DIFFERENCES; PATHOLOGICAL GAMBLERS; CHINESE ADOLESCENTS; RISK-FACTORS; POLYMORPHISM; IMPULSIVITY; POPULATION; COMPUTER	The primary aim of this study was to investigate the genetic predisposition of Internet gaming disorder (IGD), and the secondary aim was to compare the results to those of alcohol dependence (AD). Two independent case-control studies were conducted. A total of 30 male participants with IGD, diagnosed according to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, and 30 sex-matched controls participated in study 1. We designed targeted exome sequencing (TES) to test for 72 candidate genes that have been implicated in the pathogenesis of addiction. The genes included seven neurotransmitter (dopamine, serotonin, glutamate, r-aminobutyric acid (GABA), norepinephrine, acetylcholine, and opioid) system genes. A total of 31 male in-patients with AD and 29 normal male controls (NC) were enrolled in study 2. The same 72 genes included in study 1 and ten additional genes related to alcohol-metabolic enzyme were selected as the target genes, and we identified the genetic variants using the same method (TES). The IGD group had a lower frequency of the T allele of rs1044396 in the nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4), and this variant represents a protective allele against IGD. However, we did not find a significant difference in the polymorphisms of the 72 genes that encode neurotransmitter systems between the AD and NC groups. This study demonstrated that rs1044396 of CHRNA4 was significantly associated with IGD.	[Jeong, Jo-Eun; Kwak, Su-Min; Bang, Sol-hee; Cho, Hyun; Kim, Dai-Jin] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Rhee, Je-Keun; Kim, Tae-Min] Catholic Univ Korea, Coll Med, Catholic Canc Res Inst, Seoul, South Korea; [Kim, Tae-Min] Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea; [Cheon, Young-Hoon] Incheon Chamsarang Hosp, Dept Psychiat, Incheon, South Korea; [Min, Jung Ah] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Yoo, Gil Sang; Kim, Kyudong] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Jung-Seok] SMU SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Choi, Jung-Seok] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Sam-Wook] True Mind Mental Hlth Clin, Dept Psychiat, Seoul, South Korea	Kim, DJ (reprint author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea.	kdj922@chollian.net			Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI12C-0113]	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI12C-0113) to DJK, http://www.mohw.go.kr/eng/index.jsp.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Alvarez-Moya EM, 2007, COMPR PSYCHIAT, V48, P452, DOI 10.1016/j.comppsych.2007.03.008; The American Psychiatric Association, 2012, INT US DIS; Ball D, 2008, ADDICTION, V103, P360, DOI 10.1111/j.1360-0443.2007.02061.x; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Breitling LP, 2009, PHARMACOGENOMICS J, V9, P219, DOI 10.1038/tpj.2009.6; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cao FL, 2007, EUR PSYCHIAT, V22, P466, DOI 10.1016/j.eurpsy.2007.05.004; Chiu SI, 2004, CYBERPSYCHOL BEHAV, V7, P571, DOI 10.1089/1094931042403127; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; de Kloet SF, 2015, BIOCHEM PHARMACOL, V97, P425, DOI 10.1016/j.bcp.2015.07.014; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034                                                               ; Dick DM, 2003, ALCOHOL CLIN EXP RES, V27, P868, DOI 10.1097/01.ALC.0000065436.24221.63; Enoch MA, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0412-1; Faraci P, 2013, J MED INTERNET RES, V15, P220, DOI 10.2196/jmir.2935; Fattore L, 2014, FRONT NEUROENDOCRIN, V35, P272, DOI 10.1016/j.yfrne.2014.04.003; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424                                                       ; FORCIER MW, 1988, J OCCUP ENVIRON MED, V30, P246; Fuentes D, 2006, J INT NEUROPSYCH SOC, V12, P907, DOI 10.1017/S1355617706061091; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.01; Griffiths M, 2000, CYBERPSYCHOL BEHAV, V3, P211, DOI 10.1089/109493100316067                                                         ; Griffiths MD, 2004, J ADOLESCENCE, V27, P87, DOI 10.1016/j.adolescence.2003.10.007; Grucza RA, 2006, ALCOHOL RES HEALTH, V29, P172; Han DH, 2007, J ADDICT MED, V1, P133, DOI 10.1097/ADM.0b013e31811f465f; Hartmann T, 2006, J COMPUT-MEDIAT COMM, V11, P910, DOI 10.1111/j.1083-6101.2006.00301.x                                                ; HELZER JE, 1988, J STUD ALCOHOL, V49, P219, DOI 10.15288/jsa.1988.49.219                                                        ; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Internet-World-Stats, 2016, WORLD INT US 2016; Kertzman S, 2008, PSYCHIAT RES, V161, P1, DOI 10.1016/j.psychres.2007.06.026; Kim JY, 2016, J BEHAV ADDICT, V5, P631, DOI 10.1556/2006.5.2016.077; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2005, J NERV MENT DIS, V193, P273, DOI 10.1097/01.nmd.00001583373.85150.57; Koepp MJ, 1998, NATURE, V393, P266; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lee HC, 2001, J KOREAN MED SCI, V16, P745, DOI 10.3346/jkms.2001.16.6.745                                                      ; Lee YS, 2008, J AFFECT DISORDERS, V109, P165, DOI 10.1016/j.jad.2007.10.020; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x                                                ; Li MJ, 2014, TWIN RES HUM GENET, V17, P279, DOI 10.1017/thg.2014.32; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Liang LC, 2016, COMPUT HUM BEHAV, V63, P463, DOI 10.1016/j.chb.2016.04.043; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; MALETZKY BM, 1974, AM J PSYCHIAT, V131, P445; Ogletree SM, 2007, SEX ROLES, V56, P537, DOI 10.1007/s11199-007-9193-5; Montag C, 2012, J ADDICT MED, V6, P191, DOI 10.1097/ADM.0b013e31825ba7e7; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nordin C, 2007, J GAMBL STUD, V23, P113, DOI 10.1007/s10899-006-9049-x; Park BL, 2013, HUM GENET, V132, P657, DOI 10.1007/s00439-013-1281-8; Pawlikowski M, 2014, ADDICT RES THEORY, V22, P166, DOI 10.3109/16066359.2013.793313; Pinto E, 2008, ALCOHOL ALCOHOLISM, V43, P398, DOI 10.1093/alcalc/agn015; Portugal GS, 2008, BEHAV BRAIN RES, V193, P1, DOI 10.1016/j.bbr.2008.05.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rocha Santos Juliana, 2015, Front Genet, V6, P46, DOI 10.3389/fgene.2015.00046; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Sargent JD, 2010, ADDICTION, V105, P506, DOI 10.1111/j.1360-0443.2009.02782.x; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Starcevic V, 2017, CNS SPECTRUMS, V22, P7, DOI 10.1017/S1092852915000863; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tomkins DM, 2001, CAN MED ASSOC J, V164, P817; Vink JM, 2016, ADDICT BIOL, V21, P460, DOI 10.1111/adb.12218; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; World Health Organization, 2016, ICD 11 BET IN PRESS; Yau Yvonne H C, 2012, Minerva Psichiatr, V53, P153; Yee N, 2006, CYBERPSYCHOL BEHAV, V9, P772, DOI 10.1089/cpb.2006.9.772                                                          ; Yen JY, 2009, PSYCHIAT CLIN NEUROS, V63, P218, DOI 10.1111/j.1440-1819.2009.01943.x; Young KS, 1998, CYBERPSYCHOL BEHAV, V1, P237, DOI DOI 10.1089/CPB.1998.1.237	75	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188358	10.1371/journal.pone.0188358				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8OT	WOS:000417905600007		gold			2018-01-05	
J	Liao, HK; Hatanaka, F; Araoka, T; Reddy, P; Wu, MZ; Sui, YH; Yamauchi, T; Sakurai, M; O'Keefe, DD; Nunez-Delicado, E; Guillen, P; Campistol, JM; Wu, CJ; Lu, LF; Esteban, CR; Belmonte, JCI				Liao, Hsin-Kai; Hatanaka, Fumiyuki; Araoka, Toshikazu; Reddy, Pradeep; Wu, Min-Zu; Sui, Yinghui; Yamauchi, Takayoshi; Sakurai, Masahiro; O'Keefe, David D.; Nunez-Delicado, Estrella; Guillen, Pedro; Campistol, Josep M.; Wu, Cheng-Jang; Lu, Li-Fan; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos			In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation	CELL			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; STEM-CELLS; UTROPHIN TRANSGENE; MDX MOUSE; EXPRESSION; CAS9; TRANSCRIPTION; CRISPR; MICE	Current genome-editing systems generally rely on inducing DNA double-strand breaks (DSBs). This may limit their utility in clinical therapies, as unwanted mutations caused by DSBs can have deleterious effects. CRISPR/Cas9 system has recently been repurposed to enable target gene activation, allowing regulation of endogenous gene expression without creating DSBs. However, in vivo implementation of this gain-of-function system has proven difficult. Here, we report a robust system for in vivo activation of endogenous target genes through trans-epigenetic remodeling. The system relies on recruitment of Cas9 and transcriptional activation complexes to target loci by modified single guide RNAs. As proof-of-concept, we used this technology to treat mouse models of diabetes, muscular dystrophy, and acute kidney disease. Results demonstrate that CRISPR/Cas9-mediated target gene activation can be achieved in vivo, leading to measurable phenotypes and amelioration of disease symptoms. This establishes new avenues for developing targeted epigenetic therapies against human diseases.	[Liao, Hsin-Kai; Hatanaka, Fumiyuki; Araoka, Toshikazu; Reddy, Pradeep; Wu, Min-Zu; Yamauchi, Takayoshi; Sakurai, Masahiro; O'Keefe, David D.; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Araoka, Toshikazu; Wu, Min-Zu; Yamauchi, Takayoshi; Nunez-Delicado, Estrella] Univ Catolica San Antonio de Murcia, Campus Jeronimos 135, Guadalupe 30107, Spain; [Sui, Yinghui] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA; [Guillen, Pedro] Fdn Pedro Guillen, Clin CEMTRO, Ave Ventisquero de la Condesa 42, Madrid 28035, Spain; [Campistol, Josep M.] Hosp Clin Barcelona, Carrer Villarroel 170, E-08036 Barcelona, Spain; [Wu, Cheng-Jang; Lu, Li-Fan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	Belmonte, JCI (reprint author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	belmonte@salk.edu			Uehara Memorial Foundation; MDA; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Dr. Pedro Guillen; AFE; UCAM; NIH [R01 HL123755]; NIH-NCI [CCSG: P30 014195]	We are grateful to J. Naughton and J. Marlett for AAV production, C.-C. Liao, W.-M. Hsu, B. Li and C.-Y. Chung for programming script of CRISPR data mining, M.C. Ku, N. Hah and T. Nguyen for high-throughput sequencing, J. Wu for critical reading of the manuscript, and M. Schwarz for administrative help. F.H. was partially supported by the Uehara Memorial Foundation. P.R. was partially supported by the MDA. This work was supported by The Moxie Foundation, The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the G. Harold and Leila Y. Mathers Charitable Foundation, Fundacion Dr. Pedro Guillen, AFE, UCAM, NIH (R01 HL123755) and NIH-NCI CCSG: P30 014195.	Altucci L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0222-5; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen Meng, 2017, Adv Exp Med Biol, V983, P147, DOI 10.1007/978-981-10-4310-9_10; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heerboth S, 2014, GENET EPIGENETICS, V6, P9, DOI 10.4137/GEG.S12270; Hunter P, 2015, EMBO REP, V16, P276, DOI 10.15252/embr.201540121; Janghra N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150818; Jin YM, 2013, LAB INVEST, V93, P801, DOI 10.1038/labinvest.2013.64; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jurkowski TP, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0044-x; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim Ji-Yoen, 2014, J Vis Exp, P51863, DOI 10.3791/51863; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; La Russa MF, 2015, MOL CELL BIOL, V35, P3800, DOI 10.1128/MCB.00512-15; Gombash Lampe S. E., 2014, JOVE-J VIS EXP, V11; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Ling GS, 2011, RHEUMATOLOGY, V50, P1773, DOI 10.1093/rheumatology/ker198; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pfister SX, 2017, NAT REV DRUG DISCOV, V16, P241, DOI 10.1038/nrd.2016.256; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Sienkiewicz D, 2015, THER ADV NEUROL DISO, V8, P166, DOI 10.1177/1756285615586123; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Vora S, 2016, FEBS J, V283, P3181, DOI 10.1111/febs.13768; Wehling-Henricks M, 2016, HUM MOL GENET, V25, P2465, DOI 10.1093/hmg/ddw111; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	55	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1495	+		10.1016/j.cell.2017.10.025				27	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	WOS:000418044000008	29224783				2018-01-05	
J	Hosono, Y; Niknafs, YS; Prensner, JR; Iyer, MK; Dhanasekaran, SM; Mehra, R; Pitchiaya, S; Tien, J; Escara-Wilke, J; Poliakov, A; Chu, SC; Saleh, S; Sankar, K; Su, FY; Guo, SL; Qiao, YY; Freier, SM; Bui, HH; Cao, XH; Malik, R; Johnson, TM; Beer, DG; Feng, FY; Zhou, WB; Chinnaiyan, AM				Hosono, Yasuyuki; Niknafs, Yashar S.; Prensner, John R.; Iyer, Matthew K.; Dhanasekaran, Saravana M.; Mehra, Rohit; Pitchiaya, Sethuramasundaram; Tien, Jean; Escara-Wilke, June; Poliakov, Anton; Chu, Shih-Chun; Saleh, Sahal; Sankar, Keerthana; Su, Fengyun; Guo, Shuling; Qiao, Yuanyuan; Freier, Susan M.; Bui, Huynh-Hoa; Cao, Xuhong; Malik, Rohit; Johnson, Timothy M.; Beer, David G.; Feng, Felix Y.; Zhou, Weibin; Chinnaiyan, Arul M.			Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA	CELL			English	Article							ZINC-FINGER TARGETER; HUMAN TRANSCRIPTOME; CRISPR-CAS9 SYSTEM; BINDING PROTEINS; CANCER; EXPRESSION; ZEBRAFISH; PATHWAYS; TOOL; LOCALIZATION	Large-scale transcriptome sequencing efforts have vastly expanded the catalog of long non-coding RNAs (lncRNAs) with varying evolutionary conservation, lineage expression, and cancer specificity. Here, we functionally characterize a novel ultra-conserved lncRNA, THOR (ENSG00000226856), which exhibits expression exclusively in testis and a broad range of human cancers. THOR knockdown and overexpression in multiple cell lines and animal models alters cell or tumor growth supporting an oncogenic role. We discovered a conserved interaction of THOR with IGF2BP1 and show that THOR contributes to the mRNA stabilization activities of IGF2BP1. Notably, transgenic THOR knockout produced fertilization defects in zebrafish and also conferred a resistance to melanoma onset. Likewise, ectopic expression of human THOR in zebrafish accelerated the onset of melanoma. THOR represents a novel class of functionally important cancer/testis lncRNAs whose structure and function have undergone positive evolutionary selection.	[Hosono, Yasuyuki; Niknafs, Yashar S.; Prensner, John R.; Iyer, Matthew K.; Dhanasekaran, Saravana M.; Mehra, Rohit; Pitchiaya, Sethuramasundaram; Tien, Jean; Poliakov, Anton; Chu, Shih-Chun; Saleh, Sahal; Sankar, Keerthana; Su, Fengyun; Qiao, Yuanyuan; Cao, Xuhong; Malik, Rohit; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Chinnaiyan, Arul M.] Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Prensner, John R.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Iyer, Matthew K.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dhanasekaran, Saravana M.; Mehra, Rohit; Malik, Rohit; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Guo, Shuling; Freier, Susan M.; Bui, Huynh-Hoa] Ionis Pharmaceut, Carlsbad, CA USA; [Johnson, Timothy M.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Johnson, Timothy M.; Beer, David G.; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Beer, David G.] Univ Michigan, Dept Surg, Sect Thorac Surg, Ann Arbor, MI 48109 USA; [Feng, Felix Y.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Zhou, Weibin] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Zhou, Weibin] Duke Univ, Ctr Human Dis Modeling, 300 N Duke St, Durham, NC 27701 USA	Chinnaiyan, AM (reprint author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (reprint author), Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (reprint author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (reprint author), Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (reprint author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (reprint author), Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA.	arul@med.umich.edu			National Cancer Institute Early Detection Research Network [U01CA214170]; U.S. National Institutes of Health (NIH) [RO1 CA154365]; Genentech Fellowship; Prostate Cancer Foundation; U.S. Department of Defense [W81XWH-13-1-0284]; University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant; NIH [DK091405, DK081943, F30-CA-200328]; Janette Ferrantino Investigator Award; American Society of Nephrology Carl W. Gottschalk Scholar Research Grant	We thank S. Shukla, L. Xiao, A. Delekta, and Y. Zhang for technical assistance; J. Shavit and S. Kregel for discussion; and T. Saunders for mice embryos. This work was supported in part by the National Cancer Institute Early Detection Research Network (U01CA214170) and U.S. National Institutes of Health (NIH) grant RO1 CA154365 (D.G.B. and A.M.C.). A.M.C. is an American Cancer Society Research Professor, a Howard Hughes Medical Institute Investigator, and a Taubman Scholar of the University of Michigan. Y.H. was supported by a Genentech Fellowship. R. Malik is supported by a Prostate Cancer Foundation Young Investigator Award and by U.S. Department of Defense Postdoctoral Fellowship W81XWH-13-1-0284. Y.S.N. was supported by a University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant and by a Prostate Cancer Foundation Young Investigator Award. W.Z. was supported by grants from the NIH (DK091405, DK081943 sub), the Janette Ferrantino Investigator Award, and the American Society of Nephrology Carl W. Gottschalk Scholar Research Grant. Y.S.N. is supported by an NIH F30 grant (F30-CA-200328). S.G., S.M.F., and H.-H.B. are employees of Ionis Pharmaceuticals, which may develop therapeutic ASO compounds against THOR. The University of Michigan will file a patent on THOR as a target and has filed a related technology disclosure around lncRNAs diagnostics in cancer. A.M.C., Y.H., and Y.S.N. will be named co-inventors.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Gaysinskaya V, 2014, CYTOM PART A, V85A, P556, DOI 10.1002/cyto.a.22463; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hammerle M, 2013, HEPATOLOGY, V58, P1703, DOI 10.1002/hep.26537; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Holman J.D., 2014, CURRENT PROTOCOLS BI, V46, P1; Hudson RS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-13; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JH, 2015, FRONT BIOENG BIOTECH, V2, P88; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mehra R, 2014, NEOPLASIA, V16, P1121, DOI 10.1016/j.neo.2014.11.006; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Palanichamy JK, 2016, J CLIN INVEST, V126, P1495, DOI 10.1172/JCI80046; Pitchiaya S, 2012, EMBO REP, V13, P709, DOI 10.1038/embor.2012.85; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sahu Anirban, 2015, Trends Cancer, V1, P93; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Winnepenninckx VR, 2006, J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]	65	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1559	+		10.1016/j.cell.2017.11.040				34	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	WOS:000418044000013	29245011				2018-01-05	
J	Karimi, E; Ramos, M; Goncalves, JMS; Xavier, JR; Reis, MP; Costa, R				Karimi, Elham; Ramos, Miguel; Goncalves, Jorge M. S.; Xavier, Joana R.; Reis, Margarida P.; Costa, Rodrigo			Comparative Metagenomics Reveals the Distinctive Adaptive Features of the Spongia officinalis Endosymbiotic Consortium	FRONTIERS IN MICROBIOLOGY			English	Article						host-microbe interactions; marine sponges; microbiome; next-generation sequencing; symbiosis	CELL GENOMICS REVEALS; MARINE SPONGES; BACTERIAL COMMUNITIES; MICROBIAL SYMBIONTS; MEDITERRANEAN SEA; DIVERSITY; GENE; PORIBACTERIA; TRANSMISSION; CHEMOTAXIS	Current knowledge of sponge microbiome functioning derives mostly from comparative analyses with bacterioplankton communities. We employed a metagenomics-centered approach to unveil the distinct features of the Spongia officinalis endosymbiotic consortium in the context of its two primary environmental vicinities. Microbial metagenomic DNA samples (n = 10) from sponges, seawater, and sediments were subjected to Hiseq Illumina sequencing (c. 15 million 100 bp reads per sample). Totals of 10,272 InterPro (IPR) predicted protein entries and 784 rRNA gene operational taxonomic units (OTUs, 97% cut-off) were uncovered from all metagenomes. Despite the large divergence in microbial community assembly between the surveyed biotopes, the S. officinalis symbiotic community shared slightly greater similarity (p < 0.05), in terms of both taxonomy and function, to sediment than to seawater communities. The vast majority of the dominant S. officinalis symbionts (i.e., OTUs), representing several, so-far uncultivable lineages in diverse bacterial phyla, displayed higher residual abundances in sediments than in seawater. CRISPR-Cas proteins and restriction endonucleases presented much higher frequencies (accompanied by lower viral abundances) in sponges than in the environment. However, several genomic features sharply enriched in the sponge specimens, including eukaryotic-like repeat motifs (ankyrins, tetratricopeptides, WD-40, and leucine-rich repeats), and genes encoding for plasmids, sulfatases, polyketide synthases, type IV secretion proteins, and terpene/terpenoid synthases presented, to varying degrees, higher frequencies in sediments than in seawater. In contrast, much higher abundances of motility and chemotaxis genes were found in sediments and seawater than in sponges. Higher cell and surface densities, sponge cell shedding and particle uptake, and putative chemical signaling processes favoring symbiont persistence in particulate matrices all may act as mechanisms underlying the observed degrees of taxonomic connectivity and functional convergence between sponges and sediments. The reduced frequency of motility and chemotaxis genes in the sponge microbiome reinforces the notion of a prevalent mutualistic mode of living inside the host. This study highlights the S. officinalis "endosymbiome" as a distinct consortium of uncultured prokaryotes displaying a likely "sit-and-wait" strategy to nutrient foraging coupled to sophisticated anti-viral defenses, unique natural product biosynthesis, nutrient utilization and detoxification capacities, and both microbe-microbe and host-microbe gene transfer amenability.	[Karimi, Elham; Ramos, Miguel; Costa, Rodrigo] Univ Algarve, Microbial Ecol & Evolut Res Grp, Ctr Marine Sci, Faro, Portugal; [Goncalves, Jorge M. S.] Univ Algarve, Fisheries Biodivers & Conservat Res Grp, Ctr Marine Sci, Faro, Portugal; [Xavier, Joana R.] Univ Bergen, Dept Biol, Bergen, Norway; [Xavier, Joana R.] Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway; [Reis, Margarida P.] Univ Algarve, Fac Sci & Technol, Faro, Portugal; [Costa, Rodrigo] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Inst Bioengn & Biosci, Lisbon, Portugal	Costa, R (reprint author), Univ Algarve, Microbial Ecol & Evolut Res Grp, Ctr Marine Sci, Faro, Portugal.; Costa, R (reprint author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, Inst Bioengn & Biosci, Lisbon, Portugal.	rodrigoscosta@tecnico.ulisboa.pt			Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-MIC/3865/2012, PTDC/MAR-BIO/1547/2014]; Education, Audiovisual and Culture Executive Agency (European Commission, Erasmus Mundus Programme) [EMA2 lot7/SALA1206422]	This work was funded by the Portuguese Foundation for Science and Technology (FCT) through the research Grants PTDC/BIA-MIC/3865/2012 and PTDC/MAR-BIO/1547/2014, conceded to RC. EK was supported by a Ph.D. scholarship awarded by the Education, Audiovisual and Culture Executive Agency (European Commission, Erasmus Mundus Programme, Grant EMA2 lot7/SALA1206422).	Alexander BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109486; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bayer K, 2013, MAR BIOTECHNOL, V15, P63, DOI 10.1007/s10126-012-9455-2; Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.t88.10.3600-3613.2006; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Bruto M, 2017, ISME J, V11, P1043, DOI 10.1038/ismej.2016.162; Burgsdorf I, 2015, MBIO, V6, DOI 10.1128/mBio.00391-15; Christianson DW, 2017, CHEM REV, V117, P11570, DOI 10.1021/acs.chemrev.7b00287; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x                                              ; Costa R, 2013, MICROB ECOL, V65, P232, DOI 10.1007/s00248-012-0102-2; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Diez-Vives C, 2017, MOL ECOL, V26, P1432, DOI 10.1111/mec.14003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erwin PM, 2012, MICROB ECOL, V64, P771, DOI 10.1007/s00248-012-0047-5; Erwin PM, 2012, FEMS MICROBIOL ECOL, V79, P619, DOI 10.1111/j.1574-6941.2011.01243.x; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Fieseler L, 2006, ENVIRON MICROBIOL, V8, P612, DOI 10.1111/j.1462-2920.2005.00937.x; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Gao ZM, 2014, MBIO, V5, DOI 10.1128/mBio.00079-14; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Girvan HM, 2016, CURR OPIN CHEM BIOL, V31, P136, DOI 10.1016/j.cbpa.2016.02.018; GONZALEZ AG, 1984, TETRAHEDRON, V40, P4109, DOI 10.1016/0040-4020(84)85092-9                                                    ; Gordaliza M, 2010, MAR DRUGS, V8, P2849, DOI 10.3390/md8122849; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hammer O., 2001, PAST PALAEONTOLOGICA; Handelsman J., 2007, ENCY LIFE SCI; Hardoim CCP, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00611; Hardoim CCP, 2014, MOL ECOL, V23, P3097, DOI 10.1111/mec.12789; Hardoim CCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053029; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Horn H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01751; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P3589, DOI 10.1128/AAC.00570-09; Kamke J, 2013, ISME J, V7, P2287, DOI 10.1038/ismej.2013.111; Kamke J, 2010, ISME J, V4, P498, DOI 10.1038/ismej.2009.143; Kennedy J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-27; Kumar V., 2015, J I ENG, V96, P71, DOI [10.1007/s40030-014-0102-y, DOI 10.1007/S40030-014-0102-Y]; Li J, 2017, J NAT PROD, V80, P1436, DOI 10.1021/acs.jnatprod.6b01105; Lopanik N, 2004, OECOLOGIA, V139, P131, DOI 10.1007/s00442-004-1487-5; Manzo E, 2011, J NAT PROD, V74, P1241, DOI 10.1021/np200226u; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitchell A, 2016, NUCLEIC ACIDS RES, V44, pD595, DOI 10.1093/nar/gkv1195; Moitinho-Silva L, 2017, ISME J, V11, P1651, DOI 10.1038/ismej.2017.25; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Nguyen MTHD, 2014, MOL ECOL, V23, P1635, DOI 10.1111/mec.12384; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Pineda MC, 2016, J MAR BIOL ASSOC UK, V96, P481, DOI 10.1017/S0025315414001787; Pita L, 2013, FEMS MICROBIOL ECOL, V86, P268, DOI 10.1111/1574-6941.12159; Polonia ARM, 2014, MICROB ECOL, V67, P553, DOI 10.1007/s00248-013-0365-2; R Development Core Team, 2012, R LANG ENV STAT COMP; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Reynolds D, 2016, MOL ECOL, V25, P5242, DOI 10.1111/mec.13812; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rua CPJ, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv043; Schmidt JL, 1998, LIMNOL OCEANOGR, V43, P976, DOI 10.4319/lo.1998.43.5.0976                                                       ; Schonberg CHL, 2016, J MAR BIOL ASSOC UK, V96, P493, DOI 10.1017/S0025315415001411; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Siegl A, 2010, ENV MICROBIOL REP, V2, P507, DOI 10.1111/j.1758-2229.2009.00057.x; Slaby BM, 2017, ISME J, V11, P2465, DOI 10.1038/ismej.2017.101; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Szpilewska H, 2003, CURR MICROBIOL, V47, P379, DOI 10.1007/s00284-002-4024-y; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Voultsiadou E, 2008, J NAT HIST, V42, P529, DOI 10.1080/00222930701835506; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pD339, DOI 10.1093/nar/gku1023; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2016, MBIO, V7, DOI 10.1128/mBio.00135-16; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yamada Y, 2015, P NATL ACAD SCI USA, V112, P857, DOI 10.1073/pnas.1422108112; Zhang F, 2015, P NATL ACAD SCI USA, V112, P4381, DOI 10.1073/pnas.1423768112; Zhang Y, 2016, J GEOPHYS RES-BIOGEO, V121, P2261, DOI 10.1002/2016JG003390	89	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	DEC 14	2017	8								2499	10.3389/fmicb.2017.02499				16	Microbiology	Microbiology	FP8UC	WOS:000417920600001		gold			2018-01-05	
J	Miles, LB; Darido, C; Kaslin, J; Heath, JK; Jane, SM; Dworkin, S				Miles, Lee B.; Darido, Charbel; Kaslin, Jan; Heath, Joan K.; Jane, Stephen M.; Dworkin, Sebastian			Mis-expression of grainyhead-like transcription factors in zebrafish leads to defects in enveloping layer (EVL) integrity, cellular morphogenesis and axial extension	SCIENTIFIC REPORTS			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; SPINA-BIFIDA; EPIDERMAL DIFFERENTIATION; DROSOPHILA GRAINYHEAD; EMBRYONIC-DEVELOPMENT; CONVERGENT EXTENSION; MICE LACKING; E-CADHERIN; GRHL3; NEURULATION	The grainyhead-like (grhl) transcription factors play crucial roles in craniofacial development, epithelial morphogenesis, neural tube closure, and dorso-ventral patterning. By utilising the zebrafish to differentially regulate expression of family members grhl2b and grhl3, we show that both genes regulate epithelial migration, particularly convergence-extension (CE) type movements, during embryogenesis. Genetic deletion of grhl3 via CRISPR/Cas9 results in failure to complete epiboly and pre-gastrulation embryonic rupture, whereas morpholino (MO)-mediated knockdown of grhl3 signalling leads to aberrant neural tube morphogenesis at the midbrain-hindbrain boundary (MHB), a phenotype likely due to a compromised overlying enveloping layer (EVL). Further disruptions of grhl3-dependent pathways (through co-knockdown of grhl3 with target genes spec1 and arhgef19) confirm significant MHB morphogenesis and neural tube closure defects. Concomitant MO-mediated disruption of both grhl2b and grhl3 results in further extensive CE-like defects in body patterning, notochord and somite morphogenesis. Interestingly, over-expression of either grhl2b or grhl3 also leads to numerous phenotypes consistent with disrupted cellular migration during gastrulation, including embryo dorsalisation, axial duplication and impaired neural tube migration leading to cyclopia. Taken together, our study ascribes novel roles to the Grhl family in the context of embryonic development and morphogenesis.	[Miles, Lee B.; Dworkin, Sebastian] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Darido, Charbel] Peter MacCallum Canc Ctr, Victorian Comprehens Canc Ctr, Parkville, Vic 3050, Australia; [Kaslin, Jan] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3168, Australia; [Heath, Joan K.] Walter & Eliza Hall Inst Med Res, Dept Chem Biol, Parkville, Vic 3050, Australia; [Jane, Stephen M.] Monash Univ, Cent Clin Sch, Dept Med, Prahran, Vic 3181, Australia; [Jane, Stephen M.] Alfred Hosp, Dept Hematol, Prahran, Vic 3181, Australia	Dworkin, S (reprint author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia.	s.dworkin@latrobe.edu.au			Australian National Health and Medical Research Council (NHMRC) [APP1063837, APP1106697]; Australian Research Council (ARC) Discovery Early Career Researcher Awards (DECRA) [DE140100500]; La Trobe University Research Focus Area of Securing Food, Water and the Environment; VCA Clare Oliver Memorial [COF11_04]; Association for International Cancer Research (AICR) [11-0060]	The authors wish to thank Dr. Peter Lock at the La Trobe Institute for Molecular Science (LIMS) Bioimaging facility for his technical expertise. The authors were supported by grants from the Australian National Health and Medical Research Council (NHMRC, APP1063837 and APP1106697) the Australian Research Council (ARC) Discovery Early Career Researcher Awards (DECRA, DE140100500), and the La Trobe University Research Focus Area of Securing Food, Water and the Environment. CD is a Victorian Cancer Agency (VCA) Mid-Career Fellow (CR_16/5985) and was supported by a fellowship from the VCA Clare Oliver Memorial (COF11_04) and by a grant (11-0060) from The Association for International Cancer Research (AICR).	Adhikari N, 2017, HISTOCHEM CELL BIOL, V147, P5, DOI 10.1007/s00418-016-1487-7; Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Araya C, 2016, DEV DYNAM, V245, P580, DOI [10.1002/DVDY.24401, 10.1002/dvdy.24401]; Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Brouns MR, 2011, HUM MOL GENET, V20, P1536, DOI 10.1093/hmg/ddr031; Caddy J, 2010, DEV CELL, V19, P138, DOI 10.1016/j.devcel.2010.06.008; Cangkrama M, 2016, J INVEST DERMATOL, V136, P1438, DOI 10.1016/j.jid.2016.02.806; Carpinelli MR, 2017, J DENT RES, V96, P1200, DOI 10.1177/0022034517719264; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; de la Garza G., 2012, J INVEST DERMATOL; Dworkin S., 2014, MECH DEV; Dworkin S, 2007, DEV BIOL, V307, P127, DOI 10.1016/j.ydbio.2007.04.026; Dworkin S, 2017, DEV NEUROBIOL, V77, P775, DOI 10.1002/dneu.22469; Dworkin S, 2013, CELL MOL LIFE SCI, V70, P3365, DOI 10.1007/s00018-012-1240-x; Dworkin S, 2012, DEVELOPMENT, V139, P525, DOI 10.1242/dev.066522; England SJ, 2006, DEVELOPMENT, V133, P4613, DOI 10.1242/dev.02678; Erickson T, 2007, DEV BIOL, V301, P504, DOI 10.1016/j.ydbio.2006.08.022; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Goldie SJ, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0136-7; Gustavsson P, 2007, HUM MOL GENET, V16, P2640, DOI 10.1093/hmg/ddm221; Gutzman JH, 2008, MECH DEVELOP, V125, P974, DOI 10.1016/j.mod.2008.07.004; Han YC, 2011, HUM MOL GENET, V20, P3213, DOI 10.1093/hmg/ddr234; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Heyn P, 2014, CELL REP, V6, P285, DOI 10.1016/j.celrep.2013.12.030; Hislop NR, 2008, DEV BIOL, V321, P263, DOI 10.1016/j.ydbio.2008.06.026; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Janicke M, 2010, INT J DEV BIOL, V54, P837, DOI 10.1387/ijdb.092877mj; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Lemay P, 2017, HUM MUTAT, V38, P716, DOI 10.1002/humu.23214; Leslie EJ, 2016, AM J HUM GENET, V98, P744, DOI 10.1016/j.ajhg.2016.02.014; Liu F, 2015, INT J DEV BIOL, V59, P417, DOI 10.1387/ijdb.140230FL; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Maurus D, 2009, GENE DEV, V23, P1461, DOI 10.1101/gad.517009; Menke C., 2015, GENESIS; Miles LB, 2017, DEV BIOL, V429, P12, DOI 10.1016/j.ydbio.2017.06.018; Pei WH, 2009, DEV BIOL, V326, P201, DOI 10.1016/j.ydbio.2008.11.008; Peyrard-Janvid M, 2014, AM J HUM GENET, V94, P23, DOI 10.1016/j.ajhg.2013.11.009; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rifat Y., 2010, DEV BIOL; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Sumanas S, 2005, DEV BIOL, V283, P85, DOI 10.1016/j.ydbio.2005.04.007; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727                                                          ; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhao P, 2016, ACTA BIOCH BIOPH SIN, V48, P266, DOI 10.1093/abbs/gmw001	62	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 14	2017	7								17607	10.1038/s41598-017-17898-7				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8NT	WOS:000417902200022	29242584	gold			2018-01-05	
J	Moreno, E; Sieriebriennikov, B; Witte, H; Rodelsperger, C; Lightfoot, JW; Sommer, RJ				Moreno, Eduardo; Sieriebriennikov, Bogdan; Witte, Hanh; Rodelsperger, Christian; Lightfoot, James W.; Sommer, Ralf J.			Regulation of hyperoxia-induced social behaviour in Pristionchus pacificus nematodes requires a novel cilia-mediated environmental input	SCIENTIFIC REPORTS			English	Article							RETROGRADE INTRAFLAGELLAR TRANSPORT; CAENORHABDITIS-ELEGANS; C-ELEGANS; NATURAL VARIATION; PHEROMONE ATTRACTION; SENSORY CILIA; NEURONS; RESPONSES; HOMOLOG; CIRCUIT	Social behaviours are frequently utilised for defence and stress avoidance in nature. Both Caenorhabditis elegans and Pristionchus pacificus nematodes display social behaviours including clumping and bordering, to avoid hyperoxic stress conditions. Additionally, both species show natural variation in social behaviours with "social" and "solitary" strains. While the single solitary C. elegans N2 strain has evolved under laboratory domestication due to a gain-of-function mutation in the neuropeptide receptor gene npr-1, P. pacificus solitary strains are commonplace and likely ancestral. P. pacificus therefore provides an opportunity to further our understanding of the mechanisms regulating these complex behaviours and how they evolved within an ecologically relevant system. Using CRISPR/Cas9 engineering, we show that Ppa-npr-1 has minimal influence on social behaviours, indicating independent evolutionary pathways compared to C. elegans. Furthermore, solitary P. pacificus strains show an unexpected locomotive response to hyperoxic conditions, suggesting a novel regulatory mechanism counteracting social behaviours. By utilising both forward and reverse genetic approaches we identified 10 genes of the intraflagellar transport machinery in ciliated neurons that are essential for this inhibition. Therefore, a novel cilia-mediated environmental input adds an additional level of complexity to the regulation of hyperoxia-induced social behaviours in P. pacificus, a mechanism unknown in C. elegans.	[Moreno, Eduardo; Sieriebriennikov, Bogdan; Witte, Hanh; Rodelsperger, Christian; Lightfoot, James W.; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Integrat Evolutionary Biol, D-72076 Tubingen, Germany	Sommer, RJ (reprint author), Max Planck Inst Dev Biol, Dept Integrat Evolutionary Biol, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de			Max Planck Society	We thank the Max Planck Society for funding the research.	Andersen EC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004156; Bargmann C. I, 2006, CHEMOSENSATION C ELE; Baskaran P, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0466-2; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Brischoux F, 2009, BIOL LETTERS, V5, P729, DOI 10.1098/rsbl.2009.0550; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Choe J. C, 1997, EVOLUTION SOCIAL BEH; Cinkornpumin JK, 2014, ELIFE, V3, DOI 10.7554/eLife.03229; Davenport J., 1985, ENV STRESS BEHAV ADA; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Dury Guillaume J., 2014, Psyche (Cambridge), P642908; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Inglis P. N., 2007, SENSORY CILIA CAENOR; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; McGaughran A, 2013, ECOL EVOL, V3, P5209, DOI 10.1002/ece3.902; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MILLER FL, 1980, CAN FIELD NAT, V94, P52; Moreno E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2263; Morgan K, 2012, MOL ECOL, V21, P250, DOI 10.1111/j.1365-294X.2011.05382.x; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Pires-daSilva A, 2013, PRISTIONCHUS PACIFIC; Peterman E. J. G., 2017, FEBS J; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Ragsdale E. J, 2015, NEMATOLOGY MONOGRAPH, P77; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rodelsperger C, 2014, GENETICS, V196, P1153, DOI 10.1534/genetics.113.159855; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03-023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sengupta P, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002240; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Sterken MG, 2015, TRENDS GENET, V31, P224, DOI 10.1016/j.tig.2015.02.009; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Tong YG, 2010, J NEUROSCI METH, V188, P58, DOI 10.1016/j.jneumeth.2010.02.003; Weber KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013922; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	51	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 14	2017	7								17550	10.1038/s41598-017-18019-0				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8KO	WOS:000417892100001	29242625	gold			2018-01-05	
J	Tian, TR; Zhang, T; Zhou, TF; Lin, SY; Shi, SR; Lin, YF				Tian, Taoran; Zhang, Tao; Zhou, Tengfei; Lin, Shiyu; Shi, Sirong; Lin, Yunfeng			Synthesis of an ethyleneimine/tetrahedral DNA nanostructure complex and its potential application as a multi-functional delivery vehicle	NANOSCALE			English	Article							GENE DELIVERY; IN-VIVO; POLYMERIC NANOPARTICLES; HUMAN NEUTROPHILS; LIVE CELLS; DRUG; POLYETHYLENIMINE; CYTOTOXICITY; ENDOCYTOSIS; RELEASE	Nowadays, DNA nanostructures are extensively researched for their biocompatibility, editable functionality, and structural stability. Tetrahedral DNA nanostructures (TDNs), widely known for their membrane permeability, are regarded as potential candidates for drug delivery. However, the stability and membrane permeability of TDNs call for further enhancement if in vivo usage is ascribed. To overcome the drawbacks of TDNs, ethylene imine (PEI, 25 kDa, branched)-a classic cationic polymer in the field of gene delivery-was applied. Via a facile one-pot synthesis method, a PEI/TDNs complex was formed. Subsequently, a DNase protection assay, a cytotoxicity assay, endocytosis-related experiments, and lysosome staining were performed to examine the potential of PEI/TDNs as a delivery vehicle. The combination of PEI and TDNs not only overcame the drawbacks of each substance but also retained their individual merits. Traditionally, drug-delivery vehicles that enable enhanced cell entry and lysosome escape are often compromised by their toxicity and poor multifunctionality. We believe this novel PEI/TDNs complex with enhanced systemic stability, biocompatibility, cell-entry ability, and lysosome-escape ability and unsurpassed editable functionality could be a powerful tool as a multi-functional delivery vehicle in targeted drug delivery, in vivo imaging, and other related fields.	[Tian, Taoran; Zhang, Tao; Zhou, Tengfei; Lin, Shiyu; Shi, Sirong; Lin, Yunfeng] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China	Lin, YF (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China.	yunfenglin@scu.edu.cn	Lin, Yunfeng/M-5438-2013	Lin, Yunfeng/0000-0003-1224-6561	National Natural Science Foundation of China [81671031, 81470721]; Sichuan Province Youth Science and Technology Innovation Team [2014TD0001]	This study was supported by the National Natural Science Foundation of China (81671031, 81470721) and Sichuan Province Youth Science and Technology Innovation Team (2014TD0001).	Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Boeckle S, 2004, J GENE MED, V6, P1102, DOI 10.1002/jgm.598; Boletta A, 1997, HUM GENE THER, V8, P1243, DOI 10.1089/hum.1997.8.10-1243                                                      ; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cai X., 2017, BONE RES, V5, P17048; Castro CE, 2015, NANOSCALE, V7, P5913, DOI 10.1039/c4nr07153k; Chen ZZ, 2014, ACS APPL MATER INTER, V6, P14196, DOI 10.1021/am503483w; Conway JW, 2013, CHEM COMMUN, V49, P1172, DOI 10.1039/c2cc37556g; Cortez MA, 2015, J AM CHEM SOC, V137, P6541, DOI 10.1021/jacs.5b00980; Dufes C., 2008, ADV DRUG DELIVERY RE, V57, P2177; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Evans CW, 2011, ACS NANO, V5, P8640, DOI 10.1021/nn2022149; Ge ZL, 2011, SCI CHINA CHEM, V54, P1273, DOI 10.1007/s11426-011-4327-6; Gong T, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.29; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Halder A, 2005, INT J PHARMACEUT, V302, P84, DOI 10.1016/j.ijpharm.2005.06.020; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Hufnagel H, 2009, MOL THER, V17, P1411, DOI 10.1038/mt.2009.121; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; Hwang TL, 2015, COLLOID SURFACE B, V128, P119, DOI 10.1016/j.colsurfb.2015.02.022; Hwang TL, 2015, INT J NANOMED, V10, P371, DOI 10.2147/IJN.S73017; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jiang DW, 2016, ACS APPL MATER INTER, V8, P4378, DOI 10.1021/acsami.5b10792; Kafil V, 2011, BIOIMPACTS, V1, P23, DOI 10.5681/bi.2011.004; Kim K, 2016, CHEM COMMUN, V52, P2839, DOI 10.1039/c5cc09239f; Ko YT, 2012, AAPS PHARMSCITECH, V13, P373, DOI 10.1208/s12249-012-9757-8; Koyfman AY, 2009, J AM CHEM SOC, V131, P14237, DOI 10.1021/ja9015638; Kuo W. T., 2011, J NANOMATER, V2011, P605; Li J, 2011, ACS NANO, V5, P8783, DOI 10.1021/nn202774x; Liang L, 2014, ANGEW CHEM INT EDIT, V53, P7745, DOI 10.1002/anie.201403236; Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010; Moghimi SM, 2004, SCIENCE, V303, P626, DOI 10.1126/science.303.5658.626                                                    ; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Pei H, 2012, ANGEW CHEM INT EDIT, V51, P9020, DOI 10.1002/anie.201202356; Petkar KC, 2011, CRIT REV THER DRUG, V28, P101, DOI 10.1615/CritRevTherDrugCarrierSyst.v28.i2.10                                    ; Pichon C, 2010, CURR OPIN BIOTECH, V21, P640, DOI 10.1016/j.copbio.2010.07.003; Ponnuswamy N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15654; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788                                                              ; Qiang P., 2016, ACS APPL MAT INTERFA, V8; Shao X., 2017, SMALL, V13; Shi SR, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12368; Shi SR, 2016, ACS APPL MATER INTER, V8, P19353, DOI 10.1021/acsami.6b06528; Shi SR, 2016, CELL PROLIFERAT, V49, P341, DOI 10.1111/cpr.12259; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Suh J, 2012, MICROSC RES TECHNIQ, V75, P691, DOI 10.1002/jemt.21113; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Xue CY, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12307; Yao GB, 2015, ANGEW CHEM INT EDIT, V54, P2966, DOI 10.1002/anie.201410895; Zhang Q, 2014, ACS NANO, V8, P6633, DOI 10.1021/nn502058j; Ziebarth JD, 2017, J PHYS CHEM B, V121, P1941, DOI 10.1021/acs.jpcb.6b10775	55	0	0	8	8	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale	DEC 14	2017	9	46					18402	18412		10.1039/c7nr07130b				11	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	FO4OL	WOS:000416824100032	29147695				2018-01-05	
J	Beishline, K; Vladimirova, O; Tutton, S; Wang, Z; Deng, Z; Lieberman, PM				Beishline, Kate; Vladimirova, Olga; Tutton, Stephen; Wang, Zhuo; Deng, Zhong; Lieberman, Paul M.			CTCF driven TERRA transcription facilitates completion of telomere DNA replication	NATURE COMMUNICATIONS			English	Article							REPEAT-CONTAINING RNA; SINGLE-STRANDED-DNA; MAMMALIAN TELOMERES; R-LOOPS; BINDING-SITES; SUBTELOMERE; CELLS; ORGANIZATION; COHESIN; LENGTH	Telomere repeat DNA forms a nucleo-protein structure that can obstruct chromosomal DNA replication, especially under conditions of replication stress. Transcription of telomere repeats can initiate at subtelomeric CTCF-binding sites to generate telomere repeat-encoding RNA (TERRA), but the role of transcription, CTCF, and TERRA in telomere replication is not known. Here, we have used CRISPR/Cas9 gene editing to mutate CTCF-binding sites at the putative start site of TERRA transcripts for a class of subtelomeres. Under replication stress, telomeres lacking CTCF-driven TERRA exhibit sister-telomere loss and upon entry into mitosis, exhibit the formation of ultra-fine anaphase bridges and micronuclei. Importantly, these phenotypes could be rescued by the forced transcription of TERRA independent of CTCF binding. Our findings indicate that subtelomeric CTCF facilitates telomeric DNA replication by promoting TERRA transcription. Our findings also demonstrate that CTCF-driven TERRA transcription acts in cis to facilitate telomere repeat replication and chromosome stability.	[Beishline, Kate; Vladimirova, Olga; Tutton, Stephen; Wang, Zhuo; Deng, Zhong; Lieberman, Paul M.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Beishline, Kate] Bloomsburg Univ, Dept Biol & Allied Hlth Sci, Bloomsburg, PA 17815 USA	Beishline, K; Lieberman, PM (reprint author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.; Beishline, K (reprint author), Bloomsburg Univ, Dept Biol & Allied Hlth Sci, Bloomsburg, PA 17815 USA.	kbeishline@bloomu.edu; Lieberman@wistar.org			Wistar-NRSA [T32 CA09171]; National Cancer Institute [RO1 CA140652]; Wistar Institute Cancer Center [P30 CA010815]	We thank Harold Riethman for discussion and advice on telomere and subtelomere biology. Special thanks to J. Faust, J. Hayden, and F. Keeney of the Wistar Flow Cytometry and Imaging Facilities. K.B. was supported by a Wistar-NRSA sponsored Cancer Research Training Program Fellowship (T32 CA09171). This research is supported by funds from the National Cancer Institute RO1 CA140652 to PML, and the Wistar Institute Cancer Center P30 CA010815.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2012, EMBO J, V31, P4165, DOI 10.1038/emboj.2012.266; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Drosopoulos WC, 2012, J CELL BIOL, V197, P253, DOI 10.1083/jcb.201112083; Episkopou H, 2014, NUCLEIC ACIDS RES, V42, P4391, DOI 10.1093/nar/gku114; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Greider CW, 2016, GENE DEV, V30, P1483, DOI 10.1101/gad.280578.116; Hoshina S, 2013, J BIOL CHEM, V288, P30161, DOI 10.1074/jbc.M113.492504; Montero JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12534; Kaiser VB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006207; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Liu Y, 2014, CURR OPIN GENET DEV, V26, P1, DOI 10.1016/j.gde.2014.03.003; Lombrana R, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00158; de Silanes IL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5723; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Martinez P, 2015, TRENDS BIOCHEM SCI, V40, P504, DOI 10.1016/j.tibs.2015.06.003; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Nera B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10132; Nergadze SG, 2009, RNA, V15, P2186, DOI 10.1261/rna.1748309; Ng LJ, 2009, NUCLEIC ACIDS RES, V37, P1152, DOI 10.1093/nar/gkn1030; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pfeiffer V, 2013, EMBO J, V32, P2861, DOI 10.1038/emboj.2013.217; Piqueret-Stephan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32510; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Poulos RC, 2016, CELL REP, V17, P2865, DOI 10.1016/j.celrep.2016.11.055; Pugacheva EM, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0084-2; Pugacheva EM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0736-8; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Redon S, 2013, NUCLEIC ACIDS RES, V41, P9117, DOI 10.1093/nar/gkt695; Riethman H, 2005, CHROMOSOME RES, V13, P505, DOI 10.1007/s10577-005-0998-1; Rivera-Mulia JC, 2016, CURR OPIN CELL BIOL, V40, P168, DOI 10.1016/j.ceb.2016.03.022; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Stong N, 2014, GENOME RES, V24, P1039, DOI 10.1101/gr.166983.113; Tutton S, 2016, EMBO J, V35, P193, DOI 10.15252/embj.201490880; Umer HM, 2016, HUM MUTAT, V37, P904, DOI 10.1002/humu.23014; Wang Z, 2015, P NATL ACAD SCI USA, V112, pE6293, DOI 10.1073/pnas.1505962112; Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14579, DOI 10.1073/pnas.1001177107; Yu TY, 2014, P NATL ACAD SCI USA, V111, P3377, DOI 10.1073/pnas.1307415111	55	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 13	2017	8								2114	10.1038/s41467-017-02212-w				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8HV	WOS:000417884500020	29235471	gold			2018-01-05	
J	Liu, YC; Han, JH; Chen, ZC; Wu, HW; Dong, HS; Nie, GH				Liu, Yuchen; Han, Jinghong; Chen, Zhicong; Wu, Hanwei; Dong, Hongsong; Nie, Guohui			Engineering cell signaling using tunable CRISPR-Cpf1-based transcription factors	NATURE COMMUNICATIONS			English	Article							CRISPR RNA; GENE-EXPRESSION; ACTIVATION; SYSTEM; CPF1; COMPLEX; SPECIFICITIES; VARIANTS; DESIGN	The catalytically dead Cpf1 endonuclease from Acidaminococcus sp. BV3L6 (dAsCpf1) has been used to construct effective transcriptional repressors in bacteria and plants. However, it is still unclear if dAsCpf1 can function in human cells as a transcriptional regulator or a signal conductor. Here, we repurpose the dAsCpf1 system in human cells for a variety of functions, including the activation or repression of gene transcription. Moreover, we construct programmable ligand-controlled dAsCpf1 systems either by coupling crRNAs with engineered riboswitches or by fusing dAsCpf1 proteins with G protein-coupled receptors. These generalizable approaches allow us to regulate the transcription of endogenous genes in response to diverse classes of ligands, thus constructing artificial signaling pathways with rewired cellular input-output behaviors. The systems exhibit signal amplification, an important feature in cell signaling, when multiple crRNAs are processed from a single transcript. The results provide a robust and efficient platform for engineering customized cell signaling circuits.	[Liu, Yuchen; Han, Jinghong; Chen, Zhicong; Wu, Hanwei; Nie, Guohui] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Inst Translat Med, Shenzhen 518039, Peoples R China; [Han, Jinghong; Dong, Hongsong; Nie, Guohui] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Otolaryngol, Shenzhen 518039, Peoples R China	Liu, YC; Nie, GH (reprint author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Inst Translat Med, Shenzhen 518039, Peoples R China.; Nie, GH (reprint author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Otolaryngol, Shenzhen 518039, Peoples R China.	s_ycliu2007@126.com; nghui@21cn.com			National Natural Science Foundation of China [81773257, 81402103]; Support Program of Shenzhen for Life and Health Industry [20160158]; Special Support Funds of Shenzhen for Introduced High-Level Medical Team	This work was funded by the National Natural Science Foundation of China (81773257, 81402103), the Support Program of Shenzhen for Life and Health Industry (20160158) and the Special Support Funds of Shenzhen for Introduced High-Level Medical Team.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gander MW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15459; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guo JY, 2017, PROTEIN CELL, V8, P379, DOI 10.1007/s13238-016-0360-8; Heng BC, 2014, ANNU REV PHARMACOL, V54, P227, DOI 10.1146/annurev-pharmtox-011613-135921; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim SK, 2017, ACS SYNTH BIOL, V6, P1273, DOI 10.1021/acssynbio.6b00368; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Lin F, 2016, INT J BIOL SCI, V12, P1273, DOI 10.7150/ijbs.16162; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Richter F, 2016, NUCLEIC ACIDS RES, V44, P10003, DOI 10.1093/nar/gkw930; Schwarz KA, 2017, NAT CHEM BIOL, V13, P202, DOI [10.1038/NCHEMBIO.2253, 10.1038/nchembio.2253]; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tak Y. E., 2017, NAT METHODS; Tang WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15939; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18	43	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 13	2017	8								2095	10.1038/s41467-017-02265-x				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8HV	WOS:000417884500001	29235474	gold			2018-01-05	
J	Wu, Q; Ferry, QRV; Baeumler, TA; Michaels, YS; Vitsios, DM; Habib, O; Arnold, R; Jiang, XW; Maio, S; Steinkraus, BR; Tapia, M; Piazza, P; Xu, N; Hollander, GA; Milne, TA; Kim, JS; Enright, AJ; Bassett, AR; Fulga, TA				Wu, Qianxin; Ferry, Quentin R. V.; Baeumler, Toni A.; Michaels, Yale S.; Vitsios, Dimitrios M.; Habib, Omer; Arnold, Roland; Jiang, Xiaowei; Maio, Stefano; Steinkraus, Bruno R.; Tapia, Marta; Piazza, Paolo; Xu, Ni; Hollander, Georg A.; Milne, Thomas A.; Kim, Jin-Soo; Enright, Anton J.; Bassett, Andrew R.; Fulga, Tudor A.			In situ functional dissection of RNA cis-regulatory elements by multiplex CRISPR-Cas9 genome engineering	NATURE COMMUNICATIONS			English	Article							MICRORNA TARGET SITES; STRUCTURAL BASIS; MAMMALIAN MICRORNAS; WIDE IDENTIFICATION; 3' UTRS; BINDING; RECOGNITION; EXPRESSION; SEQUENCES; EVOLUTION	RNA regulatory elements (RREs) are an important yet relatively under-explored facet of gene regulation. Deciphering the prevalence and functional impact of this post-transcriptional control layer requires technologies for disrupting RREs without perturbing cellular homeostasis. Here we describe genome-engineering based evaluation of RNA regulatory element activity (GenERA), a clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 platform for in situ high-content functional analysis of RREs. We use GenERA to survey the entire regulatory landscape of a 3'UTR, and apply it in a multiplex fashion to analyse combinatorial interactions between sets of miRNA response elements (MREs), providing strong evidence for cooperative activity. We also employ this technology to probe the functionality of an entire MRE network under cellular homeostasis, and show that high-resolution analysis of the GenERA dataset can be used to extract functional features of MREs. This study provides a genome editing-based multiplex strategy for direct functional interrogation of RNA cis-regulatory elements in a native cellular environment.	[Wu, Qianxin; Ferry, Quentin R. V.; Baeumler, Toni A.; Michaels, Yale S.; Steinkraus, Bruno R.; Xu, Ni; Fulga, Tudor A.] Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Vitsios, Dimitrios M.; Enright, Anton J.] European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Habib, Omer; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 08826, South Korea; [Arnold, Roland; Jiang, Xiaowei] Univ Oxford, Mol & Populat Genet Lab, Oxford Ctr Canc Gene Res, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Maio, Stefano; Hollander, Georg A.] Univ Oxford, Weatherall Inst Mol Med, Dev Immunol, Oxford OX3 9DS, England; [Tapia, Marta; Milne, Thomas A.] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, NIHR Oxford Biomed Res Ctr Programme, Oxford OX3 9DS, England; [Piazza, Paolo] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Hollander, Georg A.] Univ Basel, Lab Paediat Immunol, Dept Biomed, CH-4058 Basel, Switzerland; [Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Bassett, Andrew R.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RF, England; [Wu, Qianxin; Bassett, Andrew R.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England	Fulga, TA (reprint author), Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	tudor.fulga@imm.ox.ac.uk			MRC [G0902418]; Wellcome Trust; Radcliffe Department of Medicine/MRC Scholars Programme Studentship; Clarendon Scholarship; WIMM Prize Fellowship; Christopher Welch Scholarship; EMBL-EBI; Institute for Basic Science [IBS-R021-D1]; Wellcome Trust [090532/Z/09/Z, 105045/Z/14/Z]; Oxford NIHR Biomedical Research Centre; ERC [340560]; MRC; MRC (Molecular Haematology Unit) [MC_UU_12009/6]; Wellcome Trust ISSF; John Fell Research Fund (OUP); University of Oxford Departments of Pathology, Biochemistry, Pharmacology and Physiology, Anatomy and Genetics; BBSRC [BB/N006550/1]; Wellcome Trust ISSF [105605/Z/14/Z]	We would like to thank Jenna Schwarz and Peiyao Zhao for help with assembling the miR184 MRE network; Ruth Williams and Maria Suciu for advice on next generation sequencing; Simon McGowan, Jelena Telenius and Nicky Gray at the Computational Biology Research Group (CBRG) University of Oxford, for assistance with processing sequencing data. Q.W. was supported by MRC (#G0902418). Q.RV.F. is supported by a Wellcome Trust PhD studentship. T.A.B. is supported by a Radcliffe Department of Medicine/MRC Scholars Programme Studentship. Y.S.M. is supported by a Clarendon Scholarship, WIMM Prize Fellowship and Christopher Welch Scholarship. D.M.V. and A.J.E. are supported by EMBL-EBI. O.H. and J.-S.K. are supported by the Institute for Basic Science (IBS-R021-D1). R.A. is supported by core funding to WTCHG (Wellcome Trust 090532/Z/09/Z) and Oxford NIHR Biomedical Research Centre. X.J. is funded by ERC Advanced Grant (340560) awarded to Ian P.M. Tomlinson. B.R.S. was supported by a MRC PhD Studentship. S.M. and G.A.H. are supported by Wellcome Trust (#105045/Z/14/Z). M.T. and T.A.M. are supported by MRC (Molecular Haematology Unit grant MC_UU_12009/6). P.P. was supported by a Wellcome Trust grant (#090532/Z/09/Z). N.X. was a summer student with T.A.F. A.R.B. was supported by Wellcome Trust ISSF, John Fell Research Fund (OUP), and University of Oxford Departments of Pathology, Biochemistry, Pharmacology and Physiology, Anatomy and Genetics. T.A.F. is supported by MRC (#G0902418), BBSRC (#BB/N006550/1) and Wellcome Trust ISSF (#105605/Z/14/Z).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Androsavich JR, 2014, NUCLEIC ACIDS RES, V42, P6945, DOI 10.1093/nar/gku344; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Bassett AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5640; Bassett AR, 2014, BIOL OPEN, V3, P42, DOI 10.1242/bio.20137120; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Broughton JP, 2013, METHODS, V63, P119, DOI 10.1016/j.ymeth.2013.03.033; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575                                           ; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J., 2014, NAT REV GENET, V15, P1; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Ho JJD, 2014, WIRES RNA, V5, P69, DOI 10.1002/wrna.1197; Hong X, 2009, P NATL ACAD SCI USA, V106, P15085, DOI 10.1073/pnas.0908149106; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jens M, 2015, NAT REV GENET, V16, P113, DOI 10.1038/nrg3853; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Y, 2015, WIRES RNA, V6, P435, DOI 10.1002/wrna.1286; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Liberali P, 2015, NAT REV GENET, V16, P18, DOI 10.1038/nrg3768; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Mayr C, 2016, TRENDS CELL BIOL, V26, P227, DOI 10.1016/j.tcb.2015.10.012; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Steinkraus BR, 2016, WIRES DEV BIOL, V5, P311, DOI 10.1002/wdev.223; Wang JX, 2015, MOL CELL, V59, P50, DOI 10.1016/j.molcel.2015.05.003; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yartseva V, 2017, NAT METHODS, V14, P201, DOI [10.1038/NMETH.4121, 10.1038/nmeth.4121]; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhao WX, 2014, NAT BIOTECHNOL, V32, P387, DOI 10.1038/nbt.2851	69	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 13	2017	8								2109	10.1038/s41467-017-00686-2				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8HV	WOS:000417884500015	29235467	gold			2018-01-05	
J	Fonseca, A; Ishoey, T; Espinoza, C; Perez-Pantoja, D; Manghisi, A; Morabito, M; Salas-Burgos, A; Gallardo, VA				Fonseca, Alexis; Ishoey, Thomas; Espinoza, Carole; Perez-Pantoja, Danilo; Manghisi, Antonio; Morabito, Marina; Salas-Burgos, Alexis; Gallardo, Victor A.			Genomic features of "Candidatus Venteria ishoeyi", a new sulfur-oxidizing macrobacterium from the Humboldt Sulfuretum off Chile	PLOS ONE			English	Article							ELECTRON-TRANSPORT PATHWAYS; FRESH-WATER BEGGIATOA; RNA SEQUENCE-ANALYSIS; C NITRITE REDUCTASE; 16S RIBOSOMAL-RNA; PSEUDOMONAS-AERUGINOSA; THIOPLOCA-CHILEAE; SULFIDE OXIDATION; MARINE BEGGIATOA; GENE CLUSTERS	The Humboldt Sulfuretum (HS), in the productive Humboldt Eastern Boundary Current Upwelling Ecosystem, extends under the hypoxic waters of the Peru-Chile Undercurrent (ca. 6 degrees S and ca. 36 degrees S). Studies show that primeval sulfuretums held diverse prokaryotic life, and, while rare today, still sustain species-rich giant sulfur-oxidizing bacterial communities. We here present the genomic features of a new bacteria of the HS, "Candidatus Venteria ishoeyi" ("Ca. V. ishoeyi") in the family Thiotrichaceae. Three identical filaments were micromanipulated from reduced sediments collected off central Chile; their DNA was extracted, amplified, and sequenced by a Roche 454 GS FLX platform. Using three sequenced libraries and through de novo genome assembly, a draft genome of 5.7 Mbp, 495 scaffolds, and a N50 of 70 kbp, was obtained. The 16S rRNA gene phylogenetic analysis showed that "Ca. V. ishoeyi" is related to non-vacuolate forms presently known as Beggiatoa or Beggiatoa-like forms. The complete set of genes involved in respiratory nitrate-reduction to dinitrogen was identified in "Ca. V. ishoeyi"; including genes likely leading to ammonification. As expected, the sulfur-oxidation pathway reported for other sulfur-oxidizing bacteria were deduced and also, key inorganic and organic carbon acquisition related genes were identified. Unexpectedly, the genome of "Ca. V. ishoeyi" contained numerous CRISPR repeats and an I-F CRISPR-Cas type system gene coding array. Findings further show that, as a member of an eons-old marine ecosystem, "Ca. V. ishoeyi" contains the needed metabolic plasticity for life in an increasingly oxygenated and variable ocean.	[Fonseca, Alexis; Salas-Burgos, Alexis] Univ Concepcion, Dept Pharmacol, Concepcion, Chile; [Fonseca, Alexis; Espinoza, Carole; Gallardo, Victor A.] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Espinoza, Carole; Gallardo, Victor A.] Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Coll Ocean Sci & Resources, Keelung, Taiwan; [Perez-Pantoja, Danilo] Univ Tecnol Metropolitana, Programa Inst Fomento Invest Desarrollo & Innovac, Santiago, Chile; [Manghisi, Antonio; Morabito, Marina] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy	Fonseca, A; Salas-Burgos, A (reprint author), Univ Concepcion, Dept Pharmacol, Concepcion, Chile.; Fonseca, A; Gallardo, VA (reprint author), Univ Concepcion, Dept Oceanog, Concepcion, Chile.; Gallardo, VA (reprint author), Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Coll Ocean Sci & Resources, Keelung, Taiwan.	afonseca@udec.cl; alsalas@udec.cl; vagallar@gmail.com		Fonseca, Alexis/0000-0003-4580-6270	National Fund for Scientific and Technological Development (FONDECYT) Project [1070552, 1110786]; VRID-Enlace [214.122117-1.0]; Synthetic Genomics, Inc. (SGI); National Commission for Scientific and Technological Research (CONICYT); international program Census of Marine Life (CoML); International Census of Marine Microbes (ICOMM)	This work was supported by National Fund for Scientific and Technological Development (FONDECYT) Project 1070552 to VAG: Financed sampling and part of the sequencing costs; National Fund for Scientific and Technological Development (FONDECYT) Project 1110786 to VAG: Financed sampling and part of the sequencing costs; VRID-Enlace 214.122117-1.0 to VAG; Synthetic Genomics, Inc. (SGI): Financed half of the costs involved in sequencing into a cooperation agreement framework; Graduate Student Scholarship: National Commission for Scientific and Technological Research (CONICYT) to carry out M. Sc. Studies, period March 2014 to March of 2016: Allowed to the author AF for the preparation of the manuscript. We further acknowledge the valuable support from the international program Census of Marine Life (CoML) and its project International Census of Marine Microbes (ICOMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, APPL ENVIRON MICROB, V65, P270; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alcaino J, 2016, SUBCELL BIOCHEM, V79, P3, DOI 10.1007/978-3-319-39126-7_1; Gallardo VA, 2013, GAYANA, V77, P136, DOI 10.4067/s0717-65382013000200008; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baas-Becking LGM, 1925, ANN BOT-LONDON, V39, P613, DOI 10.1093/oxfordjournals.aob.a089968                                              ; BELL LC, 1990, FEBS LETT, V265, P85, DOI 10.1016/0014-5793(90)80889-Q; Blin K, 2013, NUCLEIC ACIDS RES; Brinkhoff T, 2005, THIOMICROSPIRA BERGE; Brock J, 2012, ANTON LEEUW INT J G, V101, P347, DOI 10.1007/s10482-011-9640-8; Brock J, 2011, ISME J, V5, P497, DOI 10.1038/ismej.2010.135; Burnett WC, PHOSPHORITE DEPOSITS; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Dahl C, 2008, MICROBIAL SULFUR MET; DAHL C, 2008, SULFUR PHOTOTROPHIC, V27, P289, DOI DOI 10.1007/978-1-4020-6863-8_15; Dahl C, 2006, BACTERIAL INCLUSIONS, P21; Danovaro R, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0144; de Albuquerque JP, 2010, MICRON, V41, P507, DOI 10.1016/j.micron.2010.01.009; Dela Pierre F, 2014, MAR GEOL, V355, P71, DOI 10.1016/j.margeo.2014.05.010; Dubinina G, 2017, INT J SYST EVOL MICR, V67, P197, DOI 10.1099/ijsem.0.001584; DURAND P, 1993, ARCH MICROBIOL, V159, P39, DOI 10.1007/BF00244261; Einsle O, 2011, METHOD ENZYMOL, V496, P399, DOI 10.1016/B978-0-12-386489-5.00016-6; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flood BE, 2016, FRONTIERS MICROBIOLO, V7; Fomenkov A, 2015, GENOME ANNOUNCEMENTS, V3; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; FOX GE, 1977, INT J SYST BACTERIOL, V27, P44, DOI 10.1099/00207713-27-1-44                                                        ; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Gallardo T, 2015, MARINE ALGAE: BIODIVERSITY, TAXONOMY, ENVIRONMENTAL ASSESSMENT, AND BIOTECHNOLOGY, P1; Gallardo V, 2013, OCEANOGRAPHY OPEN AC; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0                                                                ; Gallardo VA, 2007, OPTICAL ENG APPL; Gallardo V, 1977, ANALES I INVESTIGACI, P23; Gallardo VA, 2010, INT MICROBIOL, V10, P97; Garrity GM, 2005, BERGEYS MANUAL SYSTE, P131; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grunke S, 2012, BIOGEOSCIENCES, V9, P2947, DOI 10.5194/bg-9-2947-2012; Hagen KD, 1996, APPL ENVIRON MICROB, V62, P947; Hedderich R, 2005, BIOL CHEM, V386, P961, DOI 10.1515/BC.2005.112; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Heussler GE, 2016, J BACTERIOL, V198, P3080, DOI 10.1128/JB.00458-16; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kamp A, 2008, MICROB ECOL, V56, P484, DOI 10.1007/s00248-008-9367-x; Kamp A, 2006, APPL ENVIRON MICROB, V72, P4755, DOI 10.1128/AEM.00163-06; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kojima H, 2015, ISME J, V9, P1166, DOI 10.1038/ismej.2014.209; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee PA, 1999, J PHYCOL, V35, P8, DOI 10.1046/j.1529-8817.1999.3510008.x; Li X, 2013, J ANTIBIOT, V66, P443, DOI 10.1038/ja.2013.52; Li YJ, 2012, J BACTERIOL, V194, P4847, DOI 10.1128/JB.00903-12; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; MacGregor BJ, 2013, MAR GENOM, V11, P53, DOI [10.1016/j.margen2013.08.001, 10.1016/j.margen.2013.08.001]; MacGregor BJ, 2013, APPL ENV MICROBIOLOG; MAIER S, 1984, INT J SYST BACTERIOL, V34, P414, DOI 10.1099/00207713-34-4-414                                                       ; MAIER S, 1990, CAN J MICROBIOL, V36, P438, DOI 10.1139/m90-077                                                                 ; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2015, NATURE REV MICROBIOL; McHatton SC, 1996, APPL ENVIRON MICROB, V62, P954; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Motomura K, 2014, APPL ENVIRON MICROB, V80, P2602, DOI 10.1128/AEM.03971-13; Muntyan MS, 2005, MICROBIOLOGY+, V74, P388, DOI 10.1007/s11021-005-0078-8; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225; NELSON DC, 1982, ARCH MICROBIOL, V133, P172, DOI 10.1007/BF00414997; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Papaspyrou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094111; Rabenhorst, 1865, FLORA EUROPAEA ALGAR; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; Salman-Carvalho V, 2016, FRONTIERS MICROBIOLO, V7; Schatz MC, 2013, BRIEF BIOINFORM, V14, P213, DOI 10.1093/bib/bbr074; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schopf JW, 2015, P NATL ACAD SCI USA, V112, P2087, DOI 10.1073/pnas.1419241112; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Schultze H.-P., 1989, Revista Geologica de Chile, V16, P183; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Schwedt A, 2012, FRONTIERS MICROBIOLO, V2, P1; Seemann T., 2014, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BTU153; Simon J, 2000, MOL MICROBIOL, V35, P686, DOI 10.1046/j.1365-2958.2000.01742.x                                                ; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sobarzo M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002350; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846                                                       ; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Stojanowic A, 2003, ARCH MICROBIOL, V180, P194, DOI 10.1007/s00203-003-0577-9; Strous M, 2012, FRONTIERS MICROBIOLO, V3; SWEERTS JPRA, 1990, NATURE, V344, P762, DOI 10.1038/344762a0                                                                ; Teske A, 2014, THE PROKARYOTES, P93; Teske A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P784, DOI 10.1007/0-387-30746-x_27; Tremberger Jr G, 2010, SPIE OPTICAL ENG APP; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; Wall J, 2008, GENETICS GENOMICS SU, P1; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Winkel M, 2016, FRONTIERS MICROBIOLO, V7; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0                                                                ; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Yamada Y, 2015, P NATL ACAD SCI USA, V112, P62; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064; Zopfi J, 2008, GEOCHIM COSMOCHIM AC, V72, P827, DOI 10.1016/j.gca.2007.11.031	108	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188371	10.1371/journal.pone.0188371				25	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8HS	WOS:000417884100016		gold			2018-01-05	
J	Takahashi, K; Inukai, T; Imamura, T; Yano, M; Tomoyasu, C; Lucas, DM; Nemoto, A; Sato, H; Huang, MX; Abe, M; Kagami, K; Shinohara, T; Watanabe, A; Somazu, S; Oshiro, H; Akahane, K; Goi, K; Kikuchi, J; Furukawa, Y; Goto, H; Minegishi, M; Iwamoto, S; Sugita, K				Takahashi, Kazuya; Inukai, Takeshi; Imamura, Toshihiko; Yano, Mio; Tomoyasu, Chihiro; Lucas, David M.; Nemoto, Atsushi; Sato, Hiroki; Huang, Meixian; Abe, Masako; Kagami, Keiko; Shinohara, Tamao; Watanabe, Atsushi; Somazu, Shinpei; Oshiro, Hiroko; Akahane, Koshi; Goi, Kumiko; Kikuchi, Jiro; Furukawa, Yusuke; Goto, Hiroaki; Minegishi, Masayoshi; Iwamoto, Shotaro; Sugita, Kanji			Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEASOME INHIBITOR BORTEZOMIB; REFRACTORY MULTIPLE-MYELOMA; SINGLE-AGENT CARFILZOMIB; P-GLYCOPROTEIN; THERAPEUTIC ADVANCES; CHILDHOOD LEUKEMIA; INDUCED APOPTOSIS; T-CELL; EXPRESSION	Prognosis of childhood acute lymphoblastic leukemia (ALL) has been dramatically improved. However, prognosis of the cases refractory to primary therapy is still poor. Recent phase 2 study on the efficacy of combination chemotherapy with bortezomib (BTZ), a proteasome inhibitor, for refractory childhood ALL demonstrated favorable clinical outcomes. However, septic death was observed in over 10% of patients, indicating the necessity of biomarkers that could predict BTZ sensitivity. We investigated in vitro BTZ sensitivity in a large panel of ALL cell lines that acted as a model system for refractory ALL, and found that Philadelphia chromosome-positive (Ph+) ALL, IKZF1 deletion, and biallelic loss of CDKN2A were associated with favorable response. Even in Ph-negative ALL cell lines, IKZF1 deletion and bilallelic loss of CDKN2A were independently associated with higher BTZ sensitivity. BTZ showed only marginal cross-resistance to four representative chemotherapeutic agents (vincristine, dexamethasone, l-asparaginase, and daunorubicin) in B-cell precursor-ALL cell lines. To improve the efficacy and safety of proteasome inhibitor combination chemotherapy, we also analyzed the anti-leukemic activity of carfilzomib (CFZ), a second-generation proteasome inhibitor, as a substitute for BTZ. CFZ showed significantly higher activity than BTZ in the majority of ALL cell lines except for the P-glycoprotein-positive t(17; 19) ALL cell lines, and IKZF1 deletion was also associated with a favorable response to CFZ treatment. P-glycoprotein inhibitors effectively restored the sensitivity to CFZ, but not BTZ, in P-glycoprotein-positive t(17; 19) ALL cell lines. P-glycoprotein overexpressing ALL cell line showed a CFZ-specific resistance, while knockout of P-glycoprotein by genome editing with a CRISPR/Cas9 system sensitized P-glycoprotein-positive t(17; 19) ALL cell line to CFZ. These observations suggested that IKZF1 deletion could be a useful biomarker to predict good sensitivity to CFZ and BTZ, and that CFZ combination chemotherapy may be a new therapeutic option with higher anti-leukemic activity for refractory ALL that contain P-glycoprotein-negative leukemia cells.	[Takahashi, Kazuya; Inukai, Takeshi; Nemoto, Atsushi; Sato, Hiroki; Huang, Meixian; Abe, Masako; Kagami, Keiko; Shinohara, Tamao; Watanabe, Atsushi; Somazu, Shinpei; Oshiro, Hiroko; Akahane, Koshi; Goi, Kumiko; Sugita, Kanji] Univ Yamanashi, Dept Pediat, Sch Med, Chuo Ku, Kofu, Yamanashi, Japan; [Imamura, Toshihiko; Yano, Mio; Tomoyasu, Chihiro] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto, Japan; [Lucas, David M.] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [Kikuchi, Jiro; Furukawa, Yusuke] Jichi Med Sch, Stem Cell Regulat, Ctr Mol Med, Shimotsuke, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Hematol Oncol & Regenerat Med, Yokohama, Kanagawa, Japan; [Minegishi, Masayoshi] Japanese Red Cross Soc, Tohoku Block Ctr, Sendai, Miyagi, Japan; [Iwamoto, Shotaro] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan	Inukai, T (reprint author), Univ Yamanashi, Dept Pediat, Sch Med, Chuo Ku, Kofu, Yamanashi, Japan.	tinukai@yamanashi.ac.jp			JSPS [15K09645]	Takeshi lnukai was supported by JSPS KAKENHI Grant Number 15K09645.	An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Ao L, 2012, MOL PHARMACEUT, V9, P2197, DOI 10.1021/mp300044b; Ariyasu T, 1998, Hum Cell, V11, P43; Asai D, 2013, CANCER MED-US, V2, P412, DOI 10.1002/cam4.87; Baudis M, 2006, PEDIATR BLOOD CANCER, V47, P757, DOI 10.1002/pbc.20635; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Brown RE, 2004, ANN CLIN LAB SCI, V34, P203; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; De Moerloose B, 2003, PEDIATR HEMAT ONCOL, V20, P381, DOI 10.1080/08880010390204007; Dhooge C, 1999, BRIT J HAEMATOL, V105, P676, DOI 10.1046/j.1365-2141.1999.01378.x; Dimopoulos MA, 2016, LANCET ONCOL, V17, P27, DOI 10.1016/S1470-2045(15)00464-7; GOASGUEN JE, 1993, BLOOD, V81, P2394; Goto H, 2009, LEUKEMIA RES, V33, P1386, DOI 10.1016/j.leukres.2008.12.003; Gupta SV, 2011, AAPS J, V13, P357, DOI 10.1208/s12248-011-9276-7; Gutman D, 2009, LEUKEMIA, V23, P2181, DOI 10.1038/leu.2009.123; Hawley TS, 2013, AM J HEMATOL, V88, P265, DOI [10.1002/ajh.23387, 10.1002/joh.23387]; HEBERT J, 1994, BLOOD, V84, P4038; Hijiya N, 2016, LEUKEMIA LYMPHOMA, V57, P748, DOI 10.3109/10428194.2015.1101098; Hirase C, 2009, LEUKEMIA RES, V33, P450, DOI 10.1016/j.leukres.2008.07.023; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; HIROSE M, 1982, GANN, V73, P600; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Horton TM, 2006, CANCER CHEMOTH PHARM, V58, P13, DOI 10.1007/s00280-005-0135-z; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P37, DOI 10.1002/pbc.21214; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Jakubowiak AJ, 2013, LEUKEMIA, V27, P2351, DOI 10.1038/leu.2013.152; Kang J, 2003, BRIT J HAEMATOL, V123, P921, DOI 10.1046/j.1365-2141.2003.04699.x                                                ; KAWAMURA M, 1995, BLOOD, V85, P2546; Kees UR, 1997, BLOOD, V89, P4161; Kortuem KM, 2013, BLOOD, V121, P893, DOI 10.1182/blood-2012-10-459883; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Lonial S, 2015, BLOOD, V126, P1536, DOI 10.1182/blood-2015-06-653261; Messinger Y, 2010, PEDIATR BLOOD CANCER, V55, P254, DOI 10.1002/pbc.22456; Messinger YH, 2012, BLOOD, V120, P285, DOI 10.1182/blood-2012-04-418640; MINEGISHI M, 1987, TOHOKU J EXP MED, V151, P283, DOI 10.1620/tjem.151.283; Moqadam FA, 2014, LEUKEMIA, V28, P1008, DOI 10.1038/leu.2013.308; Moreau P, 2017, LEUKEMIA, V31, P115, DOI 10.1038/leu.2016.186; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; O'Connor OA, 2009, CLIN CANCER RES, V15, P7085, DOI 10.1158/1078-0432.CCR-09-0822; Okabe S, 2010, EXP HEMATOL, V38, P765, DOI 10.1016/j.exphem.2010.04.017; OKUDA T, 1995, BLOOD, V85, P2321; Olsson L, 2015, BRIT J HAEMATOL, V169, P479, DOI 10.1111/bjh.13342; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; SAVIGNANO C, 1993, HAEMATOLOGICA, V78, P261; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Szczepanek J, 2010, ANTICANCER RES, V30, P2119; Uno K, 2003, BLOOD, V101, P3658, DOI 10.1182/blood-2002-06-1770                                                      ; Vij R, 2012, BRIT J HAEMATOL, V158, P739, DOI 10.1111/j.1365-2141.2012.09232.x; Williams RT, 2008, COLD SH Q B, V73, P461, DOI 10.1101/sqb.2008.73.039; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yeo KK, 2016, J PEDIAT HEMATOL ONC, V38, P345, DOI 10.1097/MPH.0000000000000560; Zahid MF, 2016, FUTURE ONCOL, V12, P1861, DOI 10.2217/fon-2016-0126	57	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188680	10.1371/journal.pone.0188680				21	Multidisciplinary Sciences	Science & Technology - Other Topics	FP8HS	WOS:000417884100024		gold			2018-01-05	
J	Kastenhuber, ER; Lalazar, G; Houlihan, SL; Tschaharganeh, DF; Baslan, T; Chen, CC; Requena, D; Tian, S; Bosbach, B; Wilkinson, JE; Simon, SM; Lowe, SW				Kastenhuber, Edward R.; Lalazar, Gadi; Houlihan, Shauna L.; Tschaharganeh, Darjus F.; Baslan, Timour; Chen, Chi-Chao; Requena, David; Tian, Sha; Bosbach, Benedikt; Wilkinson, John E.; Simon, Sanford M.; Lowe, Scott W.			DNAJB1-PRKACA fusion kinase interacts with beta-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						fibrolamellar hepatocellular carcinoma; CRISPR; mouse cancer models; protein kinase A; beta-catenin	CHROMOSOMAL REARRANGEMENTS; OXIDATIVE STRESS; MOUSE MODELS; CANCER; PHOSPHORYLATION; INHIBITION; REVEALS; GENE; ACTIVATION; GENERATION	A segmental deletion resulting in DNAJB1-PRKACA gene fusion is now recognized as the signature genetic event of fibrolamellar hepatocellular carcinoma (FL-HCC), a rare but lethal liver cancer that primarily affects adolescents and young adults. Here we implement CRISPR-Cas9 genome editing and transposon-mediated somatic gene transfer to demonstrate that expression of either the endogenous fusion protein or a chimeric cDNA leads to the formation of indolent liver tumors in mice that closely resemble human FL-HCC. Notably, overexpression of the wild-type PRKACA was unable to fully recapitulate the oncogenic activity of DNAJB1-PRKACA, implying that FL-HCC does not simply result from enhanced PRKACA expression. Tumorigenesis was significantly enhanced by genetic activation of beta-catenin, an observation supported by evidence of recurrent Wnt pathway mutations in human FL-HCC, as well as treatment with the hepatotoxin 3,5-diethoxycarbonyl-1,4-dihydrocollidine, which causes tissue injury, inflammation, and fibrosis. Our study validates the DNAJB1-PRKACA fusion kinase as an oncogenic driver and candidate drug target for FL-HCC, and establishes a practical model for preclinical studies to identify strategies to treat this disease.	[Kastenhuber, Edward R.; Houlihan, Shauna L.; Baslan, Timour; Chen, Chi-Chao; Tian, Sha; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Kastenhuber, Edward R.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lalazar, Gadi; Requena, David; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [Tschaharganeh, Darjus F.] Helmholtz Univ, German Canc Res Ctr DKFZ, Grp Cell Plast & Epigenet Remodeling, D-69120 Heidelberg, Germany; [Tschaharganeh, Darjus F.] Univ Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Bosbach, Benedikt] Pfizer Inc, Oncol Target Discovery Program, Pearl River, NY 10965 USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Lowe, SW (reprint author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.; Lowe, SW (reprint author), Howard Hughes Med Inst, New York, NY 10065 USA.	lowes@mskcc.org			Starr Cancer Consortium [I10-0098]; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, National Cancer Institute Cancer Center Core Grants [P30-CA008748, NIH P01 CA013106]; Andrew McDonough B+ Foundation; National Center for Advancing Translational Sciences (NCATS) National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [UL1 TR001866]; F31 NRSA predoctoral fellowship from the NCI/NIH [F31CA192835]; NIH [1R56CA207929]; MSKCC Single Cell Sequencing Initiative	We thank Francisco Sanchez-Rivera (MSKCC), Yadira Soto-Feliciano (Rockefeller University), and John P. Morris IV (MSKCC) for critical reading of the manuscript, and all members of the S.W.L. laboratory for advice and discussions. We thank Wei Luan and Leah Zamachek for technical assistance, and David Klimstra, Paul Romesser, Robert Bowman, Joana DeCampos Vidigal, and Andrea Ventura for critical insights and materials. We gratefully acknowledge the members of the Molecular Diagnostics Service in the Department of Pathology (MSKCC). This work was supported primarily by a project grant from the Starr Cancer Consortium (I10-0098) (to S.W.L. and S.M.S.). This work was also funded in part by the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, National Cancer Institute Cancer Center Core Grants P30-CA008748 and NIH P01 CA013106, the Andrew McDonough B+ Foundation, and Grant UL1 TR001866 from the National Center for Advancing Translational Sciences (NCATS) National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. E.R.K. is supported by an F31 NRSA predoctoral fellowship from the NCI/NIH under Award F31CA192835. G.L., D.R., and S.M.S. were supported by a grant from the NIH (1R56CA207929). T.B. is the William C. and Joyce O'Neil Charitable Trust Fellow and is supported by the MSKCC Single Cell Sequencing Initiative. S.W.L. is an investigator of the Howard Hughes Medical Institute and the Geoffrey Beene Chair for Cancer Biology.	Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Celli Romulo, 2014, J Clin Transl Hepatol, V2, P103, DOI 10.14218/JCTH.2014.00010; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Cheung J, 2015, P NATL ACAD SCI USA, V112, P1374, DOI 10.1073/pnas.1424206112; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; Cook PJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15987; Cornella H, 2015, GASTROENTEROLOGY, V148, P806, DOI 10.1053/j.gastro.2014.12.028; Darcy DG, 2015, ONCOTARGET, V6, P755, DOI 10.18632/oncotarget.2712                                                        ; Dinh TA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44653; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eggert T, 2013, UNITED EUR GASTROENT, V1, P351, DOI 10.1177/2050640613501507; Engelholm LH, 2017, GASTROENTEROLOGY, V153, P1662, DOI 10.1053/j.gastro.2017.09.008; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597                                                          ; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Graham RP, 2017, MODERN PATHOL, V30, P892, DOI 10.1038/modpathol.2017.7; Graham RP, 2015, MODERN PATHOL, V28, P822, DOI 10.1038/modpathol.2015.4; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Han T, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15945; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hohn A, 2012, FREE RADICAL BIO MED, V53, P1760, DOI 10.1016/j.freeradbiomed.2012.08.591; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4                                                   ; Kannangai R, 2007, HUM PATHOL, V38, P639, DOI 10.1016/j.humpath.2006.07.019; Kaseb AO, 2013, ONCOLOGY-BASEL, V85, P197, DOI 10.1159/000354698; Kawakami K, 2017, TRENDS GENET, V33, P784, DOI 10.1016/j.tig.2017.07.006; Kersten K, 2017, EMBO MOL MED, V9, P137, DOI 10.15252/emmm.201606857; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu Y, 2016, NATURE, V531, P471, DOI 10.1038/nature17157; Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Matter MS, 2016, HEPATOLOGY, V63, P1888, DOI 10.1002/hep.28487; Oikawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9070; PAYNE CM, 1986, ULTRASTRUCT PATHOL, V10, P539, DOI 10.3109/01913128609007211                                                       ; Preisegger KH, 1999, LAB INVEST, V79, P103; Priya S, 2013, FEBS LETT, V587, P1981, DOI 10.1016/j.febslet.2013.05.014; Riehle KJ, 2015, MODERN PATHOL, V28, P103, DOI 10.1038/modpathol.2014.78; Riggle KM, 2016, PEDIATR BLOOD CANCER, V63, P1163, DOI 10.1002/pbc.25970; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross HM, 2011, MODERN PATHOL, V24, P390, DOI 10.1038/modpathol.2010.207; Simon EP, 2015, P NATL ACAD SCI USA, V112, pE5916, DOI 10.1073/pnas.1424894112; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P17; Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965; Torbenson M, 2012, SCIENTIFICA, DOI 10.6064/2012/743790; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	59	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 12	2017	114	50					13076	13084		10.1073/pnas.1716483114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FP7IJ	WOS:000417806200039	29162699				2018-01-05	
J	Rayon-Estrada, V; Harjanto, D; Hamilton, CE; Berchiche, YA; Gantman, EC; Sakmar, TP; Bulloch, K; Gagnidze, K; Harroch, S; McEwen, BS; Papavasiliou, FN				Rayon-Estrada, Violeta; Harjanto, Dewi; Hamilton, Claire E.; Berchiche, Yamina A.; Gantman, Emily Conn; Sakmar, Thomas P.; Bulloch, Karen; Gagnidze, Khatuna; Harroch, Sheila; McEwen, Bruce S.; Papavasiliou, F. Nina			Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						epitranscriptomics; RNA; editing; APOBEC1; monocytes	B MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; HUMAN TRANSCRIPTOME; BINDING PROTEINS; HUMAN BRAIN; APOBEC-1; MICE; METHYLATION; SEQUENCE; TRANSLATION	Epitranscriptomics refers to posttranscriptional alterations on an mRNA sequence that are dynamic and reproducible, and affect gene expression in a similar way to epigenetic modifications. However, the functional relevance of those modifications for the transcript, the cell, and the organism remain poorly understood. Here, we focus on RNA editing and show that Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-1 (APOBEC1), together with its cofactor RBM47, mediates robust editing in different tissues. The majority of editing events alter the sequence of the 3'UTR of targeted transcripts, and we focus on one cell type (monocytes) and on a small set of highly edited transcripts within it to show that editing alters gene expression by modulating translation (but not RNA stability or localization). We further show that specific cellular processes (phagocytosis and transendothelial migration) are enriched for transcripts that are targets of editing and that editing alters their function. Finally, we survey bone marrow progenitors and demonstrate that common monocyte progenitor cells express high levels of APOBEC1 and are susceptible to loss of the editing enzyme. Overall, APOBEC1-mediated transcriptome diversification is required for the fine-tuning of protein expression in monocytes, suggesting an epitranscriptomic mechanism for the proper maintenance of homeostasis in innate immune cells.	[Rayon-Estrada, Violeta; Harjanto, Dewi; Hamilton, Claire E.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA; [Rayon-Estrada, Violeta; Hamilton, Claire E.; Gantman, Emily Conn] Rockefeller Univ, Rockefeller Grad Program, New York, NY 10065 USA; [Hamilton, Claire E.] Rockefeller Univ, Triinst MD PhD Program, New York, NY 10065 USA; [Berchiche, Yamina A.; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA; [Gantman, Emily Conn] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10065 USA; [Sakmar, Thomas P.] Karolinska Inst, Ctr Alzheimer Res, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, S-14157 Huddinge, Sweden; [Bulloch, Karen; Gagnidze, Khatuna] Rockefeller Univ, Neuroimmunol & Inflammat Program, New York, NY 10065 USA; [Harroch, Sheila; Papavasiliou, F. Nina] German Canc Res Ctr, Div Immune Divers, D-69120 Heidelberg, Germany; [McEwen, Bruce S.] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10065 USA; [Berchiche, Yamina A.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA	Papavasiliou, FN (reprint author), Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA.; Papavasiliou, FN (reprint author), German Canc Res Ctr, Div Immune Divers, D-69120 Heidelberg, Germany.; McEwen, BS (reprint author), Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10065 USA.	mcewen@mail.rockefeller.edu; n.papavasiliou@dkfz-heidelberg.de			New York State Department of Health [C023046]; European Research Council [649019]; Peter Deane Trust; NCI/F32 Award [F32CA183318]	We thank Drs. Fotini Gounari (University of Chicago) for advice on bone marrow reconstitution experiments and Robert Darnell (The Rockefeller University) for help with high-throughput sequencing of mRNA and miRNA isolated by cross-linking and immunoprecipitation (HITS-CLIP). We thank Sydney Sieh-Takata for help with validation of editing, Connie Zhao and the Rockefeller genomics core for help with sequencing applications, and Svetlana Mazel and the Rockefeller flow cytometry core for help with cell sorting (via the New York State Department of Health Contract C023046). The work herein was supported by European Research Council Grant 649019 (to F.N.P.), by a grant from the Peter Deane Trust (to K.B.), and by NCI/F32 Award F32CA183318 (to D.H.). All RNA-seq and HITS-CLIP raw sequence data reported here have been deposited in the National Center for Biotechnology Information Sequence Read Archive (accession no. GSE58798), along with the appropriate methods used to derive all relevant figures.	Abaza I, 2008, RNA, V14, P404, DOI 10.1261/rna.848208; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Blanc V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r79; Blanc V, 2012, J LIPID RES, V53, P2643, DOI 10.1194/jlr.M030494; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cole DC, 2017, P NATL ACAD SCI USA, V114, P13272, DOI 10.1073/pnas.1710493114; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Dance GSC, 2002, J BIOL CHEM, V277, P12703, DOI 10.1047/jbc.M111337200; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harjanto D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12145; Helwak A, 2014, NAT PROTOC, V9, P711, DOI 10.1038/nprot.2014.043; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Imamachi N, 2014, METHODS, V67, P55, DOI 10.1016/j.ymeth.2013.07.014; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Lee JH, 2017, WILEY INTERDISCIP RE, V9, P1; Li Y, 2013, INT J BIOCHEM CELL B, V45, P1843, DOI 10.1016/j.biocel.2013.05.033; Liu Q, 2015, EUR J IMMUNOL, V45, P1855, DOI 10.1002/eji.201445245; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas Stefan, 2006, RNA Biol, V3, P1; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761                                                                 ; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981                                                        ; O'Connor PBF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12915; Ogretmen B, 1998, BIOCHEMISTRY-US, V37, P11679, DOI 10.1021/bi980573c                                                               ; Orecchini E, 2017, NUCLEIC ACIDS RES, V45, P155, DOI 10.1093/nar/gkw834; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Picardi E, 2017, RNA, V23, P860, DOI 10.1261/rna.058271.116; Prohaska KM, 2014, WIRES RNA, V5, P493, DOI 10.1002/wrna.1226; Qi LH, 2014, CANCER RES, V74, P1301, DOI 10.1158/0008-5472.CAN-13-3485; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745; Severi F, 2015, RNA BIOL, V12, P389, DOI 10.1080/15476286.2015.1026033; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Teng BB, 1999, J LIPID RES, V40, P623; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Yamanaka S, 1996, J BIOL CHEM, V271, P11506, DOI 10.1074/jbc.271.19.11506                                                        ; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Zinovyev A, 2013, ADV EXP MED BIOL, V774, P189, DOI 10.1007/978-94-007-5590-1_11	50	1	1	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 12	2017	114	50					13296	13301		10.1073/pnas.1714227114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FP7IJ	WOS:000417806200077	29167373				2018-01-05	
J	Lee, JS; Shih, PY; Schaedel, ON; Quintero-Cadena, P; Rogers, AK; Sternberg, PW				Lee, James Siho; Shih, Pei-Yin; Schaedel, Oren N.; Quintero-Cadena, Porfirio; Rogers, Alicia K.; Sternberg, Paul W.			FMRFamide-like peptides expand the behavioral repertoire of a densely connected nervous system	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						phenotypic plasticity; RNA-seq; dauer; neuropeptide; FMRFamide	NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; CARBON-DIOXIDE; DAUER LARVA; DEVELOPMENTAL VARIANT; SEX DETERMINATION; LIFE-SPAN; EVOLUTION; METABOLISM	Animals, including humans, can adapt to environmental stress through phenotypic plasticity. The free-living nematode Caenorhabditis elegans can adapt to harsh environments by undergoing a whole-animal change, involving exiting reproductive development and entering the stress-resistant dauer larval stage. The dauer is a dispersal stage with dauer-specific behaviors for finding and stowing onto carrier animals, but how dauers acquire these behaviors, despite having a physically limited nervous system of 302 neurons, is poorly understood. We compared dauer and reproductive development using whole-animal RNA sequencing at fine time points and at sufficient depth to measure transcriptional changes within single cells. We detected 8,042 genes differentially expressed during dauer and reproductive development and observed striking up-regulation of neuropeptide genes during dauer entry. We knocked down neuropeptide processing using sbt-1 mutants and demonstrate that neuropeptide signaling promotes the decision to enter dauer rather than reproductive development. We also demonstrate that during dauer neuropeptides modulate the dauer-specific nictation behavior (carrier animal-hitchhiking) and are necessary for switching from repulsion to CO2 (a carrier animal cue) in non-dauers to CO2 attraction in dauers. We tested individual neuropeptides using CRISPR knockouts and existing strains and demonstrate that the combined effects of flp-10 and flp-17 mimic the effects of sbt-1 on nictation and CO2 attraction. Through meta-analysis, we discovered similar up-regulation of neuropeptides in the dauer-like infective juveniles of diverse parasitic nematodes, suggesting the antiparasitic target potential of SBT-1. Our findings reveal that, under stress, increased neuropeptide signaling in C. elegans enhances their decision-making accuracy and expands their behavioral repertoire.	[Lee, James Siho; Shih, Pei-Yin; Schaedel, Oren N.; Quintero-Cadena, Porfirio; Rogers, Alicia K.; Sternberg, Paul W.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Lee, James Siho; Shih, Pei-Yin; Schaedel, Oren N.; Quintero-Cadena, Porfirio; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Sternberg, PW (reprint author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Sternberg, PW (reprint author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]	We thank Daehan Lee for providing the nictation microchip design; Elissa Hallem for advice on CO<INF>2</INF> assays; Christopher Cronin for advice on behavioral assay setups; Mihoko Kato, Hillel Schwartz, Igor Antoshechkin, Ryoji Shinya, Han Wang, Animesh Ray, and Jonathan Liu for critically reading the manuscript; the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (Grant P40 OD010440), and Adam Antebi, Mario de Bono, and H. Robert Horvitz for providing animal strains; WormBase and WormBase SPELL for tools, datasets, and invaluable information; and the Millard and Muriel Jacobs Genetics and Genomics Laboratory for support with library construction and sequencing.	Aken BL, 2016, DATABASE; ALBERT PS, 1983, J COMP NEUROL, V219, P461, DOI 10.1002/cne.902190407                                                           ; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Blaxter M, 2015, PARASITOLOGY, V142, pS26, DOI 10.1017/S0031182014000791; Braeckman Bart P, 2009, WormBook, P1, DOI 10.1895/wormbook.1.146.1; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; BRENNER S, 1974, GENETICS, V77, P71; Cardoso Joao C R, 2012, Front Endocrinol (Lausanne), V3, P157, DOI 10.3389/fendo.2012.00157; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; De Ley P, 2006, WORMBOOK, DOI [10.1895/wormbook.1.41.1, DOI 10.1895/WORMBOOK.1.41.1]; Dockray GJ, 2004, EXP PHYSIOL, V89, P229, DOI 10.1113/expphysiol.2004.027169; Efron B., 1994, INTRO BOOTSTRAP; Elphick MR, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00093; Erkut C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082473; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5                                                   ; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghosh S, 2014, DEV BIOL, V396, P121, DOI 10.1016/j.ydbio.2014.09.028; Gilbert SF, 2000, DEV BIOL; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Gupta Bhagwati P, 2012, WormBook, P1, DOI 10.1895/wormbook.1.152.1; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; Han ZD, 2016, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00162; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Husson SJ, 2007, FEBS LETT, V581, P4288, DOI 10.1016/j.febslet.2007.08.003; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jia KL, 2002, DEVELOPMENT, V129, P221; Jones E., 2001, SCIPY OPEN SOURCE SC; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kaplan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017804; Karp X, 2016, WORMBOOK, DOI [10.1895/wormbook.1.180.1, DOI 10.1895/WORMBOOK.1.180.1]; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kim Y, 2011, BIOINFORMATICS, V27, P2772, DOI 10.1093/bioinformatics/btr445; Kiontke Karin, 2006, WormBook, P1; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0                                                                ; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar Lokesh, 2007, Bioinformation, V2, P5; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee D, 2017, BIOCHEM BIOPH RES CO, V484, P323, DOI [10.1016/j.bbrc.2017.01.113, 10.1016/j.bbrc.2017.113]; Lee H, 2012, NAT NEUROSCI, V15, P107, DOI 10.1038/nn.2975; L'Hernault SW, 2006, WORMBOOK, DOI [10.1895/wormbook.1.85.1, DOI 10.1895/WORMBOOK.1.85.1]; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Lindberg I, 1998, DNA CELL BIOL, V17, P727, DOI 10.1089/dna.1998.17.727; MADURO M, 1995, GENETICS, V141, P977; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McCoy Ciaran J, 2014, EuPA Open Proteom, V3, P262; McLaughlin KA, 2015, P NATL ACAD SCI USA, V112, P5637, DOI 10.1073/pnas.1423363112; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; McVeigh P, 2005, INT J PARASITOL, V35, P1043, DOI 10.1016/j.ijpara.2005.05.010; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Morris R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006185; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Neuwirth E, 2014, RCOLORBREWER COLORBR; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Bain O, 2003, FILARIA J, V2, P16, DOI 10.1186/1475-2883-2-16; Okumura E, 2014, J EXP BIOL, V217, P3197, DOI 10.1242/jeb.105353; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Pachter L, 2011, ARXIV11043889; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; Schroeder NE, 2013, CURR BIOL, V23, P1527, DOI 10.1016/j.cub.2013.06.058; Schwarz EM, 2015, NAT GENET, V47, P416, DOI 10.1038/ng.3237; Shen Lu-Lu, 2007, Neurosci Bull, V23, P21, DOI 10.1007/s12264-007-0003-4; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sivia D. S., 2006, DATA ANAL BAYESIAN T; Smith ES, 2013, J BIOL CHEM, V288, P37071, DOI 10.1074/jbc.M113.517367; Stoltzfus JD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001854; Sudhaus Walter, 2010, Palaeodiversity, P117; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1                                                   ; Viney ME, 2009, BIOESSAYS, V31, P496, DOI 10.1002/bies.200900010; von Reuss SH, 2012, J AM CHEM SOC, V134, P1817, DOI 10.1021/ja210202y; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5                                                    ; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Warnes GR, 2016, GPLOTS VARIOUS R PRO; WHITE JG, 1986, PHILOS T ROY SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOODWARD DE, 1993, P ROY SOC B-BIOL SCI, V252, P149, DOI 10.1098/rspb.1993.0059                                                          ; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	107	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 12	2017	114	50					E10726	E10735		10.1073/pnas.1710374114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FP7IJ	WOS:000417806200017	29167374				2018-01-05	
J	Paix, A; Folkmann, A; Goldman, DH; Kulaga, H; Grzelak, MJ; Rasoloson, D; Paidemarry, S; Green, R; Reed, RR; Seydoux, G				Paix, Alexandre; Folkmann, Andrew; Goldman, Daniel H.; Kulaga, Heather; Grzelak, Michael J.; Rasoloson, Dominique; Paidemarry, Supriya; Green, Rachel; Reed, Randall R.; Seydoux, Geraldine			Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR; HDR; short homology arms; PCR repair template; SDSA	TARGETED INTEGRATION; DONOR DNA; CELLS; CRISPR-CAS9; CRISPR/CAS9; MECHANISMS; RIBONUCLEOPROTEIN; CEREVISIAE; GENERATION; INSERTION	The RNA-guided DNA endonuclease Cas9 has emerged as a powerful tool for genome engineering. Cas9 creates targeted double-stranded breaks (DSBs) in the genome. Knockin of specific mutations (precision genome editing) requires homology-directed repair (HDR) of the DSB by synthetic donor DNAs containing the desired edits, but HDR has been reported to be variably efficient. Here, we report that linear DNAs (single and double stranded) engage in a high-efficiency HDR mechanism that requires only similar to 35 nucleotides of homology with the targeted locus to introduce edits ranging from 1 to 1,000 nucleotides. We demonstrate the utility of linear donors by introducing fluorescent protein tags in human cells and mouse embryos using PCR fragments. We find that repair is local, polarity sensitive, and prone to template switching, characteristics that are consistent with gene conversion by synthesis-dependent strand annealing. Our findings enable rational design of synthetic donor DNAs for efficient genome editing.	[Paix, Alexandre; Folkmann, Andrew; Goldman, Daniel H.; Kulaga, Heather; Grzelak, Michael J.; Rasoloson, Dominique; Paidemarry, Supriya; Green, Rachel; Reed, Randall R.; Seydoux, Geraldine] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Paix, A; Seydoux, G (reprint author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	apaix1@jhmi.edu; gseydoux@jhmi.edu			NIH [R01HD37047, R01DC004553, F32GM117814]; Damon Runyon Cancer Research Foundation [DRG-2280-16]	We thank the Johns Hopkins University (JHU) Genetic Resources Core Facility's Sequencing Facility, the JHU Transgenic Facility, and the JHU Ross Flow Cytometry Core Facility for expert support; Dr. Jonathan Weissman for the gift of HEK293T GFP1-10 cells; Andrew Holland and Tyler Moyer for tissue culture help; and Boris Zinshteyn for assistance with Illumina sequencing and data analysis. This work was supported by NIH Grants R01HD37047 (to G.S.), R01DC004553 (to R.R.R.), and F32GM117814 (to A.F.). G. S. and R.G. are investigators of the Howard Hughes Medical Institute. D.H.G. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2280-16). A.P. dedicates this work to Marcel Bodelet.	Anand RP, 2014, GENE DEV, V28, P2394, DOI 10.1101/gad.250258.114; Bothmer A., 2017, LOCUS, V8, P13905; Danner E, 2017, MAMM GENOME, V28, P262, DOI 10.1007/s00335-017-9688-5; DeWitt MA, 2017, METHODS, V121, P9, DOI 10.1016/j.ymeth.2017.04.003; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kan YN, 2017, GENOME RES, V27, P1099, DOI 10.1101/gr.214775.116; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Mehta A, 2017, MOL CELL, V65, P515, DOI 10.1016/j.molcel.2016.12.003; Moyer TC, 2015, METHOD CELL BIOL, V129, P19, DOI 10.1016/bs.mcb.2015.03.017; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Paix A, 2017, METHODS, V121, P86, DOI 10.1016/j.ymeth.2017.03.023; Paix A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw502; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Parsons JL, 2013, ANTIOXID REDOX SIGN, V18, P851, DOI 10.1089/ars.2011.4203; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tsaponina O, 2014, MOL CELL, V55, P615, DOI 10.1016/j.molcel.2014.06.025; Yamamoto Y, 2015, G3-GENES GENOM GENET, V5, P1843, DOI 10.1534/g3.115.019901; Yao X, 2017, EBIOMEDICINE, V20, P19, DOI 10.1016/j.ebiom.2017.05.015; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8	34	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 12	2017	114	50					E10745	E10754		10.1073/pnas.1711979114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FP7IJ	WOS:000417806200019	29183983				2018-01-05	
J	Tsai, WC; Dievart, A; Hsu, CC; Hsiao, YY; Chiou, SY; Huang, H; Chen, HH				Tsai, Wen-Chieh; Dievart, Anne; Hsu, Chia-Chi; Hsiao, Yu-Yun; Chiou, Shang-Yi; Huang, Hsin; Chen, Hong-Hwa			Post genomics era for orchid research	BOTANICAL STUDIES			English	Review						Comparative genomics; Genome editing; Genome evolution; GWAS; Orchidaceae; Phalaenopsis; Post genomics era; Receptor-like kinase; Secondary metabolomics; Terpene synthase	RECEPTOR-LIKE KINASES; CRASSULACEAN ACID METABOLISM; PHALAENOPSIS-APHRODITE; GENE FAMILY; PROTEIN-KINASES; PLANT GENOMES; LINKAGE MAP; TRANSPOSABLE ELEMENTS; EVOLUTIONARY HISTORY; TERPENE SYNTHASES	Among 300,000 species in angiosperms, Orchidaceae containing 30,000 species is one of the largest families. Almost every habitats on earth have orchid plants successfully colonized, and it indicates that orchids are among the plants with significant ecological and evolutionary importance. So far, four orchid genomes have been sequenced, including Phalaenopsis equestris, Dendrobium catenatum, Dendrobium officinale, and Apostaceae shengen. Here, we review the current progress and the direction of orchid research in the post genomics era. These include the orchid genome evolution, genome mapping (genome-wide association analysis, genetic map, physical map), comparative genomics (especially receptor-like kinase and terpene synthase), secondary metabolomics, and genome editing.	[Tsai, Wen-Chieh; Chen, Hong-Hwa] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 701, Taiwan; [Tsai, Wen-Chieh; Hsiao, Yu-Yun; Chen, Hong-Hwa] Natl Cheng Kung Univ, Orchid Res & Dev Ctr, Tainan 701, Taiwan; [Tsai, Wen-Chieh; Hsu, Chia-Chi; Hsiao, Yu-Yun; Chiou, Shang-Yi; Huang, Hsin; Chen, Hong-Hwa] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan; [Dievart, Anne] CIRAD, UMR AGAP, TA A 108-03,Ave Agropolis, F-34398 Montpellier, France; [Dievart, Anne] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, 800 Dongchuan Rd,Life Sci Bldg,Room 3-117, Shanghai 200240, Peoples R China	Chen, HH (reprint author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan.	hhchen@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan [105-2313-B-006-002-MY3, 105-2321-B-006-026-]	This work was supported by the Grants 105-2313-B-006-002-MY3, and 105-2321-B-006-026- to H.H.C. and W.C.T., respectively from Ministry of Science and Technology, Taiwan.	Aceto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097839; Alaba OA, 2015, G3-GENES GENOM GENET, V5, P133, DOI 10.1534/g3.114.015008; An FM, 2012, PLANT CELL PHYSIOL, V53, P1737, DOI 10.1093/pcp/pcs118; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Antolin-Llovera M, 2014, NEW PHYTOL, V204, P791, DOI 10.1111/nph.13117; Bennetzen JL, 2014, ANNU REV PLANT BIOL, V65, P505, DOI 10.1146/annurev-arplant-050213-035811; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boutanaev AM, 2015, P NATL ACAD SCI USA, V112, pE81, DOI 10.1073/pnas.1419547112; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chaney L, 2016, TRENDS PLANT SCI, V21, P770, DOI 10.1016/j.tplants.2016.05.004; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chao YT, 2014, PLANT MOL BIOL, V84, P529, DOI 10.1007/s11103-013-0150-0; Chappell J, 2002, CURR OPIN PLANT BIOL, V5, P151, DOI 10.1016/S1369-5266(02)00241-8; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen WH, 2013, SCI HORTIC-AMSTERDAM, V161, P70, DOI 10.1016/j.scienta.2013.06.045; Chen Wen-Huei, 2014, Journal of the Taiwan Society for Horticultural Science, V60, P115; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Croteau R., 2000, BIOCH MOL BIOL PLANT, V24, P1250; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Delseny M, 2010, PLANT SCI, V179, P407, DOI 10.1016/j.plantsci.2010.07.019; Delteil A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0711-x; Deng H, 2016, MOL PHYLOGENET EVOL, V94, P559, DOI 10.1016/j.ympev.2015.10.007; Deng H, 2015, ECOL EVOL, V5, P3800, DOI 10.1002/ece3.1642; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Eckardt N A, 2000, Plant Cell, V12, P2011; Eddy Sean R, 2009, Genome Inform, V23, P205; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng SG, 2013, J GENET, V92, P205, DOI 10.1007/s12041-013-0246-y; Fochi V, 2017, NEW PHYTOL, V213, P365, DOI 10.1111/nph.14279; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gebauer G, 2016, NEW PHYTOL, V211, P11, DOI 10.1111/nph.13865; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gill DE, 1989, SPECIAT CONSEQ, V458, P481; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Guo X, 2013, GENE, V527, P131, DOI 10.1016/j.gene.2013.05.073; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HANKS SK, 1995, FASEB J, V9, P576; Haruta Miyoshi, 2017, Curr Top Dev Biol, V123, P331, DOI 10.1016/bs.ctdb.2016.11.007; He GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r57; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Hruz Tomas, 2008, Advances in Bioinformatics, P420747, DOI 10.1155/2008/420747; Hsiao YY, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-14; Hsiao YY, 2013, GENE, V518, P91, DOI 10.1016/j.gene.2012.11.069; Hsiao YY, 2011, PLANT CELL PHYSIOL, V52, P1467, DOI 10.1093/pcp/pcr100; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsieh MH, 2013, J EXP BOT, V64, P3869, DOI 10.1093/jxb/ert218; Hsieh MH, 2013, PLANT SCI, V201, P25, DOI 10.1016/j.plantsci.2012.11.003; Hsu CC, 2015, PLANT PHYSIOL, V168, P175, DOI 10.1104/pp.114.254599; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Huang JZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123474; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jersakova J, 2013, BOT J LINN SOC, V172, P95, DOI 10.1111/boj.12027; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jin ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep18936; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jo K, 2009, METHODS MOL BIOL, V544, P29, DOI 10.1007/978-1-59745-483-4_3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Kao YY, 2001, ANN BOT-LONDON, V87, P387, DOI 10.1006/anbo.2000.1348; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Kulheim C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1598-x; Kui Ling, 2016, Front Plant Sci, V7, P2036, DOI 10.3389/fpls.2016.02036; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; Lee YI, 2015, ANN BOT-LONDON, V116, P423, DOI 10.1093/aob/mcv085; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Li CL, 2015, BIOMED RES INT, DOI 10.1155/2015/830618; Li DM, 2015, GENET MOL RES, V14, P6189, DOI 10.4238/2015.June.9.5; Li X., 2014, J NANOMATER, V2014, P8; Li XB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1764-1; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Lin S, 2001, J AM SOC HORTIC SCI, V126, P195; Lin WW, 2013, J INTEGR PLANT BIOL, V55, P1188, DOI 10.1111/jipb.12071; Lin YF, 2016, J EXP BOT, V67, P5051, DOI 10.1093/jxb/erw273; Liu P, 2009, J GENET GENOMICS, V36, P611, DOI 10.1016/S1673-8527(08)60153-8; Liu SS, 2015, INT J MOL SCI, V16, P30190, DOI 10.3390/ijms161226224; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Lu HC, 2007, PLANT PHYSIOL, V143, P558, DOI 10.1104/pp.106.092742; Lu JJ, 2012, GENET MOL RES, V11, P4654, DOI 10.4238/2012.December.21.1; Lu JJ, 2012, SCI HORTIC-AMSTERDAM, V137, P1, DOI 10.1016/j.scienta.2011.12.027; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Meng YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18864; Niu SC, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.83; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Oliver KR, 2013, GENOME BIOL EVOL, V5, P1886, DOI 10.1093/gbe/evt141; Otero JT, 2006, TRENDS ECOL EVOL, V21, P64, DOI 10.1016/j.tree.2005.11.016; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Pawelkowicz M, 2016, PLANT SCI, V242, P77, DOI 10.1016/j.plantsci.2015.07.025; Perotto S, 2014, PLANTA, V239, P1337, DOI 10.1007/s00425-014-2062-x; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ramsay L, 2000, GENETICS, V156, P1997; Rao X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-964; Rasmussen HN, 2009, OIKOS, V118, P334, DOI 10.1111/j.1600-0706.2008.17116.x; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Sattler MC, 2016, PLANTA, V243, P281, DOI 10.1007/s00425-015-2450-x; Sedeek KEM, 2014, MOL ECOL, V23, P6192, DOI 10.1111/mec.12992; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Stankova H, 2016, PLANT BIOTECHNOL J, V14, P1523, DOI 10.1111/pbi.12513; Su CL, 2013, PLANT CELL PHYSIOL, V54, pE11, DOI 10.1093/pcp/pct004; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Suetsugu K, 2017, MOL ECOL, V26, P1652, DOI 10.1111/mec.14021; Tan J, 2005, BIOTECHNOL LETT, V27, P1517, DOI 10.1007/s10529-005-1468-8; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Teh SL, 2011, MOL BIOL REP, V38, P3903, DOI 10.1007/s11033-010-0506-3; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Tsai CC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2508-6; Tsai WC, 2006, PLANT SCI, V170, P426, DOI 10.1016/j.plantsci.2005.08.029; Tsai WC, 2013, PLANT CELL PHYSIOL, V54, pE7, DOI 10.1093/pcp/pcs187; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Vaid N, 2013, MOL PLANT, V6, P1405, DOI 10.1093/mp/sst033; Valadares RBS, 2014, MYCORRHIZA, V24, P349, DOI 10.1007/s00572-013-0547-2; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Walsh RM, 2013, P NATL ACAD SCI USA, V110, P15514, DOI 10.1073/pnas.1314697110; Wen WW, 2016, PLANT PHYSIOL, V170, P136, DOI 10.1104/pp.15.01444; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wisecaver JH, 2017, PLANT CELL, V29, P944, DOI 10.1105/tpc.17.00009; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1871-z; Xu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123356; Xue DW, 2010, J GENET GENOMICS, V37, P197, DOI 10.1016/S1673-8527(09)60038-2; Yan L, 2015, MOL PLANT, V8, P922, DOI 10.1016/j.molp.2014.12.011; Yang FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142434; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Ye W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084920; Ye YY, 2017, PLANT CELL REP, V36, P235, DOI 10.1007/s00299-016-2084-x; Yu H, 2000, PLANT PHYSIOL, V123, P1325, DOI 10.1104/pp.123.4.1325; Zan YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-318; Zhang GQ, 2017, NATURE, V549, P379, DOI 10.1038/nature23897; Zhang GQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19029; Zhang JX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00005; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang LS, 2016, PLANT J, V86, P175, DOI 10.1111/tpj.13159; Zhao XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-747; Zhou S, 2004, J BACTERIOL, V186, P7773, DOI 10.1128/JB.186.22.7773-7782.2004; Zhu GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128592	177	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1999-3110			BOT STUD	Bot. Stud.	DEC 12	2017	58								61	10.1186/s40529-017-0213-7				22	Plant Sciences	Plant Sciences	FP7QM	WOS:000417831000002	29234904	gold			2018-01-05	
J	Lada, AG; Stepchenkova, EI; Zhuk, AS; Kliver, SF; Rogozin, IB; Polev, DE; Dhar, A; Pavlov, YI				Lada, Artem G.; Stepchenkova, Elena I.; Zhuk, Anna S.; Kliver, Sergei F.; Rogozin, Igor B.; Polev, Dmitrii E.; Dhar, Alok; Pavlov, Youri I.			Recombination Is Responsible for the Increased Recovery of Drug-Resistant Mutants with Hypermutated Genomes in Resting Yeast Diploids Expressing APOBEC Deaminases	FRONTIERS IN GENETICS			English	Article						APOBECs; kataegis; mutants in resting diploid yeast; recombination; next generation sequencing; tumorigenesis	SACCHAROMYCES-CEREVISIAE; HUMAN CANCERS; DNA-REPLICATION; CYTOSINE DEAMINASE; MUTATOR PHENOTYPE; ESCHERICHIA-COLI; BREAST-CANCER; MUTATIONS; MUTAGENESIS; MECHANISMS	DNA editing deaminases (APOBECs) are implicated in generation of mutations in somatic cells during tumorigenesis. APOBEC-dependent mutagenesis is thought to occur during transient exposure of unprotected single-stranded DNA. Mutations frequently occur in clusters (kataegis). We investigated mechanisms of mutant generation in growing and resting diploid yeast expressing APOBEC from sea lamprey, PmCDA1, whose kataegistic effect was previously shown to be associated with transcription. We have found that the frequency of canavanine-resistant mutants kept raising after growth cessation, while the profile of transcription remained unchanged. Surprisingly, the overall number of mutations in the genomes did not elevate in resting cells. Thus, mutations were accumulated during vigorous growth stage with both intense replication and transcription. We found that the elevated recovery of can1 mutant clones in non-growing cells is the result of loss of heterozygosity (LOH) leading to clusters of homozygous mutations in the chromosomal regions distal to the reporter gene. We confirmed that recombination frequency in resting cells was elevated by orders of magnitude, suggesting that cells were transiently committed to meiotic levels of recombination, a process referred to in yeast genetics as return-to-growth. In its extreme, on day 6 of starvation, a few mutant clones were haploid, likely resulting from completed meiosis. Distribution of mutations along chromosomes indicated that PmCDA1 was active during ongoing recombination events and sometimes produced characteristic kataegis near initial breakpoints. AID and APOBEC1 behaved similar to PmCDA1. We conclude that replication, transcription, and mitotic recombination contribute to the recovered APOBEC-induced mutations in resting diploids. The mechanism is relevant to the initial stages of oncogenic transformation in terminally differentiated cells, when recombination may lead to the LOH exposing recessive mutations induced by APOBECs in cell's history and to acquisition of new mutations near original break.	[Lada, Artem G.; Stepchenkova, Elena I.; Pavlov, Youri I.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lada, Artem G.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Stepchenkova, Elena I.; Zhuk, Anna S.; Kliver, Sergei F.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia; [Stepchenkova, Elena I.; Zhuk, Anna S.] Russian Acad Sci, Vavilov Inst Gen Genet, St Petersburg, Russia; [Rogozin, Igor B.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Rogozin, Igor B.] Inst Cytol & Genet, Novosibirsk, Russia; [Polev, Dmitrii E.] St Petersburg State Univ, Res Resource Ctr Biobank, Res Pk, St Petersburg, Russia; [Dhar, Alok; Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Dhar, Alok] Univ Nebraska Med Ctr, Res Core, Omaha, NE USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	Lada, AG; Pavlov, YI (reprint author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.; Lada, AG (reprint author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.; Pavlov, YI (reprint author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Pavlov, YI (reprint author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Pavlov, YI (reprint author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.	alada@ucdavis.edu; ypavlov@unmc.edu			UNMC Eppley Institute; NE DHHS LB506 [2017-48]; RFBR [15-04-08625]; St. Petersburg State University [1.42.725.2017]; Russian Science Foundation [14-50-00069]; National Library of Medicine at the National Institutes of Health/DHHS; National Institute for General Medical Science (NIGMS) [INBRE - P20GM103427-14, COBRE - 1P30GM110768-01]; Fred & Pamela Buffett Cancer Center Support Grant [P30CA036727]	This work was funded in part by UNMC Eppley Institute Pilot Grant 2015; NE DHHS LB506 Grant 2017-48; Grant RFBR # 15-04-08625, Research Grant of St. Petersburg State University # 1.42.725.2017 and by grant from Russian Science Foundation 14-50-00069. IR was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health/DHHS. The University of Nebraska DNA Sequencing Core (AD) receives partial support from the National Institute for General Medical Science (NIGMS) INBRE - P20GM103427-14 and COBRE - 1P30GM110768-01 grants as well as The Fred & Pamela Buffett Cancer Center Support Grant - P30CA036727. This publication's contents are the sole responsibility of the authors and do not necessarily represent the official views of the NIH or NIGMS.	Arana ME, 2010, SEMIN CANCER BIOL, V20, P304, DOI 10.1016/j.semcancer.2010.10.003; Bhagwat AS, 2016, P NATL ACAD SCI USA, V113, P2176, DOI 10.1073/pnas.1522325113; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chan K, 2015, ANNU REV GENET, V49, P243, DOI 10.1146/annurev-genet-112414-054714; CHERNOFF YO, 1985, GENETIKA+, V21, P564; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; ECKARDT F, 1977, MUTAT RES, V43, P327, DOI 10.1016/0027-5107(77)90056-2; ESPOSITO RE, 1974, P NATL ACAD SCI USA, V71, P3172, DOI 10.1073/pnas.71.8.3172; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; GORDENIN DA, 1981, GENETIKA+, V17, P822; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Herr AJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002282; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Kane DP, 2014, CANCER RES, V74, P1895, DOI 10.1158/0008-5472.CAN-13-2892; Kennedy SR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005151; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820                                                           ; Kozmin SG, 2013, GENETICS, V193, P803, DOI 10.1534/genetics.112.147421; KUNZ BA, 1981, ANNU REV GENET, V15, P57, DOI 10.1146/annurev.ge.15.120181.000421                                             ; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Lada AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005217; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211                                                         ; Laureau R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005781; Loeb LA, 2001, CANCER RES, V61, P3230; Lujan SA, 2014, GENOME RES, V24, P1751, DOI 10.1101/gr.178335.114; Luria SE, 1943, GENETICS, V28, P491; Maisnier-Patin S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018176; Mertz TM, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010046; MORRISON A, 1993, EMBO J, V12, P1467; MORTIMER RK, 1986, GENETICS, V113, P35; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOSKOV VN, 1990, GENETIKA+, V26, P1169; Pauklin S, 2009, GENETICS, V182, P41, DOI 10.1534/genetics.109.101683; PAVLOV YI, 1988, GENETIKA+, V24, P1752; PAVLOV YI, 1991, MUTAT RES, V253, P33, DOI 10.1016/0165-1161(91)90343-7; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308                                                     ; Quinet A, 2014, DNA REPAIR, V14, P27, DOI 10.1016/j.dnarep.2013.12.005; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2014, BIOESSAYS, V36, P382, DOI 10.1002/bies.201300140; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Saini N, 2017, DNA REPAIR, V53, P4, DOI 10.1016/j.dnarep.2017.03.003; Seplyarskiy VB, 2016, GENOME RES, V26, P174, DOI 10.1101/gr.197046.115; SHAPIRO JA, 1984, MOL GEN GENET, V194, P79, DOI 10.1007/BF00383501; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Stepchenkova EI, 2017, DNA REPAIR, V49, P60, DOI 10.1016/j.dnarep.2016.11.004; Taylor BJM, 2014, ELIFE, V3, DOI 10.7554/eLife.03553; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tran HT, 1999, GENETICS, V152, P47; Waisertreiger ISR, 2012, ENVIRON MOL MUTAGEN, V53, P699, DOI 10.1002/em.21735; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644	62	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-8021			FRONT GENET	Front. Genet.	DEC 12	2017	8								202	10.3389/fgene.2017.00202				13	Genetics & Heredity	Genetics & Heredity	FP6MQ	WOS:000417740600001		gold			2018-01-05	
J	Kiu, R; Caim, S; Alexander, S; Pachori, P; Hall, LJ				Kiu, Raymond; Caim, Shabhonam; Alexander, Sarah; Pachori, Purnima; Hall, Lindsay J.			Probing Genomic Aspects of the Multi-Host Pathogen Clostridium perfringens Reveals Significant Pangenome Diversity, and a Diverse Array of Virulence Factors	FRONTIERS IN MICROBIOLOGY			English	Article						Clostridium perfringens; pangenome; antimicrobial resistance; genomics; whole genome sequencing; Clostridial infection; exotoxins	MULTIPLE SEQUENCE ALIGNMENT; STAPHYLOCOCCUS-AUREUS; NECROTIZING ENTEROCOLITIS; ANTIBIOTIC-RESISTANCE; ENTEROTOXIN GENE; TOXIN PRODUCTION; GUT MICROBIOTA; PLASMID-BORNE; GAS-GANGRENE; ANNOTATION	Clostridium perfringens is an important cause of animal and human infections, however information about the genetic makeup of this pathogenic bacterium is currently limited. In this study, we sought to understand and characterise the genomic variation, pangenomic diversity, and key virulence traits of 56 C. perfringens strains which included 51 public, and 5 newly sequenced and annotated genomes using Whole Genome Sequencing. Our investigation revealed that C. perfringens has an "open" pangenome comprising 11667 genes and 12.6% of core genes, identified as the most divergent single species Gram-positive bacterial pangenome currently reported. Our computational analyses also defined C. perfringens phylogeny (16S rRNA gene) in relation to some 25 Clostridium species, with C. baratii and C. sardiniense determined to be the closest relatives. Profiling virulence -associated factors confirmed presence of well characterised C. perfringens-associated exotoxins genes including-toxin (plc), enterotoxin (cpe), and Perfringolysin 0 (pfo or pfoA), although interestingly there did not appear to be a close correlation with encoded toxin type and disease phenotype. Furthermore, genomic analysis indicated significant horizontal gene transfer events as defined by presence of prophage genomes, and notably absence of CRISPR defence systems in >70% (40/56) of the strains. In relation to antimicrobial resistance mechanisms, tetracycline resistance genes (tet) and anti-defensins genes (mprF) were consistently detected in silico (tet: 75%; mprF: 100%). However, pre-antibiotic era strain genomes did not encode for tet, thus implying antimicrobial selective pressures in C. perfringens evolutionary history over the past 80 years. This study provides new genomic understanding of this genetically divergent multi-host bacterium, and further expands our knowledge on this medically and veterinary important pathogen.	[Kiu, Raymond; Caim, Shabhonam; Hall, Lindsay J.] Norwich Res Pk, Quadram Inst Biosci, Gut Hlth & Food Safely, Norwich, Norfolk, England; [Kiu, Raymond] Univ East Anglia, Norwich Res Pk, Norwich Med Sch, Norwich, Norfolk, England; [Alexander, Sarah] Publ Hlth England, London, England; [Pachori, Purnima] Norwich Res Pk, Earlham Inst, Norwich, Norfolk, England	Hall, LJ (reprint author), Norwich Res Pk, Quadram Inst Biosci, Gut Hlth & Food Safely, Norwich, Norfolk, England.	lindsay.hall@quadram.ac.uk			Wellcome Trust [100974/C/13/Z, 101503/Z/13/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme grant [BB/j004529/1]; UEA international bursary (Faculty of Medical and Health Sciences)	This work was supported by a Wellcome Trust Investigator Award to LH (100974/C/13/Z) and support of the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme grant for Gut Health and Food Safety BB/j004529/1 (LH). RK is a PhD student at the Norwich Medical School of University of East Anglia (UEA), partially funded by UEA international bursary (Faculty of Medical and Health Sciences). NCTC3000 project is funded by the Wellcome Trust (101503/Z/13/Z). Funders had no input into the design of the study, analysis, or interpretation of the data, or in writing the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andersen JL, 2015, INT J ENV RES PUB HE, V12, P1487, DOI 10.3390/ijerph120201487; Angly F., 2011, MINING CRISPRS ENV D; Ashton PM, 2016, PEERJ, V4, DOI 10.7717/peerj.1752; Bannam TL, 2004, MICROBIOL-SGM, V150, P127, DOI 10.1099/mic.0.26614-0; Bennetts H. W., 1932, AUST VET J, V11, P84; Bernard G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28970; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Brady J, 2010, AVIAN PATHOL, V39, P475, DOI 10.1080/03079457.2010.521141; Browne HP, 2017, NAT REV MICROBIOL, V15, P531, DOI 10.1038/nrmicro.2017.50; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANARD B, 1992, INT J SYST BACTERIOL, V42, P312, DOI 10.1099/00207713-42-2-312                                                       ; Cole JN, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0006-2015; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812                                                       ; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Edagiz S, 2015, CAN J INFECT DIS MED, V26, P105, DOI 10.1155/2015/481076                                                             ; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eppinger M, 2010, J BACTERIOL, V192, P1685, DOI 10.1128/JB.01518-09; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gibert M, 1997, GENE, V203, P65, DOI 10.1016/S0378-1119(97)00493-9; Goh S, 2005, J MED MICROBIOL, V54, P129, DOI 10.1099/jmm0.45821-0; Gohari IM, 2017, INFECT GENET EVOL, V49, P32, DOI 10.1016/j.meegid.2016.12.028; Gohari IM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148344; Gohari IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122684; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadfield J., 2017, INTERACTIVE VISUALIZ; Harvey SM, 2002, J CLIN MICROBIOL, V40, P2260, DOI 10.1128/JCM.40.6.2260-2262.2002; Hassan KA, 2015, RES MICROBIOL, V166, P255, DOI 10.1016/j.resmic.2014.10.003; Heida FH, 2016, CLIN INFECT DIS, V62, P863, DOI 10.1093/cid/ciw016; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOBBS BC, 1953, J HYG-CAMBRIDGE, V51, P75, DOI 10.1017/S0022172400015515                                                       ; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Knight Daniel R, 2016, Front Microbiol, V7, P2138, DOI 10.3389/fmicb.2016.02138; KOCH C, 1994, FEMS MICROBIOL LETT, V123, P167, DOI 10.1111/j.1574-6968.1994.tb07217.x; KOSLOSKE AM, 1978, LANCET, V2, P1014; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Li JH, 2006, APPL ENVIRON MICROB, V72, P4561, DOI 10.1128/AEM.00177-06; Lyras D, 1996, ANTIMICROB AGENTS CH, V40, P2500; MAHONY DE, 1976, CAN J MICROBIOL, V22, P953, DOI 10.1139/m76-138                                                                 ; MASAKI T, 1988, JPN J MED SCI BIOL, V41, P27, DOI 10.7883/yoken1952.41.27                                                         ; MCCLUNG LS, 1945, J BACTERIOL, V50, P229; McInerney JO, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.40; MOLLBY R, 1976, J GEN MICROBIOL, V96, P137, DOI 10.1099/00221287-96-1-137                                                       ; Mooijman K. A., 2003, MICROCRM PREPARATION; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nagler FPO, 1939, BRIT J EXP PATHOL, V20, P473; Nagpal R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0561-y; Nagy E, 2012, J MED MICROBIOL, V61, P1393, DOI 10.1099/jmm.0.043927-0; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; Nowell VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032271; OHNOIWASHITA Y, 1986, BIOCHEMISTRY-US, V25, P6048, DOI 10.1021/bi00368a032; Osman KM, 2013, REV SCI TECH OIE, V32, P841; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; PAQUETTE G, 1967, J BACTERIOL, V94, P1437; Park M, 2016, ANAEROBE, V38, P25, DOI 10.1016/j.anaerobe.2015.11.003; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; R Development Core Team R, 2010, R LANG ENV STAT COMP; Raveh-Sadka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05477; Revitt-Mills SA, 2015, MICROBIOL AUST, V36, P114, DOI 10.1071/MA15039; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; ROOD JI, 1978, PLASMID, V1, P563, DOI 10.1016/0147-619X(78)90013-6                                                    ; Rouli L., 2015, New Microbes and New Infections, V7, P72, DOI 10.1016/j.nmni.2015.06.005; RStudio Team, 2015, RSTUDIO INT DEV R; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Seemann T., 2013, BARRNAP 0 7 RAPID RI; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sim K, 2015, CLIN INFECT DIS, V60, P389, DOI 10.1093/cid/ciu822; Stevens DL, 2002, CLIN INFECT DIS, V35, pS93, DOI 10.1086/341928; STEWART AW, 1977, J GEN MICROBIOL, V103, P45, DOI 10.1099/00221287-103-1-45                                                       ; Tansuphasiri Unchalee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P954; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; TRAUB WH, 1971, CHEMOTHERAPY, V16, P162, DOI 10.1159/000220723                                                               ; Tyrrell KL, 2006, ANTIMICROB AGENTS CH, V50, P2728, DOI 10.1128/AAC.00357-06; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; van Asten AJAM, 2009, VET MICROBIOL, V136, P411, DOI 10.1016/j.vetmic.2008.11.024; van Vliet AHM, 2015, J CLIN MICROBIOL, V53, P2877, DOI 10.1128/JCM.01357-15; Vos P., 2009, BERGEYS MANUAL SYSTE; Welch W. H., 1891, B J HOPKINS HOSP, V3, P81; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wong YM, 2014, GENOME ANNOUNCEMENTS, V2, P64; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239                                                                  	98	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	DEC 12	2017	8								2485	10.3389/fmicb.2017.02485				18	Microbiology	Microbiology	FP5ZB	WOS:000417700600002		gold			2018-01-05	
J	Jia, HG; Xu, J; Orbovic, V; Zhang, YZ; Wang, NA				Jia, Hongge; Xu, Jin; Orbovic, Vladimir; Zhang, Yunzeng; Wang, Nian			Editing Citrus Genome via SaCas9/sgRNA System	FRONTIERS IN PLANT SCIENCE			English	Article						SaCas9; sgRNA; Citrus; genome editing; off-target	STAPHYLOCOCCUS-AUREUS CAS9; IMMUNE-SYSTEM; DNA; ENDONUCLEASE; PLANTS; RECOGNITION; CRISPR-CAS9; CRISPR/CAS; PROMOTER; CSLOB1	SaCas9/sgRNA, derived from Staphylococcus aureus, is an alternative system for genome editing to Streptococcus pyogenes SpCas9/sgRNA. The smaller SaCas9 recognizes a different protospacer adjacent motif (PAM) sequence from SpCas9. SaCas9/sgRNA has been employed to edit the genomes of Arabidopsis, tobacco and rice. In this study, we aimed to test its potential in genome editing of citrus. Transient expression of SaCas9/sgRNA in Duncan grapefruit via Xcc-facilitated agroinfiltration showed it can successfully modify CsPDS and Cs2g12470. Subsequently, binary vector GFP-p1380N-SaCas9/35S-sgRNA1:AtU6-sgRNA2 was developed to edit two target sites of Cs7g03360 in transgenic Carrizo citrange. Twelve GFP-positive Carrizo transformants were successfully established, designated as #Cz1 to #Cz12. Based on targeted next generation sequencing results, the mutation rates for the two targets ranged from 15.55 to 39.13% for sgRNA1 and 49.01 to 79.67% for sgRNA2. Therefore, SaCas9/sgRNA can be used as an alternative tool to SpCas9/sgRNA for citrus genome editing.	[Jia, Hongge; Xu, Jin; Orbovic, Vladimir; Zhang, Yunzeng; Wang, Nian] Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Lake Alfred, FL 33850 USA; [Orbovic, Vladimir] Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Lake Alfred, FL USA	Wang, NA (reprint author), Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Lake Alfred, FL 33850 USA.	nianwang@ufl.edu			Florida Citrus Initiative Program; USDA NIFA AFRI Plant Biotic Interactions Program [2017-02986]	This study has been supported by Florida Citrus Initiative Program and USDA NIFA AFRI Plant Biotic Interactions Program (2017-02986).	Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bortesi L, 2016, PLANT BIOTECHNOL J, V14, P2203, DOI 10.1111/pbi.12634; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Davey MR, 2005, BIOTECHNOL ADV, V23, P131, DOI 10.1016/j.biotechadv.2004.09.008; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jia HG, 2014, PLANT CELL REP, V33, P1993, DOI 10.1007/s00299-014-1673-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Li JF, 2014, METHOD ENZYMOL, V546, P459, DOI 10.1016/B978-0-12-801185-0.00022-2; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Zhang F, 2017, PLANT CELL REP, V36, P1883, DOI 10.1007/s00299-017-2202-4	32	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	DEC 12	2017	8								2135	10.3389/fpls.2017.02135				9	Plant Sciences	Plant Sciences	FP5VE	WOS:000417690300001		gold			2018-01-05	
J	Bernheim, A; Calvo-Villamanan, A; Basier, C; Cui, L; Rocha, EPC; Touchon, M; Bikard, D				Bernheim, Aude; Calvo-Villamanan, Alicia; Basier, Clovis; Cui, Lun; Rocha, Eduardo P. C.; Touchon, Marie; Bikard, David			Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria	NATURE COMMUNICATIONS			English	Article							STREPTOCOCCUS-THERMOPHILUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENETIC ELEMENTS; STATIONARY-PHASE; PROTEIN CSN2; DNA-REPAIR; IMMUNITY; REPEATS; EVOLUTIONARY	Type II CRISPR-Cas systems introduce double-strand breaks into DNA of invading genetic material and use DNA fragments to acquire novel spacers during adaptation. These breaks can be the substrate of several DNA repair pathways, paving the way for interactions. We report that non-homologous end-joining (NHEJ) and type II-A CRISPR-Cas systems only co-occur once among 5563 fully sequenced prokaryotic genomes. We investigated experimentally the possible molecular interactions using the NHEJ pathway from Bacillus subtilis and the type II-A CRISPR-Cas systems from Streptococcus thermophilus and Streptococcus pyogenes. Our results suggest that the NHEJ system has no effect on CRISPR immunity. On the other hand, we provide evidence for the inhibition of NHEJ repair by the Csn2 protein. Our findings give insights on the complex interactions between CRISPR-Cas systems and repair mechanisms in bacteria, contributing to explain the scattered distribution of CRISPR-Cas systems in bacterial genome.	[Bernheim, Aude; Rocha, Eduardo P. C.; Touchon, Marie] Inst Pasteur, Microbial Evolutionary Genom, 25-28 Rue Dr Roux, F-75015 Paris, France; [Bernheim, Aude; Rocha, Eduardo P. C.; Touchon, Marie] CNRS, UMR3525, 25-28 Rue Dr Roux, F-75015 Paris, France; [Bernheim, Aude; Calvo-Villamanan, Alicia; Basier, Clovis; Cui, Lun; Bikard, David] Inst Pasteur, Synthet Biol Grp, 25-28 Rue Dr Roux, F-75015 Paris, France; [Bernheim, Aude] AgroParisTech, F-75005 Paris, France	Bikard, D (reprint author), Inst Pasteur, Synthet Biol Grp, 25-28 Rue Dr Roux, F-75015 Paris, France.	david.bikard@pasteur.fr		Rocha, Eduardo/0000-0001-7704-822X; Bikard, David/0000-0002-5729-1211	European Research Council (ERC) under the Europe Union's Horizon research and innovation programme (CRISPAIR) [677823]; European Research Council (ERC) under the Europe Union's Horizon research and innovation programme (EVOMOBILOME) [281605]; French Government's Investissement d'Avenir program; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; Pasteur-Weizmann consortium	We thank Philippe Horvath for providing S. thermophillus strain DGCC7710 and phage Phi2972 and Sylvain Moineau for providing plasmid pNZ123. We also want to thank them both for their very helpful advice. We thank Matt Deyell for plasmid pMD021. A.B. is a member of the "Ecole Doctorale Frontiere du vivant (FdV)". This work was supported by the European Research Council (ERC) under the Europe Union's Horizon 2020 research and innovation programme (grant CRISPAIR agreement no. 677823, and grant EVOMOBILOME no. 281605); the French Government's Investissement d'Avenir program; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (ANR-10-LABX-62-IBEID); the Pasteur-Weizmann consortium.	Abby SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110726; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Arslan Z, 2013, NUCLEIC ACIDS RES, V41, P6347, DOI 10.1093/nar/gkt315; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Drake JW, 1998, GENETICS, V148, P1667; Ellinger P, 2012, J STRUCT BIOL, V178, P350, DOI 10.1016/j.jsb.2012.04.006; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilks W. R., 1996, MARKOV CHAIN MONTE C, V512, P1; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hynes AP, 2017, NAT MICROBIOL, V2, P1374, DOI 10.1038/s41564-017-0004-7; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Koo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033401; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lee KH, 2012, PROTEINS, V80, P2573, DOI 10.1002/prot.24138; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nimwegen, 2003, TRENDS GENET, V19, P476; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Paris U, 2015, DNA REPAIR, V31, P11, DOI 10.1016/j.dnarep.2015.04.005; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Silva FJ, 2003, TRENDS GENET, V19, P176, DOI 10.1016/S0168-9525(03)00041-6; Su TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37895; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584                                                         ; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232	55	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 12	2017	8								2094	10.1038/s41467-017-02350-1				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FP5ZR	WOS:000417702300045	29234047	gold			2018-01-05	
J	MacDonald, RJ; Shrimp, JH; Jiang, H; Zhang, L; Lin, HN; Yen, A				MacDonald, Robert J.; Shrimp, Jonathan H.; Jiang, Hong; Zhang, Lu; Lin, Hening; Yen, Andrew			Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout	SCIENTIFIC REPORTS			English	Article							GROWTH-FACTOR RECEPTOR; MYELOBLASTIC-LEUKEMIA CELLS; CYCLIC ADP-RIBOSE; T-CELLS; CD38/ADP-RIBOSYL CYCLASE; PROTEIN-KINASE; C-CBL; EXPRESSION; ACTIVATION; ANTIGEN	CD38 is an ectoenzyme and receptor with key physiological roles. It metabolizes NAD(+) to adenosine diphosphate ribose (ADPR) and cyclic ADPR, regulating several processes including calcium signalling. CD38 is both a positive and negative prognostic indicator in leukaemia. In all-trans retinoic acid (RA)induced differentiation of acute promyelocytic leukaemia and HL-60 cells, CD38 is one of the earliest and most prominently upregulated proteins known. CD38 overexpression enhances differentiation, while morpholino- and siRNA-induced knockdown diminishes it. CD38, via Src family kinases and adapters, interacts with a MAPK signalling axis that propels differentiation. Motivated by evidence suggesting the importance of CD38, we sought to determine whether it functions via dimerization. We created a linker based on the suicide substrate arabinosyl-2'-fluoro-2'-deoxy NAD(+) (F-araNAD(+)), dimeric F-araNAD(+), to induce homodimerization. CD38 homodimerization did not affect RA-induced differentiation. Probing the importance of CD38 further, we created HL-60 cell lines with CRISPR/Cas9-mediated CD38 truncations. Deletion of its enzymatic domain did not affect differentiation. Apart from increased RA-induced CD11b expression, ablation of all but the first six amino acids of CD38 affected neither RA-induced differentiation nor associated signalling. Although we cannot discount the importance of this peptide, our study indicates that CD38 is not necessary for RA-induced differentiation.	[MacDonald, Robert J.; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Shrimp, Jonathan H.; Jiang, Hong; Zhang, Lu] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Yen, A (reprint author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	ay13@cornell.edu		Lin, Hening/0000-0002-0255-2701	National Institutes of Health [R01 CA152870]; New York State Department of Health [C029155]	We thank the Cornell Stem Cell and Transgenic Core Facility for generation of lentiviral particles used for CRISPR-mediated disruption of CD38. This work was supported by grant R01 CA152870 from the National Institutes of Health (Yen) and by New York State Department of Health Contract Number C029155. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebanjo OA, 1999, NAT CELL BIOL, V1, P409; Ausiello CM, 1996, CELL IMMUNOL, V173, P192, DOI 10.1006/cimm.1996.0267                                                          ; Ausiello CM, 2000, TISSUE ANTIGENS, V56, P539, DOI 10.1034/j.1399-0039.2000.560608.x; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936                                                          ; Bunaciu RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135668; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; Cockayne DA, 1998, BLOOD, V92, P1324; COLLINS SJ, 1987, BLOOD, V70, P1233; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Congleton J, 2014, CELL SIGNAL, V26, P1589, DOI 10.1016/j.cellsig.2014.03.021; Congleton J, 2011, EXP CELL RES, V317, P910, DOI 10.1016/j.yexcr.2010.12.003; D'Arena G, 2001, LEUKEMIA LYMPHOMA, V42, P109, DOI 10.3109/10428190109097682                                                       ; Deaglio S, 1998, J IMMUNOL, V160, P395; Deshpande DA, 2005, AM J PHYSIOL-LUNG C, V288, pL773, DOI 10.1152/ajplung.00217.2004; DRACH J, 1993, BIOCHEM BIOPH RES CO, V195, P545, DOI 10.1006/bbrc.1993.2080; DRACH J, 1994, CANCER RES, V54, P1746; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hussain AMM, 2000, EUR J CELL BIOL, V79, P697, DOI 10.1078/0171-9335-00099; Jiang H, 2009, J AM CHEM SOC, V131, P1658, DOI 10.1021/ja808387g; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Keyhani A, 2000, LEUKEMIA RES, V24, P153, DOI 10.1016/S0145-2126(99)00147-2; Kluba M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139971; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kontani K, 1996, J BIOL CHEM, V271, P1534; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu ZY, 1996, CYTOMETRY, V26, P1; Moreno-Garcia ME, 2005, J IMMUNOL, V174, P2687, DOI 10.4049/jimmunol.174.5.2687                                                     ; Moreno-Garcia ME, 2004, EUR J BIOCHEM, V271, P1025, DOI 10.1111/j.1432-1033.2004.04006.x; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199                                                          ; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Ondoa P, 2006, JAIDS-J ACQ IMM DEF, V41, P416, DOI 10.1097/01.qai.0000209901.12750.d0                                              ; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Sauve AA, 2002, BIOCHEMISTRY-US, V41, P8455, DOI 10.1021/bi0258795; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; SLEATH PR, 1991, J ORG CHEM, V56, P3608, DOI 10.1021/jo00011a029; Sridharan R, 2016, J BIOL CHEM, V291, P24261, DOI 10.1074/jbc.M116.733006; Sun L, 1999, J CELL BIOL, V146, P1161, DOI 10.1083/jcb.146.5.1161; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Yen A, 1998, CANCER RES, V58, P3163; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zubiaur M, 1997, J IMMUNOL, V159, P193; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200	47	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 12	2017	7								17406	10.1038/s41598-017-17720-4				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FP5UW	WOS:000417689400030	29234114	gold			2018-01-05	
J	Vilarino, M; Rashid, ST; Suchy, FP; McNabb, BR; van der Meulen, T; Fine, EJ; Ahsan, S; Mursaliyev, N; Sebastiano, V; Diab, SS; Huising, MO; Nakauchi, H; Ross, PJ				Vilarino, Marcela; Rashid, Sheikh Tamir; Suchy, Fabian Patrik; McNabb, Bret Roberts; van der Meulen, Talitha; Fine, Eli J.; Ahsan, Syed; Mursaliyev, Nurlybek; Sebastiano, Vittorio; Diab, Santiago Sain; Huising, Mark O.; Nakauchi, Hiromitsu; Ross, Pablo J.			CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep	SCIENTIFIC REPORTS			English	Article							PLURIPOTENT STEM-CELLS; BLASTOCYST COMPLEMENTATION; GENERATION; SYSTEM; MOUSE; CHIMERAS; MUTATION; ZYGOTES	One of the ultimate goals of regenerative medicine is the generation of patient-specific organs from pluripotent stem cells (PSCs). Sheep are potential hosts for growing human organs through the technique of blastocyst complementation. We report here the creation of pancreatogenesis-disabled sheep by oocyte microinjection of CRISPR/Cas9 targeting PDX1, a critical gene for pancreas development. We compared the efficiency of target mutations after microinjecting the CRISPR/Cas9 system in metaphase II (MII) oocytes and zygote stage embryos. MII oocyte microinjection reduced lysis, improved blastocyst rate, increased the number of targeted bi-allelic mutations, and resulted in similar degree of mosaicism when compared to zygote microinjection. While the use of a single sgRNA was efficient at inducing mutated fetuses, the lack of complete gene inactivation resulted in animals with an intact pancreas. When using a dual sgRNA system, we achieved complete PDX1 disruption. This PDX1(-/-)fetus lacked a pancreas and provides the basis for the production of gene-edited sheep as a host for interspecies organ generation. In the future, combining gene editing with CRISPR/Cas9 and PSCs complementation could result in a powerful approach for human organ generation.	[Vilarino, Marcela; Ross, Pablo J.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Rashid, Sheikh Tamir; Suchy, Fabian Patrik; Fine, Eli J.; Ahsan, Syed; Mursaliyev, Nurlybek; Sebastiano, Vittorio; Nakauchi, Hiromitsu] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [McNabb, Bret Roberts] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [van der Meulen, Talitha; Huising, Mark O.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Coll Biol Sci, Davis, CA 95616 USA; [Diab, Santiago Sain] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab, Davis, CA 95616 USA; [Rashid, Sheikh Tamir; Ahsan, Syed] Kings Coll London, Ctr Stem Cells & Regenerat Med, London, England; [Rashid, Sheikh Tamir; Ahsan, Syed] Kings Coll London, Inst Liver Studies, London, England	Ross, PJ (reprint author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Nakauchi, H (reprint author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	nakauchi@stanford.edu; pross@ucdavis.edu			Fulbright and Austin Eugene Lyons Fellowship; MRC Clinician Scientist Award; USDA/NIFA Multistate Research Project [W3171]; California Institute of Regenerative Medicine [LA1-06917]	M.V. was supported by Fulbright and Austin Eugene Lyons Fellowship; S.T.R. was supported by an MRC Clinician Scientist Award; work at P.R. laboratory partly funded by USDA/NIFA Multistate Research Project W3171; H.N. was supported by the California Institute of Regenerative Medicine (LA1-06917). We are grateful to Dana Van Liew for assistance with sheep care at UC Davis sheep Facility. We would like to thank James Chitwood, Bruna Tiemy Miagawa, Jonathan Ampessan, Devon Fitzpatrick, Ahmed Mahdi, Insung Park, Juan Reyes and Catalina Cabrera for helping during in vitro embryo production, embryo transferring and fetuses recovering. We thank Joshua Meckler, Juan Reyes and Helen Lindsay for assistance in bioinformatics analysis.	Bogliotti Y. S., 2016, J VIS EXP; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; John Clark A, 2002, TRANSGENESIS TECHNIQ, P273; Comizzoli P, 2000, BIOL REPROD, V62, P1677, DOI 10.1095/biolreprod62.6.1677; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Ezashi T., 2015, ANN REV ANIMAL BIOSC; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GUZ Y, 1995, DEVELOPMENT, V121, P11; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Hu R, 2017, J ANIM SCI, V95, P2019, DOI [10.2527/jas2017.1503, 10.2527/jas.2017.1503]; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Li W. R., 2017, FEBS J; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Ma T, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12406; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Murray JD, 2016, TRANSGENIC RES, V25, P321, DOI 10.1007/s11248-016-9927-7; Niu Y, 2017, ANIM GENET, V48, P242, DOI 10.1111/age.12515; Offield MF, 1996, DEVELOPMENT, V122, P983; POLZIN VJ, 1987, J ANIM SCI, V65, P325; Rashid T, 2014, CELL STEM CELL, V15, P406, DOI 10.1016/j.stem.2014.09.013; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32271; Wu J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08596-5; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Yamaguchi T, 2017, NATURE, V542, P191, DOI 10.1038/nature21070; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07442-y; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	34	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 12	2017	7								17472	10.1038/s41598-017-17805-0				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FP5UW	WOS:000417689400096	29234093	gold			2018-01-05	
J	Wang, LM; Cai, B; Zhou, SW; Zhu, HJ; Qu, L; Wang, XL; Chen, YL				Wang, Lamei; Cai, Bei; Zhou, Shiwei; Zhu, Haijing; Qu, Lei; Wang, Xiaolong; Chen, Yulin			RNA-seq reveals transcriptome changes in goats following myostatin gene knockout	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; STEAROYL-COA DESATURASE; MDX MICE; ADIPOCYTE DIFFERENTIATION; TRANSGENIC EXPRESSION; SIGNALING PATHWAY; MYOBLAST CELLS; GROWTH-FACTOR; CROSS-TALK; MUTATIONS	Myostatin (MSTN) is a powerful negative regulator of skeletal muscle mass in mammalian species that is primarily expressed in skeletal muscles, and mutations of its encoding gene can result in the double-muscling trait. In this study, the CRISPR/Cas9 technique was used to edit MSTN in Shaanbei Cashmere goats and generate knockout animals. RNA sequencing was used to determine and compare the transcriptome profiles of the muscles from three wild-type (WT) goats, three fibroblast growth factor 5 (FGF5) knockout goats (FGF5(+/-)group) and three goats with disrupted expression of both the FGF5 and MSTN genes (FM(+/-)group). The sequence reads were obtained using the Illumina HiSeq 2000 system and mapped to the Capra hircus reference genome using TopHat (v2.0.9). In total, 68.93, 62.04 and 66.26 million clean sequencing reads were obtained from the WT, FM+/- and FGF5(+/-)groups, respectively. There were 201 differentially expressed genes (DEGs) between the WT and FGF5(+/-)groups, with 86 down-and 115 up-regulated genes in the FGF5(+/-)group. Between the WT and FM(+/-)groups, 121 DEGs were identified, including 81 down- and 40 up-regulated genes in the FM(+/-)group. A total of 198 DEGs were detected between the FGF5(+/-)group and FM(+/-)group, with 128 down- and 70 up-regulated genes in the FM(+/-)group. At the transcriptome level, we found substantial changes in genes involved in fatty acid metabolism and the biosynthesis of unsaturated fatty acids, such as stearoyl-CoA dehydrogenase, 3-hydroxyacyl-CoA dehydratase 2, ELOVL fatty acid elongase 6 and fatty acid synthase, suggesting that the expression levels of these genes may be directly regulated by MSTN and that these genes are likely downstream targets of MSTN with potential roles in lipid metabolism in goats. Moreover, five randomly selected DEGs were further validated with qRT-PCR, and the results were consistent with the transcriptome analysis. The present study provides insight into the unique transcriptome profile of the MSTN knockout goat, which is a valuable resource for studying goat genomics.	[Wang, Lamei; Cai, Bei; Zhou, Shiwei; Wang, Xiaolong; Chen, Yulin] Northwets A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Zhu, Haijing; Qu, Lei] Shaanxi Prov Engn & Technol Res Ctr Cashmere Goat, Yulin, Peoples R China; [Zhu, Haijing; Qu, Lei] Yulin Univ, Life Sci Res Ctr, Yulin, Peoples R China	Chen, YL (reprint author), Northwets A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	chenyulin@nwafu.edu.cn			National Natural Science Foundation of China [31372279, 31171377, 31572369, 31402038]; China Agriculture Research System [CARS-39-12]; Major Projects for New Varieties of Genetically Modified Organisms of China [2014ZX08008-002]; key Research Program of Shaanxi Province [2017NY-072]; Special Fund for Agro-scientific Research in the Public Interest [201303059]	This work is supported by National Natural Science Foundation of China (31372279, 31171377, 31572369) to YC, and China Agriculture Research System (CARS-39-12) to YC, as well as the Major Projects for New Varieties of Genetically Modified Organisms of China (2014ZX08008-002) to YC, National Natural Science Foundation of China (31402038) and the key Research Program of Shaanxi Province (2017NY-072) to XW, and the Special Fund for Agro-scientific Research in the Public Interest (201303059) to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Belov AA, 2013, COLD SPRING HARBOR P, V5; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Braun Susanne, 2002, European Journal of Cell Biology, V81, P375, DOI 10.1078/0171-9335-00258; Breitbart A, 2011, AM J PHYSIOL-HEART C, V300, pH1973, DOI 10.1152/ajpheart.00200.2011; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Cassar-Malek I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-63; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen QL, 2016, FISH PHYSIOL BIOCHEM, V42, P979, DOI 10.1007/s10695-015-0190-2; Chiu CY, 1999, GENOMICS, V61, P66, DOI 10.1006/geno.1999.5936                                                          ; Choi KS, 2016, CELL SIGNAL, V28, P1642, DOI 10.1016/j.cellsig.2016.07.015; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Crispo M, 2014, PLOS ONE, V10; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Dominique JE, 2006, EXP CELL RES, V312, P2401, DOI 10.1016/j.yexcr.2006.04.012; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Elliott B, 2012, ACTA PHYSIOL, V205, P324, DOI 10.1111/j.1748-1716.2012.02423.x; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gal A, 2000, NAT GENET, V26, P270; Gerwins P, 2000, CRIT REV ONCOL HEMAT, V34, P185, DOI 10.1016/S1040-8428(00)00062-7; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Glenn TC, GDF11 INCREASES AGE; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; James NA, 1997, J ANIM SCI, V75, P571; Kainulainen H, 2015, MOL CELL ENDOCRINOL, V399, P131, DOI 10.1016/j.mce.2014.10.001; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910                                                              ; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805                                                      ; Kirk S, 2000, J CELL PHYSIOL, V184, P356, DOI 10.1002/1097-4652(200009)184:3<356::AID-JCP10>3.0.CO;2-R; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Kwon DY, 2013, MOL BIOL CELL, V24, P1863, DOI 10.1091/mbc.E13-01-0042; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098                                                          ; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lin J, 2010, NEUROSCIENCE, V165, P168, DOI 10.1016/j.neuroscience.2009.10.032; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Ma SSQ, 2016, VIRCHOWS ARCH, P1; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marsh A, 2016, PLOS ONE, V11; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakamura S, 2016, CURR BIOL, V26, P775, DOI 10.1016/j.cub.2016.01.024; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Ohsaki H, 2007, COMP BIOCHEM PHYS A, V148, P629, DOI 10.1016/j.cbpa.2007.08.004; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Patel UA, 2015, BIOTECHNOL PROGR, V31, P452, DOI 10.1002/btpr.2022; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Rossi AC, 2010, J PHYSIOL-LONDON, V588, P353, DOI 10.1113/jphysiol.2009.181008; Sadkowski T, 2008, J APPL GENET, V49, P237, DOI 10.1007/BF03195620; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripathi AK, 2013, APPL BIOCHEM BIOTECH, V169, P688, DOI 10.1007/s12010-012-0021-1; Uemura K, 2017, FEBS OPEN BIO, V7, P522, DOI 10.1002/2211-5463.12200; Uzman A., 2001, BIOCH MOL BIOL ED, V29, P126; Wang LW, 2010, PHARMACOGENET GENOM, V20, P401, DOI 10.1097/FPC.0b013e3283352860; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang XL, 2017, CRISPR CAS9 MEDIATED; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	98	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0187966	10.1371/journal.pone.0187966				23	Multidisciplinary Sciences	Science & Technology - Other Topics	FP5GS	WOS:000417648600006		gold			2018-01-05	
J	Zuo, ZC; Liu, J				Zuo, Zhicheng; Liu, Jin			Structure and Dynamics of Cas9 HNH Domain Catalytic State	SCIENTIFIC REPORTS			English	Article							ACCELERATED MOLECULAR-DYNAMICS; TARGET DNA RECOGNITION; PARTICLE MESH EWALD; CRYSTAL-STRUCTURE; CRISPR-CAS9 NUCLEASES; GENOME; RNA; ENDONUCLEASE; SIMULATIONS; COMPLEX	The bacterial CRISPR-Cas9 immune system has been harnessed as a powerful and versatile genome-editing tool and holds immense promise for future therapeutic applications. Despite recent advances in understanding Cas9 structures and its functional mechanism, little is known about the catalytic state of the Cas9 HNH nuclease domain, and identifying how the divalent metal ions affect the HNH domain conformational transition remains elusive. A deeper understanding of Cas9 activation and its cleavage mechanism can enable further optimization of Cas9-based genome-editing specificity and efficiency. Using two distinct molecular dynamics simulation techniques, we have obtained a cross-validated catalytically active state of Cas9 HNH domain primed for cutting the target DNA strand. Moreover, herein we demonstrate the essential roles of the catalytic Mg2+ for the active state formation and stability. Importantly, we suggest that the derived catalytic conformation of the HNH domain can be exploited for rational engineering of Cas9 variants with enhanced specificity.	[Zuo, Zhicheng; Liu, Jin] Univ North Texas, Dept Pharmaceut Sci, Univ North Texas Syst, Coll Pharm,Hlth Sci Ctr, Ft Worth, TX 76107 USA	Liu, J (reprint author), Univ North Texas, Dept Pharmaceut Sci, Univ North Texas Syst, Coll Pharm,Hlth Sci Ctr, Ft Worth, TX 76107 USA.	jin.liu@unthsc.edu			UNT Office of Research and Economic Development	The authors thank Dr. Kyle A. Emmitte for reading the manuscript and acknowledge the Texas Advanced Computing Center (TACC) at the University of Texas at Austin and the University of North Texas (UNT)'s High Performance Computing Services (a division of the University Information Technology with additional support from UNT Office of Research and Economic Development) for providing computational resources that contributed to the simulation results reported within this paper.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; Dagdas YS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao0027; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; de Oliveira CAF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002178; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869                                                                ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li PF, 2015, J CHEM THEORY COMPUT, V11, P1645, DOI 10.1021/ct500918t; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805                                                           ; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osuka S., 2017, BIORXIV; Palermo G., 2017, J AM CHEM SOC; Palermo G, 2017, P NATL ACAD SCI USA, V114, P7260, DOI 10.1073/pnas.1707645114; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Panteva MT, 2015, J COMPUT CHEM, V36, P970, DOI 10.1002/jcc.23881; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3                                                    ; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170                                                       ; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Yang M., 2017, BIORXIV; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zuo Z., 2016, SCI REP, V5; Zuo ZC, 2016, J PHYS CHEM B, V120, P2145, DOI 10.1021/acs.jpcb.5b11942	49	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 8	2017	7								17271	10.1038/s41598-017-17578-6				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FP2RA	WOS:000417464600001	29222528	gold			2018-01-05	
J	Chen, ZM; Liu, FY; Chen, YK; Liu, J; Wang, XY; Chen, AT; Deng, G; Zhang, HY; Liu, J; Hong, ZY; Zhou, JB				Chen, Zeming; Liu, Fuyao; Chen, Yanke; Liu, Jun; Wang, Xiaoying; Chen, Ann T.; Deng, Gang; Zhang, Hongyi; Liu, Jie; Hong, Zhangyong; Zhou, Jiangbing			Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles	ADVANCED FUNCTIONAL MATERIALS			English	Article						brain cancer; CRISPR; Cas9; gene therapy; liposomes; nanogels	CELL-PENETRATING PEPTIDE; BLOOD-BRAIN-BARRIER; EFFICIENT DELIVERY; MINICIRCLE DNA; CAS9 PROTEIN; RNA; CRISPR; SYSTEM; TUMORS; GLIOBLASTOMA	Due to its simplicity, versatility, and high efficiency, the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology has emerged as one of the most promising approaches for treatment of a variety of genetic diseases, including human cancers. However, further translation of CRISPR/Cas9 for cancer gene therapy requires development of safe approaches for efficient, highly specific delivery of both Cas9 and single guide RNA to tumors. Here, novel core-shell nanostructure, liposome-templated hydrogel nanoparticles (LHNPs) that are optimized for efficient codelivery of Cas9 protein and nucleic acids is reported. It is demonstrated that, when coupled with the minicircle DNA technology, LHNPs deliver CRISPR/Cas9 with efficiency greater than commercial agent Lipofectamine 2000 in cell culture and can be engineered for targeted inhibition of genes in tumors, including tumors the brain. When CRISPR/Cas9 targeting a model therapeutic gene, polo-like kinase 1 (PLK1), is delivered, LHNPs effectively inhibit tumor growth and improve tumor-bearing mouse survival. The results suggest LHNPs as versatile CRISPR/Cas9-delivery tool that can be adapted for experimentally studying the biology of cancer as well as for clinically translating cancer gene therapy.	[Chen, Zeming; Liu, Fuyao; Chen, Yanke; Liu, Jun; Wang, Xiaoying; Chen, Ann T.; Deng, Gang; Zhang, Hongyi; Liu, Jie; Zhou, Jiangbing] Yale Univ, Dept Neurosurg, New Haven, CT 06510 USA; [Chen, Zeming; Hong, Zhangyong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhou, Jiangbing] Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA	Zhou, JB (reprint author), Yale Univ, Dept Neurosurg, New Haven, CT 06510 USA.; Hong, ZY (reprint author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Zhou, JB (reprint author), Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA.	hongzy@nankai.edu.cn; jiangbing.zhou@yale.edu		Chen, Zeming/0000-0003-4222-4945	National Institutes of Health (NIH) [NS095817, NS095147]; American Brain Tumor Association; State of Connecticut; Chinese Scholarship Council	This work was supported by National Institutes of Health (NIH) Grants NS095817, NS095147, American Brain Tumor Association, and the State of Connecticut. This research was partially supported by scholarships from the Chinese Scholarship Council to Y.C., X.W., and J.L.	Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gwiazda KS, 2016, MOL THER, V24, P1570, DOI 10.1038/mt.2016.105; Han L, 2016, ACS NANO, V10, P4209, DOI 10.1021/acsnano.5b07573; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Keeney M, 2013, ACS NANO, V7, P7241, DOI 10.1021/nn402657d; Kelton WJ, 2016, CHIMIA, V70, P439, DOI 10.2533/chimia.2016.439; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Li L, 2017, ACS NANO, V11, P95, DOI 10.1021/acsnano.6b04261; Li Q, 2015, CANC TRANSL MED, V1, P176; Li SD, 2007, J CONTROL RELEASE, V123, P181, DOI 10.1016/j.jconrel.2007.09.004; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034833; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Porteous DJ, 1997, GENE THER, V4, P210, DOI 10.1038/sj.gt.3300390; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Salomone F, 2012, J CONTROL RELEASE, V163, P293, DOI 10.1016/j.jconrel.2012.09.019; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zhou JB, 2013, P NATL ACAD SCI USA, V110, P11751, DOI 10.1073/pnas.1304504110; Zhou JB, 2012, CANCER J, V18, P89, DOI 10.1097/PPO.0b013e318244d8ae; Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]; Zhou J, 2012, BIOMATERIALS, V33, P583, DOI 10.1016/j.biomaterials.2011.09.061; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	41	0	0	18	18	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	DEC 8	2017	27	46							1703036	10.1002/adfm.201703036				9	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	FO9DC	WOS:000417187200004					2018-01-05	
J	Yassin, AF; Langenberg, S; Huntemann, M; Clum, A; Pillay, M; Palaniappan, K; Varghese, N; Mikhailova, N; Mukherjee, S; Reddy, TBK; Daum, C; Shapiro, N; Ivanova, N; Woyke, T; Kyrpides, NC				Yassin, Atteyet F.; Langenberg, Stefan; Huntemann, Marcel; Clum, Alicia; Pillay, Manoj; Palaniappan, Krishnaveni; Varghese, Neha; Mikhailova, Natalia; Mukherjee, Supratim; Reddy, T. B. K.; Daum, Chris; Shapiro, Nicole; Ivanova, Natalia; Woyke, Tanja; Kyrpides, Nikos C.			Draft genome sequence of Actinotignum schaalii DSM 15541(T): Genetic insights into the lifestyle, cell fitness and virulence	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ENTNER-DOUDOROFF PATHWAY; CYTOCHROME BD OXIDASE; GRAM-POSITIVE COCCI; ESCHERICHIA-COLI; OXIDATIVE STRESS; ACTINOBACULUM-SCHAALII; METRONIDAZOLE RESISTANCE; AZOTOBACTER-VINELANDII; BACTEROIDES-FRAGILIS	The permanent draft genome sequence of Actinotignum schaalii DSM 15541(T) is presented. The annotated genome includes 2,130,987 bp, with 1777 protein-coding and 58 rRNA-coding genes. Genome sequence analysis revealed absence of genes encoding for: components of the PTS systems, enzymes of the TCA cycle, glyoxylate shunt and gluconeogensis. Genomic data revealed that A. schaalii is able to oxidize carbohydrates via glycolysis, the nonoxidative pentose phosphate and the Entner-Doudoroff pathways. Besides, the genome harbors genes encoding for enzymes involved in the conversion of pyruvate to lactate, acetate and ethanol, which are found to be the end products of carbohydrate fermentation. The genome contained the gene encoding Type I fatty acid synthase required for de novo FAS biosynthesis. The plsY and plsX genes encoding the acyltransferases necessary for phosphatidic acid biosynthesis were absent from the genome. The genome harbors genes encoding enzymes responsible for isoprene biosynthesis via the mevalonate (MVA) pathway. Genes encoding enzymes that confer resistance to reactive oxygen species (ROS) were identified. In addition, A. schaalii harbors genes that protect the genome against viral infections. These include restriction-modification (RM) systems, type II toxin-antitoxin (TA), CRISPR-Cas and abortive infection system. A. schaalii genome also encodes several virulence factors that contribute to adhesion and internalization of this pathogen such as the tad genes encoding proteins required for pili assembly, the nanI gene encoding exo-alpha-sialidase, genes encoding heat shock proteins and genes encoding type VII secretion system. These features are consistent with anaerobic and pathogenic lifestyles. Finally, resistance to ciprofloxacin occurs by mutation in chromosomal genes that encode the subunits of DNA-gyrase (GyrA) and topisomerase IV (ParC) enzymes, while resistant to metronidazole was due to the frxA gene, which encodes NADPH-flavin oxidoreductase.	[Yassin, Atteyet F.] Univ Bonn, Inst Med Mikrobiol & Immunol, Bonn, Germany; [Langenberg, Stefan; Varghese, Neha] Klin & Poliklin Hals Nasen Ohrenheilkunde Chirurg, Bonn, Germany; [Huntemann, Marcel; Clum, Alicia; Pillay, Manoj; Palaniappan, Krishnaveni; Mikhailova, Natalia; Mukherjee, Supratim; Reddy, T. B. K.; Daum, Chris; Shapiro, Nicole; Ivanova, Natalia; Woyke, Tanja; Kyrpides, Nikos C.] US DOE, Joint Genome Inst, Genome Biol Program, Walnut Creek, DC USA	Yassin, AF (reprint author), Univ Bonn, Inst Med Mikrobiol & Immunol, Bonn, Germany.	yassin@mibi03.meb.uni-bonn.de		Langenberg, Stefan/0000-0001-5817-5469	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231.	ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; ANDREESEN JR, 1969, ARCH MIKROBIOL, V69, P160, DOI 10.1007/BF00409760; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051                                                                  ; Bank S, 2010, EMERG INFECT DIS, V16, P76, DOI 10.3201/eid1601.090761; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carlier JP, 1997, ANTIMICROB AGENTS CH, V41, P1495; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439                                                  ; Cattoir V, 2010, J ANTIMICROB CHEMOTH, V65, P2514, DOI 10.1093/jac/dkq383; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.37.3.429-453.2003; Das A, 2005, J BACTERIOL, V187, P2020, DOI 10.1128/JB.187.6.2020-2029.2005; EGAN SE, 1992, J BACTERIOL, V174, P4638; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Field D, 2014, STAND GENOMIC SCI, V9; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Giuffre A, 2014, BBA-BIOENERGETICS, V1837, P1178, DOI 10.1016/j.bbabio.2014.01.016; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; Goldman BS, 1996, J BACTERIOL, V178, P6348, DOI 10.1128/jb.178.21.6348-6351.1996                                                ; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILL S, 1990, J BACTERIOL, V172, P2071, DOI 10.1128/jb.172.4.2071-2078.1990                                                 ; Hoenigl M, 2010, EMERG INFECT DIS, V16, P1171, DOI 10.3201/eid1607.100349; Hooper DC, 2002, LANCET INFECT DIS, V2, P530, DOI 10.1016/S1473-3099(02)00369-9                                                   ; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Hung GC, 2012, J CLIN MICROBIOL, V50, P2770, DOI 10.1128/JCM.01155-12; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INFERNAL, INF RNA AL; JUKES T H, 1969, P21; KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990                                                ; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb.mvj057; Klemm P, 1996, J BACTERIOL, V178, P61, DOI 10.1128/jb.178.1.61-67.1996                                                     ; Kristiansen R, 2014, GENOME ANNOUNC, V2; Kwon DH, 2000, ANTIMICROB AGENTS CH, V44, P2133, DOI 10.1128/AAC.44.8.2133-2142.2000                                                 ; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Kyrpides NC, 2014, STAND GENOMIC SCI, V9, P628, DOI 10.4056/sigs.5068949; Laabei M, 2014, GENOME RES, V24, P839, DOI 10.1101/gr.165415.113; Lawson PA, 1997, INT J SYST BACTERIOL, V47, P899, DOI 10.1099/00207713-47-3-899                                                       ; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Li M, 2011, DUK FAST EF IN PRESS; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Mukherjee S, 2017, NAT BIOTECHNOL, V35, P676, DOI 10.1038/nbt.3886; Olsen AB, 2013, BJU INT, V112, P394, DOI 10.1111/j.1464-410X.2012.11739.x; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997                                                 ; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Theron MM, 2004, J ANTIMICROB CHEMOTH, V54, P240, DOI 10.1093/jac/dkh270; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170                                                                 ; Tschudin-Sutter S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-289; Vanden Bempt Isabelle, 2011, J Clin Microbiol, V49, P2369, DOI 10.1128/JCM.00272-11; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Yassin AF, 2015, INT J SYST EVOL MICR, V65, P615, DOI 10.1099/ijs.0.069294-0; Yassin AF, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0036-7; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	90	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188914	10.1371/journal.pone.0188914				27	Multidisciplinary Sciences	Science & Technology - Other Topics	FP0ZD	WOS:000417337800048	29216246	gold			2018-01-05	
J	Ehrke-Schulz, E; Schiwon, M; Leitner, T; David, S; Bergmann, T; Liu, J; Ehrhardt, A				Ehrke-Schulz, Eric; Schiwon, Maren; Leitner, Theo; David, Stephan; Bergmann, Thorsten; Liu, Jing; Ehrhardt, Anja			CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes	SCIENTIFIC REPORTS			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; IN-VIVO; MUSCULAR-DYSTROPHY; THERAPY DEATH; T-CELLS; VIRUS; SYSTEM; EXPRESSION; ENDONUCLEASE; OPTIMIZATION	The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system revolutionized the field of gene editing but viral delivery of the CRISPR/Cas9 system has not been fully explored. Here we adapted clinically relevant high-capacity adenoviral vectors (HCAdV) devoid of all viral genes for the delivery of the CRISPR/Cas9 machinery using a single viral vector. We present a platform enabling fast transfer of the Cas9 gene and gRNA expression units into the HCAdV genome including the option to choose between constitutive or inducible Cas9 expression and gRNA multiplexing. Efficacy and versatility of this pipeline was exemplified by producing different CRISPR/Cas9-HCAdV targeting the human papillomavirus (HPV) 18 oncogene E6, the dystrophin gene causing Duchenne muscular dystrophy (DMD) and the HIV co-receptor C-C chemokine receptor type 5 (CCR5). All CRISPR/Cas9-HCAdV proved to be efficient to deliver the respective CRISPR/Cas9 expression units and to introduce the desired DNA double strand breaks at their intended target sites in immortalized and primary cells.	[Ehrke-Schulz, Eric; Schiwon, Maren; Leitner, Theo; David, Stephan; Bergmann, Thorsten; Liu, Jing; Ehrhardt, Anja] Witten Herdecke Univ, Inst Microbiol & Virol, Ctr Biomed Educ & Res ZBAF, Dept Human Med,Fac Hlth, Witten, Germany	Ehrhardt, A (reprint author), Witten Herdecke Univ, Inst Microbiol & Virol, Ctr Biomed Educ & Res ZBAF, Dept Human Med,Fac Hlth, Witten, Germany.	anja.ehrhardt@uni-wh.de			UWH Forschungsforderung; German Duchenne Foundation; Aktion Benny and Co.; Else Kroner-Fresenius Foundation; Chinese Scholarship Council (CSC)	We thank Rudolf A. Kley (Bergmannsheil University Hospital, Bochum, Germany) for providing primary human skeletal myoblasts and Philip Ng for providing 116 cells and the helper virus for HCAdV production. This work was supported by the UWH Forschungsforderung and the German Duchenne Foundation, "Aktion Benny and Co.", to E.E-S and the Else Kroner-Fresenius Foundation to AE., J.L. received a stipend from the Chinese Scholarship Council (CSC).	Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Brunetti-Pierri N, 2017, VIRUS GENES; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Ehrke-Schulz E, 2016, JOVE-J VIS EXP, DOI 10.3791/52894; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Jager L, 2009, HUM GENE THER, V20, P883, DOI 10.1089/hum.2009.020; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kennedy EM, 2015, METHODS, V91, P82, DOI 10.1016/j.ymeth.2015.08.012; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maggio I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37051; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244                                                   ; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Muck-Hausl Martin, 2015, Nucleic Acids Res, V43, pe50, DOI 10.1093/nar/gkv031; Nelson C. E., 2015, SCIENCE; O'Neal VK, 2000, MOL MED, V6, P179; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palmer DJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.39; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Saydaminova Kamola, 2015, Mol Ther Methods Clin Dev, V1, P14057, DOI 10.1038/mtm.2014.57; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180                                                              ; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Segura MM, 2008, CURR GENE THER, V8, P222, DOI 10.2174/156652308785160647; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Smith CA, 1998, HUM GENE THER, V9, P1419, DOI 10.1089/hum.1998.9.10-1419                                                      ; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tang J, 2004, GENE THER, V11, P1408, DOI 10.1038/sj.gt.3302316; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1339; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Zhang WL, 2017, CELL REP, V19, P1698, DOI 10.1016/j.celrep.2017.05.008; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	48	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 7	2017	7								17113	10.1038/s41598-017-17180-w				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FP1EG	WOS:000417353600007	29215041	gold			2018-01-05	
J	Lee, SH; Yu, J; Hwang, GH; Kim, S; Kim, HS; Ye, S; Kim, K; Park, J; Park, DY; Cho, YK; Kim, JS; Bae, S				Lee, S. H.; Yu, J.; Hwang, G-H; Kim, S.; Kim, H. S.; Ye, S.; Kim, K.; Park, J.; Park, D. Y.; Cho, Y-K; Kim, J-S; Bae, S.			CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR	ONCOGENE			English	Article							CIRCULATING TUMOR DNA; RNA-GUIDED ENDONUCLEASE; BREAST-CANCER; LIQUID BIOPSY; HUMAN-CELLS; MUTATIONS; CAS9; QUANTIFICATION; SPECIFICITIES; LANDSCAPES	Circulating tumor DNA (ctDNA) has emerged as a tumor-specific biomarker for the early detection of various cancers. To date, several techniques have been devised to enrich the extremely small amounts of ctDNA present in plasma, but they are still insufficient for cancer diagnosis, especially at the early stage. Here, we developed a novel method, CUT (CRISPR-mediated, Ultrasensitive detection of Target DNA)-PCR, which uses CRISPR endonucleases to enrich and detect the extremely small amounts of tumor DNA fragments among the much more abundant wild-type DNA fragments by specifically eliminating the wild-type sequences. We computed that by using various orthologonal CRISPR endonucleases such as SpCas9 and FnCpf1, the CUT-PCR method would be applicable to 80% of known cancer-linked substitution mutations registered in the COSMIC database. We further verified that CUT-PCR together with targeted deep sequencing enables detection of a broad range of oncogenes with high sensitivity (<0.01%) and accuracy, which is superior to conventional targeted deep sequencing. In the end, we successfully applied CUT-PCR to detect sequences with oncogenic mutations in the ctDNA of colorectal cancer patients' blood, suggesting that our technique could be adopted for diagnosing various types of cancer at early stages.	[Lee, S. H.; Kim, S.; Kim, H. S.; Ye, S.; Kim, K.; Kim, J-S] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Yu, J.] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Hwang, G-H; Bae, S.] Hanyang Univ, Dept Chem, Room 36-316,222 Wangsimni Ro, Seoul 133791, South Korea; [Kim, H. S.; Kim, J-S] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Park, J.; Cho, Y-K] Inst Basic Sci, Ctr Soft & Living Matter, Ulsan, South Korea; [Park, D. Y.] Pusan Natl Univ, Sch Med, Dept Pathol, Busan, South Korea; [Park, D. Y.] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Cho, Y-K] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea; [Bae, S.] Hanyang Univ, Res Inst Convergence Basic Sci, Seoul, South Korea	Bae, S (reprint author), Hanyang Univ, Dept Chem, Room 36-316,222 Wangsimni Ro, Seoul 133791, South Korea.	sangsubae@hanyang.ac.kr			Ministry of Health and Welfare; Korea Healthcare technology R&D Project, Ministry for Health and Welfare Affairs [HI16C1012, HI12C1845]; Institute for Basic Science [IBS-R021-D1]	We express our gratitude to all of the patients and healthy volunteers who contributed blood samples for this study. The biological specimens for this study were provided by the Pusan National University hospital, a member of the National Biobank of Korea, which is supported by the Ministry of Health and Welfare. All samples were obtained with informed consent according to the institutional review board-approved protocols. The deep-sequencing data are available at the NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) under accession number SRX1970116. This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health and Welfare Affairs (HI16C1012) to SB, (HI12C1845) to JP, DP and YC and Institute for Basic Science (IBS-R021-D1) to J-SK.	Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheng FF, 2016, ONCOTARGET, V7, P48832, DOI 10.18632/oncotarget.9453; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2016, MOL ONCOL, V10, P464, DOI 10.1016/j.molonc.2015.12.001; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Freidin MB, 2015, CLIN CHEM, V61, P1299, DOI 10.1373/clinchem.2015.242453; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kruglyak KM, 2014, EXPERT REV MOL DIAGN, V14, P635, DOI 10.1586/14737159.2014.916213; Lee SH, 2016, BMB REP, V49, P201, DOI 10.5483/BMBRep.2016.49.4.042; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Narayan A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Park JT, 2015, ONCOGENE, V34, P2801, DOI 10.1038/onc.2014.223; Park JY, 2013, NAT BIOTECHNOL, V31, P990, DOI 10.1038/nbt.2743; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Song Chen, 2016, Nucleic Acids Res, V44, pe146; Sorber L, 2017, LUNG CANCER, V107, P100, DOI 10.1016/j.lungcan.2016.04.026; Tsao SCH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11198; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xu XR, 2014, BIOMED RES INT, DOI 10.1155/2014/623509; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	43	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6823	6829		10.1038/onc.2017.281				7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	WOS:000417282500008	28846115				2018-01-05	
J	Li, YQ; Wang, LL; Wang, GS; Feng, Y; Liu, XM				Li, Yiqiong; Wang, Lulu; Wang, Guangshuai; Feng, Yue; Liu, Xiaomin			AT2G21280 Only Has a Minor Role in Chloroplast Division	FRONTIERS IN PLANT SCIENCE			English	Article						chloroplast division; AT2G21280; GC1; AtSulA; phylogenetic analysis	AGROBACTERIUM-MEDIATED TRANSFORMATION; CORRECT PLASTID DIVISION; BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI K-12; ARABIDOPSIS-THALIANA; INHIBITOR SULA; DNA-REPLICATION; OUTER-MEMBRANE; FLORAL DIP; PROTEIN	Chloroplast division is an important cellular process, which involves complicated coordination of multiple proteins. In mutant plants with chloroplast division defects, chloroplasts are usually found to be with enlarged size and reduced numbers. Previous studies have shown that AT2G21280, which was named as GC1 (GIANT CHLOROPLAST 1) or AtSulA, was an important chloroplast division gene, because either reduced expression or overexpression of the gene could result in an apparent chloroplast division phenotype (Maple et al., 2004; Raynaud et al., 2004). To further study the function of AT2G21280, we obtained mutants of this gene by CRISPR/Cas9-mediated gene editing and T-DNA insertion. Most of the chloroplasts in the mutants were similar to that of the wild type in size. Larger chloroplasts were rarely found in the mutants. Moreover, we obtained transgenic plants overexpressing AT2G21280, analyzed the chloroplast division phenotype, and found there were no significant differences between the wild type and various overexpressing plants. Phylogenetic analysis clearly indicated that AT2G21280 was not in the family of bacterial cell division protein SulA. Instead, BLAST analysis suggested that AT2G21280 is an NAD dependent epimerase/dehydratase family enzyme. Since the main results of the previous studies that AT2G21280 is an important chloroplast division gene cannot be confirmed by our intensive study and large chloroplasts are rarely found in the mutants, we think the previous names of AT2G21280 are inappropriate. Localization study results showed that AT2G21280 is a peripheral protein of the inner envelope of chloroplasts in the stroma side. AT2G21280 is well conserved in plants and cyanobacteria, suggesting its function is important, which can be revealed in the future study.	[Li, Yiqiong; Wang, Lulu; Wang, Guangshuai; Liu, Xiaomin] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Feng, Yue] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China	Liu, XM (reprint author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China.	liuxiaomin@bjfu.edu.cn			National Natural Science Foundation of China [31501090]	This work was supported by grants from the National Natural Science Foundation of China (31501090).	ARABSHAHI A, 1988, J BIOL CHEM, V263, P2638; Bent A, 2006, METH MOL B, V343, P87; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990                                                ; Chang N, 2017, PLANT CELL REP, V36, P471, DOI 10.1007/s00299-016-2096-6; Chen YD, 2012, BIOCHEMISTRY-US, V51, P3100, DOI 10.1021/bi201669d; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COLEMAN WG, 1979, J BACTERIOL, V139, P899; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; Dutta S, 2015, PLANT J, V84, P428, DOI 10.1111/tpj.13009; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; FELDMANN KA, 1987, MOL GEN GENET, V208, P1, DOI 10.1007/BF00330414; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Gao YF, 2013, PLANT J, V75, P795, DOI 10.1111/tpj.12240; GOTTESMAN S, 1981, J BACTERIOL, V148, P265; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; JONES C, 1985, P NATL ACAD SCI USA, V82, P6045, DOI 10.1073/pnas.82.18.6045; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; LUTKENHAUS JF, 1983, J BACTERIOL, V154, P1339; MAGUIN E, 1986, J BACTERIOL, V166, P733, DOI 10.1128/jb.166.3.733-738.1986                                                   ; Maple J, 2004, CURR BIOL, V14, P776, DOI 10.1016/j.cub.2004.04.031; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; Miyagishima SY, 2006, PLANT CELL, V18, P2517, DOI 10.1105/tpc.106.045484; Miyagishima S, 2011, PLANT PHYSIOL, V155, P1533, DOI 10.1104/pp.110.170688; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; Nakanishi H, 2009, CURR BIOL, V19, P151, DOI 10.1016/j.cub.2008.12.018; Nazir A, 2016, J BACTERIOL, V198, P688, DOI 10.1128/JB.00693-15; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0                                                                ; Pan D, 2013, PLANT CELL REP, V32, P173, DOI 10.1007/s00299-012-1352-7; PYKE KA, 1994, PLANT PHYSIOL, V104, P201, DOI 10.1104/pp.104.1.201                                                            ; Raynaud C, 2004, PLANT CELL, V16, P1801, DOI 10.1105/tpc.022335; Robertson EJ, 1996, PLANT PHYSIOL, V112, P149, DOI 10.1104/pp.112.1.149                                                            ; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Somers WS, 1998, STRUCT FOLD DES, V6, P1601, DOI 10.1016/S0969-2126(98)00157-9                                                   ; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354                                                            ; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Wang WH, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.11; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Yamashita Y, 1999, INFECT IMMUN, V67, P3693; Yoshida Y, 2006, SCIENCE, V313, P1435, DOI 10.1126/science.1129689; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]	45	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	DEC 7	2017	8								2095	10.3389/fpls.2017.02095				11	Plant Sciences	Plant Sciences	FO9VK	WOS:000417245500001		gold			2018-01-05	
J	Adikusuma, F; Pfitzner, C; Thomas, PQ				Adikusuma, Fatwa; Pfitzner, Chandran; Thomas, Paul Quinton			Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; MOUSE MODEL; RNA; CAS9; NUCLEASES; CRISPR-CAS9; SPECIFICITY; GENERATION; NICKASES; SYSTEM	CRISPR/Cas9 technology enables efficient, rapid and cost-effective targeted genomic modification in a wide variety of cellular contexts including cultured cells. Some applications such as generation of double knock-outs, large deletions and paired-nickase cleavage require simultaneous expression of two gRNAs. Although single plasmids that enable multiplex expression of gRNAs have been developed, these require multiple rounds of cloning and/or PCR for generation of the desired construct. Here, we describe a series of vectors that enable generation of customized dual-gRNA expression constructs via an easy onestep golden gate cloning reaction using two annealed oligonucleotide inserts with different overhangs. Through nucleofection of mouse embryonic stem cells, we demonstrate highly efficient cleavage of the target loci using the dual-guide plasmids, which are available as Cas9-nuclease or Cas9-nickase expression constructs, with or without selection markers. These vectors are a valuable addition to the CRISPR/Cas9 toolbox and will be made available to all interested researchers via the Addgene plasmid repository.	[Adikusuma, Fatwa; Pfitzner, Chandran; Thomas, Paul Quinton] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Adikusuma, Fatwa] Diponegoro Univ, Fac Med, Ctr Biomed Res, Semarang, Central Java, Indonesia; [Pfitzner, Chandran; Thomas, Paul Quinton] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Thomas, Paul Quinton] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Thomas, PQ (reprint author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Thomas, PQ (reprint author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Thomas, PQ (reprint author), South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au					Adikusuma F, 2017, MOL THER, V25, P1736, DOI 10.1016/j.ymthe.2017.05.021; Adikusuma F, 2017, GENETICS, V206, P1495, DOI 10.1534/genetics.117.202549; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083	28	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187236	10.1371/journal.pone.0187236				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FO9MS	WOS:000417212200015	29211736	gold			2018-01-05	
J	Costa, LD; Malnoy, M; Gribaudo, I				Costa, Lorenza Dalla; Malnoy, Mickael; Gribaudo, Ivana			Breeding next generation tree fruits: technical and legal challenges	HORTICULTURE RESEARCH			English	Review							VITIS-VINIFERA L.; FREE TRANSGENIC PLANTS; SOMATIC EMBRYOGENESIS; MEDIATED TRANSFORMATION; GENETIC-TRANSFORMATION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; SOMACLONAL VARIATION; MARKER GENES; GRAPEVINE	The new plant breeding technologies (NPBTs) have recently emerged as powerful tools in the context of 'green' biotechnologies. They have wide potential compared to classical genetic engineering and they are attracting the interest of politicians, stakeholders and citizens due to the revolutionary impact they may have on agriculture. Cisgenesis and genome editing potentially allow to obtain pathogen-resistant plants or plants with enhanced qualitative traits by introducing or disrupting specific genes in shorter times compared to traditional breeding programs and by means of minimal modifications in the plant genome. Grapevine, the most important fruit crop in the world from an economical point of view, is a peculiar case for NPBTs because of the load of cultural aspects, varietal traditions and consumer demands, which hinder the use of classical breeding techniques and, furthermore, the application of genetic engineering to wine grape cultivars. Here we explore the technical challenges which may hamper the application of cisgenesis and genome editing to this perennial plant, in particular focusing on the bottlenecks of the Agrobacterium-mediated gene transfer. In addition, strategies to eliminate undesired sequences from the genome and to choose proper target sites are discussed in light of peculiar features of this species. Furthermore is reported an update of the international legislative frameworks regulating NPBT products which shows conflicting positions and, in the case of the European Union, a prolonged lack of regulation.	[Costa, Lorenza Dalla; Malnoy, Mickael] Fdn Edmund Mach, Res & Innovat Ctr, Via E Mach 1,San Michele, I-38010 Adige, Italy; [Gribaudo, Ivana] CNR, IPSP CNR, Inst Sustainable Plant Protect, Strada Delle Cacce 73, I-10135 Turin, Italy	Costa, LD (reprint author), Fdn Edmund Mach, Res & Innovat Ctr, Via E Mach 1,San Michele, I-38010 Adige, Italy.	lorenza.dallacosta@fmach.it					Aldwinckle H, 2009, TRANSGENIC PLANT J, V3, P1; Armijo G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00382, 10.3389/fpls.2016.00382]; Bardini M, 2003, PLANT CELL TISS ORG, V72, P157, DOI 10.1023/A:1022208302819; Bettini O, 2016, IT1643 GLOB AGR INF; Boccacci P, 2017, SCI REP-UK, V7, DOI 10.1038/srep45670; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Bouquet A., 1989, QUAD VITIC ENOL U TO, V13, P51; Breyer D, 2014, CRIT REV PLANT SCI, V33, P286, DOI 10.1080/07352689.2013.870422; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Dabauza M, 2012, METHODS MOL BIOL, V847, P227, DOI 10.1007/978-1-61779-558-9_19; Dalla Costa L, 2010, VITIS, V49, P201; Dalla Costa L, 2016, PLANT CELL TISS ORG, V124, P471, DOI 10.1007/s11240-015-0907-z; Dalla Costa L, 2014, PLANT CELL TISS ORG, V118, P471, DOI 10.1007/s11240-014-0499-z; De Buck S, 2004, CELL MOL LIFE SCI, V61, P2632, DOI 10.1007/s00018-004-4284-8; Desperrier JC, 2003, B DE L O I V, P871; Dhekney SA, 2009, HORTSCIENCE, V44, P1400; Dutt M, 2008, PLANT SCI, V175, P423, DOI 10.1016/j.plantsci.2008.06.014; [Anonymous], 2017, Nature, V542, P392, DOI 10.1038/542392a; EFSA Panel of GMO, 2012, EFSA J, V10, P2561, DOI [DOI 10.2903/J.EFSA.2012.2561, 10.2903/j.efsa.2012.2561]; Espinoza C, 2013, BIOL RES, V46, P323, DOI 10.4067/S0716-97602013000400003; European Food Safety Authority, 2012, EFSA J, V10, P2943; Feechan A, 2013, PLANT J, V76, P661, DOI 10.1111/tpj.12327; Flachowsky H, 2008, ELECT J BIOTECHNOL, V11; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gaj MD, 2004, PLANT GROWTH REGUL, V43, P27, DOI 10.1023/B:GROW.0000038275.29262.fb; Gambino G, 2011, J EXP BOT, V62, P1089, DOI 10.1093/jxb/erq349; Gray DJ, 2014, PLANT SCI, V228, P3, DOI 10.1016/j.plantsci.2014.03.023; Gregoire M, 2010, RE APHIS REV WHETHER; Gribaudo I, 2017, ACTA HORTIC, V1155, P45; Henry Y, 1998, SOMACLONAL VARIATION, P65; High Level Group of Scientific Advisors, 2017, NEW TECHNIQUES AGR B, DOI [10.2777/574498, DOI 10.2777/574498]; Holme IB, 2013, PLANT BIOTECHNOL J, V11, P395, DOI 10.1111/pbi.12055; Hou HJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00232; Iocco P, 2001, TRANSGENIC RES, V10, P105, DOI 10.1023/A:1008989610340; Ishii T, 2016, PLANT CELL REP, V35, P1507, DOI 10.1007/s00299-016-1974-2; Jacobsen E, 2007, TRENDS BIOTECHNOL, V25, P219, DOI 10.1016/j.tibtech.2007.03.008; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Prado MJ, 2010, PLANT CELL TISS ORG, V103, P49, DOI 10.1007/s11240-010-9753-1; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joyce SM, 2003, PLANT CELL TISS ORG, V74, P103, DOI 10.1023/A:1023911927116; KAEPPLER SM, 1993, P NATL ACAD SCI USA, V90, P8773, DOI 10.1073/pnas.90.19.8773; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kicherer A, 2015, SENSORS-BASEL, V15, P4823, DOI 10.3390/s150304823; Kikkert JR, 2005, IN VITRO CELL DEV-PL, V41, P232, DOI 10.1079/IVP2004609; Klodt M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0560-x; Kost TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143980; Kovalchuk N, 2017, FUNCT PLANT BIOL, V44, P290, DOI 10.1071/FP16202; Krens FA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00286; Laaninen T, 2016, NEW PLANT BREEDING T; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Li L, 2014, SENSORS-BASEL, V14, P20078, DOI 10.3390/s141120078; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Lopez-Noguera S, 2009, PLANT CELL REP, V28, P1781, DOI 10.1007/s00299-009-0778-z; Lowder L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2076.07683; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Lusser M, 2011, NEW PLANT BREEDING T; Lynch D, 2001, REGULATION GMOS EURO; Lyznik LA, 2003, PLANT CELL REP, V21, P925, DOI 10.1007/s00299-003-0616-7; Maillot P, 2009, PLANT PHYSIOL BIOCH, V47, P743, DOI 10.1016/j.plaphy.2009.03.016; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Martinelli L, 2004, VITIS, V43, P119; Martinelli L, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P327; Martinelli L, 2009, GRAPEVINE MOL PHYSL, P461, DOI DOI 10.1007/978-90-481-2305-6_; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Nakajima I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177966; Nicole Silvia, 2013, BMC Res Notes, V6, P502, DOI 10.1186/1756-0500-6-502; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Ocana J, 2013, MOL BIOTECHNOL, V55, P236, DOI 10.1007/s12033-013-9675-3; Papadakis AK, 2009, GRAPEVINE MOL PHYSL, P429, DOI DOI 10.1007/978-90-481-2305-6_16; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Perl A, 1996, NAT BIOTECHNOL, V14, P624, DOI 10.1038/nbt0596-624; Perl A, 1998, BIOTECHNOL GENET ENG, V15, P365, DOI 10.1080/02648725.1998.10647962                                                  ; Perrone I, 2012, PLANT PHYSIOL, V160, P965, DOI 10.1104/pp.112.203455; Pessina S, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.16; Petri C, 2011, ANN APPL BIOL, V159, P302, DOI 10.1111/j.1744-7348.2011.00499.x; Petri C, 2012, PLANT CELL TISS ORG, V110, P337, DOI 10.1007/s11240-012-0155-4; Prieto H, 2011, GENETIC TRANSFORMATION, P81; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Puchta H, 2003, PLANT CELL TISS ORG, V74, P123, DOI 10.1023/A:1023934807184; REMOTTI PC, 1995, PLANT SCI, V107, P205, DOI 10.1016/0168-9452(95)04106-5; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; REUSTLE G, 1994, VITIS, V33, P173; Reustle GM, 2009, GRAPEVINE MOL PHYSL, P495; Righetti L, 2014, PLANT CELL TISS ORG, V117, P335, DOI 10.1007/s11240-014-0443-2; Schellenbaum P, 2008, PLANT CELL REP, V27, P1799, DOI 10.1007/s00299-008-0588-8; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Scorza R, 1996, J AM SOC HORTIC SCI, V121, P616; Smulders MJM, 2011, PLANT GROWTH REGUL, V63, P137, DOI 10.1007/s10725-010-9531-4; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Stam M, 2002, GENETICS, V162, P917; Sugita K, 2000, PLANT J, V22, P461, DOI 10.1046/j.1365-313X.2000.00745.x; Sung Dong Yul, 2015, Plant Breeding and Biotechnology, V3, P291, DOI 10.9787/PBB.2015.3.4.291; Torregrosa L, 2002, AM J ENOL VITICULT, V53, P183; Vanblaere T, 2011, J BIOTECHNOL, V154, P304, DOI 10.1016/j.jbiotec.2011.05.013; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; VIVIER MA, 2000, S AFR J ENOL VITIC, V21, P5; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wang Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0787-3; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Wurdig J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0291-8; Yau YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-36; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhao FX, 2011, PLANT SCI, V181, P485, DOI 10.1016/j.plantsci.2011.07.016; Zhu YM, 1997, PLANT SCI, V123, P151, DOI 10.1016/S0168-9452(96)04557-8	109	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-7276			HORTIC RES-ENGLAND	Hortic. Res.-England	DEC 6	2017	4								17067	10.1038/hortres.2017.67				11	Plant Sciences; Horticulture	Plant Sciences; Agriculture	FP0GL	WOS:000417277300001		gold			2018-01-05	
J	Petersen, MA; Ryu, JK; Chang, KJ; Etxeberria, A; Bardehle, S; Mendiola, AS; Kamau-Devers, W; Fancy, SPJ; Thor, A; Bushong, EA; Baeza-Raja, B; Syme, CA; Wu, MD; Coronado, PER; Meyer-Franke, A; Yahn, S; Pous, L; Lee, JK; Schachtrup, C; Lassmann, H; Huang, EJ; Han, MH; Absinta, M; Reich, DS; Ellisman, MH; Rowitch, DH; Chan, JR; Akassoglou, K				Petersen, Mark A.; Ryu, Jae Kyu; Chang, Kae-Jiun; Etxeberria, Ainhoa; Bardehle, Sophia; Mendiola, Andrew S.; Kamau-Devers, Wanjiru; Fancy, Stephen P. J.; Thor, Andrea; Bushong, Eric A.; Baeza-Raja, Bernat; Syme, Catriona A.; Wu, Michael D.; Coronado, Pamela E. Rios; Meyer-Franke, Anke; Yahn, Stephanie; Pous, Lauriane; Lee, Jae K.; Schachtrup, Christian; Lassmann, Hans; Huang, Eric J.; Han, May H.; Absinta, Martina; Reich, Daniel S.; Ellisman, Mark H.; Rowitch, David H.; Chan, Jonah R.; Akassoglou, Katerina			Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage	NEURON			English	Article							MULTIPLE-SCLEROSIS LESIONS; BLOOD-BRAIN-BARRIER; SPINAL-CORD-INJURY; NERVOUS-SYSTEM; HISTONE ACETYLATION; WHITE-MATTER; TGF-BETA; IN-VIVO; CNS; DIFFERENTIATION	Blood-brain barrier (BBB) disruption alters the composition of the brain microenvironment by allowing blood proteins into the CNS. However, whether blood-derived molecules serve as extrinsic inhibitors of remyelination is unknown. Here we show that the coagulation factor fibrinogen activates the bone morphogenetic protein (BMP) signaling pathway in oligodendrocyte progenitor cells (OPCs) and suppresses remyelination. Fibrinogen induces phosphorylation of Smad 1/5/8 and inhibits OPC differentiation into myelinating oligodendrocytes (OLs) while promoting an astrocytic fate in vitro. Fibrinogen effects are rescued by BMP type I receptor inhibition using dorsomorphin homolog 1 (DMH1) or CRISPR/Cas9 activin A receptor type I (ACVR1) knockout in OPCs. Fibrinogen and the BMP target Id2 are increased in demyelinated multiple sclerosis (MS) lesions. Therapeutic depletion of fibrinogen decreases BMP signaling and enhances remyelination in vivo. Targeting fibrinogen may be an upstream therapeutic strategy to promote the regenerative potential of CNS progenitors in diseases with remyelination failure.	[Petersen, Mark A.; Ryu, Jae Kyu; Bardehle, Sophia; Mendiola, Andrew S.; Kamau-Devers, Wanjiru; Baeza-Raja, Bernat; Syme, Catriona A.; Wu, Michael D.; Coronado, Pamela E. Rios; Meyer-Franke, Anke; Akassoglou, Katerina] Gladstone Inst, San Francisco, CA 94158 USA; [Petersen, Mark A.; Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Chang, Kae-Jiun; Etxeberria, Ainhoa; Fancy, Stephen P. J.; Chan, Jonah R.; Akassoglou, Katerina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kamau-Devers, Wanjiru] Berkeley City Coll, Berkeley, CA USA; [Fancy, Stephen P. J.] Univ Calif San Francisco, Newborn Brain Res Inst, San Francisco, CA 94143 USA; [Thor, Andrea; Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Wu, Michael D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA; [Yahn, Stephanie; Lee, Jae K.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Pous, Lauriane] Univ Freiburg, Fac Biol, Freiburg, Germany; [Schachtrup, Christian] Univ Freiburg, Fac Med, Inst Anat & Cell Biol, Freiburg, Germany; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Han, May H.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA USA; [Absinta, Martina; Reich, Daniel S.] NINDS, Translat Neuroradiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Salk Inst Biol Studies, San Diego, CA USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, San Francisco, CA USA; [Rowitch, David H.] Univ Cambridge, Dept Paediat, Cambridge, England	Akassoglou, K (reprint author), Gladstone Inst, San Francisco, CA 94158 USA.; Akassoglou, K (reprint author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	kakassoglou@gladstone.ucsf.edu		Akassoglou, Katerina/0000-0002-2632-1465; Lassmann, Hans/0000-0001-8617-5052	NIH [P30 AI027763, S10 RR028962, R01 NS027177, R01 GM086197, P41 GM103412]; Department of Defense (DoD) [W81XWH-11-1-0562]; Gladstone Institutes from a National Center for Research Resources Grant [RR18928]; NIH/NICHD [K12-HD072222]; Pediatric Scientist Development Program fellowship (March of Dimes) [4-FY10-461]; Pediatric Scientist Development Program fellowship (NIH/NICHD) [K12-HD000850]; A Race to Erase MS Young Investigator Award; American Heart Association [16SDG30170014]; National Multiple Sclerosis Society (NMSS) [FG-2093-A-1, FG-1507-05195]; Marilyn Hilton Bridging Award for Physician-Scientists; NINDS; NMSS [RG5203, RG4985]; NIH/NINDS [R01 NS062796, R35 NS097976]; Rachleff Endowment; DoD [MS160082]; Conrad N. Hilton Foundation	We thank Reshmi Tognatta for discussions; Belinda Cabriga, Yun-An Shen, Marielle Cavrois, and Nandhini Raman for expert technical assistance; John Lewis for graphics; and Gary Howard for editorial. The Gladstone FACS core was supported by NIH P30 AI027763, NIH S10 RR028962, Department of Defense (DoD) W81XWH-11-1-0562, and the Gladstone Institutes from a National Center for Research Resources Grant RR18928. This work was supported by NIH/NICHD K12-HD072222 grant and Pediatric Scientist Development Program fellowship (March of Dimes 4-FY10-461 and NIH/NICHD K12-HD000850) to M.A.P.; A Race to Erase MS Young Investigator Award and American Heart Association Scientist Development Grant 16SDG30170014 to J.K.R.; National Multiple Sclerosis Society (NMSS) fellowship grants FG-2093-A-1 to M.A. and FG-1507-05195 to K.J.C.; the Marilyn Hilton Bridging Award for Physician-Scientists to M.A., the NINDS Intramural Research Program to D.S.R.; NIH R01 NS027177, R01 GM086197, and P41 GM103412 to M. H.E. for support of the National Center for Microscopy and Imaging Research; the NMSS RG5203, NIH/NINDS R01 NS062796, and the Rachleff Endowment to J.R.C.; and the NIH/NINDS R35 NS097976, NMSS RG4985, DoD MS160082, and Conrad N. Hilton Foundation grants to K.A. K.A. is a co-founder of MedaRed, Inc., and K.A., J.K.R., and A.M.F. are named inventors on patents and patent applications related to fibrin. Their interests are managed by the Gladstone Institutes in accordance with its conflict of interest policy.	Absinta M, 2016, J CLIN INVEST, V126, P2597, DOI 10.1172/JCI86198; Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Back SA, 1998, J NEUROSCI, V18, P6241; Bardehle S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00354; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Choe Y, 2013, J NEUROSCI, V33, P6766, DOI 10.1523/JNEUROSCI.0128-13.2013; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Dugas Jason C, 2013, Cold Spring Harb Protoc, V2013, P745, DOI 10.1101/pdb.prot070862; Dutta DJ, 2014, DEVELOPMENT, V141, P2414, DOI 10.1242/dev.106492; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Gveric D, 2003, BRAIN, V126, P1590, DOI 10.1093/brain/awg167; Hackett AR, 2016, NEUROBIOL DIS, V89, P10, DOI 10.1016/j.nbd.2016.01.017; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Lehnardt S, 2002, J NEUROSCI, V22, P2478; Mabie PC, 1997, J NEUROSCI, V17, P4112; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; North HA, 2015, J NEUROSCI, V35, P3725, DOI 10.1523/JNEUROSCI.4546-14.2015; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; PATERSON PY, 1976, FED PROC, V35, P2428; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pedre X, 2011, J NEUROSCI, V31, P3435, DOI 10.1523/JNEUROSCI.4507-10.2011; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rosenzweig S, 2015, BRAIN RES, V1623, P123, DOI 10.1016/j.brainres.2015.02.019; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Sen U, 2009, AM J PHYSIOL-CELL PH, V296, pC840, DOI 10.1152/ajpcell.00515.2008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai HH, 2016, SCIENCE, V351, P379, DOI 10.1126/science.aad3839; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Wu MZ, 2012, J NEUROSCI, V32, P6651, DOI 10.1523/JNEUROSCI.4876-11.2012; Yates RL, 2017, ANN NEUROL, V82, P259, DOI 10.1002/ana.24997; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	51	1	1	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2017	96	5					1003	+		10.1016/j.neuron.2017.10.008				17	Neurosciences	Neurosciences & Neurology	FP0YS	WOS:000417336100009	29103804				2018-01-05	
J	Daniels, MJD; Adamson, AD; Humphreys, N; Brough, D				Daniels, Michael J. D.; Adamson, Antony D.; Humphreys, Neil; Brough, David			CRISPR/Cas9 mediated mutation of mouse IL-1 alpha nuclear localisation sequence abolishes expression	SCIENTIFIC REPORTS			English	Article							RNA SECONDARY STRUCTURE; INTERLEUKIN-1 RECEPTOR; STERILE INFLAMMATION; ACTIVATION; PRECURSOR; CELLS; IDENTIFICATION; IL-1-BETA; MECHANISM; NLRP3	Inflammation is a host defense process against infection. Inflammatory mediators include cytokines of the interleukin-1 family, such as IL-1 alpha and IL-1 beta. Unlike IL-1 beta, IL-1 alpha carries an N-terminal nuclear localisation sequence (NLS) and is trafficked to the nucleus. The importance of IL-1 alpha nuclear localisation is poorly understood. Here, we used CRISPR/Cas9 to make inactivating mutations to the NLS on the Il1 alpha gene. A colony of NLS mutant mice was successfully generated with precise knock-in mutations to incapacitate NLS function. NLS mutant mice had no gross changes in immunophenotype or inflammatory response but, surprisingly, failed to express IL-1 alpha. We deduced that, in making specific mutations in the Il1 alpha gene, we also mutated a long-noncoding (lnc) RNA in the complementary strand which has cis-regulatory transcriptional control of the Il1 alpha gene itself. The mutations generated in the Il1a gene also result in mutation of the lncRNA sequence and a predicted alteration of its secondary structure, potentially explaining a subsequent failure to function as a transcriptional activator of Il1 alpha expression. Thus, lncRNA secondary structure may regulate IL-1 alpha expression. Our results serve as a cautionary note that CRISPR -mediated genome editing without full knowledge of genomic context can result in unexpected, yet potentially informative observations.	[Daniels, Michael J. D.; Brough, David] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol,Sch Biol Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Adamson, Antony D.; Humphreys, Neil] Univ Manchester, Fac Biol Med & Hlth, Transgen Unit, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England	Brough, D (reprint author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol,Sch Biol Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.brough@manchester.ac.uk			MRC DTP [MR/K501311/1]; Wellcome Trust [097820/Z/11/B]	Michael Daniels is funded by a MRC DTP studentship (MR/K501311/1). This work was also supported by the Wellcome Trust [097820/Z/11/B].	Ahituv N, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0277-0; Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Boutin H, 2001, J NEUROSCI, V21, P5528; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Cazenave J.-P., 2004, PLATELETS MEGAKARYOC, V272; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Daniels MJD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010102; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Dinarello CA, 1996, BLOOD, V87, P2095; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Goyal A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw883; Hawn TR, 2002, MICROBES INFECT, V4, P763, DOI 10.1016/S1286-4579(02)01596-4; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li R., 2016, INT J MOL SCI, V17; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Luheshi NM, 2009, EUR J IMMUNOL, V39, P2973, DOI 10.1002/eji.200939712; Luheshi NM, 2009, TRAFFIC, V10, P16, DOI 10.1111/j.1600-0854.2008.00840.x; MAIER JAM, 1994, MOL CELL BIOL, V14, P1845, DOI 10.1128/MCB.14.3.1845                                                           ; MARTIN CA, 1990, CELL IMMUNOL, V128, P555, DOI 10.1016/0008-8749(90)90048-V; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McMahon GA, 1997, J BIOL CHEM, V272, P28202, DOI 10.1074/jbc.272.45.28202; Merhi-Soussi F, 2005, CYTOKINE, V32, P163, DOI 10.1016/j.cyto.2005.09.004; Mori N, 1996, BLOOD, V87, P3410; Mueller WF, 2015, J BIOL CHEM, V290, P27700, DOI 10.1074/jbc.M115.684035; O'Geen H, 2015, CURR OPIN CHEM BIOL, V29, P72, DOI 10.1016/j.cbpa.2015.10.001; Palmer G, 2005, CYTOKINE, V31, P153, DOI 10.1016/j.cyto.2005.03.007; Pollock AS, 2003, FASEB J, V17, P203, DOI 10.1096/fj.02-0602com                                                           ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rider P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00290; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Stevenson FT, 1997, P NATL ACAD SCI USA, V94, P508, DOI 10.1073/pnas.94.2.508; Thornton P, 2010, BLOOD, V115, P3632, DOI 10.1182/blood-2009-11-252643; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	54	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 6	2017	7								17077	10.1038/s41598-017-17387-x				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FO8KR	WOS:000417135800016	29213066	gold			2018-01-05	
J	Ma, YX; Wang, MX; Li, W; Zhang, ZP; Zhang, XW; Wu, GQ; Tan, TW; Cui, ZQ; Zhang, XE				Ma, Yingxin; Wang, Mingxiu; Li, Wei; Zhang, Zhiping; Zhang, Xiaowei; Wu, Guoqiang; Tan, Tianwei; Cui, Zongqiang; Zhang, Xian-En			Live Visualization of HIV-1 Proviral DNA Using a Dual-Color-Labeled CRISPR System	ANALYTICAL CHEMISTRY			English	Article							GENOMIC LOCI; CELL-LINES; FISH; EXPRESSION; INFECTION; TYPE-1; TALEN; TOOL	HIV latency is one of the major problems in HIV/AIDS cure. Imaging single-copy integrated proviral HIV DNA in host cell has both virology and clinical significance but remains technical challenge. Here, we developed a dual-color labeled CRISPR system to image the HIV-1 integrated proviral DNA in latently infected cells. The pair of CRISPRs was fluorescently labeled with two different color QDs using two alternative bioorthogonal ligation reactions. Integrated HIV-sequences are successfully mapped based on the colocalized signals of QDs in living cells. Compared to the existing zinc finger proteins and TALENs, the CRISPR system is much easier to operate and more efficient in imaging of internal genomic loci. Therefore, the proposed method proviral HIV-1, but also a versatile platform to image single genomic loci in living could be not cells. only a powerful tool for imaging	[Zhang, Xian-En] Chinese Acad Sci, Inst Biophys, Ctr Biol Macromol, Natl Key Lab Biomacromol, Beijing, Peoples R China; [Ma, Yingxin; Wang, Mingxiu; Li, Wei; Zhang, Zhiping; Zhang, Xiaowei; Wu, Guoqiang; Cui, Zongqiang] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Ma, Yingxin; Tan, Tianwei] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China	Zhang, XE (reprint author), Chinese Acad Sci, Inst Biophys, Ctr Biol Macromol, Natl Key Lab Biomacromol, Beijing, Peoples R China.; Cui, ZQ (reprint author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	czq@wh.iov.cn; zhangxe@ibp.ac.cn					BUTERA ST, 1994, J VIROL, V68, P2726; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Choolani M, 2000, AM J HUM GENET, V67, P422; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Deichmann M, 1997, J VIROL METHODS, V65, P19, DOI 10.1016/S0166-0934(96)02164-7; Deng LP, 2015, PROTEIN CELL, V6, P157, DOI 10.1007/s13238-015-0137-5; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GRANOWITZ EV, 1995, MOL MED, V1, P667; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Joo KI, 2008, ACS NANO, V2, P1553, DOI 10.1021/nn8002136; Kerl K, 2013, AM J DERMATOPATH, V35, P151, DOI 10.1097/DAD.0b013e318265fd08; Liu DS, 2012, J AM CHEM SOC, V134, P792, DOI 10.1021/ja209325n; Ma YX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15318; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Nemudryi AA, 2014, ACTA NATURAE, V6, P19; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16                                              	17	0	0	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	DEC 5	2017	89	23					12896	12901		10.1021/acs.analchem.7b03584				6	Chemistry, Analytical	Chemistry	FP3WV	WOS:000417549600041	29120617				2018-01-05	
J	Dinges, N; Morin, V; Kreim, N; Southall, TD; Roignant, JY				Dinges, Nadja; Morin, Violeta; Kreim, Nastasja; Southall, Tony D.; Roignant, Jean-Yves			Comprehensive Characterization of the Complex lola Locus Reveals a Novel Role in the Octopaminergic Pathway via Tyramine Beta-Hydroxylase Regulation	CELL REPORTS			English	Article							AXON GUIDANCE GENE; NEURAL STEM-CELLS; DROSOPHILA-MELANOGASTER; LIFE-SPAN; PROTEIN; EXPRESSION; DOMAIN; DIFFERENTIATION; LOCOMOTION; DOPAMINE	Longitudinals lacking (lola) is one of the most complex genes in Drosophila melanogaster, encoding up to 20 protein isoforms that include key transcription factors involved in axonal pathfinding and neural reprogramming. Most previous studies have employed loss-of-function alleles that disrupt lola common exons, making it difficult to delineate isoform-specific functions. To overcome this issue, we have generated isoform-specific mutants for all isoforms using CRISPR/Cas9. This enabled us to study specific isoforms with respect to previously characterized roles for Lola and to demonstrate a specific function for one variant in axon guidance via activation of the microtubule-associated factor Futsch. Importantly, we also reveal a role for a second variant in preventing neurodegeneration via the positive regulation of a key enzyme of the octopaminergic pathway. Thus, our comprehensive study expands the functional repertoire of Lola functions, and it adds insights into the regulatory control of neurotransmitter expression in vivo.	[Dinges, Nadja; Morin, Violeta; Roignant, Jean-Yves] Inst Mol Biol, Lab RNA Epigenet, D-55128 Mainz, Germany; [Kreim, Nastasja] Inst Mol Biol, Bioinformat Core Facil, D-55128 Mainz, Germany; [Southall, Tony D.] Imperial Coll London, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England	Roignant, JY (reprint author), Inst Mol Biol, Lab RNA Epigenet, D-55128 Mainz, Germany.	j.roignant@imb-mainz.de			Deutsche Forschungsgemeinschaft (DFG) [SPP1935, RO 4681/4-1]	We would like to thank the Bloomington Drosophila Stock Center for fly reagents; the Developmental Studies Hybridoma Bank for antibodies; the Drosophila Genomics Resource Center for plasmids; M. Monastirioti for Tbh alleles and TBH antibody; E. Giniger for Lola antibody; C. Berger for Deadpan antibody; A. Brand for DamID constructs; members of the Roignant lab for fruitful discussion; the IMB Genomics, Cytometry, Bioinformatics and Microscopy Core facilities for tremendous support; and A. Dold, C. Berger, and J. Urban for critical reading of the manuscript. Research in the laboratory of J.-Y.R. is supported by the Deutsche Forschungsgemeinschaft (DFG) SPP1935 Grant RO 4681/4-1.	Ai FK, 2012, BIOL OPEN, V1, P362, DOI 10.1242/bio.2012448; Bahadorani S, 2008, NUTR RES, V28, P377, DOI 10.1016/j.nutres.2008.03.018; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barron AB, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00163; Bass BP, 2007, DEV BIOL, V304, P771, DOI 10.1016/j.ydbio.2007.01.029; Chen J, 2013, NEUROPHARMACOLOGY, V67, P25, DOI 10.1016/j.neuropharm.2012.10.013; Crowner D, 2002, DEVELOPMENT, V129, P1317; Davies EL, 2013, DEV BIOL, V373, P310, DOI 10.1016/j.ydbio.2012.11.004; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Gates MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-37; Giesen K, 1997, DEVELOPMENT, V124, P2307; GINIGER E, 1993, DEVELOPMENT, V117, P431; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Gruntenko NE, 2016, BIOL OPEN, V5, P1706, DOI 10.1242/bio.022038; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35359; Madden K, 1999, DEV BIOL, V213, P301, DOI 10.1006/dbio.1999.9399; Marshall OJ, 2016, NAT PROTOC, V11, P1586, DOI 10.1038/nprot.2016.084; Marshall OJ, 2015, BIOINFORMATICS, V31, P3371, DOI 10.1093/bioinformatics/btv386; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Monastirioti M, 1996, J NEUROSCI, V16, P3900; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; Ohsako T, 2003, GENE, V311, P59, DOI 10.1016/S0378-1119(03)00554-7; Peng QL, 2016, J NEUROSCI, V36, P4635, DOI 10.1523/JNEUROSCI.3726-15.2016; Salmand PA, 2011, FLY, V5, P261, DOI 10.4161/fly.5.3.16509; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Southall TD, 2014, DEV CELL, V28, P685, DOI 10.1016/j.devcel.2014.01.030; Southall TD, 2013, DEV CELL, V26, P101, DOI 10.1016/j.devcel.2013.05.020; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Spokony R., 2012, SPOKONY INSERTIONS; Stathakis DG, 1999, GENETICS, V153, P361; Tripathy R, 2014, DEV BIOL, V392, P193, DOI 10.1016/j.ydbio.2014.05.026; Wissel S, 2016, G3-GENES GENOM GENET, V6, P2467, DOI 10.1534/g3.116.028571; Zhang WG, 2003, J BIOL CHEM, V278, P11696, DOI 10.1074/jbc.M213269200; Zheng L, 2008, MECH DEVELOP, V125, P18, DOI 10.1016/j.mod.2007.10.007; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	45	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	DEC 5	2017	21	10					2911	2925		10.1016/j.celrep.2017.11.015				15	Cell Biology	Cell Biology	FO8OE	WOS:000417146000024	29212035	gold			2018-01-05	
J	Guo, M; Liu, Z; Willen, J; Shaw, CP; Richard, D; Jagoda, E; Doxey, AC; Hirschhorn, J; Capellini, TD				Guo, Micheal; Liu, Zun; Willen, Jessie; Shaw, Camerson P.; Richard, Daniel; Jagoda, Evelyn; Doxey, Andrea C.; Hirschhorn, Joel; Capellini, Ternce D.			Epigenetic profiling of growth plate chondrocytes sheds insight into regulatory genetic variation influencing height	ELIFE			English	Article							PROTEIN-DNA INTERACTIONS; GENOME-WIDE ASSOCIATION; PARTITIONING HERITABILITY; R/BIOCONDUCTOR PACKAGE; LIMB DEVELOPMENT; SYNTHASE 1; LOCI; VARIANTS; EXPRESSION; CELL	GWAS have identified hundreds of height-associated loci. However, determining causal mechanisms is challenging, especially since height-relevant tissues (e.g. growth plates) are difficult to study. To uncover mechanisms by which height GWAS variants function, we performed epigenetic profiling of murine femoral growth plates. The profiled open chromatin regions recapitulate known chondrocyte and skeletal biology, are enriched at height GWAS loci, particularly near differentially expressed growth plate genes, and enriched for binding motifs of transcription factors with roles in chondrocyte biology. At specific loci, our analyses identified compelling mechanisms for GWAS variants. For example, at CHSY1, we identified a candidate causal variant (rs9920291) overlapping an open chromatin region. Reporter assays demonstrated that rs9920291 shows allelic regulatory activity, and CRISPR/Cas9 targeting of human chondrocytes demonstrates that the region regulates CHSY1 expression. Thus, integrating biologically relevant epigenetic information (here, from growth plates) with genetic association results can identify biological mechanisms important for human growth.	[Guo, Micheal; Hirschhorn, Joel; Capellini, Ternce D.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Guo, Micheal; Hirschhorn, Joel] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Guo, Micheal; Hirschhorn, Joel] Harvard Med Sch, Dept Genet, Boston, MA USA; [Liu, Zun; Willen, Jessie; Shaw, Camerson P.; Richard, Daniel; Jagoda, Evelyn; Capellini, Ternce D.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Richard, Daniel; Doxey, Andrea C.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada	Capellini, TD (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Capellini, TD (reprint author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	tcapellini@fas.harvard.edu		Guo, Michael/0000-0002-1357-6389	National Science Foundation [BCS-1518596]; National Institutes of Health [R01 DK075787]	National Science Foundation BCS-1518596 Terence D Capellini; National Institutes of Health R01 DK075787 Joel Hirschhorn	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amano K, 2008, J BIOL CHEM, V283, P29513, DOI 10.1074/jbc.M803681200; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Buenrostro JD, 2015, CURR PROTOC MOL BIOL, V109, P21, DOI DOI 10.1002/0471142727.MB2129S109; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Caronia G, 2003, DEVELOPMENT, V130, P1701, DOI 10.1242/dev.00396; Chen H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006454; Coetzee SG, 2015, BIOINFORMATICS, V31, P3847, DOI 10.1093/bioinformatics/btv470; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Dauber A, 2014, J CLIN ENDOCR METAB, V99, P3080, DOI 10.1210/jc.2014-1506; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finger F, 2003, ARTHRITIS RHEUM, V48, P3395, DOI 10.1002/art.11341; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galton F., 1886, J ANTHR I, V15, P246, DOI DOI 10.2307/2841583; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Guenther CA, 2015, BONE, V77, P31, DOI 10.1016/j.bone.2015.04.010; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Herlofsen SR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-105; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Jerkovic I, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006567; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5                                                   ; Kinsella RJ, 2011, DATABASE, V2011, P30, DOI [10.1093/database/bar030, DOI 10.1093/DATABASE/BAR030]; Kokenyesi R, 2000, ARCH BIOCHEM BIOPHYS, V383, P79, DOI 10.1006/abbi.2000.2044                                                          ; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kuss P, 2014, DEV BIOL, V385, P83, DOI 10.1016/j.ydbio.2013.10.013; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Liu CF, 2017, SEMIN CELL DEV BIOL, V62, P34, DOI 10.1016/j.semcdb.2016.10.004; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lui JLC, 2012, HUM MOL GENET, V21, P5193, DOI 10.1093/hmg/dds347; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Petit F, 2017, NAT REV GENET, V18, P245, DOI 10.1038/nrg.2016.167; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reno PL, 2016, J EXP ZOOL PART B, V326, P303, DOI 10.1002/jez.b.22688; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Samsa WE, 2017, SEMIN CELL DEV BIOL, V62, P3, DOI 10.1016/j.semcdb.2016.07.008; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Temtamy SA, 1998, CLIN DYSMORPHOL, V7, P249, DOI 10.1097/00019605-199810000-00003                                                ; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	75	0	0	1	1	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	DEC 5	2017	6								e29329	10.7554/eLife.29329				28	Biology	Life Sciences & Biomedicine - Other Topics	FO8FZ	WOS:000417121600001		gold			2018-01-05	
J	Kulkarni, M; Soolanayakanahally, R; Ogawa, S; Uga, Y; Selvaraj, MG; Kagale, S				Kulkarni, Manoj; Soolanayakanahally, Raju; Ogawa, Satoshi; Uga, Yusaku; Selvaraj, Michael G.; Kagale, Sateesh			Drought Response in Wheat: Key Genes and Regulatory Mechanisms Controlling Root System Architecture and Transpiration Efficiency	FRONTIERS IN CHEMISTRY			English	Review						wheat; drought; root traits; transpiration efficiency; transcriptional regulation; EAR motif	TRITICUM-AESTIVUM L.; WATER-USE EFFICIENCY; ZINC-FINGER PROTEIN; WRKY TRANSCRIPTION FACTORS; EAR-MOTIF; ABIOTIC STRESS; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; DOMINANT REPRESSION; WIDE IDENTIFICATION	Abiotic stresses such as, drought, heat, salinity, and flooding threaten global food security. Crop genetic improvement with increased resilience to abiotic stresses is a critical component of crop breeding strategies. Wheat is an important cereal crop and a staple food source globally. Enhanced drought tolerance in wheat is critical for sustainable food production and global food security. Recent advances in drought tolerance research have uncovered many key genes and transcription regulators governing morpho-physiological traits. Genes controlling root architecture and stomatal development play an important role in soil moisture extraction and its retention, and therefore have been targets of molecular breeding strategies for improving drought tolerance. In this systematic review, we have summarized evidence of beneficial contributions of root and stomatal traits to plant adaptation to drought stress. Specifically, we discuss a few key genes such as, DRO1 in rice and ERECTA in Arabidopsis and rice that were identified to be the enhancers of drought tolerance via regulation of root traits and transpiration efficiency. Additionally, we highlight several transcription factor families, such as, ERF (ethylene response factors), DREB (dehydration responsive element binding), ZFP (zinc finger proteins), WRKY, and MYB that were identified to be both positive and negative regulators of drought responses in wheat, rice, maize, and/or Arabidopsis. The overall aim of this review is to provide an overview of candidate genes that have been identified as regulators of drought response in plants. The lack of a reference genome sequence for wheat and non-transgenic approaches for manipulation of gene functions in wheat in the past had impeded high-resolution interrogation of functional elements, including genes and QTLs, and their application in cultivar improvement. The recent developments in wheat genomics and reverse genetics, including the availability of a gold standard reference genome sequence and advent of genome editing technologies, are expected to aid in deciphering of the functional roles of genes and regulatory networks underlying adaptive phenological traits, and utilizing the outcomes of such studies in developing drought tolerant cultivars.	[Kulkarni, Manoj; Kagale, Sateesh] Natl Res Council Canada NRC CNRC, Canadian Wheat Improvement Flagship Program, Saskatoon, SK, Canada; [Soolanayakanahally, Raju] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Ogawa, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan; [Uga, Yusaku] Natl Agr & Food Res Org NARO, Inst Crop Sci NICS, Tsukuba, Ibaraki, Japan; [Selvaraj, Michael G.] Int Ctr Trop Agr CIAT, Agrobiovers Res Area, Cali, Colombia	Kagale, S (reprint author), Natl Res Council Canada NRC CNRC, Canadian Wheat Improvement Flagship Program, Saskatoon, SK, Canada.	Sateesh.Kagale@nrc-cnrc.gc.ca			National Research Council Canada through the Canadian Wheat Improvement Flagship; Agriculture and Agri-Food Canada	This work was supported by National Research Council Canada through the Canadian Wheat Improvement Flagship to SK, MK and from Agriculture and Agri-Food Canada to RS.	Ahmad I., 2017, WHEAT IMPROVEMENT MA, P39; Ajigboye OO, 2017, PESTIC BIOCHEM PHYS, V137, P49, DOI 10.1016/j.pestbp.2016.09.008; Amalraj A, 2016, PLANT BIOTECHNOL J, V14, P820, DOI 10.1111/pbi.12432; Arai-Sanoh Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05563; Araus JL, 1998, AUST J PLANT PHYSIOL, V25, P835, DOI 10.1071/PP98071                                                                 ; Ayalew H, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1914-4; Baloch MJ, 2013, INT J AGRIC BIOL, V15, P945; BHAGWAT SG, 1993, PLANT BREEDING, V110, P129; Bota J, 2004, NEW PHYTOL, V162, P671, DOI 10.1111/j.1469-8137.2004.01056.x; Chang HP, 2016, PLANT SCI, V252, P88, DOI 10.1016/j.plantsci.2016.07.011; Chen YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153494; Cheng LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0871-8; Cheuk A, 2016, MOL GENET GENOMICS, V291, P873, DOI 10.1007/s00438-015-1152-1; Chipilski RR, 2012, Z NATURFORSCH C, V67, P181, DOI 10.5560/ZNC.2012.67c0181; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Ding WW, 2016, PLANT MOL BIOL REP, V34, P1111, DOI 10.1007/s11105-016-0991-1; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Dong LD, 2015, J EXP BOT, V66, P2635, DOI 10.1093/jxb/erv078; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Gahlaut V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182857; Gahlaut V, 2016, THEOR APPL GENET, V129, P2019, DOI 10.1007/s00122-016-2794-z; Gupta PK, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010005; Guseman JM, 2017, PLANT J, V89, P1093, DOI 10.1111/tpj.13470; He GH, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0806-4; He YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157558; He YA, 2012, J EXP BOT, V63, P1511, DOI 10.1093/jxb/err389; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hichri I, 2014, PLANT PHYSIOL, V164, P1967, DOI 10.1104/pp.113.225920; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Huang J, 2012, PLANT MOL BIOL, V80, P337, DOI 10.1007/s11103-012-9955-5; Huang LinZhou, 2013, Australian Journal of Crop Science, V7, P381; Hura T, 2017, MOL GENET GENOMICS, V292, P415, DOI 10.1007/s00438-016-1276-y; Huseynova IM, 2012, BBA-BIOENERGETICS, V1817, P1516, DOI 10.1016/j.bbabio.2012.02.037; Iannucci A, 2017, INT J GENOMICS, DOI 10.1155/2017/6876393; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Jiang YW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00811; Joo J, 2013, PLANTA, V238, P155, DOI 10.1007/s00425-013-1880-6; Joshi R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01029; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kagale S, 2010, PLANT SIGNAL BEHAV, V5, P691, DOI [10.4161/psb.5.6.11576, 10.1104/pp.109.151704]; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Khazaei H, 2010, GENET RESOUR CROP EV, V57, P307, DOI 10.1007/s10722-009-9471-x; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Li B, 2016, J EXP BOT, V67, P4155, DOI 10.1093/jxb/erw193; Li H, 2017, MOL GENET GENOMICS, V292, P1091, DOI 10.1007/s00438-017-1330-4; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Lilley JM, 2011, FIELD CROP RES, V122, P118, DOI 10.1016/j.fcr.2011.03.010; Liu CX, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1827-7; Liu HP, 2017, FUNCT INTEGR GENOMIC, V17, P237, DOI 10.1007/s10142-016-0515-y; Liu Z., 2017, PLANT BIOTECHNOL J, DOI [10.1111/pbi.12822, DOI 10.1111/PBI.12822]; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Loutfy N, 2012, J PLANT RES, V125, P173, DOI 10.1007/s10265-011-0419-9; Lucas SJ, 2017, FUNCT INTEGR GENOMIC, V17, P667, DOI 10.1007/s10142-017-0563-y; LUDLOW MM, 1990, ADV AGRON, V43, P107, DOI 10.1016/S0065-2113(08)60477-0; Luo X, 2012, PLANTA, V235, P1141, DOI 10.1007/s00425-011-1563-0; Ma DY, 2016, J PLANT GROWTH REGUL, V35, P1, DOI 10.1007/s00344-015-9500-2; Ma HL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601217; Ma J, 2017, GENOME, V60, P1068, DOI 10.1139/gen-2017-0097; Ma J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00592; Manes Y, 2012, CROP SCI, V52, P1543, DOI 10.2135/cropsci2011.10.0574; Manickavelu A, 2012, DNA RES, V19, P165, DOI 10.1093/dnares/dss001; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Merchuk-Ovnat L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00703; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Mondal B, 2017, CURR SCI INDIA, V112, P1266, DOI 10.18520/cs/v112/i06/1266-1271; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Mwadzingeni L, 2016, J INTEGR AGR, V15, P935, DOI 10.1016/S2095-3119(15)61102-9; Nadia Khan, 2017, Journal of Agricultural Science (Toronto), V9, P42; Oh E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5140; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Ovenden B, 2017, G3-GENES GENOM GENET, V7, P2821, DOI 10.1534/g3.117.039842; Pan IC, 2010, PLANTA, V232, P1075, DOI 10.1007/s00425-010-1235-5; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Pask AJD, 2013, CROP SCI, V53, P2090, DOI 10.2135/cropsci2013.01.0011; Passioura J, 2006, AGR WATER MANAGE, V80, P176, DOI 10.1016/j.agwat.2005.07.012; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Pellegrineschi A, 2004, GENOME, V47, P493, DOI [10.1139/g03-140, 10.1139/G03-140]; Peremarti A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-125; Persak H, 2014, INT J MOL SCI, V15, P2517, DOI 10.3390/ijms15022517; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Qin YX, 2015, BIOCHEM BIOPH RES CO, V464, P428, DOI 10.1016/j.bbrc.2015.06.128; Qiu ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06518-z; Rauf M, 2007, AFR J BIOTECHNOL, V6, P971; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; Richards RA, 2006, AGR WATER MANAGE, V80, P197, DOI 10.1016/j.agwat.2005.07.013; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Saeed I., 2017, Australian Journal of Crop Science, V11, P248, DOI 10.21475/ajcs.17.11.03.pne252; Scarpeci TE, 2017, J EXP BOT, V68, P673, DOI 10.1093/jxb/erw429; Schoppach R, 2014, FUNCT PLANT BIOL, V41, P257, DOI 10.1071/FP13211; Shahinnia F, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0838-9; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; Sherif S, 2013, PLANT CELL REP, V32, P1111, DOI 10.1007/s00299-013-1405-6; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Soriano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178290; Sylvester-Bradley R., 1990, PHYSL PRODUCTION IMP; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Trujillo Luis E, 2009, Biotecnol Apl, V26, P168; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Upadhyay RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101995; Upadhyay RK, 2013, J EXP BOT, V64, P3237, DOI 10.1093/jxb/ert162; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073985, 10.1371/journal.pone.0055587]; Wang F, 2015, PLANT J, V83, P224, DOI 10.1111/tpj.12879; Wang XT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00615; Wu J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01398; Xu WF, 2013, NEW PHYTOL, V197, P139, DOI 10.1111/nph.12004; Xu YF, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0583-7; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P590, DOI 10.1111/j.1365-3040.2009.02064.x; Yokota A, 2002, ANN BOT-LONDON, V89, P825, DOI [10.1093/aob/mcf074, 10.1093/aob.mcf074]; Yoo CY, 2010, PLANT CELL, V22, P4128, DOI 10.1105/tpc.110.078691; Zampieri M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa723b; Zhai Y, 2013, BIOL PLANTARUM, V57, P26, DOI 10.1007/s10535-012-0146-7; Zhang HW, 2013, PLANTA, V237, P1443, DOI 10.1007/s00425-013-1852-x; Zhang H, 2014, J EXP BOT, V65, P5795, DOI 10.1093/jxb/eru313; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151; Zheng JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128415; Zhou JX, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0134-x; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7	129	0	0	6	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2296-2646			FRONT CHEM	Front. Chem.	DEC 5	2017	5								106	10.3389/fchem.2017.00106				13	Chemistry, Multidisciplinary	Chemistry	FO7JM	WOS:000417049900001	29259968	gold			2018-01-05	
J	Li, M; Bui, M; Yang, T; Bowman, CS; White, BJ; Akbari, OS				Li, Ming; Bui, Michelle; Yang, Ting; Bowman, Christian S.; White, Bradley J.; Akbari, Omar S.			Germline Cas9 expression yields highly efficient genome engineering in a major worldwide disease vector, Aedes aegypti	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Aedes aegypti; germline; cas9; CRISPR; mutagenesis	YELLOW-FEVER MOSQUITO; DROSOPHILA-MELANOGASTER; GENE DRIVE; CRISPR/CAS9 SYSTEM; ARBOVIRUS VECTOR; ELEMENT VECTOR; VESTIGIAL GENE; SINE OCULIS; CRISPR-CAS9; EVOLUTION	The development of CRISPR/Cas9 technologies has dramatically increased the accessibility and efficiency of genome editing in many organisms. In general, in vivo germline expression of Cas9 results in substantially higher activity than embryonic injection. However, no transgenic lines expressing Cas9 have been developed for the major mosquito disease vector Aedes aegypti. Here, we describe the generation of multiple stable, transgenic Ae. aegypti strains expressing Cas9 in the germline, resulting in dramatic improvements in both the consistency and efficiency of genome modifications using CRISPR. Using these strains, we disrupted numerous genes important for normal morphological development, and even generated triple mutants from a single injection. We have also managed to increase the rates of homology-directed repair by more than an order of magnitude. Given the exceptional mutagenic efficiency and specificity of the Cas9 strains we engineered, they can be used for high-throughput reverse genetic screens to help functionally annotate the Ae. aegypti genome. Additionally, these strains represent a step toward the development of novel population control technologies targeting Ae. aegypti that rely on Cas9-based gene drives.	[Li, Ming; Bui, Michelle; Yang, Ting; Bowman, Christian S.; White, Bradley J.; Akbari, Omar S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Li, Ming; Bui, Michelle; Yang, Ting; Bowman, Christian S.; White, Bradley J.; Akbari, Omar S.] Univ Calif Riverside, Inst Integrat Genome Biol, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Li, Ming; Bui, Michelle; Yang, Ting; Akbari, Omar S.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [White, Bradley J.] Verily Life Sci, San Francisco, CA 94080 USA	Akbari, OS (reprint author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Akbari, OS (reprint author), Univ Calif Riverside, Inst Integrat Genome Biol, Ctr Dis Vector Res, Riverside, CA 92521 USA.; Akbari, OS (reprint author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	oakbari@ucsd.edu			US NIH K22 Grant [5K22AI113060]; NIH R21 Grant [1R21AI123937, 1R21AI115271]; Defense Advanced Research Project Agency Safe Genes Program [HR0011-17-2-0047]	We thank Robert Harrell for providing the pBac-3xP3dsRed and phsp-Pbac plasmids; Kate M. O'Connor-Giles for providing the p3xP3-EGFP/vasa-3xFLAG-NLS-Cas9-NLS plasmid and sequence; Alexander Knyshov for assisting with SEM imaging; and Anthony A. James for reading over the manuscript and providing insightful comments and edits. This work was supported by a private donation from https://www.maxmind.com/(to O.S.A.); US NIH K22 Grant 5K22AI113060 (to O.S.A.); NIH R21 Grant 1R21AI123937 (to O.S.A.); NIH R21 Grant 1R21AI115271 (to B.J.W.); and Defense Advanced Research Project Agency Safe Genes Program Grant HR0011-17-2-0047 (to O.S.A.).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Akbari OS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03954; Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742; Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x; Aryan A, 2014, METHODS, V69, P38, DOI 10.1016/j.ymeth.2014.02.008; Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082; Aryan A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01603; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; BIESSMANN H, 1985, P NATL ACAD SCI USA, V82, P7369, DOI 10.1073/pnas.82.21.7369; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5                                                    ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COSENS D, 1972, J INSECT PHYSIOL, V18, P627, DOI 10.1016/0022-1910(72)90190-4; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Franz Alexander W E, 2014, Curr Trop Med Rep, V1, P21; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Huang AM, 2009, COLD SPRING HARB PRO, V2009; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jusiak B, 2014, GENOM DATA, V2, P153, DOI 10.1016/j.gdata.2014.06.016; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0                                                                ; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Klein T, 1999, DEVELOPMENT, V126, P913; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947                                                          ; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Li M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00990-3; Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486; Lobo NF, 2002, INSECT MOL BIOL, V11, P133, DOI 10.1046/j.1365-2583.2002.00317.x; Ma S, 2014, SCI REP, V4, P4489; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; MERRILL VKL, 1987, DEV BIOL, V122, P379, DOI 10.1016/0012-1606(87)90303-4                                                    ; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ren LZ, 2011, AFR J BIOTECHNOL, V10, P8930; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sebo ZL, 2014, FLY, V8, P52, DOI 10.4161/fly.26828; Sharma A, 2017, SCIENCE, V356, P642, DOI 10.1126/science.aam5498; Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101210; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang Y, 2016, P NATL ACAD SCI USA, V113, pE4828, DOI 10.1073/pnas.1609792113	78	0	0	4	4	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 5	2017	114	49					E10540	E10549		10.1073/pnas.1711538114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FP0ZS	WOS:000417339700008	29138316				2018-01-05	
J	Gilbert, RA; Kelly, WJ; Altermann, E; Leahy, SC; Minchin, C; Ouwerkerk, D; Klieve, AV				Gilbert, Rosalind A.; Kelly, William J.; Altermann, Eric; Leahy, Sinead C.; Minchin, Catherine; Ouwerkerk, Diane; Klieve, Athol V.			Toward Understanding Phage: Host Interactions in the Rumen; Complete Genome Sequences of Lytic Phages Infecting Rumen Bacteria	FRONTIERS IN MICROBIOLOGY			English	Article						bacteriophage; phage; rumen; Streptococcus; Bacteroides; Ruminococcus; Siphoviridae; Podoviridae	RUMINOCOCCUS-ALBUS AR67; CRISPR-CAS SYSTEMS; STREPTOCOCCUS-BOVIS; BACTEROIDES-FRAGILIS; TRANSFER-RNA; BACTERIOPHAGES; ANNOTATION; RESTRICTION; DIVERSITY; EVOLUTION	The rumen is known to harbor dense populations of bacteriophages (phages) predicted to be capable of infecting a diverse range of rumen bacteria. While bacterial genome sequencing projects are revealing the presence of phages which can integrate their DNA into the genome of their host to form stable, lysogenic associations, little is known of the genetics of phages which utilize lytic replication. These phages infect and replicate within the host, culminating in host lysis, and the release of progeny phage particles. While lytic phages for rumen bacteria have been previously isolated, their genomes have remained largely uncharacterized. Here we report the first complete genome sequences of lytic phage isolates specifically infecting three genera of rumen bacteria: Bacteroides, Ruminococcus, and Streptococcus. All phages were classified within the viral order Caudovirales and include two phage morphotypes, representative of the Siphoviridae and Podoviridae families. The phage genomes displayed modular organization and conserved viral genes were identified which enabled further classification and determination of closest phage relatives. Co-examination of bacterial host genomes led to the identification of several genes responsible for modulating phage: host interactions, including CRISPR/Cas elements and restriction-modification phage defense systems. These findings provide new genetic information and insights into how lytic phages may interact with bacteria of the rumen microbiome.	[Gilbert, Rosalind A.; Minchin, Catherine; Ouwerkerk, Diane] EcoSci Precinct, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Gilbert, Rosalind A.; Ouwerkerk, Diane; Klieve, Athol V.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Kelly, William J.] Donvis Ltd, Palmerston North, New Zealand; [Altermann, Eric; Leahy, Sinead C.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [Altermann, Eric] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Leahy, Sinead C.] New Zealand Agr Greenhouse Gas Res Ctr, Palmerston North, New Zealand; [Klieve, Athol V.] Univ Queensland, Sch Agr & Food Sci, Gatton Campus, Gatton, Qld, Australia	Gilbert, RA (reprint author), EcoSci Precinct, Dept Agr & Fisheries, Brisbane, Qld, Australia.; Gilbert, RA (reprint author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	ros.gilbert@daf.qld.gov.au			New Zealand Government; US Department of Energy Joint Genome Institute (JGI), a DOE Office of Science User Facility through their Community Science Program [DE-AC02-05CH11231, CSP 612]; Office of Science of the US Department of Energy	The Hungate1000 project was funded by the New Zealand Government in support of the Livestock Research Group of the Global Research Alliance on Agricultural Greenhouse Gases (http://www.globalresearchalliance.org) and was a global effort by members of the Rumen Microbial Genomics Network (http://www.rmgnetwork.org). The genome sequencing and analysis component of the project was supported by the US Department of Energy Joint Genome Institute (JGI), a DOE Office of Science User Facility supported under Contract No. DE-AC02-05CH11231, through their Community Science Program (CSP 612), and used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the US Department of Energy.	Ackermann H. W., 1987, GEN PROPERTIES BACTE; ADAMS JC, 1966, EXPERIENTIA, V22, P717, DOI 10.1007/BF01901335; Altermann E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00346; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Barrangou R, 2013, WIRES RNA, V4, P267, DOI 10.1002/wrna.1159; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Blow MJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005854; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Eichorst SA, 2007, APPL ENVIRON MICROB, V73, P2708, DOI 10.1128/AEM.02140-06; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; GARVEY KJ, 1985, GENE, V40, P311, DOI 10.1016/0378-1119(85)90054-X; Gascon I, 2000, NUCLEIC ACIDS RES, V28, P2034, DOI 10.1093/nar/28.10.2034; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Gilbert R. A., 2015, RUMEN MICROBIOLOGY E, P121; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Hargreaves KR, 2015, VIRUSES-BASEL, V7, P2534, DOI 10.3390/v7052534; Harris R.S., 2007, THESIS; HUNGATE RE, 1964, ANNU REV MICROBIOL, V18, P131, DOI 10.1146/annurev.mi.18.100164.001023; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iranzo J, 2016, MBIO, V7, DOI 10.1128/mBio.00978-16; IVERSON WG, 1976, CAN J MICROBIOL, V22, P853, DOI 10.1139/m76-123                                                                 ; IVERSON WG, 1976, CAN J MICROBIOL, V22, P847, DOI 10.1139/m76-122                                                                 ; Jans C, 2015, INFECT GENET EVOL, V33, P419, DOI 10.1016/j.meegid.2014.09.017; Jans C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-200; Kang I, 2016, MAR GENOM, V29, P35, DOI 10.1016/j.margen.2016.07.001; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klieve A. V., 2005, METHODS GUT MICROBIA, P129; Klieve A. V., 2005, METHODS GUT MICROBIA, P39; Klieve AV, 2006, LETT APPL MICROBIOL, V42, P654; KLIEVE AV, 1991, FEMS MICROBIOL LETT, V80, P155; Klieve AV, 1999, LETT APPL MICROBIOL, V29, P108, DOI 10.1046/j.1365-2672.1999.00596.x; KLIEVE AV, 1989, APPL ENVIRON MICROB, V55, P1630; Klieve AV, 2004, LETT APPL MICROBIOL, V38, P333, DOI 10.1111/j.1472-765X.2004.01493.x; KLIEVE AV, 1993, APPL ENVIRON MICROB, V59, P2299; KLIEVE AV, 1988, APPL ENVIRON MICROB, V54, P1637; KLIEVE AV, 1991, CURR MICROBIOL, V23, P183, DOI 10.1007/BF02092277; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mcshan WM, 1997, MOL MICROBIOL, V23, P719, DOI 10.1046/j.1365-2958.1997.2591616.x; McTaggart T. L., 2015, GEN ANNOUNC, V3, DOI [10.1128/genomeA.01597-14, DOI 10.1128/GENOMEA.01597-14]; Meijer WJJ, 2001, MOL MICROBIOL, V39, P731, DOI 10.1046/j.1365-2958.2001.02260.x; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Ogilvie LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035053; Ohara H, 1998, PLASMID, V39, P84, DOI 10.1006/plas.1997.1324; PAYNTER MJB, 1969, APPL MICROBIOL, V18, P942; Pedruzzi I, 2015, NUCLEIC ACIDS RES, V43, pD1064, DOI 10.1093/nar/gku1002; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Puig A, 1999, APPL ENVIRON MICROB, V65, P1772; Puig M, 1999, MICROBIOL-UK, V145, P1661, DOI 10.1099/13500872-145-7-1661                                                     ; Redondo R. A., 2013, GENOME ANNOUNC, V1, DOI 10.1128/genomeA.00216-13; Rice P. M., 2011, EMBOSS USERS GUIDE P; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Ross EM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-242; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seet S. G. M., 2005, THESIS; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; STYRIAK I, 1994, CURR MICROBIOL, V28, P355, DOI 10.1007/BF01570201; TARAKANOV BV, 1976, MICROBIOLOGY+, V45, P606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Volozhantsev NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038283; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851                                           ; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; ZABRISKIE JB, 1964, J EXP MED, V119, P761, DOI 10.1084/jem.119.5.761; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	78	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	DEC 5	2017	8								2340	10.3389/fmicb.2017.02340				17	Microbiology	Microbiology	FO7HP	WOS:000417044800001	29259581	gold			2018-01-05	
J	de Vries, ARG; de Groot, PA; van den Broek, M; Daran, JMG				de Vries, Arthur R. Gorter; de Groot, Philip A.; van den Broek, Marcel; Daran, Jean-Marc G.			CRISPR-Cas9 mediated gene deletions in lager yeast Saccharomyces pastorianus	MICROBIAL CELL FACTORIES			English	Article						Saccharomyces pastorianus; Brewing; CRISPR-Cas9; Genome editing; Ribozymes	RNA-POLYMERASE-III; BREWING YEAST; HOMOLOGOUS RECOMBINATION; GENOME SEQUENCE; CAS SYSTEMS; IN-VITRO; CEREVISIAE; MUTAGENESIS; STRAINS; KU	Background: The ease of use of CRISPR-Cas9 reprogramming, its high efficacy, and its multiplexing capabilities have brought this technology at the forefront of genome editing techniques. Saccharomyces pastorianus is an aneuploid interspecific hybrid of Saccharomyces cerevisiae and Saccharomyces eubayanus that has been domesticated for centuries and is used for the industrial fermentation of lager beer. For yet uncharacterised reasons, this hybrid yeast is far more resilient to genetic alteration than its ancestor S. cerevisiae. Results: This study reports a new CRISPR-Cas9 method for accurate gene deletion in S. pastorianus. This method combined the Streptococcus pyogenes cas9 gene expressed from either a chromosomal locus or from a mobile genetic element in combination with a plasmid-borne gRNA expression cassette. While the well-established gRNA expression system using the RNA polymerase III dependent SNR52 promoter failed, expression of a gRNA flanked with Hammerhead and Hepatitis Delta Virus ribozymes using the RNA polymerase II dependent TDH3 promoter successfully led to accurate deletion of all four alleles of the SeILV6 gene in strain CBS1483. Furthermore the expression of two ribozyme-flanked gRNAs separated by a 10-bp linker in a polycistronic array successfully led to the simultaneous deletion of SeATF1 and SeATF2, genes located on two separate chromosomes. The expression of this array resulted in the precise deletion of all five and four alleles mediated by homologous recombination in the strains CBS1483 and Weihenstephan 34/70 respectively, demonstrating the multiplexing abilities of this gRNA expression design. Conclusions: These results firmly established that CRISPR-Cas9 significantly facilitates and accelerates genome editing in S. pastorianus.	[de Vries, Arthur R. Gorter; de Groot, Philip A.; van den Broek, Marcel; Daran, Jean-Marc G.] Delft Univ Technol, Dept Biotechnol, Van der Maasweg 9, NL-2629 HZ Delft, Netherlands	Daran, JMG (reprint author), Delft Univ Technol, Dept Biotechnol, Van der Maasweg 9, NL-2629 HZ Delft, Netherlands.	J.G.Daran@tudelft.nl		Daran, Jean-Marc/0000-0003-3136-8193	Dutch Ministry of Economic Affairs, Agriculture and Innovation (ELI)	This work was performed within the BE-Basic R&D Program (http://www.be-basic.org/), which was granted an FES subsidy from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (EL&I).	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; Bolat I, 2013, FEMS YEAST RES, V13, P505, DOI 10.1111/1567-1364.12051; Bolat IC, 2008, ROM BIOTECH LETT, V13, P62; BOLLAG RJ, 1989, ANNU REV GENET, V23, P199, DOI 10.1146/annurev.ge.23.120189.001215; Boulton SJ, 1996, EMBO J, V15, P5093; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Kok S, 2014, ACS SYNTH BIOL, V3, P97, DOI 10.1021/sb4001992; de Vries ARG, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03206-16; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Duong CT, 2011, METAB ENG, V13, P638, DOI 10.1016/j.ymben.2011.07.005; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; Gibson B, 2015, YEAST, V32, P17, DOI 10.1002/yea.3033; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Guffanti E, 2006, J BIOL CHEM, V281, P23945, DOI 10.1074/jbc.M513814200; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466                                                            ; Hewitt SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092203; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Kuijpers NGA, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-47; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0                                                   ; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liachko I, 2014, FEMS YEAST RES, V14, P364, DOI 10.1111/1567-1364.12123; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Murakami N, 2012, YEAST, V29, P155, DOI 10.1002/yea.2897; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Nijkamp JF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-36; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Okuno M, 2016, DNA RES, V23, P67, DOI 10.1093/dnares/dsv037; Piatkowska EM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003836; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Ryan OW, 2014, METHOD ENZYMOL, V546, P473, DOI 10.1016/B978-0-12-801185-0.00023-4; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Solis-Escalante D, 2013, FEMS YEAST RES, V13, P126, DOI 10.1111/1567-1364.12024; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B; Turowski TW, 2016, BIOCHEM SOC T, V44, P1367, DOI 10.1042/BST20160062; van den Broek M, 2015, APPL ENVIRON MICROB, V81, P6253, DOI 10.1128/AEM.01263-15; Varzakas TH, 2007, CRIT REV FOOD SCI, V47, P335, DOI 10.1080/10408390600762696; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Walther A, 2014, G3-GENES GENOM GENET, V4, P783, DOI 10.1534/g3.113.010090; Wartmann T, 2003, YEAST, V20, pS326; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Weninger A, 2016, J BIOTECHNOL, V235, P139, DOI 10.1016/j.jbiotec.2016.03.027; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315	69	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	DEC 5	2017	16								222	10.1186/s12934-017-0835-1				18	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FO7OL	WOS:000417065600002	29207996	gold			2018-01-05	
J	Musunuru, K				Musunuru, Kiran			Genome Editing The Recent History and Perspective in Cardiovascular Diseases	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY			English	Review						CRISPR; Cas9; gene therapy; genetics; genomics	PLURIPOTENT STEM-CELL; OF-FUNCTION MUTATIONS; GUIDED CAS9 NUCLEASES; IN-VIVO; MAMMALIAN-CELLS; MOUSE MODEL; CRISPR-CAS9 NUCLEASES; MUSCULAR-DYSTROPHY; ENDOGENOUS GENES; DNA CLEAVAGE	The genome-editing field has advanced to a remarkable degree in the last 5 years, culminating in the successful correction of a cardiomyopathy gene mutation in viable human embryos. In this review, the author discusses the basic principles of genome editing, recent advances in clustered regularly interspaced short palindromic repeats and clustered regularly interspaced short palindromic repeats-associated 9 technology, the impact on cardiovascular basic science research, possible therapeutic applications in patients with cardiovascular diseases, and finally the implications of potential clinical uses of human germline genome editing. (C) 2017 by the American College of Cardiology Foundation.	[Musunuru, Kiran] Univ Penn, Dept Med, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res 11 104, 3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com			National Institutes of Health [R01-HL118744, R01-GM104464, R01-DK099571, R01-HL126875]; American Heart Association	This work was partially supported by National Institutes of Health grants R01-HL118744, R01-GM104464, R01-DK099571, and R01-HL126875, and the American Heart Association. Dr. Musunuru has reported that he has no relationships relevant to the contents of this paper to disclose.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033; Bi X, 2017, EBIOMEDICINE, V18, P139, DOI 10.1016/j.ebiom.2017.03.018; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bibikova M, 2002, GENETICS, V161, P1169; Bongianino R, 2017, CIRC RES, V121, DOI 10.1161/CIRCRESAHA.117.310882; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/NMETH.4284, 10.1038/nmeth.4284]; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Chen YH, 2016, MOL THER, V24, P1508, DOI 10.1038/mt.2016.172; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329; Gu MX, 2017, CELL STEM CELL, V20, P490, DOI 10.1016/j.stem.2016.08.019; Guo YX, 2017, CIRC RES, V120, P1874, DOI 10.1161/CIRCRESAHA.116.310283; Gupta RM, 2016, ARTERIOSCL THROM VAS, V36, P15, DOI 10.1161/ATVBAHA.115.305956; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jarrett KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44624; Jiang JM, 2013, SCIENCE, V342, P111, DOI 10.1126/science.1236921; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Johansen AK, 2017, CIRC RES, V121, P1168, DOI 10.1161/CIRCRESAHA.116.310370; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Karakikes I, 2017, CIRC RES, V120, P1561, DOI 10.1161/CIRCRESAHA.116.309948; Karakikes I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7955; Kim D, 2015, NAT METHODS, V12; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kodo K, 2016, NAT CELL BIOL, V18, P1031, DOI 10.1038/ncb3411; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Liang P, 2016, J AM COLL CARDIOL, V68, P2086, DOI 10.1016/j.jacc.2016.07.779; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu Y, 2017, CELL REP, V19, P1456, DOI 10.1016/j.celrep.2017.04.064; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miano JM, 2016, ARTERIOSCL THROM VAS, V36, P1058, DOI 10.1161/ATVBAHA.116.304790; Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840; Musunuru K, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001910; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; National Academies of Sciences Engineering and Medicine, 2017, HUM GEN ED SCI ETH G; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ormond KE, 2017, AM J HUM GENET, V101, P167, DOI 10.1016/j.ajhg.2017.06.012; Pashos EE, 2017, CELL STEM CELL, V20, P558, DOI 10.1016/j.stem.2017.03.017; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pew Research Center, 2016, US PUBL WAR BIOM TEC; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI 10.1056/NEJMoa1615664; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Scheufele DA, 2017, SCIENCE, V357, P553, DOI 10.1126/science.aan3708; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Strong A, 2017, NAT REV CARDIOL, V14, P11, DOI 10.1038/nrcardio.2016.139; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Umeyama K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24413; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zhang M, 2014, P NATL ACAD SCI USA, V111, pE5383, DOI 10.1073/pnas.1419553111; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488                                                                  ; Zou J, 2015, ELIFE, V4, DOI 10.7554/eLife.09406	116	0	0	8	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0735-1097	1558-3597		J AM COLL CARDIOL	J. Am. Coll. Cardiol.	DEC 5	2017	70	22					2808	2821		10.1016/j.jacc.2017.10.002				14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	FN9KG	WOS:000416353200011	29191331				2018-01-05	
J	Bao, LY; Hannon, C; Cruz-Mignoni, A; Ptchelkine, D; Sun, MY; Miller, A; Bunjobpol, W; Quevedo, CE; Derveni, M; Chambers, J; Simmons, A; Phillips, SEV; Rabbitts, TH				Bao, Leyuan; Hannon, Clare; Cruz-Mignoni, Abimael; Ptchelkine, Denis; Sun, Mei-yi; Miller, Ami; Bunjobpol, Wilawan; Quevedo, Camilo E.; Derveni, Mariliza; Chambers, Jennifer; Simmons, Alison; Phillips, Simon E. V.; Rabbitts, Terence H.			Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein	SCIENTIFIC REPORTS			English	Article							GENE-THERAPY; HUMAN-CELLS; INHIBITORS; DELIVERY; REPLICATION; SELECTION; DOMAIN; DISCOVERY; FEATURES; CAPTURE	Preventing the protein-protein interaction of the cellular chromatin binding protein Lens Epithelium-Derived Growth Factor ( LEDGF) and human immunodeficiency virus (HIV) integrase is an important possible strategy for anti-viral treatment for AIDS. We have used Intracellular Antibody Capture technology to isolate a single VH antibody domain that binds to LEDGF. The crystal structure of the LEDGF-VH complex reveals that the single domain antibody mimics the effect of binding of HIV integrase to LEDGF which is crucial for HIV propagation. CD4-expressing T cell lines were constructed to constitutively express the LEDGF-binding VH and these cells showed interference with HIV viral replication, assayed by virus capsid protein p24 production. Therefore, pre-conditioning cells to express antibody fragments confers effective intracellular immunization for preventing chronic viral replication and can be a way to prevent HIV spread in infected patients. This raises the prospect that intracellular immunization strategies that focus on cellular components of viral integrase protein interactions can be used to combat the problems associated with latent HIV virus re-emergence in patients. New genome editing development, such as using CRISPR/cas9, offer the prospect intracellularly immunized T cells in HIV+ patients.	[Cruz-Mignoni, Abimael; Miller, Ami; Bunjobpol, Wilawan; Quevedo, Camilo E.; Derveni, Mariliza; Chambers, Jennifer; Rabbitts, Terence H.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Hannon, Clare] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0SP, England; [Cruz-Mignoni, Abimael; Ptchelkine, Denis; Phillips, Simon E. V.] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Bao, Leyuan; Sun, Mei-yi; Simmons, Alison] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Phillips, Simon E. V.] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England	Rabbitts, TH (reprint author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Mol Haematol Unit, Oxford OX3 9DS, England.	terence.rabbitts@imm.ox.ac.uk			Medical Research Council [MR/J000612/1]; Bloodwise [12051]; Wellcome Trust [099246/Z/12/Z]	This work was supported by grants from the Medical Research Council (MR/J000612/1), Bloodwise (12051) and Wellcome Trust (099246/Z/12/Z). We would like to thank Dr. Steve Carr and Dr. Ray Owens (OPPF) for the useful suggestions of protein crystallization and structure determination. We would also like to thank Dr Fusinita van den Ent for the HIV integrase clone.	BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0                                                                ; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506921402; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2015, FUTURE MED CHEM, V7, P2407, DOI 10.4155/fmc.15.162; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Dawei Zhang, 2016, Sci Rep, V6, P33477, DOI 10.1038/srep33477; Demeulemeester J, 2014, EXPERT OPIN THER PAT, V24, P609, DOI 10.1517/13543776.2014.898753; Desimmie BA, 2012, MOL THER, V20, P2064, DOI 10.1038/mt.2012.132; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Higueruelo AP, 2013, CURR OPIN PHARMACOL, V13, P791, DOI 10.1016/j.coph.2013.05.009; Huang J, 2012, NATURE, V482, P542, DOI 10.1038/nature10806; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Lobato MN, 2004, CURR MOL MED, V4, P519, DOI 10.2174/1566524043360384; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Marschall ALJ, 2014, MABS-AUSTIN, V6, P943, DOI 10.4161/mabs.29268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MM, 2015, INFECT DRUG RESIST, V8, P19, DOI 10.2147/IDR.S58706; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255                                                       ; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rondon IJ, 1997, ANNU REV MICROBIOL, V51, P257, DOI 10.1146/annurev.micro.51.1.257                                                  ; Schaecher KL, 2013, AM J MANAG CARE, V19, pS231; Serrao E, 2013, J MED CHEM, V56, P2311, DOI 10.1021/jm301632e; Sewell H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03643; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Tanaka T, 2010, NAT PROTOC, V5, P67, DOI 10.1038/nprot.2009.199; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723                                                        ; Wainberg MA, 2011, NATURE, V469, P306, DOI 10.1038/469306a; Wang M, 2017, GENE THER, V24, P144, DOI 10.1038/gt.2016.72; Yin H, 2017, NAT REV DRUG DISCOV, V16, P387, DOI 10.1038/nrd.2016.280; Zeng J, 2015, J IMMUNOL METHODS, V426, P140, DOI 10.1016/j.jim.2015.08.009	43	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 4	2017	7								16869	10.1038/s41598-017-16742-2				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FO7BK	WOS:000417025400050	29203900	gold			2018-01-05	
J	Spencer, JM; Zhang, XL				Spencer, Jeffrey M.; Zhang, Xiaoliu			Deep mutational scanning of S-pyogenes Cas9 reveals important functional domains	SCIENTIFIC REPORTS			English	Article							CRISPR-CAS9 NUCLEASES; DNA CLEAVAGE; TARGET DNA; RNA; SYSTEMS; SPECIFICITY; ENDONUCLEASE; CONSTRUCTION; MUTAGENESIS; COMPLEX	RNA-guided endonucleases (RGENs) have invigorated the field of site-specific nucleases. The success of Streptococcus pyogenes Cas9 (SpCas9) has led to the discovery of several other CRISPR-associated RGENs. As more RGENs become available, it will be necessary to refine their activity before they can be translated into the clinic. With this in mind, we sought to demonstrate how deep mutational scanning (DMS) could provide details about important functional regions in SpCas9 and speed engineering efforts. Consequently, we developed a nuclease screening platform which could distinguish active Cas9 mutants. We screened a library of 1.9 x 10 (7) with over 8500 possible non-synonymous mutations and inferred the effects of each mutation using DMS. We demonstrate that the RuvC and HNH domains are the least tolerant regions to mutation. In contrast, the Rec2 and PI domains tolerate mutation better than other regions. The mutation information defined in this work provides a foundation for further SpCas9 engineering. Together, our results demonstrate how DMS can be a powerful tool to uncover features important to RGEN function. Application of this approach to emerging RGENs should enhance their engineering and optimization for therapeutic and other applications.	[Spencer, Jeffrey M.; Zhang, Xiaoliu] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Spencer, Jeffrey M.; Zhang, Xiaoliu] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA	Zhang, XL (reprint author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.; Zhang, XL (reprint author), Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA.	xzhang5@central.uh.edu			National Institutes of Health [1R01CA187923]; William and Ella Owens Medical Research Foundation [58618]	We thank Dr. Doug Fowler (University of Washington) and Dr. Jesse Bloom (Fred Hutch) for helpful discussions about deep sequencing experimental design. Additionally, we thank Dr. Kevin MacKenzie (Baylor College of Medicine), Dr. Erin Kelleher (University of Houston), and Jason Atkins for other useful discussions. Finally, we thank Jason Atkins and Sandi Wilkenfeld for critical reading of the manuscript. This work was supported by the National Institutes of Health [1R01CA187923 to X.Z.]; and William and Ella Owens Medical Research Foundation [58618 to X.Z.]. Funding for open access charge: National Institutes of Health.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bloom JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0590-4; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chari R, 2017, ACS SYNTH BIOL, V6, P902, DOI 10.1021/acssynbio.6b00343; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen FQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14958; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Doud MB, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060155; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/nmeth.3223, 10.1038/NMETH.3223]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; MacBeath G, 1998, BIOTECHNIQUES, V24, P789; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rose JC, 2017, NAT METHODS, V14, P891, DOI [10.1038/NMETH.4368, 10.1038/nmeth.4368]; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Warren DJ, 2011, ANAL BIOCHEM, V413, P206, DOI 10.1016/j.ab.2011.02.036; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Xue HY, 2016, GENE THER, V23, P557, DOI 10.1038/gt.2016.25; You C, 2014, METHODS MOL BIOL, V1116, P183, DOI 10.1007/978-1-62703-764-8_13; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	42	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 4	2017	7								16836	10.1038/s41598-017-17081-y				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FO7BK	WOS:000417025400017	29203891	gold			2018-01-05	
J	Walton, JB; Farquharson, M; Mason, S; Port, J; Kruspig, B; Dowson, S; Stevenson, D; Murphy, D; Matzuk, M; Kim, J; Coffelt, S; Blyth, K; McNeish, IA				Walton, Josephine B.; Farquharson, Malcolm; Mason, Susan; Port, Jennifer; Kruspig, Bjorn; Dowson, Suzanne; Stevenson, David; Murphy, Daniel; Matzuk, Martin; Kim, Jaeyeon; Coffelt, Seth; Blyth, Karen; McNeish, Iain A.			CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity	SCIENTIFIC REPORTS			English	Article							FALLOPIAN-TUBE; MOUSE MODEL; CANCER; TUMOR; INHIBITORS; MUTATIONS; SURVIVAL; ASSAY	Transplantable murine models of ovarian high grade serous carcinoma (HGSC) remain an important research tool. We previously showed that ID8, a widely-used syngeneic model of ovarian cancer, lacked any of the frequent mutations in HGSC, and used CRISPR/Cas9 gene editing to generate derivatives with deletions in Trp53 and Brca2. Here we have used one ID8 Trp53(-/-) clone to generate further mutants, with additional mutations in Brca1, Pten and Nf1, all of which are frequently mutated or deleted in HGSC. We have also generated clones with triple deletions in Trp53, Brca2 and Pten. We show that ID8 Trp53(-/-); Brca1(-/-) and Trp53(-/-); Brca2(-/-) cells have defective homologous recombination and increased sensitivity to both platinum and PARP inhibitor chemotherapy compared to Trp53(-/-). By contrast, loss of Pten or Nf1 increases growth rate in vivo, and reduces survival following cisplatin chemotherapy in vivo. Finally, we have also targeted Trp53 in cells isolated from a previous transgenic murine fallopian tube carcinoma model, and confirmed that loss of p53 expression in this second model accelerates intraperitoneal growth. Together, these CRISPR-generated models represent a new and simple tool to investigate the biology of HGSC, and the ID8 cell lines are freely available to researchers.	[Walton, Josephine B.; Farquharson, Malcolm; Dowson, Suzanne; Murphy, Daniel; McNeish, Iain A.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Mason, Susan; Port, Jennifer; Kruspig, Bjorn; Stevenson, David; Murphy, Daniel; Coffelt, Seth; Blyth, Karen] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Matzuk, Martin] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Kim, Jaeyeon] Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA; [Kim, Jaeyeon] Indiana Univ Sch Med, Dept Mol Biol, Indianapolis, IN 46202 USA	McNeish, IA (reprint author), Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland.	i.mcneish@imperial.ac.uk			University of Glasgow; Cancer Research UK [C16420/A12995, C608/A15973, C596/A17196]; Marsha Rivkin Cancer Research Center	This work was funded by the University of Glasgow, Cancer Research UK [grants C16420/A12995 (I. A. McNeish), C608/A15973 (I. A. McNeish)] and Marsha Rivkin Cancer Research Center. All animal work was performed in the Biological Services Unit facilities at the Cancer Research UK Beatson Institute (Cancer Research UK grant C596/A17196).	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bayraktar S, 2015, BREAST J, V21, P260, DOI 10.1111/tbj.12392; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Candido-dos-Reis FJ, 2015, CLIN CANCER RES, V21, P652, DOI 10.1158/1078-0432.CCR-14-2497; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Gonzalez-Billalabeitia E, 2014, CANCER DISCOV, V4, P896, DOI 10.1158/2159-8290.CD-13-0230; Hua YY, 2016, ONCOTARGET, V7, P66077, DOI 10.18632/oncotarget.11808; Kaczmarczyk L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154604; Kim J, 2015, ENDOCRINOLOGY, V156, P1975, DOI 10.1210/en.2014-1977; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Macintyre G., 2017, BIORXIV; Martins FC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0526-8; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Ran F. A., 2013, NATURE PROTOCOLS, V8, P2281; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/s1470-2045(16)30559-9, 10.1016/S1470-2045(16)30559-9]; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Walton J, 2016, CANCER RES, V76, P6118, DOI 10.1158/0008-5472.CAN-16-1272; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhai YL, 2017, J PATHOL, V243, P16, DOI 10.1002/path.4927; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	32	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 4	2017	7								16827	10.1038/s41598-017-17119-1				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FO7BK	WOS:000417025400008	29203787	gold			2018-01-05	
J	Monda, JK; Whitney, IP; Tarasovetc, EV; Wilson-Kubalek, E; Milligan, RA; Grishchuk, EL; Cheeseman, IM				Monda, Julie K.; Whitney, Ian P.; Tarasovetc, Ekaterina V.; Wilson-Kubalek, Elizabeth; Milligan, Ronald A.; Grishchuk, Ekaterina L.; Cheeseman, Iain M.			Microtubule Tip Tracking by the Spindle and Kinetochore Protein Ska1 Requires Diverse Tubulin-Interacting Surfaces	CURRENT BIOLOGY			English	Article							MITOTIC PROGRESSION; NDC80 COMPLEXES; BINDING; DOMAIN; DEPOLYMERIZATION; ATTACHMENT; MECHANISM; DYNAMICS; REVEALS; INSIGHT	The macromolecular kinetochore functions to generate interactions between chromosomal DNA and spindle microtubules [1]. To facilitate chromosome movement and segregation, kinetochores must maintain associations with both growing and shrinking microtubule ends. It is critical to define the proteins and their properties that allow kinetochores to associate with dynamic microtubules. The kinetochore-localized human Ska1 complex binds to microtubules and tracks with depolymerizing microtubule ends [2]. We now demonstrate that the Ska1 complex also autonomously tracks with growing microtubule ends in vitro, a key property that would allow this complex to act at kinetochores to mediate persistent associations with dynamic microtubules. To define the basis for Ska1 complex interactions with dynamic microtubules, we investigated the tubulin-binding properties of the Ska1 microtubule binding domain. In addition to binding to the microtubule lattice and dolastatin-induced protofilament-like structures, we demonstrate that the Ska1 microtubule binding domain can associate with soluble tubulin heterodimers and promote assembly of oligomeric ring-like tubulin structures. We generated mutations on distinct surfaces of the Ska1 microtubule binding domain that disrupt binding to soluble tubulin but do not prevent microtubule binding. These mutants display compromised microtubule tracking activity in vitro and result in defective chromosome alignment and mitotic progression in cells using a CRISPR/Cas9-based replacement assay. Our work supports a model in which multiple surfaces of Ska1 interact with diverse tubulin substrates to associate with dynamic microtubule polymers and facilitate optimal chromosome segregation.	[Monda, Julie K.; Whitney, Ian P.; Cheeseman, Iain M.] Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA; [Monda, Julie K.; Cheeseman, Iain M.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Tarasovetc, Ekaterina V.; Grishchuk, Ekaterina L.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tarasovetc, Ekaterina V.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Wilson-Kubalek, Elizabeth; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Cheeseman, IM (reprint author), Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA.; Cheeseman, IM (reprint author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	icheese@wi.mit.edu			NIH [GM098389, GM052468, GM088313]; American Cancer Society [RSG-14-018-01-CCG]; Russian Science Foundation [16-14-00-224]; Leukemia & Lymphoma Society; National Science Foundation [1122374]	We thank A. Zaytsev for technical assistance and members of the Cheeseman and Grishchuk labs for stimulating discussions and critical reading of the manuscript. This work was supported in part by grants from the NIH to E.L.G. (GM098389), R.A.M. and E.W.-K. (GM052468), and I.M.C. (GM088313). E.L.G. is supported in part by Research Scholar Grant RSG-14-018-01-CCG from the American Cancer Society, and E.V.T. was supported in part by grant 16-14-00-224 from the Russian Science Foundation. This work was supported by a Scholar award to I.M.C. from the Leukemia & Lymphoma Society and a National Science Foundation Graduate Research Fellowship under grant no. 1122374 to J.K.M.	Abad MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34042; Abad MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3964; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Auckland P, 2017, J CELL BIOL, V216, P1623, DOI 10.1083/jcb.201607096; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Chatterjee C, 2016, BIOPHYS J, V110, P1593, DOI 10.1016/j.bpj.2016.02.029; Cheerambathur DK, 2017, DEV CELL, V41, P424, DOI 10.1016/j.devcel.2017.04.013; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Grishchuk Ekaterina L, 2017, Prog Mol Subcell Biol, V56, P397, DOI 10.1007/978-3-319-58592-5_17; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Janczyk PL, 2017, DEV CELL, V41, P438, DOI 10.1016/j.devcel.2017.04.020; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Maciejowski J, 2017, DEV CELL, V41, P143, DOI 10.1016/j.devcel.2017.03.025; McKinley KL, 2017, DEV CELL, V40, P405, DOI 10.1016/j.devcel.2017.01.012; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Moores CA, 2006, CELL CYCLE, V5, P1812, DOI 10.4161/cc.5.16.3134                                                            ; Peters C, 2010, EMBO J, V29, P3437, DOI 10.1038/emboj.2010.220; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redli PM, 2016, J CELL BIOL, V215, P77, DOI 10.1083/jcb.201603019; Schmidt JC, 2012, DEV CELL, V23, P968, DOI 10.1016/j.devcel.2012.09.012; Sivakumar S, 2016, ELIFE, V5, DOI 10.7554/eLife.12902; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Thomas GE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11665; Volkov V.A., 2014, J VIS EXP; Wang Q, 2014, P NATL ACAD SCI USA, V111, P11347, DOI 10.1073/pnas.1403135111; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wilson-Kubalek EM, 2016, MOL BIOL CELL, V27, P1197, DOI 10.1091/mbc.E15-12-0858; Zhang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073075; Zhang Q, 2017, CURR BIOL, V27, P1477, DOI 10.1016/j.cub.2017.03.060	40	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	DEC 4	2017	27	23					3666	+		10.1016/j.cub.2017.10.018				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FO8MF	WOS:000417140100025	29153323				2018-01-05	
J	Wang, YF; Li, J; Yao, XR; Li, W; Du, HB; Tang, ML; Xiong, W; Chai, RJ; Xu, ZG				Wang, Yanfei; Li, Jie; Yao, Xuerui; Li, Wei; Du, Haibo; Tang, Mingliang; Xiong, Wei; Chai, Renjie; Xu, Zhigang			Loss of CIB2 Causes Profound Hearing Loss and Abolishes Mechanoelectrical Transduction in Mice	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						hearing loss; Usher syndrome; CIB2; knockout mice; stereocilia; mechanoelectrical transduction	COCHLEAR HAIR-CELLS; INNER-EAR; BIOCHEMICAL-CHARACTERIZATION; CALCIUM; PROTEIN; MECHANOTRANSDUCTION; MIGRATION; DEAFNESS; CHANNEL; FAMILY	Calcium and integrin-binding protein 2 (CIB2) belongs to a protein family with four known members, CIB1 through CIB4, which are characterized by multiple calcium-binding EF-hand domains. Among the family members, the Cib1 and Cib2 genes are expressed in mouse cochlear hair cells, and mutations in the human CIB2 gene have been associated with nonsyndromic deafness DFNB48 and syndromic deafness USH1J. To further explore the function of CIB1 and CIB2 in hearing, we established Cib1 and Cib2 knockout mice using the clustered regularly interspaced short palindromic repeat (CRISPR)-associated Cas9 nuclease (CRISPR/Cas9) genome editing technique. We found that loss of CIB1 protein does not affect auditory function, whereas loss of CIB2 protein causes profound hearing loss in mice. Further investigation revealed that hair cell stereocilia development is affected in Cib2 knockout mice. Noticeably, loss of CIB2 abolishes mechanoelectrical transduction (MET) currents in auditory hair cells. In conclusion, we show here that although both CIB1 and CIB2 are readily detected in the cochlea, only loss of CIB2 results in profound hearing loss, and that CIB2 is essential for auditory hair cell MET.	[Wang, Yanfei; Yao, Xuerui; Li, Wei; Du, Haibo; Xu, Zhigang] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan, Shandong, Peoples R China; [Wang, Yanfei; Yao, Xuerui; Li, Wei; Du, Haibo; Xu, Zhigang] Shandong Normal Univ, Shandong Prov Collaborat Innovat Ctr Cell Biol, Jinan, Shandong, Peoples R China; [Li, Jie; Xiong, Wei] Tsinghua Univ, IDG McGovern Inst Brain Res, Sch Life Sci, Beijing, Peoples R China; [Tang, Mingliang; Chai, Renjie] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Tang, Mingliang; Chai, Renjie] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Chai, Renjie] Southeast Univ, Jiangsu Prov High Tech Key Lab Biomed Res, Nanjing, Jiangsu, Peoples R China	Xu, ZG (reprint author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan, Shandong, Peoples R China.; Xu, ZG (reprint author), Shandong Normal Univ, Shandong Prov Collaborat Innovat Ctr Cell Biol, Jinan, Shandong, Peoples R China.; Chai, RJ (reprint author), Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.; Chai, RJ (reprint author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.; Chai, RJ (reprint author), Southeast Univ, Jiangsu Prov High Tech Key Lab Biomed Res, Nanjing, Jiangsu, Peoples R China.	renjiec@seu.edu.cn; xuzg@sdu.edu.cn			National Key R&D Program of China [2013CB967700, 2017YFA0103900, 2017YFA0103903]; National Natural Science Foundation of China [31371355, 31401007, 31571080, 31522025, 81622013, 81470692, 31500852]; Jiangsu Province Natural Science Foundation [BK20150022, BK20140620, BK20150598, BK20160125]; Yingdong Huo Education Foundation; Fundamental Research Funds for the Central Universities	This work was supported by grants from the National Key R&D Program of China (2013CB967700, 2017YFA0103900, 2017YFA0103903), the National Natural Science Foundation of China (31371355, 31401007, 31571080, 31522025, 81622013, 81470692, 31500852), the Jiangsu Province Natural Science Foundation (BK20150022, BK20140620, BK20150598, BK20160125), the Yingdong Huo Education Foundation and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178                                                                   ; Blazejczyk M, 2009, ARCH BIOCHEM BIOPHYS, V487, P66, DOI 10.1016/j.abb.2009.05.002; Bolz H, 2001, NAT GENET, V27, P108; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Ceriani F, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-20; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321                                                            ; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; DOWNEY GP, 1990, J CELL BIOL, V110, P1975, DOI 10.1083/jcb.110.6.1975                                                          ; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753                                                   ; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Giese APJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00061-1; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Hennings JK, 2008, J NEUROCHEM, V106, P2249, DOI 10.1111/j.1471-4159.2008.05563.x; Hager M., 2008, J BIOL CHEM, DOI [10.1074/jbc.m801166200, DOI 10.1074/JBC.M801166200]; Holme RH, 2002, J COMP NEUROL, V450, P94, DOI 10.1002/cne.10301; Hutchins BI, 2013, J NEUROSCI, V33, P11361, DOI 10.1523/JNEUROSCI.3758-12.2013; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kim KX, 2013, J GEN PHYSIOL, V142, P493, DOI 10.1085/jgp.201311068; Kostyak JC, 2012, BLOOD, V119, P838, DOI 10.1182/blood-2011-04-346098; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Mammano F, 2007, PHYSIOLOGY, V22, P131, DOI 10.1152/physiol.00040.2006; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Naik MU, 2009, J THROMB HAEMOST, V7, P1906, DOI 10.1111/j.1538-7836.2009.03581.x; Naik MU, 2011, J CELL BIOCHEM, V112, P3289, DOI 10.1002/jcb.23255; Naik MU, 2011, INT J BIOCHEM CELL B, V43, P120, DOI 10.1016/j.bioce1.2010.10.003; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Patel K., 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141259; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Seco CZ, 2016, EUR J HUM GENET, V24, P542, DOI 10.1038/ejhg.2015.157; Self T, 1998, DEVELOPMENT, V125, P557; Shen J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav071; Velez-Ortega AC, 2017, ELIFE, V6, DOI 10.7554/eLife.24661; Verpy E, 2000, NAT GENET, V26, P51; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Weil D, 1995, Nature, V374, P60; Welnhofer EA, 1999, J NEUROSCI, V19, P7971; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Wu ZZ, 2017, NAT NEUROSCI, V20, P24, DOI 10.1038/nn.4449; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17; Zhao B, 2014, NEURON, V84, P954, DOI 10.1016/j.neuron.2014.10.041; Zou JH, 2017, HUM MOL GENET, V26, P624, DOI 10.1093/hmg/ddw421	56	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	DEC 4	2017	10								401	10.3389/fnmol.2017.00401				14	Neurosciences	Neurosciences & Neurology	FO5TU	WOS:000416924600001	29255404	gold			2018-01-05	
J	Lazzari, E; Mondala, PK; Delos Santos, N; Miller, AC; Pineda, G; Jiang, QF; Leu, H; Ali, SA; Ganesan, AP; Wu, CN; Costello, C; Minden, M; Chiaramonte, R; Stewart, AK; Crews, LA; Jamieson, CHM				Lazzari, Elisa; Mondala, Phoebe K.; Delos Santos, Nathaniel; Miller, Amber C.; Pineda, Gabriel; Jiang, Qingfei; Leu, Heather; Ali, Shawn A.; Ganesan, Anusha-Preethi; Wu, Christina N.; Costello, Caitlin; Minden, Mark; Chiaramonte, Raffaella; Stewart, A. Keith; Crews, Leslie A.; Jamieson, Catriona H. M.			Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma	NATURE COMMUNICATIONS			English	Article							IN-SITU HYBRIDIZATION; CANCER STEM-CELLS; PLASMA-CELLS; LEUKEMIA; GAIN; 1Q21; MAINTENANCE; INHIBITION; INTERFERON; EXPRESSION	Despite novel therapies, relapse of multiple myeloma (MM) is virtually inevitable. Amplification of chromosome 1q, which harbors the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR) 1 gene, occurs in 30-50% of MM patients and portends a poor prognosis. Since adenosine-to-inosine RNA editing has recently emerged as a driver of cancer progression, genomic amplification combined with inflammatory cytokine activation of ADAR1 could stimulate MM progression and therapeutic resistance. Here, we report that high ADAR1 RNA expression correlates with reduced patient survival rates in the MMRF CoMMpass data set. Expression of wild-type, but not mutant, ADAR1 enhances Alu-dependent editing and transcriptional activity of GLI1, a Hedgehog (Hh) pathway transcriptional activator and self-renewal agonist, and promotes immunomodulatory drug resistance in vitro. Finally, ADAR1 knockdown reduces regeneration of high-risk MM in serially transplantable patient-derived xenografts. These data demonstrate that ADAR1 promotes malignant regeneration of MM and if selectively inhibited may obviate progression and relapse.	[Lazzari, Elisa; Mondala, Phoebe K.; Delos Santos, Nathaniel; Pineda, Gabriel; Jiang, Qingfei; Leu, Heather; Ali, Shawn A.; Ganesan, Anusha-Preethi; Wu, Christina N.; Crews, Leslie A.; Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, Dept Med, Div Regenerat Med, La Jolla, CA 92037 USA; [Miller, Amber C.; Stewart, A. Keith] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Pineda, Gabriel] Natl Univ, Sch Hlth & Human Serv, Dept Hlth Sci, San Diego, CA 92123 USA; [Costello, Caitlin; Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, Dept Med, La Jolla, CA 92093 USA; [Minden, Mark] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; [Chiaramonte, Raffaella] Univ Milan, Dept Hlth Sci, I-20142 Milan, Italy	Crews, LA; Jamieson, CHM (reprint author), Univ Calif San Diego, Moores Canc Ctr, Dept Med, Div Regenerat Med, La Jolla, CA 92037 USA.; Jamieson, CHM (reprint author), Univ Calif San Diego, Moores Canc Ctr, Dept Med, La Jolla, CA 92093 USA.	lcrews@ucsd.edu; cjamieson@ucsd.edu			NCI [1R21CA194679, R21CA189705, 1R01CA205944]; NIDDK [1R01DK114468]; Multiple Myeloma Research Foundation; Blasker-Rose-Miah Fund of The San Diego Foundation; Leukemia & Lymphoma Society's Quest [0754-14]; Italian Ministry of Education, University and Research; Strauss Family Foundation; Moores Foundation; Koman Family Foundation; Sanford Stem Cell Clinical Center; NCI Cancer Center Support Grant [P30-CA 023100]	We wish to thank E. D. Ball and C. Mason at UC San Diego for technical assistance. This work was funded through the NCI (C.H.M.J., 1R21CA194679, R21CA189705, and 1R01CA205944), the NIDDK (1R01DK114468), the Multiple Myeloma Research Foundation (L. A. C.), the Blasker-Rose-Miah Fund of The San Diego Foundation (L. A. C.), the Leukemia & Lymphoma Society's Quest for CURES Research Grant Program (C. H. M. J., 0754-14), the Italian Ministry of Education, University and Research (E. L., doctoral fellowship, co-mentor R. C.), the Strauss Family Foundation, the Moores Foundation, the Koman Family Foundation, the Sanford Stem Cell Clinical Center, and a NCI Cancer Center Support Grant to the Moores Cancer Center (P30-CA 023100).	Anadon C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469; Bianchi G., 2014, CURR CANC THER REV, V29, P997; Blotta S, 2012, BLOOD, V120, P5002, DOI 10.1182/blood-2011-07-368142; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Colombo M, 2016, ONCOTARGET, V7, P56013, DOI 10.18632/oncotarget.10820; Crews LA, 2016, CELL STEM CELL, V19, P599, DOI 10.1016/j.stem.2016.08.003; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dupere-Richer D, 2017, CURR OPIN HEMATOL, V24, P336, DOI 10.1097/MOH.0000000000000358; Eifler T., 2013, BIOCHEMISTRY-US, V52, P1; Fonseca R, 2006, LEUKEMIA, V20, P2034, DOI 10.1038/sj.leu.2404403; Frigyesi I, 2014, BLOOD, V123, P1336, DOI 10.1182/blood-2013-09-529800; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Goff DJ, 2013, CELL STEM CELL, V12, P316, DOI 10.1016/j.stem.2012.12.011; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hanamura I, 2006, BLOOD, V108, P1724, DOI 10.1182/blood-2006-03-009910; Jiang QF, 2017, NAT REV CANCER, V17, P381, DOI 10.1038/nrc.2017.23; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Liu ZQ, 2014, BLOOD, V124, P2061, DOI 10.1182/blood-2014-03-557298; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Ma WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039725; Meltzer M, 2010, CTS-CLIN TRANSL SCI, V3, P73, DOI 10.1111/j.1752-8062.2010.00199.x; Nemec P, 2010, BIOL BLOOD MARROW TR, V16, P548, DOI 10.1016/j.bbmt.2009.11.025; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rihani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071776; Sadarangani A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0453-9; Shimokawa T, 2013, RNA BIOL, V10, P321, DOI 10.4161/rna.23343; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Xiao C, 2010, AM J PHYSIOL-GASTR L, V299, pG1252, DOI 10.1152/ajpgi.00512.2009; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	40	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC 4	2017	8								1922	10.1038/s41467-017-01890-w				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FO7CZ	WOS:000417029900012	29203771	gold			2018-01-05	
J	Kuang, DX; Qiao, JC; Li, Z; Wang, WW; Xia, H; Jiang, LB; Dai, JJ; Fang, Q; Dai, XY				Kuang, Dexuan; Qiao, Jichen; Li, Zhou; Wang, Weiwei; Xia, Hui; Jiang, Lubin; Dai, Jiejie; Fang, Qiang; Dai, Xueyu			Tagging to endogenous genes of Plasmodium falciparum using CRISPR/Cas9	PARASITES & VECTORS			English	Article						Plasmodium falciparum; CRISPR/Cas9; Gene editing; Gene tagging	MALARIA PARASITES; RECOMBINATION; TRANSFECTION; DISEASE; RESISTANCE; MARKER; SYSTEM	Background: Plasmodium falciparum is the deadliest malaria parasite. Currently, there are seldom commercial antibodies against P. falciparum proteins, which greatly limits the study on Plasmodium. CRISPR/Cas9 is an efficient genome editing method, which has been employed in various organisms. However, the use of this technique in P. falciparum is still limited to gene knockout, site-specific mutation and generation of green fluorescent protein (GFP) reporter line with disruption of inserted sites. Results: We have adapted the CRISPR/Cas9 system to add commercial tag sequences to endogenous genes of P. falciparum. To add HA or HA-TY1 tags to ck2 beta 1, ck2a and stk, pL6cs-hDHFR-ck2 beta 1/ck2a/stk was constructed, which contained sequences of tags, specific homologous arms, and sgRNA. The P. falciparum 3D7 strain was subsequently transfected with pUF1-BSD-Cas9 and pL6cs-hDHFR-ck2 beta 1/ck2a/stk plasmids via electroporation. After that, BSD and WR99210 drugs were added to the culture to screen parasites containing both plasmids. Twenty days after electroporation, live parasites appeared and were collected to check the tagging by PCR, DNA sequencing, Western blotting and immuno-fluorescence assays. The results showed that the tags were successfully integrated into the C-terminus of these three proteins. Conclusions: We have improved the method to integrate tags to Plasmodium falciparum genes using the CRISPR/Cas9 method, which lays the foundation for further study of Plasmodium falciparum at the molecular level.	[Kuang, Dexuan; Dai, Jiejie] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China; [Kuang, Dexuan; Qiao, Jichen; Xia, Hui; Fang, Qiang] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China; [Qiao, Jichen; Xia, Hui; Fang, Qiang] Chinese Acad Med Sci, Dept Microbiol & Parasitol, Kunming 650118, Yunnan, Peoples R China; [Qiao, Jichen; Xia, Hui; Fang, Qiang] Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu 233030, Peoples R China; [Li, Zhou; Wang, Weiwei; Jiang, Lubin; Dai, Xueyu] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Dai, JJ (reprint author), Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China.; Fang, Q (reprint author), Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China.; Fang, Q (reprint author), Chinese Acad Med Sci, Dept Microbiol & Parasitol, Kunming 650118, Yunnan, Peoples R China.; Dai, XY (reprint author), Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China.	djj@imbcams.com.cn; fq333@sohu.com; xydai@ips.ac.cn			National Natural Science Foundation of China [31571345]; Scientific Research Innovation Team Project of Anhui Colleges and Universities [2016-40]; Anhui Provincial Natural Science Foundation [1308085MH160]; Training Project for Provincial Academic Technology Leaders in Anhui Colleges and Universities [2014053]; Yunnan science and technology plan project [2016HB006]	This study was supported in part by the National Natural Science Foundation of China (No. 31571345), the Scientific Research Innovation Team Project of Anhui Colleges and Universities (2016-40), the Anhui Provincial Natural Science Foundation (1308085MH160), the Training Project for Provincial Academic Technology Leaders in Anhui Colleges and Universities (2014053), the Yunnan science and technology plan project (2016HB006).	Bhaumik S, 2013, NATL MED J INDIA, V26, P62; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Crabb BS, 2004, METH MOL B, V270, P263; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Grist EPM, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0064-6; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Dorado EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163137; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kassegne K, 2016, EXPERT REV PROTEOMIC, V13, P1091, DOI 10.1080/14789450.2016.1252675; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Norahmad NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165515; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; White NJ, 2014, LANCET, V383, P1439, DOI 10.1016/S0140-6736(14)60656-5; World Health Organisation, 2015, WORLD MAL REP 2015; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Zhang C, 2017, MOL BIOCHEM PARASIT, V212, P1, DOI 10.1016/j.molbiopara.2016.12.010	29	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 2	2017	10								595	10.1186/s13071-017-2539-0				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FO6HX	WOS:000416965200005	29197418	gold			2018-01-05	
J	Martyniszyn, A; Krahl, AC; Andre, MC; Hombach, AA; Abken, H				Martyniszyn, Alexandra; Krahl, Ann-Christin; Andre, Maya C.; Hombach, Andreas A.; Abken, Hinrich			CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies	HUMAN GENE THERAPY			English	Article						chimeric antigen receptor; CAR; adoptive cell therapy; bispecific targeting; CD19; CD20; leukemia; relapse	MODIFIED DENDRITIC CELLS; GENE-THERAPY; CANCER-IMMUNOTHERAPY; ONCOLYTIC VIRUSES; MELANOMA; COMBINATIONS; CRISPR-CAS9; VACCINES; IMMUNITY; GLIOMA	The treatment of leukemia/lymphoma by chimeric antigen receptor (CAR) redirected T cells with specificity for CD19 induced complete remissions in the majority of patients, with a realistic hope for cure. However, recent follow-up data revealed a substantial risk of relapse through leukemic cells that lack the CAR targeted antigen. In this situation, a bispecific CAR with binding domains for CD19 and CD20 is aimed at recognizing leukemic cells with only one cognate antigen. The anti-CD20-CD19 bispecific CAR induced a full T-cell response upon engagement of CD19 or CD20 on target cells showing a true `` OR'' gate recognition in redirecting T-cell activation. T cells with the anti-CD20-CD19 CAR efficiently killed patients' chronic lymphocytic leukemia cells in vitro. The bispecific CAR T cells cleared pediatric acute lymphocytic leukemia with a mixed CD19+ CD20+/CD20-phenotype from the blood and bone marrow of transplanted mice, while anti-CD20 CAR T cells left CD20-leukemic cells behind without curing the disease. Data indicate the superior anti-leukemic activity in the control of leukemia, implying that the anti-CD20-CD19 bispecific CAR T cells may reduce the risk of relapse through antigen-loss leukemic cells in the long term.	[Martyniszyn, Alexandra; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany; [Martyniszyn, Alexandra; Hombach, Andreas A.; Abken, Hinrich] Univ Hosp Cologne, Deparment Internal Med 1, Cologne, Germany; [Krahl, Ann-Christin; Andre, Maya C.] Eberhard Karls Univ Tubingen, Dept Pediat Hematol & Oncol, Univ Childrens Hosp, Tubingen, Germany; [Andre, Maya C.] Univ Childrens Hosp, Deparment Pediat Intens Care, Basel, Switzerland	Abken, H (reprint author), Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany.	hinrich.abken@uk-koeln.de			Deutsche Jose Carreras Leukamie-Stiftung, Munchen; Deutsche Forschungsgemeinschaft, Bonn; Else Kroner-Fresenius Stiftung, Bad Homburg v.d.H.; Wilhelm Sander-Stiftung, Munchen; Medical Faculty of the University of Cologne	We thank G.H. Fey, University Erlangen-Nuremberg, for discussion during the initial phase of this project. This work was supported by the Deutsche Jose Carreras Leukamie-Stiftung, Munchen, the Deutsche Forschungsgemeinschaft, Bonn, the Else Kroner-Fresenius Stiftung, Bad Homburg v.d.H., the Wilhelm Sander-Stiftung, Munchen, and the Medical Faculty of the University of Cologne.	Alexander Walter, 2016, P T, V41, P185; Argos Therapeutics, 2017, IND DAT MON COMM REC; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Bofill-De Ros X, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00142; Castillo A, 2016, COLOMB MEDICA, V47, P178; Chen S, 2016, INT J BIOL SCI, V12, P1427, DOI 10.7150/ijbs.17421; Cukier-Meisner E., 2017, MAXIMIZING NEOANTIGE; CureVac, 2017, CUREVAC PROV CLIN UP; DeFrancesco L, 2017, NAT BIOTECHNOL, V35, P193, DOI 10.1038/nbt.3812; Food and Drug Administration, 2017, HIGHL PRESCR INF; Fox BA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-214; Freedman JD, 2017, EMBO MOL MED, V9, P1067, DOI 10.15252/emmm.201707567; Havunen R, 2017, MOL THER-ONCOLYTICS, V4, P77, DOI 10.1016/j.omto.2016.12.004; Immatics, 2017, IMM ANN RES IMPRINT; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Kamran N, 2017, MOL THER, V25, P232, DOI 10.1016/j.ymthe.2016.10.003; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kohlhapp FJ, 2016, CLIN CANCER RES, V22, P1048, DOI 10.1158/1078-0432.CCR-15-2667; Marino N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177810; Markabi Sabri, 2009, Retina, V29, pS12, DOI 10.1097/IAE.0b013e3181ad24c4; McNamara MA, 2015, J IMMUNOL RES, DOI 10.1155/2015/794528; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Monnereau A, 2013, BLOOD, V122, P3492, DOI 10.1182/blood-2013-04-497586; Muik A, 2014, CANCER RES, V74, P3567, DOI 10.1158/0008-5472.CAN-13-3306; Navai N, 2016, ANN SURG ONCOL, V23, P4110, DOI 10.1245/s10434-016-5300-6; Novartis, 2017, FDA BRIEF DOC ONC DR; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Perry D, 2015, EXPERT REV NEUROTHER, V15, P327, DOI 10.1586/14737175.2015.996551; Ramamoorth Murali, 2015, J Clin Diagn Res, V9, pGE01, DOI 10.7860/JCDR/2015/10443.5394; Reardon S., 2016, NATURE, DOI [10.1038/nature.2016.20137, DOI 10.1038/NATURE.2016.20137]; Ribas A, 2005, CURR GENE THER, V5, P619, DOI 10.2174/156652305774964758; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Seymour LW, 2016, BRIT J CANCER, V114, P357, DOI 10.1038/bjc.2015.481; Sheridan C., 2017, PROVECS NEARING CLIN; Stadler CR, 2017, NAT MED, V23, P815, DOI 10.1038/nm.4356; Triozzi PL, 2005, CLIN CANCER RES, V11, P4168, DOI 10.1158/1078-0432.CCR-04-2283; Ungerechts G, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.18; Van Lint S, 2016, CANCER IMMUNOL RES, V4, P146, DOI 10.1158/2326-6066.CIR-15-0163; Van Lint S, 2015, EXPERT REV VACCINES, V14, P235, DOI 10.1586/14760584.2015.957685; Wang DH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-251; Wilgenhof S, 2013, ANN ONCOL, V24, P2686, DOI 10.1093/annonc/mdt245	43	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	DEC	2017	28	12					1147	1157		10.1089/hum.2017.126				11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FQ5OP	WOS:000418410700407					2018-01-05	
J	Richter, F; Fonfara, I; Gelfert, R; Nack, J; Charpentier, E; Moglich, A				Richter, Florian; Fonfara, Ines; Gelfert, Renate; Nack, Jennifer; Charpentier, Emmanuelle; Moeglich, Andreas			Switchable Cas9	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							INDUCIBLE CRISPR-CAS9 SYSTEM; CRYSTAL-STRUCTURE; GENE-EXPRESSION; OPTICAL CONTROL; LIVING CELLS; LIGHT; PROTEIN; RNA; TRANSCRIPTION; COMPLEX	Ever since its discovery, Cas9 from Streptococcus pyogenes has revolutionized biology by enabling analysis and engineering of genomes with unprecedented precision and ease. To fine-tune on-target effects and to mitigate adverse effects caused by untimely and off-target action of Cas9, strategies have been developed to control its activity at the post-translational stage via external trigger signals. Control is either achieved by modifying the Cas9 protein itself or its programmable RNA molecules. To date, switchable Cas9 variants responding to small ligands, light or temperature have been engineered. With these variants in hand, the regulation and modification of genomes can be accomplished in graded and ever more precise manner.	[Richter, Florian] Bayer AG, Pharmaceut, Prot Engn & Assays, D-50829 Cologne, Germany; [Fonfara, Ines; Charpentier, Emmanuelle] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Fonfara, Ines; Charpentier, Emmanuelle] Umea Univ, Lab Mol Infect Med Sweden MIMS, UCMR, Dept Mol Biol, S-90187 Umea, Sweden; [Gelfert, Renate; Nack, Jennifer; Moeglich, Andreas] Univ Bayreuth, Lehrstuhl Biochem, Bayreuth, Germany; [Moeglich, Andreas] Univ Bayreuth, Res Ctr Biomacromol, Bayreuth, Germany	Richter, F (reprint author), Bayer AG, Pharmaceut, Prot Engn & Assays, D-50829 Cologne, Germany.; Fonfara, I (reprint author), Max Planck Inst Infect Biol, D-10117 Berlin, Germany.; Fonfara, I (reprint author), Umea Univ, Lab Mol Infect Med Sweden MIMS, UCMR, Dept Mol Biol, S-90187 Umea, Sweden.	florian.richter@bayer.com; fonfara@mpiib-berlin.mpg.de			Deutsche Forschungsgemeinschaft [RI2468/1-1]; Alexander-von-Humboldt Foundation; Einstein Foundation Berlin [IPF-2012-148]; German Federal Ministry for Education and Research; Helmholtz Association; Max Planck Society; Royal Swedish Academy of Sciences; Swedish Research Council; Umea University	Research has been funded through the Deutsche Forschungsgemeinschaft [grant RI2468/1-1 to F.R.]; the Alexander-von-Humboldt Foundation [Sofja-Kovalevskaya Award to A.M.; AvH Professorship to E.C.]; the Einstein Foundation Berlin [grant IPF-2012-148 to F.R. & A.M.]; the German Federal Ministry for Education and Research [to E.C.]; the Helmholtz Association [to E.C.]; the Max Planck Society [to E.C.]; the Royal Swedish Academy of Sciences [Goran Gustafsson Prize to E.C.]; the Swedish Research Council [to E.C.]; and Umea University [to E.C.I.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bao Z, 2017, ACS SYNTH BIOL; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Bonger KM, 2014, ACS CHEM BIOL, V9, P111, DOI 10.1021/cb400755b; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Conrad KS, 2013, BIOCHEMISTRY-US, V52, P378, DOI 10.1021/bi3015373; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Didovyk A, 2016, CURR OPIN BIOTECH, V40, P177, DOI 10.1016/j.copbio.2016.06.003; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Jain PK, 2016, ANGEW CHEM INT EDIT, V55, P12440, DOI 10.1002/anie.201606123; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Luo J, 2016, NAT CHEM, V8, P1027, DOI [10.1038/NCHEM.2573, 10.1038/nchem.2573]; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Maji B, 2017, NAT CHEM BIOL, V13, P9, DOI 10.1038/nchembio.2224; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Niopek D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10624; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7                                                   ; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Renicke C, 2013, CHEM BIOL, V20, P619, DOI 10.1016/j.chembiol.2013.03.005; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Richter F, 2016, NUCLEIC ACIDS RES, V44, P10003, DOI 10.1093/nar/gkw930; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Yumerefendi H, 2016, NAT CHEM BIOL, V12, P399, DOI 10.1038/nchembio.2068; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Ziegler Thea, 2015, Front Mol Biosci, V2, P30, DOI 10.3389/fmolb.2015.00030	56	0	0	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	DEC	2017	48						119	126		10.1016/j.copbio.2017.03.025				8	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FQ4FN	WOS:000418313200017	28456061				2018-01-05	
J	Schmid-Burgk, JL				Schmid-Burgk, Jonathan L.			Disruptive non-disruptive applications of CRISPR/Cas9	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							MAMMALIAN-CELLS; ENDOGENOUS GENES; GENOME; DNA; CRISPR-CAS9; SYSTEM; ACTIVATION; TRANSCRIPTION; INFORMATION; MUTAGENESIS	The bacterial type II Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR Associated (Cas) systems, and in particular Streptococcus pyogenes CRISPR Cas9, have been broadly applied to edit the genome of bacterial and eukaryotic cells. Cas9, which is an RNA-guided programmable nuclease, is a powerful tool for disrupting protein-coding genes. Cas9 cleaves target sites to generate a double-strand break (DSB) that is repaired via an error-prone repair process, leading to insertion/deletion mutations and gene knockouts. However, Cas9 can also be used to modulate genome function without gene disruption, enabling base editing, transcriptional and epigenetic reprogramming, genome imaging, cellular barcoding, genetic recording, and genetic computation.	[Schmid-Burgk, Jonathan L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Schmid-Burgk, JL (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jschmid@broadinstitute.org					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2                                                    ; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Georgel Philippe, 2008, V415, P1, DOI 10.1007/978-1-59745-570-1_1; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Junker JP, MASSIVELY PARALLEL C; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/NMETH.4108, 10.1038/nmeth.4108]; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Klann TS, 2017, NAT BIOTECHNOL; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lackner DH, 2015, NAT COMMUN, V6; Lane AB, 2015, DEV CELL, V34, P373, DOI 10.1016/j.devcel.2015.06.003; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Richardson CD, CRISPR CAS9 GENOME E; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang S, 2016, SCI REP, V6; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	56	0	0	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	DEC	2017	48						203	209		10.1016/j.copbio.20-17.06.001				7	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FQ4FN	WOS:000418313200027	28633080				2018-01-05	
J	Baumgart, AK; Beyer, M				Baumgart, Ann-Kathrin; Beyer, Marc			Genetic engineering as a tool for the generation of mouse models to understand disease phenotypes and gene function	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							GENOME-WIDE ANALYSIS; ONE-STEP GENERATION; OFF-TARGET SITES; CRISPR-CAS9 NUCLEASES; EMBRYO MICROINJECTION; HIGHLY EFFICIENT; CAS9 NUCLEASES; KNOCKOUT MICE; TALEN; RNA	The usage of mouse models has been vital for biomedical research over the last decades, yet the generation of these models has been extremely difficult and labor-intensive. The identification and generation of nucleases able to introduce site-specific DNA double-strand breaks, particularly the CRIPSR/Cas system, is a major breakthrough for this field as the endogenous DNA repair machinery can be hijacked to specifically introduce genome modifications at these sites. This allows for the time-efficient and cost-efficient generation of mouse models by delivery of designer nucleases together with donor DNA into fertilized oocytes.	[Baumgart, Ann-Kathrin] Univ Hosp Bonn, Inst Expt Immunol, D-53127 Bonn, Germany; [Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol, D-53127 Bonn, Germany	Beyer, M (reprint author), German Ctr Neurodegenerat Dis DZNE, Mol Immunol, D-53127 Bonn, Germany.	marc.beyer@dzne.de			German Research Foundation [BE 4427/3-1]	MB is a member of the Excellence Cluster ImmunoSensation. This work was supported by the German Research Foundation (BE 4427/3-1).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeWitt MA, 2017, METHODS; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ma M, 2017, CELL RES, V27, P578, DOI 10.1038/cr.2017.29; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakao H, 2016, GENESIS, V54, P65, DOI 10.1002/dvg.22914; Nakasuji T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006578; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishio M, 2017, BIOSENS BIOELECTRON, V93, P26, DOI 10.1016/j.bios.2016.11.042; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pu JL, 2015, EXP BIOL MED, V240, P1065, DOI 10.1177/1535370215584932; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2017, BIORXIV; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077696; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sommer D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4045; Sommer D, 2015, CHROMOSOME RES, V23, P43, DOI 10.1007/s10577-014-9457-1; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Takahashi G, 2015, SCI REP-UK, V5, DOI 10.1038/srep11406; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Wefers B, 2013, NAT PROTOC, V8, P2355, DOI 10.1038/nprot.2013.142; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	63	0	0	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	DEC	2017	48						228	233		10.1016/j.copbio.2017.06.012				6	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FQ4FN	WOS:000418313200030	28704794				2018-01-05	
J	Talas, A; Kulcsar, PI; Weinhardt, N; Borsy, A; Toth, E; Szebenyi, K; Krausz, SL; Huszar, K; Vida, I; Sturm, A; Gordos, B; Hoffmann, OI; Bencsura, P; Nyeste, A; Ligeti, Z; Fodor, E; Welker, E				Talas, Andras; Kulcsar, Peter Istvan; Weinhardt, Nora; Borsy, Adrienn; Toth, Eszter; Szebenyi, Kornelia; Krausz, Sarah Laura; Huszar, Krisztina; Vida, Istvan; Sturm, Adam; Gordos, Bianka; Hoffmann, Orsolya Ivett; Bencsura, Petra; Nyeste, Antal; Ligeti, Zoltan; Fodor, Elfrieda; Welker, Ervin			A convenientmethod to pre-screen candidate guide RNAs for CRISPR/Cas9 gene editing by NHEJ-mediated integration of a 'self-cleaving' GFP-expression plasmid	DNA RESEARCH			English	Article						Cas9; CRISPR; gRNA testing; reporter assay; NHEJ-cloning	ZINC-FINGER NUCLEASES; IN-VIVO; TARGETED INTEGRATION; HUMAN-CELLS; CRISPR-CAS9 SYSTEM; CAS9 ENDONUCLEASE; INDUCED MUTATIONS; KNOCK-IN; GENOME; DNA	The efficacies of guide RNAs (gRNAs), the short RNA molecules that bind to and determine the sequence specificity of the Streptococcus pyogenes Cas9 nuclease, to mediate DNA cleavage vary dramatically. Thus, the selection of appropriate target sites, and hence spacer sequence, is critical for most applications. Here, we describe a simple, unparalleled method for experimentally pre-testing the efficiencies of various gRNAs targeting a gene. The method explores NHEJcloning, genomic integration of a GFP-expressing plasmid without homologous arms and linearized in-cell. The use of 'self-cleaving' GFP-plasmids containing universal gRNAs and corresponding targets alleviates cloning burdens when this method is applied. These universal gRNAs mediate efficient plasmid cleavage and are designed to avoid genomic targets in several model species. The method combines the advantages of the straightforward FACS detection provided by applying fluorescent reporter systems and of the PCR-based approaches being capable of testing targets in their genomic context, without necessitating any extra cloning steps. Additionally, we show that NHEJ-cloning can also be used in mammalian cells for targeted integration of donor plasmids up to 10 kb in size, with up to 30% efficiency, without any selection or enrichment.	[Talas, Andras; Krausz, Sarah Laura] Semmelweis Univ, Sch PhD Studies, Budapest, Hungary; [Talas, Andras; Kulcsar, Peter Istvan; Weinhardt, Nora; Borsy, Adrienn; Toth, Eszter; Szebenyi, Kornelia; Krausz, Sarah Laura; Huszar, Krisztina; Vida, Istvan; Sturm, Adam; Gordos, Bianka; Bencsura, Petra; Nyeste, Antal; Ligeti, Zoltan; Welker, Ervin] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Kulcsar, Peter Istvan; Weinhardt, Nora; Toth, Eszter; Huszar, Krisztina; Bencsura, Petra; Nyeste, Antal; Fodor, Elfrieda; Welker, Ervin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Kulcsar, Peter Istvan; Weinhardt, Nora] Univ Szeged, Szeged, Hungary; [Vida, Istvan] Eotvos Lorand Univ, Inst Organ Chem, Budapest, Hungary; [Hoffmann, Orsolya Ivett] NARIC Agr Biotechnol Inst, Ruminant Genome Biol Grp, Anim Biotechnol Sect, Godollo, Hungary	Welker, E (reprint author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.; Welker, E (reprint author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary.	welker.ervin@ttk.mta.hu			Hungarian Scientific Research Fund [K-82090, PD-111964]	This work was supported by the Hungarian Scientific Research Fund [K-82090, PD-111964].	Aach J., 2014, BIORXIV, DOI [DOI 10.1101/005074, 10.1101/005074]; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bachu R, 2015, BIOTECHNOL BIOENG, V112, P2154, DOI 10.1002/bit.25629; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dai J, 2010, INT J BIOL SCI, V6, P756; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; GEISINGER JM, 2016, NUCLEIC ACIDS RES, V44, DOI DOI 10.1093/NAR/GKV1542; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hagmann M, 1998, BIOL CHEM, V379, P673, DOI 10.1515/bchm.1998.379.6.673; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Huang Y, 2012, ELECTROPHORESIS, V33, P1198, DOI 10.1002/elps.201100543; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lackner DH, 2015, NAT COMMUN, V6; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Liu JG, 2012, J GENET GENOMICS, V39, P489, DOI 10.1016/j.jgg.2012.07.009; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2015, BMC P S9, V9, pO1; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Toth E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090896; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	73	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2017	24	6					609	621		10.1093/dnares/dsx029				13	Genetics & Heredity	Genetics & Heredity	FQ5SD	WOS:000418420400006	28679166	gold			2018-01-05	
J	Rizzolatti, C; Bury, P; Tatara, E; Pin, PA; Rodde, N; Berges, H; Budar, F; Mireau, H; Gielen, JJL				Rizzolatti, Carine; Bury, Paul; Tatara, Edouard; Pin, Pierre A.; Rodde, Nathalie; Berges, Helene; Budar, Francoise; Mireau, Hakim; Gielen, Jan J. L.			Map-based cloning of the fertility restoration locus Rfm1 in cultivated barley (Hordeum vulgare)	EUPHYTICA			English	Article						Hordeum vulgare; Fertility restoration; Cytoplasmic male sterility; Map-based cloning; PPR; Rfm1	CYTOPLASMIC MALE-STERILITY; PENTATRICOPEPTIDE-REPEAT PROTEIN; SECALE-CEREALE L.; RNA RECOGNITION; RESTORER GENE; PPR-PROTEIN; CMS WHEAT; GENOME; PLANTS; EVOLUTION	Hybridization technology has proven valuable in enhancing yields in many crops, but was only recently adopted in the small grain cereals. Hybrid varieties in barley (Hordeum vulgare) rely on the cytoplasmic male sterility (CMS) system msm1 derived from Hordeum vulgare ssp. spontaneum. The major restorer gene described for the msm1 system is known as Rfm1 and maps to the top of chromosome 6H. To gain further insight into mechanisms underlying male fertility restoration in barley, we used a map-based cloning approach to identify the nuclear gene involved in the restoration mechanism of this hybridization system. Taking advantage of the available genomic resources in barley in combination with a custom-made non-gridded BAC library developed from a restorer line, we cloned and sequenced the Rfm1 restorer locus. The characterization and annotation of the nucleotide sequence for the Rfm1 restorer allele allowed for the identification of the candidate gene for Rfm1. The Rfm1 locus carries a tandem repeat of a gene encoding a pentatricopeptide repeat (PPR) protein. Surprisingly, Rfm1 belongs to the PLS-DYW subfamily of PPR genes known for their involvement in RNA editing in plants organelles, but that to date have not been identified as restorer genes.	[Rizzolatti, Carine; Pin, Pierre A.; Gielen, Jan J. L.] Syngenta, Mol Genet, St Sauveur, France; [Bury, Paul] Syngenta, Cereals Breeding, Market Rasen, England; [Tatara, Edouard] Syngenta, Cereals Breeding, Chartres, France; [Rodde, Nathalie; Berges, Helene] INRA, CNRGV, Castanet Tolosan, France; [Budar, Francoise; Mireau, Hakim] Univ Paris Saclay, CNRS, INRA, Inst Jean Pierre Bourgin,AgroParisTech, Versailles, France	Rizzolatti, C (reprint author), Syngenta, Mol Genet, St Sauveur, France.	carine.rizzolatti@syngenta.com					AHOKAS H, 1983, HEREDITAS, V99, P157, DOI 10.1111/j.1601-5223.1983.tb00742.x; AHOKAS H, 1979, EUPHYTICA, V28, P409, DOI 10.1007/BF00056599                                                              ; AHOKAS H, 1982, P NATL ACAD SCI-BIOL, V79, P7605, DOI 10.1073/pnas.79.24.7605; Akagi H, 2004, THEOR APPL GENET, V108, P1449, DOI 10.1007/s00122-004-1591-2; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Castandet B, 2011, BIOCHEMISTRY-MOSCOW+, V76, P924, DOI 10.1134/S0006297911080086; Castillo A, 2014, J EXP BOT, V65, P6667, DOI 10.1093/jxb/eru388; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dahan J, 2013, RNA BIOL, V10, P1469, DOI 10.4161/rna.25568; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Gaborieau L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3117-0; Geddy R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-130; Hackauf B, 2017, THEOR APPL GENET, V130, P1179, DOI 10.1007/s00122-017-2879-3; Hackauf B, 2012, MOL BREEDING, V30, P1507, DOI 10.1007/s11032-012-9736-5; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370                                                          ; Horn R, 2014, MITOCHONDRION, V19, P198, DOI 10.1016/j.mito.2014.04.004; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Hu J, 2014, MITOCHONDRION; Islam MS, 2014, PLANT BREEDING, V133, P299, DOI 10.1111/pbr.12155; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Klein RR, 2005, THEOR APPL GENET, V111, P994, DOI 10.1007/s00122-005-2011-y; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x                                              ; Kurek I, 1997, THEOR APPL GENET, V95, P1305, DOI 10.1007/s001220050697; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Martin AC, 2008, AUST J AGR RES, V59, P206, DOI 10.1071/AR07239; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Matsuhira H, 2012, GENETICS, V192, P1347, DOI 10.1534/genetics.112.145409; Matsui K, 2001, THEOR APPL GENET, V102, P477, DOI 10.1007/s001220051670; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Melonek J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35152; Miedaner T, 2000, THEOR APPL GENET, V101, P1226, DOI 10.1007/s001220051601; Mora JRH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-35; Murakami S, 2005, PLANT BREEDING, V124, P133, DOI 10.1111/j.1439-0523.2005.01077.x; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI [10.1111/j.1467-7652.2009.00477.x, 10.1111/j.1461-7652.2009.00477.x]; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Santos AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-816; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schulte D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-247; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stojalowski S, 2013, J APPL GENET, V54, P179, DOI 10.1007/s13353-013-0144-2; Stojalowski SA, 2011, J APPL GENET, V52, P313, DOI 10.1007/s13353-011-0049-x; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Touzet P, 2014, MITOCHONDRION; Ui H, 2015, THEOR APPL GENET; Xu XB, 2009, PLANT MOL BIOL REP, V27, P511, DOI 10.1007/s11105-009-0105-4	56	0	0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	DEC	2017	213	12							UNSP 276	10.1007/s10681-017-2056-4				12	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	FQ5QE	WOS:000418414800006		gold			2018-01-05	
J	Salehi, S; Taheri, MN; Azarpira, N; Zare, A; Behzad-Behbahani, A				Salehi, Saeede; Taheri, Mohammad Naser; Azarpira, Negar; Zare, Abdolhossein; Behzad-Behbahani, Abbas			State of the art technologies to explore long non-coding RNAs in cancer	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Review						long non-coding RNAs (lncRNAs); cancer; experimental techniques; interaction networks; lncRNA function	GREEN FLUORESCENT PROTEIN; PROSTATE-CANCER; SECONDARY STRUCTURE; ANTISENSE OLIGONUCLEOTIDES; NUCLEOTIDE RESOLUTION; CHROMATIN SIGNATURE; CELL-PROLIFERATION; COLORECTAL-CANCER; BINDING PROTEINS; GENE-EXPRESSION	Long non-coding RNAs (lncRNAs) comprise a vast repertoire of RNAs playing a wide variety of crucial roles in tissue physiology in a cell-specific manner. Despite being engaged in myriads of regulatory mechanisms, many lncRNAs have still remained to be assigned any functions. A constellation of experimental techniques including single-molecule RNA in situ hybridization (sm-RNA FISH), cross-linking and immunoprecipitation (CLIP), RNA interference (RNAi), Clustered regularly interspaced short palindromic repeats (CRISPR) and so forth has been employed to shed light on lncRNA cellular localization, structure, interaction networks and functions. Here, we review these and other experimental approaches in common use for identification and characterization of lncRNAs, particularly those involved in different types of cancer, with focus on merits and demerits of each technique.	[Salehi, Saeede; Taheri, Mohammad Naser; Behzad-Behbahani, Abbas] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci, Shiraz, Iran; [Salehi, Saeede; Taheri, Mohammad Naser; Behzad-Behbahani, Abbas] Shiraz Univ Med Sci, Sch Paramed Sci, Technol Res Ctr, Shiraz, Iran; [Salehi, Saeede; Taheri, Mohammad Naser; Behzad-Behbahani, Abbas] Shiraz Univ Med Sci, Sch Paramed Sci, Dept Med Biotechnol, Shiraz, Iran; [Salehi, Saeede; Taheri, Mohammad Naser] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Azarpira, Negar; Zare, Abdolhossein] Shiraz Univ Med Sci, Namazi Hosp, Transplant Res Ctr, Shiraz, Iran	Behzad-Behbahani, A (reprint author), Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci, Shiraz, Iran.; Behzad-Behbahani, A (reprint author), Shiraz Univ Med Sci, Sch Paramed Sci, Technol Res Ctr, Shiraz, Iran.; Behzad-Behbahani, A (reprint author), Shiraz Univ Med Sci, Sch Paramed Sci, Dept Med Biotechnol, Shiraz, Iran.	behzadba@sums.ac.ir			Shiraz University of Medical Sciences, Shiraz, Iran [92-6889]	This work is based on thesis in medical biotechnology by Saeede Salehi (Project NO. 92-6889) supported by Shiraz University of Medical Sciences, Shiraz, Iran.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Bian ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23892; Bohmdorfer G, 2015, TRENDS CELL BIOL, V25, P623, DOI 10.1016/j.tcb.2015.07.002; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chakraborty D, 2012, NAT METHODS, V9, P360, DOI [10.1038/NMETH.1894, 10.1038/nmeth.1894]; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chu C, 2015, NAT STRUCT MOL BIOL, V22, P29, DOI 10.1038/nsmb.2921; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dias N, 2002, MOL CANCER THER, V1, P347; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Emst C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00168; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fatima R, 2015, MOL CELL THER, V3, P1; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Fritah S, 2014, RNA, V20, P1655, DOI 10.1261/rna.044040.113; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gong J, 2017, NUCLEIC ACIDS RES, V45, pD79, DOI 10.1093/nar/gkw835; Gonzalez I, 2015, NAT STRUCT MOL BIOL, V22, P370, DOI 10.1038/nsmb.3005; Goyal A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw883; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hajjari Mohammadreza, 2015, [Cancer Biology and Medicine, 癌症生物学与医学], V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Hall J, 2004, NAT REV GENET, V5, P552, DOI 10.1038/nrg1382; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Huang GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26524; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Huttenhofer A., 2003, NAT CELL BIOL, V5, P489; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Imamachi N, 2014, METHODS, V67, P55, DOI 10.1016/j.ymeth.2013.07.014; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Lapointe CP, 2015, NAT METHODS, V12, P1163, DOI 10.1038/nmeth.3651; Lau E, 2014, NAT REV GENET, V15, DOI 10.1038/nrg3795; Lee B, 2014, J MOL DIAGN, V16, P615, DOI 10.1016/j.jmoldx.2014.06.009; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Li Jun-Hao, 2014, Front Bioeng Biotechnol, V2, P88, DOI 10.3389/fbioe.2014.00088; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Li ZH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0442-z; Ling H, 2015, ONCOGENE, V34, P5003, DOI 10.1038/onc.2014.456; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10159; Lu ZP, 2016, CURR OPIN STRUC BIOL, V36, P142, DOI 10.1016/j.sbi.2016.01.007; Mallory AC, 2015, BIOCHIMIE, V117, P3, DOI 10.1016/j.biochi.2015.03.014; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Mauger DM, 2010, NAT BIOTECHNOL, V28, P1178, DOI 10.1038/nbt1110-1178; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; McMahon AC, 2016, CELL, V165, P742, DOI 10.1016/j.cell.2016.03.007; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Milne Thomas A., 2009, V538, P409, DOI 10.1007/978-1-59745-418-6_21; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nakagawa S, 2016, BBA-GENE REGUL MECH, V1859, P177, DOI 10.1016/j.bbagrm.2015.06.011; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nelles DA, 2015, BIOESSAYS, V37, P732, DOI 10.1002/bies.201500001; Novikova IV, 2013, INT J MOL SCI, V14, P23672, DOI 10.3390/ijms141223672; Novikova IV, 2013, METHODS, V63, P170, DOI 10.1016/j.ymeth.2013.07.030; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Orjalo Jr A., 2011, NAT METHODS, V8, P1548; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prensner JR, 2014, ONCOTARGET, V5, P1434, DOI 10.18632/oncotarget.1846                                                        ; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Quinn JJ, 2014, NAT BIOTECHNOL, V32, P933, DOI 10.1038/nbt.2943; Renganathan A, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-119; Riley KJ, 2013, MOL CELL, V49, P601, DOI 10.1016/j.molcel.2013.01.030; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roth A, 2015, NATURE, V521, P170, DOI 10.1038/521170a; Sahu Anirban, 2015, Trends Cancer, V1, P93; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI [10.1038/nchembio.434, 10.1038/.NCHEMBIO.434]; Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sharma E, 2016, MOL CELL, V62, P618, DOI 10.1016/j.molcel.2016.04.030; Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]; Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang X, 2014, MOL CELL, V56, P5, DOI 10.1016/j.molcel.2014.09.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; You MX, 2015, ANNU REV BIOPHYS, V44, P187, DOI 10.1146/annurev-biophys-060414-033954; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	143	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-4934			J CELL MOL MED	J. Cell. Mol. Med.	DEC	2017	21	12					3120	3140		10.1111/jcmm.13238				21	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FQ7WP	WOS:000418574500001	28631377	gold			2018-01-05	
J	Wang, Y; Chang, L; Zhai, JH; Wu, Q; Wang, DG; Wang, YF				Wang, Yi; Chang, Le; Zhai, Jiahui; Wu, Qiao; Wang, Donggen; Wang, Yunfang			Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						Carbamoyl phosphate synthetase 1; Sodium phenylbutyrate; Resveratrol; CRISPR/CAS9; Ammonia; Hepatocellular functions	ACUTE LIVER-FAILURE; UREA-CYCLE ENZYME; MOUSE MODELS; STEM-CELLS; HYPERAMMONEMIA; HEPATOCYTES; EXPRESSION; GENES; CPS1; MICE	Both primary hepatocytes and stem cells-derived hepatocyte-like cells (HLCs) are major sources for bioartificial liver (BAL). Maintenance of hepatocellular functions and induction of functional maturity of HLCs are critical for BAL's support effect. It remains difficult to assess and improve detoxification functions inherent to hepatocytes, including ammonia clearance. Here, we aim to assess ammonia metabolism and identify ammonia detoxification enhancer by developing an imaging strategy. In hepatoma cell line HepG2, and immortalized hepatic cell line LO2, carbamoyl phosphate synthetase 1 (CPS1) gene, the first enzyme of ammonia-eliminating urea cycle, was labelled with fluorescence protein via CRISPR/Cas9 system. With the reporter-based screening approach, cellular detoxification enhancers were selected among a collection of 182 small molecules. In both CPS1 reporter cell lines, the fluorescence intensity is positively correlated with cellular CPS1 mRNA expression, ammonia elimination and secreted urea, and reflected ammonia detoxification in a dose-dependent manner. Surprisingly, high-level CPS1 reporter clones also reserved many other critical hepatocellular functions, for example albumin secretion and cytochrome 450 metabolic functions. Sodium phenylbutyrate and resveratrol were identified to enhance metabolism-related gene expression and liver-enriched transcription factors C/EBP, HNF4. In conclusion, the CPS1-reporter system provides an economic and effective platform for assessment of cellular metabolic function and high-throughput identification of chemical compounds that improve detoxification activities in hepatic lineage cells.	[Wang, Yi; Chang, Le; Zhai, Jiahui; Wang, Donggen; Wang, Yunfang] Beijing Inst Transfus Med, Stem Cell & Tissue Engn Lab, Beijing, Peoples R China; [Wu, Qiao] Capital Med Univ, Youan Hosp, Beijing, Peoples R China	Wang, DG; Wang, YF (reprint author), Beijing Inst Transfus Med, Stem Cell & Tissue Engn Lab, Beijing, Peoples R China.	13901183367@139.com; wangyf1972@gmail.com			National High Technology Research and Development Program of China [2012AA020501]; National Natural Science Foundations of China [31370990, 81170388]; AMMS [2015CxJJ23]	We thank Ms. Long Long for her help on high-content IN Cell imaging acquisition and data analysis. This work was supported by National High Technology Research and Development Program of China (No. 2012AA020501 to Y.F.W.), the National Natural Science Foundations of China (No. 31370990, 81170388 to Y.F.W.) and the Innovation Research Program of AMMS (No. 2015CxJJ23 to Y.W.). L.C., J.Z. and Y.W. performed the research; Q.W. contributed essential reagents or tools; Y.W., D.W. and Y.F.W. designed the research; Y.W. and Y.F.W. analysed the data and wrote the paper.	Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Bao J, 2013, CELL TRANSPLANT, V22, P299, DOI 10.3727/096368912X656054; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deignan JL, 2008, MOL GENET METAB, V93, P7, DOI 10.1016/j.ymgme.2007.08.123; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Diez-Fernandez C, 2015, J GENET GENOMICS, V42, P249, DOI 10.1016/j.jgg.2015.03.009; Diez-Fernandez C, 2013, HUM MUTAT, V34, P1149, DOI 10.1002/humu.22349; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Faghihzadeh F, 2015, J RES MED SCI, V20, P797, DOI 10.4103/1735-1995.168405; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Gonzales E, 2012, J HEPATOL, V57, P695, DOI 10.1016/j.jhep.2012.04.017; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Martinez AI, 2010, MOL GENET METAB, V101, P311, DOI 10.1016/j.ymgme.2010.08.002; Kimura T, 1998, J BIOL CHEM, V273, P27505, DOI 10.1074/jbc.273.42.27505; Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413; Kristiansen RG, 2014, AM J PHYSIOL-GASTR L, V307, pG1024, DOI 10.1152/ajpgi.00244.2014; Liu HS, 2014, CELL RES, V24, P1181, DOI 10.1038/cr.2014.118; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Matoori S, 2015, ADV DRUG DELIVER REV, V90, P55, DOI 10.1016/j.addr.2015.04.009; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagasaka H, 2010, MOL GENET METAB, V100, P123, DOI 10.1016/j.ymgme.2010.02.008; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rozga J, 2006, XENOTRANSPLANTATION, V13, P380, DOI 10.1111/j.1399-3089.2006.00323.x; Schofield JP, 1999, HEPATOLOGY, V29, P181, DOI 10.1002/hep.510290112; Shi XL, 2016, CELL RES, V26, P206, DOI 10.1038/cr.2016.6; Stevens KR, 2015, J BIOMED MATER RES A, V103, P3331, DOI 10.1002/jbm.a.35478; Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204; Sussman NL, 2014, CLIN GASTROENTEROL H, V12, P1439, DOI 10.1016/j.cgh.2014.06.002; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wright G, 2011, LIVER INT, V31, P163, DOI 10.1111/j.1478-3231.2010.02302.x; Wu JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep18759; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003	35	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-4934			J CELL MOL MED	J. Cell. Mol. Med.	DEC	2017	21	12					3214	3223		10.1111/jcmm.13225				10	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FQ7WP	WOS:000418574500008	28557353	gold			2018-01-05	
J	Fang, N; Gu, TX; Wang, YH; Wang, SZ; Wang, FL; An, Y; Wei, WQ; Zhang, WJ; Guo, XQ; Nazarali, AJ; Ji, SP				Fang, Na; Gu, Tingxuan; Wang, Yahui; Wang, Shuzhen; Wang, Fengling; An, Yang; Wei, Wenqiang; Zhang, Weijuan; Guo, Xiangqian; Nazarali, Adil J.; Ji, Shaoping			Expression of PTEN-long mediated by CRISPR/Cas9 can repress U87 cell proliferation	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						PTEN-long; CRISPR/Cas9; gene edition; gene therapy	GENE-THERAPY; LUNG-CANCER; IN-VIVO; MUSCULAR-DYSTROPHY; TUMOR SUPPRESSION; DELIVERY-SYSTEMS; START CODON; MOUSE MODEL; GENOME; CUG	PTEN is a tumour suppressor that is frequently mutated in a variety of cancers. Hence, PTEN has significant potential as a therapeutic molecule. PTEN-long is an alternative translation variant, with an additional 173 amino acids added to the N-terminal of the canonical PTEN when CUG of the mRNA is utilized as the start codon. PTEN-long is secreted into serum and can re-enter cells throughout the body. One of the major barriers for gene therapy is to efficiently and specifically deliver DNA or RNA material to target cells. As an alternative approach, if a therapeutic protein can be directly delivered to target cell of interest, it should theoretically function well within the cells, particularly for genes that are deficiently expressed invivo. Most therapeutic proteins are incapable of efficiently permeating the cell membrane. In this study, we have employed CRISPR/Cas9 gene editing tool combined with single-stranded template to edit CTG of PTEN-long to ATG in the genome. Two guide RNAs close to CTG site were found to have similar efficiency in driving PTEN-long expression. Furthermore, we detected PTEN-long expression in transfected whole-cell lysate and in concentrated culture media in Western blot. Interestingly, the culture media of PTEN-long expression can reduce Akt phosphorylation level and repress U87 cell proliferation compared to wild-type U87 or control media. Taken together, PTEN-long driven by CRISPR/Cas9 imports and exports cells and represses nearby cell proliferation, indicating the PTEN-long generated by CRISPR/Cas9 has potential to be an alternative strategy for PTEN gene therapy.	[Fang, Na; Gu, Tingxuan; Wang, Yahui; Wang, Shuzhen; Wang, Fengling; An, Yang; Wei, Wenqiang; Zhang, Weijuan; Guo, Xiangqian; Ji, Shaoping] Henan Univ, Med Sch, Dept Biochem & Mol Biol, Kaifeng, Henan, Peoples R China; [Fang, Na; Ji, Shaoping] Jiangsu Superbio Co Ltd, Nanjing, Jiangsu, Peoples R China; [Nazarali, Adil J.; Ji, Shaoping] Univ Saskatchewan, Coll Pharm & Nutr & Neurosci Res Cluster, Saskatoon, SK, Canada; [Ji, Shaoping] Henan Univ, Affiliated Hosp 1, Dept Oncol, Kaifeng, Peoples R China	Ji, SP (reprint author), Henan Univ, Med Sch, Dept Biochem & Mol Biol, Kaifeng, Henan, Peoples R China.; Ji, SP (reprint author), Jiangsu Superbio Co Ltd, Nanjing, Jiangsu, Peoples R China.; Ji, SP (reprint author), Univ Saskatchewan, Coll Pharm & Nutr & Neurosci Res Cluster, Saskatoon, SK, Canada.; Ji, SP (reprint author), Henan Univ, Affiliated Hosp 1, Dept Oncol, Kaifeng, Peoples R China.	shaopingji@henu.edu.cn			National Natural Science Foundation of China [31371386]; Program for Excellent Talents in Henan Province [124200510010]; Program for researchers in educational system in Henan Province [17A310004, 15A310001]; Natural Science Foundation of Henan Province [162300410042]	This work is supported by the National Natural Science Foundation of China (No. 31371386); Program for Excellent Talents in Henan Province (No. 124200510010); Program for researchers in educational system in Henan Province (No. 17A310004 and No. 15A310001); Natural Science Foundation of Henan Province(No. 162300410042).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; AMBULOS NP, 1990, GENE, V94, P125, DOI 10.1016/0378-1119(90)90478-A; Amer Magid H, 2014, Mol Cell Ther, V2, P27, DOI 10.1186/2052-8426-2-27; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cucchiarini M, 2016, DISCOV MED, V21, P495; Gagnon KT, 2015, P NATL ACAD SCI USA, V112, P15536, DOI 10.1073/pnas.1521670112; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; He ZY, 2017, METHODS MOL BIOL, V1498, P153, DOI 10.1007/978-1-4939-6472-7_10; High K, 2014, NAT MED, V20, P476, DOI 10.1038/nm.3566; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Ibraheem D, 2014, INT J PHARMACEUT, V459, P70, DOI 10.1016/j.ijpharm.2013.11.041; Legg K, 2013, NAT CELL BIOL, V15, P894; Li D, 2013, CANCER GENE THER, V20, P251, DOI 10.1038/cgt.2013.14; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943                                                   ; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lu Y, 2014, J CONTROL RELEASE, V194, P1, DOI 10.1016/j.jconrel.2014.08.015; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Moussa EM, 2016, J PHARM SCI-US, V105, P417, DOI 10.1016/j.xphs.2015.11.002; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sachdeva M, 2015, CANCER GENE THER, V22, P509, DOI 10.1038/cgt.2015.54; Shalygin A, 2015, J BIOL CHEM, V290, P4717, DOI 10.1074/jbc.M114.601856; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199                                                         ; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tang HB, 2016, EMBO MOL MED, V8, P83, DOI 10.15252/emmm.201506006; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114250; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin L, 2015, J IMMUNOL RES, V2015; Zhang H, 2016, CANCER GENE THER, V23, P13, DOI 10.1038/cgt.2015.59; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhou J, 2016, NEUROCHEM RES, V41, P2065, DOI 10.1007/s11064-016-1918-9; Zuckermann M, 2017, BRIEF FUNCT GENOMICS, V16, P25, DOI 10.1093/bfgp/elw021	39	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-4934			J CELL MOL MED	J. Cell. Mol. Med.	DEC	2017	21	12					3337	3346		10.1111/jcmm.13236				10	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FQ7WP	WOS:000418574500019	28631420	gold			2018-01-05	
J	Kim, YR; Volpert, G; Shin, KO; Kim, SY; Shin, SH; Lee, Y; Sung, SH; Lee, YM; Ahn, JH; Pewzner-Jung, Y; Park, WJ; Futerman, AH; Park, JW				Kim, Ye-Ryung; Volpert, Giora; Shin, Kyong-Oh; Kim, So-Yeon; Shin, Sun-Hye; Lee, Younghay; Sung, Sun Hee; Lee, Yong-Moon; Ahn, Jung-Hyuck; Pewzner-Jung, Yael; Park, Woo-Jae; Futerman, Anthony H.; Park, Joo-Won			Ablation of ceramide synthase 2 exacerbates dextran sodium sulphate-induced colitis in mice due to increased intestinal permeability	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						inflammatory bowel disease; ceramide; sphingolipid; acyl chains; dextran sodium sulphate	EPITHELIAL BARRIER FUNCTION; INFLAMMATORY-BOWEL-DISEASE; ACYL-CHAIN LENGTH; TIGHT-JUNCTION; SPHINGOLIPID METABOLISM; INSULIN-RESISTANCE; MEMBRANE-FLUIDITY; FUMONISIN B-1; CELLS; LIVER	Ceramides mediate crucial cellular processes including cell death and inflammation and have recently been implicated in inflammatory bowel disease. Ceramides consist of a sphingoid long-chain base to which fatty acids of various length can be attached. We now investigate the effect of alerting the ceramide acyl chain length on a mouse model of colitis. Ceramide synthase (CerS) 2 null mice, which lack very-long acyl chain ceramides with concomitant increase of long chain bases and C16-ceramides, were more susceptible to dextran sodium sulphate-induced colitis, and their survival rate was markedly decreased compared with that of wild-type littermates. Using mixed bone-marrow chimeric mice, we showed that the host environment is primarily responsible for intestinal barrier dysfunction and increased intestinal permeability. In the colon of CerS2 null mice, the expression of junctional adhesion molecule-A was markedly decreased and the phosphorylation of myosin light chain 2 was increased. In vitro experiments using Caco-2 cells also confirmed an important role of CerS2 in maintaining epithelial barrier function; CerS2-knockdown via CRISPR-Cas9 technology impaired barrier function. In vivo myriocin administration, which normalized long-chain bases and C16-ceramides of the colon of CerS2 null mice, increased intestinal permeability as measured by serum FITC-dextran levels, indicating that altered SLs including deficiency of very-long-chain ceramides are critical for epithelial barrier function. In conclusion, deficiency of CerS2 influences intestinal barrier function and the severity of experimental colitis and may represent a potential mechanism for inflammatory bowel disease pathogenesis.	[Kim, Ye-Ryung; Kim, So-Yeon; Shin, Sun-Hye; Lee, Younghay; Ahn, Jung-Hyuck; Park, Joo-Won] Ewha Womans Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Volpert, Giora; Pewzner-Jung, Yael; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Shin, Kyong-Oh; Lee, Yong-Moon] Chungbuk Natl Univ, Coll Pharm, Chongju, South Korea; [Sung, Sun Hee] Ewha Womans Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Woo-Jae] Gachon Univ, Dept Biochem, Sch Med, Incheon, South Korea	Park, JW (reprint author), Ewha Womans Univ, Coll Med, Dept Biochem, Seoul, South Korea.; Park, WJ (reprint author), Gachon Univ, Dept Biochem, Sch Med, Incheon, South Korea.	ooze@gachon.ac.kr; joowon.park@ewha.ac.kr			Ministry of Health and Welfare, Republic of Korea [HI14C2445]; Ewha Womans University School of Medicine; Israel Science foundation [1728/15]	This work was supported by grants from the Health Technology R&D Project (HI14C2445) of the Ministry of Health and Welfare, Republic of Korea, by intramural research promotion grants from Ewha Womans University School of Medicine and by grant from the Israel Science foundation (grant number 1728/15). We thank Dr. Kwon Oran (Ewha Womans University, Department of Nutritional Science and Food Management, Seoul, South Korea) for supplying Caco-2 cells. A.H. Futerman is the Joseph Meyerhoff Professor of Biochemistry at the Weizmann Institute of Science.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255                                                     ; Bock J, 2007, WORLD J GASTROENTERO, V13, P5217, DOI 10.3748/wjg.v13.i39.5217                                                        ; Bouhet S, 2004, TOXICOL SCI, V77, P165, DOI 10.1093/toxsci/kfh006; Chassaing B., 2014, CURR PROTOC IMMUNOL, V104, P15, DOI DOI 10.1002/0471142735.IM1525S104; Coskun M, 2017, TRENDS PHARMACOL SCI, V38, P127, DOI 10.1016/j.tips.2016.10.014; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458                                                     ; Enongene EN, 2000, FOOD CHEM TOXICOL, V38, P793, DOI 10.1016/S0278-6915(00)00065-X; Ferruzza S, 2012, TOXICOL IN VITRO, V26, P1252, DOI 10.1016/j.tiv.2012.01.008; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; HOLLANDER D, 1988, GUT, V29, P1621, DOI 10.1136/gut.29.12.1621                                                          ; Huang WC, 2016, FASEB J, V30, P2945, DOI 10.1096/fj.201600394R; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Khajuria A, 2002, PHYTOMEDICINE, V9, P224, DOI 10.1078/0944-7113-00114; Kim JJ, 2012, JOVE-J VIS EXP, V60, P3678, DOI DOI 10.3791/3678; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kowapradit J, 2010, AAPS PHARMSCITECH, V11, P497, DOI 10.1208/s12249-010-9399-7; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416                                                            ; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; LEGRIMELLEC C, 1992, KIDNEY INT, V42, P825, DOI 10.1038/ki.1992.357; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin YL, 2014, CELL MOL IMMUNOL, V11, P355, DOI 10.1038/cmi.2014.15; M'Koma AE, 2013, CLIN MED INSIGHTS-GA, V6, P33, DOI 10.4137/CGast.S12731; Michielan A, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/628157; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Molodecky Natalie A, 2010, Gastroenterol Hepatol (N Y), V6, P339; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Park WJ, 2015, BIOL CHEM, V396, P693, DOI 10.1515/hsz-2014-0310; Park WJ, 2014, BBA-MOL CELL BIOL L, V1841, P1754, DOI 10.1016/j.bbalip.2014.09.009; Park WJ, 2013, J BIOL CHEM, V288, P30904, DOI 10.1074/jbc.M112.448852; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Shen L, 2009, DIGEST DIS, V27, P443, DOI 10.1159/000233282; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Tsukamoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132363; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	56	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-4934			J CELL MOL MED	J. Cell. Mol. Med.	DEC	2017	21	12					3565	3578		10.1111/jcmm.13267				14	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FQ7WP	WOS:000418574500038	28699686	gold			2018-01-05	
J	Yang, QY; Ding, B; Zhou, XP				Yang Qiu-ying; Ding Bo; Zhou Xue-ping			Geminiviruses and their application in biotechnology	JOURNAL OF INTEGRATIVE AGRICULTURE			English	Review						geminivirus; virus-based vectors; expression vectors; VIGS vectors; biotechnology	MULTAN BETASATELLITE DNA; GENE SILENCING SYSTEM; DOUBLE-STRANDED-RNA; CURLY-TOP-VIRUS; MOSAIC-VIRUS; COAT PROTEIN; FUNCTIONAL GENOMICS; CRISPR/CAS9 SYSTEM; SHUTTLE VECTOR; HELPER VIRUS	Being a major class of single-stranded DNA viruses, geminiviruses are mostly studied due to their catastrophic infectious effect on crops. These DNA viruses are characteristic for their ability in quickly multiplying viral genetic materials without integrating into the genome of plants, which makes them ideal for developing viral vectors for plants bioengineering. Geminivirus-derived vectors can be classified into expression vectors and virus-induced gene silencing (VIGS) vectors. Details of the design, construction, application and improvements of these geminivirus vectors are summarized and discussed.	[Yang Qiu-ying; Ding Bo; Zhou Xue-ping] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pest, Beijing 100193, Peoples R China	Zhou, XP (reprint author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pest, Beijing 100193, Peoples R China.	qyyang@ippcaas.cn; zzhou@zju.edu.cn			National Natural Science Foundation of China [31672006, 31390422]	This research was supported by the National Natural Science Foundation of China (31672006 and 31390422). We thank technical editor, Carl Frederick Rupprecht (Marconi Communications, Inc., USA) for thoroughly reading and editing this manuscript in grammar and words. We apologize for not being able to cover or cite all the achievements in geminivirus biotechnology research.	Ali S, 2001, PLANT MOL BIOL, V46, P325, DOI 10.1023/A:1010669204137; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; Behjatnia SAA, 1998, NUCLEIC ACIDS RES, V26, P925; BURAGOHAIN AK, 1994, J GEN VIROL, V75, P2857, DOI 10.1099/0022-1317-75-10-2857; Carrillo-Tripp J, 2006, CURR OPIN PLANT BIOL, V9, P209, DOI 10.1016/j.pbi.2006.01.012; Castillo-Gonzalez C, 2015, ELIFE, V4, DOI 10.7554/eLife.06671; Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262; Christensen N, 2009, TRAFFIC, V10, P536, DOI 10.1111/j.1600-0854.2009.00889.x; Chung HY, 2011, PLANT CELL REP, V30, P1513, DOI 10.1007/s00299-011-1062-6; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Eini O, 2016, VIRUS GENES, V52, P679, DOI 10.1007/s11262-016-1354-6; Esparza-Araiza MJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01019; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fofana IBF, 2004, PLANT MOL BIOL, V56, P613, DOI 10.1007/s11103-004-0161-y; Frischmuth T, 1998, J GEN VIROL, V79, P1265, DOI 10.1099/0022-1317-79-5-1265                                                     ; Fu DQ, 2006, MOL CELLS, V21, P153; Gao SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066046; GARDINER WE, 1988, EMBO J, V7, P899; Ghandi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19715; Golenberg EM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-9; Gould R., 2016, GENETICALLY ENG CROP; Gover O, 2014, ARCH VIROL, V159, P2263, DOI 10.1007/s00705-014-2066-7; Gu ZH, 2014, PLANT BIOTECHNOL J, V12, P638, DOI 10.1111/pbi.12169; Guan CP, 2006, VIRUS RES, V115, P150, DOI 10.1016/j.virusres.2005.08.002; Hong SH, 2004, BIOTECHNOL LETT, V26, P1433, DOI 10.1023/B:BILE.0000045647.91071.40; HOWELL SH, 1980, SCIENCE, V208, P1265, DOI 10.1126/science.208.4449.1265                                                   ; Huang CJ, 2011, J ZHEJIANG UNIV-SC B, V12, P83, DOI 10.1631/jzus.B1000157; Huang CJ, 2009, PLANT BIOTECHNOL J, V7, P254, DOI 10.1111/j.1467-7652.2008.00395.x; HULL R, 1978, TRENDS BIOCHEM SCI, V3, P254, DOI 10.1016/S0968-0004(78)95435-X                                                   ; Il Kim K, 2007, PLANT MOL BIOL, V64, P103, DOI 10.1007/s11103-007-9137-z; Jackel JN, 2015, J VIROL, V89, P3176, DOI 10.1128/JVI.02625-14; Jeyabharathy C, 2015, VIRUS RES, V195, P73, DOI 10.1016/j.virusres.2014.08.009; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531                                                                   ; Kharazmi S, 2016, MOL BIOTECHNOL, V58, P362, DOI 10.1007/s12033-016-9935-0; Kjemtrup S, 1998, PLANT J, V14, P91, DOI 10.1046/j.1365-313X.1998.00101.x                                                ; Krenz B, 2010, J VIROL METHODS, V169, P129, DOI 10.1016/j.jviromet.2010.07.010; Kumar J, 2014, ARCH VIROL, V159, P2109, DOI 10.1007/s00705-014-2039-x; Kushwaha NK, 2017, APPL MICROBIOL BIOT, V101, P2121, DOI 10.1007/s00253-016-7964-z; Li C, 2014, PLANT PHYSIOL, V166, P2179, DOI 10.1104/pp.114.246694; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Nakade S, 2017, BIOENGINEERED, V8, P265, DOI 10.1080/21655979.2017.1282018; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pandey P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-152; Peele C, 2001, PLANT J, V27, P357, DOI 10.1046/j.1365-313x.2001.01080.x; Peyret H, 2015, PLANT BIOTECHNOL J, V13, P1121, DOI 10.1111/pbi.12412; Regnard GL, 2010, PLANT BIOTECHNOL J, V8, P38, DOI 10.1111/j.1467-7652.2009.00462.x; Reichel M, 2015, PLANT BIOTECHNOL J, V13, P915, DOI 10.1111/pbi.12327; Rodriguez-Negrete E, 2013, NEW PHYTOL, V199, P464, DOI 10.1111/nph.12286; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Sha AH, 2014, PLANT PHYSIOL, V164, P36, DOI 10.1104/pp.113.231100; Shukla R, 2013, J BIOSCIENCES, V38, P45, DOI 10.1007/s12038-012-9291-6; Soitamo AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-204; STANLEY J, 1995, VIROLOGY, V206, P707, DOI 10.1016/S0042-6822(95)80093-X; Sunter G, 1997, VIROLOGY, V232, P269, DOI 10.1006/viro.1997.8549; Tamilselvi D, 2004, PLANT CELL REP, V23, P81, DOI 10.1007/s00299-004-0792-0; Tang Yang, 2013, Methods Mol Biol, V975, P99, DOI 10.1007/978-1-62703-278-0_8; TOWNSEND R, 1986, NUCLEIC ACIDS RES, V14, P1253, DOI 10.1093/nar/14.3.1253; Turnage MA, 2002, PLANT J, V30, P107, DOI 10.1046/j.1365-313X.2002.01261.x; Tuttle JR, 2015, METHODS MOL BIOL, V1287, P219, DOI 10.1007/978-1-4939-2453-0_16; Tuttle JR, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-27; Unver T, 2009, INT J PLANT GENOMICS, V2009, DOI [10.1155/2009/198680, DOI 10.1155/2009/198680]; Varsani A, 2017, ARCH VIROL, V162, P1819, DOI 10.1007/s00705-017-3268-6; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; [杨秋颖 Yang Qiuying], 2016, [中国科学. 生命科学, Scientia Sinica Vitae], V46, P524; Yang QY, 2015, GENE DEV, V29, P526, DOI 10.1101/gad.255828.114; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Zhang J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-234; Zhang J, 2012, VIRUS RES, V163, P51, DOI 10.1016/j.virusres.2011.08.009; Zhang T, 2016, J VIROL, V90, P2077, DOI 10.1128/JVI.02290-15; Zhao JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01565	72	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2095-3119			J INTEGR AGR	J. Integr. Agric.	DEC	2017	16	12					2761	2771		10.1016/S2095-3119(17)61702-7				11	Agriculture, Multidisciplinary	Agriculture	FQ4RQ	WOS:000418345800011					2018-01-05	
J	Yang, YL; Zhou, R; Li, K				Yang Ya-lan; Zhou Rong; Li Kui			Future livestock breeding: Precision breeding based on multiomics information and population personalization	JOURNAL OF INTEGRATIVE AGRICULTURE			English	Review						livestock breeding; multi-omics; population personalization	SKELETAL-MUSCLE DEVELOPMENT; GENOMIC SELECTION; MESSENGER-RNA; DNA METHYLATION; PIG BREEDS; CATTLE; TRAITS; OBESE; GENE; TRANSCRIPTOME	With the rapid development of molecular biology and related disciplines, animal breeding has moved from conventional breeding to molecular breeding. Marker-assisted selection and genomic selection have become mainstream practices in molecular breeding of livestock. However, these techniques only use information from genomic variation but not multi-omics information, thus do not fully explain the molecular basis of phenotypic variations in complex traits. In addition, the accuracy of breeding value estimation based on these techniques is occasionally controversial in different populations or varieties. Given the rapid development of high-throughput sequencing techniques and functional genome and dramatic reductions in the overall cost of sequencing, it is possible to clarify the interactions between genes and formation of phenotypes using massive sets of omic-level data from studies of the transcriptome, proteome, epigenome, and metabolome. During livestock breeding, multi-omics information regarding breeding populations and individuals should be taken into account. The interactive regulatory networks governing gene regulation and phenotype formation in diverse livestock population, varieties and species should be analyzed. In addition, a multi-omics regulatory breeding model should be constructed. Precision, population-personalized breeding is expected to become a crucial practice in future livestock breeding. Precision breeding of individuals can be achieved by combining population genomic information at multi-omics levels together with genomic selection and genome editing techniques.	[Yang Ya-lan; Zhou Rong; Li Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Li, K (reprint author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	likui@caas.cn			National High Technology Plan of China [2013 AA102502]; National Natural Science Foundation of China [313300453]; National Key Basic Research Program of China [2015CB943101]	This work was supported by National High Technology Plan of China (2013 AA102502), the National Natural Science Foundation of China (313300453) and the National Key Basic Research Program of China (2015CB943101).	Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Bai LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119396; Bertram HC, 2003, MEAT SCI, V65, P1281, DOI 10.1016/S0309-1740(03)00038-X; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Couldrey C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101853; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Do DN, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00307; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x                                                ; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; He YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039094; Hou XH, 2016, MOL GENET GENOMICS, V291, P559, DOI 10.1007/s00438-015-1126-3; Hou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052123; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Ibanez-Escriche N, 2014, LIVEST SCI, V166, P94, DOI 10.1016/j.livsci.2014.05.020; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721                                                          ; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Lund MS, 2014, LIVEST SCI, V166, P101, DOI 10.1016/j.livsci.2014.05.008; Lynch M., 1998, GENETICS ANAL QUANTI; Marino R, 2014, MEAT SCI, V98, P178, DOI 10.1016/j.meatsci.2014.05.024; Meuwissen THE, 2001, GENETICS, V157, P1819; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Pryce JE, 2012, ANIM PROD SCI, V52, P107, DOI 10.1071/AN11098; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruan JX, 2015, SCI REP, V5, P14253; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tang ZL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43166; Tang ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15544; van der Werf J., 2013, METHODS MOL BIOL MET, V1019; Villanueva B, 2004, J ANIM SCI, V82, P1305; Yang YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39883; Yang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30160; Zhao WM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08957	46	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2095-3119			J INTEGR AGR	J. Integr. Agric.	DEC	2017	16	12					2784	2791		10.1016/S2095-3119(17)61780-5				8	Agriculture, Multidisciplinary	Agriculture	FQ4RQ	WOS:000418345800013					2018-01-05	
J	Wang, YF; Huang, JJ; Zhao, JG				Wang Yan-fang; Huang Jiao-jiao; Zhao Jian-guo			Gene engineering in swine for agriculture	JOURNAL OF INTEGRATIVE AGRICULTURE			English	Review						gene engineering; genome editing; pig; agricultural application	ZINC-FINGER NUCLEASES; RESPIRATORY SYNDROME VIRUS; ONE-STEP GENERATION; GENETICALLY-MODIFIED PIGS; DOUBLE-MUSCLED PHENOTYPE; TRANSGENIC PIGS; MYOSTATIN GENE; CRISPR/CAS9 SYSTEM; HUMAN-DISEASES; KNOCKOUT PIGS	Domestic pigs are the second most important source of meat world-wide, and the genetic improvement of economic traits, such as meat production, growth, and disease resistance, is a critical point for efficient production in pigs. Through conventional breeding and selection programs in pigs, which are painstakingly slow processes, some economic traits, such as growth and backfat, have been greatly improved over the past several decades. However, the improvement of many polygenetic traits is still very slow and challenging to be improved by conventional breeding strategies. The development of reproductive knowledge and a variety of techniques, including foreign gene transfer strategies, somatic cell nuclear transfer (SCNT) and particularly, recently developed nuclease-mediated genome editing tools, has provided efficient ways to produce genetically modified (GM) pigs for the dramatic improvement of economic traits. In this review, we briefly discuss the progress of genomic markers used in pig breeding program, trace the history of genetic engineering, mainly focusing on the progress of recently developed genome editing tools, and summarize the GM pigs which have been generated to aim at the agricultural purposes. We also discuss the specific challenges facing application of gene engineering in pig breeding, and future prospects.	[Wang Yan-fang] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Huang Jiao-jiao; Zhao Jian-guo] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Zhao Jian-guo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Zhao, JG (reprint author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.; Zhao, JG (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wangyanfang@caas.cn; zhaojg@ioz.ac.cn			National Natural Science Foundation of China [81671274, 31601008, 31402045]; National Transgenic Project of China [2016ZX08009003-006]; Elite Youth Program of the Chinese Academy of Agricultural Sciences [ASTIP-IAS05]	This study was supported by the National Natural Science Foundation of China (81671274, 31601008 and 31402045), the National Transgenic Project of China (2016ZX08009003-006), and the Elite Youth Program of the Chinese Academy of Agricultural Sciences to Wang Yanfang (ASTIP-IAS05).	Bi YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31729; Brevini TAL, 2007, THERIOGENOLOGY, V68, pS206, DOI 10.1016/j.theriogenology.2007.05.043; Butler JR, 2015, INT J SURG, V23, P217, DOI 10.1016/j.ijsu.2015.07.684; Cabot RA, 2001, ANIM BIOTECHNOL, V12, P205, DOI 10.1081/ABIO-100108347; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chang Keejong, 2002, BMC Biotechnol, V2, P5, DOI 10.1186/1471-2393-2-5; Chen P, 2002, J ANIM SCI, V80, P2062; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Ernst CW, 2013, TRENDS GENET, V29, P215, DOI 10.1016/j.tig.2013.02.002; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380                                                         ; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hai T, 2017, ELIFE, V6, DOI 10.7554/eLife.26243; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hickey JM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-9; Hickey JM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-12; Hofmann A, 2003, EMBO REP, V4, P1054, DOI [10.1038/sj.embor.7400007, 10.1038/sj.embor.embor7400007]; Hu SW, 2015, ELIFE, V4, DOI 10.7554/eLife.06951; Huang J, 2014, J IMMUNOL, V193, P1496, DOI [10.4049/jimmuno1.1400915, 10.4049/jimmunol.1400915]; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jenko J, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0135-3; Jiang K, 2017, TRANSGENIC RES, V26, P515, DOI 10.1007/s11248-017-0026-1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910                                                              ; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Kijas JW, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-80; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Laible G, 2015, BIOTECHNOL J, V10, P109, DOI 10.1002/biot.201400193; Lavitrano M, 1997, TRANSPLANT P, V29, P3508, DOI 10.1016/S0041-1345(97)00998-6                                                   ; [李飞达 Li Feida], 2014, [遗传, Hereditas(Beijing)], V36, P903, DOI 10.3724/SP.J.1005.2014.0903; Li P, 2015, XENOTRANSPLANTATION, V22, P20, DOI 10.1111/xen.12131; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; LO D, 1991, EUR J IMMUNOL, V21, P1001, DOI 10.1002/eji.1830210421; Lu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169317; Ma J, 2016, GENE, V584, P7, DOI 10.1016/j.gene.2016.02.024; Marchitelli C, 2003, MAMM GENOME, V14, P392, DOI 10.1007/s00335-002-2176-5; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meuwissen THE, 2001, GENETICS, V157, P1819; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; MULLER M, 1992, GENE, V121, P263, DOI 10.1016/0378-1119(92)90130-H; Mussolino C, 2013, NAT BIOTECHNOL, V31, P208, DOI 10.1038/nbt.2527; Pena RN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122100; Nottle MB, 1999, TRANSGENIC ANIMALS IN AGRICULTURE, P145; Palgrave CJ, 2011, J VIROL, V85, P6008, DOI 10.1128/JVI.00331-11; Pan DK, 2010, SCI CHINA LIFE SCI, V53, P517, DOI 10.1007/s11427-010-0080-x; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Pereyra-Bonnet F, 2008, REPROD FERT DEVELOP, V20, P741, DOI 10.1071/RD07172; Petersen B, 2015, TRANSGENIC RES, V24, P381, DOI 10.1007/s11248-015-9862-z; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Popescu L, 2017, VIROLOGY, V501, P102, DOI 10.1016/j.virol.2016.11.012; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; PURSEL VG, 1990, J REPROD FERTIL, P77; PURSEL VG, 1993, MOL REPROD DEV, V36, P251, DOI 10.1002/mrd.1080360223; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Redel BK, 2016, TOXICOL PATHOL, V44, P428, DOI 10.1177/0192623315613160; Ren XJ, 2014, G3-GENES GENOM GENET, V4, P1955, DOI 10.1534/g3.114.013821; Ruan JX, 2015, SCI REP, V5, P14253; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tanihara F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600803; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Eenennaam AL, 2014, ANNU REV ANIM BIOSCI, V2, P105, DOI 10.1146/annurev-animal-022513-114119; Van Eenennaam AL, 2017, CURR OPIN BIOTECH, V44, P27, DOI 10.1016/j.copbio.2016.10.007; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20620; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; WEIDLE UH, 1991, GENE, V98, P185, DOI 10.1016/0378-1119(91)90172-8; Wells K D, 2017, J VIROL, V91; Wells KD, 2017, MOL REPROD DEV, V84, P1012, DOI 10.1002/mrd.22812; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Whyte JJ, 2011, MOL REPROD DEV, V78, P2, DOI 10.1002/mrd.21271; Xu P, 2016, TRANSGENIC RES, V25, P693, DOI 10.1007/s11248-016-9963-3; Yan Quanmei, 2014, Cell Regen (Lond), V3, P11, DOI 10.1186/2045-9769-3-11; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yang X, 2015, INFECT IMMUN, V83, P2836, DOI 10.1128/IAI.03101-14; Yao J, 2016, HUM GENET, V135, P1093, DOI 10.1007/s00439-016-1710-6; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhou XY, 2016, HUM MUTAT, V37, P110, DOI 10.1002/humu.22913	104	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2095-3119			J INTEGR AGR	J. Integr. Agric.	DEC	2017	16	12					2792	2804		10.1016/S2095-3119(17)61766-0				13	Agriculture, Multidisciplinary	Agriculture	FQ4RQ	WOS:000418345800014					2018-01-05	
J	Furuhata, Y; Nihongaki, Y; Sato, M; Yoshimoto, K				Furuhata, Yuichi; Nihongaki, Yuta; Sato, Moritoshi; Yoshimoto, Keitaro			Control of Adipogenic Differentiation in Mesenchymal Stem Cells via Endogenous Gene Activation Using CRISPR-Cas9	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR-Cas9; differentiation; gene activation; mesenchymal stem cells; white adipocyte; beige adipocyte	TRANSCRIPTION; BROWN; FIBROBLASTS; EXPRESSION; THERAPY; WHITE	Mesenchymal stem cells (MSCs) are of interest in regenerative medicine owing to their multilineage differentiation and self-renewal properties. Understanding the in vivo differentiation process is necessary for clinical applications including cell therapy and transplantation. This remains challenging owing to the lack of induction methods that imitate the natural programming process. Endogenous gene regulation of tissue-specific transcription factors is therefore desirable. In the present study, we demonstrated endogenous activation of adipogenic genes through the dCas9-based transcription system and achieved efficient induction of different types of adipocyte-like cells from MSCs. Interestingly, the MSCs converted via single-gene activation exhibited morphological and molecular properties of white adipocytes, while beige adipocyte-like cells were induced via multiplex gene activation of three specific transcription factors. These results reveal that the fate of MSCs can be effectively manipulated by direct activation of specific endogenous gene expression using a dCas9-based activator with reduced exogenous additives.	[Furuhata, Yuichi] Univ Tokyo, Dept Computat Biol & Med Sci, Grad Sch Frontier Sci, Minato Ku, Shirokanedai 4-6-1, Tokyo 1088639, Japan; [Nihongaki, Yuta; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan; [Yoshimoto, Keitaro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan; [Yoshimoto, Keitaro] Univ Tokyo, PRESTO, JST, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan	Sato, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.; Yoshimoto, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.; Yoshimoto, K (reprint author), Univ Tokyo, PRESTO, JST, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	cmsato@maiLecc.u-tokyo.ac.jp; ckeitaro@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI [15K13721]; JST-PRESTO [JPMJPR16FB]; JST-CREST [JPMJCR1653]; JST-START; JSPS [15J08446, 15J05897]	This work was partially supported by the JSPS KAKENHI [Grant 15K13721], JST-PRESTO [Grant JPMJPR16FB], JST-CREST [Grant JPMJCR1653], JST-START, and JSPS Research Fellowships for Young Scientists [Grants 15J08446 and 15J05897].	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Frith J, 2008, TRANSFUS MED HEMOTH, V35, P216, DOI 000127448; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Griffin MD, 2013, STEM CELLS, V31, P2033, DOI 10.1002/stem.1452; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X                                                    ; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Wei S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19648	27	0	0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	DEC	2017	6	12					2191	2197		10.1021/acssynbio.7b00246				7	Biochemical Research Methods	Biochemistry & Molecular Biology	FQ5JR	WOS:000418395600004	29077398				2018-01-05	
J	Moreb, EA; Hoover, B; Yaseen, A; Valyasevi, N; Roecker, Z; Menacho-Melgar, R; Lynch, MD				Moreb, Eirik Adim; Hoover, Benjamin; Yaseen, Adam; Valyasevi, Nisakorn; Roecker, Zoe; Menacho-Melgar, Romel; Lynch, Michael D.			Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity	ACS SYNTHETIC BIOLOGY			English	Article						genome editing; recombineering; cas9; RecA; RecA56; SOS	ESCHERICHIA-COLI; OFF-TARGET; HOMOLOGOUS RECOMBINATION; SGRNA DESIGN; IN-VITRO; GENOME; PROTEIN; SYSTEM; MUTAGENESIS; REPAIR	Phage-derived "recombineering" methods are utilized for bacterial genome editing. Recombineering results in a heterogeneous population of modified and unmodified chromosomes, and therefore selection methods, such as CRISPR-Cas9, are required to select for edited clones. Cells can evade CRISPR-Cas-induced cell death through recA-mediated induction of the SOS response. The SOS response increases RecA dependent repair as well as mutation rates through induction of the umuDC error prone polymerase. As a result, CRISPR-Cas selection is more efficient in recA mutants. We report an approach to inhibiting the SOS response and RecA activity through the expression of a mutant dominant negative form of RecA, which incorporates into wild type RecA filaments and inhibits activity. Using a plasmid-based system in which Cas9 and recA mutants are coexpressed, we can achieve increased efficiency and consistency of CRISPR-Cas9-mediated selection and recombineering in E. coli, while reducing the induction of the SOS response. To date, this approach has been shown to be independent of recA genotype and host strain lineage. Using this system, we demonstrate increased CRISPR-Cas selection efficacy with over 10 000 guides covering the E. coli chromosome. The use of dominant negative RecA or homologues may be of broad use in bacterial CRISPR-Cas-based genome editing where the SOS pathways are present.	[Moreb, Eirik Adim; Hoover, Benjamin; Yaseen, Adam; Valyasevi, Nisakorn; Roecker, Zoe; Menacho-Melgar, Romel; Lynch, Michael D.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Lynch, MD (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	michael.lynch@duke.edu			NSF EAGER [1445726]; ONR YIP [12043956]; DOE [EE0007563]; Genscript; Duke Energy Initiative; Duke Undergraduate Research Support Office; Lord Foundation of North Carolina; Duke Bass Connections Program	We would like to acknowledge Tyler Klann and Charles Gersbach with Duke Biomedical Engineering for support with next generation sequencing. In addition, we would like to thank Eric Toone and Dewey McCafferty with Duke Chemistry for support and use of key lab equipment. We would like to acknowledge the following support: NSF EAGER #1445726, ONR YIP # 12043956, DOE #EE0007563, a grant from Genscript, and funding from the Duke Energy Initiative. We would also like to thank the Duke Undergraduate Research Support Office, the Lord Foundation of North Carolina and the Duke Bass Connections Program for supporting undergraduate students on this project	Amundsen SK, 2007, GENETICS, V175, P41, DOI 10.1534/genetics.106.065524; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Boyle NR, 2013, BIOTECHNOL J, V8, P515, DOI 10.1002/biot.201200237; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Cebrian-Serrano A, 2017, MAMM GENOME, V28, P247, DOI 10.1007/s00335-017-9697-4; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Clarke L, 1992, Biotechnology, V24, P179; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989                                                 ; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Enyeart PJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.41; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; JOHNSON RD, 1995, MOL CELL BIOL, V15, P4843; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; Kuzminov A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006229; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAUDER SD, 1993, J MOL BIOL, V234, P72, DOI 10.1006/jmbi.1993.1564; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Massoni SC, 2012, J BACTERIOL, V194, P5325, DOI 10.1128/JB.00674-12; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Norman A, 2005, APPL ENVIRON MICROB, V71, P2338, DOI 10.1128/AEM.71.5.2338-2346.2005; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3                                                   ; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Prior JE, 2010, BIOTECHNOL BIOENG, V106, P326, DOI 10.1002/bit.22695; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Smith BT, 1998, GENETICS, V148, P1599; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Thomason L. C., 2014, CURR PROTOC MOL BIOL, V106, P1; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zerbini F, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0681-1; Zhao DD, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0605-5; Zheng X, 2017, BIOCHEM BIOPH RES CO, V485, P768, DOI 10.1016/j.bbrc.2017.02.129	57	0	0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	DEC	2017	6	12					2209	2218		10.1021/acssynbio.7b00174				10	Biochemical Research Methods	Biochemistry & Molecular Biology	FQ5JR	WOS:000418395600006	28915012				2018-01-05	
J	Bari, SMN; Walker, FC; Cater, K; Aslan, B; Hatoum-Aslan, A				Bari, S. M. Nayeemul; Walker, Forrest C.; Cater, Katie; Aslan, Barbaros; Hatoum-Aslan, Asma			Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10	ACS SYNTHETIC BIOLOGY			English	Article						Type III-A CRISPR-Cas; CRISPR-Cas10; bacteriophage; genome editing; staphylococci	CAS SYSTEMS; BACTERIAL PATHOGENS; ANTIVIRAL DEFENSE; SEED SEQUENCE; AUREUS; RNA; IMMUNITY; DNA; EPIDERMIDIS; RESISTANCE	Staphylococci are prevalent skin-dwelling bacteria that are also leading causes of antibiotic-resistant infections. Viruses that infect and lyse these organisms (virulent staphylococcal phages) can be used as alternatives to conventional antibiotics and represent promising tools to eliminate or manipulate specific species in the microbiome. However, since over half their genes have unknown functions, virulent staphylococcal phages carry inherent risk to cause unknown downstream side effects. Further, their swift and destructive reproductive cycle make them intractable by current genetic engineering techniques. CRISPR-Cas10 is an elaborate prokaryotic immune system that employs small RNAs and a multisubunit protein complex to detect and destroy phages and other foreign nucleic acids. Some staphylococci naturally possess CRISPR-Cas10 systems, thus providing an attractive tool already installed in the host chromosome to harness for phage genome engineering. However, the efficiency of CRISPR-Cas10 immunity against virulent staphylococcal phages and corresponding utility as a tool to facilitate their genome editing has not been explored. Here, we show that the CRISPR-Cas10 system native to Staphylococcus epidermidis exhibits robust immunity against diverse virulent staphylococcal phages. On the basis of this activity, a general two-step approach was developed to edit these phages that relies upon homologous recombination machinery encoded in the host. Variations of this approach to edit toxic phage genes and access phages that infect CRISPR-less staphylococci are also presented. This versatile set of genetic tools enables the systematic study of phage genes of unknown functions and the design of genetically defined phage-based antimicrobials that can eliminate or manipulate specific Staphylococcus species.	[Bari, S. M. Nayeemul; Walker, Forrest C.; Cater, Katie; Aslan, Barbaros; Hatoum-Aslan, Asma] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA	Hatoum-Aslan, A (reprint author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	ahatoum@ua.edu			University of Alabama (UA) College of Arts and Sciences; UA College Academy of Research, Scholarship, and Creative Activity (CARSCA); National Institutes of Health [5K22AI113106-02]	This work was supported by start-up funds from the University of Alabama (UA) College of Arts and Sciences; a grant from the UA College Academy of Research, Scholarship, and Creative Activity (CARSCA); and a grant from the National Institutes of Health [5K22AI113106-02] awarded to A.H.-A.	Ando H, 2015, CELL SYST, V1, P187, DOI 10.1016/j.cels.2015.08.013; Tormo MA, 2008, J BACTERIOL, V190, P2434, DOI 10.1128/JB.01349-07; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Borysowski J, 2011, BIODRUGS, V25, P347, DOI 10.2165/11595610-000000000-00000; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cater K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00040-17; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Cooper C. J., 2016, FRONT MICROBIOL, V7, P1; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gorski A, 2012, ADV VIRUS RES, V83, P41, DOI 10.1016/B978-0-12-394438-2.00002-5; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hatoum-Aslan A, 2014, CURR OPIN MICROBIOL, V17, P82, DOI 10.1016/j.mib.2013.12.001; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Joubert L, 2017, SCI REP-UK, V7, DOI 10.1038/srep40435; Kazmierczak Z, 2014, VIRUSES-BASEL, V6, P2551, DOI 10.3390/v6072551; Keen EC, 2017, MBIO, V8, DOI 10.1128/mBio.02115-16; Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lemay ML, 2017, ACS SYNTH BIOL, V6, P1351, DOI 10.1021/acssynbio.6b00388; Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P1133; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806                                                     ; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Uchiyama J, 2014, ISME J, V8, P1949, DOI 10.1038/ismej.2014.29; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	54	0	0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	DEC	2017	6	12					2316	2325		10.1021/acssynbio.7b00240				10	Biochemical Research Methods	Biochemistry & Molecular Biology	FQ5JR	WOS:000418395600016	28885820				2018-01-05	
J	Wu, MY; Sung, LY; Li, H; Huang, CH; Hu, YC				Wu, Meng-Ying; Sung, Li-Yu; Li, Hung; Huang, Chun-Hung; Hu, Yu-Chen			Combining CRISPR and CRISPRi Systems for Metabolic Engineering of E. coli and 1,4-BDO Biosynthesis	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR; CRISPRi; 1,4-BDO; genome engineering; gene knockdown; metabolic engineering	SEQUENCE-SPECIFIC CONTROL; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; INTERFERENCE CRISPRI; GENE-EXPRESSION; GENOME; PATHWAY; 1,4-BUTANEDIOL; STEP; INTEGRATION	Biosynthesis of 1,4-butanediol (1,4-BDO) in E. coli requires an artificial pathway that involves six genes and time-consuming, iterative genome engineering. CRISPR is an effective gene editing tool, while CRISPR interference (CRISPRi) is repurposed for programmable gene suppression. This study aimed to combine both CRISPR and CRISPRi for metabolic engineering of E. coli and 1,4-BDO production. We first exploited CRISPR to perform point mutation of gltA, replacement of native IpdA with heterologous 1pdA, knockout of sad and knock-in of two large (6.0 and 6.3 kb in length) gene cassettes encoding the six genes (cat1, sucD, 4hbd, cat2, bid, bdh) in the 1,4-BDO biosynthesis pathway. The successive E. coli engineering enabled production of 1,4-BDO to a titer of 0.9 g/L in 48 h. By combining the CRISPRi system to simultaneously suppress competing genes that divert the flux from the 1,4-BDO biosynthesis pathway (gabD, ybgC and tesB) for >85%, we further enhanced the 1,4-BDO titer for 100% to 1.8 g/L while reducing the titers of byproducts gamma-butyrolactone and succinate for 55% and 83%, respectively. These data demonstrate the potential of combining CRISPR and CRISPRi for genome engineering and metabolic flux regulation in microorganisms such as E. coli and production of chemicals (e.g., 1,4-BDO).	[Wu, Meng-Ying; Sung, Li-Yu; Li, Hung; Huang, Chun-Hung; Hu, Yu-Chen] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan	Wu, MY; Sung, LY; Li, H; Huang, CH; Hu, YC (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.	fk85023@gmail.com; skf909090@gmail.com; hli@gapp.nthu.edu.tw; evermore90725@gmail.com; yuchen@che.nthu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2622-E-007-025, 104-2622-8-007-001, 105-2622-8-007-009]	We acknowledge Prof. Roa-Pu Shen for suggestions and Prof. James Liao for providing pKD46 plasmid for recombineering. This work was supported by the Ministry of Science and Technology (MOST 103-2622-E-007-025, 104-2622-8-007-001 and 105-2622-8-007-009), Taiwan.	Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Barton NR, 2015, J IND MICROBIOL BIOT, V42, P349, DOI 10.1007/s10295-014-1541-1; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Burgard A, 2016, CURR OPIN BIOTECH, V42, P118, DOI 10.1016/j.copbio.2016.04.016; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Chen B., 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKV1533; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cress BF, 2016, NUCLEIC ACIDS RES, V44, P4472, DOI 10.1093/nar/gkw231; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gordon GC, 2016, METAB ENG, V38, P170, DOI 10.1016/j.ymben.2016.07.007; Goyal A, 2016, NUCLEIC ACIDS RES, V2016, DOI [DOI 10.1093/NAR/GKW883, 10.1093/nar/gkw883.]; Huang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0595-3; Hwang HJ, 2014, BIOTECHNOL BIOENG, V111, P1374, DOI 10.1002/bit.25196; Jakociunas T, 2017, CURR OPIN BIOTECH, V46, P134, DOI 10.1016/j.copbio.2017.03.014; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Li SY, 2016, METAB ENG, V38, P274, DOI [10.1016.j.ymben.2016.09.003, 10.1016/j.ymben.2016.09.003]; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liang LY, 2017, METAB ENG, V41, P1, DOI 10.1016/j.ymben.2017.02.009; Liu HW, 2015, METAB ENG, V29, P135, DOI 10.1016/j.ymben.2015.03.009; Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Shen CC, 2017, ACS SYNTH BIOL, V6, P1509, DOI 10.1021/acssynbio.7b00020; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; Singh Atul K, 2016, Nucleic Acids Res, V44, pe143; Tai YS, 2016, NAT CHEM BIOL, V12, P247, DOI [10.1038/NCHEMBIO.2020, 10.1038/nchembio.2020]; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Wang J, 2017, METAB ENG, V40, P148, DOI 10.1016/j.ymben.2017.02.003; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Westbrook AW, 2016, APPL ENVIRON MICROB, V82, P4876, DOI 10.1128/AEM.01159-16; Wiktor J, 2016, NUCLEIC ACIDS RES, V44, P3801, DOI 10.1093/nar/gkw214; Wu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13477; Yao L, 2016, ACS SYNTH BIOL, V5, P207, DOI 10.1021/acssynbio.5b00264; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8	50	0	0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	DEC	2017	6	12					2350	2361		10.1021/acssynbio.7b00251				12	Biochemical Research Methods	Biochemistry & Molecular Biology	FQ5JR	WOS:000418395600019	28854333				2018-01-05	
J	Tan, SZ; Prather, KLJ				Tan, Sue Zanne; Prather, Kristala L. J.			Dynamic pathway regulation: recent advances and methods of construction	CURRENT OPINION IN CHEMICAL BIOLOGY			English	Review							ENGINEERED ESCHERICHIA-COLI; SYNTHETIC ANTISENSE RNAS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PROTEIN-DEGRADATION; INTERFERENCE; CRISPR; YEAST; BIOSYNTHESIS; METABOLISM	Microbial cell factories are a renewable source for the production of biofuels and valuable chemicals. Dynamic pathway regulation has proved successful in improving production of molecules by balancing flux between growth of cells and production of metabolites. Systems for autonomous induction of pathway regulation are increasingly being developed, which include metabolite responsive promoters, biosensors, and quorum sensing systems. Since engineering such systems are dependent on the available methods for controlling protein abundance in the desired host, we review recent tools used for gene repression at the transcriptional, post -transcriptional and post-translational levels in Escherichia coli and Saccharomyces cerevisiae. These approaches may facilitate pathway engineering for biofuel and biochemical production.	[Tan, Sue Zanne; Prather, Kristala L. J.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Prather, KLJ (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	kljp@mit.edu			National Science Foundation [MCB-1330914]; MIT-Portugal Program	The work was supported by the National Science Foundation (Grant No. MCB-1330914) and the MIT-Portugal Program.	Brockman IM, 2015, METAB ENG, V28, P104, DOI 10.1016/j.ymben.2014.12.005; Cameron DE, 2014, NAT BIOTECHNOL, P32; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Crook NC, 2014, ACS SYNTH BIOL, V3, P307, DOI 10.1021/sb4001432; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; David F, 2016, ACS SYNTH BIOL, V5, P224, DOI 10.1021/acssynbio.5b00161; DOMBEK KM, 1987, APPL ENVIRON MICROB, V53, P1286; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T                  ; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gordon GC, 2016, METAB ENG, V38, P170, DOI 10.1016/j.ymben.2016.07.007; Gupta A, 2017, NAT BIOTECHNOL, V35, P273, DOI 10.1038/nbt.3796; Henard CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21585; Jakoairtnas T, 2015, METAB ENG; Johnson Christopher W., 2016, Metabolic Engineering Communications, V3, P111, DOI 10.1016/j.meteno.2016.04.002; Kim S, 2015, METAB ENG; Kunjapur AM, 2014, J AM CHEM SOC, V136, P11644, DOI 10.1021/ja506664a; Liu HW, 2015, METAB ENG, V29, P135, DOI 10.1016/j.ymben.2015.03.009; Lo TM, 2016, CELL SYST, V3, P133, DOI 10.1016/j.cels.2016.07.012; Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Meng HL, 2016, BIOTECHNOL J, V11, P530, DOI 10.1002/biot.201500351; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nakashima N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp498; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peet KC, 2015, APPL ENVIRON MICROB, V81, P2881, DOI 10.1128/AEM.03162-14; Peng BY, 2017, METAB ENG, V39, P209, DOI 10.1016/j.ymben.2016.12.003; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Rogers JK, 2015, NUCLEIC ACIDS RES, V43, P7648, DOI 10.1093/nar/gkv616; Sekar K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149746; Sheppard MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6031; Shong J, 2013, ACS SYNTH BIOL, V2, P568, DOI 10.1021/sb4000433; Skjoedt ML, 2016, NAT CHEM BIOL, V12, P951, DOI [10.1038/NCHEMBIO.2177, 10.1038/nchembio.2177]; Solomon KV, 2012, METAB ENG, V14, P661, DOI 10.1016/j.ymben.2012.08.006; Soma Y, 2014, METAB ENG; Soma Y, 2015, METAB ENG, V30, P7, DOI 10.1016/j.ymben.2015.04.005; Tan SZ, 2015, ACS SYNTH BIOL; Teixeira PG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0663-3; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; Williams TC, 2015, METAB ENG, V29, P124, DOI 10.1016/j.ymben.2015.03.008; Williams TC, 2013, ACS SYNTH BIOL; Williams TC, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0223-7; Xie W, 2014, METAB ENG; Xu P, 2014, P NATL ACAD SCI USA, V111, P11299, DOI 10.1073/pnas.1406401111; Yang YP, 2015, METAB ENG, V29, P217, DOI 10.1016/j.ymben.2015.03.018; Younger AKD, 2016, ACS SYNTH BIOL; Yuan J, 2015, MICROB CELL FACT, P14; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhu MM, 2002, BIOTECHNOL PROGR, V18, P694, DOI 10.1021/bp020281+	55	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1367-5931	1879-0402		CURR OPIN CHEM BIOL	Curr. Opin. Chem. Biol.	DEC	2017	41						28	35		10.1016/j.cbpa.2017.10.004				8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FQ5IP	WOS:000418392700006	29059607				2018-01-05	
J	Bratulic, S; Badran, AH				Bratulic, Sinisa; Badran, Ahmed H.			Modern methods for laboratory diversification of biomolecules	CURRENT OPINION IN CHEMICAL BIOLOGY			English	Review							RANDOM MUTAGENESIS; ESCHERICHIA-COLI; IN-VITRO; TRANSPOSON MUTAGENESIS; CONTINUOUS EVOLUTION; REGULATORY ELEMENTS; DIRECTED EVOLUTION; MAMMALIAN-CELLS; GENOME; DNA	Genetic variation fuels Darwinian evolution, yet spontaneous mutation rates are maintained at low levels to ensure cellular viability. Low mutation rates preclude the exhaustive exploration of sequence space for protein evolution and genome engineering applications, prompting scientists to develop methods for efficient and targeted diversification of nucleic acid sequences. Directed evolution of biomolecules relies upon the generation of unbiased genetic diversity to discover variants with desirable properties, whereas genome-engineering applications require selective modifications on a genomic scale with minimal off-targets. Here, we review the current toolkit of mutagenesis strategies employed in directed evolution and genome engineering. These state-of-the-art methods enable facile modifications and improvements of single genes, multicomponent pathways, and whole genomes for basic and applied research, while simultaneously paving the way for genome editing therapeutic interventions.	[Bratulic, Sinisa; Badran, Ahmed H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Badran, AH (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	ahbadran@broadinstitute.org			Broad Institute of MIT Harvard; National Institutes of Health Early Investigator Award [DP5-OD-024590]	This work was generously supported by the Broad Institute of MIT & Harvard and the National Institutes of Health Early Investigator Award DP5-OD-024590.	Amiram M, 2015, NAT BIOTECHNOL, V33, P1272, DOI 10.1038/nbt.3372; Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Badran AH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9425; Badran AH, 2015, CURR OPIN CHEM BIOL, V24, P1, DOI 10.1016/j.cbpa.2014.09.040; Bittker JA, 2004, P NATL ACAD SCI USA, V101, P7011, DOI 10.1073/pnas.0402202101; Joyce G. F., 1992, GENOME RES, V2, P28, DOI DOI 10.1101/GR.2.1.28; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Chaikind B, 2016, NUCLEIC ACIDS RES, V44, P9758, DOI 10.1093/nar/gkw707; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; Crook N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13051; Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dennig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026222; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Finney-Manchester SP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt150; Firnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052031; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fujii R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh147; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; Gasperini M, 2017, AM J HUM GENET, V101, P192, DOI 10.1016/j.ajhg.2017.06.010; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Gaytan P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp602; Gonzalez-Perez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090919; Goodman MF, 2016, ENVIRON MOL MUTAGEN, V57, P421, DOI 10.1002/em.22023; Greener A, 1997, MOL BIOTECHNOL, V7, P189, DOI 10.1007/BF02761755                                                              ; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Haller G, 2016, NAT METHODS, V13, P923, DOI [10.1038/NMTH.4015, 10.1038/nmeth.4015]; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Higgins SA, 2017, ACS SYNTH BIOL; Huovinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031817; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165                                                   ; Inoue F, 2017, GENOME RES, V27, P38, DOI 10.1101/gr.212092.116; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kipnis Y, 2012, PROTEIN ENG DES SEL, V25, P437, DOI 10.1093/protein/gzs023; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/nmeth.3223, 10.1038/NMETH.3223]; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488                                                           ; Lai YP, 2004, BIOTECHNOL BIOENG, V86, P622, DOI 10.1002/bit.20066; Lau YH, 2017, NUCLEIC ACIDS RES, V45, P6971, DOI 10.1093/nar/gkx415; LinGoerke JL, 1997, BIOTECHNIQUES, V23, P409; Liu SS, 2016, J BIOTECHNOL, V227, P27, DOI 10.1016/j.jbiotec.2016.03.038; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Ma Y, 2016, NAT METHODS, V13, P1; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mondon P, 2010, MUTAGEN RANDOM MUTAG, P373; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Mundhada H, 2011, CHEMBIOCHEM, V12, P1595, DOI 10.1002/cbic.201100010; Nayak DD, 2017, P NATL ACAD SCI USA, V114, P2976, DOI 10.1073/pnas.1618596114; Nyerges A, 2016, P NATL ACAD SCI USA, V113, P2502, DOI 10.1073/pnas.1520040113; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pesce D, 2016, PHILOS T R SOC LON B, V371; Ravikumar A, 2014, NAT CHEM BIOL, V10, P175, DOI [10.1038/nchembio.1439, 10.1038/NCHEMBIO.1439]; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Romanini DW, 2012, ACS SYNTH BIOL, V1, P602, DOI 10.1021/sb3000904; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Seyfang A, 2004, ANAL BIOCHEM, V324, P285, DOI 10.1016/j.ab.2003.10.012; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shu CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23536; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4; Wong TS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh028; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Yuan TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055617; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049                                                          ; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258                                                             ; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	78	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1367-5931	1879-0402		CURR OPIN CHEM BIOL	Curr. Opin. Chem. Biol.	DEC	2017	41						50	60		10.1016/j.cbpa.2017.10.010				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FQ5IP	WOS:000418392700009	29096324				2018-01-05	
J	Saeij, JP; Frickel, EM				Saeij, Jeroen P.; Frickel, Eva-Maria			Exposing Toxoplasma gondii hiding inside the vacuole: a role for GBPs, autophagy and host cell death	CURRENT OPINION IN MICROBIOLOGY			English	Review							PATHOGEN-CONTAINING VACUOLES; GUANYLATE-BINDING-PROTEINS; IRG RESISTANCE GTPASES; IFN-INDUCED GTPASES; WIDE CRISPR SCREEN; PARASITOPHOROUS VACUOLE; MEMBRANE-PROTEINS; INDUCIBLE GTPASES; HUMAN FIBROBLASTS; IMMUNITY	The intracellular parasite Toxoplasma gondii resides inside a vacuole, which shields it from the host's intracellular defense mechanisms. The cytokine interferon gamma (IFN gamma) upregulates host cell effector pathways that are able to destroy the vacuole, restrict parasite growth and induce host cell death. Interferon-inducible GTPases such as the Guanylate Binding Proteins (GBPs), autophagy proteins and ubiquitin-driven mechanisms play important roles in Toxoplasma control in mice and partly also in humans. The host inflammasome is regulated by GBPs in response to bacterial infection in murine cells and may also respond to Toxoplasma infection. Elucidation of murine Toxoplasma defense mechanisms are guiding studies on human cells, while inevitably leading to the discovery of human-specific pathways that often function in a cell type dependent manner.	[Saeij, Jeroen P.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Frickel, Eva-Maria] Francis Crick Inst, Host Toxoplasma Interact Lab, 1 Midland Rd, London NW1 1AT, England	Saeij, JP (reprint author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.; Frickel, EM (reprint author), Francis Crick Inst, Host Toxoplasma Interact Lab, 1 Midland Rd, London NW1 1AT, England.	jsaeij@ucdavis.edu; eva.frickel@crick.ac.uk			NIH [R01A1080621, R21EY024593]; Francis Crick Institute from Cancer Research UK [FC001076]; UK Medical Research Council [FC001076]; Wellcome Trust [FC001076]	The Saeij lab is funded by NIH R01A1080621 and R21EY024593. The Frickel lab is funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001076), the UK Medical Research Council (FC001076), and the Wellcome Trust (FC001076). We thank Haley Wood for drawing the figures and Barbara Clough for critical reading of the manuscript.	Biering SB, 2017, CELL HOST MICROBE, V22, P74, DOI 10.1016/j.chom.2017.06.005; Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006; Cirelli KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003927; Clough B, 2017, TRENDS PARASITOL, V33, P473, DOI 10.1016/j.pt.2017.02.007; Clough B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006027; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729                                                    ; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Fasshauer V, 2005, EUKARYOT CELL, V4, P221, DOI 10.1128/EC.4.1.221-224.2005; da Fonseca Ferreira-da-Silva M, 2014, PLOS PATHOG, V10; Finethy R, 2015, INFECT IMMUNITY; Foltz C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05487-7; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Gorfu G, 2014, MBIO, V5, DOI 10.1128/mBio.01117-13; GUPTA SL, 1994, INFECT IMMUN, V62, P2277; Hakimi MA, 2015, CURR OPIN MICROBIOL, V26, P24, DOI 10.1016/j.mib.2015.04.003; Haldar AK, 2016, MBLO, V7; Haldar AK, 2015, P NATL ACAD SCI USA, V112, pE5628, DOI 10.1073/pnas.1515966112; Haldar AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086684; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Hassan MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005619; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jensen KDC, 2016, TRENDS PARASITOL, V32, P88, DOI 10.1016/j.pt.2015.12.011; Johnston AC, 2016, CELL MICROBIOL, V18, P1056, DOI 10.1111/cmi.12579; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kravetsi E, 2016, ELIFE, V5, DOI 10.7554/eLife.11479; Krishnamurthy S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006176; Lee Y, 2015, CELL REP, V13, P223, DOI 10.1016/j.celrep.2015.09.005; Liesenfeld O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020568; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Man SM, 2015, NAT IMMUNOL; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Muller UB, 2016, CURR OPIN MICROBIOL, V32, P19, DOI 10.1016/j.mib.2016.04.009; Niedelman W, 2013, INFECT IMMUN, V81, P4341, DOI 10.1128/IAI.00416-13; Ohshima J, 2015, P NATL ACAD SCI USA, V112, pE4581, DOI 10.1073/pnas.1510031112; Ohshima J, 2014, J IMMUNOL, V192, P3328, DOI 10.4049/jimmunol.1302822; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Park S, 2016, AUTOPHAGY, V12, P1153, DOI 10.1080/15548627.2016.1178447; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Pills DM, 2014, P NATL ACAD SCI US; Qin AP, 2017, P NATL ACAD SCI USA, V114, P1365, DOI 10.1073/pnas.1619665114; Sasai M, 2017, NAT IMMUNOL, V18, P899, DOI 10.1038/ni.3767; Selleck EM, 2015, MBIO, V6, DOI 10.1128/mBio.01157-15; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; Shenoy AR, 2012, SCIENCE; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STAEHELI P, 1984, VIROLOGY, V137, P135, DOI 10.1016/0042-6822(84)90016-3; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; WINTER SV, 2011, PLOS ONE, V0006; Yamamoto M, 2012, IMMUNITY; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	60	0	0	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	DEC	2017	40						72	80		10.1016/j.mib.2017.10.021				9	Microbiology	Microbiology	FQ5IS	WOS:000418393000012	29141239	gold			2018-01-05	
J	Mall, EM; Herrmann, D; Niemann, H				Mall, Eva Maria; Herrmann, Doris; Niemann, Heiner			Murine pluripotent stem cells with a homozygous knockout of Foxg1 show reduced differentiation towards cortical progenitors in vitro	STEM CELL RESEARCH			English	Article						Foxg1; CRISPR/Cas9; Mouse pluripotent stem cells; Neuronal differentiation; Corticogenesis	HUMAN ES; CEREBRAL HEMISPHERES; EXTRINSIC SIGNALS; BRAIN; TELENCEPHALON; PROLIFERATION; SPECIFICATION; EXPRESSION; NEURONS; MICE	Foxg1 is a transcription factor critical for the development of the mammalian telencephalon. Foxg1 controls the proliferation of dorsal telencephalon progenitors and the specification of the ventral telencephalon. Homozygous knockout of Foxg1 in mice leads to severe microcephaly, attributed to premature differentiation of telencephalic progenitors, mainly of cortical progenitors. Here, we analyzed the influence of a Foxg1 knockout on differentiation of murine pluripotent stem cells (mPSCs) in an in vitro model of neuronal development. Murine PSCs were prone to neuronal differentiation in embryoid body like culture with minimal medium conditions, based on the intrinsic default of PSCs to develop into cortical progenitors. Differences between Foxg1 wildtype (Foxg1(WT)) and knockout (Foxg1(KO)) mPSCs were analyzed. Several mPSC lines with homozygous mutations in Foxg1 were produced using the CRISPR/Cas9 system leading to loss of functional domains. Analysis of mRNA expression using quantitative Real-Time (q) PCR revealed that Foxg1(KO) mPSCs expressed significantly less mRNA of Foxg1, Emx1, and VGlut1 compared to Foxg1(WT) controls, indicating reduced differentiation towards dorsal telencephalic progenitors. However, the size of the derived EB-like structures did not differ between Foxg1(WT) and Foxg1(KO) mPSCs. These results show that loss of dorsal telencephalic progenitors can be detected using a simple and rapid differentiation protocol. This study is a first hint that this differentiation method can be used to analyze even extreme phenotypes that are lethal in vivo. (c) 2017 The Authors. Published by Elsevier B.V.	[Mall, Eva Maria; Herrmann, Doris; Niemann, Heiner] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Farm Anim Genet, Hoeltystr 10, D-31531 Neustadt, Germany; [Mall, Eva Maria; Niemann, Heiner] Hannover Med Sch, Cluster Excellence REBIRTH, Carl Neuberg Str 1, D-30625 Hannover, Germany	Niemann, H (reprint author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Farm Anim Genet, Hoeltystr 10, D-31531 Neustadt, Germany.; Niemann, H (reprint author), Hannover Med Sch, Cluster Excellence REBIRTH, Carl Neuberg Str 1, D-30625 Hannover, Germany.	heiner.niemann@fli.de			DFG [EXC 62]	The project was financially supported by DFG (EXC 62) (Cluster of Excellence REBIRTH).	Baek ST, 2015, NAT MED, V21, P1445, DOI 10.1038/nm.3982; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boggio EM, 2016, NEUROSCIENCE, V324, P496, DOI 10.1016/j.neuroscience.2016.03.027; Cantz T, 2008, BIOL CHEM, V389, P889, DOI 10.1515/BC.2008.107; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Danesin C, 2012, CURR OPIN GENET DEV, V22, P323, DOI 10.1016/j.gde.2012.05.001; Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007; Dang J, 2016, CELL STEM CELL; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; Dou CL, 2000, MOL CELL BIOL, V20, P6201, DOI 10.1128/MCB.20.17.6201-6211.2000                                                ; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eagleson KL, 2007, NEUROSCIENCE, V148, P385, DOI 10.1016/j.neuroscience.2007.06.012; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Garcez P. P, 2016, ZIKA VIRUS IMPAIRS G; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674                                                         ; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Irioka T, 2005, DEV BRAIN RES, V154, P63, DOI 10.1016/j.devbrainres.2004.10.004; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kinsler R, 2010, SYNAPSE, V64, P169, DOI 10.1002/syn.20737; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Manciocco A, 2009, NEUROSCI BIOBEHAV R, V33, P18, DOI 10.1016/j.neubiorev.2008.08.002; Manuel MN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-9; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MuhChyi C, 2013, INT J DEV NEUROSCI, V31, P424, DOI 10.1016/j.ijdevneu.2013.02.006; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Patriarchi T, 2016, EUR J HUM GENET, V24, P871, DOI 10.1038/ejhg.2015.216; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen LJ, 2006, HIPPOCAMPUS, V16, P875, DOI 10.1002/hipo.20218; Siegenthaler JA, 2008, CEREB CORTEX, V18, P1865, DOI 10.1093/cercor/bhm209; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suzuki I. K., 2015, DEVELOPMENT; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Talluri TR, 2014, BIOCHEM BIOPH RES CO, V450, P581, DOI 10.1016/j.bbrc.2014.06.014; van den Ameele J, 2014, TRENDS NEUROSCI, V37, P334, DOI 10.1016/j.tins.2014.03.005; Vezzali R., 2016, ONCOTARGET; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7                                                    ; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001                                                 ; Yip DJ, 2012, DEV CELL, V22, P871, DOI 10.1016/j.devcel.2012.01.020; Zeltner N, 2015, CURR OPIN CELL BIOL, V37, P102, DOI 10.1016/j.ceb.2015.10.008	59	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	DEC	2017	25						50	60		10.1016/j.scr.2017.10.012				11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FQ3NA	WOS:000418262700011	29080444	gold			2018-01-05	
J	Steenpass, L				Steenpass, Laura			Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1	STEM CELL RESEARCH			English	Article								Retinoblastoma is a childhood cancer of the retina caused by biallelic inactivation of the tumor suppressor gene RB1. In heritable retinoblastoma, one allele is inherited in mutant form via one of the parental germ cells. To study molecular mechanisms in retinoblastoma, two sublines of H1 hESCs were generated, carrying a knock-out allele of RB1 in the heterozygous or homozygous state. Exon 3 of RB1 was targeted and modified by nucleotide deletions using the CRISPR/Cas9 nuclease system. Based on a nearby single nucleotide polymorphism, the modification could be assigned to one allele. (C) 2017 The Author. Published by Elsevier B.V.	[Steenpass, Laura] Univ Duisburg Essen, Inst Human Genet, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany	Steenpass, L (reprint author), Univ Duisburg Essen, Inst Human Genet, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany.	laura.steenpass@uni-due.de			Deutsche Forderprogramm fur Augenheilkunde from Bayer	The project was funded by the Deutsche Forderprogramm fur Augenheilkunde - an initiative from Bayer - grant period 2016/2017. I thank Michaela Hiber and Elke Jurgens for performing STR analysis and karyotype analysis. Teratoma assay was performed by Dr. Diana Klein (Institute of Cell Biology, University Hospital Essen) and analysed by Dr. Agnes Bankfalvi (Institute of Pathology, University Hospital Essen). Flow cytometric analysis of pluripotency was conducted by Martina Cremanns (Institute of TransfusionMedicine, University Hospital Essen).	Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Stanurova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30792; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	3	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	DEC	2017	25						270	273		10.1016/j.scr.2017.07.005				4	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FQ3NA	WOS:000418262700039	29246572	gold			2018-01-05	
J	Li, J; Summerlin, M; Nitiss, KC; Nitiss, JL; Hanakahi, LA				Li, Jing; Summerlin, Matthew; Nitiss, Karin C.; Nitiss, John L.; Hanakahi, Leslyn A.			TDP1 is required for efficient non-homologous end joining in human cells	DNA REPAIR			English	Article						Tyrosyl-DNA phosphodiesterase 1; TDP1; Non-homologous end joining; NHEJ; XLF	TYROSYL-DNA PHOSPHODIESTERASE; STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; TOPOISOMERASE-I; V(D)J RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SPINOCEREBELLAR ATAXIA; FUNCTIONAL REDUNDANCY; COVALENT COMPLEXES; SUBSTRATE CLEAVAGE	Tyrosyl-DNA phosphodiesterase 1 (TDP1) can remove a wide variety of 3' and 5' terminal DNA adducts. Genetic studies in yeast identified TDP1 as a regulator of non-homologous end joining (NHEJ) fidelity in the repair of double-strand breaks (DSBs) lacking terminal adducts. In this communication, we show that TDP1 plays an important role in joining cohesive DSBs in human cells. To investigate the role of TDP1 in NHEJ in live human cells we used CRISPR/cas9 to produce TDP1-knockout (TDP1-KO) HEK-293 cells. As expected, human TDP1-KO cells were highly sensitive to topoisomerase poisons and ionizing radiation. Using a chromosomally-integrated NHEJ reporter substrate to compare end joining between wild type and TDP1-KO cells, we found that TDP1-KO cells have a 5-fold reduced ability to repair I-Seel-generated DSBs. Extracts prepared from TDP1-KO cells had reduced NHEJ activity in vitro, as compared to extracts from wild type cells. Analysis of end joining junctions showed that TDP1 deficiency reduced end-joining fidelity, with a significant increase in insertion events, similar to previous observations in yeast. It has been reported that phosphorylation of TDP1 serine 81 (TDP1-S81) by ATM and DNA-PK stabilizes TDP1 and recruits TDP1 to sites of DNA damage. We found that end joining in TDP1KO cells was partially restored by the non-phosphorylatable mutant TDP1-S81A, but not by the phosphomimetic TDP1-S81E. We previously reported that TDP1 physically interacted with XLF. In this study, we found that XLF binding by TDP1 was reduced 2-fold by the S81A mutation, and 10-fold by the S81E phosphomimetic mutation. Our results demonstrate a novel role for TDP1 in NHEJ in human cells. We hypothesize that TDP1 participation in human NHEJ is mediated by interaction with XLF, and that TDP1-XLF interactions and subsequent NHEJ events are regulated by phosphorylation of TDP1-S81.	[Li, Jing; Summerlin, Matthew] Univ Illinois, Dept Med Chem & Pharmacognosy, 1601 Parkview Ave, Chicago, IL 61107 USA; [Nitiss, Karin C.; Nitiss, John L.; Hanakahi, Leslyn A.] Univ Illinois, Coll Pharm, Biopharmaceut Sci, 1601 Parkview Ave, Chicago, IL 61107 USA	Hanakahi, LA (reprint author), Univ Illinois, Coll Pharm, Biopharmaceut Sci, 1601 Parkview Ave, Chicago, IL 61107 USA.	Hanakahi@uic.edu			UIC Cancer Center [CC-2012-017]; NIH [CA52814, CA87651]	We thank Kayeromi Gomez for assistance with statistical analysis, Barrie Bode, Clare Kron, James Gabel and Michele Crase for assistance with the Northern Illinois University irradiator, Cindy Li for western blots of DNA-PKcs-pS2056, Janet Tang for assessment of SN-38 sensitivity, and Guoxing Zheng for the use of his FACS Calibur. We gratefully acknowledge the valuable contributions of the University of Illinois Chicago (UIC) Research Resource Core (RRC) DNA Services Facility (DNAS) and Flow Cytometry Service (FCS), and the UIC Cancer Center Genome Editing Core (GEC); We gratefully acknowledge funding from the UIC Cancer Center [grant number CC-2012-017] to LAH, NIH [grant number CA52814] to JLN, and [grant number CA87651] to LAH and JLN.	Alagoz M, 2014, NUCLEIC ACIDS RES, V42, P3089, DOI 10.1093/nar/gkt1260; Bahmed K, 2010, P NATL ACAD SCI USA, V107, P4057, DOI 10.1073/pnas.0909917107; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bebenek K, 2005, J BIOL CHEM, V280, P20051, DOI 10.1074/jbs.M501981200; Ben Hassine S, 2009, EMBO J, V28, P632, DOI 10.1038/emboj.2009.9; Bennardo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001194; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Cheung JCY, 2008, NUCLEIC ACIDS RES, V36, P5713, DOI 10.1093/nar/gkn572; Chiang SC, 2010, CELL CYCLE, V9, P588, DOI 10.4161/cc.9.3.10598                                                            ; Comeaux EQ, 2015, J BIOL CHEM, V290, P6203, DOI 10.1074/jbc.M114.635284; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Gapud EJ, 2011, CELL CYCLE, V10, P1928, DOI 10.4161/cc.10.12.16011; Gapud EJ, 2011, P NATL ACAD SCI USA, V108, P2022, DOI 10.1073/pnas.1013295108; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Grundy GJ, 2013, EMBO J, V32, P112, DOI 10.1038/emboj.2012.304; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Guo DY, 2014, P NATL ACAD SCI USA, V111, P15816, DOI 10.1073/pnas.1415011111; Hammel M, 2016, J BIOL CHEM, V291, P26987, DOI 10.1074/jbc.M116.751867; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi L, 2011, MOL CANCER RES, V9, P1366, DOI 10.1158/1541-7786.MCR-11-0230; Hanakahi LA, 2007, PROTEIN EXPRES PURIF, V52, P139, DOI 10.1016/j.pep.2006.10.002; Hawkins AJ, 2009, DNA REPAIR, V8, P654, DOI 10.1016/j.dnarep.2008.12.012; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; HENNER WD, 1983, J BIOL CHEM, V258, P711; Heo J, 2015, DNA REPAIR, V30, P28, DOI 10.1016/j.dnarep.2015.03.003; Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang SYN, 2013, NUCLEIC ACIDS RES, V41, P7793, DOI 10.1093/nar/gkt483; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kumar V, 2016, P NATL ACAD SCI USA, V113, P10619, DOI 10.1073/pnas.1611882113; Kumar V, 2014, DNA REPAIR, V16, P11, DOI 10.1016/j.dnarep.2014.01.010; Lee SY, 2010, PLANT PHYSIOL, V154, P1460, DOI 10.1104/pp.110.165068; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Liang ZB, 2016, NUCLEIC ACIDS RES, V44, P2769, DOI 10.1093/nar/gkw013; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Miao ZH, 2006, DNA REPAIR, V5, P1489, DOI 10.1016/j.dnarep.2006.07.004; Motea EA, 2010, BBA-PROTEINS PROTEOM, V1804, P1151, DOI 10.1016/j.bbapap.2009.06.030; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Oksenych V, 2013, P NATL ACAD SCI USA, V110, P2234, DOI 10.1073/pnas.1222573110; Oksenych V, 2012, P NATL ACAD SCI USA, V109, P2455, DOI 10.1073/pnas.1121458109; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Raymond AC, 2005, J BIOL CHEM, V280, P22029, DOI 10.1074/jbc.M502148200; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170	64	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	DEC	2017	60						40	49		10.1016/j.dnarep.2017.10.003				10	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	FQ2UT	WOS:000418214200006	29078113				2018-01-05	
J	Yi, YY; Tsai, SH; Cheng, JC; Wang, EY; Anglesio, MS; Cochrane, DR; Fuller, M; Gibb, EA; Wei, W; Huntsman, DG; Karsan, A; Hoodless, PA				Yi, Yuyin; Tsai, Shu-Huei; Cheng, Jung-Chien; Wang, Evan Y.; Anglesio, Michael S.; Cochrane, Dawn R.; Fuller, Megan; Gibb, Ewan A.; Wei, Wei; Huntsman, David G.; Karsan, Aly; Hoodless, Pamela A.			APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner	GYNECOLOGIC ONCOLOGY			English	Article							EXPRESSION; MUTATIONS; RECEPTOR; ADENOCARCINOMA; CARCINOMA; PATHWAY; ELABELA; PHOSPHORYLATION; ANGIOGENESIS; DERIVATIVES	Objective. APELA is a small, secreted peptide that can function as a ligand for the G-protein coupled receptor, Apelin Receptor (APLNR, APJ). APELA plays an essential role in endoderm differentiation and cardiac development during embryogenesis. We investigated whether APELA exerts any functions in cancer progression. Methods. The Cancer Genome Atlas (TCGA) RNA sequencing datasets, microarray from an OCCC mouse model, and RNA isolated from fresh frozen and FFPE patient tissue were used to assess APELA expression. APEIA knockout ovarian clear cell carcinoma (OCCC) cell lines were generated using CRISPR/Cas9. Results. APELA was expressed in various ovarian cancer histotypes and was especially elevated in OCCC. Disruption of APELA expression in OCCC cell lines suppressed cell growth and migration, and altered cell-cycle progression. Moreover, addition of human recombinant APELA peptide to the OCCC cell line OVISE promoted cell growth and migration. Interestingly, OVISE cells do not express APLNR, suggesting that APELA can function through an APLNR-independent pathway. Furthermore, APELA affected cell growth and cell cycle progression in a p53-dependent manner. In addition, APELA knockdown induced p53 expression in cancer cell lines. Conclusions. Our findings uncover a potential oncogenic role for APELA in promoting ovarian tumour progression and provide a possible therapeutic strategy in ovarian cancer by targeting APELA. (c) 2017 Elsevier Inc. All rights reserved.	[Yi, Yuyin; Tsai, Shu-Huei; Cheng, Jung-Chien; Wang, Evan Y.; Wei, Wei; Hoodless, Pamela A.] BC Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Yi, Yuyin; Wang, Evan Y.; Hoodless, Pamela A.] Univ British Columbia, Cell & Dev Biol Program, Vancouver, BC V6T 1Z4, Canada; [Cheng, Jung-Chien; Hoodless, Pamela A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Anglesio, Michael S.; Huntsman, David G.] Univ British Columbia, Dept Gynecol & Obstet, Vancouver, BC V6Z 2K5, Canada; [Anglesio, Michael S.; Cochrane, Dawn R.; Huntsman, David G.] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Fuller, Megan; Gibb, Ewan A.; Karsan, Aly] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Huntsman, David G.; Karsan, Aly] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada	Hoodless, PA (reprint author), BC Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	hoodless@bccrc.ca			Cancer Research Society [21466]; Canadian Institutes of Health Research [MOP-64354, MOP-97744]; Gray Family Ovarian Clear Cell Carcinoma Research Resource; BC Cancer Foundation; Vancouver General Hospital; University of British Columbia Hospital Foundation	This study was supported by an operating grant from the Cancer Research Society (21466) (https://www.crs-src.ca/) to P.A.H and the Canadian Institutes of Health Research (MOP-64354 and MOP-97744) (http://www.cihr-irsc.gc.ca/) to A.K. The Gray Family Ovarian Clear Cell Carcinoma Research Resource, the BC Cancer Foundation, the Vancouver General Hospital and the University of British Columbia Hospital Foundation provide financial support to OVCARE (http://www.ovcare.ca).	Alvarez RD, 2016, GYNECOL ONCOL, V141, P413, DOI 10.1016/j.ygyno.2016.04.541; Anglesio MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072162; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Berta J, 2010, J THORAC ONCOL, V5, P1120, DOI 10.1097/JTO.0b013e3181e2c1ff; Cao Y., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3003149; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Freyer L, 2017, CELL REP, V20, P2116, DOI 10.1016/j.celrep.2017.08.014; Gibb EA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0142-6; Hashiguchi Y, 2006, GYNECOL ONCOL, V101, P71, DOI 10.1016/j.ygyno.2005.09.047; Hassan AS, 2010, GENE EXPR PATTERNS, V10, P127, DOI 10.1016/j.gep.2010.02.001; Helker C.S., 2015, ELIFE, V4; Ho L, 2017, SCIENCE; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Hoffmann M, 2017, TOXICOL LETT, V269, P15, DOI 10.1016/j.toxlet.2017.01.006; Karnezis AN, 2017, NAT REV CANCER, V17, P65, DOI 10.1038/nrc.2016.113; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kunduzova O, 2008, FASEB J, V22, P4146, DOI 10.1096/fj.07-104018; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Lv DG, 2016, CLIN EXP PHARMACOL P, V43, P569, DOI 10.1111/1440-1681.12563; Mackenzie R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1421-8; Okamoto A, 2014, INT J GYNECOL CANCER, V24, pS20, DOI 10.1097/IGC.0000000000000289; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Peng XW, 2015, INT J MOL MED, V36, P733, DOI 10.3892/ijmm.2015.2265; Perjes A, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0521-6; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sorli SC, 2007, ONCOGENE, V26, P7692, DOI 10.1038/sj.onc.1210573; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Uehara Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132751; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08170; Wiegand KC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-120; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189	41	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	DEC	2017	147	3					663	671		10.1016/j.ygyno.2017.10.016				9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	FQ2SQ	WOS:000418208700030	29079036				2018-01-05	
J	Denecke, S; Fusetto, R; Batterham, P				Denecke, Shane; Fusetto, Roberto; Batterham, Philip			Describing the role of Drosophila melanogaster ABC transporters in insecticide biology using CRISPR-Cas9 knockouts	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						P-glycoprotein; ABCB1; Multi-drug resistance; CRISPR-Cas9; Drosophila melanogaster; Insecticide resistance	BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; MALPIGHIAN TUBULES; TOBACCO HORNWORM; MOLECULAR-BASIS; MECHANISM; BINDING; METABOLITES; PREDICTION	ABC transporters have a well-established role in drug resistance, effluxing xenobiotics from cells and tissues within the organism. More recently, research has been dedicated to understanding the role insect ABC transporters play in insecticide toxicity, but progress in understanding the contribution of specific transporters has been hampered by the lack of functional genetic tools. Here, we report knockouts of three Drosophila melanogaster ABC transporter genes, Mdr49, Mdr50, and Mdr65, that are homologous to the well-studied mammalian ABCB1 (P-glycoprotein). Each knockout mutant was created in the same wild type background and tested against a panel of insecticides representing different chemical classes. Mdr65 knockouts were more susceptible to all neuroactive insecticides tested, but Mdr49 and Mdr50 knockouts showed increased susceptibility or resistance depending on the insecticide used. Mdr65 was chosen for further analysis. Calculation of LC50 values for the Mdr65 knockout allowed the substrate specificity of this transporter to be examined. No obvious distinguishing structural features were shared among MDR65 substrates. A role for Mdr65 in insecticide transport was confirmed by testing the capacity of the knockout to synergize with the ABC inhibitor verapamil and by measuring the levels of insecticide retained in the body of knockout flies. These data unambiguously establish the influence of ABC transporters on the capacity of wild type D. melanogaster to tolerate insecticide exposure and suggest that both tissue and substrate specificity underpin this capacity. (C) 2017 Elsevier Ltd. All rights reserved.	[Denecke, Shane; Fusetto, Roberto; Batterham, Philip] Univ Melbourne, Sch BioSci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Fusetto, Roberto] Univ Melbourne, Sch Chem, Inst Mol Sci & Biotechnol Bio21, ARC Ctr Excellence Free Rad Chem & Biotechnol, Melbourne, Vic 3010, Australia	Batterham, P (reprint author), Univ Melbourne, Sch BioSci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	p.batterham@unimelb.edu.au			University of Melbourne; Melbourne International Research Scholarship	The authors would like to thank the University of Melbourne for the Writing Up Scholarship and the Melbourne International Research Scholarship granted to S.D. and R.F. that supported the research reported here. Furthermore, we acknowledge Nate Ferraro for assisting in editing the manuscript. Lastly, we must thank Michael Murray of the University of Melbourne for providing fly facilities during the renovations of our own flyroom.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chufan EE, 2015, ADV CANCER RES, V125, P71, DOI 10.1016/bs.acr.2014.10.003; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Demel MA, 2008, EXPERT OPIN DRUG MET, V4, P1167, DOI [10.1517/17425255.4.9.1167, 10.1517/17425255.4.9.1167 ]; Denecke S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11092-5; Denecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145051; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; DeSalvo MK, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00346; DOW JAT, 1994, J EXP BIOL, V197, P421; Epis S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-349; Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052; Gaertner LS, 1998, J EXP BIOL, V201, P2637; Gellatly KJ, 2015, PESTIC BIOCHEM PHYS, V121, P107, DOI 10.1016/j.pestbp.2015.01.001; Groen S.C., 2016, INSECT BIOCH MOL BIO; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Kaschny M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004781; Lara FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134779; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Merzendorfer H, 2014, ADV INSECT PHYSL; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; Nauen R, 1998, PESTIC SCI, V52, P53, DOI 10.1002/(SICI)1096-9063(199801)52:1<53::AID-PS621>3.0.CO;2-6                    ; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; R Core Team, 2017, R LANG ENV STAT COMP; Rane RV, 2016, CURR OPIN INSECT SCI, V13, P70, DOI 10.1016/j.cois.2015.12.001; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Robertson J. L., 2007, BIOASSAYS ARTHROPODS; ROSENHEIM JA, 1989, J ECON ENTOMOL, V82, P331, DOI 10.1093/jee/82.2.331                                                            ; Schinkel AH, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2012.09.027; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Sun HN, 2017, INSECT BIOCHEM MOLEC, V89, P11, DOI 10.1016/j.ibmb.2017.08.002; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wang YH, 2004, DRUG METAB DISPOS, V32, P259, DOI 10.1124/dmd.32.2.259                                                            ; YUSA K, 1989, CANCER RES, V49, P5002; Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/BSE0500043, 10.1042/bse0500043]	50	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	DEC	2017	91						1	9		10.1016/j.ibmb.2017.09.017				9	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	FQ2WC	WOS:000418217700001	29056374				2018-01-05	
J	Liu, JQ; Liu, R; Gray, P; Liu, ZY; Cui, XX; Li, GH; Liu, Z				Liu, Jinqi; Liu, Ren; Gray, Peter; Liu, Zhenyi; Cui, Xiaoxia; Li, Guanghua; Liu, Zhong			Development of a luciferase reporter Jurkat cell line under the control of endogenous interleukin-2 promoter	JOURNAL OF IMMUNOLOGICAL METHODS			English	Article						Luciferase reporter assay; Jurkat; IL-2 promoter; CRISPR-Cas9	FACTOR RECEPTOR-LIGAND; HUMAN T-CELLS; NF-KAPPA-B; TRANSCRIPTION FACTORS; CANCER-IMMUNOTHERAPY; ENHANCER; ACTIVATION; ELEMENTS; AP-1; GITR	Dining new drug development, it is critical to have a cell-based reporter bioassay to measure drug-mediated physiological changes. In a conventional reporter cell line, a reporter expression construct is randomly inserted into the host cell genome with the reporter gene under control of an engineered promoter. This design ensures high signal output but may not represent the true physiological cell signaling. Here we used the CRISPR/Cas9 technology to engineer a Jurkat cell line by replacing one interleukin 2 (IL2) allele with firefly luciferase gene while keeping the other IL2 allele intact. The expression of luciferase is thus under control of endogenous IL2 promoter. We demonstrated that, in this engineered cell line, the IL-2 secretion pathway remained intact and luciferase activity significantly increased upon stimulation with phorbol ester or CD3/CD28 antibodies. We next expressed glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) in this cell line and observed dose-dependent IL-2 and luciferase responses to GITR agonist antibody. Thus we have successfully constructed a reporter cell line by engineering a reporter gene under control of an endogenous target gene promoter. This novel strategy may provide a more physiologically relevant alternative to the traditional method of reporter cell line construction.	[Liu, Jinqi; Liu, Ren; Gray, Peter; Li, Guanghua; Liu, Zhong] Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Liu, Zhenyi; Cui, Xiaoxia] Horizon Discovery, 2033 Westport Ctr Dr, St Louis, MO 63146 USA; [Liu, Jinqi] Bristol Myers Squibb, 3551 Lawrenceville Rd, Princeton, NJ 08540 USA; [Gray, Peter] Johnson & Johnson, Janssen Pharmaceut Co, 200 Great Valley Pkwy, Malvern, PA 19355 USA; [Cui, Xiaoxia] Washington Univ, Genome Engn & iPSC Ctr, 4515 McKinley Bldg, St Louis, MO 63110 USA; [Liu, Zhong] Adello Biol, 20 New England Ave, Piscataway, NJ 08854 USA	Liu, JQ; Liu, R (reprint author), Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	jinqi.liu@bms.com; ren.liu@merck.com; pgray15@ITS.JNJ.com; Zhenyi.Liu@horizondiscovery.com; guanghua.li@merck.com; zhong.liu@adellobio.com			Merck Co., Inc.; Horizon Discovery	The authors thank Yue Zhang and Danila Giacone for scientific discussion. This work was supported and permitted to be published by Merck & Co., Inc. Horizon Discovery provided support in the form of salaries for Zhenyi L and XC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715                                                            ; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244                                                         ; Grailer J., 2016, QUANTITATIVE CELLBAS, V76, P4878; GRANELLIPIPERNO A, 1991, J IMMUNOL, V147, P2734; Hanabuchi S, 2006, BLOOD, V107, P3617, DOI 10.1182/blood-2005-08-3419; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Jutz S, 2016, J IMMUNOL METHODS, V430, P10, DOI 10.1016/j.jim.2016.01.007; KAMPS MP, 1990, MOL CELL BIOL, V10, P5464, DOI 10.1128/MCB.10.10.5464                                                          ; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Kyi C, 2016, IMMUNOTHERAPY-UK, V8, P821, DOI 10.2217/imt-2016-0002; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X                                                    ; Leyland R, 2017, CLIN CANCER RES, V23, P3416, DOI 10.1158/1078-0432.CCR-16-2000; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Ohtsuka T, 1996, BBA-MOL CELL RES, V1310, P223, DOI 10.1016/0167-4889(95)00172-7                                                    ; PARRA E, 1995, J IMMUNOL, V155, P1132; PAWELEC G, 1982, EUR J IMMUNOL, V12, P387, DOI 10.1002/eji.1830120506; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404                                                         ; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vilgelm AE, 2016, J LEUKOCYTE BIOL, V100, P275, DOI 10.1189/jlb.5RI0116-013RR; WEISS A, 1984, J IMMUNOL, V133, P123	34	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1759	1872-7905		J IMMUNOL METHODS	J. Immunol. Methods	DEC	2017	451						48	53		10.1016/j.jim.2017.08.006				6	Biochemical Research Methods; Immunology	Biochemistry & Molecular Biology; Immunology	FP9JE	WOS:000417962500006	28847736				2018-01-05	
J	Hasse, HL; Lescale, C; Bianchi, JJ; Yu, W; Bedora-Faure, M; Deriano, L				Hasse, Helene Lenden; Lescale, Chloe; Bianchi, Joy J.; Yu, Wei; Bedora-Faure, Marie; Deriano, Ludovic			Generation and CRISPR/Cas9 editing of transformed progenitor B cells as a pseudo-physiological system to study DNA repair gene function in V(D)J recombination	JOURNAL OF IMMUNOLOGICAL METHODS			English	Article						V(D)J recombination; Recombination-activating gene (RAG) endonuclease; Nonhomologous end joining (NHEJ); v-Abl transformed pro-B cells; CRISPR/Cas9-mediated gene knock-out	STRAND BREAK REPAIR; LIGASE IV; END RESECTION; XLF; PAXX; XRCC4; PATHWAY; GENOME; MICE; DIFFERENTIATION	Antigen receptor gene assembly is accomplished in developing lymphocytes by the V(D)J recombination reaction, which can be separated into two steps: DNA cleavage by the recombination-activating gene (RAG) nuclease and joining of DNA double strand breaks (DSBs) by components of the nonhomologous end joining (NHEJ) pathway. Deficiencies for NHEJ factors can result in immunodeficiency and a propensity to accumulate genomic instability, thus highlighting the importance of identifying all players in this process and deciphering their functions. Bcl2 transgenic v-Abl kinase-transformed pro-B cells provide a pseudo-physiological cellular system to study V(D)J recombination. Treatment of v-Abl/Bcl2 pro-B cells with the Abl kinase inhibitor Imatinib leads to G1 cell cycle arrest, the rapid induction of Rag1/2 gene expression and V(D)J recombination. In this system, the Bcl2 transgene alleviates Imatinib-induced apoptosis enabling the analysis of induced V(D)J recombination. Although powerful, the use of mouse models carrying the Bcl2 transgene for the generation of v-AN pro-B cell lines is time and money consuming. Here, we describe a method for generating v-Abl/Bcl2 pro-B cell lines from wild type mice and for performing gene knock-out using episomal CRISPR/Cas9 targeting vectors. Using this approach, we generated distinct NHEJ-deficient pro-B cell lines and quantified V(D)J recombination levels in these cells. Furthermore, this methodology can be adapted to generate pro-B cell lines deficient for any gene suspected to play a role in V(D)J recombination, and more generally DSB repair.	[Hasse, Helene Lenden; Lescale, Chloe; Bianchi, Joy J.; Yu, Wei; Bedora-Faure, Marie; Deriano, Ludovic] Inst Pasteur, Dept Genomes & Genet, Dept Immunol, Genome Integr Immun & Canc Unit, F-75015 Paris, France; [Bianchi, Joy J.] Univ Paris 05, Sorbonne Paris Cite, Cellule Pasteur, F-75015 Paris, France	Deriano, L (reprint author), Inst Pasteur, Dept Genomes & Genet, Dept Immunol, Genome Integr Immun & Canc Unit, F-75015 Paris, France.	ludovic.deriano@pasteur.fr			Institut Pasteur; European Research Council [310917]; Institut National du Cancer [PLBIO16-181]	We thank Bernardo Reina San Martin, Erika Brunet and Jean-Pierre de Villartay for initial discussion and reagents and the Institut Pasteur Cytometry Platform and Center for Human Immunology for their help. This work was supported by the Institut Pasteur, the European Research Council under the ERC starting grant agreement # 310917 and the Institut National du Cancer (# PLBIO16-181). J.J.B. is a BioSPC/Universite Paris 5 doctoral Fellow.	ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x                                              ; Balmus G, 2016, GENE DEV, V30, P2152, DOI 10.1101/gad.290510.116; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Canela A, 2016, MOL CELL, V63, P898, DOI 10.1016/j.molcel.2016.06.034; Craxton A, 2015, CELL DEATH DIFFER, V22, P890, DOI 10.1038/cdd.2015.22; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; de Villartay JP, 2009, ADV EXP MED BIOL, V650, P46; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Dorsett Y, 2014, MOL CELL, V56, P808, DOI 10.1016/j.molcel.2014.10.024; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6                                                   ; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358                                                                   ; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Hung PJ, 2017, CELL CYCLE, V16, P286, DOI 10.1080/15384101.2016.1253640; Kollmann K, 2011, BLOOD, V117, P4065, DOI 10.1182/blood-2010-07-299644; Kumar V, 2016, P NATL ACAD SCI USA, V113, P10619, DOI 10.1073/pnas.1611882113; Kumar V, 2014, DNA REPAIR, V16, P11, DOI 10.1016/j.dnarep.2014.01.010; Lescale C, 2017, MECH AGEING DEV, V165, P3, DOI 10.1016/j.mad.2016.11.003; Lescale C, 2016, CELL REP, V16, P2967, DOI 10.1016/j.celrep.2016.08.069; Lescale C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10529; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X                                                   ; Liu XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13816; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206                                                           ; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Ochi T, 2015, SCIENCE, V347, P185, DOI 10.1126/science.1261971; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tadi SK, 2016, CELL REP, V17, P541, DOI 10.1016/j.celrep.2016.09.026; Vera G, 2013, MOL CELL BIOL, V33, P701, DOI 10.1128/MCB.01057-12; Xing MT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7233; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	40	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1759	1872-7905		J IMMUNOL METHODS	J. Immunol. Methods	DEC	2017	451						71	77		10.1016/j.jim.2017.08.007				7	Biochemical Research Methods; Immunology	Biochemistry & Molecular Biology; Immunology	FP9JE	WOS:000417962500009	28882611	gold			2018-01-05	
J	Ludvigsen, J; Porcellato, D; L'Abee-Lund, TM; Amdam, GV; Rudi, K				Ludvigsen, Jane; Porcellato, Davide; L'Abee-Lund, Trine M.; Amdam, Gro V.; Rudi, Knut			Geographically widespread honeybee-gut symbiont subgroups show locally distinct antibiotic-resistant patterns	MOLECULAR ECOLOGY			English	Article						Apis mellifera; gut symbionts; population ecology; tetracycline resistance; WGS	MULTIPLE SEQUENCE ALIGNMENT; TETRACYCLINE RESISTANCE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; SPECIES DEFINITION; GENE-TRANSFER; BUMBLE BEES; MICROBIOTA; BACTEROIDES; COLONIES	How long-term antibiotic treatment affects host bacterial associations is still largely unknown. The honeybee-gut microbiota has a simple composition, so we used this gut community to investigate how long-term antibiotic treatment affects host-associated microbiota. We investigated the phylogenetic relatedness, genomic content (GC percentage, genome size, number of genes and CRISPR) and antibiotic-resistant genes (ARG) for strains from two abundant members of the honeybee core gut microbiota (Gilliamella apicola and Snodgrassella alvi). Domesticated honeybees are subjected to geographically different management policies, so we used two research apiaries, representing different antibiotic treatment regimens in their apiculture: low antibiotic usage (Norway) and high antibiotic usage (Arizona, USA). We applied whole-genome shotgun sequencing on 48G.apicola and 22 S.alvi. We identified three predominating subgroups of G.apicola in honeybees from both Norway and Arizona. For G.apicola, genetic content substantially varied between subgroups and distance similarity calculations showed similarity discrepancy between subgroups. Functional differences between subgroups, such as pectin-degrading enzymes (G.apicola), were also identified. In addition, we identified horizontal gene transfer (HGT) of transposon (Tn10)-associated tetracycline resistance (Tet B) across the G.apicola subgroups in the Arizonan honeybees, using interspace polymorphisms in the Tet B determinant. Our results support that honeybee-gut symbiont subgroups can resist long-term antibiotic treatment and maintain functionality through acquisition of geographically distinct antibiotic-resistant genes by HGT.	[Ludvigsen, Jane; Porcellato, Davide; Rudi, Knut] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [L'Abee-Lund, Trine M.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Amdam, Gro V.] Norwegian Univ Life Sci, Fac Ecol & Nat Resource Management, As, Norway; [Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Rudi, K (reprint author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	knut.rudi@nmbu.no					Akhtar M, 2009, MICROB ECOL, V58, P509, DOI 10.1007/s00248-009-9533-9; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; APPELBAUM PC, 1992, CLIN INFECT DIS, V15, P77, DOI 10.1093/clinids/15.1.77                                                         ; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Baharoglu Z, 2011, ANTIMICROB AGENTS CH, V55, P2438, DOI 10.1128/AAC.01549-10; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bryan A, 2004, APPL ENVIRON MICROB, V70, P2503, DOI 10.1128/AEM.70.4.2503-2507.2004; Brynildsrud O, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1108-8; Burall LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150797; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chait R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10333; Chalmers R, 2000, J BACTERIOL, V182, P2970, DOI 10.1128/JB.182.10.2970-2972.2000                                                ; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Di Cesare A, 2015, MOL ECOL, V24, P3888, DOI 10.1111/mec.13293; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hannan S, 2010, FEMS IMMUNOL MED MIC, V59, P345, DOI 10.1111/j.1574-695X.2010.00661.x; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Jiang L, 2013, SCI TOTAL ENVIRON, V458, P267, DOI 10.1016/j.scitotenv.2013.04.038; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kumar S Ganesh, 2013, J Nat Sci Biol Med, V4, P286, DOI 10.4103/0976-9668.116970; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Kwong Waldan K, 2015, Gut Microbes, V6, P214, DOI 10.1080/19490976.2015.1047129; Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111; Levy SB, 2013, MBIO, V4, DOI 10.1128/mBio.00045-13; Lopatkin AJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.44, 10.1038/NMICROBIOL.2016.44]; Ludvigsen J, 2015, MICROBES ENVIRON, V30, P235, DOI 10.1264/jsme2.ME15019; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Nesme J, 2014, CURR BIOL, V24, P1096, DOI 10.1016/j.cub.2014.03.036; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Reybroeck W, 2012, VET MICROBIOL, V158, P1, DOI 10.1016/j.vetmic.2012.01.012; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sankar SA, 2015, SYST APPL MICROBIOL, V38, P276, DOI 10.1016/j.syapm.2015.03.004; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seyfried EE, 2010, MICROB ECOL, V59, P799, DOI 10.1007/s00248-009-9624-7; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001                                                   ; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Snipen L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0517-0; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Spivak M, 2000, AM BEE J, V140, P867; Sprockett DD, 2011, GENE, V479, P29, DOI 10.1016/j.gene.2011.02.009; Thompson HM, 2005, FOOD ADDIT CONTAM, V22, P573, DOI 10.1080/02652030500089986; Tian B., 2012, MBIO, V3; Twiss E, 2005, MOL MICROBIOL, V57, P1593, DOI 10.1111/j.1365-2958.2005.04794.x; Whittle G, 2002, CELL MOL LIFE SCI, V59, P2044, DOI 10.1007/s000180200004                                                           ; Wilkerson C, 2004, ANTIMICROB AGENTS CH, V48, P1066, DOI 10.1128/AAC.48.3.1066-1067.2004; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	71	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	DEC	2017	26	23					6590	6607		10.1111/mec.14392				18	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	FQ3JB	WOS:000418252300008	29087008				2018-01-05	
J	Kim, HK; Noh, YH; Nilius, B; Ko, KS; Rhee, BD; Kim, N; Han, J				Kim, Hyoung Kyu; Noh, Yeon Hee; Nilius, Bernd; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Nari; Han, Jin			Current and upcoming mitochondrial targets for cancer therapy	SEMINARS IN CANCER BIOLOGY			English	Review						Mitochondria; Mitochondria channels; Cancer stem cell; Cancer immunotherapy; CRISPR-Cas9	CHRONIC LYMPHOCYTIC-LEUKEMIA; DEPENDENT ANION CHANNELS; INDEPENDENT CELL-DEATH; BAX-INDUCED APOPTOSIS; K-ATP CHANNELS; STEM-CELLS; CALCIUM UNIPORTER; OXIDATIVE STRESS; BREAST-CANCER; POTASSIUM CHANNEL	Mitochondria are essential intracellular organelles that regulate energy metabolism, cell death, and signaling pathways that are important for cell proliferation and differentiation. Therefore, mitochondria are fundamentally implicated in cancer biology, including initiation, growth, metastasis, relapse, and acquired drug resistance. Based on these implications, mitochondria have been proposed as a major therapeutic target for cancer treatment. In addition to classical view of mitochondria in cancer biology, recent studies found novel pathophysiological roles of mitochondria in cancer. In this review, we introduce recent concepts of mitochondrial roles in cancer biology including mitochondrial DNA mutation and epigenetic modulation, energy metabolism reprogramming, mitochondrial channels, involvement in metastasis and drug resistance, and cancer stem cells. We also discuss the role of mitochondria in emerging cancer therapeutic strategies, especially cancer immunotherapy and CRISPR-Cas9 system gene therapy.	[Kim, Hyoung Kyu; Noh, Yeon Hee; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Nari; Han, Jin] Inje Univ, Natl Res Lab Mitochondrial Signaling, Dept Physiol,Cardiovasc & Metab Dis Ctr, Dept Hlth Sci & Technol,Plus Project Team BK21,Co, Busan, South Korea; [Kim, Hyoung Kyu] Inje Univ, Coll Med, Dept Integrated Biomed Sci, Busan, South Korea; [Nilius, Bernd] Katholieke Univ Leuven, Dept Cell Mol Med, B-3000 Leuven, Belgium	Han, J (reprint author), Inje Univ, Natl Res Lab Mitochondrial Signaling, Dept Physiol, Cardiovasc & Metab Dis Ctr,Coll Med, Bokji Ro 75, Busan 47392, South Korea.	phyhanj@inje.ac.kr			Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2010-0020224, 2015R1A2A1A13001900, 2015R1D1A1A01057937]	This study was supported by a grant from the Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2010-0020224, 2015R1A2A1A13001900 and 2015R1D1A1A01057937), Republic of Korea >.	Acuna-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x; Adam J., 2011, CANCER CELL, P524; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Alvero AB, 2011, MOL CANCER THER, V10, P1385, DOI 10.1158/1535-7163.MCT-11-0023; Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Amantini C, 2009, CARCINOGENESIS, V30, P1320, DOI 10.1093/carcin/bgp138; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Arroyo J.D., 2016, CELL METAB; Bahamonde MI, 2003, J BIOL CHEM, V278, P33284, DOI 10.1074/jbc.M302814200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Balmer ML, 2016, IMMUNITY, V45, P233, DOI 10.1016/j.immuni.2016.07.024; Bao L., 2016, J BIOL CHEM; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Berneburg M, 2006, EXP DERMATOL, V15, P1005, DOI 10.1111/j.1600-0625.2006.00508.x; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Brand A., 2016, CELL METAB; Burr SP, 2016, CELL METAB, V24, P740, DOI 10.1016/j.cmet.2016.09.015; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8                                                   ; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Capt C, 2016, MITOCHONDRIAL DNA A, V27, P3098, DOI 10.3109/19401736.2014.1003924; Cardaci S., 2012, INT J CELL BIOL, V2012, P9, DOI DOI 10.1155/2012/161837; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen CL, 2016, CELL METAB, V23, P206, DOI 10.1016/j.cmet.2015.12.004; Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Clark R, 2010, ADV EXP MED BIOL, V654, P165, DOI 10.1007/978-90-481-3271-3_8; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Curry MC, 2013, BIOCHEM BIOPH RES CO, V434, P695, DOI 10.1016/j.bbrc.2013.04.015; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Cuong DV, 2016, KOREAN J PHYSIOL PHA, V20, P213, DOI 10.4196/kjpp.2016.20.2.213; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Dong Z, 2016, CELL DEATH DIFFER, V23, P1602, DOI 10.1038/cdd.2016.47; Farnie G, 2015, ONCOTARGET, V6, P30472, DOI 10.18632/oncotarget.5401; Felipe A, 2012, CURR MED CHEM, V19, P661, DOI 10.2174/092986712798992048                                                      ; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Feng S, 2012, MOL MED REP, V6, P125, DOI 10.3892/mmr.2012.870; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Ferreira A, 2015, EUR J CLIN INVEST, V45, P44, DOI 10.1111/eci.12359; Fogleman S, 2016, AM J STEM CELLS, V5, P39; Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114; Giampazolias E, 2016, FEBS J, V283, P803, DOI 10.1111/febs.13603; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Goh J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-191; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hall DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096866; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzig S, 2013, NAT CELL BIOL, V15, P1398, DOI 10.1038/ncb2891; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Huang LY, 2015, MOL NEUROBIOL, V52, P626, DOI 10.1007/s12035-014-8888-1; Hurt CM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003774; Iacobazzi V, 2013, MOL GENET METAB, V110, P25, DOI 10.1016/j.ymgme.2013.07.012; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jo A, 2015, BIOMED RES INT, DOI 10.1155/2015/305716; Kajma A, 2012, BBA-BIOENERGETICS, V1817, P1867, DOI 10.1016/j.bbabio.2012.02.029; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kim HK, 2007, AM J PHYSIOL-CELL PH, V293, pC761, DOI 10.1152/ajpcell.00043.2007; Kim HK, 2016, REV PHYSIOL BIOCH P, V170, P101, DOI 10.1007/112_2015_5004; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kosztka L, 2011, MELANOMA RES, V21, P308, DOI 10.1097/CMR.0b013e3283462713; Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751; La-Beck NM, 2015, PHARMACOTHERAPY, V35, P963, DOI 10.1002/phar.1643; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Leanza L, 2014, ONCOGENE, V33, P5569, DOI 10.1038/onc.2013.578; Leanza L, 2013, LEUKEMIA, V27, P1782, DOI 10.1038/leu.2013.56; LeBleu V.S., 2014, NAT CELL BIOL, V16; Li LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144441; Liu B, 2010, MOL CELL BIOCHEM, V337, P25, DOI 10.1007/s11010-009-0283-2; Loureiro Rute, 2013, Recent Pat Endocr Metab Immune Drug Discov, V7, P102; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Luo C, 2016, NATURE, V537, P422, DOI 10.1038/nature19347; Luo Ji, 2016, Trends Cancer, V2, P313, DOI 10.1016/j.trecan.2016.05.001; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maiti AK, 2010, PHARMACOGENOMICS J, V10, P94, DOI 10.1038/tpj.2009.49; Maiti A.K., 2012, CHEMOTHE OPEN ACCESS, V2012; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Marchi Saverio, 2013, Commun Integr Biol, V6, pe23818, DOI 10.4161/cib.23818; Marchi S, 2013, CURR BIOL, V23, P58, DOI 10.1016/j.cub.2012.11.026; Margineantu DH, 2016, CURR OPIN GENET DEV, V38, P110, DOI 10.1016/j.gde.2016.05.004; Marrache S, 2013, ACS NANO, V7, P7392, DOI 10.1021/nn403158n; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Mayer MJ, 2015, PROSTATE CANCER P D, V18, P303, DOI 10.1038/pcan.2015.35; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Miyake T., 2015, GLIA; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Murphy MP, 2016, MOL CELL, V64, P5, DOI 10.1016/j.molcel.2016.09.022; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Nita I.I., 2016, BIOCH BIOPHYS ACTA; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Okon IS, 2015, PHARMACOL RES, V100, P170, DOI 10.1016/j.phrs.2015.06.013; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010                                                        ; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100                                                         ; Peixoto PM, 2012, MITOCHONDRION, V12, P14, DOI 10.1016/j.mito.2011.03.003; Peruzzo R, 2016, EUR BIOPHYS J BIOPHY, V45, P685, DOI 10.1007/s00249-016-1143-0; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Priault M, 1999, EUR J BIOCHEM, V260, P684, DOI 10.1046/j.1432-1327.1999.00198.x; Quast SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039290; Quindry J.C., 2010, AM J PHYSL HEART CIR; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006                                                        ; Rusznak Z, 2008, VIRCHOWS ARCH, V452, P415, DOI 10.1007/s00428-007-0545-x; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Seo JH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002507; Shan CL, 2014, J BIOL CHEM, V289, P21413, DOI 10.1074/jbc.M114.581124; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Simamura E, 2008, J BIOENERG BIOMEMBR, V40, P213, DOI 10.1007/s10863-008-9158-6; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Song IS, 2015, WORLD J STEM CELLS, V7, P418, DOI 10.4252/wjsc.v7.i2.418; Song IS, 2015, GASTROENTEROLOGY, V149, P1006, DOI 10.1053/j.gastro.2015.06.007; Song I.S., 2013, INT J CANC; Sotgia F, 2012, CELL CYCLE, V11, P1445, DOI 10.4161/cc.19841; Suh KS, 2007, MOL CARCINOGEN, V46, P599, DOI 10.1002/mc.20324; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Suzuki-Karasaki M, 2014, INT J ONCOL, V44, P616, DOI 10.3892/ijo.2013.2215; Szabo I, 2011, CELL DEATH DIFFER, V18, P427, DOI 10.1038/cdd.2010.112; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Toczylowska-Maminska R, 2014, J INVEST DERMATOL, V134, P764, DOI 10.1038/jid.2013.422; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tosatto A, 2016, EMBO MOL MED, V8, P569, DOI 10.15252/emmm.201606255; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Uddin M.H., 2014, J CANC SCI THER, V2014; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vlashi E, 2014, BREAST CANCER RES TR, V146, P525, DOI 10.1007/s10549-014-3051-2; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Thu VT, 2012, CARDIOVASC RES, V94, P342, DOI 10.1093/cvr/cvs122; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wallace D C, 2001, Novartis Found Symp, V235, P247; Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40                                               ; Wallace D.C., 2001, NOVART FDN SYMP, V235, P263, DOI DOI 10.1146/ANNUREV.GENET.39.110304.095751; Wang S, 2015, PROTEIN CELL, V6, P472, DOI 10.1007/s13238-015-0177-x; WARBURG O, 1956, SCIENCE, V124, P269; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI [10.1038/.nchembio.1712, 10.1038/nchembio.1712]; Wen SL, 2013, ONCOL LETT, V6, P1098, DOI 10.3892/ol.2013.1492; Wolf FI, 2009, CANCER BIOL THER, V8, P615, DOI 10.4161/cbt.8.7.8152                                                            ; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang MK, 2009, J PHARMACOL SCI, V109, P222, DOI 10.1254/jphs.08132FP; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Ye XQ, 2011, STEM CELL REV REP, V7, P153, DOI 10.1007/s12015-010-9122-9; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhang Y, 2016, AGING-US, V8, P1163, DOI 10.18632/aging.100979; Zhao R, 2017, J CELL PHYSIOL, V232, P1957, DOI 10.1002/jcp.25704; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	173	0	0	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X	1096-3650		SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2017	47						154	167		10.1016/j.semcancer.2017.06.006				14	Oncology	Oncology	FQ2YH	WOS:000418223400015	28627410				2018-01-05	
J	Egami, Y; Kawai, K; Araki, N				Egami, Youhei; Kawai, Katsuhisa; Araki, Nobukazu			RhoC regulates the actin remodeling required for phagosome formation during Fc gamma R-mediated phagocytosis	JOURNAL OF CELL SCIENCE			English	Article						RhoC; mDia1; F-actin; Fc gamma R; Phagocytosis; Macrophages	DIAPHANOUS-RELATED FORMINS; ALDRICH-SYNDROME PROTEIN; SUPEROXIDE FORMATION; OPSONIZED ZYMOSANS; APOPTOTIC CELLS; FAMILY GTPASES; CUP FORMATION; MACROPHAGES; CDC42; RAC1	Phagosome formation is a complicated process that requires spatiotemporally regulated actin reorganization. We found that RhoC GTPase is a critical regulator of Fc gamma R-mediated phagocytosis in macrophages. Our live-cell imaging revealed that RhoC, but not RhoA, is recruited to phagocytic cups engulfing IgG-opsonized erythrocytes (IgG-Es). RhoC silencing through RNAi, CRISPR/Cas-mediated RhoC knockout, and the expression of dominant-negative or constitutively active RhoC mutants suppressed the phagocytosis of IgG-Es. Moreover, RhoC-GTP pulldown experiments showed that endogenous RhoC is transiently activated during phagosome formation. Notably, actin-driven pseudopod extension, which is required for the formation of phagocytic cups, was severely impaired in cells expressing the constitutively active mutant RhoC-G14V, which induced abnormal F-actin accumulation underneath the plasma membrane. mDia1 (encoded by DIAPH1), a Rho-dependent actin nucleation factor, and RhoC were colocalized at the phagocytic cups. Similar to what was seen for RhoC, mDia1 silencing through RNAi inhibited phagosome formation. Additionally, the coexpression of mDia1 with constitutively active mutant RhoC-G14V or expression of active mutant mDia1-Delta N3 drastically inhibited the uptake of IgG-Es. These data suggest that RhoC modulates phagosome formation be modifying actin cytoskeletal remodeling via mDia1.	[Egami, Youhei; Kawai, Katsuhisa; Araki, Nobukazu] Kagawa Univ, Dept Histol & Cell Biol, Sch Med, Miki, Kagawa 7610793, Japan	Egami, Y; Araki, N (reprint author), Kagawa Univ, Dept Histol & Cell Biol, Sch Med, Miki, Kagawa 7610793, Japan.	youhei@med.kagawa-u.ac.jp; naraki@med.kagawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [16K08468]; JSPS KAKENHI [26670094, 26860136]; Kagawa University Scientific Research Encourages Research Funding	This study was supported by the Japan Society for the Promotion of Science (JSPS) (KAKENHI grant number 16K08468 to Y.E., and was also supported in part by JSPS KAKENHI grant number 26670094 to N.A. and grant number 26860136 to K.K.). The work was partially funded by Kagawa University Scientific Research Encourages Research Funding 2015.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Donnelly SK, 2014, CELL ADHES MIGR, V8, P526, DOI 10.4161/cam.29712; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egami Y, 2015, J IMMUNOL RES, DOI 10.1155/2015/429439; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Ikeda Y, 2017, J CELL SCI, V130, P2530, DOI 10.1242/jcs.201749; Jaumouille V, 2011, CURR OPIN CELL BIOL, V23, P22, DOI 10.1016/j.ceb.2010.10.006; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Kim JS, 2004, J BIOL CHEM, V279, P21589, DOI 10.1074/jbc.M308386200; Kuhn S., 2014, SMALL GTPASES, V5; Lang P, 1996, EMBO J, V15, P510; Li Y, 2012, FREE RADICAL BIO MED, V52, P1796, DOI 10.1016/j.freeradbiomed.2012.02.004; Lorenzi R, 2000, BLOOD, V95, P2943; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2000, NAT CELL BIOL, V2, P246; Naj X, 2013, INFECT IMMUN, V81, P1683, DOI 10.1128/IAI.01411-12; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Patel A., 2016, SMALL GTPASES, V8, P114; Pryzwansky Katherine B., 1998, Cell Biochemistry and Biophysics, V28, P251, DOI 10.1007/BF02737813; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Tzircotis G, 2011, J CELL SCI, V124, P2897, DOI 10.1242/jcs.084269; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vicente-Manzanares M, 2003, J IMMUNOL, V171, P1023, DOI 10.4049/jimmunol.171.2.1023                                                     ; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yoon YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20992; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zawistowski JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079877; Zhang JM, 2005, MOL BIOL CELL, V16, P824	59	0	0	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	DEC	2017	130	24					4168	4179		10.1242/jcs.202739				12	Cell Biology	Cell Biology	FQ0LV	WOS:000418049200012	29113998				2018-01-05	
J	Zeira, R; Zehavi, M; Shamir, R				Zeira, Ron; Zehavi, Meirav; Shamir, Ron			A Linear-Time Algorithm for the Copy Number Transformation Problem	JOURNAL OF COMPUTATIONAL BIOLOGY			English	Article						copy number; edit distance; genome rearrangement	HYBRIDIZATION	Problems of genome rearrangement are central in both evolution and cancer. Most evolutionary scenarios have been studied under the assumption that the genome contains a single copy of each gene. In contrast, tumor genomes undergo deletions and duplications, and thus, the number of copies of genes varies. The number of copies of each segment along a chromosome is called its copy number profile (CNP). Understanding CNP changes can assist in predicting disease progression and treatment. To date, questions related to distances between CNPs gained little scientific attention. Here we focus on the following fundamental problem, introduced by Schwarz et al.: given two CNPs, u and v, compute the minimum number of operations transforming u into v, where the edit operations are segmental deletions and amplifications. We establish the computational complexity of this problem, showing that it is solvable in linear time and constant space.	[Zeira, Ron; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Zehavi, Meirav] Univ Bergen, Dept Informat, Bergen, Norway	Zeira, R (reprint author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	ronzeira@post.tau.ac.il			Israeli Science Foundation [317/13]; Israel Cancer Association; Dotan Hemato-Oncology Research Center at Tel Aviv University; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israeli Center of Research Excellence (I-CORE) Gene Regulation in Complex Human Disease [41/ 11]; I-CORE in Algorithms; Simons Institute for the Theory of Computing in Berkeley; Postdoctoral Fellowship for Women of Israel's Council for Higher Education	We thank the referees for many helpful comments. This study was supported by the Israeli Science Foundation (grant 317/13), the Israel Cancer Association, and the Dotan Hemato-Oncology Research Center at Tel Aviv University. R.Z. was supported by fellowships from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University and from the Israeli Center of Research Excellence (I-CORE) Gene Regulation in Complex Human Disease (Center No 41/ 11). M.Z. was supported by a fellowship from the I-CORE in Algorithms and the Simons Institute for the Theory of Computing in Berkeley and by the Postdoctoral Fellowship for Women of Israel's Council for Higher Education.	Abo RP, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1211; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chowdhury SA, 2015, BIOINFORMATICS, V31, P258, DOI 10.1093/bioinformatics/btv233; Chowdhury SA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003740; Chowdhury SA, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/btt205; El-Kebir M., 2016, COPY NUMBER EVOLUTIO, P137; Fertin G., 2009, COMBINATORICS GENOME; Letouze E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r76; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; Mohri M, 2004, STUD FUZZ SOFT COMP, V148, P551; Mohri M., 2003, International Journal of Foundations of Computer Science, V14, P957, DOI 10.1142/S0129054103002114; Oesper L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S10; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Savard OT, 2011, J COMPUT BIOL, V18, P1185, DOI 10.1089/cmb.2011.0136; Schwarz RF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003535; Shamir R., 2016, LEIBNIZ INT P INFORM, V54, P16; Shao MF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S13; Tannier E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-120; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103	19	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1066-5277	1557-8666		J COMPUT BIOL	J. Comput. Biol.	DEC	2017	24	12					1179	1194		10.1089/cmb.2017.0060				16	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FP7HO	WOS:000417803700002	28837352				2018-01-05	
J	Oggu, GS; Sasikumar, S; Reddy, N; Ella, KKR; Rao, CM; Bokara, KK				Oggu, Gopi Suresh; Sasikumar, Shyama; Reddy, Nirosha; Ella, Kranthi Kiran Reddy; Rao, Ch Mohan; Bokara, Kiran Kumar			Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity	STEM CELL REVIEWS AND REPORTS			English	Review						Mesenchymal stem cells; Viral vectors; Gene delivery; Stem cell applications; CRISPR/Cas; Optogenetics; Pharmacogenomics	MARROW STROMAL CELLS; BORNA-DISEASE VIRUS; VERSUS-HOST-DISEASE; TARGETED ONCOLYTIC POXVIRUS; REGULATORY T-CELLS; BONE-MARROW; MAMMALIAN-CELLS; IN-VIVO; INTERFERON-GAMMA; PROGENITOR CELLS	A significant number of clinical trials have been undertaken to explore the use of mesenchymal stem cells (MSCs) for the treatment of several diseases such as Crohn's disease, diabetes, bone defects, myocardial infarction, stroke etc., Due to their efficiency in homing to the tissue injury sites, their differentiation potential, the capability to secrete a large amount of trophic factors and their immunomodulatory effects, MSCs are becoming increasingly popular and expected to be one of the promising therapeutic approaches. However, challenges associated with the isolation of pure MSC populations, their culture and expansion, specific phenotypic characterization, multi-potential differentiation and challenges of efficient transplantation limit their usage. The current strategies of cell-based therapies emphasize introducing beneficial genes, which will improve the therapeutic ability of MSCs and have better homing efficiency. The continuous improvement in gene transfer technologies has broad implications in stem cell biology. Although viral vectors are efficient vehicles for gene delivery, construction of viral vectors with desired genes, their safety and immunogenicity limit their use in clinical applications. We review current gene delivery approaches, including viral and plasmid vectors, for transfecting MSC with beneficial genes. The review also discusses the use of a few emerging technologies that could be used to improve the transfer/induction of desirable genes for cell therapy.	[Oggu, Gopi Suresh; Sasikumar, Shyama; Rao, Ch Mohan; Bokara, Kiran Kumar] CSIR Ctr Cellular & Mol Biol, Med Biotechnol Complex,Uppal Rd, Hyderabad 500007, Telangana, India; [Reddy, Nirosha; Ella, Kranthi Kiran Reddy] MNR Dent Coll & Hosp, Sangareddy 500076, Telangana, India	Bokara, KK (reprint author), CSIR Ctr Cellular & Mol Biol, Med Biotechnol Complex,Uppal Rd, Hyderabad 500007, Telangana, India.	bokarakiran@ccmb.res.in			CSIR network project mIND [BSC-0115]; Department of Science and Technology, Government of India	Authors acknowledge Dr. T, Ramakrishna for critical reading of the manuscript and suggestions. Kiran Kumar acknowledge CSIR network project mIND (BSC-0115) for financial assistance. Ch. Mohan Rao acknowledges the Department of Science and Technology, Government of India for the Sir JC Bose National Fellowship.	Afessa B, 2001, BONE MARROW TRANSPL, V28, P425, DOI 10.1038/sj.bmt.1703142; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Al-Mahayri ZN, 2017, PHARMACOGENOMICS, V18, P687, DOI 10.2217/pgs-2017-0005; Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612; Albitar A., 2017, J CELLULAR BIOCH; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Avasthi S, 2008, INTERNET J MED UPDAT, V3, P22; Azzam T, 2002, MACROMOLECULES, V35, P9947, DOI 10.1021/ma0209592; Bachrach U, 2005, CURR PROTEIN PEPT SC, V6, P559, DOI 10.2174/138920305774933240; Baik KY, 2011, SMALL, V7, P741, DOI 10.1002/smll.201001930; Bak XY, 2010, CANCER GENE THER, V17, P721, DOI 10.1038/cgt.2010.32; Bak XY, 2011, HUM GENE THER, V22, P1365, DOI 10.1089/hum.2010.212; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0                                                   ; Bang OY, 2016, J STROKE, V18, P256, DOI 10.5853/jos.2016.01263; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Baron F, 2010, BIOL BLOOD MARROW TR, V16, P838, DOI 10.1016/j.bbmt.2010.01.011; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Bhattacharya M, 2011, J BIOMED MATER RES A, V96A, P75, DOI 10.1002/jbm.a.32958; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Bokara KK, 2014, CURR STEM CELL RES T, V9, P458, DOI 10.2174/1574888X09666140828122903                                               ; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486                                                        ; Cao X, 2011, INT J NANOMED, V6, P3335, DOI 10.2147/IJN.S27370; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; Cavarretta IT, 2010, MOL THER, V18, P223, DOI 10.1038/mt.2009.237; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cellot G, 2011, J NEUROSCI, V31, P12945, DOI 10.1523/JNEUROSCI.1332-11.2011; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071; Chen HC, 2009, BIOMATERIALS, V30, P674, DOI 10.1016/j.biomaterials.2008.10.017; Cho JW, 2012, J GASTROEN HEPATOL, V27, P1362, DOI 10.1111/j.1440-1746.2012.07137.x; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi YJ, 2010, J NEUROL SCI, V298, P28, DOI 10.1016/j.jns.2010.09.003; Chuang CK, 2010, TISSUE ENG PT A, V16, P479, DOI [10.1089/ten.tea.2009.0401, 10.1089/ten.TEA.2009.0401]; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3                                                   ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Correia AS, 2005, ANN MED, V37, P487, DOI 10.1080/07853890500327967; DAHLBERG JE, 1988, ADV VET SCI COMP MED, V32, P1; Dazzi F, 2008, EUR J IMMUNOL, V38, P1479, DOI 10.1002/eji.200838433; de Melo SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128922; DELATORRE JC, 1994, J VIROL, V68, P7669; Delavar HM, 2016, J MEMBRANE BIOL, V249, P215, DOI 10.1007/s00232-016-9883-4; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838                                                       ; Efimenko AY, 2015, BIORESEARCH OPEN ACC, V4, P26, DOI 10.1089/biores.2014.0042; Fabbro A, 2012, ACS NANO, V6, P2041, DOI 10.1021/nn203519r; FABIAN I, 1988, BLOOD, V72, P913; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ferreira E, 2012, EUR CELLS MATER, V24, P18, DOI 10.22203/eCM.v024a02                                                            ; Frisch J, 2014, HUM GENE THER, V25, P1050, DOI 10.1089/hum.2014.091; Frisch J, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt491; Fu TS, 2015, SPINE J, V15, P2036, DOI 10.1016/j.spinee.2014.11.002; Gall J, 1996, J VIROL, V70, P2116; Gao LZ, 2006, CHEMBIOCHEM, V7, P239, DOI 10.1002/cbic.200500227; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; George JC, 2010, TRANSL RES, V155, P10, DOI 10.1016/j.trsl.2009.06.009; Gopalakrishnan ARK, 2016, GENE THER, V23, P580, DOI 10.1038/gt.2016.30; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; Guo ST, 2010, ACS NANO, V4, P5505, DOI 10.1021/nn101638u; Guru A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv079; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Han SW, 2008, NANOMED-NANOTECHNOL, V4, P215, DOI 10.1016/j.nano.2008.03.005; Harris DT, 2014, BIOMEDICINES, V2, P50, DOI 10.3390/biomedicines2010050; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hu FH, 2013, CELL REPROGRAM, V15, P224, DOI 10.1089/cell.2012.0077; Hu JZ, 2016, NEUROSCIENCE, V328, P40, DOI 10.1016/j.neuroscience.2016.04.031; Hu YC, 2006, ADV VIRUS RES, V68, P287, DOI 10.1016/S0065-3527(06)68008-1; HUANG S, 1994, BLOOD, V83, P1515; Ikeda Y, 2016, GENE THER, V23, P256, DOI 10.1038/gt.2015.108; Ito H, 2004, GENE THER, V11, P34, DOI 10.1038/sj.gt.3302102; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jeon SY, 2012, BIOMATERIALS, V33, P4413, DOI 10.1016/j.biomaterials.2012.02.051; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joo SY, 2010, CYTOTHERAPY, V12, P361, DOI 10.3109/14653240903502712; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Joydeep D, 2016, SCI REP, V6, P37480; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Ke J, 2011, ARCH ORAL BIOL, V56, P619, DOI 10.1016/j.archoralbio.2010.12.010; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Khera M, 2015, J SEX MED, V12, P1105, DOI 10.1111/jsm.12871; Kim EH, 2016, CELL TRANSPLANT, V25, P1489, DOI 10.3727/096368916X690430; Kim HJ, 2011, STEM CELLS DEV, V20, P2103, DOI 10.1089/scd.2010.0516; Kim HH, 2007, INT J PHARM, V335, P70, DOI 10.1016/j.ijpharm.2006.11.017; Kim NY, 2010, J GENE MED, V12, P779, DOI 10.1002/jgm.1497; Kim TH, 2013, J BIOMED MATER RES A, V101, P1651, DOI 10.1002/jbm.a.34466; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Knaan-Shanzer S, 2005, STEM CELLS, V23, P1598, DOI 10.1634/stemcells.2005-0016                                                     ; KOLB HJ, 1990, BLOOD, V76, P2462; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kuzmina LA, 2012, STEM CELLS INT, DOI 10.1155/2012/968213; Laker C, 1998, J VIROL, V72, P339; Lamb A., 1996, FIELDS VIROLOGY; Langman LJ, 2016, J MOL DIAGN, V18, P638, DOI 10.1016/j.jmoldx.2016.03.007; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee EXW, 2011, MOL PHARMACEUT, V8, P1515, DOI 10.1021/mp200127u; Leoni V, 2015, ONCOTARGET, V6, P34774, DOI 10.18632/oncotarget.5793; Li MX, 2010, HUM GENE THER, V21, P1527, DOI 10.1089/hum.2010.005; Li WZ, 2008, J GENE MED, V10, P897, DOI 10.1002/jgm.1208; Li WZ, 2007, J MAGN MAGN MATER, V311, P336, DOI 10.1016/j.jmmm.2006.11.201; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liao JC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071073; Liao JC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020147; Licinio J., 2009, PHARMACOGENOMICS SEA; Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu T, 2016, CANCER LETT, V373, P109, DOI 10.1016/j.canlet.2016.01.030; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Liu Z, 2015, CELL PHYSIOL BIOCHEM, V37, P321, DOI 10.1159/000430356; Ljungman P, 2008, BONE MARROW TRANSPL, V42, P227, DOI 10.1038/bmt.2008.162; Lo B, 2009, ENDOCR REV, V30, P204, DOI 10.1210/er.2008-0031; Lu CH, 2012, TISSUE ENG PT A, V18, P2114, DOI [10.1089/ten.tea.2012.0010, 10.1089/ten.TEA.2012.0010]; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Marigo I, 2011, SEMIN IMMUNOPATHOL, V33, P593, DOI 10.1007/s00281-011-0267-7; Masotti A, 2009, COLLOID SURFACE B, V68, P136, DOI 10.1016/j.colsurfb.2008.09.017; McCarter SD, 2003, GENE THER, V10, P1629, DOI 10.1038/sj.gt.3302063; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Merrihew RV, 2001, J VIROL, V75, P903, DOI 10.1128/JVI.75.2.903-909.2001                                                   ; Meyer U. A., 2002, PHARMACOGENOMICS SEA, P1; Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Nadig Roopa R, 2009, J Conserv Dent, V12, P131, DOI 10.4103/0972-0707.58329; Nakashima M, 2003, HUM GENE THER, V14, P591, DOI 10.1089/104303403764539369; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Nowakowski A, 2013, ACTA NEUROBIOL EXP, V73, P1; Otani K, 2009, J CONTROL RELEASE, V133, P146, DOI 10.1016/j.jconrel.2008.09.088; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Park SA, 2011, INT J ONCOL, V38, P97, DOI 10.3892/ijo_00000828; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pliss A, 2017, ACS PHOTONICS, V4, P806, DOI 10.1021/acsphotonics.6b00475; Prockop DJ, 2017, CYTOTHERAPY, V19, P1, DOI 10.1016/j.jcyt.2016.09.008; Qin YH, 2014, POSTGRAD MED J, V90, P643, DOI 10.1136/postgradmedj-2013-132387; Ramos CA, 2010, STEM CELLS, V28, P1107, DOI 10.1002/stem.433; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rejman J, 2006, J LIPOSOME RES, V16, P237, DOI 10.1080/08982100600848819; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rome C., 2008, MOL IMAGING; Rose RA, 2008, CIRC RES, V103, pE120, DOI 10.1161/CIRCRESAHA.108.186908; Ruponen M, 2001, J BIOL CHEM, V276, P33875, DOI 10.1074/jbc.M011553200                                                          ; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Ryser MF, 2008, TISSUE ENG PT C-METH, V14, P179, DOI 10.1089/ten.tec.2007.0359; Ryu CH, 2011, HUM GENE THER, V22, P733, DOI 10.1089/hum.2010.187; Sanchez-Antequera Y, 2011, BLOOD, V117, pE171, DOI 10.1182/blood-2010-08-302646; SCHNEEMANN A, 1995, VIROLOGY, V210, P1, DOI 10.1006/viro.1995.1311; Scholefield J., 2016, CURRENT STEM CELL RE, V2, P95; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858; Simoes S, 1999, GENE THER, V6, P1798, DOI 10.1038/sj.gt.3301015; Simoes Sergio, 2005, Expert Opin Drug Deliv, V2, P237, DOI 10.1517/17425247.2.2.237; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sokolik C, 2015, CELL SYST, V1, P117, DOI 10.1016/j.cels.2015.08.001; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Steinbeck JA, 2015, NEURON, V86, P187, DOI 10.1016/j.neuron.2015.03.002; Studeny M, 2004, J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Subramanian A, 1999, NAT BIOTECHNOL, V17, P873; Sun QS, 2014, GENES DIS, V1, P113, DOI 10.1016/j.gendis.2014.07.003; Sun XL, 2011, CANCER LETT, V312, P168, DOI 10.1016/j.canlet.2011.07.035; Sung LY, 2007, BIOMATERIALS, V28, P3437, DOI 10.1016/j.biomaterials.2007.04.008; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Tan WB, 2007, BIOMATERIALS, V28, P1565, DOI 10.1016/j.biomaterials.2006.11.018; Tao K, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0280-9; Thakor DK, 2011, TISSUE ENG PART C-ME, V17, P131, DOI [10.1089/ten.tec.2010.0120, 10.1089/ten.TEC.2010.0120]; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomas H. A., 2013, LENTIVIRAL GENE THER; Treacy O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042662; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408                                                      ; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Vallhov H, 2007, NANO LETT, V7, P3576, DOI 10.1021/nI0714785; van Eekelen M, 2010, ONCOGENE, V29, P3185, DOI 10.1038/onc.2010.75; vanBesien KW, 1997, BONE MARROW TRANSPL, V19, P977, DOI 10.1038/sj.bmt.1700781; Van Hassselt J. C., 2017, CURRENT OPINION SYST, V4, P9; Venkatesan JK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt113; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang KC, 2005, BIOTECHNOL BIOENG, V89, P464, DOI 10.1002/bit.20385; Wang WW, 2014, CLIN HEMORHEOL MICRO, V58, P19, DOI 10.3233/CH-141883; Webber BR, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.14; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Wen YT, 2012, BIOMATERIALS, V33, P8111, DOI 10.1016/j.biomaterials.2012.07.032; Wright JF, 2009, HUM GENE THER, V20, P698, DOI 10.1089/hum.2009.064; Wu HC, 2010, ADV FUNCT MATER, V20, P67, DOI 10.1002/adfm.200901108; Xiang QL, 2017, J CELL PHYSIOL, V232, P996, DOI 10.1002/jcp.25578; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407                                                         ; Ye Z, 2008, HEPATOB PANCREAT DIS, V7, P608; Yin T, 2015, MOL MED REP, V12, P5093, DOI 10.3892/mmr.2015.4089; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zaldumbide A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048093; Zanotti L, 2016, LEUKEMIA, V30, P1143, DOI 10.1038/leu.2016.33; Zeng JM, 2009, MOL THER, V17, P1585, DOI 10.1038/mt.2009.124; Zhang GQ, 2003, J VIROL, V77, P12243, DOI 10.1128/JVI.77.22.12243-12251.2003; Zhang J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0240-9; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhou H, 2010, BIOL BLOOD MARROW TR, V16, P403, DOI 10.1016/j.bbmt.2009.11.006	215	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1550-8943	1558-6804		STEM CELL REV REP	Stem Cell Rev. Rep.	DEC	2017	13	6					725	740		10.1007/s12015-017-9760-2				16	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FQ0XU	WOS:000418081400004	28815481				2018-01-05	
J	Selinski, S; Blaszkewicz, M; Ickstadt, K; Gerullis, H; Otto, T; Roth, E; Volkert, F; Ovsiannikov, D; Moormann, O; Banfi, G; Nyirady, P; Vermeulen, SH; Garcia-Closas, M; Figueroa, JD; Johnson, A; Karagas, MR; Kogevinas, M; Malats, N; Schwenn, M; Silverman, DT; Koutros, S; Rothman, N; Kiemeney, LA; Hengstler, JG; Golka, K				Selinski, Silvia; Blaszkewicz, Meinolf; Ickstadt, Katja; Gerullis, Holger; Otto, Thomas; Roth, Emanuel; Volkert, Frank; Ovsiannikov, Daniel; Moormann, Oliver; Banfi, Gergely; Nyirady, Peter; Vermeulen, Sita H.; Garcia-Closas, Montserrat; Figueroa, Jonine D.; Johnson, Alison; Karagas, Margaret R.; Kogevinas, Manolis; Malats, Nuria; Schwenn, Molly; Silverman, Debra T.; Koutros, Stella; Rothman, Nathaniel; Kiemeney, Lambertus A.; Hengstler, Jan G.; Golka, Klaus			Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer	CARCINOGENESIS			English	Article							GENOME-WIDE ASSOCIATION; S-TRANSFERASE M1; MESSENGER-RNA EXPRESSION; UREA TRANSPORTER GENE; NAT2 SLOW ACETYLATION; CONFERS SUSCEPTIBILITY; SEQUENCE VARIANT; GSTM1 NULL; POLYMORPHISMS; LOCUS	Little is known whether genetic variants identified in genome-wide association studies interact to increase bladder cancer risk. Recently, we identified two-and three-variant combinations associated with a particular increase of bladder cancer risk in a urinary bladder cancer case-control series (Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), 1501 cases, 1565 controls). In an independent case-control series (Nijmegen Bladder Cancer Study, NBCS, 1468 cases, 1720 controls) we confirmed these two-and three-variant combinations. Pooled analysis of the two studies as discovery group (IfADo-NBCS) resulted in sufficient statistical power to test up to four-variant combinations by a logistic regression approach. The New England and Spanish Bladder Cancer Studies (2080 cases and 2167 controls) were used as a replication series. Twelve previously identified risk variants were considered. The strongest four-variant combination was obtained in never smokers. The combination of rs1014971[AA] near apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (APOBEC3A) and chromobox homolog 6 (CBX6), solute carrier family 1s4 (urea transporter), member 1 (Kidd blood group) (SLC14A1) exon single nucleotide polymorphism (SNP) rs1058396[AG, GG], UDP glucuronosyltransferase 1 family, polypeptide A complex locus (UGT1A) intron SNP rs11892031[AA] and rs8102137[CC, CT] near cyclin E1 (CCNE1) resulted in an unadjusted odds ratio (OR) of 2.59 (95% CI = 1.93-3.47; P = 1.87 x 10(-10)), while the individual variant ORs ranged only between 1.11 and 1.30. The combination replicated in the New England and Spanish Bladder Cancer Studies (ORunadjusted = 1.60, 95% CI = 1.10-2.33; P = 0.013). The four-variant combination is relatively frequent, with 25% in never smoking cases and 11% in never smoking controls (total study group: 19% cases, 14% controls). In conclusion, we show that four high-risk variants can statistically interact to confer increased bladder cancer risk particularly in never smokers.	[Selinski, Silvia; Blaszkewicz, Meinolf] TU Dortmund, Leibniz Inst Arbeitsforsch, Syst Toxicol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Ickstadt, Katja] TU Dortmund Univ, Fac Stat, Dortmund, Germany; [Gerullis, Holger; Otto, Thomas] Lukasklin Neuss, Dept Urol, Neuss, Germany; [Gerullis, Holger] Carl von Ossietzky Univ Oldenburg, Klinikum Oldenburg, Univ Hosp Urol, Sch Med & Hlth Sci, Oldenburg, Germany; [Roth, Emanuel; Volkert, Frank] Paul Gerhardt Fdn, Evangel Hosp, Dept Urol, Lutherstadt Wittenberg, Germany; [Ovsiannikov, Daniel; Moormann, Oliver] St Josefs Hosp, Dept Urol, Dortmund, Germany; [Ovsiannikov, Daniel] Kemperhof Hosp, Dept Urol & Pediat Urol, Koblenz, Germany; [Banfi, Gergely; Nyirady, Peter] Semmelweis Univ, Dept Urol, Budapest, Hungary; [Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr Radboudumc, Dept Hlth Evidence HEV 133, Nijmegen, Netherlands; [Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr Radboudumc, Dept Urol URO 659, Nijmegen, Netherlands; [Garcia-Closas, Montserrat; Silverman, Debra T.; Koutros, Stella; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA; [Figueroa, Jonine D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, CRUK Edinburgh Ctr, Edinburgh, Midlothian, Scotland; [Johnson, Alison] Vermont Canc Registry, Vermont Dept Hlth, Burlington, VT 05401 USA; [Karagas, Margaret R.] Geisel Sch Med Dartmouth, Dept Epidemiol, Hanover, NH 03756 USA; [Kogevinas, Manolis] ISGlobal, Ctr Res Environm Epidemiol CREAL, Canc Program, Barcelona, Spain; [Kogevinas, Manolis] Hlth Res Inst Carlos III, CIBER Epidemiol & Publ Hlth CIBER ESP, Madrid, Spain; [Kogevinas, Manolis] Hosp del Mar, Med Res Inst, Barcelona, Spain; [Kogevinas, Manolis] Univ Pompeu Fabra, Barcelona, Spain; [Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Malats, Nuria] CIBERONC, Madrid, Spain; [Schwenn, Molly] Maine Canc Registry, Maine Dept Hlth & Human Serv, Augusta, ME 04333 USA	Selinski, S (reprint author), TU Dortmund, Leibniz Inst Arbeitsforsch, Syst Toxicol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	Selinski@ifado.de			Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Center [SFB 876]; Intramural Research Program of the National Institutes of Health; Division of Cancer Epidemiology and Genetics, National Cancer Institute [Z01 CP010187-13]	KI's work has been supported by Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Center SFB 876 "Providing Information by Resource-Constrained Analysis", project C4. The NBS (source of controls) and the NBCS (source of the cases) were funded by the Radboud university medical center. This work was supported by the Intramural Research Program of the National Institutes of Health and the Division of Cancer Epidemiology and Genetics, National Cancer Institute (Z01 CP010187-13).	Arand M, 1996, ANAL BIOCHEM, V236, P184, DOI 10.1006/abio.1996.0153; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159                                                         ; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Devi SS, 2008, CHEMOSPHERE, V70, P1835, DOI 10.1016/j.chemosphere.2007.08.008; di Martino E, 2012, ADV UROL, DOI 10.1155/2012/429213; Dudek AM, 2013, INT J MOL SCI, V14, P12346, DOI 10.3390/ijms140612346; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; Figueroa JD, 2016, HUM MOL GENET, V25, P1203, DOI 10.1093/hmg/ddv492; Figueroa JD, 2014, HUM MOL GENET, V23, P1387, DOI 10.1093/hmg/ddt519; Gakis G, 2013, WORLD J UROL, V31, P1059, DOI 10.1007/s00345-013-1037-z; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1                                                   ; Garcia-Closas M, 2013, CANCER RES, V73, P2211, DOI 10.1158/0008-5472.CAN-12-2388; Garcia-Closas M, 2011, HUM MOL GENET, V20, P4282, DOI 10.1093/hmg/ddr342; Golka K, 2011, ARCH TOXICOL, V85, P539, DOI 10.1007/s00204-011-0676-3; Golka K, 2009, PHARMACOGENET GENOM, V19, P903, DOI 10.1097/FPC.0b013e328331b554; Ha GH, 2013, CANCER LETT, V336, P24, DOI 10.1016/j.canlet.2013.04.022; Hengstler JG, 1998, RECENT RES CANCER, V154, P47; Jiang Z, 2011, EXP BIOL MED, V236, P723, DOI 10.1258/ebm.2011.010295; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kempkes M, 1996, ARCH TOXICOL, V71, P123, DOI 10.1007/s002040050366; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kohaar I, 2013, J NATL CANCER I, V105, P69, DOI 10.1093/jnci/djs458; Koutros S, 2013, INT J CANCER, V133, P3008, DOI 10.1002/ijc.28325; Krause G., 2004, MARKER SUSCEPTIBILIT, V9, P183; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Moore LE, 2011, CARCINOGENESIS, V32, P182, DOI 10.1093/carcin/bgq223; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Ovsiannikov D, 2012, J TOXICOL ENV HEAL A, V75, P557, DOI 10.1080/15287394.2012.675308; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rafnar T, 2014, HUM MOL GENET, V23, P5545, DOI 10.1093/hmg/ddu264; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Schwender H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137937; Schwender H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051880; Selinski S, 2014, EXCLI J, V13, P1198; Selinski S, 2014, ARCH TOXICOL, V88, P1469, DOI 10.1007/s00204-014-1297-4; Selinski S, 2013, ARCH TOXICOL, V87, P2129, DOI 10.1007/s00204-013-1157-7; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; Thakur HC, 2013, BIOL CHEM, V394, P1411, DOI 10.1515/hsz-2013-0184; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang ML, 2014, INT J CANCER, V135, P2653, DOI 10.1002/ijc.28898; Wang ML, 2009, CARCINOGENESIS, V30, P991, DOI 10.1093/carcin/bgp091; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zhigang Z, 2008, INT J CANCER, V122, P864, DOI 10.1002/ijc.23150	48	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	DEC	2017	38	12					1167	1179		10.1093/carcin/bgx102				13	Oncology	Oncology	FP6JB	WOS:000417730900002	29028944				2018-01-05	
J	Tong, ZC; Du, Y; Ling, JQ; Huang, LJ; Ma, JL				Tong, Zhongchun; Du, Yu; Ling, Junqi; Huang, Lijia; Ma, Jinglei			Relevance of the clustered regularly interspaced short palindromic repeats of Enterococcus faecalis strains isolated from retreatment root canals on periapical lesions, resistance to irrigants and biofilms	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						Enterococcus faecalis; clustered regularly interspaced short palindromic repeats; chlorhexidine; sodium hypochlorite; biofilm	CRISPR-CAS SYSTEMS; FAILED ENDODONTIC TREATMENT; PATHOGENICITY ISLAND; IN-VITRO; EVOLUTION; VIRULENCE; BACTERIA; TEETH	A high prevalence of Enterococcus faecalis (E. faecalis) is observed in teeth with root canal treatment failures. Clustered regularly interspaced short palindromic repeats (CRISPR) are widely distributed in prokaryotes that have adaptive immune systems against mobile elements, including pathogenic genes. The present study investigated the relevance of the CRISPR in E. faecalis strains isolated from retreated root canals on biofilms, periapical lesions and drug resistance. A total of 20 E. faecalis strains were extracted from the root canals of teeth referred for root canal retreatment. CRISPR-Cas loci were identified by two pairs of relevant primers and polymerase chain reaction. The susceptibility of the 20 isolated strains to intracanal irrigants was evaluated by 1- and 5-minute challenges with a mixture of a tetracycline isomer, an acid and a detergent (MTAD), 2% chlorhexidine (CHX) and 5.25% sodium hypochlorite (NaOCl). The microtiter plate assay and crystal violet staining were used to compare the biofilm formation of the E. faecalis isolate strains. Out of the 20 E. faecalis isolate strains, 5 strains that lacked CRISPR-cas determinants exhibited significant periapical lesions. Among the 15 strains containing CRISPR-cas determinants, 8 were isolated from root canals with inadequate fillings and 7 were isolated from root canals without any fillings. The five strains lacking CRISPR-cas loci were observed to be more resistant to MTAD and 2% CHX than the 15 strains that had CRISPR-cas loci. All of the strains exhibited the same susceptibility to 5.25% NaOCl. Furthermore, the 5 strains lacking CRISPR-cas determinants generated more biofilm than the other 15 strains. Thus, the results of the present study suggested that E. faecalis root canal isolates lacking CRISPR-cas exhibit higher resistance to intracanal irrigants, stronger biofilm formation and generate significant periapical lesions.	[Tong, Zhongchun; Du, Yu; Ling, Junqi; Huang, Lijia; Ma, Jinglei] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, 56 Lingyuan West Rd, Guangzhou 510055, Guangdong, Peoples R China; [Tong, Zhongchun; Du, Yu; Ling, Junqi; Huang, Lijia; Ma, Jinglei] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China	Ling, JQ (reprint author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, 56 Lingyuan West Rd, Guangzhou 510055, Guangdong, Peoples R China.	junqi_ling@hotmail.com			Guangdong Natural Science Foundation [S2013040014932, 2014A030313026]	The authors are grateful to Elsevier Language Editing Services for editing the draft of this manuscript. The present study was supported by grants from the Guangdong Natural Science Foundation (nos. S2013040014932 and 2014A030313026).	Al-Ahmad A, 2009, J ENDODONT, V35, P986, DOI 10.1016/j.joen.2009.04.013; Andrup L, 1998, APMIS, V106, P47; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2013, WIRES RNA, V4, P267, DOI 10.1002/wrna.1159; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Dahl A, 2013, EXPERT REV CARDIOVAS, V11, P1247, DOI 10.1586/14779072.2013.832482; Duggan JM, 2007, J ENDODONT, V33, P815, DOI 10.1016/j.joen.2007.02.016; Figdor D, 2003, ORAL MICROBIOL IMMUN, V18, P234, DOI 10.1034/j.1399-302X.2003.00072.x                                                ; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Kanisavaran ZM, 2008, INT DENT J, V58, P247, DOI 10.1922/IDJ_1910Mohamadi11; Lindenstrauss AG, 2011, SYST APPL MICROBIOL, V34, P553, DOI 10.1016/j.syapm.2011.05.002; Liu HY, 2010, J ENDODONT, V36, P630, DOI 10.1016/j.joen.2009.11.016; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Marraffini LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003765; Moharnmadi Z, 2008, INT DENT J, V58, P329, DOI 10.1922/IDJ_1961Mohammadi13; Molloy S, 2012, NAT REV MICROBIOL, V10, DOI 10.1038/nrmicro2812; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peciuliene V, 2000, J ENDODONT, V26, P593, DOI 10.1097/00004770-200010000-00004; Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004                                                ; Sakamoto M, 2008, ORAL MICROBIOL IMMUN, V23, P275, DOI 10.1111/j.1399-302X.2007.00423.x; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Singla MG, 2011, ORAL SURG ORAL MED O, V112, pE70, DOI 10.1016/j.tripleo.2011.02.015; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8                                                   ; Tong ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089209; Tong ZX, 2013, J ENDODONT, V39, P674, DOI 10.1016/j.joen.2012.12.010; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zehnder M, 2009, INT ENDOD J, V42, P277, DOI 10.1111/j.1365-2591.2008.01537.x; Zhang Q, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r40; Zoletti GO, 2006, J ENDODONT, V32, P722, DOI 10.1016/j.joen.2006.02.001	38	0	0	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2017	14	6					5491	5496		10.3892/etm.2017.5205				6	Medicine, Research & Experimental	Research & Experimental Medicine	FP7LE	WOS:000417815000035					2018-01-05	
J	Zhang, SY; Wang, FS; Zhang, Z				Zhang, Shuye; Wang, Fusheng; Zhang, Zheng			Current advances in the elimination of hepatitis B in China by 2030	FRONTIERS OF MEDICINE			English	Review						HBV; CHB; biomarker; functional cure; coinfection	CORE-RELATED ANTIGEN; HBEAG-POSITIVE PATIENTS; HBV CAPSID INHIBITORS; TO-CHILD TRANSMISSION; VIRUS-REPLICATION; SURFACE-ANTIGEN; PEGYLATED-INTERFERON; CRISPR/CAS9 SYSTEM; RISK-FACTORS; INFECTION	With its 78 million chronic carriers, hepatitis B virus (HBV) infection is still one of the leading public health challenges in China. Over the last two decades, China has made great progress on the prevention of HBV transmission through national vaccination programs. Zero transmission from mother to infant has been proposed as the current goal. Available anti-HBV therapy is efficacious in suppressing HBV replication; however, it fails to completely cure patients with chronic hepatitis B and even requires lifelong treatment. To reduce the costs and improve the efficacy, several trials have been recently conducted in China to optimize the current anti-HBV managements. Novel biomarkers were identified to predict treatment outcomes, and new promising treatment strategies were developed. Reports also indicate that coinfections of HBV with other hepatotropic viruses and human immunodeficiency virus are common in China and cause severe liver diseases, which should be recognized early and treated properly. Work is still needed to eliminate hepatitis B in China by 2030.	[Zhang, Shuye] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China; [Zhang, Shuye] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Wang, Fusheng] Beijing 302 Hosp, Dept Infect Dis, Beijing 100039, Peoples R China; [Zhang, Zheng] Beijiing 302 Hosp, Res Ctr Clin & Translat Med, Beijing 100039, Peoples R China	Zhang, Z (reprint author), Beijiing 302 Hosp, Res Ctr Clin & Translat Med, Beijing 100039, Peoples R China.	zhangzheng1975@aliyun.com			Major State Basic Research Development Program [2015CB554300]; National Natural Science Foundation of China [91442127]	This review was funded by the Major State Basic Research Development Program (No. 2015CB554300 to SZ) and the National Natural Science Foundation of China (No. 91442127 to ZZ). The authors also thank Ms. Jingjing Yan at the Shanghai Public Health Clinical Center for her assistance in preparing the figure.	Bian YJ, 2017, HEPATOLOGY, V66, P1067, DOI 10.1002/hep.29239; Bourliere Marc, 2017, Lancet Gastroenterol Hepatol, V2, P177, DOI 10.1016/S2468-1253(16)30189-3; Brouwer WP, 2015, HEPATOLOGY, V61, P1512, DOI 10.1002/hep.27586; Cao ZH, 2017, HEPATOLOGY, V66, P1058, DOI 10.1002/hep.29213; Chen C, 2016, WORLD J GASTROENTERO, V22, P10388, DOI 10.3748/wjg.v22.i47.10388; Chen EQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00111-0; Chen F, 2017, J GASTROEN HEPATOL, V32, P515, DOI 10.1111/jgh.13460; Chen GF, 2017, HEPATOLOGY, V66, P13, DOI 10.1002/hep.29109; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Chen X, 2016, HEPATOLOGY; Cheng X, 2016, 2015 INT HBV M SEP 2; Cheung KS, 2017, J VIRAL HEPATITIS, V24, P654, DOI 10.1111/jvh.12688; Chi H, 2015, HEPATOLOGY, V62, p1183A; [中华医学会肝病学分会 Chinese Society of Hepatology Chinese M], 2015, [中华肝脏病杂志, Chinese Journal of Hepatology], V23, P888; Cui FQ, 2017, EMERG INFECT DIS, V23, P765, DOI 10.3201/eid2305.161477; Cui FuQiang, 2016, Chinese Journal of Viral Diseases, V6, P81; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Fan R, 2016, LANCET INFECT DIS, V16, P1103, DOI 10.1016/S1473-3099(16)30327-9; Fan R, 2016, GUT, V65, P313, DOI 10.1136/gutjnl-2014-308546; Gao Y, 2017, HUM VACC IMMUNOTHER, V13, P1768, DOI 10.1080/21645515.2017.1319021; Han MF, 2016, ANTIVIR THER, V21, P337, DOI 10.3851/IMP3019; Huang SM, 2016, INT J STD AIDS, V27, P890, DOI 10.1177/0956462415600570; Jiao YM, 2015, CLIN INFECT DIS, V60, P128, DOI 10.1093/cid/ciu710; Kang Y, 2017, J HOSP INFECT, V96, P342, DOI 10.1016/j.jhin.2017.04.007; Lempp FA, 2016, NAT REV GASTRO HEPAT, V13, P580, DOI 10.1038/nrgastro.2016.126; Li A, 2010, CLIN VACCINE IMMUNOL, V17, P464, DOI 10.1128/CVI.00457-09; Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091; Li JQ, 2017, HUM VACC IMMUNOTHER, V13, P986, DOI 10.1080/21645515.2016.1276125; Li YJ, 2016, JAIDS-J ACQ IMM DEF, V72, P39, DOI 10.1097/QAI.0000000000000927; Liang TJ, 2015, HEPATOLOGY, V62, P1893, DOI 10.1002/hep.28025; Liang XF, 2013, VACCINE, V31, pJ8, DOI 10.1016/j.vaccine.2012.12.019; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liao BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115888; Liao XY, 2015, HUM VACC IMMUNOTHER, V11, P1534, DOI 10.4161/21645515.2014.980206; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Lu F M, 2017, Zhonghua Gan Zang Bing Za Zhi, V25, P105, DOI 10.3760/cma.j.issn.1007-3418.2017.02.005; Ma H, 2016, CHINESE MED J-PEKING, V129, P2212, DOI 10.4103/0366-6999.189904; Mutz P, 2016, 2016 INT HBV M SEP 2; Ning Q, 2014, J HEPATOL, V61, P777, DOI 10.1016/j.jhep.2014.05.044; Pan CQ, 2016, NEW ENGL J MED, V374, P2324, DOI 10.1056/NEJMoa1508660; Pei YM, 2017, J MED CHEM, V60, P6461, DOI 10.1021/acs.jmedchem.6b01442; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Qiu ZX, 2017, J MED CHEM, V60, P3352, DOI 10.1021/acs.jmedchem.7b00083; Qiu ZX, 2016, J MED CHEM, V59, P7651, DOI 10.1021/acs.jmedchem.6b00879; Qu CF, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001774; Ren H, 2016, HEPATOL INT, V10, pO101; Ren QY, 2017, BIOORGAN MED CHEM, V25, P1042, DOI 10.1016/j.bmc.2016.12.017; Ren YD, 2017, HEPATOLOGY, V65, P1765, DOI 10.1002/hep.29008; Riveiro-Barciela M, 2017, CLIN MICROBIOL INFEC, V23, P860, DOI 10.1016/j.cmi.2017.03.003; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Seto WK, 2016, AM J GASTROENTEROL, V111, P1788, DOI 10.1038/ajg.2016.436; Shi Y, 2015, HEPATOLOGY, V62, P232, DOI 10.1002/hep.27795; Siederdissen CHZ, 2017, BEST PRACT RES CL GA, V31, P281, DOI 10.1016/j.bpg.2017.04.009; Singh KP, 2017, AIDS, V31, P2035, DOI 10.1097/QAD.0000000000001574; Song GJ, 2017, J MED VIROL, V89, P463, DOI 10.1002/jmv.24657; Song LW, 2015, CLIN MICROBIOL INFEC, V21, P197, DOI 10.1016/j.cmi.2014.10.002; Sun J, 2016, J HEPATOL, V65, P674, DOI 10.1016/j.jhep.2016.05.024; Sun J, 2014, HEPATOLOGY, V59, P1283, DOI 10.1002/hep.26885; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; Tang LD, 2017, EXPERT OPIN DRUG DIS, V12, P5, DOI 10.1080/17460441.2017.1255195; van Campenhout MJH, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.02.002; Wang AL, 2015, B WORLD HEALTH ORGAN, V93, P52, DOI 10.2471/BLT.14.139626; Wang C, 2017, CLIN GASTROENTEROL H, V15, P132, DOI 10.1016/j.cgh.2016.06.023; Wang J, 2017, THERANOSTICS, V7, P3090, DOI 10.7150/thno.18114; Wang J, 2016, J HEPATOL, V65, P700, DOI 10.1016/j.jhep.2016.05.029; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Wang XZ, 2016, CELL MOL IMMUNOL, V13, P849, DOI 10.1038/cmi.2015.64; Wang X, 2016, EXPERT REV VACCINES, V15, P815, DOI 10.1586/14760584.2016.1143365; Wang YJ, 2015, ANTIMICROB AGENTS CH, V59, P7061, DOI 10.1128/AAC.01558-15; World Health Organizaiton, 2017, GLOB HEP REP 2017, P3; Wong DKH, 2017, LIVER INT, V37, P995, DOI 10.1111/liv.13346; Wu SL, 2017, J MED VIROL, V89, P443, DOI 10.1002/jmv.24666; Wu S, 2017, J VIROL, V91, DOI 10.1128/JVI.00519-17; Xie J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20659; Xu DZ, 2013, J HEPATOL, V59, P450, DOI 10.1016/j.jhep.2013.05.003; Xu DZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002565; Yang L, 2016, ANTIVIR RES, V125, P25, DOI 10.1016/j.antiviral.2015.11.004; Yang T, 2017, J MED VIROL; Yi PP, 2016, J CLIN VIROL, V77, P32, DOI 10.1016/j.jcv.2016.02.003; Yu R, 2014, FRONT MED-PRC, V8, P135, DOI 10.1007/s11684-014-0331-5; Yuan Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130209; Zhang FJ, 2014, LANCET INFECT DIS, V14, P1065, DOI 10.1016/S1473-3099(14)70946-6; Zhang S, 2017, ALIMENT PHARM THER, V45, P701, DOI 10.1111/apt.13938; Zhang TY, 2016, GUT, V65, P658, DOI 10.1136/gutjnl-2014-308964; Zhang W, 2017, J VIRAL HEPATITIS, V24, P618, DOI 10.1111/jvh.12695; Zhang ZQ, 2016, J VIROL METHODS, V235, P92, DOI 10.1016/j.jviromet.2016.05.016; Zhu FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087154; Zhuang H., 2016, J CLIN HEPATOL, V32, P2227; Zlotnick A, 2015, ANTIVIR RES, V121, P82, DOI 10.1016/j.antiviral.2015.06.020; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x; Zoulim F, 2016, CURR OPIN VIROL, V18, P109, DOI 10.1016/j.coviro.2016.06.004	92	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2095-0217	2095-0225		FRONT MED-PRC	Front. Med.	DEC	2017	11	4					490	501		10.1007/s11684-017-0598-4				12	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	FP5ZW	WOS:000417702800005	29170919				2018-01-05	
J	Shi, XH; Wang, XF; Xu, XX; Feng, YL; Li, SZ; Feng, SY; Wang, B; Wang, SP				Shi, Xiaohong; Wang, Xuefei; Xu, Xixi; Feng, Yongliang; Li, Shuzhen; Feng, Shuying; Wang, Bo; Wang, Suping			Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission	FRONTIERS OF MEDICINE			English	Article						PBMC; HBV cccDNA; HBV rcDNA; HBV intrauterine transmission	HEPATITIS-B-VIRUS; VIRAL REPLICATION; RISK-FACTORS; INFECTION; CCCDNA; IMMUNOPROPHYLAXIS; IMMUNOGLOBULIN; INTERRUPTION; CRISPR/CAS9; MOTHER	This study determined the effect of hepatitis B virus (HBV) replication in peripheral blood mononuclear cell (PBMC) from HBsAg-positive mothers on HBV intrauterine transmission. A total of 150 HBsAg-positive mothers and their neonates were recruited in this study. Within 24 h after birth, HBV serological markers, serum HBV DNA, PBMC HBV relaxed circular DNA (rcDNA), and covalently closed circular DNA (cccDNA) were measured in the HBsAg-positive mothers and their neonates before passive-active immune prophylaxis. The relationship between HBV replication in PBMC and HBV intrauterine transmission was examined through Chisquare test and logistic regression. The rate of HBV intrauterine transmission was 8.00% (12/150) in the 150 neonates born to HBsAg-positive mothers. The positivities of PBMC HBV rcDNA and cccDNA in the HBsAg-positive mothers were 36.67% (55/150) and 10% (15/150), respectively. Maternal PBMC HBV cccDNA was a risk factor of HBV intrauterine transmission (OR = 6.003, 95% CI: 1.249-28.855). Maternal serum HBeAg was a risk factor of PBMC HBV rcDNA (OR = 3.896, 95% CI: 1.929-7.876) and PBMC HBV cccDNA (OR = 3.74, 95% CI: 1.186-11.793) in the HBsAg-positive mothers. Administration of hepatitis B immune globulin was a protective factor of PBMC HBV cccDNA (OR = 0.312, 95%CI: 0.102-0.954) during pregnancy. The positivity of PBMC HBV rcDNA was related to that of cccDNA in the HBsAg-positive mothers (chi (2)= 5.087, P = 0.024). This study suggests that PBMC is a reservoir of HBV and an extrahepatic site for virus replication and plays a critical role in HBV intrauterine transmission.	[Shi, Xiaohong; Wang, Xuefei; Xu, Xixi; Feng, Yongliang; Li, Shuzhen; Wang, Suping] Shanxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Taiyuan 030001, Shanxi, Peoples R China; [Feng, Shuying; Wang, Bo] Third People Hosp Taiyuan City, Dept Obstet & Gynaecol, Taiyuan 030001, Shanxi, Peoples R China	Wang, SP (reprint author), Shanxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Taiyuan 030001, Shanxi, Peoples R China.	supingwang@sxmu.edu.cn			National Natural Science Foundation of China [30070669, 81573212]	This study was supported by the National Natural Science Foundation of China (Nos. 30070669 and 81573212).	Bai GQ, 2011, ARCH GYNECOL OBSTET, V283, P317, DOI 10.1007/s00404-010-1366-8; Basar O, 2013, CLIN RES HEPATOL GAS, V37, P152, DOI 10.1016/j.clinre.2012.07.003; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brind A, 1997, J HEPATOL, V26, P228, DOI 10.1016/S0168-8278(97)80035-9; Cabrerizo M, 2000, HEPATOLOGY, V32, P116, DOI 10.1053/jhep.2000.8541; Cai DW, 2016, ANTIVIR RES, V132, P26, DOI 10.1016/j.antiviral.2016.05.005; Cardoso AC, 2012, LIVER INT, V32, P612, DOI 10.1111/j.1478-3231.2011.02660.x; Coffin CS, 2011, J VIRAL HEPATITIS, V18, P415, DOI 10.1111/j.1365-2893.2010.01321.x; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Guo Z, 2013, J VIRAL HEPATITIS, V20, P317, DOI 10.1111/jvh.12032; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Li F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36483; Li XM, 2004, WORLD J GASTROENTERO, V10, P3215; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Shao QL, 2013, ARCH GYNECOL OBSTET, V288, P1257, DOI 10.1007/s00404-013-2893-x; Shi XH, 2004, CHIN J PUBL HLTH, V20, P513; StollBecker S, 1997, J VIROL, V71, P5399; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Wang XJ, 2006, J GUANGDONG MED COLL, V24, P131; Wei Jun-ni, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P240; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Xu YY, 2015, INT J BIOL SCI, V11, P266, DOI 10.7150/ijbs.10813; Yu MM, 2012, EPIDEMIOL INFECT, V140, P1454, DOI 10.1017/S0950268811002068; Yuan J, 2006, J VIRAL HEPATITIS, V13, P597, DOI 10.1111/j.1365-2893.2006.00738.x; [张永乐 ZHANG Yongle], 2008, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V22, P342; Zhu QR, 2003, CHINESE MED J-PEKING, V116, P685; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x	29	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2095-0217	2095-0225		FRONT MED-PRC	Front. Med.	DEC	2017	11	4					548	553		10.1007/s11684-017-0597-5				6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	FP5ZW	WOS:000417702800011	29170913				2018-01-05	
J	Zhang, YP; Zhang, XY; Cheng, C; Mu, W; Liu, XJ; Li, N; Wei, XF; Liu, X; Xia, CQ; Wang, HY				Zhang, Yongping; Zhang, Xingying; Cheng, Chen; Mu, Wei; Liu, Xiaojuan; Li, Na; Wei, Xiaofei; Liu, Xiang; Xia, Changqing; Wang, Haoyi			CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells	FRONTIERS OF MEDICINE			English	Article						CAR-T; CRISPR-Cas9; LAG-3	LYMPHOCYTE-ACTIVATION GENE-3; NEGATIVE REGULATORY FUNCTION; CHRONIC VIRAL-INFECTION; CLASS-II LIGAND; CD223; PD-1; EXHAUSTION; EXPRESSION; MOLECULES; MELANOMA	T cells engineered with chimeric antigen receptor (CAR) have been successfully applied to treat advanced refractory B cell malignancy. However, many challenges remain in extending its application toward the treatment of solid tumors. The immunosuppressive nature of tumor microenvironment is considered one of the key factors limiting CAR-T efficacy. One negative regulator of Tcell activity is lymphocyte activation gene-3 (LAG-3). We successfully generated LAG-3 knockout Tand CAR-T cells with high efficiency using CRISPR-Cas9 mediated gene editing and found that the viability and immune phenotype were not dramatically changed during in vitro culture. LAG-3 knockout CAR-T cells displayed robust antigen-specific antitumor activity in cell culture and in murine xenograft model, which is comparable to standard CAR-T cells. Our study demonstrates an efficient approach to silence immune checkpoint in CAR-T cells via gene editing.	[Zhang, Yongping; Xia, Changqing] Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing 100053, Peoples R China; [Zhang, Xingying; Cheng, Chen; Mu, Wei; Liu, Xiaojuan; Li, Na; Liu, Xiang; Wang, Haoyi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100190, Peoples R China; [Zhang, Xingying; Mu, Wei; Wang, Haoyi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Cheng, Chen] Univ Sci & Technol China, Grad Sch, Hefei 230026, Anhui, Peoples R China; [Xia, Changqing] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Wei, Xiaofei] Beijing Cord Blood Bank, Beijing 100176, Peoples R China	Xia, CQ (reprint author), Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing 100053, Peoples R China.; Wang, HY (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100190, Peoples R China.; Wang, HY (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Xia, CQ (reprint author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	cqx65@yahoo.com; wanghaoyi@ioz.ac.cn			National Natural Science Foundation of China [31471215]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010409]; National High Technology Research and Development Program of China (863 Program) [2015AA020307]; Young Thousand Talent Project	We would like to thank Junning Wei and Yi Yang (Beijing Cord Blood Bank) for their help in preparing the cord blood samples. This work was supported by the National Natural Science Foundation of China (No. 31471215), the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDA01010409), and the National High Technology Research and Development Program of China (863 Program, No. 2015AA020307). Haoyi Wang is supported by the "Young Thousand Talent Project."	BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Hannier S, 1999, INT IMMUNOL, V11, P1745, DOI 10.1093/intimm/11.11.1745; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Kakarla S, 2014, CANCER J, V20, P151, DOI 10.1097/PPO.0000000000000032; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Macon-Lemaitre L, 2005, IMMUNOLOGY, V115, P170, DOI 10.1111/j.1365-2567.2005.02145.x; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McClanahan F, 2015, BLOOD, V126, P212, DOI 10.1182/blood-2015-02-626754; Menger L, 2016, CANCER RES, V76, P2087, DOI 10.1158/0008-5472.CAN-15-3352; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Richter K, 2010, INT IMMUNOL, V22, P13, DOI 10.1093/intimm/dxp107; Sierro S, 2011, EXPERT OPIN THER TAR, V15, P91, DOI 10.1517/14712598.2011.540563; Su S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40272; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450                                                     ; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392                                                    ; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Xu F, 2014, CANCER RES, V74, P3418, DOI 10.1158/0008-5472.CAN-13-2690	34	1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2095-0217	2095-0225		FRONT MED-PRC	Front. Med.	DEC	2017	11	4					554	562		10.1007/s11684-017-0543-6				9	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	FP5ZW	WOS:000417702800012	28625015				2018-01-05	
J	Zhou, YJ; Jiang, T; Hu, SH; Wang, MX; Ming, DS; Chen, SC				Zhou, Yajun; Jiang, Tao; Hu, Shaohua; Wang, Mingxi; Ming, Desong; Chen, Shicheng			Genomic insights of Pannonibacter phragmitetus strain 31801 isolated from a patient with a liver abscess	MICROBIOLOGYOPEN			English	Article						antibiotic resistance mechanism; comparative genomic analysis; genomic sequencing; Pannonibacter phragmitetus; pathogenesis	ACHROMOBACTER GROUP-B; HUNGARIAN SODA LAKE; HEXAVALENT CHROMIUM REDUCTION; DECOMPOSING REED RHIZOMES; VI-SECRETION-SYSTEM; CYCLIC DI-GMP; ACINETOBACTER-BAUMANNII; BORDETELLA-PERTUSSIS; EFFLUX PUMP; PSEUDOMONAS-AERUGINOSA	Pannonibacter phragmitetus is a bioremediation reagent for the detoxification of heavy metals and polycyclic aromatic compounds (PAHs) while it rarely infects healthy populations. However, infection by the opportunistic pathogen P. phragmitetus complicates diagnosis and treatments, and poses a serious threat to immunocompromised patients owing to its multidrug resistance. Unfortunately, genome features, antimicrobial resistance, and virulence potentials in P. phragmitetus have not been reported before. A predominant colony (31801) was isolated from a liver abscess patient, indicating that it accounted for the infection. To investigate its infection mechanism(s) in depth, we sequenced this bacterial genome and tested its antimicrobial resistance. Average nucleotide identity (ANI) analysis assigned the bacterium to the species P.phragmitetus (ANI, >95%). Comparative genomics analyses among Pannonibacter spp. representing the different living niches were used to describe the Pannonibacter pan-genomes and to examine virulence factors, prophages, CRISPR arrays, and genomic islands. Pannonibacter phragmitetus 31801 consisted of one chromosome and one plasmid, while the plasmid was absent in other Pannonibacter isolates. Pannonibacter phragmitetus 31801 may have a great infection potential because a lot of genes encoding toxins, flagellum formation, iron uptake, and virulence factor secretion systems in its genome. Moreover, the genome has 24 genomic islands and 2 prophages. A combination of antimicrobial susceptibility tests and the detailed antibiotic resistance gene analysis provide useful information about the drug resistance mechanisms and therefore can be used to guide the treatment strategy for the bacterial infection.	[Zhou, Yajun; Jiang, Tao; Hu, Shaohua; Wang, Mingxi] Huaqiao Univ, Sch Biomed Sci, Yun Leung Lab Mol Diagnost, Xiamen 361021, Fujian, Peoples R China; [Wang, Mingxi] Weifang Med Univ, Inst Nanomed Technol, Weifang, Shandong, Peoples R China; [Wang, Mingxi] Weifang Med Univ, Dept Lab Med, Weifang, Shandong, Peoples R China; [Ming, Desong] Fujian Med Univ, Dept Clin Lab, Quanzhou Hosp 1, Fuzhou, Fujian, Peoples R China; [Chen, Shicheng] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Wang, MX (reprint author), Huaqiao Univ, Sch Biomed Sci, Yun Leung Lab Mol Diagnost, Xiamen 361021, Fujian, Peoples R China.; Ming, DS (reprint author), Fujian Med Univ, Dept Clin Lab, Quanzhou Hosp 1, Fuzhou, Fujian, Peoples R China.; Chen, SC (reprint author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mxwang@hqu.edu.cn; mds6430@126.com; shicheng@msu.edu			Huaqiao University Graduate Student Scientific Research Innovation Ability Cultivation Plan Projects [2014Z24]; Fong Shu Fook Tong and Fong Yun Wah Foundations [14X30127]; Technology Planning Projects of Quanzhou Social Development Fields [2014Z24]; Major Support Research Project of National Key Colleges Construction of Quanzhou Medical College [2013A13]	Huaqiao University Graduate Student Scientific Research Innovation Ability Cultivation Plan Projects, Grant/Award Number: 2014Z24; Fong Shu Fook Tong and Fong Yun Wah Foundations, Grant/Award Number: 14X30127; Technology Planning Projects of Quanzhou Social Development Fields, Grant/Award Number: 2014Z24; Major Support Research Project of National Key Colleges Construction of Quanzhou Medical College, Grant/Award Number: 2013A13	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandyopadhyay S, 2013, ARCH MICROBIOL, V195, P1, DOI 10.1007/s00203-012-0840-z; Basler M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0021; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blom J, 2016, NUCLEIC ACIDS RES, V44, pW22, DOI 10.1093/nar/gkw255; Borsodi AK, 2005, MICROB ECOL, V50, P9, DOI 10.1007/s00248-004-0063-1; Borsodi AK, 2003, INT J SYST EVOL MICR, V53, P555, DOI 10.1099/ijs.0.02356-0; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chai LY, 2009, J ENVIRON SCI HEAL A, V44, P615, DOI 10.1080/10934520902784690; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Coman C, 2013, EXTREMOPHILES, V17, P523, DOI 10.1007/s00792-013-0537-5; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Fauconnier A, 2001, INT J MED MICROBIOL, V290, P693; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; GLASER P, 1988, EMBO J, V7, P3997; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; GROSS MK, 1992, P NATL ACAD SCI USA, V89, P4898, DOI 10.1073/pnas.89.11.4898; GUILFOILE PG, 1992, J BACTERIOL, V174, P3659; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; HOLMES B, 1993, J CLIN MICROBIOL, V31, P1007; Holmes B, 1992, MED MICROBIOL LETT, V1, P177; Holmes B, 2006, INT J SYST EVOL MICR, V56, P2945, DOI 10.1099/ijs.0.64563-0; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Institute CLS, 2013, CLSI PERF STAND ANT; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jenks PJ, 1997, J INFECTION, V34, P143, DOI 10.1016/S0163-4453(97)92490-7; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kehrenberg C, 2007, ANTIMICROB AGENTS CH, V51, P483, DOI 10.1128/AAC.01340-06; LABRO MT, 1992, INFECTION, V20, pS45, DOI 10.1007/BF01709951; Lau CHF, 2014, MBIO, V5, DOI 10.1128/mBio.01068-14; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Lu S, 2012, MOL MICROBIOL, V86, P1132, DOI 10.1111/mmi.12046; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; May M, 2014, NATURE, V509, pS4, DOI 10.1038/509S4a; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; MCKINLEY KP, 1990, J INFECTION, V20, P262, DOI 10.1016/0163-4453(90)91294-N; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Standards  National committee for clinical laboratory standards, 2013, CLSI PER STAND ANT D; Standards  National committee for clinical laboratory standards., 2006, PERFORMANCE STANDARD, P4; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Shi Y, 2012, BIOPROC BIOSYST ENG, V35, P843, DOI 10.1007/s00449-011-0668-y; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Wang M, 2017, FRONT MED, V4, DOI 10.3389/fmed.2017.00048; Wang X., 2016, GENOME ANNOUNCEMENTS, V4; Wang YY, 2013, ENVIRON SCI POLLUT R, V20, P5593, DOI 10.1007/s11356-013-1526-z; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xu L, 2012, APPL BIOCHEM BIOTECH, V166, P933, DOI 10.1007/s12010-011-9481-y; Xu L, 2011, J IND MICROBIOL BIOT, V38, P1709, DOI 10.1007/s10295-011-0960-5; Xu L, 2011, J HAZARD MATER, V189, P787, DOI 10.1016/j.jhazmat.2011.03.009; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	77	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-8827			MICROBIOLOGYOPEN	MicrobiologyOpen	DEC	2017	6	6							e515	10.1002/mbo3.515				14	Microbiology	Microbiology	FP8LA	WOS:000417893600004		gold			2018-01-05	
J	Wu, X; Kim, TK; Baxter, D; Scherler, K; Gordon, A; Fong, O; Etheridge, A; Galas, DJ; Wang, K				Wu, Xiaogang; Kim, Taek-Kyun; Baxter, David; Scherler, Kelsey; Gordon, Aaron; Fong, Olivia; Etheridge, Alton; Galas, David J.; Wang, Kai			sRNAnalyzer-a flexible and customizable small RNA sequencing data analysis pipeline	NUCLEIC ACIDS RESEARCH			English	Article							BODY-FLUIDS; MICRORNA GENES; BIOMARKERS; FRAGMENTS; SPECTRUM; MIRBASE; GENOMES; TOOLS; BLOOD	Although many tools have been developed to analyze small RNA sequencing (sRNA-Seq) data, it remains challenging to accurately analyze the small RNA population, mainly due to multiple sequence ID assignment caused by short read length. Additional issues in small RNA analysis include low consistency of microRNA (miRNA) measurement results across different platforms, miRNA mapping associated with miRNA sequence variation (isomiR) and RNA editing, and the origin of those unmapped reads after screening against all endogenous reference sequence databases. To address these issues, we built a comprehensive and customizable sRNA-Seq data analysis pipeline--sRNAnalyzer, which enables: (i) comprehensive miRNA profiling strategies to better handle isomiRs and summarization based on each nucleotide position to detect potential SNPs in miRNAs, (ii) different sequence mapping result assignment approaches to simulate results from microarray/qRT-PCR platforms and a local probabilistic model to assign mapping results to the mostlikely IDs, (iii) comprehensive ribosomal RNA filtering for accurate mapping of exogenous RNAs and summarization based on taxonomy annotation. We evaluated our pipeline on both artificial samples (including synthetic miRNA and Escherichia coli cultures) and biological samples (human tissue and plasma). sRNAnalyzer is implemented in Perl and available at: http://srnanalyzer. systemsbiology. net/.	[Wu, Xiaogang; Kim, Taek-Kyun; Baxter, David; Scherler, Kelsey; Gordon, Aaron; Wang, Kai] Inst Syst Biol, Seattle, WA 98109 USA; [Fong, Olivia; Etheridge, Alton; Galas, David J.] Pacific Northwest Res Inst, Seattle, WA 98122 USA	Wang, K (reprint author), Inst Syst Biol, Seattle, WA 98109 USA.	kwang@systemsbiology.org			US Department of Defense [W911NF-10-2-0111, HDTRA1-13-C-0055]; National Institutes of Health (NIH) Extracellular RNA Communication Consortium (ERCC) [1U01HL126496]; NIH ERCP Consortium [1U01HL126496]	US Department of Defense [W911NF-10-2-0111, HDTRA1-13-C-0055]; National Institutes of Health (NIH) Extracellular RNA Communication Consortium (ERCC) [1U01HL126496]. Funding for open access charge: NIH ERCP Consortium [1U01HL126496].	Anderson P, 2014, FEBS LETT, V588, P4297, DOI 10.1016/j.febslet.2014.09.001; Barturen G., 2014, METHODS NEXT GENER S, V1, P21; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Chevillet JR, 2014, MOLECULES, V19, P6080, DOI 10.3390/molecules19056080; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dhahbi Joseph M, 2014, Biomark Cancer, V6, P37, DOI 10.4137/BIC.S20764; Etheridge Alton, 2013, Frontiers in Genetics, V4, P115, DOI 10.3389/fgene.2013.00115; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173                                                            ; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Meng YJ, 2012, RNA BIOL, V9, P249, DOI 10.4161/rna.19230; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rohr C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067461; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Wang K, 2013, TOXICOL SCI, V132, P478, DOI 10.1093/toxsci/kft014; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246	36	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	DEC 1	2017	45	21					12140	12151		10.1093/nar/gkx999				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FP5VO	WOS:000417691300014	29069500	gold			2018-01-05	
J	Swiat, MA; Dashko, S; den Ridder, M; Wijsman, M; van der Oost, J; Daran, JM; Daran-Lapujade, P				Swiat, Michal A.; Dashko, Sofia; den Ridder, Maxime; Wijsman, Melanie; van der Oost, John; Daran, Jean-Marc; Daran-Lapujade, Pascale			FnCpf1: a novel and efficient genome editing tool for Saccharomyces cerevisiae	NUCLEIC ACIDS RESEARCH			English	Article							CRISPR-CAS SYSTEMS; TARGETED MUTAGENESIS; HUMAN-CELLS; IN-VIVO; YEAST; CPF1; RNA; DNA; BIOTECHNOLOGY; ENDONUCLEASE	Cpf1 is a new class II family of CRISPR-Cas RNA-programmable endonucleases with unique features that make it a very attractive alternative or complement to Cas9 for genome engineering. Using constitutively expressed Cpf1 from Francisella novicida, the present study demonstrates that FnCpf1 can mediate RNA-guided DNA cleavage at targeted genomic loci in the popular model and industrial yeast Sac-charomyces cerevisiae. FnCpf1 very efficiently and precisely promoted repair DNA recombination with efficiencies up to 100%. Furthermore, FnCpf1 was shown to introduce point mutations with high fidelity. While editing multiple loci with Cas9 is hampered by the need for multiple or complex expression constructs, processing itself a customized CRISPR array FnCpf1 was able to edit four genes simultaneously in yeast with a 100% efficiency. A remarkable observation was the unexpected, strong preference of FnCpf1 to cleave DNA at target sites harbouring 5'-TTTV-3' PAM sequences, a motif reported to be favoured by Cpf1 homologs of Acidaminococcus and Lachnospiraceae. The present study supplies several experimentally tested guidelines for crRNA design, as well as plasmids for FnCpf1 expression and easy construction of crRNA expression cassettes in S. cerevisiae. FnCpf1 proves to be a powerful addition to S. cerevisiae CRISPR toolbox.	[Swiat, Michal A.; Dashko, Sofia; den Ridder, Maxime; Wijsman, Melanie; Daran, Jean-Marc; Daran-Lapujade, Pascale] Delft Univ Technol, Dept Biotechnol, van der Maasweg 9, NL-2629 HZ Delft, Netherlands; [van der Oost, John] Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands	Daran-Lapujade, P (reprint author), Delft Univ Technol, Dept Biotechnol, van der Maasweg 9, NL-2629 HZ Delft, Netherlands.	p.a.s.daran-lapujade@tudelft.nl		Daran-Lapujade, Pascale/0000-0002-4097-7831; Daran, Jean-Marc/0000-0003-3136-8193	AdLibYeast ERC consolidator [648141]; European Union's Horizon Framework Programme for Research and Innovation; project: Model-Based Construction and Optimisation of Versatile Chassis Yeast Strains for Production of Valuable Lipid and Aromatic Compounds [720824]; ERC consolidator [648141]	AdLibYeast ERC consolidator [648141 to P.D.L.]; European Union's Horizon 2020 Framework Programme for Research and Innovation; project: Model-Based Construction and Optimisation of Versatile Chassis Yeast Strains for Production of Valuable Lipid and Aromatic Compounds [720824 to J.M.D.]. Funding for open access charge: ERC consolidator [648141].	Acland A, 2013, NUCLEIC ACIDS RES, V41, pD8, DOI 10.1093/nar/gks1189; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Braglia P, 2005, J BIOL CHEM, V280, P19551, DOI 10.1074/jbc.M412238200; Deaner M, 2017, ACS SYNTH BIOL, V6, P1931, DOI 10.1021/acssynbio.7b00163; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; DORFMAN BZ, 1969, GENETICS, V61, P377; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Entian KD, 2007, METHOD MICROBIOL, V36, P629, DOI 10.1016/S0580-9517(06)36025-4; Estrela R, 2016, CURR OPIN BIOTECH, V38, P79, DOI 10.1016/j.copbio.2016.01.005; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gao L., 2017, NAT BIOTECHNOL; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kuijpers NGA, 2013, FEMS YEAST RES, V13, P769, DOI 10.1111/1567-1364.12087; Kuijpers NGA, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-47; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee JH, 2017, BIORESOURCE TECHNOL, V245, P1575, DOI 10.1016/j.biortech.2017.05.065; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nijkamp JF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-36; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; SIKORSKI RS, 1989, GENETICS, V122, P19; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; van der Oost J, 2015, MICROB BIOTECHNOL, V8, P34, DOI 10.1111/1751-7915.12251; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Vervoort Y, 2017, CURR OPIN BIOTECH, V46, P120, DOI 10.1016/j.copbio.2017.02.011; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	61	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	DEC 1	2017	45	21					12585	12598		10.1093/nar/gkx1007				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FP5VO	WOS:000417691300045	29106617	gold			2018-01-05	
J	Schwach, V; Verkerk, AO; Mol, M; Monshouwer-Kloots, JJ; Devalla, HD; Orlova, VV; Anastassiadis, K; Mummery, CL; Davis, RP; Passier, R				Schwach, Verena; Verkerk, Arie O.; Mol, Mervyn; Monshouwer-Kloots, Jantine J.; Devalla, Harsha D.; Orlova, Valeria V.; Anastassiadis, Konstantinos; Mummery, Christine L.; Davis, Richard P.; Passier, Robert			A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes	STEM CELL REPORTS			English	Article							ORPHAN NUCLEAR RECEPTOR; EXPRESSION; PROMOTER; DIFFERENTIATION; KNOCKDOWNS; SARCOLIPIN; TFS	Reporter cell lines have already proven valuable in identifying, tracking, and purifying cardiac subtypes and progenitors during differentiation of human pluripotent stem cells (hPSCs). We previously showed that chick ovalbumin upstream promoter transcription factor II (COUP-TFII) is highly enriched in human atrial cardiomyocytes (CMs), but not ventricular. Here, we targeted mCherry to the COUP-TFII genomic locus in hPSCs expressing GFP from the NKX2.5 locus. This dual atrial NKX2.5(EGFP/+)-COUP-TF(IImCherry/+)reporter line allowed identification and selection of GFP(+)(G(+))/mCherry(+) (M+) CMs following cardiac differentiation. These cells exhibited transcriptional and functional properties of atrial CMs, whereas G(+)/M- CMs displayed ventricular characteristics. Via CRISPR/Cas9-mediated knockout, we demonstrated that COUP-TFII is not required for atrial specification in hPSCs. This new tool allowed selection of human atrial and ventricular CMs from mixed populations, of relevance for studying cardiac specification, developing human atrial disease models, and examining distinct effects of drugs on the atrium versus ventricle.	[Schwach, Verena; Mol, Mervyn; Monshouwer-Kloots, Jantine J.; Devalla, Harsha D.; Orlova, Valeria V.; Mummery, Christine L.; Davis, Richard P.; Passier, Robert] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands; [Verkerk, Arie O.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Amsterdam, Netherlands; [Anastassiadis, Konstantinos] Tech Univ Dresden, Biotechnol Ctr, Stem Cell Engn, Dresden, Germany; [Passier, Robert] Univ Twente, MIRA Inst, Dept Appl Stem Cell Technol, Twente, Netherlands	Passier, R (reprint author), Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands.; Passier, R (reprint author), Univ Twente, MIRA Inst, Dept Appl Stem Cell Technol, Twente, Netherlands.	robert.passier@utwente.nl		Mol, Mervyn/0000-0002-5380-5393	LUMC (BW-plus) doctoral grant; ERC-AdG STEMCARDIOVASC; EU FP7; ERC-StG STEMCARDIORISK; Netherlands Organisation for Scientific Research [NWO] [VIDI-917.15.303]; European Community's Seventh Framework Programme (FP7) [602423]; Eurostars Cardiopredict [E!9527];  [ZonMw-MKMD-40-42600-98-036]	Funding for this study is gratefully acknowledged from the following sources: LUMC (BW-plus) doctoral grant to V.S., ERC-AdG STEMCARDIOVASC and EU FP7 to C.L.M., ERC-StG STEMCARDIORISK and VIDI-917.15.303 (the Netherlands Organisation for Scientific Research [NWO]) to R.P.D., the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602423: Plurimes to V.V.O., C.L.M., and K. A., Eurostars Cardiopredict E!9527 to V.S., H.D.D., and R.P., and ZonMw-MKMD-40-42600-98-036 to R.P. The authors would like to thank Dorien Ward-Van Oostwaard for technical advice on the culture ofhumanstemcellsandcardiac differentiation, JoopC. Wiegant and Berend J. van Meer for technical assistance during microscopy, the Department of Molecular Cell Biology of the LUMC for karyotyping, Sabrina Veld and Guido M. de Roo for assistance with cell sorting, and Christian B. Schwach for illustrations.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914                                                           ; Al Turki S, 2014, AM J HUM GENET, V94, P574, DOI 10.1016/j.ajhg.2014.03.007; Beqqali A, 2009, CELL MOL LIFE SCI, V66, P800, DOI 10.1007/s00018-009-8476-0; Birket MJ, 2015, CELL REP, V13, P733, DOI 10.1016/j.celrep.2015.09.025; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Devalla HD, 2015, EMBO MOL MED, V7, P394, DOI 10.15252/emmm.201404757; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Giles WR, 2016, BIOPHYS J, V110, P278, DOI 10.1016/j.bpj.2015.06.070; Hoekstra M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00346; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iyer D, 2015, DEVELOPMENT, V142, P1528, DOI 10.1242/dev.119271; Josowitz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101316; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim BJ, 2009, DEV BIOL, V326, P378, DOI 10.1016/j.ydbio.2008.11.001; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; Lin FJ, 2012, ARTERIOSCL THROM VAS, V32, pE135, DOI 10.1161/ATVBAHA.112.300255; Maddah M, 2015, STEM CELL REP, V4, P621, DOI 10.1016/j.stemcr.2015.02.007; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sala L, 2016, BRIT J PHARMACOL, V174, P3749; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Tang LS, 2005, GENE EXPR PATTERNS, V5, P587, DOI 10.1016/j.modgep.2005.03.012; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; van Meer BJ, 2016, STEM CELLS, V34, P2008, DOI 10.1002/stem.2403; van Putten RMEM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00007; Wu SP, 2013, DEV CELL, V25, P417, DOI 10.1016/j.devcel.2013.04.017; Yamazaki T, 2013, BIOCHEM J, V452, P345, DOI 10.1042/BJ20121200; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yu CT, 2012, DEVELOPMENT, V139, P2330, DOI 10.1242/dev.076299; Zhang P, 2002, MECH DEVELOP, V119, P109, DOI 10.1016/S0925-4773(02)00286-1; Zheng JY, 2014, CIRC-HEART FAIL, V7, P194, DOI 10.1161/CIRCHEARTFAILURE.113.000519	38	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	DEC	2017	9	6					1765	1779		10.1016/j.stemcr.2017.10.024				15	Cell & Tissue Engineering; Cell Biology	Cell Biology	FP5VH	WOS:000417690600004	29173897	gold			2018-01-05	
J	Hamey, JJ; Wienert, B; Quinlan, KGR; Wilkins, MR				Hamey, Joshua J.; Wienert, Beeke; Quinlan, Kate G. R.; Wilkins, Marc R.			METTL21B Is a Novel Human Lysine Methyltransferase of Translation Elongation Factor 1A: Discovery by CRISPR/Cas9 Knockout	MOLECULAR & CELLULAR PROTEOMICS			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; COMPUTATIONAL PLATFORM; ARGININE METHYLATION; PROTEIN METHYLATION; PROTEOMIC ANALYSIS; HUMAN-CELLS; IDENTIFICATION; GENE; YEAST; MITOCHONDRIAL	Lysine methylation is widespread on human proteins, however the enzymes that catalyze its addition remain largely unknown. This limits our capacity to study the function and regulation of this modification. Here we used the CRISPR/Cas9 system to knockout putative protein methyltransferases METTL21B and METTL23 in K562 cells, to determine if they methylate elongation factor eEF1A. The known eEF1A methyltransferase EEF1AKMT1 was also knocked out as a control. Targeted mass spectrometry revealed the loss of lysine 165 methylation upon knockout of METTL21B, and the expected loss of lysine 79 methylation on knockout of EEF1AKMT1. No loss of eEF1A methylation was seen in the METTL23 knockout. Recombinant METTL21B was shown in vitro to catalyze methylation on lysine 165 in eEF1A1 and eEF1A2, confirming it as the methyltransferase responsible for this methylation site. Proteomic analysis by SILAC revealed specific upregulation of large ribosomal subunit proteins in the METTL21B knockout, and changes to further processes related to eEF1A function in knockouts of both METTL21B and EEF1AKMT1. This indicates that the methylation of lysine 165 in human eEF1A has a very specific role. METTL21B exists only in vertebrates, with its target lysine showing similar evolutionary conservation. We suggest METTL21B be renamed eEF1A-KMT3. This is the first study to specifically generate CRISPR/Cas9 knockouts of putative protein methyltransferase genes, for substrate discovery and site mapping. Our approach should prove useful for the discovery of further novel methyltransferases, and more generally for the discovery of sites for other protein-modifying enzymes.	[Hamey, Joshua J.; Wienert, Beeke; Quinlan, Kate G. R.; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Wilkins, MR (reprint author), Univ New South Wales, Syst Biol Initiat, Sch Biotechnol & Biomol Sci, Sydney, NS 2052, Australia.	m.wilkins@unsw.edu.au			Australian Postgraduate Award; University of New South Wales; Australian Research Council	JJH acknowledges support from an Australian Postgraduate Award and additional support from the University of New South Wales. MRW acknowledges support from the Australian Research Council and from the University of New South Wales. Mass spectrometric results were obtained at the Bioanalytical Mass Spectrometry Facility within the Mark Wainwright Analytical Centre of the University of New South Wales.	Bernkopf M, 2014, HUM MOL GENET, V23, P4015, DOI 10.1093/hmg/ddu115; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; DEVER TE, 1989, J BIOL CHEM, V264, P20518; Dzialo MC, 2014, BIOCHEM BIOPH RES CO, V455, P382, DOI 10.1016/j.bbrc.2014.11.022; Dzialo MC, 2014, J BIOL CHEM, V289, P30511, DOI 10.1074/jbc.M114.605527; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Geoghegan V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7758; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hamey JJ, 2016, FEBS OPEN BIO, V6, P1320, DOI 10.1002/2211-5463.12153; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2014, J BONE MINER RES, V29, P1531, DOI 10.1002/jbmr.2200; Huesgen PF, 2015, NAT METHODS, V12, P55, DOI 10.1038/nmeth.3177; Jakobsson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131426; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Jakobsson M. E., 2017, NUCL ACIDS RES; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mok J, 2009, NAT PROTOC, V4, P1820, DOI 10.1038/nprot.2009.194; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Olsen JB, 2016, MOL CELL PROTEOMICS, V15, P892, DOI 10.1074/mcp.M115.053280; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Perez WB, 2014, J BIOL CHEM, V289, P20928, DOI 10.1074/jbc.M114.570077; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Richter-Dennerlein R, 2015, NAT REV MOL CELL BIO, V16, P586, DOI 10.1038/nrm4051; Shahijanian F, 2014, HUM MOL GENET, V23, P1425, DOI 10.1093/hmg/ddt529; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva RC, 2016, J CELL SCI, V129, P4521, DOI 10.1242/jcs.194738; Sylvestersen KB, 2014, MOL CELL PROTEOMICS, V13, P2072, DOI 10.1074/mcp.O113.032748; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Webb KJ, 2011, J BIOL CHEM, V286, P18405, DOI 10.1074/jbc.M110.200410; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Wu ZX, 2015, MOL CELL PROTEOMICS, V14, P329, DOI 10.1074/mcp.M114.044255; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhao F, 2017, J BONE MINER METAB, V35, P437, DOI 10.1007/s00774-016-0774-7	68	0	0	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	DEC	2017	16	12					2229	2242		10.1074/mcp.M116.066308				14	Biochemical Research Methods	Biochemistry & Molecular Biology	FP3SJ	WOS:000417537800014	28663172				2018-01-05	
J	Yin, H; Song, CQ; Suresh, S; Wu, QQ; Walsh, S; Rhym, LH; Mintzer, E; Bolukbasi, MF; Zhu, LJ; Kauffman, K; Mou, HW; Oberholzer, A; Ding, JM; Kwan, SY; Bogorad, RL; Zatsepin, T; Koteliansky, V; Wolfe, SA; Xue, W; Langer, R; Anderson, DG				Yin, Hao; Song, Chun-Qing; Suresh, Sneha; Wu, Qiongqiong; Walsh, Stephen; Rhym, Luke Hyunsik; Mintzer, Esther; Bolukbasi, Mehmet Fatih; Zhu, Lihua Julie; Kauffman, Kevin; Mou, Haiwei; Oberholzer, Alicia; Ding, Junmei; Kwan, Suet-Yan; Bogorad, Roman L.; Zatsepin, Timofei; Koteliansky, Victor; Wolfe, Scot A.; Xue, Wen; Langer, Robert; Anderson, Daniel G.			Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing	NATURE BIOTECHNOLOGY			English	Article							CRISPR-CAS NUCLEASES; INDUCED LIVER-INJURY; MOUSE MODEL; LACTOFERRIN PROTECTS; MUSCULAR-DYSTROPHY; HUMAN-CELLS; TARGET DNA; DELIVERY; MICE; NANOPARTICLES	Efficient genome editing with Cas9-sgRNAin vivo has required the use of viral delivery systems, which have limitations for clinical applications. Translational efforts to develop other RNA therapeutics have shown that judicious chemical modification of RNAs can improve therapeutic efficacy by reducing susceptibility to nuclease degradation. Guided by the structure of the Cas9-sgRNA complex, we identify regions of sgRNA that can be modified while maintaining or enhancing genome-editing activity, and we develop an optimal set of chemical modifications for in vivo applications. Using lipid nanoparticle formulations of these enhanced sgRNAs (e-sgRNA) and mRNA encoding Cas9, we show that a single intravenous injection into mice induces >80% editing of Pcsk9 in the liver. Serum Pcsk9 is reduced to undetectable levels, and cholesterol levels are significantly lowered about 35% to 40% in animals. This strategy may enable non-viral, Cas9-based genome editing in the liver in clinical settings.	[Yin, Hao; Suresh, Sneha; Wu, Qiongqiong; Walsh, Stephen; Rhym, Luke Hyunsik; Kauffman, Kevin; Oberholzer, Alicia; Ding, Junmei; Bogorad, Roman L.; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Song, Chun-Qing; Mou, Haiwei; Kwan, Suet-Yan; Xue, Wen] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA; [Rhym, Luke Hyunsik; Kauffman, Kevin; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Mintzer, Esther; Bolukbasi, Mehmet Fatih; Zhu, Lihua Julie; Wolfe, Scot A.; Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Bolukbasi, Mehmet Fatih; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Zhu, Lihua Julie; Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA USA; [Zatsepin, Timofei; Koteliansky, Victor] Skolkovo Inst Sci & Technol, Ctr Translat Biomed, Moscow, Russia; [Zatsepin, Timofei] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia; [Langer, Robert; Anderson, Daniel G.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Anderson, DG (reprint author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu			National Institutes of Health (NIH) [5R00CA169512, DP2HL137167, P01HL131471]; Russian Scientific Fund [14-34-00017]; Skoltech Center; NIH [5-U54-CA151884-04]; Cancer Center Support (core) grant from the NIH [P30-CA14051]	We thank T. Jacks, P. Sharp, T. Tammela, Z. Weng, G. Gao, E. Sontheimer and A. Vegas for discussions and for sharing reagents, Y. Li and A. Park for technical assistance, and K. Cormier for histology. This work is supported by grants from the National Institutes of Health (NIH), 5R00CA169512, DP2HL137167 and P01HL131471 (to W.X.). V.K. acknowledges support from the Russian Scientific Fund, Grant number 14-34-00017. H.Y. is supported by Skoltech Center and 5-U54-CA151884-04 (NIH). This work is supported in part by Cancer Center Support (core) grant P30-CA14051 from the NIH. We thank the Swanson Biotechnology Center for technical support.	Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Howard JAK, 1996, TETRAHEDRON, V52, P12613, DOI 10.1016/0040-4020(96)00749-1                                                    ; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Patra A, 2012, ANGEW CHEM INT EDIT, V51, P11863, DOI 10.1002/anie.201204946; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang M, 2017, GENE THER, V24, P144, DOI 10.1038/gt.2016.72; Yin H, 2007, HEPATOLOGY, V45, P159, DOI 10.1002/hep.21493; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2010, HEPATOLOGY, V51, P1007, DOI 10.1002/hep.23476; Yin H, 2010, LIVER INT, V30, P623, DOI 10.1111/j.1478-3231.2009.02199.x; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhu LHJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3746-y; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	48	0	0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2017	35	12					1179	+		10.1038/nbt.4005				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FP4TQ	WOS:000417609700024	29131148				2018-01-05	
J	Liu, T; Zhang, ZX; Yu, CJ; Zeng, C; Xu, XQ; Wu, GX; Huang, Z; Li, WH				Liu, Ting; Zhang, Zhenxing; Yu, Chunjie; Zeng, Chang; Xu, Xiaoqing; Wu, Guixian; Huang, Zan; Li, Wenhua			Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							ACUTE MEGAKARYOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; BCR-ABL; ARSENIC TRIOXIDE; CONCISE GUIDE; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; NOTCH PATHWAY; CELL-LINE; PHARMACOLOGY	BACKGROUND AND PURPOSE The poor prognosis of acute megakaryoblastic leukaemia (AMKL) means there is a need to develop novel therapeutic methods to treat this condition. It was recently shown that inducing megakaryoblasts to undergo terminal differentiation is effective as a treatment for AMKL. This encouraged us to identify a compound that induces megakaryocyte differentiation, which could then act as a potent anti-leukaemia agent. EXPERIMENTAL APPROACH The effects of tetrandrine on the expression of CD41 and cell morphology were investigated in AMKL cells. We used CRISPR/Cas9 knockout system to knock out ATG7 and verify the role of autophagy in tetrandrine-induced megakaryocyte differentiation. shNotch1 and CA-Akt were transfected into K562 cells to examine the downstream pathways of ROS signalling and the mechanistic basis of the tetrandrine-induced megakaryocyte differentiation. The anti-leukaemia effects of tetrandrine were analysed both in vitro and in vivo. KEY RESULTS A low dose of tetrandrine induced cell cycle arrest and megakaryocyte differentiation in AMKL cells via activation of autophagy. Molecularly, we demonstrated that this effect is mediated by activation of Notch1 and Akt and subsequent accumulation of ROS. In contrast, in normal mouse fetal liver cells, although tetrandrine induced autophagy, it did not affect cell proliferation or promote megakaryocyte differentiation, suggesting a specific effect of tetrandrine in malignant megakaryoblasts. Finally, tetrandrine also showed in vivo efficacy in an AMKL xenograft mouse model. CONCLUSIONS AND IMPLICATIONS Modulating autophagy-mediated differentiation may be a novel strategy for treating AMKL, and tetrandrine has the potential to be developed as a differentiation-inducing agent for AMKL chemotherapy.	[Liu, Ting; Zhang, Zhenxing; Yu, Chunjie; Zeng, Chang; Xu, Xiaoqing; Wu, Guixian; Huang, Zan; Li, Wenhua] Wuhan Univ, Hubei Key Lab Cell Homeostasis, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Li, WH (reprint author), Wuhan Univ, Hubei Key Lab Cell Homeostasis, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	whli@whu.edu.cn			National Basic Research Programme of China [2014CB910600]; National Natural Science Foundation of China [81273540, 81472684]; Programme for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0436]	This study was supported by the National Basic Research Programme of China (2014CB910600), the National Natural Science Foundation of China (81273540 and 81472684) and the Programme for New Century Excellent Talents in University of Ministry of Education of China (NCET-13-0436).	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6024, DOI 10.1111/bph.13354; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5979, DOI 10.1111/bph.13353; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5729, DOI 10.1111/bph.13347; Athale UH, 2001, BLOOD, V97, P3727, DOI 10.1182/blood.V97.12.3727                                                       ; Bruserud O, 2000, Oncologist, V5, P454, DOI 10.1634/theoncologist.5-6-454; Cao Y, 2015, EXP HEMATOL, V43, P488, DOI 10.1016/j.exphem.2015.01.001; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260                                                    ; Chadwick N, 2008, BLOOD CELL MOL DIS, V41, P270, DOI 10.1016/j.bcmd.2008.06.003; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889                                                           ; Coombs CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.25; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Eliades A, 2012, J CELL PHYSIOL, V227, P3355, DOI 10.1002/jcp.24071; Elzinga BM, 2013, AM J HEMATOL, V88, P455, DOI 10.1002/ajh.23428; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Gong K, 2012, J BIOL CHEM, V287, P35576, DOI 10.1074/jbc.M112.370585; Goussetis DJ, 2013, AUTOPHAGY, V9, P93, DOI 10.4161/auto.22259; Goussetis DJ, 2012, BLOOD, V120, P3555, DOI 10.1182/blood-2012-01-402578; Goussetis DJ, 2010, J BIOL CHEM, V285, P29989, DOI 10.1074/jbc.M109.090530; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Han SH, 2015, BMB REP, V48, P691, DOI 10.5483/BMBRep.2015.48.12.100; Kamitsuji Y, 2008, CELL DEATH DIFFER, V15, P1712, DOI 10.1038/cdd.2008.107; Kania E, 2015, BIOMED RES INT, DOI 10.1155/2015/352794; Kannan S, 2013, J EXP MED, V210, P321, DOI 10.1084/jem.20121527; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Krause DS, 2013, CLIN CANCER RES, V19, P6084, DOI 10.1158/1078-0432.CCR-12-2604; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; Liu L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.512; Liu T, 2016, ONCOTARGET, V7, P40800, DOI 10.18632/oncotarget.8315; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Luo MJ, 2016, AUTOPHAGY, V12, P1973, DOI 10.1080/15548627.2016.1217381; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Marchwicka A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00125; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Mei LF, 2015, BRIT J PHARMACOL, V172, P2232, DOI 10.1111/bph.13045; Mercher T, 2002, GENE CHROMOSOME CANC, V33, P22, DOI 10.1002/gcc.1208                                                                ; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Nurhayati RW, 2014, CELL MOL BIOL LETT, V19, P590, DOI 10.2478/s11658-014-0215-3; Ojima Y, 2013, EXP CELL RES, V319, P2205, DOI 10.1016/j.yexcr.2013.06.002; Oki Y, 2006, BLOOD, V107, P880, DOI 10.1182/blood-2005-06-2450; Palomero T, 2008, CLIN CANCER RES, V14, P5314, DOI 10.1158/1078-0432.CCR-07-4864; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Sardina JL, 2010, CELL DEATH DIFFER, V17, P1842, DOI 10.1038/cdd.2010.67; Sawayama Y, 2008, LEUKEMIA, V22, P956, DOI 10.1038/leu.2008.8; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; SCHIFF PL, 1987, J NAT PROD, V50, P529, DOI 10.1021/np50052a001; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Wan J, 2013, BRIT J CANCER, V109, P342, DOI 10.1038/bjc.2013.334; Wang HQ, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-4; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.ieukres.2008.06.023	56	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	DEC	2017	174	23					4308	4328		10.1111/bph.14031				21	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FP3VL	WOS:000417546000008	28901537				2018-01-05	
J	Shen, CX; Que, ZQ; Xia, YM; Tang, N; Li, D; He, RH; Cao, ML				Shen, Chunxiu; Que, Zhiqun; Xia, Yumei; Tang, Ning; Li, Ding; He, Ronghua; Cao, Mengliang			Knock out of the annexin gene OsAnn3 via CRISPR/Cas9-mediated genome editing decreased cold tolerance in rice	JOURNAL OF PLANT BIOLOGY			English	Article						Annexins; Cold tolerance; CRISPR/Cas9; Rice	CRISPR-CAS SYSTEM; TARGETED MUTAGENESIS; STRESS-RESPONSE; LOW-TEMPERATURE; ABIOTIC STRESS; PROTEIN; RNA; EXPRESSION; ARABIDOPSIS; IDENTIFICATION	Plant annexins are Ca2+-dependent phospholipid-binding proteins and exist as multigene families in plants. They are implicated in the regulation of plant development as well as protection from environmental stresses. In this study, the rice annexin gene OsAnn3 knockout was performed via the CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR associated proteins) mediated genome editing. Thus, mutant plantlets were successfully obtained. We identified cold tolerance phenotype of T-1 mutant lines from T0 biallelic mutants using the 4 similar to 6A degrees C for 3 days cold treatment. The results showed that REC (the relative electrical conductivity) of T-1 mutant lines was increased, and the survival ratio of T-1 mutant lines was decreased dramatically compared with the wild type after the exposure to cold treatment. It was suggested that OsAnn3 was involved in cold tolerance of rice.	[Xia, Yumei; Tang, Ning; Cao, Mengliang] Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha 410125, Hunan, Peoples R China; [Shen, Chunxiu; Que, Zhiqun] Yichun Univ, Coll Life Sci Resources & Environm Sci, Yichun 336000, Peoples R China; [Cao, Mengliang] Hunan Agr Univ, Collaborat Innovat Ctr, Changsha 410128, Hunan, Peoples R China; [Li, Ding] Hunan Univ Technol, Dept Biotechnol, Hunan Key Lab Green Packaging & Applicat Biol Nan, Zhuzhou 412007, Peoples R China; [He, Ronghua] Agr Comm Ningyuan Cty, Yongzhou 425600, Peoples R China	Cao, ML (reprint author), Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha 410125, Hunan, Peoples R China.; Cao, ML (reprint author), Hunan Agr Univ, Collaborat Innovat Ctr, Changsha 410128, Hunan, Peoples R China.	mlcao@hhrrc.ac.cn			National Key Technology RD Program [2014AA10A603]; National Program of Transgenic Variety Development of China [2011ZX08001-001, 2011ZX08001-004]; Key Science and Technology Program of Hunan Province [2014FJ2014]; Open Research Fund of the State Key Laboratory of Hybrid Rice (Hunan Hybrid Rice Research Center) [2014KF04]; National Natural Science Foundation of China [31660379]; Science and Technology Program of Jiangxi Province Education Department [GJJ151039]	This research was financially supported by the National Key Technology R&D Program (2014AA10A603), the National Program of Transgenic Variety Development of China (2011ZX08001-001, 2011ZX08001-004), the Key Science and Technology Program of Hunan Province (2014FJ2014), the Open Research Fund of the State Key Laboratory of Hybrid Rice (Hunan Hybrid Rice Research Center) (No. 2014KF04), National Natural Science Foundation of China (Grant No. 31660379) and Science and Technology Program of Jiangxi Province Education Department (GJJ151039).	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Breton G, 2000, PLANT CELL PHYSIOL, V41, P177; Cantero A, 2006, PLANT PHYSIOL BIOCH, V44, P13, DOI 10.1016/j.plaphy.2006.02.002; Chu P, 2012, PLANTA, V235, P1271, DOI 10.1007/s00425-011-1573-y; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gidrol X, 1996, P NATL ACAD SCI USA, V93, P11268, DOI 10.1073/pnas.93.20.11268; Anshita Goel, 2011, Genomics, Proteomics & Bioinformatics, V9, P138, DOI 10.1016/S1672-0229(11)60017-X; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hashimoto M, 2009, PROTEIN PEPTIDE LETT, V16, P685, DOI 10.2174/092986609788490140                                                      ; Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7; Hu TZ, 2012, APPL BIOCHEM BIOTECH, V166, P222, DOI 10.1007/s12010-011-9418-5; Jami SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047801; Jami SK, 2012, PLANT CELL REP, V31, P813, DOI 10.1007/s00299-011-1201-0; Jami SK, 2009, PLANT PHYSIOL BIOCH, V47, P977, DOI 10.1016/j.plaphy.2009.08.005; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konopka-Postupolska D, 2011, PLANT SCI, V181, P230, DOI 10.1016/j.plantsci.2011.05.013; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Kovacs I, 1998, PLANT J, V15, P185, DOI 10.1046/j.1365-313X.1998.00194.x; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liu CT, 2012, PLANTA, V235, P1157, DOI 10.1007/s00425-011-1564-z; Loukehaich R, 2012, J EXP BOT, V63, P5593, DOI 10.1093/jxb/ers220; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219                                                         ; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Prakash M, 2009, PLANT CELL TISS ORG, V98, P87; Qiao B, 2015, J EXP BOT, V66, P5853, DOI 10.1093/jxb/erv294; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen CX, 2014, J PLANT BIOL, V57, P337, DOI 10.1007/s12374-014-0183-1; Singh A, 2014, FEBS J, V281, P894, DOI 10.1111/febs.12656; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023                                                    ; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109                                                              ; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Vandeputte O, 2007, MOL PLANT PATHOL, V8, P185, DOI 10.1111/J.1364-3703.2007.00385.X; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103026914; Wen JQ, 2002, PLANT PHYSIOL, V129, P1880, DOI 10.1104/pp.006072; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yan HF, 2016, PLANT MOL BIOL REP, V34, P467, DOI 10.1007/s11105-015-0935-1; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yang GX, 2003, PLANT PHYSIOL BIOCH, V41, P369, DOI 10.1016/S0981-9428(03)00032-9; Yusuke S., 2000, PLANT J, V23, P319	60	0	0	5	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1226-9239	1867-0725		J PLANT BIOL	J. Plant Biol.	DEC	2017	60	6					539	547		10.1007/s12374-016-0400-1				9	Plant Sciences	Plant Sciences	FP6LQ	WOS:000417738000001					2018-01-05	
J	Wang, KP; Jin, Q; Ruan, DG; Yang, Y; Liu, QS; Wu, H; Zhou, ZW; Ouyang, Z; Liu, ZM; Zhao, Y; Zhao, BT; Zhang, QJ; Peng, JY; Lai, CD; Fan, NN; Liang, YH; Lan, T; Li, N; Wang, XS; Wang, XL; Fan, Y; Doevendans, PA; Sluijter, JPG; Liu, PT; Li, XP; Lai, LX				Wang, Kepin; Jin, Qin; Ruan, Degong; Yang, Yi; Liu, Qishuai; Wu, Han; Zhou, Zhiwei; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Zhao, Bentian; Zhang, Quanjun; Peng, Jiangyun; Lai, Chengdan; Fan, Nana; Liang, Yanhui; Lan, Ting; Li, Nan; Wang, Xiaoshan; Wang, Xinlu; Fan, Yong; Doevendans, Pieter A.; Sluijter, Joost P. G.; Liu, Pentao; Li, Xiaoping; Lai, Liangxue			Cre-dependent Cas9-expressing pigs enable efficient in vivo genome editing	GENOME RESEARCH			English	Article							ONE-STEP GENERATION; CHROMOSOMAL REARRANGEMENTS; MUSCULAR-DYSTROPHY; CRISPR/CAS9 SYSTEM; CYNOMOLGUS MONKEY; LUNG-CANCER; MOUSE MODEL; GENE; MICE; DELIVERY	Despite being time-consuming and costly, generating genome-edited pigs holds great promise for agricultural, biomedical, and pharmaceutical applications. To further facilitate genome editing in pigs, we report here establishment of a pig line with Cre-inducible Cas9 expression that allows a variety of ex vivo genome editing in fibroblast cells including single-and multigene modifications, chromosome rearrangements, and efficient in vivo genetic modifications. As a proof of principle, we were able to simultaneously inactivate five tumor suppressor genes (TP53, PTEN, APC, BRCA1, and BRCA2) and activate one oncogene (KRAS), achieved by delivering Cre recombinase and sgRNAs, which caused rapid lung tumor development. The efficient genome editing shown here demonstrates that these pigs can serve as a powerful tool for dissecting in vivo gene functions and biological processes in a temporal manner and for streamlining the production of genome-edited pigs for disease modeling.	[Wang, Kepin; Jin, Qin; Ruan, Degong; Liu, Qishuai; Wu, Han; Zhou, Zhiwei; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Zhao, Bentian; Zhang, Quanjun; Peng, Jiangyun; Lai, Chengdan; Fan, Nana; Liang, Yanhui; Lan, Ting; Li, Nan; Wang, Xiaoshan; Li, Xiaoping; Lai, Liangxue] Guangzhou Med Univ, Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci,CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Kepin; Jin, Qin; Ruan, Degong; Liu, Qishuai; Wu, Han; Zhou, Zhiwei; Peng, Jiangyun; Liang, Yanhui; Lan, Ting; Li, Nan; Wang, Xiaoshan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Kepin; Jin, Qin; Ruan, Degong; Liu, Qishuai; Wu, Han; Zhou, Zhiwei; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Zhao, Bentian; Zhang, Quanjun; Peng, Jiangyun; Lai, Chengdan; Fan, Nana; Liang, Yanhui; Lan, Ting; Li, Nan; Wang, Xiaoshan; Li, Xiaoping; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Yang, Yi; Fan, Yong] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Reprod & Genet,Key Lab Major Obstet Dis G, Guangzhou 510150, Guangdong, Peoples R China; [Wang, Xinlu] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Nucl Med, Guangzhou 510010, Guangdong, Peoples R China; [Doevendans, Pieter A.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Expt Cardiol Lab, Dept Cardiol, NL-3584 CX Utrecht, Netherlands; [Doevendans, Pieter A.; Sluijter, Joost P. G.] Netherlands Heart Inst, NL-3584 CX Utrecht, Netherlands; [Liu, Pentao] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus Hinxton, Cambridge CB10 1HH, England; [Lai, Liangxue] Jilin Univ, Coll Vet Med, Inst Zoonosis, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130062, Jilin, Peoples R China	Li, XP; Lai, LX (reprint author), Guangzhou Med Univ, Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci,CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.; Li, XP; Lai, LX (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.; Lai, LX (reprint author), Jilin Univ, Coll Vet Med, Inst Zoonosis, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130062, Jilin, Peoples R China.	li_xiaoping@gibh.ac.cn; lai_liangxue@gibh.ac.cn			National Natural Science Foundation of China [81672317, 81671121, 31601187, 31401271]; Bureau of International Cooperation; Chinese Academy of Sciences [154144KYSB20150033]; Science and Technology Planning Project of Guangdong Province, China [2013B060300017, 2014B020225003, 2014B030301058, 2015A030310119, 2016A020216023, 2016B030229006]; Bureau of Science and Technology of Guangzhou Municipality [201505011111498]	This work was supported by grants from the National Natural Science Foundation of China (81672317, 81671121, 31601187, 31401271), the Bureau of International Cooperation, The Chinese Academy of Sciences (154144KYSB20150033), the Science and Technology Planning Project of Guangdong Province, China (2013B060300017, 2014B020225003, 2014B030301058, 2015A030310119, 2016A020216023, 2016B030229006), and the Bureau of Science and Technology of Guangzhou Municipality (201505011111498).	Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bode G, 2010, J PHARMACOL TOXICOL, V62, P196, DOI 10.1016/j.vascn.2010.05.009; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Chow RD, 2017, NAT NEUROSCI, V20, P1329, DOI 10.1038/nn.4620; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Deng YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014662; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014; Flisikowska T, 2016, THERIOGENOLOGY, V86, P433, DOI 10.1016/j.theriogenology.2016.04.058; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Niu D, 2017, SCIENCE, V357, P1303, DOI 10.1126/science.aan4187; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Su Yue-Chiu, 2006, Kaohsiung Journal of Medical Sciences, V22, P14; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xie C, 2016, CELL RES, V26, P1099, DOI 10.1038/cr.2016.101; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang Y, 2016, J MOL CELL BIOL, V8, P174, DOI 10.1093/jmcb/mjw008; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zou QJ, 2015, J MOL CELL BIOL, V7, P580, DOI 10.1093/jmcb/mjv061; Zou QJ, 2014, J BIOL CHEM, V289, P5250, DOI 10.1074/jbc.M113.516112	51	0	0	3	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2017	27	12					2061	2071		10.1101/gr.222521.117				11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FO7IR	WOS:000417047600009	29146772				2018-01-05	
J	Wess, L; Schnieders, F				Wess, Ludger; Schnieders, Frank			Immuno-OncologyThe Translational Runway for Gene Therapy: Gene Therapeutics to Address Multiple Immune Targets	HUMAN GENE THERAPY			English	Review						gene therapy; immuno-oncology; vector; oncolytic virus; multi-target	DENDRITIC CELLS; CANCER; IMMUNOTHERAPY; MELANOMA; COMBINATIONS; CRISPR-CAS9; VACCINES; GLIOMA; VIRUS	Cancer therapy is once again experiencing a paradigm shift. This shift is based on extensive clinical experience demonstrating that cancer cannot be successfully fought by addressing only single targets or pathways. Even the combination of several neo-antigens in cancer vaccines is not sufficient for successful, lasting tumor eradication. The focus has therefore shifted to the immune system's role in cancer and the striking abilities of cancer cells to manipulate and/or deactivate the immune system. Researchers and pharma companies have started to target the processes and cells known to support immune surveillance and the elimination of tumor cells. Immune processes, however, require novel concepts beyond the traditional single-target-single drug paradigm and need parallel targeting of diverse cells and mechanisms. This review gives a perspective on the role of gene therapy technologies in the evolving immuno-oncology space and identifies gene therapy as a major driver in the development and regulation of effective cancer immunotherapy. Present challenges and breakthroughs ranging from chimeric antigen receptor T-cell therapy, gene-modified oncolytic viruses, combination cancer vaccines, to RNA therapeutics are spotlighted. Gene therapy is recognized as the most prominent technology enabling effective immuno-oncology strategies.	[Wess, Ludger] Akampion, Hamburg, Germany; [Schnieders, Frank] Provecs Med, Hamburg, Germany	Schnieders, F (reprint author), Provecs Med GmbH, Spectrum UKE, Martinistr 64, D-20251 Hamburg, Germany.	f.schnieders@provecs.com					Alexander Walter, 2016, P T, V41, P185; Argos Therapeutics, IND DAT MON COMM REC; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Bofill-De Ros X, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00142; Castillo A, 2016, COLOMB MEDICA, V47, P178; Chen S, 2016, INT J BIOL SCI, V12, P1427, DOI 10.7150/ijbs.17421; Cukier-Meisner E., 2017, BIOCENTURY; CureVac, CUREVAC PROV CLIN UP; DeFrancesco L, 2017, NAT BIOTECHNOL, V35, P193, DOI 10.1038/nbt.3812; Food and Drug Administration, HIGHL PRESCR INF; Fox BA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-214; Freedman JD, 2017, EMBO MOL MED, V9, P1067, DOI 10.15252/emmm.201707567; Havunen R, 2017, MOL THER-ONCOLYTICS, V4, P77, DOI 10.1016/j.omto.2016.12.004; Immatics, IMM ANN RES IMPR PHA; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Kamran N, 2017, MOL THER, V25, P232, DOI 10.1016/j.ymthe.2016.10.003; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kohlhapp FJ, 2016, CLIN CANCER RES, V22, P1048, DOI 10.1158/1078-0432.CCR-15-2667; Marino N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177810; Markabi Sabri, 2009, Retina, V29, pS12, DOI 10.1097/IAE.0b013e3181ad24c4; McNamara MA, 2015, J IMMUNOL RES, DOI 10.1155/2015/794528; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Monnereau A, 2013, BLOOD, V122, P3492, DOI 10.1182/blood-2013-04-497586; Muik A, 2014, CANCER RES, V74, P3567, DOI 10.1158/0008-5472.CAN-13-3306; Navai N, 2016, ANN SURG ONCOL, V23, P4110, DOI 10.1245/s10434-016-5300-6; Novartis, FDA BRIEF DOC ONC DR; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Perry D, 2015, EXPERT REV NEUROTHER, V15, P327, DOI 10.1586/14737175.2015.996551; Ramamoorth Murali, 2015, J Clin Diagn Res, V9, pGE01, DOI 10.7860/JCDR/2015/10443.5394; Reardon S., 2016, NATURE, DOI [10.1038/nature.2016.20137, DOI 10.1038/NATURE.2016.20137]; Ribas A, 2005, CURR GENE THER, V5, P619, DOI 10.2174/156652305774964758; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Seymour LW, 2016, BRIT J CANCER, V114, P357, DOI 10.1038/bjc.2015.481; Sheridan C., PROVECS NEARING CLIN; Stadler CR, 2017, NAT MED, V23, P815, DOI 10.1038/nm.4356; Triozzi PL, 2005, CLIN CANCER RES, V11, P4168, DOI 10.1158/1078-0432.CCR-04-2283; Ungerechts G, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.18; Van Lint S, 2016, CANCER IMMUNOL RES, V4, P146, DOI 10.1158/2326-6066.CIR-15-0163; Van Lint S, 2015, EXPERT REV VACCINES, V14, P235, DOI 10.1586/14760584.2015.957685; Wang DH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-251; Wilgenhof S, 2013, ANN ONCOL, V24, P2686, DOI 10.1093/annonc/mdt245	43	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	DEC	2017	28	12					1130	1137		10.1089/hum.2017.145				8	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FQ5OP	WOS:000417598300001					2018-01-05	
J	Oatley, JM				Oatley, Jon M.			Recent advances for spermatogonial stem cell transplantation in livestock	REPRODUCTION FERTILITY AND DEVELOPMENT			English	Article; Proceedings Paper	Annual Conference of the International-Embryo-Technology-Society (IETS)	JAN 13-16, 2018	Bangkok, THAILAND	Int Embryo Technol Soc		cattle; pig	LONG-TERM CULTURE; GERM-CELL; SELF-RENEWAL; MOUSE TESTES; TRANSMISSION; NANOS2; PIGS; MICE	At the foundation of spermatogenesis are the actions of spermatogonial stem cells (SSCs), and a remarkable feature of these cells is the capacity to regenerate spermatogenesis following transplantation into testes of a recipient male that lacks endogenous germline. This ability could be exploited in livestock production as a breeding tool to enhance genetic gain. A key element to success is derivation of culture conditions that support proliferation of SSCs to provide sufficient numbers of cells for transfer into multiple recipient males. Using methodology devised for rodent cells as a foundation, advances in culturing cattle SSCs have occurred over the past few years and efforts are underway to extend this capability to pig cells. Another critical component to SSC transplantation is generation of males with germline ablation but intact somatic support cell function that can serve as surrogate sires for donor-derived spermatogenesis in a natural mating scheme. Recent advances in pigs using gene editing technologies have demonstrated that knockout of a key male germ cell-specific gene, namely NANOS2, leads to male-specific germline ablation but otherwise normal physiology, including intact seminiferous tubules. Together with recent advances in culturing spermatogonia of higher-order mammals, the now efficient means of producing germline-ablated recipient males have brought the application of SSC transplantation in livestock as a production tool closer to reality than ever before.	[Oatley, Jon M.] Washington State Univ, Coll Vet Med, Ctr Reprod Biol, Sch Mol Biosci, Pullman, WA 99164 USA	Oatley, JM (reprint author), Washington State Univ, Coll Vet Med, Ctr Reprod Biol, Sch Mol Biosci, Pullman, WA 99164 USA.	joatley@vetmed.wsu.edu					Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Chan F, 2014, GENE DEV, V28, P1351, DOI 10.1101/gad.240465.114; De Rooij DG, 2000, J ANDROL, V21, P776; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Helsel AR, 2017, STEM CELL REP, V8, P1430, DOI 10.1016/j.stemcr.2017.03.004; Helsel AR, 2017, DEVELOPMENT, V144, P624, DOI 10.1242/dev.146928; Helsel AR, 2017, METHODS MOL BIOL, V1463, P155, DOI 10.1007/978-1-4939-4017-2_12; Honaramooz A, 2002, BIOL REPROD, V66, P21, DOI 10.1095/biolreprod66.1.21; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI [10.1095/biolreprod.103.017012, 10.1095/biloreprod.103.017012]; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2011, FASEB J, V25, P2604, DOI 10.1096/fj.10-175802; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oatley MJ, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.139832; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Saga Y, 2010, CELL MOL LIFE SCI, V67, P3815, DOI 10.1007/s00018-010-0456-x; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Zeng WX, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104422; Zhang Z, 2006, J ANDROL, V27, P365, DOI 10.2164/jandrol.05179	24	0	0	0	0	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	1031-3613	1448-5990		REPROD FERT DEVELOP	Reprod. Fertil. Dev.	DEC	2017	30	1					44	49		10.1071/RD17418				6	Developmental Biology; Reproductive Biology; Zoology	Developmental Biology; Reproductive Biology; Zoology	FO6LY	WOS:000416975900004					2018-01-05	
J	Alberio, R				Alberio, Ramiro			Transcriptional and epigenetic control of cell fate decisions in early embryos	REPRODUCTION FERTILITY AND DEVELOPMENT			English	Article; Proceedings Paper	Annual Conference of the International-Embryo-Technology-Society (IETS)	JAN 13-16, 2018	Bangkok, THAILAND	Int Embryo Technol Soc		epiblast; gastrulation; lineage segregation; primordial germ cells; stem cells	PRIMORDIAL GERM-CELLS; EPIBLAST STEM-CELLS; EARLY MOUSE EMBRYO; HUMAN PREIMPLANTATION EMBRYOS; PRIMITIVE ENDODERM FORMATION; GROUND-STATE PLURIPOTENCY; EARLY LINEAGE SEGREGATION; GENE-EXPRESSION ANALYSIS; DNA DEMETHYLATION; MAMMALIAN DEVELOPMENT	Mammalian embryo development is characterised by regulative mechanisms of lineage segregation and cell specification. A combination of carefully orchestrated gene expression networks, signalling pathways and epigenetic marks defines specific developmental stages that can now be resolved at the single-cell level. These new ways to depict developmental processes have the potential to provide answers to unresolved questions on how lineage allocation and cell fate decisions are made during embryogenesis. Over the past few years, a flurry of studies reporting detailed single-cell transcription profiles in early embryos has complemented observations acquired using live cell imaging following gene editing techniques to manipulate specific genes. The adoption of this newly available toolkit is reshaping how researchers are designing experiments and how they view animal development. This review presents an overview of the current knowledge on lineage segregation and cell specification in mammals, and discusses some of the outstanding questions that current technological advances can help scientists address, like never before.	[Alberio, Ramiro] Univ Nottingham, Sch Biosci, Nottingham LE12 5RD, England	Alberio, R (reprint author), Univ Nottingham, Sch Biosci, Nottingham LE12 5RD, England.	ramiro.alberio@nottingham.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M001466/1]	Work in the author's laboratory is funded by Biotechnology and Biological Sciences Research Council (BBSRC; BB/M001466/1).	Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082                                                          ; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Behringer RR, 2000, GENESIS, V28, P23, DOI 10.1002/1526-968X(200009)28:1<23::AID-GENE30>3.0.CO;2-G; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Bou G, 2017, DEVELOPMENT, V144, P1296, DOI 10.1242/dev.141085; Bou G, 2016, DEV BIOL, V410, P36, DOI 10.1016/j.ydbio.2015.12.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brewer JR, 2016, GENE DEV, V30, P751, DOI 10.1101/gad.277137.115; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Campolo F, 2013, STEM CELLS, V31, P1408, DOI 10.1002/stem.1392; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Cauffman G, 2009, HUM REPROD, V24, P63, DOI 10.1093/humrep/den351; Chatfield J, 2014, DEVELOPMENT, V141, P2429, DOI 10.1242/dev.105346; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X                                                   ; Clark SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0944-x; Cui XS, 2004, ANIM REPROD SCI, V84, P169, DOI 10.1016/j.anireprosci.2003.10.005; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; De Paepe C, 2013, HUM REPROD, V28, P740, DOI 10.1093/humrep/des432; Denicol AC, 2014, FASEB J, V28, P3975, DOI 10.1096/fj.14-253112; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eakin GS, 2004, SEMIN CELL DEV BIOL, V15, P619, DOI 10.1016/j.semcdb.2004.04.008; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Flechon JE, 2004, GENESIS, V38, P13, DOI 10.1002/gene.10244; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Goolam M, 2016, CELL, V165, P61, DOI 10.1016/j.cell.2016.01.047; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Jachowicz JW, 2017, NAT GENET, V49, P1502, DOI 10.1038/ng.3945; Johnson AD, 2015, DEVELOPMENT, V142, P2730, DOI 10.1242/dev.113993; JOHNSON MH, 1983, DEV BIOL, V95, P211, DOI 10.1016/0012-1606(83)90019-2; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kang MJ, 2017, DEV CELL, V41, P496, DOI 10.1016/j.devcel.2017.05.003; Khan DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034110; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kobayashi T, 2017, NATURE, V546, P416, DOI 10.1038/nature22812; Korotkevich E, 2017, DEV CELL, V40, P235, DOI 10.1016/j.devcel.2017.01.006; KOYAMA H, 1994, BIOL REPROD, V50, P163, DOI 10.1095/biolreprod50.1.163; Krivega M, 2015, MOL HUM REPROD, V21, P711, DOI 10.1093/molehr/gav036; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Kunath T, 2014, PLACENTA, V35, P1079, DOI 10.1016/j.placenta.2014.09.008; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Maitre JL, 2016, NATURE, V536, P344, DOI 10.1038/nature18958; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; McLean Z, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120832; Meilhac SM, 2009, DEV BIOL, V331, P210, DOI 10.1016/j.ydbio.2009.04.036; Meng F, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.134254; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3                                                   ; Molotkov A, 2017, DEV CELL, V41, P511, DOI 10.1016/j.devcel.2017.05.004; Morris SA, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130104; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Nakamura T, 2016, NATURE, V537, P57, DOI [10.1038/nature19096, 10.1038/nature19322]; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nikas G, 1996, BIOL REPROD, V55, P32, DOI 10.1095/biolreprod55.1.32; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Ozawa Manabu, 2016, BMC Res Notes, V9, P250, DOI 10.1186/s13104-016-2038-y; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Pearton DJ, 2014, DEV BIOL, V392, P344, DOI 10.1016/j.ydbio.2014.05.012; Pearton DJ, 2011, DEV BIOL, V360, P343, DOI 10.1016/j.ydbio.2011.10.007; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004                                                    ; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Peter IS, 2017, P NATL ACAD SCI USA, V114, P5862, DOI 10.1073/pnas.1610616114; Petropoulos S, 2016, CELL, V165, P1012, DOI 10.1016/j.cell.2016.03.023; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; REIMA I, 1993, DIFFERENTIATION, V54, P35; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Sasaki K, 2016, DEV CELL, V39, P169, DOI 10.1016/j.devcel.2016.09.007; Savatier P, 2017, STEM CELL RES, V19, P104, DOI 10.1016/j.scr.2017.01.008; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Sjoblom C, 1999, HUM REPROD, V14, P3069, DOI 10.1093/humrep/14.12.3069                                                       ; STEPTOE PC, 1971, NATURE, V229, P132, DOI 10.1038/229132a0; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Szczepanska K, 2011, DIFFERENTIATION, V82, P1, DOI 10.1016/j.diff.2011.04.001; Takashima Y, 2015, CELL, V162, P452, DOI 10.1016/j.cell.2015.06.052; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Magana GV, 2014, DEV BIOL, V387, P15, DOI 10.1016/j.ydbio.2014.01.008; Van de Pavert SA, 2001, MOL REPROD DEV, V59, P390, DOI 10.1002/mrd.1045; Van der Jeught M, 2014, HUM REPROD, V29, P41, DOI 10.1093/humrep/det400; VanSoom A, 1997, BIOL REPROD, V57, P1041, DOI 10.1095/biolreprod57.5.1041; von Meyenn F, 2016, MOL CELL, V62, P983, DOI 10.1016/j.molcel.2016.06.005; Wei QQ, 2017, BIOL REPROD, V97, P5, DOI 10.1093/biolre/iox071; White MD, 2016, CELL, V165, P75, DOI 10.1016/j.cell.2016.02.032; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105                                                           ; Wolpert L., 2008, TRIUMPH EMBRYO; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshida M, 2016, DEV DYNAM, V245, P67, DOI [10.1002/dvdy.24352, 10.1002/DVDY.24352]; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361	137	0	0	2	2	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	1031-3613	1448-5990		REPROD FERT DEVELOP	Reprod. Fertil. Dev.	DEC	2017	30	1					73	84		10.1071/RD17403				12	Developmental Biology; Reproductive Biology; Zoology	Developmental Biology; Reproductive Biology; Zoology	FO6LY	WOS:000416975900008					2018-01-05	
J	Bustos, FJ; Ampuero, E; Jury, N; Aguilar, R; Falahi, F; Toledo, J; Ahumada, J; Lata, J; Cubillos, P; Henriquez, B; Guerra, MV; Stehberg, J; Neve, RL; Inestrosa, NC; Wyneken, U; Fuenzalida, M; Hartel, S; Sena-Esteves, M; Varela-Nallar, L; Rots, MG; Montecino, M; van Zundert, B				Bustos, Fernando J.; Ampuero, Estibaliz; Jury, Nur; Aguilar, Rodrigo; Falahi, Fahimeh; Toledo, Jorge; Ahumada, Juan; Lata, Jaclyn; Cubillos, Paula; Henriquez, Berta; Guerra, Miguel V.; Stehberg, Jimmy; Neve, Rachael L.; Inestrosa, Nibaldo C.; Wyneken, Ursula; Fuenzalida, Marco; Hartel, Steffen; Sena-Esteves, Miguel; Varela-Nallar, Lorena; Rots, Marianne G.; Montecino, Martin; van Zundert, Brigitte			Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer's disease mice	BRAIN			English	Article						ATF; ZFP; PSD-95; epigenetics; Alzheimer's disease	ARTIFICIAL TRANSCRIPTION FACTORS; MOUSE MODEL; IN-VIVO; DNA METHYLATION; NMDA RECEPTORS; HISTONE MODIFICATIONS; HIPPOCAMPAL-NEURONS; MUSCULAR-DYSTROPHY; PSD-95; EXPRESSION	Expression of Dlg4, which encodes the postsynaptic receptor clustering protein PSD95, is decreased in ageing and Alzheimer's disease. Bustos et al. engineer a zinc finger protein that modifies Dlg4 expression by changing its epigenetic state, and use the construct to rescue memory deficits in aged and Alzheimer's disease mice.The Dlg4 gene encodes for post-synaptic density protein 95 (PSD95), a major synaptic protein that clusters glutamate receptors and is critical for plasticity. PSD95 levels are diminished in ageing and neurodegenerative disorders, including Alzheimer's disease and Huntington's disease. The epigenetic mechanisms that (dys)regulate transcription of Dlg4/PSD95, or other plasticity genes, are largely unknown, limiting the development of targeted epigenome therapy. We analysed the Dlg4/PSD95 epigenetic landscape in hippocampal tissue and designed a Dlg4/PSD95 gene-targeting strategy: a Dlg4/PSD95 zinc finger DNA-binding domain was engineered and fused to effector domains to either repress (G9a, Suvdel76, SKD) or activate (VP64) transcription, generating artificial transcription factors or epigenetic editors (methylating H3K9). These epi-editors altered critical histone marks and subsequently Dlg4/PSD95 expression, which, importantly, impacted several hippocampal neuron plasticity processes. Intriguingly, transduction of the artificial transcription factor PSD95-VP64 rescued memory deficits in aged and Alzheimer's disease mice. Conclusively, this work validates PSD95 as a key player in memory and establishes epigenetic editing as a potential therapy to treat human neurological disorders.	[Bustos, Fernando J.; Ampuero, Estibaliz; Jury, Nur; Aguilar, Rodrigo; Cubillos, Paula; Henriquez, Berta; Guerra, Miguel V.; Stehberg, Jimmy; Varela-Nallar, Lorena; Montecino, Martin; van Zundert, Brigitte] Univ Andres Bello, Ctr Biomed Res, Fac Biol Sci, Ave Republ 217, Santiago, Chile; [Bustos, Fernando J.; Ampuero, Estibaliz; Jury, Nur; Aguilar, Rodrigo; Cubillos, Paula; Henriquez, Berta; Guerra, Miguel V.; Stehberg, Jimmy; Varela-Nallar, Lorena; Montecino, Martin; van Zundert, Brigitte] Univ Andres Bello, Fac Med, Ave Republ 217, Santiago, Chile; [Bustos, Fernando J.; Aguilar, Rodrigo; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile; [Falahi, Fahimeh; Rots, Marianne G.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Toledo, Jorge; Hartel, Steffen] Natl Ctr Hlth Informat Syst CENS, Biomed Neurosci Inst, Anat & Dev Biol, SCIAN Lab,Inst Biomed Sci,CIMT, Santiago, Chile; [Toledo, Jorge; Hartel, Steffen] Univ Chile, Fac Med, Santiago, Chile; [Ahumada, Juan; Fuenzalida, Marco] Univ Valparaiso, Fac Ciencias, Dept Fisiol, Ctr Neurobiol & Plasticidad Cerebral, Valparaiso, Chile; [Lata, Jaclyn; Sena-Esteves, Miguel] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Lata, Jaclyn; Sena-Esteves, Miguel] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Biol Sci, CARE Biomed Res Ctr, Santiago, Chile; [Wyneken, Ursula] Univ Los Andes, Lab Neurociencias, Santiago, Chile; [Henriquez, Berta] Univ San Sebastian, Fac Sci, Santiago, Chile; [Neve, Rachael L.] Massachusetts Gen Hosp, Gene Delivery Technol Core, Cambridge, MA USA	Montecino, M; van Zundert, B (reprint author), Univ Andres Bello, Ctr Biomed Res, Fac Biol Sci, Ave Republ 217, Santiago, Chile.; Montecino, M; van Zundert, B (reprint author), Univ Andres Bello, Fac Med, Ave Republ 217, Santiago, Chile.; Montecino, M (reprint author), FONDAP Ctr Genome Regulat, Santiago, Chile.; Rots, MG (reprint author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	m.g.rots@umcg.nl; mmontecino@unab.cl; bvanzundert@unab.cl			Fondecyt [1140301, 1170878, 3130582, 1150933, 3110138, 1130614, 1151029]; ALS Therapy Alliance [2014-F-034]; Anillo-RING [ACT1114]; FONDEQUIP EQM [140166]; DRI USA [2013-0030]; Nucleus [DI-603-14/N, DI-4-17/N]; FONDAP [15090007]; FP7-PEOPLE-IRSES EULAMDIMA; Conicyt [24110099, 201161486]; Anillo [ACT-1414]; Millennium Nucleus NUMIND [NC-130011]; Millenium Scientific Initiative of the Ministry of Economy, Development and Tourism (Chile); FONDEQUIP [EQM140119]; CONICYT PIA [ACT1402]; ICM [P09-015-F]; CORFO [16CTTS-66390]; DAAD [57220037, 57168868]; CONICYT-PFB [12/2007]; Basal Center of Excellence in Aging and Regeneration; NIH/NINDS [NS093941]	This work was supported by Fondecyt 1140301, ALS Therapy Alliance-2014-F-034, Anillo-RING ACT1114, and FONDEQUIP EQM 140166 (B.v.Z.); DRI USA 2013-0030 (B.v.Z., L.V.-N., M.M.); Nucleus DI-603-14/N and DI-4-17/N (B.v.Z., L.V.-N., J.S.); FONDAP 15090007 and Fondecyt 1170878 (M.M.); FP7-PEOPLE-2011-IRSES EULAMDIMA (B.v.Z., M.M.); Conicyt 24110099 (F.J.B.), Fondecyt-3130582 (E.A.); Conicyt 201161486 (N.J.); Fondecyt 1150933 (L.V.-N.); Fondecyt 3110138 (B.H.); FONDECYT 1130614, Anillo ACT-1414 and Millennium Nucleus NUMIND (NC-130011) Millenium Scientific Initiative of the Ministry of Economy, Development and Tourism (Chile) (M.F.); Fondecyt 1151029, FONDEQUIP EQM140119, CONICYT PIA ACT1402, ICM P09-015-F, CORFO 16CTTS-66390 and DAAD 57220037 & 57168868 CONICYT-PFB 12/2007 (J.T., S.H.). Basal Center of Excellence in Aging and Regeneration (N.C.I.). NIH/NINDS grant NS093941 (M.S-E).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ampuero E, 2017, J CELL PHYSIOL, V232, P1187, DOI 10.1002/jcp.25605; Arbuckle MI, 2010, EMBO REP, V11, P473, DOI 10.1038/embor.2010.63; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Beltran AS, 2011, EPIGENETICS-US, V6, P224, DOI 10.4161/epi.6.2.13700; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neurosceince.2005.11.057; Bustos FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094037; Bustos FJ, 2017, J CELL PHYSL, V27, P8334; Cano-Rodriguez D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12284; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen GQ, 2000, NATURE, V408, P975; Chen H, 2014, NUCLEIC ACIDS RES, V42, P1563, DOI 10.1093/nar/gkt1019; de Bartolomeis A, 2014, MOL NEUROBIOL, V49, P484, DOI 10.1007/s12035-013-8534-3; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Dekker AD, 2014, NEUROSCI BIOBEHAV R, V45, P72, DOI 10.1016/j.neubiorev.2014.05.004; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159                                                           ; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Falahi F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00022; Falahi F, 2013, MOL CANCER RES, V11, P1029, DOI 10.1158/1541-7786.MCR-12-0567; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; Fuenzalida M, 2007, J NEUROSCI, V27, P11940, DOI 10.1523/JNEUROSCI.0900-07.2007; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Hartel K, 2007, CELL CALCIUM, V42, P271, DOI 10.1016/j.ceca.2006.12.004; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Heller EA, 2016, J NEUROSCI, V36, P4690, DOI 10.1523/JNEUROSCI.0013-16.2016; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huisman C, 2013, MOL ONCOL, V7, P669, DOI 10.1016/j.molonc.2013.02.017; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046340; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kanasty RL, 2012, MOL THER, V20, P513, DOI 10.1038/mt.2011.294; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kungulovski G, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0002-z; Laganiere J, 2010, J NEUROSCI, V30, P16469, DOI 10.1523/JNEUROSCI.2440-10.2010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; Savioz A, 2014, AGEING RES REV, V18, P86, DOI 10.1016/j.arr.2014.09.004; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Serrano FG, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-61; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; van Zundert B, 2008, J NEUROSCI, V28, P10864, DOI 10.1523/JNEUROSCI.1340-08.2008; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Voigt P, 2013, NAT BIOTECHNOL, V31, P1097, DOI 10.1038/nbt.2756; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Zhang JP, 2014, J NEUROGENET, V28, P98, DOI 10.3109/01677063.2014.892486; Zhang LF, 2003, GENOMICS, V82, P660, DOI 10.1016/S0888-7543(03)00211-8	73	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2017	140		12				3252	3268		10.1093/brain/awx272				17	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FP0ZB	WOS:000417337600025	29155979				2018-01-05	
J	Yu, J; Chen, L; Chen, Y; Hasan, MK; Ghia, EM; Zhang, L; Wu, R; Rassenti, LZ; Widhopf, GF; Shen, Z; Briggs, SP; Kipps, TJ				Yu, J.; Chen, L.; Chen, Y.; Hasan, M. K.; Ghia, E. M.; Zhang, L.; Wu, R.; Rassenti, L. Z.; Widhopf, G. F.; Shen, Z.; Briggs, S. P.; Kipps, T. J.			Wnt5a induces ROR1 to associate with 14-3-3 zeta for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells	LEUKEMIA			English	Article							SURFACE EXPRESSION; PROTEINS; BINDING; CANCER; PHOSPHORYLATION; RECOGNITION; SPECIFICITY	Wnt5a can activate Rho GTPases in chronic lymphocytic leukemia (CLL) cells by inducing the recruitment of ARHGEF2 to ROR1. Mass spectrometry on immune precipitates of Wnt5a-activated ROR1 identified 14-3-3 zeta, which was confirmed by co-immunoprecipitation. The capacity of Wnt5a to induce ROR1 to complex with 14-3-3 zeta could be blocked in CLL cells by treatment with cirmtuzumab, a humanized mAb targeting ROR1. Silencing 14-3-3 zeta via small interfering RNA impaired the capacity of Wnt5a to: (1) induce recruitment of ARHGEF2 to ROR1, (2) enhance in vitro exchange activity of ARHGEF2 and (3) induce activation of RhoA and Rac1 in CLL cells. Furthermore, CRISPR/Cas9 deletion of 14-3-3 zeta in ROR1-negative CLL cell-line MEC1, and in MEC1 cells transfected to express ROR1 (MEC1-ROR1), demonstrated that 14-3-3 zeta was necessary for the growth/engraftment advantage of MEC1-ROR1 over MEC1 cells. We identified a binding motif (RSPS(857)SAS) in ROR1 for 14-3-3 zeta. Site-directed mutagenesis of ROR1 demonstrated that serine-857 was required for the recruitment of 14-3-3. and ARHGEF2 to ROR1, and activation of RhoA and Rac1. Collectively, this study reveals that 14-3-3 zeta plays a critical role in Wnt5a/ROR1 signaling, leading to enhanced CLL migration and proliferation.	[Yu, J.; Chen, L.; Chen, Y.; Hasan, M. K.; Ghia, E. M.; Zhang, L.; Wu, R.; Rassenti, L. Z.; Widhopf, G. F.; Kipps, T. J.] Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr,Room 4307, La Jolla, CA 92093 USA; [Shen, Z.; Briggs, S. P.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Kipps, TJ (reprint author), Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr,Room 4307, La Jolla, CA 92093 USA.	tkipps@ucsd.edu			California Institute for Regenerative Medicine (CIRM) grant [DR3-06924]; UC San Diego Foundation Blood Cancer Research Fund (BCRF); SPORE grant from the Leukemia and Lymphoma Society [7005-14]; PO1 grant from the NIH [5P01CA081534-14]	We thank Dr Kersi Pestonjamasp for fluorescence confocal microscopy analysis and University of California-San Diego Moores Cancer Center Microscopy Core Facility for technical help. We thank California Institute for Regenerative Medicine (CIRM) grant (DR3-06924) for supporting us to generate anti-ROR1 mAb, cirmtuzumab. This work was supported by the UC San Diego Foundation Blood Cancer Research Fund (BCRF), a SPORE grant (7005-14) from the Leukemia and Lymphoma Society, and a PO1 grant (5P01CA081534-14) from the NIH for the CLL Research Consortium.	Bialkowska K, 2003, J BIOL CHEM, V278, P33342, DOI 10.1074/jbc.M301217200; Choi MY, 2015, CL LYMPH MYELOM LEUK, V15, pS167, DOI 10.1016/j.clml.2015.02.010; Choudhury A, 2010, BRIT J HAEMATOL, V151, P327, DOI 10.1111/j.1365-2141.2010.08362.x; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Cui B, 2016, BLOOD, V128, P2931, DOI [10.1182/blood-2016-04712562, 10.1182/blood-2016-04-712562]; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617                                               ; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258                                                         ; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hofbauer SW, 2014, BLOOD, V123, P2181, DOI 10.1182/blood-2013-08-523563; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078339; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kent OA, 2017, ONCOTARGET, V8, P4484, DOI 10.18632/oncotarget.13152; Kipps Thomas J, 2017, Nat Rev Dis Primers, V3, P17008, DOI 10.1038/nrdp.2017.8; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979                                                         ; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Widhopf GF, 2014, P NATL ACAD SCI USA, V111, P793, DOI 10.1073/pnas.1308374111; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yu J, 2016, J CLIN INVEST, V126, P585, DOI 10.1172/JCI83535; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029554; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024	30	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2017	31	12					2608	2614		10.1038/leu.2017.132				7	Oncology; Hematology	Oncology; Hematology	FO8ZJ	WOS:000417177100009	28465528				2018-01-05	
J	Ohguchi, H; Harada, T; Sagawa, M; Kikuchi, S; Tai, YT; Richardson, PG; Hideshima, T; Anderson, KC				Ohguchi, H.; Harada, T.; Sagawa, M.; Kikuchi, S.; Tai, Y-T; Richardson, P. G.; Hideshima, T.; Anderson, K. C.			KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival	LEUKEMIA			English	Article							NF-KAPPA-B; DEMETHYLASE JMJD3 CONTRIBUTES; LARGE GENE LISTS; H3K27 DEMETHYLASE; EXPRESSION; DEGRADATION; PROGRESSION; INHIBITION; INK4A/ARF; THERAPY	Recent studies have delineated cancer-type-specific roles of histone 3 lysine 27 ( H3K27) demethylase KDM6B/JMJD3 depending on its H3K27 demethylase activity. Here we show that KDM6B is expressed in multiple myeloma ( MM) cells; and that shRNA-mediated knockdown and CRISPR-mediated knockout of KDM6B abrogate MM cell growth and survival. Tumor necrosis factor-a or bone marrow stromal cell culture supernatants induce KDM6B, which is blocked by IKK beta inhibitor MLN120B, suggesting that KDM6B is regulated by NF-kappa B signaling in MM cells. RNA-seq and subsequent ChIP-qPCR analyses reveal that KDM6B is recruited to the loci of genes encoding components of MAPK signaling pathway including ELK1 and FOS, and upregulates expression of these genes without affecting H3K27 methylation level. Overexpression of catalytically inactive KDM6B activates expression of MAPK pathway-related genes, confirming its function independent of demethylase activity. We further demonstrate that downstream targets of KDM6B, ELK1 and FOS, confer MM cell growth. Our study therefore delineates KDM6B function that links NF-kappa B and MAPK signaling pathway mediating MM cell growth and survival, and validates KDM6B as a novel therapeutic target in MM.	[Ohguchi, H.; Harada, T.; Sagawa, M.; Kikuchi, S.; Tai, Y-T; Richardson, P. G.; Hideshima, T.; Anderson, K. C.] Harvard Med Sch, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr, Dept Med Oncol, Boston, MA USA	Anderson, KC (reprint author), Dana Farber Canc Inst, Dept Med Oncol, Mayer 557,450 Brookline Ave, Boston, MA 02215 USA.	kenneth_anderson@dfci.harvard.edu			NIH [SPORE P50-CA100707, P01-CA078378, R01-CA050947, R01-CA178264]	We thank Dr John Quackenbush and members of the Center for Cancer Computational Biology, Dana-Farber Cancer Institute for assistance with RNA-seq analysis. This research was supported by NIH grants SPORE P50-CA100707 (KCA), P01-CA078378 (KCA), R01-CA050947 (KCA) and R01-CA178264 (T Hideshima and KCA). KCA is an American Cancer Society Clinical Research Professor.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/nchembio.1858, 10.1038/NCHEMBIO.1858]; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Manier S, 2017, NAT REV CLIN ONCOL, V14, P100, DOI 10.1038/nrclinonc.2016.122; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ohguchi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10258; Park WY, 2016, CANCER RES, V76, P161, DOI 10.1158/0008-5472.CAN-15-0536; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shah N, 2004, BLOOD, V104, P2873, DOI 10.1182/blood-2003-10-3720; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Walker BA, 2015, J CLIN ONCOL, V33, P3911, DOI 10.1200/JCO.2014.59.1503; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhang Y, 2016, ONCOTARGET, V7, P29387, DOI 10.18632/oncotarget.8836; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006	34	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2017	31	12					2661	2669		10.1038/leu.2017.141				9	Oncology; Hematology	Oncology; Hematology	FO8ZJ	WOS:000417177100015	28487543				2018-01-05	
J	Rossetti, C; Picardi, E; Ye, M; Camilli, G; D'Erchia, AM; Cucina, L; Locatelli, F; Fianchi, L; Teofili, L; Pesole, G; Gallo, A; Sorrentino, R				Rossetti, C.; Picardi, E.; Ye, M.; Camilli, G.; D'Erchia, A. M.; Cucina, L.; Locatelli, F.; Fianchi, L.; Teofili, L.; Pesole, G.; Gallo, A.; Sorrentino, R.			RNA editing signature during myeloid leukemia cell differentiation	LEUKEMIA			English	Article							ERYTHEMATOSUS T-LYMPHOCYTES; HEPATOCELLULAR-CARCINOMA; ADENOSINE-DEAMINASE; GENE TRANSCRIPTS; HUMAN-DISEASE; ADAR1; EXPRESSION; ERYTHROPOIESIS; INTERFERON; DIVERSITY	Adenosine deaminases acting on RNA (ADARs) are key proteins for hematopoietic stem cell self-renewal and for survival of differentiating progenitor cells. However, their specific role in myeloid cell maturation has been poorly investigated. Here we show that ADAR1 is present at basal level in the primary myeloid leukemia cells obtained from patients at diagnosis as well as in myeloid U-937 and THP1 cell lines and its expression correlates with the editing levels. Upon phorbol-myristate acetate or Vitamin D3/granulocyte macrophage colony-stimulating factor (GM-CSF)-driven differentiation, both ADAR1 and ADAR2 enzymes are upregulated, with a concomitant global increase of A-to-I RNA editing. ADAR1 silencing caused an editing decrease at specific ADAR1 target genes, without, however, interfering with cell differentiation or with ADAR2 activity. Remarkably, ADAR2 is absent in the undifferentiated cell stage, due to its elimination through the ubiquitin-proteasome pathway, being strongly upregulated at the end of the differentiation process. Of note, peripheral blood monocytes display editing events at the selected targets similar to those found in differentiated cell lines. Taken together, the data indicate that ADAR enzymes play important and distinct roles in myeloid cells.	[Rossetti, C.; Ye, M.; Camilli, G.; Sorrentino, R.] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Via Sardi 70, Rome, Italy; [Picardi, E.; D'Erchia, A. M.; Pesole, G.] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Picardi, E.; D'Erchia, A. M.; Pesole, G.] CNR, Inst Biomembranes Bioenerget & Mol Biotechnol, Bari, Italy; [Cucina, L.; Locatelli, F.; Gallo, A.] Bambino Gesu Childrens Hosp IRCCS, Dept Pediat Oncohaematol, Rome, Italy; [Locatelli, F.] Univ Pavia, Dept Pediat Sci, Pavia, Italy; [Fianchi, L.; Teofili, L.] Catholic Univ, Inst Hematol, Rome, Italy	Sorrentino, R (reprint author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Via Sardi 70, Rome, Italy.	rosa.sorrentino@uniroma1.it			Ministero della Universita e Ricerca Scientifica (PRIN) by Associazione Italiana Ricerca sul Cancro (AIRC) [2012NA9E9Y_0029]; Flagship InterOmics project	This work was supported by Ministero della Universita e Ricerca Scientifica (PRIN: 2012NA9E9Y_0029) by Associazione Italiana Ricerca sul Cancro (AIRC to AG) and by the Flagship InterOmics project. Publication costs for open access have been funded by the Flagship InterOmics project.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Baek YS, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-18; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Camilli G, 2016, J LEUKOCYTE BIOL, V99, P121, DOI 10.1189/jlb.1A0415-172R; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; D'Antonio M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S6-S3; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dawson TR, 2004, J BIOL CHEM, V279, P4941, DOI 10.1074/jbc.M310068200; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371                                                               ; Gallo A, 2013, NAT MED, V19, P130, DOI 10.1038/nm.3072; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Higuchi M, 2000, NATURE, V406, P78; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Laxminarayana D, 2007, IMMUNOLOGY, V121, P359, DOI 10.1111/j.1365-2567.2007.02582.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Y, 2013, INT J BIOCHEM CELL B, V45, P1843, DOI 10.1016/j.biocel.2013.05.033; Liddicoat BJ, 2016, EXP HEMATOL, V44, P947, DOI 10.1016/j.exphem.2016.06.250; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Orlowski RJ, 2008, IMMUNOLOGY, V125, P408, DOI 10.1111/j.1365-2567.2008.02850.x; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Picardi E, 2016, NUCLEIC ACIDS RES, V45, pD750; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Shifera AS, 2009, ARCH BIOCHEM BIOPHYS, V490, P145, DOI 10.1016/j.abb.2009.08.013; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Steinman RA, 1998, BLOOD, V91, P4531; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Thomas JM, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600187; Tomaselli S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0575-z; Tomaselli S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-255; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915; XuFeng R, 2009, P NATL ACAD SCI USA, V106, P17763, DOI 10.1073/pnas.0903324106; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	49	3	3	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2017	31	12					2824	2832		10.1038/leu.2017.134				9	Oncology; Hematology	Oncology; Hematology	FO8ZJ	WOS:000417177100034	28484266				2018-01-05	
J	Mateos-Gomez, PA; Kent, T; Deng, SK; McDevitt, S; Kashkina, E; Hoang, TM; Pomerantz, RT; Sfeir, A				Mateos-Gomez, Pedro A.; Kent, Tatiana; Deng, Sarah K.; McDevitt, Shane; Kashkina, Ekaterina; Hoang, Trung M.; Pomerantz, Richard T.; Sfeir, Agnel			The helicase domain of Pol theta counteracts RPA to promote alt-NHEJ	NATURE STRUCTURAL & MOLECULAR BIOLOGY			English	Article							DNA-POLYMERASE-THETA; DOUBLE-STRAND BREAKS; HOMOLOGOUS-RECOMBINATION; END-RESECTION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; MEDIATED REPAIR; GENES; REPLICATION; MECHANISM	Mammalian polymerase theta (Pol theta) is a multifunctional enzyme that promotes error-prone DNA repair by alternative nonhomologous end joining (alt-NHEJ). Here we present structure-function analyses that reveal that, in addition to the polymerase domain, Pol theta-helicase activity plays a central role during double-strand break (DSB) repair. Our results show that the helicase domain promotes chromosomal translocations by alt-NHEJ in mouse embryonic stem cells and also suppresses CRISPR-Cas9-mediated gene targeting by homologous recombination (HR). In vitro assays demonstrate that Pol theta-helicase activity facilitates the removal of RPA from resected DSBs to allow their annealing and subsequent joining by alt-NHEJ. Consistent with an antagonistic role for RPA during alt-NHEJ, inhibition of RPA1 enhances end joining and suppresses recombination. Taken together, our results reveal that the balance between HR and alt-NHEJ is controlled by opposing activities of Pol theta and RPA, providing further insight into the regulation of repair-pathway choice in mammalian cells.	[Mateos-Gomez, Pedro A.; Deng, Sarah K.; Sfeir, Agnel] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA; [Mateos-Gomez, Pedro A.; Deng, Sarah K.; Sfeir, Agnel] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Kent, Tatiana; McDevitt, Shane; Kashkina, Ekaterina; Hoang, Trung M.; Pomerantz, Richard T.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Sfeir, A (reprint author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA.; Sfeir, A (reprint author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	agnel.sfeir@med.nyu.edu			Pershing Square Sohn cancer research alliance; Vfoundation; Pew-Stewart scholars award; National Institutes of Health [1R01GM115472-01]; Department of Defense [BC134020]; Leukemia & Lymphoma Society	We thank R. Greenberg (University of Pennsylvania) and T. de Lange (The Rockefeller University) for providing key reagents. We are grateful to A. Pinzaru and R. Barry for providing comments on the manuscript. This work was supported by grants from Pershing Square Sohn cancer research alliance (A. S.), the Vfoundation (A. S.), Pew-Stewart scholars award (A. S.), and the National Institutes of Health award 1R01GM115472-01 (R. T. P.). P. A. M.-G. is supported by a fellowship from the Department of Defense (BC134020). S. K. D. is supported by an award from The Leukemia & Lymphoma Society.	Adelman CA, 2013, NATURE, V502, P381, DOI 10.1038/nature12565; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Audry J, 2015, EMBO J, V34, P1942, DOI 10.15252/embj.201490773; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Beagan K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006813; Black SJ, 2016, GENES, V7, pE67; Bothmer A., 2017, LOCUS, V8, P13905; Boulton SJ, 1996, EMBO J, V15, P5093; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; de Rugy TG, 2016, BIOL OPEN, V5, P1485, DOI 10.1242/bio.018028; Decottignies A, 2007, GENETICS, V176, P1403, DOI 10.1534/genetics.107.071621; Deng SK, 2014, NAT STRUCT MOL BIOL, V21, P405, DOI 10.1038/nsmb.2786; Doksani Y, 2016, CELL REP, V17, P1646, DOI 10.1016/j.celrep.2016.10.008; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Harris PV, 1996, MOL CELL BIOL, V16, P5764; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Hogg M, 2012, NUCLEIC ACIDS RES, V40, P2611, DOI 10.1093/nar/gkr1102; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Kent T, 2016, NUCLEIC ACIDS RES, V44, P9381, DOI 10.1093/nar/gkw721; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Newman JA, 2015, STRUCTURE, V23, P2319, DOI 10.1016/j.str.2015.10.014; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Prasad R, 2009, NUCLEIC ACIDS RES, V37, P1868, DOI 10.1093/nar/gkp035; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Saito S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16112; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Shima N, 2004, MOL CELL BIOL, V24, P10381, DOI 10.1128/MCB.24.23.10381-10389.2004; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thyme S. B., 2016, CELL REP; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; van Kregten M, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.164, 10.1038/NPLANTS.2016.164]; Villarreal DD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003026; Wood RD, 2016, DNA REPAIR, V44, P22, DOI 10.1016/j.dnarep.2016.05.003; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zahn KE, 2015, NAT STRUCT MOL BIOL, V22, P304, DOI 10.1038/nsmb.2993; Zelensky AN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00124-3	58	1	1	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1545-9993	1545-9985		NAT STRUCT MOL BIOL	Nat. Struct. Mol. Biol.	DEC	2017	24	12					1116	+		10.1038/nsmb.3494				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FP0IE	WOS:000417281800016	29058711				2018-01-05	
J	Kim, YK; Refaeli, I; Brooks, CR; Jing, PF; Gulieva, RE; Hughes, MR; Cruz, NM; Liu, YN; Churchill, AJ; Wang, YL; Fu, HX; Pippin, JW; Lin, LY; Shankland, SJ; Vogl, AW; McNagny, KM; Freedman, BS				Kim, Yong Kyun; Refaeli, Ido; Brooks, Craig R.; Jing, Peifeng; Gulieva, Ramila E.; Hughes, Michael R.; Cruz, Nelly M.; Liu, Yannan; Churchill, Angela J.; Wang, Yuliang; Fu, Hongxia; Pippin, Jeffrey W.; Lin, Lih Y.; Shankland, Stuart J.; Vogl, A. Wayne; McNagny, Kelly M.; Freedman, Benjamin S.			Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development	STEM CELLS			English	Article						Pluripotent stem cells; Kidney; Adhesion receptors; Differentiation; Gene targeting; Developmental biology; Focal segmental glomerulosclerosis; Nephrogenesis; Cell adhesion; Foot processes; Slit diaphragm; Podocalyxin; Nephrin; Podocin; Genome editing; Biophysics	PLURIPOTENT STEM-CELLS; INTERMEDIATE MESODERM; NEPHRON PROGENITORS; GLOMERULAR PROTEIN; ENDOTHELIAL-CELLS; PODOCALYXIN; EXPRESSION; TRANSPLANTATION; COMPLEX; MICE	A critical event during kidney organogenesis is the differentiation of podocytes, specialized epithelial cells that filter blood plasma to form urine. Podocytes derived from human pluripotent stem cells (hPSC-podocytes) have recently been generated in nephron-like kidney organoids, but the developmental stage of these cells and their capacity to reveal disease mechanisms remains unclear. Here, we show that hPSC-podocytes phenocopy mammalian podocytes at the capillary loop stage (CLS), recapitulating key features of ultrastructure, gene expression, and mutant phenotype. hPSC-podocytes in vitro progressively establish junction-rich basal membranes (nephrin(+)podocin(+)ZO-1(+)) and microvillus-rich apical membranes (podocalyxin(+)), similar to CLS podocytes in vivo. Ultrastructural, biophysical, and transcriptomic analysis of podocalyxin-knockout hPSCs and derived podocytes, generated using CRISPR/Cas9, reveals defects in the assembly of microvilli and lateral spaces between developing podocytes, resulting in failed junctional migration. These defects are phenocopied in CLS glomeruli of podocalyxin-deficient mice, which cannot produce urine, thereby demonstrating that podocalyxin has a conserved and essential role in mammalian podocyte maturation. Defining the maturity of hPSC-podocytes and their capacity to reveal and recapitulate pathophysiological mechanisms establishes a powerful framework for studying human kidney disease and regeneration. Stem Cells2017;35:2366-2378	[Kim, Yong Kyun; Gulieva, Ramila E.; Cruz, Nelly M.; Churchill, Angela J.; Pippin, Jeffrey W.; Shankland, Stuart J.; Freedman, Benjamin S.] Univ Washington, Sch Med, Div Nephrol, Seattle, WA 98195 USA; [Kim, Yong Kyun; Gulieva, Ramila E.; Cruz, Nelly M.; Churchill, Angela J.; Freedman, Benjamin S.] Univ Washington, Sch Med, Kidney Res Inst, Seattle, WA 98195 USA; [Kim, Yong Kyun; Gulieva, Ramila E.; Cruz, Nelly M.; Churchill, Angela J.; Wang, Yuliang; Fu, Hongxia; Freedman, Benjamin S.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kim, Yong Kyun; Gulieva, Ramila E.; Cruz, Nelly M.; Churchill, Angela J.; Fu, Hongxia; Pippin, Jeffrey W.; Shankland, Stuart J.; Freedman, Benjamin S.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Fu, Hongxia] Univ Washington, Sch Med, Div Hematol, Dept Med, Seattle, WA 98195 USA; [Fu, Hongxia] Univ Washington, Sch Med, Dept Bioengn, Seattle, WA 98195 USA; [Refaeli, Ido; Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Refaeli, Ido; Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Brooks, Craig R.] Vanderbilt Univ, Sch Med, Div Nephrol, Nashville, TN 37212 USA; [Jing, Peifeng; Liu, Yannan; Lin, Lih Y.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Wang, Yuliang] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA USA	McNagny, KM (reprint author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada.; Freedman, BS (reprint author), Univ Washington, Div Nephrol, Dept Med, Sch Med, 850 Republican St,Box 358056, Seattle, WA 98109 USA.	kelly@brc.ubc.ca; benof@uw.edu			NIH National Institute of Diabetes and Digestive and Kidney Diseases [K01DK102826, R01DK097598, UH2DK107343]; National Heart, Lung, and Blood Institute [K25HL135432]; National Institute of General Medical Sciences [P01GM081619]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R24HD000836]; National Kidney Foundation Young Investigator Grant; American Society of Nephrology Carl W. Gottschalk Research Scholar Award; Natural Sciences and Engineering Research Council of Canada [RGPIN-155397-13]; Directorate for Biological Sciences, National Science Foundation [IDBR DBI-1353718]	We thank Ed Parker (University of Washington [UW]) for TEM, Ryan Vander werff (University of British Columbia) for transcriptomics, Ryuichi Nishinakamura (Kumamoto University) for NPHS1-GFP cells, and Jonathan Himmelfarb (UW) and Jennifer Harder (University of Michigan) for discussions. This work was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases K01DK102826 (to B.S.F.); R01DK097598 and UH2DK107343 (to S.J.S.); National Heart, Lung, and Blood Institute K25HL135432 (to H.F.); National Institute of General Medical Sciences P01GM081619 (to Y.W.); Eunice Kennedy Shriver National Institute of Child Health and Human Development R24HD000836 (to Laboratory of Developmental Biology); National Kidney Foundation Young Investigator Grant (to B.S.F.); American Society of Nephrology Carl W. Gottschalk Research Scholar Award (to B.S.F.); Natural Sciences and Engineering Research Council of Canada (RGPIN-155397-13) (to A.W.V.); Directorate for Biological Sciences, National Science Foundation (IDBR DBI-1353718) (to L.Y.L.); and an unrestricted gift from the Northwest Kidney Centers to the Kidney Research Institute.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Barua M, 2014, KIDNEY INT, V85, P124, DOI 10.1038/ki.2013.354; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Boute N, 2000, NAT GENET, V24, P349; Brown AC, 2015, DEV CELL, V34, P229, DOI 10.1016/j.devcel.2015.06.021; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Chuang JZ, 2010, MOL BIOL CELL, V21, P3017, DOI 10.1091/mbc.E09-10-0907; Debruin EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108881; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13                                                            ; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Guo G, 2004, J AM SOC NEPHROL, V15, P2851, DOI 10.1097/01.ASN.0000143474.91362.C4; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Horrillo A, 2016, EUR J CELL BIOL, V95, P265, DOI 10.1016/j.ejcb.2016.04.006; Jing PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19924; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; KERJASCHKI D, 1985, AM J PATHOL, V118, P343; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim YG, 1999, KIDNEY INT, V55, P2349, DOI 10.1046/j.1523-1755.1999.00504.x; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; REEVES W, 1978, LAB INVEST, V39, P90; Reiser J, 2000, J AM SOC NEPHROL, V11, P1; Rogers SA, 1998, KIDNEY INT, V54, P27, DOI 10.1046/j.1523-1755.1998.00971.x                                                ; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; RYAN G, 1995, DEVELOPMENT, V121, P867; Saleem MA, 2002, J AM SOC NEPHROL, V13; Sharmin S, 2016, J AM SOC NEPHROL, V27, P1778, DOI 10.1681/ASN.2015010096; Snyder KA, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0562-7; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219                                                           ; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Wegner B, 2010, AM J PHYSIOL-RENAL, V298, pF1492, DOI 10.1152/ajprenal.00030.2010; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505	44	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	DEC	2017	35	12					2366	2378		10.1002/stem.2707				13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	FO9YQ	WOS:000417255100005	28905451				2018-01-05	
J	Gettinger, S; Choi, JM; Hastings, K; Truini, A; Datar, I; Sowell, R; Wurtz, A; Dong, WL; Cai, GP; Melnick, MA; Du, VY; Schlessinger, J; Goldberg, SB; Chiang, AN; Sanmamed, MF; Melero, I; Agorreta, J; Montuenga, LM; Lifton, R; Ferrone, S; Kavathas, P; Rimm, DL; Kaech, SM; Schalper, K; Herbst, RS; Politi, K				Gettinger, Scott; Choi, Jungmin; Hastings, Katherine; Truini, Anna; Datar, Ila; Sowell, Ryan; Wurtz, Anna; Dong, Weilai; Cai, Guoping; Melnick, Mary Ann; Du, Victor Y.; Schlessinger, Joseph; Goldberg, Sarah B.; Chiang, Anne; Sanmamed, Miguel F.; Melero, Ignacio; Agorreta, Jackeline; Montuenga, Luis M.; Lifton, Richard; Ferrone, Soldano; Kavathas, Paula; Rimm, David L.; Kaech, Susan M.; Schalper, Kurt; Herbst, Roy S.; Politi, Katerina			Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer	CANCER DISCOVERY			English	Article							PD-1 BLOCKADE; METASTATIC MELANOMA; 1ST-LINE TREATMENT; ANTITUMOR-ACTIVITY; CTLA-4 BLOCKADE; MALIGNANT-CELLS; OPEN-LABEL; NIVOLUMAB; IMMUNOTHERAPY; MUTATIONS	Mechanisms of acquired resistance to immune checkpoint inhibitors (ICI) are poorly understood. We leveraged a collection of 14 ICI-resistant lung cancer samples to investigate whether alterations in genes encoding HLA Class I antigen processing and presentation machinery (APM) components or interferon signaling play a role in acquired resistance to PD-1 or PD-L1 antagonistic antibodies. Recurrent mutations or copy-number changes were not detected in our cohort. In one case, we found acquired homozygous loss of B2M that caused lack of cell-surface HLA Class I expression in the tumor and a matched patient-derived xenograft (PDX). Downregulation of B2M was also found in two additional PDXs established from ICI-resistant tumors. CRISPR-mediated knockout of B2m in an immunocompetent lung cancer mouse model conferred resistance to PD-1 blockade in vivo, proving its role in resistance to ICIs. These results indicate that HLA Class I APM disruption can mediate escape from ICIs in lung cancer. SIGNIFICANCE: As programmed death 1 axis inhibitors are becoming more established in standard treatment algorithms for diverse malignancies, acquired resistance to these therapies is increasingly being encountered. Here, we found that defective antigen processing and presentation can serve as a mechanism of such resistance in lung cancer. (C) 2017 AACR.	[Gettinger, Scott; Wurtz, Anna; Goldberg, Sarah B.; Chiang, Anne; Schalper, Kurt; Herbst, Roy S.; Politi, Katerina] Yale Univ, Sch Med, Dept Med, Sect Med Oncol, New Haven, CT 06510 USA; [Gettinger, Scott; Hastings, Katherine; Truini, Anna; Wurtz, Anna; Melnick, Mary Ann; Schlessinger, Joseph; Goldberg, Sarah B.; Chiang, Anne; Kavathas, Paula; Rimm, David L.; Kaech, Susan M.; Schalper, Kurt; Herbst, Roy S.; Politi, Katerina] Yale Univ, Sch Med, Yale Canc Ctr, 333 Cedar St, New Haven, CT USA; [Choi, Jungmin; Dong, Weilai; Lifton, Richard] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Datar, Ila; Cai, Guoping; Rimm, David L.; Schalper, Kurt; Politi, Katerina] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Sowell, Ryan; Du, Victor Y.; Sanmamed, Miguel F.; Kavathas, Paula; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT USA; [Schlessinger, Joseph; Herbst, Roy S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Melero, Ignacio; Agorreta, Jackeline; Montuenga, Luis M.] CIMA, Pamplona, Spain; [Melero, Ignacio; Agorreta, Jackeline; Montuenga, Luis M.] Clin Univ Navarra, Pamplona, Spain; [Melero, Ignacio; Agorreta, Jackeline; Montuenga, Luis M.] Ctr Invest Biomed Red Oncol CIBERONC, Madrid, Spain; [Ferrone, Soldano] Massachusetts Gen Hosp, Dept Surg, Harvard Med Sch, Boston, MA 02114 USA; [Kavathas, Paula] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Lifton, Richard] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Gettinger, S (reprint author), Yale Univ, Sch Med, Dept Med, Sect Med Oncol, New Haven, CT 06510 USA.; Politi, K (reprint author), Yale Univ, Sch Med, 333 Cedar St,SHM 234D, New Haven, CT 06510 USA.	scott.gettinger@yale.edu; katerina.politi@yale.edu			NIH/NCI: the Yale SPORE in Lung Cancer [P50CA196530, R01CA195720, F32CA210516]; Stand Up To Cancer Lung Dream grant, Department of Defense Lung Cancer Research Program Career Development Award [LC150383]; Lung Cancer Research Foundation; Italian Association for Cancer Research (AIRC); Leslie H. Warner Fellowship; Diane and David Heller Foundation; Beatrice Klienberg Neuwirth Research Program; Melissa Marottoli Hogan Foundation; NIH/NCI Cancer Center Support Grant [P30 CA016359]	This work was supported by the following NIH/NCI grants: the Yale SPORE in Lung Cancer (P50CA196530) to R.S. Herbst, R01CA195720 to K. Politi and S.M. Kaech, and F32CA210516 to K. Hastings. Additional support came from a Stand Up To Cancer Lung Dream grant, Department of Defense Lung Cancer Research Program Career Development Award #LC150383 to K. Schalper, a Lung Cancer Research Foundation grant to K. Schalper, a fellowship from the Italian Association for Cancer Research (AIRC) to A. Truini, the Leslie H. Warner Fellowship to K. Hastings, The Diane and David Heller Foundation, The Beatrice Klienberg Neuwirth Research Program, and the Melissa Marottoli Hogan Foundation. Yale Cancer Center Shared Resources used in this article were in part supported by NIH/NCI Cancer Center Support Grant P30 CA016359.	Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antonia S, 2016, LANCET ONCOL, V17, P299, DOI 10.1016/S1470-2045(15)00544-6; Azpilikueta A, 2016, J THORAC ONCOL, V11, P524, DOI 10.1016/j.jtho.2016.01.013; Barlesi F, 2016, ANN ONCOL, V27; Benitez R, 1998, TISSUE ANTIGENS, V52, P520, DOI 10.1111/j.1399-0039.1998.tb03082.x                                              ; Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P1359, DOI 10.1007/s00262-012-1321-6; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2017, AACR ANN M; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Cai YY, 2016, CANCER CELL, V29, P751, DOI 10.1016/j.ccell.2016.04.003; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Carlson JM, 2016, NAT MED, V22, P606, DOI 10.1038/nm.4100; Chang CC, 2005, ADV CANCER RES, V93, P189, DOI 10.1016/S0065-230X(05)93006-6                                                   ; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; del Campo AB, 2014, INT J CANCER, V134, P102, DOI 10.1002/ijc.28338; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027                                                          ; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Paschen A, 2006, CLIN CANCER RES, V12, P3297, DOI 10.1158/1078-0432.CCR-05-2174; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Pereira C, 2017, CLIN CANCER RES, V23, P3203, DOI 10.1158/1078-0432.CCR-16-1946; Reck M, 2016, NEW ENGL J MED, DOI [10.1056/NEJ-Moa1606774, DOI 10.1056/NEJ-M0A1606774]; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sucker A, 2014, CLIN CANCER RES, V20, P6593, DOI 10.1158/1078-0432.CCR-14-0567; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; ZATLOUKAL P, 2009, J CLIN ONCOL S, V27; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	51	0	0	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2159-8274	2159-8290		CANCER DISCOV	Cancer Discov.	DEC	2017	7	12					1420	1435		10.1158/2159-8290.CD-17-0593				16	Oncology	Oncology	FO7QH	WOS:000417070700024	29025772				2018-01-05	
J	Li, SM; Nishikawa, T; Kaneda, Y				Li, Simin; Nishikawa, Tomoyuki; Kaneda, Yasufumi			Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells	CANCER SCIENCE			English	Article						Breast cancer; HVJ-E; ICAM-1; NK; Sendai virus	NF-KAPPA-B; T-CELLS; ANTITUMOR IMMUNITY; BREAST-CANCER; NK CELLS; RIG-I; ICAM-1; MELANOMA; ACTIVATION; INFECTION	We have already reported that the inactivated Sendai virus (hemagglutinating virus of Japan; HVJ) envelope (HVJ-E) has multiple anticancer effects, including induction of cancer-selective cell death and activation of anticancer immunity. The HVJ-E stimulates dendritic cells to produce cytokines and chemokines such as -interferon, interleukin-6, chemokine (C-C motif) ligand 5, and chemokine (C-X-C motif) ligand 10, which activate both CD8(+) T cells and natural killer (NK) cells and recruit them to the tumor microenvironment. However, the effect of HVJ-E on modulating the sensitivity of cancer cells to immune cell attack has yet to be investigated. In this study, we found that HVJ-E induced the production of intercellular adhesion molecule-1 (ICAM-1, CD54), a ligand of lymphocyte function-associated antigen 1, in several cancer cell lines through the activation of nuclear factor-B downstream of retinoic acid-inducible gene I and the mitochondrial antiviral signaling pathway. The upregulation of ICAM-1 on the surface of cancer cells increased the sensitivity of cancer cells to NK cells. Knocking out expression of ICAM-1 in MDA-MB-231 cells using the CRISPR/Cas9 method significantly reduced the killing effect of NK cells on ICAM-1-depleted MDA-MB-231 cells. In addition, HVJ-E suppressed tumor growth in MDA-MB-231 tumor-bearing SCID mice, and the HVJ-E antitumor effect was impaired when NK cells were depleted by treatment with the anti-asialo GM1 antibody. Our findings suggest that HVJ-E enhances NK cell sensitivity against cancer cells by increasing ICAM-1 expression on the cancer cell surface.	[Li, Simin; Nishikawa, Tomoyuki; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan	Kaneda, Y (reprint author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	kaneday@gts.med.osaka-u.ac.jp			Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [10-03]; Japan Society for the Promotion of Science	Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (Project ID: 10-03) and Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science.	Amrani Y, 2000, MOL PHARMACOL, V58, P237; 배종면, 2016, [Journal of Preventive Medicine and Public Health, 예방의학회지], V49, P367; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653                                                     ; BASSI V, 1995, J CLIN ENDOCR METAB, V80, P1129, DOI 10.1210/jc.80.4.1129; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259                                                   ; CHADWICK BS, 1992, J IMMUNOL, V149, P3150; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI [10.1016/j.viro1.2012.09.038, 10.1016/j.virol.2012.09.038]; Fujihara A, 2008, CANCER IMMUNOL IMMUN, V57, P73, DOI 10.1007/s00262-007-0351-y; GOTOH B, 1990, EMBO J, V9, P4189; Guo P, 2014, P NATL ACAD SCI USA, V111, P14710, DOI 10.1073/pnas.1408556111; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Janeway C., 2001, IMMUNOBIOLOGY; Jenkinson SR, 2005, J IMMUNOL, V174, P3401, DOI 10.4049/jimmunol.174.6.3401                                                     ; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jiang Y, 2016, ONCOTARGET, V7, P36034, DOI 10.18632/oncotarget.9105; KAISERLIAN D, 1991, EUR J IMMUNOL, V21, P2415, DOI 10.1002/eji.1830211018; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Kawaguchi Y, 2009, INT J CANCER, V124, P2478, DOI 10.1002/ijc.24234; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kikuchi T, 1999, CANCER LETT, V142, P201, DOI 10.1016/S0304-3835(99)00169-X                                                   ; Kurooka M, 2007, CANCER RES, V67, P227, DOI 10.1158/0008-5472.CAN-06-1615; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Matsukura Satoshi, 1996, Allergology International, V45, P97, DOI 10.2332/allergolint.45.97; Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MULLIGAN MS, 1993, AM J PATHOL, V142, P1739; Nishikawa T, 2014, MOL THER, V22, P2046, DOI [10.7038/mt.2014.128, 10.1038/mt.2014.128]; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707                                                         ; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876; Romagne F, 2009, BLOOD, V114, P2667, DOI 10.1182/blood-2009-02-206532; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sakaguchi T, 2008, P JPN ACAD B-PHYS, V84, P439, DOI 10.2183/pjab/84.439; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671                                                      ; Takehara Y, 2013, CLIN IMMUNOL, V149, P1, DOI 10.1016/j.clim.2013.05.019; Takimoto T, 2002, J VIROL, V76, P13028, DOI 10.1128/JVI.76.24.13028-13033.2002; Tanaka M, 2010, INT J CANCER, V126, P1982, DOI 10.1002/ijc.24965; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vankayalapati R, 2004, J IMMUNOL, V172, P130, DOI 10.4049/jimmunol.172.1.130                                                      ; Wu LY, 2011, CELL MOL IMMUNOL, V8, P433, DOI 10.1038/cmi.2011.20; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yang M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.144	50	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1349-7006			CANCER SCI	Cancer Sci.	DEC	2017	108	12					2333	2341		10.1111/cas.13408				9	Oncology	Oncology	FO7TL	WOS:000417079600003	28945328				2018-01-05	
J	Medwig, TN; Matus, DQ				Medwig, Taylor N.; Matus, David Q.			Breaking down barriers: the evolution of cell invasion	CURRENT OPINION IN GENETICS & DEVELOPMENT			English	Review							PLANE ILLUMINATION MICROSCOPY; MATERNAL-FETAL INTERFACE; SEA-URCHIN EMBRYO; BASEMENT-MEMBRANE; IN-VIVO; ANCHOR-CELL; MESENCHYMAL TRANSITION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DISC EVERSION	Cell invasion is a specialized cell behavior that likely co-evolved with the emergence of basement membranes in metazoans as a mechanism to break down the barriers that separate tissues. A variety of conserved and lineage-specific biological processes that occur during development and homeostasis rely on cell invasive behavior. Recent innovations in genome editing and live-cell imaging have shed some light on the programs that mediate acquisition of an invasive phenotype; however, comparative approaches among species are necessary to understand how this cell behavior evolved. Here, we discuss the contexts of cell invasion, highlighting both established and emerging model systems, and underscore gaps in our understanding of the evolution of this key cellular behavior.	[Medwig, Taylor N.; Matus, David Q.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Matus, DQ (reprint author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	david.matus@stonybrook.edu			NIH National Cancer Institute award [5R00CA154870-05]; National Institute of General Medical Sciences award [1R01GM121597-01]; Carol M. Baldwin Foundation; Damon Runyon Cancer Research Foundation [DRR-47-17]; NIH Office of Research Infrastructure Programs [P40 OD010440]	We apologize to the authors whose work could not be cited due to space limitations. We thank Abraham Kohrman and Ben Martin for helpful comments and Travis Hill for providing the illustrations used in Figure 1. We also thank Eric Haag, whose constructive feedback greatly improved the manuscript. This work was supported by NIH National Cancer Institute (5R00CA154870-05) and National Institute of General Medical Sciences (1R01GM121597-01) awards (to D.Q.M.), as well as by the Carol M. Baldwin Foundation. D.Q.M. is a Damon Runyon-Rachleff Innovator supported (in part) by the Damon Runyon Cancer Research Foundation (DRR-47-17). In addition, some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Aiello NM, 2016, DIS MODEL MECH, V9, P105, DOI 10.1242/dmm.023184; Rabadan MA, 2016, DEVELOPMENT, V143, P2194, DOI 10.1242/dev.134981; Carter AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0070; Chen HW, 2010, CELL RES, V20, P238, DOI 10.1038/cr.2010.7; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Dickinson AJG, 2006, DEV BIOL, V295, P700, DOI 10.1016/j.ydbio.2006.03.054; Dickinson AJG, 2009, DEVELOPMENT, V136, P1071, DOI 10.1242/dev.032912; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Dominguez F, 2005, FASEB J, V19, P1056, DOI 10.1096/fj.05-3781hyp; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; FESSLER LI, 1993, DEVELOPMENT, V117, P1061; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fu QY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11088; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Genbacev O, 2000, PLACENTA, V21, pS45, DOI 10.1053/plac.1999.0523; Genbacev O, 2000, AM J PATHOL, V157, P1337, DOI 10.1016/S0002-9440(10)64648-2                                                   ; Glentis A, 2014, CELL ADHES MIGR, V8, P236, DOI 10.4161/cam.28733; Hagedorn EJ, 2014, J CELL BIOL, V204, P1209, DOI 10.1083/jcb.201312098; Hagedorn EJ, 2013, J CELL BIOL, V201, P903, DOI 10.1083/jcb.201301091; Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; Harney AS, 2015, CANCER DISCOV, V5, P932, DOI 10.1158/2159-8290.CD-15-0012; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hilbrant M, 2016, ELIFE, V5, DOI 10.7554/eLife.13834; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Hiramatsu R, 2013, DEV CELL, V27, P131, DOI 10.1016/j.devcel.2013.09.026; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hynes RO, 2012, COLD SPRING HARB PER, V4, P4903, DOI DOI 10.1101/CSHPERSPECT.A004903; Ihara S, 2011, NAT CELL BIOL, V13, P641, DOI 10.1038/ncb2233; Jacox L, 2016, CELL REP, V16, P1445, DOI 10.1016/j.celrep.2016.06.073; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent LN, 2011, MOL CELL BIOL, V31, P4801, DOI 10.1128/MCB.05780-11; Kohrman AQ, 2017, TRENDS CELL BIOL, V27, P12, DOI 10.1016/j.tcb.2016.08.003; Leys SP, 2012, J EXP ZOOL PART B, V318B, P438, DOI 10.1002/jez.b.21442; Li Z, 2014, INT J MOL MED, V33, P383, DOI 10.3892/ijmm.2013.1577; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; LIN CW, 1993, AGENTS ACTIONS, V39, pC215, DOI 10.1007/BF01972770; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Lohmer LL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005786; Lohmer LL, 2014, CELL ADHES MIGR, V8, P246, DOI 10.4161/cam.28406; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Lyons DC, 2012, WIRES DEV BIOL, V1, P231, DOI 10.1002/wdev.18; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Matus DQ, 2015, DEV CELL, V35, P162, DOI 10.1016/j.devcel.2015.10.002; Matus DQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5184; McCauley BS, 2010, DEV BIOL, V340, P200, DOI 10.1016/j.ydbio.2009.11.020; McClatchey STH, 2016, ELIFE, V5, DOI 10.7554/eLife.17218; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Mogi K, 2010, CELLS TISSUES ORGANS, V192, P1, DOI 10.1159/000286231; Morrissey MA, 2013, WORM, V2, DOI [DOI 10.4161/WORM.26169, 10.4161/worm.26169]; Morrissey MA, 2015, J CELL SCI, V128, P1661, DOI 10.1242/jcs.168021; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nakaya Y, 2013, J CELL BIOL, V202, P637, DOI 10.1083/jcb.201302075; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Pastor-Pareja JC, 2004, DEV CELL, V7, P387, DOI 10.1016/j.devcel.2004.07.022; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Rankis V, 2012, DEV BIOL, V364, P162; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rinkevich Y, 2013, DEV CELL, V24, P76, DOI 10.1016/j.devcel.2012.11.010; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Royer LA, 2016, NAT BIOTECHNOL, V34, P1267, DOI 10.1038/nbt.3708; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; SANDERS EJ, 1989, J CELL SCI, V92, P497; Saunders LR, 2014, DEVELOPMENT, V141, P1503, DOI 10.1242/dev.101436; Sherwood DR, 2005, CELL, V121, P951, DOI 10.1016/j.cell.2005.03.031; Sherwood DR, 2003, DEV CELL, V5, P21, DOI 10.1016/S1534-5807(03)00168-0; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933                                                           ; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Tao G, 2011, DEV BIOL, V359, P209, DOI 10.1016/j.ydbio.2011.08.022; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Weissman IL, 2015, P NATL ACAD SCI USA, V112, P8922, DOI 10.1073/pnas.1505464112; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wu C, 2009, NAT MED, V15, P519, DOI 10.1038/nm.1957; Ziel JW, 2009, NAT CELL BIOL, V11, P183, DOI 10.1038/ncb1825	90	0	0	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-437X	1879-0380		CURR OPIN GENET DEV	Curr. Opin. Genet. Dev.	DEC	2017	47						33	40		10.1016/j.gde.2017.08.003				8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	FO7MK	WOS:000417059600006	28881331	gold			2018-01-05	
J	Campbell, LA; Richie, CT; Zhang, YJ; Heathward, EJ; Coke, LM; Park, EY; Harvey, BK				Campbell, Lee A.; Richie, Christopher T.; Zhang, Yajun; Heathward, Emily J.; Coke, Lamarque M.; Park, Emily Y.; Harvey, Brandon K.			In vitro modeling of HIV proviral activity in microglia	FEBS JOURNAL			English	Article						CRISPR; Cas9; HIV; microglia; NanoLuciferase; NeuroAIDS	HUMAN-IMMUNODEFICIENCY-VIRUS; NEURONAL CELL-DEATH; NF-KAPPA-B; GENE-EXPRESSION; T-CELLS; ACTIVATION; INFECTION; TRANSCRIPTION; DEMENTIA; SYSTEM	Microglia, the resident macrophages of the brain, play a key role in the pathogenesis of HIV-associated neurocognitive disorders (HAND) due to their productive infection by HIV. This results in the release of neurotoxic viral proteins and pro-inflammatory compounds which negatively affect the functionality of surrounding neurons. Because models of HIV infection within the brain are limited, we aimed to create a novel microglia cell line with an integrated HIV provirus capable of recreating several hallmarks of HIV infection. We utilized clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene editing technology and integrated a modified HIV provirus into CHME-5 immortalized microglia to create HIV-NanoLuc CHME-5. In the modified provirus, the Gag-Pol region is replaced with the coding region for NanoLuciferase (NanoLuc), which allows for the rapid assay of HIV long terminal repeat activity using a luminescent substrate, while still containing the necessary genetic material to produce established neurotoxic viral proteins (e.g. tat, nef, gp120). We confirmed that HIV-NanoLuc CHME-5 microglia express NanoLuc, along with the HIV viral protein Nef. We subsequently exposed these cells to a battery of experiments to modulate the activity of the provirus. Proviral activity was enhanced by treating the cells with pro-inflammatory factors lipopolysaccharide (LPS) and tumor necrosis factor alpha and by overexpressing the viral regulatory protein Tat. Conversely, genetic modification of the toll-like receptor-4 gene by CRISPR/Cas9 reduced LPS-mediated proviral activation, and pharmacological application of NF-B inhibitor sulfasalazine similarly diminished proviral activity. Overall, these data suggest that HIV-NanoLuc CHME-5 may be a useful tool in the study of HIV-mediated neuropathology and proviral regulation.	[Campbell, Lee A.; Richie, Christopher T.; Zhang, Yajun; Heathward, Emily J.; Coke, Lamarque M.; Park, Emily Y.; Harvey, Brandon K.] NIDA, Intramural Res Program, Biomed Res Ctr, Suite 200,251 Bayview Blvd, Baltimore, MD 21224 USA	Harvey, BK (reprint author), NIDA, Intramural Res Program, Biomed Res Ctr, Suite 200,251 Bayview Blvd, Baltimore, MD 21224 USA.	bharvey@mail.nih.gov			Intramural Research Program at the National Institute on Drug Abuse	The authors thank Dr. K. Whitaker for support with MAGPIX Multiplexing assays. The authors thank F. Zhang for pspCas9n(BB)-2A-Puro (PX462; Addgene plasmid #48141) and pSpCas9(BB)-2A-Puro (PX459; Addgene plasmid # 48139). The authors thank C. Gersbach for phU6-gRNA (Addgene plasmid # 53188). This project was supported by the Intramural Research Program at the National Institute on Drug Abuse.	Ashutosh CC, 2012, CELL DEATH DIS, V3, pe332, DOI DOI 10.1038/CDDIS.2012.54; ATWOOD WJ, 1994, AIDS RES HUM RETROV, V10, P1207, DOI 10.1089/aid.1994.10.1207; Bachis A, 2016, NEUROBIOL AGING, V46, P160, DOI 10.1016/j.neurobiolaging.2016.07.001; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cassol E, 2014, AIDS, V28, P1579, DOI 10.1097/QAD.0000000000000303; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; CONANT K, 1994, ADV NEUROIMMUNOL, V4, P287, DOI 10.1016/S0960-5428(06)80269-X                                                   ; Dutta R, 2012, J NEUROSCI, V32, P9917, DOI 10.1523/JNEUROSCI.0870-12.2012; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; El-Hage N, 2015, J VIROL, V89, P1024, DOI 10.1128/JVI.02022-14; Fang J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-267; Garcia-Mesa Y, 2017, J NEUROVIROL, V23, P47, DOI 10.1007/s13365-016-0499-3; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Henderson MJ, 2014, MOL BIOL CELL, V25, P2828, DOI 10.1091/mbc.E14-06-1141; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; LI YX, 1992, J VIROL, V66, P6587; LI YX, 1991, J VIROL, V65, P3973; Lisi L, 2016, J NEUROCHEM, V136, P363, DOI 10.1111/jnc.13393; Mangino G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130189; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nosheny RL, 2004, EUR J NEUROSCI, V20, P2857, DOI 10.1111/j.1460-9568.2004.03764.x; Podhaizer EM, 2012, J NEUROIMMUNE PHARM, V7, P877, DOI 10.1007/s11481-011-9326-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rawat P, 2017, J NEUROVIROL, V23, P33, DOI 10.1007/s13365-016-0472-1; Rosati A, 2009, J CELL PHYSIOL, V218, P264, DOI 10.1002/jcp.21604; Samikkannu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31784; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wires ES, 2012, J NEUROVIROL, V18, P400, DOI 10.1007/s13365-012-0103-4; Xing HQ, 2017, NEUROPATHOLOGY, V37, P25, DOI 10.1111/neup.12321; Xing HQ, 2009, J NEUROPATH EXP NEUR, V68, P199, DOI 10.1097/NEN.0b013e31819715df; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789                                                          ; Zenon F, 2015, J NEUROVIROL, V21, P544, DOI 10.1007/s13365-015-0358-7; Zhou L, 2013, INFECT DIS REP, V5, P38, DOI 10.4081/idr.2013.s1.e8	56	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2017	284	23					4096	4114		10.1111/febs.14293				19	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO8UI	WOS:000417162900011	29114997				2018-01-05	
J	Berberich, H; Terwesten, F; Rakow, S; Sahu, P; Bouchard, C; Meixner, M; Philipsen, S; Kolb, P; Bauer, UM				Berberich, Hannah; Terwesten, Felix; Rakow, Sinja; Sahu, Peeyush; Bouchard, Caroline; Meixner, Marion; Philipsen, Sjaak; Kolb, Peter; Bauer, Uta-Maria			Identification and insilico structural analysis of Gallus gallus protein arginine methyltransferase 4 (PRMT4)	FEBS OPEN BIO			English	Article						epigenetic regulation; histone arginine methylation; homology modeling; Pleckstrin homology domain; protein arginine methyltransferase 4; protein-protein docking	SITE-SPECIFIC METHYLATION; GENE-EXPRESSION; HISTONE H3; CARM1; DIFFERENTIATION; TRANSCRIPTION; COMPLEX; CANCER; SWITCH; CELLS	Protein arginine methyltransferase 4 (PRMT4) is an essential epigenetic regulator of fundamental and conserved processes during vertebrate development, such as pluripotency and differentiation. Surprisingly, PRMT4 homologs have been identified in nearly all vertebrate classes except the avian genome. This raises the possibility that in birds PRMT4 functions are taken over by other PRMT family members. Here, we reveal the existence of a bona fidePRMT4 homolog in the chicken, Gallus gallus. Using a biochemical approach, we initially purified a putative chicken PRMT4 protein and thus provided the first evidence for the presence of an endogenous PRMT4-specific enzymatic activity toward histone H3 arginine 17 (H3R17) in avian cells. We then isolated a G.gallus PRMT4 (ggPRMT4) transcript encompassing the complete open reading frame. Recombinant ggPRMT4 possesses intrinsic methyltransferase activity toward H3R17. CRISPR/Cas9-mediated deletion of ggPRMT4 demonstrated that the transcript identified here encodes avian PRMT4. Combining protein-protein docking and homology modeling based on published crystal structures of murine PRMT4, we found a strong structural similarity of the catalytic core domain between chicken and mammalian PRMT4. Strikingly, insilico structural comparison of the N-terminal Pleckstrin homology (PH) domain of avian and murine PRMT4 identified strictly conserved amino acids that are involved in an interaction interface toward the catalytic core domain, facilitating for the first time a prediction of the relative spatial arrangement of these two domains. Our novel findings are particularly exciting in light of the essential function of the PH domain in substrate recognition and methylation by PRMT4.	[Berberich, Hannah; Rakow, Sinja; Sahu, Peeyush; Bouchard, Caroline; Meixner, Marion; Bauer, Uta-Maria] Philipps Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Terwesten, Felix; Kolb, Peter] Philipps Univ Marburg, Inst Pharmaceut Chem, Marburg, Germany; [Philipsen, Sjaak] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Bauer, UM (reprint author), Philipps Univ Marburg, Inst Mol Biol & Tumor Res IMT, BMFZ, Hans Meerwein Str 2, D-35043 Marburg, Germany.	bauer@imt.uni-marburg.de	Kolb, Peter/A-3782-2008	Kolb, Peter/0000-0003-4089-614X	DFG (Deutsche Forschungsgemeinschaft) [TRR81/2 A03, BA 2292/1, BA 2292/4]; Deutsche Jose Carreras Leukamie-Stiftung EV [DJCLS R 13/17]; Landsteiner Foundation for Blood Transfusion Research [LSBR 1627]; Netherlands Organization for Scientific Research [ZonMw TOP 40-00812-98-12128]	We thank all members of the UMB laboratory for their support during the work progress and Inge Sprenger and Christiane Rohrbach for technical assistance. We thank Guntram Suske and Alexander Brehm for their valuable suggestions. This work was funded as part of the TRR81/2 A03, BA 2292/1, and BA 2292/4 by the DFG (Deutsche Forschungsgemeinschaft) and of the DJCLS R 13/17 by the Deutsche Jose Carreras Leukamie-Stiftung EV to UMB and Landsteiner Foundation for Blood Transfusion Research (LSBR 1627) and Netherlands Organization for Scientific Research (ZonMw TOP 40-00812-98-12128) to SP.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Case DA, 2014, AMBER; Chemical Computing Group Inc, 2013, MOL OP ENV MOE 2013; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chevillard-Briet M, 2002, EMBO J, V21, P5457, DOI 10.1093/emboj/cdf548; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Hein K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005892; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Kim D, 2010, J BIOL CHEM, V285, P1147, DOI 10.1074/jbc.M109.035865; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; KLEMPNAUER KH, 1983, J VIROL, V48, P565; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944                                                       ; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shishkova E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15571; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Streubel G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003343; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Wu JC, 2012, P NATL ACAD SCI USA, V109, P5675, DOI 10.1073/pnas.1114905109; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856	49	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2211-5463			FEBS OPEN BIO	FEBS Open Bio	DEC	2017	7	12					1909	1923		10.1002/2211-5463.12323				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO8CD	WOS:000417109000008	29226078	gold			2018-01-05	
J	Xia, XH				Xia, Xuhua			ARSDA: A New Approach for Storing, Transmitting and Analyzing Transcriptomic Data	G3-GENES GENOMES GENETICS			English	Article						transcriptomics; novel storage solution; quantifying expression of paralogous genes; sequence format; ARSDA	REFERENCE-BASED COMPRESSION; THROUGHPUT SEQUENCING DATA; GENOME-WIDE ANALYSIS; DE-BRUIJN GRAPH; RNA-SEQ; GENE-EXPRESSION; TRYPANOSOMATID MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; EDITING COMPLEX; READ ALIGNMENT	Two major stumbling blocks exist in high-throughput sequencing (HTS) data analysis. The first is the sheer file size, typically in gigabytes when uncompressed, causing problems in storage, transmission, and analysis. However, these files do not need to be so large, and can be reduced without loss of information. Each HTS file, either in compressed. SRA or plain text. fastq format, contains numerous identical reads stored as separate entries. For example, among 44,603,541 forward reads in the SRR4011234. sra file (from a Bacillus subtilis transcriptomic study) deposited at NCBI's SRA database, one read has 497,027 identical copies. Instead of storing them as separate entries, one can and should store them as a single entry with the SeqID_NumCopy format (which I dub as FASTA+ format). The second is the proper allocation of reads that map equally well to paralogous genes. I illustrate in detail a new method for such allocation. I have developed ARSDA software that implement these new approaches. A number of HTS files for model species are in the process of being processed and deposited at http://coevol rdc.uottawa.cato demonstrate that this approach not only saves a huge amount of storage space and transmission bandwidth, but also dramatically reduces time in downstream data analysis. Instead of matching the 497,027 identical reads separately against the B. subtilis genome, one only needs to match it once. ARSDA includes functions to take advantage of HTS data in the new sequence format for downstream data analysis such as gene expression characterization. I contrasted gene expression results between ARSDA and Cufflinks so readers can better appreciate the strength of ARSDA. ARSDA is freely available for Windows, Linux. and Macintosh computers at http://dambe.bio.uottawa.ca/ARSDA/ARSDA.aspx.	[Xia, Xuhua] Univ Ottawa, Dept Biol, Ottawa, ON K1H 8M5, Canada; [Xia, Xuhua] Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	Xia, XH (reprint author), Univ Ottawa, Dept Biol, 30 Marie Curie, Ottawa, ON K1N 6N5, Canada.	xxia@uottawa.ca		Xia, Xuhua/0000-0002-3092-7566	Natural Science and Engineering Research Council of Canada [RGPIN/261252]	Nabil Benabbou of Center for Advanced Computing of Queen's University helped me with testing compression software tools on the center's servers. ARSDA was demonstrated in two workshops, one organized by J. Lu of Peking University, and another by E. Pranckeviciene of University of Vilnius. I thank participants, as well as J. Silke, J. Wang, Y. Wei, and C. Vlasschaert, for their feedback. Two anonymous reviewers offered outstanding feedback leading to substantial improvement of the manuscript. This study is funded by the Discovery Grant from Natural Science and Engineering Research Council (RGPIN/261252) of Canada.	ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9                                                    ; Alatortsev VS, 2008, MOL CELL BIOL, V28, P2437, DOI 10.1128/MCB.01886-07; Andrews S., 2017, FASTQC BABRAHAM BIOI; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Awan AR, 2013, P NATL ACAD SCI USA, V110, P12762, DOI 10.1073/pnas.1218353110; Benoit G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0709-7; Dai M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S7; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; GB Editorial Team, 2011, GENOME BIOL, V12, P402; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Janin L, 2014, BIOINFORMATICS, V30, P2796, DOI 10.1093/bioinformatics/btu387; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawashima T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004249; Kingsford C, 2015, BIOINFORMATICS, V31, P1920, DOI 10.1093/bioinformatics/btv071; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; LAMOND AI, 1988, TRENDS BIOCHEM SCI, V13, P283, DOI 10.1016/0968-0004(88)90117-X                                                    ; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Liu B, 2016, BIOINFORMATICS, V32, P3224, DOI 10.1093/bioinformatics/btw371; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolae M, 2015, BIOINFORMATICS, V31, P3276, DOI 10.1093/bioinformatics/btv384; Numanagic I, 2016, NAT METHODS, V13, P1005, DOI [10.1038/NMETH.4037, 10.1038/nmeth.4037]; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Pobre V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1237-6; Roberts A, 2013, BIOINFORMATICS, V29, P1631, DOI 10.1093/bioinformatics/btt197; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rogers MF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r4; Rogozin IB, 2014, GENOME BIOL EVOL, V6, P754, DOI 10.1093/gbe/evu051; Simpson RM, 2016, RNA, V22, P677, DOI 10.1261/rna.055160.115; Stepankiw N, 2015, NUCLEIC ACIDS RES, V43, P8488, DOI 10.1093/nar/gkv763; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vlasschaert C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20039; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Zhu ZX, 2015, BIOINFORMATICS, V31, P426, DOI 10.1093/bioinformatics/btu656; Zhu ZX, 2015, BRIEF BIOINFORM, V16, P1, DOI 10.1093/bib/bbt087	46	0	0	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	DEC	2017	7	12					3839	3848		10.1534/g3.117.300271				10	Genetics & Heredity	Genetics & Heredity	FO7RN	WOS:000417073900001	29079682	gold			2018-01-05	
J	Jie, H; Li, ZL; Wang, P; Zhao, LJ; Zhang, Q; Yao, XM; Song, XR; Zhao, YL; Yao, SH				Jie, Hui; Li, Zhuoling; Wang, Ping; Zhao, Linjie; Zhang, Qian; Yao, Xiaomin; Song, Xiangrong; Zhao, Yinglan; Yao, Shaohua			A simple method based on Sanger sequencing and MS Word wildcard searching to identify Cas9-induced frameshift mutations	LABORATORY INVESTIGATION			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; CRYSTAL-STRUCTURE; DNA; CELLS; RNA; ENDONUCLEASE; CRISPR-CAS9; REPAIR; MOUSE	Recent advances in targeted genome editing have enabled sequence-specific modifications in eukaryotic genomes. As it can be easily reprogrammed, the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 nuclease system has been studied extensively and is now a widely used genome editing tool. Generally, Cas9 nucleases are designed to target the coding regions in exons of protein-coding genes, which are expected to cause frameshift indel mutations and interrupt protein expression. In such cases, it is often necessary to separate single clones that harbor double frameshift mutant alleles from clones that harbor the wild-type allele or an in-frame mutant allele. We developed a simple and efficient method to identify frameshift mutations in diploid genomes based on Sanger sequencing and MS Word wildcard searching (SWS). As indel mutations induced by Cas9 are varied, Sanger sequencing of PCR products from a single mutant genome will generate double peaks that begin at the indel sites. By positioning the putative sequences deduced from the double peak regions in the sequencing graph onto the wild-type sequence by MS Word wildcard searching, it is possible to predict exactly how many nucleotides were deleted or inserted in each allele of the genome. The SWS strategy greatly facilitates the process of identifying single clones with biallelic frameshift mutations from pooled cells or model organisms.	[Jie, Hui; Li, Zhuoling; Wang, Ping; Zhao, Linjie; Zhang, Qian; Yao, Xiaomin; Song, Xiangrong; Zhao, Yinglan; Yao, Shaohua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Canc Ctr, 17 3rd Sect South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China	Zhao, YL; Yao, SH (reprint author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, 17 3rd Sect South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.; Zhao, YL; Yao, SH (reprint author), Sichuan Univ, West China Hosp, Canc Ctr, 17 3rd Sect South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.	zhaoyinglan@scu.edu.cn; shaohuayao@scu.edu.cn			Hi-Tech Research and Development (863) Program of China [2015AA020309]; National Natural Science Foundation of China (NSFC) [81372143]	This work was supported by Hi-Tech Research and Development (863) Program of China 2015AA020309 and the National Natural Science Foundation of China (NSFC) 81372143. We thank Dr Margaret Biswas, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of the manuscript.	Bassett AR, 2014, CELL REP, V6, P1178, DOI 10.1016/j.celrep.2014.03.017; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bohne F, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0215-4; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; CHUAN YY, 2014, PLOS ONE, V9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Li Ting, 2013, Methods Mol Biol, V978, P63, DOI 10.1007/978-1-62703-293-3_5; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Ma YW, 2014, FEBS J, V281, P5186, DOI 10.1111/febs.13110; Masago K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1925-2; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	26	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	DEC	2017	97	12					1500	1507		10.1038/labinvest.2017.83				8	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	FO3LW	WOS:000416733500008	28825696				2018-01-05	
J	Shi, CX; Kortum, KM; Zhu, YX; Bruins, LA; Jedlowski, P; Votruba, PG; Luo, ML; Stewart, RA; Ahmann, J; Braggio, E; Stewart, AK				Shi, Chang-Xin; Kortuem, K. Martin; Zhu, Yuan Xiao; Bruins, Laura A.; Jedlowski, Patrick; Votruba, Patrick G.; Luo, Moulun; Stewart, Robert A.; Ahmann, Jonathan; Braggio, Esteban; Stewart, A. Keith			CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma	MOLECULAR CANCER THERAPEUTICS			English	Article							STREPTOMYCES STRAIN; MOLECULAR-BASIS; HUMAN-CELLS; RESISTANCE; PROTEIN; INHIBITOR; DEXAMETHASONE; MUTATIONS; PSMB5; OVEREXPRESSION	Bortezomib is highly effective in the treatment of multiple myeloma; however, emergent drug resistance is common. Consequently, we employed CRISPR targeting 19,052 human genes to identify unbiased targets that contribute to bortezomib resistance. Specifically, we engineered an RPMI8226 multiple myeloma cell line to express Cas9 infected by lentiviral vector CRISPR library and cultured derived cells in doses of bortezomib lethal to parental cells. Sequencing was performed on surviving cells to identify inactivated genes responsible for drug resistance. From two independent whole-genome screens, we selected 31 candidate genes and constructed a second CRISPR sgRNA library, specifically targeting each of these 31 genes with four sgRNAs. After secondary screening for bortezomib resistance, the top 20 "resistance" genes were selected for individual validation. Of these 20 targets, the proteasome regulatory subunit PSMC6 was the only gene validated to reproducibly confer bortezomib resistance. We confirmed that inhibition of chymotrypsin- like proteasome activity by bortezomib was significantly reduced in cells lacking PSMC6. We individually investigated other members of the PSMC group (PSMC1 to 5) and found that deficiency in each of those subunits also imparts bortezomib resistance. We found 36 mutations in 19S proteasome subunits out of 895 patients in the IA10 release of the CoMMpass study (https://themmrf.org). Our findings demonstrate that the PSMC6 subunit is the most prominent target required for bortezomib sensitivity in multiple myeloma cells and should be examined in drug-refractory populations. (C) 2017 AACR.	[Shi, Chang-Xin; Kortuem, K. Martin; Zhu, Yuan Xiao; Bruins, Laura A.; Jedlowski, Patrick; Stewart, Robert A.; Ahmann, Jonathan; Braggio, Esteban; Stewart, A. Keith] Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ USA; [Kortuem, K. Martin] Univ Hosp Wurzburg, Dept Hematol, Wurzburg, Germany; [Votruba, Patrick G.] Mayo Clin Arizona, Bioinformat Syst, Scottsdale, AZ USA; [Luo, Moulun] Arizona State Univ, Mayo ASU Ctr Metab & Vasc Biol, Scottsdale, AZ USA; [Stewart, A. Keith] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Stewart, AK (reprint author), Mayo Clin Arizona, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	stewart.keith@mayo.edu			NIH [RO1CA183968, RO1CA167511]	A.K. Stewart is supported by NIH grants RO1CA183968 and RO1CA167511.	Acosta-Alvear D, 2015, ELIFE, V4, DOI 10.7554/eLife.08153; Balsas P, 2012, LEUKEMIA RES, V36, P212, DOI 10.1016/j.leukres.2011.09.011; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Egan JB, 2013, BRIT J HAEMATOL, V161, P748, DOI 10.1111/bjh.12291; Franke NE, 2012, LEUKEMIA, V26, P757, DOI 10.1038/leu.2011.256; FURUSAKI A, 1978, J CHEM SOC CHEM COMM, P800, DOI 10.1039/c39780000800; FURUSAKI A, 1982, B CHEM SOC JPN, V55, P3681, DOI 10.1246/bcsj.55.3681                                                            ; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596                                                            ; Kortum KM, 2016, BLOOD, V128, P1226, DOI 10.1182/blood-2016-02-698092; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Kumar SK, 2014, LANCET ONCOL, V15, P1503, DOI 10.1016/S1470-2045(14)71125-8; Laubach JP, 2011, EXPERT REV HEMATOL, V4, P51, DOI 10.1586/EHM.10.83; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Lichter DI, 2012, BLOOD, V120, P4513, DOI 10.1182/blood-2012-05-426924; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Niewerth D, 2015, DRUG RESIST UPDATE, V18, P18, DOI 10.1016/j.drup.2014.12.001; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Politou M, 2006, LEUKEMIA RES, V30, P240, DOI 10.1016/j.leukres.2005.06.014; Reeder CB, 2014, BRIT J HAEMATOL, V167, P563, DOI 10.1111/bjh.13004; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Rosenthal A, 2016, BRIT J HAEMATOL, V174, P323, DOI 10.1111/bjh.13765; Ruckrich T, 2009, LEUKEMIA, V23, P1098, DOI 10.1038/leu.2009.8; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheffer M, 2014, 56 M AM SOC HEM 2014; Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651; TAKATSUKI A, 1977, AGR BIOL CHEM TOKYO, V41, P2307, DOI 10.1080/00021369.1977.10862856                                                  ; Tsvetkov P, 2015, ELIFE, V4, DOI 10.7554/eLife.08467; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002	38	0	0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2017	16	12					2862	2870		10.1158/1535-7163.MCT-17-0130				9	Oncology	Oncology	FO6KM	WOS:000416971900021	28958990				2018-01-05	
J	Ukai, H; Kiyonari, H; Ueda, HR				Ukai, Hideki; Kiyonari, Hiroshi; Ueda, Hiroki R.			Production of knock-in mice in a single generation from embryonic stem cells	NATURE PROTOCOLS			English	Article							ALTERED PAM SPECIFICITIES; ZINC-FINGER NUCLEASES; ENGINEERED CRISPR-CAS9; SELF-RENEWAL; MOUSE; GENE; TALEN; CRISPR/CAS; CAS9; INHIBITOR	The system-level identification and analysis of molecular networks in mammals can be accelerated by 'next-generation' genetics, defined as genetics that does not require crossing of multiple generations of animals in order to achieve the desired genetic makeup. We have established a highly efficient procedure for producing knock-in (KI) mice within a single generation, by optimizing the genome-editing protocol for KI embryonic stem (ES) cells and the protocol for the generation of fully ES-cell-derived mice (ES mice). Using this protocol, the production of chimeric mice is eliminated, and, therefore, there is no requirement for the crossing of chimeric mice to produce mice that carry the KI gene in all cells of the body. Our procedure thus shortens the time required to produce KI ES mice from about a year to similar to 3 months. Various kinds of KI ES mice can be produced with a minimized amount of work, facilitating the elucidation of organism-level phenomena using a systems biology approach. In this report, we describe the basic technologies and protocols for this procedure, and discuss the current challenges for next-generation mammalian genetics in organism-level systems biology studies.	[Ukai, Hideki; Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Osaka, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Ueda, Hiroki R.] Univ Tokyo, Dept Syst Pharmacol, Tokyo, Japan	Ueda, HR (reprint author), RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Osaka, Japan.; Ueda, HR (reprint author), Univ Tokyo, Dept Syst Pharmacol, Tokyo, Japan.	uedah-tky@umin.ac.jp			AMED-CREST; CREST; Brain/MINDS; Basic Science and Platform Technology Program for Innovative Biological Medicine; Cell Innovation Program; KAKENHI from JSPS [25221004, 23115006]; RIKEN; RIKEN QBiC; Takeda Science Foundation	We thank our laboratory members at RIKEN QBiC, RIKEN CLST, and the University of Tokyo, in particular, S. Morino and M. Muramatsu, for their help in maintaining the ESCs and preparing materials; J. Garcon and K. Yamanaka for producing ES mice; M. Ukai for help with the genotyping of ESCs; and M. Kaneko, M. Shigeta and M. Okugawa for help in preparing the manuscript. This work was supported by grants from AMED-CREST (H.R.U.), CREST (H.R.U.), Brain/MINDS (H.R.U.), the Basic Science and Platform Technology Program for Innovative Biological Medicine (H.R.U.), and the Cell Innovation Program (H.R.U.), KAKENHI Grants-in-Aid from JSPS (Scientific Research S, 25221004, H.R.U.; Scientific Research on Innovative Areas, 23115006, H.R.U.), and the strategic programs for R&D of RIKEN (H.R.U.), an intramural Grant-in-Aid from the RIKEN QBiC (H.R.U.), and grants from Takeda Science Foundation (H.R.U.).	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hermann M., 2014, JOVE-J VIS EXP, V86, P50930; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hohenstein Peter, 2008, Pathogenetics, V1, P3, DOI 10.1186/1755-8417-1-3; Huang JJ, 2008, STEM CELLS, V26, P1883, DOI 10.1634/stemcells.2008-0164; JOHNSON MH, 1986, J EMBRYOL EXP MORPH, V93, P239; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li XY, 2005, REPRODUCTION, V130, P53, DOI 10.1530/rep.1.00667; LU TY, 1980, P NATL ACAD SCI-BIOL, V77, P6012, DOI 10.1073/pnas.77.10.6012; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Murata T, 2004, GENE EXPR PATTERNS, V5, P171, DOI 10.1016/j.modgep.2004.08.007; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424                                                         ; Nagy A, 2010, METHOD ENZYMOL, V476, P123, DOI 10.1016/S0076-6879(10)76008-0; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakao H, 2016, GENESIS, V54, P65, DOI 10.1002/dvg.22914; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; NIWA H, 1991, GENE, V108, P193; Ode KL, 2017, MOL CELL, V65, P176, DOI 10.1016/j.molcel.2016.11.022; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sakuma T, 2015, INT J MOL SCI, V16, P23849, DOI 10.3390/ijms161023849; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Schwenk F, 2003, MOL CELL BIOL, V23, P3982, DOI 10.1128/MCB.23.11.3982-3989.2003; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Sommer D, 2015, CHROMOSOME RES, V23, P43, DOI 10.1007/s10577-014-9457-1; Sunagawa GA, 2016, CELL REP, V14, P662, DOI 10.1016/j.celrep.2015.12.052; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tatsuki F, 2016, NEURON, V90, P70, DOI 10.1016/j.neuron.2016.02.032; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wang YL, 2016, PROTEIN CELL, V7, P152, DOI 10.1007/s13238-015-0228-3; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2                                                   ; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zhang P, 2012, IN VITRO CELL DEV-AN, V48, P30, DOI 10.1007/s11626-011-9471-y	70	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	DEC	2017	12	12					2513	2530		10.1038/nprot.2017.110				18	Biochemical Research Methods	Biochemistry & Molecular Biology	FO2KO	WOS:000416606400005	29189772				2018-01-05	
J	Yang, YF; Zhu, GN; Li, R; Yan, SJ; Fu, DQ; Zhu, BZ; Tian, HQ; Luo, YB; Zhu, HL				Yang, Yongfang; Zhu, Guoning; Li, Rui; Yan, Shijie; Fu, Daqi; Zhu, Benzhong; Tian, Huiqin; Luo, Yunbo; Zhu, Hongliang			The RNA Editing Factor SlORRM4 Is Required for Normal Fruit Ripening in Tomato	PLANT PHYSIOLOGY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; MOTIF-CONTAINING PROTEIN; SEED DEVELOPMENT; PLANT DEVELOPMENT; PPR PROTEIN; INTRON 1; MITOCHONDRIAL; MAIZE; GENE; ARABIDOPSIS	RNA editing plays a key posttranscriptional role in gene expression. Existing studies on cytidine-to-uridine RNA editing in plants have focused on maize (Zea mays), rice (Oryza sativa), and Arabidopsis (Arabidopsis thaliana). However, the importance and regulation of RNA editing in several critical agronomic processes are not well understood, a notable example of which is fruit ripening. Here, we analyzed the expression profile of 33 RNA editing factors and identified 11 putative tomato (Solanum lycopersicum) fruit ripening-related factors. A rapid virus-induced gene silencing assay indicated that the organelle RNA recognition motif-containing protein SlORRM4 affected tomato fruit ripening. Knocking out SlORRM4 expression using a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 genome editing strategy delayed tomato fruit ripening by lowering respiratory rate and ethylene production. Additionally, the expression of numerous genes associated with fruit ripening and mitochondrial functions changed significantly when SlORRM4 was knocked out. Moreover, the loss of SlORRM4 function significantly reduced RNA editing of many mitochondrial transcripts, leading to low-level expression of some core subunits that are critical for mitochondrial complex assembly (i.e. Nad3, Cytc1, and COX II). Taken together, these results indicate that SlORRM4 is involved in RNA editing of transcripts in ripening fruit that influence mitochondrial function and key aspects of fruit ripening.	[Yang, Yongfang; Zhu, Guoning; Li, Rui; Fu, Daqi; Zhu, Benzhong; Tian, Huiqin; Luo, Yunbo; Zhu, Hongliang] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Yan, Shijie] Tianjin Agr Univ, Coll Food Sci & Biol Engn, Tianjin 300384, Peoples R China	Zhu, HL (reprint author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	hlzhu@cau.edu.cn			National Key R&D Program of China [2016YFD0400901]; National Natural Science Foundation of China [31672208, 31622050, 91540118]	This work was supported by the National Key R&D Program of China (2016YFD0400901) and the National Natural Science Foundation of China (31672208, 31622050, and 91540118) to H.Z.	Adams KL, 2001, GENETICS, V158, P1289; Anders S, 2010, MOL BIOL, V43, P17; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.arplant.38.1.155; Chen XZ, 2017, MOL PLANT, V10, P427, DOI 10.1016/j.molp.2016.08.008; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Graewe Stefanie, 2009, Biotechnology Journal, V4, P895, DOI 10.1002/biot.200900035; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Hackett JB, 2017, PLANT PHYSIOL, V173, P2278, DOI 10.1104/pp.16.01623; KADOWAKI K, 1995, CURR GENET, V28, P415, DOI 10.1007/BF00310809; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Keren I, 2012, PLANT J, V71, P413, DOI 10.1111/j.1365-313X.2012.04998.x; Kuhn K, 2015, PLANT PHYSIOL, V167, P228, DOI 10.1104/pp.114.249946; Lang ZB, 2017, P NATL ACAD SCI USA, V114, pE4511, DOI 10.1073/pnas.1705233114; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li R, 2017, PLANT BIOTE IN PRESS; Li WT, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012310038; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Logan DC, 2006, J EXP BOT, V57, P1225, DOI 10.1093/jxb/erj151; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Qi WW, 2017, GENETICS, V205, P1489, DOI 10.1534/genetics.116.199331; Qin GZ, 2016, PLANT PHYSIOL, V172, P1596, DOI 10.1104/pp.16.01269; Rhodes MJC, 1980, BIOCH PLANTS COMPREH, V2, P419; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shi XW, 2017, J EXP BOT, V68, P2833, DOI 10.1093/jxb/erx139; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Sun F, 2015, PLANT J, V84, P283, DOI 10.1111/tpj.12993; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Eck J, 2006, METH MOL B, V343, P459; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang G, 2012, SEED DEV OMICS TECHN, P81; Wang G, 2017, NEW PHYTOL, V214, P1563, DOI 10.1111/nph.14507; Wang X, 2016, NEW PHYTOL, V209, P1442, DOI 10.1111/nph.13718; Welchen E, 2012, BBA-BIOENERGETICS, V1817, P990, DOI 10.1016/j.bbabio.2012.04.008; Weng L, 2015, PLANT PHYSIOL, V167, P931, DOI 10.1104/pp.114.255174; Yan HX, 2012, PLANT CELL REP, V31, P1713, DOI 10.1007/s00299-012-1285-1; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yang YZ, 2017, NEW PHYTOL, V214, P782, DOI 10.1111/nph.14424; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zhang ZG, 2017, MOL PLANT, V10, P86, DOI 10.1016/j.molp.2016.08.009; Zhu BZ, 2015, J EXP BOT, V66, P4483, DOI 10.1093/jxb/erv203	54	0	0	6	6	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	DEC	2017	175	4					1690	1702		10.1104/pp.17.01265				13	Plant Sciences	Plant Sciences	FO7UW	WOS:000417083900015	29061908				2018-01-05	
J	Ueda, M; Matsui, A; Tanaka, M; Nakamura, T; Abe, T; Sako, K; Sasaki, T; Kim, JM; Ito, A; Nishino, N; Shimada, H; Yoshida, M; Seki, M				Ueda, Minoru; Matsui, Akihiro; Tanaka, Maho; Nakamura, Tomoe; Abe, Takahiro; Sako, Kaori; Sasaki, Taku; Kim, Jong-Myong; Ito, Akihiro; Nishino, Norikazu; Shimada, Hiroaki; Yoshida, Minoru; Seki, Motoaki			The Distinct Roles of Class I and II RPD3-Like Histone Deacetylases in Salinity Stress Response	PLANT PHYSIOLOGY			English	Article							NAC TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; (ARYLOXOPROPENYL)PYRROLYL HYDROXYAMIDES; LEAF SENESCENCE; INHIBITORS; PLANTS; ACETYLATION; EXPRESSION; DROUGHT	Histone acetylation is an essential process in the epigenetic regulation of diverse biological processes, including environmental stress responses in plants. Previously, our research group identified a histone deacetylase (HDAC) inhibitor (HDI) that confers salt tolerance in Arabidopsis (Arabidopsis thaliana). In this study, we demonstrate that class I HDAC (HDA19) and class II HDACs (HDA5/14/15/18) control responses to salt stress through different pathways. The screening of 12 different selective HDIs indicated that seven newly reported HDIs enhance salt tolerance. Genetic analysis, based on a pharmacological study, identified which HDACs function in salinity stress tolerance. In the wild-type Columbia-0 background, hda19 plants exhibit tolerance to high-salinity stress, while hda5/14/15/18 plants exhibit hypersensitivity to salt stress. Transcriptome analysis revealed that the effect of HDA19 deficiency on the response to salinity stress is distinct from that of HDA5/14/15/18 deficiencies. In hda19 plants, the expression levels of stress tolerance-related genes, late embryogenesis abundant proteins that prevent protein aggregation and positive regulators such as ABI5 and NAC019 in abscisic acid signaling, were induced strongly relative to the wild type. Neither of these elements was up-regulated in the hda5/14/15/18 plants. The mutagenesis of HDA19 by genome editing in the hda5/14/15/18 plants enhanced salt tolerance, suggesting that suppression of HDA19 masks the phenotype caused by the suppression of class II HDACs in the salinity stress response. Collectively, our results demonstrate that HDIs that inhibit class I HDACs allow the rescue of plants from salinity stress regardless of their selectivity, and they provide insight into the hierarchal regulation of environmental stress responses through HDAC isoforms.	[Ueda, Minoru; Matsui, Akihiro; Tanaka, Maho; Nakamura, Tomoe; Abe, Takahiro; Sako, Kaori; Sasaki, Taku; Kim, Jong-Myong; Seki, Motoaki] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Yokohama, Kanagawa 2300045, Japan; [Ueda, Minoru; Sasaki, Taku; Seki, Motoaki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Nakamura, Tomoe; Shimada, Hiroaki] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Abe, Takahiro; Seki, Motoaki] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan; [Ito, Akihiro; Nishino, Norikazu; Yoshida, Minoru] RIKEN Ctr Sustainable Resource Sci, Chem Genom Res Grp, Wako, Saitama 3510198, Japan	Seki, M (reprint author), RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Yokohama, Kanagawa 2300045, Japan.; Seki, M (reprint author), Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan.; Seki, M (reprint author), Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan.	motoaki.seki@riken.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674	RIKEN; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [JPMJCR13B4]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI on Innovative Areas) [16H01476]	This work was supported by grants to M.U. and M.S. from RIKEN and by grants to M.S. from the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (grant no. JPMJCR13B4) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI on Innovative Areas; grant no. 16H01476).	Alinsug MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030846; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ammar R, 2012, ELIFE, V2012, P1; Nguyen AH, 2015, PLANT CELL PHYSIOL, V56, P1762, DOI 10.1093/pcp/pcv096; Asensi-Fabado MA, 2017, BBA-GENE REGUL MECH, V1860, P106, DOI 10.1016/j.bbagrm.2016.07.015; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; BROSCH G, 1995, PLANT CELL, V7, P1941; Brosch G, 1996, BIOCHEMISTRY-US, V35, P15907, DOI 10.1021/bi961294x; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Davie JR, 2003, J NUTR, V133, p2485S; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fong PM, 2006, CELL RES, V16, P479, DOI 10.1038/sj.cr.7310059; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Gu DC, 2017, NUCLEIC ACIDS RES, V45, P7137, DOI 10.1093/nar/gkx283; Han ZF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00310; Hao YH, 2016, P NATL ACAD SCI USA, V113, P10418, DOI 10.1073/pnas.1521363113; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127                                                         ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaul S, 2000, NATURE, V408, P796; Kim JM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00114; Kim JM, 2012, PLANT CELL PHYSIOL, V53, P794, DOI 10.1093/pcp/pcs004; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Konig AC, 2014, PLANT PHYSIOL, V164, P1401, DOI 10.1104/pp.113.232496; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee WK, 2016, NUCLEIC ACIDS RES, V44, P4610, DOI 10.1093/nar/gkw067; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Liu XC, 2013, PLANT CELL, V25, P1258, DOI 10.1105/tpc.113.109710; Lobera M, 2013, NAT CHEM BIOL, V9, P319, DOI [10.1038/nchembio.1223, 10.1038/NCHEMBIO.1223]; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Luger K, 1997, NATURE, V389, P251; Luo M, 2015, PLANT J, V82, P925, DOI 10.1111/tpj.12868; Luo M, 2012, J EXP BOT, V63, P3297, DOI 10.1093/jxb/ers059; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; Ma XJ, 2013, PLANT CELL REP, V32, P465, DOI 10.1007/s00299-013-1393-6; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2003, J MED CHEM, V46, P4826, DOI 10.1021/jm034167p; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mehdi S, 2016, PLANT CELL, V28, P42, DOI 10.1105/tpc.15.00763; Narita K, 2009, CHEM-EUR J, V15, P11174, DOI 10.1002/chem.200901552; Patanun O, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02039; Perrella G, 2013, PLANT CELL, V25, P3491, DOI 10.1105/tpc.113.114835; Podzimska-Sroka Dagmara, 2015, Plants-Basel, V4, P412, DOI 10.3390/plants4030412; Provart NJ, 2016, NEW PHYTOL, V209, P921, DOI 10.1111/nph.13687; Ryu H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5138; Sako K, 2016, PLANT CELL PHYSIOL, V57, P776, DOI 10.1093/pcp/pcv199; Sakuraba Y, 2015, PLANT CELL, V27, P1771, DOI 10.1105/tpc.15.00222; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Seto E., 2014, COLD SPRING HARB S, V6, P18713; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Siow D, 2014, BIOCHEM BIOPH RES CO, V449, P268, DOI 10.1016/j.bbrc.2014.05.016; Skubacz A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01884; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takasaki H, 2015, PLANT J, V84, P1114, DOI 10.1111/tpj.13067; Tian L, 2003, GENETICS, V165, P399; Tran HT, 2012, PLANT J, V71, P263, DOI 10.1111/j.1365-313X.2012.04984.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; TSUJI N, 1976, J ANTIBIOT, V29, P1; Venturelli S, 2015, PLANT CELL, V27, P3175, DOI 10.1105/tpc.15.00585; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yoshida M., 1990, BIOL CHEM, V265, P17174; Zheng Y, 2016, J EXP BOT, V67, P1703, DOI 10.1093/jxb/erv562	79	0	0	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	DEC	2017	175	4					1760	1773		10.1104/pp.17.01332				14	Plant Sciences	Plant Sciences	FO7UW	WOS:000417083900020	29018096				2018-01-05	
J	Guzzardo, PM; Rashkova, C; dos Santos, RL; Tehrani, R; Collin, P; Burckstummer, T				Guzzardo, Paloma M.; Rashkova, Christina; dos Santos, Rodrigo L.; Tehrani, Raha; Collin, Philippe; Buerckstuemmer, Tilmann			A small cassette enables conditional gene inactivation by CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							HUMAN-CELLS; TRANSCRIPTION; GENERATION; DEGRON; CAS9	The availability of CRISPR/Cas9 technology has enabled the rapid establishment of gene knockouts in many cell types and even whole organisms. However, conditional inactivation of essential genes remains a challenge. We devised an approach named DECAI ( DEgradation based on Cre-regulatedArtificial Intron). It utilizes a small cassette of just 201 nucleotides that is inserted into the coding exon of a target gene using CRISPR/Cas9 technology and homology-directed repair. As its sequence is derived from an artificial intron, the cassette is removed by the splicing machinery and thus leaves no trace in the "off-state". Upon activation with Cre recombinase ("on-state"), the intron is crippled and the target gene is disrupted by a series of stop codons. We exemplify the utility of this approach on several nonessential and essential human genes. Clones bearing the conditional knockout cassette are recovered at frequencies above 5% and cassette function can be traced at the genomic DNA and the mRNA level. Importantly, cassette activation leads to loss of gene expression as judged by flow cytometry, Western blot or immunofluorescence. Altogether, this highlights the broad utility of the approach for conditional gene inactivation and suggests that this tool could be used to study the loss-of-function phenotypes of essential genes.	[Guzzardo, Paloma M.; Rashkova, Christina; Buerckstuemmer, Tilmann] Horizon Genom GmbH, Vienna, Austria; [dos Santos, Rodrigo L.; Tehrani, Raha; Collin, Philippe] Horizon Discovery Ltd, Cambridge, England	Burckstummer, T (reprint author), Horizon Genom GmbH, Vienna, Austria.	t.buerckstuemmer@horizondiscovery.com					Andersson-Rolf A, 2017, NAT METHODS, V14, P287, DOI [10.1038/NMETH.4156, 10.1038/nmeth.4156]; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Buckley DL, 2015, ACS CHEM BIOL, V10, P1831, DOI 10.1021/acschembio.5b00442; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Chen Y, 2013, BIOCHEM BIOPH RES CO, V431, P197, DOI 10.1016/j.bbrc.2012.12.135; Chung HK, 2015, NAT CHEM BIOL, V11, P713, DOI [10.1038/NCHEMBIO.1869, 10.1038/nchembio.1869]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Solis CA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00070; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Gapp BV, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166890; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kim J, 2008, CELL, V133, P1290, DOI 10.1016/j.cell.2008.06.004; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sibley C. R., 2017, EUROPE PMC FUNDERS G, V17, P407; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	24	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 1	2017	7								16770	10.1038/s41598-017-16931-z				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FO5YO	WOS:000416938200078	29196747	gold			2018-01-05	
J	Nagy, G; Szebenyi, C; Csernetics, A; Vaz, AG; Toth, EJ; Vagvolgyi, C; Papp, T				Nagy, Gabor; Szebenyi, Csilla; Csernetics, Arpad; Vaz, Amanda Grace; Toth, Eszter Judit; Vagvolgyi, Csaba; Papp, Tamas			Development of a plasmid free CRISPR-Cas9 system for the genetic modification of Mucor circinelloides	SCIENTIFIC REPORTS			English	Article							HMG-COA REDUCTASE; OXIDATIVE-STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; RHIZOPUS-ORYZAE; CAROTENE PRODUCTION; MEDIATED DELIVERY; EXPRESSION; FUNGI; RNA; TRANSFORMATION	Mucor circinelloides and other members of Mucorales are filamentous fungi, widely used as model organisms in basic and applied studies. Although genetic manipulation methods have been described for some Mucoral fungi, construction of stable integrative transformants by homologous recombination has remained a great challenge in these organisms. In the present study, a plasmid free CRISPR-Cas9 system was firstly developed for the genetic modification of a Mucoral fungus. The described method offers a rapid but robust tool to obtain mitotically stable mutants of M. circinelloides via targeted integration of the desired DNA. It does not require plasmid construction and its expression in the recipient organism. Instead, it involves the direct introduction of the guide RNA and the Cas9 enzyme and, in case of homology directed repair (HDR), the template DNA into the recipient strain. Efficiency of the method for non-homologous end joining (NHEJ) and HDR was tested by disrupting two different genes, i.e. carB encoding phytoene dehydrogenase and hmgR2 encoding 3-hydroxy-3-methylglutaryl-CoA reductase, of M. circinelloides. Both NHEJ and HDR resulted in stable gene disruption mutants. While NHEJ caused extensive deletions upstream from the protospacer adjacent motif, HDR assured the integration of the deletion cassette at the targeted site.	[Nagy, Gabor; Szebenyi, Csilla; Csernetics, Arpad; Vaz, Amanda Grace; Toth, Eszter Judit; Papp, Tamas] Univ Szeged, Hungarian Acad Sci, MTA SZTE Fungal Pathogen Mech Res Grp, Kozep Fasor 52, H-6726 Szeged, Hungary; [Szebenyi, Csilla; Csernetics, Arpad; Vaz, Amanda Grace; Toth, Eszter Judit; Vagvolgyi, Csaba; Papp, Tamas] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Kozep Fasor 52, H-6726 Szeged, Hungary	Papp, T (reprint author), Univ Szeged, Hungarian Acad Sci, MTA SZTE Fungal Pathogen Mech Res Grp, Kozep Fasor 52, H-6726 Szeged, Hungary.; Papp, T (reprint author), Univ Szeged, Fac Sci & Informat, Dept Microbiol, Kozep Fasor 52, H-6726 Szeged, Hungary.	pappt@bio.u-szeged.hu		Vagvolgyi, Csaba/0000-0003-0009-7773	Hungarian Academy of Sciences [LP2016-8/2016]; Hungarian Academy of Sciences Postdoctoral Research Programme [45.0.080];  [GINOP-2.3.2-15-2016-00035]	This study was supported by the "Momentum" Grant of the Hungarian Academy of Sciences (LP2016-8/2016) and the project GINOP-2.3.2-15-2016-00035. A.Cs. is supported by the Hungarian Academy of Sciences Postdoctoral Research Programme (Postdoc-16, 45.0.080).	Arras SDM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164322; Avalos J, 2015, CURR GENET, V61, P309, DOI 10.1007/s00294-014-0454-x; Babu P. D., 2009, World Journal of Dairy & Food Sciences, V4, P22; Bidle KA, 2007, EXTREMOPHILES, V11, P49, DOI 10.1007/s00792-006-0008-3; Branco MR, 2004, J BIOL CHEM, V279, P6501, DOI 10.1074/jbc.M311818200; Camino LP, 2015, FUNGAL BIOL-UK, V119, P1007, DOI 10.1016/j.funbio.2015.07.005; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Corrochano LM, 2016, CURR BIOL, V26, P1577, DOI 10.1016/j.cub.2016.04.038; Corrochano LM, 2010, FUNGAL GENET BIOL, V47, P893, DOI 10.1016/j.fgb.2010.04.007; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Enkler L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35766; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Garre V, 2015, FUNG BIOL-US, P49, DOI 10.1007/978-3-319-10142-2_4; Gebremariam T, 2014, J CLIN INVEST, V124, P237, DOI 10.1172/JCI71349; Gutierrez A, 2011, J MICROBIOL METH, V84, P442, DOI 10.1016/j.mimet.2011.01.002; Higgins VJ, 2003, APPL ENVIRON MICROB, V69, P4777, DOI 10.1128/AEM.69.8.4777-4787.2003; Kavanagh K, 2007, GENETIC MANIPULATION, P305; Ibrahim AS, 2010, MOL MICROBIOL, V77, P587, DOI 10.1111/j.1365-2958.2010.07234.x; Katragkou A, 2014, CLIN MICROBIOL INFEC, V20, P74, DOI 10.1111/1469-0691.12466; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kuzina V, 2007, APPL MICROBIOL BIOT, V76, P991, DOI 10.1007/s00253-007-1069-7; Lee SC, 2015, MOL MICROBIOL, V97, P844, DOI 10.1111/mmi.13071; Lee SC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003625; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu JJ, 2016, APPL ENVIRON MICROB, V82, P2280, DOI 10.1128/AEM.00057-16; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Marisco G, 2011, YEAST, V28, P363, DOI 10.1002/yea.1844; Meussen BJ, 2012, APPL MICROBIOL BIOT, V94, P875, DOI 10.1007/s00253-012-4033-0; Michielse CB, 2004, MOL GENET GENOMICS, V271, P499, DOI 10.1007/s00438-004-1003-y; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; NAGY A, 1994, CURR GENET, V26, P45, DOI 10.1007/BF00326303                                                              ; Nagy G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-93; Nicolas FE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1443-2; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Papp T, 2006, APPL MICROBIOL BIOT, V69, P526, DOI 10.1007/s00253-005-0026-6; Papp T, 2012, METHOD MOL BIOL, P123; Papp T, 2016, FUNG BIOL-US, P97, DOI 10.1007/978-3-319-27951-0_4; Papp T, 2013, APPL MICROBIOL BIOT, V97, P4937, DOI 10.1007/s00253-012-4610-2; Papp T, 2010, PROGRESS IN MYCOLOGY, P75, DOI 10.1007/978-90-481-3713-8_3; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Riley TT, 2016, ANN PHARMACOTHER, V50, P747, DOI 10.1177/1060028016655425; Ruiz-Vazquez RM, 2015, ADV GENET, V91, P55, DOI 10.1016/bs.adgen.2015.07.002; Shi TQ, 2017, APPL MICROBIOL BIOT, V101, P7435, DOI 10.1007/s00253-017-8497-9; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Torres-Martinez S., 2012, MICROBIAL CAROTENOID, P85; Valle-Maldonado MI, 2015, MOL BIOL REP, V42, P705, DOI 10.1007/s11033-014-3818-x; VANHEESWIJCK R, 1984, CARLSBERG RES COMMUN, V49, P691, DOI 10.1007/BF02907500                                                              ; Vaupotic T, 2008, STUD MYCOL, P61, DOI 10.3114/sim.2008.61.05; Vincent J.H, 2003, APPL ENVIRON MICROB, V67, P4777; Voigt K, 2016, BIOCH MOL BIOL, VIII, P361; Wang GY, 2002, METAB ENG, V4, P193, DOI 10.1006/mben.2002.0225; Wang LQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003027; Wostemeyer J, 2016, MYCOTA, V1, P203; Yan GL, 2012, CURR MICROBIOL, V64, P159, DOI 10.1007/s00284-011-0044-9; Zhang GC, 2014, APPL ENVIRON MICROB, V80, P7694, DOI 10.1128/AEM.02310-14; Zhang YT, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0493-8; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	65	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 1	2017	7								16800	10.1038/s41598-017-17118-2				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FO5YO	WOS:000416938200108	29196656	gold			2018-01-05	
J	Taketani, Y; Kitamoto, K; Sakisaka, T; Kimakura, M; Toyono, T; Yamagami, S; Amano, S; Kuroda, M; Moore, T; Usui, T; Ouchi, Y				Taketani, Yukako; Kitamoto, Kohdai; Sakisaka, Toshihiro; Kimakura, Mikiko; Toyono, Tetsuya; Yamagami, Satoru; Amano, Shiro; Kuroda, Masahiko; Moore, Tara; Usui, Tomohiko; Ouchi, Yasuo			Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR/Cas9-induced homology-directed repair	SCIENTIFIC REPORTS			English	Article							CRISPR-CAS SYSTEMS; HUMAN-CELLS; MUTATIONS; CLASSIFICATION; GENOMES; MOUSE; DNA	Granular corneal dystrophy (GCD) is an autosomal dominant hereditary disease in which multiple discrete and irregularly shaped granular opacities are deposited in the corneal stroma. GCD is caused by a point mutation in the transforming growth factor-beta-induced (TGFBI) gene, located on chromosome 5q31. Here, we report the first successful application of CRISPR-Cas9-mediated genome editing for the correction of a TGFBI mutation in GCD patient-derived primary corneal keratocytes via homology-directed repair (HDR). To correct genetic defects in GCD patient cells, we designed a disease-specific guide RNA (gRNA) targeting the R124H mutation of TGFBI, which causes GCD type 2 (GCD2). An R124H mutation in primary human corneal keratocytes derived from a GCD2 patient was corrected by delivering a CRISPR plasmid expressing Cas9/gRNA and a single-stranded oligodeoxynucleotide HDR donor template in vitro. The gene correction efficiency was 20.6% in heterozygous cells and 41.3% in homozygous cells. No off-target effects were detected. These results reveal a new therapeutic strategy for GCD2; this method may also be applicable to other heredity corneal diseases.	[Taketani, Yukako; Kitamoto, Kohdai; Sakisaka, Toshihiro; Kimakura, Mikiko; Toyono, Tetsuya; Usui, Tomohiko] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yamagami, Satoru] Nihon Univ, Itabashi Hosp, Tokyo, Japan; [Amano, Shiro] Inoue Eye Hosp, Tokyo, Japan; [Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Moore, Tara] Ulster Univ, Biomed Sci Res Inst, Ctr Mol Biosci, Coleraine, Londonderry, North Ireland; [Moore, Tara] Avellino Labs, Menlo Pk, CA USA; [Ouchi, Yasuo] Chiba Univ, Sch Med, Dept Mucosal Immunol, Chiba, Japan	Usui, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.; Ouchi, Y (reprint author), Chiba Univ, Sch Med, Dept Mucosal Immunol, Chiba, Japan.	tomohiko-tky@umin.ac.jp; o-yasuo@chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology. We would like to thank Azusa Nakamura, assistant researcher, for her assistance with the experiments.	Akiya S, 1999, OPHTHALMOLOGICA, V213, P58, DOI 10.1159/000027395; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Dinh R, 1999, OPHTHALMOLOGY, V106, P1490, DOI 10.1016/S0161-6420(99)90441-4; DUBORD PJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P788; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kim HS, 2001, CORNEA, V20, P844, DOI 10.1097/00003226-200111000-00013; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mallet JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162212; Mashima Y, 2000, AM J OPHTHALMOL, V130, P516, DOI 10.1016/S0002-9394(00)00571-7; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sakai R, 2002, INVEST OPHTH VIS SCI, V43, P1749; Stechschulte SU, 2001, INVEST OPHTH VIS SCI, V42, P1975; STUART JC, 1975, AM J OPHTHALMOL, V79, P18, DOI 10.1016/0002-9394(75)90451-1                                                    ; Toyono T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116838; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Wiles MV, 2015, MAMM GENOME, V26, P501, DOI 10.1007/s00335-015-9565-z; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yamagami S, 2007, OPHTHALMOLOGY, V114, P433, DOI 10.1016/j.ophtha.2006.07.042; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	36	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 1	2017	7								16713	10.1038/s41598-017-16308-2				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FO5YO	WOS:000416938200021	29196743	gold			2018-01-05	
J	Pal, K; Bystry, V; Reigl, T; Demko, M; Krejci, A; Touloumenidou, T; Stalika, E; Tichy, B; Ghia, P; Stamatopoulos, K; Pospisilova, S; Malcikova, J; Darzentas, N				Pal, Karol; Bystry, Vojtech; Reigl, Tomas; Demko, Martin; Krejci, Adam; Touloumenidou, Tasoula; Stalika, Evangelia; Tichy, Boris; Ghia, Paolo; Stamatopoulos, Kostas; Pospisilova, Sarka; Malcikova, Jitka; Darzentas, Nikos		European Res Initiative CLL ERIC-T	GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data	BIOINFORMATICS			English	Article							P53	Motivation: Sanger sequencing is still being employed for sequence variant detection by many laboratories, especially in a clinical setting. However, chromatogram interpretation often requires manual inspection and in some cases, considerable expertise. Results: We present GLASS, a web-based Sanger sequence trace viewer, editor, aligner and variant caller, built to assist with the assessment of variations in 'curated' or user-provided genes. Critically, it produces a standardized variant output as recommended by the Human Genome Variation Society.	[Pal, Karol; Bystry, Vojtech; Reigl, Tomas; Demko, Martin; Krejci, Adam; Tichy, Boris; Pospisilova, Sarka; Malcikova, Jitka; Darzentas, Nikos] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Touloumenidou, Tasoula] G Papanicolaou Hosp, Hematol Dept, Thessaloniki, Greece; [Touloumenidou, Tasoula] G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece; [Stalika, Evangelia; Stamatopoulos, Kostas] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece; [Ghia, Paolo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, IRCCS, Div Mol Oncol,Dept Oncohematol, Milan, Italy; [Pospisilova, Sarka; Malcikova, Jitka] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic	Malcikova, J; Darzentas, N (reprint author), Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic.; Malcikova, J (reprint author), Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic.	malcikova.jitka@fnbrno.cz; nikos.darzentas@gmail.com			Faculty of Medicine, Masaryk University [MUNI/A//1106/2016]; CEITEC [LQ1601]; EU's Horizon [692298]; Ministry of Health of the Czech Republic [16-34272A]; MEYS-NPS [I-LO1413]; NCMG research infrastructure (MEYS CR) [LM2015091]; MetaCentrum [LM2010005]; CERIT-SC (CERIT Scientific Cloud, Operational Program Research and Development for Innovations) [CZ.1.05/3.2.00/08.0144];  [TEO2000058/2014-2019]	This work was supported by Faculty of Medicine, Masaryk University MUNI/A//1106/2016; CEITEC 2020 (LQ1601); TEO2000058/2014-2019; EU's Horizon 2020 No. 692298 (MEDGENET); Ministry of Health of the Czech Republic grant nr. 16-34272A; MEYS-NPS I-LO1413; NCMG research infrastructure (LM2015091, MEYS CR). Computational resources by MetaCentrum (LM2010005) and CERIT-SC (CERIT Scientific Cloud, Operational Program Research and Development for Innovations, Reg. no. CZ.1.05/3.2.00/08.0144).	Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Flaman JM, 1996, ONCOGENE, V12, P813; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963	3	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	DEC 1	2017	33	23					3802	3804		10.1093/bioinformatics/btx423				3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FO6UQ	WOS:000417004100017	29036643				2018-01-05	
J	Wang, XN; Tilford, C; Neuhaus, I; Mintier, G; Guo, Q; Feder, JN; Kirov, S				Wang, Xuning; Tilford, Charles; Neuhaus, Isaac; Mintier, Gabe; Guo, Qi; Feder, John N.; Kirov, Stefan			CRISPR-DAV: CRISPR NGS data analysis and visualization pipeline	BIOINFORMATICS			English	Article							GENOME EDITING ASSESSMENT; ANALYZER; REPAIR	A Summary: The simplicity and precision of CRISPR/Cas9 system has brought in a new era of gene editing. Screening for desired clones with CRISPR-mediated genomic edits in a large number of samples is made possible by next generation sequencing (NGS) due to its multiplexing. Here we present CRISPR-DAV (CRISPR Data Analysis and Visualization) pipeline to analyze the CRISPR NGS data in a high throughput manner. In the pipeline, Burrows-Wheeler Aligner and Assembly Based ReAlignment are used for small and large indel detection, and results are presented in a comprehensive set of charts and interactive alignment view.	[Wang, Xuning; Tilford, Charles; Neuhaus, Isaac; Kirov, Stefan] Bristol Myers Squibb Co, Translat Bioinformat & Computat Genom, Pennington, NJ 08534 USA; [Mintier, Gabe; Feder, John N.] Bristol Myers Squibb Co, Leads Discovery & Optimizat, Pennington, NJ 08534 USA; [Guo, Qi] Bristol Myers Squibb Co, Genome Biol, Pennington, NJ 08534 USA	Wang, XN (reprint author), Bristol Myers Squibb Co, Translat Bioinformat & Computat Genom, Pennington, NJ 08534 USA.	xuning.wang@bms.com					Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Boel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30330; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026	12	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	DEC 1	2017	33	23					3811	3812		10.1093/bioinformatics/btx518				2	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FO6UQ	WOS:000417004100020	28961906				2018-01-05	
J	Kim, K; Ryu, D; Dongiovanni, P; Ozcan, L; Nayak, S; Ueberheide, B; Valenti, L; Auwerx, J; Pajvani, UB				Kim, KyeongJin; Ryu, Dongryeol; Dongiovanni, Paola; Ozcan, Lale; Nayak, Shruti; Ueberheide, Beatrix; Valenti, Luca; Auwerx, Johan; Pajvani, Utpal B.			Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis	GASTROENTEROLOGY			English	Article						Triglyceride; Insulin Signaling; Gene Regulation; Signal Transduction	FATTY LIVER-DISEASE; RECEPTOR KNOCKOUT MICE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; LIPID-METABOLISM; POSTPRANDIAL HYPERGLYCEMIA; BLOOD-GLUCOSE; OB/OB MICE; LIPOGENESIS; AKT	BACKGROUND & AIMS: Obesity-induced nonalcoholic fatty liver disease (NAFLD) develops, in part, via excess insulin-stimulated hepatic de novo lipogenesis, which increases, paradoxically, in patients with obesity-induced insulin resistance. Pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) terminates insulin signaling by dephosphorylating Akt; levels of PHLPP2 are reduced in livers from obese mice. We investigated whether loss of hepatic PHLPP2 is sufficient to induce fatty liver in mice, mechanisms of PHLPP2 degradation in fatty liver, and expression of genes that regulate PHLPP2 in livers of patients with NAFLD. METHODS: C57BL/6J mice (controls), obese db/db mice, and mice with liver-specific deletion of PHLPP2 (L-PHLPP2) fed either normal chow or high-fat diet (HFD) were analyzed for metabolic phenotypes, including glucose tolerance and hepatic steatosis. PHLPP2-deficient primary hepatocytes or CRISPR/Cas9-mediated PHLPP2-knockout hepatoma cells were analyzed for insulin signaling and gene expression. We performed mass spectrometry analyses of liver tissues from C57BL/6J mice transduced with Ad-HA-Flag-PHLPP2 to identify posttranslational modifications to PHLPP2 and proteins that interact with PHLPP2. We measured levels of mRNAs by quantitative reverse transcription polymerase chain reaction in liver biopsies from patients with varying degrees of hepatic steatosis. RESULTS: PHLPP2-knockout hepatoma cells and hepatocytes from L-PHLPP2 mice showed normal initiation of insulin signaling, but prolonged insulin action. Chow-fed L-PHLPP2 mice had normal glucose tolerance but hepatic steatosis. In HFD-fed C57BL/6J or db/db obese mice, endogenous PHLPP2 was degraded by glucagon and PKA-dependent phosphorylation of PHLPP2 (at Ser1119 and Ser1210), which led to PHLPP2 binding to potassium channel tetramerization domain containing 17 (KCTD17), a substrate-adaptor for Cul3-RING ubiquitin ligases. Levels of KCTD17 mRNA were increased in livers of HFD-fed C57BL/6J or db/db obese mice and in liver biopsies patients with NAFLD, compared with liver tissues from healthy control mice or patients without steatosis. Knockdown of KCTD17 with small hairpin RNA in primary hepatocytes increased PHLPP2 protein but not Phlpp2 mRNA, indicating that KCTD17 mediates PHLPP2 degradation. KCTD17 knockdown in obese mice prevented PHLPP2 degradation and decreased expression of lipogenic genes. CONCLUSIONS: In mouse models of obesity, we found that PHLPP2 degradation induced lipogenesis without affecting gluconeogenesis. KCTD17, which is up-regulated in liver tissues of obese mice and patients with NAFLD, binds to phosphorylated PHLPP2 to target it for ubiquitin-mediated degradation; this increases expression of genes that regulate lipogenesis to promote hepatic steatosis. Inhibitors of this pathway might be developed for treatment of patients with NAFLD.	[Kim, KyeongJin; Ozcan, Lale; Pajvani, Utpal B.] Columbia Univ, Dept Med, Russ Berrie Med Sci Pavilionm 1150 St, New York, NY 10032 USA; [Ryu, Dongryeol; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Ryu, Dongryeol] Pusan Natl Univ, Sch Korean Med & Hlth Aging Korean Med Res Ctr, Dept Korean Med Sci, Busan, South Korea; [Dongiovanni, Paola; Valenti, Luca] Univ Milan, DEPT, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med & Metab Dis, Milan, Italy; [Nayak, Shruti; Ueberheide, Beatrix] NYU, Sch Med, Prote Lab, Div Adv Res & Technol, New York, NY USA; [Ueberheide, Beatrix] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY USA	Pajvani, UB (reprint author), Columbia Univ, Dept Med, Russ Berrie Med Sci Pavilionm 1150 St, New York, NY 10032 USA.	up2104@columbia.edu			National Institutes of Health [DK103818, AG043930]; Edward Mallinckrodt, Jr. Foundation Grant; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation [31003A- 140780]; Swiss Initiative for Systems Biology [51RTP0-151019]; MyFirst AIRC [16888]; Paul Marks Scholarship; Pusan National University Research Grant	This work was supported by National Institutes of Health grant DK103818 (UBP) and AG043930 (JA), an Edward Mallinckrodt, Jr. Foundation Grant (UBP), the Ecole Polytechnique Federale de Lausanne (JA), the Swiss National Science Foundation (31003A- 140780; JA), the AgingX program of the Swiss Initiative for Systems Biology (51RTP0-151019; JA), MyFirst AIRC Grant (16888; LV), a Paul Marks Scholarship (UBP) and Pusan National University Research Grant 2017 (DR).	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Balasubramanian D, 2016, MBIO, V7, DOI 10.1128/mBio.00818-16; Bern M., 2012, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI1320S40; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BUTLER PC, 1991, DIABETES, V40, P73, DOI 10.2337/diabetes.40.1.73                                                        ; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inaba H, 2016, J CELL BIOL, V212, P409, DOI 10.1083/jcb.201507046; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Ji AX, 2016, J MOL BIOL, V428, P92, DOI 10.1016/j.jmb.2015.08.019; Kasahara K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6081; Kazierad DJ, 2016, DIABETES OBES METAB, V18, P795, DOI 10.1111/dom.12672; Kelly RP, 2015, DIABETES OBES METAB, V17, P414, DOI 10.1111/dom.12446; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim KC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12449; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; LEFEBVRE PJ, 1995, DIABETES CARE, V18, P715, DOI 10.2337/diacare.18.5.715                                                        ; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Pajvani UB, 2015, DIABETOLOGIA, V58, P2459, DOI 10.1007/s00125-015-3722-5; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Summers SA, 1997, BIOCHEM SOC T, V25, P981, DOI 10.1042/bst0250981                                                              ; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Valenti L, 2016, LIVER INT, V36, P1563, DOI 10.1111/liv.13185; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Williams EG, 2016, SCIENCE, V352, DOI 10.1126/science.aad0189; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	49	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2017	153	6					1568	+		10.1053/j.gastro.2017.08.039				23	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FO5WU	WOS:000416933500027	28859855				2018-01-05	
J	Engelholm, LH; Riaz, A; Serra, D; Dagnaes-Hansen, F; Johansen, JV; Santoni-Rugiu, E; Hansen, SH; Niola, F; Froin, M				Engelholm, Lars H.; Riaz, Anjum; Serra, Denise; Dagnaes-Hansen, Frederik; Johansen, Jens V.; Santoni-Rugiu, Eric; Hansen, Steen H.; Niola, Francesco; Froedin, Morten			CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma	GASTROENTEROLOGY			English	Article						Liver Cancer; Protein Kinase A; PKA; Genomic Engineering; Mouse Model	CLINICOPATHOLOGICAL FEATURES; CHROMOSOMAL REARRANGEMENTS; CANCER; EXPRESSION; ENRICHMENT; REVEALS; MUTATIONS; SIGNATURE; SAMPLES; SYSTEM	BACKGROUND & AIMS: Fibrolamellar hepatocellular carcinoma (FL-HCC) is a primary liver cancer that predominantly affects children and young adults with no underlying liver disease. A somatic, 400 Kb deletion on chromosome 19 that fuses part of the DnaJ heat shock protein family (Hsp40) member B1 gene (DNAJB1) to the protein kinase cAMP-activated catalytic subunit alpha gene (PRKACA) has been repeatedly identified in patients with FL-HCC. However, the DNAJB1-PRKACA gene fusion has not been shown to induce liver tumorigenesis. We used the CRISPR/Cas9 technique to delete in mice the syntenic region on chromosome 8 to create a Dnajb1-Prkaca fusion and monitored the mice for liver tumor development. METHODS: We delivered CRISPR/Cas9 vectors designed to juxtapose exon 1 of Dnajb1 with exon 2 of Prkaca to create the Dnajb1-Prkaca gene fusion associated with FL-HCC, or control Cas9 vector, via hydrodynamic tail vein injection to livers of 8-week-old female FVB/N mice. These mice did not have any other engineered genetic alterations and were not exposed to liver toxins or carcinogens. Liver tissues were collected 14 months after delivery; genomic DNA was analyzed by PCR to detect the Dnajb1-Prkaca fusion, and tissues were characterized by histology, immunohistochemistry, RNA sequencing, and whole-exome sequencing. RESULTS: Livers from 12 of the 15 mice given the vectors to induce the Dnajb1-Prkaca gene fusion, but none of the 11 mice given the control vector, developed neoplasms. The tumors contained the Dnajb1-Prkaca gene fusion and had histologic and cytologic features of human FL-HCCs: large polygonal cells with granular, eosinophilic, and mitochondria-rich cytoplasm, prominent nucleoli, and markers of hepatocytes and cholangiocytes. In comparing expression levels of genes between the mouse tumor and non-tumor liver cells, we identified changes similar to those detected in human FL-HCC, which included genes that affect cell cycle and mitosis regulation. Genomic analysis of mouse neoplasms induced by the Dnajb1-Prkaca fusion revealed a lack of mutations in genes commonly associated with liver cancers, as observed in human FL-HCC. CONCLUSIONS: Using CRISPR/Cas9 technology, we found generation of the Dnajb1-Prkaca fusion gene in wild-type mice to be sufficient to initiate formation of tumors that have many features of human FL-HCC. Strategies to block DNAJB1-PRKACA might be developed as therapeutics for this form of liver cancer.	[Engelholm, Lars H.] Rigshosp, Finsen Lab, Copenhagen, Denmark; [Engelholm, Lars H.; Riaz, Anjum; Serra, Denise; Johansen, Jens V.; Hansen, Steen H.; Niola, Francesco; Froedin, Morten] Univ Copenhagen, Fac Hlth & Med Sci, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Santoni-Rugiu, Eric] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark; [Hansen, Steen H.] Boston Childrens Hosp, GI Cell Biol Res Lab, Boston, MA USA; [Hansen, Steen H.] Harvard Med Sch, Boston, MA USA	Niola, F; Froin, M (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	francesco.niola@outlook.com; morten.frodin@bric.ku.dk			Danish Cancer Society [R146-A9563-B3551, R124-A7632-15-S2]; Danish Council for Independent Research [DFF-Mobilex 4092-00235, 0602-02368B]; Lundbeck Foundation [R165-2013-15743]; University of Copenhagen Excellence Programme for Interdisciplinary Research-CDO; NIH [R01 CA205158, R21 CA184656]; Roy and Lynne Frank Foundation	This work was supported by the Danish Cancer Society (R146-A9563-B3551 to F.N. and R124-A7632-15-S2 to M.F.), the Danish Council for Independent Research (DFF-Mobilex 4092-00235 to F.N. and 0602-02368B to M.F.), the Lundbeck Foundation (R165-2013-15743 to F.N.), the University of Copenhagen Excellence Programme for Interdisciplinary Research-CDO2016 (to M.F.) and NIH R01 CA205158, R21 CA184656 and an endowed investigatorship from the Roy and Lynne Frank Foundation (to S.H.H.).	Abdul-Al HM, 2010, INT J SURG PATHOL, V18, P313, DOI 10.1177/1066896910364229; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BERMAN MA, 1988, HUM PATHOL, V19, P784, DOI 10.1016/S0046-8177(88)80261-2; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; ClinicalTrials.gov, MULT OP LAB STUD OR; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornella H, 2015, GASTROENTEROLOGY, V148, P806, DOI 10.1053/j.gastro.2014.12.028; CRAIG JR, 1980, CANCER, V46, P372, DOI 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Dagnaes-Hansen F, 2002, J MOL MED-JMM, V80, P665, DOI 10.1007/s00109-002-0371-1; Darcy DG, 2015, ONCOTARGET, V6, P755, DOI 10.18632/oncotarget.2712                                                        ; Dinh TA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44653; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El-Serag HB, 2004, HEPATOLOGY, V39, P798, DOI 10.1002/hep.20096; FARHI DC, 1982, CANCER, V50, P702, DOI 10.1002/1097-0142(19820815)50:4<702::AID-CNCR2820500414>3.0.CO;2-F; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Graham RP, 2015, MODERN PATHOL, V28, P822, DOI 10.1038/modpathol.2015.4; Griffith OL, 2016, ANN ONCOL, V27, P1148, DOI 10.1093/annonc/mdw135; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; HODGSON HJF, 1987, J HEPATOL, V5, P241, DOI 10.1016/S0168-8278(87)80580-9; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Kakar S, 2005, MODERN PATHOL, V18, P1417, DOI 10.1038/modpathol.3800449; Katsha A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0375-4; Lagana SM, 2013, APPL IMMUNOHISTO M M, V21, P254, DOI 10.1097/PAI.0b013e3182642c9c; Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Malouf GG, 2014, HEPATOLOGY, V59, P2228, DOI 10.1002/hep.27018; Oikawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9070; PAYNE CM, 1986, ULTRASTRUCT PATHOL, V10, P539, DOI 10.3109/01913128609007211                                                       ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riggle KM, 2016, PEDIATR BLOOD CANCER, V63, P1163, DOI 10.1002/pbc.25970; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross HM, 2011, MODERN PATHOL, V24, P390, DOI 10.1038/modpathol.2010.207; Rosti G, 2017, NAT REV CLIN ONCOL, V14, P141, DOI 10.1038/nrclinonc.2016.139; Simon EP, 2015, P NATL ACAD SCI USA, V112, pE5916, DOI 10.1073/pnas.1424894112; Sorenson EC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176562; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torbenson M., 2012, SCI CAIRO, V2012; Torbenson M, 2007, ADV ANAT PATHOL, V14, P217, DOI 10.1097/PAP.0b013e3180504913                                                    ; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward SC, 2011, SEMIN LIVER DIS, V31, P61, DOI 10.1055/s-0031-1272835; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105; Xu L, 2015, HUM MOL GENET, V24, P50, DOI 10.1093/hmg/ddu418; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	52	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2017	153	6					1662	+		10.1053/j.gastro.2017.09.008				22	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FO5WU	WOS:000416933500034	28923495	gold			2018-01-05	
J	Li, YY; Wang, R; Qiao, N; Peng, GD; Zhang, K; Tang, K; Han, JDJ; Jing, NH				Li, Yuanyuan; Wang, Ran; Qiao, Nan; Peng, Guangdun; Zhang, Ke; Tang, Ke; Han, Jing-Dong J.; Jing, Naihe			Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; human; neurodevelopment; neurodifferentiation; transcriptomics	CEREBRAL-CORTEX DEVELOPMENT; SEPTO-OPTIC DYSPLASIA; MOUSE EMBRYO; NEURAL-STEM; HUMAN NEUROECTODERM; HESX1 MUTATIONS; HUMAN BRAIN; DIRECTED DIFFERENTIATION; CLINICAL SPECTRUM; GENE-FUNCTION	Proper neural commitment is essential for ensuring the appropriate development of the human brain and for preventing neurodevelopmental diseases such as autism spectrum disorders, schizophrenia, and intellectual disorders. However, the molecular mechanisms underlying the neural commitment in humans remain elusive. Here, we report the establishment of a neural differentiation system based on human embryonic stem cells (hESCs) and on comprehensive RNA sequencing analysis of transcriptome dynamics during early hESC differentiation. Using weighted gene co-expression network analysis, we reveal that the hESC neurodevelopmental trajectory has five stages: pluripotency (day 0); differentiation initiation (days 2, 4, and 6); neural commitment (days 8-10); neural progenitor cell proliferation (days 12, 14, and 16); and neuronal differentiation (days 18, 20, and 22). These stages were characterized by unique module genes, which may recapitulate the early human cortical development. Moreover, a comparison of our RNA-sequencing data with several other transcriptome profiling datasets from mice and humans indicated that Module 3 associated with the day 8-10 stage is a critical window of fate switch from the pluripotency to the neural lineage. Interestingly, at this stage, no key extrinsic signals were activated. In contrast, using CRISPR/Cas9-mediated gene knockouts, we also found that intrinsic hub transcription factors, including the schizophrenia-associated SIX3 gene and septo-optic dysplasia-related HESX1 gene, are required to program hESC neural determination. Our results improve the understanding of the mechanism of neural commitment in the human brain and may help elucidate the etiology of human mental disorders and advance therapies for managing these conditions.	[Li, Yuanyuan; Wang, Ran; Peng, Guangdun; Zhang, Ke; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Qiao, Nan; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Key Lab Computat Biol, Chinese Acad Sci Max Planck Partner Inst Computat, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China; [Jing, Naihe] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Jing, NH (reprint author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Jing, NH (reprint author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	njing@sibcb.ac.cn			"Strategic Priority Research Program" of the Chinese Academy of Sciences Grant [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [31430058, 31571513, 31630043, 91519314, 31661143042]	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01010201, National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and National Natural Science Foundation of China Grants 31430058, 31571513, 31630043, 91519314, and 31661143042. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI 10.1038/NMETH.2728; Bhinge A, 2014, EMBO J, V33, P1271, DOI 10.1002/embj.201387215; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Cajal M, 2012, DEVELOPMENT, V139, P423, DOI 10.1242/dev.075499; Carlin D, 2012, DEVELOPMENT, V139, P2614, DOI 10.1242/dev.076018; Carvalho LR, 2003, J CLIN INVEST, V112, P1192, DOI 10.1172/JCI200318589; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Chovsepian A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00036; Cohen RN, 2003, J CLIN ENDOCR METAB, V88, P4832, DOI 10.1210/jc.2002-021868; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hehr U, 2010, HUM GENET, V127, P555, DOI 10.1007/s00439-010-0797-4; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kostovic I, 2006, DEV MED CHILD NEUROL, V48, P388, DOI 10.1017/S0012162206000831; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lacbawan F, 2009, J MED GENET, V46, P389, DOI 10.1136/jmg.2008.063818; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Ozair MZ, 2013, WIRES DEV BIOL, V2, P479, DOI 10.1002/wdev.90; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Parish EV, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0311-6; Pasquier L, 2000, EUR J HUM GENET, V8, P797, DOI 10.1038/sj.ejhg.5200540                                                         ; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ribeiro LA, 2006, AM J MED GENET A, V140A, P2577, DOI 10.1002/ajmg.a.31377; Sansom S. N., 2009, COLD SPRING HARB PER, V1; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sobrier ML, 2006, J CLIN ENDOCR METAB, V91, P4528, DOI 10.1210/jc.2006-0426; Solomon BD, 2009, AM J MED GENET A, V149A, P919, DOI 10.1002/ajmg.a.32813; Strangward P, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006267; Tajima T, 2003, J CLIN ENDOCR METAB, V88, P45, DOI 10.1210/jc.2002-02818; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wallis DE, 1999, NAT GENET, V22, P196; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weinstein DC, 1997, CURR OPIN NEUROBIOL, V7, P7, DOI 10.1016/S0959-4388(97)80114-6                                                   ; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Yeung J, 2016, J NEUROSCI, V36, P9057, DOI 10.1523/JNEUROSCI.4385-15.2016; Yoo YD, 2011, STEM CELLS, V29, P1975, DOI 10.1002/stem.758; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhu QQ, 2014, ELIFE, V3, DOI 10.7554/eLife.02224	76	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19590	19604		10.1074/jbc.M117.796383				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO5OZ	WOS:000416911300005					2018-01-05	
J	Zhao, N; Wang, G; Das, AT; Berkhout, B				Zhao, Na; Wang, Gang; Das, Atze T.; Berkhout, Ben			Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article						HIV; CRISPR-Cas9; RNAi; combination therapy; escape; resistance; HIV-1; RNA interference; antiretroviral resistance	CD4 T-CELLS; LENTIVIRAL VECTOR; CRISPR/CAS9 SYSTEM; HEMATOPOIETIC STEM; VIRAL ESCAPE; GUIDE RNAS; REPLICATION; INFECTION; APPEARANCE; EVOLUTION	Many potent antiviral drugs have been developed against HIV-1, and their combined action is usually successful in achieving durable virus suppression in infected individuals. This success is based on two effects: additive or even synergistic virus inhibition and an increase in the genetic threshold for development of drug resistance. More recently, several genetic approaches have been developed to attack the HIV-1 genome in a gene therapy setting. We set out to test the combinatorial possibilities for a therapy based on the CRISPR-Cas9 and RNA interference (RNAi) mechanisms that attack the viral DNA and RNA, respectively. When two different sites in the HIV-1 genome were targeted, either with dual CRISPR-Cas9 antivirals or with a combination of CRISPR-Cas9 and RNAi antivirals, we observed additive inhibition, much like what was reported for antiviral drugs. However, when the same or overlapping viral sequence was attacked by the antivirals, rapid escape from a CRISPR-Cas9 antiviral, assisted by the error-prone nonhomologous end joining (NHEJ) DNA repair machinery, accelerated the development of cross-resistance to the other CRISPR-Cas9 or RNAi antiviral. Thus, genetic antiviral approaches can be combined, but overlap should be avoided.	[Zhao, Na; Wang, Gang; Das, Atze T.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol, Amsterdam, Netherlands	Das, AT; Berkhout, B (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol, Amsterdam, Netherlands.	a.t.das@amc.uva.nl; b.berkhout@amc.uva.nl			China Scholarship Council	G. Wang is a recipient of a fellowship of the China Scholarship Council.	ANTONELLI G, 1994, ANTIVIR CHEM CHEMOTH, V5, P51, DOI 10.1177/095632029400500108                                                      ; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Centlivre M, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.48; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Gao Y, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-5; Haasnoot Joost, 2009, V189, P243; Herrera-Carrillo E, 2016, BIOCHEM SOC T, V44, P1355, DOI 10.1042/BST20160060; Hill A, 2009, AIDS, V23, P2237, DOI 10.1097/QAD.0b013e328332c3a5; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Keulen W, 1997, J VIROL, V71, P3346; KOBAYASHIISHIHARA, 2012, RETROVIROLOGY, V9, DOI DOI 10.1186/1742-4690-9-38; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; MERMER B, 1990, NUCLEIC ACIDS RES, V18, P2037, DOI 10.1093/nar/18.8.2037                                                           ; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pham H, 2016, METHODS MOL BIOL, V1358, P43, DOI 10.1007/978-1-4939-3067-8_3; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schopman NCT, 2012, ANTIMICROB AGENTS CH, V56, P479, DOI 10.1128/AAC.05491-11; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tebas P, 2013, BLOOD, V121, P1524, DOI 10.1182/blood-2012-07-447250; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Walker JE, 2012, J VIROL, V86, P5719, DOI 10.1128/JVI.06300-11; Wang G, 2016, CELL REP, V17, P2819, DOI 10.1016/j.celrep.2016.11.057; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	40	0	0	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	DEC	2017	61	12							e01486-17	10.1128/AAC.01486-17				10	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	FO2CH	WOS:000416578900056					2018-01-05	
J	Solomon, LA; Batista, CR; DeKoter, RP				Solomon, Lauren A.; Batista, Carolina R.; DeKoter, Rodney P.			Lenalidomide modulates gene expression in human ABC-DLBCL cells by regulating IKAROS interaction with an intronic control region of SPIB	EXPERIMENTAL HEMATOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOMA; DIFFERENTIATION; TRANSCRIPTION; GENOME; PU.1; BCR; PROLIFERATION; ACTIVATION; REPRESSION	Activated B-cell diffuse large B-cell lymphoma (ABC-DLBCL) is associated with a poor prognosis compared with other DLBCL types and therefore represents a top priority for developing novel therapies. Lenalidomide, an immunomodulatory drug in trials for treatment of ABC-DLBCL, targets the transcription factor IKAROS for degradation by the cereblon E3 ubiquitin ligase complex. In this study, we investigated whether the gene encoding the transcription factor SPI-B is a target of IKAROS. Using cultured ABC-DLBCL cell lines, we found that high levels of SPI-B expression conferred resistance to lenalidomide. Lenalidomide treatment of ABC-DLBCL cells resulted in downregulation of SPIB at the level of transcription. SPIB was regulated directly by IKAROS through a binding site located in the first intron of the gene. Inhibition of IKAROS binding using CRISPR/Cas9-mediated transcriptional repression downregulated endogenous SPIB transcription. Finally, ectopic expression of IKAROS protected SPIB from downregulation. These results show that the mechanism of action of lenalidomide in ABC-DLBCL cells involves downregulation of SPIB transcription by cereblon-induced degradation of IKAROS. These results have implications for the design of synthetic lethal therapy for the treatment of ABC-DLBCL. (C) 2017 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.	[Solomon, Lauren A.; Batista, Carolina R.; DeKoter, Rodney P.] Western Univ, Schulich Sch Med & Dent, Ctr Human Immunol, Dept Microbiol & Immunol, London, ON, Canada; [DeKoter, Rodney P.] Lawson Res Inst, Childrens Hlth Res Inst, Div Genet & Dev, London, ON, Canada	DeKoter, RP (reprint author), Western Univ, Schulich Sch Med & Dent, Ctr Human Immunol, Dept Microbiol & Immunol, London, ON, Canada.	rdekoter@uwo.ca			Leukemia & Lymphoma Society of Canada (Toronto, Ontario, Canada); Canadian Institutes of Health Research (Ottawa, Ontario, Canada) [142258]	This work was supported by grants from the Leukemia & Lymphoma Society of Canada (Toronto, Ontario, Canada) and the Canadian Institutes of Health Research (Ottawa, Ontario, Canada) (142258).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arora M, 2016, THER ADV HEMATOL, V7, P209, DOI 10.1177/2040620716652861; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Care MA, 2014, NUCLEIC ACIDS RES, V42, P7588, DOI 10.1093/nar/gku451; Christie DA, 2015, J IMMUNOL, V194, P595, DOI 10.4049/jimmunol.1401569; Dahut WL, 2009, J CLIN PHARMACOL, V49, P650, DOI 10.1177/0091270009335001; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fink EC, 2015, BLOOD, V126, P2366, DOI 10.1182/blood-2015-07-567958; Georgopoulos K, 2017, GENE DEV, V31, P439, DOI [10.1101/gad.297002.117, 10.1101/gad.297002]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014                                                      ; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Li SKH, 2015, MOL CELL BIOL, V35, P1619, DOI 10.1128/MCB.00117-15; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206                                                           ; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pasqualucci L, 2014, CANCER CELL, V25, P132, DOI 10.1016/j.ccr.2013.12.012; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Roschewski M, 2014, NAT REV CLIN ONCOL, V11, P12, DOI 10.1038/nrclinonc.2013.197; Schmidlin H, 2008, BLOOD, V112, P1804, DOI 10.1182/blood-2008-01-136440; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Solomon LA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1303-0; Vitanza NA, 2014, PEDIATR BLOOD CANCER, V61, P1779, DOI 10.1002/pbc.25119; Xu LS, 2012, J IMMUNOL, V189, P3347, DOI 10.4049/jimmunol.1201267; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yokota T, 2016, CANCER SCI, V107, P721, DOI 10.1111/cas.12927; Younes A, 2017, NAT REV CLIN ONCOL, V14, P335, DOI 10.1038/nrclinonc.2016.205; Young RM, 2015, SEMIN HEMATOL, V52, P77, DOI 10.1053/j.seminhematol.2015.01.008; Zhou YS, 2014, BRIT J HAEMATOL, V166, P677, DOI 10.1111/bjh.12936	37	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	DEC	2017	56						46	57		10.1016/j.exphem.2017.09.002				12	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	FO2MT	WOS:000416614100005	28893618				2018-01-05	
J	Chen, J; Xue, J; Ruan, JS; Zhao, J; Tang, BS; Duan, RH				Chen, Jia; Xue, Jin; Ruan, Jingsong; Zhao, Juan; Tang, Beisha; Duan, Ranhui			Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin	FASEB JOURNAL			English	Article						Parkinson disease; E3 ubiquitin ligase; CRISPR	E3 UBIQUITIN LIGASE; AUTOPHAGIC CLEARANCE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; IN-VITRO; DISEASE; MITOPHAGY; DEGRADATION; DEGENERATION; PROTEASOME	Mitochondrial kinase PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin function in a common pathway to regulate mitochondrial homeostasis contributing to the pathogenesis of Parkinson disease. The carboxyl terminus of Hsc70-interacting protein (CHIP) acts as a heat shock protein 70/heat shock protein 90 cochaperone to mediate protein folding or as an E3 ubiquitin ligase to target proteins for degradation. In this study, overexpression of Drosophila CHIP suppressed a range of Pink1 mutant phenotypes in flies, including abnormal wing posture, thoracic indentation, locomotion defects, muscle degeneration, and loss of dopaminergic neurons. Mitochondrial defects of Pink1 mutant, such as excessive fusion, reduced ATP content, and crista disorganization, were rescued by CHIP but not its ligase-dead mutants. Similar phenotypes and mitochondrial impairment were ameliorated in Parkin mutant flies by wild-type CHIP. Inactivation of CHIP with null fly mutants resulted in mitochondrial defects, such as reduced thoracic ATP content at 3 d old, decreased thoracic mitochondrial DNA content, and defective mitochondrial morphology at 60 d old. CHIP mutants did not exacerbate the phenotypes of Pink1 mutant flies but markedly shortened the life span of Parkin mutant flies. These results indicate that CHIP is involved in mitochondrial integrity and may act downstream of Pink1 in parallel with Parkin.-Chen, J., Xue, J., Ruan, J., Zhao, J., Tang, B., Duan, R. Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin.	[Chen, Jia; Xue, Jin; Ruan, Jingsong; Zhao, Juan; Tang, Beisha; Duan, Ranhui] Cent S Univ, Xiangya Hosp, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China	Tang, BS (reprint author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.; Duan, RH (reprint author), State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	bstang7398@163.com; duanranhui@sklmg.edu.cn			National Natural Science Foundation of China [81571253, 81172513, 81071028]; Doctoral Student Autonomous Exploration Project of Central South University [2015zzts091]	The authors thank Z. Zhang, K. Xia, C. Tang, T. Zhang, and R. Wang (State Key Laboratory of Medical Genetics) for technical support and valuable comments. The authors thank the Drosophila Stock Center (Indiana University, Bloomington, IN, USA) and the Tsinghua Fly Center (Tsinghua University, Beijing Shi, China) for fly stocks. This work was supported by National Natural Science Foundation of China (Grants 81571253, 81172513, and 81071028) and the Doctoral Student Autonomous Exploration Project of Central South University (Grant 2015zzts091). The authors declare no conflicts of interest.	Arun S, 2016, CURR NEUROPHARMACOL, V14, P143, DOI 10.2174/1570159X13666150703154541; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Connell P, 2001, NAT CELL BIOL, V3, P93; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4                                                   ; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505                                                           ; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Palubinsky AM, 2015, ANTIOXID REDOX SIGN, V23, P535, DOI 10.1089/ars.2014.6102; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Paul I, 2015, INT J BIOCHEM CELL B, V58, P37, DOI 10.1016/j.biocel.2014.10.027; Paul I, 2014, BIOMED RES INT, DOI 10.1155/2014/918183; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9                                                   ; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton A, 2016, NEURON, V90, P1154, DOI 10.1016/j.neuron.2016.05.040; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2011, ADV GENET, V73, P1, DOI 10.1016/B978-0-12-380860-8.00001-X; Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yung C, 2016, MOL NEUROBIOL, V53, P6270, DOI 10.1007/s12035-015-9537-z; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	64	0	0	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5234	5245		10.1096/fj.201700011R				12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	WOS:000416588300010	28778978				2018-01-05	
J	Machowski, EE; Kana, BD				Machowski, Edith Erika; Kana, Bavesh Davandra			Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article						GeneXpert; Hain MTBDRplus; Mycobacterium smegmatis; Mycobacterium tuberculosis; Staphylococcus aureus; biomimicry; molecular diagnostics; rifampin resistance; tuberculosis	EXTERNAL QUALITY ASSESSMENT; CASSETTE CHROMOSOME MEC; DRIED CULTURE SPOTS; RIFAMPICIN-RESISTANCE; RAPID DETECTION; SOUTH-AFRICA; DNA; CHALLENGES; MUTATIONS; EVOLUTION	Molecular diagnostics have revolutionized the management of health care through enhanced detection of disease or infection and effective enrollment into treatment. In recognition of this, the World Health Organization approved the rollout of nucleic acid amplification technologies for identification of Mycobacterium tuberculosis using platforms such as GeneXpert MTB/RIF, the GenoType MTBDRplus line probe assay, and, more recently, GeneXpert MTB/RIF Ultra. These assays can simultaneously detect tuberculosis infection and assess rifampin resistance. However, their widespread use in health systems requires verification and quality assurance programs. To enable development of these, we report the construction of genetically modified strains of Mycobacterium smegmatis that mimic the profile of Mycobacterium tuberculosis on both the GeneXpert MTB/RIF and the MTBDRplus line probe diagnostic tests. Using site-specific gene editing, we also created derivatives that faithfully mimic the diagnostic result of rifampin-resistant M. tuberculosis, with mutations at positions 513, 516, 526, 531, and 533 in the rifampin resistance-determining region of the rpoB gene. Next, we extended this approach to other diseases and demonstrated that a Staphylococcus aureus gene sequence can be introduced into M. smegmatis to generate a positive response for the SCCmec probe in the GeneXpert SA Nasal Complete molecular diagnostic cartridge, designed for identification of methicillin-resistant S. aureus. These biomimetic strains are cost-effective, have low biohazard content, accurately mimic drug resistance, and can be produced with relative ease, thus illustrating their potential for widespread use as verification standards for diagnosis of a variety of diseases.	[Machowski, Edith Erika; Kana, Bavesh Davandra] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, DST NRF Ctr Excellence Biomed TB Res, Johannesburg, South Africa; [Machowski, Edith Erika; Kana, Bavesh Davandra] Natl Hlth Lab Serv, Johannesburg, South Africa; [Kana, Bavesh Davandra] Ctr AIDS Programme Res South Africa, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Durban, South Africa	Kana, BD (reprint author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, DST NRF Ctr Excellence Biomed TB Res, Johannesburg, South Africa.; Kana, BD (reprint author), Natl Hlth Lab Serv, Johannesburg, South Africa.; Kana, BD (reprint author), Ctr AIDS Programme Res South Africa, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Durban, South Africa.	bavesh.kana@nhls.ac.za			Howard Hughes Medical Institute; South African National Research Foundation; South African Medical Research Council; Wits Enterprise through Technology Innovation Agency-South African Department of Science and Technology at the University of the Witwatersrand	This work was supported by funding from an International Early Career Scientist Award from the Howard Hughes Medical Institute (to B.D.K.), the South African National Research Foundation (to B.D.K.), the South African Medical Research Council (to B.D.K.), and a seed grant from Wits Enterprise (through the Technology Innovation Agency-South African Department of Science and Technology) at the University of the Witwatersrand (to B.D.K. and E.E.M.).	Aragon LM, 2006, J ANTIMICROB CHEMOTH, V57, P825, DOI 10.1093/jac/dkl058; Bergmann JS, 1997, DIAGN MICR INFEC DIS, V28, P153, DOI 10.1016/S0732-8893(97)00006-0; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boundy S, 2013, J BIOL CHEM, V288, P132, DOI 10.1074/jbc.M112.385138; Gaora PO, 1997, MED PRIN PRACT, V6, P91; Girosi F, 2006, NATURE S1, V444, pS3; Gordhan B G, 2001, Methods Mol Med, V54, P77, DOI 10.1385/1-59259-147-7:077; Gous N, 2015, J CLIN MICROBIOL, V53, P1365, DOI 10.1128/JCM.03340-14; Gous N, 2013, J CLIN MICROBIOL, V51, P4018, DOI 10.1128/JCM.01715-13; Heemskerk D, 2015, SPRBRIEF PUB HEALT, P27, DOI 10.1007/978-3-319-19132-4_4; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000                                                 ; Koch A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.17; McNerney R, 2015, DIAGNOSTICS, V5, P200, DOI 10.3390/diagnostics5020200; Migliori GB, 2008, CAN J INFECT DIS MED, V19, P169, DOI 10.1155/2008/857901                                                             ; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166                                                           ; Nikolayevskyy V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152926; Pai M, 2017, ELIFE, V6, DOI 10.7554/eLife.25956.001; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Rahman AAA, 2016, 2016 IEEE SYMPOSIUM ON COMPUTER APPLICATIONS & INDUSTRIAL ELECTRONICS (ISCAIE), P11, DOI [10.1109/ISCAIE.2016.7575028, 10.1109/TDC.2016.7519913]; Scott LE, 2011, J CLIN MICROBIOL, V49, P4356, DOI 10.1128/JCM.05167-11; SIDDIQI SH, 1981, J CLIN PATHOL, V34, P927, DOI 10.1136/jcp.34.8.927; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stevens WS, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0040-2016; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0                                                                ; Sulis G, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.78; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Turlej A, 2011, POL J MICROBIOL, V60, P95; World Health Organization, TREATM GUID DRUG RES; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; Wolk DM, 2009, J CLIN MICROBIOL, V47, P823, DOI 10.1128/JCM.01884-08	32	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	DEC	2017	55	12					3384	3394		10.1128/JCM.01111-17				11	Microbiology	Microbiology	FN7UV	WOS:000416225200012	28931561				2018-01-05	
J	Tak, YE; Kleinstiver, BP; Nunez, JK; Hsu, JY; Horng, JE; Gong, JY; Weissman, JS; Joung, JK				Tak, Y. Esther; Kleinstiver, Benjamin P.; Nunez, James K.; Hsu, Jonathan Y.; Horng, Joy E.; Gong, Jingyi; Weissman, Jonathan S.; Joung, J. Keith			Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors	NATURE METHODS			English	Article							HUMAN-CELLS; CRISPR RNA; GENOME; CPF1; ACTIVATION; SPECIFICITIES; REPRESSION; SYSTEM	Targeted and inducible regulation of mammalian gene expression is a broadly important capability. We engineered drug-inducible catalytically inactive Cpf1 nuclease fused to transcriptional activation domains to tune the expression of endogenous genes in human cells. Leveraging the multiplex capability of the Cpf1 platform, we demonstrate both synergistic and combinatorial gene expression in human cells. Our work should enable the development of multiplex gene perturbation library screens for understanding complex cellular phenotypes.	[Tak, Y. Esther; Kleinstiver, Benjamin P.; Hsu, Jonathan Y.; Horng, Joy E.; Gong, Jingyi; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Tak, Y. Esther; Kleinstiver, Benjamin P.; Hsu, Jonathan Y.; Horng, Joy E.; Gong, Jingyi; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Tak, Y. Esther; Kleinstiver, Benjamin P.; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Nunez, James K.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA; [Hsu, Jonathan Y.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Weissman, Jonathan S.] Howard Hughes Med Inst, San Francisco, CA USA	Joung, JK (reprint author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA.; Joung, JK (reprint author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.; Joung, JK (reprint author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	jjoung@mgh.harvard.edu			Banting (Natural Sciences and Engineering Research Council of Canada); Charles A. King Trust; National Institutes of Health [R35 GM118158, NIH R01 GM107427, R01 DA036858, U01 CA168370]; Howard Hughes Medical Institute; Desmond and Ann Heathwood Massachusetts General Hospital Research Scholar Award	We thank M. Welch and A. Sousa for technical assistance with constructing certain plasmids. B.P.K. acknowledges support from Banting (Natural Sciences and Engineering Research Council of Canada) and Charles A. King Trust Postdoctoral Fellowships. This work was supported by the National Institutes of Health R35 GM118158 (J.K.J.), NIH R01 GM107427 (J.K.J.), R01 DA036858 (J.S.W.) and U01 CA168370 (J.S.W.), the Howard Hughes Medical Institute (J.S.W.), and the Desmond and Ann Heathwood Massachusetts General Hospital Research Scholar Award (J.K.J.).	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Bao ZH, 2017, ACS SYNTH BIOL, V6, P686, DOI 10.1021/acssynbio.6b00313; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Kim SK, 2017, ACS SYNTH BIOL, V6, P1273, DOI 10.1021/acssynbio.6b00368; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Rivera Victor M, 2012, Cold Spring Harb Protoc, V2012, P821, DOI 10.1101/pdb.prot070144; TANG X, 2017, NAT PLANTS, V3; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18	22	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	DEC	2017	14	12					1163	+		10.1038/nmeth.4483				6	Biochemical Research Methods	Biochemistry & Molecular Biology	FO2KD	WOS:000416604800019	29083402				2018-01-05	
J	Michlits, G; Hubmann, M; Wu, SH; Vainorius, G; Budusan, E; Zhuk, S; Burkard, TR; Novatchkova, M; Aichinger, M; Lu, YQ; Reece-Hoyes, J; Nitsch, R; Schramek, D; Hoepfner, D; Elling, U				Michlits, Georg; Hubmann, Maria; Wu, Szu-Hsien; Vainorius, Gintautas; Budusan, Elena; Zhuk, Sergei; Burkard, Thomas R.; Novatchkova, Maria; Aichinger, Martin; Lu, Yiqing; Reece-Hoyes, John; Nitsch, Roberto; Schramek, Daniel; Hoepfner, Dominic; Elling, Ulrich			CRISPR-UMI : single-cell lineage tracing of pooled CRISPR-Cas9 screens	NATURE METHODS			English	Article							DNA-DAMAGE RESPONSE; GENETIC SCREENS; GROWTH-FACTOR; STEM-CELLS; E3 LIGASE; GENOME; DESIGN; PLURIPOTENCY; INHIBITION; DATABASE	Pooled CRISPR screens are a powerful tool for assessments of gene function. However, conventional analysis is based exclusively on the relative abundance of integrated single guide RNAs (sgRNAs) between populations, which does not discern distinct phenotypes and editing outcomes generated by identical sgRNAs. Here we present CRISPR-UMI, a single-cell lineage-tracing methodology for pooled screening to account for cell heterogeneity. We generated complex sgRNA libraries with unique molecular identifiers (UMIs) that allowed for screening of clonally expanded, individually tagged cells. A proof-of-principle CRISPR-UMI negative-selection screen provided increased sensitivity and robustness compared with conventional analysis by accounting for underlying cellular and editing-outcome heterogeneity and detection of outlier clones. Furthermore, a CRISPR-UMI positive-selection screen uncovered new roadblocks in reprogramming mouse embryonic fibroblasts as pluripotent stem cells, distinguishing reprogramming frequency and speed (i.e., effect size and probability). CRISPR-UMI boosts the predictive power, sensitivity, and information content of pooled CRISPR screens.	[Michlits, Georg; Hubmann, Maria; Wu, Szu-Hsien; Vainorius, Gintautas; Budusan, Elena; Zhuk, Sergei; Burkard, Thomas R.; Novatchkova, Maria; Elling, Ulrich] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, Vienna, Austria; [Burkard, Thomas R.; Novatchkova, Maria; Aichinger, Martin] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Lu, Yiqing; Schramek, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol, Toronto, ON, Canada; [Lu, Yiqing; Schramek, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Reece-Hoyes, John] Novartis Inst BioMed Res, Cambridge, MA USA; [Nitsch, Roberto] AstraZeneca R&D, Discovery Sci RAD, Gothenburg, Sweden; [Hoepfner, Dominic] Novartis Inst BioMed Res, Basel, Switzerland	Elling, U (reprint author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, Vienna, Austria.	ulrich.elling@imba.oeaw.ac.at		Burkard, Thomas/0000-0002-0884-2929	IMBA; Austrian Academy of Sciences (OEAW); Novartis Institute of Biomedical Research; AstraZeneca	We acknowledge everybody involved in the generation of data and of the manuscript. We thank J. Zuber (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria) for the retroviral backbone used to generate the guide library, and K. Hochedlinger (Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Cambridge, Massachusetts, USA; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA) for provision of the Dox-inducible reprogramming system. We thank A. Stark for important suggestions and critical reading of the manuscript, J. Jude for critical discussion and sharing of protocols, and P. Svoboda for discussion and advice. We are grateful to all IMBA/IMP services, in particular bioinformatics, biooptics, molecular biology, media kitchen, and graphics for technical support, as well as to J. Brennecke and A. Andersen (Life Science Editors) for critical reading and editing of the manuscript. We thank the VBCF NGS facility. This work was supported by IMBA, the Austrian Academy of Sciences (OEAW), Novartis Institute of Biomedical Research, and AstraZeneca.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238                                                        ; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Card DAG, 2010, J BIOL CHEM, V285, P15653, DOI 10.1074/jbc.M109.096156; Cheloufi S, 2015, NATURE, V528, P218, DOI 10.1038/nature15749; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilmore-Hebert M, 2010, MOL CANCER RES, V8, P1388, DOI 10.1158/1541-7786.MCR-10-0042; Graham DB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0823-x; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; He W, 2011, NUCLEIC ACIDS RES, V39, P4719, DOI 10.1093/nar/gkq1264; Heigwer F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0915-2; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Icli B, 2012, BIOCHEM BIOPH RES CO, V418, P116, DOI 10.1016/j.bbrc.2011.12.144; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koidl S, 2016, INT J BIOCHEM CELL B, V79, P478, DOI 10.1016/j.biocel.2016.06.011; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao JY, 2013, MOL THER, V21, P1242, DOI 10.1038/mt.2013.60; Liu L, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.36; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Michlits G., 2017, CRISPR UMI STEP STEP; Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770; Mukherjee B, 2010, SEMIN RADIAT ONCOL, V20, P250, DOI 10.1016/j.semradonc.2010.05.002; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rauscher B, 2017, NUCLEIC ACIDS RES, V45, pD679, DOI 10.1093/nar/gkw997; Richter F, 2016, NUCLEIC ACIDS RES, V44, P10003, DOI 10.1093/nar/gkw930; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smilenov LB, 2005, CANCER RES, V65, P933; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	56	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	DEC	2017	14	12					1191	+		10.1038/NMETH.4466				11	Biochemical Research Methods	Biochemistry & Molecular Biology	FO2KD	WOS:000416604800024	29039415				2018-01-05	
J	Maubach, G; Naumann, M				Maubach, Gunter; Naumann, Michael			NEMO Links Nuclear Factor-kappa B to Human Diseases	TRENDS IN MOLECULAR MEDICINE			English	Review							ESSENTIAL MODULATOR NEMO; ANHIDROTIC ECTODERMAL DYSPLASIA; CHAIN ASSEMBLY COMPLEX; CHRONIC INTESTINAL INFLAMMATION; PROTEIN-PROTEIN INTERACTIONS; BINDING DOMAIN PEPTIDE; GAMMA-DEFICIENT MICE; C-TERMINAL DOMAIN; OF-THE-LITERATURE; INCONTINENTIA PIGMENTI	The nuclear factor (NF)-kappa B essential modulator (NEMO) is a key regulator in NF-kappa B-mediated signaling. By transmitting extracellular or intracellular signals, NEMO can control NF-kappa B-regulated genes. NEMO dysfunction is associated with inherited diseases such as incontinentia pigmenti (IP), ectodermal dysplasia, anhidrotic, with immunodeficiency (EDA-ID), and some cancers. We focus on molecular studies, human case reports, and mouse models emphasizing the significance of NEMO molecular interactions and modifications in health and diseases. This knowledge opens new opportunities to engineer suitable drugs that may putatively target precise NEMO functions attributable to various diseases, while leaving other functions intact, and eliminating cytotoxicity. Indeed, with the advent of novel gene editing tools such as clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas)9, treating some inherited diseases may in the long run, become a reality.	[Maubach, Gunter; Naumann, Michael] Otto von Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany	Naumann, M (reprint author), Otto von Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany.	Naumann@med.ovgu.de			Federal Ministry of Education and Research [031A304]	We would like to thank Michelle C.C. Lim for critical reading of the manuscript. The work was in part supported by a grant to M.N. (031A304) by the Federal Ministry of Education and Research.	Abbott JK, 2014, BONE MARROW TRANSPL, V49, P1446, DOI 10.1038/bmt.2014.157; Abe S, 2011, BRAIN DEV-JPN, V33, P28, DOI 10.1016/j.braindev.2010.04.002; Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Aigelsreiter A, 2012, HUM PATHOL, V43, P1012, DOI 10.1016/j.humpath.2011.08.009; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Bagneris C, 2015, J BIOL CHEM, V290, P16539, DOI 10.1074/jbc.M114.622928; Bal E, 2017, J ALLERGY CLIN IMMUN; Bates PJ, 2017, BBA-GEN SUBJECTS, V1861, P1414, DOI 10.1016/j.bbagen.2016.12.015; Biswas S, 2017, J VIROL, V91, DOI 10.1128/JVI.00276-17; Blackwell K, 2013, MOL CELL BIOL, V33, P1901, DOI 10.1128/MCB.01416-12; Brady G, 2017, J VIROL, V91, DOI 10.1128/JVI.00545-17; Bruno PA, 2016, ANGEW CHEM INT EDIT, V55, P14997, DOI 10.1002/anie.201607990; Buinauskaite E, 2010, PEDIATR DERMATOL, V27, P492, DOI 10.1111/j.1525-1470.2010.01261.x; Carlberg VM, 2014, PEDIATR DERMATOL, V31, P716, DOI 10.1111/pde.12103; Catici DAM, 2015, J BIOL CHEM, V290, P14130, DOI 10.1074/jbc.M115.640417; Chen YZ, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2159; Conte MI, 2014, HUM MUTAT, V35, P165, DOI 10.1002/humu.22483; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2006, CELL DEATH DIFFER, V13, P843, DOI 10.1038/sj.cdd.4401841; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852                                                    ; de Jong MF, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.84, 10.1038/nmicrobiol.2016.84]; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20050085; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Fusco F, 2004, HUM MOL GENET, V13, P1763, DOI 10.1093/hmg/ddh192; Fusco F, 2008, HUM MUTAT, V29, P595, DOI 10.1002/humu.20739; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Fusco F, 2012, HUM MOL GENET, V21, P1260, DOI 10.1093/hmg/ddr556; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Grubisha O, 2010, J MOL BIOL, V395, P89, DOI 10.1016/j.jmb.2009.10.018; Guan X, 2012, STEM CELL RES, V8, P410, DOI 10.1016/j.scr.2011.12.007; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hooper C, 2014, J BIOL CHEM, V289, P33161, DOI 10.1074/jbc.M114.582478; Hubeau M, 2011, BLOOD, V118, P926, DOI 10.1182/blood-2010-10-315234; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jun JC, 2013, CELL REP, V4, P352, DOI 10.1016/j.celrep.2013.06.036; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Klemann C, 2016, CLIN IMMUNOL, V164, P52, DOI 10.1016/j.clim.2016.01.010; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kondylis V, 2015, CANCER CELL, V28, P582, DOI 10.1016/j.ccell.2015.10.001; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kumar A, 2004, J MOL MED-JMM, V82, P434, DOI 10.1007/s00109-004-0555-y; Laber D. A, 2005, J CLIN ONCOL, V23; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maier HJ, 2013, ONCOGENE, V32, P2690, DOI 10.1038/onc.2012.272; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Minic S, 2014, CLIN GENET, V85, P536, DOI 10.1111/cge.12223; Miot C, 2017, BLOOD; Mizukami T, 2012, J CLIN IMMUNOL, V32, P39, DOI 10.1007/s10875-011-9600-0; Modell AE, 2016, TRENDS PHARMACOL SCI, V37, P702, DOI 10.1016/j.tips.2016.05.008; Motamedi MHK, 2010, INDIAN J PATHOL MICR, V53, P302, DOI 10.4103/0377-4929.64291; Ndikuyeze GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095404; Neish AS, 2011, TRENDS MICROBIOL, V19, P596, DOI 10.1016/j.tim.2011.08.004; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Nowicka AM, 2016, ONCOGENE, V35, P3125, DOI 10.1038/onc.2015.400; O'Doherty M, 2011, BRIT J OPHTHALMOL, V95, P11, DOI 10.1136/bjo.2009.164434; Okita M, 2013, J DERMATOL, V40, P272, DOI 10.1111/1346-8138.12091; Orange JS, 2004, J ALLERGY CLIN IMMUN, V113, P725, DOI 10.1016/j.jaci.2004.01.762; Orange JS, 2002, J CLIN INVEST, V109, P1501, DOI 10.1172/JCI200214858; Oster SF, 2009, EXP EYE RES, V88, P613, DOI 10.1016/j.exer.2008.10.027; Pai Sung-Yun, 2008, J Allergy Clin Immunol, V122, P1113, DOI 10.1016/j.jaci.2008.08.026; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Pescatore A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.245; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ramirez-Alejo N, 2015, CLIN IMMUNOL, V160, P163, DOI 10.1016/j.clim.2015.06.007; Ricci S, 2017, J CLIN IMMUNOL, V37, P7, DOI 10.1007/s10875-016-0350-x; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Rothwarf DM, 1998, NATURE, V395, P297; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Scheuerle A. E, 1993, GENEREVIEWS R; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4                                                   ; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Scholefield J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12629; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681                                                     ; Shifera AS, 2010, BIOCHEM BIOPH RES CO, V396, P585, DOI 10.1016/j.bbrc.2010.05.012; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Smahi A, 2000, NATURE, V405, P466; Smit Judith J, 2013, J Biol Chem, V288, P31728, DOI 10.1074/jbc.M113.495846; Soundararajan V, 2011, INNATE IMMUN-LONDON, V17, P548, DOI 10.1177/1753425910377099; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Trzeciak WH, 2016, J APPL GENET, V57, P51, DOI 10.1007/s13353-015-0307-4; VINCENDEAU M, 2016, SCI REP, V6; Vinolo E, 2006, J BIOL CHEM, V281, P6334, DOI 10.1074/jbc.M510118200; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12; Witt A, 2017, CELL DEATH DIFFER, V24, P1160, DOI 10.1038/cdd.2017.33; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang YB, 2014, CANCER DISCOV, V4, P480, DOI 10.1158/2159-8290.CD-13-0915; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zarzycka B, 2016, DRUG DISCOV TODAY, V21, P48, DOI 10.1016/j.drudis.2015.09.011; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zilberman-Rudenko J, 2016, P NATL ACAD SCI USA, V113, P1612, DOI 10.1073/pnas.1518163113	123	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	DEC	2017	23	12					1138	1155		10.1016/j.molmed.2017.10.004				18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FO3AX	WOS:000416683200008	29128367				2018-01-05	
J	Singh, N; Shi, JW; June, CH; Ruella, M				Singh, Nathan; Shi, Junwei; June, Carl H.; Ruella, Marco			Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer	CURRENT HEMATOLOGIC MALIGNANCY REPORTS			English	Review						CRISPR-Cas9; TALEN; Zinc-finger nucleases; Adoptive cell therapy; Chimeric antigen receptor T cells (CART); Immunotherapy; PD-1; Gene-editing	ZINC-FINGER NUCLEASES; CHIMERIC-ANTIGEN-RECEPTOR; DONOR LEUKOCYTE INFUSIONS; ACUTE-LEUKEMIA; LUNG-CANCER; BONE-MARROW; THERAPY; EXPRESSION; NIVOLUMAB; MELANOMA	In this review, we discuss the most recent developments in gene-editing technology and discuss their application to adoptive T cell immunotherapy. Engineered T cell therapies targeting cancer antigens have demonstrated significant efficacy in specific patient populations. Most impressively, CD19-directed chimeric antigen receptor T cells (CART19) have led to impressive responses in patients with B-cell leukemia and lymphoma. CTL019, or KYMRIAH (TM) (tisagenlecleucel), a CD19 CAR T cell product developed by Novartis and the University of Pennsylvania, was recently approved for clinical use by the Food and Drug Administration, representing a landmark in the application of adoptive T cell therapies. As CART19 enters routine clinical use, improving the efficacy of this exciting platform is the next step in broader application. Novel gene-editing technologies like CRISPR-Cas9 allow facile editing of specific genes within the genome, generating a powerful platform to further optimize the activity of engineered T cells.	[Singh, Nathan; June, Carl H.; Ruella, Marco] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Singh, Nathan] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Singh, Nathan; June, Carl H.; Ruella, Marco] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Shi, Junwei; June, Carl H.; Ruella, Marco] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [June, Carl H.] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA	Ruella, M (reprint author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; Ruella, M (reprint author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; Ruella, M (reprint author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	marco.ruella@uphs.upenn.edu			SITC (EMD-Serono Cancer Immunotherapy Clinical Fellowship); AACR (Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research); Gabrielle's Angel Foundation; SIES-AIL; ASH Scholar Award; NCI [K99 CA212302-01A1]	This work was supported by grants from the SITC (EMD-Serono Cancer Immunotherapy Clinical Fellowship, PI: M.R.), the AACR (Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research, PI: M.R.), the Gabrielle's Angel Foundation (PI: M.R.), the SIES-AIL (PI: M.R.), the ASH Scholar Award (PI: M.R.), and the NCI (K99 CA212302-01A1, PI: M.R.).	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; BARNES DWH, 1957, BRIT J HAEMATOL, V3, P241, DOI 10.1111/j.1365-2141.1957.tb05793.x; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gomes-Silva D, 2017, BLOOD, V130, P285, DOI 10.1182/blood-2017-01-761320; HIGANO CS, 1990, TRANSPLANTATION, V50, P175; Kim MY, 2016, MOL THER, V24, pS108, DOI 10.1016/S1525-0016(16)33082-9                                                   ; KOLB HJ, 1990, BLOOD, V76, P2462; Loren AW, 2008, BONE MARROW TRANSPL, V41, P483, DOI 10.1038/sj.bmt.1705898; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARMONT AM, 1991, BLOOD, V78, P2120; MATHE G, 1965, CANCER RES, V25, P1525; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; MITCHISON NA, 1955, J EXP MED, V102, P157, DOI 10.1084/jem.102.2.157; Parkhurst M, 2017, CLIN CANCER RES, V23, P2491, DOI 10.1158/1078-0432.CCR-16-2680; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 1999, J CLIN ONCOL, V17, P1234, DOI 10.1200/JCO.1999.17.4.1234                                                      ; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Rech Andrew J, 2017, N Engl J Med, V376, pe11; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ren J, 2017, VERSATILE SYSTEM RAP; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Ren JT, 2017, ONCOTARGET, V8, P17002, DOI 10.18632/oncotarget.15218; Ruella M, 2014, IMMUNOL REV, V257, P14, DOI 10.1111/imr.12136; Singh N., 2016, SCI TRANSL MED, V8, P320; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yousefi H, 2017, EXPERT REV CLIN IMMU, V13, P1001, DOI 10.1080/1744666X.2017.1366315; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; [Anonymous], 2016, MOL THERAPY J AM SOC, V24, pS1	53	0	0	9	9	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1558-8211	1558-822X		CURR HEMATOL MALIG R	Curr. Hematol. Malig. Rep.	DEC	2017	12	6					522	529		10.1007/s11899-017-0417-7				8	Oncology; Hematology	Oncology; Hematology	FO0HS	WOS:000416424900004	29039115				2018-01-05	
J	Mitkin, NA; Muratova, AM; Sharonov, GV; Korneev, KV; Sviriaeva, EN; Mazurov, D; Schwartz, AM; Kuprash, DV				Mitkin, Nikita A.; Muratova, Alisa M.; Sharonov, George V.; Korneev, Kirill V.; Sviriaeva, Ekaterina N.; Mazurov, Dmitriy; Schwartz, Anton M.; Kuprash, Dmitry V.			p63 and p73 repress CXCR5 chemokine receptor gene expression in p53 deficient MCF-7 breast cancer cells during genotoxic stress	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						p53; p63; p73; CXCR5; Chemokine receptors; NFkB	NF-KAPPA-B; LYMPH-NODE METASTASIS; DNA-DAMAGE; ANTICANCER THERAPY; HUMAN TUMORS; CROSS-TALK; FAMILY; DATABASE; MUTATION; PATHWAY	Many types of chemotherapeutic agents induce of DNA-damage that is accompanied by activation of p53 tumor suppressor, a key regulator of tumor development and progression. In our previous study we demonstrated that p53 could repress CXCR5 chemokine receptor gene in MCF-7 breast cancer cells via attenuation of NFkB activity. In this work we aimed to determine individual roles of p53 family members in the regulation of CXCR5 gene expression under genotoxic stress. DNA-alkylating agent methyl methanesulfonate caused a reduction in CXCR5 expression not only in parental MCF-7 cells but also in MCF-7-p53off cells with CRISPR/Cas9-mediated inactivation of the p53 gene. Since p53 knockout was associated with elevated expression of its p63 and p73 homologues, we knocked out p63 using CRISPR/Cas9 system and knocked down p73 using specific siRNA. The CXCR5 promoter activity, CXCR5 expression and CXCL13-directed migration in MCF-7 cells with inactivation of all three p53 family genes were completely insensitive to genotoxic stress, while pairwise p53 + p63 or p53 + p73 inactivation resulted in partial effects. Using deletion analysis and site-directed mutagenesis, we demonstrated that effects of NFkB on the CXCR5 promoter inversely correlated with p63 and p73 levels. Thus, all three p53 family members mediate the effects of genotoxic stress on the CXCR5 promoter using the same mechanism associated with attenuation of NFkB activity. Understanding of this mechanism could facilitate prognosis of tumor responses to chemotherapy.	[Mitkin, Nikita A.; Muratova, Alisa M.; Korneev, Kirill V.; Sviriaeva, Ekaterina N.; Schwartz, Anton M.; Kuprash, Dmitry V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Intracellular Signaling Hlth & Dis, Vavilov Str 32, Moscow 119991, Russia; [Muratova, Alisa M.; Korneev, Kirill V.; Kuprash, Dmitry V.] Lomonosov Moscow State Univ, Dept Immunol, Leninskye Gory 1, Moscow 119234, Russia; [Sharonov, George V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia; [Sharonov, George V.] Lomonosov Moscow State Univ, Fac Med, Leninskye Gory 1, Moscow 119234, Russia; [Mazurov, Dmitriy] Russian Acad Sci, Inst Gene Biol, 34-5 Vavilov St, Moscow 119334, Russia	Kuprash, DV (reprint author), Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Intracellular Signaling Hlth & Dis, Vavilov Str 32, Moscow 119991, Russia.	kuprash@eimb.ru			Russian Science Foundation [14-14-01140]; Russian Foundation for Basic Research [16-34-01088]	Experiments on evaluation of MMS influence on CXCR5, p53, p63 and p73 levels (Figs. 1-3) were supported by grant 16-34-01088 from Russian Foundation for Basic Research. Genome editing of MCF-7 cell line using CRISPR/Cas9 system and experiments with the modified cells (Fig. 4-8) were supported by grant 14-14-01140 from Russian Science Foundation.	Afanasyeva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098349; Bae YH, 2014, GENES GENOM, V36, P171, DOI 10.1007/s13258-013-0154-9; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bertheau P, 2008, PATHOBIOLOGY, V75, P132, DOI 10.1159/000123851; Bisio A, 2014, ONCOTARGET, V5, P12111, DOI 10.18632/oncotarget.2545                                                        ; Biswas S, 2014, BREAST CANCER RES TR, V143, P265, DOI 10.1007/s10549-013-2811-8; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Candi E, 2014, HUM MUTAT, V35, P702, DOI 10.1002/humu.22523; Cooks T, 2014, CARCINOGENESIS, V35, P1680, DOI 10.1093/carcin/bgu134; Costanzo A, 2014, FEBS LETT, V588, P2590, DOI 10.1016/j.febslet.2014.06.047; Dalmases A, 2014, ONCOTARGET, V5, P196, DOI 10.18632/oncotarget.1556                                                        ; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Edlund K, 2012, P NATL ACAD SCI USA, V109, P9551, DOI 10.1073/pnas.1200019109; Essmann F, 2012, BRIT J PHARMACOL, V165, P328, DOI 10.1111/j.1476-5381.2011.01570.x; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Ghose J, 2015, RNA BIOL, V12, P457, DOI 10.1080/15476286.2015.1014288; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; GUO G, 2015, J IMMUNOTHER CANC, V3; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266                                                           ; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Inoue Kazushi, 2014, Subcell Biochem, V85, P17, DOI 10.1007/978-94-017-9211-0_2; Jung N, 2000, EUR J BIOCHEM, V267, P6180, DOI 10.1046/j.1432-1327.2000.01692.x                                                ; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Korneev KV, 2017, CYTOKINE, V89, P127, DOI 10.1016/j.cyto.2016.01.021; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Levrero M, 2000, J CELL SCI, V113, P1661; Lowe JM, 2014, CELL CYCLE, V13, P2983, DOI 10.4161/15384101.2014.959852; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matin RN, 2013, J EXP MED, V210, P581, DOI 10.1084/jem.20121439; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Mitkin NA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00515; Mitkin NA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09330; Moll UM, 2004, MOL CANCER RES, V2, P371; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.44014914; Panse J, 2008, BRIT J CANCER, V99, P930, DOI 10.1038/sj.bjc.6604621; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Puszynski K, 2009, IET SYST BIOL, V3, P356, DOI 10.1049/iet-syb.2008.0172; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reisman D, 2012, BIOCHEM RES INT, DOI 10.1155/2012/808934; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ryou SM, 2006, BIOCHEM BIOPH RES CO, V345, P623, DOI 10.1016/j.bbrc.2006.04.120; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Schafer C, 2017, CELL SIGNAL, V29, P218, DOI 10.1016/j.cellsig.2016.11.002; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Sen T, 2011, J BIOL CHEM, V286, P43204, DOI 10.1074/jbc.M111.257105; Son DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051116; Stantic M, 2015, P NATL ACAD SCI USA, V112, P220, DOI 10.1073/pnas.1421697112; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Wagner T, 2015, ONCOTARGET, V6, P7123, DOI 10.18632/oncotarget.3344                                                        ; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Westfall MD, 2005, CELL CYCLE, V4, P710, DOI 10.4161/cc.4.5.1685; Wolf I, 1998, J BIOL CHEM, V273, P28831, DOI 10.1074/jbc.273.44.28831                                                        ; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127                                                                ; Zangen R, 2005, CELL CYCLE, V4, P1313, DOI 10.4161/cc.4.10.2066                                                            ; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	71	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	DEC	2017	1860	12					1169	1178		10.1016/j.bbagrm.2017.10.003				10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FO1DM	WOS:000416496900002	29107083				2018-01-05	
J	Peng, AH; Chen, SC; Lei, TG; Xu, LZ; He, YR; Wu, L; Yao, LX; Zou, XP				Peng, Aihong; Chen, Shanchun; Lei, Tiangang; Xu, Lanzhen; He, Yongrui; Wu, Liu; Yao, Lixiao; Zou, Xiuping			Engineering canker-resistant plants through CRISPR/Cas9-targeted editing of the susceptibility gene CsLOB1 promoter in citrus	PLANT BIOTECHNOLOGY JOURNAL			English	Article						citrus canker; CsLOB1; genome editing; CRISPR; Cas9; resistance	AGROBACTERIUM-MEDIATED TRANSFORMATION; EFFECTOR-BINDING ELEMENTS; AXONOPODIS-PV.-CITRI; XANTHOMONAS-CITRI; TARGETED MUTAGENESIS; LATER GENERATIONS; BACTERIAL-BLIGHT; DISEASE; RICE; GENOME	Citrus canker, caused by Xanthomonas citri subsp. citri (Xcc), is severely damaging to the global citrus industry. Targeted editing of host disease-susceptibility genes represents an interesting and potentially durable alternative in plant breeding for resistance. Here, we report improvement of citrus canker resistance through CRISPR/Cas9-targeted modification of the susceptibility gene CsLOB1 promoter in citrus. Wanjincheng orange (Citrus sinensis Osbeck) harbours at least three copies of the CsLOB1(G) allele and one copy of the CsLOB1(-) allele. The promoter of both alleles contains the effector binding element (EBEPthA4), which is recognized by the main effector PthA4 of Xcc to activate CsLOB1 expression to promote citrus canker development. Five pCas9/CsLOB1sgRNA constructs were designed to modify the EBEPthA4 of the CsLOB1 promoter in Wanjincheng orange. Among these constructs, mutation rates were 11.5%-64.7%. Homozygous mutants were generated directly from citrus explants. Sixteen lines that harboured EBEPthA4 modifications were identified from 38 mutant plants. Four mutation lines (S2-5, S2-6, S2-12 and S5-13), in which promoter editing disrupted CsLOB1 induction in response to Xcc infection, showed enhanced resistance to citrus canker compared with the wild type. No canker symptoms were observed in the S2-6 and S5-13 lines. Promoter editing of CsLOB1(G) alone was sufficient to enhance citrus canker resistance in Wanjincheng orange. Deletion of the entire EBEPthA4 sequence from both CsLOB1 alleles conferred a high degree of resistance to citrus canker. The results demonstrate that CRISPR/Cas9-mediated promoter editing of CsLOB1 is an efficient strategy for generation of canker-resistant citrus cultivars.	[Peng, Aihong; Chen, Shanchun; Lei, Tiangang; Xu, Lanzhen; He, Yongrui; Yao, Lixiao; Zou, Xiuping] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China; [Peng, Aihong; Chen, Shanchun; Lei, Tiangang; Xu, Lanzhen; He, Yongrui; Yao, Lixiao; Zou, Xiuping] Natl Ctr Citrus Variety Improvement, Chongqing, Peoples R China; [Peng, Aihong; Chen, Shanchun; Lei, Tiangang; Xu, Lanzhen; He, Yongrui; Wu, Liu; Yao, Lixiao; Zou, Xiuping] Southwest Univ, Citrus Res Inst, Chongqing, Peoples R China	Zou, XP (reprint author), Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China.; Zou, XP (reprint author), Natl Ctr Citrus Variety Improvement, Chongqing, Peoples R China.; Zou, XP (reprint author), Southwest Univ, Citrus Res Inst, Chongqing, Peoples R China.	zouxiuping@cric.cn			National Natural Sciences Foundation of China [31272150]; Earmarked Fund for China Agriculture Research System [CARS-27]; Natural Science Foundation Project of CQ [CSTC2015jcyjA80041]; Fundamental Research Funds for the Central Universities [XDJK2014A018]	This work was supported by grants from the National Natural Sciences Foundation of China (31272150, to X. Zou), the Earmarked Fund for China Agriculture Research System (CARS-27, to S. Chen), the Natural Science Foundation Project of CQ (CSTC2015jcyjA80041, to A. Peng) and the Fundamental Research Funds for the Central Universities (XDJK2014A018 to Y. He). Sincere thanks are extended to Dr. Junhua Hu (Citrus Research Institute, Southwestern University, Chongqing, China) for providing the XccYN1 strain.	Abe VY, 2016, MOL PLANT PATHOL, V17, P1223, DOI 10.1111/mpp.12359; Al-Saadi A, 2007, MOL PLANT MICROBE IN, V20, P934, DOI 10.1094/MPMI-20-8-0934; Vojnov AA, 2010, APPL MICROBIOL BIOT, V87, P467, DOI 10.1007/s00253-010-2631-2; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Blanvillain-Baufume S, 2017, PLANT BIOTECHNOL J, V15, P306, DOI 10.1111/pbi.12613; Boch J, 2014, NEW PHYTOL, V204, P823, DOI 10.1111/nph.13015; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dominguez A, 2004, MOL BREEDING, V14, P171, DOI 10.1023/B:MOLB.0000038005.73265.61                                              ; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gawehns F, 2013, MICROB BIOTECHNOL, V6, P223, DOI 10.1111/1751-7915.12023; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gmitter FG, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P9, DOI 10.1079/9780851990194.0009; Gong XQ, 2013, PLANT CELL TISS ORG, V113, P137, DOI 10.1007/s11240-012-0267-x; Gottwald T. R, 2002, PLANT HLTH PROG, V10, P1; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI [10.1046/j.1364-3703.2004.00197.x, 10.1046/J.1364-3703.2003.00197.X]; Gu KY, 2009, MOL PLANT PATHOL, V10, P829, DOI 10.1111/j.1364-3703.2009.00567.x; Hu Y, 2014, P NATL ACAD SCI USA, V111, pE521, DOI 10.1073/pnas.1313271111; Jia H., 2016, PLANT BIOTECHNOL J; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2015, METHODS MOL BIOL, V1284, P239, DOI 10.1007/978-1-4939-2444-8_12; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li Z, 2014, MOL PLANT, V7, P912, DOI 10.1093/mp/sst176; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; McGrann GRD, 2014, J EXP BOT, V65, P1025, DOI 10.1093/jxb/ert452; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Pena L, 2004, ANN BOT-LONDON, V94, P67, DOI 10.1093/aob/mch117; Peng AH, 2015, PLANT CELL TISS ORG, V123, P1, DOI 10.1007/s11240-015-0799-y; Pereira ALA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-157; Samanta MK, 2016, TRANSGENIC RES, V25, P561, DOI 10.1007/s11248-016-9953-5; Stover E, 2014, HORTSCIENCE, V49, P4; van Schie CCN, 2014, ANNU REV PHYTOPATHOL, V52, P551, DOI 10.1146/annurev-phyto-102313-045854; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Wu Xuebing, 2014, Quant Biol, V2, P59; Xu C, 2016, TRENDS PLANT SCI, V21, P159, DOI 10.1016/j.tplants.2015.10.010; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838; Zou XP, 2008, IN VITRO CELL DEV-PL, V44, P169, DOI 10.1007/s11627-008-9106-5; Zou XP, 2014, PLANT CELL TISS ORG, V117, P85, DOI 10.1007/s11240-013-0423-y	49	11	11	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	DEC	2017	15	12					1509	1519		10.1111/pbi.12733				11	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FN5LX	WOS:000416050200002	28371200	gold			2018-01-05	
J	Li, CX; Liu, CL; Qi, XT; Wu, YC; Fei, XH; Mao, L; Cheng, BJ; Li, XH; Xie, CX				Li, Chuxi; Liu, Changlin; Qi, Xiantao; Wu, Yongchun; Fei, Xiaohong; Mao, Long; Cheng, Beijiu; Li, Xinhai; Xie, Chuanxiao			RNA-guided Cas9 as an invivo desired-target mutator in maize	PLANT BIOTECHNOLOGY JOURNAL			English	Article						genome editing; desired-target mutator; sexual plant breeding	ZEA-MAYS L.; PARTICLE BOMBARDMENT; CRISPR/CAS9 SYSTEM; LEAF ANGLE; PLANTS; RICE; TRANSFORMATION; CRISPR-CAS9; YIELD; ARCHITECTURE	The RNA-guided Cas9 system is a versatile tool for genome editing. Here, we established a RNA-guided endonuclease (RGEN) system as an invivo desired-target mutator (DTM) in maize to reduce the linkage drag during breeding procedure, using the LIGULELESS1 (LG1) locus as a proof-of-concept. Our system showed 51.5%-91.2% mutation frequency in T0 transgenic plants. We then crossed the T1 plants stably expressing DTM with six diverse recipient maize lines and found that 11.79%-28.71% of the plants tested were mutants induced by the DTM effect. Analysis of successive F2 plants indicated that the mutations induced by the DTM effect were largely heritable. Moreover, DTM-generated hybrids had significantly smaller leaf angles that were reduced more than 50% when compared with that of the wild type. Planting experiments showed that DTM-generated maize plants can be grown with significantly higher density and hence greater yield potential. Our work demonstrate that stably expressed RGEN could be implemented as an invivoDTM to rapidly generate and spread desired mutations in maize through hybridization and subsequent backcrossing, and hence bypassing the linkage drag effect in convention introgression methodology. This proof-of-concept experiment can be a potentially much more efficient breeding strategy in crops employing the RNA-guided Cas9 genome editing.	[Li, Chuxi; Liu, Changlin; Qi, Xiantao; Mao, Long; Li, Xinhai; Xie, Chuanxiao] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Qi, Xiantao; Cheng, Beijiu] Anhui Agr Univ, Hefei, Anhui, Peoples R China; [Wu, Yongchun] AgGene Biotech Seed Ind Grp, Shenzhen, Peoples R China	Xie, CX (reprint author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	xiechuanxiao@caas.cn			National Key Program on Transgenic Research [2016ZX08009-001]; National Science Foundation of China [31361140364]; Ministry of Science and Technology [2015BAD02B0203]; Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences [Y2017XM03]	This research was supported by the National Key Program on Transgenic Research (No. 2016ZX08009-001), the National Science Foundation of China (No. 31361140364), a grant from the Ministry of Science and Technology (2015BAD02B0203) andthe Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (Y2017XM03).	BECRAFT PW, 1991, PLANT CELL, V3, P801; Birch RG, 1997, ANNU REV PLANT PHYS, V48, P297, DOI 10.1146/annurev.arplant.48.1.297; Brekke B, 2011, CROP SCI, V51, P1965, DOI 10.2135/cropsci2010.09.0563; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Ci XK, 2011, CROP SCI, V51, P13, DOI 10.2135/cropsci2010.04.0207; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Fowler JE, 1996, DEV GENET, V18, P198, DOI 10.1002/(SICI)1520-6408(1996)18:3<198::AID-DVG2>3.0.CO;2-4; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gupta M, 2004, GMO HANDBOOK: GENETICALLY MODIFIED ANIMALS, MICROBES, AND PLANTS IN BIOTECHNOLOGY, P219; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Huang SW, 2016, NAT GENET, V48, P109, DOI 10.1038/ng.3484; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Johnston R, 2014, PLANT CELL, V26, P4718, DOI 10.1105/tpc.114.132688; Ku LX, 2010, THEOR APPL GENET, V121, P951, DOI 10.1007/s00122-010-1364-z; LAMBERT RJ, 1978, CROP SCI, V18, P499, DOI 10.2135/cropsci1978.0011183X001800030037x                                       ; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7648; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Moon J, 2013, DEVELOPMENT, V140, P405, DOI 10.1242/dev.085787; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Porteus MH, 2009, NATURE, V459, P337, DOI 10.1038/459337a; R Core Team, 2016, R LANG ENV STAT COMP; REGISTER JC, 1994, PLANT MOL BIOL, V25, P951, DOI 10.1007/BF00014669; RHODES CA, 1988, SCIENCE, V240, P204, DOI 10.1126/science.2832947; Ribaut JM, 2007, J EXP BOT, V58, P351, DOI 10.1093/jxb/erl214; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shou HX, 2004, MOL BREEDING, V13, P201, DOI 10.1023/B:MOLB.0000018767.64586.53; Sinclair TR, 1999, SCIENCE, V283, P1456; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Bhatia Varnika, 2014, Journal of Crop Science and Biotechnology, V17, P147, DOI 10.1007/s12892-013-0135-1; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; [Chuanxiao Xie 谢传晓], 2007, Journal of Genetics and Genomics, V34, P738, DOI 10.1016/S1673-8527(07)60083-6; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890	45	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	DEC	2017	15	12					1566	1576		10.1111/pbi.12739				11	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FN5LX	WOS:000416050200007	28379609	gold			2018-01-05	
J	Walton, D				Walton, Douglas			The Slippery Slope Argument in the Ethical Debate on Genetic Engineering of Humans	SCIENCE AND ENGINEERING ETHICS			English	Article						Argumentation schemes; Genetic enhancement; Gene editing; Germline therapy	THERAPY	This article applies tools from argumentation theory to slippery slope arguments used in current ethical debates on genetic engineering. Among the tools used are argumentation schemes, value-based argumentation, critical questions, and burden of proof. It is argued that so-called drivers such as social acceptance and rapid technological development are also important factors that need to be taken into account alongside the argumentation scheme. It is shown that the slippery slope argument is basically a reasonable (but defeasible) form of argument, but is often flawed when used in ethical debates because of failures to meet the requirements of its scheme.	[Walton, Douglas] Univ Windsor, Dept Philosophy, CRRAR, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada	Walton, D (reprint author), Univ Windsor, Dept Philosophy, CRRAR, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	waltoncrrar@gmail.com			Social Sciences and Humanities Research Council of Canada [435-2012-0104]	I would like to thank The Social Sciences and Humanities Research Council of Canada for Insight Grant 435-2012-0104 that supported the work in this paper, and acknowledge my indebtedness to the four very helpful referees who provided me with many detailed constructive criticisms, insightful comments, and corrections.	Barry V. E, 1976, PRACTICAL LOGIC; Beardsley M. C., 1966, THINKING STRAIGHT; Bench-Capon T. J. M, 2002, TECHNICAL REPORT; Corner A, 2011, J MEM LANG, V64, P133, DOI 10.1016/j.jml.2010.10.002; Galton F., 1869, HEREDITARY GENIUS; GARDNER W, 1995, J MED PHILOS, V20, P65, DOI 10.1093/jmp/20.1.65                                                             ; HOLTUG N, 1993, BIOETHICS, V7, P402, DOI 10.1111/j.1467-8519.1993.tb00231.x; Hook S, 1970, PARADOXES FREEDOM; Hurley P, 1982, CONCISE INTRO LOGIC; Kneale W., 1962, DEV LOGIC; Launis Veikko, 2002, Med Health Care Philos, V5, P169, DOI 10.1023/A:1016052122403; Bashford A., 2010, OXFORD HDB HIST EUGE, P3; Lifton Robert J., 1986, NAZI DOCTORS MED KIL; Macagno F, 2014, EMOTIVE LANGUAGE IN ARGUMENTATION, P1, DOI 10.1017/CBO9781139565776; RESNIK D, 1994, J MED PHILOS, V19, P23, DOI 10.1093/jmp/19.1.23                                                             ; Rizzo MJ, 2003, UCLA LAW REV, V51, P539; Saliger F., 2007, Z INT STRAFRECHTSDOG, V9, P341; SCHAUER F, 1985, HARVARD LAW REV, V99, P361, DOI 10.2307/1341127                                                                 ; VANDERBURG W, 1991, ETHICS, V102, P42, DOI 10.1086/293369                                                                  ; Walton D, 2008, ARGUMENTATION SCHEMES, P1, DOI 10.1017/CBO9780511802034; Walton Douglas N, 1992, SLIPPERY SLOPE ARGUM; Walton D, 2015, INFORMAL LOG, V35, P273	22	1	1	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1353-3452	1471-5546		SCI ENG ETHICS	Sci. Eng. Ethics	DEC	2017	23	6					1507	1528		10.1007/s11948-016-9861-3				22	Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science; Multidisciplinary Sciences; Philosophy	Social Sciences - Other Topics; Engineering; History & Philosophy of Science; Science & Technology - Other Topics; Philosophy	FO0LK	WOS:000416435700003	28000092				2018-01-05	
J	Ahteensuu, M				Ahteensuu, Marko			Synthetic Biology, Genome Editing, and the Risk of Bioterrorism	SCIENCE AND ENGINEERING ETHICS			English	Article						Synthetic biology; Biosecurity; Risk; Regulation; Ethics; European Union	VIRUS; ETHICS; TRANSMISSION; KNOWLEDGE; FERRETS	The SynBioSecurity argument says that synthetic biology introduces new risks of intentional misuse of synthetic pathogens and that, therefore, there is a need for extra regulations and oversight. This paper provides an analysis of the argument, sets forth a new version of it, and identifies three developments that raise biosecurity risks compared to the situation earlier. The developments include (1) a spread of the required know-how, (2) improved availability of the techniques, instruments and biological parts, and (3) new technical possibilities such as "resurrecting" disappeared pathogens. It is first shown that the general argument from SynBioSecurity needs to be qualified and that many improvements to biosecurity have already been implemented, most notably in the United States. Second, I suggest a new strain of the argument: the situation that most branches of synthetic biology fall under the gene technology regulation in the European Union and that this regulation in its current form does not adequately address SynBioSecurity risks together provide a weighty reason to review and possibly refine the legislation as well as the supervisory practices. Ethically speaking, the rise in the relative risk of bioterrorism brings to the fore new extrinsic issues.	[Ahteensuu, Marko] Univ Turku, Turku Inst Adv Studies, Unit Philosophy, Assistentikatu 7, Turku 20014, Finland	Ahteensuu, M (reprint author), Univ Turku, Turku Inst Adv Studies, Unit Philosophy, Assistentikatu 7, Turku 20014, Finland.	mataah@utu.fi					Ahteensuu M., 2008, REPORTS DEP PHILOS; Ahteensuu M., 2016, REPORTS DEP PHILOS, P16; Boldt J, 2008, NAT BIOTECHNOL, V26, P387, DOI 10.1038/nbt0408-387; Bovenkerk B., 2012, BIOTECHNOLOGY DEBATE; Bugl H, 2007, NAT BIOTECHNOL, V25, P627, DOI 10.1038/nbt0607-627; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087                                                   ; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; Cirigliano A, 2017, SCI ENG ETHICS, V23, P365, DOI 10.1007/s11948-016-9774-1; CPB = Secretariat of the Convention on Biological Diversity, 2000, CART PROT BIOS CONV; Cressey D, 2007, NATURE, V448, P732, DOI 10.1038/448732a; Douglas T, 2010, J MED ETHICS, V36, P687, DOI 10.1136/jme.2010.038232; EASAC = European Academies Science Advisory Council, 2011, SYNTH BIOL INTR; EEA = European Environment Agency, 2001, LATE LESSONS EARLY W; Garfinkel MS, 2007, SYNTHETIC GENOMICS O; Garfinkle M., 2014, ETHICS EMERGING TECH, P533; Heavey P, 2013, BIOETHICS, V27, P442, DOI 10.1111/bioe.12052; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; International Risk Governance Council (IRGC), 2010, GUID APPR RISK GOV S; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Jefferson C., 2014, FRONTIERS PUBLIC HLT, V2, P1; Jonas H., 1984, IMPERATIVE RESPONSIB; Kaebnick GE, 2013, BASIC BIOETH, P1, DOI 10.7551/mitpress/9780262019392.001.0001; Kaiser J, 2015, SCIENCE; Kelle A, 2009, SYNTHETIC BIOLOGY: THE TECHNOSCIENCE AND ITS SOCIETAL CONSEQUENCES, P101, DOI 10.1007/978-90-481-2678-1_7; Kelle A, 2009, EMBO REP, V10, pS23, DOI 10.1038/embor.2009.119; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Mukunda Gautam, 2009, Politics Life Sci, V28, P2, DOI 10.2990/28_2_2; NSABB = National Science Advisory Board for Biosecurity, 2006, ADDR BIOS REL SYNTH; NSABB = National Science Advisory Board for Biosecurity, 2010, ADD BIOS REL SYNTH B; OECD, 2014, EM POL ISS SYNTH BIO; Oye K. A., 2012, PROACTIVE ADAPTIVE G; Parens E., 2009, ETHICAL ISSUES SYNTH; Pennisi E., 2012, SCIENCE; Pierce RL, 2012, J MED ETHICS, V38, P636, DOI 10.1136/medethics-2012-100563; Posner RA, 2004, CATASTROPHE RISK RES; Presidential Commission for the Study of Bioethical Issues, 2010, NEW DIR ETH SYNTH BI; Randerson J., 2006, GUARDIAN; Sample I., 2014, GUARDIAN; Schmidt M, 2009, SYNTHETIC BIOLOGY: THE TECHNOSCIENCE AND ITS SOCIETAL CONSEQUENCES, P81, DOI 10.1007/978-90-481-2678-1_6; Scientific Committees/European Commission, 2014, OP SYNTH BIOL 1 DEF; Scientific Committees/European Commission, 2015, OP SYNTH BIOL 2 RISK; Scientific Committees/European Commission, 2015, FIN OP SYNTH BIOL 3; Sissonen Susanna, 2012, Duodecim, V128, P2217; Sissonen Susanna, 2012, Duodecim, V128, P283; Smith K, 2013, BIOETHICS, V27, P453, DOI 10.1111/bioe.12050; Sunstein Cass, 2007, WORST CASE SCENARIOS; Treaty on European Union, 1992, OFFICIAL J C, V191, P35; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Weiss S, 2015, ISR MED ASSOC J, V17, P269	54	0	0	11	11	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1353-3452	1471-5546		SCI ENG ETHICS	Sci. Eng. Ethics	DEC	2017	23	6					1541	1561		10.1007/s11948-016-9868-9				21	Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science; Multidisciplinary Sciences; Philosophy	Social Sciences - Other Topics; Engineering; History & Philosophy of Science; Science & Technology - Other Topics; Philosophy	FO0LK	WOS:000416435700005	28074376				2018-01-05	
J	Etard, C; Joshi, S; Stegmaier, J; Mikut, R; Strahle, U				Etard, Christelle; Joshi, Swarnima; Stegmaier, Johannes; Mikut, Ralf; Straehle, Uwe			Tracking of Indels by DEcomposition is a Simple and Effective Method to Assess Efficiency of Guide RNAs in Zebrafish	ZEBRAFISH			English	Article						guide-RNAs; efficiencies; zebrafish; TIDE	GENOME; CRISPR/CAS9	A bottleneck in CRISPR/Cas9 genome editing is variable efficiencies of in silico-designed gRNAs. We evaluated the sensitivity of the TIDE method (Tracking of Indels by DEcomposition) introduced by Brinkman et al. in 2014 for assessing the cutting efficiencies of gRNAs in zebrafish. We show that this simple method, which involves bulk polymerase chain reaction amplification and Sanger sequencing, is highly effective in tracking well-performing gRNAs in pools of genomic DNA derived from injected embryos. The method is equally effective for tracing INDELs in heterozygotes.	[Etard, Christelle; Joshi, Swarnima; Straehle, Uwe] KIT, ITG, D-76344 Eggenstein Leopoldshafen, Germany; [Stegmaier, Johannes; Mikut, Ralf] KIT, Inst Appl Comp Sci IAI, Karlsruhe, Germany	Strahle, U (reprint author), KIT, ITG, D-76344 Eggenstein Leopoldshafen, Germany.	uwe.straehle@kit.edu	Mikut, Ralf/A-5949-2013	Mikut, Ralf/0000-0001-9100-5496	HGF; DFG [STR 39/8-1]; BMBF-MIE "Molecular Interaction Engineering'' [031A095 C]; EU Horizon 2020, Marie Sklodowska-Curie program [643062]	The authors are grateful to Dr. T. Dickmeis for critical reading of the article. We thank N. Borel and our fish house team. This work was funded by HGF, DFG (STR 39/8-1), BMBF-MIE "Molecular Interaction Engineering'' (031A095 C), and EU Horizon 2020, Marie Sklodowska-Curie program (grant no. 643062).	Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chuai GH, 2017, TRENDS BIOTECHNOL, V35, P12, DOI 10.1016/j.tibtech.2016.06.008; Feng Y, 2016, G3-GENES GENOM GENET, V6, P2517, DOI [10.1534/g3.116.031914, 10.1534/g3.116.031914/-/DC1]; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; KC R, 2016, SCI REP, V6; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368	12	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1545-8547	1557-8542		ZEBRAFISH	Zebrafish	DEC	2017	14	6					586	588		10.1089/zeb.2017.1454				3	Developmental Biology; Zoology	Developmental Biology; Zoology	FN9HB	WOS:000416340100012	28767326				2018-01-05	
J	Lostale-Seijo, I; Louzao, I; Juanes, M; Montenegro, J				Lostale-Seijo, Irene; Louzao, Iria; Juanes, Marisa; Montenegro, Javier			Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition	CHEMICAL SCIENCE			English	Article							EFFICIENT DELIVERY; IN-VIVO; CAS9; RNA; PROTEINS; CRISPR; NANOPARTICLES; ENDONUCLEASE; DISCOVERY; PATHWAYS	The discovery of RNA guided endonucleases has emerged as one of the most important tools for gene edition and biotechnology. The selectivity and simplicity of the CRISPR/Cas9 strategy allows the straightforward targeting and editing of particular loci in the cell genome without the requirement of protein engineering. However, the transfection of plasmids encoding the Cas9 and the guide RNA could lead to undesired permanent recombination and immunogenic responses. Therefore, the direct delivery of transient Cas9 ribonucleoprotein constitutes an advantageous strategy for gene edition and other potential therapeutic applications of the CRISPR/Cas9 system. The covalent fusion of Cas9 with penetrating peptides requires multiple incubation steps with the target cells to achieve efficient levels of gene edition. These and other recent reports suggested that covalent conjugation of the anionic Cas9 ribonucleoprotein to cationic peptides would be associated with a hindered nuclease activity due to undesired electrostatic interactions. We here report a supramolecular strategy for the direct delivery of Cas9 by an amphiphilic penetrating peptide that was prepared by a hydrazone bond formation between a cationic peptide scaffold and a hydrophobic aldehyde tail. The peptide/protein non-covalent nanoparticles performed with similar efficiency and less toxicity than one of the best methods described to date. To the best of our knowledge this report constitutes the first supramolecular strategy for the direct delivery of Cas9 using a penetrating peptide vehicle. The results reported here confirmed that peptide amphiphilic vectors can deliver Cas9 in a single incubation step, with good efficiency and low toxicity. This work will encourage the search and development of conceptually new synthetic systems for transitory endonucleases direct delivery.	[Lostale-Seijo, Irene; Louzao, Iria; Juanes, Marisa; Montenegro, Javier] Univ Santiago de Compostela, Dept Quim Organ, Ctr Singular Invest Quim Biol & Mat Mol CIQUS, Santiago De Compostela 15782, Spain	Montenegro, J (reprint author), Univ Santiago de Compostela, Dept Quim Organ, Ctr Singular Invest Quim Biol & Mat Mol CIQUS, Santiago De Compostela 15782, Spain.	javier.montenegro@usc.es			Spanish Agencia Estatal de Investigacion (AEI) [CTQ2014-59646-R]; Xunta de Galicia [ED431G/09, 2016-AD031]; ERDF; MINECO; Ramon y Cajal [RYC-2013-13784]; ERC [DYNAP-677786]; Young Investigator Grant from Human Frontier Science Research Program [RGY0066/2017]	We thank Rebeca Menaya-Vargas for assistance with cell protocols and Dr Lisa K. Busch for the kind gift of DF1-EGFP cells. This work was partially supported by the Spanish Agencia Estatal de Investigacion (AEI) [CTQ2014-59646-R], the Xunta de Galicia (ED431G/09 and 2016-AD031) and the ERDF. M. J. received a F. P. I. fellowship from MINECO. J. M. received a Ramon y Cajal (RYC-2013-13784), an ERC Starting Investigator Grant (DYNAP-677786) and a Young Investigator Grant from the Human Frontier Science Research Program (RGY0066/2017).	Akishiba M, 2017, NAT CHEM, V9, P751, DOI [10.1038/nchem.2779, 10.1038/NCHEM.2779]; Alarcon A. Munoz, 2013, FUSION PROTEIN TECHN, P397; Appelbaum JS, 2012, CHEM BIOL, V19, P819, DOI 10.1016/j.chembiol.2012.05.022; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; De Santis E, 2015, CHEM SOC REV, V44, P8288, DOI 10.1039/c5cs00470e; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fuertes A, 2017, CHEM COMMUN, V53, P7861, DOI 10.1039/c7cc02997g; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gehin C, 2013, J AM CHEM SOC, V135, P9295, DOI 10.1021/ja404153m; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kelton WJ, 2016, CHIMIA, V70, P439, DOI 10.2533/chimia.2016.439; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; KIM E, 2017, NAT COMMUN, V8; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lee JH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601838; Li M, 2015, J AM CHEM SOC, V137, P14084, DOI 10.1021/jacs.5b05694; Louzao I, 2017, J MATER CHEM B, V5, P4426, DOI 10.1039/c7tb00179g; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2016, TRENDS MICROBIOL, V24, P811, DOI 10.1016/j.tim.2016.06.005; Mojica FJM, 2016, FEBS J, V283, P3162, DOI 10.1111/febs.13766; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; Pattanayak V, 2014, METHOD ENZYMOL, V546, P47, DOI 10.1016/B978-0-12-801185-0.00003-9; Priegue JM, 2016, ANGEW CHEM INT EDIT, V55, P7492, DOI 10.1002/anie.201601441; Radis-Baptista G, 2017, J BIOTECHNOL, V252, P15, DOI 10.1016/j.jbiotec.2017.05.002; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Song MJ, 2017, BIOTECHNOL PROGR, V33, P1035, DOI 10.1002/btpr.2484; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Suresh B, 2017, METHODS MOL BIOL, V1507, P81, DOI 10.1007/978-1-4939-6518-2_7; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Yi CL, 2017, ACCOUNTS CHEM RES, V50, P12, DOI 10.1021/acs.accounts.6b00343; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yu X, 2016, BIOTECHNOL LETT, V38, P919, DOI 10.1007/s10529-016-2064-9; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	43	0	0	22	22	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.	DEC 1	2017	8	12					7923	7931		10.1039/c7sc03918b				9	Chemistry, Multidisciplinary	Chemistry	FN3DL	WOS:000415877000004					2018-01-05	
J	Tazaki, A; Tanaka, EM; Fei, JF				Tazaki, Akira; Tanaka, Elly M.; Fei, Ji-Feng			Salamander spinal cord regeneration: The ultimate positive control in vertebrate spinal cord regeneration	DEVELOPMENTAL BIOLOGY			English	Article							PERIPHERAL NERVOUS-SYSTEM; NEURAL STEM-CELL; AXOLOTL TAIL REGENERATION; ADULT-RAT; HEART REGENERATION; GLIAL-CELLS; INJURY; EPENDYMA; URODELE; DIFFERENTIATION	Repairing injured tissues / organs is one of the major challenges for the maintenance of proper organ function in adulthood. In mammals, the central nervous system including the spinal cord, once established during embryonic development, has very limited capacity to regenerate. In contrast, salamanders such as axolotls can fully regenerate the injured spinal cord, making this a very powerful vertebrate model system for studying this process. Here we discuss the cellular and molecular requirements for spinal cord regeneration in the axolotl. The recent development of tools to test molecular function, including CRISPR-mediated gene editing, has lead to the identification of key players involved in the cell response to injury that ultimately leads to outgrowth of neural stem cells that are competent to replay the process of spinal cord development to replace the damaged/missing tissue.	[Tazaki, Akira; Tanaka, Elly M.] Res Inst Mol Pathol IMP, Vienna Bioctr VBC, Campus Vienna Bioctr, A-1030 Vienna, Austria; [Fei, Ji-Feng] South China Normal Univ, Inst Brain Res & Rehabil, Guangzhou, Guangdong, Peoples R China	Tazaki, A (reprint author), Res Inst Mol Pathol IMP, Vienna Bioctr VBC, Campus Vienna Bioctr, A-1030 Vienna, Austria.	akira.tazaki@imp.ac.at			DFG [SFB655, TA274/3-3]; South China Normal University [S82111-E2, 8S0109]	ET and AT was supported by DFG SFB655: From cells to tissues. ET and JFF were supported by TA274/3-3 from the DFG. JFF was supported by Research Start Grants S82111-E2 and 8S0109 from South China Normal University.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Albors AR, 2015, ELIFE, V4, DOI 10.7554/eLife.10230; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; ARSANTO JP, 1992, J EXP ZOOL, V264, P273, DOI 10.1002/jez.1402640307; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI [10.1172/JC172181, 10.1172/JCI72181]; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; BARRETT CP, 1981, EXP NEUROL, V73, P365, DOI 10.1016/0014-4886(81)90272-7                                                    ; Benraiss A, 1999, DEV GENES EVOL, V209, P363, DOI 10.1007/s004270050265; Benraiss A, 1996, DEV DYNAM, V205, P135, DOI 10.1002/(SICI)1097-0177(199602)205:2<135::AID-AJA5>3.0.CO;2-J; Benraiss A, 1997, DEV DYNAM, V209, P15; BERNSTEIN JJ, 1985, BRAIN RES, V327, P135, DOI 10.1016/0006-8993(85)91507-0; BRUNI JE, 1987, J ANAT, V152, P55; BUTLER EG, 1967, DEV BIOL, V15, P464, DOI 10.1016/0012-1606(67)90038-3; BUTLER EG, 1965, J EXP ZOOL, V160, P47, DOI 10.1002/jez.1401600106; Butler SJ, 2015, DEV BIOL, V398, P135, DOI 10.1016/j.ydbio.2014.09.033; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804                                                         ; EGAR M, 1972, EXP NEUROL, V37, P422, DOI 10.1016/0014-4886(72)90085-4; Fei JF, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.2; Fei JF, 2014, STEM CELL REP, V3, P444, DOI 10.1016/j.stemcr.2014.06.018; GERAUDIE J, 1988, AM J ANAT, V183, P359, DOI 10.1002/aja.1001830409                                                          ; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; HOLDER N, 1988, TRENDS NEUROSCI, V11, P94, DOI 10.1016/0166-2236(88)90151-8; HOLDER N, 1991, J COMP NEUROL, V303, P534, DOI 10.1002/cne.903030403; Horner PJ, 2000, J NEUROSCI, V20, P2218; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3                                                   ; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kirkham M, 2011, NEUROSCI LETT, V497, P11, DOI 10.1016/j.neulet.2011.04.007; LIUZZI FJ, 1987, BRAIN RES, V403, P385, DOI 10.1016/0006-8993(87)90081-3; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Mchedlishvili L, 2012, P NATL ACAD SCI USA, V109, pE2258, DOI 10.1073/pnas.1116738109; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Nomura H, 2010, NEUROREPORT, V21, P871, DOI 10.1097/WNR.0b013e32833d9695; NORDLANDER RH, 1978, J COMP NEUROL, V180, P349, DOI 10.1002/cne.901800211; OHARA CM, 1992, DEV DYNAM, V193, P103, DOI 10.1002/aja.1001930202                                                          ; Olivera-Martinez I, 2014, DEVELOPMENT, V141, P3266, DOI 10.1242/dev.112623; Petit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024538; PIATT J, 1955, J EXP ZOOL, V129, P177, DOI 10.1002/jez.1401290109; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Popovich P. G., 2002, J NEUROPATHOL EXP NE; Quiroz JFD, 2014, DIS MODEL MECH, V7, P601, DOI 10.1242/dmm.014837; Rost F, 2016, ELIFE, V5, DOI 10.7554/eLife.20357; Sabin K, 2015, DEV BIOL, V408, P14, DOI 10.1016/j.ydbio.2015.10.012; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; SEITZ R, 1981, CELL TISSUE RES, V220, P61; Sugiura T, 2016, NATURE, V531, P237, DOI [10.1038/536023a, 10.1038/nature16974]; Walder S, 2003, DEV GENES EVOL, V213, P625, DOI 10.1007/s00427-003-0364-2; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Yamamoto S, 2001, J NEUROSCI, V21, P9814; ZAMMIT PS, 1993, NEUROSCIENCE, V54, P781, DOI 10.1016/0306-4522(93)90247-D; ZAMORA AJ, 1978, ANAT EMBRYOL, V154, P67, DOI 10.1007/BF00317955                                                              ; Zhang F, 2003, DEV DYNAM, V226, P341, DOI 10.1002/dvdy.10230; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	60	0	0	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	DEC 1	2017	432	1					63	71		10.1016/j.ydbio.2017.09.034				9	Developmental Biology	Developmental Biology	FN8SZ	WOS:000416297100008	29030146				2018-01-05	
J	Gandhi, S; Piacentino, ML; Vieceli, FM; Bronner, ME				Gandhi, Shashank; Piacentino, Michael L.; Vieceli, Felipe M.; Bronner, Marianne E.			Optimization of CRISPR/Cas9 genome editing for loss-of-function in the early chick embryo	DEVELOPMENTAL BIOLOGY			English	Article						CRISPR/Cas9; Chick embryos; gRNA; Neural crest; Knockout	CRANIAL NEURAL CREST; TRANSCRIPTION FACTOR; RNA INTERFERENCE; RATIONAL DESIGN; U6 PROMOTERS; HUMAN-CELLS; IN-VIVO; SYSTEM; EXPRESSION; ENHANCER	The advent of CRISPR/Cas9 has made genome editing possible in virtually any organism, including those not previously amenable to genetic manipulations. Here, we present an optimization of CRISPR/Cas9 for application to early avian embryos with improved efficiency via a three-fold strategy. First, we employed Cas9 protein flanked with two nuclear localization signal sequences for improved nuclear localization. Second, we used a modified guide RNA (gRNA) scaffold that obviates premature termination of transcription and unstable Cas9-gRNA interactions. Third, we used a chick-specific U6 promoter that yields 4-fold higher gRNA expression than the previously utilized human U6. For rapid screening of gRNAs for in vivo applications, we also generated a chicken fibroblast cell line that constitutively expresses Cas9. As proof of principle, we performed electroporation-based loss-of-function studies in the early chick embryo to knock out Pax7 and Sox10, key transcription factors with known functions in neural crest development. The results show that CRISPR/Cas9-mediated deletion causes loss of their respective proteins and transcripts, as well as predicted downstream targets. Taken together, the results reveal the utility of this optimized CRISPR/Cas9 method for targeted gene knockout in chicken embryos in a manner that is reproducible, robust and specific.	[Gandhi, Shashank; Piacentino, Michael L.; Vieceli, Felipe M.; Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Bronner, ME (reprint author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mbronner@caltech.edu			National Institutes of Health (NIH) [R01 DE024157, F32 HD088022]; Brazilian National Council for Scientific and Technological Development [PDE 207656/2014-2]	We would like to thank Alberto Stolfi from Lionel Christiaen's lab (New York University) and Chao-Yuan Yeh from Cheng-Ming Chuong's lab (University of Southern California) for reagents, Erica Hutchins for technical assistance, Yuwei Li, Meyer Barembaum and the rest of the Bronner lab for valuable discussions on the project, Elena K. Perry for helpful comments on the manuscript, the Caltech Biological Imaging Facility for technical assistance on imaging, and Jamie Tijerina with the Caltech Flow Cytometry Facility for assistance with flow cytometry. This work was partially supported by the National Institutes of Health (NIH) [R01 DE024157 to MEB and F32 HD088022 to MLP] and the Brazilian National Council for Scientific and Technological Development [PDE 207656/2014-2 to FMV].	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Arede N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002638; Bai Y., 2016, GENES GENOMES GENET; Barembaum M, 2013, DEV BIOL, V382, P567, DOI 10.1016/j.ydbio.2013.08.009; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Betancur P, 2011, DEVELOPMENT, V138, P3689, DOI 10.1242/dev.057836; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corey DR, 2001, GENOME BIOL, V2; Darnell DK, 2000, METH MOL B, V135, P25; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ezin AM, 2009, DEV BIOL, V330, P221, DOI 10.1016/j.ydbio.2009.03.018; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gandhi S, 2017, DEV BIOL, V425, P8, DOI 10.1016/j.ydbio.2017.03.003; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Ghislain J, 2003, DEVELOPMENT, V130, P941, DOI 10.1242/dev.00318; Green SA, 2015, NATURE, V520, P474, DOI 10.1038/nature14436; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Jinek M., 2013, ELIFE, V2013; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kos R, 2001, DEVELOPMENT, V128, P1467; Kudo T, 2005, J REPROD DEVELOP, V51, P411, DOI 10.1262/jrd.16094; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Le Douarin NM, 1982, NEURAL CREST; Lopes R, 2016, NAT REV MOL CELL BIO, V17, P597, DOI 10.1038/nrm.2016.79; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nishiyama A, 2008, DEV GROWTH DIFFER, V50, P521, DOI [10.1111/j.1440-169x.2008.01039.x, 10.1111/j.1440-169X.2008.01039.x]; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Roellig D, 2017, ELIFE, V6, DOI 10.7554/eLife.21620; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Sauka-Spengler T, 2008, METHOD CELL BIOL, V87, P237, DOI 10.1016/S0091-679X(08)00212-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Simoes-Costa MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003142; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stolfi A, 2014, DEVELOPMENT, V141, P4115, DOI 10.1242/dev.114488; Streit A, 2013, GENESIS, V51, P296, DOI 10.1002/dvg.22359; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wise TG, 2007, ANIM BIOTECHNOL, V18, P153, DOI 10.1080/10495390600867515	62	0	0	10	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	DEC 1	2017	432	1					86	97		10.1016/j.ydbio.2017.08.036				12	Developmental Biology	Developmental Biology	FN8SZ	WOS:000416297100010	29150011				2018-01-05	
J	Morange, M				Morange, Michel			What history tells us XLIV: The construction of the zinc finger nucleases	JOURNAL OF BIOSCIENCES			English	Article						CRISPR-Cas9; homologous recombination; meganucleases; protein domains; restriction enzymes; synthetic biology; zinc finger	I-SCE-I; SITE-SPECIFIC ENDONUCLEASE; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; RESTRICTION-ENDONUCLEASE; MAMMALIAN-CELLS; DNA RECOGNITION; CLEAVAGE; INTRON; PROTEIN		[Morange, Michel] Ecole Normale Super, Ctr Cavailles Republ Savoirs Lettres Sci Philosop, 29 Rue Ulm, F-75230 Paris 05, France	Morange, M (reprint author), Ecole Normale Super, Ctr Cavailles Republ Savoirs Lettres Sci Philosop, 29 Rue Ulm, F-75230 Paris 05, France.	morange@biologie.ens.fr					Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022                                                         ; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; KIM YG, 1994, P NATL ACAD SCI USA, V91, P883, DOI 10.1073/pnas.91.3.883                                                           ; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; LI L, 1992, P NATL ACAD SCI USA, V89, P4275, DOI 10.1073/pnas.89.10.4275; MILLER J, 1985, EMBO J, V4, P1609; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Morange M, 2016, J BIOSCIENCES, V41, P9, DOI 10.1007/s12038-016-9597-x; Morange M, 2015, J BIOSCIENCES, V40, P829, DOI 10.1007/s12038-015-9575-8; Morange M, 2015, J BIOSCIENCES, V40, P3, DOI 10.1007/s12038-015-9504-x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PLESSIS A, 1992, GENETICS, V130, P451; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; THIERRY A, 1991, NUCLEIC ACIDS RES, V19, P189, DOI 10.1093/nar/19.1.189; THIERRY A, 1992, NUCLEIC ACIDS RES, V20, P5625, DOI 10.1093/nar/20.21.5625; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556	30	0	0	2	2	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0250-5991	0973-7138		J BIOSCIENCES	J. Biosci.	DEC	2017	42	4					527	530		10.1007/s12038-017-9723-4				4	Biology	Life Sciences & Biomedicine - Other Topics	FN6HF	WOS:000416114100002	29229870				2018-01-05	
J	Esposito, G; Tremolaterra, MR; Marsocci, E; Tandurella, ICM; Fioretti, T; Savarese, M; Carsana, A				Esposito, Gabriella; Tremolaterra, Maria Roberta; Marsocci, Evelina; Tandurella, Igor C. M.; Fioretti, Tiziana; Savarese, Maria; Carsana, Antonella			Precise mapping of 17 deletion breakpoints within the central hotspot deletion region (introns 50 and 51) of the DMD gene	JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HOT-SPOT; MECHANISMS; SEQUENCE; DISEASE; REARRANGEMENTS; MUTATIONS; INSIGHTS; DNA	Exon deletions in the human DMD gene, which encodes the dystrophin protein, are the molecular defect in 50-70% of cases of Duchenne/Becker muscular dystrophies. Deletions are preferentially clustered in the 5' (exons 2-20) and the central (exons 45-53) region of DMD, likely because local DNA structure predisposes to specific breakage or recombination events. Notably, innovative therapeutic strategies may rescue dystrophin function by homology-based specific targeting of sequences within the central DMD hot spot deletion region. To further study molecular mechanisms that generate such frequent genome variations and to identify residual intronic sequences, we sequenced 17 deletion breakpoints within introns 50 and 51 of DMD and analyzed the surrounding genomic architecture. There was no breakpoint clustering within the introns nor extensive homology between sequences adjacent to each junction. However, at or near the breakpoint, we found microhomology, short tandem repeats, interspersed repeat elements and short sequence stretches that predispose to DNA deletion or bending. Identification of such structural elements contributes to elucidate general mechanisms generating deletion within the DMD gene. Moreover, precise mapping of deletion breakpoints and localization of repeated elements are of interest, because residual intronic sequences may be targeted by therapeutic strategies based on genome editing correction.	[Esposito, Gabriella; Tremolaterra, Maria Roberta; Carsana, Antonella] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Via San Pansini 5, I-80131 Naples, Italy; [Esposito, Gabriella; Marsocci, Evelina; Tandurella, Igor C. M.; Savarese, Maria; Carsana, Antonella] CEINGE Adv Biotechnol, Naples, Italy; [Fioretti, Tiziana] IRCCS SDN, Naples, Italy; [Marsocci, Evelina] Lab Athena, Via Ilaria Alpi 62, I-47522 Cesena, Italy; [Tandurella, Igor C. M.] Osped Oncol Riferimento Reg Armando Businco, I-09121 Cagliari, Italy	Carsana, A (reprint author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Via San Pansini 5, I-80131 Naples, Italy.	carsana@unina.it			Ministry of Health, Italy [RF-2011-02349269]; Regione Campania (Convenzione CEINGE-Regione Campania)	This work has been supported by Ministry of Health, Italy, grant RF-2011-02349269 to GE and by Regione Campania (Convenzione CEINGE-Regione Campania, G.R: 27/12/2007).	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Ankala A, 2012, GENOME RES, V22, P25, DOI 10.1101/gr.123463.111; Baskin B, 2014, MOL GENET GENOM MED, V2, P539, DOI 10.1002/mgg3.108; BLONDEN LAJ, 1991, GENOMICS, V10, P631, DOI 10.1016/0888-7543(91)90445-K                                                    ; Carsana A, 2005, ANN HUM GENET, V69, P253, DOI 10.1046/j.1529-8817.2005.00160.x; Carsana A, 2007, J MOL DIAGN, V9, P64, DOI 10.2353/jmoldx.2007.060056; Carsana Antonella, 2010, Front Biosci (Elite Ed), V2, P547, DOI 10.2741/e113; Chen C, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092271, 10.1371/journal.pone.0085522, 10.1371/journal.pone.0100297, 10.1371/journal.pone.0115694, 10.1371/journal.pone.0087856, 10.1371/journal.pone.0099802, 10.1371/journal.pone.0089305, 10.1371/journal.pone.0104862]; DRMANAC R, 1986, NUCLEIC ACIDS RES, V14, P4691, DOI 10.1093/nar/14.11.4691; Esposito G, 2013, CLIN CHEM LAB MED, V51, P2239, DOI 10.1515/cclm-2013-0209; Frisso G, 2004, CLIN CHEM, V50, P1435, DOI 10.1373/clinchem.2004.033795; Gualandi F, 2006, GENE, V370, P26, DOI 10.1016/j.gene.2005.11.002; Ishmukhametova A, 2012, EUR J HUM GENET, V20, P1096, DOI 10.1038/ejhg.2012.51; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; KRAWCZAK M, 1991, HUM GENET, V86, P425; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; LOVE DR, 1991, GENOMICS, V10, P57, DOI 10.1016/0888-7543(91)90484-V; McNaughton JC, 1998, GENE, V222, P41, DOI 10.1016/S0378-1119(98)00466-1; Mitsui J, 2010, AM J HUM GENET, V87, P75, DOI 10.1016/j.ajhg.2010.06.006; Miyazaki D, 2009, J HUM GENET, V54, P127, DOI 10.1038/jhg.2008.8; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4                                                   ; Nobile C, 2002, HUM GENET, V110, P418, DOI 10.1007/s00439-002-0721-7; Oshima J, 2009, HUM GENET, V126, P411, DOI 10.1007/s00439-009-0679-9; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Paolella G, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-64; RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Sironi M, 2003, HUM GENET, V112, P272, DOI 10.1007/s00439-002-0881-5; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; Veropalumbo C, 2012, J PAEDIATR CHILD H, V48, P886, DOI 10.1111/j.1440-1754.2010.01730.x; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073                                                                	33	0	0	5	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	DEC	2017	62	12					1057	1063		10.1038/jhg.2017.84				7	Genetics & Heredity	Genetics & Heredity	FN9KI	WOS:000416353600008	28878337				2018-01-05	
J	Serre, L; Girard, M; Ramadan, A; Menut, P; Rouquie, N; Lucca, LE; Mahiddine, K; Leobon, B; Mars, LT; Guerder, S				Serre, Laurent; Girard, Maeva; Ramadan, Abdoulraouf; Menut, Paul; Rouquie, Nelly; Lucca, Liliana E.; Mahiddine, Karim; Leobon, Bertrand; Mars, Lennart T.; Guerder, Sylvie			Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis	JOURNAL OF IMMUNOLOGY			English	Article							MHC CLASS-II; T-CELL TOLERANCE; EPITHELIAL-CELLS; SELF-ANTIGEN; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; GENE-EXPRESSION; MICE; AIRE; MECHANISMS	The genetic predisposition to multiple sclerosis (MS) is most strongly conveyed by MHC class II haplotypes, possibly by shaping the autoimmune CD4 T cell repertoire. Whether Ag-processing enzymes contribute to MS susceptibility by editing the peptide repertoire presented by these MHC haplotypes is unclear. Thymus-specific serine protease (TSSP) is expressed by thymic epithelial cells and thymic dendritic cells (DCs) and, in these two stromal compartments, TSSP edits the peptide repertoire presented by class II molecules. We show in this article that TSSP increases experimental autoimmune encephalomyelitis severity by limiting central tolerance to myelin oligodendrocyte glycoprotein. The effect on experimental autoimmune encephalomyelitis severity was MHC class II allele dependent, because the lack of TSSP expression conferred protection in NOD mice but not in C57BL/6 mice. Importantly, although human thymic DCs express TSSP, individuals segregate into two groups having a high or 10-fold lower level of expression. Therefore, the level of TSSP expression by thymic DCs may modify the risk factors for MS conferred by some MHC class II haplotypes.	[Serre, Laurent; Girard, Maeva; Ramadan, Abdoulraouf; Menut, Paul; Rouquie, Nelly; Lucca, Liliana E.; Mahiddine, Karim; Mars, Lennart T.; Guerder, Sylvie] INSERM, U1043, F-31300 Toulouse, France; [Serre, Laurent; Girard, Maeva; Ramadan, Abdoulraouf; Menut, Paul; Rouquie, Nelly; Lucca, Liliana E.; Mahiddine, Karim; Mars, Lennart T.; Guerder, Sylvie] CNRS, UMR5282, F-31300 Toulouse, France; [Serre, Laurent; Girard, Maeva; Ramadan, Abdoulraouf; Menut, Paul; Rouquie, Nelly; Lucca, Liliana E.; Mahiddine, Karim; Mars, Lennart T.; Guerder, Sylvie] Univ Toulouse III Paul Sabatier, Ctr Physiopathol Toulouse Purpan, F-31300 Toulouse, France; [Leobon, Bertrand] Childrens Hosp Toulouse, Dept Pediat Cardiol & Cardiovasc Surg, F-31300 Toulouse, France; [Mars, Lennart T.] INSERM, UMR995, Lille Inflammat Res Int Ctr, F-59000 Lille, France; [Mars, Lennart T.] Univ Lille, Ctr Excellence LICEND, F-59000 Lille, France; [Mars, Lennart T.] Univ Lille, FHU IMMINeNT, F-59000 Lille, France	Guerder, S (reprint author), CHU Purpan, INSERM, UMR1043, Ctr Physiopathol Toulouse Purpan, Batiment A,BP 3028, F-31024 Toulouse 3, France.	Sylvie.guerder@inserm.fr	Mars, Lennart/K-7593-2014		INSERM; CNRS; Agence Nationale de la Recherche [ANR-10-BLAN-1332]; Fondation Aide a la Recherche sur la Sclerose En Plaque; Medical Research Foundation; European Foundation for the Study of Diabetes/Sanofi; Initiative damp;apos;excellence Toulouse; Midi-Pyrenees Region; Ministere de lamp;amp;amp;apos;Education Nationale; Fondation ARSEP	This work was supported in part by INSERM and CNRS and by grants from Agence Nationale de la Recherche (ANR-10-BLAN-1332), Fondation Aide a la Recherche sur la Sclerose En Plaque, the Medical Research Foundation, The European Foundation for the Study of Diabetes/Sanofi, Initiative d'excellence Toulouse, and the Midi-Pyrenees Region. L.S. and M.G. were supported by a doctoral fellowship from the Ministere de l'Education Nationale, and L.S. was supported by a doctoral fellowship from Fondation ARSEP.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618                                                     ; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Lucca LE, 2016, EUR J IMMUNOL, V46, P2247, DOI 10.1002/eji.201646416; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Maron R, 1999, INT IMMUNOL, V11, P1573, DOI 10.1093/intimm/11.9.1573                                                        ; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007                                                    ; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Serre L, 2015, EUR J IMMUNOL, V45, P1946, DOI 10.1002/eji.201445290; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Viret C, 2015, J IMMUNOL, V195, P1964, DOI 10.4049/jimmunol.1401683; Viret C, 2011, J CLIN INVEST, V121, P1810, DOI 10.1172/JCI43314; Viret C, 2011, J EXP MED, V208, P3, DOI 10.1084/jem.20100027; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zhang MF, 2003, J IMMUNOL, V170, P3954, DOI 10.4049/jimmunol.170.8.3954                                                     ; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	35	0	0	2	2	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2017	199	11					3748	3756		10.4049/jimmunol.1700667				9	Immunology	Immunology	FN4ID	WOS:000415967800006	29061767				2018-01-05	
J	Benston, S				Benston, Shawna			Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR	JOURNAL OF MEDICAL ETHICS			English	Article							GERMLINE GENE MODIFICATION; GENOME; SCIENCE; DISEASE	The ease and applicability of CRISPR/Cas9-a new and precise gene editing and reproductive technology-have garnered hype and heightened concern about its potential 'unprecedented and horrific consequences' and have led many scientific leaders to call for a moratorium on its research and use. CRISPR appears distinctly more controversial than previous technological innovations (genetic or otherwise), with a greater reach and speed of human treatment and enhancement; however, we have seen similarly inflated hopes and fears in response to other medical innovations for well over a century. One intervention that has both historically and recently incited alarm-vaccines-serves as a pertinent example of what could go wrong if a technology's reach is shortened due to inflated fears. By comparing the vaccine controversy and the CRISPR debate, we can help separate the hype from the realistic potential of these technologies. How our society grapples with such innovations will determine the extent to which their impact on our individual and collective health will be beneficial. We must recognise the need for a tempered approach to CRISPR conversation leading to regulation and ethical application. Although CRISPR's reach will continue expanding with ongoing research, thus requiring continuous evaluation, the lessons we have learned from the vaccine controversy demonstrate that our approach must not be to shut down regulation and application now, but to thoughtfully conjoin productive debate and action so that therapeutic gene editing can alleviate suffering as soon as possible without precipitating social outcomes we would belatedly deplore.	[Benston, Shawna] Columbia Univ, Ctr Res Eth Legal & Social Implicat Psychiat Neur, New York, NY USA	Benston, S (reprint author), 108 East 96th St,Apt 9E, New York, NY 10128 USA.	Shawna.benston@gmail.com			National Human Genome Research Institute [1P50HG007257-04]	National Human Genome Research Institute (1P50HG007257-04).	Achenbach J, 2015, WASH POST; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Baltimore D, 2015, HUMAN GENE EDITING I; Baltimore D, 2015, WALL STREET J; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Baumann M, 2016, NANOETHICS, V10, P139, DOI 10.1007/s11569-016-0259-0; Billings PR, 1999, LANCET, V353, P1873, DOI 10.1016/S0140-6736(99)01173-3; Blendon RJ, 2016, NEW ENGL J MED, V374, P1406, DOI 10.1056/NEJMp1602010; Bono JM, 2015, MOL ECOL, V24, P3810, DOI 10.1111/mec.13252; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Carroll AE, 2015, NY TIMES; Charo RA, 2016, NEW ENGL J MED, V374, P901, DOI 10.1056/NEJMp1600891; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Colgrove J, 2005, ISIS, V96, P167, DOI 10.1086/431531; Connor S., 2015, INDEPENDENT; Constenla D, 2015, VACCINE, V33, P1527, DOI 10.1016/j.vaccine.2015.01.059; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Doherty M, 2016, VACCINE, V34, P6707, DOI 10.1016/j.vaccine.2016.10.025; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Edwards J., 2016, CELEBRITIES WHO HAVE; Frankel MS, 2000, HUMAN INHERITABLE GE; Gillott J, 2001, J MED ETHICS, V27, P21; Gray KA, 2015, WELLCOME TRUST BLOG; Gyngell C, 2015, BIOETHICS, V29, P241, DOI 10.1111/bioe.12098; Han AP, 2016, LOOK CRISPR CAS9 TRE; Hanlon M., 2015, ONCE WE START EDITIN; Higgins CM, 1907, CASE COMPULSORY VACC; Holland Mary, 2014, OR L REV, V93, P1; Howe EM, 2007, AM BIOL TEACH, V69, P467, DOI 10.1662/0002-7685(2007)69[467:ANCTWT]2.0.CO;2                                   ; Jana LA, 2013, VACCINOPHOBIA VACCIN, P1; Johnston RD, 2003, RADICAL MIDDLE CLASS; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; King DS, 1999, J MED ETHICS, V25, P176, DOI 10.1136/jme.25.2.176                                                            ; Lander ES, 2015, NEW ENGL J MED, V373, P5, DOI 10.1056/NEJMp1506446; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Lewis T, 2015, BUS INSID; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liss-Schultz N., 2016, MOTHER JONES; Maldarelli C, 2016, POP SCI; McIlwain L., 2012, FIGHT BEST PLAN WORS; Miller JJ, 2016, HUM LIFE REV N Y, V42, P90; Mnookin S, 2012, THE PANIC VIRUS; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Nott JC, 1867, NASHV J MED SURG, V2, P372; Omer SB, 2013, NEW ENGL J MED, V368, P1374, DOI 10.1056/NEJMp1300765; Parens E., 2015, CAN PARENTS BE TRUST; Pearson K, 1904, AM J SOCIOL, V10, P1; Phillips MR, 2007, DEF, V49, P57; Polcz S, J LAW BIOSCI; Pollack A., 2014, NY TIMES; Regalado A., MIT TECHNOL REV; Regalado A., 2016, MIT TECHNOL REV; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanders R, BERKELEY NEWS; Smith M, 2015, PEDIATR REV, V36, P227, DOI 10.1542/pir.36-6-227; Thomas J, 2011, J HLTH BIOMED LAW, V7, P449; Times LA, 2015, WHY CRISPR CAS9 IS B; Wade N., 2015, NY TIMES; Warmflash D, 2016, GENE EDITING HUMAN E; Yarris L, PROGRAMMABLE DNA SCI; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; [Anonymous], 2015, NAT MED, V21, P295, DOI 10.1038/nm.3845; [Anonymous], 2017, REV VACC INJ TABL	65	0	0	7	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	DEC	2017	43	12					819	823		10.1136/medethics-2016-103666				5	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	FN6VI	WOS:000416153900006	28473627				2018-01-05	
J	Dhanjal, JK; Radhakrishnan, N; Sundar, D				Dhanjal, Jaspreet Kaur; Radhakrishnan, Navaneethan; Sundar, Durai			Identifying synthetic lethal targets using CRISPR/Cas9 system	METHODS			English	Article						Synthetic lethality; CRISPR/Cas9; Knockout library; Arrayed screen; Pooled screen	HUMAN-CELLS; POLY(ADP-RIBOSE) POLYMERASE; GENETIC SCREENS; CANCER-CELLS; HUMAN GENOME; RNAI SCREEN; CRISPR-CAS9; TUMORS; CAS9; IDENTIFICATION	Synthetic lethality occurs when co-occurrence of two genetic events is unfavorable for the survival of the cell or organism. The conventional approach of high throughput screening of synthetic lethal targets using chemical compounds has been replaced by RNAi technology. CRISPR/Cas9, an RNA guided endonuclease system is the most recent technology for this work. Here, we have discussed the major considerations involved in designing a CRISPR/Cas9 based screening experiment for identification of synthetic lethal targets. It mainly includes CRISPR library to be used, cell types for conducting the experiment, the most appropriate screening strategy and ways of selecting the desired phenotypes from the complete cell population. The complete knockdown of genes can be achieved using CRISPR/Cas9 knockout libraries. For higher quality loss-of-function screens, haploid cells with defective homology-directed DNA repair mechanism could be used. Two widely used screening formats include arrayed and pooled screens followed by negative or positive selection of the cells with desired phenotype. However, pooled screening format with negative selection of cells serves the best. The advantages of using CRISPR/Cas9 system over the other RNAi approaches have also been discussed. Finally, some studies using CRISPR/Cas9 for genome-wide knockout screening in human cells and computational approaches for identification of synthetic lethal interactions have been discussed. (C) 2017 Elsevier Inc. All rights reserved.	[Dhanjal, Jaspreet Kaur; Radhakrishnan, Navaneethan; Sundar, Durai] Indian Inst Technol Delhi, DAILAB, Dept Biochem Engn & Biotechnol, Hauz Khas, New Delhi 110016, India	Sundar, D (reprint author), Indian Inst Technol Delhi, DAILAB, Dept Biochem Engn & Biotechnol, Hauz Khas, New Delhi 110016, India.	bez138509@iitd.ac.in; ird11463@iitd.ac.in; sundar@dbeb.iitd.ac.in		Radhakrishnan, Navaneethan/0000-0003-1645-4827	Council of Scientific and Industrial Research (CSIR), Govt. of India	JIM acknowledges the award of Senior Research Fellowship (SRF) from Council of Scientific and Industrial Research (CSIR), Govt. of India.	Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Arora S, 2010, GYNECOL ONCOL, V118, P220, DOI 10.1016/j.ygyno.2010.05.006; Bae S., 2014, BIOINFORMATICS; Barbosa-Silva A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-435; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bridges CB, 1922, AM NAT, V56, P51, DOI 10.1086/279847; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Conde-Pueyo N, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-116; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DOBZHANSKY T, 1946, GENETICS, V31, P269; Doench J. G., 2016, NAT BIOTECHNOL; Etemadmoghadam D, 2013, P NATL ACAD SCI USA, V110, P19489, DOI 10.1073/pnas.1314302110; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fontaine JF, 2009, NUCLEIC ACIDS RES, V37, pW141, DOI 10.1093/nar/gkp353; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilsdorf M., 2009, NUCLEIC ACIDS RES, V38, pD448; Guo J, 2015, NUCLEIC ACIDS RES, V44, pD1011; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horn T., 2006, NUCL ACIDS RES S1, V35, pD492; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Hutchinson Lisa, 2010, Nat Rev Clin Oncol, V7, P549, DOI 10.1038/nrclinonc.2010.143; Jacquemont C, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-26; Jerby-Arnon L, 2014, CELL, V158, P1199, DOI 10.1016/j.cell.2014.07.027; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kranz D., 2014, EMBO J; Kuhn M., 2013, NUCLEIC ACIDS RES, V42, pD401, DOI DOI 10.1093/NAR/GKT1207; Li XY, 2016, J TOXICOL SCI, V41, P45, DOI 10.2131/jts.41.45; Lin Y., 2014, NUCLEIC ACIDS RES; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin RW, 2008, CELL, V132, P919, DOI 10.1016/j.cell.2008.03.006; Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770; Montague T. G., 2014, NUCLEIC ACIDS RES; Ryan CJ, 2014, CANCER CELL, V26, P306, DOI 10.1016/j.ccr.2014.08.008; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Srihari S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0086-1; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Thompson Jordan M., 2015, Yale Journal of Biology and Medicine, V88, P145; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xue HY, 2016, J MED GENET, V53, P91, DOI 10.1136/jmedgenet-2015-103409; Yang W, 2012, NUCLEIC ACIDS RES, V41, pD955, DOI [DOI 10.1093/NAR/GKS1111, 10.1093/nar/gks1111]	62	2	2	6	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	DEC 1	2017	131						66	73		10.1016/j.ymeth.2017.07.007				8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN7JB	WOS:000416193400006	28710008				2018-01-05	
J	Reczek, CR; Birsoy, K; Kong, H; Martinez-Reyes, I; Wang, T; Gao, P; Sabatini, DM; Chandel, NS				Reczek, Colleen R.; Birsoy, Kivanc; Kong, Hyewon; Martinez-Reyes, Inmaculada; Wang, Tim; Gao, Peng; Sabatini, David M.; Chandel, Navdeep S.			A CRISPR screen identifies a pathway required for paraquat-induced cell death	NATURE CHEMICAL BIOLOGY			English	Article							PARKINSONS-DISEASE; HERBICIDE PARAQUAT; PROTEIN ATP7A; REDUCTASE; TOXICITY; COPPER; CYTOTOXICITY; MITOCHONDRIA; SENSITIVITY; MECHANISMS	Paraquat, a herbicide linked to Parkinson's disease, generates reactive oxygen species (ROS), which causes cell death. Because the source of paraquat-induced ROS production remains unknown, we conducted a CRISPR-based positive-selection screen to identify metabolic genes essential for paraquat-induced cell death. Our screen uncovered three genes, POR (cytochrome P450 oxidoreductase), ATP7A (copper transporter), and SLC4SA4 (sucrose transporter), required for paraquat-induced cell death. Furthermore, our results revealed POR as the source of paraquat-induced ROS production. Thus, our study highlights the use of functional genomic screens for uncovering redox biology.	[Reczek, Colleen R.; Martinez-Reyes, Inmaculada; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Birsoy, Kivanc] Rockefeller Univ, Lab Metab Regulat & Genet, New York, NY 10021 USA; [Kong, Hyewon; Wang, Tim; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02139 USA; [Wang, Tim; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Wang, Tim; Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wang, Tim; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Gao, Peng] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Metabol Core Facil, Chicago, IL 60611 USA	Chandel, NS (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	nav@northwestern.edu			National Institute of Aging grant [5P01AG049665]; National Institutes of Health postdoctoral training grant [T32 HL076139-11]; Irma T. Hirschl/Monique Weill-Caulier Trust Award; Sidney Kimmel Foundation; National Institutes of Health pre-doctoral training grant [T32 C A9560-30]; National institutes of Health [K22 CA1936600]; Searle Scholar Award	We thank the Genome Technology Core of the Whitehead Institute for deep sequencing the genomic DNA samples. We thank the Flow Cytometry Core of Northwestern University for providing the BD LSRFortessa cell analyzer to assess cell viability. We are grateful to M.P. Murphy (University of Cambridge) for providing us MitoParaquat. This work was supported by a National Institute of Aging grant (5P01AG049665) to N.S.C. C.R.R. was supported by a National Institutes of Health postdoctoral training grant (T32 HL076139-11). H.K. was supported by a National Institutes of Health pre-doctoral training grant (T32 C A9560-30). K.B. was supported by grants from the National institutes of Health (K22 CA1936600), a Searle Scholar Award, an Irma T. Hirschl/Monique Weill-Caulier Trust Award, and the Sidney Kimmel Foundation. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Blanco-Ayala T, 2014, FREE RADICAL RES, V48, P623, DOI 10.3109/10715762.2014.899694; CLEJAN L, 1989, BIOCHEM PHARMACOL, V38, P1779, DOI 10.1016/0006-2952(89)90412-7; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cocheme HM, 2009, METHOD ENZYMOL, V456, P395, DOI 10.1016/S0076-6879(08)04422-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dierick HA, 1997, HUM MOL GENET, V6, P409, DOI 10.1093/hmg/6.3.409; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003; Gray JP, 2007, J BIOL CHEM, V282, P7939, DOI 10.1074/jbc.M611817200; Han JF, 2006, TOXICOL SCI, V91, P42, DOI 10.1093/toxsci/kfj139; He Lei, 2009, Human Genomics, V3, P195; Hong SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111674; Huang CP, 2014, METALLOMICS, V6, P654, DOI 10.1039/c3mt00331k; Ishihara Y, 2006, TOXICOL APPL PHARM, V214, P109, DOI 10.1016/j.taap.2005.12.003; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; KELNER MJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P366, DOI 10.1016/0003-9861(89)90450-5; KRALL J, 1988, J BIOL CHEM, V263, P1910; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107                                                           ; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SS, 2016, J THORAC DIS, V8, P2485, DOI 10.21037/jtd.2016.08.08; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021; SAITO M, 1985, Journal of Free Radicals in Biology and Medicine, V1, P179, DOI 10.1016/0748-5514(85)90116-3; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shukla AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098886; Sun IO, 2016, KIDNEY RES CLIN PRAC, V35, P102, DOI 10.1016/j.krcp.2016.01.003; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X                                                   	40	0	0	7	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2017	13	12					1274	+		10.1038/NCHEMBIO.2499				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN3RZ	WOS:000415917900012	29058724				2018-01-05	
J	Ruan, JX; Xu, J; Chen-Tsai, RY; Li, K				Ruan, Jinxue; Xu, Jie; Chen-Tsai, Ruby Yanru; Li, Kui			Genome editing in livestock: Are we ready for a revolution in animal breeding industry?	TRANSGENIC RESEARCH			English	Review						Genome editing; Livestock; Breeding; Industry	ZINC-FINGER NUCLEASES; CRISPR/CAS9 SYSTEM; ZYGOTE INJECTION; TRANSGENIC PIGS; GENE KNOCKOUT; MEISHAN PIGS; MYOSTATIN; GENERATION; CATTLE; MUTATIONS	Genome editing is a powerful technology that can efficiently alter the genome of organisms to achieve targeted modification of endogenous genes and targeted integration of exogenous genes. Current genome-editing tools mainly include ZFN, TALEN and CRISPR/Cas9, which have been successfully applied to all species tested including zebrafish, humans, mice, rats, monkeys, pigs, cattle, sheep, goats and others. The application of genome editing has quickly swept through the entire biomedical field, including livestock breeding. Traditional livestock breeding is associated with rate limiting issues such as long breeding cycle and limitations of genetic resources. Genome editing tools offer solutions to these problems at affordable costs. Generation of gene-edited livestock with improved traits has proven feasible and valuable. For example, the CD163 gene-edited pig is resistant to porcine reproductive and respiratory syndrome (PRRS, also referred to as "blue ear disease"), and a SP110 gene knock-in cow less susceptible to tuberculosis. Given the high efficiency and low cost of genome editing tools, particularly CRISPR/Cas9, it is foreseeable that a significant number of genome edited livestock animals will be produced in the near future; hence it is imperative to comprehensively evaluate the pros and cons they will bring to the livestock breeding industry. Only with these considerations in mind, we will be able to fully take the advantage of the genome editing era in livestock breeding.	[Ruan, Jinxue; Li, Kui] Foshan Univ, Coll Life Sci, Xianhu Univ Rd, Foshan 528231, Guangdong, Peoples R China; [Ruan, Jinxue; Xu, Jie] Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI 48109 USA; [Chen-Tsai, Ruby Yanru] Appl StemCell Inc, Milpitas, CA 95035 USA; [Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chen-Tsai, RY (reprint author), Appl StemCell Inc, Milpitas, CA 95035 USA.; Li, K (reprint author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	ruby.tsai@appliedstemcell.com; likui@caas.cn			National Transgenic Project of China [2016ZX08006-001]; National Key Basic Research Program of China [2015CB943101]; Foshan University Initiative Scientific Research Program	This work was supported by The National Transgenic Project of China (2016ZX08006-001) and National Key Basic Research Program of China (2015CB943101) and Foshan University Initiative Scientific Research Program.	Aldemita RR, 2015, GM CROPS FOOD, V6, P150, DOI 10.1080/21645698.2015.1056972; Araki M, 2014, TRENDS BIOTECHNOL, V32, P234, DOI 10.1016/j.tibtech.2014.03.005; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Cai CB, 2017, ONCOTARGET, V8, P34911, DOI 10.18632/oncotarget.16822; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen HB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-64; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davoli Roberta, 2007, Briefings in Functional Genomics & Proteomics, V6, P313, DOI 10.1093/bfgp/elm036; Deng SL, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-196; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Feng WY, 2015, INT J MOL SCI, V16, P6545, DOI 10.3390/ijms16036545; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Jonas E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00049; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li R, 2017, BIOTECHNOL ADV, V35, P302, DOI 10.1016/j.biotechadv.2017.01.005; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; LI Y, 2016, J ANIM SCI BIOTECHNO, V7; Lillico SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21645; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Liu X, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3368; Liu X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3565; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; OLLIVIER L, 1982, ANN GENET SEL ANIM, V14, P481, DOI 10.1186/1297-9686-14-4-481; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruan JX, 2015, SCI REP, V5, P14253; Sato M, 2014, XENOTRANSPLANTATION, V21, P291, DOI 10.1111/xen.12089; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Tang MX, 2014, TRANSGENIC RES, V23, P557, DOI 10.1007/s11248-014-9796-x; Tang MX, 2011, TRANSGENIC RES, V20, P749, DOI 10.1007/s11248-010-9457-7; Tao CY, 2016, APPL BIOCHEM BIOTECH, V179, P938, DOI 10.1007/s12010-016-2041-8; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Waltz E, 2016, NAT BIOTECHNOL, V34, P7, DOI 10.1038/nbt0116-7a; Waltz E, 2012, NAT BIOTECHNOL, V30, P215, DOI 10.1038/nbt.2143; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wei JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11735; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Whyte JJ, 2011, MOL REPROD DEV, V78, P2, DOI 10.1002/mrd.21271; Wood R J, 1973, Folia Mendeliana, V58, P231; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yang SB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-7; Yao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06926; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153	58	0	0	22	22	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	DEC	2017	26	6					715	726		10.1007/s11248-017-0049-7				12	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FN4DX	WOS:000415954900001	29094286				2018-01-05	
J	Wang, KK; Tang, XC; Xie, ZC; Zou, XD; Li, MJ; Yuan, HM; Guo, NN; Ouyang, HS; Jiao, HP; Pang, DX				Wang, Kankan; Tang, Xiaochun; Xie, Zicong; Zou, Xiaodong; Li, Mengjing; Yuan, Hongming; Guo, Nannan; Ouyang, Hongsheng; Jiao, Huping; Pang, Daxin			CRISPR/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs	TRANSGENIC RESEARCH			English	Article						Erhualian pigs; CRISPR/Cas9; Myostatin; Double-muscled phenotype; SCNT	DOUBLE-MUSCLED PHENOTYPE; GENE; GENERATION; MUTATIONS; CATTLE; SYSTEM; SHEEP; MASS; DOGS	CRISPR/Cas9 has emerged as one of the most popular genome editing tools due to its simple design and high efficiency in multiple species. Myostatin (MSTN) negatively regulates skeletal muscle growth and mutations in myostatin cause double-muscled phenotype in various animals. Here, we generated myostatin mutation in Erhualian pigs using a combination of CRISPR/Cas9 and somatic cell nuclear transfer. The protein level of myostatin precursor decreased dramatically in mutant cloned piglets. Unlike myostatin knockout Landrace, which often encountered health issues and died shortly after birth, Erhualian pigs harboring homozygous mutations were viable. Moreover, myostatin knockout Erhualian pigs exhibited partial double-muscled phenotype such as prominent muscular protrusion, wider back and hip compared with wild-type piglets. Genome editing in Chinese indigenous pig breeds thus holds great promise not only for improving growth performance, but also for protecting endangered genetic resources.	[Wang, Kankan; Tang, Xiaochun; Xie, Zicong; Zou, Xiaodong; Li, Mengjing; Yuan, Hongming; Guo, Nannan; Ouyang, Hongsheng; Jiao, Huping; Pang, Daxin] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, 5333 Xian Rd, Changchun 130062, Jilin, Peoples R China	Jiao, HP; Pang, DX (reprint author), Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, 5333 Xian Rd, Changchun 130062, Jilin, Peoples R China.	jiaohp@jlu.edu.cn; pdx@jlu.edu.cn			Special Funds for Cultivation and Breeding of New Transgenic Organisms [2013ZX08006]; National Natural Science Foundation of China [30871841]	We would like to thank Xue Chen, Tingting Yu and Chunyi Lu for technical assistance. This work was supported by Special Funds for Cultivation and Breeding of New Transgenic Organisms [No. 2013ZX08006] and the National Natural Science Foundation of China [Grants 30871841].	Ai HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056001; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910                                                              ; Kang JD, 2017, RSC ADV, V7, P12541, DOI 10.1039/c6ra28579a; Kang Q, 2014, PROD ASAS; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Rao S, 2016, MOL REPROD DEV, V83, P61, DOI 10.1002/mrd.22591; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vu V, 2015, CELL, V162, P391, DOI 10.1016/j.cell.2015.06.037; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Zhang ZG, 1986, PIG BREEDS IN CHINA; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zou QJ, 2015, J MOL CELL BIOL, V7, P580, DOI 10.1093/jmcb/mjv061	24	0	0	16	16	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	DEC	2017	26	6					799	805		10.1007/s11248-017-0044-z				7	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FN4DX	WOS:000415954900008	28993973				2018-01-05	
J	Bull, JJ; Barrick, JE				Bull, James J.; Barrick, Jeffrey E.			Arresting Evolution	TRENDS IN GENETICS			English	Review							GENE DRIVE; NATURAL-POPULATIONS; LETHAL MUTAGENESIS; VIRUS EVOLUTION; CHAIN-REACTION; RNA VIRUS; BACTERIA; GENOME; REARRANGEMENT; RESISTANCE	Evolution in the form of selective breeding has long been harnessed as a useful tool by humans. However, rapid evolution can also be a danger to our health and a stumbling block for biotechnology. Unwanted evolution can underlie the emergence of drug and pesticide resistance, cancer, and weeds. It makes live vaccines and engineered cells inherently unreliable and unpredictable, and therefore potentially unsafe. Yet, there are strategies that have been and can possibly be used to stop or slow many types of evolution. We review and classify existing population genetics-inspired methods for arresting evolution. Then, we discuss how genome editing techniques enable a radically new set of approaches to limit evolution.	[Bull, James J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Bull, James J.; Barrick, Jeffrey E.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	Barrick, JE (reprint author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Barrick, JE (reprint author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	jbarrick@cm.utexas.edu			National Institutes of Health [R01-GM088344]; National Science Foundation [CBET-1554179]	This work was supported by the National Institutes of Health (R01-GM088344 to JJB) and National Science Foundation (CBET-1554179 to JEB).	Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059; Barroso-Batista J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9945; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Berkhout B, 1999, J VIROL, V73, P1138; Bull JJ, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev005; Bull JJ, 2012, MOL BIOL EVOL, V29, P2997, DOI 10.1093/molbev/mss119; Bull JJ, 2008, GENETICS, V180, P1061, DOI 10.1534/genetics.108.091413; Bull JJ, 1995, J MOL EVOL, V41, P1160; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0                                                                ; Cecchini N, 2013, G3-GENES GENOM GENET, V3, P1389, DOI 10.1534/g3.113.006403; Champer J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006796; Chesley P, 1936, GENETICS, V21, P525; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Crow J. F., 1970, INTRO POPULATION GEN; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Falconer DS, 1996, QUANTITATIVE GENETIC; Flanagan EB, 2001, J VIROL, V75, P6107, DOI 10.1128/JVI.75.13.6107-6114.2001; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gerrish PJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0329; Gould F, 2008, P ROY SOC B-BIOL SCI, V275, P2823, DOI 10.1098/rspb.2008.0846; Gould F, 2008, EVOLUTION, V62, P500, DOI 10.1111/j.1558-5646.2007.00298.x; Gyssens IC, 2011, INT J ANTIMICROB AG, V38, P11, DOI 10.1016/j.ijantimicag.2011.09.002; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hanley Kathryn A, 2011, Evolution (N Y), V4, P635; Harcombe WR, 2005, APPL ENVIRON MICROB, V71, P5254, DOI 10.1128/AEM.71.9.5254-5259.2005; Hartl D. L., 2006, PRINCIPLES POPULATIO; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hope EA, 2017, GENETICS, V206, P1153, DOI 10.1534/genetics.116.198895; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Kloth C, 2013, UPSTREAM IND BIOTECH, P297; KONDRASHOV AS, 1994, GENETICS, V137, P311; Krakauer DC, 2000, EVOLUTION, V54, P731; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103                                                      ; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Lythgoe KA, 2017, TRENDS MICROBIOL, V25, P336, DOI 10.1016/j.tim.2017.03.003; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; PROUT T, 1953, Acta Genet Stat Med, V4, P148; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; SANDLER L, 1959, GENETICS, V44, P233; Sandoval CM, 2014, METAB ENG, V25, P215, DOI 10.1016/j.ymben.2014.07.006; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1543, DOI 10.1603/0022-0493-93.6.1543                                                     ; Shanks GD, 2015, T ROY SOC TROP MED H, V109, P182, DOI 10.1093/trstmh/tru199; Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1916, DOI 10.1093/molbev/mst094; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Sleight Sean C, 2010, J Biol Eng, V4, P12, DOI 10.1186/1754-1611-4-12; Suarez GA, 2017, APPL ENV MICROBIOL; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Wertz GW, 1998, P NATL ACAD SCI USA, V95, P3501, DOI 10.1073/pnas.95.7.3501                                                          ; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Yang S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks972; Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112	67	0	0	20	20	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0168-9525	1362-4555		TRENDS GENET	Trends Genet.	DEC	2017	33	12					910	920		10.1016/j.tig.2017.09.008				11	Genetics & Heredity	Genetics & Heredity	FN2BN	WOS:000415795100004		gold			2018-01-05	
J	McCoy, CJ; Atkinson, LE; Robb, E; Marks, NJ; Maule, AG; Mousley, A				McCoy, Ciaran J.; Atkinson, Louise E.; Robb, Emily; Marks, Nikki J.; Maule, Aaron G.; Mousley, Angela			Tool-Driven Advances in Neuropeptide Research from a Nematode Parasite Perspective	TRENDS IN PARASITOLOGY			English	Review							ASCARIS-SUUM; RNA INTERFERENCE; CAENORHABDITIS-ELEGANS; HAEMONCHUS-CONTORTUS; MASS-SPECTROMETRY; ENDOGENOUS NEUROPEPTIDES; MELOIDOGYNE-INCOGNITA; LOCOMOTORY BEHAVIOR; GENE DISRUPTION; PHYLUM NEMATODA	Expanding 'omics' datasets for parasitic nematodes have accelerated the identification of putative drug targets derived from the nematode nervous system. However, novel drug target validation is hampered by the absence of adequate localisation, functional characterisation, and receptor deorphanisation tools in key nematode pathogens. Reverse genetics techniques have advanced to encompass transgenic, targeted mutagenesis, gene silencing (RNA interference), and genome editing (CRISPR/Cas9) approaches in Caenorhabditis elegans. Unfortunately the translation to nematode pathogens has been slow, such that parasite-focused toolbox development and optimisation is critical. Here we review the discovery, localisation, and functional characterisation toolkit available for parasitic nematode neuropeptide research, and assess the scope and limitations of the tools and techniques for novel nematicide discovery.	[McCoy, Ciaran J.; Atkinson, Louise E.; Robb, Emily; Marks, Nikki J.; Maule, Aaron G.; Mousley, Angela] Queens Univ Belfast, Microbes & Pathogen Biol, Inst Global Food Secur, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland	Mousley, A (reprint author), Queens Univ Belfast, Microbes & Pathogen Biol, Inst Global Food Secur, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland.	a.mousley@qub.ac.uk			Boehringer Ingelheim [BB/M010392/1, BB/H019472/1]	The authors would like to acknowledge support from the Biotechnology and Biological Sciences Research Council/Merial Animal Health (now Boehringer Ingelheim); BB/M010392/1, BB/H019472/1.	Anderson RC, 2014, MOL BIOCHEM PARASIT, V195, P54, DOI 10.1016/j.molbiopara.2014.07.002; Anjam MS, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0123-9; Atkinson LE, 2016, INT J PARASITOL, V46, P723, DOI 10.1016/j.ijpara.2016.05.010; Atkinson LE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003169; Barcala M., 2010, METHOD MOL BIOL, V883, P87; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Bixel GM., 2015, CURR PROTOC TOXICOL, V64; Bolkova J, 2016, METHODS, V98, P42, DOI 10.1016/j.ymeth.2015.11.008; Britton C, 2016, ADV PARASIT, V93, P599, DOI 10.1016/bs.apar.2016.02.017; Britton C, 2012, EXP PARASITOL, V132, P56, DOI 10.1016/j.exppara.2011.08.002; Caers J., 2014, JOVE-J VIS EXP, V28; Campos TDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-242; Cardoso Joao C R, 2012, Front Endocrinol (Lausanne), V3, P157, DOI 10.3389/fendo.2012.00157; COWDEN C, 1995, PEPTIDES, V16, P491, DOI 10.1016/0196-9781(94)00211-N; COWDEN C, 1989, NEURON, V2, P1465, DOI 10.1016/0896-6273(89)90192-X; COWDEN C, 1993, PEPTIDES, V14, P423, DOI 10.1016/0196-9781(93)90127-3; Dalzell JJ, 2012, PARASITOLOGY, V139, P589, DOI 10.1017/S0031182011001946; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Davis RE, 2001, PEPTIDES, V22, P7, DOI 10.1016/S0196-9781(00)00351-X; DELCASTILLO J, 1989, Q J EXP PHYSIOL CMS, V74, P1071, DOI 10.1113/expphysiol.1989.sp003334                                                ; Ezcurra M, 2016, J NEUROSCI, V36, P3157, DOI 10.1523/JNEUROSCI.1128-15.2016; Filippidis G, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1886729; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Geldhof P, 2006, INT J PARASITOL, V36, P801, DOI 10.1016/j.ijpara.2005.12.004; Goldschmidt R, 1908, Z WISS ZOOL ABT A, V90, P73; Goldschmidt R., 1910, FESTSCHR HERTWIG, VII; Han ZD, 2016, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00162; Hobert O., 2013, WORMBOOK, DOI 10.1895/wormbook.1.161.1; Howe KL, 2017, MOL BIOCHEM PARASIT, V215, P2, DOI 10.1016/j.molbiopara.2016.11.005; Husson S. J., 2014, EUPA OPEN PROTEOMICS, V3, P280; Husson SJ., 2012, WORMBOOK, DOI doi/10.1895/wormbook.1.156.1; Issa Z, 2005, INT J PARASITOL, V35, P935, DOI 10.1016/j.ijpara.2005.06.001; Janssen T, 2010, ANN NY ACAD SCI, V1200, P1, DOI 10.1111/j.1749-6632.2010.05506.x; Jarecki JL, 2013, ACS CHEM NEUROSCI, V4, P418, DOI 10.1021/cn3001334; Jarecki JL, 2011, J PROTEOME RES, V10, P3098, DOI 10.1021/pr2001176; Jarecki JL, 2010, ACS CHEM NEUROSCI, V1, P505, DOI 10.1021/cn1000217; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Ji HL, 2013, J EXP BOT, V64, P3885, DOI 10.1093/jxb/ert219; KEATING CD, 1995, PARASITOLOGY, V111, P515, DOI 10.1017/S0031182000066026                                                       ; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Knox DP, 2007, TRENDS PARASITOL, V23, P105, DOI 10.1016/j.pt.2007.01.007; Konop CJ, 2015, J AM SOC MASS SPECTR, V26, P2009, DOI 10.1007/s13361-015-1177-z; Konop CJ, 2015, ACS CHEM NEUROSCI, V6, P855, DOI 10.1021/cn5003623; Laurent P, 2015, ELIFE, V4, DOI 10.7554/eLife.04241; Law WJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004794; Lendner M, 2008, MOL BIOCHEM PARASIT, V161, P21, DOI 10.1016/j.molbiopara.2008.06.003; Li C, 2010, ADV EXP MED BIOL, V692, P98; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Lok JB, 2017, PARASITOLOGY, V144, P327, DOI 10.1017/S0031182016000391; MANOUSIS T, 1990, IN VITRO CELL DEV B, V26, P1105; Marcellino C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001494; Marks NJ, 1999, MOL BIOCHEM PARASIT, V100, P185, DOI 10.1016/S0166-6851(99)00057-2; Masler EP, 2007, J HELMINTHOL, V81, P421, DOI 10.1017/S0022149X07850243; Masler EP, 2012, NEMATOLOGY, V14, P605, DOI 10.1163/156854111X617879; Maule AG, 2011, TRENDS PARASITOL, V27, P505, DOI 10.1016/j.pt.2011.07.004; Mccoy CJ, 2015, INT J PARASITOL, V45, P673, DOI 10.1016/j.ijpara.2015.05.003; McCoy Ciaran J, 2014, EuPA Open Proteom, V3, P262; McVeigh P, 2005, INT J PARASITOL, V35, P1043, DOI 10.1016/j.ijpara.2005.05.010; McVeigh P, 2008, INT J PARASITOL, V38, P1493, DOI 10.1016/j.ijpara.2008.05.006; McVeigh P, 2006, TRENDS PARASITOL, V22, P385, DOI 10.1016/j.pt.2006.06.010; McVeigh P, 2012, INT J PARASITOL-DRUG, V2, P76, DOI 10.1016/j.ijpddr.2011.10.004; Mousley A, 2004, TRENDS PARASITOL, V20, P482, DOI 10.1016/j.pt.2004.07.011; Mousley A, 2013, PARASITIC NEMATODES: MOLECULAR BIOLOGY, BIOCHEMISTRY AND IMMUNOLOGY, 2ND EDITION, P279, DOI 10.1079/9781845937591.0279; Mousley A, 2010, ADV EXP MED BIOL, V692, P78; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nelson MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142938; Papolu PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080603; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Reinitz CA, 2000, MOL BIOCHEM PARASIT, V111, P185, DOI 10.1016/S0166-6851(00)00317-0; Reinitz CA, 2011, MOL BIOCHEM PARASIT, V180, P27, DOI 10.1016/j.molbiopara.2011.08.001; Rosa BA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002678; Samarasinghe B, 2011, INT J PARASITOL, V41, P51, DOI 10.1016/j.ijpara.2010.07.005; Sarkies P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002061; Selkirk ME, 2012, PARASITOLOGY, V139, P605, DOI 10.1017/S0031182011002332; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Sloan MA, 2015, MOL BIOCHEM PARASIT, V204, P44, DOI 10.1016/j.molbiopara.2015.12.006; Storey B, 2014, INT J PARASITOL-DRUG, V4, P233, DOI 10.1016/j.ijpddr.2014.08.003; Stretton AOW, 2013, ASCARIS: THE NEGLECTED PARASITE, P127, DOI 10.1016/B978-0-12-396978-1.00006-9; Trojanowski NF, 2015, J NEUROSCI, V35, P14571, DOI 10.1523/JNEUROSCI.1369-15.2015; Tzelos T., 2013, J HELMINTHOL, V18, P1; Visser A, 2006, PARASITOLOGY, V133, P777, DOI 10.1017/S0031182006001004; Ward JD, 2015, GENETICS, V201, P1279, DOI 10.1534/genetics.115.182717; Warnock ND, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006237; Weeks JC, 2016, INT J PARASITOL-DRUG, V6, P314, DOI 10.1016/j.ijpddr.2016.08.001; WHITE JG, 1986, PHILOS T ROY SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wit J, 2017, TRENDS PARASITOL, V33, P388, DOI 10.1016/j.pt.2017.01.009; Witola WH, 2016, VET PARASITOL, V223, P1, DOI 10.1016/j.vetpar.2016.04.008; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Yew JY, 2005, J COMP NEUROL, V488, P396, DOI 10.1002/cne.20587; Zamanian M, 2016, FEBS J, V283, P3204, DOI 10.1111/febs.13781; Zamanian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040787; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	94	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4922	1471-5007		TRENDS PARASITOL	Trends Parasitol.	DEC	2017	33	12					986	1002		10.1016/j.pt.2017.08.009				17	Parasitology	Parasitology	FN8DY	WOS:000416251400010	28986106				2018-01-05	
J	Mohsen, Z; Sim, H; Garcia-Galiano, D; Han, XF; Bellefontaine, N; Saunders, TL; Elias, CF				Mohsen, Zaid; Sim, Hosung; Garcia-Galiano, David; Han, Xingfa; Bellefontaine, Nicole; Saunders, Thomas L.; Elias, Carol F.			Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model	BRAIN STRUCTURE & FUNCTION			English	Article						Kallmann syndrome; Infertility; GnRH migration; HPG axis; CRISPR/Cas9	MALE SYRIAN-HAMSTER; GENES-ENCODING PROKINETICIN-2; PROTEIN-COUPLED RECEPTORS; SEPTO-OPTIC DYSPLASIA; KALLMANN-SYNDROME; PARAVENTRICULAR NUCLEUS; LUTEINIZING-HORMONE; OLFACTORY-BULB; HYPOGONADOTROPIC HYPOGONADISM; FOS IMMUNOREACTIVITY	Prokineticin receptor 2 (PROKR2) is predominantly expressed in the mammalian central nervous system. Loss-of-function mutations of PROKR2 in humans are associated with Kallmann syndrome due to the disruption of gonadotropin releasing hormone neuronal migration and deficient olfactory bulb morphogenesis. PROKR2 has been also implicated in the neuroendocrine control of GnRH neurons post-migration and other physiological systems. However, the brain circuitry and mechanisms associated with these actions have been difficult to investigate mainly due to the widespread distribution of Prokr2-expressing cells, and the lack of animal models and molecular tools. Here, we describe the generation, validation and characterization of a new mouse model that expresses Cre recombinase driven by the Prokr2 promoter, using CRISPR-Cas9 technology. Cre expression was visualized using reporter genes, tdTomato and GFP, in males and females. Expression of Cre-induced reporter genes was found in brain sites previously described to express Prokr2, e.g., the paraventricular and the suprachiasmatic nuclei, and the area postrema. The Prokr2-Cre mouse model was further validated by colocalization of Cre-induced GFP and Prokr2 mRNA. No disruption of Prokr2 expression, GnRH neuronal migration or fertility was observed. Comparative analysis of Prokr2-Cre expression in male and female brains revealed a sexually dimorphic distribution confirmed by in situ hybridization. In females, higher Cre activity was found in the medial preoptic area, ventromedial nucleus of the hypothalamus, arcuate nucleus, medial amygdala and lateral parabrachial nucleus. In males, Cre was higher in the amygdalo-hippocampal area. The sexually dimorphic pattern of Prokr2 expression indicates differential roles in reproductive function and, potentially, in other physiological systems.	[Mohsen, Zaid; Sim, Hosung; Garcia-Galiano, David; Han, Xingfa; Bellefontaine, Nicole; Elias, Carol F.] Univ Michigan, Dept Mol & Integrat Physiol, 1137 E Catherine St,7732B Med Sci 2, Ann Arbor, MI 48109 USA; [Han, Xingfa] Sichuan Agr Univ, Isotope Res Lab, Yaan 625014, Peoples R China; [Saunders, Thomas L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Transgen Anim Model Core, Ann Arbor, MI 48109 USA; [Elias, Carol F.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA	Elias, CF (reprint author), Univ Michigan, Dept Mol & Integrat Physiol, 1137 E Catherine St,7732B Med Sci 2, Ann Arbor, MI 48109 USA.; Elias, CF (reprint author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.	cfelias@med.umich.edu		Elias, Carol F/0000-0001-9878-9203	NIH [P30CA046592, DK34933, P30DK08194, HD69702]; T32 fellowship	We would like to thank Drs. Crowley and Balasubramanian (MGH, Harvard University, Boston) for insightful discussions and encouragement for the production of this mouse model. We also thank Susan Allen for the expert technical assistance. We acknowledge Wanda Filipiak and Galina Gavrilina for the preparation of transgenic mice and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities. Core support was provided by the following NIH Grants: P30CA046592, DK34933 (University of Michigan Gut Peptide Research Center), P30DK08194 (University of Michigan George M. O'Brien Renal Core Center). Research support was provided by NIH HD69702 Grant (to C.F.E.) and T32 fellowship (to H.S.).	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Abreu AP, 2012, MOL ENDOCRINOL, V26, P1417, DOI 10.1210/me.2012-1102; Abreu AP, 2010, NEUROENDOCRINOLOGY, V91, P283, DOI 10.1159/000308880; Allen SJ, 2016, AM J PHYSIOL-REG I, V310, pR1258, DOI 10.1152/ajpregu.00529.2015; Asakura Yumi, 2015, Clin Pediatr Endocrinol, V24, P27, DOI 10.1297/cpe.24.27; Balasubramanian R, 2011, MOL CELL ENDOCRINOL, V346, P44, DOI 10.1016/j.mce.2011.05.040; Becker K, 2011, ADV PROTOCOLS ANIMAL, P99; BELTRAMINO C, 1978, BRAIN RES, V144, P95, DOI 10.1016/0006-8993(78)90437-7; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Borges BC, 2016, MOL METAB, V5, P379, DOI 10.1016/j.molmet.2016.03.003; Bressler SC, 1996, NEUROSCIENCE, V71, P1063, DOI 10.1016/0306-4522(95)00493-9; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Canto P, 2009, J ANDROL, V30, P41, DOI 10.2164/jandrol.108.005314; Cariboni A, 2007, TRENDS NEUROSCI, V30, P638, DOI 10.1016/j.tins.2007.09.002; Cheng MY, 2006, J COMP NEUROL, V498, P796, DOI 10.1002/cne.21087; Cheng MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-17; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coolen LM, 1996, BRAIN RES, V738, P67, DOI 10.1016/0006-8993(96)00763-9                                                    ; Correa FA, 2015, ENDOCR CONNECT, V4, P100, DOI 10.1530/EC-15-0015; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; Cravo RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058698; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Donato J, 2013, NEUROSCIENCE, V241, P67, DOI 10.1016/j.neuroscience.2013.03.013; Donato J, 2010, ENDOCRINOLOGY, V151, P5415, DOI 10.1210/en.2010-0651; Donato J, 2009, J NEUROSCI, V29, P5240, DOI 10.1523/JNEUROSCI.0405-09.2009; Elias CF, 2014, AM J PHYSIOL-REG I, V306, pR1, DOI 10.1152/ajpregu.00444.2013; Flanagan-Cato LM, 2011, FRONT NEUROENDOCRIN, V32, P124, DOI 10.1016/j.yfrne.2011.02.008; Gardiner JV, 2010, DIABETES, V59, P397, DOI 10.2337/db09-1198; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Gennequin B, 2013, BIOCHEM BIOPH RES CO, V441, P815, DOI 10.1016/j.bbrc.2013.10.138; GOODWIN EC, 1992, J BIOL CHEM, V267, P16330; Hu WP, 2007, SLEEP, V30, P247; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Lee AYF, 2014, FEBS OPEN BIO, V4, P637, DOI 10.1016/j.fob.2014.06.007; Leroy C, 2008, EUR J HUM GENET, V16, P865, DOI 10.1038/ejhg.2008.15; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; McCabe MJ, 2013, J CLIN ENDOCR METAB, V98, pE547, DOI 10.1210/jc.2012-3067; Meredith M, 2004, J NEUROSCI, V24, P5719, DOI 10.1523/JNEUROSCI.1139-04.2004; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; NORGREN RB, 1991, ENDOCRINOLOGY, V128, P1676, DOI 10.1210/endo-128-3-1676                                                         ; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; Raivio T, 2012, J CLIN ENDOCR METAB, V97, pE694, DOI 10.1210/jc.2011-2938; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RASIA AA, 1991, BRAZ J MED BIOL RES, V24, P1041; Reynaud R, 2012, J CLIN ENDOCR METAB, V97, pE1068, DOI 10.1210/jc.2011-3056; Sadagurski M, 2012, CELL METAB, V15, P703, DOI 10.1016/j.cmet.2012.04.011; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Sarfati J, 2010, FRONT HORM RES, V39, P121, DOI 10.1159/000312698; SAWCHENKO PE, 1995, J NEUROENDOCRINOL, V7, P721, DOI 10.1111/j.1365-2826.1995.tb00814.x; SAWCHENKO PE, 1984, J NEUROSCI, V4, P1118; Sawchenko PE, 1996, PROG BRAIN RES, V107, P201; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schick JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32326; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Shah BP, 2014, P NATL ACAD SCI USA, V111, P13193, DOI 10.1073/pnas.1407843111; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107                                                           ; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058; Sinisi AA, 2008, HUM REPROD, V23, P2380, DOI 10.1093/humrep/den247; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LY, 2014, NAT MED, V20, P488, DOI 10.1038/nm.3527; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; WOOD RI, 1995, J NEUROSCI, V15, P7261; Wood RI, 1997, NEUROSCIENCE, V78, P1027, DOI 10.1016/S0306-4522(96)00629-X; Xiao LP, 2014, SUSTAIN CHEM PROCESS, V2, P9, DOI DOI 10.1371/J0URNAL.P0NE.0090860; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	90	0	0	6	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	DEC	2017	222	9					4111	4129		10.1007/s00429-017-1456-5				19	Anatomy & Morphology; Neurosciences	Anatomy & Morphology; Neurosciences & Neurology	FM8RL	WOS:000415357100017	28616754				2018-01-05	
J	de Jong, TJ				de Jong, Tom J.			Gene drives do not always increase in frequency: from genetic models to risk assessment	JOURNAL FUR VERBRAUCHERSCHUTZ UND LEBENSMITTELSICHERHEIT-JOURNAL OF CONSUMER PROTECTION AND FOOD SAFETY			English	Review						Gene drive; CRISPR-Cas9; Homing; Environmental risk analysis; Contained use	HOMING ENDONUCLEASE GENES; MUTAGENIC CHAIN-REACTION; NATURAL-POPULATIONS; VECTOR; EVOLUTION	Homing genes encode endonucleases that make a double stranded break in the DNA, destroying a target site on the homologous chromosome. When the cell repairs the break the homing allele is copied, converting a heterozygote into a homozygote. This results in gene drive (GD), an overrepresentation of the homing allele in the next generation. GD may propel CRISPR-Cas9 genes and new genes physically coupled to the GD through natural populations. I revisit the population genetic models of GD with the aim of making these models more understandable to non-specialists. What can we learn about risk evaluation from the models? A GD with no or a small effect on fitness (viability) always spreads in the population and goes to fixation. That is provided that no resistance mechanism evolves, for instance due to a mutation in the target site. However, when GDs have a large negative effect on fitness, their spread depends on a threshold or they may not spread at all. The chance of GDs increasing until fixation is much higher in systems with meiotic drive than in systems with embryo conversion. The presence or absence of a meiotic promoter is therefore relevant to take into account in the environmental risk assessment.	[de Jong, Tom J.] Leiden Univ, Inst Biol Leiden, POB 9505, NL-2300 RA Leiden, Netherlands	de Jong, TJ (reprint author), Leiden Univ, Inst Biol Leiden, POB 9505, NL-2300 RA Leiden, Netherlands.	tomdejong@yahoo.com		de Jong, Tom/0000-0003-2198-9121			Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Alberts B., 2014, MOL BIOL CELL; Alphey N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1071; Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; Arpaia S, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3200; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2006, GENES CONFLICT BIOL; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Collins JP, 2016, GENE DRIVES HORIZON; de Jong TJ, 2013, ENVIRON SCI POLICY, V27, P135, DOI 10.1016/j.envsci.2012.12.002; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Ellstrand NM, 2013, ANNU REV ECOL SYST, V44, P1; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gonen S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-016-0280-3; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hartl DL, 1989, PRINCIPLES POPULATIO; Lindholm AK, 2016, TRENDS ECOL EVOL, V31, P315, DOI 10.1016/j.tree.2016.02.001; Stefanova LD, 2013, GENETIKA, V49, P1021; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; SUGUNA SG, 1974, J COMMUNICABLE DIS, V6, P102; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592	27	0	0	7	7	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1661-5751	1661-5867		J VERBRAUCH LEBENSM	J. Verbrauch. Lebensm.	DEC	2017	12	4					299	307		10.1007/s00003-017-1131-z				9	Food Science & Technology	Food Science & Technology	FM8SZ	WOS:000415361200002		gold			2018-01-05	
J	Al Masud, HMA; Watanabe, T; Yoshida, M; Sato, Y; Goshima, F; Kimura, H; Murata, T				Al Masud, H. M. Abdullah; Watanabe, Takahiro; Yoshida, Masahiro; Sato, Yoshitaka; Goshima, Fumi; Kimura, Hiroshi; Murata, Takayuki			Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production	JOURNAL OF VIROLOGY			English	Article						BAC; BKRF4; CRISPR/Cas9; Epstein-Barr virus; lytic replication	SARCOMA-ASSOCIATED HERPESVIRUS; RIBOSOMAL S6 KINASE; EARLY PROTEIN BZLF1; LYTIC REPLICATION; TEGUMENT PROTEIN; HUMAN-CELLS; ORF45 PROTEIN; PHOSPHORYLATION; ACTIVATION; VIRIONS	Epstein-Barr virus (EBV), a member of human gammaherpesvirus, infects mainly B cells. EBV has two alternative life cycles, latent and lytic, and is reactivated occasionally from the latent stage to the lytic cycle. To combat EBV-associated disorders, understanding the molecular mechanisms of the EBV lytic replication cycle is also important. Here, we focused on an EBV lytic gene, BKRF4. Using our anti-BKRF4 antibody, we revealed that the BKRF4 gene product is expressed during the lytic cycle with late kinetics. To characterize the role of BKRF4, we constructed BKRF4-knockout mutants using the bacterial artificial chromosome (BAC) and CRISPR/Cas9 systems. Although disruption of the BKRF4 gene had almost no effect on viral protein expression and DNA synthesis, it significantly decreased progeny virion levels in HEK293 and Akata cells. Furthermore, we show that BKRF4 is involved not only in production of progeny virions but also in increasing the infectivity of the virus particles. Immunoprecipitation assays revealed that BKRF4 interacted with a virion protein, BGLF2. We showed that the C-terminal region of BKRF4 was critical for this interaction and for efficient progeny production. Immunofluorescence analysis revealed that BKRF4 partially colocalized with BGLF2 in the nucleus and perinuclear region. Finally, we showed that BKRF4 is a phosphorylated, possible tegument protein and that the EBV protein kinase BGLF4 may be important for this phosphorylation. Taken together, our data suggest that BKRF4 is involved in the production of infectious virions. IMPORTANCE Although the latent genes of EBV have been studied extensively, the lytic genes are less well characterized. This study focused on one such lytic gene, BKRF4, which is conserved only among gammaherpesviruses (ORF45 of Kaposi's sarcoma-associated herpesvirus or murine herpesvirus 68). After preparing the BKRF4 knockout virus using B95-8 EBV-BAC, we demonstrated that the BKRF4 gene was involved in infectious progeny particle production. Importantly, we successfully generated a BKRF4 knockout virus of Akata using CRISPR/Cas9 technology, confirming the phenotype in this separate strain. We further showed that BKRF4 interacted with another virion protein, BGLF2, and demonstrated the importance of this interaction in infectious virion production. These results shed light on the elusive process of EBV progeny maturation in the lytic cycle. Notably, this study describes a successful example of the generation and characterization of an EBV construct with a disrupted lytic gene using CRISPR/Cas9 technology.	[Al Masud, H. M. Abdullah; Watanabe, Takahiro; Yoshida, Masahiro; Sato, Yoshitaka; Goshima, Fumi; Kimura, Hiroshi; Murata, Takayuki] Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi, Japan; [Murata, Takayuki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi, Japan	Murata, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi, Japan.; Murata, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi, Japan.	tmurata@fujita-hu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [15K08494, 17H04081, 16H06231]; Japan Agency for Medical Research and Development [17fm0208016, 16ek0109098]; Takeda Science Foundation; Toyoaki Scholarship Foundation	This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (to T.M. [15K08494], H.K. [17H04081], and Y.S. [16H06231]), the Japan Agency for Medical Research and Development (to T.M. [Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic, 17fm0208016] and H.K. [Practical Research Project for Rare/Intractable Diseases, 16ek0109098]), and the Takeda Science Foundation and Toyoaki Scholarship Foundation (to T.M.).	Abada R, 2008, J VIROL, V82, P2230, DOI 10.1128/JVI.02285-07; Asai R, 2006, J VIROL, V80, P5125, DOI 10.1128/JVI.02674-05; Avey D, 2016, J VIROL, V90, P5953, DOI 10.1128/JVI.00516-16; Avey D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004993; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Chiu YF, 2012, J VIROL, V86, P9647, DOI 10.1128/JVI.01126-12; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245                                                         ; Diefenbach RJ, 2015, VIRUS RES, V210, P308, DOI 10.1016/j.virusres.2015.09.007; Fu BS, 2015, J VIROL, V89, P195, DOI 10.1128/JVI.01937-14; Gillen J, 2015, J VIROL, V89, P4918, DOI 10.1128/JVI.02925-14; Hammerschmidt W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013029; Jia QM, 2005, J VIROL, V79, P5129, DOI 10.1128/JVI.79.8.5129-5141.2005; Jia X, 2016, J VIROL, V90, P7587, DOI 10.1128/JVI.03231-15; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Katsumura KR, 2009, J GEN VIROL, V90, P2331, DOI 10.1099/vir.0.012831-0; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Kuang ES, 2011, J BIOL CHEM, V286, P41171, DOI 10.1074/jbc.M111.280982; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; Li XJ, 2015, J VIROL, V89, P6895, DOI 10.1128/JVI.00274-15; Liang QM, 2012, J VIROL, V86, P10162, DOI 10.1128/JVI.05224-11; Lieberman PM, 2015, CURR TOP MICROBIOL, V390, P71, DOI 10.1007/978-3-319-22822-8_5; Liu XueQiao, 2015, J Virol, V90, P1129, DOI 10.1128/JVI.01410-15; Murata T, 2014, REV MED VIROL, V24, P242, DOI 10.1002/rmv.1786; Murata T, 2014, MICROBIOL IMMUNOL, V58, P307, DOI 10.1111/1348-0421.12155; Murata T, 2014, REV MED VIROL, V24, P142, DOI 10.1002/rmv.1780; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Narita Y, 2013, J VIROL, V87, P2120, DOI 10.1128/JVI.02634-12; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Owen DJ, 2015, VIRUSES-BASEL, V7, P5084, DOI 10.3390/v7092861; Sathish N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00098; Sathish N, 2011, J BIOL CHEM, V286, P746, DOI 10.1074/jbc.M110.150920; Sathish N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000332; Sugimoto A, 2011, J VIROL, V85, P6127, DOI 10.1128/JVI.00258-11; Suzuki M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00280; Wang X, 2015, 3RD INTERNATIONAL CONFERENCE ON ADVANCED COMPOSITE MATERIALS AND MANUFACTURING ENGINEERING (CMME 2015), P10; Watanabe T, 2015, VIROLOGY, V484, P33, DOI 10.1016/j.virol.2015.05.010; Wu JJ, 2016, J VIROL, V90, P1741, DOI 10.1128/JVI.02738-15; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yuen KS, 2017, METHODS MOL BIOL, V1498, P23, DOI 10.1007/978-1-4939-6472-7_2; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010573; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	45	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2017	91	23							UNSP e00975-17	10.1128/JVI.00975-17				18	Virology	Virology	FM7VW	WOS:000415289800010					2018-01-05	
J	Weisblum, Y; Oiknine-Djian, E; Zakay-Rones, Z; Vorontsov, O; Haimov-Kochman, R; Nevo, Y; Stockheim, D; Yagel, S; Panet, A; Wolf, DG				Weisblum, Yiska; Oiknine-Djian, Esther; Zakay-Rones, Zichria; Vorontsov, Olesya; Haimov-Kochman, Ronit; Nevo, Yuval; Stockheim, David; Yagel, Simcha; Panet, Amos; Wolf, Dana G.			APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector	JOURNAL OF VIROLOGY			English	Article						APOBEC; HCMV; antiviral cellular restrictions; congenital infection; decidua; intrinsic immunity; placental innate immunity; viral placental transmission	URACIL-DNA GLYCOSYLASE; SIMPLEX-VIRUS 1; IN-VIVO; HUMAN-PAPILLOMAVIRUS; CYTIDINE DEAMINASES; RESTRICTION FACTORS; GENE-EXPRESSION; ZIKA VIRUS; TRANSMISSION; REPLICATION	Human cytomegalovirus (HCMV) is the leading cause of congenital infection and is associated with a wide range of neurodevelopmental disabilities and intrauterine growth restriction. Yet our current understanding of the mechanisms modulating transplacental HCMV transmission is poor. The placenta, given its critical function in protecting the fetus, has evolved effective yet largely uncharacterized innate immune barriers against invading pathogens. Here we show that the intrinsic cellular restriction factor apolipoprotein B editing catalytic subunit-like 3A (APOBEC3A [A3A]) is profoundly upregulated following ex vivo HCMV infection in human decidual tissues-constituting the maternal aspect of the placenta. We directly demonstrated that A3A severely restricted HCMV replication upon controlled overexpression in epithelial cells, acting by a cytidine deamination mechanism to introduce hypermutations into the viral genome. Importantly, we further found that A3 editing of HCMV DNA occurs both ex vivo in HCMV-infected decidual organ cultures and in vivo in amniotic fluid samples obtained during natural congenital infection. Our results reveal a previously unexplored role for A3A as an innate anti-HCMV effector, activated by HCMV infection in the maternal-fetal interface. These findings pave the way to new insights into the potential impact of APOBEC proteins on HCMV pathogenesis. IMPORTANCE In view of the grave outcomes associated with congenital HCMV infection, there is an urgent need to better understand the innate mechanisms acting to limit transplacental viral transmission. Toward this goal, our findings reveal the role of the intrinsic cellular restriction factor A3A (which has never before been studied in the context of HCMV infection and vertical viral transmission) as a potent anti-HCMV innate barrier, activated by HCMV infection in the authentic tissues of the maternal-fetal interface. The detection of naturally occurring hypermutations in clinical amniotic fluid samples of congenitally infected fetuses further supports the idea of the occurrence of A3 editing of the viral genome in the setting of congenital HCMV infection. Given the widely differential tissue distribution characteristics and biological functions of the members of the A3 protein family, our findings should pave the way to future studies examining the potential impact of A3A as well as of other A3s on HCMV pathogenesis.	[Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya; Wolf, Dana G.] Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel; [Weisblum, Yiska; Oiknine-Djian, Esther; Zakay-Rones, Zichria; Vorontsov, Olesya; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Biochem, Jerusalem, Israel; [Weisblum, Yiska; Oiknine-Djian, Esther; Zakay-Rones, Zichria; Vorontsov, Olesya; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, IMRIC, Chanock Ctr Virol, Jerusalem, Israel; [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya; Wolf, Dana G.] Hebrew Univ Jerusalem, Fac Med, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel; [Haimov-Kochman, Ronit; Yagel, Simcha] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Nevo, Yuval] Hebrew Univ Jerusalem, I CORE Computat Ctr, Bioinformat Unit, Jerusalem, Israel; [Nevo, Yuval] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel; [Stockheim, David] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel	Wolf, DG (reprint author), Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel.; Wolf, DG (reprint author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel.	dana.wolf@ekmd.huji.ac.il			Israel Science Foundation; European Union Seventh Framework Programme [316655]; Israeli Ministry of Health	This work was supported by grants from the Israel Science Foundation, European Union Seventh Framework Programme 562 FP7/2012-2016 (grant agreement number 316655), and the Israeli Ministry of Health.	Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Caval V, 2015, NUCLEIC ACIDS RES, V43, P9340, DOI 10.1093/nar/gkv935; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001                                                ; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Fodil-Cornu N, 2008, CELL HOST MICROBE, V3, P59, DOI 10.1016/j.chom.2008.01.005; Gee P, 2011, J VIROL, V85, P9726, DOI 10.1128/JVI.05288-11; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mocarski E. S., 2013, FIELDS VIROLOGY, P1960; Nakaya Y, 2016, J VIROL, V90, P8005, DOI 10.1128/JVI.00973-16; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Richardson SR, 2014, ELIFE, V3, DOI 10.7554/eLife.02008; Rossini G, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/607276; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Underwood MR, 1998, J VIROL, V72, P717; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vieira VC, 2013, BIOMED RES INT, DOI 10.1155/2013/683095; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Weisblum Y, 2016, J VIROL; Weisblum Y, 2015, VIROLOGY, V485, P289, DOI 10.1016/j.virol.2015.06.023; Weisblum Y, 2014, SEMIN IMMUNOPATHOL, V36, P615, DOI 10.1007/s00281-014-0449-1; Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11; White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895; Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	55	0	0	6	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2017	91	23							UNSP e01296-17	10.1128/JVI.01296-17				13	Virology	Virology	FM7VW	WOS:000415289800030					2018-01-05	
J	Choi, H; Song, J; Park, G; Kim, J				Choi, Hwan; Song, Juhyun; Park, Guiyeon; Kim, Jongpil			Modeling of Autism Using Organoid Technology	MOLECULAR NEUROBIOLOGY			English	Review						Autism; Organoids; Induced pluripotent stem cells (iPSCs); Clustered regularly interspersed short palindromic repeat-associated protein 9 (CRISPR/Cas9)	PLURIPOTENT STEM-CELLS; GENOME-WIDE ASSOCIATION; FAMILY-BASED ASSOCIATION; IN-VITRO MODEL; SPECTRUM DISORDERS; DIRECTED DIFFERENTIATION; 3-DIMENSIONAL CULTURE; CEREBRAL ORGANOIDS; CRISPR-CAS9 SYSTEM; EXTRINSIC SIGNALS	Autism is a neurodevelopmental disease caused by multiple mutations during development. However, a suitable disease model to study the molecular pathway of disease onset and progression is not available. Although many studies have used human stem cells such as induced pluripotent stem cells and embryonic stem cells to investigate the disease pathogenesis, these stem cell techniques are limited in their abilities to study the pathology and mechanism of pathogenesis of neurodevelopmental diseases such as autism. Therefore, researchers are focusing on the strengths of three-dimensional (3D) structures mimicking organs, organoids, for modeling autism. In this review, we highlight the advantages of 3D organoid systems to investigate the mechanisms of the pathogenesis of autism. Further, because the onset of autism is determined by genetic background, we suggest the application of the clustered regularly interspersed short palindromic repeat-associated protein 9 (CRISPR/Cas9) technique for genome editing in 3D organoid systems to study mutations that cause autism. We propose that 3D organoid systems combined with the CRISPR/Cas9 technique may advance autism research.	[Choi, Hwan; Park, Guiyeon; Kim, Jongpil] Dongguk Univ, Dept Biomed Engn BK21Plus, Lab Stem Cells & Reprogramming, 3 Ga, Seoul 100715, South Korea; [Song, Juhyun] Chonnam Natl Univ, Dept Neurol, Med Sch, Gwangju, South Korea	Kim, J (reprint author), Dongguk Univ, Dept Biomed Engn BK21Plus, Lab Stem Cells & Reprogramming, 3 Ga, Seoul 100715, South Korea.	jk2316@gmail.com			Korea Health Technology R&D Project, Ministry of Health and Welfare [HI16C1176]	This work was supported by the Korea Health Technology R&D Project, Ministry of Health and Welfare (HI16C1176).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131; Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8                                                   ; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Banerjee S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00058; Barger BD, 2013, J AUTISM DEV DISORD, V43, P817, DOI 10.1007/s10803-012-1621-x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Bethge WA, 2008, BLOOD CELL MOL DIS, V40, P13, DOI 10.1016/j.bcmd.2007.07.001; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Brito C, 2012, METHODS, V56, P452, DOI 10.1016/j.ymeth.2012.03.005; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj/mp/4001011; Chaste P, 2015, BIOL PSYCHIAT, V77, P775, DOI 10.1016/j.biopsych.2014.09.017; Chen JL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00276; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6503a1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connolly JJ, 2013, CHILD DEV, V84, P17, DOI 10.1111/j.1467-8624.2012.01838.x; Cyranoski D, 2012, NATURE, V488, P444, DOI 10.1038/488444a; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; De Rubeis S, 2015, HUM MOL GENET, V24, pR24, DOI 10.1093/hmg/ddv273; Doll CA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00030; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gonzalez F, 2016, DEV DYNAM, V245, P788, DOI [10.1002/DVDY.24414, 10.1002/dvdy.24414]; Grobarczyk B, 2015, STEM CELL REV REP, V11, P774, DOI 10.1007/s12015-015-9600-1; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Kim SA, 2006, NEUROPSYCHOBIOLOGY, V54, P160, DOI 10.1159/000098651; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee EJ, 2015, CURR OPIN PHARMACOL, V20, P8, DOI 10.1016/j.coph.2014.10.007; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Liu XX, 2016, AUTISM RES, V9, P340, DOI 10.1002/aur.1536; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Lundstrom S, 2012, ARCH GEN PSYCHIAT, V69, P46, DOI 10.1001/archgenpsychiatry.2011.144; Ma DQ, 2010, AM J MED GENET B, V153B, P477, DOI 10.1002/ajmg.b.31003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Martelli MF, 2014, BLOOD, V124, P638, DOI [10.1182/blood-2014-03564401, 10.1182/blood-2014-03-564401]; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Mazurek MO, 2013, J ABNORM CHILD PSYCH, V41, P165, DOI 10.1007/s10802-012-9668-x; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Mondrinos MJ, 2014, TISSUE ENG PT A, V20, P2892, DOI [10.1089/ten.TEA.2014.0085, 10.1089/ten.tea.2014.0085]; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Mungenast AE, 2016, MOL CELL NEUROSCI, V73, P13, DOI 10.1016/j.mcn.2015.11.010; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Neuhofer D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00100; Nguyen A, 2010, FASEB J, V24, P3036, DOI [10.1096/fj.09-154484, 10.1096/fj.10-154484]; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Orlacchio A, 2010, CURR MED CHEM, V17, P595, DOI 10.2174/092986710790416272                                                      ; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012; Port RG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00414; Qin J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-61; Qin MD, 2016, INT J BIOL SCI, V12, P558, DOI 10.7150/ijbs.11051; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson EB, 2011, ARCH GEN PSYCHIAT, V68, P1113, DOI 10.1001/archgenpsychiatry.2011.119; Roche-Martinez A, 2011, REV NEUROLOGIA, V52, P597; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Rudie JD, 2012, NEURON, V75, P904, DOI 10.1016/j.neuron.2012.07.010; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Simsek S., 2016, STEM CELLS TRANSL ME; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Stolerman ES, 2016, EUR J MED GENET, V59, P189, DOI 10.1016/j.ejmg.2016.02.010; Striano P, 2011, NEUROLOGY, V76, P1600, DOI 10.1212/WNL.0b013e3182194bbf; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648                                                                  ; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Talebizadeh Z, 2004, J AUTISM DEV DISORD, V34, P735, DOI 10.1007/s10803-004-5295-x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tilot AK, 2015, NEUROTHERAPEUTICS, V12, P609, DOI 10.1007/s13311-015-0356-8; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Visser JC, 2016, NEUROSCI BIOBEHAV R, V65, P229, DOI 10.1016/j.neubiorev.2016.03.019; Vogel G, 2013, SCIENCE, V341, P946, DOI 10.1126/science.341.6149.946; Wang LF, 2008, AM J MED GENET B, V147B, P434, DOI 10.1002/ajmg.b.30623; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang ZL, 2014, AM J MED GENET B, V165, P192, DOI 10.1002/ajmg.b.32222; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xia Xiaofeng, 2009, V549, P51, DOI 10.1007/978-1-60327-931-4_4; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Yamasue H, 2016, PSYCHIAT CLIN NEUROS, V70, P89, DOI 10.1111/pcn.12364; Yang SY, 2010, PSYCHIAT RES, V178, P199, DOI 10.1016/j.psychres.2009.11.007; Yang Y, 2017, CEREB CORTEX, V27, P793, DOI 10.1093/cercor/bhv297; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001                                                 ; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yoo HJ, 2012, NEUROSCI LETT, V512, P89, DOI 10.1016/j.neulet.2012.01.061; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zhu L, 2014, HUM MOL GENET, V23, P1563, DOI 10.1093/hmg/ddt547; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	141	0	0	21	21	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2017	54	10					7789	7795		10.1007/s12035-016-0274-8				7	Neurosciences	Neurosciences & Neurology	FM8MF	WOS:000415341900019	27844287				2018-01-05	
J	Shevidi, S; Uchida, A; Schudrowitz, N; Wessel, GM; Yajima, M				Shevidi, Saba; Uchida, Alicia; Schudrowitz, Natalie; Wessel, Gary M.; Yajima, Mamiko			Single Nucleotide Editing Without DNA Cleavage Using CRISPR/Cas9-deaminase in the Sea Urchin Embryo	DEVELOPMENTAL DYNAMICS			English	Article						CRISPR; Cas9; deaminase; genome editing; sea urchin	TARGETED MUTAGENESIS; POINT MUTATION; HEART-DISEASE; RNA; SYSTEM; ENDORIBONUCLEASE; ENDONUCLEASE; RECOGNITION; PROKARYOTES; MATURATION	Background: A single base pair mutation in the genome can result in many congenital disorders in humans. The recent gene editing approach using CRISPR/Cas9 has rapidly become a powerful tool to replicate or repair such mutations in the genome. These approaches rely on cleaving DNA, while presenting unexpected risks. Results: In this study, we demonstrate a modified CRISPR/Cas9 system fused to cytosine deaminase (Cas9-DA), which induces a single nucleotide conversion in the genome. Cas9-DA was introduced into sea urchin eggs with sgRNAs targeted for SpAlx1, SpDsh, or SpPks, each of which is critical for skeletogenesis, embryonic axis formation, or pigment formation, respectively. We found that both Cas9 and Cas9-DA edit the genome, and cause predicted phenotypic changes at a similar efficiency. Cas9, however, resulted in significant deletions in the genome centered on the gRNA target sequence, whereas Cas9-DA resulted in single or double nucleotide editing of C to T conversions within the gRNA target sequence. Conclusions: These results suggest that the Cas9-DA approach may be useful for manipulating gene activity with decreased risks of genomic aberrations. (C) 2017 Wiley Periodicals, Inc.	[Shevidi, Saba; Uchida, Alicia; Schudrowitz, Natalie; Wessel, Gary M.; Yajima, Mamiko] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Yajima, M (reprint author), 185 Meeting St,BOX GL173, Providence, RI 02912 USA.	mamiko_yajima@brown.edu			American Heart Association Scientist Development Grant [14SDG18350021]; NIH [2R01HD028152, R21HD075561]	Grant sponsor: American Heart Association Scientist Development Grant; Grant number: 14SDG18350021; Grant sponsor: NIH; Grant numbers: 2R01HD028152, R21HD075561.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bertolini S, 2001, ATHEROSCLEROSIS, V154, P599, DOI 10.1016/S0021-9150(00)00587-6                                                   ; Byrum CA, 2009, DEV DYNAM, V238, P1649, DOI 10.1002/dvdy.21978; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Fernandes Humberto, 2016, Postepy Biochem, V62, P315; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9                                                   ; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Ikeda Y, 2002, CIRC J, V66, P561, DOI 10.1253/circj.66.561; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato L, 2012, J IMMUNOL, V188, P3559, DOI 10.4049/jimmunol.1102397; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Lin CY, 2016, DEV BIOL, V409, P420, DOI 10.1016/j.ydbio.2015.11.018; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nishida K, 2016, SCIENCE, V353, P6305; Oulhen N, 2016, MOL REPROD DEV, V83, P1046, DOI 10.1002/mrd.22757; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sasakura Y, 2010, ZOOL SCI, V27, P256, DOI 10.2108/zsj.27.256; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Seplyarskiy VB, 2016, GENOME RES, V26, P174, DOI 10.1101/gr.197046.115; Sharma T, 2010, DEVELOPMENT, V137, P1149, DOI 10.1242/dev.048652; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Sugi T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030295; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	37	0	0	11	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	DEC	2017	246	12					1036	1046		10.1002/DVDY.24586				11	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	FM8SR	WOS:000415360400008	28857338				2018-01-05	
J	Prangishvili, D; Bamford, DH; Forterre, P; Iranzo, J; Koonin, EV; Krupovic, M				Prangishvili, David; Bamford, Dennis H.; Forterre, Patrick; Iranzo, Jaime; Koonin, Eugene V.; Krupovic, Mart			The enigmatic archaeal virosphere	NATURE REVIEWS MICROBIOLOGY			English	Review							TURRETED ICOSAHEDRAL VIRUS; SPINDLE-SHAPED VIRUS; STRANDED DNA VIRUSES; X-RAY CRYSTALLOGRAPHY; CRISPR-CAS SYSTEMS; HOST INTERACTIONS; HYPERTHERMOPHILIC ARCHAEA; SULFOLOBUS-ISLANDICUS; VIRION ARCHITECTURE; HALOPHILIC ARCHAEA	One of the most prominent features of archaea is the extraordinary diversity of their DNA viruses. Many archaeal viruses differ substantially in morphology from bacterial and eukaryotic viruses and represent unique virus families. The distinct nature of archaeal viruses also extends to the gene composition and architectures of their genomes and the properties of the proteins that they encode. Environmental research has revealed prominent roles of archaeal viruses in influencing microbial communities in ocean ecosystems, and recent metagenomic studies have uncovered new groups of archaeal viruses that infect extremophiles and mesophiles in diverse habitats. In this Review, we summarize recent advances in our understanding of the genomic and morphological diversity of archaeal viruses and the molecular biology of their life cycles and virus-host interactions, including interactions with archaeal CRISPR-Cas systems. We also examine the potential origins and evolution of archaeal viruses and discuss their place in the global virosphere.	[Prangishvili, David; Forterre, Patrick; Krupovic, Mart] Inst Pasteur, Dept Microbiol, 25 Rue Dr Roux, F-75015 Paris, France; [Bamford, Dennis H.] Univ Helsinki, Dept Biosci, Helsinki 00014, Finland; [Iranzo, Jaime; Koonin, Eugene V.] Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Prangishvili, D; Krupovic, M (reprint author), Inst Pasteur, Dept Microbiol, 25 Rue Dr Roux, F-75015 Paris, France.	david.prangishvili@pasteur.fr; krupovic@pasteur.fr		Bamford, Dennis/0000-0002-6438-8118	l'Agence Nationale de la Recherche (France) project EXAVIR; European Union's Horizon research and innovation programme, project VIRUS-X [685778]; Academy Professors programme, Academy of Finland [283072, 255342]; European Research Council under the European Union's Seventh Framework Program/Project EVOMOBIL - ERC [340440]; US Department of Health and Human Services; l'Agence Nationale de la Recherche (France) project ENVIRA	D.P. is supported by l'Agence Nationale de la Recherche (France) project EXAVIR and by the European Union's Horizon 2020 research and innovation programme under grant agreement 685778, project VIRUS-X. D.H.B. was supported by the Academy Professors programme, Academy of Finland funding grants 283072 and 255342. P.F. is supported by the European Research Council under the European Union's Seventh Framework Program (FP/2007-2013)/Project EVOMOBIL - ERC Grant Agreement no. 340440. J.I. and E.V.K. are supported by intramural funds of the US Department of Health and Human Services (to the National Library of Medicine). M.K. is supported by l'Agence Nationale de la Recherche (France) project ENVIRA.	Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Adriaenssens EM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010014; Arnold HP, 2000, VIROLOGY, V272, P409, DOI 10.1006/viro.2000.0375; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bath C, 2006, VIROLOGY, V350, P228, DOI 10.1016/j.virol.2006.02.005; Bettstetter M, 2003, VIROLOGY, V315, P68, DOI 10.1016/S0042-6822(03)00481-1; Bidgood SR, 2015, VIRUSES-BASEL, V7, P4800, DOI 10.3390/v7082844; Bize A, 2008, RES MICROBIOL, V159, P358, DOI 10.1016/j.resmic.2008.04.009; Bize A, 2009, P NATL ACAD SCI USA, V106, P11306, DOI 10.1073/pnas.0901238106; Bolduc B, 2012, J VIROL, V86, P5562, DOI 10.1128/JVI.07196-11; Brumfield SK, 2009, J VIROL, V83, P5964, DOI 10.1128/JVI.02668-08; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Chow CET, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00265; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Danovaro R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600492; Daum B, 2014, P NATL ACAD SCI USA, V111, P3829, DOI 10.1073/pnas.1319245111; Dellas N, 2016, J VIROL, V90, P2729, DOI 10.1128/JVI.02435-15; Dellas Nikki, 2013, Life-Basel, V3, P118, DOI 10.3390/life3010118; Demina TA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9020032; Deng L, 2014, J VIROL, V88, P10264, DOI 10.1128/JVI.01495-14; DiMaio F, 2015, SCIENCE, V348, P914, DOI 10.1126/science.aaa4181; Emerson JB, 2013, ARCHAEA, V2013; Erdmann S, 2014, MOL MICROBIOL, V91, P900, DOI 10.1111/mmi.12503; Erdmann S, 2014, EXTREMOPHILES, V18, P51, DOI 10.1007/s00792-013-0591-z; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Forterre P., 2013, ARCHAEA, V2013, DOI DOI 10.1155/2013/372396; Garda-Heredia I., 2012, PLOS ONE, V7; Gardner AF, 2014, J VIROL, V88, P7105, DOI 10.1128/JVI.00636-14; Garrett RA, 2010, ENVIRON MICROBIOL, V12, P2918, DOI 10.1111/j.1462-2920.2010.02266.x; Geslin C, 2007, J BACTERIOL, V189, P4510, DOI 10.1128/JB.01896-06; Gil-Carton D, 2015, STRUCTURE, V23, P1866, DOI 10.1016/j.str.2015.07.015; Gorlas A, 2013, APPL ENVIRON MICROB, V79, P3822, DOI 10.1128/AEM.00525-13; Goulet A, 2010, ACTA CRYSTALLOGR D, V66, P304, DOI 10.1107/S0907444909051798; Goulet A, 2009, P NATL ACAD SCI USA, V106, P21155, DOI 10.1073/pnas.0909893106; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gudbergsdottir SR, 2016, ENVIRON MICROBIOL, V18, P863, DOI 10.1111/1462-2920.13079; Happonen LJ, 2013, J VIROL, V87, P8388, DOI 10.1128/JVI.00831-13; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Haring M, 2005, J VIROL, V79, P9904, DOI 10.1128/JVI.79.15.9904-9911.2005; Haring M, 2004, VIROLOGY, V323, P233, DOI 10.1016/j.virol.2004.03.002; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Hochstein RA, 2016, J VIROL, V90, P3458, DOI 10.1128/JVI.03098-15; Hong C, 2015, P NATL ACAD SCI USA, V112, P2449, DOI 10.1073/pnas.1425008112; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Iranzo Jaime, 2017, Commun Integr Biol, V10, pe1296614, DOI 10.1080/19420889.2017.1296614; Iranzo J, 2016, J VIROL, V90, P11043, DOI 10.1128/JVI.01622-16; Iranzo J, 2016, MBIO, V7, DOI 10.1128/mBio.00978-16; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Iverson EA, 2017, J VIROL, V91, DOI 10.1128/JVI.02406-16; Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kasson P, 2017, ELIFE, V6; Kazlauskas D, 2016, NUCLEIC ACIDS RES, V44, P4551, DOI 10.1093/nar/gkw322; Khayat R, 2005, P NATL ACAD SCI USA, V102, P18944, DOI 10.1073/pnas.0506383102; Klein R, 2012, MOL MICROBIOL, V83, P137, DOI 10.1111/j.1365-2958.2011.07921.x; Kristensen DM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0817-4; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; Krupovic M, 2017, CURR OPIN MICROBIOL, V38, P36, DOI 10.1016/j.mib.2017.04.004; Krupovic M, 2017, P NATL ACAD SCI USA, V114, pE2401, DOI 10.1073/pnas.1621061114; Krupovic M, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0093-2; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Krupovic M, 2014, J VIROL, V88, P2354, DOI 10.1128/JVI.02941-13; Krupovic M, 2013, CURR OPIN VIROL, V3, P578, DOI 10.1016/j.coviro.2013.06.010; Krupovic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049044; Krupovic M, 2012, ADV VIRUS RES, V82, P33, DOI 10.1016/B978-0-12-394621-8.00012-1; Krupovic M, 2011, CURR OPIN VIROL, V1, P118, DOI 10.1016/j.coviro.2011.06.001; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Krupovic M, 2011, BIOCHEM SOC T, V39, P82, DOI 10.1042/BST0390082; Krupovic M, 2010, MOL BIOL EVOL, V27, P2716, DOI 10.1093/molbev/msq161; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Labonte JM, 2015, ISME J, V9, P2386, DOI 10.1038/ismej.2015.48; Liu JF, 2017, MOL MICROBIOL, V105, P540, DOI 10.1111/mmi.13716; Liu Y., 2017, J VIROL, V91; Lloyd KG, 2013, APPL ENVIRON MICROB, V79, P7790, DOI 10.1128/AEM.02090-13; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lopez-Garcia P, 2000, J BACTERIOL, V182, P4998, DOI 10.1128/JB.182.17.4998-5000.2000                                                ; Luo YN, 2002, FEMS MICROBIOL LETT, V208, P47; Lurie-Weinberger MN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004833; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; MARTIN A, 1984, EMBO J, V3, P2165; Martinez-Alvarez L, 2017, J VIROL, V91, DOI 10.1128/JVI.00486-17; Martinez-Alvarez L, 2016, NUCLEIC ACIDS RES, V44, P8799, DOI 10.1093/nar/gkw636; Martinez-Garcia M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5542; Mochizuki T, 2012, P NATL ACAD SCI USA, V109, P13386, DOI 10.1073/pnas.1203668109; Mochizuki T, 2011, J BACTERIOL, V193, P5412, DOI 10.1128/JB.05101-11; Mochizuki T, 2010, VIROLOGY, V402, P347, DOI 10.1016/j.virol.2010.03.046; Mousaei M, 2016, RNA BIOL, V13, P1166, DOI 10.1080/15476286.2016.1229735; Nigro OD, 2017, MBIO, V8, DOI 10.1128/mBio.02129-16; Nishimura Y, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00359-16; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Paul BG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7585; Pawlowski A, 2014, ARCH VIROL, V159, P1541, DOI 10.1007/s00705-013-1970-6; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; PEETERS E, 2017, VIRUSES, V9; Peng X, 2007, VIROLOGY, V364, P237, DOI 10.1016/j.virol.2007.03.005; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; Philosof A, 2017, CURR BIOL, V27, P1362, DOI 10.1016/j.cub.2017.03.052; Pietila MK, 2016, ARCH VIROL, V161, P249, DOI 10.1007/s00705-015-2613-x; Pietila MK, 2014, TRENDS MICROBIOL, V22, P334, DOI 10.1016/j.tim.2014.02.007; Pietila MK, 2013, P NATL ACAD SCI USA, V110, P10604, DOI 10.1073/pnas.1303047110; Pietila MK, 2013, J VIROL, V87, P3248, DOI 10.1128/JVI.03397-12; Pietila MK, 2012, J VIROL, V86, P5067, DOI 10.1128/JVI.06915-11; Pietila MK, 2010, J VIROL, V84, P788, DOI 10.1128/JVI.01347-09; Pietila MK, 2009, MOL MICROBIOL, V72, P307, DOI 10.1111/j.1365-2958.2009.06642.x; Pina M, 2014, MOL MICROBIOL, V92, P1313, DOI 10.1111/mmi.12630; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Porter K, 2005, VIROLOGY, V335, P22, DOI 10.1016/j.virol.2005.01.043; Prangishvili D, 1999, GENETICS, V152, P1387; Prangishvili D, 2006, J MOL BIOL, V359, P1203, DOI 10.1016/j.jmb.2006.04.027; Prangishvili D, 2015, ANN NY ACAD SCI, V1341, P35, DOI 10.1111/nyas.12710; Prangishvili D, 2013, ANNU REV MICROBIOL, V67, P565, DOI 10.1146/annurev-micro-092412-155633; Prangishvili D, 2013, BIOCHEM SOC T, V41, P443, DOI 10.1042/BST20120313; Prangishvili D, 2012, ARCH VIROL, V157, P791, DOI 10.1007/s00705-012-1229-7; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Quax TEF, 2011, P NATL ACAD SCI USA, V108, P3354, DOI 10.1073/pnas.1018052108; Quax TEF, 2010, VIROLOGY, V404, P1, DOI 10.1016/j.virol.2010.04.020; Quemin ERJ, 2016, MBIO, V7, DOI 10.1128/mBio.01439-16; Quemin ERJ, 2015, J VIROL, V89, P11681, DOI 10.1128/JVI.02270-15; Quemin ERJ, 2013, J VIROL, V87, P13379, DOI 10.1128/JVI.02742-13; Redder P, 2009, ENVIRON MICROBIOL, V11, P2849, DOI 10.1111/j.1462-2920.2009.02009.x; Rensen E, 2015, BIOCHIMIE, V118, P365, DOI 10.1016/j.biochi.2015.06.007; Rensen EI, 2016, P NATL ACAD SCI USA, V113, P2478, DOI 10.1073/pnas.1518929113; Ressing ME, 2015, CURR TOP MICROBIOL, V391, P355, DOI 10.1007/978-3-319-22834-1_12; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; Roine E, 2010, J VIROL, V84, P3682, DOI 10.1128/JVI.01879-09; Roux S, 2016, NATURE, V537, P689, DOI 10.1038/nature19366; Santos F, 2007, ENVIRON MICROBIOL, V9, P1711, DOI 10.1111/j.1462-2920.2007.01289.x; Santos F, 2011, ISME J, V5, P1621, DOI 10.1038/ismej.2011.34; SCHLEPER C, 1992, P NATL ACAD SCI USA, V89, P7645, DOI 10.1073/pnas.89.16.7645; Scourfield EJ, 2017, BIOCHEM SOC T, V45, P613, DOI 10.1042/BST20160479; Sencilo A, 2013, RNA BIOL, V10, P803, DOI 10.4161/rna.24045; Sencilo A, 2012, NUCLEIC ACIDS RES, V40, P5523, DOI 10.1093/nar/gks215; Servin-Garciduenas LE., 2013, GENOME ANNOUNC, V1; Servin-Garciduenas LE., 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00040-12; Shmakov SA, 2017, MBIO, V8, DOI 10.1128/mBio.01397-17; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Sinclair RM, 2017, J VIROL, V91, DOI 10.1128/JVI.02275-16; Snyder JC, 2011, J VIROL, V85, P6287, DOI 10.1128/JVI.00379-11; Sontheimer EJ, 2017, CURR OPIN MICROBIOL, V37, P120, DOI 10.1016/j.mib.2017.06.003; Stedman K, 2011, SPRINGER INDEX VIRUS, P561; Stedman KM, 2015, VIROLOGY, V474, P105, DOI 10.1016/j.virol.2014.10.014; Stromsten NJ, 2005, J MOL BIOL, V348, P617, DOI 10.1016/j.jmb.2005.03.002; Suhanovsky MM, 2015, VIROLOGY, V479, P487, DOI 10.1016/j.virol.2015.02.055; Szymczyna BR, 2009, STRUCTURE, V17, P499, DOI 10.1016/j.str.2009.03.001; Takano Y, 2010, NAT GEOSCI, V3, P858, DOI [10.1038/ngeo983, 10.1038/NGEO983]; Uldahl KB, 2016, J VIROL, V90, P5693, DOI 10.1128/JVI.00075-16; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Veesler D, 2013, P NATL ACAD SCI USA, V110, P5504, DOI 10.1073/pnas.1300601110; Vestergaard G, 2005, VIROLOGY, V336, P83, DOI 10.1016/j.virol.2005.02.025; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; Wang YC, 2016, J BACTERIOL, V198, P1952, DOI 10.1128/JB.00131-16; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xiang XY, 2005, J VIROL, V79, P8677, DOI 10.1128/JVI.7914.8677-8686.2005; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z; Yu XK, 2017, SCIENCE, V356, P1350, DOI 10.1126/science.aam6892; Zhao JH, 2016, CURR OPIN VIROL, V17, P39, DOI 10.1016/j.coviro.2015.12.002	164	0	0	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1740-1526	1740-1534		NAT REV MICROBIOL	Nat. Rev. Microbiol.	DEC	2017	15	12					724	739		10.1038/nrmicro.2017.125				16	Microbiology	Microbiology	FM2VJ	WOS:000414858500008	29123227				2018-01-05	
J	Ishii, T				Ishii, Tetsuya			The ethics of creating genetically modified children using genome editing	CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY			English	Review						CRISPR; Cas9; ethics; genome editing; germline; reproduction	GERMLINE; ZYGOTES	Purpose of reviewTo review the recent ethical, legal, and social issues surrounding human reproduction involving germline genome editing.Recent findingsGenome editing techniques, such as CRISPR/Cas9, have facilitated genetic modification in human embryos. The most likely purpose of germline genome editing is the prevention of serious genetic disease in offspring. However, complex issues still remain, including irremediable risks to fetuses and future generations, the role of women, the availability of alternatives, long-term follow-up, health insurance coverage, misuse for human enhancement, and the potential effects on adoption. Further discussions, a broad consensus, and appropriate regulations are required before human germline genome editing is introduced into the global society.SummaryBefore germline genome editing is used for disease prevention, a broad consensus must be formed by carefully discussing its ethical, legal, and social issues.	[Ishii, Tetsuya] Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan	Ishii, T (reprint author), Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan.	tishii@general.hokudai.ac.jp		Ishii, Tetsuya/0000-0002-7085-7750	JSPS [26460586]	The author thanks JSPS for funding: KAKENHI Grant Number 26460586.	Baylis F, 2004, BIOETHICS, V18, P1, DOI 10.1111/j.1467-8519.2004.00376.x                                                ; Baylis F, 2017, NAT HUM BEHAV, V1, P103; Church G, 2015, NATURE, V528, pS7, DOI 10.1038/528S7a; Cohen IG, 2016, SCIENCE, V353, P545, DOI 10.1126/science.aag2960; Committee on Science Technology and Law, POL GLOB AFF NAT AC; Evitt NH, 2015, AM J BIOETHICS, V15, P25, DOI 10.1080/15265161.2015.1104160; Gregorowius D, 2017, EMBO REP, V18, P355, DOI 10.15252/embr.201643054; Gyngell C, 2017, J APPL PHILOS, V34, P498, DOI 10.1111/japp.12249; Harris J, 2015, AM J BIOETHICS, V15, P30, DOI 10.1080/15265161.2015.1104163; International Federation for Fertility Societies, 2016, GLOBAL REPROD HLTH, V1, P1; Ishii T, 2017, BRIEF FUNCT GENOMICS, V16, P46, DOI 10.1093/bfgp/elv053; Ishii T, 2017, REPROD BIOMED ONLINE, V34, P27, DOI 10.1016/j.rbmo.2016.09.009; Ishii T, 2015, TRENDS MOL MED, V21, P473, DOI 10.1016/j.molmed.2015.05.006; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; McGonigle IV, 2016, GENET RES, V98, DOI 10.1017/S0016672316000094; National Academies of Science Engineering and Medicine (NASEM), HUM GEN ED SCI ETH G; Palacios-Gonzalez C, 2017, J LAW BIOSCI, V4, P50, DOI 10.1093/jlb/lsw065; Simonstein F, 2017, SCI ENG ETHICS, DOI [10. 1007/s11948-017-9875-5., DOI 10.1007/S11948-017-9875-5]; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; US President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, SPL LIF REP SOC ETH; Walton D, 2017, SCI ENG ETHICS, V23, P1507, DOI 10.1007/s11948-016-9861-3	23	0	0	27	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1752-296X	1752-2978		CURR OPIN ENDOCRINOL	Curr. Opin. Endocrinol. Diabetes Obes.	DEC	2017	24	6					418	423		10.1097/MED.0000000000000369				6	Endocrinology & Metabolism	Endocrinology & Metabolism	FM5UW	WOS:000415107500006	28885275				2018-01-05	
J	Ekser, B; Li, P; Cooper, DKC				Ekser, Burcin; Li, Ping; Cooper, David K. C.			Xenotransplantation: past, present, and future	CURRENT OPINION IN ORGAN TRANSPLANTATION			English	Review						clinical; clustered regularly interspaced short palindromic repeats; experimental; genetic engineering; xenotransplantation	ASSOCIATION CONSENSUS STATEMENT; UNDERTAKING CLINICAL-TRIALS; PORCINE ISLET PRODUCTS; PIG-LIVER XENOTRANSPLANTATION; OF-THE-LITERATURE; INTERNATIONAL XENOTRANSPLANTATION; 1ST UPDATE; ORGAN XENOTRANSPLANTATION; COSTIMULATION BLOCKADE; CORNEAL XENOTRANSPLANTATION	Purpose of review To review the progress in the field of xenotransplantation with special attention to most recent encouraging findings which will eventually bring xenotransplantation to the clinic in the near future. Recent findings Starting from early 2000, with the introduction of galactose-1,3-galactose (Gal)-knockout pigs, prolonged survival especially in heart and kidney xenotransplantation was recorded. However, remaining antibody barriers to non-Gal antigens continue to be the hurdle to overcome. The production of genetically engineered pigs was difficult requiring prolonged time. However, advances in gene editing, such as zinc finger nucleases, transcription activator-like effector nucleases, and most recently clustered regularly interspaced short palindromic repeats (CRISPR) technology made the production of genetically engineered pigs easier and available to more researchers. Today, the survival of pig-to-nonhuman primate heterotopic heart, kidney, and islet xenotransplantation reached more than 900, more than 400, and more than 600 days, respectively. The availability of multiple-gene pigs (five or six genetic modifications) and/or newer costimulation blockade agents significantly contributed to this success. Now, the field is getting ready for clinical trials with an international consensus. Summary Clinical trials in cellular or solid organ xenotransplantation are getting closer with convincing preclinical data from many centers. The next decade will show us new achievements and additional barriers in clinical xenotransplantation.	[Ekser, Burcin; Li, Ping] Indiana Univ Sch Med, Dept Surg, Div Transplant Surg, 550N Univ Blvd,UH 4601, Indianapolis, IN 46202 USA; [Cooper, David K. C.] Univ Alabama Birmingham, Dept Surg, Xenotransplantat Program, Birmingham, AL 35294 USA	Ekser, B (reprint author), Indiana Univ Sch Med, Dept Surg, Div Transplant Surg, 550N Univ Blvd,UH 4601, Indianapolis, IN 46202 USA.	bekser@iupui.edu			Department of Surgery; NIH NIAID [AI090959]	Work on xenotransplantation in the Xenotransplantation Research Laboratory at Indiana University has been supported by internal funds of the Department of Surgery. Work on xenotransplantation at the University of Alabama at Birmingham is supported in part by NIH NIAID U19 grant AI090959.	Abalovich A, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12315; Arefanian H, 2016, CELL TRANSPLANT, V25, P327, DOI 10.3727/096368915X688506; Argaw T, 2016, XENOTRANSPLANTATION, V23, P151, DOI 10.1111/xen.12230; Badin RA, 2016, AM J TRANSPLANT, V16, P2016, DOI 10.1111/ajt.13704; Bottino R, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12283; Buermann A, 2016, XENOTRANSPLANTATION, V23, P347, DOI 10.1111/xen.12261; Burdorf L, 2016, XENOTRANSPLANTATION, V23, P222, DOI 10.1111/xen.12236; Butler JR, 2017, J SURG RES, V212, P238, DOI 10.1016/j.jss.2017.01.025; Butler JR, 2017, J THORAC CARDIOV SUR, V153, P488, DOI 10.1016/j.jtcvs.2016.08.067; Butler JR, 2016, TRANSGENIC RES, V25, P751, DOI 10.1007/s11248-016-9958-0; Butler JR, 2016, XENOTRANSPLANTATION, V23, P106, DOI 10.1111/xen.12217; Butler JR, 2016, TRANSPLANTATION, V100, P571, DOI 10.1097/TP.0000000000001071; Cavicchioli L, 2017, VET PATHOL, V54, P336, DOI 10.1177/0300985816669407; Choi HJ, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12314; Cooper DKC, 2017, TRANSPLANTATION, V101, P1551, DOI 10.1097/TP.0000000000001582; Cooper DKC, 2016, TRANSPLANTATION, V100, P2301, DOI 10.1097/TP.0000000000001371; Cooper DKC, 2016, TRANSPLANTATION, V100, P2039, DOI 10.1097/TP.0000000000001319; Cooper DKC, 2016, XENOTRANSPLANTATION, V23, P328, DOI 10.1111/xen.12251; Cooper DKC, 2016, GLYCOBIOLOGY, V26, P571, DOI 10.1093/glycob/cww028; Cooper DKC, 2016, XENOTRANSPLANTATION, V23, P83, DOI 10.1111/xen.12219; Cooper DKC, 2016, XENOTRANSPLANTATION, V23, P46, DOI 10.1111/xen.12226; Cooper DKC, 2016, J PATHOL, V238, P288, DOI 10.1002/path.4635; Cooper DKC, 2015, INT J SURG, V23, P205, DOI 10.1016/j.ijsu.2015.06.060; Cooper DKC, 2014, XENOTRANSPLANTATION, V21, P397, DOI 10.1111/xen.12127; Cooper DKC, 2017, XENOTRANSPLANTATION, V24, DOI [10.1111/xen.12306.Review, DOI 10.1111/XEN.12306.REVIEW]; Cowan PJ, 2017, AM J TRANSPLANT, V17, P2531, DOI 10.1111/ajt.14311; Cowan PJ, 2017, TRANSPLANTATION, V101, P692, DOI 10.1097/TP.0000000000001641; Cowan PJ, 2016, XENOTRANSPLANTATION, V23, P32, DOI 10.1111/xen.12224; Cowan PJ, 2016, TRANSPLANTATION, V100, P485, DOI 10.1097/TP.0000000000001073; Cozzi E, 2016, XENOTRANSPLANTATION, V23, P14, DOI 10.1111/xen.12222; DENNER J, 2017, VIRUSES BASEL, V9; Denner J, 2016, ANN TRANSPL, V21, P717, DOI 10.12659/AOT.900531; Denner J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080215; Denner J, 2016, XENOTRANSPLANTATION, V23, P53, DOI 10.1111/xen.12227; Denner J, 2015, INT J SURG, V23, P306, DOI 10.1016/j.ijsu.2015.08.032; Dong XJ, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12282; Ekser B, 2016, EBIOMEDICINE, V12, P22, DOI 10.1016/j.ebiom.2016.09.023; Ekser B, 2015, INT J SURG, V23, P199, DOI 10.1016/j.ijsu.2015.06.066; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Ekser B, 2009, TRANSPLANTATION, V88, P1041, DOI 10.1097/TP.0b013e3181ba0555; Ezzelarab MB, 2015, XENOTRANSPLANTATION, V22, P32, DOI 10.1111/xen.12133; Fischer K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29081; Gao HC, 2017, J REPROD DEVELOP, V63, P17, DOI 10.1262/jrd.2016-079; Gazda LS, 2016, XENOTRANSPLANTATION, V23, P444, DOI 10.1111/xen.12277; Haque MR, 2017, J CONTROL RELEASE, V258, P10, DOI 10.1016/j.jconrel.2017.04.021; Hara H, 2010, XENOTRANSPLANTATION, V17, P338, DOI 10.1111/j.1399-3089.2010.00608.x; Hawthorne WJ, 2016, CURR OPIN ORGAN TRAN, V21, P476, DOI 10.1097/MOT.0000000000000353; Hering BJ, 2016, XENOTRANSPLANTATION, V23, P3, DOI 10.1111/xen.12231; Hering BJ, 2016, XENOTRANSPLANTATION, V23, P60, DOI 10.1111/xen.12228; Higginbotham L, 2015, XENOTRANSPLANTATION, V22, P221, DOI 10.1111/xen.12166; Hwang JH, 2016, CELL REPROGRAM, V18, P207, DOI 10.1089/cell.2015.0065; Iwase H, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12289; Iwase H, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12296; Iwase H, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12293; Iwase H, 2016, XENOTRANSPLANTATION, V23, P293, DOI 10.1111/xen.12243; Iwase H, 2015, XENOTRANSPLANTATION, V22, P302, DOI 10.1111/xen.12174; Iwase H, 2015, XENOTRANSPLANTATION, V22, P211, DOI 10.1111/xen.12167; Kang HJ, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12299; Kim DH, 2016, XENOTRANSPLANTATION, V23, P202, DOI 10.1111/xen.12234; Kim GA, 2017, TRANSGENIC RES, V26, P435, DOI 10.1007/s11248-017-0021-6; Kim J, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12298; Kim JM, 2016, XENOTRANSPLANTATION, V23, P472, DOI 10.1111/xen.12266; Kim MJ, 2017, J DRUG TARGET, V25, P350, DOI 10.1080/1061186X.2016.1258704; Kim S, 2017, AM J TRANSPLANT, V17; Kwon DJ, 2017, TRANSGENIC RES, V26, P153, DOI 10.1007/s11248-016-9979-8; Laird C, 2016, CURR OPIN ORGAN TRAN, V21, P272, DOI 10.1097/MOT.0000000000000311; Laird CT, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12294; Lambrigts D, 1998, TRANSPLANTATION, V66, P547, DOI 10.1097/00007890-199809150-00001                                                ; Lee HS, 2016, AM J TRANSPLANT, V16, P44, DOI 10.1111/ajt.13467; Lee W, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12276; Lee W, 2016, XENOTRANSPLANTATION, V23, P370, DOI 10.1111/xen.12254; Lee W, 2016, XENOTRANSPLANTATION, V23, P137, DOI 10.1111/xen.12229; Lee W, 2016, CORNEA, V35, P105, DOI 10.1097/ICO.0000000000000635; Li T, 2017, TRANSPLANTATION, V101, P2330, DOI 10.1097/TP.0000000000001676; Liu ZZ, 2017, CELL TRANSPLANT, V26, P925, DOI 10.3727/096368917X694859; Machaidze Z, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12297; Mahou R, 2016, XENOTRANSPLANTATION, V23, P179, DOI 10.1111/xen.12240; Martens GR, 2017, TRANSPLANTATION, V101, pE86, DOI 10.1097/TP.0000000000001646; Marx H, 2017, J PROTEOME RES, V16, P2887, DOI 10.1021/acs.jproteome.7b00184; Mathieu R, 2016, XENOTRANSPLANTATION, V23, P258, DOI 10.1111/xen.12247; Matsumoto S, 2016, EBIOMEDICINE, V12, P255, DOI 10.1016/j.ebiom.2016.08.034; Mohiuddin MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11138; Morozov VA, 2016, XENOTRANSPLANTATION, V23, P490, DOI 10.1111/xen.12265; Morozov VA, 2017, VIRUS RES, V227, P34, DOI 10.1016/j.virusres.2016.08.012; Murthy R, 2016, ANN THORAC SURG, V101, P1605, DOI 10.1016/j.athoracsur.2015.10.017; Navarro-Alvarez N, 2016, AM J TRANSPLANT, V16, P1715, DOI 10.1111/ajt.13647; Niemann H, 2016, TRANSGENIC RES, V25, P361, DOI 10.1007/s11248-016-9934-8; Olver IN, 2016, MED J AUSTRALIA, V204, P212, DOI 10.5694/mja16.00130; Paris LL, 2015, XENOTRANSPLANTATION, V22, P203, DOI 10.1111/xen.12164; Paris W, 2016, XENOTRANSPLANTATION, V23, P335, DOI 10.1111/xen.12263; Park HS, 2017, J TISSUE ENG REGEN M, V11, P1274, DOI 10.1002/term.2029; Perkel JM, 2016, NAT BIOTECHNOL, V34, P3, DOI 10.1038/nbt0116-3; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; Rayat GR, 2016, XENOTRANSPLANTATION, V23, P38, DOI 10.1111/xen.12225; Reuven EM, 2016, XENOTRANSPLANTATION, V23, P381, DOI 10.1111/xen.12260; Rios A, 2016, XENOTRANSPLANTATION, V23, P269, DOI 10.1111/xen.12250; Salomon DR, 2016, NEW ENGL J MED, V374, P1089, DOI 10.1056/NEJMcibr1515623; Samy KP, 2017, J IMMUNOL RES, DOI 10.1155/2017/8415205; Schuurman HJ, 2016, XENOTRANSPLANTATION, V23, P440, DOI 10.1111/xen.12280; Schuurman HJ, 2016, XENOTRANSPLANTATION, V23, P175, DOI 10.1111/xen.12244; Schuurman HJ, 2015, INT J SURG, V23, P312, DOI 10.1016/j.ijsu.2015.09.051; Shah JA, 2017, AM J TRANSPLANT, V17, P2178, DOI 10.1111/ajt.14341; Shin JS, 2015, AM J TRANSPLANT, V15, P2837, DOI 10.1111/ajt.13345; Spizzo T, 2016, XENOTRANSPLANTATION, V23, P25, DOI 10.1111/xen.12223; Tanabe T, 2017, AM J TRANSPLANT, V17, P1778, DOI 10.1111/ajt.14210; Tena AA, 2017, TRANSPLANTATION, V101, P316, DOI 10.1097/TP.0000000000001267; Wijkstrom M, 2017, KIDNEY INT, V91, P790, DOI 10.1016/j.kint.2016.08.035; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; [Anonymous], 2016, NAT BIOTECHNOL, V34, DOI [10.1038/nbt.3466, DOI 10.1038/NBT.3466]	109	0	0	14	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1087-2418	1531-7013		CURR OPIN ORGAN TRAN	Curr. Opin. Organ Transpl.	DEC	2017	22	6					513	521		10.1097/MOT.0000000000000463				9	Transplantation	Transplantation	FM5VQ	WOS:000415109700002	28901971				2018-01-05	
J	Yamada, K; Sykes, M; Sachs, DH				Yamada, Kazuhiko; Sykes, Megan; Sachs, David H.			Tolerance in xenotransplantation	CURRENT OPINION IN ORGAN TRANSPLANTATION			English	Review						immune tolerance; mixed chimerism; thymus transplantation; vascularized thymic transplantation; xenotransplantation	HUMAN T-CELLS; IMMUNOSUPPRESSED NONHUMAN-PRIMATES; THYMIC LOBE TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HUMAN IMMUNE-SYSTEM; LONG-TERM SURVIVAL; MINIATURE SWINE; MIXED CHIMERISM; XENOGRAFT REJECTION; PORCINE ISLETS	Purpose of review This review describes recent progress in tolerance-inducing strategies across xenogeneic immunological barriers as well as the potential benefit of a tolerance strategy for islets and kidney xenotransplantation. Recent findings Using advanced gene editing technologies, xenotransplantation from multitransgenic alpha-1,3-galactosyltransferase knockout pigs has demonstrated marked prolongation of renal xenograft survival, ranging from days to greater than several months for life-supporting kidneys, and more than 2 years in a heterotopic nonlife-supporting cardiac xenograft model. Continuous administration of multiple immunosuppressive drugs has been required and attempts to taper immunosuppression have been unsuccessful. It appears likely that low levels of T cell dependent antibodies and activation of innate responses are responsible for xenograft loss. Mixed chimerism and thymic transplantation approaches have achieved xenogeneic tolerance in pig-to-mouse models and both have recently been extended to pig-to-baboon models. Encouraging results have been reported, including persistence of macrochimerism, prolonged pig skin graft survival, donor-specific unresponsiveness in vitro and detection of recent T cell emigrants in vivo. Summary Although tolerance induction in vivo has not yet been achieved in pig-to-baboon models, recent results are encouraging that this goal will be attainable through genetic engineering of porcine donors.	[Yamada, Kazuhiko; Sykes, Megan; Sachs, David H.] Columbia Univ, Dept Med, Columbia Ctr Translat Immunol, New York, NY USA; [Yamada, Kazuhiko; Sykes, Megan; Sachs, David H.] Columbia Univ, Dept Surg, New York, NY USA; [Sykes, Megan] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA	Sachs, DH (reprint author), Columbia Ctr Translat Immunol, 630 W 168th St,BB1705, New York, NY 10032 USA.	DHS2142@cumc.columbia.edu	Ucar, Abdullah/P-8329-2017		NIH [P01AI45897]	This research was supported by NIH grant P01AI45897.	AKSENTIJEVICH I, 1992, TRANSPLANTATION, V53, P1108, DOI 10.1097/00007890-199205000-00025; Bashuda H, 2005, J CLIN INVEST, V115, P1896, DOI 10.1172/JCI23743; Bottino R, 2014, AM J TRANSPLANT, V14, P2275, DOI 10.1111/ajt.12868; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Cowan PJ, 2016, CURR OPIN ORGAN TRAN, V21, P461, DOI 10.1097/MOT.0000000000000347; Cretin N, 2002, J IMMUNOL, V168, P1479, DOI 10.4049/jimmunol.168.3.1479                                                     ; Duquesnoy RJ, 2004, TRANSPLANT INT, V17, P22, DOI 10.1007/s00147-003-0641-z; Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721; Fudaba Y, 2008, J IMMUNOL, V181, P7649, DOI 10.4049/jimmunol.181.11.7649                                                    ; Griesemer AD, 2009, AM J TRANSPLANT, V9, P2669, DOI 10.1111/j.1600-6143.2009.02849.x; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Griesemer A, 2010, XENOTRANSPLANTATION, V17, P300, DOI 10.1111/j.1399-3089.2010.00600.x; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Haller GW, 1999, J IMMUNOL, V163, P3785; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Higginbotham L, 2015, XENOTRANSPLANTATION, V22, P221, DOI 10.1111/xen.12166; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Iwase H, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12289; Iwase H, 2015, XENOTRANSPLANTATION, V22, P302, DOI 10.1111/xen.12174; Kalscheuer H, 2014, J IMMUNOL, V192, P3442, DOI 10.4049/jimmunol.1302886; Kamano C, 2004, P NATL ACAD SCI USA, V101, P3827, DOI 10.1073/pnas.0306666101; KarlssonParra A, 1996, TRANSPLANTATION, V61, P1313, DOI 10.1097/00007890-199605150-00005; Kawahara T, 2007, AM J TRANSPLANT, V7, P2090, DOI 10.1111/j.1600-6143.2007.01905.x; Kawahara T, 2005, AM J TRANSPLANT, V5, P2821, DOI 10.1111/j.1600-6143.2005.01121.x; KAWAI T, 1995, TRANSPLANTATION, V59, P256, DOI 10.1097/00007890-199501270-00018; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; LaMattina JC, 2002, TRANSPLANTATION, V73, P826, DOI 10.1097/00007890-200203150-00032                                                ; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; LEE LA, 1994, P NATL ACAD SCI USA, V91, P10864, DOI 10.1073/pnas.91.23.10864; Li HW, 2017, AM J TRANSPLANT, V17, P353, DOI 10.1111/ajt.13957; Liang F, 2013, XENOTRANSPLANTATION, V20, P458, DOI 10.1111/xen.12065; Martens GR, 2017, TRANSPLANTATION, V101, pE86, DOI 10.1097/TP.0000000000001646; Matsumoto S, 2016, EBIOMEDICINE, V12, P255, DOI 10.1016/j.ebiom.2016.08.034; Mohiuddin MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11138; MOSES RD, 1990, J EXP MED, V172, P567, DOI 10.1084/jem.172.2.567; MURRAY AG, 1994, IMMUNITY, V1, P57, DOI 10.1016/1074-7613(94)90009-4; Nikolic B, 1999, J IMMUNOL, V162, P3402; Nobori S, 2006, TRANSPLANTATION, V81, P26, DOI 10.1097/01.tp.0000200368.03991.e0; Nobori S, 2006, P NATL ACAD SCI USA, V103, P19081, DOI 10.1073/pnas.0605159103; Ohdan H, 1999, J CLIN INVEST, V104, P281, DOI 10.1172/JCI6656                                                                 ; Ohdan H, 2001, TRANSPLANTATION, V71, P1532, DOI 10.1097/00007890-200106150-00009                                                ; Ohdan H, 2001, XENOTRANSPLANTATION, V8, P227, DOI 10.1034/j.1399-3089.2001.00006.x; Okada M, 2012, BIOL BLOOD MARROW TR, V18, P633, DOI 10.1016/j.bbmt.2011.08.010; Okumi M, 2016, AM J TRANSPLANT, V16, P886, DOI 10.1111/ajt.13502; Rodriguez-Barbosa JI, 2001, TRANSPLANTATION, V72, P1223, DOI 10.1097/00007890-200110150-00007; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Seebach JD, 1996, XENOTRANSPLANTATION, V3, P188, DOI 10.1111/j.1399-3089.1996.tb00137.x; Shimizu I, 2008, TRANSPLANTATION, V86, P601, DOI 10.1097/TP.0b013e318182d47a; Shimizu I, 2007, BLOOD, V109, P1773, DOI 10.1182/blood-2006-02-002386; Shin JS, 2015, AM J TRANSPLANT, V15, P2837, DOI 10.1111/ajt.13345; Shin JS, 2016, XENOTRANSPLANTATION, V23, P300, DOI 10.1111/xen.12246; Strober S, 2011, SEMIN IMMUNOL, V23, P273, DOI 10.1016/j.smim.2011.05.001; Tanabe T, 2017, AM J TRANSPLANT, V17, P1778, DOI 10.1111/ajt.14210; Tasaki M, 2015, AM J TRANSPLANT, V15, P974, DOI 10.1111/ajt.13070; Tena AA, 2017, TRANSPLANTATION, V101, P316, DOI 10.1097/TP.0000000000001267; Todo S, 2016, HEPATOLOGY, V64, P632, DOI 10.1002/hep.28459; Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x; van der Windt DJ, 2009, AM J TRANSPLANT, V9, P2716, DOI 10.1111/j.1600-6143.2009.02850.x; Wang CF, 2011, CELL TRANSPLANT, V20, P1915, DOI [10.3727/096368911x566253, 10.3727/096368911X566253]; Wang H, 2007, BLOOD, V109, P836, DOI 10.1182/blood-2006-04-019794; Wong BS, 2006, TRANSPLANTATION, V82, P314, DOI 10.1097/01.tp.0000228907.12073.0b; Yamada K, 2000, J IMMUNOL, V164, P3079, DOI 10.4049/jimmunol.164.6.3079                                                     ; YAMADA K, 1995, J IMMUNOL, V155, P5249; Yamada K, 1999, TRANSPLANTATION, V68, P1684, DOI 10.1097/00007890-199912150-00011; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yamada Y, 2012, AM J TRANSPLANT, V12, P330, DOI 10.1111/j.1600-6143.2011.03795.x; Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335; Yang YG, 2010, XENOTRANSPLANTATION, V17, P267, DOI 10.1111/j.1399-3089.2010.00601.x; Zhao Y, 2003, TRANSPLANTATION, V75, P1832, DOI 10.1097/01.TP.0000065292.20062.F0; Zhao Y, 2001, TRANSPLANTATION, V72, P1608, DOI 10.1097/00007890-200111270-00006	70	0	0	11	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1087-2418	1531-7013		CURR OPIN ORGAN TRAN	Curr. Opin. Organ Transpl.	DEC	2017	22	6					522	528		10.1097/MOT.0000000000000466				7	Transplantation	Transplantation	FM5VQ	WOS:000415109700003	28937406				2018-01-05	
J	Xing, T; Li, XQ; Laroche, A; Tian, LN; Tubei, K; Wang, XJ				Xing, Tim; Li, Xiu-Qing; Laroche, Andre; Tian, Lining; Tubei, Kipkios; Wang, Xiaojing			Protoplasts in the analysis of early plant-pathogen interactions: current applications and perspectives	EUROPEAN JOURNAL OF PLANT PATHOLOGY			English	Article						Protoplast; Effector; Elicitor; R gene; Signal perception; Transduction; Transient gene expression; Protein-protein interaction; Disease resistance	PROGRAMMED CELL-DEATH; ARABIDOPSIS MESOPHYLL PROTOPLASTS; LATE BLIGHT RESISTANCE; IMMUNE-SYSTEM; TRANSIENT EXPRESSION; GENE-EXPRESSION; PROTEIN; DEFENSE; WALL; FUSICOCCIN	Transient gene expression in protoplasts has been applied to the analysis of gene expression, promoter activity, subcellular localization of proteins, and genome editing. Its advantages have been realized in recent years in various physiological, biochemical, genetic, and molecular biological studies. The omics and systems biology studies of plant development and their interactions with the environment have revitalized this approach. Early plant-pathogen interaction represents one of the most unique signalling research areas. Here, we try to discuss some developments and current applications of the protoplast system. It is for sure that the system will significantly bridge the gap between high throughput approaches and functional analysis in the study of plant-pathogen interactions in the omics era.	[Xing, Tim; Tubei, Kipkios] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Li, Xiu-Qing] Agr & Agri Food Canada, Fredericton Res & Dev Ctr, Fredericton, NB, Canada; [Laroche, Andre] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Tian, Lining] Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada; [Wang, Xiaojing] South China Normal Univ, Coll Life Sci, Guangdong Key Lab Biotechnol Plant Dev, Guangzhou 510631, Guangdong, Peoples R China	Xing, T (reprint author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.; Wang, XJ (reprint author), South China Normal Univ, Coll Life Sci, Guangdong Key Lab Biotechnol Plant Dev, Guangzhou 510631, Guangdong, Peoples R China.	Tim.Xing@Carleton.ca; wangxj@scnu.edu.cn			Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China	This work was supported by a research grant to T.X. from Natural Sciences and Engineering Research Council of Canada and a research grant to X.J.W. from National Natural Science Foundation of China.	Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; BALLIO A, 1968, EXPERIENTIA, V24, P631, DOI 10.1007/BF02153818; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Daub ME, 2005, FEMS MICROBIOL LETT, V252, P197, DOI 10.1016/j.femsle.2005.08.033; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dowd PF, 1999, NAT TOXINS, V7, P337, DOI 10.1002/1522-7189(199911/12)7:6<337::AID-NT69>3.0.CO;2-O; Ek-Ramos MJ, 2010, J BIOL CHEM, V285, P17584, DOI 10.1074/jbc.M110.117416; Ek-Ramos MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110807; Faraco M, 2011, PLANT PHYSIOL, V156, P474, DOI 10.1104/pp.111.173708; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; GOH CH, 1995, PLANT PHYSIOL, V109, P187, DOI 10.1104/pp.109.1.187                                                            ; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Grzebelus E, 2013, PLANT CELL TISS ORG, V115, P209, DOI 10.1007/s11240-013-0353-8; Hafke JB, 2007, PLANT PHYSIOL, V145, P703, DOI 10.1104/pp.107.105940; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hlavackova V, 2007, PLANT SIGNAL BEHAV, V2, P103, DOI 10.4161/psb.2.2.3616; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Iakimova Elena T., 2007, Journal of Fruit and Ornamental Plant Research, V15, P5; Iakovidis M, 2016, GENETICS, V204, P337, DOI 10.1534/genetics.116.190678; Iwahashi H, 1999, CHEM-BIOL INTERACT, V118, P201, DOI 10.1016/S0009-2797(99)00080-0                                                   ; Jacob Francois, 1974, LOGIC LIVING SYSTEMS; Jia ZQ, 2010, J INTEGR PLANT BIOL, V52, P476, DOI 10.1111/j.1744-7909.2010.00915.x; JOHANSSON F, 1993, PLANT CELL, V5, P321; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kirsch C, 2000, MOL PLANT PATHOL, V1, P243, DOI 10.1046/j.1364-3703.2000.00029.x; Komarova TV, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00101; Koschmann J, 2012, PLANT PHYSIOL, V160, P178, DOI 10.1104/pp.112.198259; Lewis LA, 2015, PLANT CELL, V27, P3038, DOI 10.1105/tpc.15.00471; Li JF, 2014, NAT PROTOC, V9, P939, DOI 10.1038/nprot.2014.061; Li JF, 2013, PLANT CELL, V25, P1507, DOI 10.1105/tpc.113.112235; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lu H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00157; Ma LS, 2012, METHODS MOL BIOL, V835, P61, DOI 10.1007/978-1-61779-501-5_4; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Park CJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1932; Randhawa H, 2012, CAN J PLANT SCI, V92, P713, DOI [10.4141/CJPS2011-252, 10.4141/cjps2011-252]; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.127.4.1466; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Vidhyasekaran P, 2007, FUNGAL PATHOGENESIS, P469; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Wang YH, 2013, MOL BREEDING, V32, P437, DOI 10.1007/s11032-013-9882-4; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wodak SJ, 2013, CURR OPIN STRUC BIOL, V23, P941, DOI 10.1016/j.sbi.2013.08.002; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu Y, 2003, PLANT J, V33, P131, DOI 10.1046/j.0960-7412.2002.001614.x; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xing T, 2003, CAN J PLANT PATHOL, V25, P209; Xing T, 2001, PLANT MOL BIOL, V46, P109, DOI 10.1023/A:1010633215445; Xing T, 2015, BOTANY, V93, P325, DOI 10.1139/cjb-2014-0219; Xing T, 2011, PLANT SIGNAL BEHAV, V6, P1469, DOI 10.4161/psb.6.10.17345; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260; Zhang HK, 2004, CELL RES, V14, P27, DOI 10.1038/sj.cr.7290199; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	68	0	0	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-1873	1573-8469		EUR J PLANT PATHOL	Eur. J. Plant Pathol.	DEC	2017	149	4					1001	1010		10.1007/s10658-017-1230-9				10	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	FM0XK	WOS:000414691500019					2018-01-05	
J	Kambhampati, S; Kurepin, LV; Kisiala, AB; Bruce, KE; Cober, ER; Morrison, MJ; Emery, RJN				Kambhampati, Shrikaar; Kurepin, Leonid V.; Kisiala, Anna B.; Bruce, Kahlan E.; Cober, Elroy R.; Morrison, Malcolm J.; Emery, R. J. Neil			Yield associated traits correlate with cytokinin profiles in developing pods and seeds of field-grown soybean cultivars	FIELD CROPS RESEARCH			English	Article						Cytokinin; Developmental stages; Seed set; Seed filling; Soybean; Thousand seed weight; Yield	MAX L MERR; GLYCINE-MAX; ABSCISIC-ACID; SET; BIOSYNTHESIS; 6-BENZYLAMINOPURINE; ARABIDOPSIS; FLOWERS; BARLEY; TRANSLOCATION	While lab and greenhouse based studies have long indicated that cytokinins (CK) promote yield increases in soybean (Glycine max L.), it is not known if the relationship would be valid under more complex field conditions. Thus, an ambitious CK metabolite analysis was undertaken involving long-term field trials of commercial and historical soybean varieties to determine if differences between CK profiles are related to variation in yield performance. Twenty-seven cultivars were evaluated in this study representing a wide range of performance and assessed for 12 agronomically important plant and seed parameters under field conditions. Identification and quantification of 14 forms of CK was undertaken by high-performance liquid chromatography tandem mass spectrometry (HPLC MS/MS) at three stages of reproductive development that are critical for yield determination (R4-R6). This revealed a substantial increase in CK levels, especially the highly metabolically active free bases, in the high yielding cultivars of soybean. Significant correlations between yield components and the most active CK form, tZ (trans-Zeatin), were detected at both R4 and R5 stages. A similar trend was observed for cZ (cis-Zeatin), indicating a possible role of both zeatin isomers in pod and early seed development. Positive, significant relationships between yield and cytokinins were maintained also at R6 stage; however, a switch in hormone profiles and increased levels of isopentenyl adenine (iP) types of CK in high yielding cultivars suggested that the presence of iP derivatives allowed developing seeds to maintain their active role in sink organs and attract assimilates during the seed filling phases, when the metabolism of the maturing plant was generally slowing down. Results suggested that cytokinin metabolites or their associated genes, may serve as a valuable, early indicators of yield performance in marker-assisted breeding programs for soybean or be manipulated through gene editing techniques.	[Kambhampati, Shrikaar; Kurepin, Leonid V.] Univ Western Ontario, Dept Biol, 1151 Richmond St, London, ON N6A 5B7, Canada; [Kisiala, Anna B.; Bruce, Kahlan E.; Emery, R. J. Neil] Trent Univ, Biol Dept, 2190 East Bank Dr, Peterborough, ON K9J 7B8, Canada; [Cober, Elroy R.; Morrison, Malcolm J.] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, 960 Carling Ave, Ottawa, ON K1A 0C6, Canada	Emery, RJN (reprint author), Trent Univ, Biol Dept, 2190 East Bank Dr, Peterborough, ON K9J 7B8, Canada.	skambham@uwo.ca; Ikurepin@uwo.ca; annakisiala@trentu.ca; kahlancoates@gmail.com; elroy.cober@agr.gc.ca; malcolm.morrison@agr.gc.ca; nemery@trentu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Industry partner SEVITA International	The authors acknowledge the funding support of the Natural Sciences and Engineering Research Council of Canada (NSERC) for a Collaborative Research and Development Grant and Industry partner SEVITA International.	ABERNETHY RH, 1977, CAN J PLANT SCI, V57, P713, DOI 10.4141/cjps77-104                                                              ; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; ATKINS CA, 1993, AUST J AGR RES, V44, P1799, DOI 10.1071/AR9931799; Bottcher C, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0611-5; Brugiere N, 2008, PLANT MOL BIOL, V67, P215, DOI 10.1007/s11103-008-9312-x; CARLSON DR, 1987, PLANT PHYSIOL, V84, P233, DOI 10.1104/pp.84.2.233; CROSBY KE, 1981, PLANT PHYSIOL, V68, P985, DOI 10.1104/pp.68.5.985; DYER DJ, 1987, PLANT PHYSIOL, V84, P240, DOI 10.1104/pp.84.2.240                                                             ; Emery RJN, 2000, PLANT PHYSIOL, V123, P1593, DOI 10.1104/pp.123.4.1593; Emery RJN, 1998, PLANT PHYSIOL, V117, P1515, DOI 10.1104/pp.117.4.1515                                                           ; Farrow SC, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-42; Fehr W. R., 1977, STAGES SOYBEAN DEV; Giron D, 2014, J CHEM ECOL, V40, P826, DOI 10.1007/s10886-014-0466-5; Gotz KP, 2007, J EXP BOT, V58, P3183, DOI 10.1093/jxb/erm164; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; HUFF A, 1980, J EXP BOT, V31, P751, DOI 10.1093/jxb/31.3.751                                                            ; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; Jameson PE, 2016, J EXP BOT, V67, P593, DOI 10.1093/jxb/erv461; Jiskrova E, 2016, NEW BIOTECHNOL, V33, P735, DOI 10.1016/j.nbt.2015.12.010; Kamada-Nobusada T, 2009, PHYTOCHEMISTRY, V70, P444, DOI 10.1016/j.phytochem.2009.02.007; Kiba T, 2013, DEV CELL, V27, P452, DOI 10.1016/j.devcel.2013.10.004; Kokubun M., 2011, SOYBEAN BIOCH CHEM P; Kokubun Makie, 2000, Plant Production Science, V3, P354; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Larissa P.B., 2014, AFR J AGR RES, V9, P2799; Li J, 2013, P NATL ACAD SCI USA, V110, P15479, DOI 10.1073/pnas.1305175110; Lomin SN, 2015, J EXP BOT, V66, P1851, DOI 10.1093/jxb/eru522; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Morrison EN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130945; Morrison EN, 2015, MYCOLOGIA, V107, P245, DOI 10.3852/14-157; MOSJIDIS CO, 1993, ANN BOT-LONDON, V71, P193, DOI 10.1006/anbo.1993.1024                                                          ; Nagel L, 2001, ANN BOT-LONDON, V88, P27, DOI 10.1006/anbo.2001.1423; Pedersen P, 2003, CROP SCI, V44, P508; PETERSON CM, 1990, BOT GAZ, V151, P322, DOI 10.1086/337832; Powell AE, 2013, PLANT PHYSIOL BIOCH, V64, P33, DOI 10.1016/j.plaphy.2012.12.010; Quesnelle PE, 2007, CAN J BOT, V85, P91, DOI 10.1139/B06-149; Nguyen QT, 2016, CURR GENOMICS, V17, P241, DOI 10.2174/1389202917666160202220238; REESE RN, 1995, J EXP BOT, V46, P957, DOI 10.1093/jxb/46.8.957                                                            ; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Yamburenko MV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176060; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052	44	0	0	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4290	1872-6852		FIELD CROP RES	Field Crop. Res.	DEC	2017	214						175	184		10.1016/j.fcr.2017.09.009				10	Agronomy	Agriculture	FM0AT	WOS:000414621900018					2018-01-05	
J	Dangi, AK; Dubey, KK; Shukla, P				Dangi, Arun Kumar; Dubey, Kashyap Kumar; Shukla, Pratyoosh			Strategies to Improve Saccharomyces cerevisiae: Technological Advancements and Evolutionary Engineering	INDIAN JOURNAL OF MICROBIOLOGY			English	Review						Saccharomyces cerevisiae; Baker's yeast; Metabolic engineering; Systems biology; Dough leavening; Strain improvement	INDUSTRIAL YEAST STRAINS; SEAMLESS GENE DELETION; DE-NOVO BIOSYNTHESIS; BAKERS-YEAST; LEAVENING ABILITY; STRESS CONDITIONS; AROMA PROFILES; LEAN DOUGH; BREAD; FERMENTATION	Bakery industries are thriving to augment the diverse properties of Saccharomyces cerevisiae to increase its flavor, texture and nutritional parameters to attract the more consumers. The improved technologies adopted for quality improvement of baker's yeast are attracting the attention of industry and it is playing a pivotal role in redesigning the quality parameters. Modern yeast strain improvement tactics revolve around the use of several advanced technologies such as evolutionary engineering, systems biology, metabolic engineering, genome editing. The review mainly deals with the technologies for improving S. cerevisiae, with the objective of broadening the range of its industrial applications.	[Dangi, Arun Kumar; Shukla, Pratyoosh] Maharshi Dayanand Univ, Dept Microbiol, Enzyme Technol & Prot Bioinformat Lab, Rohtak 124001, Haryana, India; [Dubey, Kashyap Kumar] Cent Univ Haryana, Dept Biotechnol, Mahendergarh, India	Shukla, P (reprint author), Maharshi Dayanand Univ, Dept Microbiol, Enzyme Technol & Prot Bioinformat Lab, Rohtak 124001, Haryana, India.	pratyoosh.shukla@gmail.com					Ando A, 2016, J BIOSCI BIOENG, V122, P441, DOI 10.1016/j.jbiosc.2016.03.006; Aslankoohi Elham, 2016, PLoS One, V11, pe0165126, DOI 10.1371/journal.pone.0165126; Ballester-Tomas L, 2016, J BIOTECHNOL, V221, P70, DOI 10.1016/j.jbiotec.2016.01.029; Ballester-Tomas L, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0289-2; Berterame NM, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox056; Birch AN, 2013, FOOD RES INT, V52, P160, DOI 10.1016/j.foodres.2013.03.011; Brochado AR, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-84; Cakar ZP, 2012, FEMS YEAST RES, V12, P171, DOI 10.1111/j.1567-1364.2011.00775.x; Carlquist M, 2015, YEAST, V32, P123, DOI 10.1002/yea.3058; Chambers PJ, 2009, YEAST BIOTECHNOLOGY, V2009, P433, DOI DOI 10.1007/978-1-4020-8292-4_; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Chopda VR, 2015, BIORESOURCE TECHNOL, V196, P160, DOI 10.1016/j.biortech.2015.07.050; Donalies UEB, 2008, ADV BIOCHEM ENG BIOT, V111, P67, DOI 10.1007/10_2008_099; Dong J, 2016, J IND MICROBIOL BIOT, V43, P817, DOI 10.1007/s10295-016-1753-7; Dong J, 2013, ANAL BIOCHEM, V439, P30, DOI 10.1016/j.ab.2013.04.005; Gandhi A, 2017, CRIT REV FOOD SCI, V57, P3464, DOI 10.1080/10408398.2015.1136805; Generoso WC, 2015, CURR OPIN BIOTECH, V33, P1, DOI 10.1016/j.copbio.2014.09.004; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Gobbetti M, 2014, FOOD MICROBIOL, V37, P30, DOI 10.1016/j.fm.2013.04.012; Gottardi M, 2017, APPL MICROBIOL BIOT, V101, P4883, DOI 10.1007/s00253-017-8220-x; Gupta SK, 2017, CRIT REV BIOTECHNOL, V37, P672, DOI 10.1080/07388551.2016.1214557; Hansen EH, 2009, APPL ENVIRON MICROB, V75, P2765, DOI 10.1128/AEM.02681-08; He J, 2012, INDIAN J MICROBIOL, V52, P442, DOI 10.1007/s12088-012-0259-x; Ilowefah M, 2014, FOODS, V3, P149, DOI 10.3390/foods3010149; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Joseph R, 2014, ENCY FOOD MICROBIOLO, P823, DOI [10.1016/B978-0-12-384730-0.00361-X, DOI 10.1016/B978-0-12-384730-0.00361-X]; Kim SR, 2013, BIOTECHNOL ADV, V31, P851, DOI 10.1016/j.biotechadv.2013.03.004; Krivoruchko A, 2015, CURR OPIN BIOTECH, V35, P7, DOI 10.1016/j.copbio.2014.12.004; Yadavilli SK, 2013, J PHARM RES, V7, P792, DOI DOI 10.1016/J.JOPR.2013.07.014; Kumar V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2015.01421; Lai HM, 2007, BAKERY PRODUCTS SCI, P3, DOI 10.1002/9780470277553; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lin X, 2015, J IND MICROBIOL BIOT, V42, P939, DOI 10.1007/s10295-015-1618-5; Lin X, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0093-4; McIlwain SJ, 2016, G3-GENES GENOM GENET, V6, P1757, DOI 10.1534/g3.116.029389; Mendes I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3816-1; Miskovic L, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0838-5; Nakagawa Y, 2017, J BIOSCI BIOENG, V123, P319, DOI 10.1016/j.jbiosc.2016.10.008; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; O'Shea N, 2016, EUR FOOD RES TECHNOL, V242, P1503, DOI 10.1007/s00217-016-2651-y; Pandey B, 2016, PLANT GENE, V6, P48; Papapetridis I, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0791-3; Papasidero D, 2016, ENERGY, V116, P1417, DOI 10.1016/j.energy.2016.06.046; Pavlopoulos GA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0077-2; Pereira Rui, 2016, Metabolic Engineering Communications, V3, P153, DOI 10.1016/j.meteno.2016.05.002; Perez-Torrado R, 2015, BIOTECHNOL PROGR, V31, P20, DOI 10.1002/btpr.1993; Petel C, 2017, TRENDS FOOD SCI TECH, V59, P105, DOI 10.1016/j.tifs.2016.10.015; Pozo-Bayon MA, 2006, FOOD REV INT, V22, P335, DOI 10.1080/87559120600864829; Ramirez-Gaona M, 2017, NUCLEIC ACIDS RES, V45, pD440, DOI 10.1093/nar/gkw1058; Sainsbury PD, 2013, ACS CHEM BIOL, V8, P2151, DOI 10.1021/cb400505a; Salim-ur-Rehman, 2006, TRENDS FOOD SCI TECH, V17, P557, DOI 10.1016/j.tifs.2006.03.006; Sasano Y, 2013, INT J FOOD MICROBIOL, V165, P241, DOI 10.1016/j.ijfoodmicro.2013.05.015; Serra S, 2005, TRENDS BIOTECHNOL, V23, P193, DOI 10.1016/j.tibtech.2005.02.003; Singh PK, 2015, BRIEF FUNCT GENOMICS, V14, P166, DOI 10.1093/bfgp/elu023; Smit BA, 2009, APPL MICROBIOL BIOT, V81, P987, DOI 10.1007/s00253-008-1758-x; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Struyf N, 2017, COMPR REV FOOD SCI F, V16, P850, DOI 10.1111/1541-4337.12282; Sun X-Y, 2016, EUR SPINE J, V2016, P1, DOI DOI 10.1371/J0URNAL.P0NE.0147410; Takagi H, 2015, STRESS BIOL YEASTS F, P23, DOI DOI 10.1007/978-4-431-55248-2-2; Takagi H, 2017, BIOTECHNOLOGY YEASTS, P63, DOI DOI 10.1007/978-3-319-58829-2_3; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; Tsolmonbaatar A, 2016, INT J FOOD MICROBIOL, V238, P233, DOI 10.1016/j.ijfoodmicro.2016.09.015; Turanli-Yildiz B, 2017, J BIOSCI BIOENG, V124, P309, DOI 10.1016/j.jbiosc.2017.04.012; Vervoort Y, 2017, CURR OPIN BIOTECH, V46, P120, DOI 10.1016/j.copbio.2017.02.011; Watanabe D, 2017, J BIOSCI BIOENG, V123, P183, DOI 10.1016/j.jbiosc.2016.08.004; Winkler JD, 2014, GENOMICS, V104, P406, DOI 10.1016/j.ygeno.2014.09.006; Yadav R, 2016, CRIT REV FOOD SCI NU, DOI [10.1080/10408398.2016.1274877, DOI 10.1080/10408398.2016.1274877]; Yoshiyama Y, 2015, J BIOSCI BIOENG, V119, P172, DOI 10.1016/j.jbiosc.2014.06.021; Young E, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-24; Zha MS, 2017, J AGR FOOD CHEM, V65, P5503, DOI 10.1021/acs.jafc.7b01359; Zhang C, 2007, J AGR FOOD CHEM, V55, P9620, DOI 10.1021/jf0717034; Zhang CY, 2016, APPL MICROBIOL BIOT, V100, P6375, DOI 10.1007/s00253-016-7449-0; Zhang CY, 2015, J FOOD SCI, V80, pM2879, DOI 10.1111/1750-3841.13137; Zhang CY, 2015, WORLD J MICROB BIOT, V31, P1241, DOI 10.1007/s11274-015-1874-6; Zhang M, 2010, WORLD J MICROB BIOT, V26, P1041, DOI 10.1007/s11274-009-0267-0	76	0	0	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0046-8991	0973-7715		INDIAN J MICROBIOL	Indian J. Microbiol.	DEC	2017	57	4					378	386		10.1007/s12088-017-0679-8				9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FL8MP	WOS:000414504200002	29151637				2018-01-05	
J	Chari, R; Church, GM				Chari, Raj; Church, George M.			Beyond editing to writing large genomes	NATURE REVIEWS GENETICS			English	Review							PLURIPOTENT STEM-CELL; BACTERIAL ARTIFICIAL CHROMOSOMES; SITE-SPECIFIC RECOMBINATION; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; CRE RECOMBINASE; CRYSTAL-STRUCTURE; IN-VIVO; GENE CORRECTION	Recent exponential advances in genome sequencing and engineering technologies have enabled an unprecedented level of interrogation into the impact of DNA variation (genotype) on cellular function (phenotype). Furthermore, these advances have also prompted realistic discussion of writing and radically re-writing complex genomes. In this Perspective, we detail the motivation for large-scale engineering, discuss the progress made from such projects in bacteria and yeast and describe how various genome-engineering technologies will contribute to this effort. Finally, we describe the features of an ideal platform and provide a roadmap to facilitate the efficient writing of large genomes.	[Chari, Raj; Church, George M.] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Church, George M.] Wyss Inst Biol Inspired Engn, 3 Blackfan Circle, Boston, MA 02115 USA	Church, GM (reprint author), Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Church, GM (reprint author), Wyss Inst Biol Inspired Engn, 3 Blackfan Circle, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu			NIH grant [RM1HG008525]	This work was supported by NIH grant RM1HG008525 "Center for Genomically Engineered Organs".	Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI 10.1093/nar/gkq589; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/nmeth.4265, 10.1038/NMETH.4265]; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Beaton BP, 2015, XENOTRANSPLANTATION, V22, P379, DOI 10.1111/xen.12194; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Birling Marie-Christine, 2009, Methods Mol Biol, V561, P245, DOI 10.1007/978-1-60327-019-9_16; Boeke JD, 2016, SCIENCE, V353, P126, DOI 10.1126/science.aaf6850; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/nmeth.2450, 10.1038/NMETH.2450]; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Church G, 2015, NATURE, V528, pS7, DOI 10.1038/528S7a; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070                                                           ; Doudna J, 2015, NATURE, V528, pS6, DOI 10.1038/528S6a; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; EauClaire SF, 2016, J IND MICROBIOL BIOT, V43, P1001, DOI 10.1007/s10295-016-1776-0; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Eroshenko N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3509; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113; Gaj T, 2014, J AM CHEM SOC, V136, P5047, DOI 10.1021/ja4130059; Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gellhaus K, 2010, HUM GENE THER, V21, P543, DOI 10.1089/hum.2009.167; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Gouble A, 2006, J GENE MED, V8, P616, DOI 10.1002/jgm.879; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452                                                    ; Haimovich AD, 2015, NAT REV GENET, V16, P501, DOI 10.1038/nrg3956; Hatada S, 2000, P NATL ACAD SCI USA, V97, P13807, DOI 10.1073/pnas.240462897; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Igoucheva O, 2001, GENE THER, V8, P391, DOI 10.1038/sj.gt.3301414; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Javidi-Parsijani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177444; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Karakikes I, 2017, CIRC RES, V120, P1561, DOI 10.1161/CIRCRESAHA.116.309948; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/nmeth.2918, 10.1038/NMETH.2918]; Lacroix B, 2016, MBIO, V7, DOI 10.1128/mBio.00863-16; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; Lensing SV, 2016, NAT METHODS, V13, P855, DOI 10.1038/nmeth.3960; Li LP, 2013, NAT PROTOC, V8, P1567, DOI 10.1038/nprot.2013.093; Lin JF, 2015, NUCLEIC ACIDS RES, V43, P1112, DOI 10.1093/nar/gku1339; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.203; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nishida K, 2016, SCIENCE, V353, P8729; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ordovas L, 2015, STEM CELL REP, V5, P918, DOI 10.1016/j.stemcr.2015.09.004; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601                                                               ; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Ostrov N, 2016, SCIENCE, V353, P819, DOI 10.1126/science.aaf3639; Ou HL, 2013, J BIOTECHNOL, V167, P427, DOI 10.1016/j.jbiotec.2013.08.001; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Peisach E, 2003, J MOL BIOL, V330, P1, DOI 10.1016/S0022-2836(03)00572-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Richardson SM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4557; Rios X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036697; Robert MA, 2012, HUM GENE THER METHOD, V23, P393, DOI 10.1089/hgtb.2012.122; Robertson DE, 2011, PHOTOSYNTH RES, V107, P269, DOI 10.1007/s11120-011-9631-7; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Salhi A, 2016, NUCLEIC ACIDS RES, V44, pD624, DOI 10.1093/nar/gkv1147; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Saraf-Levy T, 2006, BIOORGAN MED CHEM, V14, P3081, DOI 10.1016/j.bmc.2005.12.016; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schandera J, 2016, TRENDS GENET, V32, P385, DOI 10.1016/j.tig.2016.04.006; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Szalay T, 2015, NAT BIOTECHNOL, V33, P1087, DOI 10.1038/nbt.3360; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Voziyanova E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt341; Wallen MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139123; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/nmeth.1971, 10.1038/NMETH.1971]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004200; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wolfs JM, 2014, NUCLEIC ACIDS RES, V42, P8816, DOI 10.1093/nar/gku573; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Xu K, 2015, MOL CELLS, V38, P33, DOI 10.14348/molcells.2015.2163; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981; Zhang X, 2014, G3-GENES GENOM GENET, V4, P2409, DOI 10.1534/g3.114.013979; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	167	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-0056	1471-0064		NAT REV GENET	Nat. Rev. Genet.	DEC	2017	18	12					749	760		10.1038/nrg.2017.59				12	Genetics & Heredity	Genetics & Heredity	FM5VJ	WOS:000415108900010	28852223				2018-01-05	
J	Zhang, F; LeBlanc, C; Irish, VF; Jacob, Y				Zhang, Fei; LeBlanc, Chantal; Irish, Vivian F.; Jacob, Yannick			Rapid and efficient CRISPR/Cas9 gene editing in Citrus using the YAO promoter	PLANT CELL REPORTS			English	Article							GENOME; EXPRESSION; SYSTEM; PLANTS		[Zhang, Fei; LeBlanc, Chantal; Irish, Vivian F.; Jacob, Yannick] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Irish, Vivian F.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Irish, VF; Jacob, Y (reprint author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Irish, VF (reprint author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	vivian.irish@yale.edu; yannick.jacob@yale.edu			Citrus Research Board [5200-151]; Yale University Brown Fellowship	This project was supported by Grant # 5200-151 from the Citrus Research Board to V.F.I. and Y.J.F.Z. was supported in part by a Yale University Brown Fellowship. We thank Dr. Qi Xie (Chinese Academy of Sciences) for sending us plasmid constructs used in this study. We also thank members of the Irish and Jacob labs for discussions and advice during the course of this work.	Aguero J, 2014, VIROLOGY, V460, P154, DOI 10.1016/j.virol.2014.04.017; BENFEY PN, 1989, EMBO J, V8, P2195; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Li ZJ, 2001, PLANT SCI, V160, P877, DOI 10.1016/S0168-9452(01)00336-3; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Meng YY, 2017, PLANT CELL REP, V36, P371, DOI 10.1007/s00299-016-2069-9; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Wang X, 2017, NAT GENET, V49, P765, DOI 10.1038/ng.3839; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004	12	1	1	29	29	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	DEC	2017	36	12					1883	1887		10.1007/s00299-017-2202-4				5	Plant Sciences	Plant Sciences	FL8MH	WOS:000414503400004	28864834				2018-01-05	
J	Tang, YD; Liu, JT; Wang, TY; Sun, MX; Tian, ZJ; Cai, XH				Tang, Yan-Dong; Liu, Ji-Ting; Wang, Tong-Yun; Sun, Ming-Xia; Tian, Zhi-Jun; Cai, Xue-Hui			CRISPR/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication	ARCHIVES OF VIROLOGY			English	Article						CRISPR/Cas9; Pseudorabies virus; Inhibition; SgRNA	INHIBIT HIV-1 REPLICATION; GENOMIC CHARACTERIZATION; CELLS; CHINA; GENE; ENDONUCLEASE; VARIANT; ESCAPE; INFECTION; STRATEGY	Pseudorabies virus (PRV) is a swine herpesvirus that causes significant morbidity and mortality in swine populations and has caused huge economic losses in the worldwide swine industry. Currently, there is no effective antiviral drug in clinical use for PRV infection; it is also difficult to eliminate PRV from infected swine. In our study, we set out to combat these swine herpesvirus infections by exploiting the CRISPR/Cas9 system. We designed 75 single guide RNAs (sgRNA) by targeting both essential and non-essential genes across the genome of PRV. We applied a firefly luciferase-tagged reporter PRV virus for high-throughput sgRNA screening and found that most of the sgRNAs significantly inhibited PRV replication. More importantly, using a transfection assay, we demonstrated that simultaneous targeting of PRV with multiple sgRNAs completely abolished the production of infectious viruses in cells. These data suggest that CRISPR/Cas9 could be a novel therapeutic agent against PRV in the future.	[Tang, Yan-Dong; Liu, Ji-Ting; Wang, Tong-Yun; Sun, Ming-Xia; Tian, Zhi-Jun; Cai, Xue-Hui] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, 678 HaPing Rd, Harbin 150069, Heilongjiang, Peoples R China	Cai, XH (reprint author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, 678 HaPing Rd, Harbin 150069, Heilongjiang, Peoples R China.	cai139@hvri.ac.cn			National Program on Key Research Project [2016YFD0500100]	This study was supported by grants from the National Program on Key Research Project (2016YFD0500100).	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Guo JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02110; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Luo YZ, 2014, VET MICROBIOL, V174, P107, DOI 10.1016/j.vetmic.2014.09.003; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; METTENLEITER TC, 1991, COMP IMMUNOL MICROB, V14, P151, DOI 10.1016/0147-9571(91)90128-Z; Peng ZY, 2016, VIRUS RES, V223, P197, DOI 10.1016/j.virusres.2016.08.001; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Soppe JA, 2017, TRENDS MICROBIOL, V25, P833, DOI 10.1016/j.tim.2017.04.005; Tang YD, 2016, VIRUS RES, V225, P33, DOI 10.1016/j.virusres.2016.09.004; Tang YD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040090; Tong W, 2015, VET MICROBIOL, V181, P236, DOI 10.1016/j.vetmic.2015.09.021; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yu XL, 2014, EMERG INFECT DIS, V20, P102, DOI 10.3201/eid2001.130531	29	0	0	17	17	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	DEC	2017	162	12					3881	3886		10.1007/s00705-017-3553-4				6	Virology	Virology	FL7RY	WOS:000414448700032	28900740				2018-01-05	
J	Liang, C; Li, FF; Wang, LY; Zhang, ZK; Wang, C; He, B; Li, J; Chen, ZH; Shaikh, AB; Liu, J; Wu, XH; Peng, SL; Dang, L; Guo, BS; He, XJ; Au, DWT; Lu, C; Zhu, HL; Zhang, BT; Lu, AP; Zhang, G				Liang, Chao; Li, Fangfei; Wang, Luyao; Zhang, Zong-Kang; Wang, Chao; He, Bing; Li, Jie; Chen, Zhihao; Shaikh, Atik Badshah; Liu, Jin; Wu, Xiaohao; Peng, Songlin; Dang, Lei; Guo, Baosheng; He, Xiaojuan; Au, D. W. T.; Lu, Cheng; Zhu, Hailong; Zhang, Bao-Ting; Lu, Aiping; Zhang, Ge			Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma	BIOMATERIALS			English	Article						Osteosarcoma; CRISPR/Cas9; VEGFA; Aptamer; In vivo delivery	ENDOTHELIAL GROWTH-FACTOR; VON-WILLEBRAND-FACTOR; LUNG METASTASIS; GENE DELIVERY; CRISPR-CAS9 SYSTEM; NONVIRAL VECTORS; IN-VITRO; CANCER; ANGIOGENESIS; EXPRESSION	Osteosarcoma (OS) is a highly aggressive pediatric cancer, characterized by frequent lung metastasis and pathologic bone destruction. Vascular endothelial growth factor A (VEGFA), highly expressed in OS, not only contributes to angiogenesis within the tumor microenvironment via paracrine stimulation of vascular endothelial cells, but also acts as an autocrine survival factor for tumor cell themselves, thus making it a promising therapeutic target for OS. CRISPR/Cas9 is a versatile genome editing technology and holds tremendous promise for cancer treatment. However, a major bottleneck to achieve the therapeutic potential of the CRISPR/Cas9 is the lack of in vivo tumor-targeted delivery systems. Here, we screened an OS cell-specific aptamer (LC09) and developed a LC09-functionalized PEG-PEI-Cholesterol (PPC) lipopolymer encapsulating CRISPR/Cas9 plasmids encoding VEGFA gRNA and Cas9. Our results demonstrated that LCO9 facilitated selective distribution of CRISPR/Cas9 in both orthotopic OS and lung metastasis, leading to effective VEGFA genome editing in tumor, decreased VEGFA expression and secretion, inhibited orthotopic OS malignancy and lung metastasis, as well as reduced angiogenesis and bone lesion with no detectable toxicity. The delivery system simultaneously restrained autocrine and paracrine VEGFA signaling in tumor cells and could facilitate translating CRISPR-Cas9 into clinical cancer treatment. (C) 2017 Elsevier Ltd. All rights reserved.	[Liang, Chao; Li, Fangfei; Wang, Luyao; Chen, Zhihao; Shaikh, Atik Badshah; Liu, Jin; Wu, Xiaohao; Dang, Lei; Guo, Baosheng; He, Xiaojuan; Zhu, Hailong; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Law Sau Fai Inst Adv Translat Med Bone & Joint Di, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Liang, Chao; Li, Fangfei; Wang, Luyao; Wang, Chao; He, Bing; Shaikh, Atik Badshah; Liu, Jin; Wu, Xiaohao; Dang, Lei; Guo, Baosheng; Zhu, Hailong; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Inst Integrated Bioinfomed & Translat Sci, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Liang, Chao; Li, Fangfei; Wang, Luyao; Wang, Chao; He, Bing; Shaikh, Atik Badshah; Liu, Jin; Wu, Xiaohao; Dang, Lei; Guo, Baosheng; Zhu, Hailong; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Inst Precis Med & Innovat Drug Discovery, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Liang, Chao; Li, Fangfei; Wang, Luyao; He, Bing; Shaikh, Atik Badshah; Liu, Jin; Wu, Xiaohao; Dang, Lei; Guo, Baosheng; Lu, Aiping; Zhang, Ge] HKBU Inst Res & Continuing Educ, Shenzhen Lab Combinatorial Cpds & Targeted Drug D, Shenzhen, Peoples R China; [Zhang, Zong-Kang; Li, Jie; Zhang, Bao-Ting] Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Peng, Songlin] Ji Nan Univ, Coll Med 2, Shenzhen Peoples Hosp, Dept Spine Surg, Shenzhen, Peoples R China; [He, Xiaojuan; Lu, Cheng; Lu, Aiping] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Au, D. W. T.] City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China; [Lu, Aiping] Shanghai Acad Chinese Med Sci, Inst Arthrit Res, Shanghai, Peoples R China	Liang, C; Li, FF; Zhu, HL; Lu, AP; Zhang, G (reprint author), Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China.; Zhang, BT (reprint author), Chinese Univ Hong Kong, Chung Chi Coll, Li Wai Chun Bldg, Shatin, Hong Kong, Peoples R China.	liangchao@hkbu.edu.hk; fangfeili@hkbu.edu.hk; hlzhu@hkbu.edu.hk; zhangbaoting@cuhk.edu.hk; aipinglu@hkbu.edu.hk; zhangge@hkbu.edu.hk	Zhang, Baoting/B-6273-2015	ZHANG, Ge/0000-0002-7807-7695	Ministry of Science and Technology of China [2013ZX09301307]; Hong Kong General Research Fund [HKBU479111, HKBU478312, HKBU262913, HKBU12102914, HKBU261113, HKBU212111, HKBU212613, CUHK14112915, CUHK489213]; Natural Science Foundation Council of China [81272045, 81703049, 81401833, 81470072, N_HKBU435/12]; Croucher Foundation [CASI4BU/CAS14201]; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University [RC-IRMS/12-13/02, RC-IRMS/13-14/02, RC-IRMS/15-16/01]; Hong Kong Baptist University Strategic Development Fund [SDF13-1209-P01]; Hong Kong Research Grants Council Early Career Scheme [489213]; Inter-institutional Collaborative Research Scheme of Hong Kong Baptist University [RC-ICRS/14-15/01]; Faculty Research Grant of Hong Kong Baptist University [FRG1/13-14/024, FRG2/13-14/006, FRG2/14-15/010, FRG2/14-15/063]; China Academy of Chinese Medical Sciences [Z0252, Z0293]; Science and Technology Innovation Commission of Shenzhen Municipality Funds [JCYJ20170307161659648]; Research Grants Council	We thank the technical staff (Ms. Yeuk Siu Cheung and Mr. Chi Leung Chan) from Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, Hong Kong Baptist University for providing critical comments and technical support. This study was supported by the Ministry of Science and Technology of China (2013ZX09301307 to A.L.), the Hong Kong General Research Fund (HKBU479111 to G.Z., HKBU478312 to G.Z., HKBU262913 to G.Z., HKBU12102914 to G.Z., HKBU261113 to A.L. HKBU212111 to H.Z., HKBU212613 to H.Z., CUHK14112915 to B.Z. and CUHK489213 to B.Z.), the Natural Science Foundation Council of China (81272045 to G.Z., 81703049 to F.L, 81272045 to B.G., 81401833 to B.G. and 81470072 to X.H.), the Research Grants Council and Natural Science Foundation Council of China (N_HKBU435/12 to G.Z.), the Croucher Foundation (Gnt#CASI4BU/CAS14201 to G.Z.), the Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University (RC-IRMS/12-13/02 to A.L., RC-IRMS/13-14/02 to G.Z. and RC-IRMS/15-16/01 to A.L.), the Hong Kong Baptist University Strategic Development Fund (SDF13-1209-P01 to A.L.), the Hong Kong Research Grants Council Early Career Scheme (489213 to G.Z.), the Inter-institutional Collaborative Research Scheme of Hong Kong Baptist University (RC-ICRS/14-15/01 to G.Z.), the Faculty Research Grant of Hong Kong Baptist University (FRG1/13-14/024 to G.Z., FRG2/13-14/006 to G.Z., FRG2/14-15/010 to G.Z. and FRG2/14-15/063 to H.Z.), the China Academy of Chinese Medical Sciences (Z0252 and Z0293 to A.L.), Science and Technology Innovation Commission of Shenzhen Municipality Funds (JCYJ20170307161659648 to F.L).	Alvarez RD, 2014, GYNECOL ONCOL, V133, P433, DOI 10.1016/j.ygyno.2014.03.571; Anwer K, 2010, GENE THER, V17, P360, DOI 10.1038/gt.2009.159; Baaten Bas Jg, 2010, Commun Integr Biol, V3, P508, DOI 10.4161/cib.3.6.13495; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; Botter SM, 2014, CURR OPIN PHARMACOL, V16, P15, DOI 10.1016/j.coph.2014.02.002; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chen HX, 2001, ONCOLOGY-NY, V15, P1017; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daft PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121568; Di Gregoli K, 2014, ARTERIOSCL THROM VAS, V34, P1990, DOI 10.1161/ATVBAHA.114.304088; Feng NP, 2015, NEUROSCI LETT, V591, P1, DOI 10.1016/j.neulet.2015.02.002; Fewell JG, 2005, J CONTROL RELEASE, V109, P288, DOI 10.1016/j.jconrel.2005.09.024; Furgeson DY, 2002, PHARMACEUT RES, V19, P382, DOI 10.1023/A:1015166806366                                                         ; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goodwin AM, 2007, MICROVASC RES, V74, P172, DOI 10.1016/j.mvr.2007.05.006; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Jason G., 2005, J CONTROL RELEASE, V109, P288; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kundu ZS, 2014, INDIAN J ORTHOP, V48, P238, DOI 10.4103/0019-5413.132491; Lawhorn IEB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113232; Li L, 2017, ACS NANO, V11, P95, DOI 10.1021/acsnano.6b04261; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Li SH, 2009, J PATHOL, V218, P327, DOI 10.1002/path.2543; Li SD, 2008, MOL THER, V16, P163, DOI 10.1038/sj.mt.6300323; Li ZW, 2013, ONCOTARGET, V4, P2532, DOI 10.18632/oncotarget.1503                                                        ; Liang C, 2015, NAT MED, V21, P288, DOI 10.1038/nm.3791; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Merdad A, 2014, ANTICANCER RES, V34, P1355; Meyers PA, 2011, CANCER-AM CANCER SOC, V117, P1736, DOI 10.1002/cncr.25744; MIETTINEN M, 1994, MODERN PATHOL, V7, P82; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Nguyen M, 1997, INVEST NEW DRUG, V15, P29, DOI 10.1023/A:1005766511385; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Niu G, 2010, CURR DRUG TARGETS, V11, P1000, DOI 10.2174/138945010791591395                                                      ; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rockey WM, 2011, NUCLEIC ACID THER, V21, P299, DOI 10.1089/nat.2011.0313; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; Saha Debabrata, 2013, South Asian J Cancer, V2, P56, DOI 10.4103/2278-330X.110483; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9                   ; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi R, 2015, ONCOL LETT, V10, P1848, DOI 10.3892/ol.2015.3444; Song WH, 2015, NAT PROTOC, V10, P1459, DOI 10.1038/nprot.2015.097; Staddon AP, 2002, ONCOLOGIST, V7, P144, DOI 10.1634/theoncologist.7-2-144; Tahergorabi Z, 2012, IRAN J BASIC MED SCI, V15, P1110; Tanaka T, 2013, CLIN EXP METASTAS, V30, P369, DOI 10.1007/s10585-012-9543-8; Turner DC, 2014, CLIN CANCER RES, V20, P2783, DOI 10.1158/1078-0432.CCR-13-2364; Uluckan O, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.37; Wang DA, 2002, BIOMACROMOLECULES, V3, P1197, DOI 10.1021/bm025563c; Wang J, 2011, NANOMEDICINE-UK, V6, P1605, DOI [10.2217/NNM.11.141, 10.2217/nnm.11.141]; Weiss KR, 2006, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01.blo.0000229333.98781.56; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang Y, 2011, CURR MED CHEM, V18, P4185, DOI 10.2174/092986711797189547                                                      ; Zhang Y, 2012, MOL CANCER RES, V10, P516, DOI 10.1158/1541-7786.MCR-11-0473; Zhao J, 2015, INT J CLIN EXP MED, V8, P12411; Zhou JH, 2011, OLIGONUCLEOTIDES, V21, P1, DOI 10.1089/oli.2010.0264	78	0	0	78	78	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	DEC	2017	147						68	85		10.1016/j.biomaterials.2017.09.015				18	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FK6JJ	WOS:000413609700006	28938163				2018-01-05	
J	Wakai, S; Arazoe, T; Ogino, C; Kondo, A				Wakai, Satoshi; Arazoe, Takayoshi; Ogino, Chiaki; Kondo, Akihiko			Future insights in fungal metabolic engineering	BIORESOURCE TECHNOLOGY			English	Review						Filamentous fungi; Metabolic engineering; Genome editing; Bioproduction	MORTIERELLA-ALPINA 1S-4; LACTIC ACID PRODUCTION; ASPERGILLUS-ORYZAE; FILAMENTOUS FUNGI; CULTURE-CONDITIONS; ARACHIDONIC-ACID; GENE-CLUSTER; HETEROLOGOUS PROTEINS; BIODIESEL PRODUCTION; ENHANCED PRODUCTION	Filamentous fungi exhibit versatile abilities, including organic acid fermentation, protein production, and secondary metabolism, amongst others, and thus have applications in the medical and food industries. Previous genomic analyses of several filamentous fungi revealed their further potential as host microorganisms for bioproduction. Recent advancements in molecular genetics, marker recycling, and genome editing could be used to alter transformation and metabolism, based on optimized design carbolated with computer science. In this review, we detail the current applications of filamentous fungi and describe modern molecular genetic tools that could be used to expand the role of these microorganisms in bioproduction. The present review shed light on the possibility of filamentous fungi as host microorganisms in the field of bioproduction in the future. (C) 2017 Elsevier Ltd. All rights reserved.	[Wakai, Satoshi; Arazoe, Takayoshi; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Ogino, Chiaki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015		Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This work was supported by the Special Coordination Funds for Promoting Science and Technology, the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	AIDOO KE, 1981, EUR J APPL MICROBIOL, V12, P6, DOI 10.1007/BF00508111                                                              ; Alberti F, 2017, APPL MICROBIOL BIOT, V101, P493, DOI 10.1007/s00253-016-8034-2; Araki M, 2015, BIOINFORMATICS, V31, P905, DOI 10.1093/bioinformatics/btu750; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P1335, DOI 10.1002/bit.25559; Bourdichon F, 2012, INT J FOOD MICROBIOL, V154, P87, DOI 10.1016/j.ijfoodmicro.2011.12.030; Brown SH, 2013, APPL MICROBIOL BIOT, V97, P8903, DOI 10.1007/s00253-013-5132-2; CARREZ D, 1990, GENE, V94, P147, DOI 10.1016/0378-1119(90)90381-Z; Certik M, 1997, LETT APPL MICROBIOL, V25, P101, DOI 10.1046/j.1472-765X.1997.00173.x; Cheng KK, 2012, BIOFUEL BIOPROD BIOR, V6, P302, DOI 10.1002/bbb.1327; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Conesa A, 2000, APPL ENVIRON MICROB, V66, P3016, DOI 10.1128/AEM.66.7.3016-3023.2000; Conesa A, 2001, FUNGAL GENET BIOL, V33, P155, DOI [10.1006/fgbi.2001.1276, 10.1006/fgbe.2001.1276]; de Vries RP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1151-0; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Delmas S, 2014, APPL ENVIRON MICROB, V80, P3484, DOI 10.1128/AEM.00625-14; Dufosse L, 2014, CURR OPIN BIOTECH, V26, P56, DOI 10.1016/j.copbio.2013.09.007; DURAND H, 1988, ENZYME MICROB TECH, V10, P341, DOI 10.1016/0141-0229(88)90012-9; Eiteman MA, 2015, BIOTECHNOL LETT, V37, P955, DOI 10.1007/s10529-015-1769-5; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; Fernandez FJ, 2013, CURR OPIN STRUC BIOL, V23, P365, DOI 10.1016/j.sbi.2013.02.002; Fu YQ, 2016, BIORESOURCE TECHNOL, V218, P410, DOI 10.1016/j.biortech.2016.06.127; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gandolfi S, 2015, BIORESOURCE TECHNOL, V191, P59, DOI 10.1016/j.biortech.2015.04.118; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1, DOI 10.1007/s002530050880                                                           ; Hama S, 2008, APPL MICROBIOL BIOT, V79, P1009, DOI 10.1007/s00253-008-1502-6; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Hao GF, 2016, APPL ENVIRON MICROB, V82, P3280, DOI 10.1128/AEM.00572-16; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; JAREONKITMONGKOL S, 1992, J GEN MICROBIOL, V138, P997, DOI 10.1099/00221287-138-5-997                                                      ; Jin FJ, 2007, APPL MICROBIOL BIOT, V76, P1059, DOI 10.1007/s00253-007-1088-4; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Krappmann S., 2016, MED MYCOL; Kuenz A, 2012, APPL MICROBIOL BIOT, V96, P1209, DOI 10.1007/s00253-012-4221-y; Kuivanen J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0613-5; Kuivanen J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-014-0184-2; Kurian JV, 2005, J POLYM ENVIRON, V13, P159, DOI 10.1007/s10924-005-2947-7; Lee SS, 2013, J MICROBIOL BIOTECHN, V23, P959, DOI 10.4014/jmb.1303.03026; Li Q, 2008, APPL MICROBIOL BIOT, V80, P749, DOI 10.1007/s00253-008-1625-9; Liaud N, 2014, FUNGAL BIOL BIOTECHN, V1, P1, DOI DOI 10.1186/S40694-014-0001-Z; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Maruyama JI, 2008, BIOTECHNOL LETT, V30, P1811, DOI 10.1007/s10529-008-9763-9; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Meyer Vera, 2016, Fungal Biol Biotechnol, V3, P6, DOI 10.1186/s40694-016-0024-8; Meyer V, 2011, APPL ENVIRON MICROB, V77, P2975, DOI 10.1128/AEM.02740-10; Miyazawa K, 2016, BIOSCI BIOTECH BIOCH, V80, P1853, DOI 10.1080/09168451.2016.1209968; Mizutani O, 2017, J BIOSCI BIOENG, V123, P287, DOI 10.1016/j.jbiosc.2016.09.014; Mizutani O, 2012, APPL ENVIRON MICROB, V78, P4126, DOI 10.1128/AEM.00080-12; Mogensen JM, 2009, INT J FOOD MICROBIOL, V132, P141, DOI 10.1016/j.ijfoodmicro.2009.04.011; Nevalainen KMH, 2005, TRENDS BIOTECHNOL, V23, P468, DOI 10.1016/j.tibtech.2005.06.002; Nielsen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169712; Nielsen MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072871; Nishida K, 2016, SCIENCE, V353, P8729; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Okabe M, 2009, APPL MICROBIOL BIOT, V84, P597, DOI 10.1007/s00253-009-2132-3; Okazaki F, 2012, APPL MICROBIOL BIOT, V96, P81, DOI 10.1007/s00253-012-4158-1; Papanikolaou S, 2004, BIORESOURCE TECHNOL, V95, P287, DOI 10.1016/j.biortech.2004.02.016; Plassard Claude, 2009, Fungal Biology Reviews, V23, P30, DOI 10.1016/j.fbr.2009.08.002; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Qin H., 2017, PROCESS BIOCH; Robert T, 2016, GREEN CHEM, V18, P2922, DOI 10.1039/c6gc00605a; Roche CM, 2014, BIOTECHNOL BIOENG, V111, P1097, DOI 10.1002/bit.25211; Ruan ZH, 2012, BIORESOURCE TECHNOL, V110, P198, DOI 10.1016/j.biortech.2012.01.053; Ruijter GJG, 1999, MICROBIOL-UK, V145, P2569, DOI 10.1099/00221287-145-9-2569                                                     ; Sakai K, 2008, J BIOSCI BIOENG, V106, P466, DOI 10.1263/jbb.106.466; Sakai K, 2012, APPL MICROBIOL BIOT, V93, P2011, DOI 10.1007/s00253-011-3657-9; Sakuradani E, 2002, APPL MICROBIOL BIOT, V60, P281, DOI 10.1007/s00253-002-1128-z; Sakuradani E, 2013, J BIOSCI BIOENG, V116, P417, DOI 10.1016/j.jbiosc.2013.04.008; Savitha J., 2016, GENOME ANNOUNC, V4, P9; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; SHIMIZU S, 1988, BIOCHEM BIOPH RES CO, V150, P335, DOI 10.1016/0006-291X(88)90525-6; SHINMEN Y, 1989, APPL MICROBIOL BIOT, V31, P11, DOI 10.1007/BF00252518                                                              ; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Stewart P, 1996, APPL ENVIRON MICROB, V62, P860; Takeno S, 2005, APPL ENVIRON MICROB, V71, P5124, DOI 10.1128/AEM.71.9.5124-5128.2005; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vendruscolo F, 2016, APPL BIOCHEM BIOTECH, V178, P211, DOI 10.1007/s12010-015-1880-z; Wakai S, 2014, BIORESOURCE TECHNOL, V173, P376, DOI 10.1016/j.biortech.2014.09.094; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Weyda I, 2017, J MICROBIOL METH, V135, P26, DOI 10.1016/j.mimet.2017.01.015; Yadwad VB, 1996, MYCOL RES, V100, P356, DOI 10.1016/S0953-7562(96)80169-9                                                   ; Yamada R, 2015, BIOSCI BIOTECH BIOCH, V79, P1034, DOI 10.1080/09168451.2015.1006568; Yamada R, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-71; Yang L, 2016, APPL MICROBIOL BIOT, V100, P1799, DOI 10.1007/s00253-015-7086-z; Yoon J, 2011, APPL MICROBIOL BIOT, V89, P747, DOI 10.1007/s00253-010-2937-0; Yoon J, 2010, APPL ENVIRON MICROB, V76, P5718, DOI 10.1128/AEM.03087-09; Yoon J, 2009, APPL MICROBIOL BIOT, V82, P691, DOI 10.1007/s00253-008-1815-5; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang GX, 2014, PLASMID, V71, P16, DOI 10.1016/j.plasmid.2014.01.001; Zhang SC, 2016, J BIOSCI BIOENG, V122, P482, DOI 10.1016/j.jbiosc.2016.03.014	99	0	0	35	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	DEC	2017	245		B		SI		1314	1326		10.1016/j.biortech.2017.04.095				13	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	FJ8SG	WOS:000413038300003	28483354				2018-01-05	
J	Sarkari, P; Marx, H; Blumhoff, ML; Mattanovich, D; Sauer, M; Steiger, MG				Sarkari, Parveen; Marx, Hans; Blumhoff, Marzena L. .; Mattanovich, Diethard; Sauer, Michael; Steiger, Matthias G.			An efficient tool for metabolic pathway construction and gene integration for Aspergillus niger	BIORESOURCE TECHNOLOGY			English	Article						AMA1; GoldenMOCS; Aconitic acid; Modular cloning; CRISPR/Cas9	AUTONOMOUSLY REPLICATING PLASMID; NIDULANS; TRANSFORMATION; CLONING	Metabolic engineering requires functional genetic tools for easy and quick generation of multiple pathway variants. A genetic engineering toolbox for A. niger is presented, which facilitates the generation of strains carrying heterologous expression cassettes at a defined genetic locus. The system is compatible with Golden Gate cloning, which facilitates the DNA construction process and provides high design flexibility. The integration process is mediated by a CRISPR/Cas9 strategy involving the cutting of both the genetic integration locus (pyrG) as well as the integrating plasmid. Only a transient expression of Cas9 is necessary and the carrying plasmid is readily lost using a size-reduced AMA1 variant. A high integration efficiency into the fungal genome of up to 100% can be achieved, thus reducing the screening process significantly. The feasibility of the approach was demonstrated by the integration of an expression cassette enabling the production of aconitic acid in A. niger. (C) 2017 Elsevier Ltd. All rights reserved.	[Sarkari, Parveen; Mattanovich, Diethard; Sauer, Michael; Steiger, Matthias G.] ACIB GmbH, Muthgasse 18, A-1190 Vienna, Austria; [Sarkari, Parveen; Marx, Hans; Blumhoff, Marzena L. .; Mattanovich, Diethard; Sauer, Michael; Steiger, Matthias G.] Univ Nat Resources & Life Sci, Vienna BOKU, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria; [Blumhoff, Marzena L. .] Univ Appl Sci FH Campus Wien, Sch Bioengn, Vienna, Austria; [Blumhoff, Marzena L. .] Boehringer Ingelheim RCV GmbH & Co KG, Dr Boehringer Gasse 5-11, A-1121 Vienna, Austria	Sauer, M (reprint author), Univ Nat Resources & Life Sci, Vienna BOKU, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.	michael.sauer@boku.ac.at		Steiger, Matthias/0000-0002-8985-2343; Marx, Hans/0000-0002-0451-1719; Sauer, Michael/0000-0003-0510-2447; Mattanovich, Diethard/0000-0002-0907-4167	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET	We thank Ursula Kiesswetter, Christine Sanystra and Stefanie Wiesauer for excellent technical assistance in the lab. This work was supported by the Federal Ministry of Science, Research and Economy (BMWFW), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol, the Government of Lower Austria and Business Agency Vienna through the COMET Funding Program managed by the Austrian Research Promotion Agency FFG.	Aleksenko A, 1997, FUNGAL GENET BIOL, V21, P373, DOI 10.1006/fgbi.1997.0980                                                          ; Arentshorst Mark, 2015, Fungal Biol Biotechnol, V2, P2, DOI 10.1186/s40694-015-0012-4; Arentshorst M, 2012, METHODS MOL BIOL, V835, P133, DOI 10.1007/978-1-61779-501-5_9; Blumhoff M, 2013, APPL MICROBIOL BIOT, V97, P259, DOI 10.1007/s00253-012-4207-9; CAO J, 2016, NUCL ACIDS RES, V44; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J                                                    ; GEMS DH, 1993, CURR GENET, V24, P520, DOI 10.1007/BF00351716                                                              ; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Krappmann S., 2016, MED MYCOL; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; Meyer V, 2011, APPL ENVIRON MICROB, V77, P2975, DOI 10.1128/AEM.02740-10; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Osherov N, 2000, FUNGAL GENET BIOL, V31, P181, DOI 10.1006/fgbi.2000.1236; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Sambrook J, 2001, MOL CLONING LAB MANU; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; Steiger MG, 2016, METAB ENG, V35, P95, DOI 10.1016/j.ymben.2016.02.003; VERDOES JC, 1994, GENE, V146, P159, DOI 10.1016/0378-1119(94)90288-7; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Woolston BM, 2013, ANNU REV CHEM BIOMOL, V4, P259, DOI 10.1146/annurev-chembioeng-061312-103312	27	2	2	34	34	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	DEC	2017	245		B		SI		1327	1333		10.1016/j.biortech.2017.05.004				7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	FJ8SG	WOS:000413038300004	28533066				2018-01-05	
J	Kao, PH; Ng, IS				Kao, Pei-Hsun; Ng, I-Son			CRISPRi mediated phosphoenolpyruvate carboxylase regulation to enhance the production of lipid in Chlamydomonas reinhardtii	BIORESOURCE TECHNOLOGY			English	Article						CRISPR/dCas9; Microalgae; Chlamydomonas reinhardtii; Lipid; Gene regulation	EXPRESSION; BIOSYNTHESIS; MICROALGAE; INTERFERENCE; PERSPECTIVES; KNOCKOUT; GROWTH; GENES	In this study, CRISPRi (clustered regularly interspaced short palindromic repeats interference) was used for the first time to regulate expression of exogenously supplied rfp gene as a proof-of-concept, and endogenous PEPC1 gene as a proof-of-function in Chlamydomonas reinhardtii. The efficiency of 94% and stability of 7 generations via CRISPRi mediated gene regulation in C. reinhardtii have been demonstrated by RFP. Gene PEPC1 encoding proteins are essential for controlling the carbon flux that enters the TCA cycle and plays a crucial role in carbon partitioning of substrates in competition with lipid synthesis. All CrPEPC1 down-regulated strains have lower chlorophyll color, but higher biomass concentration and lipid accumulation rate. The present results revealed that CRISPRi based transcriptional silencing was applicable in C. reinhardtii and expanded the way to improve the yield, titer and productivity of microalgae-based products. (C) 2017 Elsevier Ltd. All rights reserved.	[Kao, Pei-Hsun; Ng, I-Son] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan; [Ng, I-Son] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 70101, Taiwan	Ng, IS (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.	yswu@mail.ncku.edu.tw			Ministry of Science and Technology [MOST 105-2221-E-006-225-MY3, MOST 105-2621-M-006-012-MY3, MOST 104-2621-M-006-008, MOST-105-2218-E-006-021]	The authors are grateful to the financial support for this study provided by the Ministry of Science and Technology (MOST 105-2221-E-006-225-MY3 and MOST 105-2621-M-006-012-MY3, MOST 104-2621-M-006-008, MOST-105-2218-E-006-021). The authors also express their gratitude to Prof. Jo-Shu Chang and Dr. Dillirani Nagarajan in National Cheng Kung University, Prof. Tse-Min Lee in National Sun Yat-sen University to give many supports in this study.	Ahmad I, 2015, PLANT BIOTECHNOL J, V13, P540, DOI 10.1111/pbi.12278; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Chen CY, 2011, BIORESOURCE TECHNOL, V102, P71, DOI 10.1016/j.biortech.2010.06.159; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chew KW, 2017, BIORESOURCE TECHNOL, V229, P53, DOI 10.1016/j.biortech.2017.01.006; Deng XD, 2014, BIOTECHNOL LETT, V36, P2199, DOI 10.1007/s10529-014-1593-3; Deng XD, 2011, BIOMASS BIOENERG, V35, P1811, DOI 10.1016/j.biombioe.2011.01.005; Elhadi D, 2016, METAB ENG, V38, P358, DOI 10.1016/j.ymben.2016.09.001; Ettema TJG, 2004, J BACTERIOL, V186, P7754, DOI 10.1128/JB.186.22.7754-7762.2004; Fan JH, 2014, BIORESOURCE TECHNOL, V164, P214, DOI 10.1016/j.biortech.2014.04.087; Gordon GC, 2016, METAB ENG, V38, P170, DOI 10.1016/j.ymben.2016.07.007; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363                                                ; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Ho SH, 2014, BIOTECHNOL ADV, V32, P1448, DOI 10.1016/j.biotechadv.2014.09.002; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0595-3; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228                                                          ; LEPAGE G, 1986, J LIPID RES, V27, P114; Li SY, 2016, METAB ENG, V38, P274, DOI [10.1016.j.ymben.2016.09.003, 10.1016/j.ymben.2016.09.003]; Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013; Mussgnug JH, 2015, APPL MICROBIOL BIOT, V99, P5407, DOI 10.1007/s00253-015-6698-7; Nymark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24951; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Pathirana MS, 1997, PLANT J, V12, P293, DOI 10.1046/j.1365-313X.1997.12020293.x; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Song CW, 2015, BIOTECHNOL J, V10, P56, DOI 10.1002/biot.201400057; Wang QT, 2016, PLANT J, V88, P1071, DOI 10.1111/tpj.13307; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; XU ZP, 2016, SCI REP UK, V6; Yao L, 2016, ACS SYNTH BIOL, V5, P207, DOI 10.1021/acssynbio.5b00264	35	2	2	25	25	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	DEC	2017	245		B		SI		1527	1537		10.1016/j.biortech.2017.04.111				11	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	FJ8SG	WOS:000413038300029	28501380				2018-01-05	
J	Lee, JH; Wendisch, VF				Lee, Jin-Ho; Wendisch, Volker F.			Production of amino acids - Genetic and metabolic engineering approaches	BIORESOURCE TECHNOLOGY			English	Article						Amino acids; Transcriptional regulator; Regulon; Functional tools; Systems metabolic engineering	DEPENDENT TRANSCRIPTIONAL REGULATION; THROUGHPUT SCREENING METHOD; ALTERNATIVE CARBON-SOURCES; L-ISOLEUCINE PRODUCTION; ESCHERICHIA-COLI-CELLS; L-ARGININE PRODUCTION; T7 RNA-POLYMERASE; CORYNEBACTERIUM-GLUTAMICUM; REDUCED-GENOME; L-LYSINE	The biotechnological production of amino acids occurs at the million-ton scale and annually about 6 million tons of L-glutamate and L-lysine are produced by Escherichia coli and Corynebacterium glutamicum strains. L-glutamate and L-lysine production from starch hydrolysates and molasses is very efficient and access to alternative carbon sources and new products has been enabled by metabolic engineering. This review focusses on genetic and metabolic engineering of amino acid producing strains. In particular, rational approaches involving modulation of transcriptional regulators, regulons, and attenuators will be discussed. To address current limitations of metabolic engineering, this article gives insights on recent systems metabolic engineering approaches based on functional tools and method such as genome reduction, amino acid sensors based on transcriptional regulators and riboswitches, CRISPR interference, small regulatory RNAs, DNA scaffolding, and optogenetic control, and discusses future prospects. (C) 2017 Elsevier Ltd. All rights reserved.	[Lee, Jin-Ho] Kyungsung Univ, Sch Food Biotechnol & Nutr, Major Food Sci & Biotechnol, 309 Suyeong Ro, Busan 48434, South Korea; [Wendisch, Volker F.] Bielefeld Univ, Genet Prokaryotes, Fac Biol, Bielefeld, Germany; [Wendisch, Volker F.] Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany	Wendisch, VF (reprint author), Bielefeld Univ, Genet Prokaryotes, Fac Biol, Bielefeld, Germany.; Wendisch, VF (reprint author), Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany.	volker.wendisch@uni-bielefeld.de		Wendisch, Volker F./0000-0003-3473-0012	Basic Science Research Program through the National Research Foundation of Korea [NRF-2015R1D1A1A01057250]	VF Wendisch wishes to thank all current and former group members for their excellent contributions. VFW gratefully acknowledges the collaboration with many academic and industrial researchers on metabolic engineering of amino acid producing strains. JH Lee acknowledges supported by Basic Science Research Program through the National Research Foundation of Korea (NRF-2015R1D1A1A01057250).	Akeno Y, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-49; Baumgart M, 2013, APPL ENVIRON MICROB, V79, P6006, DOI 10.1128/AEM.01634-13; Bellmann A, 2001, MICROBIOL-SGM, V147, P1765, DOI 10.1099/00221287-147-7-1765                                                     ; Binder D, 2016, CHEMBIOCHEM, V17, P296, DOI 10.1002/cbic.201500609; Binder D, 2014, INTEGR BIOL-UK, V6, P755, DOI 10.1039/c4ib00027g; Binder S, 2013, NUCLEIC ACIDS RES, V41, P6360, DOI 10.1093/nar/gkt312; Brune I, 2007, J BACTERIOL, V189, P2720, DOI 10.1128/JB.01876-06; Buckle-Vallant V, 2014, APPL MICROBIOL BIOT, V98, P297, DOI 10.1007/s00253-013-5310-2; BYERLY KA, 1990, J BACTERIOL, V172, P2839, DOI 10.1128/jb.172.6.2839-2843.1990                                                 ; Caldara M, 2006, MICROBIOL-SGM, V152, P3343, DOI 10.1099/mic.0.29088-0; Chavez-Bejar MI, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-108; Chou CJ, 2010, CHEMBIOCHEM, V11, P972, DOI 10.1002/cbic.201000041; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Eberhardt D, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0085-0; Feher T, 2007, CHEM REV, V107, P3498, DOI 10.1021/cr0683111; Frank S, 2013, J BIOTECHNOL, V163, P273, DOI 10.1016/j.jbiotec.2012.09.002; Ginesy M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0211-y; Gu PF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-30; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Heider SAE, 2014, APPL MICROBIOL BIOT, V98, P1223, DOI 10.1007/s00253-013-5359-y; Henke N.A., 2016, MAR DRUGS, V14; Henke NA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00633; Hinzpeter F, 2017, BIOPHYS J, V112, P767, DOI 10.1016/j.bpj.2016.11.3194; Hirasawa T, 2016, CURR OPIN BIOTECH, V42, P133, DOI 10.1016/j.copbio.2016.04.017; Holatko J, 2009, J BIOTECHNOL, V139, P203, DOI 10.1016/j.jbiotec.2008.12.005; Huang JF, 2017, BIOTECHNOL BIOENG, V114, P843, DOI 10.1002/bit.26198; Ikeda M, 2006, APPL MICROBIOL BIOT, V69, P615, DOI 10.1007/s00253-005-0252-y; Iwadate Y, 2011, FEMS MICROBIOL LETT, V322, P25, DOI 10.1111/j.1574-6968.2011.02331.x; Jensen JVK, 2015, J BIOTECHNOL, V214, P85, DOI 10.1016/j.jbiotec.2015.09.017; Karcagi I, 2016, MOL BIOL EVOL, V33, P1257, DOI 10.1093/molbev/msw009; Kortmann M, 2015, MICROB BIOTECHNOL, V8, P253, DOI 10.1111/1751-7915.12236; Kubota T, 2014, MOL MICROBIOL, V92, P356, DOI 10.1111/mmi.12560; Kusen PM, 2016, ACS CHEM BIOL, V11, P2915, DOI 10.1021/acschembio.6b00462; Lai SJ, 2012, SCI CHINA LIFE SCI, V55, P283, DOI 10.1007/s11427-012-4304-0; Laishram RS, 2007, GENE DEV, V21, P1258, DOI 10.1101/gad.1520507; LaMonte BL, 2006, MICROBIOL-SGM, V152, P1451, DOI 10.1099/mic.0.28489-0; Lange C, 2012, J BIOTECHNOL, V158, P231, DOI 10.1016/j.jbiotec.2011.06.003; Lee JH, 2013, APPL ENVIRON MICROB, V79, P774, DOI 10.1128/AEM.02578-12; Lee JH, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-2; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Lee MJ, 2016, METAB ENG, V36, P48, DOI 10.1016/j.ymben.2016.02.007; Lee SY, 2011, APPL ENVIRON MICROB, V77, P711, DOI 10.1128/AEM.01610-10; Liu YN, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0311-8; LORENZ E, 1995, J BACTERIOL, V177, P4113, DOI 10.1128/jb.177.14.4113-4120.1995                                                ; Lubitz D, 2016, APPL MICROBIOL BIOT, V100, P8465, DOI 10.1007/s00253-016-7695-1; Mahr R, 2016, APPL MICROBIOL BIOT, V100, P6739, DOI 10.1007/s00253-016-7575-8; Majerfeld I, 2005, NUCLEIC ACIDS RES, V33, P5482, DOI 10.1093/nar/gki861; Makarova K.S., 2001, GENOME BIOL, V2; Man ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28629; Marbaniang CN, 2012, J BACTERIOL, V194, P5657, DOI 10.1128/JB.00947-12; Martinez-Garcia E, 2016, CURR OPIN BIOTECH, V42, P216, DOI 10.1016/j.copbio.2016.09.001; Marx A, 2003, J BIOTECHNOL, V104, P185, DOI 10.1016/S0168-1656(03)00153-6; MAXON ME, 1989, P NATL ACAD SCI USA, V86, P85, DOI 10.1073/pnas.86.1.85                                                            ; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Morbach S, 2000, J BIOSCI BIOENG, V90, P501, DOI 10.1016/S1389-1723(01)80030-X; Mustafi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085731; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Neshat A, 2014, J BIOTECHNOL, V190, P55, DOI 10.1016/j.jbiotec.2014.05.033; Netzer R, 2004, ARCH MICROBIOL, V182, P354, DOI 10.1007/s00203-004-0710-4; Ostrov N, 2016, SCIENCE, V353, P819, DOI 10.1126/science.aaf3639; Park JH, 2008, CURR OPIN BIOTECH, V19, P454, DOI 10.1016/j.copbio.2008.08.007; Park JH, 2012, ACS SYNTH BIOL, V1, P532, DOI 10.1021/sb300071a; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Peeters E, 2009, MOL MICROBIOL, V74, P1513, DOI 10.1111/j.1365-2958.2009.06950.x; Perez-Garcia F, 2016, APPL MICROBIOL BIOT, V100, P8075, DOI 10.1007/s00253-016-7682-6; Perez-Garcia F., 2017, BIOTECHNOL J; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Qin TY, 2015, BIOTECHNOL APPL BIOC, V62, P563, DOI 10.1002/bab.1290; Rey DA, 2005, MOL MICROBIOL, V56, P871, DOI 10.1111/j.1365-2958.2005.04586.x; Riedel C, 2001, J MOL MICROB BIOTECH, V3, P573; Schendzielorz G, 2014, ACS SYNTH BIOL, V3, P21, DOI 10.1021/sb400059y; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; Schweitzer JE, 2009, J BIOTECHNOL, V139, P214, DOI 10.1016/j.jbiotec.2008.12.008; Sharma SS, 2007, METAB ENG, V9, P133, DOI 10.1016/j.ymben.2006.10.002; Suzuki N, 2005, APPL MICROBIOL BIOT, V69, P151, DOI 10.1007/s00253-005-1976-4; Taniguchi Hironori, 2017, Metabolic Engineering Communications, V4, P1, DOI 10.1016/j.meteno.2017.01.001; Teramoto H, 2009, APPL ENVIRON MICROB, V75, P3461, DOI 10.1128/AEM.00163-09; Tripet BP, 2011, BIOCHEMISTRY-US, V50, P5140, DOI 10.1021/bi200389k; Unthan S, 2015, BIOTECHNOL J, V10, P290, DOI 10.1002/biot.201400041; Vogt M, 2014, METAB ENG, V22, P40, DOI 10.1016/j.ymben.2013.12.001; Vrljic M, 1996, MOL MICROBIOL, V22, P815, DOI 10.1046/j.1365-2958.1996.01527.x; Wang Y, 2016, J IND MICROBIOL BIOT, V43, P1227, DOI 10.1007/s10295-016-1803-1; Wang YS, 2010, MOL BIOSYST, V6, P1575, DOI 10.1039/c002155e; WEISSBACH H, 1991, MOL MICROBIOL, V5, P1593, DOI 10.1111/j.1365-2958.1991.tb01905.x; Wendisch VF, 2016, J BIOTECHNOL, V234, P139, DOI 10.1016/j.jbiotec.2016.07.022; Wendisch VF, 2014, CURR OPIN BIOTECH, V30, P51, DOI 10.1016/j.copbio.2014.05.004; Xu MJ, 2013, CURR MICROBIOL, V67, P271, DOI 10.1007/s00284-013-0358-x; Xue XL, 2015, ACS SYNTH BIOL, V4, P700, DOI 10.1021/sb500324p; Yang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2404; Yin L, 2013, J APPL MICROBIOL, V114, P1369, DOI 10.1111/jam.12141; Zhang B, 2016, BIOTECHNOL LETT, V38, P2153, DOI 10.1007/s10529-016-2207-z; Zhao ZJ, 2011, J IND MICROBIOL BIOT, V38, P1921, DOI 10.1007/s10295-011-0978-8; Zhou LB, 2015, ACS SYNTH BIOL, V4, P1335, DOI 10.1021/acssynbio.5b00075; Zhou LB, 2015, ACS SYNTH BIOL, V4, P729, DOI 10.1021/sb500332c	96	3	3	33	33	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	DEC	2017	245		B		SI		1575	1587		10.1016/j.biortech.2017.05.065				13	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	FJ8SG	WOS:000413038300035	28552565				2018-01-05	
J	Chung, CY; Wang, Q; Yang, S; Ponce, SA; Kirsch, BJ; Zhang, H; Betenbaugh, MJ				Chung, Cheng-Yu; Wang, Qiong; Yang, Shuang; Ponce, Sean A.; Kirsch, Brian J.; Zhang, Hui; Betenbaugh, Michael J.			Combinatorial genome and protein engineering yields monoclonal antibodies with hypergalactosylation from CHO cells	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						antibody engineering; Chinese hamster ovary cells; CRISPR; Cas 9 genome editing; glycoengineering	DEPENDENT CELLULAR CYTOTOXICITY; N-GLYCAN; EFFECTOR FUNCTIONS; OLIGOSACCHARIDE; CARBOHYDRATE; COMPLEMENT; GALACTOSE; THERAPY; BINDING; CANCER	One of the key quality attributes of monoclonal antibodies is the glycan pattern and distribution. Two terminal galactose residues typically represent a small fraction of the total glycans from antibodies. However, antibodies with defined glycosylation properties including enhanced galactosylation have been shown to exhibit altered properties for these important biomedical modalities. In this study, the disruption of two -2,3 sialyltransferases (ST3GAL4 and ST3GAL6) from Chinese Hamster Ovary (CHO) cells was combined with protein engineering of the Fc region to generate an IgG containing 80% bigalactosylated and fucosylated (G2F) glycoforms. Expression of the same single amino acid mutant (F241A) IgG in CHO cells with a triple gene knockout of fucosyltransferase (FUT8) plus ST3GAL4 and ST3GAL6 lowered the galactosylation glycoprofile to 65% bigalactosylated G2 glycans. However, overexpression of IgGs with four amino acid substitutions recovered the G2 glycoform composition approximately 80%. Combining genome and protein engineering in CHO cells will provide a new antibody production platform that enables biotechnologists to generate glycoforms standards for specific biomedical and biotechnology applications.	[Chung, Cheng-Yu; Wang, Qiong; Ponce, Sean A.; Kirsch, Brian J.; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Yang, Shuang; Zhang, Hui] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Betenbaugh, MJ (reprint author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	beten@jhu.edu			National Science Foundation [1264802, 1512265]	National Science Foundation, Grant numbers: 1264802, 1512265	Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2                                                    ; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chung CY, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600502; Dodev TS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05885; Geisler C, 2015, J BIOTECHNOL, V193, P52, DOI 10.1016/j.jbiotec.2014.11.013; Giddens JP, 2015, METHODS MOL BIOL, V1321, P375, DOI 10.1007/978-1-4939-2760-9_25; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Imai-Nishiya H, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-84; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Lund J, 1996, J IMMUNOL, V157, P4963; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Quast I, 2015, J CLIN INVEST, V125, P4160, DOI 10.1172/JCI82695; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Strome SE, 2007, ONCOLOGIST, V12, P1084, DOI 10.1634/theoncologist.12-9-1084; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yang Shuang, 2014, Curr Protoc Chem Biol, V6, P191, DOI 10.1002/9780470559277.ch140085; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375	27	0	0	15	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	DEC	2017	114	12					2848	2856		10.1002/bit.26375				9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FK7DN	WOS:000413664900015	28926673				2018-01-05	
J	Schwartz, C; Frogue, K; Ramesh, A; Misa, J; Wheeldon, I				Schwartz, Cory; Frogue, Keith; Ramesh, Adithya; Misa, Joshua; Wheeldon, Ian			CRISPRi repression of nonhomologous end-joining for enhanced genome engineering via homologous recombination in Yarrowia lipolytica	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						CRISPR interference; DNA repair; gene repression; genome engineering; non-conventional yeast; transcriptional regulation	DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; FISSION YEAST; DNA BREAK; GENE; REPAIR; PATHWAY; EFFICIENCY; MECHANISM	In many organisms of biotechnological importance precise genome editing is limited by inherently low homologous recombination (HR) efficiencies. A number of strategies exist to increase the effectiveness of this native DNA repair pathway; however, most strategies rely on permanently disabling competing repair pathways, thus reducing an organism's capacity to repair naturally occurring double strand breaks. Here, we describe a CRISPR interference (CRISPRi) system for gene repression in the oleochemical-producing yeast Yarrowia lipolytica. By using a multiplexed sgRNA targeting strategy, we demonstrate efficient repression of eight out of nine targeted genes to enhance HR. Strains with nonhomologous end-joining repressed were shown to have increased rates of HR when transformed with a linear DNA fragment with homology to a genomic locus. With multiplexed targeting of KU70 and KU80, and enhanced repression with Mxi1 fused to deactivated Cas9 (dCas9), rates of HR as high as 90% were achieved. The developed CRISPRi system enables enhanced HR in Y. lipolytica without permanent genetic knockouts and promises to be a potent tool for other metabolic engineering, synthetic biology, and functional genomics studies.	[Schwartz, Cory; Frogue, Keith; Ramesh, Adithya; Misa, Joshua; Wheeldon, Ian] Univ Calif Riverside, Chem & Environm Engn, Riverside, CA 92521 USA	Wheeldon, I (reprint author), Univ Calif Riverside, Chem & Environm Engn, Riverside, CA 92521 USA.	iwheeldon@engr.ucr.edu			Division of Chemical, Bioengineering, Environmental, and Transport Systems [NSF CBET-1403264]	Division of Chemical, Bioengineering, Environmental, and Transport Systems, Grant number: NSF CBET-1403264	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Deaner M, 2017, METAB ENG, V40, P14, DOI 10.1016/j.ymben.2017.01.012; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Duina AA, 2014, GENETICS, V197, P33, DOI 10.1534/genetics.114.163188; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gao SL, 2016, J IND MICROBIOL BIOT, V43, P1085, DOI 10.1007/s10295-016-1789-8; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Harper J.V., 2005, CELL CYCLE CONTROL M, V296, P157; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabran P, 2012, DNA RES, V19, P231, DOI 10.1093/dnares/dss007; Kegel A, 2006, NUCLEIC ACIDS RES, V34, P1633, DOI 10.1093/nar/gkl064; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Li P, 2012, DNA REPAIR, V11, P120, DOI 10.1016/j.dnarep.2011.10.011; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lobs A., 2017, BIOTECHNOL BIOFUELS, V10; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; Mages GJ, 1996, J BIOL CHEM, V271, P7910, DOI 10.1074/jbc.271.14.7910                                                         ; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mathiasen DP, 2014, FEMS MICROBIOL REV, V38, P172, DOI 10.1111/1574-6976.12066; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Qiao KJ, 2017, NAT BIOTECHNOL, V35, P173, DOI 10.1038/nbt.3763; Radzisheuskaya Aliaksandra, 2016, Nucleic Acids Res, V44, pe141; Rakicka M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0286-z; Rodriguez GM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0562-6; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Schwartz C, 2017, ACS SYNTH BIOL, V6, P402, DOI 10.1021/acssynbio.6b00285; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Singh Atul K, 2016, Nucleic Acids Res, V44, pe143; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155                                             ; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsakraklides V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133434; Untergasser A., 2012, NUCLEIC ACIDS RES, V40, P115, DOI DOI 10.1093/NAR/GKS596; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veis J, 2007, MOL CELL BIOL, V27, P8364, DOI 10.1128/MCB.01253-07; Verbeke J, 2013, BIOTECHNOL LETT, V35, P571, DOI 10.1007/s10529-012-1107-0; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365                                                                   ; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007	62	1	1	19	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	DEC	2017	114	12					2896	2906		10.1002/bit.26404				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FK7DN	WOS:000413664900019	28832943				2018-01-05	
J	Lopez-Guerrero, AM; Pascual-Caro, C; Martin-Romero, FJ; Pozo-Guisado, E				Lopez-Guerrero, Aida M.; Pascual-Caro, Carlos; Javier Martin-Romero, Francisco; Pozo-Guisado, Eulalia			Store-operated calcium entry is dispensable for the activation of ERK1/2 pathway in prostate cancer cells	CELLULAR SIGNALLING			English	Article						Calcium; CRISPR; ERK1/2; SOCE; Src; STIM1	CHANNEL FUNCTION; CA2+ SENSOR; KINASE; STIM1; PHOSPHORYLATION; GROWTH; PROGRESSION; RAF; INACTIVATION; RAF/MEK/ERK	STIM1, the endoplasmic reticulum Ca2+ sensor that modulates the activity of plasma membrane Ca2+ channels, becomes phosphorylated at ERK1/2 target sites during Ca2+ store depletion triggered by thapsigargin or epidermal growth factor (EGF). This ERK1/2-dependent phosphorylation regulates STIM1 localization and dissociation from microtubules, and it is known that enhances the binding to ORAI1, a store-operated Ca2+ entry (SOCE) channel, leading to the activation of this Ca2+ influx pathway. However, there remained some evidence of a role for SOCE in the activation of ERK1/2, and here we assessed the contribution of SOCE to ERK1/2 activation by generating a STIM1-deficient cell line by CRISPR/Cas9 genome editing of the STIM1 locus in prostate cancer PC3 cells. The genomic modification consisted of a 16 base -pair insertion in exon 5 of both alleles, therefore abrogating STIM1 synthesis. STIM1-KO cells did show a striking decrease in Ca2+ influx in response to thapsigargin or EGF, a result that demonstrates that SOCE mediates Ca2+ entry in PC3 cells during stimulation with EGF. Moreover, identical levels of total ERK1/2 were found in STIM1-KO cells and the parental cell line, and ERK1/2 activation was fully activated in KO cells, both in the presence and in the absence of extracellular Ca2+, a result that supports that STIM1 and SOCE are not required for ERK1/2 activation. This activation was sensitive to Src kinase inhibition, but not to CAMKII nor PKC inhibition, a result that sets STIM1 and SOCE as downstream targets of the axis Src-Raf-MEK-ERK, rather than upstream regulators.	[Lopez-Guerrero, Aida M.; Pascual-Caro, Carlos; Javier Martin-Romero, Francisco] Univ Extremadura, Dept Biochem & Mol Biol, Sch Life Sci, Badajoz 06006, Spain; [Lopez-Guerrero, Aida M.; Pascual-Caro, Carlos; Javier Martin-Romero, Francisco; Pozo-Guisado, Eulalia] Univ Extremadura, Inst Mol Pathol & Biomarkers, Badajoz 06006, Spain; [Pozo-Guisado, Eulalia] Univ Extremadura, Sch Med, Dept Cell Biol, Badajoz 06006, Spain	Martin-Romero, FJ (reprint author), Univ Extremadura, Dept Biochem & Mol Biol, Sch Life Sci, Badajoz 06006, Spain.; Martin-Romero, FJ; Pozo-Guisado, E (reprint author), Univ Extremadura, Inst Mol Pathol & Biomarkers, Badajoz 06006, Spain.; Pozo-Guisado, E (reprint author), Univ Extremadura, Sch Med, Dept Cell Biol, Badajoz 06006, Spain.	ailogue@unex.es; carlospc@unex.es; fjmartin@unex.es; epozo@unex.es		PASCUAL-CARO, CARLOS/0000-0002-2345-393X; Martin-Romero, Francisco Javier/0000-0001-6796-7396	Spanish Ministerio de Economia y Competitividad; European Social Fund [BFU2014-52401-P]; Spanish Ministerio de Economia y Competitividad [BES-2012-052061]; Ministerio de Educacion, Cultura y Deporte [FPU13/03430]	FJM-R thanks the Spanish Ministerio de Economia y Competitividad and European Social Fund (grant BFU2014-52401-P) for support. AML-G and CP-C were supported by predoctoral fellowships from the Spanish Ministerio de Economia y Competitividad (BES-2012-052061), and Ministerio de Educacion, Cultura y Deporte (FPU13/03430), respectively.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828                                                        ; Casas-Rua V, 2015, BBA-MOL CELL RES, V1853, P233, DOI 10.1016/j.bbamcr.2014.10.027; Casas-Rua V, 2013, BIOCHEM PHARMACOL, V86, P1555, DOI 10.1016/j.bcp.2013.09.018; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313                                                               ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; El Sheikh SS, 2004, NEOPLASIA, V6, P846, DOI 10.1593/neo.04379; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Ginnan R, 2004, AM J PHYSIOL-CELL PH, V286, pC1281, DOI 10.1152/ajpcell.00202.2003; Gomez-Fernandez C, 2009, REPRODUCTION, V138, P211, DOI 10.1530/REP-09-0126; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopez-Guerrero AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00331-4; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-17312; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Pozo-Guisado Eulalia, 2013, Commun Integr Biol, V6, pe26283, DOI 10.4161/cib.26283; Pozo-Guisado E, 2013, J CELL SCI, V126, P3170, DOI 10.1242/jcs.125054; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robertson BW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-260; Rojas-Fernandez A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09811; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1093/jcb.200502019; Rosado JA, 2001, J BIOL CHEM, V276, P15659, DOI 10.1074/jbc.M009218200; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Sherwood ER, 1998, BRIT J CANCER, V77, P855, DOI 10.1038/bjc.1998.142; Soltoff SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072881; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Tomas-Martin P, 2015, CELL SIGNAL, V27, P545, DOI 10.1016/j.cellsig.2014.12.017; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512                                                        ; Umemura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089292; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200                                                          ; Xu JM, 2016, ONCOL REP, V35, P3496, DOI 10.3892/or.2016.4704; Xu WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048867; Yamada KM, 2001, J CELL SCI, V114, P2375; Yang IH, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-41; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhong WX, 2016, NEUROPHARMACOLOGY, V103, P195, DOI 10.1016/j.neuropharm.2015.11.023	49	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	DEC	2017	40						44	52		10.1016/j.cellsig.2017.08.010				9	Cell Biology	Cell Biology	FM0AJ	WOS:000414620900005	28866365	gold			2018-01-05	
J	Lee, HJ; Lee, KY; Jung, KM; Park, KJ; Lee, KO; Suh, JY; Yao, YX; Nair, V; Han, JY				Lee, Hong Jo; Lee, Kyung Youn; Jung, Kyung Min; Park, Kyung Je; Lee, Ko On; Suh, Jeong-Yong; Yao, Yongxiu; Nair, Venugopal; Han, Jae Yong			Precise gene editing of chicken Na plus /H plus exchange type 1 (chNHE1) confers resistance to avian leukosis virus subgroup J (ALV-J)	DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY			English	Article						ALV subgroup J; Chicken Na plus /H+ exchange 1; Precise gene editing; CRISPR/Cas9	ONE-STEP GENERATION; RECEPTOR GENE; DECREASED SUSCEPTIBILITY; INTRONIC DELETIONS; NA+/H+ EXCHANGER; SARCOMA-VIRUSES; IN-VITRO; INFECTION; PROTEIN; TVA	Avian leukosis virus subgroup J (ALV-J), first isolated in the late 1980s, has caused economic losses to the poultry industry in many countries. As all chicken lines studied to date are susceptible to ALV infection, there is enormous interest in developing resistant chicken lines. The ALV-J receptor, chicken Na+/H+ exchange 1 (chNHE1) and the critical amino acid sequences involved in viral attachment and entry have already been characterized. However, there are no reported attempts to induce resistance to the virus by targeted genome modification of the receptor sequences. In an attempt to induce resistance to ALV-J infection, we used clustered regularly interspaced short palindromic repeats (CRISPR)-associated (CRISPR/Cas9)-based genome editing approaches to modify critical residues of the chNHE1 receptor in chicken cells. The susceptibility of the modified cell lines to ALV-J infection was examined using enhanced green fluorescent protein (EGFP)-expressing marker viruses. We showed that modifying the chNHE1 receptor by artificially generating a premature stop codon induced absolute resistance to viral infection, with mutations of the tryptophan residue at position 38 (Trp38) being very critical. Single stranded oligodeoxynucleotide (ssODN)-mediated targeted recombination of the Trp38 region revealed that deletions involving the Trp38 residue were most effective in conferring resistance to ALV-J. Moreover, protein structure analysis of the chNHE1 receptor sequence suggested that its intrinsically disordered region undergoes local conformational changes through genetic alteration. Collectively, these results demonstrate that targeted mutations on chNHE1 alter the susceptibility to ALV-J and the technique is expected to contribute to develop disease-resistant chicken lines. (C) 2017 Elsevier Ltd. All rights reserved.	[Lee, Hong Jo; Lee, Kyung Youn; Jung, Kyung Min; Park, Kyung Je; Lee, Ko On; Suh, Jeong-Yong; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea; [Suh, Jeong-Yong; Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Nagano, Japan; [Yao, Yongxiu; Nair, Venugopal] Pirbright Inst, Woking GU24 0NF, Surrey, England	Han, JY (reprint author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea.; Han, JY (reprint author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.	cszjjang@naver.com; leelctmn@naver.com; jkm89@snu.ac.kr; kjpark@snu.ac.kr; koonlee@snu.ac.kr; jysuh@snu.ac.kr; yongxiu.yao@pirbright.ac.uk; venugopal.nair@pirbright.ac.uk; jaehan@snu.ac.kr	Nair, Venugopal/D-4447-2016; Institute, Pirbright/K-4476-2014	Nair, Venugopal/0000-0002-8255-516X; 	National Research Foundation of Korea grant - Korea government (MSIP) [2015R1A3A2033826]; Royal Society International Professorships [IC160046]; United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) Partnership award [BB/M027481/1]	This work was supported by a National Research Foundation of Korea grant funded by the Korea government (MSIP) (No. 2015R1A3A2033826). Authors also acknowledge the funding support from the Royal Society International Professorships (No. IC160046) and the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) Partnership award (BB/M027481/1).	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Abu-Bonsrah KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34524; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chai N, 2006, P NATL ACAD SCI USA, V103, P5531, DOI 10.1073/pnas.0509785103; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen WG, 2015, SCI REP-UK, V5, DOI 10.1038/srep09900; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; Elleder D, 2004, J VIROL, V78, P13489, DOI 10.1128/JVI.13489-13500.2004; Feng M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00624; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091                                                          ; Klucking S, 2002, J VIROL, V76, P7918, DOI 10.1128/JVI.76.15.7918-7921.2002; Knauss DJ, 2002, J VIROL, V76, P5404, DOI 10.1128/JVI.76.11.5404-5410.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kucerova D, 2013, J VIROL, V87, P8399, DOI 10.1128/JVI.03180-12; Malhotra S, 1996, J VIROL, V70, P321; Munguia A, 2008, J VIROL, V82, P11419, DOI 10.1128/JVI.01408-08; Pan W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-552; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reinisova M, 2008, J VIROL, V82, P2097, DOI 10.1128/JVI.02206-07; Reinisova M, 2012, J VIROL, V86, P2021, DOI 10.1128/JVI.05771-11; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Rong LJ, 1998, J VIROL, V72, P4552; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Uversky VN, 2016, J BIOL CHEM, V291, P6681, DOI 10.1074/jbc.R115.685859; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169768; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431	38	1	1	13	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0145-305X	1879-0089		DEV COMP IMMUNOL	Dev. Comp. Immunol.	DEC	2017	77						340	349		10.1016/j.dci.2017.09.006				10	Fisheries; Immunology; Zoology	Fisheries; Immunology; Zoology	FK3LR	WOS:000413387100036	28899753				2018-01-05	
J	Morange, M				Morange, Michel			Human germline editing: a historical perspective	HISTORY AND PHILOSOPHY OF THE LIFE SCIENCES			English	Article						CRISPR-Cas9; Eugenics; Genome editing; Germline modification; Somatic gene therapy	ZINC-FINGER NUCLEASES; SITE-SPECIFIC ENDONUCLEASE; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MUSCULAR-DYSTROPHY; IMMUNE-SYSTEM; GENE-THERAPY; CRISPR-CAS; DNA; CELLS	The development of the genome editing system called CRISPR-Cas9 has opened a huge debate on the possibility of modifying the human germline. But the types of changes that could and/or ought to be made have not been discussed. To cast some light on this debate, I will describe the story of the CRISPR-Cas9 system. Then, I will briefly review the projects for modification of the human species that were discussed by biologists throughout the twentieth century. Lastly, I will show that for plenty of reasons, both scientific and societal, germline modification is no longer a priority for our societies.	[Morange, Michel] Ecole Normale Super, Ctr Cavailles, Republ Savoirs, 29 Rue Ulm, F-75230 Paris 05, France	Morange, M (reprint author), Ecole Normale Super, Ctr Cavailles, Republ Savoirs, 29 Rue Ulm, F-75230 Paris 05, France.	morange@biologie.ens.fr					Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; DAVIS BD, 1970, SCIENCE, V170, P1279, DOI 10.1126/science.170.3964.1279                                                   ; Delisle R., 2009, PHILOSOPHIES NEODARW; HOTCHKISS RD, 1965, J HERED, V56, P197, DOI 10.1093/oxfordjournals.jhered.a107414                                           ; Huxley A., 1932, BRAVE NEW WORLD; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Knight J, 2001, NATURE, V413, P12, DOI 10.1038/35092627                                                                ; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Monod J., 1971, CHANCE NECESSITY ESS; Morange M, 2016, J BIOSCIENCES, V41, P9, DOI 10.1007/s12038-016-9597-x; Morange M, 2015, J BIOSCIENCES, V40, P829, DOI 10.1007/s12038-015-9575-8; Morange M, 2015, J BIOSCIENCES, V40, P221, DOI 10.1007/s12038-015-9532-6; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Stock G., 2002, REDESIGNING HUMANS; Tang YP, 1999, NATURE, V401, P63; Tasan I, 2016, HUM GENET, V135, P1011, DOI 10.1007/s00439-016-1688-0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wadman M, 1998, NATURE, V392, P317, DOI 10.1038/32721                                                                   	29	0	0	26	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0391-9714	1742-6316		HIST PHIL LIFE SCI	Hist. Philos. Life Sci.	DEC	2017	39	4							34	10.1007/s40656-017-0161-2				10	History & Philosophy Of Science	History & Philosophy of Science	FK7RL	WOS:000413704800007	29038945				2018-01-05	
J	Do, CT; Douzal-Chouakria, A; Marie, S; Rombaut, M; Varasteh, S				Do, Cao-Tri; Douzal-Chouakria, Ahlame; Marie, Sylvain; Rombaut, Michele; Varasteh, Saeed			Multi-modal and multi-scale temporal metric learning for a robust time series nearest neighbors classification	INFORMATION SCIENCES			English	Article						Metric learning; Time series; Classification; kNN; Svm; Dissimilarity space; Multi-modal metric; Multi-scale metric	GENE-EXPRESSION DATA; EDIT DISTANCE; SIMILARITY MEASURE; RECOGNITION; KERNEL; TRANSFORMATION; MACHINE	The definition of a metric between time series is inherent to several data analysis and mining tasks, including clustering, classification or forecasting. Time series data present naturally several modalities covering their amplitude, behavior or frequential spectrum, that may be expressed with varying delays and at multiple temporal scales exhibited globally or locally. Combining several modalities at multiple temporal scales to learn a holistic metric is a key challenge for many real temporal data applications. This paper proposes a Multi-modal and Multi-scale Temporal Metric Learning ((MTML)-T-2) approach for a robust time series nearest neighbors classification. The solution lies in embedding time series into a dissimilarity space where a pairwise SVM is used to learn both linear and non linear combined metric. A sparse and interpretable variant of the solution shows the ability of the learned temporal metric to localize accurately discriminative modalities as well as their temporal scales. A wide range of 30 public and challenging datasets, encompassing images, traces and ECG data, are used to show the efficiency and the potential of (MTML)-T-2 for an effective time series nearest neighbors classification. (C) 2017 Elsevier Inc. All rights reserved.	[Do, Cao-Tri; Douzal-Chouakria, Ahlame; Varasteh, Saeed] Univ Grenoble Alpes, Grenoble INP, CNRS, LIG, F-38000 Grenoble, France; [Do, Cao-Tri; Rombaut, Michele] Univ Grenoble Alpes, GIPSA Lab, Grenoble, France; [Do, Cao-Tri; Marie, Sylvain] Schneider Elect, Eybens, France	Douzal-Chouakria, A (reprint author), Univ Grenoble Alpes, Grenoble INP, CNRS, LIG, F-38000 Grenoble, France.	Ahlame.Douzal@imag.fr		MARIE, Sylvain/0000-0002-5929-1047			Abraham Z., 2010, P SIAM INT C DAT MIN, P653; Bagnall A, 2015, IEEE T KNOWL DATA EN, V27, P2522, DOI 10.1109/TKDE.2015.2416723; Balasubramaniyan R, 2005, BIOINFORMATICS, V21, P1069, DOI 10.1093/bioinformatics/bti095; Batista GEAPA, 2014, DATA MIN KNOWL DISC, V28, P634, DOI 10.1007/s10618-013-0312-3; Bellet A., 2015, SYNTH LECT ARTIF INT, V9, P1; Bellet A, 2016, NEUROCOMPUTING, V214, P155, DOI 10.1016/j.neucom.2016.06.006; Bellet A, 2012, MACH LEARN, V89, P5, DOI 10.1007/s10994-012-5293-8; Berndt DJ, 1994, P KDD WORKSH SEATTL, P359; Bille P, 2005, THEOR COMPUT SCI, V337, P217, DOI 10.1016/j.tcs.2004.12.030; Caiado J, 2006, COMPUT STAT DATA AN, V50, P2668, DOI 10.1016/j.csda.2005.04.012; Chen Y., 2015, UCR TIME SERIES CLAS; Chouakria AD, 2007, ADV DATA ANAL CLASSI, V1, P5, DOI 10.1007/s11634-006-0004-6; Chouakria-Douzal A, 2003, LECT NOTES COMPUT SC, V2810, P566, DOI 10.1007/978-3-540-45231-7_52; Cuturi M., 2011, ICML, P929; D'Urso P, 2009, FUZZY SET SYST, V160, P3565, DOI 10.1016/j.fss.2009.04.013; Davis J. V., 2007, P 24 INT C MACH LEAR, P209, DOI DOI 10.1145/1273496.127352; Do C., 2015, P 23 EUR SIGN PROC C, P2391; Do CT, 2015, EUR SIGNAL PR CONF, P2346, DOI 10.1109/EUSIPCO.2015.7362804; Do C.-T., 2015, P INT WORKSH ADV AN, P131; Douzal-Chouakria A, 2012, PATTERN RECOGN, V45, P1076, DOI 10.1016/j.patcog.2011.08.018; Douzal-Chouakria A, 2010, PATTERN RECOGN LETT, V31, P1608, DOI 10.1016/j.patrec.2010.05.008; Douzal-Chouakria A., 2015, P AALTD 2015, P39; Duin RPW, 2012, PATTERN RECOGN LETT, V33, P826, DOI 10.1016/j.patrec.2011.04.019; Frambourg C, 2013, LECT NOTES COMPUT SC, V8207, P198, DOI 10.1007/978-3-642-41398-8_18; Gao XB, 2010, PATTERN ANAL APPL, V13, P113, DOI 10.1007/s10044-008-0141-y; Lajugie R., 2014, P ADV NEUR INF PROC, P1817; Gartner T., 2003, SIGKDD EXPLORATIONS, V5, P49, DOI DOI 10.1145/959242.959248; HAASDONK B, 2004, JOINT PATT REC S, V3175, P220; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Jeong YS, 2011, PATTERN RECOGN, V44, P2231, DOI 10.1016/j.patcog.2010.09.022; Kakizawa Y, 1998, J AM STAT ASSOC, V93, P328, DOI 10.2307/2669629; Keogh E.J., 2001, SDM, V1, P5, DOI DOI 10.1137/1.9781611972719.1; KRUSKAL WH, 1958, J AM STAT ASSOC, V53, P814, DOI 10.2307/2281954; Kruskall J., 1983, SYMMETRIC TIME WARPI; Kulis B., 2012, FDN TRENDS MACH LEAR, V5, P287, DOI DOI 10.1561/2200000019; Lhermitte S, 2011, REMOTE SENS ENVIRON, V115, P3129, DOI 10.1016/j.rse.2011.06.020; Marteau PF, 2009, IEEE T PATTERN ANAL, V31, P306, DOI 10.1109/TPAMI.2008.76; Montero P, 2014, J STAT SOFTW, V62, P1; Nicolae M.-I., 2016, ARXIV161004783; Oncina J, 2006, PATTERN RECOGN, V39, P1575, DOI 10.1016/j.patcog.2006.03.011; Pekalska E, 2002, J MACH LEARN RES, V2, P175, DOI 10.1162/15324430260185592; Diaz SP, 2010, J CLASSIF, V27, P333, DOI 10.1007/s00357-010-9064-6; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rydell J, 2008, INT CONF ACOUST SPEE, P453, DOI 10.1109/ICASSP.2008.4517644; Sahidullah M, 2012, SPEECH COMMUN, V54, P543, DOI 10.1016/j.specom.2011.11.004; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055                                                      ; Salvador S., 2004, P KDD WORKSH MIN TEM; Shimodaira H, 2002, ADV NEUR IN, V14, P921; Son YS, 2008, PATTERN RECOGN LETT, V29, P232, DOI 10.1016/j.patrec.2007.09.015; Stefan A, 2013, IEEE T KNOWL DATA EN, V25, P1425, DOI 10.1109/TKDE.2012.88; Wang Z., 2016, ARXIV161106455; Weinberger K.Q., 2005, P ADV NEUR INF PROC, P1473; Yu DR, 2011, INFORM SCIENCES, V181, P2787, DOI 10.1016/j.ins.2011.03.001; Zhang H., 2006, INFORMATICA, V30; Zhu J, 2004, ADV NEUR IN, V16, P49	55	0	0	15	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0020-0255	1872-6291		INFORM SCIENCES	Inf. Sci.	DEC	2017	418						272	285		10.1016/j.ins.2017.08.020				14	Computer Science, Information Systems	Computer Science	FI8LE	WOS:000412253300018					2018-01-05	
J	Burmistrz, M; Martinez, JIR; Krochmal, D; Staniec, D; Pyrc, K				Burmistrz, Michal; Martinez, Jose Ignacio Rodriguez; Krochmal, Daniel; Staniec, Dominika; Pyrc, Krzysztof			Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System	JOURNAL OF BACTERIOLOGY			English	Article						CRISPR; CRISPR-Cas; Porphyromonas gingivalis; biogenesis; crRNA	PROCESSES PRE-CRRNA; ANTIVIRAL DEFENSE; ASPIRATION PNEUMONIA; ESCHERICHIA-COLI; IMMUNE-SYSTEM; DNA; CASCADE; COMPLEX; PROKARYOTES; PERIODONTITIS	The CRISPR-Cas (clustered regularly interspaced short palindromic repeat-CRISPR- associated protein) system is unique to prokaryotes and provides the majority of bacteria and archaea with immunity against nucleic acids of foreign origin. CRISPR RNAs (crRNAs) are the key element of this system, since they are responsible for its selectivity and effectiveness. Typical crRNAs consist of a spacer sequence flanked with 5 ' and 3 ' handles originating from repeat sequences that are important for recognition of these small RNAs by the Cas machinery. In this investigation, we studied the type I-C CRISPR-Cas system in Porphyromonas gingivalis, a human pathogen associated with periodontitis, rheumatoid arthritis, cardiovascular disease, and aspiration pneumonia. We demonstrated the importance of the 5 ' handle for crRNA recognition by the effector complex and consequently activity, as well as secondary trimming of the 3 '= handle, which was not affected by modifications of the repeat sequence. IMPORTANCE Porphyromonas gingivalis, a clinically relevant Gram-negative, anaerobic bacterium, is one of the major etiologic agents of periodontitis and has been linked with the development of other clinical conditions, including rheumatoid arthritis, cardiovascular disease, and aspiration pneumonia. The presented results on the biogenesis and functions of crRNAs expand our understanding of CRISPR-Cas cellular defenses in P. gingivalis and of horizontal gene transfer in bacteria.	[Burmistrz, Michal; Martinez, Jose Ignacio Rodriguez; Krochmal, Daniel; Staniec, Dominika; Pyrc, Krzysztof] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Microbiol Dept, Krakow, Poland; [Burmistrz, Michal; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland	Pyrc, K (reprint author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Microbiol Dept, Krakow, Poland.; Pyrc, K (reprint author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.	k.a.pyrc@uj.edu.pl		Pyrc, Krzysztof/0000-0002-3867-7688	National Science Center, Poland [2011/01/D/NZ6/00269]; European Union (Molecular Biotechnology for Health) [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education	This work was supported by a grant from the National Science Center, Poland (2011/01/D/NZ6/00269), to K.P. The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a beneficiary of structural funds from the European Union (grant no. POIG.02.01.00-12-064/08, Molecular Biotechnology for Health). The Faculty of Biochemistry, Biophysics and Biotechnology is a partner of the Leading National Research Center (KNOW), supported by the Ministry of Science and Higher Education.	Belanger M, 2007, CURR PROTOC MICROBIO; Benedyk M, 2016, J INNATE IMMUN, V8, P185, DOI 10.1159/000441724; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burmistrz M, 2015, J BACTERIOL, V197, P2631, DOI 10.1128/JB.00261-15; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cobb CM, 2009, PERIODONTOL 2000, V50, P13, DOI 10.1111/j.1600-0757.2008.00284.x; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Friedewald VE, 2009, AM J CARDIOL, V104, P59, DOI 10.1016/j.amjcard.2009.05.002; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Koo Y, 2013, J MOL BIOL, V425, P3799, DOI 10.1016/j.jmb.2013.02.032; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Phillips P, 2014, FEMS MICROBIOL LETT, V351, P202, DOI 10.1111/1574-6968.12320; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x                                              ; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Watanabe T, 2013, GENOME BIOL EVOL, V5, P1099, DOI 10.1093/gbe/evt075; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	0	0	10	10	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	DEC	2017	199	23							UNSP e00275-17	10.1128/JB.00275-17				12	Microbiology	Microbiology	FL1VM	WOS:000414002500002					2018-01-05	
J	Zhang, H; McCarty, N				Zhang, Han; McCarty, Nami			CRISPR Editing in Biological and Biomedical Investigation	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						CRISPR-Cas9; DISEASE MODELS; GENOME EDITING; GENE CORRECTION; CRISPRi; CRISPRa; IMAGING	DUCHENNE MUSCULAR-DYSTROPHY; INHIBIT HIV-1 REPLICATION; RNA-GUIDED ENDONUCLEASE; PLURIPOTENT STEM-CELLS; IN-VIVO; GENE-EXPRESSION; HUMAN GENOME; MOUSE MODEL; TRANSCRIPTIONAL ACTIVATION; HOMOLOGOUS RECOMBINATION	The revolutionary technology for genome editing known as the clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein 9 (Cas9) system has sparked advancements in biological and biomedical research. The scientific breakthrough of the development of CRISPR-Cas9 technology has allowed us to recapitulate human diseases by generating animal models of interest ranging from zebrafish to non-human primates. The CRISPR-Cas9 system can also be used to delineate the mechanisms underlying the development of human disorders and to precisely correct disease-causing mutations. Repurposing this technology enables wider applications in transcriptome and epigenome manipulation and holds promise to reach the clinic. In this review, we highlight the latest advances of the CRISPR-Cas9 system in different platforms and discuss the hurdles and challenges this technology is facing. J. Cell. Biochem. 118: 4152-4162, 2017. (c) 2017 Wiley Periodicals, Inc.	[Zhang, Han; McCarty, Nami] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Ctr Stem Cell & Regenerat Dis, Houston, TX 77030 USA	McCarty, N (reprint author), Univ Texas Hlth Sci Ctr Houston, 1825 Pressler St,IMM 630H, Houston, TX 77030 USA.	nami.mccarty@uth.tmc.edu			NIH/NCI [R01CA181319, R21CA202212]	Grant sponsor: NIH/NCI; Grant numbers: R01CA181319, R21CA202212.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Akiyama T, 2015, NATURE, V527, P375, DOI 10.1038/nature15730; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Bibikova M, 2002, GENETICS, V161, P1169; Bluteau D, 2016, J CLIN INVEST, V126, P3580, DOI 10.1172/JCI88010; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BURGESS DJ, 2016, NAT REV GENET, V17; Chan LN, 2017, NATURE, V542, P479, DOI 10.1038/nature21076; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Ferry QRV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14633; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ghodsizadeh O, 2014, NAT METHODS, V11, P1090, DOI 10.1038/nmeth.3164                                                              ; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Go DE, 2016, CURR MOL MED, V16, P343, DOI 10.2174/1566524016666160316150847; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Guo JY, 2017, PROTEIN CELL, V8, P379, DOI 10.1007/s13238-016-0360-8; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Han K, 2017, NAT BIOTECHNOL; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heckl D, 2015, MOL CELL, V58, P560, DOI 10.1016/j.molcel.2015.05.016; Heman-Ackah SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28420; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Housden BE, 2017, NAT REV GENET, V18, P24, DOI 10.1038/nrg.2016.118; Hu Lingli, 2016, Front Immunol, V7, P696, DOI 10.3389/fimmu.2016.00696; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim K, 2017, GENOME RES, V27, P419, DOI 10.1101/gr.219089.116; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; KOCH L, 2016, NAT REV GENET, V17; Koch L, 2015, NAT REV GENET, V16, P70, DOI 10.1038/nrg3898; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Koirala P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14422; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long LJ, 2015, CELL RES, V25, P638, DOI 10.1038/cr.2015.35; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Olson S, 2016, INT SUMMIT HUMAN GEN; Osborn MJ, 2016, STEM CELLS DEV, V25, P1591, DOI 10.1089/scd.2016.0149; Park CY, 2016, NAT PROTOC, V11, P2154, DOI 10.1038/nprot.2016.129; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep42458; Park S, 2017, STEM CELL REP, V8, P1076, DOI 10.1016/j.stemcr.2016.12.017; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Redel BK, 2016, TOXICOL PATHOL, V44, P428, DOI 10.1177/0192623315613160; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; RUDIN N, 1989, GENETICS, V122, P519; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen F, 2016, MOL CANCER RES, V14, P518, DOI 10.1158/1541-7786.MCR-16-0013; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tagde A, 2016, BLOOD, V127, P2587, DOI 10.1182/blood-2015-07-659151; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; VandenDriessche T, 2016, MOL THER, V24, P414, DOI 10.1038/mt.2016.29; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yao L, 2016, ACS SYNTH BIOL, V5, P207, DOI 10.1021/acssynbio.5b00264; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2017, AUTOPHAGY, V13, P627, DOI 10.1080/15548627.2016.1271516; Zhang H, 2016, CANCER RES, V76, P6410, DOI 10.1158/0008-5472.CAN-16-0595; Zhang H, 2016, BRIT J HAEMATOL, V175, P208, DOI 10.1111/bjh.14297; Zhang H, 2016, ONCOTARGET, V7, P14350, DOI 10.18632/oncotarget.7320; Zhou YX, 2017, CELL RES, V27, P298, DOI 10.1038/cr.2017.9; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zou QJ, 2015, J MOL CELL BIOL, V7, P580, DOI 10.1093/jmcb/mjv061	127	1	1	56	56	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	DEC	2017	118	12					4152	4162		10.1002/jcb.26111				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK4QP	WOS:000413481300004	28467679				2018-01-05	
J	Su, HF; Lin, JF; Tan, FR				Su, HaiFeng; Lin, JiaFu; Tan, FuRong			Progress and perspective of biosynthetic platform for higher-order biofuels	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Metabolic engineering; Biosynthetic platform; Higher-order biofuels; Crispr-Cas9	BETA-OXIDATION CYCLE; COMPLETE GENOME SEQUENCE; BRANCHED-CHAIN ALCOHOLS; GAMMA-LINOLENIC ACID; PSEUDOMONAS-DACUNHAE CELLS; ALPHA-OLEFIN BIOSYNTHESIS; BACILLUS-COAGULANS STRAIN; DELBRUECKII MUTANT UC-3; L-ALANINE PRODUCTION; OPEN RACEWAY POND	The exploitation of innate microbial capacities and/or the importation of novel diverse biosynthetic pathways have become one of the predominant research directions, with both being used to convert fermentable substrates into higher-order biofuels with long carbon chains ( > 6) approximating those of gasoline with rating octane value. However, one of the primary issues has been which microorganic biosynthetic platform is most appropriate for transformation into an efficient cell factory for the production of higher-order biofuels. It is indistinct whether such a microorganism would ultimately be engineered using a native, newly isolated strain, a recombinant strain, or a model organism as the starting host. Different biosynthetic platforms microorganisms naturally have different genetic backgrounds, thus presenting different levels of complexity for metabolic networks, the incorporation of different physiological characteristics, cell structural properties, and/or biological activities. These complexities affect strategic formulations of synthetic biology, optimization designs of systems metabolic engineering, selection of metabolic pathways, and operation process difficulties in the realm of evolutionary engineering at the systems level. Here, we offer a global review of existing research for selected, engineered microorganisms designed to produce higher-order biofuels. Our focus on these microorganisms centers on the optimal production of higher-order biofuels using the construction of novel metabolic pathways and/or the alteration of existing pathways as well as examples of their application in recent years. We also discuss potential candidate microorganic biosynthetic platform and offer insight into the circumstances under which each should be used. Finally, we highlight the perspective that developing microorganisms has great possibility, but has not been extensively explored as a viable platform. In this paper, the review is placed in contrast with Crispr-Cas9 genome editing technology that will play an increasingly important role, which can be used to overcome the complex genetic metabolic background of microorganisms at more advanced levels.	[Su, HaiFeng] Chinese Acad Sci, Chongqing Inst Green & Interligent Technol, 266,Fangzheng Ave,Shuitu High Tech Pk, Chongqing 400714, Peoples R China; [Tan, FuRong] Minist Agr, Biogas Inst, Chengdu 610041, Sichuan, Peoples R China; [Lin, JiaFu] Chengdu Univ, Antibiot Res & Reevaluat Key Lab Sichuan Prov, Sichuan Ind Inst Antibiot, Chengdu, Sichuan, Peoples R China	Su, HF (reprint author), Chinese Acad Sci, Chongqing Inst Green & Interligent Technol, 266,Fangzheng Ave,Shuitu High Tech Pk, Chongqing 400714, Peoples R China.; Tan, FR (reprint author), Minist Agr, Biogas Inst, Chengdu 610041, Sichuan, Peoples R China.	suhaifeng@cigit.ac.cn; furong987@126.com			earmarked fund for National Natural Science Foundation of China [21502186]; Science and Technology Project of Chongqing City Land, Resources and Housing Administration Bureau [CQGT-KJ-2015022]; Applied Basic Research Programs of Sichuan province [2014JY0065]	This work was supported by the earmarked fund for National Natural Science Foundation of China (Grant Nos. 21502186), Science and Technology Project of Chongqing City Land, Resources and Housing Administration Bureau (CQGT-KJ-2015022), and the Applied Basic Research Programs of Sichuan province (NO. 2014JY0065).	Adsul M, 2007, APPL ENVIRON MICROB, V73, P5055, DOI 10.1128/AEM.00774-07; Ahmad AL, 2011, RENEW SUST ENERG REV, V15, P584, DOI 10.1016/j.rser.2010.09.018; Alberts B., 2013, ESSENTIAL CELL BIOL; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Altaras NE, 2001, BIOTECHNOL PROGR, V17, P52, DOI 10.1021/bp000130b; Alvarez HM, 1996, ARCH MICROBIOL, V165, P377, DOI 10.1007/s002030050341; Ashokkumar V, 2014, BIORESOURCE TECHNOL, V172, P186, DOI 10.1016/j.biortech.2014.08.100; Ashokkumar V, 2012, BIORESOURCE TECHNOL, V104, P394, DOI 10.1016/j.biortech.2011.10.093; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; Becker J, 2012, CURR OPIN BIOTECH, V23, P631, DOI 10.1016/j.copbio.2011.11.012; Belaich JP, 1997, J BIOTECHNOL, V57, P3, DOI 10.1016/S0168-1656(97)00085-0; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Bhandiwad A, 2014, METAB ENG, V21, P17, DOI 10.1016/j.ymben.2013.10.012; Bi CH, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-107; Biswas R, 2015, METAB ENG, P8; Biswas R, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0204-4; Biswas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086389; Blombach Bastian, 2011, Bioeng Bugs, V2, P346, DOI 10.4161/bbug.2.6.17845; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Branduardi P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-68; Brat D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-65; Calik G, 1997, CHEM ENG J, V65, P109, DOI 10.1016/S1385-8947(96)03159-2; Cao DL, 2015, J MICROBIOL METH, V109, P74, DOI 10.1016/j.mimet.2014.12.013; Carrau FM, 2008, FEMS YEAST RES, V8, P1196, DOI 10.1111/j.1567-1364.2008.00412.x; Caspeta L, 2013, BIOTECHNOL J, V8, P534, DOI 10.1002/biot.201200345; Cayol JL, 1996, INT J SYST BACTERIOL, V46, P628, DOI 10.1099/00207713-46-2-628                                                       ; Certik M, 1996, J AM OIL CHEM SOC, V73, P357, DOI 10.1007/BF02523431; Chen R, 2015, BIOTECHNOL LETT, P1; Chen T, 2014, BIORESOURCE TECHNOL, V151, P411, DOI 10.1016/j.biortech.2013.10.017; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Chen XY, 2015, J IND MICROBIOL BIOT, V42, P1473, DOI 10.1007/s10295-015-1656-z; CHIBATA I, 1965, APPL MICROBIOL, V13, P638; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; CHRISTAKOPOULOS P, 1989, ENZYME MICROB TECH, V11, P236, DOI 10.1016/0141-0229(89)90098-7; CHRISTAKOPOULOS P, 1991, ENZYME MICROB TECH, V13, P272, DOI 10.1016/0141-0229(91)90141-V; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cintolesi A, 2014, METAB ENG, V23, P100, DOI 10.1016/j.ymben.2014.02.011; Clomburg JM, 2012, ACS SYNTH BIOL, V1, P541, DOI 10.1021/sb3000782; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connor MR, 2009, CURR OPIN BIOTECH, V20, P307, DOI 10.1016/j.copbio.2009.04.002; d'Espaux L, 2015, CURR OPIN CHEM BIOL, V29, P58, DOI 10.1016/j.cbpa.2015.09.009; Daroch M, 2013, APPL ENERG, V102, P1371, DOI 10.1016/j.apenergy.2012.07.031; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578                                                              ; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Dekishima Y, 2011, J AM CHEM SOC, V133, P11399, DOI 10.1021/ja203814d; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; DESHPANDE V, 1986, ENZYME MICROB TECH, V8, P149, DOI 10.1016/0141-0229(86)90103-1                                                    ; Dhamankar H, 2011, CURR OPIN STRUC BIOL, V21, P488, DOI 10.1016/j.sbi.2011.05.001; Dobson R, 2012, J IND MICROBIOL BIOT, V39, P217, DOI 10.1007/s10295-011-1038-0; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dumbrepatil A, 2008, APPL ENVIRON MICROB, V74, P333, DOI 10.1128/AEM.01595-07; Dunlop MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-32; Endo M, 2014, PLANT CELL PHYSL, P154; Fan CL, 2012, APPL BIOCHEM BIOTECH, V168, P1867, DOI 10.1007/s12010-012-9903-5; Fathima AA, 2016, BIORESOURCE TECHNOL, V202, P253, DOI 10.1016/j.biortech.2015.11.075; FazeliNejad S, 2013, BIORESOURCES, V8, P5524; Ortiz-Marquez JCF, 2013, TRENDS BIOTECHNOL, V31, P521, DOI 10.1016/j.tibtech.2013.05.006; Feinberg L, 2011, J BACTERIOL, V193, P2906, DOI 10.1128/JB.00322-11; FINNERTY WR, 1992, ANNU REV MICROBIOL, V46, P193, DOI 10.1146/annurev.mi.46.100192.001205; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; FUSEE MC, 1984, APPL ENVIRON MICROB, V48, P694; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GAXIOLA R, 1992, EMBO J, V11, P3157; Generoso WC, 2015, CURR OPIN BIOTECH, V33, P1, DOI 10.1016/j.copbio.2014.09.004; GONG CS, 1981, BIOTECHNOL LETT, V3, P77, DOI 10.1007/BF00145114                                                              ; Green EM, 2011, CURR OPIN BIOTECH, V22, P337, DOI 10.1016/j.copbio.2011.02.004; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Guerrero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050470; Gulevich AY, 2012, BIOTECHNOL LETT, V34, P463, DOI 10.1007/s10529-011-0797-z; Harwood J, 1999, LIPID SYNTHESIS MANU, P422; Hashemzadeh-Cigari F, 2014, J ANIM PHYSIOL AN N, V98, P290, DOI 10.1111/jpn.12079; Herrero O, 2008, METAB ENG, V10, P78, DOI 10.1016/j.ymben.2007.11.001; Heufer KA, 2013, P COMBUST INST, V34, P511, DOI 10.1016/j.proci.2012.05.103; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Ho SH, 2013, BIORESOURCE TECHNOL, V135, P191, DOI 10.1016/j.biortech.2012.10.015; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Hou XH, 2012, AMINO ACIDS, V43, P2301, DOI 10.1007/s00726-012-1308-9; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hu Z, 2014, ACTA HYDROBIOL SIN, V38, P1084; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Huo YX, 2011, NAT BIOTECHNOL, V29, P346, DOI 10.1038/nbt.1789; INOUE A, 1991, J FERMENT BIOENG, V71, P194, DOI 10.1016/0922-338X(91)90109-T; Jain A, 2013, APPL MICROBIOL BIOT, V97, P905, DOI 10.1007/s00253-012-4511-4; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jang YS, 2012, BIOTECHNOL ADV, V30, P989, DOI 10.1016/j.biotechadv.2011.08.015; Jensen JVK, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-63; Jia KZ, 2010, ENG LIFE SCI, V10, P422, DOI 10.1002/elsc.201000076; Jiang W, 2013, NUCLEIC ACIDS RES, V41, P16; Jojima T, 2015, APPL MICROBIOL BIOT, V99, P1165, DOI 10.1007/s00253-014-6223-4; Jyothi AN, 2005, PROCESS BIOCHEM, V40, P3576, DOI 10.1016/j.procbio.2005.03.046; Kapoor RK, 2015, BIORESOURCE TECHNOL, V189, P99, DOI 10.1016/j.biortech.2015.03.100; Karimi K, 2006, ENZYME MICROB TECH, V40, P138, DOI 10.1016/j.enzmictec.2005.10.046; Kataeva IA, J BACTERIOL; Kaushal R, 2016, BIOMASS BIOENERG, V85, P243, DOI 10.1016/j.biombioe.2015.12.010; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; KEMBHAVI AA, 1993, APPL BIOCHEM BIOTECH, V38, P83, DOI 10.1007/BF02916414; KEREM Z, 1992, APPL ENVIRON MICROB, V58, P1121; Kim S, 2015, J IND MICROBIOL BIOT, V42, P465, DOI 10.1007/s10295-015-1589-6; Kivisto A, 2012, J BIOTECHNOL, V158, P242, DOI 10.1016/j.jbiotec.2011.10.013; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; KOBAYASHI K, 1971, AGR BIOL CHEM TOKYO, V35, P1241, DOI 10.1080/00021369.1971.10860069                                                  ; Kondo T, 2012, J BIOTECHNOL, V159, P32, DOI 10.1016/j.jbiotec.2012.01.022; Kosa M, 2011, TRENDS BIOTECHNOL, V29, P53, DOI 10.1016/j.tibtech.2010.11.002; Koussa J, 2014, BIOMED RES INT, V2014; Kumagai H, 2013, PROKARYOTES, P169; Kumar D, 2003, PROCESS BIOCHEM, V38, P1165, DOI 10.1016/S0032-9592(02)00287-X; Kumar P, 2015, INDIAN J MICROBIOL, V55, P1, DOI 10.1007/s12088-014-0509-1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kurosawa K., 2015, BIOTECHNOL BIOFUELS, V8, P1; Kurosawa K, 2014, J MICROB BIOCH TECHN, V2014; Kurosawa K, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-134; Kwon YD, 2011, J BIOSCI BIOENG, V111, P26, DOI 10.1016/j.jbiosc.2010.08.007; Lan EI, 2013, BIORESOURCE TECHNOL, V135, P339, DOI 10.1016/j.biortech.2012.09.104; Laughery MF, 2015, YEAST, V32, P711, DOI 10.1002/yea.3098; Lee JM, 2011, BIOMASS BIOENERG, V35, P626, DOI 10.1016/j.biombioe.2010.10.021; Lee SJ, 2014, SYNTH BIOL APPL IND, V87; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibech.2005.05.003; Lee WH, 2012, BIOPROC BIOSYST ENG, V35, P1467, DOI 10.1007/s00449-012-0736-y; LEE YE, 1993, INT J SYST BACTERIOL, V43, P41, DOI 10.1099/00207713-43-1-41                                                        ; Lennartsson PR, 2012, PROCESS BIOCHEM, V47, P836, DOI 10.1016/j.procbio.2012.02.019; Lenz O, 2002, J MOL MICROB BIOTECH, V4, P255; Lestari S, 2009, CHEMSUSCHEM, V2, P1109, DOI 10.1002/cssc.200900107; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Li SS, 2011, APPL MICROBIOL BIOT, V91, P577, DOI 10.1007/s00253-011-3280-9; Li XQ, 2014, PHOTOSYNTH RES, V120, P301, DOI 10.1007/s11120-014-9987-6; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Lian JZ, 2015, ACS SYNTH BIOL, V4, P332, DOI 10.1021/sb500243c; Lima S, 2009, J MOL BIOL, V388, P98, DOI 10.1016/j.jmb.2009.02.055; Liu R, 2015, CELL DISCOV, P15; Lu JN, 2012, APPL MICROBIOL BIOT, V96, P283, DOI 10.1007/s00253-012-4320-9; Lund P, 2015, ADV BIOENERGY SUSTAI; Mainguet SE, 2010, BIOTECHNOL J, V5, P1297, DOI 10.1002/biot.201000276; Marcheschi RJ, 2012, ACS CHEM BIOL, V7, P689, DOI 10.1021/cb200313e; MARTEAU P, 1990, AM J CLIN NUTR, V52, P685; Martinkova L, 2009, ENVIRON INT, V35, P162, DOI 10.1016/j.envint.2008.07.018; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matsuda F, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-119; Matsuda F, 2012, BIOSCI BIOTECH BIOCH, V76, P2139, DOI 10.1271/bbb.120420; Matsushika A, 2008, J BIOSCI BIOENG, V105, P296, DOI 10.1263/jbb.105.296; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; McCool GJ, 1999, J BACTERIOL, V181, P585; MCDONALD LC, 1987, APPL ENVIRON MICROB, V53, P1382; Meiswinkel TM, 2013, BIORESOURCE TECHNOL, V145, P254, DOI 10.1016/j.biortech.2013.02.053; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Menon V, 2012, PROG ENERG COMBUST, V38, P522, DOI 10.1016/j.pecs.2012.02.002; Metting FB, 1996, J IND MICROBIOL BIOT, V17, P477, DOI 10.1007/BF01574779; Miller EN, 2009, APPL ENVIRON MICROB, V75, P4315, DOI 10.1128/AEM.00567-09; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Minty J.J., 2011, BMC GENET, V10, P1; Mitra D, 2012, BIORESOURCE TECHNOL, V107, P368, DOI 10.1016/j.biortech.2011.12.031; Moreau A, 2015, BIOMASS BIOENERG, V72, P256, DOI 10.1016/j.biombioe.2014.10.028; MUKHERJEE KD, 1991, APPL MICROBIOL BIOT, V35, P579; Mukhopadhyay A, 2015, TRENDS MICROBIOL, V23, P498, DOI 10.1016/j.tim.2015.04.008; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Okamoto K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-121; Okamoto K, 2010, BIOTECHNOL LETT, V32, P909, DOI 10.1007/s10529-010-0243-7; OKAZAKI H, 1969, AGR BIOL CHEM TOKYO, V33, P764, DOI 10.1080/00021369.1969.10859379                                                  ; Oren A, 2002, J IND MICROBIOL BIOT, V28, P56, DOI 10.1038/sj.jim.7000176; Ozdemir I, 2012, APPL ENVIRON MICROB, V78, P768, DOI 10.1128/AEM.07031-11; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Petit E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118285; Pfleger BF, 2015, METAB ENG, V29, P1, DOI 10.1016/j.ymben.2015.01.009; Planson AG, 2012, BIOTECHNOL BIOENG, V109, P846, DOI 10.1002/bit.24356; Podkaminer KK, 2011, BIOTECHNOL BIOENG, V108, P1268, DOI 10.1002/bit.23050; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rabinovitch-Deere CA, 2013, CHEM REV, V113, P4611, DOI 10.1021/cr300361t; Radakovits R, 2011, METAB ENG, V13, P89, DOI 10.1016/j.ymben.2010.10.003; Ramluckan K, 2014, FUEL, V116, P103, DOI 10.1016/j.fuel.2013.07.118; Rasmussen ML, 2010, BIORESOURCE TECHNOL, V101, P3526, DOI 10.1016/j.biortech.2009.12.115; Rawat I, 2013, APPL ENERG, V103, P444, DOI 10.1016/j.apenergy.2012.10.004; Reddy HK, 2014, FUEL, V115, P720, DOI 10.1016/j.fuel.2013.07.090; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; Roldao A, 2012, SYSTEMS METABOLIC EN, P271; Roopnarain A, 2014, BIORESOURCE TECHNOL, V156, P408, DOI 10.1016/j.biortech.2014.01.092; Roush D. W., 2014, CURR BIOTECHNOL, V3, P3, DOI [10.2174/221155010301140303102741, DOI 10.2174/221155010301140303102741]; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Sakai S, 2007, APPL ENVIRON MICROB, V73, P2349, DOI 10.1128/AEM.02880-06; Sanchez BJ, 2015, INTEGR BIOL-UK, V7, P846, DOI 10.1039/c5ib00083a; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sardessai Y, 2002, RES MICROBIOL, V153, P263, DOI 10.1016/S0923-2508(02)01319-0                                                   ; Savakis P, 2015, CURR OPIN BIOTECH, V33, P8, DOI 10.1016/j.copbio.2014.09.007; Schadeweg V, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0673-0; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schneider J, 2011, J BIOTECHNOL, V154, P191, DOI 10.1016/j.jbiotec.2010.07.009; Sekowska A, 2001, GENOME BIOL, V2; Selle K, 2015, TRENDS MICROBIOL, V23, P225, DOI 10.1016/j.tim.2015.01.008; SENUMA M, 1989, J FERMENT BIOENG, V67, P233, DOI 10.1016/0922-338X(89)90224-9; SHAH NP, 1995, INT DAIRY J, V5, P515, DOI 10.1016/0958-6946(95)00028-2; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shaw AJ, 2008, ENZYME MICROB TECH, V42, P453, DOI 10.1016/j.enzmictec.2009.01.005; SHAW R, 1965, BIOCHIM BIOPHYS ACTA, V98, P230, DOI 10.1016/0005-2760(65)90117-7                                                    ; Si T, 2014, METAB ENG, V22, P60, DOI 10.1016/j.ymben.2014.01.002; Silver AG, 2015, INVESTIGATION ATOMIZ; Singhvi M, 2010, GREEN CHEM, V12, P1106, DOI 10.1039/b925975a; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; Stovicek Vratislav, 2015, Metabolic Engineering Communications, V2, P13, DOI 10.1016/j.meteno.2015.03.001; Su HF, 2015, ACS SUSTAIN CHEM ENG, V3, P2002, DOI 10.1021/acssuschemeng.5b00538; Su HF, 2015, BIORESOURCE TECHNOL, V187, P149, DOI 10.1016/j.biortech.2015.03.107; Su HF, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0199-3; Su HF, 2015, RSC ADV, V5, P12624, DOI 10.1039/c4ra16576d; Su HF, 2014, RSC ADV, V4, P65021, DOI 10.1039/c4ra08668f; SUN D, 2007, J TIANJIN U, V4; SVETLICHNYI V A, 1990, Mikrobiologiya, V59, P871; Taherzadeh MJ, 2003, BIORESOURCE TECHNOL, V88, P167, DOI 10.1016/S0960-8524(03)00010-5; TAKEDA Y, 1990, J FERMENT BIOENG, V70, P177, DOI 10.1016/0922-338X(90)90180-5; TAKINAMI K, 1965, AGR BIOL CHEM TOKYO, V29, P351, DOI 10.1080/00021369.1965.10858397                                                  ; Talluri S, 2013, BIORESOURCE TECHNOL, V139, P272, DOI 10.1016/j.biortech.2013.04.005; Tamura Y, BIOSCI BIOTECHNOL BI; Tang R, 1978, ACTA MICROBIOL SIN, V18, P45; Tao F, 2012, J BACTERIOL, V194, P5985, DOI 10.1128/JB.01482-12; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tolonen AC, 2015, APPL ENVIRON MICROB, V81, P5440, DOI 10.1128/AEM.00619-15; Tomko T, 2015, GENOMIC SCI CONTRACT, VXIII, P220; Tracy BP, 2012, CURR OPIN BIOTECH, V23, P364, DOI 10.1016/j.copbio.2011.10.008; Ungerer J, 2012, ENERG ENVIRON SCI, V5, P8998, DOI 10.1039/c2ee22555g; VALLINO JJ, 1993, BIOTECHNOL BIOENG, V41, P633, DOI 10.1002/bit.260410606; van der Pol EC, BIORESOUR TECHNOL; VanFossen AL, BIOTECHNOL BIOENG; Vasudevan PT, 2008, J IND MICROBIOL BIOT, V35, P421, DOI 10.1007/s10295-008-0312-2; Venugopalan A, 2015, BIORESOURCE TECHNOL, V188, P251, DOI 10.1016/j.biortech.2014.12.106; Wakayama M, 2005, J IND MICROBIOL BIOT, V32, P383, DOI 10.1007/s10295-005-0257-7; Wang F, 2014, BIORESOURCE TECHNOL, V166, P602, DOI 10.1016/j.biortech.2014.05.068; Wang LM, 2013, BIORESOURCE TECHNOL, V130, P174, DOI 10.1016/j.biortech.2012.11.144; Wang WH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-69; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Wang YZ, 2011, J IND MICROBIOL BIOT, V38, P1371, DOI 10.1007/s10295-010-0920-5; Warnick TA, INT J SYST EVOL MICR; WATANABE M, 1990, APPL MICROBIOL BIOT, V34, P154, DOI 10.1007/BF00166772                                                              ; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; WIEGEL J, 1985, APPL ENVIRON MICROB, V49, P656; Wieschalka S, 2012, APPL MICROBIOL BIOT, V94, P449, DOI 10.1007/s00253-011-3843-9; Wongwisansri S, 2013, BIORESOURCE TECHNOL, V132, P410, DOI 10.1016/j.biortech.2012.11.117; Wu CH, 2008, TRENDS MICROBIOL, V16, P181, DOI 10.1016/j.tim.2008.01-003; Xiong W, 2015, NAT PLANTS, P1; Xu H, 2009, BIOCHEM ENG J, V43, P41, DOI 10.1016/j.bej.2008.08.007; Xu Q, 2010, BIORESOURCE TECHNOL, V101, P6262, DOI 10.1016/j.biortech.2010.02.086; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x                                              ; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Ye LD, 2013, BIORESOURCE TECHNOL, V132, P38, DOI 10.1016/j.biortech.2013.01.011; Yoon HS, 2013, J APPL GENET, V54, P129, DOI 10.1007/s13353-012-0117-x; Yoshino T, 2015, APPL MICROBIOL BIOT, V99, P1521, DOI 10.1007/s00253-014-6286-2; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; Zerva A, 2014, BIORESOURCE TECHNOL, V162, P294, DOI 10.1016/j.biortech.2014.03.137; Zhang GC, 2014, APPL ENVIRON MICROB, V80, P7694, DOI 10.1128/AEM.02310-14; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhang S, 2014, PERSPECT PHYCOL, P73; Zhang S, 1989, MICROBIOLOGY, V5, P264; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhang X, 2009, APPL ENVIRON MICROB, V75, P7807, DOI 10.1128/AEM.01758-09; Zhang X, 2008, J ORG CHEM, V73, P889, DOI 10.1021/jo701974n; Zhang YM, 2014, BIORESOURCE TECHNOL, V158, P396, DOI 10.1016/j.biortech.2014.02.128; ZHILINA TN, 1992, SYST APPL MICROBIOL, V15, P275, DOI 10.1016/S0723-2020(11)80101-3                                                   ; Zhu LJ, 2012, TRENDS MICROBIOL, V20, P94, DOI 10.1016/j.tim.2011.12.003; Zhu T, 2015, GREEN CHEM, V17, P421, DOI 10.1039/c4gc01730g; Zhuang QQ, 2014, METAB ENG, V24, P78, DOI 10.1016/j.ymben.2014.05.004; Zuroff TR, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-59; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457                                                      	278	0	0	20	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	DEC	2017	80						801	826		10.1016/j.rser.2017.05.158				26	GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels	Science & Technology - Other Topics; Energy & Fuels	FJ5JK	WOS:000412787600064					2018-01-05	
J	Li, QC; Yin, KQ; Xie, XL; Zhao, F; Xia, J; Chen, Y; Hu, YC; Xu, LJ; Chen, X; Jiao, XA				Li, Qiuchun; Yin, Kequan; Xie, Xiaolei; Zhao, Fei; Xia, Jie; Chen, Yun; Hu, Yachen; Xu, Lijuan; Chen, Xiang; Jiao, Xinan			Detection and CRISPR subtyping of Salmonella spp. isolated from whole raw chickens in Yangzhou from China	FOOD CONTROL			English	Article						Salmonella; MPN; CRISPR; Poultry	RETAIL CHICKEN; ANTIMICROBIAL RESISTANCE; CAMPYLOBACTER-SPP.; PREVALENCE; ENTERICA; POULTRY; MEAT; CARCASSES; EPIDEMIOLOGY; TYPHIMURIUM	This study was undertaken to acquire data on Salmonella contamination of whole raw chickens, eggs, and vegetables available to consumers in Yangzhou city, China, between April 2011 and March 2012. In total, 240 chicken carcasses were tested, and the overall contamination rate for Salmonella was 33.8%. While the prevalence of Salmonella in 100 eggs and 155 vegetable samples was 7.0% and 3.2%, respectively. The 84 isolated strains were identified in 19 different serotypes with Salmonella enterica serovar Indiana (S. Indiana) (25.0%), S. Typhimurium (21.4%) and S. Enteritidis (17.9%) as the predominant serovars. Moreover, the median load of the contaminated chicken samples reached 6.4 MPN/100 g with 3.6 MPN/100 g as the 25th percentile and 15.0 MPN/100 gas the 75th percentile. Chicken carcasses collected in October had not only the highest prevalence of Salmonella (70%), but also the highest median load (33 MPN/100 g) and 75th percentile load (460 MPN/100 g), while the lowest prevalence (10%) was in April. The clustered regularly interspaced short palindromic repeats (CRISPR) subtyping method was then used to identify serotypes of Salmonella and distinguish strains from the same Salmonella serotypes. We found that 85.7% of strains were distributed in 11 serotypes speculated by CRISPR typing, which corresponded to the identified serotypes by O and H antiserum. The speculated serotypes of 7.1% of the strains by CRISPR typing are very close to the identified ones, as they belong to the same O group with a small difference in the O or H antigen. All of the above findings implied that CRISPR typing could be applied to serotyping of Salmonella. In addition, CRISPR typing method could be used to subtype different strains from the same serotype, specifically S. Hadar. (C) 2017 Elsevier Ltd. All rights reserved.	[Li, Qiuchun; Yin, Kequan; Xie, Xiaolei; Xia, Jie; Chen, Yun; Hu, Yachen; Xu, Lijuan; Chen, Xiang; Jiao, Xinan] Yangzhou Univ, Minist Agr China, Key Lab Prevent & Control Biol Hazard Factors Ani, Yangzhou, Jiangsu, Peoples R China; [Li, Qiuchun; Yin, Kequan; Xie, Xiaolei; Zhao, Fei; Xia, Jie; Chen, Yun; Hu, Yachen; Xu, Lijuan; Chen, Xiang; Jiao, Xinan] Yangzhou Univ, Ctr Prevent & Control Important Anim Infect Dis &, Jiangsu Key Lab Zoonosis Jiangsu Coinnovat, Yangzhou, Jiangsu, Peoples R China; [Chen, Xiang; Jiao, Xinan] Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Yangzhou, Jiangsu, Peoples R China	Li, QC; Jiao, XA (reprint author), Yangzhou Univ, Minist Agr China, Key Lab Prevent & Control Biol Hazard Factors Ani, Yangzhou, Jiangsu, Peoples R China.	qcli@yzu.edu.cn; jiao@yzu.edu.cn			National Key Research and Development Program of China [2017YFD0500105, 2017YFD0500705]; Special Fund for Agro-scientific Research in the Public Interest [201403054]; National Natural Science Foundation of China [31230070, 31320103907]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Key Research and Development Program of China (2017YFD0500105, 2017YFD0500705); Special Fund for Agro-scientific Research in the Public Interest (201403054); The National Natural Science Foundation of China (31230070, 31320103907); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alali WQ, 2012, J FOOD PROTECT, V75, P1469, DOI 10.4315/0362-028X.JFP-12-080; Almeida F, 2017, J MICROBIOL METH, V133, P55, DOI 10.1016/j.mimet.2016.12.020; Brichta-Harhay DM, 2008, LETT APPL MICROBIOL, V46, P186, DOI 10.1111/j.1472-765X.2007.02289.x; CDC, 2016, NAT ANT RES MON SYST; CDC, 2014, NAT ANT RES MON SYST; Chousalkar K, 2016, VET MICROBIOL, V192, P67, DOI 10.1016/j.vetmic.2016.06.013; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Domenech E, 2015, FOOD CONTROL, V57, P18, DOI 10.1016/j.foodcont.2015.04.001; Dominguez C, 2002, INT J FOOD MICROBIOL, V72, P165, DOI 10.1016/S0168-1605(01)00638-9; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P1134, DOI 10.4315/0362-028X.JFP-11-513; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Gill CO, 2005, J FOOD PROTECT, V68, P2718, DOI 10.4315/0362-028X-68.12.2718                                                    ; Harris LJ, 2016, J FOOD PROTECT, V79, P1304, DOI 10.4315/0362-028X.JFP-16-054; Harrison WA, 2001, LETT APPL MICROBIOL, V33, P450, DOI 10.1046/j.1472-765X.2001.01031.x; Jorgensen F, 2002, INT J FOOD MICROBIOL, V76, P151, DOI 10.1016/S0168-1605(02)00027-2; Li H, 2014, J CLIN MICROBIOL, V52, P2955, DOI 10.1128/JCM.00696-14; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Marin C, 2009, POULTRY SCI, V88, P1999, DOI 10.3382/ps.2009-00040; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Shariat N, 2013, FOOD MICROBIOL, V34, P164, DOI 10.1016/j.fm.2012.11.012; Sodagari HR, 2015, J INFECT DEV COUNTR, V9, P463, DOI 10.3855/jidc.5945; Ta YT, 2012, J FOOD PROTECT, V75, P1851, DOI 10.4315/0362-028X.JFP-12-130; Wilke A, 2011, WORLD POULTRY SCI J, V67, P615, DOI 10.1017/S0043933911000717; Xie XL, 2017, VET MICROBIOL, V203, P81, DOI 10.1016/j.vetmic.2017.02.010; Yang BW, 2011, J FOOD PROTECT, V74, P1724, DOI 10.4315/0362-028X.JFP-11-215; Zdragas A, 2012, LETT APPL MICROBIOL, V55, P308, DOI 10.1111/j.1472-765X.2012.03298.x; Zheng HJ, 2017, FOOD CONTROL, V73, P474, DOI 10.1016/j.foodcont.2016.08.051; Zhu JH, 2014, FOOD CONTROL, V44, P198, DOI 10.1016/j.foodcont.2014.03.050	30	0	0	13	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-7135	1873-7129		FOOD CONTROL	Food Control	DEC	2017	82						291	297		10.1016/j.foodcont.2017.07.008				7	Food Science & Technology	Food Science & Technology	FH0ZD	WOS:000410868300036					2018-01-05	
J	Basiri, M; Behmanesh, M; Tahamtani, Y; Khalooghi, K; Moradmand, A; Baharvand, H				Basiri, Mohsen; Behmanesh, Mehrdad; Tahamtani, Yaser; Khalooghi, Keynoosh; Moradmand, Azadeh; Baharvand, Hossein			The Convenience of Single Homology Arm Donor DNA and CRISPR/Cas9-Nickase for Targeted Insertion of Long DNA Fragment	CELL JOURNAL			English	Article						CRISPR-Cas Systems; Gene Targeting; Embryonic Stem Cells; Pdx1	TIME QUANTITATIVE PCR; EMBRYONIC STEM-CELLS; STRAND BREAK REPAIR; TRANSGENIC ANIMALS; GENOME; CAS9; SPECIFICITY; RECOMBINATION; SYSTEM; ENDS	Objective: CRISPR/Cas9 technology provides a powerful tool for targeted modification of genomes. In this system, a donor DNA harboring two flanking homology arms is mostly used for targeted insertion of long exogenous DNA. Here, we introduced an alternative design for the donor DNA by incorporation of a single short homology arm into a circular plasmid. Materials and Methods: In this experimental study, single homology arm donor was applied along with a single guide RNA (sgRNA) specific to the homology region, and either Cas9 or its mutant nickase variant (Cas9n). Using Pdx1 gene as the target locus the functionality of this system was evaluated in MIN6 cell line and murine embryonic stem cells (ESCs). Results: Both wild type Cas9 and Cas9n could conduct the knock-in process with this system. We successfully applied this strategy with Cas9n for generation of Pdx1GFP knock-in mouse ESC lines. Altogether, our results demonstrated that a combination of a single homology arm donor, a single guide RNA and Cas9n is capable of precisely incorporating DNA fragments of multiple kilo base pairs into the targeted genomic locus. Conclusion: While taking advantage of low off-target mutagenesis of the Cas9n, our new design strategy may facilitate the targeting process. Consequently, this strategy can be applied in knock-in or insertional inactivation studies.	[Basiri, Mohsen; Behmanesh, Mehrdad] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, POB 14115-154, Tehran, Iran; [Basiri, Mohsen; Tahamtani, Yaser; Khalooghi, Keynoosh; Moradmand, Azadeh; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, POB 16635-148, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, Tehran, Iran	Behmanesh, M (reprint author), Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, POB 14115-154, Tehran, Iran.; Baharvand, H (reprint author), ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, POB 16635-148, Tehran, Iran.	behmanesh@modares.ac.ir; baharvand@royaninstitute.org			Royan Institute and Tarbiat Modares University	We are grateful to Dr. Morteza Zarrabi and Ehsan Janzamin for their assistance with flow cytometry. We also appreciate the technical assistance of Elmira Rezaei, Fazel Samani and Behrouz Asgari. This study was financially supported by grants from Royan Institute and Tarbiat Modares University. Authors certify no potential conflicts of interest.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Ballester M, 2004, BIOTECHNIQUES, V37, P610; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fujii W, BIOCH BIOPHYS RES CO, V445, P791; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Hassani SN, 2014, STEM CELL REV REP, V10, P16, DOI 10.1007/s12015-013-9473-0; Hassani SN, 2012, STEM CELL REV REP, V8, P472, DOI 10.1007/s12015-011-9306-y; HASTY P, 1992, MOL CELL BIOL, V12, P2464, DOI 10.1128/MCB.12.6.2464                                                           ; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rassouli H, 2013, CELL J, V15, P190; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	22	1	1	125	693	ROYAN INST	TEHRAN	PO BOX 19395-4644, TEHRAN, 00000, IRAN	2228-5806	2228-5814		CELL J	Cell J.	WIN	2017	18	4					532	539						8	Cell Biology	Cell Biology	EA7EO	WOS:000386792500006	28042537				2018-01-05	
J	Barbieri, EM; Muir, P; Akhuetie-Oni, BO; Yellman, CM; Isaacs, FJ				Barbieri, Edward M.; Muir, Paul; Akhuetie-Oni, Benjamin O.; Yellman, Christopher M.; Isaacs, Farren J.			Precise Editing at DNA Replication Forks Enables Multiplex Genome Engineering in Eukaryotes	CELL			English	Article							LAGGING-STRAND SYNTHESIS; SACCHAROMYCES-CEREVISIAE; RAD51 RECOMBINASE; PROTEIN-A; IN-VIVO; YEAST; REPAIR; OLIGONUCLEOTIDES; TRANSFORMATION; MUTAGENESIS	We describe a multiplex genome engineering technology in Saccharomyces cerevisiae based on annealing synthetic oligonucleotides at the lagging strand of DNA replication. The mechanism is independent of Rad51-directed homologous recombination and avoids the creation of double-strand DNA breaks, enabling precise chromosome modifications at single base-pair resolution with an efficiency of >40%, without unintended mutagenic changes at the targeted genetic loci. We observed the simultaneous incorporation of up to 12 oligonucleotides with as many as 60 targeted mutations in one transformation. Iterative transformations of a complex pool of oligonucleotides rapidly produced large combinatorial genomic diversity >10(5). This method was used to diversify a heterologous beta-carotene biosynthetic pathway that produced genetic variants with precise mutations in promoters, genes, and terminators, leading to altered carotenoid levels. Our approach of engineering the conserved processes of DNA replication, repair, and recombination could be automated and establishes a general strategy for multiplex combinatorial genome engineering in eukaryotes.	[Barbieri, Edward M.; Muir, Paul; Akhuetie-Oni, Benjamin O.; Yellman, Christopher M.; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Barbieri, Edward M.; Muir, Paul; Akhuetie-Oni, Benjamin O.; Yellman, Christopher M.; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Yellman, Christopher M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	Isaacs, FJ (reprint author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Isaacs, FJ (reprint author), Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA.	farren.isaacs@yale.edu			NSF-GRFP [1122492]; NIH Predoctoral Training Grant in Genetics [T32GM007499]; Howard Hughes Medical Institute; DARPA [HR0011-15-C-0091, N66001-12-C-4020]; DOE [DE-FG02-02ER63445]; NIH [1R01GM117230-01, 1U54CA209992-01]; Arnold and Mabel Beckman Foundation	We thank P. Sung, S. Dellaporta, M. Hochstrasser, T. Xu, and J. Rinehart; the anonymous reviewers; and members of the Isaacs Lab for valuable feedback. We thank G. S. Roeder for generous access to lab and reagents. E. M. B. is funded by NSF-GRFP (1122492) and an NIH Predoctoral Training Grant in Genetics (T32GM007499). C. M. Y. was funded by the Howard Hughes Medical Institute. F. J. I. gratefully acknowledges support from DARPA (HR0011-15-C-0091 and N66001-12-C-4020), DOE (DE-FG02-02ER63445), NIH (1R01GM117230-01 and 1U54CA209992-01), and the Arnold and Mabel Beckman Foundation. E. M. B. and F. J. I. have filed a provisional application with the US Patent and Trademark Office on this work. F. J. I. is a founder of enEvolv.	Amiram M, 2015, NAT BIOTECHNOL, V33, P1272, DOI 10.1038/nbt.3372; Anand R, 2017, NATURE, V544, P377, DOI 10.1038/nature22046; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Boeke JD, 2016, SCIENCE, V353, P126, DOI 10.1126/science.aaf6850; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brachmann CB, 1998, YEAST, V14, P115; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Collonnier C, 2017, PLANT BIOTECHNOL J, V15, P122, DOI 10.1111/pbi.12596; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.243959100; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; DETLOFF P, 1991, MOL CELL BIOL, V11, P737, DOI 10.1128/MCB.11.2.737                                                            ; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kow YW, 2007, P NATL ACAD SCI USA, V104, P11352, DOI 10.1073/pnas.0704695104; Krivoruchko A, 2015, CURR OPIN BIOTECH, V35, P7, DOI 10.1016/j.copbio.2014.12.004; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lang GI, 2013, G3-GENES GENOM GENET, V3, P1453, DOI 10.1534/g3.113.006429; Lee M, 2014, J BIOL CHEM, V289, P15064, DOI 10.1074/jbc.M114.548388; Heng Li., 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352; Liu L, 2004, NUCLEIC ACIDS RES, V32, P2093, DOI 10.1093/nar/gkh506; Lubliner S, 2013, NUCLEIC ACIDS RES, V41, P5569, DOI 10.1093/nar/gkt256; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mitchell LA, 2015, NUCLEIC ACIDS RES, V43, P6620, DOI 10.1093/nar/gkv466; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Rivera-Torres N, 2016, PLANT BIOTECHNOL J, V14, P463, DOI 10.1111/pbi.12473; Rodriguez GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042905; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Storici F, 2003, GENET ENG P, V25, P189; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V43, P11, DOI DOI 10.1002/0471250953.BI1110S43; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WU CA, 1992, J BIOL CHEM, V267, P4030; Xie WP, 2015, METAB ENG, V30, P69, DOI 10.1016/j.ymben.2015.04.009; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; YAMAMOTO T, 1992, YEAST, V8, P935, DOI 10.1002/yea.320081104                                                           ; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Zhang GC, 2014, APPL ENVIRON MICROB, V80, P7694, DOI 10.1128/AEM.02310-14	59	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1453	+		10.1016/j.cell.2017.10.034				28	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FP1HP	WOS:000417362700024	29153834				2018-01-05	
J	Jacobs, EZ; Warrier, S; Volders, PJ; D'haene, E; Van Lombergen, E; Vantomme, L; Van der Jeught, M; Heindryckx, B; Menten, B; Vergult, S				Jacobs, Eva Z.; Warrier, Sharat; Volders, Pieter-Jan; D'haene, Eva; Van Lombergen, Eva; Vantomme, Lies; Van der Jeught, Margot; Heindryckx, Bjorn; Menten, Bjorn; Vergult, Sarah			CRISPR/Cas9-mediated genome editing in naive human embryonic stem cells	SCIENTIFIC REPORTS			English	Article							HUMAN PLURIPOTENCY; CRISPR CAS9; DIFFERENTIATION; LINEAGE; DISEASE; STATE; EPIBLAST; SEQ; GENERATION; DERIVATION	The combination of genome-edited human embryonic stem cells (hESCs) and subsequent neural differentiation is a powerful tool to study neurodevelopmental disorders. Since the naive state of pluripotency has favourable characteristics for efficient genome-editing, we optimized a workflow for the CRISPR/Cas9 system in these naive stem cells. Editing efficiencies of respectively 1.3-8.4% and 3.819% were generated with the Cas9 nuclease and the D10A Cas9 nickase mutant. Next to this, wildtype and genome-edited naive hESCs were successfully differentiated to neural progenitor cells. As a proofof- principle of our workflow, two monoclonal genome-edited naive hESCs colonies were obtained for TUNA, a long non-coding RNA involved in pluripotency and neural differentiation. In these genome-edited hESCs, an effect was seen on expression of TUNA, although not on neural differentiation potential. In conclusion, we optimized a genome-editing workflow in naive hESCs that can be used to study candidate genes involved in neural differentiation and/or functioning.	[Jacobs, Eva Z.; Volders, Pieter-Jan; D'haene, Eva; Van Lombergen, Eva; Vantomme, Lies; Menten, Bjorn; Vergult, Sarah] Univ Ghent, Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Warrier, Sharat; Van der Jeught, Margot; Heindryckx, Bjorn] Ghent Univ Hosp, Dept Reprod Med, Ghent Fertil & Stem Cell Team G FaST, Ghent, Belgium	Vergult, S (reprint author), Univ Ghent, Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.	sarah.vergult@ugent.be			Fund for Scientific Research Flanders (FWO) [11B0117N, 11A9817N]; FWO [12Q7817N, FWO/KAN/1507816N]; Ghent University grant, Faculty Health and Medical Sciences; Agency for Innovation by Science and Technology (IWT) [150042]; Ferring Pharmaceuticals (Aalst, Belgium)	E.Z.J. and E.D. are supported by respectively doctoral grands 11B0117N and 11A9817N, from the Fund for Scientific Research Flanders (FWO). S.V. is supported by postdoctoral grant 12Q7817N from the FWO. We thank Ferring Pharmaceuticals (Aalst, Belgium) for an unrestricted educational grant. B.H. and this research are supported by a Ghent University grant, Faculty Health and Medical Sciences; a research grant from FWO (FWO/KAN/1507816N) and the Agency for Innovation by Science and Technology (IWT, Project Number 150042). We thank Mina Popovic and Jasin Taelman for the fruitful discussions regarding the primed and naive pluripotency markers.	Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Boel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30330; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Byrne SM, 2014, METHOD ENZYMOL, V546, P119, DOI 10.1016/B978-0-12-801185-0.00006-4; Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/NMETH.4284, 10.1038/nmeth.4284]; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Choudhary P, 2017, STEM CELL TRANSL MED, V6, P490, DOI 10.5966/sctm.2016-0088; De Leeneer K, 2015, HUM MUTAT, V36, P379, DOI 10.1002/humu.22739; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dodsworth BT, 2015, STEM CELLS, V33, P3181, DOI 10.1002/stem.2085; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duggal G, 2015, STEM CELLS, V33, P2686, DOI 10.1002/stem.2071; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fonoudi H, 2017, STEM CELL TRANSL MED, V6, P1452, DOI 10.1002/sctm.16-0476; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Goyal A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw883; Gu Q, 2012, PROTEIN CELL, V3, P71, DOI 10.1007/s13238-012-2007-8; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Horii T, 2013, PEERJ, V1, DOI 10.7717/peerj.230; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim SJ, 2017, STEM CELL RES, V19, P52, DOI 10.1016/j.scr.2016.12.028; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Lee JH, 2017, CELL REP, V19, P20, DOI 10.1016/j.celrep.2017.03.036; Li R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050702; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Nair G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13339; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Saurat NG, 2016, METHODS MOL BIOL, V1303, P267, DOI 10.1007/978-1-4939-2627-5_16; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Warrier S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15055; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yang YY, 2016, STEM CELL TRANSL MED, V5, P267, DOI 10.5966/sctm.2015-0157erratum	51	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 30	2017	7								16650	10.1038/s41598-017-16932-y				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FO5JI	WOS:000416891400052	29192200	gold			2018-01-05	
J	Zhao, DD; Feng, X; Zhu, XN; Wu, T; Zhang, XL; Bi, CH				Zhao, Dongdong; Feng, Xu; Zhu, Xinna; Wu, Tao; Zhang, Xueli; Bi, Changhao			CRISPR/Cas9-assisted gRNA-free one-step genome editing with no sequence limitations and improved targeting efficiency	SCIENTIFIC REPORTS			English	Article							RNA-GUIDED ENDONUCLEASES; ZINC-FINGER NUCLEASES; ESCHERICHIA-COLI; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; SYSTEM; MUTAGENESIS; SOFTWARE; GENES; SITES	The CRISPR/Cas9 system is a powerful, revolutionary tool for genome editing. However, it is not without limitations. There are PAM-free and CRISPR-tolerant regions that cannot be modified by the standard CRISPR/Cas9 system, and off-target activity impedes its broader applications. To avoid these drawbacks, we developed a very simple CRISPR/Cas9-assisted gRNA-free one-step (CAGO) genome editing technique which does not require the construction of a plasmid to express a specific gRNA. Instead, a universal N20 sequence with a very high targeting efficiency is inserted into the E. coli chromosome by homologous recombination, which in turn undergoes a double-stranded break by CRISPR/Cas9 and induces an intra-chromosomal recombination event to accomplish the editing process. This technique was shown to be able to edit PAM-free and CRISPR-tolerant regions with no off-target effects in Escherichia coli. When applied to multi-locus editing, CAGO was able to modify one locus in two days with a near 100% editing efficiency. Furthermore, modified CAGO was used to edit large regions of up to 100 kbp with at least 75% efficiency. Finally, genome editing by CAGO only requires a transformation procedure and the construction of a linear donor DNA cassette, which was further simplified by applying a modular design strategy. Although the technique was established in E. coli, it should be applicable to other organisms with only minor modifications.	[Zhao, Dongdong; Feng, Xu; Zhu, Xinna; Wu, Tao; Zhang, Xueli; Bi, Changhao] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Zhao, Dongdong; Feng, Xu; Zhu, Xinna; Wu, Tao; Zhang, Xueli; Bi, Changhao] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Feng, Xu] China West Normal Univ, Sch Iife Sci, Nanchong 637002, Peoples R China; [Wu, Tao] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing 100083, Peoples R China	Zhang, XL; Bi, CH (reprint author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Zhang, XL; Bi, CH (reprint author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China.	zhang_xl@tib.cas.cn; bi_ch@tib.cas.cn			National High Technology Research and Development Program of China [2015AA020202]; Tianjin Municipal Science and Technology Commission [14ZCZDSY00067]; Chinese Academy of Sciences [ZDRW-ZS-2016-3]; Novo Nordisk - Chinese Academy of Sciences (NN-CAS) [NNCAS-2015-2]	This research was financially supported by the National High Technology Research and Development Program of China (2015AA020202), the Tianjin Key Technology R&D program of Tianjin Municipal Science and Technology Commission (14ZCZDSY00067), the Key deployment project of the Chinese Academy of Sciences (ZDRW-ZS-2016-3) and the Novo Nordisk - Chinese Academy of Sciences (NN-CAS) Research Fund (NNCAS-2015-2).	Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bibikova M, 2002, GENETICS, V161, P1169; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chung M. E., 2016, BIOTECHNOLOGY BIOENG; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Mey M, 2007, J IND MICROBIOL BIOT, V34, P689, DOI 10.1007/s10295-007-0244-2; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kleinstiver B. P., 2015, NATURE BIOTECHNOLOGY, V33; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang H., 2017, FRONTIERS MICROBIOLO, V8; Zhao D., 2016, MICROBIAL CELL FACTO, V15; Zhao J, 2013, METAB ENG, V17, P42, DOI 10.1016/j.ymben.2013.02.002; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	37	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 30	2017	7								16624	10.1038/s41598-017-16998-8				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FO5JI	WOS:000416891400026	29192199	gold			2018-01-05	
J	Park, JJ; Yoo, CG; Flanagan, A; Pu, YQ; Debnath, S; Ge, YX; Ragauskas, AJ; Wang, ZY				Park, Jong-Jin; Yoo, Chang Geun; Flanagan, Amy; Pu, Yunqiao; Debnath, Smriti; Ge, Yaxin; Ragauskas, Arthur J.; Wang, Zeng-Yu			Defined tetra-allelic gene disruption of the 4-coumarate:coenzyme A ligase 1 (Pv4CL1) gene by CRISPR/Cas9 in switchgrass results in lignin reduction and improved sugar release	BIOTECHNOLOGY FOR BIOFUELS			English	Article						Genome editing; CRISPR/Cas9; Switchgrass; Panicum virgatum; Bioenergy; Lignin biosynthesis; 4-Coumarate:coenzyme A ligase; 4CL; Sugar release	PANICUM-VIRGATUM L.; TRANSGENIC SWITCHGRASS; REDUCED RECALCITRANCE; BIOFUEL PRODUCTION; GENOMICS; SYSTEM; FORAGE; YIELDS; LEADS; CROP	Background: The development of genome editing technologies offers new prospects in improving bioenergy crops like switchgrass (Panicum virgatum). Switchgrass is an outcrossing species with an allotetraploid genome (2n = 4x = 36), a complexity which forms an impediment to generating homozygous knock-out plants. Lignin, a major component of the plant cell wall and a contributor to cellulosic feedstock's recalcitrance to decomposition, stands as a barrier to efficient biofuel production by limiting enzyme access to cell wall polymers during the fermentation process. Results: We developed a CRISPR/Cas9 genome editing system in switchgrass to target a key enzyme involved in the early steps of monolignol biosynthesis, 4-Coumarate: coenzyme A ligase (4CL). Three 4CL genes, Pv4CL1, Pv4CL2, and Pv4CL3, were identified in switchgrass. Expression analysis revealed that Pv4CL1 transcripts were more abundant in the stem than in the leaf, while Pv4CL2 transcripts were barely detectable and Pv4CL3 was mainly expressed in the leaf. Pv4CL1 was selected as the target for CRISPR/Cas9 editing because of its preferential expression in highly lignified stem tissues. Specific guide RNA was constructed to target Pv4CL1. After introducing the construct into switchgrass calli, 39 transgenic plants were regenerated. Using two rounds of PCR screening and sequencing, four plants were confirmed to have tetra-allelic mutations simultaneously. The Pv4CL1 knock-out plants had reduced cell wall thickness, an 8-30% reduction in total lignin content, a 7-11% increase in glucose release, and a 23-32% increase in xylose release. Conclusion: This study established a successful CRISPR/Cas9 system in switchgrass with mutation efficiency reaching 10%. The system allows the precise targeting of the selected Pv4CL1 gene to create switchgrass knock-out mutant plants with decreased lignin content and reduced recalcitrance.	[Park, Jong-Jin; Flanagan, Amy; Debnath, Smriti; Ge, Yaxin; Wang, Zeng-Yu] Noble Res Inst, Ardmore, OK 73401 USA; [Park, Jong-Jin; Yoo, Chang Geun; Flanagan, Amy; Pu, Yunqiao; Ragauskas, Arthur J.; Wang, Zeng-Yu] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Pu, Yunqiao; Ragauskas, Arthur J.] Oak Ridge Natl Lab, Biosci Div, Joint Inst Biol Sci, Oak Ridge, TN 37830 USA; [Ragauskas, Arthur J.] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN 37996 USA; [Ragauskas, Arthur J.] Univ Tennessee, Inst Agr, Dept Forestry Wildlife & Fisheries, Ctr Renewable Carbon, Knoxville, TN 37996 USA	Wang, ZY (reprint author), Noble Res Inst, Ardmore, OK 73401 USA.; Wang, ZY (reprint author), Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.	zywang@noble.org			BioEnergy Science Center; Samuel Roberts Noble Foundation; Office of Biological and Environmental Research in the DOE Office of Science [DE-AC05-00OR22725]	This work was supported by the BioEnergy Science Center and The Samuel Roberts Noble Foundation. The BioEnergy Science Center (DE-AC05-00OR22725) is a US Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science.	Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Baxter HL, 2014, PLANT BIOTECHNOL J, V12, P914, DOI 10.1111/pbi.12195; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dumitrache A, 2017, PLANT BIOTECHNOL J, V15, P688, DOI 10.1111/pbi.12666; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ge YX, 2011, CROP SCI, V51, P2698, DOI 10.2135/cropsci2011.01.0057; Gou J, 2017, NEW PHYTOL; Hardin CF, 2013, BIOENERG RES, V6, P755, DOI 10.1007/s12155-012-9292-1; Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776                                                               ; LAPIERRE C, 1995, RES CHEM INTERMEDIAT, V21, P397, DOI 10.1007/BF03052266                                                              ; Lee D, 1997, PLANT CELL, V9, P1985; Liu S, 2017, FRONT PLANT SCI; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Mann DGJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-74; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x                                        ; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; Shen H, 2013, PLANT CELL, V25, P4342, DOI 10.1105/tpc.113.118828; Stuible HP, 2001, J BIOL CHEM, V276, P26893, DOI 10.1074/jbc.M100355200; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZY, 2012, ANN BOT-LONDON, V110, P1317, DOI 10.1093/aob/mcs027; Wu ZY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0516-z; Xi YJ, 2009, METHODS MOL BIOL, V581, P53, DOI 10.1007/978-1-60761-214-8_4; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x	35	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-6834			BIOTECHNOL BIOFUELS	Biotechnol. Biofuels	NOV 30	2017	10								284	10.1186/s13068-017-0972-0				11	Biotechnology & Applied Microbiology; Energy & Fuels	Biotechnology & Applied Microbiology; Energy & Fuels	FO5CG	WOS:000416866100001	29213323	gold			2018-01-05	
J	Chen, SC; Blom, J; Loch, TP; Faisal, M; Walker, ED				Chen, Shicheng; Blom, Jochen; Loch, Thomas P.; Faisal, Mohamed; Walker, Edward D.			The Emerging Fish Pathogen Flavobacterium spartansii Isolated from Chinook Salmon: Comparative Genome Analysis and Molecular Manipulation	FRONTIERS IN MICROBIOLOGY			English	Article						Flavobacterium spartansii; genome analysis; virulence factors; mutation	JOHNSONIAE GLIDING MOTILITY; IX SECRETION SYSTEM; CRISPR-CAS SYSTEMS; TETRACYCLINE RESISTANCE; CONJUGATIVE TRANSPOSON; VIRULENCE FACTORS; GENE-TRANSFER; SEQUENCE; BACTEROIDES; PSYCHROPHILUM	Flavobacterium spartansii strain T16(T) was isolated from a disease outbreak in hatchery-reared Chinook salmon (Oncorhynchus tshawytscha) fingerlings. To gain insight into its genomic content, structure and virulence pathogenesis factors, comparative genome analyses were performed using genomes from environmental and virulent Flavobacterium strains. F. spartansii shared low average nucleotide identity (ANI) to well-known fish-pathogenic flavobacteria (e.g., F. columnare, F. psychrophilum, and F. branchiophilum), indicating that it is a new and emerging fish pathogen. The genome in T16T had a length of 5,359,952 bp, a GC-content 35.7%, and 4,422 predicted protein-coding sequences. Flavobacterium core genome analysis showed that the number of shared genes decreased with the addition of input genomes and converged at 1182 genes. At least 8 genomic islands and 5 prophages were predicted in T16(T). At least 133 virulence factors associated with virulence in pathogenic bacteria were highly conserved in F. spartansii T16(T). Furthermore, genes linked to virulence in other bacterial species (e.g., those encoding for a type IX secretion system, collagenase and hemolysin) were found in the genome of F. spartansii T16(T) and were conserved in most of the analyzed pathogenic Flavobacterium. F. spartansii was resistant to ampicillin and penicillin, consistent with the presence of multiple genes encoding diverse lactamases and the penicillin-binding protein in the genome. To allow for future investigations into F. spartansii virulence in vivo, a transposon-based random mutagenesis strategy was attempted in F. spartansii T16(T) using pHimarEm1. Four putative gliding motility deficient mutants were obtained and the insertion sites of pHimarEm1 in the genome of these mutants were characterized. In total, study results clarify some of the mechanisms by which emerging flavobacterial fish pathogens may cause disease and also provide direly needed tools to investigate their pathogenesis.	[Chen, Shicheng; Walker, Edward D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Blom, Jochen] Justus Liebig Univ, Bioinformat & Syst Biol, Giessen, Germany; [Loch, Thomas P.; Faisal, Mohamed] Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Faisal, Mohamed] Michigan State Univ, Dept Fisheries & Wildlife, Coll Agr & Nat Resources, E Lansing, MI 48824 USA	Chen, SC (reprint author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	shicheng@msu.edu			NIH [R37AI21884]	This project was funded by NIH grant R37AI21884.	Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baba H, 2002, INFECT IMMUN, V70, P107, DOI 10.1128/IAI.70.1.107-113.2002; Barbier P, 2012, J BACTERIOL, V194, P3024, DOI 10.1128/JB.00420-12; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bartelme R. P., 2016, GENOME ANNOUNC, V4, DOI 10.1128/genomeA.00624-16; Blom J, 2016, NUCLEIC ACIDS RES, V44, pW22, DOI 10.1093/nar/gkw255; Bowker J. D., 2016, GUIDE USING DRUGS BI; Braun TF, 2005, J BACTERIOL, V187, P6943, DOI 10.1128/JB.187.20.6943-6952.2005; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Castillo D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152515; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen S, 2007, APPL ENVIRON MICROB, V73, P1089, DOI 10.1128/AEM.01577-06; Chen SC, 2007, J BACTERIOL, V189, P5108, DOI 10.1128/JB.00401-07; Chen SC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01483; de Diego I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23123; Drulis-Kawa Z, 2012, CURR PROTEIN PEPT SC, V13, P699, DOI 10.2174/138920312804871193                                                      ; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Dutta C., 2015, ENCY METAGENOMICS GE, P251; Franco AA, 2004, J BACTERIOL, V186, P6077, DOI 10.1128/jb.186.18.6077-6092.2004; Gorenc K, 2012, FOLIA MICROBIOL, V57, P285, DOI 10.1007/s12223-012-0126-5; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; HAWKE J P, 1992, Journal of Aquatic Animal Health, V4, P109, DOI 10.1577/1548-8667(1992)004<0109:SIAASO>2.3.CO;2; Hunnicutt DW, 2001, J BACTERIOL, V183, P4167, DOI 10.1128/JB.183.14.4167-4175.2001; Jackson R. W., 2011, MOB GENET ELEMENTS, V1, P55, DOI DOI 10.4161/MGE.1.1.16432; Jeters RT, 2009, J BACTERIOL, V191, P6374, DOI 10.1128/JB.00739-09; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kayansamruaj P, 2017, INFECT GENET EVOL, V54, P7, DOI 10.1016/j.meegid.2017.06.012; Klein CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079786; Kolton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076704; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kulkarni SS, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00884-16; Kumru S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01375; Laanto E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00158-7; Lassalle F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004941; Loch TP, 2016, J FISH DIS, V39, P483, DOI 10.1111/jfd.12363; Loch TP, 2017, FISH VIRUSES AND BACTERIA: PATHOBIOLOGY AND PROTECTION, P211, DOI 10.1079/9781780647784.0211; Loch TP, 2015, J ADV RES, V6, P283, DOI 10.1016/j.jare.2014.10.009; Loch TP, 2014, DIS AQUAT ORGAN, V112, P45, DOI 10.3354/dao02791; Loch TP, 2014, INT J SYST EVOL MICR, V64, P406, DOI 10.1099/ijs.0.051433-0; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McBride MJ, 2015, CURR OPIN MICROBIOL, V28, P72, DOI 10.1016/j.mib.2015.07.016; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Morgan P, 1996, REV MED MICROBIOL, V7, P221; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Nakayama H, 2016, BIOSCI BIOTECH BIOCH, V80, P135, DOI 10.1080/09168451.2015.1079477; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001                                                   ; SPEER BS, 1990, J BACTERIOL, V172, P292; SPEER BS, 1991, J BACTERIOL, V173, P176, DOI 10.1128/jb.173.1.176-183.1991                                                   ; Starliper CE, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P606, DOI 10.1079/9781845935542.0606; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Whitman K. A., 2004, FINFISH SHELLFISH BA, P258; Wiens G. D., 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00889-14, DOI 10.1128/GENOMEA.00889-14]; Wu AKK, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-3; Zhang Y., 2016, GENOME ANNOUNC, V4, DOI 10.1128/genomeA.00900-16; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Zhu YT, 2016, J BACTERIOL, V198, P1743, DOI 10.1128/JB.01020-15	71	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 30	2017	8								2339	10.3389/fmicb.2017.02339				15	Microbiology	Microbiology	FO1MX	WOS:000416526900001	29250046	gold			2018-01-05	
J	Tanaka, R; Higuchi, T; Kohatsu, S; Sato, K; Yamamoto, D				Tanaka, Ryoya; Higuchi, Tomohiro; Kohatsu, Soh; Sato, Kosei; Yamamoto, Daisuke			Optogenetic Activation of the fruitless-Labeled Circuitry in Drosophila subobscura Males Induces Mating Motor Acts	JOURNAL OF NEUROSCIENCE			English	Article						courtship; CRISPR/Cas9; Drosophila; fruitless	CENTRAL-NERVOUS-SYSTEM; MALE-SPECIFIC MUSCLE; COURTSHIP SONG; EXPRESSION PATTERNS; SEXUAL ORIENTATION; NEURAL CIRCUITRY; GENE; BEHAVIOR; MELANOGASTER; SELECTION	It remains an enigma how the nervous system of different animal species produces different behaviors. We studied the neural circuitry for mating behavior in Drosophila subobscura, a species that displays unique courtship actions not shared by other members of the genera including the genetic model D. melanogaster, in which the core courtship circuitry has been identified. We disrupted the D. subobscura fruitless (fru) gene, a master regulator for the courtship circuitry formation in D. melanogaster, resulting in complete loss of mating behavior. We also generated fru(soChrimV), which expresses the optogenetic activator Chrimson fused with a fluorescent marker under the native fru promoter. The fru-labeled circuitry in D. subobscura visualized by fru(soChrimV) revealed differences between females and males, optogenetic activation of which in males induced mating behavior including attempted copulation. These findings provide a substrate for neurogenetic dissection and manipulation of behavior in non-model animals, and will help to elucidate the neural basis for behavioral diversification.	[Tanaka, Ryoya; Higuchi, Tomohiro; Kohatsu, Soh; Sato, Kosei; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 9808577, Japan	Yamamoto, D (reprint author), Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	daichan@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [17K19371, 17H05935, 16H06371];  [15J05088]	This work was supported, in part, by Grant-in-Aids for Scientific Research (Nos. 17K19371, 17H05935, and 16H06371) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) to D.Y., and a Grant-in-Aid for JSPS fellows (15J05088) to R.T. We thank A. Utsumi for secretarial assistance.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Cande J, 2014, CELL REP, V8, P362, DOI 10.1016/j.celrep.2014.06.023; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clowney EJ, 2015, NEURON, V87, P1036, DOI 10.1016/j.neuron.2015.07.025; CURRIE DA, 1995, DEVELOPMENT, V121, P2549; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ding Y, 2016, NATURE, V536, P329, DOI 10.1038/nature19093; Ferri SL, 2008, J NEUROGENET, V22, P17, DOI 10.1080/01677060701671947; Gailey DA, 1997, P NATL ACAD SCI USA, V94, P4543, DOI 10.1073/pnas.94.9.4543; GAILEY DA, 1991, DEVELOPMENT, V113, P879; Gleason JM, 2004, GENETICS, V166, P1303, DOI 10.1534/genetics.166.3.1303; Goodwin SF, 2000, GENETICS, V154, P725; Hagedorn J, 2008, P WORK C ADV VIS INT, P317; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450                                                            ; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Immonen E, 2009, BEHAV ECOL, V20, P289, DOI 10.1093/beheco/arp008; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Ito H, 2016, CURR BIOL, V26, P1532, DOI 10.1016/j.cub.2016.04.067; Ito H, 2012, CELL, V149, P1327, DOI 10.1016/j.cell.2012.04.025; Kallman BR, 2015, ELIFE, V4, DOI 10.7554/eLife.11188; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/nmeth.2836, 10.1038/NMETH.2836]; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kohatsu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7457; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kohl J, 2013, CELL, V155, P1610, DOI 10.1016/j.cell.2013.11.025; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D                        ; Luo L, 2016, PRINCIPLES NEUROBIOL; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Maynard Smith J, 1956, J GENET, V54, P261, DOI DOI 10.1007/BF02982781; Milani R, 1950, DROS INFORM SERV, V24, P88; Neville MC, 2014, CURR BIOL, V24, P229, DOI 10.1016/j.cub.2013.11.035; Nojima T, 2010, CURR BIOL, V20, P836, DOI 10.1016/j.cub.2010.02.064; Ren QZ, 2016, CURR BIOL, V26, P2583, DOI 10.1016/j.cub.2016.07.086; Reznick DN, 2009, NATURE, V457, P837, DOI 10.1038/nature07894; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4                                                   ; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Song HJ, 2002, GENETICS, V162, P1703; Spieth HT, 1952, B AM MUS NAT HIST, V99, P399; STEELE RH, 1986, ANIM BEHAV, V34, P1087, DOI 10.1016/S0003-3472(86)80168-3; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Takayanagi S, 2015, J NEUROGENET, V29, P23, DOI 10.3109/01677063.2014.983101; Tanaka R, 2016, INSECT MOL BIOL, V25, P355, DOI 10.1111/imb.12232; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Villella A, 1997, GENETICS, V147, P1107; von Philipsborn AC, 2014, CURR BIOL, V24, P242, DOI 10.1016/j.cub.2013.12.015; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Yamamoto D, 2013, J NEUROGENET, V27, P130, DOI 10.3109/01677063.2013.800060; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	62	0	0	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	NOV 29	2017	37	48					11662	11674		10.1523/JNEUROSCI.1943-17.2017				13	Neurosciences	Neurosciences & Neurology	FP1KT	WOS:000417372300013	29109241				2018-01-05	
J	Tang, ZL; Wang, S; Tu, C; Wang, T; Ma, CW; Liu, Y; Xiao, SX; Wang, XP				Tang, Zhuang-li; Wang, Shuang; Tu, Chen; Wang, Tian; Ma, Cheng-wen; Liu, Yan; Xiao, Sheng-xiang; Wang, Xiao-peng			Eight Novel Mutations of the ADAR1 Gene in Chinese Patients with Dyschromatosis Symmetrica Hereditaria	GENETIC TESTING AND MOLECULAR BIOMARKERS			English	Article; Early Access						ADAR1; dyschromatosis symmetrica hereditaria; gene mutation	ADENOSINE-DEAMINASE GENE; EDITING ENZYME ADAR1; Z-DNA; RNA; INTERFERON; DSRNA	Aims: To identify potential novel gene mutations in Chinese patients with dyschromatosis symmetrica hereditaria (DSH). Methods: We enrolled 8 Chinese patients with familial DSH, 5 Chinese patients with sporadic DSH, and 100 randomly selected healthy individuals in this study. The genome of each participant was extracted from peripheral blood samples. Sanger sequencing was performed after polymerase chain reaction. Comparison between the outcomes and the NCBI database was made, thus novel mutations were identified. Results: We detected eight novel heterozygous mutations and five previously reported mutations in our patients. The novel mutations include c.1934+3A>G, c.2749A>G, c.2311insA, c.3233G>A, c.3019+1G>T, c.2894C>A, c.1202_1205del, and c.2280C>A. All these detected novel mutations consist of two frame-shift mutations, three missense mutations, one nonsense mutation, and two splice-site mutations. Conclusions: The findings of this study expand our knowledge of ADAR1 gene mutations in DSH. All of these results will contribute to identifying the correlation between the phenotypes and genotypes. Furthermore, they will help better understand and reveal the pathogenic mechanism.	[Tang, Zhuang-li; Wang, Shuang; Tu, Chen; Wang, Tian; Liu, Yan; Xiao, Sheng-xiang; Wang, Xiao-peng] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Dermatol & Venereol, Xi 5 Rd 157, Xian 710004, Shaanxi, Peoples R China; [Ma, Cheng-wen] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gen Surg, Xian, Shaanxi, Peoples R China	Wang, XP (reprint author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Dermatol & Venereol, Xi 5 Rd 157, Xian 710004, Shaanxi, Peoples R China.	wxpdoctor@mail.xjtu.edu.cn			Nature Science Foundation of China [81101184]	This study was supported by the Nature Science Foundation of China (grant No. 81101184). The authors appreciate the efforts of the staff members involved in this study and thank the patients for their participation.	Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371                                                               ; Hayashi M, 2013, J DERMATOL, V40, P336, DOI 10.1111/j.1346-8138.2012.01661.x; Herbert A, 2002, MOL CELL, V10, P1235, DOI 10.1016/S1097-2765(02)00737-2                                                   ; Herbert A, 2001, P NATL ACAD SCI USA, V98, P12132, DOI 10.1073/pnas.211419898; Hou YX, 2007, ACTA DERM-VENEREOL, V87, P18, DOI 10.2340/00015555-0168; Lee NR, 2015, MOL CELLS, V38, P759, DOI 10.14348/molcells.2015.0047; Li M, 2010, ARCH DERMATOL RES, V302, P469, DOI 10.1007/s00403-010-1039-2; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115074; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Miyamura Y, 2003, AM J HUM GENET, V73, P693, DOI 10.1086/378209; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Sharma R, 2011, J DERMATOL SCI, V64, P70, DOI 10.1016/j.jdermsci.2011.06.013; Song C, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120129; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; WANG Y, 1995, J MOL BIOL, V254, P184, DOI 10.1006/jmbi.1995.0610; Zhang XJ, 2003, J INVEST DERMATOL, V120, P776, DOI 10.1046/j.1523-1747.2003.12130.x	22	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1945-0265	1945-0257		GENET TEST MOL BIOMA	Genet. Test. Mol. Biomark.	NOV 29	2017										10.1089/gtmb.2017.0207		NOV	2017	5	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FP0KE	WOS:000417287400001					2018-01-05	
J	Remy, S; Chenouard, V; Tesson, L; Usal, C; Menoret, S; Brusselle, L; Heslan, JM; Nguyen, TH; Bellien, J; Merot, J; De Cian, A; Giovannangeli, C; Concordet, JP; Anegon, I				Remy, Severine; Chenouard, Vanessa; Tesson, Laurent; Usal, Claire; Menoret, Severine; Brusselle, Lucas; Heslan, Jean-Marie; Tuan Huan Nguyen; Bellien, Jeremy; Merot, Jean; De Cian, Anne; Giovannangeli, Carine; Concordet, Jean-Paul; Anegon, Ignacio			Generation of gene-edited rats by delivery of CRISPR/Cas9 protein and donor DNA into intact zygotes using electroporation	SCIENTIFIC REPORTS			English	Article							HOMOLOGY-DIRECTED REPAIR; KNOCKOUT RATS; EMBRYO MICROINJECTION; ZONA-PELLUCIDA; MOUSE ZYGOTES; PLASMID DNA; GENOME; NUCLEASES; MICE; INSERTION	The generation of gene-edited animals using the CRISPRs/Cas9 system is based on microinjection into zygotes which is inefficient, time consuming and demands high technical skills. We report the optimization of an electroporation method for intact rat zygotes using sgRNAs and Cas9 protein in combination or not with ssODNs (similar to 100 nt). This resulted in high frequency of knockouts, between 15 and 50% of analyzed animals. Importantly, using ssODNs as donor template resulted in precise knock-in mutations in 25-100% of analyzed animals, comparable to microinjection. Electroporation of long ssDNA or dsDNA donors successfully used in microinjection in the past did not allow generation of genome-edited animals despite dsDNA visualization within zygotes. Thus, simultaneous electroporation of a large number of intact rat zygotes is a rapid, simple, and efficient method for the generation of a variety of genome-edited rats.	[Remy, Severine; Chenouard, Vanessa; Tesson, Laurent; Usal, Claire; Menoret, Severine; Brusselle, Lucas; Heslan, Jean-Marie; Tuan Huan Nguyen; Anegon, Ignacio] Univ Nantes, Ctr Rech Transplantat & Immunol UMR1064, INSERM, Nantes, France; [Remy, Severine; Chenouard, Vanessa; Tesson, Laurent; Usal, Claire; Menoret, Severine; Brusselle, Lucas; Heslan, Jean-Marie; Tuan Huan Nguyen; Anegon, Ignacio] CHU Nantes, ITUN, Nantes, France; [Remy, Severine; Chenouard, Vanessa; Tesson, Laurent; Usal, Claire; Menoret, Severine; Brusselle, Lucas; Heslan, Jean-Marie; Anegon, Ignacio] INSERM, Platform Transgen Rats & ImmunoPhen, UMR CRTI 1064, F-44093 Nantes, France; [Heslan, Jean-Marie; Tuan Huan Nguyen] INSERM, UMR CRTI 1064, Platform GenoCellEdit, F-44093 Nantes, France; [Bellien, Jeremy] INSERM, U1096, F-76031 Rouen, France; [Merot, Jean] CNRS, Inst Thorax, INSERM, UMR 6291,UMR 1087, F-44007 Nantes, France; [De Cian, Anne; Giovannangeli, Carine; Concordet, Jean-Paul] CNRS, INSERM, U565, UMR7196, F-75005 Paris, France	Remy, S; Anegon, I (reprint author), Univ Nantes, Ctr Rech Transplantat & Immunol UMR1064, INSERM, Nantes, France.; Remy, S; Anegon, I (reprint author), CHU Nantes, ITUN, Nantes, France.; Remy, S; Anegon, I (reprint author), INSERM, Platform Transgen Rats & ImmunoPhen, UMR CRTI 1064, F-44093 Nantes, France.	severine.remy@univ-nantes.fr; ignacio.anegon@univ-nantes.fr			Region Pays de la Loire through Biogenouest; "TEFOR" project; Investissements d'Avenir" French Government program [ANRII-INSB-0014]; LabCom "SOURIRAT" [ANR-14-LAB5-0008]; Labex IGO project, "Investissements d'Avenir" French Government program [ANR-11-LABX-0016-01]; IHU-Cesti project, "Investissements d'Avenir" French Government program [ANR-10-IBHU-005]; Nantes Metropole; Region Pays de la Loire; Fondation Progreffe	We thank the integrative genomic facility of Nantes for sequencing experiments. We also thank the MicroPICell facility of Nantes for confocal analyses. This work was financially supported by the Region Pays de la Loire through Biogenouest and by the "TEFOR" project funded by the Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR) (ANRII-INSB-0014). It was also partially funded by the LabCom "SOURIRAT" (ANR-14-LAB5-0008). This work was realized in the context of the Labex IGO project (no ANR-11-LABX-0016-01) and the IHU-Cesti project (ANR-10-IBHU-005) which both are part of the "Investissements d'Avenir" French Government program managed by the ANR. The IHU-Cesti project is also supported by Nantes Metropole and Region Pays de la Loire. This work was also realized in the context of the support provided by the Fondation Progreffe.	Badding MA, 2013, GENE THER, V20, P616, DOI 10.1038/gt.2012.77; BRONSON RA, 1970, J REPROD FERTIL, V22, P129; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Escoffre JM, 2011, BBA-BIOMEMBRANES, V1808, P1538, DOI 10.1016/j.bbamem.2010.10.009; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Hashimoto M., 2016, DEV BIOL; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Kaneko Takehito, 2017, Methods Mol Biol, V1630, P81, DOI 10.1007/978-1-4939-7128-2_7; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Lam AP, 2010, GENE THER, V17, P439, DOI 10.1038/gt.2010.31; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Miller AM, 2009, ADV DRUG DELIVER REV, V61, P603, DOI 10.1016/j.addr.2009.02.008; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; MODLINSKI JA, 1970, J EMBRYOL EXP MORPH, V23, P539; Nemudryi AA, 2014, ACTA NATURAE, V6, P19; Okuyama M, 2012, J REPROD DEVELOP, V58, P295, DOI 10.1262/jrd.11-092H; Osborn MJ, 2013, J IMMUNOL, V190, P1481, DOI 10.4049/jimmunol.1203041; Paix A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw502; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043748; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Remy S, 2014, GENOME RES, V24, P1371, DOI 10.1101/gr.171538.113; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Rosazza C, 2013, MOL THER, V21, P2217, DOI [10.1038/mt.2073.182, 10.1038/mt.2013.182]; Rosazza C, 2011, MOL THER, V19, P913, DOI 10.1038/mt.2010.303; Sato M, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0115-8; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Young JL, 2015, ADV GENET, V89, P49, DOI 10.1016/bs.adgen.2014.10.003	34	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 29	2017	7								16554	10.1038/s41598-017-16328-y				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FO0BZ	WOS:000416409100014	29185448	gold			2018-01-05	
J	Amoasii, L; Long, CZ; Li, H; Mireault, AA; Shelton, JM; Sanchez-Ortiz, E; McAnally, JR; Bhattacharyya, S; Schmidt, F; Grimm, D; Hauschka, SD; Bassel-Duby, R; Olson, EN				Amoasii, Leonela; Long, Chengzu; Li, Hui; Mireault, Alex A.; Shelton, John M.; Sanchez-Ortiz, Efrain; McAnally, John R.; Bhattacharyya, Samadrita; Schmidt, Florian; Grimm, Dirk; Hauschka, Stephen D.; Bassel-Duby, Rhonda; Olson, Eric N.			Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy	SCIENCE TRANSLATIONAL MEDICINE			English	Article							EXONIC SPLICING ENHANCERS; ADENOASSOCIATED VIRUS; DUCHENNE; MUSCLE; GENE; THERAPY; MICE; ETEPLIRSEN; MUTATIONS; MYOBLASTS	Duchenne muscular dystrophy (DMD) is a severe, progressive muscle disease caused by mutations in the dystrophin gene. The majority of DMD mutations are deletions that prematurely terminate the dystrophin protein. Deletions of exon 50 of the dystrophin gene are among the most common single exon deletions causing DMD. Such mutations can be corrected by skipping exon 51, thereby restoring the dystrophin reading frame. Using clustered regularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/Cas9), we generated a DMD mouse model by deleting exon 50. These Delta Ex50 mice displayed severe muscle dysfunction, which was corrected by systemic delivery of adeno-associated virus encoding CRISPR/Cas9 genome editing components. We optimized the method for dystrophin reading frame correction using a single guide RNA that created reframing mutations and allowed skipping of exon 51. In conjunction with muscle-specific expression of Cas9, this approach restored up to 90% of dystrophin protein expression throughout skeletal muscles and the heart of Delta Ex50 mice. This method of permanently bypassing DMD mutations using a single cut in genomic DNA represents a step toward clinical correction of DMD mutations and potentially those of other neuromuscular disorders.	[Amoasii, Leonela; Long, Chengzu; Li, Hui; Mireault, Alex A.; Sanchez-Ortiz, Efrain; McAnally, John R.; Bhattacharyya, Samadrita; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Dallas, Senator Paul D Wellstone Muscular Dystrophy Coope, Hamon Ctr Regenerat Sci & Med, Southern Med Ctr,Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schmidt, Florian; Grimm, Dirk] Heidelberg Univ Hosp, BioQuant Ctr, DZIF Partner, Ctr Infect Dis,Virol,Cluster Excellence Cell Netw, D-69120 Heidelberg, Germany; [Hauschka, Stephen D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Long, Chengzu] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY 10016 USA	Olson, EN (reprint author), Univ Texas Dallas, Senator Paul D Wellstone Muscular Dystrophy Coope, Hamon Ctr Regenerat Sci & Med, Southern Med Ctr,Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu		Amoasii, Leonela/0000-0001-7960-2749	NIH [HL130253, HL-077439, DK-099653, AR-067294, AR-18860]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [U54 HD 087351, U54 AR-065139]; Robert A. Welch Foundation [1-0025]; German Research Foundation [SFB1129, TRR179, EXC81]; German Center for Infection Research [TTU HIV 04.803]; Deutsche Duchenne-Stiftung; Muscular Dystrophy Association	This work was supported by grants from the NIH (HL130253, HL-077439, DK-099653, and AR-067294), Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (U54 HD 087351), the Robert A. Welch Foundation (grant 1-0025 to E.N.O.), by grants to D.G. from the German Research Foundation (SFB1129, TRR179, and EXC81), the German Center for Infection Research (TTU HIV 04.803) and Deutsche Duchenne-Stiftung, and by grants to S.D.H. from the Muscular Dystrophy Association, the NIH (AR-18860), and a Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (U54 AR-065139).	Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P1, DOI 10.1089/nat.2016.0657; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Arnett ALH, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.38; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHAMBERLAIN JS, 1985, MOL CELL BIOL, V5, P484, DOI 10.1128/MCB.5.3.484                                                             ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dowling JJ, 2016, NAT REV NEUROL, V12, P675, DOI 10.1038/nrneurol.2016.180; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855                                                            ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kodippili K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088280; Le Hir M, 2013, MOL THER, V21, P1551, DOI 10.1038/mt.2013.121; Li YY, 2016, J INT MED RES, V44, P99, DOI 10.1177/0300060515613223; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martari M, 2009, HUM GENE THER, V20, P759, DOI 10.1089/hum.2008.197; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303                                                     ; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4                                                   ; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; O'Brien KF, 2001, MOL GENET METAB, V74, P75, DOI 10.1006/mgme.2001.3220; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Ramos J, 2015, EXPERT OPIN ORPHAN D, V3, P1255, DOI 10.1517/21678707.2015.1088780; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romitti PA, 2015, PEDIATRICS, V135, P513, DOI 10.1542/peds.2014-2044; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Shin JH, 2013, MOL THER, V21, P750, DOI 10.1038/mt.2012.283; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stein CA, 2016, MOL THER, V24, P1884, DOI 10.1038/mt.2016.188; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van Berlo JH, 2014, NAT MED, V20, P1386, DOI 10.1038/nm.3764; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yue YP, 2015, HUM MOL GENET, V24, P5880, DOI 10.1093/hmg/ddv310; Zhang Y., 2017, NANO RES, V3, P1; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	48	0	0	4	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	NOV 29	2017	9	418							eaan8081	10.1126/scitranslmed.aan8081				11	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FO1LN	WOS:000416522500003					2018-01-05	
J	Kim, SM; Yang, Y; Oh, SJ; Hong, Y; Seo, M; Jang, M				Kim, Seung Min; Yang, Yoosoo; Oh, Seung Ja; Hong, Yeonsun; Seo, Minkoo; Jang, Mihue			Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting	JOURNAL OF CONTROLLED RELEASE			English	Article						CRISPR/Cas9; Gene editing; Cancer therapy, combination therapy; Delivery vehicle; Exosomes; PARP-1; Cisplatin	EXTRACELLULAR VESICLES; OVARIAN-CANCER; COMMUNICATORS; NANOCARRIERS; RESISTANCE; VEHICLES; IMMUNITY; SIRNA; PARP	An intracellular delivery system for CRISPR/Cas9 is crucial for its application as a therapeutic genome editing technology in a broad range of diseases. Current vehicles carrying CRISPR/Cas9 limit in vivo delivery because of low tolerance and immunogenicity; thus, the in vivo delivery of genome editing remains challenging. Here, we report that cancer-derived exosomes function as natural carriers that can efficiently deliver CRISPR/Cas9 plasmids to cancer. Compared to epithelial cell-derived exosomes, cancer-derived exosomes provide potential vehicles for effective in vivo delivery via selective accumulation in ovarian cancer tumors of SKOV3 xenograft mice, most likely because of their cell tropism. CRISPR/Cas9-loaded exosomes can suppress expression of poly (ADP-ribose) polymerase-1 (PARP-1), resulting in the induction of apoptosis in ovarian cancer. Furthermore, the inhibition of PARP-1 by CRISPR/Cas9-mediated genome editing enhances the chemosensitivity to cisplatin, showing synergistic cytotoxicity. Based on these results, tumor-derived exosomes may be very promising for cancer therapeutics in the future.	[Kim, Seung Min; Yang, Yoosoo; Hong, Yeonsun; Jang, Mihue] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea; [Yang, Yoosoo] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Seoul 02792, South Korea; [Oh, Seung Ja] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Biomat, Seoul 136791, South Korea; [Hong, Yeonsun] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 02841, South Korea; [Seo, Minkoo] Prostem Co Ltd, 708 Eonju Ro, Seoul 06061, South Korea	Jang, M (reprint author), Korea Inst Sci & Technol, 5,Hwarang Ro 14 Gil, Seoul 02792, South Korea.	mihue@kist.re.kr			intramural research program of KIST [2E26910]	This research was supported by the intramural research program (2E26910) of KIST.	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Annunziata C. M., 2010, F1000 BIOL REP, V2; Barile L., 2017, PHARM THER; Coakley G, 2015, TRENDS PARASITOL, V31, P477, DOI [10.1016/j.pt.2015.06.009, 10.1016/j.pt.2015.05.009]; Do K, 2013, CLIN CANCER RES, V19, P977, DOI 10.1158/1078-0432.CCR-12-0163; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545                                                    ; Kim EJ, 2017, KOREAN J INTERN MED, V32, P42, DOI 10.3904/kjim.2016.198; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Li M, 2015, ONCOGENE, V34, P3349, DOI 10.1038/onc.2014.295; Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Lorenzer C, 2015, J CONTROL RELEASE, V203, P1, DOI 10.1016/j.jconrel.2015.02.003; Michels J, 2014, ONCOGENE, V33, P3894, DOI 10.1038/onc.2013.352; Montoni A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00018; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pothuri B, 2013, ANN ONCOL, V24, P22, DOI 10.1093/annonc/mdt307; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Ruiss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025294; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seow Y, 2009, MOL THER, V17, P767, DOI 10.1038/mt.2009.41; Sercombe L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00286; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; van den Boorn JG, 2013, ADV DRUG DELIVER REV, V65, P331, DOI 10.1016/j.addr.2012.06.011; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang JH, 2014, BLOOD, V124, P555, DOI [10.1182/blood-2014-03562439, 10.1182/blood-2014-03-562439]; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wei W, 2016, ONCOL LETT, V12, P4561, DOI 10.3892/ol.2016.5226; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zlotogorski-Hurvitz A, 2015, J HISTOCHEM CYTOCHEM, V63, P181, DOI 10.1369/0022155414564219	39	0	0	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	NOV 28	2017	266						8	16		10.1016/j.jconrel.2017.09.013				9	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	FP0VJ	WOS:000417325400002	28916446				2018-01-05	
J	Liu, C; Zhang, L; Liu, H; Cheng, K				Liu, Chang; Zhang, Li; Liu, Hao; Cheng, Kun			Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications	JOURNAL OF CONTROLLED RELEASE			English	Review						CRISPR-Cas9; Delivery; Gene-editing; Gene therapy; Non-viral delivery; Nanoparticle	PEPTIDE-MEDIATED DELIVERY; SINGLE LENTIVIRAL VECTOR; HEPATITIS-B-VIRUS; IN-VIVO; HUMAN-CELLS; CAS SYSTEMS; GUIDE RNA; INTRACELLULAR DELIVERY; HYDRODYNAMIC DELIVERY; HEMATOPOIETIC STEM	The CRISPR-Cas9 genome-editing system is a part of the adaptive immune system in archaea and bacteria to defend against invasive nucleic acids from phages and plasmids. The single guide RNA (sgRNA) of the system recognizes its target sequence in the genome, and the Cas9 nuclease of the system acts as a pair of scissors to cleave the double strands of DNA. Since its discovery, CRISPR-Cas9 has become the most robust platform for genome engineering in eukaryotic cells. Recently, the CRISPR-Cas9 system has triggered enormous interest in therapeutic applications. CRISPR-Cas9 can be applied to correct disease-causing gene mutations or engineer T cells for cancer immunotherapy. The first clinical trial using the CRISPR-Cas9 technology was conducted in 2016. Despite the great promise of the CRISPR-Cas9 technology, several challenges remain to be tackled before its successful applications for human patients. The greatest challenge is the safe and efficient delivery of the CRISPR-Cas9 genome-editing system to target cells in human body. In this review, we will introduce the molecular mechanism and different strategies to edit genes using the CRISPR-Cas9 system. We will then highlight the current systems that have been developed to deliver CRISPR-Cas9 in vitro and in vivo for various therapeutic purposes.	[Liu, Chang; Zhang, Li; Liu, Hao; Cheng, Kun] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, 2464 Charlotte St, Kansas City, MO 64108 USA	Cheng, K (reprint author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, 2464 Charlotte St, Kansas City, MO 64108 USA.	chengkun@umkc.edu			American Cancer Society-Lee National Denim Day Research Scholar Grant [RSG-15-132-01-CDD]; National Institutes of Health [1R01AA021510, 1R01GM121798]	Kun Cheng, PhD was supported by an American Cancer Society-Lee National Denim Day Research Scholar Grant (RSG-15-132-01-CDD). This work is partly supported by the awards (1R01AA021510, 1R01GM121798) from the National Institutes of Health.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Al-Dosari MS, 2005, ADV GENET, V54, P65, DOI 10.1016/S0065-2660(05)54004-5; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick T. J., 2013, NUCLEIC ACIDS RES; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fei J.-F., 2016, REGEN MED, V1, P16002; Fei JF, 2014, CELL REP, V7, P398, DOI 10.1016/j.celrep.2014.03.033; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2014, CELL MOL LIFE SCI, V71, P449, DOI 10.1007/s00018-013-1438-6; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Grimm D., 2003, Current Gene Therapy, V3, P281, DOI 10.2174/1566523034578285; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Horii T., 2014, SCI REP, V4; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hruscha A, 2015, METHODS MOL BIOL, V1254, P341, DOI 10.1007/978-1-4939-2152-2_24; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu R, 2014, ANGEW CHEM INT EDIT, V53, P5821, DOI 10.1002/anie.201400323; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kabadi AM, 2014, MOL THER, V22, pS124; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kang YK, 2017, BIOCONJUGATE CHEM, V28, P957, DOI 10.1021/acs.bioconjchem.6b00676; Katz MG, 2013, HUM GENE THER, V24, P914, DOI 10.1089/hum.2013.2517; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; LI L, 2014, CYTOTHERAPY S, V16, pS37; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Maggio I., 2014, SCI REP, V4; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mashiko D., 2013, SCI REP, V3; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mout R., 2017, ACS NANO; Mout R, 2017, BIOCONJUGATE CHEM, V28, P880, DOI 10.1021/acs.bioconjchem.7b00057; Mulvihill JJ, 2017, BRIT MED BULL, V122, P17, DOI 10.1093/bmb/ldx002; Nakagawa Y, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0144-x; Nakamura H, 2004, MECH DEVELOP, V121, P1137, DOI 10.1016/j.mod.2004.05.013; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Raghavan A., 2016, BIORXIV; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramanan V., 2015, SCI REP, V5; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sampson TR, 2014, BIOESSAYS, V36, P34, DOI 10.1002/bies.201300135; Sasaki H, 2014, DEV GROWTH DIFFER, V56, P499, DOI 10.1111/dgd.12149; Schnell T, 2000, HUM GENE THER, V11, P439, DOI 10.1089/10430340050015905                                                       ; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Seeger C., 2014, MOL THER, V3; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Suda T, 2015, ADV GENET, V89, P89, DOI 10.1016/bs.adgen.2014.10.002; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Suresh B, 2017, METHODS MOL BIOL, V1507, P81, DOI 10.1007/978-1-4939-6518-2_7; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thummel R, 2006, DEV BIOL, V295, P356, DOI 10.1016/j.ydbio.2006.04.095; Travis J, 2015, SCIENCE, V350, P1299, DOI 10.1126/science.350.6266.1299; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Worthen Christal A, 2017, Methods Mol Biol, V1627, P245, DOI 10.1007/978-1-4939-7113-8_17; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yan Quanmei, 2014, Cell Regen (Lond), V3, P12, DOI 10.1186/2045-9769-3-12; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yuan M., 2016, VIRUSES, V8; Yusa K, 2015, HUM GENE THER, V26, pA3; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zufferey R, 1998, J VIROL, V72, P9873; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	118	0	0	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	NOV 28	2017	266						17	26		10.1016/j.jconrel.2017.09.012				10	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	FP0VJ	WOS:000417325400003	28911805				2018-01-05	
J	Hudaiberdiev, S; Shmakov, S; Wolf, YI; Terns, MP; Makarova, KS; Koonin, EV				Hudaiberdiev, Sanjarbek; Shmakov, Sergey; Wolf, Yuri I.; Terns, Michael P.; Makarova, Kira S.; Koonin, Eugene V.			Phylogenomics of Cas4 family nucleases	BMC EVOLUTIONARY BIOLOGY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DEFENSE SYSTEMS; DNA-REPAIR; HELICASE-NUCLEASE; ADAPTIVE IMMUNITY; CRISPR; PROTEIN; ADAPTATION; EVOLUTION; BACTERIAL	Background: The Cas4 family endonuclease is a component of the adaptation module in many variants of CRISPR-Cas adaptive immunity systems. Unlike most of the other Cas proteins, Cas4 is often encoded outside CRISPR-cas loci (solo-Cas4) and is also found in mobile genetic elements (MGE-Cas4). Results: As part of our ongoing investigation of CRISPR-Cas evolution, we explored the phylogenomics of the Cas4 family. About 90% of the archaeal genomes encode Cas4 compared to only about 20% of the bacterial genomes. Many archaea encode both the CRISPR-associated form (CAS-Cas4) and solo-Cas4, whereas in bacteria, this combination is extremely rare. The solo-cas4 genes are over-represented in environmental bacteria and archaea with small genomes that typically lack CRISPR-Cas, suggesting that Cas4 could perform uncharacterized defense or repair functions in these microbes. Phylogenomic analysis indicates that both the CRISPR-associated cas4 genes are often transferred horizontally but almost exclusively, as part of the adaptation module. The evolutionary integrity of the adaptation module sharply contrasts the rampant shuffling of CRISPR-cas modules whereby a given variant of the adaptation module can combine with virtually any effector module. The solo-cas4 genes evolve primarily via vertical inheritance and are subject only to occasional horizontal transfer. The selection pressure on cas4 genes does not substantially differ between CAS-Cas4 and solo-cas4, and is close to the genomic median. Thus, cas4 genes, similarly to cas1 and cas2, evolve similarly to 'regular' microbial genes involved in various cellular functions, showing no evidence of direct involvement in virus-host arms races. A notable feature of the Cas4 family evolution is the frequent recruitment of cas4 genes by various mobile genetic elements (MGE), particularly, archaeal viruses. The functions of Cas4 in these elements are unknown and potentially might involve anti-defense roles. Conclusions: Unlike most of the other Cas proteins, Cas4 family members are as often encoded by stand-alone genes as they are incorporated in CRISPR-Cas systems. In addition, cas4 genes were repeatedly recruited by MGE, perhaps, for anti-defense functions. Experimental characterization of the solo and MGE-encoded Cas4 nucleases is expected to reveal currently uncharacterized defense and anti-defense systems and their interactions with CRISPR-Cas systems.	[Hudaiberdiev, Sanjarbek; Shmakov, Sergey; Wolf, Yuri I.; Makarova, Kira S.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA; [Shmakov, Sergey] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia; [Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Koonin, EV (reprint author), NIH, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA.	koonin@ncbi.nlm.nih.gov			US Department of Health and Human Services (the National Library of Medicine); NIH [R35 118,160]	This work was supported by intramural funds of the US Department of Health and Human Services (the National Library of Medicine, to EVK) and by the NIH grant R35 118,160 (to MPT).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Butterer A, 2014, NUCLEIC ACIDS RES, V42, P5139, DOI 10.1093/nar/gku122; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epshtein V, 2015, BIOESSAYS, V37, P12, DOI 10.1002/bies.201400106; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gupta YK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8363; Hooton SPT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00355; Hooton Steven P T, 2014, Front Microbiol, V5, P744, DOI 10.3389/fmicb.2014.00744; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Krajewski WW, 2014, NATURE, V508, P416, DOI 10.1038/nature13037; Kristensen DM, 2017, NUCLEIC ACIDS RES, V45, pD210, DOI 10.1093/nar/gkw934; Krupovic M, 2017, CURR OPIN M IN PRESS; Krupovic M, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0093-2; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Lemak S, 2014, NUCLEIC ACIDS RES, V42, P11144, DOI 10.1093/nar/gku797; Lemak S, 2013, J AM CHEM SOC, V135, P17476, DOI 10.1021/ja408729b; Lenhart JS, 2012, MICROBIOL MOL BIOL R, V76, P530, DOI 10.1128/MMBR.05020-11; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Liu T, 2017, NUCLEIC ACIDS RES, V45, P8978, DOI 10.1093/nar/gkx612; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Marinus MG, 2014, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.ESP-0003-2013, DOI 10.1128/ECOSALPLUS.ESP-0003-2013]; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo P, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0942-y; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schwarz FW, 2013, SCIENCE, V340, P353, DOI 10.1126/science.1231122; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2017, MBIO IN PRESS; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Wilkinson M, 2016, ELIFE, V5; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232; Zhou C, 2015, ELIFE, V4, DOI 10.7554/eLife.09832	55	0	0	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2148			BMC EVOL BIOL	BMC Evol. Biol.	NOV 28	2017	17								232	10.1186/s12862-017-1081-1				14	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	FO0TJ	WOS:000416461300001	29179671	gold			2018-01-05	
J	Erives, AJ				Erives, Albert J.			Phylogenetic analysis of the core histone doublet and DNA topo II genes of Marseilleviridae: evidence of proto-eukaryotic provenance	EPIGENETICS & CHROMATIN			English	Article						Chromatin; Origin of eukaryotic chromatin; Core histones; Nucleosomes; DNA topoisomerase II; Eukaryotic replisome; Marseilleviridae; NCLDV; Archaea; CRISPR	PROPOSED FAMILY MARSEILLEVIRIDAE; COMPLETE GENOME SEQUENCE; TRYPANOSOMA-BRUCEI; TOPOISOMERASE-II; FUSION PROTEIN; GIANT VIRUSES; EVOLUTION; INFERENCE; CHROMATIN; MRBAYES	While the genomes of eukaryotes and Archaea both encode the histone-fold domain, only eukaryotes encode the core histone paralogs H2A, H2B, H3, and H4. With DNA, these core histones assemble into the nucleosomal octamer underlying eukaryotic chromatin. Importantly, core histones for H2A and H3 are maintained as neofunctionalized paralogs adapted for general bulk chromatin (canonical H2 and H3) or specialized chromatin (H2A.Z enriched at gene promoters and cenH3s enriched at centromeres). In this context, the identification of core histone-like "doublets" in the cytoplasmic replication factories of the Marseilleviridae (MV) is a novel finding with possible relevance to understanding the origin of eukaryotic chromatin. Here, we analyze and compare the core histone doublet genes from all known MV genomes as well as other MV genes relevant to the origin of the eukaryotic replisome. Using different phylogenetic approaches, we show that MV histone domains encode obligate H2B-H2A and H4-H3 dimers of possible proto-eukaryotic origin. MV core histone moieties form sister clades to each of the four eukaryotic clades of canonical and variant core histones. This suggests that MV core histone moieties diverged prior to eukaryotic neofunctionalizations associated with paired linear chromosomes and variant histone octamer assembly. We also show that MV genomes encode a proto-eukaryotic DNA topoisomerase II enzyme that forms a sister clade to eukaryotes. This is a relevant finding given that DNA topo II influences histone deposition and chromatin compaction and is the second most abundant nuclear protein after histones. The combined domain architecture and phylogenomic analyses presented here suggest that a primitive origin for MV histone genes is a more parsimonious explanation than horizontal gene transfers + gene fusions + sufficient divergence to eliminate relatedness to eukaryotic neofunctionalizations within the H2A and H3 clades without loss of relatedness to each of the four core histone clades. We thus suggest MV histone doublet genes and their DNA topo II gene possibly were acquired from an organism with a chromatinized replisome that diverged prior to the origin of eukaryotic core histone variants for H2/H2A.Z and H3/cenH3. These results also imply that core histones were utilized ancestrally in viral DNA compaction and/or protection from host endonucleases.	[Erives, Albert J.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Erives, AJ (reprint author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu			University of Iowa, Department of Biology	Author thanks the University of Iowa, Department of Biology, for funds to partially defray travel expenses to the 2017 Chromosomal Pairing Meeting in Brunswick, Maine, to present and discuss these results.	Aherfi S, 2014, VIROLOGY, V466, P27, DOI 10.1016/j.virol.2014.07.014; Aherfi S, 2014, ARCH VIROL, V159, P2349, DOI 10.1007/s00705-014-2023-5; Aherfi S, 2013, VIRUS GENES, V47, P550, DOI 10.1007/s11262-013-0965-4; Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Akiyoshi B, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130023; Ammar R, 2012, ELIFE, V2012, P1; Arantes TS, 2016, J VIROL, V90, P5246, DOI 10.1128/JVI.00177-16; Bailey KA, 1999, NUCLEIC ACIDS RES, V27, P532, DOI 10.1093/nar/27.2.532                                                            ; Boughalmi M, 2013, INTERVIROLOGY, V56, P386, DOI 10.1159/000354560; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Clavarie JM, 2013, COMMUN INTEGR BIOL, V6, DOI DOI 10.4161/cib.25685; Dawson SC, 2007, CHROMOSOMA, V116, P175, DOI 10.1007/s00412-006-0091-3; Doutre G, 2014, J VIROL, V88, P14340, DOI 10.1128/JVI.02414-14; Drinnenberg IA, 2014, ELIFE, V3, DOI 10.7554/eLife.03676; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fedry J, 2017, CELL, V168, P904, DOI 10.1016/j.cell.2017.01.024; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; He D, 2014, CURR BIOL, V24, P465, DOI 10.1016/j.cub.2014.01.036; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henikoff S, 2012, CHROMOSOMA, V121, P341, DOI 10.1007/s00412-012-0372-y; Horlbeck MA, 2016, ELIFE, P5; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Masonbrink RE, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0383-3; Mattiroli F, 2017, SCIENCE, V357, P609, DOI 10.1126/science.aaj1849; Michely S, 2013, GENOME BIOL EVOL, V5, P848, DOI 10.1093/gbe/evt053; Nasir A, 2016, ARCHAEA, V2016; Nikolaou C, 2013, NUCLEIC ACIDS RES, V41, P9243, DOI 10.1093/nar/gkt707; Pinello JF, 2017, CURR BIOL, V27, P651, DOI 10.1016/j.cub.2017.01.049; Reeve JN, 2004, BIOCHEM SOC T, V32, P227, DOI 10.1042/BST0320227; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Rochette NC, 2014, MOL BIOL EVOL, V31, P832, DOI 10.1093/molbev/mst272; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Talbert PB, 2013, TRENDS GENET, V29, P499, DOI 10.1016/j.tig.2013.06.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Thomas V, 2011, ENVIRON MICROBIOL, V13, P1454, DOI 10.1111/j.1462-2920.2011.02446.x; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Turner BM, 2014, BBA-GENE REGUL MECH, V1839, P623, DOI 10.1016/j.bbagrm.2014.01.001; Van Doninck K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000401; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211                                                   ; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851                                           ; Woyke T, 2014, SCIENCE, V346, P698, DOI 10.1126/science.1258871; Yuan J, 2015, NEW PHYTOL, V206, P839, DOI 10.1111/nph.13235; Yutin N, 2014, VIROLOGY, V466, P38, DOI 10.1016/j.virol.2014.06.032; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223	59	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-8935			EPIGENET CHROMATIN	Epigenetics Chromatin	NOV 28	2017	10						1	11	55	10.1186/s13072-017-0162-0				11	Genetics & Heredity	Genetics & Heredity	FN9GF	WOS:000416336800001	29179736	gold			2018-01-05	
J	Xiong, J; Tao, T; Luo, Z; Yan, SG; Liu, Y; Yu, XQ; Liu, GL; Xia, H; Luo, LJ				Xiong, Jie; Tao, Tao; Luo, Zhi; Yan, Shuaigang; Liu, Yi; Yu, Xinqiao; Liu, Guolan; Xia, Hui; Luo, Lijun			RNA Editing Responses to Oxidative Stress between a Wild Abortive Type Male-Sterile Line and Its Maintainer Line	FRONTIERS IN PLANT SCIENCE			English	Article						pentatricopeptide repeat protein; PPR; stress acclimation; stress tolerance; transmembrane domains; ccmB; ccmC	PENTATRICOPEPTIDE REPEAT PROTEIN; CYTOPLASMIC MALE-STERILITY; ELECTRON-TRANSPORT CHAIN; PLANT-MITOCHONDRIA; ARABIDOPSIS-THALIANA; SEED DEVELOPMENT; RICE; ENCODES; TOLERANCE; MAIZE	RNA editing of mitochondrial gene transcripts plays a central role during plant development and evolutionary adaptation. RNA editing has previously been reported to differ between the rice cytoplasmic male sterile (CMS) line and its maintainer line, which has been suggested as a cause for their different performances under environmental stress. To specifically test this hypothesis, a wild abortive (WA) CMS line (Huhan-1A) and its maintainer line (Huhan-1B) were utilized to investigate performances in response to oxidative stress, as well as RNA editing efficiencies on transcripts of six selected mitochondrial genes. Compared to themaintainer line, Huhan-1A represented both lower plant height and total antioxidant capacity, possessed higher total soluble protein and chlorophyll contents, accumulated less H2O2 content on the 3rd day after treatment (DAT), and exhibited higher survival ratio after re-watering. Furthermore, a total of 90 editing sites were detected on transcripts of six mitochondrial genes (atp9, nad2, nad7, nad9, ccmB, and ccmC) in both Huhan-1A and Huhan-1B on the 0, 1st, and 3rd DAT. Forty-eight sites were furthermore determined as stress-responsive sites (SRS). Generally, in response to oxidative stress, SRS in Huhan-1A increased the resulting editing efficiencies, while SRS in Huhan-1B decreased the resulting editing efficiencies. In addition, 33 and 22 sites at ccmB and ccmC were differentially edited between Huhan-1A and Huhan-1B, respectively, on the 0, 1st, and 3rd DAT. Editing efficiencies of ccmB and ccmC were generally lower in Huhan-1A (ccmB, 37.3-47.8%; ccmC, 41.2-52.3%) than those in Huhan-1B (ccmB, 82.6-86.5%; ccmC, 81.0-82.9%). Deficiencies of RNA editing in Huhan-1A at ccmB and ccmC could lead to the loss of transmembrane domains in their protein structures. Consequently, differences in RNA editing at ccmB and ccmC between the WA-CMS line and its maintainer line partially explained their different performances under stress. Moreover, we detected differences in expressions of pentatricopeptide repeat (PPR) genes between both lines, as well as significant correlations with RNA editing. Our study indicated potential associations of RNA editing and PPR genes in rice tolerance to abiotic stresses. However, the underlying molecular mechanisms of stress-adaptation, which are attributed to RNA editing on transcripts of mitochondrial genes, require further investigation.	[Xiong, Jie; Tao, Tao; Luo, Zhi; Yan, Shuaigang; Liu, Yi; Luo, Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Xiong, Jie; Tao, Tao; Luo, Zhi; Yan, Shuaigang; Liu, Yi; Yu, Xinqiao; Liu, Guolan; Xia, Hui; Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Luo, LJ (reprint author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.; Xia, H; Luo, LJ (reprint author), Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China.	hxia@sagc.org.cn; lijun@sagc.org.cn			Shanghai Agriculture Applied Technology Development Program, China [G2016060107, G201401]; National High-Tech Research and Development Program of China (863 Plan) [2014AA10A603, 2014AA10A604]; Shanghai Natural Science Foundation of China [17ZR1425500]; Shared Platform of Crop Germplasm Resources in Shanghai [15DZ2290700]; Shanghai Sailing Program [16YF1410000]; National Natural Science Foundation of China [41375157]	This research was supported by the Shanghai Agriculture Applied Technology Development Program, China (Grant No. G2016060107), the National High-Tech Research and Development Program of China (863 Plan) (Grant No. 2014AA10A603, 2014AA10A604), the Shanghai Natural Science Foundation of China (Grant No. 17ZR1425500), the Shared Platform of Crop Germplasm Resources in Shanghai (15DZ2290700), the Shanghai Sailing Program (Grant No. 16YF1410000), the National Natural Science Foundation of China (Grant No. 41375157), and the Shanghai Agriculture Applied Technology Development Program, China (Grant No. G201401). The funding bodies had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Armstrong AF, 2006, PLANT CELL ENVIRON, V29, P940, DOI 10.1111/j.1365-3040.2005.01475.x; Asaf S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152937; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Cheng ShiHua, 2004, Rice Science, V11, P225; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hossain MA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00420; Hu CF, 2010, PROTOPLASMA, V241, P91, DOI 10.1007/s00709-009-0101-4; Hu JH, 2013, MITOCHONDRION, V13, P87, DOI 10.1016/j.mito.2013.01.011; KADOWAKI K, 1995, CURR GENET, V28, P415, DOI 10.1007/BF00310809; Keunen E, 2011, INT J MOL SCI, V12, P6894, DOI 10.3390/ijms12106894; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurihara-Yonemoto S, 2010, CURR GENET, V56, P529, DOI 10.1007/s00294-010-0320-4; Li SQ, 2012, PLANT SCI, V195, P143, DOI 10.1016/j.plantsci.2012.05.014; Li XJ, 2014, PLANT J, V79, P797, DOI 10.1111/tpj.12584; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Nakajima Y, 2001, CURR GENET, V40, P209, DOI 10.1007/s002940100249; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Petrov V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00069; Saxena I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00570; Sechet J, 2015, MOL PLANT, V8, P644, DOI 10.1016/j.molp.2014.12.005; Tan JJ, 2014, MOL PLANT, V7, P1329, DOI 10.1093/mp/ssu054; Toda T, 2012, PLANT J, V72, P450, DOI 10.1111/j.1365-313X.2012.05091.x; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Wang K, 2013, NEW PHYTOL, V198, P408, DOI 10.1111/nph.12180; Xia H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00011; Yang YZ, 2017, NEW PHYTOL, V214, P782, DOI 10.1111/nph.14424; Yap A, 2015, PLANT J, V81, P661, DOI 10.1111/tpj.12756; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; [张天豹 Zhang Tianbao], 2015, [分子植物育种, Molecular Plant Breeding], V13, P1502; Zhu Q, 2014, MOL PLANT, V7, P290, DOI 10.1093/mp/sst102	43	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	NOV 28	2017	8								2023	10.3389/fpls.2017.02023				12	Plant Sciences	Plant Sciences	FN8XE	WOS:000416310300001	29234339	gold			2018-01-05	
J	Basila, M; Kelley, ML; Smith, AV				Basila, Megan; Kelley, Melissa L.; Smith, Anja van Brabant			Minimal 2 '-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity	PLOS ONE			English	Article							HUMAN T-CELLS; OLIGONUCLEOTIDE SYNTHESIS; CAS9 RIBONUCLEOPROTEINS; GENOME; DELIVERY; DNA; HYBRIDIZATION; ENDONUCLEASE; INTERFERENCE; CRRNA	Since its initial application in mammalian cells, CRISPR-Cas9 has rapidly become a preferred method for genome engineering experiments. The Cas9 nuclease is targeted to genomic DNA using guide RNAs (gRNA), either as the native dual RNA system consisting of a DNA-targeting CRISPR RNA (crRNA) and a trans-activating crRNA (tracrRNA), or as a chimeric single guide RNA (sgRNA). Entirely DNA-free CRISPR-Cas9 systems using either Cas9 protein or Cas9 mRNA and chemically synthesized gRNAs allow for transient expression of CRISPR-Cas9 components, thereby reducing the potential for off-targeting, which is a significant advantage in therapeutic applications. In addition, the use of synthetic gRNA allows for the incorporation of chemical modifications for enhanced properties including improved stability. Previous studies have demonstrated the utility of chemically modified gRNAs, but have focused on one pattern with multiple modifications in co-electroporation with Cas9 mRNA or multiple modifications and patterns with Cas9 plasmid lipid co-transfections. Here we present gene editing results using a series of chemically modified synthetic sgRNA molecules and chemically modified crRNA: tracrRNA molecules in both electroporation and lipid transfection assessing indel formation and/ or phenotypic gene knockout. We show that while modifications are required for co-electroporation with Cas9 mRNA, some modification patterns of the gRNA are toxic to cells compared to the unmodified gRNA and most modification patterns do not significantly improve gene editing efficiency. We also present modification patterns of the gRNA that can modestly improve Cas9 gene editing efficiency when co-transfected with Cas9 mRNA or Cas9 protein (> 1.5-fold difference). These results indicate that for certain applications, including those relevant to primary cells, the incorporation of some, but not all chemical modification patterns on synthetic crRNA: tracrRNA or sgRNA can be beneficial to CRISPR-Cas9 gene editing.	[Basila, Megan; Kelley, Melissa L.; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA	Smith, AV (reprint author), Dharmacon, Lafayette, CO 80026 USA.	anja.smith@horizondiscovery.com			GE Healthcare Dharmacon, Inc.	This work was funded by GE Healthcare Dharmacon, Inc. The funder provided support in the form of salaries for authors [MB, MLK, AvBS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019                                                          ; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; FISHER TL, 1993, NUCLEIC ACIDS RES, V21, P3857, DOI 10.1093/nar/21.16.3857; Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132; Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v                                                               ; Scaringe SA, 2000, METHOD ENZYMOL, V317, P3; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Strezoska Z, 2017, J BIOTECHNOL, V251, P189, DOI 10.1016/j.jbiotec.2017.04.017; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Yang L, 2014, METHOD MOL BIOL, V1114, P291; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188593	10.1371/journal.pone.0188593				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FN8QZ	WOS:000416291900104		gold			2018-01-05	
J	Posner, M; Murray, KL; McDonald, MS; Eighinger, H; Andrew, B; Drossman, A; Haley, Z; Nussbaum, J; David, LL; Lampi, KJ				Posner, Mason; Murray, Kelly L.; McDonald, Matthew S.; Eighinger, Hayden; Andrew, Brandon; Drossman, Amy; Haley, Zachary; Nussbaum, Justin; David, Larry L.; Lampi, Kirsten J.			The zebrafish as a model system for analyzing mammalian and native alpha-crystallin promoter function	PEERJ			English	Article						Zebrafish; Lens; Crystallins; Promoters; GFP; Proteomics; Mass spectrometry; Gene expression; Vision	SHOCK-PROTEIN GENE; A-CRYSTALLIN; B-CRYSTALLIN; DANIO-RERIO; C-MAF; LENS DEVELOPMENT; TRANSGENIC MICE; OCULAR LENS; EXPRESSION; PAX6	Previous studies have used the zebrafish to investigate the biology of lens crystalhn proteins and their roles in development and disease. However, little is known about zebrafish alpha-crystallin promoter function, how it compares to that of mammals, or whether mammalian alpha-crystallin promoter activity can be assessed using zebrafish embryos. We injected a variety of alpha-crystallin promoter fragments from each species combined with the coding sequence for green fluorescent protein (GFP) into zebrafish zygotes to determine the resulting spatiotemporal expression patterns in the developing embryo. We also measured mRNA levels and protein abundance for all three zebrafish alpha-crystallins. Our data showed that mouse and zebrafish alpha A-crystallin promoters generated similar GFP expression in the lens, but with earlier onset when using mouse promoters.Expression was also found in notochord and skeletal muscle in a smaller percentageof embryos. Mouse alpha B-crystallin promoter fragments drove GFP expression primarily in zebrafish skeletal muscle, with less common expression in notochord, lens, heart and in extraocular regions of the eye. A short fragment containing only a lens-specific enhancer region increased lens and notochord GFP expression while decreasing muscle expression, suggesting that the influence of mouse promoter control regions carries over into zebrafish embryos. The two paralogous zebrafish alpha B-crystallin promoters produced subtly different expression profiles, with the aBa promoter driving expression equally in notochord and skeletal muscle while the aBb promoter resulted primarily in skeletal muscle expression. Messenger RNA for zebrafish aA increased between 1 and 2 days post fertilization (dpf), alpha Ba increased between 4 and 5 dpf, but aBb remained at baseline levels through 5 dpf. Parallel reaction monitoring (PRM) mass spectrometry was used to detect alpha A, aBa, and alpha Bb peptides in digests of zebrafish embryos. In whole embryos, alpha A-crystallin was first detected by 2 dpf, peaked in abundance by 4-5 dpf, and was localized to the eye. alpha Ba was detected in whole embryo at nearly constant levels from 1-6 dpf, was also localized primarily to the eye, and its abundance in extraocular tissues decreased from 4-7 dpf. In contrast, due to its low abundance, no alpha Bb protein could be detected in whole embryo, or dissected eye and extraocular tissues. Our results show that mammalian alpha-crystallin promoters can be efficiently screened in zebrafish embryos and that their controlling regions are well conserved. An ontogenetic shift in zebrafish aBa-crystallin promoter activity provides an interesting system for examining the evolution and control of tissue specificity. Future studies that combine these promoter based approaches with the expanding ability to engineer the zebrafish genome via techniques such as CRISPR/Cas9 will allow the manipulation of protein expression to test hypotheses about lens crystallin function and its relation to lens biology and disease.	[Posner, Mason; Murray, Kelly L.; McDonald, Matthew S.; Eighinger, Hayden; Andrew, Brandon; Drossman, Amy; Haley, Zachary] Ashland Univ, Dept Biol Toxicol, Ashland, OH 44805 USA; [Nussbaum, Justin] Lakeland Community Coll, Dept Biol, Kirtland, OH USA; [David, Larry L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Lampi, Kirsten J.] Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA	Posner, M (reprint author), Ashland Univ, Dept Biol Toxicol, Ashland, OH 44805 USA.	mposner@ashland.edu			National Eye Institute of the National Institutes of Health [EY013535]; Provost Office of Ashland University; National Eye Institute [EY027012, EY10572]; Choose Ohio First scholarship	This work was supported by an R15 AREA grant from the National Eye Institute of the National Institutes of Health to Mason Posner (EY013535) and from grants to support faculty/student research from the Provost Office of Ashland University. A summer student research stipend was provided to Kelly L. Murray as part of a Choose Ohio First scholarship grant to Ashland University. The proteomic analysis was supported by National Eye Institute grants EY027012 and EY10572 to Larry David and Kirsten Lampi. There was no additional external funding received for this study.	Bourmaud A, 2016, PROTEOMICS, V16, P2146, DOI 10.1002/pmic.201500543; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen WV, 2001, BBA-GENE STRUCT EXPR, V1519, P30, DOI 10.1016/S0167-4781(01)00201-9; Chhetri J, 2014, EYE, V28, P367, DOI 10.1038/eye.2014.19; Clemens DM, 2013, INVEST OPHTH VIS SCI, V54, P5136, DOI 10.1167/iovs.13-12337; Cvekl A, 2017, GENOME BIOL EVOL, V9, P2075, DOI 10.1093/gbe/evx153; Dahlman JM, 2005, MOL VIS, V11, P88; Davidson AE, 2003, DEV BIOL, V263, P191, DOI 10.1016/S0012-1606(03)00439-1; DUBIN RA, 1991, MOL CELL BIOL, V11, P4340, DOI 10.1128/MCB.11.9.4340                                                           ; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; GERNOLD M, 1993, DEV GENET, V14, P103, DOI 10.1002/dvg.1020140204; Gestri G, 2012, DEV NEUROBIOL, V72, P302, DOI 10.1002/dneu.20919; Goishi K, 2006, DEVELOPMENT, V133, P2585, DOI 10.1242/dev.02424; Gopal-Srivastava R, 2000, MECH DEVELOP, V92, P125, DOI 10.1016/S0925-4773(99)00341-X; GOPALSRIVASTAVA R, 1994, NUCLEIC ACIDS RES, V22, P1281, DOI 10.1093/nar/22.7.1281; Greiling TMS, 2010, INVEST OPHTH VIS SCI, V51, P1540, DOI 10.1167/iovs.09-4388; Greiling TMS, 2009, MOL VIS, V15, P2313; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Haynes JI, 1996, DEV DYNAM, V207, P75, DOI 10.1002/(SICI)1097-0177(199609)207:1<75::AID-AJA8>3.0.CO;2-T; Hou H-H, 2006, DEV DYNAM, V235, P435, DOI [10.1002/dvdy.20652, DOI 10.1002/DVDY.20652]; Hough RB, 2002, P NATL ACAD SCI USA, V99, P8145, DOI 10.1073/pnas.122231099; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Koteiche HA, 2015, BIOCHEMISTRY-US, V54, P5949, DOI 10.1021/acs.biochem.5b00678; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mao L, 2006, GENE EXPR PATTERNS, V6, P127, DOI 10.1016/j.modgep.2005.07.002; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Morris AC, 2011, BIRTH DEFECTS RES C, V93, P215, DOI 10.1002/bdrc.20211; Posner M, 1999, BBA-GENE STRUCT EXPR, V1447, P271, DOI 10.1016/S0167-4781(99)00155-4; Posner M, 2008, MOL VIS, V14, P806; Posner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034438; R Core Team, 2017, R LANG ENV STAT COMP; R Studio Team, 2015, R STUD INT DEV ENV R; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Runkle S, 2002, MOL VIS, V8, P45; Smith AA, 2006, FEBS J, V273, P481, DOI 10.1111/j.1742-4658.2005.05080.x; Swamynathan SK, 2002, J BIOL CHEM, V277, P49700, DOI 10.1074/jbc.M209700200; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Van de Peer Yves, 2003, Journal of Structural and Functional Genomics, V3, P65, DOI 10.1023/A:1022652814749; Vihtelic TS, 2008, INT REV CEL MOL BIO, V269, P341, DOI 10.1016/S1937-6448(08)01006-X; Wages P, 2013, MOL VIS, V19, P408; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403                                             ; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Xie Q, 2016, J BIOL CHEM, V291, P3947, DOI 10.1074/jbc.M115.705103; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	50	0	0	1	1	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	NOV 27	2017	5								e4093	10.7717/peerj.4093				27	Multidisciplinary Sciences	Science & Technology - Other Topics	FN8HB	WOS:000416262700001	29201567				2018-01-05	
J	Trumbach, D; Pfeiffer, S; Poppe, M; Scherb, H; Doll, S; Wurst, W; Schick, JA				Truembach, Dietrich; Pfeiffer, Susanne; Poppe, Manuel; Scherb, Hagen; Doll, Sebastian; Wurst, Wolfgang; Schick, Joel A.			ENCoRE: an efficient software for CRISPR screens identifies new players in extrinsic apoptosis	BMC GENOMICS			English	Article						CRISPR; Cas9; Screen; Software; TNFalpha; Apoptosis	HUMAN-CELLS; GENETIC SCREENS; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL GENOMICS; HNRNP F; CARBOXYLESTERASES; FERROPTOSIS; SYSTEM; INTERFERENCE; SUPPRESSION	Background: As CRISPR/Cas9 mediated screens with pooled guide libraries in somatic cells become increasingly established, an unmet need for rapid and accurate companion informatics tools has emerged. We have developed a lightweight and efficient software to easily manipulate large raw next generation sequencing datasets derived from such screens into informative relational context with graphical support. The advantages of the software entitled ENCoRE (Easy NGS-to-Gene CRISPR REsults) include a simple graphical workflow, platform independence, local and fast multithreaded processing, data pre-processing and gene mapping with custom library import. Results: We demonstrate the capabilities of ENCoRE to interrogate results from a pooled CRISPR cellular viability screen following Tumor Necrosis Factor-alpha challenge. The results not only identified stereotypical players in extrinsic apoptotic signaling but two as yet uncharacterized members of the extrinsic apoptotic cascade, Smg7 and Ces2a. We further validated and characterized cell lines containing mutations in these genes against a panel of cell death stimuli and involvement in p53 signaling. Conclusions: In summary, this software enables bench scientists with sensitive data or without access to informatic cores to rapidly interpret results from large scale experiments resulting from pooled CRISPR/Cas9 library screens.	[Truembach, Dietrich; Poppe, Manuel; Doll, Sebastian; Wurst, Wolfgang] Helmholtz Zentrum Munich, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Pfeiffer, Susanne; Schick, Joel A.] Helmholtz Zentrum Munich, Inst Mol Toxicol & Pharmacol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Scherb, Hagen] Helmholtz Zentrum Munich, Inst Computat Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Chair Dev Genet, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis DZNE Site Munich, Feodor Lynen Str 17, D-81377 Munich, Germany; [Wurst, Wolfgang] Munich Cluster Syst Neurol SyNergy, Feodor Lynen Str 17, D-81377 Munich, Germany	Schick, JA (reprint author), Helmholtz Zentrum Munich, Inst Mol Toxicol & Pharmacol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	joel.schick@helmholtz-muenchen.de			Helmholtz Portfolio Theme 'Supercomputing and Modelling for the Human Brain' (SMHB)	This work was funded (in part) by the Helmholtz Portfolio Theme 'Supercomputing and Modelling for the Human Brain' (SMHB).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bassett AR, 2015, J GENET GENOMICS, V42, P301, DOI 10.1016/j.jgg.2015.03.011; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/nchembio.2239, 10.1038/NCHEMBIO.2239]; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Harrison EH, 1998, ANNU REV NUTR, V18, P259, DOI 10.1146/annurev.nutr.18.1.259                                                   ; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jia J, 2015, CELL DEATH DIFFER; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Lee DH, 2010, J PROTEOME RES, V9, P5668, DOI 10.1021/pr100478u; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu J, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-95; Luo HW, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.42; Nakamura-Lopez Y, 2009, CELL BIOL INT, V33, P1026, DOI 10.1016/j.cellbi.2009.06.010; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanghani SP, 2009, PROTEIN PEPTIDE LETT, V16, P1207, DOI 10.2174/092986609789071324                                                      ; Sanghani SP, 2002, EUR J BIOCHEM, V269, P4387, DOI 10.1046/j.1432-1033.2002.03121.x; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Trumbach D, 2017, ENCORE; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vora S, 2016, FEBS J, V283, P3181, DOI 10.1111/febs.13768; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; White R, 2012, J BIOL CHEM, V287, P1742, DOI 10.1074/jbc.M111.235010; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	49	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 25	2017	18								905	10.1186/s12864-017-4285-2				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FN6NH	WOS:000416131200003	29178829	gold			2018-01-05	
J	Sengupta, R; Mendenhall, A; Sarkar, N; Mukherjee, C; Afshari, A; Huang, J; Lu, B				Sengupta, Ranjita; Mendenhall, Amy; Sarkar, Nandita; Mukherjee, Chandreyee; Afshari, Amirali; Huang, Joseph; Lu, Biao			Viral Cre-LoxP tools aid genome engineering in mammalian cells	JOURNAL OF BIOLOGICAL ENGINEERING			English	Article						Cre-LoxP; Cre recombinase; Lentiviral vector; AAV vector; Genome editing; Talen	DNA RECOMBINATION; TALEN; BACTERIOPHAGE-P1; CRISPR-CAS9; EXPRESSION; NUCLEASES; VECTORS; LIBRARY; REPAIR; MOUSE	Background: Targeted nucleases have transformed genome editing technology, providing more efficient methods to make targeted changes in mammalian genome. In parallel, there is an increasing demand of Cre-LoxP technology for complex genome manipulation such as large deletion, addition, gene fusion and conditional removal of gene sequences at the target site. However, an efficient and easy-to-use Cre-recombinase delivery system remains lacking. Results: We designed and constructed two sets of expression vectors for Cre-recombinase using two highly efficient viral systems, the integrative lentivirus and non-integrative adeno associated virus. We demonstrate the effectiveness of those methods in Cre-delivery into stably-engineered HEK293 cells harboring LoxP-floxed red fluorescent protein (RFP) and puromycin (Puro) resistant reporters. The delivered Cre recombinase effectively excised the floxed RFP-Puro either directly or conditionally, therefore validating the function of these molecular tools. Given the convenient options of two selections markers, these viral-based systems offer a robust and easy-to-use tool for advanced genome editing, expanding complicated genome engineering to a variety of cell types and conditions. Conclusions: We have developed and functionally validated two viral-based Cre-recombinase delivery systems for efficient genome manipulation in various mammalian cells. The ease of gene delivery with the built-in reporters and inducible element enables live cell monitoring, drug selection and temporal knockout, broadening applications of genome editing.	[Sengupta, Ranjita; Mendenhall, Amy; Mukherjee, Chandreyee; Afshari, Amirali; Huang, Joseph] Syst Biosci, 2436 Embarcadero Way, Palo Alto, CA 94303 USA; [Sarkar, Nandita] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Lu, Biao] Santa Clara Univ, Dept Bioengn, 500 El Camino Real, Santa Clara, CA 95053 USA	Lu, B (reprint author), Santa Clara Univ, Dept Bioengn, 500 El Camino Real, Santa Clara, CA 95053 USA.	blu2@scu.edu			R&D fund from System Biosciences; Department of Bioengineering	This work was supported by R&D fund from System Biosciences, a start-up fund from the Department of Bioengineering.	Choi JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-17; Collins M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gersbach CA, 2014, NAT METHODS, V11, P1009, DOI 10.1038/nmeth.3113; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6                                                    ; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Mendenhall A, 2012, JOVE-J VIS EXP, DOI 10.3791/3171; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.3.CO;2-2; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861                                                         ; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Potter M, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.34; Santiago-Ortiz J, 2015, GENE THER, V22, P934, DOI 10.1038/gt.2015.74; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Sengupta R, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0044-z; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; STERNBERG N, 1983, ANNU REV GENET, V17, P123, DOI 10.1146/annurev.ge.17.120183.001011; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Uhde-Stone C, 2014, RNA, V20, P948, DOI [10.1261/ma.042010.113, 10.1261/rna.042010.113]; Uhde-Stone C, 2014, BIOCHEM BIOPH RES CO, V443, P1189, DOI 10.1016/j.bbrc.2013.12.111; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhang ZW, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0060-9; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	43	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-1611			J BIOL ENG	J. Biol. Eng.	NOV 24	2017	11								45	10.1186/s13036-017-0087-y				9	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FO4MV	WOS:000416819500001	29204184	gold			2018-01-05	
J	Cox, DBT; Gootenberg, JS; Abudayyeh, OO; Franklin, B; Kellner, MJ; Joung, J; Zhang, F				Cox, David B. T.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Franklin, Brian; Kellner, Max J.; Joung, Julia; Zhang, Feng			RNA editing with CRISPR-Cas13	SCIENCE			English	Article							CAS SYSTEMS; GENOME; DEAMINASES; MUTATIONS; SUBSTRATE; ADAR1; IFIH1; GUIDE; BASE	Nucleic acid editing holds promise for treating genetic disease, particularly at the RNA level, where disease-relevant sequences can be rescued to yield functional protein products. Type VI CRISPR-Cas systems contain the programmable single-effector RNA-guided ribonuclease Cas13. We profiled type VI systems in order to engineer a Cas13 ortholog capable of robust knockdown and demonstrated RNA editing by using catalytically inactive Cas13 (dCas13) to direct adenosine-to-inosine deaminase activity by ADAR2 (adenosine deaminase acting on RNA type 2) to transcripts in mammalian cells. This system, referred to as RNA Editing for Programmable A to I Replacement (REPAIR), which has no strict sequence constraints, can be used to edit full-length transcripts containing pathogenic mutations. We further engineered this system to create a high-specificity variant and minimized the system to facilitate viral delivery. REPAIR presents a promising RNA-editing platform with broad applicability for research, therapeutics, and biotechnology.	[Cox, David B. T.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Franklin, Brian; Kellner, Max J.; Joung, Julia; Zhang, Feng] Massachusetts Inst Technol MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Cox, David B. T.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Franklin, Brian; Kellner, Max J.; Joung, Julia; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cox, David B. T.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Franklin, Brian; Kellner, Max J.; Joung, Julia; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Cox, David B. T.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Franklin, Brian; Kellner, Max J.; Joung, Julia; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cox, David B. T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cox, David B. T.; Abudayyeh, Omar O.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Zhang, F (reprint author), Massachusetts Inst Technol MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org			National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; NIH F30 National Research Service Award [1F30-CA210382]; NIH [1R01-HG009761, 1R01-MH110049, 1DP1-HL141201]; Howard Hughes Medical Institute; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation	We thank R. Munshi, A. Baumann, A. Philippakis, and E. Banks for computational guidance; C. Muus for sequencing assistance; A. Smargon for gene synthesis of a Cas13b orthologs 1-8; V. Verdine for assistance with RNA sequencing library preparation; and R. Macrae: R. Belliveau and the entire F.Z. laboratory for discussions and support. D.B.T.C. is supported by award T32GM007753 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. O.O.A. is supported by a Paul and Daisy Soros Fellowship and a NIH F30 National Research Service Award 1F30-CA210382. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by NIH grants 1R01-HG009761, 1R01-MH110049, and 1DP1-HL141201; the Howard Hughes Medical Institute; the New York Stem Cell Foundation; the Simons Foundation; the Paul G. Allen Family Foundation; the Vallee Foundation; and J. and P. Poitras, R. Metcalfe, and D. Cheng. D.B.T.C.: J.S.G., O.O.A., and F.Z. are co-inventors on U.S. provisional patent application no. 62/525,181 relating to REPAIR and other applications relating to CRISPR and CRISPR-Cas13 technology filed by the Broad Institute. Sequencing data are available at Sequence Read Archive under BioProject accession no. PRJNA414340. The authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the F.Z. laboratory website (www.genome-engineering.org) and GitHub (github.com/fengzhanglab).	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Fukuda M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41478; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuttan A, 2012, P NATL ACAD SCI USA, V109, pE3295, DOI 10.1073/pnas.1212548109; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Li YH, 2010, J INVEST DERMATOL, V130, P2768, DOI 10.1038/jid.2010.214; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; MONTIELGONZALEZ MF, 2016, NUCL ACIDS RES, V44; Nishida K, 2016, SCIENCE, V353, P8729; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Stafforst T, 2012, ANGEW CHEM INT EDIT, V51, P11166, DOI 10.1002/anie.201206489; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Wang YR, 2015, ACS CHEM BIOL, V10, P2512, DOI 10.1021/acschembio.5b00711; Wettengel J, 2017, NUCLEIC ACIDS RES, V45, P2797, DOI 10.1093/nar/gkw911; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zheng YX, 2017, NUCLEIC ACIDS RES, V45, P3369, DOI 10.1093/nar/gkx050	32	1	1	8	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1019	+		10.1126/science.aaq0180				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FO2FN	WOS:000416590400033	29070703				2018-01-05	
J	Zuo, EW; Huo, XN; Yao, X; Hu, XD; Sun, YD; Yin, JH; He, BB; Wang, X; Shi, LY; Ping, J; Wei, Y; Ying, WQ; Wei, W; Liu, WJ; Tang, C; Li, YX; Hu, JZ; Yang, H				Zuo, Erwei; Huo, Xiaona; Yao, Xuan; Hu, Xinde; Sun, Yidi; Yin, Jianhang; He, Bingbing; Wang, Xing; Shi, Linyu; Ping, Jie; Wei, Yu; Ying, Wenqin; Wei, Wei; Liu, Wenjia; Tang, Cheng; Li, Yixue; Hu, Jiazhi; Yang, Hui			CRISPR/Cas9-mediated targeted chromosome elimination	GENOME BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; DOUBLE-STRANDED BREAKS; MUSCULAR-DYSTROPHY; TURNER-SYNDROME; MOUSE MODEL; GENOME; MICE; DNA; GENERATION; ANEUPLOIDY	Background: The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown. Results: Here we demonstrate the use of the CRISPR/Cas9 system to eliminate targeted chromosomes. Using either multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-specific sites or a cocktail of multiple sgRNAs, each targeting one specific site, we found that a sex chromosome could be selectively eliminated in cultured cells, embryos, and tissues in vivo. Furthermore, this approach was able to produce a targeted autosome loss in aneuploid mouse embryonic stem cells with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cancer cells. Conclusions: CRISPR/Cas9-mediated targeted chromosome elimination offers a new approach to develop animal models with chromosome deletions, and a potential therapeutic strategy for human aneuploidy diseases involving additional chromosomes.	[Zuo, Erwei; Huo, Xiaona; Yao, Xuan; Hu, Xinde; He, Bingbing; Wang, Xing; Shi, Linyu; Wei, Yu; Ying, Wenqin; Wei, Wei; Liu, Wenjia; Tang, Cheng; Yang, Hui] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,Shanghai Inst Biol Sci, State Key Lab Neurosci,Key Lab Primate Neurobiol, Shanghai 200031, Peoples R China; [Yin, Jianhang; Hu, Jiazhi] Peking Univ, State Key Lab Membrane Biol, Sch Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yin, Jianhang; Hu, Jiazhi] Peking Univ, Minstry Educ, Key Lab Cell Proliferat & Differentiat, Sch Life Sci,Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Sun, Yidi; Li, Yixue] Chinese Acad Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [He, Bingbing; Wang, Xing] Univ Chinese Acad Sci, Shanghai 200031, Peoples R China; [Ping, Jie] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37232 USA; [Wei, Yu] Shanghai Univ, Shanghai 200444, Peoples R China; [Wei, Wei] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Guangxi, Peoples R China	Yang, H (reprint author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,Shanghai Inst Biol Sci, State Key Lab Neurosci,Key Lab Primate Neurobiol, Shanghai 200031, Peoples R China.; Hu, JZ (reprint author), Peking Univ, State Key Lab Membrane Biol, Sch Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Hu, JZ (reprint author), Peking Univ, Minstry Educ, Key Lab Cell Proliferat & Differentiat, Sch Life Sci,Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	hujz@pku.edu.cn; huiyang@ion.ac.cn		yang, hui/0000-0003-3590-722X	National Science and Technology Major Project [2017YFC1001302]; CAS [XDB02050007, XDA01010409]; MoST863 Program [2015AA020307]; NSFC [31522037, 31771485]; China Youth Thousand Talents Program; Chinese Academy of Sciences	This work was supported by National Science and Technology Major Project (2017YFC1001302), CAS Strategic Priority Research Program (XDB02050007, XDA01010409), the MoST863 Program (2015AA020307), NSFC grants (31522037, 31771485), China Youth Thousand Talents Program, Break through project of Chinese Academy of Sciences.	Adikusuma F, 2017, MOL THER, V25, P1736, DOI 10.1016/j.ymthe.2017.05.021; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bondy CA, 2009, HORM RES, V71, P52, DOI 10.1159/000178039; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P381; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Donaldson MDC, 2006, ARCH DIS CHILD, V91, P513, DOI 10.1136/adc.2003.035907; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Garrison E, 2016, ARXIV201612073907, V1207, P3907; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; HUNT PA, 1991, DEVELOPMENT, V111, P1137; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Probst FJ, 2008, J HERED, V99, P512, DOI 10.1093/jhered/esn027; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Sheppard O, 2012, SCI WORLD J, DOI 10.1100/2012/214078; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Zhong Q, 2012, FERTIL STERIL, V98, P775, DOI 10.1016/j.fertnstert.2012.08.021	49	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	NOV 24	2017	18								224	10.1186/s13059-017-1354-4				18	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FN5JK	WOS:000416043200001	29178945	gold			2018-01-05	
J	Wenne, R				Wenne, Roman			Single nucleotide polymorphism markers with applications in aquaculture and assessment of its impact on natural populations	AQUATIC LIVING RESOURCES			English	Review						Aquaculture and mariculture; identification of escapees; SNP; QTL; resistance to pathogens; genomic selection; gene editing	SALMON SALMO-SALAR; QUANTITATIVE TRAIT LOCI; FATTY-ACID-COMPOSITION; GENOME-WIDE ASSOCIATION; WILD ATLANTIC SALMON; CARP CYPRINUS-CARPIO; BIVALVE MACOMA-BALTHICA; GENETIC-LINKAGE MAP; CRAB PORTUNUS-TRITUBERCULATUS; SOLE CYNOGLOSSUS-SEMILAEVIS	An increase in aquatic animal production can be achieved by extending aquaculture areas geographically, utilizing new species for culture, and using new technologies. Among new technologies useful for the increase of aquaculture production is the application of genetics and genomics. New molecular tools that benefit aquaculture have been developed. There has been a large number of experimental and review papers published concerning molecular markers and the range of their applications, including aquaculture and food product analyses. Analysis of single nucleotide polymorphisms (SNPs) has emerged as genotyping technology with wide and significant applications in aquaculture. SNPs can be used for construction of genetic linkage maps, finding quantitative trait loci (QTL) for useful traits like growth, body weight, grilsing, thermal and low oxygen tolerance, resistance to stress and diseases, mapping sex determination loci and identification of progeny in selection and chromosome manipulation experiments, assessment of genomic selectionand marker assisted selection in aquaculture. Genome-wide association studies (GWAS) facilitate the finding associations between SNPs and a trait in related or unrelated specimens. However, many traits are complex and can be controlled by number of QTL. Genotyping by genome reduction complexity sequencing emerged as an efficient and applicable technology in genomic selection. Identification of genes, sequences and nucleotides (substitutions) directly influencing phenotypic variations opens the possibility of marker-assisted selection for desirable characters in culture. SNP and QTL associations can be enhanced using genome editing technology. Examples of successful applications of SNPs in aquaculture of fish, crustacean and mollusk species, representing most geographic areas, and ecological risks assessment are reviewed.	[Wenne, Roman] Polish Acad Sci, Inst Oceanol, Powstancow Warszawy 55, PL-81712 Sopot, Poland	Wenne, R (reprint author), Polish Acad Sci, Inst Oceanol, Powstancow Warszawy 55, PL-81712 Sopot, Poland.	rwenne@iopan.gda.pl			National Science Centre in Poland [2011/01/M/NZ9/07207]; statutory topic IV.1 in the IO PAS Sopot	This study was partially funded by project: 2011/01/M/NZ9/07207 of the National Science Centre in Poland to RW and statutory topic IV.1 in the IO PAS Sopot.	ABDELRAHMAN H, 2017, BMC GENOMICS, V18; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Ao JQ, 2015, INT J MOL SCI, V16, P26237, DOI 10.3390/ijms161125951; Aoki J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1600-7; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bangera R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3487-y; Baptista M, 2014, HELGOLAND MAR RES, V68, P465, DOI 10.1007/s10152-014-0402-7; Baranski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085413; Ben Ayed R, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0530-6; Bernas R, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0208-y; Besnier F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-937; Boichard D, 2016, CR BIOL, V339, P274, DOI 10.1016/j.crvi.2016.04.007; Boulding EG, 2008, HEREDITY, V101, P381, DOI 10.1038/hdy.2008.67; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Brown JK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2773-4; Brynildsrud O, 2014, ISME J, V8, P746, DOI 10.1038/ismej.2013.186; Bylemans J, 2016, AQUACULT ENV INTERAC, V8, P131, DOI 10.3354/aei00164; CALHOUN WE, 1983, AQUACULTURE, V33, P365, DOI 10.1016/0044-8486(83)90415-5                                                    ; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Correa K, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0291-8; Correa K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2038-7; Cosenza G, 2017, J DAIRY RES, V84, P170, DOI 10.1017/S0022029917000127; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; Cui ZK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42213; Dai P, 2015, GENE, V566, P194, DOI 10.1016/j.gene.2015.04.047; Danzmann RG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2363-5; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Dehler CE, 2016, MAR BIOTECHNOL, V18, P449, DOI 10.1007/s10126-016-9708-6; Dominik S, 2010, AQUACULTURE, V308, pS56, DOI 10.1016/j.aquaculture.2010.05.038; Dong Y, 2016, J WORLD AQUACULT SOC, V47, P873, DOI 10.1111/jwas.12334; Drywa A, 2013, MAR GENOM, V9, P25, DOI 10.1016/j.margen.2012.08.001; Du XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104960; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Dunham RA, 2014, AQUACULTURE, V420, pS121, DOI 10.1016/j.aquaculture.2013.10.020; Eisbrenner WS, 2014, HEREDITY, V113, P86, DOI 10.1038/hdy.2013.55; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Espinoza-Valles I, 2015, MICROBIOL-SGM, V161, P1762, DOI 10.1099/mic.0.000141; Everett MV, 2014, EVOL APPL, V7, P480, DOI 10.1111/eva.12147; FAO, 2017, GEN BAS BIOT AQ; Food and Agriculture Organization of the United Nations - FAO, 2016, STAT WORLD FISH AQ 2; Feng LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089039; Fernandes MB, 2012, INT UROL NEPHROL, V44, P1571, DOI 10.1007/s11255-012-0227-8; Fu GH, 2014, INT J MOL SCI, V15, P22028, DOI 10.3390/ijms151222028; Fu GH, 2014, FISH SHELLFISH IMMUN, V40, P331, DOI 10.1016/j.fsi.2014.07.019; Fu GH, 2014, FISH SHELLFISH IMMUN, V37, P131, DOI 10.1016/j.fsi.2014.01.019; Garcia F, 2016, AQUACULTURE, V464, P229, DOI 10.1016/j.aquaculture.2016.06.031; Garcia-Ortega A, 2016, AQUACULTURE, V452, P1, DOI 10.1016/j.aquaculture.2015.10.020; Gjedrem T, 2012, AQUACULTURE, V350, P117, DOI 10.1016/j.aquaculture.2012.04.008; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-74; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Gonzalez-Pena D, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00203; Guo HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051005; Gutierrez AP, 2016, MAR GENOM, V26, P41, DOI 10.1016/j.margen.2015.12.007; Gutierrez AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119730; Gutierrez AP, 2012, AQUACULTURE, V358, P61, DOI 10.1016/j.aquaculture.2012.06.017; Hao GJ, 2015, AQUACULTURE, V442, P125, DOI 10.1016/j.aquaculture.2015.02.007; Hayes B, 2005, AQUACULTURE, V250, P70, DOI 10.1016/j.aquaculture.2005.03.008; Heino M, 2015, AQUACULT ENV INTERAC, V6, P185, DOI 10.3354/aei00126; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; JARZEBSKI A, 1990, COMP BIOCHEM PHYS B, V97, P81, DOI 10.1016/0305-0491(90)90181-R; JARZEBSKI A, 1986, COMP BIOCHEM PHYS B, V85, P135, DOI 10.1016/0305-0491(86)90234-8                                                    ; JARZEBSKI A, 1986, MAR BIOL, V91, P27, DOI 10.1007/BF00397567                                                              ; Jenneckens I, 2001, J APPL ICHTHYOL, V17, P39, DOI 10.1046/j.1439-0426.2001.00234.x; Jia ZY, 2015, J APPL ICHTHYOL, V31, P1102, DOI 10.1111/jai.12862; Jiang L, 2017, G3-GENES GENOM GENET, V7, P583, DOI 10.1534/g3.116.036822; Jilberto F, 2017, FOOD CHEM, V229, P716, DOI 10.1016/j.foodchem.2017.02.109; Jin SB, 2015, GENET MOL RES, V14, P18913, DOI 10.4238/2015.December.28.40; Jin SB, 2015, GENET MOL RES, V14, P3557, DOI 10.4238/2015.April.17.5; Jones DB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-810; Jung H, 2014, MAR BIOTECHNOL, V16, P161, DOI 10.1007/s10126-013-9555-7; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; Kijas JW, 2016, ANIM GENET, V47, P258, DOI 10.1111/age.12409; Kijewski T, 2009, AQUACULTURE, V287, P292, DOI 10.1016/j.aquaculture.2008.10.048; Kitaoka M, 2008, J AGR FOOD CHEM, V56, P6246, DOI 10.1021/jf800300k; Klinbunga S, 2015, AQUACULTURE, V435, P18, DOI 10.1016/j.aquaculture.2014.09.013; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kuang YY, 2015, AQUACULTURE, V435, P100, DOI 10.1016/j.aquaculture.2014.09.020; Kumar G, 2017, FISH RES, V186, P11, DOI 10.1016/j.fishres.2016.07.021; Laghari MY, 2014, MOL BIOL REP, V41, P721, DOI 10.1007/s11033-013-2911-x; Lal MM, 2016, MAR GENOM, V25, P57, DOI 10.1016/j.margen.2015.10.010; Leitwein M, 2016, J FISH BIOL, V89, P2717, DOI 10.1111/jfb.13131; Li B, 2017, THEOR APPL GENET, V130, P1467, DOI 10.1007/s00122-017-2902-8; Li C, 2014, MOL ECOL RESOUR, V14, P1261, DOI 10.1111/1755-0998.12272; Li MH, 2017, SCI BULL, V62, P165, DOI 10.1016/j.scib.2017.01.003; Li SJ, 2017, GENETICA, V145, P175, DOI 10.1007/s10709-017-9956-z; [李文升 Li Wen sheng], 2011, [基因组学与应用生物学, Genomics and Applied Biology], V30, P316; Li XH, 2013, FISH SHELLFISH IMMUN, V34, P1560, DOI 10.1016/j.fsi.2013.03.373; Li XP, 2013, FISH SHELLFISH IMMUN, V35, P1604, DOI 10.1016/j.fsi.2013.09.004; Li Y, 2015, DNA RES, V22, P39, DOI 10.1093/dnares/dsu038; LIAO ZW, 2017, SCI REP UK, V7; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lillehammer M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-39; Lin ZY, 2012, DEV COMP IMMUNOL, V37, P164, DOI 10.1016/j.dci.2011.09.003; Linlokken AN, 2017, ECOL EVOL, V7, P4963, DOI 10.1002/ece3.3070; Liu HY, 2017, G3-GENES GENOM GENET, V7, P2473, DOI 10.1534/g3.117.041376; Liu L, 2017, EVOL APPL, V10, P276, DOI 10.1111/eva.12450; Liu S, 2016, ANIM GENET, V47, P81, DOI 10.1111/age.12372; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu SX, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00298; Liu SX, 2015, MAR BIOTECHNOL, V17, P328, DOI 10.1007/s10126-015-9621-4; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Loukovitis D, 2012, ANIM GENET, V43, P753, DOI 10.1111/j.1365-2052.2012.02346.x; Lu X, 2016, MOL GENET GENOMICS, V291, P1391, DOI 10.1007/s00438-016-1192-1; Lv JJ, 2015, CELL STRESS CHAPERON, V20, P811, DOI 10.1007/s12192-015-0602-3; Lv JJ, 2015, GENE, V566, P229, DOI 10.1016/j.gene.2015.04.050; Macqueen DJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3862-8; MAIR GC, 1991, THEOR APPL GENET, V82, P144, DOI 10.1007/BF00226205; Makinen H, 2015, EVOL APPL, V8, P93, DOI 10.1111/eva.12230; Martinez P, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00340; McAndrew B, 2011, J AGR SCI, V149, P143, DOI 10.1017/S0021859610001152; McKinney GJ, 2016, MOL ECOL RESOUR, V16, P769, DOI 10.1111/1755-0998.12479; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moen T, 2015, GENETICS, V200, P1313, DOI 10.1534/genetics.115.175406; Moen T, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P166, DOI 10.1079/9781845935559.0166; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nguyen TTT, 2014, AQUACULTURE, V420, P295, DOI 10.1016/j.aquaculture.2013.11.021; Ni J, 2012, CHIN J OCEANOL LIMN, V30, P279, DOI 10.1007/s00343-012-1078-y; Nunez-Acuna G, 2014, COMP BIOCHEM PHYS D, V10, P9, DOI 10.1016/j.cbd.2014.01.003; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Oyarzun PA, 2013, AQUAC RES, V44, P1805, DOI 10.1111/j.1365-2109.2012.03184.x; Ozaki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064987; Ozerov MY, 2016, MOL ECOL, V25, P1275, DOI 10.1111/mec.13570; Palaiokostas C, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0148-y; Palaiokostas C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-566; Palaiokostas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068389; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Palti Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138435; Penaloza C, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-112; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pino-Querido A, 2015, AQUAC RES, V46, P1721, DOI 10.1111/are.12329; Pocwierz-Kotus A, 2014, ANIM GENET, V45, P96, DOI 10.1111/age.12095; Pocwierz-Kotus A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0121-9; POLAK L, 1987, COMP BIOCHEM PHYS B, V88, P881, DOI 10.1016/0305-0491(87)90259-8; Prasertlux S, 2015, AQUACULTURE, V448, P531, DOI 10.1016/j.aquaculture.2015.05.050; Pritchard VL, 2016, EVOL APPL, V9, P1017, DOI 10.1111/eva.12407; Qi HG, 2010, MOL BIOL REP, V37, P3779, DOI 10.1007/s11033-010-0032-3; Qu CM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3607-8; Rabier CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156086; Rengmark AH, 2007, AQUACULTURE, V272, P146, DOI 10.1016/j.aquaculture.2007.08.035; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Robledo D, 2017, REV AQUACULTURE; Robledo D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020243; Robledo D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2142-8; Salazar S, 2016, FISH SHELLFISH IMMUN, V51, P97, DOI 10.1016/j.fsi.2016.02.005; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Sansuwan K, 2017, AQUAC RES, V48, P1836, DOI 10.1111/are.13021; Sato S, 2014, T AM FISH SOC, V143, P1231, DOI 10.1080/00028487.2014.901251; Sauvage C, 2012, G3-GENES GENOM GENET, V2, P707, DOI 10.1534/g3.112.001990; Shao CW, 2015, DNA RES, V22, P161, DOI 10.1093/dnares/dsv001; Shen YB, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15014526; Shen YB, 2016, FISH SHELLFISH IMMUN, V54, P276, DOI 10.1016/j.fsi.2016.04.021; Shen YB, 2015, FISH SHELLFISH IMMUN, V45, P717, DOI 10.1016/j.fsi.2015.05.047; Sodeland M, 2013, AQUACULTURE, V408, P169, DOI 10.1016/j.aquaculture.2013.05.029; Su JG, 2012, DEV COMP IMMUNOL, V36, P450, DOI 10.1016/j.dci.2011.08.015; Sun CF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3830-3; Sun L, 2014, PLOS ONE, V9; Tao WJ, 2003, HEREDITY, V91, P60, DOI 10.1038/sj.hdy.6800281; Toonen RJ, 2013, PEERJ, V1, P203, DOI [10.7717/peerj.203, DOI 10.7717/PEERJ.203]; Tsai HY, 2016, G3-GENES GENOM GENET, V6, P2173, DOI 10.1534/g3.116.029009; Tsai HY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0215-y; Tsai HY, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0226-9; Tsai HY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2117-9; TSAI HY, 2016, INT J MOL SCI, V17; Tsigenopoulos CS, 2014, MAR GENOM, V18, P77, DOI 10.1016/j.margen.2014.09.008; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Vallejo RL, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0293-6; Vallejo RL, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00096; van Son M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3752-0; Vasemagi A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/628204; Vera M, 2010, AQUAC RES, V41, pe568, DOI 10.1111/j.1365-2109.2010.02550.x; Vervalle J, 2013, J SHELLFISH RES, V32, P89, DOI 10.2983/035.032.0115; Wang GL, 2013, FISH SHELLFISH IMMUN, V34, P1366, DOI 10.1016/j.fsi.2013.02.006; WANG L, 2015, SCI REP UK, V5; Wang L, 2017, MAR BIOTECHNOL, V19, P255, DOI 10.1007/s10126-017-9747-7; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/NMETH.2023, 10.1038/nmeth.2023]; Wang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120410; Wenne R, 2016, POLAR BIOL, V39, P343, DOI 10.1007/s00300-015-1785-x; WENNE R, 1989, BIOCHEM SYST ECOL, V17, P583, DOI 10.1016/0305-1978(89)90103-8                                                    ; WENNE R, 1987, MAR BIOL, V96, P73, DOI 10.1007/BF00394839; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Wenne R, 2016, METHODS MOL BIOL, V1452, P97, DOI 10.1007/978-1-4939-3774-5_6; Wenne R, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016012; Wennerstrom L, 2013, BIODIVERS CONSERV, V22, P3045, DOI 10.1007/s10531-013-0570-9; Xia JH, 2014, MAR BIOTECHNOL, V16, P1, DOI 10.1007/s10126-013-9524-1; Xia JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-295; XIAO SJ, 2016, PEER J, V4; Xu DD, 2013, MAR BIOTECHNOL, V15, P221, DOI 10.1007/s10126-012-9480-1; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Yanez JM, 2016, MOL ECOL RESOUR, V16, P1002, DOI 10.1111/1755-0998.12503; Yanez JM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00128; Yang CY, 2015, CELL STRESS CHAPERON, V20, P297, DOI 10.1007/s12192-014-0546-z; Yang CY, 2013, GENE, V526, P429, DOI 10.1016/j.gene.2013.05.033; [杨宇晖 Yang Yuhui], 2011, [遗传, Hereditas(Beijing)], V33, P996, DOI 10.3724/SP.J.1005.2011.00996; [殷勤 Yin Qin], 2011, [遗传, Hereditas(Beijing)], V33, P168, DOI 10.3724/SP.J.1005.2011.00168; You XX, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-113; Yue GH, 2017, AQUACULTURE, V468, P337, DOI 10.1016/j.aquaculture.2016.10.036; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zbawicka M, 2014, AQUAT BIOL, V21, P25, DOI 10.3354/ab00566; Zbawicka M, 2012, MAR BIOL, V159, P1347, DOI 10.1007/s00227-012-1915-8; Zeng QF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40347; Zhang B, 2016, MOL GENET GENOMICS, V291, P1615, DOI 10.1007/s00438-016-1208-x; Zhou T, 2017, MOL GENET GENOMICS, V292, P231, DOI 10.1007/s00438-016-1269-x; Zhu B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3847-7	210	0	0	1	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0990-7440	1765-2952		AQUAT LIVING RESOUR	Aquat. Living Resour.	NOV 23	2017	31								2	10.1051/a1r/2017043				17	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	FO6CJ	WOS:000416948900002					2018-01-05	
J	Gaudelli, NM; Komor, AC; Rees, HA; Packer, MS; Badran, AH; Bryson, DI; Liu, DR				Gaudelli, Nicole M.; Komor, Alexis C.; Rees, Holly A.; Packer, Michael S.; Badran, Ahmed H.; Bryson, David I.; Liu, David R.			Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage	NATURE			English	Article							ADENOSINE-DEAMINASE; CYTOSINE DEAMINATION; DIRECTED EVOLUTION; ESCHERICHIA-COLI; TARGET BASE; RNA; PRECISE; TADA; MUTATION; EMBRYOS	The spontaneous deamination of cytosine is a major source of transitions from C.G to T.A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A.T base pairs to G.C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A.T to G.C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A.T base pairs efficiently to G.C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.	[Gaudelli, Nicole M.; Komor, Alexis C.; Rees, Holly A.; Packer, Michael S.; Badran, Ahmed H.; Bryson, David I.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gaudelli, Nicole M.; Komor, Alexis C.; Rees, Holly A.; Packer, Michael S.; Badran, Ahmed H.; Bryson, David I.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Gaudelli, Nicole M.; Komor, Alexis C.; Rees, Holly A.; Packer, Michael S.; Badran, Ahmed H.; Bryson, David I.; Liu, David R.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Komor, Alexis C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Packer, Michael S.; Bryson, David I.] Beam Therapeut, 675 West Kendall St, Cambridge, MA 02139 USA	Liu, DR (reprint author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (reprint author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Liu, DR (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	drliu@fas.harvard.edu			DARPA [HR0011-17-2-0049]; US NIH [RM1 HG009490, R01 EB022376, R35 GM118062]; HHMI; Ruth L. Kirchstein National Research Service Awards [F32 GM 112366, F32 GM106621];  [T32 GM008313]	This work was supported by DARPA HR0011-17-2-0049, US NIH RM1 HG009490, R01 EB022376, and R35 GM118062, and HHMI. A. C. K. and D.I.B. were Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellows (F32 GM 112366 and F32 GM106621, respectively). M.S.P. was an NSF Graduate Research Fellow and was supported by training grant T32 GM008313. We thank Z. Niziolek for technical assistance. N.M.G. thanks A.E. Martin for his encouragement.	Alexander J, 2009, GENET MED, V11, P307, DOI [10.1097/GIM.0b013e31819d30f2, 10.1097/GIM.0b013e31819d3012]; Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Billon P, 2017, MOL CELL, V67, P1068, DOI 10.1016/j.molcel.2017.08.008; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fukui K., 2010, J NUCL ACIDS, V2010, P2010, DOI DOI 10.4061/2010/260512; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Grunebaum E, 2013, CURR OPIN ALLERGY CL, V13, P630, DOI 10.1097/ACI.0000000000000006; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim J, 2006, BIOCHEMISTRY-US, V45, P6407, DOI 10.1021/bi0522394; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor A. C., 2017, ACS CHEM BIOL; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Kwart D, 2017, NAT PROTOC, V12, P329, DOI 10.1038/nprot.2016.171; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lewis CA, 2016, P NATL ACAD SCI USA, V113, P8194, DOI 10.1073/pnas.1607580113; Li GL, 2017, PROTEIN CELL, V8, P776, DOI 10.1007/s13238-017-0458-7; Liang PP, 2017, PROTEIN CELL, V8, P811, DOI 10.1007/s13238-017-0475-6; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Muller KM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni116; Nishida K, 2016, SCIENCE, V353, P8729; Packer MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01055-9; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; SATOMURA A, 2017, SCI REP UK, V7; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Tang WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15939; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; Wienert B, 2017, BLOOD, V130, P803, DOI 10.1182/blood-2017-02-767400; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362                                                            ; Yasui M, 2008, J MOL BIOL, V377, P1015, DOI 10.1016/j.jmb.2008.01.033; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zheng YX, 2017, NUCLEIC ACIDS RES, V45, P3369, DOI 10.1093/nar/gkx050; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	43	2	2	22	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2017	551	7681					464	+		10.1038/nature24644				21	Multidisciplinary Sciences	Science & Technology - Other Topics	FN5JO	WOS:000416043700037	29160308				2018-01-05	
J	Christie, KA; Courtney, DG; DeDionisio, LA; Shern, CC; De Majumdar, S; Mairs, LC; Nesbit, MA; Moore, CBT				Christie, Kathleen A.; Courtney, David G.; DeDionisio, Larry A.; Shern, Connie Chao; De Majumdar, Shyamasree; Mairs, Laura C.; Nesbit, M. Andrew; Moore, C. B. Tara			Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders	SCIENTIFIC REPORTS			English	Article								CRISPR/Cas9 holds immense potential to treat a range of genetic disorders. Allele-specific gene disruption induced by non-homologous end-joining (NHEJ) DNA repair offers a potential treatment option for autosomal dominant disease. Here, we successfully delivered a plasmid encoding S. pyogenes Cas9 and sgRNA to the corneal epithelium by intrastromal injection and acheived long-term knockdown of a corneal epithelial reporter gene, demonstrating gene disruption via NHEJ in vivo. In addition, we used TGFBI corneal dystrophies as a model of autosomal dominant disease to assess the use of CRISPR/Cas9 in two allele-specific systems, comparing cleavage using a SNP-derived PAM to a guide specific approach. In vitro, cleavage via a SNP-derived PAM was found to confer stringent allele-specific cleavage, while a guide-specific approach lacked the ability to distinguish between the wild-type and mutant alleles. The failings of the guide-specific approach highlights the necessity for meticulous guide design and assessment, as various degrees of allele-specificity are achieved depending on the guide sequence employed. A major concern for the use of CRISPR/Cas9 is its tendency to cleave DNA non-specifically at "off-target" sites. Confirmation that S. pyogenes Cas9 lacks the specificity to discriminate between alleles differing by a single base-pair regardless of the position in the guide is demonstrated.	[Christie, Kathleen A.; Courtney, David G.; De Majumdar, Shyamasree; Mairs, Laura C.; Nesbit, M. Andrew; Moore, C. B. Tara] Ulster Univ, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [DeDionisio, Larry A.; Shern, Connie Chao; Moore, C. B. Tara] Avellino Labs, Menlo Pk, CA 94025 USA	Moore, CBT (reprint author), Ulster Univ, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland.; Moore, CBT (reprint author), Avellino Labs, Menlo Pk, CA 94025 USA.	t.moore@ulster.ac.uk		DeDionisio, Lawrence/0000-0001-5109-2388	Avellino Laboratories	We are grateful to Prof Feng Zhang, Broad Institute MIT, USA for kindly providing a novel AsCpf1 mutant nuclease pre-publication. This work has been supported by Avellino Laboratories.		0	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 23	2017	7								16174	10.1038/s41598-017-16279-4				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FN6MU	WOS:000416129800004	29170458	gold			2018-01-05	
J	Tajkarimi, M; Wexler, HM				Tajkarimi, Mehrdad; Wexler, Hannah M.			CRISPR-Cas Systems in Bacteroides fragilis, an Important Pathobiont in the Human Gut Microbiome	FRONTIERS IN MICROBIOLOGY			English	Article						Bacteroides; virulence; CRISPR-Cas system; phage; immune defense; gut microbiome; pathobiome	PROVIDES ACQUIRED-RESISTANCE; MULTIDRUG-RESISTANT; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; IMMUNITY; GENES; CLASSIFICATION; PROKARYOTES; EVOLUTION; BACTERIA	Background: While CRISPR-Cas systems have been identified in bacteria from a wide variety of ecological niches, there are no studies to describe CRISPR-Cas elements in Bacteroides species, the most prevalent anaerobic bacteria in the lower intestinal tract. Microbes of the genus Bacteroides make up similar to 25% of the total gut microbiome. Bacteroides fragilis comprises only 2% of the total Bacteroides in the gut, yet causes of >70% of Bacteroides infections. The factors causing it to transition from benign resident of the gut microbiome to virulent pathogen are not well understood, but a combination of horizontal gene transfer (HGT) of virulence genes and differential transcription of endogenous genes are clearly involved. The CRISPR-Cas system is a multi-functional system described in prokaryotes that may be involved in control both of HGT and of gene regulation. Results: Clustered regularly interspaced short palindromic repeats (CRISPR) elements in all strains of B. fragilis (n = 109) with publically available genomes were identified. Three different CRISPR-Cas types, corresponding most closely to Type IB, Type IIIB, and Type IIC, were identified. Thirty-five strains had two CRISPR-Cas types, and three strains included all three CRISPR-Cas types in their respective genomes. The cas 1 gene in the Type IIIB system encoded a reverse-transcriptase/Cas1 fusion protein rarely found in prokaryotes. We identified a short CRISPR (3 DR) with no associated cas genes present in most of the isolates; these CRISPRs were found immediately upstream of a hipA/hipB operon and we speculate that this element may be involved in regulation of this operon related to formation of persister cells during antimicrobial exposure. Also, blood isolates of B. fragilis did not have Type IIC CRISPR-Cas systems and had atypical Type IIIB CRISPR-Cas systems that were lacking adjacent cas genes. Conclusions: This is the first systematic report of CRISPR-Cas systems in a wide range of B. fragilis strains from a variety of sources. There are four apparent CRISPR-Cas systems in B. fragilis - three systems have adjacent cas genes. Understanding CRISPR/Cas function in B. fragilis will elucidate their role in gene expression, DNA repair and ability to survive exposure to antibiotics. Also, based on their unique CRISPR-Cas arrays, their phylogenetic clustering and their virulence potential, we are proposing that blood isolates of B. fragilis be viewed a separate subgroup.	[Tajkarimi, Mehrdad; Wexler, Hannah M.] Brentwood Biomed Res Inst, Los Angeles, CA 90025 USA; [Wexler, Hannah M.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Wexler, Hannah M.] GLAVA Hlth Care Syst, Los Angeles, CA 90073 USA	Wexler, HM (reprint author), Brentwood Biomed Res Inst, Los Angeles, CA 90025 USA.; Wexler, HM (reprint author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.; Wexler, HM (reprint author), GLAVA Hlth Care Syst, Los Angeles, CA 90073 USA.	hwexler@ucla.edu			Department of Veteran's Affairs [BX000563-01A1]; National Institutes of Health [R21 AI109545-01]	These studies were supported by grants to HW from the Department of Veteran's Affairs (BX000563-01A1) and the National Institutes of Health (R21 AI109545-01).	Alkhnbashi OS, 2016, BIOINFORMATICS, V32, P576, DOI 10.1093/bioinformatics/btw454; Ank N, 2015, INT J ANTIMICROB AG, V46, P117, DOI 10.1016/j.ijantimicag.2015.02.024; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI 10.1093/nar/gkt1030; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Capozzi V, 2009, FOOD RES INT, V42, P1501, DOI 10.1016/j.foodres.2009.08.001; Carte J, 2014, MOL MICROBIOL, V93, P98, DOI 10.1111/mmi.12644; Chenard C, 2016, MBIO, V7, DOI 10.1128/mBio.00667-16; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Coyne MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01305-14; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004                                                 ; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Husain F., 2017, MICROB GENOM, V4, DOI 10.1099/mgen.0.000136; Husain F., 2014, MOB GENET ELEMENTS, V4, DOI 10.4161/mge.29801; Iacobino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071324; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kalapila A, 2013, MMWR-MORBID MORTAL W, V62, P694; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Nikitina A. S., 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00450-15, DOI 10.1128/GENOMEA.00450-15]; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Patrick S, 2010, MICROBIOL-SGM, V156, P3255, DOI 10.1099/mic.0.042978-0; Pierce JV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158171; PRIVITERA G, 1979, J INFECT DIS, V139, P97, DOI 10.1093/infdis/139.1.97                                                         ; Pumbwe L, 2007, CLIN MICROBIOL INFEC, V13, P183, DOI 10.1111/j.1469-0691.2006.01620.x; Pumbwe L, 2007, MICROB DRUG RESIST, V13, P96, DOI 10.1089/mdr.2007.719; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Risse J, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0101-6; Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413; Salipante SJ, 2015, EMERG INFECT DIS, V21, P95, DOI 10.3201/eid2101.140662; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schapiro JM, 2004, J CLIN MICROBIOL, V42, P4127, DOI 10.1128/JCM.42.9.4127-4129.2004; Schumacher MA, 2015, NATURE, V524, P59, DOI 10.1038/nature14662; Science U.o.M.S.o.M.I.f.G., 2013, GSCID GEN SEQ CTR IN; Sherwood JE, 2011, ANAEROBE, V17, P152, DOI 10.1016/j.anaerobe.2011.02.007; Soki J, 2016, J ANTIMICROB CHEMOTH, V71, P2441, DOI 10.1093/jac/dkw175; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sydenham TV, 2015, ANAEROBE, V31, P59, DOI 10.1016/j.anaerobe.2014.10.009; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wexler H. M., 2014, PROKARYOTES OTHER MA, P459; Zhu DK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3040-4	75	0	0	7	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 23	2017	8								2234	10.3389/fmicb.2017.02234				21	Microbiology	Microbiology	FN4KU	WOS:000415975100001	29218031	gold			2018-01-05	
J	Borodinsky, LN				Borodinsky, Laura N.			Xenopus laevis as a Model Organism for the Study of Spinal Cord Formation, Development, Function and Regeneration	FRONTIERS IN NEURAL CIRCUITS			English	Review						neural tube defects; spinal cord injury; morphogenetic proteins; sensorimotor response; spinal neuron differentiation; axon guidance; calcium-dependent activity; neural plasticity	NEURAL-TUBE CLOSURE; GROWTH CONE GUIDANCE; PROTEIN-KINASE-C; DEVELOPING NEUROMUSCULAR SYNAPSES; INDUCED SYNAPTIC POTENTIATION; ELECTRICAL-ACTIVITY; TAIL REGENERATION; SONIC HEDGEHOG; CONVERGENT EXTENSION; APICAL CONSTRICTION	The spinal cord is the first central nervous system structure to develop during vertebrate embryogenesis, underscoring its importance to the organism. Because of its early formation, accessibility to the developing spinal cord in amniotes is challenging, often invasive and the experimental approaches amenable to model systems like mammals are limited. In contrast, amphibians, in general and the African-clawed frog Xenopus laevis, in particular, offer model systems in which the formation of the spinal cord, the differentiation of spinal neurons and glia and the establishment of spinal neuron and neuromuscular synapses can be easily investigated with minimal perturbations to the whole organism. The significant advances on gene editing and microscopy along with the recent completion of the Xenopus laevis genome sequencing have reinvigorated the use of this classic model species to elucidate the mechanisms of spinal cord formation, development, function and regeneration.	[Borodinsky, Laura N.] Univ Calif Davis, Sch Med, Shriners Hosp Children, Dept Physiol & Membrane Biol, Sacramento, CA 95817 USA; [Borodinsky, Laura N.] Univ Calif Davis, Sch Med, Shriners Hosp Children, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA	Borodinsky, LN (reprint author), Univ Calif Davis, Sch Med, Shriners Hosp Children, Dept Physiol & Membrane Biol, Sacramento, CA 95817 USA.; Borodinsky, LN (reprint author), Univ Calif Davis, Sch Med, Shriners Hosp Children, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA.	lnborodinsky@ucdavis.edu			Basil O'Connor Starter Scholar Research Award from the March of Dimes Foundation [5-FY09-131]; Esther A. and Joseph Klingenstein Fund; Klingenstein Foundation Award in Neuroscience; National Science Foundation (NSF) [1120796]; NIH-National Institute of Neurological Disorders and Stroke (NINDS) [R01NS073055]; Shriners Hospital for Children [86500-NCA, 85220-NCA, 85300-NCA]	The work in the lab has been supported by the Basil O'Connor Starter Scholar Research Award Grant 5-FY09-131 from the March of Dimes Foundation, Esther A. and Joseph Klingenstein Fund, Klingenstein Foundation Award in Neuroscience, National Science Foundation (NSF) 1120796, NIH-National Institute of Neurological Disorders and Stroke (NINDS) R01NS073055 and Shriners Hospital for Children 86500-NCA, 85220-NCA and 85300-NCA grants to LNB.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; AKERS RM, 1986, SCIENCE, V231, P613, DOI 10.1126/science.3945801; Balashova OA, 2017, DEVELOPMENT, V144, P1518, DOI 10.1242/dev.137315; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8                                                   ; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Belgacem YH, 2015, P NATL ACAD SCI USA, V112, P4140, DOI 10.1073/pnas.1419690112; Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Borodinsky LN, 2007, P NATL ACAD SCI USA, V104, P335, DOI 10.1073/pnas.0607450104; Borodinsky LN, 2015, DEV NEUROBIOL, V75, P349, DOI 10.1002/dneu.22254; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982                                                   ; Boulanger L, 1999, NAT NEUROSCI, V2, P346; Buhl E, 2015, J PHYSIOL-LONDON, V593, P4423, DOI 10.1113/JP270792; Burger C, 1996, J NEUROSCI, V16, P1412; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998                                                    ; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Christodoulou N, 2015, CELL REP, V13, P2189, DOI 10.1016/j.celrep.2015.11.017; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; Davidson LA, 1999, DEVELOPMENT, V126, P4547; Edlund AF, 2013, DEV DYNAM, V242, P1134, DOI 10.1002/dvdy.24004; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GU X, 1993, J NEUROSCI, V13, P4936; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Gurantz D, 1996, J NEUROSCI, V16, P3287; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hansen CS, 1997, DEVELOPMENT, V124, P483; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030                                                    ; JACOBSON AG, 1986, J EMBRYOL EXP MORPH, V96, P19; JACOBSON M, 1986, DEV BIOL, V116, P524, DOI 10.1016/0012-1606(86)90153-3                                                    ; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; KELLER R, 1992, DEV DYNAM, V193, P218, DOI 10.1002/aja.1001930303                                                          ; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302                                                          ; KELLER R, 1992, DEVELOPMENT, P81; KENGAKU M, 1993, DEVELOPMENT, V119, P1067; KINTNER CR, 1987, DEVELOPMENT, V99, P311; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; LANG DM, 1995, J NEUROSCI, V15, P99; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Lee-Liu D, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-12; LeSuer JA, 1999, DEVELOPMENT, V126, P137; LeSueur JA, 2002, DEV CELL, V2, P771, DOI 10.1016/S1534-5807(02)00172-7                                                   ; Li WC, 2003, J NEUROSCI, V23, P9068; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lombard-Banek C, 2017, GENESIS, V55, DOI 10.1002/dvg.23012; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Love NR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-70; Marchal L, 2009, P NATL ACAD SCI USA, V106, P17437, DOI 10.1073/pnas.0906352106; Marek KW, 2010, NAT NEUROSCI, V13, P944, DOI 10.1038/nn.2582; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mizuseki K, 1998, NEURON, V21, P77, DOI 10.1016/S0896-6273(00)80516-4; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; Nicetto D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003188; Nieuwkoop PD, 1994, NORMAL TABLE XENOPUS; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; ODOWD DK, 1983, NATURE, V303, P619, DOI 10.1038/303619a0; ODOWD DK, 1988, J NEUROSCI, V8, P792; Ossipova O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4734; OTTE AP, 1988, NATURE, V334, P618, DOI 10.1038/334618a0; OTTE AP, 1992, CELL, V68, P1021, DOI 10.1016/0092-8674(92)90074-M; OTTE AP, 1991, SCIENCE, V251, P570, DOI 10.1126/science.1990433                                                         ; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; RIBERA AB, 1989, NEURON, V2, P1055, DOI 10.1016/0896-6273(89)90229-8; Ribera AB, 1996, J NEUROSCI, V16, P1123; ROBERTS A, 1981, SCIENCE, V213, P1032, DOI 10.1126/science.7196599; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; Sokol SY, 2016, CURR TOP DEV BIOL, V117, P359, DOI 10.1016/bs.ctdb.2015.11.036; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864                                                                   ; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133                                                              ; SPEMANN H, 1938, EMBRYONIC DEV INDUCT; SPITZER NC, 1976, BRAIN RES, V107, P610, DOI 10.1016/0006-8993(76)90148-7                                                    ; Swapna I, 2012, P NATL ACAD SCI USA, V109, P16336, DOI 10.1073/pnas.1202818109; Tandon P, 2017, DEV BIOL, V426, P325, DOI 10.1016/j.ydbio.2016.04.009; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Tu MK, 2014, CELL CALCIUM, V56, P34, DOI 10.1016/j.ceca.2014.04.004; Wallentin J, 2013, SCIENCE, V339, P1057, DOI 10.1126/science.1230969; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2001, CURR BIOL, V11, P652, DOI 10.1016/S0960-9822(01)00201-9; Wan JJ, 1999, SCIENCE, V285, P1725, DOI 10.1126/science.285.5434.1725; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xu SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001286; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P11674, DOI 10.1073/pnas.1018512108; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0                                                                	106	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5110			FRONT NEURAL CIRCUIT	Front. Neural Circuits	NOV 23	2017	11								90	10.3389/fncir.2017.00090				9	Neurosciences	Neurosciences & Neurology	FN4VN	WOS:000416004900001	29218002	gold			2018-01-05	
J	Carlson-Stevermer, J; Abdeen, AA; Kohlenberg, L; Goedland, M; Molugu, K; Lou, M; Saha, K				Carlson-Stevermer, Jared; Abdeen, Amr A.; Kohlenberg, Lucille; Goedland, Madelyn; Molugu, Kaivalya; Lou, Meng; Saha, Krishanu			Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing	NATURE COMMUNICATIONS			English	Article							PLURIPOTENT STEM-CELLS; CAS9 NUCLEASE; MOUSE MODEL; TARGET DNA; DONOR DNA; IN-VIVO; GENOME; LOCUS; DELIVERY; COMPLEX	Writing specific DNA sequences into the human genome is challenging with non-viral gene-editing reagents, since most of the edited sequences contain various imprecise insertions or deletions. We developed a modular RNA aptamer-streptavidin strategy, termed S1mplex, to complex CRISPR-Cas9 ribonucleoproteins with a nucleic acid donor template, as well as other biotinylated molecules such as quantum dots. In human cells, tailored S1mplexes increase the ratio of precisely edited to imprecisely edited alleles up to 18-fold higher than standard gene-editing methods, and enrich cell populations containing multiplexed precise edits up to 42-fold. These advances with versatile, preassembled reagents could greatly reduce the time and cost of in vitro or ex vivo gene-editing applications in precision medicine and drug discovery and aid in the development of increased and serial dosing regimens for somatic gene editing in vivo.	[Carlson-Stevermer, Jared; Abdeen, Amr A.; Kohlenberg, Lucille; Goedland, Madelyn; Molugu, Kaivalya; Lou, Meng; Saha, Krishanu] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA; [Carlson-Stevermer, Jared; Goedland, Madelyn; Saha, Krishanu] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	Saha, K (reprint author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA.; Saha, K (reprint author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	ksaha@wisc.edu			National Science Foundation [CBET-1350178, CBET-1645123]; National Institute for Health [1R35GM119644-01]; Environmental Protection Agency [EPA-G2013 -STAR-L1]; Burroughs Wellcome Fund (Innovation in Regulatory Science Award); Wisconsin Alumni Research Foundation; Wisconsin Institute for Discovery	We thank members of the Saha lab for helpful discussion and comments on the manuscript. We also thank plasmid depositors to Addgene, ArtforScience, James Thomson lab for use of their BD FACS Aria, the University of Wisconsin Biotechnology Center, and the University of Wisconsin Carbone Cancer Center Flow Cytometry Laboratory for technical support. We thank Aldevron and Mirus Bio for supplying reagents and technical support. We further thank M. Suzuki and T. Kamp for sharing Pompe hiPSCs. We acknowledge generous financial support from the National Science Foundation (CBET-1350178 and CBET-1645123), National Institute for Health (1R35GM119644-01), Environmental Protection Agency (EPA-G2013 -STAR-L1), Burroughs Wellcome Fund (Innovation in Regulatory Science Award), Wisconsin Alumni Research Foundation, and the Wisconsin Institute for Discovery.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bao G, 2013, ANNU REV BIOMED ENG, V15, P253, DOI 10.1146/annurev-bioeng-071812-152409; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carlson-Stevermer J, 2016, STEM CELL REP, V6, P109, DOI 10.1016/j.stemcr.2015.11.014; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Gaj T, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx154; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Le Trong I, 2011, ACTA CRYSTALLOGR D, V67, P813, DOI 10.1107/S0907444911027806; Lee K, 2017, ELIFE, V6, DOI 10.7554/eLife.25312; Leppek K., 2013, NUCLEIC ACIDS RES, V42; Li H., 2017, BIORXIV; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu X, 2017, CELL, V170, P1028, DOI 10.1016/j.cell.2017.08.003; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Ma M, 2017, CELL RES, V27, P578, DOI 10.1038/cr.2017.29; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Papapetrou EP, 2016, NAT MED, V22, P1392, DOI 10.1038/nm.4238; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Petronzelli F, 2010, CANCER BIOTHER RADIO, V25, P563, DOI 10.1089/cbr.2010.0797; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raval KK, 2015, J BIOL CHEM, V290, P3121, DOI 10.1074/jbc.M114.628628; Ravin S. S. D., 2017, SCI TRANSL MED, V9; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2017, BIORXIV; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Soldner F., 2017, GENOME EDITING NEURO, P1; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Tabebordbar M., 2017, GENOME EDITING NEURO, P103; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	56	0	0	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 23	2017	8								1711	10.1038/s41467-017-01875-9				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FN7WH	WOS:000416229000001	29167458	gold			2018-01-05	
J	Kweon, J; Jang, AH; Kim, DE; Yang, JW; Yoon, M; Shin, HR; Kim, JS; Kim, Y				Kweon, Jiyeon; Jang, An-Hee; Kim, Da-Eun; Yang, Jin Wook; Yoon, Mijung; Shin, Ha Rim; Kim, Jin-Soo; Kim, Yongsub			Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1	NATURE COMMUNICATIONS			English	Article							ALTERED PAM SPECIFICITIES; CRISPR-CAS9 NUCLEASES; HUMAN-CELLS; GENOME; ENDONUCLEASES; ACTIVATION; VARIANTS; KNOCKOUT; COMPLEX; MICE	The bacteria-derived clustered regularly interspaced short palindromic repeat (CRISPR)-Cas systems are powerful tools for genome engineering. Recently, in addition to Cas protein engineering, the improvement of guide RNAs are also performed, contributing to broadening the research area of CRISPR-Cas9 systems. Here we develop a fusion guide RNA (fgRNA) that functions with both Cas9 and Cpf1 proteins to induce mutations in human cells. Furthermore, we demonstrate that fgRNAs can be used in multiplex genome editing and orthogonal genome manipulation with two types of Cas proteins. Our results show that fgRNAs can be used as a tool for performing multiple gene manipulations.	[Kweon, Jiyeon; Jang, An-Hee; Yang, Jin Wook; Yoon, Mijung; Shin, Ha Rim; Kim, Yongsub] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul 05505, South Korea; [Kim, Da-Eun; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 08826, South Korea; [Kim, Da-Eun; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 08826, South Korea	Kim, Y (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul 05505, South Korea.	yongsub1.kim@gmail.com			National Research Foundation of Korea [2016R1D1A1A02937096, 2017M3A9B4062419, 2016R1A6A3A04009014]	This work was supported by the National Research Foundation of Korea (2016R1D1A1A02937096, 2017M3A9B4062419, and 2016R1A6A3A04009014).	Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	23	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 23	2017	8								1723	10.1038/s41467-017-01650-w				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FN7WK	WOS:000416229300009	29167440	gold			2018-01-05	
J	Lian, JZ; HamediRad, M; Hu, SM; Zhao, HM				Lian, Jiazhang; HamediRad, Mohammad; Hu, Sumeng; Zhao, Huimin			Combinatorial metabolic engineering using an orthogonal tri-functional CRISPR system	NATURE COMMUNICATIONS			English	Article							SACCHAROMYCES-CEREVISIAE; PATHWAY OPTIMIZATION; GENOME INTEGRATION; ESCHERICHIA-COLI; GENE-EXPRESSION; FATTY-ACIDS; CAS9; ACTIVATION; YEAST; REPRESSION	Designing an optimal microbial cell factory often requires overexpression, knock-down, and knock-out of multiple gene targets. Unfortunately, such rewiring of cellular metabolism is often carried out sequentially and with low throughput. Here, we report a combinatorial metabolic engineering strategy based on an orthogonal tri-functional CRISPR system that combines transcriptional activation, transcriptional interference, and gene deletion (CRISPR-AID) in the yeast Saccharomyces cerevisiae. This strategy enables perturbation of the metabolic and regulatory networks in a modular, parallel, and high-throughput manner. We demonstrate the application of CRISPR-AID not only to increase the production of beta-carotene by 3-fold in a single step, but also to achieve 2.5-fold improvement in the display of an endoglucanase on the yeast surface by optimizing multiple metabolic engineering targets in a combinatorial manner.	[Lian, Jiazhang; HamediRad, Mohammad; Hu, Sumeng; Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Lian, Jiazhang] Zhejiang Univ, Coll Chem & Biol Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	zhao5@illinois.edu		Lian, Jiazhang/0000-0001-9784-9876; Zhao, Huimin/0000-0002-9069-6739	Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign; U.S. Department of Energy [DE-SC0018260]; Shen Postdoc Fellowship from the University of Illinois at Urbana-Champaign	This work was supported by the Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign and the U.S. Department of Energy (DE-SC0018260). J.L. also acknowledges the support of the Shen Postdoc Fellowship from the University of Illinois at Urbana-Champaign. We thank Dr Tong Si for his help and suggestions on yeast surface display and Dr Barbara Pilas from the Roy J. Carver Biotechnology Center for flow cytometry analysis and FACS.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Bao ZH, 2016, WIRES SYST BIOL MED, V8, P5, DOI 10.1002/wsbm.1319; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Du J, 2011, J IND MICROBIOL BIOT, V38, P873, DOI 10.1007/s10295-011-0970-3; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goncalves C, 2010, ANAL METHODS-UK, V2, P2046, DOI 10.1039/c0ay00525h; Hegemann Johannes H, 2006, Methods Mol Biol, V313, P129; Hou J, 2012, FEMS YEAST RES, V12, P491, DOI 10.1111/j.1567-1364.2012.00810.x; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jensen ED, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0664-2; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; La Russa MF, 2015, MOL CELL BIOL, V35, P3800, DOI 10.1128/MCB.00512-15; Lian JZ, 2016, BIOTECHNOL BIOENG, V113, P2462, DOI 10.1002/bit.26004; Lian JZ, 2016, ACS SYNTH BIOL, V5, P689, DOI 10.1021/acssynbio.6b00019; Lian JZ, 2015, ACS SYNTH BIOL, V4, P332, DOI 10.1021/sb500243c; Lian JZ, 2015, J IND MICROBIOL BIOT, V42, P437, DOI 10.1007/s10295-014-1518-0; Lian JZ, 2014, METAB ENG, V24, P139, DOI 10.1016/j.ymben.2014.05.010; Lian JZ, 2014, METAB ENG, V23, P92, DOI 10.1016/j.ymben.2014.02.003; Liu ZH, 2017, ACS SYNTH BIOL, V6, P601, DOI 10.1021/acssynbio.6b00331; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Ozaydin B, 2013, METAB ENG, V15, P174, DOI 10.1016/j.ymben.2012.07.010; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Si T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15187; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Tang HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25654; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Xie WP, 2015, METAB ENG, V28, P8, DOI 10.1016/j.ymben.2014.11.007; Xu P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2425; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	56	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 22	2017	8								1688	10.1038/s41467-017-01695-x				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FN7VF	WOS:000416226200017	29167442	gold			2018-01-05	
J	Weatherley, DAV; Boswell, MT; Rowland-Jones, SL				Weatherley, Daryl Anne Victoria; Boswell, Michael Terence; Rowland-Jones, Sarah L.			Targeting TRIM5 alpha in HIV Cure Strategies for the CRISPR-Cas9 Era	FRONTIERS IN IMMUNOLOGY			English	Article						TRI M5 alpha; HIV-1; HIV-2; PRYSPRY/B30.2; CRISPR-Cas9; adeno-associated virus; gene editing	SINGLE AMINO-ACID; STAPHYLOCOCCUS-AUREUS CAS9; ZINC-FINGER NUCLEASES; T-CELLS; IN-VIVO; ANTIRETROVIRAL THERAPY; GENE-THERAPY; RESTRICTION ACTIVITY; HEMATOPOIETIC STEM; LENTIVIRAL VECTOR	In the past decade, studies of innate immune activity against HIV-1 and other retroviruses have revealed a powerful array of host factors that can attack the virus at various stages of its life cycle in human and primate cells, raising the prospect that these antiviral factors could be manipulated in immunotherapeutic strategies for HIV infection. This has not proved straightforward: while HIV accessory genes encode proteins that subvert or destroy many of these restriction factors, others, such as human TRIM5 alpha show limited potency against HIV-1. However, HIV-1 is much more susceptible to simian versions of TRIM5a: could this information be translated into the development of an effective gene therapy for HIV infection? Reigniting research into the restriction factor TRIM5a in the era of superior gene editing technology such as CRISPR-Cas9 presents an exciting opportunity to revisit this prospect.	[Weatherley, Daryl Anne Victoria; Boswell, Michael Terence; Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Med, Oxford, England	Rowland-Jones, SL (reprint author), Univ Oxford, Nuffield Dept Med, Oxford, England.	sarah.rowland-jones@ndm.ox.ac.uk			Commonwealth Scholarship; Research Council of Norway; Rosetrees Foundation; British HIV Association; Centre for AIDS research, University of Kumamoto	MB is funded via a Commonwealth Scholarship. The SR-J lab receives grant support from the Research Council of Norway, the Rosetrees Foundation, the British HIV Association, and the Centre for AIDS research, University of Kumamoto.	Anderson J, 2005, MOL THER, V12, P687, DOI 10.1016/j.ymthe.2005.07.291; Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Anderson J, 2008, HUM GENE THER, V19, P217, DOI 10.1089/hum.2007.108; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Battivelli E, 2011, J VIROL, V85, P11846, DOI 10.1128/JVI.05201-11; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; da Silva RC, 2016, IMMUNOL RES, V64, P1237, DOI 10.1007/s12026-016-8810-1; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Goldschmidt V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-54; Granier C, 2013, J VIROL, V87, P10368, DOI 10.1128/JVI.01313-13; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Jallow S, 2015, EUR J IMMUNOL, V45, P2232, DOI 10.1002/eji.201545451; Javanbakht H, 2006, VIROLOGY, V354, P15, DOI 10.1016/j.virol.2006.06.031; Jung U, 2015, HUM GENE THER, V26, P664, DOI 10.1089/hum.2015.059; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Kambal A, 2011, MOL THER, V19, P584, DOI 10.1038/mt.2010.269; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kootstra NA, 2007, AIDS, V21, P2015, DOI 10.1097/QAD.0b013e3282effa87                                                    ; Lamers CHJ, 2011, BLOOD, V117, P72, DOI 10.1182/blood-2010-07-294520; Lascano J, 2016, J VIROL, V90, P308, DOI 10.1128/JVI.02496-15; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Li YL, 2016, ELIFE, V5, DOI 10.7554/eLife.16269; Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Liu FL, 2011, JAIDS-J ACQ IMM DEF, V56, P306, DOI 10.1097/QAI.0b013e318205a59b; Loeb M, 2011, J INFECT DIS, V204, P1031, DOI 10.1093/infdis/jir493; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nakajima T, 2009, AIDS, V23, P2091, DOI 10.1097/QAD.0b013e328331567a; Nakayama EE, 2013, AIDS RES HUM RETROV, V29, P919, DOI [10.1089/aid.2012.0369, 10.1089/AID.2012.0369]; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Onyango CO, 2010, VACCINE, V28, pB60, DOI 10.1016/j.vaccine.2009.08.060; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pham QT, 2010, GENE THER, V17, P859, DOI 10.1038/gt.2010.40; Price H, 2010, AIDS, V24, P1813, DOI 10.1097/QAD.0b013e32833b5256; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Richardson MW, 2014, MOL THER, V22, P1084, DOI 10.1038/mt.2014.52; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.club.2005.11.045; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schiroli G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0820; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Speelmon EC, 2006, J VIROL, V80, P2463, DOI 10.1128/JVI.80.5.2463-2471.2006; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sultana T, 2016, J GEN VIROL, V97, P963, DOI 10.1099/jgv.0.000408; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van der Loeff MFS, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-46; Veillette M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-25; Walker JE, 2012, J VIROL, V86, P5719, DOI 10.1128/JVI.06300-11; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Xu L, 2017, MOL THER, V25, P1782, DOI 10.1016/j.ymthe.2017.04.027; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Yin Y, 2014, J GENE MED, V16, P97, DOI 10.1002/jgm.2763; Yu S, 2017, HUM GENE THER, DOI [10.1089/hum.2017.032, DOI 10.1089/HUM.2017.032]; Zhang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32565; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277; Zonari E, 2017, STEM CELL REP, V8, P977, DOI 10.1016/j.stemcr.2017.02.010	79	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 22	2017	8								1616	10.3389/fimmu.2017.01616				7	Immunology	Immunology	FN4XS	WOS:000416010600001	29213273	gold			2018-01-05	
J	Yan, SJ; Lu, YL; He, L; Zhao, XZ; Wu, LH; Zhu, HZ; Jiang, ML; Su, Y; Cao, W; Tian, WD; Xing, QH				Yan, Sijia; Lu, Yulan; He, Lin; Zhao, Xinzhi; Wu, Lihua; Zhu, Huizhong; Jiang, Menglin; Su, Yu; Cao, Wei; Tian, Weidong; Xing, Qinghe			Dynamic Editome of Zebrafish under Aminoglycosides Treatment and Its Potential Involvement in Ototoxicity	FRONTIERS IN PHARMACOLOGY			English	Article						zebrafish; RNA-editing; RNA-Seq; aminoglycosides (AG); ototoxicity	PROTEIN-TYROSINE-PHOSPHATASE; RNA EDITING SITES; HAIR CELL-DEATH; LATERAL-LINE; GENE-EXPRESSION; DANIO-RERIO; BRAIN-DEVELOPMENT; RIBOSOMAL-RNA; HUMAN-DISEASE; HEARING-LOSS	RNA editing is an important co- and post-transcriptional event that generates RNA and protein diversity. Aminoglycosides are a group of bactericidal antibiotics and a mainstay of antimicrobial therapy for several life-threatening infections. However, aminoglycosides can induce ototoxicity, resulting in damage to the organs responsible for hearing and balance. At low concentrations, aminoglycosides can bind to many RNA sequences and critically influence RNA editing. We used a bioinformatics approach to investigate the effect of aminoglycosides on global mRNA editing events to gain insight into the interactions between mRNA editing and aminoglycoside ototoxicity. We identified 6,850 mRNA editing sites in protein coding genes in embryonic zebrafish, and in about 10% of these, the degree of RNA editing changed more than 15% under aminoglycosides treatment. Twelve ear-development or ototoxicity related genes, including plekhm1, fgfr1a, sox9a, and calrl2, exhibited remarkable changes in mRNA editing levels in zebrafish treated with aminoglycosides. Our results indicate that aminoglycosides may have a widespread and complicated influence on the progress of mRNA editing and expression. Furthermore, these results highlight the potential importance of mRNA editing in the pathogenesis and etiology of aminoglycoside-induced ototoxicity.	[Yan, Sijia; He, Lin; Zhao, Xinzhi; Zhu, Huizhong; Jiang, Menglin; Su, Yu; Xing, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Yan, Sijia; Lu, Yulan; He, Lin; Zhao, Xinzhi; Zhu, Huizhong; Jiang, Menglin; Su, Yu; Xing, Qinghe] Fudan Univ, Childrens Hosp, Shanghai, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiatr Disorders, Minist Educ, Shanghai, Peoples R China; [Wu, Lihua] Zhengzhou Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Cao, Wei] Zhengzhou Univ, Zhengzhou Cent Hosp, Zhengzhou, Henan, Peoples R China; [Tian, Weidong] Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai, Peoples R China	Xing, QH (reprint author), Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.; Xing, QH (reprint author), Fudan Univ, Childrens Hosp, Shanghai, Peoples R China.; Cao, W (reprint author), Zhengzhou Univ, Zhengzhou Cent Hosp, Zhengzhou, Henan, Peoples R China.; Tian, WD (reprint author), Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai, Peoples R China.	caoweiyu@hotmail.com; weidong.tian@fudan.edu.cn; xingqinghe@hotmail.com			National Natural Science Foundation of China [31371274, 31611130035, 81171992]; 973 Projects [2011CB710801]; Shanghai Municipal Commission of Science and Technology Program [14DJ1400101]; Scientific and Technological Research in Open Collaborative Projects of Henan Province [152106000044]	This work was supported by the National Natural Science Foundation of China (grants 31371274, 31611130035, and 81171992), the 973 Projects (2011CB710801) and the Shanghai Municipal Commission of Science and Technology Program (14DJ1400101). Scientific and Technological Research in Open Collaborative Projects of Henan Province (152106000044).	AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D                                                    ; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Azaiez H, 2014, HUM MUTAT, V35, P819, DOI 10.1002/humu.22557; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Dehne N, 2002, HEARING RES, V169, P47, DOI 10.1016/S0378-5955(02)00338-6                                                   ; Disney MD, 2008, J AM CHEM SOC, V130, P11185, DOI 10.1021/ja803234t; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Eran A, 2013, MOL PSYCHIATR, V18, P1041, DOI 10.1038/mp.2012.118; Gallo A, 2017, HUM GENET, V136, P1265, DOI 10.1007/s00439-017-1837-0; Girotto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080323; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808; Hashizume O, 2015, SCI REP-UK, V5, DOI 10.1038/srep10434; Head JR, 2013, DEV DYNAM, V242, P832, DOI 10.1002/dvdy.23973; Hendrix M, 1997, J AM CHEM SOC, V119, P3641, DOI 10.1021/ja964290o                                                               ; Hermann T, 1999, J MED CHEM, V42, P1250, DOI 10.1021/jm981108g                                                               ; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Karasawa T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.80; Karasawa T, 2011, TOXICOL SCI, V124, P378, DOI 10.1093/toxsci/kfr196; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kaul M, 2002, BIOCHEMISTRY-US, V41, P7695, DOI 10.1021/bi020130f; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Klaue Y, 2003, RNA, V9, P839, DOI 10.1261/rna.2167603; Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914                                                          ; Leitner MG, 2011, MOL PHARMACOL, V79, P51, DOI 10.1124/mol.110.068130; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097133; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Maas Stefan, 2006, RNA Biol, V3, P1; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291                                                         ; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Owens KN, 2009, HEARING RES, V253, P32, DOI 10.1016/j.heares.2009.03.001; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pirvola U, 2000, J NEUROSCI, V20, P6125; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Pozo P, 2012, NEURAL PLAST, DOI 10.1155/2012/173728; Qiu S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3115-2; Null RCTR, 2013, COMPUTING, V1, P12; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; SCAGLIONE F, 1995, J CHEMOTHERAPY, V7, P63; Schatz A, 1944, P SOC EXP BIOL MED, V57, P244; Schirle NT, 2010, ORG BIOMOL CHEM, V8, P4898, DOI 10.1039/c0ob00309c; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shamay-Ramot A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005702; Sie CP, 2009, FEBS LETT, V583, P1171, DOI 10.1016/j.febslet.2009.02.044; Sone M, 1998, HEARING RES, V115, P217, DOI 10.1016/S0378-5955(97)00191-3; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Stamatiou GA, 2013, OTOL NEUROTOL, V34, P961, DOI 10.1097/MAO.0b013e3182898272; Steiner AB, 2014, P NATL ACAD SCI USA, V111, pE1393, DOI 10.1073/pnas.1318692111; Stengel D, 2017, COMP BIOCHEM PHYS C, V193, P18, DOI 10.1016/j.cbpc.2016.11.001; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Vemaraju S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003068; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang JL, 2015, J NEUROSCI, V35, P234, DOI 10.1523/JNEUROSCI.3353-14.2015; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; Wright MB, 1998, J BIOL CHEM, V273, P23929, DOI 10.1074/jbc.273.37.23929; Zhang F, 2017, BIOINFORMATICS, V33, P3538, DOI 10.1093/bioinformatics/btx473	87	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	NOV 22	2017	8								854	10.3389/fphar.2017.00854				13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FN3QW	WOS:000415914900001	29213239	gold			2018-01-05	
J	Fei, JF; Schuez, M; Knapp, D; Taniguchi, Y; Drechsel, DN; Tanaka, EM				Fei, Ji-Feng; Schuez, Maritta; Knapp, Dunja; Taniguchi, Yuka; Drechsel, David N.; Tanaka, Elly M.			Efficient gene knockin in axolotl and its use to test the role of satellite cells in limb regeneration	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR/Cas9; knockin; neural stem cells; regeneration; satellite cells	CRISPR-CAS9 RIBONUCLEOPROTEIN COMPLEXES; CAS9 RIBONUCLEOPROTEINS; STEM-CELLS; GENOME; ZEBRAFISH; GENERATION; SOX2; MARKER; SYSTEM; MICE	Salamanders exhibit extensive regenerative capacities and serve as a unique model in regeneration research. However, due to the lack of targeted gene knockin approaches, it has been difficult to label and manipulate some of the cell populations that are crucial for understanding the mechanisms underlying regeneration. Here we have established highly efficient gene knockin approaches in the axolotl (Ambystoma mexicanum) based on the CRISPR/Cas9 technology. Using a homology-independent method, we successfully inserted both the Cherry reporter gene and a larger membrane-tagged Cherry-ERT2-Cre-ERT2 (similar to 5-kb) cassette into axolotl Sox2 and Pax7 genomic loci. Depending on the size of the DNA fragments for integration, 5-15% of the F0 transgenic axolotl are positive for the transgene. Using these techniques, we have labeled and traced the PAX7-positive satellite cells as a major source contributing to myogenesis during axolotl limb regeneration. Our work brings a key genetic tool to molecular and cellular studies of axolotl regeneration.	[Fei, Ji-Feng; Schuez, Maritta; Knapp, Dunja; Taniguchi, Yuka; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, DFG, D-01307 Dresden, Germany; [Fei, Ji-Feng; Taniguchi, Yuka; Drechsel, David N.; Tanaka, Elly M.] Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria; [Fei, Ji-Feng] South China Normal Univ, Inst Brain Res & Rehabil, Guangzhou 510631, Guangdong, Peoples R China; [Drechsel, David N.] Max Planck Inst Mol Cell Biol & Genet, Prot Express Facil, D-01307 Dresden, Germany	Fei, JF; Tanaka, EM (reprint author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden, DFG, D-01307 Dresden, Germany.; Fei, JF; Tanaka, EM (reprint author), Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria.; Fei, JF (reprint author), South China Normal Univ, Inst Brain Res & Rehabil, Guangzhou 510631, Guangdong, Peoples R China.	jifengfei@m.scnu.edu.cn; elly.tanaka@imp.ac.at			Human Frontier Science Program [RGP0016/2010]; German Research Foundation (DFG) [274/3-2, 274/3-3, 274/2-3/SFB655]; CRTD Seed grant for zinc-finger nucleases; CRTD Postdoctoral Seed Grant; European Research Council Advanced Investigator Grant [294324]; DFG Center for Regenerative Therapies Dresden (CRTD) [FZ111]; South China Normal University [S82111, 8S0109]	We thank Beate Gruhl, Anja Wagner, and Simone Kaudel for outstanding animal care. This study was supported by Human Frontier Science Program Grant RGP0016/2010; German Research Foundation (DFG) Grants 274/3-2, 274/3-3, and 274/2-3/SFB655 from Cells into Tissues; European Research Council Advanced Investigator Grant 294324; Central Funding grants from the DFG Center for Regenerative Therapies Dresden (CRTD) Grant FZ111; a CRTD Seed grant for zinc-finger nucleases; CRTD Postdoctoral Seed Grant 2015; and Research Start Grants S82111 and 8S0109 from South China Normal University.	Albors AR, 2015, ELIFE, V4, DOI 10.7554/eLife.10230; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fei JF, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.2; Fei JF, 2014, STEM CELL REP, V3, P444, DOI 10.1016/j.stemcr.2014.06.018; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; HE XJ, 2016, NUCL ACIDS RES, V44; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6                                                    ; Khattak S, 2013, STEM CELL REP, V1, P90, DOI 10.1016/j.stemcr.2013.03.002; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Nguyen PD, 2017, CELL STEM CELL, V21, P107, DOI 10.1016/j.stem.2017.06.003; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; SCHRECKENBERG GM, 1975, DEV BIOL, V42, P391, DOI 10.1016/0012-1606(75)90343-7; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	30	0	0	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 21	2017	114	47					12501	12506		10.1073/pnas.1706855114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FO1GB	WOS:000416503700059	29087939				2018-01-05	
J	Farrer, RA				Farrer, Rhys A.			Synima: a Synteny imaging tool for annotated genome assemblies	BMC BIOINFORMATICS			English	Article						Synteny; Imaging tool; Orthology; Visualization	ORTHOLOGS; EVOLUTIONARY; SEQUENCES; PARALOGS; DATABASE; GENES; PLANT	Background: Ortholog prediction and synteny visualization across whole genomes are valuable methods for detecting and representing a range of evolutionary processes such as genome expansion, chromosomal rearrangement, and chromosomal translocation. Few standalone methods are currently available to visualize synteny across any number of annotated genomes. Results: Here, I present a Synteny Imaging tool (Synima) written in Perl, which uses the graphical features of R. Synima takes orthologues computed from reciprocal best BLAST hits or OrthoMCL, and DAGchainer, and outputs an overview of genome-wide synteny in PDF. Each of these programs are included with the Synima package, and a pipeline for their use. Synima has a range of graphical parameters including size, colours, order, and labels, which are specified in a config file generated by the first run of Synima - and can be subsequently edited. Synima runs quickly on a command line to generate informative and publication quality figures. Synima is open source and freely available from https://github.com/rhysf/Synima under the MIT License. Conclusions: Synima should be a valuable tool for visualizing synteny between two or more annotated genome assemblies.	[Farrer, Rhys A.] Imperial Coll London, Dept Infect Dis Epidemiol, London W2 1PG, England; [Farrer, Rhys A.] UCL, Dept Genet Environm & Evolut, London WC1E 6BT, England	Farrer, RA (reprint author), Imperial Coll London, Dept Infect Dis Epidemiol, London W2 1PG, England.; Farrer, RA (reprint author), UCL, Dept Genet Environm & Evolut, London WC1E 6BT, England.	rfarrer@broadinstitute.org			MIT / Wellcome Trust Fellowship	This work was supported by an MIT / Wellcome Trust Fellowship.	Altenhoff AM, 2015, NUCLEIC ACIDS RES, V43, pD240, DOI 10.1093/nar/gku1158; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Delcher A. L., 2003, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI1003S00, 10.1002/0471250953.bi1003s00]; Farrer RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14742; Farret RA, 2015, MBIO, V6, DOI 10.1128/mBio.00868-15; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; GIBBS AJ, 1970, EUR J BIOCHEM, V16, P1, DOI 10.1111/j.1432-1033.1970.tb01046.x; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ma LG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10956; Munoz JF, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00213-16; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2001.5197; Riley DR, USING SYBIL INTERACT; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Zdobnov EM, 2017, NUCLEIC ACIDS RES, V45, pD744, DOI 10.1093/nar/gkw1119	26	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	NOV 21	2017	18								507	10.1186/s12859-017-1939-7				4	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	FN5LW	WOS:000416050100004	29162056	gold			2018-01-05	
J	Mikheikin, A; Olsen, A; Leslie, K; Russell-Pavier, F; Yacoot, A; Picco, L; Payton, O; Toor, A; Chesney, A; Gimzewski, JK; Mishra, B; Reed, J				Mikheikin, Andrey; Olsen, Anita; Leslie, Kevin; Russell-Pavier, Freddie; Yacoot, Andrew; Picco, Loren; Payton, Oliver; Toor, Amir; Chesney, Alden; Gimzewski, James K.; Mishra, Bud; Reed, Jason			DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle	NATURE COMMUNICATIONS			English	Article							ATOMIC-FORCE MICROSCOPY; FOLLICULAR LYMPHOMA; GENOMIC DNA; BRCA1; MICA; BREAST; CANCER; GRADE; GENE; PCR	Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnology and single-molecule genomics: (1) we describe a labeling technique (CRISPR-Cas9 nanoparticles) for high-speed AFM-based physical mapping of DNA and (2) the first successful demonstration of using DVD optics to image DNA molecules with high-speed AFM. As a proof of principle, we used this new "nanomapping" method to detect and map precisely BCL2-IGH translocations present in lymph node biopsies of follicular lymphoma patents. This HS-AFM "nanomapping" technique can be complementary to both sequencing and other physical mapping approaches.	[Mikheikin, Andrey; Olsen, Anita; Leslie, Kevin; Reed, Jason] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA; [Russell-Pavier, Freddie; Yacoot, Andrew] Natl Phys Lab, Hampton Rd, Teddington TW11 0LW, Middx, England; [Russell-Pavier, Freddie; Picco, Loren; Payton, Oliver] Interface Anal Ctr, HH Wills Phys Lab, Tyndall Ave, Bristol BS8 1TL, Avon, England; [Toor, Amir] VCU Sch Med, Dept Internal Med, Richmond, VA 23284 USA; [Toor, Amir; Chesney, Alden; Reed, Jason] VCU Massey Canc Ctr, Richmond, VA 23284 USA; [Chesney, Alden] VCU Sch Med, Dept Pathol, Richmond, VA 23284 USA; [Gimzewski, James K.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Mishra, Bud] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Mishra, Bud] NYU, Courant Inst Math Sci, Dept Math, New York, NY 10012 USA	Reed, J (reprint author), Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA.; Reed, J (reprint author), VCU Massey Canc Ctr, Richmond, VA 23284 USA.	jcreed@vcu.edu		Russell-Pavier, Freddie/0000-0002-2150-6989; gimzewski, james/0000-0003-4333-6957	National Institutes of Health [R01GM094388, R01CA185189]; VCU Massey Cancer Center Tissue and Data Acquisition and Analysis Core; NIH-NCI Cancer Center Support Grant [P30 CA016059]	Funding for this work was provided by National Institutes of Health grant R01GM094388 to J.R., B.M. and J.K.G. and grant R01CA185189 to J.R. Services in support of the research project was provided by the VCU Massey Cancer Center Tissue and Data Acquisition and Analysis Core, supported, in part, with funding from NIH-NCI Cancer Center Support Grant P30 CA016059.	Adams JD, 2016, NAT NANOTECHNOL, V11, P147, DOI [10.1038/nnano.2015.254, 10.1038/NNANO.2015.254]; Akasaka H, 2000, CANCER RES, V60, P2335; Akasaka T, 1998, GENE CHROMOSOME CANC, V21, P17, DOI 10.1002/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B; Anantharaman TS, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P385; Anantharaman TS, 1997, J COMPUT BIOL, V4, P91, DOI 10.1089/cmb.1997.4.91; Baday M, 2012, NANO LETT, V12, P3861, DOI 10.1021/nl302069q; Bustamante C, 1996, ANNU REV BIOPH BIOM, V25, P395; De Brakeleer S, 2013, HUM MUTAT, V34, P785, DOI 10.1002/humu.22297; FLORIJN RJ, 1995, HUM MOL GENET, V4, P831, DOI 10.1093/hmg/4.5.831; Gu K, 2008, ARCH PATHOL LAB MED, V132, P1355, DOI 10.1043/1543-2165(2008)132[1355:PDOBIF]2.0.CO;2; Hansma HG, 1996, BIOPHYS J, V70, P1933, DOI 10.1016/S0006-3495(96)79757-6                                                   ; Hsueh C, 2010, ACS APPL MATER INTER, V2, P3249, DOI 10.1021/am100697z; Hwu ET, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3673001; Hwu ET, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2817750; Jeffet J, 2016, ACS NANO, V10, P9823, DOI 10.1021/acsnano.6b05398; Jia HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05737; Jing JP, 1998, P NATL ACAD SCI USA, V95, P8046, DOI 10.1073/pnas.95.14.8046; Judkins T, 2012, CANCER-AM CANCER SOC, V118, P5210, DOI 10.1002/cncr.27556; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaykov A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19636; Klapetek P, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/065501; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Kroenlein H, 2012, GENE CHROMOSOME CANC, V51, P290, DOI 10.1002/gcc.21915; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lai ZW, 1999, NAT GENET, V23, P309, DOI 10.1038/15484; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Liao HS, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4826494; Liao HS, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898019; McCaffrey J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv878; Mikheikin A, 2016, ANAL CHEM, V88, P2527, DOI 10.1021/acs.analchem.5b04023; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Picco LM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044030; Puget N, 1997, CANCER RES, V57, P828; Qiagen, 2012, QIAAMP DNA FFPE TISS; Quercioli F, 1999, REV SCI INSTRUM, V70, P3620, DOI 10.1063/1.1149969; Reed J, 2012, J R SOC INTERFACE, V9, P2341, DOI 10.1098/rsif.2012.0024; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rusk N, 2014, NAT METHODS, V11, P887, DOI 10.1038/nmeth.3085; Seong MW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-645; Shlyakhtenko LS, 1999, BIOPHYS J, V77, P568, DOI 10.1016/S0006-3495(99)76913-4; Sundstrom A, 2012, IEEE T INF TECHNOL B, V16, P1200, DOI 10.1109/TITB.2012.2206819; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vranken C, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1406; Weinberg OK, 2007, J MOL DIAGN, V9, P530, DOI 10.2353/jmoldx.2007.070038; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705                                                            	46	0	0	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 21	2017	8								1665	10.1038/s41467-017-01891-9				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FN5IB	WOS:000416039500001	29162844	gold			2018-01-05	
J	Mougiakos, I; Mohanraju, P; Bosma, EF; Vrouwe, V; Bou, MF; Naduthodi, MIS; Gussak, A; Brinkman, RBL; van Kranenburg, R; van der Oost, J				Mougiakos, Ioannis; Mohanraju, Prarthana; Bosma, Elleke F.; Vrouwe, Valentijn; Bou, Max Finger; Naduthodi, Mihris I. S.; Gussak, Alex; Brinkman, Rudolf B. L.; van Kranenburg, Richard; van der Oost, John			Characterizing a thermostable Cas9 for bacterial genome editing and silencing	NATURE COMMUNICATIONS			English	Article							SEQUENCE-SPECIFIC CONTROL; GENE-EXPRESSION; PSEUDOMONAS-PUTIDA; ETHANOL-PRODUCTION; BACILLUS-SMITHII; DNA CLEAVAGE; CRISPR; IMMUNITY; SYSTEMS; ENDONUCLEASE	CRISPR-Cas9-based genome engineering tools have revolutionized fundamental research and biotechnological exploitation of both eukaryotes and prokaryotes. However, the mesophilic nature of the established Cas9 systems does not allow for applications that require enhanced stability, including engineering at elevated temperatures. Here we identify and characterize ThermoCas9 from the thermophilic bacterium Geobacillus thermodenitrificans T12. We show that in vitro ThermoCas9 is active between 20 and 70 degrees C, has stringent PAM-preference at lower temperatures, tolerates fewer spacer-protospacer mismatches than SpCas9 and its activity at elevated temperatures depends on the sgRNA-structure. We develop ThermoCas9-based engineering tools for gene deletion and transcriptional silencing at 55 degrees C in Bacillus smithii and for gene deletion at 37 degrees C in Pseudomonas putida. Altogether, our findings provide fundamental insights into a thermophilic CRISPR-Cas family member and establish a Cas9-based bacterial genome editing and silencing tool with a broad temperature range.	[Mougiakos, Ioannis; Mohanraju, Prarthana; Bosma, Elleke F.; Vrouwe, Valentijn; Bou, Max Finger; Naduthodi, Mihris I. S.; Gussak, Alex; van Kranenburg, Richard; van der Oost, John] Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Brinkman, Rudolf B. L.; van Kranenburg, Richard] Corbion, Arkelsedijk 46, NL-4206 AC Gorinchem, Netherlands; [Bosma, Elleke F.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Kemitorvet B220, DK-2800 Lyngby, Denmark	van der Oost, J (reprint author), Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	john.vanderoost@wur.nl		van Kranenburg, Richard/0000-0001-5856-1546	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs; NWO/TOP grant [714.015.001]	We would like to thank Koen Weenink, Steven Aalvink and Bastienne Vriesendorp for their technical assistance. R.v.K. and R.B.L.B. are employed by Corbion. I.M. and E.F.B. are supported by the Dutch Technology Foundation STW, which is part of The Netherlands Organization for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs. J.v.d.O. and P.M. are supported by the NWO/TOP grant 714.015.001.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Aparicio T, 2016, BIOTECHNOL J, V11, P1309, DOI 10.1002/biot.201600317; Ausubel F., 1987, CURRENT PROTOCOLS MO; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhalla A, 2013, BIORESOURCE TECHNOL, V128, P751, DOI 10.1016/j.biortech.2012.10.145; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bosma EF, 2013, CURR BIOTECHNOL, V2, P360, DOI DOI 10.2174/18722083113076660028; Bosma EF, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0286-5; Bosma EF, 2015, APPL ENVIRON MICROB, V81, P1874, DOI 10.1128/AEM.03640-14; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen HF, 2014, J BIOL CHEM, V289, P13284, DOI 10.1074/jbc.M113.539726; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daas MJA, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0618-7; Daas M. J. A., 2017, CURR MICROBIOL; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; LI YJ, 2016, NUCLEIC ACIDS RES, V44; Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Martinez-Garcia E, 2016, CURR OPIN BIOTECH, V42, P216, DOI 10.1016/j.copbio.2016.09.001; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mougiakos I, 2017, ACS SYNTH BIOL, V6, P849, DOI 10.1021/acssynbio.6b00339; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Nakade S, 2017, BIOENGINEERED, V8, P265, DOI 10.1080/21655979.2017.1282018; Nike PI, 2016, CURR OPIN CHEM BIOL, V34, P20, DOI 10.1016/j.cbpa.2016.05.011; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Olson DG, 2015, CURR OPIN BIOTECH, V33, P130, DOI 10.1016/j.copbio.2015.02.006; Poblete-Castro I, 2012, APPL MICROBIOL BIOT, V93, P2279, DOI 10.1007/s00253-012-3928-0; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sambrook J, 1989, MOL CLONING LAB MANU; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Taylor MP, 2011, MICROB BIOTECHNOL, V4, P438, DOI 10.1111/j.1751-7915.2010.00246.x; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiktor J, 2016, NUCLEIC ACIDS RES, V44, P3801, DOI 10.1093/nar/gkw214; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xu J, 2015, J GENET GENOMICS, V42, P141, DOI 10.1016/j.jgg.2015.02.007; Yan MY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00947-17; Zeldes BM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01209; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020	58	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 21	2017	8								1647	10.1038/s41467-017-01591-4				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FN7UC	WOS:000416223300003	29162801	gold			2018-01-05	
J	Feng, XP; Peng, C; Chen, Y; Liu, XD; Feng, XJ; He, Y				Feng, Xuping; Peng, Cheng; Chen, Yue; Liu, Xiaodan; Feng, Xujun; He, Yong			Discrimination of CRISPR/Cas9-induced mutants of rice seeds using near-infrared hyperspectral imaging	SCIENTIFIC REPORTS			English	Article							REFLECTANCE SPECTROSCOPY; VARIABLE SELECTION; NIR-SPECTROSCOPY; CLASSIFICATION; KERNELS; REGRESSION; MACHINE; STARCH; GENES; OILS	Identifying individuals with target mutant phenotypes is a significant procedure in mutant exploitation for implementing genome editing technology in a crop breeding programme. In the present study, a rapid and non-invasive method was proposed to identify CRISPR/Cas9-induced rice mutants from their acceptor lines (huaidao-1 and nanjing46) using hyperspectral imaging in the near-infrared (NIR) range (874.41-1733.91 nm) combined with chemometric analysis. The hyperspectral imaging data were analysed using principal component analysis (PCA) for exploratory purposes, and a support vector machine (SVM) and an extreme learning machine (ELM) were applied to build discrimination models for classification. Meanwhile, PCA loadings and a successive projections algorithm (SPA) were used for extracting optimal spectral wavelengths. The SVM-SPA model achieved best performance, with classification accuracies of 93% and 92.75% being observed for calibration and prediction sets for huaidao-1 and 91.25% and 89.50% for nanjing46, respectively. Furthermore, the classification of mutant seeds was visualized on prediction maps by predicting the features of each pixel on individual hyperspectral images based on the SPA-SVM model. The above results indicated that NIR hyperspectral imaging together with chemometric data analysis could be a reliable tool for identifying CRISPR/Cas9-induced rice mutants, which would help to accelerate selection and crop breeding processes.	[Feng, Xuping; Liu, Xiaodan; He, Yong] Zhejiang Univ, Minist Agr, Coll Biosyst Engn & Food Sci, Key Lab Spect, Hangzhou 310058, Zhejiang, Peoples R China; [Peng, Cheng; Feng, Xujun] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, Hangzhou 310021, Zhejiang, Peoples R China; [Chen, Yue] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou 310021, Zhejiang, Peoples R China	He, Y (reprint author), Zhejiang Univ, Minist Agr, Coll Biosyst Engn & Food Sci, Key Lab Spect, Hangzhou 310058, Zhejiang, Peoples R China.; Feng, XJ (reprint author), Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, Hangzhou 310021, Zhejiang, Peoples R China.	njjfxu@163.com; yhe@zju.edu.cn			863 National High-Tech Research and Development Plan [2013AA102301]; National Keypoint Research and Invention Programme of the Thirteenth State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control [2010DS700124-KF1712]; Chinese Postdoctoral Science Foundation [2006M601940]	This work was supported financially by the 863 National High-Tech Research and Development Plan (Project No: 2013AA102301), National Keypoint Research and Invention Programme of the Thirteenth State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (No. 2010DS700124-KF1712) and the Chinese Postdoctoral Science Foundation (2006M601940).	Alishahi A, 2010, SPECTROCHIM ACTA A, V75, P1, DOI 10.1016/j.saa.2009.10.001; Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8                                                   ; Baptista MS, 1996, ANAL CHEM, V68, P971, DOI 10.1021/ac951025x                                                               ; BARTON FE, 1992, APPL SPECTROSC, V46, P420, DOI 10.1366/0003702924125375                                                        ; Batten GD, 1998, AUST J EXP AGR, V38, P697, DOI 10.1071/EA97146; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Campbell MR, 2000, CEREAL CHEM, V77, P774, DOI 10.1094/CCHEM.2000.77.6.774; Cao H. X, 2016, INT J GENOMICS, V2016; Gao JF, 2013, COMPUT ELECTRON AGR, V99, P186, DOI 10.1016/j.compag.2013.09.011; Garcia-Molina MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152292; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; IKEGAYA K, 1987, J JPN SOC FOOD SCI, V34, P254; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Jetter K, 2000, ANAL CHIM ACTA, V420, P169, DOI 10.1016/S0003-2670(00)00889-8; Kim JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms5292; Lammertyn J, 1998, T ASAE, V41, P1089; Luna AS, 2013, SPECTROCHIM ACTA A, V100, P115, DOI 10.1016/j.saa.2012.02.085; Mavroforakis ME, 2006, IEEE T NEURAL NETWOR, V17, P671, DOI 10.1109/TNN.2006.873281; Munck L, 2004, J CEREAL SCI, V40, P213, DOI 10.1016/j.jcs.2004.07.006; OSBORNE BG, 1981, J SCI FOOD AGR, V32, P328, DOI 10.1002/jsfa.2740320403; Peng XT, 2014, REMOTE SENS-BASEL, V6, P2699, DOI 10.3390/rs6042699; Rodriguez-Pulido FJ, 2014, TALANTA, V122, P145, DOI [10.1016/j.talanta.2014.011044, 10.1016/j.talanta.2014.01.044]; Rodriguez-Pulido FJ, 2013, POSTHARVEST BIOL TEC, V76, P74, DOI 10.1016/j.postharvbio.2012.09.007; Rosa LN, 2017, ANAL CHIM ACTA, V961, P42, DOI 10.1016/j.aca.2017.01.019; SAERENS M, 2004, P 15 EUR C MACH LEAR, V3201, P371; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Serranti S, 2013, TALANTA, V103, P276, DOI 10.1016/j.talanta.2012.10.044; Tade M. O., 2012, CHEM PRODUCT PROCESS, V7; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; Pu H., 2016, FOOD ANAL METHOD, V9, P1; Williams P, 2009, ANAL CHIM ACTA, V653, P121, DOI 10.1016/j.aca.2009.09.005; Williams PJ, 2016, FOOD CHEM, V209, P131, DOI 10.1016/j.foodchem.2016.04.044; Wold S, 1996, J CHEMOMETR, V10, P463; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Zhang L, 2015, RICE SCI, V22, P245, DOI 10.1016/j.rsci.2015.09.004; Zhao HY, 2014, FOOD CHEM, V152, P316, DOI 10.1016/j.foodchem.2013.11.122; Zheng J, 2015, BREEDING SCI, V65, P120, DOI 10.1270/jsbbs.65.120; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	39	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 21	2017	7								15934	10.1038/s41598-017-16254-z				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FN4NK	WOS:000415983600022	29162881	gold			2018-01-05	
J	Wu, ZG; Yang, Y; Huang, G; Lin, J; Xia, YY; Zhu, YX				Wu, Zhiguo; Yang, Yan; Huang, Gai; Lin, Jing; Xia, Yuying; Zhu, Yuxian			Cotton functional genomics reveals global insight into genome evolution and fiber development	JOURNAL OF GENETICS AND GENOMICS			English	Review						Cotton; Functional genomics; Genome evolution; Fiber development	GOSSYPIUM-HIRSUTUM L.; BACILLUS-THURINGIENSIS TOXIN; NAC TRANSCRIPTION FACTOR; TRANSGENIC COTTON; GENE FAMILY; PINK-BOLLWORM; TARGETED MUTAGENESIS; EXPRESSION PATTERNS; LEPIDOPTERAN PESTS; CRISPR/CAS9 SYSTEM	Due to the economic value of natural textile fiber, cotton has attracted much research attention, which has led to the publication of two diploid genomes and two tetraploid genomes. These big data facilitate functional genomic study in cotton, and allow researchers to investigate cotton genome structure, gene expression, and protein function on the global scale using high-throughput methods. In this review, we summarized recent studies of cotton genomes. Population genomic analyses revealed the domestication history of cultivated upland cotton and the roles of transposable elements in cotton genome evolution. Alternative splicing of cotton transcriptomes was evaluated genome-widely. Several important gene families like MYC, NAC, Sus and GhPLD alpha 1 were systematically identified and classified based on genetic structure and biological function. High-throughput proteomics also unraveled the key functional proteins correlated with fiber development. Functional genomic studies have provided unprecedented insights into global-scale methods for cotton research. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Wu, Zhiguo; Lin, Jing; Zhu, Yuxian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Yang, Yan; Xia, Yuying; Zhu, Yuxian] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Hubei, Peoples R China; [Huang, Gai] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Zhu, YX (reprint author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.; Zhu, YX (reprint author), Wuhan Univ, Inst Adv Studies, Wuhan 430072, Hubei, Peoples R China.	zhuyx@whu.edu.cn			Natural Science Foundation of China [21602162, 31690090]; National Science and Technology Major Project [2016ZX08005003-001]; Fundamental Research Funds for the Central Universities [104862016]	This work was supported by the Natural Science Foundation of China (Nos. 21602162 and 31690090), the National Science and Technology Major Project (No. 2016ZX08005003-001), and the Fundamental Research Funds for the Central Universities (No. 104862016).	Baur ME, 2003, BIOL CONTROL, V26, P325, DOI 10.1016/S1049-9644(02)00160-3; Bevan MW, 2017, NATURE, V543, P346, DOI 10.1038/nature22011; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chen XG, 2017, SCI REP-UK, V7, DOI 10.1038/srep44304; Cheng HQ, 2016, J EXP BOT, V67, P1935, DOI 10.1093/jxb/erw016; Effenberger I, 2017, APPL MICROBIOL BIOT, V101, P2021, DOI 10.1007/s00253-016-7997-3; Fabrick JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035658; Fang L, 2017, NAT GENET, V49, P1089, DOI 10.1038/ng.3887; FLINT HM, 1995, SOUTHWEST ENTOMOL, V20, P281; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Gowda A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12213; Gunapati S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24978; Hagerty AM, 2005, ENVIRON ENTOMOL, V34, P105, DOI 10.1603/0046-225X-34.1.105                                                      ; Hardee DD, 1997, J ECON ENTOMOL, V90, P663, DOI 10.1093/jee/90.2.663                                                            ; HE QL, 2016, SCI REP UK, V6; He X, 2016, PLANT CELL REP, V35, P2167, DOI 10.1007/s00299-016-2027-6; Hu HY, 2016, PLANT J, V88, P921, DOI 10.1111/tpj.13273; Huang JF, 2016, SCI CHINA LIFE SCI, V59, P194, DOI 10.1007/s11427-015-4991-4; Jiao Y, 2016, SCI CHINA LIFE SCI, V59, P825, DOI 10.1007/s11427-016-5086-6; Jin X, 2016, SCI CHINA LIFE SCI, V59, P154, DOI 10.1007/s11427-016-4999-4; Jin X, 2013, J INTEGR PLANT BIOL, V55, P576, DOI 10.1111/jipb.12066; Krempl C, 2016, INSECT BIOCHEM MOLEC, V71, P49, DOI 10.1016/j.ibmb.2016.02.005; Li C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43902; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li Q, 2014, MOL PLANT, V7, P829, DOI 10.1093/mp/sst175; Liu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0390-4; LIU XM, 2015, SCI REP UK, V5; Ma D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10456; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Meng YY, 2011, J PROTEOME RES, V10, P5416, DOI 10.1021/pr200671d; Ni M, 2017, PLANT BIOTECHNOL J, V15, P1204, DOI 10.1111/pbi.12709; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Ponsard S, 2002, ENVIRON ENTOMOL, V31, P1197, DOI 10.1603/0046-225X-31.6.1197                                                     ; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin Y, 2017, J PROTEOME RES, V16, P2811, DOI 10.1021/acs.jproteome.7b00122; Ribeiro TP, 2017, PLANT BIOTECHNOL J, V15, P997, DOI 10.1111/pbi.12694; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Salih H, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0436-8; Shang HH, 2016, SCI CHINA LIFE SCI, V59, P142, DOI 10.1007/s11427-016-5001-1; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Shukla AK, 2016, NAT BIOTECHNOL, V34, P1046, DOI 10.1038/nbt.3665; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tang K, 2017, ACTA BIOCH BIOPH SIN, V49, P33, DOI 10.1093/abbs/gmw113; Tang K, 2016, SCI CHINA LIFE SCI, V59, P130, DOI 10.1007/s11427-015-4916-2; Tian X, 2016, SCI CHINA LIFE SCI, V59, P122, DOI 10.1007/s11427-016-5003-z; Wang K, 2016, SCI CHINA LIFE SCI, V59, P112, DOI 10.1007/s11427-015-4928-y; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang MJ, 2017, NAT GENET, V49, P579, DOI 10.1038/ng.3807; Wang P., 2017, PLANT BIOTECHNOL J, DOI [10.1111/pbi.12755, DOI 10.1111/PBI.12755]; Wang Q, 2016, SCI CHINA LIFE SCI, V59, P172, DOI 10.1007/s11427-015-4920-6; Wang WN, 2016, G3-GENES GENOM GENET, V6, P3951, DOI 10.1534/g3.116.034512; WILSON FD, 1992, J ECON ENTOMOL, V85, P1516, DOI 10.1093/jee/85.4.1516                                                           ; Xiao GH, 2016, J INTEGR PLANT BIOL, V58, P577, DOI 10.1111/jipb.12429; Yue Z, 2016, PLANT BIOTECHNOL J, V14, P1747, DOI 10.1111/pbi.12534; Zhang B, 2016, PROTEOME SCI, V14, DOI 10.1186/s12953-016-0101-1; Zhang HY, 2016, MOL GENET GENOMICS, V291, P1293, DOI 10.1007/s00438-016-1188-x; Zhang T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.153, 10.1038/nplants.2016.153]; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao Y., 2016, EURASIP J ADV SIG PR, V2016, P1; Zhu YX, 2016, SCI CHINA LIFE SCI, V59, P109, DOI 10.1007/s11427-016-5017-6; Zou CS, 2013, J INTEGR PLANT BIOL, V55, P643, DOI 10.1111/jipb.12068	65	0	0	7	7	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	NOV 20	2017	44	11					511	518		10.1016/j.jgg.2017.09.009				8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FO7IS	WOS:000417047700001	29169921				2018-01-05	
J	Cheng, FY; Gong, LY; Zhao, DH; Yang, HB; Zhou, J; Li, M; Xiang, H				Cheng, Feiyue; Gong, Luyao; Zhao, Dahe; Yang, Haibo; Zhou, Jian; Li, Ming; Xiang, Hua			Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon	JOURNAL OF GENETICS AND GENOMICS			English	Article						Haloarcula hispanica; CRISPR-Cas; Genome editing; Polyploid	HALOARCHAEON HALOFERAX-MEDITERRANEI; PROVIDES ACQUIRED-RESISTANCE; HALOARCULA-HISPANICA; ADAPTIVE IMMUNITY; POLYHYDROXYALKANOATE ACCUMULATION; GRANULE FORMATION; SEED SEQUENCE; HUMAN-CELLS; RNA; SYSTEMS	Research on CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR associated protein) systems has led to the revolutionary CRISPR/Cas9 genome editing technique. However, for most archaea and half of bacteria, exploitation of their native CRISPR-Cas machineries may be more straightforward and convenient. In this study, we harnessed the native type I-B CRISPR-Cas system for precise genome editing in the polyploid haloarchaeon Haloarcula hispanica. After testing different designs, the editing tool was optimized to be a single plasmid that carries both the self-targeting mini-CRISPR and a 600-800 bp donor. Significantly, chromosomal modifications, such as gene deletion, gene tagging or single nucleotide substitution, were precisely introduced into the vast majority of the transformants. Moreover, we showed that simultaneous editing of two genomic loci could also be readily achieved by one step. In summary, our data demonstrate that the haloarchaeal CRISPR-Cas system can be harnessed for genome editing in this polyploid archaeon, and highlight the convenience and efficiency of the native CRISPR-based genome editing strategy. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Cheng, Feiyue; Gong, Luyao; Zhao, Dahe; Yang, Haibo; Zhou, Jian; Li, Ming; Xiang, Hua] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Cheng, Feiyue; Gong, Luyao; Zhao, Dahe; Yang, Haibo; Xiang, Hua] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Li, M; Xiang, H (reprint author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.; Xiang, H (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	lim_im@im.ac.cn; xiangh@im.ac.cn			National Natural Science Foundation of China [31571283]; CAS-SAFEA International Partnership Program for Creative Research Teams	This work was supported by the grants from the National Natural Science Foundation of China (No. 31571283) and by the CAS-SAFEA International Partnership Program for Creative Research Teams.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cai SF, 2015, APPL ENVIRON MICROB, V81, P373, DOI 10.1128/AEM.02878-14; Cai SF, 2012, APPL ENVIRON MICROB, V78, P1946, DOI 10.1128/AEM.07114-11; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022                                                                 ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Li M, 2017, NUCLEIC ACIDS RES, V45, P4642, DOI 10.1093/nar/gkx229; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Li M, 2013, J BACTERIOL, V195, P867, DOI 10.1128/JB.01688-12; LI YJ, 2016, NUCLEIC ACIDS RES, V44; Liu HL, 2011, J GENET GENOMICS, V38, P261, DOI 10.1016/j.jgg.2011.05.003; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Sambrook J, 1989, MOL CLONING LAB MANU; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stachler AE, 2017, NUCLEIC ACIDS RES, V45, P5208, DOI 10.1093/nar/gkx150; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wu ZF, 2014, NUCLEIC ACIDS RES, V42, P2282, DOI 10.1093/nar/gkt1214; Zerulla K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094819; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	49	0	0	3	3	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	NOV 20	2017	44	11					541	548		10.1016/j.jgg.2017.09.010				8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FO7IS	WOS:000417047700004	29169919				2018-01-05	
J	Hao, N; Shearwin, KE; Dodd, IB				Hao, Nan; Shearwin, Keith E.; Dodd, Ian B.			Programmable DNA looping using engineered bivalent dCas9 complexes	NATURE COMMUNICATIONS			English	Article							RNA-GUIDED ENDONUCLEASE; CRISPR-CAS NUCLEASES; GENE-REGULATION; TARGET DNA; ESCHERICHIA-COLI; IN-VIVO; TRANSCRIPTION; RANGE; RECOGNITION; REPRESSION	DNA looping is a ubiquitous and critical feature of gene regulation. Although DNA looping can be efficiently detected, tools to readily manipulate DNA looping are limited. Here we develop CRISPR-based DNA looping reagents for creation of programmable DNA loops. Cleavage-defective Cas9 proteins of different specificity are linked by heterodimerization or translational fusion to create bivalent complexes able to link two separate DNA regions. After model-directed optimization, the reagents are validated using a quantitative DNA looping assay in E. coli. Looping efficiency is similar to 15% for a 4.7 kb loop, but is significantly improved by loop multiplexing with additional guides. Bivalent dCas9 complexes are also used to activate endogenous norVW genes by rewiring chromosomal DNA to bring distal enhancer elements to the gene promoters. Such reagents should allow manipulation of DNA looping in a variety of cell types, aiding understanding of endogenous loops and enabling creation of new regulatory connections.	[Hao, Nan; Shearwin, Keith E.; Dodd, Ian B.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia	Hao, N (reprint author), Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia.	nan.hao@adelaide.edu.au		Hao, Nan/0000-0001-5836-3507	National Health and Medical Research Council [GNT1100653]; Australian Research Council [DE150100091, DP160101450]	We are grateful to members of the Shearwin lab, particularly David Priest, for discussions. This work was supported by the National Health and Medical Research Council via a project Grant (GNT1100653) to I.B.D., K.E.S., and N.H. and the Australian Research Council via a Discovery Early Career Researcher Award to N.H. (DE150100091) and Discovery Grant to K.E.S. (DP160101450).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Cambray G, 2013, NUCLEIC ACIDS RES, V41, P5139, DOI 10.1093/nar/gkt163; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Chetverina D, 2014, BIOESSAYS, V36, P163, DOI 10.1002/bies.201300125; Cui L, 2013, P NATL ACAD SCI USA, V110, P2922, DOI 10.1073/pnas.1221322110; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001                                                ; Hao N, 2017, NUCLEIC ACIDS RES, V45, P5074, DOI 10.1093/nar/gkx069; Hao N, 2016, NUCLEIC ACIDS RES, V44, P6625, DOI 10.1093/nar/gkw600; Hao N, 2014, NUCLEIC ACIDS RES, V42, P8861, DOI 10.1093/nar/gku627; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Johnson S, 2012, NUCLEIC ACIDS RES, V40, P7728, DOI 10.1093/nar/gks473; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Khetrapal V, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv248; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kwon D, 2009, DEVELOPMENT, V136, P3067, DOI 10.1242/dev.036426; Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401; Morgan SL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15993; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Priest DG, 2014, P NATL ACAD SCI USA, V111, pE4449, DOI 10.1073/pnas.1410764111; Priest DG, 2014, P NATL ACAD SCI USA, V111, P349, DOI 10.1073/pnas.1317817111; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sarkar M, 2008, MOL BIOSYST, V4, P599, DOI 10.1039/b802481b; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215                                             ; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Spitz F, 2016, SEMIN CELL DEV BIOL, V57, P57, DOI 10.1016/j.semcdb.2016.06.017; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI [10.1021/s400021j, 10.1021/sb400021j]; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Umbarger MA, 2012, METHODS, V58, P212, DOI 10.1016/j.ymeth.2012.06.017; WEDEL A, 1990, SCIENCE, V248, P486, DOI 10.1126/science.1970441; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	55	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 20	2017	8								1628	10.1038/s41467-017-01873-x				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FN1OG	WOS:000415759900011	29158476	gold			2018-01-05	
J	Spahn, PN; Bath, T; Weiss, RJ; Kim, J; Esko, JD; Lewis, NE; Harismendy, O				Spahn, Philipp N.; Bath, Tyler; Weiss, Ryan J.; Kim, Jihoon; Esko, Jeffrey D.; Lewis, Nathan E.; Harismendy, Olivier			PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens	SCIENTIFIC REPORTS			English	Article							GENETIC SCREENS; CRISPR-CAS9; PACKAGE	Large-scale genetic screens using CRISPR/Cas9 technology have emerged as a major tool for functional genomics. With its increased popularity, experimental biologists frequently acquire large sequencing datasets for which they often do not have an easy analysis option. While a few bioinformatic tools have been developed for this purpose, their utility is still hindered either due to limited functionality or the requirement of bioinformatic expertise. To make sequencing data analysis of CRISPR/Cas9 screens more accessible to a wide range of scientists, we developed a Platform-independent Analysis of Pooled Screens using Python (PinAPL-Py), which is operated as an intuitive web-service. PinAPL-Py implements state-of-the-art tools and statistical models, assembled in a comprehensive workflow covering sequence quality control, automated sgRNA sequence extraction, alignment, sgRNA enrichment/depletion analysis and gene ranking. The workflow is set up to use a variety of popular sgRNA libraries as well as custom libraries that can be easily uploaded. Various analysis options are offered, suitable to analyze a large variety of CRISPR/Cas9 screening experiments. Analysis output includes ranked lists of sgRNAs and genes, and publication-ready plots. PinAPL-Py helps to advance genome-wide screening efforts by combining comprehensive functionality with user-friendly implementation. PinAPL-Py is freely accessible at http://pinapl-py.ucsd.edu with instructions and test datasets.	[Spahn, Philipp N.; Lewis, Nathan E.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Spahn, Philipp N.; Lewis, Nathan E.] Univ Calif San Diego, Novo Nordisk Fdn Ctr Biosustainabil, La Jolla, CA 92093 USA; [Weiss, Ryan J.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Bath, Tyler; Kim, Jihoon; Harismendy, Olivier] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA; [Harismendy, Olivier] Univ Calif San Diego, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA	Lewis, NE (reprint author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.; Lewis, NE (reprint author), Univ Calif San Diego, Novo Nordisk Fdn Ctr Biosustainabil, La Jolla, CA 92093 USA.; Harismendy, O (reprint author), Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA.; Harismendy, O (reprint author), Univ Calif San Diego, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA.	n4lewis@ucsd.edu; oharismendy@ucsd.edu			Novo Nordisk Foundation [NNF16CC0021858, NNF10CC1016517]; NIGMS [R35 GM119850, P50 GM085764]; NCI [R21 CA199292, R21 CA177519]; DOD [OC140179]; NHLBI [U54 HL108460, U24 HL126127]	We would like to acknowledge the valuable feedback from the participants of the CRISPR screening workshop organized by the San Diego Center for Systems Biology in October 2016 as well as the members of the UC San Diego CRISPR screening discussion group. In particular, we would like to thank Kristen Jepsen and her team at the UCSD Institute for Genomic Medicine. In addition, we would like to thank Julie la Cour Karrotki from the Center for Biosustainability at DTU for helpful feedback. This work was supported by generous funding from the Novo Nordisk Foundation provided to the Center for Biosustainability (NNF16CC0021858 and NNF10CC1016517), and grants from NIGMS (R35 GM119850 & P50 GM085764), NCI (R21 CA199292 & R21 CA177519), DOD (OC140179) and NHLBI (U54 HL108460 and U24 HL126127).	Cameron A., 2013, REGRESSION ANAL COUN; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jeong H.-H., 2017, BIOINFORMATICS; Kim J, 2014, BIOINFORMATICS, V30, P2826, DOI 10.1093/bioinformatics/btu377; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li W., 2014, GEOSCI J, P1; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Winter J, 2016, BIOINFORMATICS, V32, P632, DOI 10.1093/bioinformatics/btv617; Wucherpfennig KW, 2016, CURR OPIN IMMUNOL, V41, P55, DOI [10.1016/j.coi.2016.05.007, 10.1016/j.coi.2016.05:007]; Xue HY, 2016, J MED GENET, V53, P91, DOI 10.1136/jmedgenet-2015-103409	18	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 20	2017	7								15854	10.1038/s41598-017-16193-9				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FN0TM	WOS:000415692800026	29158538	gold			2018-01-05	
J	Zinad, HS; Natasya, I; Werner, A				Zinad, Hany S.; Natasya, Inas; Werner, Andreas			Natural Antisense Transcripts at the Interface between Host Genome and Mobile Genetic Elements	FRONTIERS IN MICROBIOLOGY			English	Article						natural antisense transcripts; gene expression regulation; double stranded RNA (dsRNA); non-coding RNA; RNA interference; DNA methylation; histone modifications	DOUBLE-STRANDED-RNA; MALE GERM-CELLS; QUESTIONING ANTIVIRAL RNAI; LONG NONCODING RNAS; ENDOGENOUS SIRNAS; PKR ACTIVATION; ENDO-SIRNAS; EXPRESSION; CANCER; INTERFERENCE	Non-coding RNAs are involved in epigenetic processes, playing a role in the regulation of gene expression at the transcriptional and post-transcriptional levels. A particular group of ncRNA are natural antisense transcripts (NATs); these are transcribed in the opposite direction to protein coding transcripts and are widespread in eukaryotes. Their abundance, evidence of phylogenetic conservation and an increasing number of well-characterized examples of antisense-mediated gene regulation are indicative of essential biological roles of NATs. There is evidence to suggest that they interfere with their corresponding sense transcript to elicit concordant and discordant regulation. The main mechanisms involved include transcriptional interference as well as dsRNA formation. Sense-antisense hybrid formation can trigger RNA interference, RNA editing or protein kinase R. However, the exact molecular mechanisms elicited by NATs in the context of these regulatory roles are currently poorly understood. Several examples confirm that ectopic expression of antisense transcripts trigger epigenetic silencing of the related sense transcript. Genomic approaches suggest that the antisense transcriptome carries a broader biological significance which goes beyond the physiological regulation of the directly related sense transcripts. Because NATs show evidence of conservation we speculate that they played a role in evolution, with early eukaryotes gaining selective advantage through the regulatory effects. With the surge of genome and transcriptome sequencing projects, there is promise of a more comprehensive understanding of the biological role of NATs and the regulatory mechanisms involved.	[Zinad, Hany S.; Natasya, Inas; Werner, Andreas] Newcastle Univ, Inst Cell & Mol Biosci, RNA Interest Grp, Newcastle Upon Tyne, Tyne & Wear, England	Werner, A (reprint author), Newcastle Univ, Inst Cell & Mol Biosci, RNA Interest Grp, Newcastle Upon Tyne, Tyne & Wear, England.	andreas.werner@ncl.ac.uk			Higher Committee for Education Development in Iraq (HCED)	HZ is supported by a grant from the Higher Committee for Education Development in Iraq (HCED).	Abrusan G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000172; Balbin OA, 2015, GENOME RES, V25, P1068, DOI 10.1101/gr.180596.114; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698                                                          ; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Carlile M, 2009, NUCLEIC ACIDS RES, V37, P2274, DOI 10.1093/nar/gkp088; Cayre A, 2003, BREAST CANCER RES, V5, pR223, DOI 10.1186/bcr652; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen L, 2012, EPIGENETICS-US, V7, P758, DOI 10.4161/epi.20706; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Dang Y, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0706-3; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Duharcourt S, 2009, TRENDS GENET, V25, P344, DOI 10.1016/j.tig.2009.05.007; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garcia-Lopez J, 2014, BBA-GENE REGUL MECH, V1839, P463, DOI 10.1016/j.bbagrm.2014.04.006; Goff LA, 2015, GENOME RES, V25, P1456, DOI 10.1101/gr.191122.115; Grzechnik P, 2014, TRENDS BIOCHEM SCI, V39, P319, DOI 10.1016/j.tibs.2014.05.001; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hastings ML, 1997, NUCLEIC ACIDS RES, V25, P4296, DOI 10.1093/nar/25.21.4296; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507                                                        ; Heubach J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0371-8; Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Jeffrey KL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.53; Jha A, 2015, NUCLEIC ACIDS RES, V43, P8713, DOI 10.1093/nar/gkv871; Kanduri C, 2016, BBA-GENE REGUL MECH, V1859, P102, DOI 10.1016/j.bbagrm.2015.05.006; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Laiho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061558; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee TL, 2009, BIRTH DEFECTS RES C, V87, P43, DOI 10.1002/bdrc.20147; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2                                                   ; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Ling KH, 2016, GENOMICS, V107, P88, DOI 10.1016/j.ygeno.2016.01.006; Ling MHT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-243; Liu JB, 2015, ONCOL REP, V34, P2343, DOI 10.3892/or.2015.4205; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mohammad F, 2010, DEVELOPMENT, V137, P2493, DOI 10.1242/dev.048181; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Munir M, 2013, VIRULENCE, V4, P85, DOI 10.4161/viru.23134; Ning QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42775; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Piatek MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178219; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rossignol F, 2002, GENE, V299, P135, DOI 10.1016/S0378-1119(02)01049-1; Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112; Schmauss Claudia, 2002, Sci STKE, V2002, ppe26, DOI 10.1126/stke.2002.133.pe26; Shendure J, 2002, GENOME BIOL, V3; Sleutels F, 2002, NATURE, V415, P810; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Stein P, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.10050013, 10.1371/journal.pgen.1005013]; Svobodova E, 2016, PFLUG ARCH EUR J PHY, V468, P1089, DOI 10.1007/s00424-016-1817-6; tenOever BR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.52; Thakur N, 2004, MOL CELL BIOL, V24, P7855, DOI 10.1128/MCB.24.18.7855-7862.2004; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157                                                                  ; Uesaka M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-35; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wang L., 2014, BIOMED RES INT, V2014, P10, DOI DOI 10.1109/IEEM.2014.7058646; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wegmann D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003587; Weinberg MS, 2016, NUCLEIC ACIDS RES, V44, P6505, DOI 10.1093/nar/gkw139; Werner A, 2007, PHYSIOL GENOMICS, V28, P294, DOI 10.1152/physiolgenomics.00127.2006; Werner A, 2015, ANN NY ACAD SCI, V1341, P156, DOI 10.1111/nyas.12608; Werner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-19; Werner A, 2010, BIOCHEM SOC T, V38, P1144, DOI 10.1042/BST0381144; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568                                                            ; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wight M, 2013, ESSAYS BIOCHEM, V54, P91, DOI [10.1042/BSE0540091, 10.1042/bse0540091]; Wood Emily J., 2013, Frontiers in Genetics, V4, P183, DOI 10.3389/fgene.2013.00183; Wyler E, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1329-5; Xia J, 2013, HUM MOL GENET, V22, P737, DOI 10.1093/hmg/dds481; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	92	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 20	2017	8								2292	10.3389/fmicb.2017.02292				9	Microbiology	Microbiology	FN0MN	WOS:000415672300001	29209299	gold			2018-01-05	
J	Rueda, FO; Bista, M; Newton, MD; Goeppert, AU; Cuomo, ME; Gordon, E; Kroner, F; Read, JA; Wrigley, JD; Rueda, D; Taylor, BJM				Rueda, Fernando Orden; Bista, Michal; Newton, Matthew D.; Goeppert, Anne U.; Cuomo, M. Emanuela; Gordon, Euan; Kroener, Felix; Read, Jon A.; Wrigley, Jonathan D.; Rueda, David; Taylor, Benjamin J. M.			Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease	NATURE COMMUNICATIONS			English	Article							CRISPR-CAS9 NUCLEASES; SPECIFICITY	The CRISPR-Cas9 RNA-guided endonuclease system allows precise and efficient modification of complex genomes and is continuously developed to enhance specificity, alter targeting and add new functional moieties. However, one area yet to be explored is the base chemistry of the associated RNA molecules. Here we show the design and optimisation of hybrid DNA-RNA CRISPR and tracr molecules based on structure-guided approaches. Through careful mapping of the ribose requirements of Cas9, we develop hybrid versions possessing minimal RNA residues, which are sufficient to direct specific nuclease activity in vitro and in vivo with reduced off-target activity. We identify critical regions within these molecules that require ribose nucleotides and show a direct correlation between binding affinity/stability and cellular activity. This is the first demonstration of a non-RNA-guided Cas9 endonuclease and first step towards eliminating the ribose dependency of Cas9 to develop a XNA-programmable endonuclease.	[Rueda, Fernando Orden; Bista, Michal; Goeppert, Anne U.; Cuomo, M. Emanuela; Read, Jon A.; Wrigley, Jonathan D.; Taylor, Benjamin J. M.] AstraZeneca, IMED Biotech Unit, Discovery Sci, Cambridge, England; [Newton, Matthew D.; Rueda, David] Imperial Coll London, Dept Med, Mol Virol, London W12 0NN, England; [Newton, Matthew D.; Rueda, David] Imperial Coll London, MRC London Inst Med Sci, London W12 0NN, England; [Gordon, Euan] AstraZeneca, Discovery Sci IMED Biotech Unit, Gothenburg, Sweden; [Kroener, Felix] Dynam Biosensors GmbH, Lochhamer Str 15, D-82152 Martinsried, Germany	Taylor, BJM (reprint author), AstraZeneca, IMED Biotech Unit, Discovery Sci, Cambridge, England.	Benjamin.Taylor@astrazeneca.com		Rueda, David/0000-0003-4657-6323	MRC London Institute of Medical Sciences [RCUK MC-A658-5TY10]; Imperial College London; BBSRC	Thanks to the AZ Discovery Sciences Cellular Reagents and Transgenics teams for critical discussions. Additional thanks to AZ colleagues Claire McWhirter, David Fisher, Ander Gunnarsson, Mikko Holtta, Marcello Maresca, Tim Kaminski, Martin Packer and Amir Taheri-Ghahfarokhi for helpful and insightful discussions. The Rueda lab is funded by a core grant of MRC London Institute of Medical Sciences (RCUK MC-A658-5TY10) and a start-up grant from Imperial College London. MDN is funded by a BBSRC studentship.	Bisaria N, 2017, CELL SYST, V4, P21, DOI 10.1016/j.cels.2016.12.010; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Enghiad B, 2017, ACS SYNTH BIOL, V6, P752, DOI 10.1021/acssynbio.6b00324; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoerter JAH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020359; Jiang F., 2016, SCIENCE, V8282, P1; Jiang WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9101; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lamichhane R, 2010, METHODS, V52, P192, DOI 10.1016/j.ymeth.2010.06.010; Langer A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12066; Lee NCO, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv112; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Lim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13350; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Natsume T, 2007, CHEM PHYS LETT, V434, P133, DOI 10.1016/j.cplett.2006.12.017; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Riche CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10780; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Senavirathne G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10209; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wood S., 2013, ENCY BIOPHYSICS, P809; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017	33	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 20	2017	8								1610	10.1038/s41467-017-01732-9				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FN1NW	WOS:000415758800001	29151576	gold			2018-01-05	
J	Kolimi, N; Ajjugal, Y; Rathinavelan, T				Kolimi, Narendar; Ajjugal, Yogeeshwar; Rathinavelan, Thenmalarchelvi			A B-Z junction induced by an A ... A mismatch in GAC repeats in the gene for cartilage oligomeric matrix protein promotes binding with the hZ(ADAR1) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD; molecular dynamics; NMR; RNA editing; trinucleotide repeat disease; cartilage oligomeric matrix protein; human adar1 protein; pseudoachdroplasia	Z-ALPHA DOMAIN; HANDED Z-DNA; MULTIPLE EPIPHYSEAL DYSPLASIA; BASE TRIPLET NONISOMORPHISM; NUCLEIC-ACID STRUCTURES; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; ATOMIC-RESOLUTION; EDITING ENZYME; Z TRANSITION	GAC repeat expansion from five to seven in the exonic region of the gene for cartilage oligomeric matrix protein (COMP) leads to pseudoachondroplasia, a skeletal abnormality. However, the molecular mechanism by which GAC expansions in the COMP gene lead to skeletal dysplasias is poorly understood. Here we used molecular dynamics simulations, which indicate that an A ... A mismatch in a d(GAC)(6)<bold>d</bold>(GAC)(6) duplex induces negative supercoiling, leading to a local B-to-Z DNA transition. This transition facilitates the binding of d(GAC)(7)<bold>d</bold>(GAC)(7) with the Z-binding domain of human adenosine deaminase acting on RNA 1 (ADAR1, hZ(ADAR1)), as confirmed by CD, NMR, and microscale thermophoresis studies. The CD results indicated that hZ(ADAR1) recognizes the zigzag backbone of d(GAC)(7)<bold>d</bold>(GAC)(7) at the B-Z junction and subsequently converts it into Z-DNA via the so-called passive mechanism. Molecular dynamics simulations carried out for the modeled hZ(ADAR1)-d(GAC)(6).d(GAC)(6) complex confirmed the retention of previously reported important interactions between the two molecules. These findings suggest that hZ(ADAR1) binding with the GAC hairpin stem in COMP can lead to a non-genetic, RNA editing-mediated substitution in COMP that may then play a crucial role in the development of pseudoachondroplasia.	[Kolimi, Narendar; Ajjugal, Yogeeshwar; Rathinavelan, Thenmalarchelvi] Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi 502285, Telangana State, India	Rathinavelan, T (reprint author), Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi 502285, Telangana State, India.	tr@iith.ac.in			Department of Biotechnology, Government of India IYBA [BT/06/IYBA/2012]; Department of Biotechnology, Government of India BIO-CaRE [102/IFD/SAN/1811/2013-2014]; Department of Biotechnology, Government of India RD [102/IFD/SAN/3426/2013-2014]; Indian Institute of Technology Hyderabad; Ministry of Human Resources Development, Government of India	This work was supported by the Department of Biotechnology, Government of India IYBA-2012 (D.O. No. BT/06/IYBA/2012), BIO-CaRE (SAN. No. 102/IFD/SAN/1811/2013-2014), and R&D (SAN. No. 102/IFD/SAN/3426/2013-2014) and the Indian Institute of Technology Hyderabad (to T. R.). The Ministry of Human Resources Development, Government of India provided fellowships to N. K. and Y. A. The authors declare that they have no conflicts of interest with the contents of this article.	Ananth P, 2013, RNA, V19, P1038, DOI 10.1261/rna.036905.112; Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Berger I, 1998, BIOCHEMISTRY-US, V37, P13313, DOI 10.1021/bi9813126; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Case D. A., 2012, AMBER 12; Dans PD, 2014, NUCLEIC ACIDS RES, V42, P11304, DOI 10.1093/nar/gku809; DeLano WL, 2012, PYMOL MOL GRAPHICS S; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Goldsmith G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155090; Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325                                                              ; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5                                                    ; Jackson GC, 2012, HUM MUTAT, V33, P144, DOI 10.1002/humu.21611; Jeong M, 2014, ARCH BIOCHEM BIOPHYS, V558, P95, DOI 10.1016/j.abb.2014.06.026; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kang YM, 2009, J AM CHEM SOC, V131, P11485, DOI 10.1021/ja902654u; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; Khan N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004162; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kim D, 2014, NUCLEIC ACIDS RES, V42, P5937, DOI 10.1093/nar/gku189; Kim D, 2009, NUCLEIC ACIDS RES, V37, P4353, DOI 10.1093/nar/gkp364; Kimura T, 2004, J ORG CHEM, V69, P1169, DOI 10.1021/jo035194q; Krepl M, 2012, J CHEM THEORY COMPUT, V8, P2506, DOI 10.1021/ct300275s; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405                                                          ; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MEIER JC, 2016, FRONT MOL NEUROSCI, V9; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245                                                          ; Mochmann LH, 2004, NUCLEIC ACIDS RES, V32, P4469, DOI 10.1093/nar/gkh787; Moradi M, 2013, NUCLEIC ACIDS RES, V41, P33, DOI 10.1093/nar/gks1003; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; NORDHEIM A, 1982, CELL, V31, P309, DOI 10.1016/0092-8674(82)90124-6; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Patro LPP, 2017, J MOL BIOL, V429, P2438, DOI 10.1016/j.jmb.2017.06.013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; POHL FM, 1972, J MOL BIOL, V67, P375, DOI 10.1016/0022-2836(72)90457-3                                                    ; Rathinavelan T, 2006, BIOPOLYMERS, V82, P443, DOI [10.1002/bip.20484, 10.1002/BIP.20484]; Rathinavelan T, 2014, J MOL BIOL, V426, P2958, DOI 10.1016/j.jmb.2014.06.009; Rathinavelan T, 2011, J BIOL CHEM, V286, P4922, DOI 10.1074/jbc.M110.159434; Schade M, 1999, P NATL ACAD SCI USA, V96, P12465, DOI 10.1073/pnas.96.22.12465; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761                                                             ; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Singh Minati, 2012, Front Genet, V3, P326, DOI 10.3389/fgene.2012.00326; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Susic S, 1998, HUM MUTAT, pS125; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Thenmalarchelvi R, 2005, NUCLEIC ACIDS RES, V33, P43, DOI 10.1093/nar/gki143; Tufan AC, 2007, EUR J HUM GENET, V15, P1023, DOI 10.1038/sj.ejhg.5201882; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vorlickova M, 2001, EUR BIOPHYS J BIOPHY, V30, P179, DOI 10.1007/s002490000121; Vorlickova M, 1999, NUCLEIC ACIDS RES, V27, P581, DOI 10.1093/nar/27.2.581; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X                                                   ; Yildirim I, 2013, J AM CHEM SOC, V135, P3528, DOI 10.1021/ja3108627	57	0	0	3	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18732	18746		10.1074/jbc.M117.796235				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN2TT	WOS:000415848000001					2018-01-05	
J	Yablonovitch, AL; Fu, J; Li, KX; Mahato, S; Kang, L; Rashkovetsky, E; Korol, AB; Tang, H; Michalak, P; Zelhof, AC; Nevo, E; Li, JB				Yablonovitch, Arielle L.; Fu, Jeremy; Li, Kexin; Mahato, Simpla; Kang, Lin; Rashkovetsky, Eugenia; Korol, Abraham B.; Tang, Hua; Michalak, Pawel; Zelhof, Andrew C.; Nevo, Eviatar; Li, Jin Billy			Regulation of gene expression and RNA editing in Drosophila adapting to divergent microclimates	NATURE COMMUNICATIONS			English	Article							DNA-SEQUENCING DATA; EVOLUTION-CANYON; CALCIUM-CHANNEL; MELANOGASTER; ADAPTATION; ISRAEL; POPULATION; DIFFERENTIATION; COURTSHIP; FRAMEWORK	Determining the mechanisms by which a species adapts to its environment is a key endeavor in the study of evolution. In particular, relatively little is known about how transcriptional processes are fine-tuned to adjust to different environmental conditions. Here we study Drosophila melanogaster from 'Evolution Canyon' in Israel, which consists of two opposing slopes with divergent microclimates. We identify several hundred differentially expressed genes and dozens of differentially edited sites between flies from each slope, correlate these changes with genetic differences, and use CRISPR mutagenesis to validate that an intronic SNP in prominin regulates its editing levels. We also demonstrate that while temperature affects editing levels at more sites than genetic differences, genetically regulated sites tend to be less affected by temperature. This work shows the extent to which gene expression and RNA editing differ between flies from different microclimates, and provides insights into the regulation responsible for these differences.	[Yablonovitch, Arielle L.; Fu, Jeremy; Tang, Hua; Li, Jin Billy] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Yablonovitch, Arielle L.; Li, Jin Billy] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Li, Kexin; Rashkovetsky, Eugenia; Korol, Abraham B.; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel; [Li, Kexin] Chinese Acad Agr Sci, Inst Apicultural Res, Beijing 100093, Peoples R China; [Mahato, Simpla; Zelhof, Andrew C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kang, Lin; Michalak, Pawel] Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA; [Michalak, Pawel] Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA; [Michalak, Pawel] Virginia Maryland Coll Vet Med, Ctr Hlth Res 1, Blacksburg, VA 24060 USA	Li, JB (reprint author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Li, JB (reprint author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Nevo, E (reprint author), Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel.	nevo@research.haifa.ac.il; jin.billy.li@stanford.edu			NIH [T32 GM008294, R21EY024125, R01 GM102484, R01 GM124215, R01 MH115080]; Binational USA-Israel Science Foundation Grant BSF [2011438]; Research Foundation of Ancell-Teicher for Genetics and Molecular Evolution; Ellison Medical Foundation	We thank members of the Li lab for comments, as well as Hunter Fraser, Tom Clandinin, Joe Lipsick, and Stephen Montgomery for helpful discussions. We also thank Drew Stenesen and Helmut Kramer for assistance with phenotyping flies. This work was supported by an NIH Molecular Biophysics Predoctoral Research Training Grant T32 GM008294 (A.L.Y.), Binational USA-Israel Science Foundation Grant BSF # 2011438 ( K.L., E.R., A.B.K., E.N.), NIH grant R21EY024125 (S.M. and A.C.Z.), Research Foundation of Ancell-Teicher for Genetics and Molecular Evolution (E.N.), and NIH grants R01 GM102484, R01 GM124215, and R01 MH115080 and the Ellison Medical Foundation (J.B.L.).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Boitard S, 2013, MOL ECOL RESOUR, V13, P337, DOI 10.1111/1755-0998.12063; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buchumenski I, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006931; Catalan A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005987; Catalan A, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-654; Celniker SE, 2002, GENOME BIOL, V3; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003813; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x                                               ; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duan Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006648; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Fraser HB, 2013, GENOME RES, V23, P1089, DOI 10.1101/gr.152710.112; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Higuchi M, 2000, NATURE, V406, P78; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; Hubner S, 2013, P NATL ACAD SCI USA, V110, P21059, DOI 10.1073/pnas.1321533111; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Kim YB, 2014, P NATL ACAD SCI USA, V111, P10630, DOI 10.1073/pnas.1410372111; Korol A, 2006, P NATL ACAD SCI USA, V103, P18184, DOI 10.1073/pnas.0608777103; Kurmangaliyev YZ, 2016, G3-GENES GENOM GENET, V6, P391, DOI 10.1534/g3.115.024471; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LIAO Y, 2013, NUCLEIC ACIDS RES, V41, P108, DOI DOI 10.1093/NAR/GKT214; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Martin AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004549; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3, DOI [10.4081/eb.2009.e3, DOI 10.4081/EB.2009.E3]; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; Nie J, 2012, DEV BIOL, V371, P312, DOI 10.1016/j.ydbio.2012.08.024; O'Leary Nuala A, 2016, Nucleic Acids Res, V44, pD733, DOI 10.1093/nar/gkv1189; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Pavlicek T, 2008, ISR J ECOL EVOL, V54, P165, DOI 10.1080/15659801.2008.10639620                                                  ; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Peixoto AA, 1998, GENETICS, V148, P827; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramaswami G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9194; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Rashkovetsky E, 2006, HEREDITY, V96, P353, DOI 10.1038/sj.hdy.6800784; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rieder LE, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0111-3; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Roy S., 2014, J BIOMOL TECH S, V25, pS13; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Sang TK, 2002, DEVELOPMENT, V129, P143; Sapiro AL, 2015, CELL REP, V11, P697, DOI 10.1016/j.celrep.2015.04.005; Schrider DR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005928; Smith LA, 1998, GENETICS, V149, P1407; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Sousa-Nunes R, 2009, GENE DEV, V23, P359, DOI 10.1101/gad.1723609; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Svetec N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005869; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van der Auwera G. A., 2013, CURR PROTOC BIOINFOR, V43; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006191; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006563; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736	74	1	1	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 17	2017	8								1570	10.1038/s41467-017-01658-2				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FN0DX	WOS:000415648900002	29146998	gold			2018-01-05	
J	Zhou, H; Zhou, M; Li, D; Manthey, J; Lioutikova, E; Wang, H; Zeng, X				Zhou, Hong; Zhou, Michael; Li, Daisy; Manthey, Joseph; Lioutikova, Ekaterina; Wang, Hong; Zeng, Xiao			Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm	BMC GENOMICS			English	Article; Proceedings Paper	IEEE International Conference on Bioinformatics and Biomedicine (BIBM) - Genomics	DEC 15-18, 2016	Shenzhen, PEOPLES R CHINA	IEEE		sgRNA; Off-target homology; Crispr; Cas9; Computational algorithm; Genome wide	GUIDE RNA; SPECIFICITY; DNA; ENDONUCLEASE; NUCLEASES; SYSTEMS; NICKASES; CLEAVAGE; CELLS	Background: The beauty and power of the genome editing mechanism, CRISPR Cas9 endonuclease system, lies in the fact that it is RNA-programmable such that Cas9 can be guided to any genomic loci complementary to a 20-nt RNA, single guide RNA (sgRNA), to cleave double stranded DNA, allowing the introduction of wanted mutations. Unfortunately, it has been reported repeatedly that the sgRNA can also guide Cas9 to off-target sites where the DNA sequence is homologous to sgRNA. Results: Using human genome and Streptococcus pyogenes Cas9 (SpCas9) as an example, this article mathematically analyzed the probabilities of off-target homologies of sgRNAs and discovered that for large genome size such as human genome, potential off-target homologies are inevitable for sgRNA selection. A highly efficient computationl algorithm was developed for whole genome sgRNA design and off-target homology searches. By means of a dynamically constructed sequence-indexed database and a simplified sequence alignment method, this algorithm achieves very high efficiency while guaranteeing the identification of all existing potential off-target homologies. Via this algorithm, 1,876,775 sgRNAs were designed for the 19,153 human mRNA genes and only two sgRNAs were found to be free of off-target homology. Conclusions: By means of the novel and efficient sgRNA homology search algorithm introduced in this article, genome wide sgRNA design and off-target analysis were conducted and the results confirmed the mathematical analysis that for a sgRNA sequence, it is almost impossible to escape potential off-target homologies. Future innovations on the CRISPR Cas9 gene editing technology need to focus on how to eliminate the Cas9 off-target activity.	[Zhou, Hong; Manthey, Joseph; Lioutikova, Ekaterina] Univ St Joseph, Dept Math Sci, 1678 Asylum Ave, Hartford, CT 06117 USA; [Zhou, Michael; Li, Daisy] Hall High Sch, 975 N Main St, Hartford, CT 06117 USA; [Wang, Hong] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan L Cullman Lab Canc Res, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA; [Wang, Hong] Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Canc Prevent Res, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA; [Zeng, Xiao] PBSG LLC, POB 771, Braddock Heights, MD 21714 USA	Zhou, H (reprint author), Univ St Joseph, Dept Math Sci, 1678 Asylum Ave, Hartford, CT 06117 USA.	hzhou@usj.edu			University of Saint Joseph	The publication costs were funded by Hong Zhou's institutional award from University of Saint Joseph.	Aach J, 2014, BIORXIV; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Travis J, 2015, SCIENCE, V350, P1456, DOI 10.1126/science.350.6267.1456; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhou M, 2016, IEEE INT C BIOINFORM, P449, DOI 10.1109/BIBM.2016.7822558	24	0	0	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 17	2017	18			9					826	10.1186/s12864-017-4225-1				8	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FM9WJ	WOS:000415622500003	29219081	gold			2018-01-05	
J	Bangpanwimon, K; Sottisuporn, J; Mittraparp-arthorn, P; Ueaphatthanaphanich, W; Rattanasupar, A; Pourcel, C; Vuddhakul, V				Bangpanwimon, Khotchawan; Sottisuporn, Jaksin; Mittraparp-arthorn, Pimonsri; Ueaphatthanaphanich, Warattaya; Rattanasupar, Attapon; Pourcel, Christine; Vuddhakul, Varaporn			CRISPR-like sequences in Helicobacter pylori and application in genotyping	GUT PATHOGENS			English	Article						Helicobacter pylori; vacA-like gene; vlpC gene; Orphan CRISPR array; CRISPR-like sequences; CRISPR-virulence typing	CAS SYSTEMS; BIOPSY SPECIMENS; ADAPTIVE IMMUNITY; PCR; DNA; DIVERSITY; BACTERIA; EVOLUTIONARY; RESISTANCE; ARCHAEA	Background: Many bacteria and archaea possess a defense system called clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (CRISPR-Cas system) against invaders such as phages or plasmids. This system has not been demonstrated in Helicobacter pylori. The numbers of spacer in CRISPR array differ among bacterial strains and can be used as a genetic marker for bacterial typing. Results: A total of 36 H. pylori isolates were collected from patients in three hospitals located in the central (PBH) and southern (SKH) regions of Thailand. It is of interest that CRISPR-like sequences of this bacterium were detected in vlpC encoded for VacA-like protein C. Virulence genes were investigated and the most pathogenic genotype (cagA vacA s1m1) was detected in 17 out of 29 (58.6%) isolates from PBH and 5 out of 7 (71.4%) from SKH. vapD gene was identified in each one isolate from PBH and SKH. CRISPR-like sequences and virulence genes of 20 isolates of H. pylori obtained in this study were analyzed and CRISPR-virulence typing was constructed and compared to profiles obtained by the random amplification of polymorphic DNA (RAPD) technique. The discriminatory power (DI) of CRISPR-virulence typing was not different from RAPD typing. Conclusion: CRISPR-virulence typing in H. pylori is easy and reliable for epidemiology and can be used for inter-laboratory interpretation.	[Bangpanwimon, Khotchawan; Mittraparp-arthorn, Pimonsri; Vuddhakul, Varaporn] Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand; [Sottisuporn, Jaksin] Prince Songkla Univ, NKC Inst Gastroenterol & Hepatol, Songklanagarind Hosp, Fac Med, Hat Yai, Thailand; [Ueaphatthanaphanich, Warattaya] Vichaiyut Hosp, Microbiol Lab, Bangkok, Thailand; [Rattanasupar, Attapon] Hat Yai Hosp, KC Ctr Gastroenterol & Hepatol, Hat Yai, Thailand; [Pourcel, Christine] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France	Vuddhakul, V (reprint author), Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand.	varaporn.v@psu.ac.th			Prince of Songkla University; Thailand Research Fund (TRF) [PHD/0224/2558]	This work was financially supported by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0224/2558) and the Prince of Songkla University through the Scholarship for Outstanding GPA.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P6221, DOI 10.1093/nar/20.23.6221; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Almeida F, 2017, J MICROBIOL METH, V133, P55, DOI 10.1016/j.mimet.2016.12.020; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Berg D E, 1997, Methods Mol Med, V8, P117, DOI 10.1385/0-89603-381-3:117; Bridge Dacie R, 2013, Gut Microbes, V4, P101, DOI 10.4161/gmic.23797; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Burucoa C, 1999, J CLIN MICROBIOL, V37, P4071; Calleros L, 2017, J MICROBIOL METH, V132, P86, DOI 10.1016/j.mimet.2016.11.012; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997                                                 ; Chattopadhyay S, 2004, J CLIN MICROBIOL, V42, P2821, DOI 10.1128/JCM.42.6.2821-2824.2004; CHEETHAM BF, 1995, MOL MICROBIOL, V18, P201, DOI 10.1111/j.1365-2958.1995.mmi_18020201.x; Colding H, 1999, FEMS IMMUNOL MED MIC, V24, P193, DOI 10.1111/j.1574-695X.1999.tb01282.x; Conrad MD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001573; Foegeding NJ, 2016, TOXINS, V8, DOI 10.3390/toxins8060173; Gherardi G, 2015, DIAGN MICR INFEC DIS, V81, P219, DOI 10.1016/j.diagmicrobio.2014.11.005; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hullahalli K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138890; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465; Katz ME, 1991, MICROBIOLOGY, V137, P2117, DOI [10.1099/00221287-137-9-2117, DOI 10.1099/00221287-137-9-2117]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; Kwon DH, 1998, DIGEST DIS SCI, V43, P980, DOI 10.1023/A:1018818431828                                                         ; LAGE AP, 1995, J CLIN MICROBIOL, V33, P2752; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Morales-Espinosa R, 2008, BIOQUIMIA, V33, P43; Nelson KE, 1999, NATURE, V399, P323; Park CY, 2003, J CLIN MICROBIOL, V41, P3336, DOI 10.1128/JCM.41.7.3336-3338.2003; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Radin JN, 2013, MBIO, V4, DOI 10.1128/mBio.00613-12; Rahmatabadi SS, 2016, J BASIC MICROB, V56, P645, DOI 10.1002/jobm.201500707; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shariat N, 2013, FOOD MICROBIOL, V34, P164, DOI 10.1016/j.fm.2012.11.012; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sun HH, 2015, FOODBORNE PATHOG DIS, V12, P68, DOI 10.1089/fpd.2014.1792; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yang SY, 2015, BIOCHEM BIOPH RES CO, V464, P894, DOI 10.1016/j.bbrc.2015.07.062	45	1	1	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-4749			GUT PATHOG	Gut Pathogens	NOV 17	2017	9								65	10.1186/s13099-017-0215-8				9	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	FM9GQ	WOS:000415574300001	29177012	gold			2018-01-05	
J	Jarosz, DF; Khurana, V				Jarosz, Daniel F.; Khurana, Vikram			Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations	CELL			English	Review							PRION-INDUCING DOMAIN; ALPHA-SYNUCLEIN; YEAST PRION; PARKINSONS-DISEASE; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASES; LEWY BODIES; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; GENETIC-VARIATION	Protein conformational states-from intrinsically disordered ensembles to amyloids that underlie the self-templating, infectious properties of prion-like proteins-have attracted much attention. Here, we highlight the diversity, including differences in biophysical properties, that drive distinct biological functions and pathologies among self-templating proteins. Advances in chemical genomics, gene editing, and model systems now permit deconstruction of the complex interplay between these protein states and the host factors that react to them. These methods reveal that conformational switches modulate normal and abnormal information transfer and that intimate relationships exist between the intrinsic function of proteins and the deleterious consequences of their misfolding.	[Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Jarosz, Daniel F.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Khurana, Vikram] Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Khurana, Vikram] Harvard Med Sch, Boston, MA 02115 USA; [Khurana, Vikram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Khurana, Vikram] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Jarosz, DF (reprint author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Jarosz, DF (reprint author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.; Khurana, V (reprint author), Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Khurana, V (reprint author), Harvard Med Sch, Boston, MA 02115 USA.; Khurana, V (reprint author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Khurana, V (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jarosz@stanford.edu; vkhurana@bwh.harvard.edu					Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809                                                              ; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Burke RE, 2008, ANN NEUROL, V64, P485, DOI 10.1002/ana.21541; Byers JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003992; CARLSON GA, 1989, P NATL ACAD SCI USA, V86, P7475, DOI 10.1073/pnas.86.19.7475; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373                                                         ; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chung CY, 2017, CELL SYST, V4, P242, DOI 10.1016/j.cels.2017.01.002; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; COX BS, 1980, GENETICS, V95, P589; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dong JJ, 2010, NAT STRUCT MOL BIOL, V17, P1422, DOI 10.1038/nsmb.1954; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; DUFFY PE, 1965, J NEUROPATH EXP NEUR, V24, P398, DOI 10.1097/00005072-196507000-00003                                                ; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Fersht A., 1998, STRUCTURE MECH PROTE; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005                                                     ; Garcia DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17978; Garcia DM, 2014, FEMS YEAST RES, V14, P136, DOI 10.1111/1567-1364.12116; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0                                                   ; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309                                                           ; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0                                                               ; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; He B., 2017, MOL NEUROBIOL, V1854, P769; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Keogh MJ, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.220; Khan MR, 2015, CELL, V163, P1468, DOI 10.1016/j.cell.2015.11.020; Khurana V, 2017, CELL SYST, V4, P147, DOI 10.1016/j.cels.2017.02.007; Khurana V, 2015, NAT REV NEUROL, V11, P339, DOI 10.1038/nrneurol.2015.79; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Kuemmerle S, 1999, ANN NEUROL, V46, P842; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LACROUTE F, 1971, J BACTERIOL, V106, P519; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Mao X., 2016, SCIENCE, V3, P353, DOI DOI 10.1126/SCIENCE.AAH3374; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93                                                     ; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Melentijevic I, 2017, NATURE, V542, P367, DOI 10.1038/nature21362; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Morgan DO, 1996, CURR OPIN CELL BIOL, V8, P767, DOI 10.1016/S0955-0674(96)80076-7; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Musacchio T, 2017, ANN NEUROL, V81, P825, DOI 10.1002/ana.24947; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Pearce MMP, 2017, CURR OPIN GENET DEV, V44, P149, DOI 10.1016/j.gde.2017.03.011; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qi C, 2017, EXP NEUROBIOL, V26, P97, DOI 10.5607/en.2017.26.2.97; Rabouille C, 2017, TRENDS CELL BIOL, V27, P230, DOI 10.1016/j.tcb.2016.11.007; Reyes JF, 2014, GLIA, V62, P387, DOI 10.1002/glia.22611; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666                                                            ; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 2000, TRENDS CELL BIOL, V10, P98, DOI 10.1016/S0962-8924(99)01711-0; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shearin H, 2014, J VIROL, V88, P8640, DOI 10.1128/JVI.00378-14; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Stopschinski BE, 2017, LANCET NEUROL, V16, P323, DOI 10.1016/S1474-4422(17)30037-6; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Treusch S, 2012, J CELL BIOL, V197, P369, DOI 10.1083/jcb.201108146; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Volpicelli-Daley LA, 2016, J NEUROSCI, V36, P7415, DOI 10.1523/JNEUROSCI.3642-15.2016; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a                                                                 ; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI [10.1038/nrn2016.13, 10.1038/nrn.2016.13]; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Warrick JM, 1999, NAT GENET, V23, P425; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170                                                         ; Wickner RB, 2007, PRION, V1, P94, DOI 10.4161/pri.1.2.4664                                                            ; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	146	0	0	10	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2017	171	5					1001	1014		10.1016/j.cell.2017.10.047				14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FM8DY	WOS:000415317000006	29149602				2018-01-05	
J	Yuen, G; Khan, FJ; Gao, SJ; Stommel, JM; Batchelor, E; Wu, XL; Luo, J				Yuen, Garmen; Khan, Fehad J.; Gao, Shaojian; Stommel, Jayne M.; Batchelor, Eric; Wu, Xiaolin; Luo, Ji			CRISPR/Cas9-mediated gene knockout is insensitive to target copy number but is dependent on guide RNA potency and Cas9/sgRNA threshold expression level	NUCLEIC ACIDS RESEARCH			English	Article							HUMAN GENOME; HUMAN-CELLS; CRISPR-CAS9; CAS9; ENDONUCLEASE; IDENTIFICATION; INTEGRATION; EFFICIENCY; CLEAVAGE; SCREENS	CRISPR/Cas9 is a powerful gene editing tool for gene knockout studies and functional genomic screens. Successful implementation of CRISPR often requires Cas9 to elicit efficient target knockout in a population of cells. In this study, we investigated the role of several key factors, including variation in target copy number, inherent potency of sgRNA guides, and expression level of Cas9 and sgRNA, in determining CRISPR knockout efficiency. Using isogenic, clonal cell lines with variable copy numbers of an EGFP transgene, we discovered that CRISPR knockout is relatively insensitive to target copy number, but is highly dependent on the potency of the sgRNA guide sequence. Kinetic analysis revealed that most target mutation occurs between 5 and 10 days following Cas9/sgRNA transduction, while sgRNAs with different potencies differ by their knockout time course and by their terminal-phase knockout efficiency. We showed that prolonged, low level expression of Cas9 and sgRNA often fails to elicit target mutation, particularly if the potency of the sgRNA is also low. Our findings provide new insights into the behavior of CRISPR/Cas9 in mammalian cells that could be used for future improvement of this platform.	[Yuen, Garmen; Khan, Fehad J.; Luo, Ji] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Khan, Fehad J.] NIH, Undergrad Scholarship Program, Bldg 10, Bethesda, MD 20892 USA; [Gao, Shaojian] NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Stommel, Jayne M.] NCI, Radiat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Batchelor, Eric] NCI, Pathol Lab, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Wu, Xiaolin] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Frederick, MD USA	Luo, J (reprint author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	ji.luo@nih.gov			National Cancer Institute; US National Cancer Institute Intramural [ZIA BC 011304, ZIA BC 011441]	US National Cancer Institute Intramural [ZIA BC 011304 to J.L., ZIA BC 011441 to J.M.S.]. Funding for open access charge: National Cancer Institute.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Ravin SS, 2014, J VIROL, V88, P4504, DOI 10.1128/JVI.00011-14; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jensen KT, 2017, FEBS LETT, V591, P1892, DOI 10.1002/1873-3468.12707; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Luo Ji, 2016, Trends Cancer, V2, P313, DOI 10.1016/j.trecan.2016.05.001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xia XG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng098	34	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 16	2017	45	20					12039	12053		10.1093/nar/gkx843				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN6YW	WOS:000416164300048	29036671	gold			2018-01-05	
J	Martinez, V; Lauritsen, I; Hobel, T; Li, SY; Nielsen, AT; Norholm, MHH				Martinez, Virginia; Lauritsen, Ida; Hobel, Tonja; Li, Songyuan; Nielsen, Alex Toftgaard; Norholm, Morten H. H.			CRISPR/Cas9-based genome editing for simultaneous interference with gene expression and protein stability	NUCLEIC ACIDS RESEARCH			English	Article							ESCHERICHIA-COLI; CRISPR; BACTERIA; DNA; EUKARYOTES; CLONING	Interference with genes is the foundation of reverse genetics and is key to manipulation of living cells for biomedical and biotechnological applications. However, classical genetic knockout and transcriptional knockdown technologies have different drawbacks and offer no control over existing protein levels. Here, we describe an efficient genome editing approach that affects specific protein abundances by changing the rates of both RNA synthesis and protein degradation, based on the two cross-kingdom control mechanisms CRISPRi and the N-end rule for protein stability. In addition, our approach demonstrates that CRISPRi efficiency is dependent on endogenous gene expression levels. The method has broad applications in e.g. study of essential genes and antibiotics discovery.	[Martinez, Virginia; Lauritsen, Ida; Hobel, Tonja; Li, Songyuan; Nielsen, Alex Toftgaard; Norholm, Morten H. H.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	Norholm, MHH (reprint author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark.	morno@biosustain.dtu.dk			Novo Nordisk Foundation; Novozymes; Novo Nordisk	Novo Nordisk Foundation; Novo Nordisk and Novozymes (to I.L.). Funding for open access charge: Novo Nordisk Foundation	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/NMETH.3727, 10.1038/nmeth.3727]; Brockman IM, 2015, BIOTECHNOL J, V10, P1360, DOI 10.1002/biot.201400422; Cameron DE, 2014, NAT BIOTECHNOL, V32, P1276, DOI 10.1038/nbt.3053; Cavaleiro AM, 2015, ACS SYNTH BIOL, V4, P1042, DOI 10.1021/acssynbio.5b00113; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lennen R. M., 2015, NUCLEIC ACIDS RES, V44, pe36; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Sekar K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149746; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI [10.1021/s400021j, 10.1021/sb400021j]; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	29	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 16	2017	45	20							e171	10.1093/nar/gkx797				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN6YW	WOS:000416164300005	28981713	gold			2018-01-05	
J	Fontanals-Cirera, B; Hasson, D; Vardabasso, C; Di Micco, R; Agrawal, P; Chowdhury, A; Gantz, M; de Pablos-Aragoneses, A; Morgenstern, A; Wu, P; Filipescu, D; Valle-Garcia, D; Darvishian, F; Roe, JS; Davies, MA; Vakoc, CR; Hernando, E; Bernstein, E				Fontanals-Cirera, Barbara; Hasson, Dan; Vardabasso, Chiara; Di Micco, Raffaella; Agrawal, Praveen; Chowdhury, Asif; Gantz, Madeleine; de Pablos-Aragoneses, Ana; Morgenstern, Ari; Wu, Pamela; Filipescu, Dan; Valle-Garcia, David; Darvishian, Farbod; Roe, Jae-Seok; Davies, Michael A.; Vakoc, Christopher R.; Hernando, Eva; Bernstein, Emily			Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene	MOLECULAR CELL			English	Article							KINASE 7 PTK7; TRANSCRIPTION FACTORS; GASTRIC ADENOCARCINOMA; BROMODOMAIN INHIBITION; CHROMATIN ARCHITECTURE; SELECTIVE-INHIBITION; INTEGRATIVE ANALYSIS; MALIGNANT-MELANOMA; SUPER-ENHANCERS; CELL IDENTITY	Bromodomain and extraterminal domain inhibitors (BETi) represent promising therapeutic agents for metastatic melanoma, yet their mechanism of action remains unclear. Here we interrogated the transcriptional effects of BETi and identified AMIGO2, a transmembrane molecule, as a BET target gene essential for melanoma cell survival. AMIGO2 is upregulated in melanoma cells and tissues compared to human melanocytes and nevi, and AMIGO2 silencing in melanoma cells induces G1/S arrest followed by apoptosis. We identified the pseudokinase PTK7 as an AMIGO2 interactor whose function is regulated by AMIGO2. Epigenomic profiling and genome editing revealed that AMIGO2 is regulated by a melanoma-specific BRD2/4-bound promoter and super-enhancer configuration. Upon BETi treatment, BETs are evicted from these regulatory elements, resulting in AMIGO2 silencing and changes in PTK7 proteolytic processing. Collectively, this study uncovers mechanisms underlying the therapeutic effects of BETi in melanoma and reveals the AMIGO2-PTK7 axis as a targetable pathway for metastatic melanoma.	[Fontanals-Cirera, Barbara; Di Micco, Raffaella; Agrawal, Praveen; de Pablos-Aragoneses, Ana; Morgenstern, Ari; Darvishian, Farbod; Hernando, Eva] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10003 USA; [Fontanals-Cirera, Barbara; Di Micco, Raffaella; Agrawal, Praveen; de Pablos-Aragoneses, Ana; Morgenstern, Ari; Darvishian, Farbod; Hernando, Eva] NYU, Langone Med Ctr, Interdisciplinary Melanoma Cooperat Grp, New York, NY 10003 USA; [Hasson, Dan; Vardabasso, Chiara; Chowdhury, Asif; Gantz, Madeleine; Filipescu, Dan; Valle-Garcia, David; Bernstein, Emily] Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1470 Madison Ave, New York, NY 10029 USA; [Hasson, Dan; Vardabasso, Chiara; Chowdhury, Asif; Gantz, Madeleine; Filipescu, Dan; Valle-Garcia, David; Bernstein, Emily] Icahn Sch Med Mt Sinai, Dept Dermatol, 1470 Madison Ave, New York, NY 10029 USA; [Wu, Pamela] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY USA; [Roe, Jae-Seok; Vakoc, Christopher R.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	Hernando, E (reprint author), NYU, Langone Med Ctr, Dept Pathol, New York, NY 10003 USA.; Hernando, E (reprint author), NYU, Langone Med Ctr, Interdisciplinary Melanoma Cooperat Grp, New York, NY 10003 USA.; Bernstein, E (reprint author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1470 Madison Ave, New York, NY 10029 USA.; Bernstein, E (reprint author), Icahn Sch Med Mt Sinai, Dept Dermatol, 1470 Madison Ave, New York, NY 10029 USA.	eva.hernando-monge@nyumc.org; emily.bernstein@mssm.edu		Hernando, Eva/0000-0003-1023-0312; Valle-Garcia, David/0000-0002-3397-3103; Filipescu, Dan/0000-0001-6381-2557	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; MD Anderson Cancer Center Support Grant [P30CA016672]; Scientific Computing at ISMMS, Office of Research Infrastructure of the NIH [S10OD018522]; ISMMS Cancer Center Support Grant [P30CA196521]; Leukemia and Lymphoma Society; Pershing Square Sohn Cancer Research Alliance; Starr Cancer Consortium; NIH/NCI [R01CA174793, R01CA154683]; Dermatology Foundation; Human Frontier Science Program postdoctoral fellowship; New York Stem Cell Foundation; Hirschl/Weill-Caulier Research Award; Melanoma Research Alliance; Harry J. Lloyd Charitable Trust;  [R01CA155234];  [R01CA163891]	The authors thank Jay Bradner, Jian Jin, Iman Osman, Joanna Wysocka, Tomek Swigut, and Rana Moubarak for advice and reagents; Histopathology Core, Genomics Technology Center, and Proteomics Laboratory at NYU Langone Medical Center, supported by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center; and Genomics Core Facility and Gayatri Panda at Icahn School of Medicine at Mount Sinai (ISMMS) and Alicia Alonso (Epigenomics Core at Weill Cornell Medicine) for sequencing assistance. The authors also thank the Functional Proteomics RPPA Core facility, supported by MD Anderson Cancer Center Support Grant P30CA016672. This work was supported by Scientific Computing at ISMMS, Office of Research Infrastructure of the NIH to ISMMS (S10OD018522), ISMMS Cancer Center Support Grant P30CA196521, Leukemia and Lymphoma Society, Pershing Square Sohn Cancer Research Alliance, the Starr Cancer Consortium, and NIH/NCI R01CA174793 (J.-S.R. and C.R.V.); Dermatology Foundation (D.H.); Human Frontier Science Program postdoctoral fellowship and New York Stem Cell Foundation Druckenmiller postdoctoral fellowship (R.D.M.); R01CA155234 and R01CA163891 (E.H.); and Hirschl/Weill-Caulier Research Award, Melanoma Research Alliance, Harry J. Lloyd Charitable Trust, and NIH/NCI R01CA154683 (E.B.).	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Buenrostro JD, 2015, CURR PROTOC MOL BIOL, V109, P21, DOI DOI 10.1002/0471142727.MB2129S109; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Damelin M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2611; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; de Miera EVS, 2012, PIGM CELL MELANOMA R, V25, P395, DOI 10.1111/j.1755-148X.2012.00994.x; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Di Micco R, 2014, CELL REP, V9, P234, DOI 10.1016/j.celrep.2014.08.055; Draker R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003047; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Fecher LA, 2013, ONCOLOGIST, V18, P733, DOI 10.1634/theoncologist.2012-0483; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fu YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17186; Gallagher SJ, 2014, J INVEST DERMATOL, V134, P2795, DOI 10.1038/jid.2014.243; Golubkov VS, 2014, J BIOL CHEM, V289, P24238, DOI 10.1074/jbc.M114.574459; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Guo X, 2015, TUMOR BIOL, V36, P9303, DOI 10.1007/s13277-015-3676-8; Hanssen LLP, 2017, NAT CELL BIOL, V19, P952, DOI 10.1038/ncb3573; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Ito T, 2016, HISTOPATHOLOGY, V69, P63, DOI 10.1111/his.12909; Kanda Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43567; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuphal S, 2013, EXP MOL PATHOL, V95, P156, DOI 10.1016/j.yexmp.2013.06.012; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Miyashita A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144241; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Ono T, 2003, J NEUROSCI, V23, P5887; Ooi WF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12983; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Park ES, 2010, MOL CANCER THER, V9, P257, DOI 10.1158/1535-7163.MCT-09-0743; Park H, 2015, J CELL BIOL, V211, P619, DOI 10.1083/jcb.201503113; Penna E, 2013, CANCER RES, V73, P4098, DOI 10.1158/0008-5472.CAN-12-3686; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Prud'homme GJ, 2012, ONCOTARGET, V3, P921; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabenau KE, 2004, ONCOGENE, V23, P5056, DOI 10.1038/sj.onc.1207681; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Souroullas GP, 2016, NAT MED, V22, P632, DOI 10.1038/nm.4092; Surface LE, 2016, CELL REP, V14, P1142, DOI 10.1016/j.celrep.2015.12.100; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vardabasso C, 2015, MOL CELL, V59, P75, DOI 10.1016/j.molcel.2015.05.009; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Vizkeleti L, 2012, TUMOR BIOL, V33, P2189, DOI 10.1007/s13277-012-0480-6; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zhang P, 2015, ONCOTARGET, V6, P9834, DOI 10.18632/oncotarget.3383                                                        ; Zhang Y, 2008, GENOME BIOL, V9, pR137, DOI DOI 10.1186/GB-2008-9-9-R137; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	82	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	NOV 16	2017	68	4					731	+		10.1016/j.molcel.2017.11.004				23	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FM8EJ	WOS:000415318300009	29149598				2018-01-05	
J	Liu, J; Wang, Y; Lu, YJ; Zheng, P; Sun, JB; Ma, YH				Liu, Jiao; Wang, Yu; Lu, Yujiao; Zheng, Ping; Sun, Jibin; Ma, Yanhe			Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum	MICROBIAL CELL FACTORIES			English	Article						CRISPR/Cas9; Genome editing; Corynebacterium glutamicum; Plasmid-borne templates; Gene deletion/insertion; Single-nucleotide editing; Double-locus editing	ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CLOSTRIDIUM-BEIJERINCKII; SELECTION MARKER; GENE REPLACEMENT; CAS SYSTEMS; EXPRESSION; RNA; EFFICIENCY; PROTEIN	Background: Corynebacterium glutamicum is an important industrial workhorse and advanced genetic engineering tools are urgently demanded. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR) and their CRISPR-associated proteins (Cas) have revolutionized the field of genome engineering. The CRISPR/Cas9 system that utilizes NGG as protospacer adjacent motif (PAM) and has good targeting specificity can be developed into a powerful tool for efficient and precise genome editing of C. glutamicum. Results: Herein, we developed a versatile CRISPR/Cas9 genome editing toolbox for C. glutamicum. Cas9 and gRNA expression cassettes were reconstituted to combat Cas9 toxicity and facilitate effective termination of gRNA transcription. Co-transformation of Cas9 and gRNA expression plasmids was exploited to overcome high-frequency mutation of cas9, allowing not only highly efficient gene deletion and insertion with plasmid-borne editing templates (efficiencies up to 60.0 and 62.5%, respectively) but also simple and time-saving operation. Furthermore, CRISPR/Cas9-mediated ssDNA recombineering was developed to precisely introduce small modifications and single-nucleotide changes into the genome of C. glutamicum with efficiencies over 80.0%. Notably, double-locus editing was also achieved in C. glutamicum. This toolbox works well in several C. glutamicum strains including the widely-used strains ATCC 13032 and ATCC 13869. Conclusions: In this study, we developed a CRISPR/Cas9 toolbox that could facilitate markerless gene deletion, gene insertion, precise base editing, and double-locus editing in C. glutamicum. The CRISPR/Cas9 toolbox holds promise for accelerating the engineering of C. glutamicum and advancing its application in the production of biochemicals and biofuels.	[Liu, Jiao; Wang, Yu; Lu, Yujiao; Zheng, Ping; Sun, Jibin] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Liu, Jiao; Wang, Yu; Lu, Yujiao; Zheng, Ping; Sun, Jibin; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China	Zheng, P; Sun, JB (reprint author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	p@tib.cas.cn; jb@tib.cas.cn			National Natural Science Foundation of China [31700044, 31370829]; Key Research Program of the Chinese Academy of Sciences [ZDRW-ZS-2016-2]; first Special Support Plan for Talents Development and High-level Innovation and Entrepreneurship Team of the Tianjin Municipal City	This work was supported by the National Natural Science Foundation of China (31700044 and 31370829), the Key Research Program of the Chinese Academy of Sciences (ZDRW-ZS-2016-2), and the first Special Support Plan for Talents Development and High-level Innovation and Entrepreneurship Team of the Tianjin Municipal City.	Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Becker J, 2016, ADV BIOCHEM ENG BIOT, V162, P217; Becker J, 2016, IND BIOTECHNOLOGY, P183; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Binder S, 2013, NUCLEIC ACIDS RES, V41, P6360, DOI 10.1093/nar/gkt312; Cho JS, 2017, METAB ENG, V42, P157, DOI 10.1016/j.ymben.2017.06.010; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Jakoby M, 1999, BIOTECHNOL TECH, V13, P437, DOI 10.1023/A:1008968419217                                                         ; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim IK, 2011, J MICROBIOL METH, V84, P128, DOI 10.1016/j.mimet.2010.10.007; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Krylov AA, 2014, J MICROBIOL METH, V105, P109, DOI 10.1016/j.mimet.2014.07.028; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Ma WW, 2015, BIOTECHNOL LETT, V37, P609, DOI 10.1007/s10529-014-1718-8; Nagaraju S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0638-3; Nakamura J, 2006, PLASMID, V56, P179, DOI 10.1016/j.plasmid.2006.05.003; Nakamura Y, 2003, GENE, V317, P149, DOI 10.1016/S0378-1119(03)00653-X; Nesvera J, 1997, J BACTERIOL, V179, P1525, DOI 10.1128/jb.179.5.1525-1532.1997                                                 ; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; OZAKI A, 1984, MOL GEN GENET, V196, P175, DOI 10.1007/BF00334113; PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x; Pines G, 2015, ACS SYNTH BIOL, V4, P604, DOI [10.1021/sb500282v, 10.1021/s13500282v]; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Resende BC, 2011, GENE, V482, P1, DOI 10.1016/j.gene.2011.03.008; Ruan YL, 2015, BIOTECHNOL LETT, V37, P2445, DOI 10.1007/s10529-015-1934-x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Standage-Beier K, 2015, ACS SYNTH BIOL, V4, P1217, DOI 10.1021/acssynbio.5b00132; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Vertes AA, 2005, APPL ENVIRON MICROB, V71, P7633, DOI 10.1128/AEM.71.12.7633-7642.2005; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Westbrook AW, 2016, APPL ENVIRON MICROB, V82, P4876, DOI 10.1128/AEM.01159-16; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943; Zhao DD, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0605-5	56	0	0	21	21	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	NOV 16	2017	16								205	10.1186/s12934-017-0815-5				17	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FM8KD	WOS:000415335100002	29145843	gold			2018-01-05	
J	Hodgens, C; Nimchuk, ZL; Kieber, JJ				Hodgens, Charles; Nimchuk, Zachary L.; Kieber, Joseph J.			indCAPS: A tool for designing screening primers for CRISPR/Cas9 mutagenesis events	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; B RESPONSE REGULATORS; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; CYTOKININ RECEPTORS; STABILITY; DNA; LOCALIZATION; MODEL; AHK4	Genetic manipulation of organisms using CRISPR/Cas9 technology generally produces small insertions/deletions (indels) that can be difficult to detect. Here, we describe a technique to easily and rapidly identify such indels. Sequence-identified mutations that alter a restriction enzyme recognition site can be readily distinguished from wild-type alleles using a cleaved amplified polymorphic sequence (CAPS) technique. If a restriction site is created or altered by the mutation such that only one allele contains the restriction site, a polymerase chain reaction (PCR) followed by a restriction digest can be used to distinguish the two alleles. However, in the case of most CRISPR-induced alleles, no such restriction sites are present in the target sequences. In this case, a derived CAPS (dCAPS) approach can be used in which mismatches are purposefully introduced in the oligonucleotide primers to create a restriction site in one, but not both, of the amplified templates. Web-based tools exist to aid dCAPS primer design, but when supplied sequences that include indels, the current tools often fail to suggest appropriate primers. Here, we report the development of a Python-based, species-agnostic web tool, called indCAPS, suitable for the design of PCR primers used in dCAPS assays that is compatible with indels. This tool should have wide utility for screening editing events following CRISPR/Cas9 mutagenesis as well as for identifying specific editing events in a pool of CRISPR-mediated mutagenesis events. This tool was field-tested in a CRISPR mutagenesis experiment targeting a cytokinin receptor (AHK3) in Arabidopsis thaliana. The tool suggested primers that successfully distinguished between wild-type and edited alleles of a target locus and facilitated the isolation of two novel ahk3 null alleles. Users can access indCAPS and design PCR primers to employ dCAPS to identify CRISPR/Cas9 alleles at http://indcaps.kieber.cloudapps.unc.edu/.	[Hodgens, Charles; Nimchuk, Zachary L.; Kieber, Joseph J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Nimchuk, Zachary L.; Kieber, Joseph J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Kieber, JJ (reprint author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Kieber, JJ (reprint author), Univ N Carolina, Dept Biol, Chapel Hill, NC USA.	jkieber@unc.edu			National Science Foundation [IOS-1238051, IOS-1455607]	This work was supported by a grant from the National Science Foundation (IOS-1238051 and IOS-1455607) https://www.nsf.gov/div/index.jsp?div=IOS. The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We would like to thank G. Eric Schaller, Brian Nalley, Christian Burr, Amala John, Joanna Polko, Lauren Ross, and Ariel Aldrette for helping with the visual design of the website and the figures for this paper and Jamie Winshell for technical support. This work was supported by grants from the National Science Foundation (IOS-1238051 and IOS-1455607).	Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Caesar K, 2011, J EXP BOT, V62, P5571, DOI 10.1093/jxb/err238; Cheng CY, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.1111/tpj.12084; Cheng CY, 2013, PLANT J, V73, P929, DOI 10.1111/tpj.12084; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Farboud B, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.287; Housden BE, 2016, COLD SPRING HARB PRO, V2016; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Karkute SG, 2017, FRONT PLANT SCI, V8; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x                                                ; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Punwani JA, 2010, PLANT SIGNAL BEHAV, V5, P896, DOI 10.1111/j.1365-313X.2010.04165.x; Punwani JA, 2010, PLANT J, V62, P473, DOI 10.1111/j.1365-313X.2010.04165.x; Simsek M, 2000, J Sci Res Med Sci, V2, P11; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501                                                          ; Tandon P, 2017, DEV BIOL, V426, P325, DOI 10.1016/j.ydbio.2016.04.009; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Wulfetange K, 2011, PLANT PHYSIOL, V156, P1808, DOI 10.1104/pp.111.180539; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188406	10.1371/journal.pone.0188406				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FM7MC	WOS:000415260400074	29141013	gold			2018-01-05	
J	Palermo, G; Ricci, CG; Fernando, A; Basak, R; Jinek, M; Rivalta, I; Batista, VS; McCammon, JA				Palermo, Giulia; Ricci, Clarisse G.; Fernando, Amendra; Basak, Rajshekhar; Jinek, Martin; Rivalta, Ivan; Batista, Victor S.; McCammon, J. Andrew			Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							MOLECULAR SIMULATIONS; DNA; RNA; CAS9; ENDONUCLEASE; NUCLEASES; DYNAMICS; CLEAVAGE; COMPLEX	CRISPR-Cas9 is a genome editing technology with major impact in life sciences. In this system, the endonuclease Cas9 generates double strand breaks in DNA upon RNA-guided recognition of a complementary DNA sequence, which strictly requires the presence of a protospacer adjacent motif (PAM) next to the target site. Although PAM recognition is essential for cleavage, it is unknown whether and how PAM binding activates Cas9 for DNA cleavage at spatially distant sites. Here, we find evidence of a PAM-induced allosteric mechanism revealed by microsecond molecular dynamics simulations. PAM acts as an allosteric effector and triggers the interdependent conformational dynamics of the Cas9 catalytic domains (HNH and RuvC), responsible for concerted cleavage of the two DNA strands. Targeting such an allosteric mechanism should enable control of CRISPR-Cas9 functionality.	[Palermo, Giulia; Ricci, Clarisse G.; McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Palermo, Giulia; Ricci, Clarisse G.; McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Palermo, Giulia; Ricci, Clarisse G.; McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Fernando, Amendra; Basak, Rajshekhar; Batista, Victor S.] Yale Univ, Dept Chem, POB 208107, New Haven, CT 06520 USA; [Jinek, Martin] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Rivalta, Ivan] Univ Claude Bernard Lyon 1, CNRS, Ens Lyon, Lab Chim UMR 5182, F-69342 Lyon, France	Palermo, G (reprint author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Palermo, G (reprint author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Palermo, G (reprint author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	gpalermo@ucsd.edu		Rivalta, Ivan/0000-0002-1208-602X; Palermo, Giulia/0000-0003-1404-8737; Jinek, Martin/0000-0002-7601-210X; Fernando, Amendra/0000-0002-2102-3899	Swiss National Science Foundation [P300PA_164698]; NIH; NSF; HHMI; NBCR; SDSC; NIH [1R01GM106121-01A1]; ENS-Lyon [900/S81/BS81-FR14, MI-LOURD-FR15]; XSEDE grant [MCA93S013]	G.P. thanks the Swiss National Science Foundation for her postdoctoral grant P300PA_164698. J.A.M. thanks NIH, NSF, HHMI, NBCR and SDSC grants. V.S.B. thanks NIH grant 1R01GM106121-01A1 and computational time from NERSC. I.R thanks ENS-Lyon (grants: 900/S81/BS81-FR14, MI-LOURD-FR15) and PSMN. Computing time was provided by the XSEDE grant MCA93S013 to J.A.M.	Adhireksan Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14860; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palermo G, 2017, P NATL ACAD SCI USA, V114, P7260, DOI 10.1073/pnas.1707645114; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Palermo G, 2015, ACCOUNTS CHEM RES, V48, P220, DOI 10.1021/ar500314j; Ricci CG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19940; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011	20	0	0	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	NOV 15	2017	139	45					16028	16031		10.1021/jacs.7b05313				4	Chemistry, Multidisciplinary	Chemistry	FN1YA	WOS:000415785900002	28764328				2018-01-05	
J	Nishiyama, J; Mikuni, T; Yasuda, R				Nishiyama, Jun; Mikuni, Takayasu; Yasuda, Ryohei			Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain	NEURON			English	Article							CRISPR/CAS9-MEDIATED KNOCK-IN; STRAND BREAK REPAIR; ONE-STEP GENERATION; ADENOASSOCIATED VIRUS; TARGETED INTEGRATION; VECTOR DELIVERY; GENE-EXPRESSION; DRIVER LINES; MICE; EFFICIENT	Precise genome editing via homology-directed repair (HDR) in targeted cells, particularly in vivo, provides an invaluable tool for biomedical research. However, HDR has been considered to be largely restricted to dividing cells, making it challenging to apply the technique in postmitotic neurons. Here we show that precise genome editing via HDR is possible in mature postmitotic neurons as well as mitotic cells in mice brain by combining CRISPR-Cas9-mediated DNA cleavage and the efficient delivery of donor template with adeno-associated virus (AAV). Using this strategy, we achieved efficient tagging of endogenous proteins in primary and organotypic cultures in vitro and developing, adult, aged, and pathological brains in vivo. Thus, AAV- and CRISPR-Cas9-mediated HDR will be broadly useful for precise genome editing in basic and translational neuroscience.	[Nishiyama, Jun; Mikuni, Takayasu; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA; [Mikuni, Takayasu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Mikuni, T; Yasuda, R (reprint author), Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA.; Mikuni, T (reprint author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.	takayasu.mikuni@mpfi.org; ryohei.yasuda@mpfi.org			National Institute of Health [R01MH080047, DP1NS096787]; Human Frontier Science Program [LT000974/2014-L]; JST/PRESTO, Japan [JPMJPR16F9]	The authors thank L. Colgan for critical reading of the manuscript; the R.Y. lab members for discussion; T. Laviv and Y. Sugaya for advice on in vivo virus injection; E. Szatmari for sharing aged J20 mice; K. Liu and J. Richards for technical assistance; and D. Kloetzer for laboratory management. This work was supported by the National Institute of Health (R01MH080047 and DP1NS096787 to R.Y.), the Human Frontier Science Program (long-term fellowship LT000974/2014-L to T.M.) and JST/PRESTO, Japan (JPMJPR16F9 to T.M.).	Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433                                                   ; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ke MT, 2016, CELL REP, V14, P2718, DOI 10.1016/j.celrep.2016.02.057; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Mucke L, 2000, J NEUROSCI, V20, P4050; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Porteus MH, 2003, MOL CELL BIOL, V23, P3558, DOI 10.1128/MCB.23.10.3558-3565.2003; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Rahim AA, 2012, GENE THER, V19, P936, DOI 10.1038/gt.2011.157; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M                                                    ; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Uemura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35861; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622	54	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 15	2017	96	4					755	+		10.1016/j.neuron.2017.10.004				19	Neurosciences	Neurosciences & Neurology	FM8CC	WOS:000415310800009	29056297				2018-01-05	
J	Sabirov, RZ; Merzlyak, PG; Okada, T; Islam, MR; Uramoto, H; Mori, T; Makino, Y; Matsuura, H; Xie, Y; Okada, Y				Sabirov, Ravshan Z.; Merzlyak, Petr G.; Okada, Toshiaki; Islam, Md Rafiqul; Uramoto, Hiromi; Mori, Tomoko; Makino, Yumiko; Matsuura, Hiroshi; Xie, Yu; Okada, Yasunobu			The organic anion transporter SLCO2A1 constitutes the core component of the Maxi-Cl channel	EMBO JOURNAL			English	Article						anion channel; Maxi-Cl; molecular entity; organic anion transporter; SLCO2A1	PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; INDUCED ATP RELEASE; CONDUCTANCE CHLORIDE CHANNELS; L929 FIBROSARCOMA CELLS; PROSTAGLANDIN TRANSPORTER; MOLECULAR PHYSIOLOGY; SEPARATE PATHWAYS; GENE SLCO2A1; MUTATIONS; IDENTIFICATION	The maxi-anion channels (MACs) are expressed in cells from mammals to amphibians with similar to 60% exhibiting a phenotype called Maxi-Cl. Maxi-Cl serves as the most efficient pathway for regulated fluxes of inorganic and organic anions including ATP. However, its molecular entity has long been elusive. By subjecting proteins isolated from bleb membranes rich in Maxi-Cl activity to LC-MS/MS combined with targeted siRNA screening, CRISPR/Cas9-mediated knockout, and heterologous overexpression, we identified the organic anion transporter SLCO2A1, known as a prostaglandin transporter (PGT), as a key component of Maxi-Cl. Recombinant SLCO2A1 exhibited Maxi-Cl activity in reconstituted proteoliposomes. When SLCO2A1, but not its two disease-causing mutants, was heterologously expressed in cells which lack endogenous SLCO2A1 expression and Maxi-Cl activity, Maxi-Cl currents became activated. The charge-neutralized mutant became weakly cation-selective with exhibiting a smaller single-channel conductance. Slco2a1 silencing in vitro and in vivo, respectively, suppressed the release of ATP from swollen C127 cells and from Langendorff-perfused mouse hearts subjected to ischemia-reperfusion. These findings indicate that SLCO2A1 is an essential core component of the ATP-conductive Maxi-Cl channel.	[Sabirov, Ravshan Z.; Merzlyak, Petr G.; Okada, Toshiaki; Islam, Md Rafiqul; Okada, Yasunobu] Natl Inst Physiol Sci, Int Collaborat Res Project, Okazaki, Aichi, Japan; [Sabirov, Ravshan Z.; Merzlyak, Petr G.] Uzbek Acad Sci, Inst Bioorgan Chem, Lab Mol Physiol, Tashkent, Uzbekistan; [Okada, Toshiaki] Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi, Japan; [Uramoto, Hiromi] Jin Ai Univ, Dept Hlth & Nutr, Echizen, Japan; [Mori, Tomoko; Makino, Yumiko] Natl Inst Basic Biol, Core Res Facil, Okazaki, Aichi, Japan; [Matsuura, Hiroshi; Xie, Yu] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga, Japan; [Okada, Yasunobu] Kyoto Prefectural Univ Med, Dept Physiol, Kyoto, Japan; [Okada, Yasunobu] SOKENDAI, Hayama, Kanagawa, Japan	Okada, Y (reprint author), Natl Inst Physiol Sci, Int Collaborat Res Project, Okazaki, Aichi, Japan.; Okada, Y (reprint author), Kyoto Prefectural Univ Med, Dept Physiol, Kyoto, Japan.; Okada, Y (reprint author), SOKENDAI, Hayama, Kanagawa, Japan.	okada@nips.ac.jp			JSPS [26263045, 17K19517, 16K08510]; Center for Science and Technology; Academy of Sciences of Uzbekistan; JSPS Postdoctoral Fellowship	We thank A. Toychiev and N. Tsiferova for assistance with preliminary patch-clamping on blebs and proteoliposomes, J.-Y. Bai for help with isolated heart experiments, K. Hosoya (Univ. Toyama) for providing anti-SLCO2A1 antibody, E. Kurganov for help with homology modeling, K. Shigemoto and N. Yasui for their technical assistance, and T. Okayasu for secretarial help. This work was supported by Grants-in-Aid for Scientific Research from JSPS to Y.O. (#26263045 and #17K19517) and that from JSPS to T.O. (#16K08510), as well as by Grants-in-Aid from the Center for Science and Technology and Academy of Sciences of Uzbekistan to R.Z.S. and P.G.M. M.R.I. was supported by JSPS Postdoctoral Fellowship.	Bell PD, 2009, PURINERG SIGNAL, V5, P461, DOI 10.1007/s11302-009-9148-0; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Chan BS, 2002, BIOCHEMISTRY-US, V41, P9215, DOI 10.1021/bi020301; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; COULOMBE A, 1992, PFLUG ARCH EUR J PHY, V422, P143, DOI 10.1007/BF00370413; DERMIETZEL R, 1994, P NATL ACAD SCI USA, V91, P499, DOI 10.1073/pnas.91.2.499; Dubyak GR, 2012, AM J PHYSIOL-CELL PH, V303, pC913, DOI 10.1152/ajpcell.00285.2012; Dutta AK, 2004, J PHYSIOL-LONDON, V559, P799, DOI 10.1113/jphysiol.2004.069245; Fahlke C, 2016, PFLUG ARCH EUR J PHY, V468, P491, DOI 10.1007/s00424-015-1768-3; Hazama A, 2000, J PHYSIOL-LONDON, V523, P1, DOI 10.1111/j.1469-7793.2000.t01-6-00001.x; Hosoe N, 2017, J CROHNS COLITIS, V11, P1277, DOI 10.1093/ecco-jcc/jjx068; Islam MR, 2012, AM J PHYSIOL-CELL PH, V303, pC924, DOI 10.1152/ajpcell.00459.2011; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369                                                         ; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Li A, 2011, CELL PHYSIOL BIOCHEM, V28, P1135, DOI 10.1159/000335865; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; MCGILL JM, 1992, AM J PHYSIOL, V262, pG703; Nam JH, 2006, PFLUG ARCH EUR J PHY, V452, P707, DOI 10.1007/s00424-006-0084-3; Ninomiya H, 2002, AM J PHYSIOL-HEART C, V282, pH1810, DOI 10.1152/ajpheart.00760.2001; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Okada T, 2017, CHANNELS, V11, P109, DOI 10.1080/19336950.2016.1247133; Okada Y, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P283; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Riquelme G, 2004, J BIOL CHEM, V279, P50601, DOI 10.1074/jbc.M407859200; Riquelme G, 2009, PLACENTA, V30, P659, DOI 10.1016/j.placenta.2009.06.002; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sabirov RZ, 2016, PFLUG ARCH EUR J PHY, V468, P405, DOI 10.1007/s00424-015-1774-5; Sabirov RZ, 2012, BBA-BIOMEMBRANES, V1818, P1570, DOI 10.1016/j.bbamem.2011.09.024; Sabirov R, 2009, J PHYSIOL SCI, V59, P3, DOI 10.1007/s12576-008-0008-4; Sabirov RZ, 2006, J BIOL CHEM, V281, P1897, DOI 10.1074/jbc.M509482200; Sabirov RZ, 2004, BIOPHYS J, V87, P1672, DOI 10.1529/biophysj.104.043174; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sanderson J, 2014, EXP EYE RES, V127, P270, DOI 10.1016/j.exer.2014.08.009; Sasaki T, 2012, J DERMATOL SCI, V68, P36, DOI 10.1016/j.jdermsci.2012.07.008; Sato-Numata K, 2016, PFLUG ARCH EUR J PHY, V468, P795, DOI 10.1007/s00424-015-1786-1; Scheel O, 2005, NATURE, V436, P424, DOI 10.1038/nature0386O; SCHLICHTER LC, 1990, PFLUG ARCH EUR J PHY, V416, P413, DOI 10.1007/BF00370748; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schuster Victor L, 2015, Trans Am Clin Climatol Assoc, V126, P248; Schuster VL, 2002, PROSTAG OTH LIPID M, V68-9, P633, DOI 10.1016/S0090-6980(02)00061-8; Schuster VL, 1998, ANNU REV PHYSIOL, V60, P221, DOI 10.1146/annurev.physiol.60.1.221                                                ; Seifert W, 2012, HUM MUTAT, V33, P660, DOI 10.1002/humu.22042; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711; SUN XP, 1992, J PHYSIOL-LONDON, V448, P355, DOI 10.1113/jphysiol.1992.sp019046                                                  ; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Taruno A, 2013, BIOESSAYS, V35, P1111, DOI 10.1002/bies.201300077; Toychiev AH, 2009, AM J PHYSIOL-CELL PH, V297, pC990, DOI 10.1152/ajpcell.00131.2009; Umeno J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005581; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077; Wee S, 2007, J PHARMACOL EXP THER, V323, P861, DOI 10.1124/jpet.107.125815; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang Z, 2014, GENE, V534, P421, DOI 10.1016/j.gene.2013.10.051; Zhang ZL, 2012, AM J HUM GENET, V90, P125, DOI 10.1016/j.ajhg.2011.11.019	62	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-4189	1460-2075		EMBO J	Embo J.	NOV 15	2017	36	22					3309	3324		10.15252/embj.201796685				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FM6RN	WOS:000415184300005	29046334				2018-01-05	
J	Monteuuis, G; Suomi, F; Keratar, JM; Masud, AJ; Kastaniotis, AJ				Monteuuis, Geoffray; Suomi, Fumi; Keratar, Juha M.; Masud, Ali J.; Kastaniotis, Alexander J.			A conserved mammalian mitochondrial isoform of acetyl-CoA carboxylase ACC1 provides the malonyl-CoA essential for mitochondrial biogenesis in tandem with ACSF3	BIOCHEMICAL JOURNAL			English	Article							FATTY-ACID SYNTHESIS; BREAST-CANCER; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; TOOLS FRAMEWORK; COENZYME-A; EMBL-EBI; BIOSYNTHESIS; BRCA1; PROTEIN	Mitochondrial fatty acid synthesis (mtFAS) is a highly conserved pathway essential for mitochondrial biogenesis. The mtFAS process is required for mitochondrial respiratory chain assembly and function, synthesis of the lipoic acid cofactor indispensable for the function of several mitochondrial enzyme complexes and essential for embryonic development in mice. Mutations in human mtFAS have been reported to lead to neurodegenerative disease. The source of malonyl-CoA for mtFAS in mammals has remained unclear. We report the identification of a conserved vertebrate mitochondrial isoform of ACC1 expressed from an ACACA transcript splicing variant. A specific knockdown (KD) of the corresponding transcript in mouse cells, or CRISPR/Cas9-mediated inactivation of the putative mitochondrial targeting sequence in human cells, leads to decreased lipoylation and mitochondrial fragmentation. Simultaneous KD of ACSF3, encoding a mitochondrial malonyl-CoA synthetase previously implicated in the mtFAS process, resulted in almost complete ablation of protein lipoylation, indicating that these enzymes have a redundant function in mtFAS. The discovery of a mitochondrial isoform of ACC1 required for lipoic acid synthesis has intriguing consequences for our understanding of mitochondrial disorders, metabolic regulation of mitochondrial biogenesis and cancer.	[Monteuuis, Geoffray; Suomi, Fumi; Keratar, Juha M.; Masud, Ali J.; Kastaniotis, Alexander J.] Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Suomi, Fumi] Univ Helsinki, Inst Biotechnol, Helsinki 00290, Finland	Kastaniotis, AJ (reprint author), Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland.	alexander.kastaniotis@oulu.fi			Academy of Finland; Sigrid Juselius Foundation; Biocenter Oulu; AFM-Telethon	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Biocenter Oulu and AFM-Telethon.	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Aken BL, 2016, DATABASE, V2016, DOI DOI 10.1093/DATABASE/BAW093; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999                                                         ; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chen C, 2014, J BIOL CHEM, V289, P17184, DOI 10.1074/jbc.M114.550806; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Focke M, 2003, PLANT PHYSIOL, V133, P875, DOI 10.1104/pp.103.027375; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan X, 2016, PLANT J, V85, P581, DOI 10.1111/tpj.13130; HALENZ DR, 1962, J BIOL CHEM, V237, P2140; Heimer G, 2016, AM J HUM GENET, V99, P1229, DOI 10.1016/j.ajhg.2016.09.021; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Jackson KC, 2014, J LIPID RES, V55, P668, DOI 10.1194/jlr.M043851; Kastaniotis AJ, 2017, BBA-MOL CELL BIOL L, V1862, P39, DOI 10.1016/j.bbalip.2016.08.011; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513                                                        ; Kursu VAS, 2013, MOL MICROBIOL, V90, P824, DOI 10.1111/mmi.12402; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; Nair RR, 2017, HUM MOL GENET, V26, P2104, DOI 10.1093/hmg/ddx105; Pereira KD, 2016, J CELL PHYSIOL, V231, P2682, DOI 10.1002/jcp.25370; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray H, 2006, J MOL BIOL, V359, P973, DOI 10.1016/j.jmb.2006.04.010; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.E04-11-1028; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sloan JL, 2011, NAT GENET, V43, P883, DOI 10.1038/ng.908; Suomi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114738; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Travers MT, 2005, GENOMICS, V85, P71, DOI 10.1016/j.ygeno.2004.10.001; Tress ML, 2017, TRENDS BIOCHEM SCI, V42, P98, DOI 10.1016/j.tibs.2016.08.008; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Witkowski A, 2011, J BIOL CHEM, V286, P33729, DOI 10.1074/jbc.M111.291591; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200	45	0	0	0	0	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0264-6021	1470-8728		BIOCHEM J	Biochem. J.	NOV 15	2017	474		22				3783	3797		10.1042/BCJ20170416				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FM8HY	WOS:000415328400007	28986507				2018-01-05	
J	Zhang, F; Lu, YL; Yan, SJ; Xing, QH; Tian, WD				Zhang, Feng; Lu, Yulan; Yan, Sijia; Xing, Qinghe; Tian, Weidong			SPRINT: an SNP-free toolkit for identifying RNA editing sites	BIOINFORMATICS			English	Article							LARGE GENE LISTS; ACCURATE IDENTIFICATION; HUMAN TRANSCRIPTOME; BETA-TRCP; SEQUENCE; DEGRADATION; LANDSCAPE; DIVERSITY; ALIGNMENT; DISEASE	RNA editing generates post-transcriptional sequence alterations. Detection of RNA editing sites (RESs) typically requires the filtering of SNVs called from RNA-seq data using an SNP database, an obstacle that is difficult to overcome for most organisms. Here, we present a novel method named SPRINT that identifies RESs without the need to filter out SNPs. SPRINT also integrates the detection of hyper RESs from remapped reads, and has been fully automated to any RNA-seq data with reference genome sequence available. We have rigorously validated SPRINT's effectiveness in detecting RESs using RNA-seq data of samples in which genes encoding RNA editing enzymes are knock down or over-expressed, and have also demonstrated its superiority over current methods. We have applied SPRINT to investigate RNA editing across tissues and species, and also in the development of mouse embryonic central nervous system. A web resource (http://sprint.tianlab.cn) of RESs identified by SPRINT has been constructed.	[Zhang, Feng; Tian, Weidong] Fudan Univ, State Key Lab Genet Engn, Shanghai 200436, Peoples R China; [Zhang, Feng; Tian, Weidong] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Shanghai 200436, Peoples R China; [Zhang, Feng; Tian, Weidong] Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai 200436, Peoples R China; [Lu, Yulan] Fudan Univ, Pediat Res Inst, Translat Med Res Ctr Children Dev & Dis, Mol Genet Diag Ctr,Shanghai Key Lab Birth Defect, Shanghai 201102, Peoples R China; [Yan, Sijia; Xing, Qinghe; Tian, Weidong] Fudan Univ, Childrens Hosp, Shanghai 201102, Peoples R China; [Yan, Sijia; Xing, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Tian, WD (reprint author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200436, Peoples R China.; Tian, WD (reprint author), Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Shanghai 200436, Peoples R China.; Tian, WD (reprint author), Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai 200436, Peoples R China.; Tian, WD (reprint author), Fudan Univ, Childrens Hosp, Shanghai 201102, Peoples R China.	weidong.tian@fudan.edu.cn			National Natural Science Foundation of China [31671367, 31471245]; Shanghai Municipal Commission of Science and Technology Program [14DJ1400100]; National Key Research and Development Program of China [2016YFC1000505]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120071110018]; Innovation Program of Shanghai Municipal Education Commission [13ZZ006]; Shanghai Shuguang Program [13SG05]	This work was supported by the National Natural Science Foundation of China [31671367, 31471245]; the Shanghai Municipal Commission of Science and Technology Program [14DJ1400100]; the National Key Research and Development Program of China [2016YFC1000505]; the Specialized Research Fund for the Doctoral Program of Higher Education of China [20120071110018]; the Innovation Program of Shanghai Municipal Education Commission [13ZZ006]; Shanghai Shuguang Program [13SG05].	Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Benne R, 1996, NATURE, V380, P391, DOI 10.1038/380391a0                                                                ; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Blanc V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r79; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gaisler-Salomon I, 2014, NEUROBIOL AGING, V35, P1785, DOI 10.1016/j.neurobiolaging.2014.02.018; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; John D, 2017, BRIEF BIOINFORM, V18, P993, DOI 10.1093/bib/bbw087; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lal D, 2015, EPILEPSY RES, V115, P95, DOI 10.1016/j.eplepsyres.2015.05.010; Lanore F, 2012, J NEUROSCI, V32, P17882, DOI 10.1523/JNEUROSCI.2049-12.2012; Li BM, 2009, NEUROPHARMACOLOGY, V57, P375, DOI 10.1016/j.neuropharm.2009.07.004; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maydanovych O, 2006, CHEM REV, V106, P3397, DOI 10.1021/cr050314a; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Piechotta M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1432-8; Pirouz M, 2015, CELL CYCLE, V14, P1596, DOI 10.1080/15384101.2015.1026485; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Ruiz-Orera J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005721; Shikanai T, 2015, BBA-BIOENERGETICS, V1847, P779, DOI 10.1016/j.bbabio.2014.12.010; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Sun YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150465; Tempel Sebastien, 2012, Methods Mol Biol, V859, P29, DOI 10.1007/978-1-61779-603-6_2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner SJ, 2015, NEUROLOGY, V84, P586, DOI 10.1212/WNL.0000000000001228; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang ZJ, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0143-4; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114; Zhong HJ, 2014, GENET MOL RES, V13, P8714, DOI 10.4238/2014.October.27.12; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	55	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	NOV 15	2017	33	22					3538	3548		10.1093/bioinformatics/btx473				11	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FM5KX	WOS:000415074800005	29036410				2018-01-05	
J	Xiong, YY; Xie, XW; Wang, YZ; Ma, WB; Liang, PP; Zhou, SY; Dai, ZM				Xiong, Yuanyan; Xie, Xiaowei; Wang, Yanzhi; Ma, Wenbing; Liang, Puping; Zhou Songyang; Dai, Zhiming			pgRNAFinder: a web-based tool to design distance independent paired-gRNA	BIOINFORMATICS			English	Article							HUMAN-CELLS; CAS9; SPECIFICITY; CRISPR-CAS9	The CRISPR/Cas System has been shown to be an efficient and accurate genome-editing technique. There exist a number of tools to design the guide RNA sequences and predict potential off-target sites. However, most of the existing computational tools on gRNA design are restricted to small deletions. To address this issue, we present pgRNAFinder, with an easy-to-use web interface, which enables researchers to design single or distance-free paired-gRNA sequences. The web interface of pgRNAFinder contains both gRNA search and scoring system. After users input query sequences, it searches gRNA by 3' protospacer-adjacent motif (PAM), and possible off-targets, and scores the conservation of the deleted sequences rapidly. Filters can be applied to identify high-quality CRISPR sites. PgRNAFinder offers gRNA design functionality for 8 vertebrate genomes. Furthermore, to keep pgRNAFinder open, extensible to any organism, we provide the source package for local use.	[Xiong, Yuanyan; Xie, Xiaowei; Wang, Yanzhi; Ma, Wenbing; Liang, Puping; Zhou Songyang] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou 510006, Guangdong, Peoples R China; [Xiong, Yuanyan; Xie, Xiaowei; Wang, Yanzhi; Ma, Wenbing; Liang, Puping; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China; [Zhou Songyang] Baylor Coll Med, Cell Based Assay Screening Core, Houston, TX 77030 USA; [Zhou Songyang] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Zhou Songyang] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhou Songyang] Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Dai, Zhiming] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou 510006, Guangdong, Peoples R China; [Dai, Zhiming] Sun Yat Sen Univ, Guangdong Prov Key Lab Big Data Anal & Proc, Guangzhou 510006, Guangdong, Peoples R China	Zhou, SY (reprint author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou 510006, Guangdong, Peoples R China.; Zhou, SY (reprint author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China.; Zhou, SY (reprint author), Baylor Coll Med, Cell Based Assay Screening Core, Houston, TX 77030 USA.; Zhou, SY (reprint author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.; Zhou, SY (reprint author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zhou, SY (reprint author), Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Dai, ZM (reprint author), Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou 510006, Guangdong, Peoples R China.; Dai, ZM (reprint author), Sun Yat Sen Univ, Guangdong Prov Key Lab Big Data Anal & Proc, Guangzhou 510006, Guangdong, Peoples R China.	songyang@bcm.edu; daizhim@mail.sysu.edu.cn			National Natural Science Foundation of China (NSFC) [31171397, 31271533, 31301085, 81330055, 91640119]; Pearl River Nova Program of Guangzhou [2012T50739, 201710010044]; National Natural Science Funds of Guangdong Province for Distinguished Young Scholar [2014A030306044]; CPRIT [RP160462]; Welch Foundation [Q-1673]	The research has been supported by National Natural Science Foundation of China (NSFC) (Grant 31171397,31271533, 31301085,81330055, and 91640119), Pearl River Nova Program of Guangzhou (2012T50739 and 201710010044), National Natural Science Funds of Guangdong Province for Distinguished Young Scholar (2014A030306044), CPRIT RP160462, and the Welch Foundation Q-1673.	Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115	18	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	NOV 15	2017	33	22					3642	3644		10.1093/bioinformatics/btx472				3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FM5KX	WOS:000415074800018	28961776				2018-01-05	
J	Nithin, C; Thomas, A; Basak, J; Bahadur, RP				Nithin, Chandran; Thomas, Amal; Basak, Jolly; Bahadur, Ranjit Prasad			Genome-wide identification of miRNAs and lncRNAs in Cajanus cajan	BMC GENOMICS			English	Article						miRNA; lncRNA; Cajanus Cajan; SSR signature; genome-wide analysis	LONG NONCODING RNAS; CUP-SHAPED-COTYLEDON; MICRORNA-TARGET RECOGNITION; SHOOT APICAL MERISTEM; MEDICAGO-TRUNCATULA; OSMOTIC ADJUSTMENT; GENE-EXPRESSION; MESSENGER-RNA; ARABIDOPSIS; TRANSCRIPTION	Background: Non-coding RNAs (ncRNAs) are important players in the post transcriptional regulation of gene expression (PTGR). On one hand, microRNAs (miRNAs) are an abundant class of small ncRNAs (similar to 22nt long) that negatively regulate gene expression at the levels of messenger RNAs stability and translation inhibition, on the other hand, long ncRNAs (lncRNAs) are a large and diverse class of transcribed non-protein coding RNA molecules (> 200nt) that play both up-regulatory as well as down-regulatory roles at the transcriptional level. Cajanus cajan, a leguminosae pulse crop grown in tropical and subtropical areas of the world, is a source of high value protein to vegetarians or very poor populations globally. Hence, genome-wide identification of miRNAs and lncRNAs in C. cajan is extremely important to understand their role in PTGR with a possible implication to generate improve variety of crops. Results: We have identified 616 mature miRNAs in C. cajan belonging to 118 families, of which 578 are novel and not reported in MirBase21. A total of 1373 target sequences were identified for 180 miRNAs. Of these, 298 targets were characterized at the protein level. Besides, we have also predicted 3919 lncRNAs. Additionally, we have identified 87 of the predicted lncRNAs to be targeted by 66 miRNAs. Conclusions: miRNA and lncRNAs in plants are known to control a variety of traits including yield, quality and stress tolerance. Owing to its agricultural importance and medicinal value, the identified miRNA, lncRNA and their targets in C. cajan may be useful for genome editing to improve better quality crop. A thorough understanding of ncRNA-based cellular regulatory networks will aid in the improvement of C. cajan agricultural traits.	[Nithin, Chandran; Thomas, Amal; Bahadur, Ranjit Prasad] Indian Inst Technol, Dept Biotechnol, Computat Struct Biol Lab, Kharagpur, W Bengal, India; [Basak, Jolly] Visva Bharati, Dept Biotechnol, Santini Ketan, W Bengal, India; [Thomas, Amal] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA USA	Bahadur, RP (reprint author), Indian Inst Technol, Dept Biotechnol, Computat Struct Biol Lab, Kharagpur, W Bengal, India.; Basak, J (reprint author), Visva Bharati, Dept Biotechnol, Santini Ketan, W Bengal, India.	jolly.basak@visva-bharati.ac.in; r.bahadur@hijli.iitkgp.ernet.in			IIT Kharagpur	CN is thankful to the IIT Kharagpur for research fellowship. RPB and JB acknowledge DBT, India.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290; Aida M, 1999, DEVELOPMENT, V126, P1563; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Burleigh SH, 1997, PLANT MOL BIOL, V34, P199, DOI 10.1023/A:1005841119665; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen M, 2009, FEBS LETT, V583, P2959, DOI 10.1016/j.febslet.2009.08.004; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; FLOWER DJ, 1987, FIELD CROP RES, V17, P229, DOI 10.1016/0378-4290(87)90037-2; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; Guo N, 2014, MOL BIOL REP, V41, P4965, DOI 10.1007/s11033-014-3362-8; He Y., 2013, MOL BIOL, V2, pe106; Helliwell CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021513; Heo JB, 2011, EPIGENETICS-US, V6, P544, DOI 10.4161/epi.6.5.15235; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hu JH, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23604; Hu JH, 2013, J BIOTECHNOL, V164, P520, DOI 10.1016/j.jbiotec.2013.01.026; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Huynen M, 1997, J MOL BIOL, V267, P1104, DOI 10.1006/jmbi.1997.0889; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kompelli S. K., 2015, Australian Journal of Crop Science, V9, P215; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Loong SNK, 2007, RNA, V13, P170, DOI 10.1261/rna.223807; Larsson E, 2012, ANN BOT-LONDON, V110, P923, DOI 10.1093/aob/mcs151; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Moulton V, 2000, J COMPUT BIOL, V7, P277, DOI 10.1089/10665270050081522; Nene Y. L., 1990, PIGEONPEA; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581                                                                ; Nie L, 2012, AM J TRANSL RES, V4, P127; Nithin C, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0516-3; O'Donovan C, 2002, BRIEF BIOINFORM, V3, P275, DOI DOI 10.1093/BIB/3.3.275; Pal D, 2011, BIOL ACTIVITIES MED, V2; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2                                                   ; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saxena K. B., 2002, Journal of Crop Production, V5, P227, DOI 10.1300/J144v05n01_10; Saxena K. B., 2010, Health, V2, P1335, DOI 10.4236/health.2010.211199; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schultes EA, 1999, J MOL EVOL, V49, P76, DOI 10.1007/PL00006536                                                              ; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma S., 2011, J FUNCT ENV BOT, V1, P91, DOI [10.5958/j.2231-1742.1.2.010, DOI 10.5958/J.2231-1742.1.2.010]; SINGH U, 1984, QUAL PLANT, V34, P273, DOI 10.1007/BF01126556; Sinha SK, 1977, FOOD LEGUMES DISTRIB; Subbarao GV, 2000, EUR J AGRON, V12, P239, DOI 10.1016/S1161-0301(00)00050-2; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Sun QW, 2013, SCIENCE, V340, P619, DOI 10.1126/science.1234848; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wasaki J, 2003, NEW PHYTOL, V158, P239, DOI [10.1046/j.1469-8137.2003.00748.x, 10.1046/j.1469-8137.2003.00865.x]; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yang L, 2011, DEVELOPMENT, V138, P245, DOI 10.1242/dev.058578; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu JF, 2013, PLANT CELL REP, V32, P1339, DOI 10.1007/s00299-013-1446-x; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	94	0	0	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 15	2017	18								878	10.1186/s12864-017-4232-2				14	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FM8QS	WOS:000415355200001	29141604	gold			2018-01-05	
J	Kim, S; Bae, T; Hwang, J; Kim, JS				Kim, Sojung; Bae, Taegeun; Hwang, Jaewoong; Kim, Jin-Soo			Rescue of high-specificity Cas9 variants using sgRNAs with matched 5 ' nucleotides	GENOME BIOLOGY			English	Article						CRISPR-Cas; Off-target effect; Engineered Cas9 variants; Hammerhead ribozyme-linked sgRNA	HUMAN-CELLS; GUIDE RNAS; GENOME; NUCLEASES; ENDONUCLEASE	We report that engineered Cas9 variants with improved specificity-eCas9-1.1 and Cas9-HF1-are often poorly active in human cells, when complexed with single guide RNAs (sgRNAs) with a mismatch at the 5' terminus, relative to target DNA sequences. Because the nucleotide at the 5' end of sgRNAs, expressed under the control of the commonly-used U6 promoter, is fixed to a guanine, these attenuated Cas9 variants are not useful at many target sites. By using sgRNAs with matched 5' nucleotides, produced by linking them to a self-cleaving ribozyme, the editing activity of Cas9 variants can be rescued without sacrificing high specificity.	[Kim, Sojung; Bae, Taegeun; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Bae, Taegeun; Kim, Jin-Soo] Korea Univ Sci & Technol, IBS Sch, Seoul, South Korea; [Hwang, Jaewoong; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Kim, JS (reprint author), Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea.; Kim, JS (reprint author), Korea Univ Sci & Technol, IBS Sch, Seoul, South Korea.; Kim, JS (reprint author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	jskim01@snu.ac.kr		Kim, Sojung/0000-0002-2690-875X	Institute for Basic Science (IBS) [R021-D1]	This work was supported by the Institute for Basic Science (IBS-R021-D1).	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, NCBI SEQUENCE READ A; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227	18	0	0	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	NOV 15	2017	18								218	10.1186/s13059-017-1355-3				6	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FM8AW	WOS:000415306700002	29141659	gold			2018-01-05	
J	Thillaiappan, NB; Chavda, AP; Tovey, SC; Prole, DL; Taylor, CW				Thillaiappan, Nagendra Babu; Chavda, Alap P.; Tovey, Stephen C.; Prole, David L.; Taylor, Colin W.			Ca2+ signals initiate at immobile IP3 receptors adjacent to ER-plasma membrane junctions	NATURE COMMUNICATIONS			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; OPERATED CALCIUM-CHANNELS; SINGLE-PARTICLE TRACKING; ENDOPLASMIC-RETICULUM; 1,4,5-TRISPHOSPHATE RECEPTORS; CYTOPLASMIC DYNEIN; CONTACT SITES; HIPPOCAMPAL-NEURONS; LATERAL DIFFUSION; MAMMALIAN-CELLS	IP3 receptors (IP(3)Rs) release Ca2+ from the ER when they bind IP3 and Ca2+. The spatial organization of IP(3)Rs determines both the propagation of Ca2+ signals between IP(3)Rs and the selective regulation of cellular responses. Here we use gene editing to fluorescently tag endogenous IP(3)Rs, and super-resolution microscopy to determine the geography of IP(3)Rs and Ca2+ signals within living cells. We show that native IP(3)Rs cluster within ER membranes. Most IP3R clusters are mobile, moved by diffusion and microtubule motors. Ca2+ signals are generated by a small population of immobile IP(3)Rs. These IP(3)Rs are licensed to respond, but they do not readily mix with mobile IP(3)Rs. The licensed IP(3)Rs reside alongside ER-plasma membrane junctions where STIM1, which regulates store-operated Ca2+ entry, accumulates after depletion of Ca2+ stores. IP(3)Rs tethered close to ER-plasma membrane junctions are licensed to respond and optimally placed to be activated by endogenous IP3 and to regulate Ca2+ entry.	[Thillaiappan, Nagendra Babu; Chavda, Alap P.; Tovey, Stephen C.; Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Chavda, Alap P.] Cactus Commun Pvt Ltd, 510 Shalimar Morya Pk, Mumbai 400053, Maharashtra, India; [Tovey, Stephen C.] Cairn Res Ltd, Graveney Rd, Kent ME13 8UP, England	Prole, DL; Taylor, CW (reprint author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	dp350@cam.ac.uk; cwt1000@cam.ac.uk		Prole, David/0000-0003-2782-6665; Thillaiappan, Nagendra Babu/0000-0001-5641-4067	Biotechnology and Biological Sciences Research Council, UK [L0000075]; Wellcome Trust [101844]; Cambridge Commonwealth, European and International Trust	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (L0000075) and the Wellcome Trust (101844). N.B.T. was supported by The Cambridge Commonwealth, European and International Trust. We thank V. Allen (Manchester) for plasmids for KHC-CT, p50-mCherry and GFP-ER, J. Liou (UT Southwestern, Dallas) for GFP-MAPPER plasmid, D. Beech (Leeds) for human Orai1 plasmid, R. Blunck (Montreal) for PIF software, F. Levet and J.-B. Sibarita (Bordeaux) for SR-Tesseler software, T. Wagner (Dortmund) for the TraJClassifier plugin and helpful discussions. We are grateful to M. Falke (Berlin) for advice.	Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bentley M, 2015, J CELL BIOL, V208, P273, DOI 10.1083/jcb.201408056; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928                                                  ; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785                                                               ; Chakraborty S, 2016, J CELL SCI, V129, P3903, DOI 10.1242/jcs.191585; Chalmers M, 2006, BIOCHEM J, V394, P57, DOI 10.1042/BJ20051130; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Costantini LM, 2013, DNA CELL BIOL, V32, P622, DOI 10.1089/dna.2013.2172; Dickinson GD, 2012, BIOPHYS J, V102, P1826, DOI 10.1016/j.bpj.2012.03.029; Dixon RE, 2015, ELIFE, V4, DOI 10.7554/eLife.05608; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Friel CT, 2012, J MUSCLE RES CELL M, V33, P377, DOI 10.1007/s10974-012-9289-6; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geyer M, 2015, CELL REP, V12, P79, DOI 10.1016/j.celrep.2015.06.001; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200                                                          ; Kechkar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062918; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/nmeth.3579, 10.1038/NMETH.3579]; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Lur G, 2009, CURR BIOL, V19, P1648, DOI 10.1016/j.cub.2009.07.072; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; McGuire H, 2012, J BIOL CHEM, V287, P35912, DOI 10.1074/jbc.M112.402057; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Pantazaka E, 2011, J BIOL CHEM, V286, P23378, DOI 10.1074/jbc.M111.236372; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parker I, 2010, J GEN PHYSIOL, V136, P119, DOI 10.1085/jgp.200910390; Perni S, 2015, P NATL ACAD SCI USA, V112, pE5533, DOI 10.1073/pnas.1515606112; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rabut G., 2004, LIVE CELL IMAGING LA, P101; Rahman T, 2009, NATURE, V458, P655; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Ross WN, 2012, NAT REV NEUROSCI, V13, P157, DOI 10.1038/nrn3168; Lopez Sanjurjo CI, 2013, J CELL SCI, V126, P289; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0                                                   ; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654                                                        ; Smith IF, 2014, BIOPHYS J, V107, P834, DOI 10.1016/j.bpj.2014.05.051; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Steele EM, 2014, BIOPHYS J, V106, P566, DOI 10.1016/j.bpj.2013.12.040; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069                                                                ; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; Thomas D, 2000, CURR BIOL, V10, P8, DOI 10.1016/S0960-9822(99)00258-4; Thurley K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005237; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tojyo Y, 2008, J PHARMACOL SCI, V107, P138, DOI 10.1254/jphs.08021FP; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Valenzuela JI, 2014, J CELL SCI, V127, P3382, DOI 10.1242/jcs.151092; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Wagner T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170165; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465                                                            ; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	76	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 15	2017	8								1505	10.1038/s41467-017-01644-8				16	Multidisciplinary Sciences	Science & Technology - Other Topics	FM7MP	WOS:000415262100006	29138405	gold			2018-01-05	
J	Wang, QK; Chen, SL; Xiao, QQ; Liu, ZP; Liu, S; Hou, PP; Zhou, L; Hou, W; Ho, WZ; Li, CM; Wu, L; Guo, DY				Wang, Qiankun; Chen, Shuliang; Xiao, Qiaoqiao; Liu, Zhepeng; Liu, Shuai; Hou, Panpan; Zhou, Li; Hou, Wei; Ho, Wenzhe; Li, Chunmei; Wu, Li; Guo, Deyin			Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection	RETROVIROLOGY			English	Article						CXCR4; HIV-1; Primary CD4(+) T cells; Adeno-associated virus; CRISPR/SaCas9	IMMUNODEFICIENCY-VIRUS TYPE-1; GENE-THERAPY; T-CELLS; CORECEPTOR; INDIVIDUALS; CRISPR/CAS9; RNA; RECEPTOR; PROTEIN; CURE	Background: The CRISPR/Cas9 system has been widely used for genome editing in mammalian cells. CXCR4 is a co-receptor for human immunodeficiency virus type 1 (HIV-1) entry, and loss of CXCR4 function can protect cells from CXCR4 (X4)-tropic HIV-1 infection, making CXCR4 an important target for HIV-1 gene therapy. However, the large size of the CRISPR/SpCas9 system presents an obstacle to its efficient delivery into primary CD4(+) T cells. Recently, a small Staphylococcus aureus Cas9 (SaCas9) has been developed as a genome editing tool can address this question. Therefore, it provides a promising strategy for HIV-1 gene therapy if it is used to target CXCR4. Results: Here, we employed a short version of Cas9 from Staphylococcus aureus (SaCas9) for targeting CXCR4. We demonstrated that transduction of lenti-virus expressing SaCas9 and selected single-guided RNAs of CXCR4 in human CD4(+) T cell lines efficiently induced the editing of the CXCR4 gene, making these cell lines resistant to X4-tropic HIV-1 infection. Moreover, we efficiently transduced primary human CD4(+) T cells using adeno-associated virus-delivered CRISPR/SaCas9 and disrupted CXCR4 expression. We also showed that CXCR4-edited primary CD4(+) T cells proliferated normally and were resistant to HIV-1 infection. Conclusions: Our study provides a basis for possible application of CXCR4-targeted genome editing by CRISPR/SaCas9 in HIV-1 gene therapy.	[Wang, Qiankun; Chen, Shuliang; Xiao, Qiaoqiao; Liu, Zhepeng; Liu, Shuai; Hou, Wei; Ho, Wenzhe; Li, Chunmei; Guo, Deyin] Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China; [Chen, Shuliang; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA; [Hou, Panpan] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Zhou, Li] Wuhan Univ, Ctr Expt Anim, Anim Biosafety Level Lab 3, Wuhan, Hubei, Peoples R China; [Li, Chunmei; Guo, Deyin] Sun Yat Sen Univ, Sch Med Shenzhen, Zhongshan Erlu 74, Guangzhou 510080, Guangdong, Peoples R China	Chen, SL; Guo, DY (reprint author), Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China.; Chen, SL (reprint author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA.; Guo, DY (reprint author), Sun Yat Sen Univ, Sch Med Shenzhen, Zhongshan Erlu 74, Guangzhou 510080, Guangdong, Peoples R China.	chen-shuliang@whu.edu.cn; guodeyin@mail.sysu.edu.cn		Wu, Li/0000-0002-5468-2487	China National Special Research Program of Major Infectious Diseases [2014ZX10001003]; Hubei Provincial Science and Technology Innovation Team [2012FFA043]; Hubei Province's Outstanding Medical Academic Leader Program; Natural Science Foundation of China [81401659]; China Postdoctoral Science Foundation [2015T80838, 2014M560622]; National Institutes of Health of the USA [AI104483, AI127667, AI120209]; China Scholarship Council	This work was funded by the China National Special Research Program of Major Infectious Diseases (2014ZX10001003) and Hubei Provincial Science and Technology Innovation Team Grant (2012FFA043). DG is supported by the Hubei Province's Outstanding Medical Academic Leader Program. This work was also supported by the Natural Science Foundation of China (81401659) and China Postdoctoral Science Foundation (2015T80838 and 2014M560622) to SC. LW is supported by Grants (AI104483, AI127667, and AI120209) from the National Institutes of Health of the USA. This work was partially supported by the scholarship to SC from the China Scholarship Council.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Anderson JL, 2015, AIDS RES HUM RETROV, V31, P36, DOI [10.1089/aid.2014.0236, 10.1089/AID.2014.0236]; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Cecilia D, 1998, J VIROL, V72, P6988; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Chung SH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3158; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621                                                           ; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Didigu CA, BLOOD; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Holehonnur R, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0100-7; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Huang W, 2009, AIDS RES HUM RETROV, V25, P795, DOI 10.1089/aid.2008.0252; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kaminski R, 2016, GENE THER, V23, P696, DOI 10.1038/gt.2016.45; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu Y, 2014, MOL BIOTECHNOL, V56, P890, DOI 10.1007/s12033-014-9768-7; Liu ZP, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0174-2; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang CX, 2016, AIDS PATIENT CARE ST, V30, P539, DOI 10.1089/apc.2016.0233; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310	42	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-4690			RETROVIROLOGY	Retrovirology	NOV 15	2017	14								51	10.1186/s12977-017-0375-0				12	Virology	Virology	FM8QJ	WOS:000415354100001	29141633	gold			2018-01-05	
J	Yoshino, H; Nohata, N; Miyamoto, K; Yonemori, M; Sakaguchi, T; Sugita, S; Itesako, T; Kofuji, S; Nakagawa, M; Dahiya, R; Enokida, H				Yoshino, Hirofumi; Nohata, Nijiro; Miyamoto, Kazutaka; Yonemori, Masaya; Sakaguchi, Takashi; Sugita, Satoshi; Itesako, Toshihiko; Kofuji, Satoshi; Nakagawa, Masayuki; Dahiya, Rajvir; Enokida, Hideki			PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2 alpha-Targeting Therapy for Renal Cell Carcinoma	CANCER RESEARCH			English	Article							CANCER GENOMICS; KIDNEY CANCER; HYPOXIA; PROLIFERATION; ANTAGONIST; METABOLISM	Continuous activation of hypoxia-inducible factor (HIF) is important for progression of renal cell carcinoma (RCC) and acquired resistance to antiangiogenic multikinase and mTOR inhibitors. Recently, HIF2 alpha antagonists PT2385 and PT2399 were developed and are being evaluated in a phase I clinical trial for advanced or metastatic clear cell RCC (ccRCC). However, resistance to HIF2 alpha antagonists would be expected to develop. In this study, we identified signals activated by HIF2 alpha deficiency as candidate mediators of resistance to the HIF2 alpha antagonists. We established sunitinib-resistant tumor cells in vivo and created HIF2 alpha-deficient variants of these cells using CRISPR/Cas9 technology. Mechanistic investigations revealed that a regulator of the serine biosynthesis pathway, phosphoglycerate dehydrogenase (PHGDH), was upregulated commonly in HIF2 alpha-deficient tumor cells along with the serine biosynthesis pathway itself. Accordingly, treatment with a PHGDH inhibitor reduced the growth of HIF2 alpha-deficient tumor cells in vivo and in vitro by inducing apoptosis. Our findings identify the serine biosynthesis pathway as a source of candidate therapeutic targets to eradicate advanced or metastatic ccRCC resistant to HIF2 alpha antagonists. (C) 2017 AACR.	[Yoshino, Hirofumi; Miyamoto, Kazutaka; Yonemori, Masaya; Sakaguchi, Takashi; Sugita, Satoshi; Itesako, Toshihiko; Nakagawa, Masayuki; Enokida, Hideki] Kagoshima Univ, Dept Urol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan; [Nohata, Nijiro] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Kofuji, Satoshi] Hiroshima Univ, Dept Physiol Chem, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Dahiya, Rajvir] VA Med Ctr, Dept Urol, 4150 Clement St, San Francisco, CA 94121 USA; [Dahiya, Rajvir] UCSF, 4150 Clement St, San Francisco, CA 94121 USA	Enokida, H (reprint author), Kagoshima Univ, Dept Urol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.; Dahiya, R (reprint author), VA Med Ctr, Dept Urol, 4150 Clement St, San Francisco, CA 94121 USA.; Dahiya, R (reprint author), UCSF, 4150 Clement St, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu; enokida@m.kufm.kagoshima-u.ac.jp			KAKENHI (KIBAN-B) [16H05464, 17H04332]; KAKENHI (KIBAN-C) [16K11015, 17K11148]; KAKENHI (WAKATE-B) [17K16799]; Department of Veterans Affairs VA Merit Review [101BX001123]; Home for Innovative Researchers and Academic Knowledge Users (HIRAKU);  [NIH-RO1CA199694]	This study was supported by the KAKENHI (KIBAN-B) 16H05464 (M. Nakagawa) and 17H04332 (H. Enokida), KAKENHI (KIBAN-C) 16K11015 (H. Yoshino) and 17K11148 (T. Itesako), KAKENHI (WAKATE-B) 17K16799 (M. Yonemori), and the Department of Veterans Affairs VA Merit Review101BX001123 (R. Dahiya), and NIH-RO1CA199694 (R. Dahiya). S. Kofuji was supported, in part, by Home for Innovative Researchers and Academic Knowledge Users (HIRAKU).	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Frezza C, 2016, NAT CHEM BIOL, V12, P389, DOI 10.1038/nchembio.2086; Gao J., 2013, SCI SIGNAL, V6, pl1, DOI DOI 10.1126/SCISIGNAL.2004088; Garcia-Donas J, 2013, ANN ONCOL, V24, P2409, DOI 10.1093/annonc/mdt219; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Margulis V, 2011, EUR UROL, V60, P673, DOI 10.1016/j.eururo.2011.06.042; Matsumoto M, 2017, NAT METHODS, V14, P251, DOI [10.1038/nmeth.4116, 10.1038/NMETH.4116]; Mullarky E, 2016, P NATL ACAD SCI USA, V113, pE1585, DOI 10.1073/pnas.1602228113; Ou Y, 2015, J BIOL CHEM, V290, P457, DOI 10.1074/jbc.M114.616359; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Yamasaki T, 2013, CANCER SCI, V104, P1411, DOI 10.1111/cas.12240; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Yoshino H, 2017, ONCOTARGET, V8, P20881, DOI 10.18632/oncotarget.14930; Yoshino H, 2013, CANCER SCI, V104, P1567, DOI 10.1111/cas.12280	30	0	0	3	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	NOV 15	2017	77	22					6321	6329		10.1158/0008-5472.CAN-17-1589				9	Oncology	Oncology	FM5VA	WOS:000415107900024	28951458				2018-01-05	
J	Yau, EH; Kummetha, IR; Lichinchi, G; Tang, R; Zhang, YL; Rana, TM				Yau, Edwin H.; Kummetha, Indrasena Reddy; Lichinchi, Gianluigi; Tang, Rachel; Zhang, Yunlin; Rana, Tariq M.			Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers	CANCER RESEARCH			English	Article							TUMOR-GROWTH; ONCOGENIC TRANSCRIPTION; PANCREATIC-CANCER; ESSENTIAL GENES; LUNG-CANCER; INO80; IDENTIFICATION; ACTIVATION; TARGET; METABOLISM	Targeting mutant KRAS signaling pathways continues to attract attention as a therapeutic strategy for KRAS-driven tumors. In this study, we exploited the power of the CRISPR-Cas9 system to identify genes affecting the tumor xenograft growth of human mutant KRAS (KRAS(MUT)) colorectal cancers. Using pooled lentiviral single-guide RNA libraries, we conducted a genome-wide loss-of-function genetic screen in an isogenic pair of human colorectal cancer cell lines harboring mutant or wild-type KRAS. The screen identified novel and established synthetic enhancers or synthetic lethals for KRAS(MUT) colorectal cancer, including targetable metabolic genes. Notably, genetic disruption or pharmacologic inhibition of the metabolic enzymes NAD kinase or ketohexokinase was growth inhibitory in vivo. In addition, the chromatin remodeling protein INO80C was identified as a novel tumor suppressor in KRAS(MUT) colorectal and pancreatic tumor xenografts. Our findings define a novel targetable set of therapeutic targets for KRASMUT tumors. (C) 2017 AACR.	[Yau, Edwin H.; Kummetha, Indrasena Reddy; Lichinchi, Gianluigi; Tang, Rachel; Zhang, Yunlin; Rana, Tariq M.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Yau, Edwin H.; Kummetha, Indrasena Reddy; Lichinchi, Gianluigi; Tang, Rachel; Zhang, Yunlin; Rana, Tariq M.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA; [Yau, Edwin H.] Univ Calif San Diego, Sch Med, Dept Internal Med, Div Hematol Oncol, La Jolla, CA 92093 USA; [Yau, Edwin H.; Rana, Tariq M.] Univ Calif San Diego, Solid Tumor Therapeut Program, Moores Canc Ctr, La Jolla, CA 92093 USA; [Yau, Edwin H.] Roswell Pk Canc Inst, Dept Canc Genet & Genom, Buffalo, NY 14263 USA	Rana, TM (reprint author), Univ Calif San Diego, 9500 Gilman Dr MC0762, La Jolla, CA 92093 USA.	trana@ucsd.edu			NIH [CA177322]; NCI of the NIH [T32CA121938]	This work was supported in part by the NIH (CA177322). E.H. Yau was supported by the NCI of the NIH under Award Number T32CA121938.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Deneen B, 2003, CANCER RES, V63, P4268; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hikasa H, 2016, CELL REP, V14, P2950, DOI 10.1016/j.celrep.2016.02.075; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2016, BMB REP, V49, P357, DOI 10.5483/BMBRep.2016.49.7.104; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; Li X, 2016, SPLICING SWITCH KETO, V18, P561; Li XJ, 2016, CELL CYCLE, V15, P2689, DOI 10.1080/15384101.2016.1204861; Liu HB, 2010, CANCER RES, V70, P6368, DOI 10.1158/0008-5472.CAN-09-4615; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Maryanoff BE, 2011, ACS MED CHEM LETT, V2, P538, DOI 10.1021/ml200070g; Morrow KA, 2016, ONCOTARGET, V7, P17991, DOI 10.18632/oncotarget.7494; Muto Y, 2004, J MOL BIOL, V341, P185, DOI 10.1016/j.jmb.2004.04.078; Ohkura N, 2002, J BIOL CHEM, V277, P535, DOI 10.1074/jbc.M109018200; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Segala G, 2016, MOL CELL, V64, P334, DOI 10.1016/j.molcel.2016.08.034; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Silvany RE, 2000, ONCOGENE, V19, P4523, DOI 10.1038/sj.onc.1203811; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Tedeschi PM, 2016, CLIN CANCER RES, V22, P5189, DOI 10.1158/1078-0432.CCR-16-1129; Tedeschi PM, 2015, MOL PHARMACOL, V88, P720, DOI 10.1124/mol.114.096727; Terada Y, 2006, MOL CELL BIOL, V26, P8149, DOI 10.1128/MCB.01170-06; Tsang YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10500; van Eenennaam H, 2001, J BIOL CHEM, V276, P31635, DOI 10.1074/jbc.M103399200; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Xue Y, 2015, GENE DEV, V29, P350, DOI 10.1101/gad.256255.114; Yao W, 2016, MOL CELL BIOL, V36, P979, DOI 10.1128/MCB.00801-15; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang S, 2017, ONCOGENE, V36, P1430, DOI 10.1038/onc.2016.311; Zhou BY, 2016, GENE DEV, V30, P1440, DOI 10.1101/gad.277178.115; Zhou Y, 2016, CANCER RES, V76, P5777, DOI 10.1158/0008-5472.CAN-15-2936	43	0	0	10	10	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	NOV 15	2017	77	22					6330	6339		10.1158/0008-5472.CAN-17-2043				10	Oncology	Oncology	FM5VA	WOS:000415107900025	28954733				2018-01-05	
J	Kawashima, A; Karasawa, T; Tago, K; Kimura, H; Kamata, R; Usui-Kawanishi, F; Watanabe, S; Ohta, S; Funakoshi-Tago, M; Yanagisawa, K; Kasahara, T; Suzuki, K; Takahashi, M				Kawashima, Akira; Karasawa, Tadayoshi; Tago, Kenji; Kimura, Hiroaki; Kamata, Ryo; Usui-Kawanishi, Fumitake; Watanabe, Sachiko; Ohta, Satoshi; Funakoshi-Tago, Megumi; Yanagisawa, Ken; Kasahara, Tadashi; Suzuki, Koichi; Takahashi, Masafumi			ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages	JOURNAL OF IMMUNOLOGY			English	Article							CASPASE-1 ACTIVATION; IMMUNE-SYSTEM; LIGASE; ASC; TRIAD1; DEUBIQUITINATION; PYROPTOSOME; DEGRADATION; INHIBITORS; APOPTOSIS	The nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a molecular platform that induces caspase-1 activation and subsequent IL-1b maturation, and is implicated in inflammatory diseases; however, little is known about the negative regulation of NLRP3 inflammasome activation. In this article, we identified an E3 ligase, Ariadne homolog 2 (ARIH2), as a posttranslational negative regulator of NLRP3 inflammasome activity in macrophages. ARIH2 interacted with NLRP3 via its NACHT domain (aa 220-575) in the NLRP3 inflammasome complex. In particular, we found that while using mutants of ARIH2 and ubiquitin, the really interesting new gene 2 domain of ARIH2 was required for NLRP3 ubiquitination linked through K48 and K63. Deletion of endogenous ARIH2 using CRISPR/Cas9 genome editing inhibited NLRP3 ubiquitination and promoted NLRP3 inflammasome activation, resulting in apoptosis-associated speck-like protein containing a caspase recruitment domain oligomerization, pro-IL-1b processing, and IL-1b production. Conversely, ARIH2 overexpression promoted NLRP3 ubiquitination and inhibited NLRP3 inflammasome activation. Our findings reveal a novel mechanism of ubiquitination-dependent negative regulation of the NLRP3 inflammasome by ARIH2 and highlight ARIH2 as a potential therapeutic target for inflammatory diseases.	[Kawashima, Akira; Karasawa, Tadayoshi; Kimura, Hiroaki; Kamata, Ryo; Usui-Kawanishi, Fumitake; Watanabe, Sachiko; Kasahara, Tadashi; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Tago, Kenji; Ohta, Satoshi; Yanagisawa, Ken] Jichi Med Univ, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan; [Funakoshi-Tago, Megumi] Keio Univ, Fac Pharm, Tokyo 1058512, Japan; [Suzuki, Koichi] Teikyo Univ, Fac Med Technol, Dept Clin Lab Sci, Tokyo 1738605, Japan	Kawashima, A; Takahashi, M (reprint author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	akirak5243@gmail.com; masafumi2@jichi.ac.jp		Kimura, Hiroaki/0000-0002-7441-0382; Suzuki, Koichi/0000-0001-8659-4660	Japan Society for the Promotion of Science; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology	This work was supported by grants from the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (to A.K. and M.T.), the Takeda Science Foundation (to M.T.), the Ministry of Education, Culture, Sports, Science and Technology supported program for the Strategic Foundation at Private Universities (to M.T.), and the Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (to M.T.).	Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Han S, 2015, J BIOL CHEM, V290, P18124, DOI 10.1074/jbc.M115.645549; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Karasawa T, 2015, FEBS OPEN BIO, V5, P348, DOI 10.1016/j.fob.2015.04.011; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Komada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10901; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kuo ML, 2004, CELL CYCLE, V3, P1367, DOI 10.4161/cc.3.11.1244                                                            ; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lin AE, 2013, NAT IMMUNOL, V14, P27, DOI 10.1038/ni.2478; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Marteijn JA, 2009, LEUKEMIA, V23, P1480, DOI 10.1038/leu.2009.57; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Miyoshi H, 1998, J VIROL, V72, P8150; Parelkar SS, 2012, J MOL NEUROSCI, V46, P109, DOI 10.1007/s12031-011-9535-1; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Raz V, 2014, AM J PATHOL, V184, P1119, DOI 10.1016/j.ajpath.2013.12.011; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388                                                              ; Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zinngrebe J, 2014, EMBO REP, V15, P28, DOI 10.1002/embr.201338025	35	0	0	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 15	2017	199	10					3614	3622		10.4049/jimmunol.1700184				9	Immunology	Immunology	FM0MK	WOS:000414660600021	29021376				2018-01-05	
J	Azetsu, Y; Inohaya, K; Takano, Y; Kinoshita, M; Tasaki, M; Kudo, A				Azetsu, Yuki; Inohaya, Keiji; Takano, Yoshiro; Kinoshita, Masato; Tasaki, Mai; Kudo, Akira			The sp7 gene is required for maturation of osteoblast-lineage cells in medaka (Oryzias latipes) vertebral column development	DEVELOPMENTAL BIOLOGY			English	Article						Skeletal development; Vertebral column; Osteoblast; Teleost; Medaka	BONE-FORMATION; TRANSGENIC MEDAKA; DIFFERENTIATION; TELEOST; OSTERIX; MINERALIZATION; EXPRESSION; GENERATION; NOTOCHORD; CBFA1	Sp7 is a zinc finger transcription factor that is essential for osteoblast differentiation in mammals. To verify the characteristic features of osteoblast-lineage cells in teleosts, we established medaka sp7 mutants using a transcription activator-like effector nuclease (TALEN) genome editing system. These mutants showed severe defects in the formation of skeletal structures. In particular, the neural and the hemal arches were not formed, although the chordal centra were formed. Analysis of the transgenic medaka revealed that sp7 mutant had normal distribution of type X collagen al a (collOala)-positive osteoblast-like cells around the centrum and at the proximal region of the vertebral arch. The sp7 mutant phenotype could be rescued by exogenous sp7 expression in col10a1a-positive cells, as well as in sp7-positive osteoblast cells. Furthermore, runx2-positive osteoblast progenitors were observed on the vertebral arches, but not on the centrum, during vertebral column development. In addition, these osteoblast progenitors differentiated into the collOal a-positive cells. In sp7 mutant, the runx2-positive cells were normally distributed at the region of unformed vertebral arch but failed to differentiate into collOal a-positive cells. These results indicate that osteoblast-lineage cells undergo two distinct differentiation processes during development of the vertebral arch and the centrum. Nevertheless, our results verified that sp7 gene expression in osteoblast-lineage cells is required for differentiation into mature osteoblasts to form the vertebral column and other skeletal structures.	[Azetsu, Yuki; Inohaya, Keiji; Tasaki, Mai; Kudo, Akira] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan; [Takano, Yoshiro] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan	Inohaya, K; Kudo, A (reprint author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	kinohaya@bio.titech.ac.jp; akudo@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26506005]	We thank Dr. S. Ansai (Kyoto University) for helpful technical advice about the TALEN technology. We are also grateful to NBRP Medaka (https://shigen.nig.ac.jp/medaka/) for providing the fosmid and the BAC clones and Dr. M. Chatani for gift of the 2A-EGFP DNA fragment. This work was supported by Grants-in-Aid to K.I from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, [Grant no. 26506005].	Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Fleming A, 2004, DEVELOPMENT, V131, P873, DOI 10.1242/dev.00952; Grotmol S, 2003, ANAT EMBRYOL, V207, P263, DOI 10.1007/s00429-003-0349-y; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Inohaya K, 2000, DEV GENES EVOL, V210, P570, DOI 10.1007/s004270000094; Inohaya K, 2007, DEV DYNAM, V236, P3031, DOI 10.1002/dvdy.21329; Inohaya K, 2010, DEVELOPMENT, V137, P1807, DOI 10.1242/dev.051540; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kague E, 2016, DEV BIOL, V413, P160, DOI 10.1016/j.ydbio.2016.03.011; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5                                                   ; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Renn J, 2010, J APPL ICHTHYOL, V26, P196, DOI 10.1111/j.1439-0426.2010.01404.x; Renn J, 2009, DEV DYNAM, V238, P241, DOI 10.1002/dvdy.21836; Renn J, 2014, MATRIX BIOL, V34, P193, DOI 10.1016/j.matbio.2013.12.008; Renn J, 2013, DEV BIOL, V381, P134, DOI 10.1016/j.ydbio.2013.05.030; Wakamatsu Yuko, 1993, Molecular Marine Biology and Biotechnology, V2, P325; Willems B, 2012, DEV BIOL, V364, P128, DOI 10.1016/j.ydbio.2012.01.023; Yasutake J, 2004, MECH DEVELOP, V121, P883, DOI 10.1016/j.mod.2004.03.008; Yu TS, 2017, DEVELOPMENT, V144, P265, DOI 10.1242/dev.139550	22	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	NOV 15	2017	431	2					252	262		10.1016/j.ydbio.2017.09.010				11	Developmental Biology	Developmental Biology	FM0AW	WOS:000414622200014	28899668				2018-01-05	
J	Miyamoto, T; Akutsu, SN; Fukumitsu, A; Morino, H; Masatsuna, Y; Hosoba, K; Kawakami, H; Yamamoto, T; Shimizu, K; Ohashi, H; Matsuura, S				Miyamoto, Tatsuo; Akutsu, Silvia Natsuko; Fukumitsu, Akihiro; Morino, Hiroyuki; Masatsuna, Yoshinori; Hosoba, Kosuke; Kawakami, Hideshi; Yamamoto, Takashi; Shimizu, Kenji; Ohashi, Hirofumi; Matsuura, Shinya			PLK1-mediated phosphorylation of WDR62/MCPH2 ensures proper mitotic spindle orientation	HUMAN MOLECULAR GENETICS			English	Article							WD40-REPEAT PROTEIN 62; PLK1 SUBSTRATE; WDR62; PROGRESSION; IDENTIFICATION; NEUROGENESIS; MICROTUBULES; PROGENITORS; MUTATIONS; CDK5RAP2	Primary microcephaly (MCPH) is an autosomal recessive disorder characterized by congenital reduction of head circumference. Here, we identified compound heterozygous mutations c.731 C > T (p.Ser 244 Leu) and c.2413 G > T (p.Glu 805 X) in the WDR62/MCPH2 gene, which encodes the mitotic centrosomal protein WDR62, in two siblings in a Japanese family with microcephaly using whole-exome sequencing. However, the molecular and cellular pathology of microcephaly caused by WDR62/MCPH2 mutation remains unclear. To clarify the physiological role of WDR62, we used the CRISPR/Cas9 system and single-stranded oligonucleotides as a point-mutation-targeting donor to generate human cell lines with knock-in of WDR62/MCPH2 c.731 C > T (p.Ser 244 Leu) missense mutation. In normal metaphase, the mitotic spindle forms parallel to the substratum to ensure symmetric cell division, while WDR62/MCPH2-mutated cells exhibited a randomized spindle orientation caused by the impaired astral microtubule assembly. It was shown that a mitotic kinase, Polo-like kinase 1 (PLK1), is required for the maintenance of spindle orientation through astral microtubule development. In this study, we demonstrated that WDR62 is a PLK1 substrate that is phosphorylated at Ser 897, and that this phosphorylation at the spindle poles promotes astral microtubule assembly to stabilize spindle orientation. Our findings provide insights into the role of the PLK1-WDR62 pathway in the maintenance of proper spindle orientation.	[Miyamoto, Tatsuo; Akutsu, Silvia Natsuko; Fukumitsu, Akihiro; Masatsuna, Yoshinori; Hosoba, Kosuke; Matsuura, Shinya] Hiroshima Univ, Dept Genet & Cell Biol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Morino, Hiroyuki; Kawakami, Hideshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Hiroshima 7348553, Japan; [Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Shimizu, Kenji; Ohashi, Hirofumi] Saitama Childrens Med Ctr, Dept Genet, Saitama 3308777, Japan	Matsuura, S (reprint author), Hiroshima Univ, Dept Genet & Cell Biol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan.	shinya@hiroshima-u.ac.jp	Kawakami, Hideshi/A-2086-2009; Matsuura, Shinya/U-4182-2017; Yamamoto, Takashi/U-4790-2017	Kawakami, Hideshi/0000-0002-1405-0901; Matsuura, Shinya/0000-0001-5294-081X; Yamamoto, Takashi/0000-0002-6516-2903	Ministry of Education, Culture, Sports, Science and Technology of Japan; Center of World Intelligence Projects for Nuclear S&T and Human Resource Development from the Japan Science and Technology Agency; Ministry of Health, Labor and Welfare; AMED-PRIME from the Japan Agency for Medical Research and Development, AMED; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ono Medical Research Foundation; Takeda Science Foundation; Phoenix Leader Education Program Research Grant	Ministry of Education, Culture, Sports, Science and Technology of Japan (to S.M. and T.M.); the Center of World Intelligence Projects for Nuclear S&T and Human Resource Development from the Japan Science and Technology Agency (to S.M.); a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare (to S.M.); AMED-PRIME from the Japan Agency for Medical Research and Development, AMED (to T.M.); research grants from the Naito Foundation (to S.M. and T.M.); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T.M.); Ono Medical Research Foundation (to T.M.); Takeda Science Foundation (to T.M.); a Phoenix Leader Education Program Research Grant (to S.A.).	Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bogoyevitch MA, 2012, J CELL SCI, V125, P5096, DOI 10.1242/jcs.107326; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Gai M, 2016, EMBO REP, V17, P1396, DOI 10.15252/embr.201541823; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Hanafusa H, 2015, NAT CELL BIOL, V17, P1024, DOI 10.1038/ncb3204; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lim NR, 2016, CELL CYCLE, V15, P413, DOI 10.1080/15384101.2015.1127472; Lim NR, 2015, J CELL SCI, V128, P527, DOI 10.1242/jcs.157537; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Miyamoto T, 2015, CELL REP, V10, P664, DOI 10.1016/j.celrep.2015.01.003; Miyamoto T, 2011, HUM MOL GENET, V20, P2058, DOI 10.1093/hmg/ddr090; Morino H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0180-4; Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015; Nair AR, 2016, CELL REP, V14, P1100, DOI 10.1016/j.celrep.2015.12.097; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Sgourdou P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43708; Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016; Yan MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10449; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050	31	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	NOV 15	2017	26	22					4429	4440		10.1093/hmg/ddx330				12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FL7CM	WOS:000414403900011	28973348				2018-01-05	
J	Heman-Ackah, SM; Manzano, R; Hoozemans, JJM; Scheper, W; Flynn, R; Haerty, W; Cowley, SA; Bassett, AR; Wood, MJA				Heman-Ackah, Sabrina M.; Manzano, Raquel; Hoozemans, Jeroen J. M.; Scheper, Wiep; Flynn, Rowan; Haerty, Wilfried; Cowley, Sally A.; Bassett, Andrew R.; Wood, Matthew J. A.			Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons	HUMAN MOLECULAR GENETICS			English	Article							FACTOR XBP1; EXPRESSION; DUPLICATION; ACTIVATION	The recent generation of induced pluripotent stem cells (iPSCs) from a patient with Parkinson's disease (PD) resulting from triplication of the alpha-synuclein (SNCA) gene locus allows unprecedented opportunities to explore its contribution to the molecular pathogenesis of PD. We used the double-nicking CRISPR/Cas9 system to conduct site-specific mutagenesis of SNCA in these cells, generating an isogenic iPSC line with normalized SNCA gene dosage. Comparative gene expression analysis of neuronal derivatives from these iPSCs revealed an ER stress phenotype, marked by induction of the IRE1 alpha/XBP1 axis of the unfolded protein response (UPR) and culminating in terminal UPR activation. Neuropathological analysis of post-mortem brain tissue demonstrated that pIRE1 alpha is expressed in PD brains within neurons containing elevated levels of alpha-synuclein or Lewy bodies. Having used this pair of isogenic iPSCs to define this phenotype, these cells can be further applied in UPR-targeted drug discovery towards the development of disease-modifying therapeutics.	[Heman-Ackah, Sabrina M.; Manzano, Raquel; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Heman-Ackah, Sabrina M.] NIH, NIH Oxford Cambridge Scholars Program, Bldg 10, Bethesda, MD 20892 USA; [Heman-Ackah, Sabrina M.] Univ North Carolina Chapel Hill, UNC MD PhD Program, Chapel Hill, NC 27599 USA; [Hoozemans, Jeroen J. M.] Vrije Univ Amsterdam, Dept Pathol, Neurosci Campus Amsterdam, Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Scheper, Wiep] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Scheper, Wiep] Vrije Univ Amsterdam, Alzheimer Ctr, Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Scheper, Wiep] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Flynn, Rowan; Cowley, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, James Martin Stem Cell Facil, Oxford OX1 3RE, England; [Haerty, Wilfried] Earlham Inst, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Bassett, Andrew R.] Univ Oxford, Sir William Dunn Sch Pathol, Genome Engn Oxford, Oxford OX1 3RE, England; [Bassett, Andrew R.] Wellcome Trust Res Labs, Human Gene Editing, Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England	Heman-Ackah, SM; Wood, MJA (reprint author), Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.; Heman-Ackah, SM (reprint author), NIH, NIH Oxford Cambridge Scholars Program, Bldg 10, Bethesda, MD 20892 USA.; Heman-Ackah, SM (reprint author), Univ North Carolina Chapel Hill, UNC MD PhD Program, Chapel Hill, NC 27599 USA.; Bassett, AR (reprint author), Univ Oxford, Sir William Dunn Sch Pathol, Genome Engn Oxford, Oxford OX1 3RE, England.; Bassett, AR (reprint author), Wellcome Trust Res Labs, Human Gene Editing, Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	hemanackah.sabrina@gmail.com; ab42@sanger.ac.uk; matthew.wood@dpag.ox.ac.uk			Cure Parkinson's Trust; John Fell OUP Research Fund; Wellcome Trust ISSF; BBSRC; Institute Strategic Programme Grant [BB/J004669/1]; University of North Carolina at Chapel Hill School of Medicine MD-PhD Program; NIH Oxford-Cambridge Scholars Program; ISAO; ZonMW; Alzheimer Nederland; Janssen Pharmaceuticals; Wellcome Trust [WTISSF121302]; Oxford Martin School [LC0910-004]; EU IMI [StemBANCC]; Innovative Medicines Initiative Joint Undertaking [115439]; European Union' Seventh Framework Programme (FP7); EFPIA companies; Departments of Pathology, Biochemistry, DPAG and Pharmacology	Cure Parkinson's Trust and John Fell OUP Research Fund to S.M.H.-A., the John Fell OUP Research Fund to M.J.A.W. Wellcome Trust ISSF and contributions from the Departments of Pathology, Biochemistry, DPAG and Pharmacology. BBSRC, Institute Strategic Programme Grant [BB/J004669/1] (W.H.), University of North Carolina at Chapel Hill School of Medicine MD-PhD Program and NIH Oxford-Cambridge Scholars Program (S.M.H.-A.), ISAO, ZonMW, Alzheimer Nederland, and a Stellar grant from Janssen Pharmaceuticals (W.S.). The James Martin Stem Cell Facility (SAC., R.F.) receives financial support from the Wellcome Trust [WTISSF121302], the Oxford Martin School [LC0910-004] and EU IMI [StemBANCC]; the research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115439, resources of which are composed of financial contribution from the European Union' Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. This publication reflects only the authors' views, and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Castillo-Carranza DL, 2012, NEUROCHEM RES, V37, P1707, DOI 10.1007/s11064-012-0780-7; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1                                                   ; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cruz C, 2001, FEBS LETT, V488, P74, DOI 10.1016/S0014-5793(00)02371-1; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Flierl A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112413; Griffith HR, 2008, ALZHEIMERS DEMENT, V4, P421, DOI 10.1016/j.jalz.2008.04.008; Heman-Ackah SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28420; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lynch-Day M. A., 2012, COLD SPRING HARB PER, V2; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912                                                      ; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Oliveira L. M., 2015, ELEVATED ALPHA SYNUC, V6, pe1994; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyes JF, 2015, NEUROBIOL DIS, V77, P266, DOI 10.1016/j.nbd.2014.07.003; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278                                                         ; Singleton A. C. J., 2007, PARKINSONS DIS GENET, P19; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103	29	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	NOV 15	2017	26	22					4441	4450		10.1093/hmg/ddx331				10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FL7CM	WOS:000414403900012	28973645				2018-01-05	
J	Padhy, B; Hayat, B; Nanda, GG; Mohanty, PP; Alone, DP				Padhy, Biswajit; Hayat, Bushra; Nanda, Gargi Gouranga; Mohanty, Pranjya Paramita; Alone, Debasmita Pankaj			Pseudoexfoliation and Alzheimer's associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression	HUMAN MOLECULAR GENETICS			English	Article							SHOCK TRANSCRIPTION FACTOR-1; EXTRACELLULAR CHAPERONE; GENOME-WIDE; CLUSTERIN; DISEASE; HSF1; CELLS; POLYMORPHISMS; DEFICIENCY; TOXICITY	Genetic variants at PTK2B-CLU locus pose as high-risk factors for many age-related disorders. However, the role of these variants in disease progression is less characterized. In this study, we aimed to investigate the functional significance of a clusterin intronic SNP, rs2279590, that has been associated with pseudoexfoliation, Alzheimer's disease (AD) and diabetes. We have previously shown that the alleles at rs2279590 differentially regulate clusterin (CLU) gene expression in lens capsule tissues. This polymorphism resides in an active regulatory region marked by H3K27Ac and DNase I hypersensitive site and is an eQTL for CLU expression. Here, we report the presence of an enhancer element in surrounding region of rs2279590. Deletion of a 115 bp intronic region flanking the rs2279590 variant through CRISPR-Cas9 genome editing in HEK293 cells demonstrated a decreased clusterin gene expression. Electrophoretic mobility shift and chromatin immunoprecipitation assays show that rs2279590 with allele 'A' constitutes a transcription factor binding site for heat shock factor-1 (HSF1) but not with allele 'G'. By binding to allele 'A', HSF1 abrogates the enhancer effect of the locus as validated by reporter assays. Interestingly, rs2279590 locus has a widespread enhancer effect on two nearby genes, protein tyrosine kinase 2 beta (PTK2B) and epoxide hydrolase-2 (EPHX2); both of which have been previously associated with AD as risk factors. To summarize, our study unveils a mechanistic role of the common variant rs2279590 that can affect a variety of aging disorders by regulating the expression of a specific set of genes.	[Padhy, Biswajit; Hayat, Bushra; Nanda, Gargi Gouranga; Alone, Debasmita Pankaj] NISER Bhubaneswar, Sch Biol Sci, PO Jatni, Khurja 752050, India; [Padhy, Biswajit; Hayat, Bushra; Nanda, Gargi Gouranga; Alone, Debasmita Pankaj] Homi Bhabha Natl Inst, Training Sch Complex, Bombay 400094, Maharashtra, India; [Mohanty, Pranjya Paramita] Cuttack Eye Hosp & Res Inst, JPM Rotary Club, Cuttack 753014, Orissa, India	Alone, DP (reprint author), Natl Inst Sci Educ & Res, Sch Biol Sci, Mol Genet Lab, PO Jatni, Khurja 752050, Odisha, India.	debasmita@niser.ac.in			Council of Scientific and Industrial Research (India) [27(0317)/16/EMR-II]; National Institute of Science Education and Research, Department of Atomic Energy (India)	National Institute of Science Education and Research, Department of Atomic Energy (India); Council of Scientific and Industrial Research (India) Grant no. 27(0317)/16/EMR-II.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Caccamo AE, 2004, BIOCHEM J, V382, P157, DOI 10.1042/BJ20040158                                                              ; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Chapuis J, 2017, ACTA NEUROPATHOL, V133, P955, DOI 10.1007/s00401-016-1652-z; Chen LH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.016; Daimon M, 2011, METABOLISM, V60, P815, DOI 10.1016/j.metabol.2010.07.033; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dourlen P, 2017, MOL PSYCHIATR, V22, P874, DOI 10.1038/mp.2016.59; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Giri M, 2016, CLIN INTERV AGING, V11, P665, DOI 10.2147/CIA.S105769; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Gouras GK, 2013, J NEUROCHEM, V124, P747, DOI 10.1111/jnc.12098; Jiang YQ, 2013, BRAIN RES, V1519, P105, DOI 10.1016/j.brainres.2013.04.059; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Kim EH, 2016, HUM MOL GENET, V25, P211, DOI 10.1093/hmg/ddv445; Kohler C, 2013, NEUROBIOL AGING, V34, P1369, DOI 10.1016/j.neurobiolaging.2012.11.010; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Krumbiegel M, 2009, INVEST OPHTH VIS SCI, V50, P2796, DOI 10.1167/iovs.08-2339; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lechler MC, 2017, CELL REP, V18, P454, DOI 10.1016/j.celrep.2016.12.033; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Ortner V, 2015, CELL STRESS CHAPERON, V20, P277, DOI 10.1007/s12192-014-0540-5; Padhy B, 2014, EXP EYE RES, V127, P69, DOI 10.1016/j.exer.2014.07.005; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Szymanski M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.17; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Wang X, 2014, J NEUROSCI, V34, P7253, DOI 10.1523/JNEUROSCI.4936-13.2014; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Zenkel M, 2006, INVEST OPHTH VIS SCI, V47, P1982, DOI 10.1167/iovs.05-1580; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099665	35	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	NOV 15	2017	26	22					4519	4529		10.1093/hmg/ddx329				11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FL7CM	WOS:000414403900018	28973302				2018-01-05	
J	Inoue, K; Oliveira, LMA; Abeliovich, A				Inoue, Keiichi; Oliveira, Luis M. A.; Abeliovich, Asa			CRISPR Transcriptional Activation Analysis Unmasks an Occult gamma-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts	CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; APP INTRACELLULAR DOMAIN; AMYLOID BETA-PEPTIDES; TAU-TRANSGENIC MICE; A-BETA; PRESENILIN-1 MUTATIONS; MISSENSE MUTATIONS; NEURONS; MECHANISM; GENE	Mutations in presenilin (PSEN) 1 and 2, which encode components of the g-secretase (GS) complex, cause familial Alzheimer's disease (FAD). It is hypothesized that altered GS-mediated processing of the amyloid precursor protein (APP) to the Ab42 fragment, which is accumulated in diseased brain, may be pathogenic. Here, we describe an in vitro model system that enables the facile analysis of neuronal disease mechanisms in non-neuronal patient cells using CRISPR gene activation of endogenous disease-relevant genes. In FAD patient-derived fibroblast cultures, CRISPR activation of APP or BACE unmasked an occult processivity defect in downstream GS-mediated carboxypeptidase cleavage of APP, ultimately leading to higher Ab42 levels. These data suggest that, selectively in neurons, relatively high levels of BACE1 activity lead to substrate pressure on FAD-mutant GS complexes, promoting CNS Ab42 accumulation. Our results introduce an additional platform for analysis of neurological disease.	[Inoue, Keiichi; Oliveira, Luis M. A.; Abeliovich, Asa] Columbia Univ, Med Ctr, Taub Inst, Dept Pathol Cell Biol & Neurol, 650 West 168th St, New York, NY 10032 USA	Inoue, K; Abeliovich, A (reprint author), Columbia Univ, Med Ctr, Taub Inst, Dept Pathol Cell Biol & Neurol, 650 West 168th St, New York, NY 10032 USA.	keiichiinoue@gakushikai.jp; asa.abeliovich@gmail.com		Inoue, Keiichi/0000-0002-7101-486X	NIH grant [4R01AG042317-05]	We thank D. Trono, M. Wernig, R. Jaenisch, and F. Zhang for providing the plasmids. This work was supported by NIH grant 4R01AG042317-05 (to K.I., L.M.A.O., and A.A.). A. A. is a co-founder of and consultant for Alector LLC and Prevail Therapeutics.	Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Connolly GP, 1998, TRENDS PHARMACOL SCI, V19, P171, DOI 10.1016/S0165-6147(98)01202-4; Coutinho MF, 2016, MOL GENET METAB, V117, P53, DOI 10.1016/j.ymgme.2015.08.008; De Strooper B, 2015, ANNU REV PHARMACOL, V55, P419, DOI 10.1146/annurev-pharmtox-010814-124309; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Etcheberrigaray R, 1999, MOL NEUROBIOL, V20, P93, DOI 10.1007/BF02742436                                                              ; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994                                                         ; Heilig EA, 2013, J NEUROSCI, V33, P11606, DOI 10.1523/JNEUROSCI.0954-13.2013; Heilig EA, 2010, J BIOL CHEM, V285, P22350, DOI 10.1074/jbc.M110.116962; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622                                                         ; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li Y, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-59; Mahairaki V, 2014, STEM CELLS DEV, V23, P2996, DOI 10.1089/scd.2013.0511; Moore S, 2015, CELL REP, V11, P689, DOI 10.1016/j.celrep.2015.03.068; Muratore CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105807; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Oliveira LMA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.318; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Parenti G, 2015, ANNU REV MED, V66, P471, DOI 10.1146/annurev-med-122313-085916; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Qiang L, 2014, BIOL PSYCHIAT, V75, P945, DOI 10.1016/j.biopsych.2013.10.027; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0                                                                ; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Watanabe H, 2012, J NEUROSCI, V32, P5085, DOI 10.1523/JNEUROSCI.0317-12.2012; Wines-Samuelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010195; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Xia D, 2016, NEURON, V90, P417, DOI 10.1016/j.neuron.2016.03.009; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	54	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	NOV 14	2017	21	7					1727	1736		10.1016/j.celrep.2017.10.075				10	Cell Biology	Cell Biology	FM5KK	WOS:000415073200003	29141208	gold			2018-01-05	
J	Li, P; Mitra, S; Spolski, R; Oh, J; Liao, W; Tang, ZH; Mo, F; Li, XW; West, EE; Gromer, D; Lin, JX; Liu, CY; Ruan, YJ; Leonard, WJ				Li, Peng; Mitra, Suman; Spolski, Rosanne; Oh, Jangsuk; Liao, Wei; Tang, Zhonghui; Mo, Fei; Li, Xingwang; West, Erin E.; Gromer, Daniel; Lin, Jian-Xin; Liu, Chengyu; Ruan, Yijun; Leonard, Warren J.			STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						superenhancer; STAT5; ChIA-PET; Il2ra gene; IL-2	SEVERE COMBINED IMMUNODEFICIENCY; SUPER-ENHANCER; T-CELLS; TRANSCRIPTION FACTORS; FAMILY CYTOKINES; MOLECULAR-BASIS; GAMMA-CHAIN; RECEPTOR; STAT5; DIFFERENTIATION	Cytokines critically control immune responses, but how regulatory programs are altered to allow T cells to differentially respond to distinct cytokine stimuli remains poorly understood. Here, we have globally analyzed enhancer elements bound by IL-2-activated STAT5 and IL-21-activated STAT3 in T cells and identified Il2ra as the top-ranked gene regulated by an IL-2-activated STAT5-bound superenhancer and one of the top genes regulated by STAT3-bound superenhancers. Moreover, we found that STAT5 binding was rapidly superenriched at genes highly induced by IL-2 and that IL-2-activated STAT5 binding induces new and augmented chromatin interactions within superenhancer-containing genes. Based on chromatin interaction analysis by paired-end tag (ChIA-PET) sequencing data, we used CRISPR-Cas9 gene editing to target three of the STAT5 binding sites within the Il2ra superenhancer in mice. Each mutation decreased STAT5 binding and altered IL-2-induced Il2ra gene expression, revealing that individual elements within the superenhancer were not functionally redundant and that all were required for normal gene expression. Thus, we demonstrate cooperative utilization of superenhancer elements to optimize gene expression and show that STAT5 mediates IL-2-induced chromatin looping at superenhancers to preferentially regulate highly inducible genes, thereby providing new insights into the mechanisms underlying cytokine-dependent superenhancer function.	[Li, Peng; Mitra, Suman; Spolski, Rosanne; Oh, Jangsuk; Liao, Wei; Mo, Fei; West, Erin E.; Gromer, Daniel; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Lab Mol Immunol, Bethesda, MD 20892 USA; [Li, Peng; Mitra, Suman; Spolski, Rosanne; Oh, Jangsuk; Liao, Wei; Mo, Fei; West, Erin E.; Gromer, Daniel; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Immunol Ctr, NIH, Bethesda, MD 20892 USA; [Tang, Zhonghui; Li, Xingwang; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Farmington, CT 06030 USA; [Tang, Zhonghui; Mo, Fei; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Gromer, Daniel] NIH, Med Res Scholars Program, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, Bethesda, MD 20892 USA; [Mitra, Suman] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Inflammatory & Autoimmune Dis, S-43183 Gothenburg, Sweden; [Gromer, Daniel] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Li, P; Leonard, WJ (reprint author), NHLBI, Lab Mol Immunol, Bethesda, MD 20892 USA.; Li, P; Leonard, WJ (reprint author), NHLBI, Immunol Ctr, NIH, Bethesda, MD 20892 USA.	lip3@nhbli.nih.gov; wjl@helix.nih.gov			Division of Intramural Research and Transgenic Core at the NHLBI; Jackson Laboratory for Genomic Medicine	This work was supported by the Division of Intramural Research and Transgenic Core at the NHLBI and the Jackson Laboratory for Genomic Medicine.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747                                                       ; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; John S, 1999, MOL CELL BIOL, V19, P1910; John S, 1996, EMBO J, V15, P5627; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lecine P, 1996, MOL CELL BIOL, V16, P6829; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Leonard WJ, 1996, ANNU REV MED, V47, P229; LEONARD WJ, 1994, IMMUNOL REV, V138, P61, DOI 10.1111/j.1600-065X.1994.tb00847.x; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293                                                ; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1                                                   ; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221                                                         ; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	0	0	3	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 14	2017	114	46					12111	12119		10.1073/pnas.1714019114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM6OL	WOS:000415173300041	29078395				2018-01-05	
J	Jeon, S; Lim, JM; Lee, HG; Shin, SE; Kang, NK; Park, YI; Oh, HM; Jeong, WJ; Jeong, BR; Chang, YK				Jeon, Seungjib; Lim, Jong-Min; Lee, Hyung-Gwan; Shin, Sung-Eun; Kang, Nam Kyu; Park, Youn-Il; Oh, Hee-Mock; Jeong, Won-Joong; Jeong, Byeong-ryool; Chang, Yong Keun			Current status and perspectives of genome editing technology for microalgae	BIOTECHNOLOGY FOR BIOFUELS			English	Review						Genetic engineering; Microalgae; Genome editing; CRISPR/Cas9; Biofuels; GMO conflicts	ZINC-FINGER NUCLEASES; DOMINANT SELECTABLE MARKER; AGROBACTERIUM-MEDIATED TRANSFORMATION; DIATOM PHAEODACTYLUM-TRICORNUTUM; ALGA CHLAMYDOMONAS-REINHARDTII; HIGH-VELOCITY MICROPROJECTILES; NITRATE REDUCTASE GENE; CRISPR-CAS SYSTEM; GREEN-ALGA; KNOCK-IN	Genome editing techniques are critical for manipulating genes not only to investigate their functions in biology but also to improve traits for genetic engineering in biotechnology. Genome editing has been greatly facilitated by engineered nucleases, dubbed molecular scissors, including zinc-finger nuclease (ZFN), TAL effector endonuclease (TALEN) and clustered regularly interspaced palindromic sequences (CRISPR)/Cas9. In particular, CRISPR/Cas9 has revolutionized genome editing fields with its simplicity, efficiency and accuracy compared to previous nucleases. CRISPR/Cas9-induced genome editing is being used in numerous organisms including microalgae. Microalgae have been subjected to extensive genetic and biological engineering due to their great potential as sustainable biofuel and chemical feedstocks. However, progress in microalgal engineering is slow mainly due to a lack of a proper transformation toolbox, and the same problem also applies to genome editing techniques. Given these problems, there are a few reports on successful genome editing in microalgae. It is, thus, time to consider the problems and solutions of genome editing in microalgae as well as further applications of this exciting technology for other scientific and engineering purposes.	[Jeon, Seungjib; Kang, Nam Kyu; Jeong, Byeong-ryool; Chang, Yong Keun] Adv Biomass Res & Dev Ctr ABC, 291 Daehak Ro, Daejeon 34141, South Korea; [Jeon, Seungjib; Jeong, Byeong-ryool; Chang, Yong Keun] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, 291 Daehak Ro, Daejeon 34141, South Korea; [Lim, Jong-Min; Jeong, Won-Joong] KRIBB, Plant Syst Engn Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Lee, Hyung-Gwan; Oh, Hee-Mock] KRIBB, Cell Factory Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Shin, Sung-Eun] LG Chem, 188 Munji Ro, Daejeon 34122, South Korea; [Park, Youn-Il] Chungnam Natl Univ, Dept Biol Sci, Daejeon 34134, South Korea	Jeong, BR; Chang, YK (reprint author), Adv Biomass Res & Dev Ctr ABC, 291 Daehak Ro, Daejeon 34141, South Korea.; Jeong, BR; Chang, YK (reprint author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	bjeong@kaist.ac.kr; changyk@kaist.ac.kr		Jeong, Byeong-ryool/0000-0003-0642-1650	Advanced Biomass R&D Center (ABC) - Ministry of Science, ICT and Future Planning [ABC-2011-0031350, ABC-2010-0029728, ABC-2011-0031343, ABC-2010-0029723, NRF-2015M3A6A2065747]	This work was supported by the Advanced Biomass R&D Center (ABC) of Global Frontier Project funded by the Ministry of Science, ICT and Future Planning (ABC-2011-0031350, ABC-2010-0029728, ABC-2011-0031343, ABC-2010-0029723 and NRF-2015M3A6A2065747).	Ajjawi I, 2017, NAT BIOTECHNOL, V35, P647, DOI 10.1038/nbt.3865; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Arnold AA, 2015, BBA-BIOMEMBRANES, V1848, P369, DOI 10.1016/j.bbamem.2014.07.017; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Bedell VM, NATURE; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bibikova M, 2002, GENETICS, V161, P1169; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bortesi L, 2016, PLANT BIOTECHNOL J, V14, P2203, DOI 10.1111/pbi.12634; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Casas-Mollano JA, 2008, P NATL ACAD SCI USA, V105, P6486, DOI 10.1073/pnas.0711310105; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925                                                             ; Cerutti H, 1997, GENETICS, V145, P97; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Chang K., 2017, NY TIMES, pD1; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Choi KR, BIOTECHNOL ADV; Chow KC, 1999, PLANT CELL REP, V18, P778, DOI 10.1007/s002990050660                                                           ; Cohen J, 2017, SCIENCE, V355, P786, DOI 10.1126/science.355.6327.786; Cohen J, 2017, SCIENCE, V355, P680, DOI 10.1126/science.355.6326.680; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; Dawson HN, 1997, CURR MICROBIOL, V35, P356, DOI 10.1007/s002849900268; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; DEBUCHY R, 1989, EMBO J, V8, P2803; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; [Anonymous], 2017, Nature, V542, P392, DOI 10.1038/542392a; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng YX, 2014, SCI REP-UK, V4, DOI 10.1038/srep03632; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; FERRIS PJ, 1995, GENETICS, V141, P543; Finer JJ, 2010, BIOTECH AGR FOREST, V64, P3, DOI 10.1007/978-3-642-02391-0_1; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geng DG, 2004, ACTA BOT SIN, V46, P342; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Guha Tuhin Kumar, 2017, Comput Struct Biotechnol J, V15, P146, DOI 10.1016/j.csbj.2016.12.006; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023                                                         ; Hammond SM, 2000, NATURE, V404, P293; Hawkins RL, 1999, CURR MICROBIOL, V38, P335, DOI 10.1007/PL00006813                                                              ; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Hirakawa Y, 2014, GENOME BIOL EVOL, V6, P974, DOI 10.1093/gbe/evu071; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jeon S, 2017, HDB HYDROCARBON LIPI, P1; Jeong BR, 2002, P NATL ACAD SCI USA, V99, P1076, DOI 10.1073/pnas.022392999; Jiang F, 2017, ANN REV BIO IN PRESS; Jiang WZ, 2017, PLANT BIOTECHNOL J, V15, P648, DOI 10.1111/pbi.12663; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang NK, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0386-9; Kao PH, 2017, BIORESOURCE TECHNOL, V245, P1527, DOI 10.1016/j.biortech.2017.04.111; Karas BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7925; Kathiresan S, 2015, J BIOTECHNOL, V196, P33, DOI 10.1016/j.jbiotec.2015.01.006; Kathiresan S, 2009, J PHYCOL, V45, P642, DOI 10.1111/j.1529-8817.2009.00688.x; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim DH, 2002, MAR BIOTECHNOL, V4, P63, DOI 10.1007/s1012601-0070-x; KIM E, 2017, NAT COMMUN, V8; Kim EJ, 2015, BIORESOURCE TECHNOL, V184, P23, DOI 10.1016/j.biortech.2014.10.119; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim J, 2016, NAT BIOTECHNOL, V34, P1014, DOI 10.1038/nbt.3680; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kovar JL, 2002, PLANT J, V29, P109, DOI 10.1046/j.1365-313x.2002.01193.x                                                ; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; La Russa MF, 2015, MOL CELL BIOL, V35, P3800, DOI 10.1128/MCB.00512-15; Lambowitz A. M., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003616; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; LAZZERI PA, 1991, THEOR APPL GENET, V81, P437, DOI 10.1007/BF00219433; Ledford H, 2017, NATURE, V542, P401, DOI 10.1038/nature.2017.21502; LEE KY, 1990, PLANT CELL, V2, P415; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Levasseur A, 2016, NATURE, V531, P249, DOI 10.1038/nature17146; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2014, APPL MICROBIOL BIOT, V98, P5069, DOI 10.1007/s00253-014-5593-y; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N                   ; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masani MYA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096831; Mathur J, 1998, METH MOL B, V82, P267; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; MAYFIELD SP, 1990, P NATL ACAD SCI USA, V87, P2087, DOI 10.1073/pnas.87.6.2087; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nam Kyu Kang, 2015, Biotechnology Reports, V8, P10, DOI 10.1016/j.btre.2015.08.004; NATHANS D, 1975, ANNU REV BIOCHEM, V44, P273, DOI 10.1146/annurev.bi.44.070175.001421                                             ; NELSON JAE, 1995, MOL CELL BIOL, V15, P5762; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011                                                           ; NICOLSON MO, 1972, VIROLOGY, V48, P14, DOI 10.1016/0042-6822(72)90109-2; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Niu YF, 2011, GENET MOL RES, V10, P3427, DOI 10.4238/2011.October.21.1; Nymark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24951; Ohnuma M, 2009, PROTOPLASMA, V236, P107, DOI 10.1007/s00709-009-0056-5; Pan K, 2011, J PHYCOL, V47, P1425, DOI 10.1111/j.1529-8817.2011.01057.x; Pavlovic G, 2016, TRANSGENIC RES, V25, P254; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Puchta H, 2013, INT J DEV BIOL, V57, P629, DOI 10.1387/ijdb.130194hp; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radakovits R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3356; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Salsman J, 2017, BIOCHEM CELL BIOL, V95, P187, DOI 10.1139/bcb-2016-0137; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Seol J. H., 2017, MUTAT RES, DOI [10.1016/j.mrfmmm.2017.07.002, DOI 10.1016/J.MRFMMM.2017.07.002]; Seth K, 2016, BIOCHEM BIOPH RES CO, V480, P499, DOI 10.1016/j.bbrc.2016.10.130; SHIMAMOTO K, 1989, NATURE, V338, P274, DOI 10.1038/338274a0                                                                ; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Singh J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000216; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3                                                   ; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; SONG YN, 2017, SCI REP UK, V7; Steinbrenner J, 2006, APPL ENVIRON MICROB, V72, P7477, DOI 10.1128/AEM.01461-06; Stevens DR, 1996, MOL GEN GENET, V251, P23; SUGISAKI H, 1981, GENE, V16, P73; Sun GH, 2008, MAR BIOTECHNOL, V10, P219, DOI 10.1007/s10126-007-9056-7; Sun Y, 2005, MOL BIOTECHNOL, V30, P185, DOI 10.1385/MB:30:3:185; Sun Y, 2006, GENE, V377, P140, DOI 10.1016/j.gene.2006.03.018; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Talebi AF, 2014, BIOFUEL RES J, V1, P91, DOI 10.18331/brj2015.1.3.6; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Tuggle CK, 2015, P NATL ACAD SCI USA, V112, P3854, DOI 10.1073/pnas.1502972112; Ungerer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39681; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang QT, 2016, PLANT J, V88, P1071, DOI 10.1111/tpj.13307; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Wijshake T, 2014, BBA-MOL BASIS DIS, V1842, P1942, DOI 10.1016/j.bbadis.2014.04.020; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Wu JZ, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0349-2; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159                                                   ; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Xu SY, 2013, NUCLEIC ACIDS RES, V41, P378, DOI 10.1093/nar/gks1043; Yamasaki T, 2016, PLANT J, V85, P258, DOI 10.1111/tpj.13107; Yang B, 2015, ALGAL RES, V12, P134, DOI 10.1016/j.algal.2015.08.012; Zaidi SSEA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01673; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang CM, 2002, PLANT J, V31, P25, DOI 10.1046/j.1365-313X.2002.01331.x; Zhang DW, 2017, MECH DEVELOP, V143, P42, DOI 10.1016/j.mod.2017.01.004; Zhang JH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0128-4; ZHANG K, 2017, FRONT PLANT SCI, V8; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	189	0	0	40	40	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-6834			BIOTECHNOL BIOFUELS	Biotechnol. Biofuels	NOV 14	2017	10								267	10.1186/s13068-017-0957-z				18	Biotechnology & Applied Microbiology; Energy & Fuels	Biotechnology & Applied Microbiology; Energy & Fuels	FM5GW	WOS:000415061800001	29163669	gold			2018-01-05	
J	Boesze-Battaglia, K; Walker, LP; Dhingra, A; Kandror, K; Tang, HY; Shenker, BJ				Boesze-Battaglia, Kathleen; Walker, Lisa P.; Dhingra, Anuradha; Kandror, Konstantin; Tang, Hsin-Yao; Shenker, Bruce J.			Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY			English	Article						lymphocytes; toxin; cytolethal distending toxin; Aggregatibacter actinomycetemcomitans; pathogenesis; cell cycle arrest; apoptosis	HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; CYCLE ARREST; BACTERIAL TOXINS; G(2) ARREST; PHOSPHATIDYLINOSITOL-3,4,5-TRIPHOSPHATE PHOSPHATASE; MEMBRANE TRAFFICKING; LIPID RAFTS; DNA-DAMAGE; PC12 CELLS	The Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is a heterotrimeric AB(2) toxin capable of inducing lymphocytes, and other cell types, to undergo cell cycle arrest and apoptosis. Exposure to Cdt results in binding to the cell surface followed by internalization and translocation of the active subunit, CdtB, to intracellular compartments. These events are dependent upon toxin binding to cholesterol in the context of lipid rich membrane microdomains often referred to as lipid rafts. We now demonstrate that, in addition to binding to the plasma membrane of lymphocytes, another early and critical event initiated by Cdt is the translocation of the host cell protein, cellugyrin (synaptogyrin-2) to the same cholesterol-rich microdomains. Furthermore, we demonstrate that cellugyrin is an intracellular binding partner for CdtB as demonstrated by immunoprecipitation. Using CRISPR/cas9 gene editing we established a Jurkat cell line deficient in cellugyrin expression (Jurkat(Cg-)); these cells were capable of binding Cdt, but unable to internalize CdtB. Furthermore, Jurkat(Cg-) cells were not susceptible to Cdt-induced toxicity; these cells failed to exhibit blockade of the PI-3K signaling pathway, cell cycle arrest or cell death. We propose that cellugyrin plays a critical role in the internalization and translocation of CdtB to critical intracellular target sites. These studies provide critical new insight into the mechanism by which Cdt, and in particular, CdtB is able to induce toxicity.	[Boesze-Battaglia, Kathleen; Dhingra, Anuradha] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Walker, Lisa P.; Shenker, Bruce J.] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Kandror, Konstantin] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Tang, Hsin-Yao] Wistar Inst Anat & Biol, Wistar Prote & Metabol Core Facil, 3601 Spruce St, Philadelphia, PA 19104 USA	Shenker, BJ (reprint author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	shenker@upenn.edu			National Institutes of Health [DE06014, DE023071]	This work was supported by the National Institutes of Health grants DE06014 and DE023071.	Ahnert-Hilger G, 2013, CURR TOP MICROBIOL, V364, P159, DOI 10.1007/978-3-642-33570-9_8; Backert S, 2017, TOXINS, V9, DOI 10.3390/toxins9040115; Belfort GM, 2005, J BIOL CHEM, V280, P7262, DOI 10.1074/jbc.M404851200; Belfort GM, 2003, J BIOL CHEM, V278, P47971, DOI 10.1074/jbc.M304174200; Bielaszewska M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006159; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Boesze-Battaglia Kathleen, 2006, V332, P169; Boesze-Battaglia K, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00081; Boesze-Battaglia K, 2015, INFECT IMMUN, V83, P4042, DOI 10.1128/IAI.00788-15; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Cortes-Bratti X, 2001, TOXICON, V39, P1729, DOI 10.1016/S0041-0101(01)00159-3; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000                                                ; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Rycke J, 2001, FEMS MICROBIOL LETT, V203, P141, DOI 10.1016/S0378-1097(01)00344-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson DS, 2009, ADV EXP MED BIOL, V666, P1; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Eshraghi A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004295; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Frisan T, 2002, INT J MED MICROBIOL, V291, P495; Gargi A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00124; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172; Guerra L, 2009, BBA-MOL CELL RES, V1793, P489, DOI 10.1016/j.bbamcr.2008.11.017; Guidi R, 2013, CELL MICROBIOL, V15, P2034, DOI 10.1111/cmi.12172; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Hubner K, 2002, INT REV CYTOL, V214, P103; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; Kim JY, 2012, MOL BIOL CELL, V23, P910, DOI 10.1091/mbc.E11-10-0839; Kioumourtzoglou D, 2015, J CELL SCI, V128, P2423, DOI 10.1242/jcs.166561; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066202; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lebrun I, 2009, MINI-REV MED CHEM, V9, P820, DOI 10.2174/138955709788452603                                                      ; Medina-Kauwe LK, 2007, ADV DRUG DELIVER REV, V59, P798, DOI 10.1016/j.addr.2007.06.009; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Orrell KE, 2017, CRIT REV BIOCHEM MOL, V52, P461, DOI 10.1080/10409238.2017.1325831; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Personnic N, 2016, TRENDS MICROBIOL, V24, P450, DOI 10.1016/j.tim.2016.02.003; Reyes-Reveles J, 2017, J BIOL CHEM, V292, P8038, DOI 10.1074/jbc.M116.770784; Scuron MD, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2015.00168; Shenker BJ, 2016, MOL ORAL MICROBIOL, V31, P33, DOI 10.1111/omi.12127; SHENKER BJ, 1982, J IMMUNOL, V128, P148; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228                                                     ; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410                                                      ; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435                                                      ; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612                                                     ; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099                                                     ; Shenker BJ, 2016, CELL MICROBIOL, V18, P223, DOI 10.1111/cmi.12497; Shenker BJ, 2015, INFECT IMMUN, V83, P1487, DOI 10.1128/IAI.03132-14; Shenker BJ, 2014, CELL MICROBIOL, V16, P1391, DOI 10.1111/cmi.12299; Shenker BJ, 2010, MOL IMMUNOL, V48, P203, DOI 10.1016/j.molimm.2010.08.009; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sun QY, 2016, J BIOL CHEM, V291, P16138, DOI 10.1074/jbc.M116.715599; Swanson JA, 2014, CELL MICROBIOL, V16, P1473, DOI 10.1111/cmi.12334; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Xu Z, 2006, MOL ENDOCRINOL, V20, P2890, DOI 10.1210/me.2006-0193; Zhou MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032580	67	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2235-2988			FRONT CELL INFECT MI	Front. Cell. Infect. Microbiol.	NOV 14	2017	7								469	10.3389/fcimb.2017.00469				14	Immunology; Microbiology	Immunology; Microbiology	FM5GN	WOS:000415060700001	29184850	gold			2018-01-05	
J	Peng, F; Wang, XY; Sun, Y; Dong, GB; Yang, YK; Liu, XX; Bai, ZG				Peng, Feng; Wang, Xinyue; Sun, Yang; Dong, Guibin; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu			Efficient gene editing in Corynebacterium glutamicum using the CRISPR/Cas9 system	MICROBIAL CELL FACTORIES			English	Article						CRISPR/Cas9; Corynebacterium glutamicum; Genome editing; Protein expression	ESCHERICHIA-COLI; INTERFERENCE CRISPRI; DELETION SYSTEM; PLATFORM STRAIN; EXPRESSION; CONSTRUCTION; CELLS; PROTEINS; VECTORS; GENOMES	Background: Corynebacterium glutamicum (C. glutamicum) has traditionally been used as a microbial cell factory for the industrial production of many amino acids and other industrially important commodities. C. glutamicum has recently been established as a host for recombinant protein expression; however, some intrinsic disadvantages could be improved by genetic modification. Gene editing techniques, such as deletion, insertion, or replacement, are important tools for modifying chromosomes. Results: In this research, we report a CRISPR/Cas9 system in C. glutamicum for rapid and efficient genome editing, including gene deletion and insertion. The system consists of two plasmids: one containing a target-specific guide RNA and a homologous sequence to a target gene, the other expressing Cas9 protein. With high efficiency (up to 100%), this system was used to disrupt the porB, mepA, clpX and Ncgl0911 genes, which affect the ability to express proteins. The porB-and mepA-deletion strains had enhanced expression of green fluorescent protein, compared with the wild-type stain. This system can also be used to engineer point mutations and gene insertions. Conclusions: In this study, we adapted the CRISPR/Cas9 system from S. pyogens to gene deletion, point mutations and insertion in C. glutamicum. Compared with published genome modification methods, methods based on the CRISPR/Cas9 system can rapidly and efficiently achieve genome editing. Our research provides a powerful tool for facilitating the study of gene function, metabolic pathways, and enhanced productivity in C. glutamicum.	[Peng, Feng; Wang, Xinyue; Sun, Yang; Dong, Guibin; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Peoples R China; [Peng, Feng; Wang, Xinyue; Sun, Yang; Dong, Guibin; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi 214122, Peoples R China; [Peng, Feng; Wang, Xinyue; Sun, Yang; Dong, Guibin; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Peoples R China	Liu, XX; Bai, ZG (reprint author), Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Peoples R China.	liuxiuxia@jiangnan.edu.cn; baizhonghu@jiangnan.edu.cn		Yang, Yankun/0000-0003-4815-6832	National Basic Research Program of China (973 Program) [2013CB733602]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province [BK20150148]; Research Innovation Program for College Graduates of Jiangsu Province [KYLX16-0808]; Jiangsu Science and Technology [BK20131181]	This study was funded by the National Basic Research Program of China (973 Program) (Grant Number 2013CB733602), and the 111 Project (No. 111-2-06), a project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Natural Science Foundation of Jiangsu Province (Grant Number BK20150148). This paper was supported by Research Innovation Program for College Graduates of Jiangsu Province (KYLX16-0808) and Jiangsu Science and Technology under Grant BK20131181.	Baumgart M, 2013, APPL ENVIRON MICROB, V79, P6006, DOI 10.1128/AEM.01634-13; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bott M, 2012, APPL MICROBIOL BIOT, V94, P1131, DOI 10.1007/s00253-012-4060-x; Chen WH, 2017, J AM CHEM SOC, V139, P3790, DOI 10.1021/jacs.6b13317; Choi JW, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0401-7; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dong ZQ, 2016, ANTIVIR RES, V130, P50, DOI 10.1016/j.antiviral.2016.03.009; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JY, 2013, PLASMID, V70, P303, DOI 10.1016/j.plasmid.2013.07.001; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; Jakoby M, 1999, BIOTECHNOL TECH, V13, P437, DOI 10.1023/A:1008968419217                                                         ; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Kallscheuer N, 2016, METAB ENG, V38, P47, DOI 10.1016/j.ymben.2016.06.003; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lemay ML, 2017, ACS SYNTH BIOL, V6, P1351, DOI 10.1021/acssynbio.6b00388; Liu XX, 2016, CRIT REV BIOTECHNOL, V36, P652, DOI 10.3109/07388551.2015.1004519; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Nesvera J, 2011, APPL MICROBIOL BIOT, V90, P1641, DOI 10.1007/s00253-011-3272-9; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shin KC, 2016, J AGR FOOD CHEM, V64, P8146, DOI 10.1021/acs.jafc.6b03588; Srivastava P, 2005, PROTEIN EXPRES PURIF, V40, P221, DOI 10.1016/j.pep.2004.06.017; Sun Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167156; Suzuki N, 2005, APPL MICROBIOL BIOT, V67, P225, DOI 10.1007/s00253-004-1772-6; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Trentini DB, 2016, NATURE, V539, P48, DOI 10.1038/nature20122; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Yim SS, 2014, APPL MICROBIOL BIOT, V98, P273, DOI 10.1007/s00253-013-5315-x; Zerbini F, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0681-1; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943; Zhao DD, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0605-5	42	0	0	13	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	NOV 14	2017	16								201	10.1186/s12934-017-0814-6				13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FM7NN	WOS:000415265500005	29137643	gold			2018-01-05	
J	Dale, J; James, A; Paul, JY; Khanna, H; Smith, M; Peraza-Echeverria, S; Garcia-Bastidas, F; Kema, G; Waterhouse, P; Mengersen, K; Harding, R				Dale, James; James, Anthony; Paul, Jean-Yves; Khanna, Harjeet; Smith, Mark; Peraza-Echeverria, Santy; Garcia-Bastidas, Fernando; Kema, Gert; Waterhouse, Peter; Mengersen, Kerrie; Harding, Robert			Transgenic Cavendish bananas with resistance to Fusarium wilt tropical race 4	NATURE COMMUNICATIONS			English	Article							F-SP CUBENSE; NUCLEOTIDE-BINDING; MUSA SPP.; DISEASE; GENES; AAA	Banana (Musa spp.) is a staple food for more than 400 million people. Over 40% of world production and virtually all the export trade is based on Cavendish banana. However, Cavendish banana is under threat from a virulent fungus, Fusarium oxysporum f. sp. cubense tropical race 4 (TR4) for which no acceptable resistant replacement has been identified. Here we report the identification of transgenic Cavendish with resistance to TR4. In our 3-year field trial, two lines of transgenic Cavendish, one transformed with RGA2, a gene isolated from a TR4-resistant diploid banana, and the other with a nematode-derived gene, Ced9, remain disease free. Transgene expression in the RGA2 lines is strongly correlated with resistance. Endogenous RGA2 homologs are also present in Cavendish but are expressed tenfold lower than that in our most resistant transgenic line. The expression of these homologs can potentially be elevated through gene editing, to provide non-transgenic resistance.	[Dale, James; James, Anthony; Paul, Jean-Yves; Khanna, Harjeet; Peraza-Echeverria, Santy; Waterhouse, Peter; Harding, Robert] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia; [Smith, Mark] Darwin Banana Farming Co, Lambells Lagoon, NT 0822, Australia; [Garcia-Bastidas, Fernando; Kema, Gert] Wageningen Univ & Res Ctr, Plant Res Int, NL-6700 Wageningen, Netherlands; [Mengersen, Kerrie] Queensland Univ Technol, Sci & Engn Fac, Brisbane, Qld 4001, Australia; [Khanna, Harjeet] Sugar Res Australia, Indooroopilly, Qld 4068, Australia; [Peraza-Echeverria, Santy] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida 97205, Yucatan, Mexico	Dale, J (reprint author), Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia.	j.dale@qut.edu.au	Khanna, Harjeet/I-9938-2012	Khanna, Harjeet/0000-0001-6094-0924	Australian Research Council; LaManna Group	This research was supported by an Australian Research Council Linkage Grant with the LaManna Group as the industry partner. We thank Martin Dickman (Texas A&M University) for providing the original Ced9 sequence.	Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Garcia-Bastidas F, 2014, PLANT DIS, V98, P694, DOI 10.1094/PDIS-09-13-0954-PDN; Ghag SB, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu037; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; James AP, 2011, PLANT DIS, V95, P57, DOI 10.1094/PDIS-07-10-0519; Joobeur T, 2004, PLANT J, V39, P283, DOI 10.1111/j.1365-313X.2004.02134.x; Karangwa P, 2016, CROP PROT, V84, P132, DOI 10.1016/j.cropro.2016.03.003; Khanna H, 2004, MOL BREEDING, V14, P239, DOI 10.1023/B:MOLB.0000047771.34186.e8; Leslie JF, 2006, FUSARIUM LAB MANUAL; Ori N, 1997, PLANT CELL, V9, P521; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Peraza-Echeverria S, 2008, MOL BREEDING, V22, P565, DOI 10.1007/s11032-008-9199-x; Peraza-Echeverria S, 2009, MOL BREEDING, V23, P431, DOI 10.1007/s11032-008-9247-6; Peraza-Echeverria S, 2007, THESIS; Ploetz RC, 2015, ANNU REV PHYTOPATHOL, V53, P269, DOI 10.1146/annurev-phyto-080614-120305; Ploetz RC, 2015, CROP PROT, V73, P7, DOI 10.1016/j.cropro.2015.01.007; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI DOI 10.1007/978-3-642-59524-0_3; Sambrook J, 2001, MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith MK, 2006, AUST J EXP AGR, V46, P107, DOI 10.1071/EA04175; Stover R. H., 1962, FUSARIAL WILT PANAMA; Valderrama-Chairez ML, 2002, PLANT MOL BIOL REP, V20, P279, DOI 10.1007/BF02782463                                                              ; Walduck G., 2007, IDENTIFICATION BANAN	25	0	0	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 14	2017	8								1496	10.1038/s41467-017-01670-6				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FM5ZU	WOS:000415124000023	29133817	gold			2018-01-05	
J	Arias-Fuenzalida, J; Jarazo, J; Qing, XB; Walter, J; Gomez-Giro, G; Nickels, SL; Zaehres, H; Scholer, HR; Schwamborn, JC				Arias-Fuenzalida, Jonathan; Jarazo, Javier; Qing, Xiaobing; Walter, Jonas; Gomez-Giro, Gemma; Nickels, Sarah Louise; Zaehres, Holm; Schoeler, Hans Robert; Schwamborn, Jens Christian			FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling	STEM CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; PIGGYBAC TRANSPOSASE; MUTATIONS; GENERATION	Genome editing and human induced pluripotent stem cells hold great promise for the development of isogenic disease models and the correction of disease-associated mutations for isogenic tissue therapy. CRISPR-Cas9 has emerged as a versatile and simple tool for engineering human cells for such purposes. However, the current protocols to derive genome-edited lines require the screening of a great number of clones to obtain one free of random integration or on-locus non-homologous end joining (NHEJ)-containing alleles. Here, we describe an efficient method to derive biallelic genome-edited populations by the use of fluorescent markers. We call this technique FACS-assisted CRISPR-Cas9 editing (FACE). FACE allows the derivation of correctly edited polyclones carrying a positive selection fluorescent module and the exclusion of non-edited, random integrations and on-target allele NHEJ-containing cells. We derived a set of isogenic lines containing Parkinson's-disease-associated mutations in a-synuclein and present their comparative phenotypes.	[Arias-Fuenzalida, Jonathan; Jarazo, Javier; Qing, Xiaobing; Walter, Jonas; Gomez-Giro, Gemma; Nickels, Sarah Louise; Schwamborn, Jens Christian] Univ Luxembourg, Dev & Cellular Biol, LCSB, 7 Ave Hauts Fourneaux, L-4362 Luxembourg, Luxembourg; [Arias-Fuenzalida, Jonathan] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Nickels, Sarah Louise] Univ Luxembourg, LSRU, Syst Biol, 6 Ave Swing, L-4367 Luxembourg, Luxembourg; [Gomez-Giro, Gemma; Zaehres, Holm; Schoeler, Hans Robert] Max Planck Inst Mol Biomed, Lab Cell & Dev Biol, Roentgenstr 20, Munster, Germany; [Zaehres, Holm] Ruhr Univ Bochum, Med Fac, Dept Anat & Mol Embryol, D-44801 Bochum, Germany; [Schoeler, Hans Robert] Westphalian Wilhelms Univ Muenster, Med Fac, D-48149 Munster, Germany	Schwamborn, JC (reprint author), Univ Luxembourg, Dev & Cellular Biol, LCSB, 7 Ave Hauts Fourneaux, L-4362 Luxembourg, Luxembourg.	jens.schwamborn@uni.lu			LCSB Pluripotent Stem Cell Core Facility; FNR (AFR, Aides a la Formation-Recherche); NCL-Stiftung; Pelican award from the Fondation du Pelican de Mie et Pierre Hippert-Faber; EU Joint Programme-Neurodegenerative Disease Research (JPND) project [INTER/JPND/14/02, INTER/JPND/15/11092422]; European Union's Horizon Research and Innovation Program [668738]	We would like to thank Prof. F. Zhang from the McGovern Institute for Brain Research for providing the Cas9 vector. We acknowledge G. Preciat for valuable feedback on optimization. We acknowledge Prof. J. Hejna, E. Berger, and S. Bolognin for their valuable comments on the manuscript. This project was supported by the LCSB Pluripotent Stem Cell Core Facility. J. J., J.W., and X.Q. were supported by fellowships from the FNR (AFR, Aides a la Formation-Recherche). G. G.-G. was supported by NCL-Stiftung. J.J. is supported by a Pelican award from the Fondation du Pelican de Mie et Pierre Hippert-Faber. This is an EU Joint Programme-Neurodegenerative Disease Research (JPND) project (INTER/JPND/14/02; INTER/JPND/15/11092422). Further support comes from the SysMedPD project, which has received funding from the European Union's Horizon 2020 Research and Innovation Program under grant agreement no. 668738. Jens Schwamborn is founder, CSO, and shareholder of Braingineering Technologies Sarl. J.C.S., J.A.F., J.J., and X.Q. are inventors on the patent (LU92964).	Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bozi M, 2014, EUR J NEUROL, V21, P963, DOI 10.1111/ene.12315; CALIGIORE D, 2016, NPJ PARKINSONS DIS, V2; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; EGGENSCHWILER R, 2016, SCI REP, V6; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001                                                 ; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586                                                          ; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Ishihara-Paul L, 2008, NEUROLOGY, V71, P896, DOI 10.1212/01.wnl.0000323812.40708.1f; Ishii A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108236; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Tsai SQ, 2014, CELL STEM CELL, V15, P3, DOI 10.1016/j.stem.2014.06.017; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	28	0	0	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	NOV 14	2017	9	5					1423	1431		10.1016/j.stemcr.2017.08.026				9	Cell & Tissue Engineering; Cell Biology	Cell Biology	FM6DL	WOS:000415139400009	28988985	gold			2018-01-05	
J	Chen, ZW; Nie, HS; Wang, YM; Pei, HL; Li, SS; Zhang, LD; Hua, JP				Chen, Zhiwen; Nie, Hushuai; Wang, Yumei; Pei, Haili; Li, Shuangshuang; Zhang, Lida; Hua, Jinping			Rapid evolutionary divergence of diploid and allotetraploid Gossypium mitochondrial genomes	BMC GENOMICS			English	Article						Mitochondrial genomes; Comparative genomics; Multiple DNA rearrangement; Unique segments; Repeat sequences; Gossypium	CYTOPLASMIC MALE-STERILITY; COTTON GOSSYPIUM; ARABIDOPSIS-THALIANA; HORIZONTAL TRANSFER; PLANT-MITOCHONDRIA; REPAIR MECHANISMS; PROVIDES INSIGHTS; GENE CONTENT; SEQUENCE; DNA	Background: Cotton (Gossypium spp.) is commonly grouped into eight diploid genomic groups and an allotetraploid genomic group, AD. The mitochondrial genomes supply new information to understand both the evolution process and the mechanism of cytoplasmic male sterility. Based on previously released mitochondrial genomes of G. hirsutum (AD(1)), G. barbadense (AD(2)), G. raimondii (D-5) and G. arboreum (A(2)), together with data of six other mitochondrial genomes, to elucidate the evolution and diversity of mitochondrial genomes within Gossypium. Results: Six Gossypium mitochondrial genomes, including three diploid species from D and three allotetraploid species from AD genome groups (G. thurberi D-1, G. davidsonii D3-d and G. trilobum D-8; G. tomentosum AD(3), G. mustelinum AD(4) and G. darwinii AD(5)), were assembled as the single circular molecules of lengths about 644 kb in diploid species and 677 kb in allotetraploid species, respectively. The genomic structures of mitochondrial in D group species were identical but differed from the mitogenome of G. arboreum (A2), as well as from the mitogenomes of five species of the AD group. There mainly existed four or six large repeats in the mitogenomes of the A + AD or D group species, respectively. These variations in repeat sequences caused the major inversions and translocations within the mitochondrial genome. The mitochondrial genome complexity in Gossypium presented eight unique segments in D group species, three specific fragments in A + AD group species and a large segment (more than 11 kb) in diploid species. These insertions or deletions were most probably generated from crossovers between repetitive or homologous regions. Unlike the highly variable genome structure, evolutionary distance of mitochondrial genes was 1/6th the frequency of that in chloroplast genes of Gossypium. RNA editing events were conserved in cotton mitochondrial genes. We confirmed two near full length of the integration of the mitochondrial genome into chromosome 1 of G. raimondii and chromosome A03 of G. hirsutum, respectively, with insertion time less than 1.03 MYA. Conclusion: Ten Gossypium mitochondrial sequences highlight the insights to the evolution of cotton mitogenomes.	[Chen, Zhiwen; Nie, Hushuai; Pei, Haili; Li, Shuangshuang; Hua, Jinping] China Agr Univ, Coll Agron & Biotechnol, Beijing Key Lab Crop Genet Improvement,Lab Cotton, Minist Educ,Key Lab Crop Heterosis & Utilizat, Beijing 100193, Peoples R China; [Wang, Yumei] Hubei Acad Agr Sci, Inst Cash Crops, Wuhan 430064, Hubei, Peoples R China; [Zhang, Lida] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai 200240, Peoples R China	Hua, JP (reprint author), China Agr Univ, Coll Agron & Biotechnol, Beijing Key Lab Crop Genet Improvement,Lab Cotton, Minist Educ,Key Lab Crop Heterosis & Utilizat, Beijing 100193, Peoples R China.	jinping_hua@cau.edu.cn			National Natural Science Foundation of China [31671741]	This work was supported by grant from the National Natural Science Foundation of China (31671741) to J. Hua.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Backert S, 1997, TRENDS PLANT SCI, V2, P477, DOI 10.1016/S1360-1385(97)01148-5                                                   ; Bendich AJ, 2007, BIOESSAYS, V29, P474, DOI 10.1002/bies.20576; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonen L, 2006, NEW PHYTOL, V172, P379, DOI 10.1111/j.1469-8137.2006.01904.x; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Chen Z, 2017, PLANT BIOLOGY, V19, P484, DOI 10.1111/plb.12536; Chen ZW, 2017, CRIT REV PLANT SCI, V36, P55, DOI 10.1080/07352689.2017.1327762; Chen ZW, 2017, MOL PHYLOGENET EVOL, V112, P268, DOI 10.1016/j.ympev.2017.04.014; Chen ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157183; Christensen AC, 2014, GENOME BIOL EVOL, V6, P1448, DOI 10.1093/gbe/evu115; Christensen AC, 2013, GENOME BIOL EVOL, V5, P1079, DOI 10.1093/gbe/evt069; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davila JI, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-64; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Eberhard JR, 2016, MOL PHYLOGENET EVOL, V94, P34, DOI 10.1016/j.ympev.2015.08.011; Gallagher JP, 2017, SYST BOT, V42, P115, DOI 10.1600/036364417X694593; Galtier N, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-61; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274                                                        ; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Gualberto JM, 2017, ANNU REV PLANT BIOL, V68, P225, DOI 10.1146/annurev-arplant-043015-112232; Guo WH, 2016, MOL BIOL EVOL, V33, P1448, DOI 10.1093/molbev/msw024; Horn R, 2014, MITOCHONDRION, V19, P198, DOI 10.1016/j.mito.2014.04.004; Hu J, 2014, MITOCHONDRION, V19, P282, DOI 10.1016/j.mito.2014.02.008; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kitazaki K., 2010, Journal of Botany, V2010, P620137, DOI 10.1155/2010/620137; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li SS, 2013, CHINESE SCI BULL, V58, P4608, DOI 10.1007/s11434-013-5962-4; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069476; LIU XM, 2015, SCI REP UK, V5; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Mower JP, 2012, PLANT GENOME DIVERSI, V1, P123, DOI DOI 10.1007/978-3-7091-1130-7_; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Oldenburg DJ, 2001, J MOL BIOL, V310, P549, DOI 10.1006/jmbi.2001.4783; Oldenburg DJ, 1996, PLANT CELL, V8, P447; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Shearman JR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-45; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Skippington E, 2015, P NATL ACAD SCI USA, V112, pE3515, DOI 10.1073/pnas.1504491112; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Suzuki H, 2013, MOL GENET GENOMICS, V288, P445, DOI 10.1007/s00438-013-0764-6; Suzuki H, 2013, THEOR APPL GENET, V126, P1521, DOI 10.1007/s00122-013-2070-4; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-352; Tang HW, 2017, CELL RES, V27, P130, DOI 10.1038/cr.2016.115; Tang MY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1988-0; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2015, MONOGRAPH, V24; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yang J, 2016, PLANT BIOLOGY, V18, P527, DOI 10.1111/plb.12414; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JF, 2008, PLANT CELL REP, V27, P553, DOI 10.1007/s00299-007-0492-7; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	89	0	0	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 13	2017	18								876	10.1186/s12864-017-4282-5				15	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FM5VI	WOS:000415108800001	29132310	gold			2018-01-05	
J	Cheng, XL; Peuckert, C; Wolfl, S				Cheng, Xinlai; Peuckert, Christiane; Woelfl, Stefan			Essential role of mitochondrial Stat3 in p38(MAPK) mediated apoptosis under oxidative stress	SCIENTIFIC REPORTS			English	Article							P38 MAP KINASES; CANCER-CELLS; INDUCE APOPTOSIS; ACTIVATION; DERIVATIVES; INHIBITOR; SRC; TUMORIGENESIS; INFLAMMATION; THIOREDOXIN	Stat3 is an oncogene, frequently associated with malignant transformation. A body of evidence implicates that phospho-Stat3(Y705) contributes to its nucleic translocation, while phospho-Stat3(S727) leads to the accumulation in mitochondria. Both are of importance for tumor cell proliferation. In comparison to well-characterized signaling pathways interplaying with Stat3(Y705), little is known about Stat3(S727). In this work, we studied the influence of Stat3 deficiency on the viability of cells exposed to H2O2 or hypoxia using siRNA and CRISPR/Cas9 genome-editing. We found dysregulation of mitochondrial activity, which was associated with excessive ROS formation and reduced mitochondrial membrane potential, and observed a synergistic effect for oxidative stress-mediated apoptosis in Stat3-KD cells or cells carrying Stat3(Y705F), but not Stat3(S727D), suggesting the importance of functional mitochondrial Stat3 in this context. We also found that ROS-mediated activation of ASK1/p38(MAPK) was involved and adding antioxidants, p38(MAPK) inhibitor, or genetic repression of ASK1 could easily rescue the cellular damage. Our finding reveals a new role of mitochondrial Stat3 in preventing ASK1/p38(MAPK)-mediated apoptosis, wich further support the notion that selective inhibition mitochondrial Stat3 could provide a primsing target for chemotherapy.	[Cheng, Xinlai; Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany; [Peuckert, Christiane] Uppsala Univ, Dept Organismal Biol, S-75236 Uppsala, Sweden	Cheng, XL (reprint author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	x.cheng@uni-heidelberg.de		Cheng, Xinlai/0000-0001-6441-3742	Deutsche Forschungsgemeinschaft [CH 1690/2-1]; BMBF grant program Drug-iPS [FKZ 0315398B]; BMBF grant program SysToxChip [FKZ 031A303E]	We thank Yasamin Dabiri for her support to prepare Stat3 plasmids. This work was supported by Deutsche Forschungsgemeinschaft (CH 1690/2-1) and the BMBF grant programs Drug-iPS (FKZ 0315398B) and SysToxChip (FKZ 031A303E).	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5                                                   ; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553                                                           ; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cheng XL, 2017, J MED CHEM, V60, P4949, DOI 10.1021/acs.jmedchem.7b00324; Cheng Xinlai, 2016, Adv Exp Med Biol, V929, P269; Cheng XL, 2016, MOL ONCOL, V10, P806, DOI 10.1016/j.molonc.2016.01.008; Cheng XL, 2015, J MED CHEM, V58, P5742, DOI 10.1021/acs.jmedchem.5b00226; Cheng X, 2015, J MED CHEM, V58, P4976, DOI 10.1021/acs.jmedchem.5b00144; Cheng XL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-221; Cheng XL, 2014, BIOORGAN MED CHEM, V22, P247, DOI 10.1016/j.bmc.2013.11.031; Cheng XL, 2012, CHEM BIOL, V19, P1423, DOI 10.1016/j.chembiol.2012.09.008; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuenda A., 1773, BIOCHIM BIOPHYS ACTA, P1358; Dabiri Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05813-z; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Galluzzi L, 2012, ONCOGENE, V31, P2805, DOI 10.1038/onc.2011.459; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kim JH, 2009, J BIOL CHEM, V284, P35425, DOI 10.1074/jbc.M109.051516; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Lochead J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131233; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Nam S, 2012, MOL ONCOL, V6, P276, DOI 10.1016/j.molonc.2012.02.002; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4                                                   ; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Perona Rosario, 2006, Clin Transl Oncol, V8, P77, DOI 10.1007/s12094-006-0162-1; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Szczepanek K, 2012, TRENDS CELL BIOL, V22, P429, DOI 10.1016/j.tcb.2012.05.001; Trevino Jose G., 2006, Angiogenesis, V9, P101, DOI 10.1007/s10456-006-9038-9; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057; Zhao CG, 2016, TRENDS PHARMACOL SCI, V37, P47, DOI 10.1016/j.tips.2015.10.001	58	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 13	2017	7								15388	10.1038/s41598-017-15342-4				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FM4VF	WOS:000415022900024	29133922	gold			2018-01-05	
J	Ghahfarokhi, MK; Dormiani, K; Mohammadi, A; Jafarpour, F; Nasr-Esfahani, MH				Ghahfarokhi, Milad Khorramian; Dormiani, Kianoush; Mohammadi, Ali; Jafarpour, Farnoosh; Nasr-Esfahani, Mohammad Hossein			Blastocyst Formation Rate and Transgene Expression are Associated with Gene Insertion into Safe and Non-Safe Harbors in the Cattle Genome	SCIENTIFIC REPORTS			English	Article							PHI-C31 INTEGRASE SYSTEM; HUMAN SERUM-ALBUMIN; STEM-CELL LINES; PHIC31 INTEGRASE; BOVINE GENOME; PLASMID DNA; IN-VIVO; SITE; THERAPY; IDENTIFICATION	Integration target site is the most important factor in successful production of transgenic animals. However, stable expression of transgene without disturbing the function of the host genome depends on promoter methylation, transgene copy number and transcriptional activity in integration regions. Recently, new genome-editing tools have made much progress, however little attention has been paid to the identification of genomic safe harbors. The aim of the present study was to evaluate the effect of insertion site, promoter and copy number of transgene on the production of embryos from cattle fibroblast cells following somatic cell nuclear transfer (SCNT). So, three donor vectors were constructed with EGFP gene under control of different promoters. Each vector was integrated into safe and non-safe harbors in the genome using phiC31 integrase. Transgenic clones with a single copy of each vector were isolated. Each clone was analyzed to find site and frequency of integration, expression level and promoter methylation before SCNT, as well as transgene expression level and blastocyst formation rate after SCNT. The data obtained demonstrated that BF5, as a safe harbor, not only showed a stable expression, but also the rate of in vitro-produced embryos from BF5-clones are similar to that of non-transfected cells.	[Ghahfarokhi, Milad Khorramian; Mohammadi, Ali] Shiraz Univ, Sch Vet Med, Div Biotechnol, Dept Pathobiol, Shiraz, Iran; [Dormiani, Kianoush; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Mol Biotechnol, Cell Sci Res Ctr, Esfahan, Iran; [Jafarpour, Farnoosh; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Reprod & Dev, Reprod Biomed Ctr, Esfahan, Iran	Nasr-Esfahani, MH (reprint author), ACECR, Royan Inst Biotechnol, Dept Mol Biotechnol, Cell Sci Res Ctr, Esfahan, Iran.; Nasr-Esfahani, MH (reprint author), ACECR, Royan Inst Biotechnol, Dept Reprod & Dev, Reprod Biomed Ctr, Esfahan, Iran.	mh.nasr-esfahani@royaninstitute.org					Aneja MK, 2009, EXP MOL MED, V41, P919, DOI 10.3858/emm.2009.41.12.098; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Calos MP, 2006, CURR GENE THER, V6, P633, DOI 10.2174/156652306779010642; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chalberg TW, 2005, INVEST OPHTH VIS SCI, V46, P2140, DOI 10.1167/iovs.04-1252; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139                                                      ; Ho SCL, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0300-y; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hosseini SM, 2013, CELL REPROGRAM, V15, P15, DOI 10.1089/cell.2012.0033; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jafarpour F, 2011, CELL REPROGRAM, V13, P483, DOI 10.1089/cell.2011.0005; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; KOTIN RM, 1992, EMBO J, V11, P5071; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2015, TRANSGENIC RES, V24, P875, DOI 10.1007/s11248-015-9898-0; Luo Y, 2013, BIOTECHNOL LETT, V35, P529, DOI 10.1007/s10529-012-1125-y; Ma QW, 2006, BIOCHEM BIOPH RES CO, V345, P984, DOI 10.1016/j.bbrc.2006.04.145; Nishiumi F, 2009, CELL STRUCT FUNCT, V34, P47, DOI 10.1247/csf.08044                                                               ; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ou HL, 2009, FEBS J, V276, P155, DOI 10.1111/j.1742-4658.2008.06762.x; Ou HL, 2013, J BIOTECHNOL, V167, P427, DOI 10.1016/j.jbiotec.2013.08.001; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qu LJ, 2012, J GENET GENOMICS, V39, P217, DOI 10.1016/j.jgg.2012.03.004; Tang W, 2007, J EXP BOT, V58, P545, DOI 10.1093/jxb/erl228; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; van den Pol AN, 1998, J NEUROSCI, V18, P10640; Watanabe S, 2011, NEW BIOTECHNOL, V28, P312, DOI 10.1016/j.nbt.2010.11.001; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yew NS, 2002, MOL THER, V5, P731, DOI 10.1106/mthe.2002.0598; Yu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04240; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062457; Zhang Q, 2015, GENET MOL RES, V14, P2006, DOI 10.4238/2015.March.20.10; Zheng CY, 2014, INT J MED SCI, V11, P404, DOI 10.7150/ijms.8033	40	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 13	2017	7								15432	10.1038/s41598-017-15648-3				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FM4VF	WOS:000415022900068	29133827	gold			2018-01-05	
J	Vierbuchen, T; Bang, C; Rosigkeit, H; Schmitz, RA; Heine, H				Vierbuchen, Tim; Bang, Corinna; Rosigkeit, Hanna; Schmitz, Ruth A.; Heine, Holger			The human-associated archaeon Methanosphaera stadtmanae is recognized through its RNA and induces TLR8-Dependent NLRP3 inflammasome activation	FRONTIERS IN IMMUNOLOGY			English	Article						archaea; Methanosphaera stadtmanae; innate immunity; inflammasome; TLR8; NLRP3; monocytes	INNATE IMMUNE-SYSTEM; HUMAN GUT MICROBIOTA; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; BACTERIAL RNA; HUMAN MONOCYTES; BREATH-METHANE; DISEASE; CANCER	The archaeon Methanosphaera stadtmanae is a member of the gut microbiota; yet, the molecular cross-talk between archaea and the human immune system and its potential contribution to inflammatory diseases has not been evaluated. Although archaea are as bacteria prokaryotes, they form a distinct domain having unique features such as different cell wall structures and membrane lipids. So far, no microbe-associated molecular patterns of archaea which activate innate immune receptors have been identified. By stimulating human myeloid cells with M. stadtmanae and purified archaeal nucleic acids, we identified both the microorganism and its RNA as potent stimuli for the innate immune system. To dissect the recognition and activation pathways induced by M. stadtmanae, human monocytic BLaER1 knockout cells were generated using the CRISPR/Cas9 system targeting components of TLR and inflammasome signaling. While the recognition of M. stadtmanae is mediated by TLR7 and TLR8, activation of the NLRP3 inflammasome depends solely on TLR8 engagement. Notably, this process resembles hallmarks of both the canonical and the recently described alternative inflammasome activation. Thus, we have demonstrated for the first time the specific recognition of and response to an archaeon by human cells at the molecular level.	[Vierbuchen, Tim; Rosigkeit, Hanna; Heine, Holger] Res Ctr Borstel, Div Innate Immun, Borstel, Germany; [Bang, Corinna; Schmitz, Ruth A.] Christian Albrechts Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Heine, Holger] German Ctr Lung Res DZL, ARCN, Borstel, Germany	Heine, H (reprint author), Res Ctr Borstel, Div Innate Immun, Borstel, Germany.; Heine, H (reprint author), German Ctr Lung Res DZL, ARCN, Borstel, Germany.	hheine@fz-borstel.de			DFG (German research foundation) [HH2758/4-2, SCHM1051/11-2]	This work was supported by the DFG (German research foundation) (grant number HH2758/4-2 and grant number SCHM1051/11-2).	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bang C, 2012, ANTIMICROB AGENTS CH, V56, P4123, DOI 10.1128/AAC.00661-12; Bang C, 2015, FEMS MICROBIOL REV, V39, P631, DOI 10.1093/femsre/fuv010; Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Basseri Robert J, 2012, Gastroenterol Hepatol (N Y), V8, P22; Bernatchez E, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13163; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Eigenbrod T, 2015, J IMMUNOL, V195, P411, DOI 10.4049/jimmunol.1500530; Forbes JD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01081; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo HT, 2014, J BIOL CHEM, V289, P21716, DOI 10.1074/jbc.M114.566620; HAINES A, 1977, LANCET, V2, P481; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531                                                     ; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KARLIN DA, 1982, J NATL CANCER I, V69, P573; Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861; Lazaridis LD, 2017, DIGEST DIS SCI, V62, P2348, DOI 10.1007/s10620-017-4609-8; Lecours PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087734; Lecours PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023326; Lee BL, 2014, TRENDS CELL BIOL, V24, P360, DOI 10.1016/j.tcb.2013.12.002; Lee HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027773; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Makni-Maalej K, 2015, J LEUKOCYTE BIOL, V97, P1081, DOI 10.1189/jlb.2A1214-623R; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mathur R, 2013, J CLIN ENDOCR METAB, V98, pE698, DOI 10.1210/jc.2012-3144; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; PIQUE JM, 1984, GASTROENTEROLOGY, V87, P601; Prochnicki T, 2016, F1000RES, V5; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Raymann K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00026-17; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Sha WW, 2014, P NATL ACAD SCI USA, V111, P16059, DOI 10.1073/pnas.1412487111; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Stein K, 2017, J ALLERGY CLIN IMMUN, V139, P667, DOI 10.1016/j.jaci.2016.06.018; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Turpin J, 1986, J Clin Apher, V3, P111, DOI 10.1002/jca.2920030207; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578                                                         ; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030	61	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 13	2017	8								1535	10.3389/fimmu.2017.01535				13	Immunology	Immunology	FM3LX	WOS:000414908500001	29181003	gold			2018-01-05	
J	Zuberi, A; Ahmad, N; Khan, AU				Zuberi, Azna; Ahmad, Nayeem; Khan, Asad U.			CRISPRi Induced of Fimbriae Gene (fimH) of a Uropathogenic Escherichia coli: An Approach to Inhibit Microbial Biofilms	FRONTIERS IN IMMUNOLOGY			English	Article						biofilm; CRISPRi; fimH; bacteria; immunity; gene; fimbriae	SINGLE-NUCLEOTIDE POLYMORPHISMS; SEQUENCE-SPECIFIC CONTROL; INTERFERENCE CRISPRI; ADHESIN FIMH; EXPRESSION; USHER; SECRETION; REVEALS; DOMAIN	Urinary tract infection (UTI) is one the common infections caused by the recalcitrant nature of biofilms, developed after the pathogen has adhered to the inner lining of the urinary tract. Although significant research has been made in recent years to control these types of infection, but as of yet, no approach has sufficiently been able to reduce the prevalence of UTIs. The main objective of this study was to prevent UTIs through targeting the fimH gene, which is the major virulent factor responsible for biofilm formation. The novelty of this work lies in the use of CRISPRi, a gene specific editing tool to control such types of infections. Accordingly, the system was designed to target fimH gene, responsible for bacterial adherence and this approach was successfully validated by performing microscopic, biofilm and adherence assays.	[Zuberi, Azna; Ahmad, Nayeem; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India	Khan, AU (reprint author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com			Interdisciplinary Biotechnology Unit	This work was supported by internal funds of Interdisciplinary Biotechnology Unit.	Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Berne C, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0018-2015; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Borowsky L, 2009, BRAZ J MICROBIOL, V40, P458, DOI 10.1590/S1517-83822009000300007; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Dias RCS, 2010, J CLIN MICROBIOL, V48, P483, DOI 10.1128/JCM.01858-09; Hojati Z, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.17520; Ji WY, 2014, ACS SYNTH BIOL, V3, P929, DOI 10.1021/sb500036q; Johnson J R, 1987, Infect Dis Clin North Am, V1, P773; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1                                                          ; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Misba L, 2016, BIOFOULING, V32, P313, DOI 10.1080/08927014.2016.1141899; Mittal S, 2015, PATHOG GLOB HEALTH, V109, P26, DOI 10.1179/2047773215Y.0000000001; Munera D, 2008, MOL MICROBIOL, V69, P911, DOI 10.1111/j.1365-2958.2008.06325.x; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; Soto S.M., 2014, ADV BIOL, V2014, P13, DOI DOI 10.1155/2014/543974; Tartof SY, 2007, J MED MICROBIOL, V56, P1363, DOI 10.1099/jmm.0.47262-0; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; Warren JW, 1996, CLIN PRESENTATIONS E, P3; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Zuberi A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00214	28	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 13	2017	8								1552	10.3389/fimmu.2017.01552				8	Immunology	Immunology	FM3MM	WOS:000414910200001	29181009	gold			2018-01-05	
J	Yang, JC; Zhang, LH; Diao, HY; Xia, NB; Zhou, YQ; Zhao, JL; Shen, B				Yang, Jichao; Zhang, Lihong; Diao, Huiyan; Xia, Ningbo; Zhou, Yanqin; Zhao, Junlong; Shen, Bang			ANK1 and DnaK-TPR, Two Tetratricopeptide Repeat-Containing Proteins Primarily Expressed in Toxoplasma Bradyzoites, Do Not Contribute to Bradyzoite Differentiation	FRONTIERS IN MICROBIOLOGY			English	Article						Toxoplasma gondii; bradyzoite; ANK1; DnaK-TPR; stage conversion	CYST FORMATION; TISSUE CYST; GONDII BRADYZOITES; GENE-EXPRESSION; IN-VITRO; IDENTIFICATION; STAGE; BAG1; EPIDEMIOLOGY; INTERFERON	Toxoplasma gondii is an important zoonotic pathogen infecting one third of the world population and numerous animals. A key factor to its wide distribution is the ability to interconvert between fast replicating tachyzoites and slowly growing bradyzoites, and to establish lifelong chronic infection in intermediate hosts. Although it is well accepted that stage conversion plays key roles in the pathogenesis and transmission of the parasite, little is known about the molecular mechanisms behind it. Using existing gene expression data from TOXODB and published work, we looked for proteins with novel functional domains and whose expression is up-regulated in the bradyzoite stage, hoping to find molecules that have critical roles in regulating stage conversion and bradyzoite formation. In this study we characterized two such proteins ANK1 and DnaK-TPR, both of which are primarily expressed in bradyzoites and contain novel motifs to mediate protein-protein interactions. Through CRISPR/CAS9 directed gene editing technology, both genes were individually knocked out in type 1 strain TgHB2 and type 2 strain ME49. Disruption of neither of these two genes affected the growth or replication of tachyzoites in vitro, consistent with their minimal expression at this stage. However, mutants lacking ANK1 or DnaK-TPR displayed modest virulence attenuation during mice infection. Surprisingly, inactivation of neither ANK1 nor DnaK-TPR seemed to have a significant impact on bradyzoite differentiation in vitro or cyst formation in vivo. These results suggest that ANK1 and DnaK-TPR probably do not directly contribute to bradyzoite differentiation, but likely affect other aspects of bradyzoite biology.	[Yang, Jichao; Zhang, Lihong; Diao, Huiyan; Xia, Ningbo; Zhou, Yanqin; Zhao, Junlong; Shen, Bang] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhao, Junlong] Hubei Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Hubei, Peoples R China; [Zhao, Junlong; Shen, Bang] Key Lab Prevent Med Hubei Prov, Wuhan, Hubei, Peoples R China	Shen, B (reprint author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Shen, B (reprint author), Key Lab Prevent Med Hubei Prov, Wuhan, Hubei, Peoples R China.	shenbang@mail.hzau.edu.cn			National Key R&D Program of China [2017YFD0500402]; National Natural Science Foundation of China [31572508]; Fundamental Research Funds for the Central Universities in China [2662015PY104]; Natural Science Foundation of Hubei Province [2017CFA020]	This work was supported the National Key R&D Program of China (Project# 2017YFD0500402), National Natural Science Foundation of China (Project# 31572508), the Fundamental Research Funds for the Central Universities in China (Project# 2662015PY104) and The Natural Science Foundation of Hubei Province (Grant# 2017CFA020).	Abdelbaset AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173745; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; BOHNE W, 1993, INFECT IMMUN, V61, P1141; Bohne W, 1998, MOL BIOCHEM PARASIT, V92, P291, DOI 10.1016/S0166-6851(97)00236-3; Buchholz KR, 2013, EUKARYOT CELL, V12, P399, DOI 10.1128/EC.00343-12; Buchholz KR, 2011, EUKARYOT CELL, V10, P1637, DOI 10.1128/EC.05182-11; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; da Silva MDF, 2008, MOL BIOSYST, V4, P824, DOI 10.1039/b800520f; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Friesen J, 2008, MOL BIOCHEM PARASIT, V157, P228, DOI 10.1016/j.molbiopara.2007.10.005; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Manger ID, 1998, INFECT IMMUN, V66, P1632; Meireles LR, 2015, REV INST MED TROP SP, V57, P369, DOI 10.1590/S0036-46652015000500001; Mouveaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105820; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI 10.2217/FMB.09.89; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; REMINGTON JS, 1968, SCIENCE, V161, P804, DOI 10.1126/science.161.3843.804; Selseleh M, 2012, KOREAN J PARASITOL, V50, P199, DOI 10.3347/kjp.2012.50.3.199; Shen B., 2014, MBIO, V5, P1114, DOI DOI 10.1128/MBI0.01114-14; Shen B, 2016, ONCOTARGET, V7, P87351, DOI 10.18632/oncotarget.13568; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039                                                          ; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; Ueno A, 2011, EXP PARASITOL, V127, P795, DOI 10.1016/j.exppara.2011.01.015; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; WEISS LM, 1995, J EUKARYOT MICROBIOL, V42, P150, DOI 10.1111/j.1550-7408.1995.tb01556.x; Weiss LM, 2000, FRONT BIOSCI, V5, pD391, DOI 10.2741/Weiss; White MW, 2014, CELL MICROBIOL, V16, P466, DOI 10.1111/cmi.12267; Wohlfert EA, 2017, TRENDS PARASITOL, V33, P519, DOI 10.1016/j.pt.2017.04.001; Zhang YW, 1999, MOL MICROBIOL, V31, P691, DOI 10.1046/j.1365-2958.1999.01210.x	44	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 13	2017	8								2210	10.3389/fmicb.2017.02210				12	Microbiology	Microbiology	FM3HJ	WOS:000414894800001	29180989	gold			2018-01-05	
J	Das, S; Senapati, P; Chen, Z; Reddy, MA; Ganguly, R; Lanting, L; Mandi, V; Bansal, A; Leung, A; Zhang, S; Jia, Y; Wu, XW; Schones, DE; Natarajan, R				Das, Sadhan; Senapati, Parijat; Chen, Zhuo; Reddy, Marpadga A.; Ganguly, Rituparna; Lanting, Linda; Mandi, Varun; Bansal, Anita; Leung, Amy; Zhang, Selena; Jia, Ye; Wu, Xiwei; Schones, Dustin E.; Natarajan, Rama			Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells	NATURE COMMUNICATIONS			English	Article							NF-KAPPA-B; ETS-1 TRANSCRIPTION FACTOR; GENE-EXPRESSION; HUMAN GENOME; HISTONE MODIFICATIONS; SELECTIVE-INHIBITION; BET BROMODOMAINS; NONCODING RNAS; DNA ELEMENTS; INFLAMMATION	Angiotensin II (AngII) promotes hypertension and atherosclerosis by activating growth-promoting and pro-inflammatory gene expression in vascular smooth muscle cells (VSMCs). Enhancers and super-enhancers (SEs) play critical roles in driving disease-associated gene expression. However, enhancers/SEs mediating VSMC dysfunction remain uncharacterized. Here, we show that AngII alters vascular enhancer and SE repertoires in cultured VSMCs in vitro, ex vivo, and in AngII-infused mice aortas in vivo. AngII-induced enhancers/SEs are enriched in binding sites for signal-dependent transcription factors and dependent on key signaling kinases. Moreover, CRISPR-Cas9-mediated deletion of candidate enhancers/SEs, targeting SEs with the bromodomain and extra-terminal domain inhibitor JQ1, or knockdown of overlapping long noncoding RNAs (lncRNAs) blocks AngII-induced genes associated with growth-factor signaling and atherosclerosis. Furthermore, JQ1 ameliorates AngII-induced hypertension, medial hypertrophy and inflammation in vivo in mice. These results demonstrate AngII-induced signals integrate enhancers/SEs and lncRNAs to increase expression of genes involved in VSMC dysfunction, and could uncover novel therapies.	[Das, Sadhan; Senapati, Parijat; Chen, Zhuo; Reddy, Marpadga A.; Ganguly, Rituparna; Lanting, Linda; Mandi, Varun; Bansal, Anita; Leung, Amy; Zhang, Selena; Jia, Ye; Schones, Dustin E.; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Diabet Metab Res Inst, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	Natarajan, R (reprint author), City Hope Natl Med Ctr, Beckman Res Inst, Diabet Metab Res Inst, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA.	rnatarajan@coh.org		Leung, Amy/0000-0002-5175-430X; Senapati, Parijat/0000-0002-7324-1230; Das, Sadhan/0000-0002-7153-9519	National Institutes of Health (NIH) [R01 HL106089, NIH R01 DK 081705, R01 DK065073, K01DK104993]; National Cancer Institute of the NIH [P30CA33572]	Supported by grants from the National Institutes of Health (NIH) R01 HL106089, NIH R01 DK 081705, and R01 DK065073 (to R.N.), and K01DK104993 (to A.L.). Research reported in this publication included work performed in the following cores: Integrative Genomics and DNA/RNA synthesis, supported by the National Cancer Institute of the NIH under award number P30CA33572. We are very grateful to Tina Montgomery (Shared Resources/Pathology Core Laboratory of City of Hope) for the mouse histology, Dr James Bradner and Dr Jun Qi (Dana-Farber Cancer Institute, Boston, MA) for the BRD4 inhibitor JQ1, and Merck (Whitehouse Station, NJ) for the gift of losartan.	Ahn JD, 2001, DIABETOLOGIA, V44, P713, DOI 10.1007/s001250051680; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burton DGA, 2009, EXP GERONTOL, V44, P659, DOI 10.1016/j.exger.2009.07.004; Cao ZM, 2012, ACTA DIABETOL, V49, P243, DOI 10.1007/s00592-011-0328-3; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chen XL, 1998, CIRC RES, V83, P952; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002                                                       ; Duan QM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5084; Duan Q, 2016, INT J CARDIOL, V223, P428, DOI 10.1016/j.ijcard.2016.08.238; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Han YQ, 1999, CIRC RES, V84, P695; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horita H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10830; HultgardhNilsson A, 1996, CIRC RES, V78, P589; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; Jin Fulai, 2011, Transcription, V2, P226, DOI 10.4161/trns.2.5.17712; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; Jin W, 2012, J BIOL CHEM, V287, P15672, DOI 10.1074/jbc.M111.322669; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meloche J, 2015, CIRC RES, V117, P525, DOI 10.1161/CIRCRESAHA.115.307004; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Morishita R, 1998, BIOCHEM BIOPH RES CO, V243, P361, DOI 10.1006/bbrc.1997.8012; Ounzain S, 2014, J MOL CELL CARDIOL, V76, P55, DOI 10.1016/j.yjmcc.2014.08.009; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sahar S, 2005, CIRC RES, V96, P1064, DOI 10.1161/01.RES.0000168210.10358.f4; Sahar S, 2007, ARTERIOSCL THROM VAS, V27, P1528, DOI 10.1161/ATVBAHA.107.145862; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Suarez-Alvarez B, 2017, J AM SOC NEPHROL, V28, P504, DOI 10.1681/ASN.2015080910; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKEUCHI K, 1990, BIOCHEM BIOPH RES CO, V172, P1189, DOI 10.1016/0006-291X(90)91574-C; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vucicevic D, 2015, CELL CYCLE, V14, P253, DOI 10.4161/15384101.2014.977641; WA W., 2013, CELL, V153, P22; Wang BW, 2015, EBIOMEDICINE, V2, P1650, DOI 10.1016/j.ebiom.2015.09.045; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	70	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 13	2017	8								1467	10.1038/s41467-017-01629-7				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FM3OH	WOS:000414915900029	29133788	gold			2018-01-05	
J	Saunderson, EA; Stepper, P; Gomm, JJ; Hoa, L; Morgan, A; Allen, MD; Jones, JL; Gribben, JG; Jurkowski, TP; Ficz, G				Saunderson, Emily A.; Stepper, Peter; Gomm, Jennifer J.; Hoa, Lily; Morgan, Adrienne; Allen, Michael D.; Jones, J. Louise; Gribben, John G.; Jurkowski, Tomasz P.; Ficz, Gabriella			Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors	NATURE COMMUNICATIONS			English	Article							MAMMARY EPITHELIAL-CELLS; CPG-ISLAND METHYLATION; TUMOR-SUPPRESSOR GENE; DNA METHYLATION; PROMOTER HYPERMETHYLATION; CANCER DEVELOPMENT; IN-VIVO; P16(INK4A); IMMORTALIZATION; TUMORIGENESIS	Aberrant promoter DNA hypermethylation is a hallmark of cancer; however, whether this is sufficient to drive cellular transformation is not clear. To investigate this question, we use a CRISPR-dCas9 epigenetic editing tool, where an inactive form of Cas9 is fused to DNA methyltransferase effectors. Using this system, here we show simultaneous de novo DNA methylation of genes commonly methylated in cancer, CDKN2A, RASSF1, HIC1 and PTEN in primary breast cells isolated from healthy human breast tissue. We find that promoter methylation is maintained in this system, even in the absence of the fusion construct, and this prevents cells from engaging senescence arrest. Our data show that the key driver of this phenotype is repression of CDKN2A transcript p16 where myoepithelial cells harbour cancer-like gene expression but do not exhibit anchorage-independent growth. This work demonstrates that hit-and-run epigenetic events can prevent senescence entry, which may facilitate tumour initiation.	[Saunderson, Emily A.; Gomm, Jennifer J.; Hoa, Lily; Morgan, Adrienne; Allen, Michael D.; Jones, J. Louise; Gribben, John G.; Ficz, Gabriella] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England; [Stepper, Peter; Jurkowski, Tomasz P.] Univ Stuttgart, Fac Chem, Dept Biochem, Inst Biochem & Tech Biochem, D-70569 Stuttgart, Germany	Ficz, G (reprint author), Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England.; Jurkowski, TP (reprint author), Univ Stuttgart, Fac Chem, Dept Biochem, Inst Biochem & Tech Biochem, D-70569 Stuttgart, Germany.	tomasz.jurkowski@ibc.uni-stuttgart.de; g.ficz@qmul.ac.uk		Jurkowski, Tomasz/0000-0002-2012-0240; Allen, Michael/0000-0003-2121-8087	MRC NIRG [MR/M01892X/1]; Baden-Wurtemberg Stiftung [95011370]; Barts Cancer Institute	This work was supported by MRC NIRG award to G.F. [Grant Ref: MR/M01892X/1] and Baden-Wurtemberg Stiftung [95011370 to T.P.J.] and Barts Cancer Institute. The authors wish to acknowledge the role of the Breast Cancer Now Tissue Bank in preparing and making available the cells used in the generation of this publication. We thank Dr. Miguel Branco, Miss Hemalvi Patani and Dr. Michael Rushton for their advice on preparation of the manuscript.	Allen MD, 2014, CLIN CANCER RES, V20, P344, DOI 10.1158/1078-0432.CCR-13-1504; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bernstein DL, 2015, J CLIN INVEST, V125, P1998, DOI 10.1172/JCI77321; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Cano-Rodriguez D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12284; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6                                                   ; Cui CH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0819-6; Dammann R, 2001, CANCER RES, V61, P3105; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Foster SA, 1998, MOL CELL BIOL, V18, P1793, DOI 10.1128/MCB.18.4.1793                                                           ; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; GOMM JJ, 1995, ANAL BIOCHEM, V226, P91, DOI 10.1006/abio.1995.1196; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; Holst CR, 2003, CANCER RES, V63, P1596; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huschtscha LI, 1998, CANCER RES, V58, P3508; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiyono T, 1998, NATURE, V396, P84; Klajic J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-456; Kungulovski G, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0002-z; Lehmann U, 2002, AM J PATHOL, V160, P605, DOI 10.1016/S0002-9440(10)64880-8; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Locke WJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3237; Lowe R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0748-4; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; Nomura W, 2007, J AM CHEM SOC, V129, P8676, DOI 10.1021/ja0705588; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646                                                           ; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Rodilla V, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002069; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sadeq V, 2011, MED ONCOL, V28, P420, DOI 10.1007/s12032-010-9473-8; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Siddiqui S, 2016, BREAST CANCER-TOKYO, V23, P922, DOI 10.1007/s12282-015-0665-0; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Tlsty TD, 2004, J MAMMARY GLAND BIOL, V9, P263, DOI 10.1023/B:JOMG.0000048773.95897.5f                                              ; Tlsty TD, 2001, J MAMMARY GLAND BIOL, V6, P235, DOI 10.1023/A:1011369026168                                                         ; Uhlmann K, 2003, INT J CANCER, V106, P52, DOI 10.1002/ijc.11175; van Hoesel AQ, 2013, BRIT J CANCER, V108, P2033, DOI 10.1038/bjc.2013.136; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P1; Wang L, 2012, MOL MED REP, V6, P904, DOI 10.3892/mmr.2012.1001; Yu DH, 2014, J CLIN INVEST, V124, P3708, DOI 10.1172/JCI76507	63	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 13	2017	8								1450	10.1038/s41467-017-01078-2				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FM3OH	WOS:000414915900012	29133799	gold			2018-01-05	
J	Solomon, O; Di Segni, A; Cesarkas, K; Porath, HT; Marcu-Malina, V; Mizrahi, O; Stern-Ginossar, N; Kol, N; Farage-Barhom, S; Glick-Saar, E; Lerenthal, Y; Levanon, EY; Amariglio, N; Unger, R; Goldstein, I; Eyal, E; Rechavi, G				Solomon, Oz; Di Segni, Ayelet; Cesarkas, Karen; Porath, Hagit T.; Marcu-Malina, Victoria; Mizrahi, Orel; Stern-Ginossar, Noam; Kol, Nitzan; Farage-Barhom, Sarit; Glick-Saar, Efrat; Lerenthal, Yaniv; Levanon, Erez Y.; Amariglio, Ninette; Unger, Ron; Goldstein, Itamar; Eyal, Eran; Rechavi, Gidi			RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure	NATURE COMMUNICATIONS			English	Article							IN-VIVO; MESSENGER-RNA; ENZYME ADAR1; UNWINDING ACTIVITY; GLOBAL ANALYSIS; NONCODING RNA; HUMAN GENES; GENOME; ADENOSINE; DSRNA	Adenosine deaminase acting on RNA 1 (ADAR1) is the master RNA editor, catalyzing the deamination of adenosine to inosine. RNA editing is vital for preventing abnormal activation of cytosolic nucleic acid sensing pathways by self-double-stranded RNAs. Here we determine, by parallel analysis of RNA secondary structure sequencing (PARS-seq), the global RNA secondary structure changes in ADAR1 deficient cells. Surprisingly, ADAR1 silencing resulted in a lower global double-stranded to single-stranded RNA ratio, suggesting that A-to-I editing can stabilize a large subset of imperfect RNA duplexes. The duplexes destabilized by editing are composed of vastly complementary inverted Alus found in untranslated regions of genes performing vital biological processes, including housekeeping functions and type-I interferon responses. They are predominantly cytoplasmic and generally demonstrate higher ribosomal occupancy. Our findings imply that the editing effect on RNA secondary structure is context dependent and underline the intricate regulatory role of ADAR1 on global RNA secondary structure.	[Solomon, Oz; Di Segni, Ayelet; Cesarkas, Karen; Marcu-Malina, Victoria; Kol, Nitzan; Farage-Barhom, Sarit; Glick-Saar, Efrat; Lerenthal, Yaniv; Amariglio, Ninette; Goldstein, Itamar; Eyal, Eran; Rechavi, Gidi] Sheba Med Ctr, Canc Res Ctr, IL-52621 Ramat Gan, Israel; [Solomon, Oz; Di Segni, Ayelet; Cesarkas, Karen; Marcu-Malina, Victoria; Kol, Nitzan; Farage-Barhom, Sarit; Glick-Saar, Efrat; Lerenthal, Yaniv; Amariglio, Ninette; Goldstein, Itamar; Eyal, Eran; Rechavi, Gidi] Sheba Med Ctr, Wohl Inst Translat Med, IL-52621 Ramat Gan, Israel; [Solomon, Oz; Porath, Hagit T.; Levanon, Erez Y.; Amariglio, Ninette; Unger, Ron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Mizrahi, Orel; Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Goldstein, Itamar; Rechavi, Gidi] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Eyal, E; Rechavi, G (reprint author), Sheba Med Ctr, Canc Res Ctr, IL-52621 Ramat Gan, Israel.; Eyal, E; Rechavi, G (reprint author), Sheba Med Ctr, Wohl Inst Translat Med, IL-52621 Ramat Gan, Israel.; Rechavi, G (reprint author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	Eran.Eyal@sheba.health.gov.il; Gidi.rechavi@sheba.health.gov.il			Varda and Boaz Dotan Research Center in Hemato-oncology; Canadian Institute of Health Research joint Canada-Israel health research [108188-001]; Flight Attendant Medical Research Institute (FAMRI); Israeli Centers of Research Excellence (I-CORE); ISF Gene Regulation in Complex Human Disease Center; ISF Chromatin and RNA Gene Regulation Center	We thank Eran Segal, Howard Chang and Yue Wan for their useful advice regarding the PARS-seq protocol. We thank Mali Salmon-Divon for useful advice regarding the splicing analysis. We thank Tirza Doniger for helping us with the data. The work of O.S. was done in partial fulfillment of the requirements of the Faculty of Life-Sciences, Bar-Ilan University, Israel. this work was supported by the Varda and Boaz Dotan Research Center in Hemato-oncology affiliated to the Tel Aviv University, the Canadian Institute of Health Research joint Canada-Israel health research Grant No. 108188-001, the Flight Attendant Medical Research Institute (FAMRI), Israeli Centers of Research Excellence (I-CORE), ISF Gene Regulation in Complex Human Disease Center, ISF Chromatin and RNA Gene Regulation Center. G.R. holds the Djerassi Chair in Oncology, Tel Aviv University, Israel.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Ben-Shoshan SO, 2017, RNA BIOL, V14, P587, DOI 10.1080/15476286.2016.1203501; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Corley M, 2015, NUCLEIC ACIDS RES, V43, P1859, DOI 10.1093/nar/gkv010; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gosai SJ, 2015, MOL CELL, V57, P376, DOI 10.1016/j.molcel.2014.12.004; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heraud-Farlow JE, 2016, J MOL MED, V94, P1095, DOI 10.1007/s00109-016-1416-1; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163                                                              ; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Incarnato D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0491-2; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lai D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks241; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marcu-Malina V, 2016, ONCOTARGET, V7, P54370, DOI 10.18632/oncotarget.11029; Michel AM, 2015, PROTEOMICS, V15, P2410, DOI 10.1002/pmic.201400603; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ouyang ZQ, 2013, GENOME RES, V23, P377, DOI 10.1101/gr.138545.112; Park E, 2013, WIRES RNA, V4, P423, DOI 10.1002/wrna.1168; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Serra MJ, 2004, NUCLEIC ACIDS RES, V32, P1824, DOI 10.1093/nar/gkh501; Solomon O, 2013, RNA, V19, P591, DOI 10.1261/rna.038042.112; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Sugimoto Y, 2015, NATURE, V519, P491, DOI 10.1038/nature14280; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Vendeix FAP, 2009, RNA, V15, P2278, DOI 10.1261/rna.1734309; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wan Y, 2013, NAT PROTOC, V8, P849, DOI 10.1038/nprot.2013.045; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20248; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zou CC, 2015, NUCLEIC ACIDS RES, V43, P9187, DOI 10.1093/nar/gkv950	79	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 13	2017	8								1440	10.1038/s41467-017-01458-8				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FM3OH	WOS:000414915900002	29129909	gold			2018-01-05	
J	Killian, T; Dickopf, S; Haas, AK; Kirstenpfad, C; Mayer, K; Brinkmann, U				Killian, Tobias; Dickopf, Steffen; Haas, Alexander K.; Kirstenpfad, Claudia; Mayer, Klaus; Brinkmann, Ulrich			Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing	SCIENTIFIC REPORTS			English	Article							ZINC-FINGER NUCLEASES; OFF-TARGET; HUMAN-CELLS; MAMMALIAN-CELLS; T-CELLS; IN-VIVO; GENOME; CRISPR-CAS9; SPECIFICITY; CAS9	We have devised an effective and robust method for the characterization of gene-editing events. The efficacy of editing-mediated mono-and bi-allelic gene inactivation and integration events is quantified based on colony counts. The combination of diphtheria toxin (DT) and puromycin (PM) selection enables analyses of 10,000-100,000 individual cells, assessing hundreds of clones with inactivated genes per experiment. Mono-and bi-allelic gene inactivation is differentiated by DT resistance, which occurs only upon bi-allelic inactivation. PM resistance indicates integration. The robustness and generalizability of the method were demonstrated by quantifying the frequency of gene inactivation and cassette integration under different editing approaches: CRISPR/Cas9-mediated complete inactivation was similar to 30-50-fold more frequent than cassette integration. Mono-allelic inactivation without integration occurred > 100-fold more frequently than integration. Assessment of gRNA length confirmed 20mers to be most effective length for inactivation, while 16-18mers provided the highest overall integration efficacy. The overall efficacy was similar to 2-fold higher for CRISPR/Cas9 than for zinc-finger nuclease and was significantly increased upon modulation of non-homologous end joining or homology-directed repair. The frequencies and ratios of editing events were similar for two different DPH genes (independent of the target sequence or chromosomal location), which indicates that the optimization parameters identified with this method can be generalized.	[Killian, Tobias; Dickopf, Steffen; Haas, Alexander K.; Kirstenpfad, Claudia; Mayer, Klaus; Brinkmann, Ulrich] Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Therapeut Modal Large Mol Res, Nonnenwald 2, D-82372 Penzberg, Germany	Brinkmann, U (reprint author), Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Therapeut Modal Large Mol Res, Nonnenwald 2, D-82372 Penzberg, Germany.	ulrich.brinkmann@roche.com					Bauer DE, 2015, JOVE-J VIS EXP, DOI 10.3791/52118; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cebrian-Serrano A, 2017, MAMM GENOME, V28, P247, DOI 10.1007/s00335-017-9697-4; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Greco GE, 2016, DNA REPAIR, V43, P18, DOI 10.1016/j.dnarep.2016.04.004; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Liu YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep07521; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McMahon MA, 2012, NAT METHODS, V9, P28, DOI 10.1038/nmeth.1811; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Stahl S, 2015, P NATL ACAD SCI USA, V112, P10732, DOI 10.1073/pnas.1512863112; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; VARA JA, 1986, NUCLEIC ACIDS RES, V14, P4617, DOI 10.1093/nar/14.11.4617                                                          ; Weidle UH, 2014, CANCER GENOM PROTEOM, V11, P25; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	53	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 13	2017	7								15480	10.1038/s41598-017-15206-x				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FM4VG	WOS:000415023200041	29133816	gold			2018-01-05	
J	Dai, CP; Zhang, XN; Xie, D; Tang, PP; Li, CM; Zuo, Y; Jiang, BF; Xue, CP				Dai, Cuiping; Zhang, Xuning; Xie, Da; Tang, Peipei; Li, Chunmei; Zuo, Yi; Jiang, Baofei; Xue, Caiping			Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells	ONCOTARGET			English	Article						protein phosphatase 2A (PP2A); LB-100; colorectal cancer (CRC); AMP-activated protein kinase (AMPK) and mTOR	PROTEIN PHOSPHATASE 2A; CELLULAR-ENERGY; METABOLIC CHECKPOINT; CARCINOMA CELLS; NONCODING RNA; GROWTH; KINASE; MTOR; PHOSPHORYLATION; AUTOPHAGY	LB-100 is a novel PP2A inhibitor. Its activity in human colorectal cancer (CRC) cells was tested. The in vitro studies demonstrated that LB-100 inhibited survival and proliferation of both established CRC cells (HCT-116 and HT-29 lines) and primary human colon cancer cells. Further, LB-100 activated apoptosis and induced G1-S cell cycle arrest in CRC cells. LB-100 inhibited PP2A activity and activated AMPK signaling in CRC cells. AMPKa1 dominant negative mutation, shRNA-mediated knockdown or complete knockout (by CRISPR/Cas9 method) largely attenuated LB-100-induced AMPK activation and HCT-116 cytotoxicity. Notably, microRNA-17-92-mediated silence of PP2A (regulatory B subunit) also activated AMPK and induced HCT-116 cell death. Such effects were again largely attenuated by AMPKa mutation, silence or complete knockout. In vivo studies showed that intraperitoneal injection of LB-100 inhibited HCT-116 xenograft growth in nude mice. Its anti-tumor activity was largely compromised against HCT-116 tumors-derived from AMPKa1-knockout cells. We conclude that targeting PP2A by LB-100 and microRNA-17-92 activates AMPK signaling to inhibit CRC cells.	[Dai, Cuiping] Jiangsu Food & Pharmaceut Sci Coll, Fac Hlth, Huaian, Peoples R China; [Zhang, Xuning; Tang, Peipei; Li, Chunmei; Xue, Caiping] Jiangsu Coll Nursing, Huaian Key Lab Gastrointestinal Canc, Huaian, Peoples R China; [Xie, Da] Nanjing Med Univ, Affiliated Hosp 2, Oncol Dept, Nanjing, Jiangsu, Peoples R China; [Zuo, Yi] Nantong Univ, Dept Med, Xinglin Coll, Nantong, Peoples R China; [Jiang, Baofei] First Peoples Hosp Huaian City, Gastrointestinal Surg, Huaian, Peoples R China	Xue, CP (reprint author), Jiangsu Coll Nursing, Huaian Key Lab Gastrointestinal Canc, Huaian, Peoples R China.; Jiang, BF (reprint author), First Peoples Hosp Huaian City, Gastrointestinal Surg, Huaian, Peoples R China.	slhjliangcq@163.com; xuecplwtg@163.com			"533 Talents Project" of Huaian City; Medical Technology Development Project of Health Department of Jiangsu Province [J200912]; Social Development Fund of Technology Project, in Huaian City, Jiangsu Province, China [HAS2009002-3]; Science and Technology Development Project, in Huaian City, Jiangsu Province, China [HAS2009002-3, HAS201605]	This study was supported in part by the "533 Talents Project" research project in 2011 of Huaian City (Hygiene category 78), by the Medical Technology Development Project of Health Department of Jiangsu Province (J200912), by the Social Development Fund of Technology Project, in Huaian City, Jiangsu Province, China (HAS2009002-3) and by the Science and Technology Development Project, in Huaian City, Jiangsu Province, China (HAS201605 and HAS2009002-3).	Bai XL, 2014, MOL CANCER THER, V13, P2062, DOI 10.1158/1535-7163.MCT-13-0800; Bai XL, 2014, CANCER LETT, V355, P281, DOI 10.1016/j.canlet.2014.09.048; Chang KE, 2015, MOL CANCER THER, V14, P90, DOI 10.1158/1535-7163.MCT-14-0496; Chen GQ, 2015, ONCOTARGET, V6, P24148, DOI 10.18632/oncotarget.4376; Chen MB, 2017, ONCOTARGET, V8, P31288, DOI 10.18632/oncotarget.16126; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen MB, 2014, CELL SIGNAL, V26, P102, DOI 10.1016/j.cellsig.2013.07.017; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Chung V, 2017, CLIN CANCER RES, V23, P3277, DOI 10.1158/1078-0432.CCR-16-2299; Cunningham CE, 2016, ONCOTARGET, V7, P61544, DOI 10.18632/oncotarget.11399; Dal Bo M, 2015, ONCOTARGET, V6, P19381; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Francipane MG, 2014, ONCOTARGET, V5, P49, DOI 10.18632/oncotarget.1548                                                        ; Fu QH, 2016, TUMOR BIOL, V37, P7277, DOI 10.1007/s13277-015-4560-2; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; Gordon IK, 2015, MOL CANCER THER, V14, P1540, DOI 10.1158/1535-7163.MCT-14-0614; Guo SG, 2017, BIOCHEM BIOPH RES CO, V487, P660, DOI 10.1016/j.bbrc.2017.04.111; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jablonska E, 2017, EXP HEMATOL, V46, P56, DOI 10.1016/j.exphem.2016.09.011; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jo DH, 2014, ONCOTARGET, V5, P11513, DOI 10.18632/oncotarget.2546                                                        ; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kaur A, 2016, BIOCHEM SOC T, V44, P1683, DOI 10.1042/BST20160161; Khanna A, 2013, CANCER RES, V73, P6548, DOI 10.1158/0008-5472.CAN-13-1994; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuipers EJ, 2013, NAT REV CLIN ONCOL, V10, P130, DOI 10.1038/nrclinonc.2013.12; Lai TY, 2016, ONCOTARGET, V7, P4542, DOI 10.18632/oncotarget.6609; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Li C, 2015, CANCER BIOL THER, V16, P34, DOI 10.4161/15384047.2014.972274; Li JP, 2016, ONCOTARGET, V7, P77815, DOI 10.18632/oncotarget.12802; Li KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25525; Li ZW, 2016, ONCOTARGET; Lu PH, 2016, ONCOTARGET, V7, P45889, DOI 10.18632/oncotarget.9969; Lu XS, 2017, ONCOTARGET, V8, P988, DOI 10.18632/oncotarget.13519; McCarthy N., 2014, NAT REV CANCER, V14, P297; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pandurangan AK, 2013, ASIAN PAC J CANCER P, V14, P2201, DOI 10.7314/APJCP.2013.14.4.2201; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Perera ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095549; Pineda CT, 2015, AUTOPHAGY, V11, P844, DOI 10.1080/15548627.2015.1034420; Plews RL, 2015, J CLIN ENDOCR METAB, V100, pE748, DOI 10.1210/jc.2014-1777; Qin LS, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0174-1; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saxton RA, 2017, CELL, V168, P960, DOI 10.1016/j.cell.2017.02.004; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2000.7630; Wang L, 2016, ONCOTARGET, V7, P51713, DOI 10.18632/oncotarget.10563; Wu L, 2015, BIOCHEM BIOPH RES CO, V466, P547, DOI 10.1016/j.bbrc.2015.09.068; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Zhang WF, 2015, ONCOTARGET, V6, P5253, DOI 10.18632/oncotarget.2867                                                        ; Zhao Z, 2017, ONCOTARGET, V8, P18312, DOI 10.18632/oncotarget.15436; Zhijun H, 2016, TUMOUR BIOL	69	0	0	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	NOV 10	2017	8	56					95810	95823		10.18632/oncotarget.21336				14	Oncology; Cell Biology	Oncology; Cell Biology	FM3VP	WOS:000414937900062	29221169				2018-01-05	
J	Wu, DM; Ma, LP; Song, GL; Long, Y; Liu, HX; Liu, Y; Ping, J				Wu, Dong-Mei; Ma, Liang-Peng; Song, Gui-Li; Long, Yong; Liu, Han-Xiao; Liu, Yang; Ping, Jie			Steroidogenic factor-1 hypermethylation in maternal rat blood could serve as a biomarker for intrauterine growth retardation	ONCOTARGET			English	Article						steroidogenic factor-1 (SF-1); DNA methylation; intrauterine growth retardation (IUGR); clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9); biomarker	FETAL ADRENAL STEROIDOGENESIS; DNA METHYLATION; EPIGENETIC ALTERATIONS; HISTONE ACETYLATION; FOOD RESTRICTION; OFFSPRING RATS; EXPRESSION; IUGR; ASSOCIATION; PREGNANCY	Intrauterine growth retardation (IUGR) is a common obstetric complication lacking an optimal method for prenatal screening. DNA methylation profile in maternal blood holds significant promise for prenatal screening. Here, we aimed to screen out potential IUGR biomarkers in maternal blood from the perspective of DNA methylation. The IUGR rat model was established by prenatal maternal undernutrition. High-throughput bisulfite sequencing of genomic DNA methylation followed by functional clustering analysis for differentially methylated region (DMR)-associated genes demonstrated that genes regulating transcription had the most significantly changed DNA methylation status in maternal blood with IUGR. Genes about apoptosis and placental development were also changed. Besides increased placental apoptosis, IUGR rats demonstrated the same hypermethylated CpG sites of steroidogenic factor-1 (SF-1, a DMR-associated transcription factor about placenta) promoter in maternal blood and placentae. Further, ff1b, the SF-1 ortholog, was knocked out in zebrafish by CRISPR/Cas9 technology. The knock-out zebrafish demonstrated developmental inhibition and increased IUGR rates, which confirmed the role of SF-1 in IUGR development. Finally, hypermethylated SF-1 was observed in human maternal blood of IUGR. This study firstly presented distinct DNA methylation profile in maternal blood of IUGR and showed hypermethylated SF-1 could be a potential IUGR biomarker in maternal rat blood.	[Wu, Dong-Mei; Ma, Liang-Peng; Liu, Han-Xiao; Liu, Yang; Ping, Jie] Wuhan Univ, Sch Basic Med Sci, Dept Pharmacol, Wuhan 430071, Hubei, Peoples R China; [Song, Gui-Li; Long, Yong] Chinese Acad Sci, Key Lab Biodivers & Conservat Aquat Organism, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; [Ma, Liang-Peng] Wuhan First Hosp, Dept Pharm, Wuhan 430022, Hubei, Peoples R China	Ping, J (reprint author), Wuhan Univ, Sch Basic Med Sci, Dept Pharmacol, Wuhan 430071, Hubei, Peoples R China.	pingjie@whu.edu.cn			National Natural Science Foundation of China [81673215, 81273107]; Applied Fundamental Research Project of Wuhan [2017060201010199]	This work was supported by Grants from the National Natural Science Foundation of China (No. 81673215, 81273107), and the Applied Fundamental Research Project of Wuhan (No. 2017060201010199).	Bamberger A M, 1996, Mol Hum Reprod, V2, P457, DOI 10.1093/molehr/2.6.457; Bamfo JEAK, 2011, J PREGNANCY, DOI 10.1155/2011/640715; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Chai C, 2003, DEV BIOL, V260, P226, DOI 10.1016/S0012-1606(03)00219-7; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016506; Cunningham F, 2010, WILLIAMS OBSTET; El-Baz MAH, 2015, ENVIRON TOXICOL PHAR, V39, P589, DOI 10.1016/j.etap.2015.01.009; Engelbregt MJT, 2001, PEDIATR RES, V50, P474, DOI 10.1203/00006450-200110000-00009; Flores-Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044152; Fonseca BM, 2012, REPROD BIOL, V12, P97, DOI 10.1016/S1642-431X(12)60080-1                                                   ; Da Silveira VMF, 2008, REV SAUDE PUBL, V42, P10, DOI 10.1590/S0034-89102008000100002; Gascoin-Lachambre G, 2010, PLACENTA, V31, P151, DOI 10.1016/j.placenta.2009.11.008; Genbacev O, 2003, REPROD TOXICOL, V17, P509, DOI 10.1016/S0890-6238(03)00094-7; Gluckman PD, 1997, HORM RES, V48, P11, DOI 10.1159/000191257                                                               ; Hermsen SAB, 2011, TOXICOL IN VITRO, V25, P745, DOI 10.1016/j.tiv.2011.01.005; Hoivik EA, 2013, MOL CELL ENDOCRINOL, V371, P133, DOI 10.1016/j.mce.2012.12.028; Huang HG, 2015, TOXICOL APPL PHARM, V288, P84, DOI 10.1016/j.taap.2015.07.005; Huang J, 2012, CLIN EXP PHARMACOL P, V39, P357, DOI 10.1111/j.1440-1681.2012.05676.x; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Ivorra C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0384-5; Jia RZ, 2014, CELL PHYSIOL BIOCHEM, V34, P628, DOI 10.1159/000363028; Kim MJ, 2013, PLACENTA, V34, P57, DOI 10.1016/j.placenta.2012.11.001; Kundakovic M, 2015, P NATL ACAD SCI USA, V112, P6807, DOI 10.1073/pnas.1408355111; Leeuwerke M, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.131698; Liu L, 2014, DRUG METAB REV, V45, P49; Longtine MS, 2012, PLACENTA, V33, P352, DOI 10.1016/j.placenta.2012.01.017; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Mazilu JK, 2010, MOL GENET METAB, V101, P391, DOI 10.1016/j.ymgme.2010.09.011; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Parviainen H, 2013, PATHOL RES PRACT, V209, P503, DOI 10.1016/j.prp.2013.06.002; Ping J, 2014, TOXICOLOGY, V321, P53, DOI 10.1016/j.tox.2014.03.011; Poudel R, 2015, AM J PHYSIOL-REG I, V308, pR151, DOI 10.1152/ajpregu.00036.2014; Rahat B, 2016, PLACENTA, V44, P46, DOI 10.1016/j.placenta.2016.06.003; Reamon-Buettner SM, 2014, REPROD TOXICOL, V45, P117, DOI 10.1016/j.reprotox.2014.02.009; Rena V, 2011, MOL ENDOCRINOL, V25, P1364, DOI 10.1210/me.2010-0503; Shang XY, 2014, FISH SHELLFISH IMMUN, V40, P154, DOI 10.1016/j.fsi.2014.06.033; Sifakis S, 2015, MOL MED REP, V11, P2367, DOI 10.3892/mmr.2014.3118; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Su EJ, 2007, BIOL REPROD, V77, P517, DOI 10.1095/bioreprod.106.059451; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; van der Linde S, 2014, J DEV ORIG HLTH DIS, V5, P314, DOI 10.1017/S2040174414000245; Vidmar T, 2011, DEV REPROD TOXICOLOG, P542; Waddell BJ, 2012, PLACENTA, V33, P533, DOI 10.1016/j.placenta.2012.03.008; Whitehead CL, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.011; Whitehead CL, 2013, J CLIN ENDOCR METAB, V98, pE429, DOI 10.1210/jc.2012-2468; Yan YE, 2014, TOXICOL APPL PHARM, V277, P231, DOI 10.1016/j.taap.2014.03.019; Zhang L, 2013, ARCH MED RES, V44, P335, DOI 10.1016/j.arcmed.2013.07.006	49	0	0	5	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	NOV 10	2017	8	56					96139	96153		10.18632/oncotarget.21767				15	Oncology; Cell Biology	Oncology; Cell Biology	FM3VP	WOS:000414937900086	29221193				2018-01-05	
J	McGovern, JL; Wright, GP; Stauss, HJ				McGovern, Jenny L.; Wright, Graham P.; Stauss, Hans J.			Engineering Specificity and Function of Therapeutic Regulatory T Cells	FRONTIERS IN IMMUNOLOGY			English	Review						regulatory T cells; gene therapy; immunotherapy; chimeric antigen receptor; T cell receptor; autoimmunity	CHIMERIC ANTIGEN RECEPTOR; CENTRAL-NERVOUS-SYSTEM; FOXP3 EXPRESSION; IN-VITRO; RHEUMATOID-ARTHRITIS; EPIGENETIC CHANGES; RESPONSES; SUPPRESSION; GAMMA; TREG	Adoptive therapy with polyclonal regulatory T cells (Tregs) has shown efficacy in sup-pressing detrimental immune responses in experimental models of autoimmunity and transplantation. The lack of specificity is a potential limitation of Treg therapy, as studies in mice have demonstrated that specificity can enhance the therapeutic potency of Treg. We will discuss that vectors encoding T cell receptors or chimeric antigen receptors provide an efficient gene-transfer platform to reliably produce Tregs of defined antigen specificity, thus overcoming the considerable difficulties of isolating low-frequency, antigen-specific cells that may be present in the natural Treg repertoire. The recent observations that Tregs can polarize into distinct lineages similar to the Th1, Th2, and Th17 subsets described for conventional T helper cells raise the possibility that Th1-, Th2-, and Th17-driven pathology may require matching Treg subsets for optimal therapeutic efficacy. In the future, genetic engineering may serve not only to enforce FoxP3 expression and a stable Treg phenotype but it may also enable the expression of particular transcription factors that drive differentiation into defined Treg subsets. Together, established and recently developed gene transfer and editing tools provide exciting opportunities to produce tailor-made antigen-specific Treg products with defined functional activities.	[McGovern, Jenny L.; Stauss, Hans J.] UCL, Inst Immun & Transplantat, Royal Free Hosp, UCL Div Infect & Immun, London, England; [Wright, Graham P.] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland	Stauss, HJ (reprint author), UCL, Inst Immun & Transplantat, Royal Free Hosp, UCL Div Infect & Immun, London, England.	h.stauss@ucl.ac.uk			Experimental Cancer Medicine Centre; Wellcome Trust [109677/15/Z]; Bloodwise Programme Award [13004]; UK NIHR UCL/UCLH Biomedical Research Centre, UK	This study was supported by Experimental Cancer Medicine Centre, UK NIHR UCL/UCLH Biomedical Research Centre, UK; Wellcome Trust Pathfinder Award (109677/15/Z); and Bloodwise Programme Award (13004).	AARDA, 2011, COST BURD AUT DIS LA; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Blat D, 2014, MOL THER, V22, P1018, DOI 10.1038/mt.2014.41; Boardman DA, 2017, AM J TRANSPLANT, V17, P931, DOI 10.1111/ajt.14185; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Curran KJ, 2012, J GENE MED, V14, P405, DOI 10.1002/jgm.2604; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Elinav E, 2009, GASTROENTEROLOGY, V136, P1721, DOI 10.1053/j.gastro.2009.01.049; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Golovina TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015868; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Hull CM, 2017, J AUTOIMMUN, V79, P63, DOI 10.1016/j.jaut.2017.01.001; Kim YC, 2015, BLOOD, V125, P1107, DOI 10.1182/blood-2014-04-566786; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712                                                     ; Lahl K, 2009, J IMMUNOL, V183, P5662, DOI 10.4049/jimmunol.0803762; Lerner A, 2015, INT J CELIAC DIS, V3, P151, DOI [10.12691/ijcd-3-4-8, DOI 10.12691/IJCD-3-4-8]; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; MacDonald KG, 2016, J CLIN INVEST, V126, P1413, DOI 10.1172/JCI82771; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2005, ARTHRITIS RHEUM, V52, P2212, DOI 10.1002/art.21195; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Nomura M, 2017, TRANSPL IMMUNOL, V42, P24, DOI 10.1016/j.trim.2017.05.002; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schiaffino S, 2017, FEBS J, V284, P517, DOI 10.1111/febs.13827; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tresoldi E, 2011, HAEMATOL-HEMATOL J, V96, P1357, DOI 10.3324/haematol.2011.041483; Velica P, 2015, CANCER RES, V75, P2641, DOI 10.1158/0008-5472.CAN-14-3283; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Yoon J, 2017, BLOOD, V129, P238, DOI 10.1182/blood-2016-07-727834	47	0	0	8	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 10	2017	8								1517	10.3389/fimmu.2017.01517				6	Immunology	Immunology	FM2SW	WOS:000414851200001	29176976	gold			2018-01-05	
J	Harrington, LB; Paez-Espino, D; Staahl, BT; Chen, JS; Ma, EB; Kyrpides, NC; Doudna, JA				Harrington, Lucas B.; Paez-Espino, David; Staahl, Brett T.; Chen, Janice S.; Ma, Enbo; Kyrpides, Nikos C.; Doudna, Jennifer A.			A thermostable Cas9 with increased lifetime in human plasma	NATURE COMMUNICATIONS			English	Article							NEISSERIA-MENINGITIDIS; HALF-LIFE; DUAL-RNA; SYSTEMS; PROTEINS; THERAPEUTICS; CRISPR-CAS9; PREDICTION; EVOLUTION; CLEAVAGE	CRISPR-Cas9 is a powerful technology that has enabled genome editing in a wide range of species. However, the currently developed Cas9 homologs all originate from mesophilic bacteria, making them susceptible to degradation and unsuitable for applications requiring cleavage at elevated temperatures. Here, we show that the Cas9 protein from the thermophilic bacterium Geobacillus stearothermophilus (GeoCas9) catalyzes RNA-guided DNA cleavage at elevated temperatures. GeoCas9 is active at temperatures up to 70 degrees C, compared to 45 degrees C for Streptococcus pyogenes Cas9 (SpyCas9), which expands the temperature range for CRISPR-Cas9 applications. We also found that GeoCas9 is an effective tool for editing mammalian genomes when delivered as a ribonucleoprotein (RNP) complex. Together with an increased lifetime in human plasma, the thermostable GeoCas9 provides the foundation for improved RNP delivery in vivo and expands the temperature range of CRISPR-Cas9.	[Harrington, Lucas B.; Staahl, Brett T.; Chen, Janice S.; Ma, Enbo; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Paez-Espino, David; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Paez-Espino, David/0000-0002-2939-5398; Kyrpides, Nikos/0000-0002-6131-0462	Paul G. Allen Frontiers Group; National Science Foundation [MCB-1244557]	We thank A. Tambe, N. Ma, and K. Zhou for technical assistance and discussions. L.B.H. and J.S.C. are supported by US National Science Foundation Graduate Research Fellowships. J.A.D. is an investigator of the Howard Hughes Medical Institute. This research was supported in part by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group and the National Science Foundation (MCB-1244557 to J.A.D.).	Amrani N., 2017, PREPRINT; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L., 2013, SCIENCE; Cordova LT, 2015, METAB ENG, V32, P74, DOI 10.1016/j.ymben.2015.09.009; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Donk P J, 1920, J Bacteriol, V5, P373; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland A. E., 2015, GENOME BIOL; FUJII M, 1983, J BACTERIOL, V154, P831; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Ingram L. O., 2010, J BIOMED BIOTECHNOL, V2010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver B. P., 2015, NATURE; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LI YJ, 2016, NUCLEIC ACIDS RES, V44; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mougiakos I., 2017, ACS SYNTH BIOL; Narasimhan D, 2010, PROTEIN ENG DES SEL, V23, P537, DOI 10.1093/protein/gzq025; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Staahl B. T., 2017, NAT BIOTECHNOL; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xiang G., 2016, J GENET GENOMICS; Zeldes BM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01209; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	46	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 10	2017	8								1424	10.1038/s41467-017-01408-4				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FM2YR	WOS:000414869900010	29127284	gold			2018-01-05	
J	Shibata, M; Nishimasu, H; Kodera, N; Hirano, S; Ando, T; Uchihashi, T; Nureki, O				Shibata, Mikihiro; Nishimasu, Hiroshi; Kodera, Noriyuki; Hirano, Seiichi; Ando, Toshio; Uchihashi, Takayuki; Nureki, Osamu			Real-space and real-time dynamics of CRISPR-Cas9 visualized by high-speed atomic force microscopy	NATURE COMMUNICATIONS			English	Article							TARGET DNA RECOGNITION; CRYSTAL-STRUCTURE; RNA; CAS9; COMPLEX; ENDONUCLEASE; CLEAVAGE; IMMUNITY; INTERROGATION; SYSTEMS	The CRISPR-associated endonuclease Cas9 binds to a guide RNA and cleaves double-stranded DNA with a sequence complementary to the RNA guide. The Cas9-RNA system has been harnessed for numerous applications, such as genome editing. Here we use high-speed atomic force microscopy (HS-AFM) to visualize the real-space and real-time dynamics of CRISPR-Cas9 in action. HS-AFM movies indicate that, whereas apo-Cas9 adopts unexpected flexible conformations, Cas9-RNA forms a stable bilobed structure and interrogates target sites on the DNA by three-dimensional diffusion. These movies also provide real-time visualization of the Cas9-mediated DNA cleavage process. Notably, the Cas9 HNH nuclease domain fluctuates upon DNA binding, and subsequently adopts an active conformation, where the HNH active site is docked at the cleavage site in the target DNA. Collectively, our HS-AFM data extend our understanding of the action mechanism of CRISPR-Cas9.	[Shibata, Mikihiro] Kanazawa Univ, Inst Frontier Sci Initiat, High Speed AFM Biol Applicat Unit, Kanazawa, Ishikawa 9201192, Japan; [Shibata, Mikihiro; Kodera, Noriyuki; Ando, Toshio; Uchihashi, Takayuki] Kanazawa Univ, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Nishimasu, Hiroshi; Hirano, Seiichi; Nureki, Osamu] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Nishimasu, Hiroshi; Kodera, Noriyuki] JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Ando, Toshio; Uchihashi, Takayuki] JST, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Uchihashi, Takayuki] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki] Nagoya Univ, Dept Phys, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Shibata, M (reprint author), Kanazawa Univ, Inst Frontier Sci Initiat, High Speed AFM Biol Applicat Unit, Kanazawa, Ishikawa 9201192, Japan.; Shibata, M (reprint author), Kanazawa Univ, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan.; Nishimasu, H; Nureki, O (reprint author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.; Nishimasu, H (reprint author), JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	msshibata@staff.kanazawa-u.ac.jp; nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp	Uchihashi, Takayuki/D-5209-2011		Kao Foundation for Arts and Science; Brain Science Foundation; JST/PRESTO [JPMJPR13L8, JPMJPR13L4]; JST/CREST [JPMJCR13M1]; Japan Agency for Medical Research and Development, AMED; JSPS KAKENHI [JP16K18523, 26291010, 15H01463, 15H04360, 24227005, 26119003, 16H00830, 16H00758, 15H03540]	This work was supported by the Kao Foundation for Arts and Science (M.S.), the Brain Science Foundation (M.S.), JST/PRESTO (H.N. (JPMJPR13L8) and N.K. (JPMJPR13L4)), JST/CREST (T.A. (JPMJCR13M1)), the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED (O.N.), and JSPS KAKENHI Grant Numbers JP16K18523 (M.S.), 26291010 and 15H01463 (H.N.), 15H04360 (N.K.), 24227005 and 26119003 (T.A.), and 16H00830, 16H00758 and 15H03540 (T.U.).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Ando T, 2014, CHEM REV, V114, P3120, DOI 10.1021/cr4003837; Chiaruttini N, 2015, CELL, V163, P866, DOI 10.1016/j.cell.2015.10.017; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dagdas YS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao0027; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Miyagi A, 2016, NAT NANOTECHNOL, V11, P783, DOI [10.1038/nnano.2016.89, 10.1038/NNANO.2016.89]; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	31	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 10	2017	8								1430	10.1038/s41467-017-01466-8				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM2YR	WOS:000414869900016	29127285	gold			2018-01-05	
J	van Rooijen, R; Kruijer, W; Boesten, R; van Eeuwijk, FA; Harbinson, J; Aarts, MGM				van Rooijen, Roxanne; Kruijer, Willem; Boesten, Rene; van Eeuwijk, Fred A.; Harbinson, Jeremy; Aarts, Mark G. M.			Natural variation of YELLOW SEEDLING1 affects photosynthetic acclimation of Arabidopsis thaliana	NATURE COMMUNICATIONS			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; LIGHT ENVIRONMENT; PLANT-LEAVES; EXCESS LIGHT; GROWTH; EXPRESSION; NUCLEAR; GT-1	Exploiting genetic variation for more efficient photosynthesis is an underexplored route towards new crop varieties. This study demonstrates the genetic dissection of higher plant photosynthesis efficiency down to the genomic DNA level, by confirming that allelic sequence variation at the Arabidopsis thaliana YELLOW SEEDLING1 (YS1) gene explains natural diversity in photosynthesis acclimation to high irradiance. We use a genome-wide association study to identify quantitative trait loci (QTLs) involved in the Arabidopsis photosynthetic acclimation response. Candidate genes underlying the QTLs are prioritized according to functional clues regarding gene ontology, expression and function. Reverse genetics and quantitative complementation confirm the candidacy of YS1, which encodes a pentatrico-peptide-repeat (PPR) protein involved in RNA editing of plastid-encoded genes (anterograde signalling). Gene expression analysis and allele sequence comparisons reveal polymorphisms in a light-responsive element in the YS1 promoter that affect its expression, and that of its downstream targets, resulting in the variation in photosynthetic acclimation.	[van Rooijen, Roxanne; Boesten, Rene; Aarts, Mark G. M.] Wageningen Univ & Res, Lab Genet, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [van Rooijen, Roxanne; Harbinson, Jeremy] Wageningen Univ & Res, Hort & Prod Physiol Grp, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Kruijer, Willem; van Eeuwijk, Fred A.] Wageningen Univ & Res, Math & Stat Methods Grp Biometris, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [van Rooijen, Roxanne] Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany	Aarts, MGM (reprint author), Wageningen Univ & Res, Lab Genet, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	mark.aarts@wur.nl		Aarts, Mark/0000-0001-5257-0740; van Rooijen, Roxanne/0000-0002-7867-2670	Dutch Ministry of Economic Affairs; Dutch Technology Foundation (STW), part of Netherlands Organisation for Scientific Research (NWO)	We thank Prof Dr Maarten Koornneef, Dr Padraic Flood, and Dr Aina Prinzenberg for critical reading of the manuscript; Prof Dr Christoph Benning for his kind donation of the knock-out line for DGS1; and Dr Akira Suzuki for his kind donation of the knock-out line for ASN2. This project was carried out within the research programme of BioSolar Cells, co-financed by the Dutch Ministry of Economic Affairs. W.K. was partially funded by the Learning from Nature project of the Dutch Technology Foundation (STW), which is part of the Netherlands Organisation for Scientific Research (NWO).	Bac-Molenaar JA, 2015, J EXP BOT, V66, P5567, DOI 10.1093/jxb/erv176; Bailey S, 2004, PLANTA, V218, P793, DOI 10.1007/s00425-003-1158-5; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Driever SM, 2014, J EXP BOT, V65, P4959, DOI 10.1093/jxb/eru253; Flood PJ, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0113-y; Flood PJ, 2011, TRENDS PLANT SCI, V16, P327, DOI 10.1016/j.tplants.2011.02.005; GILMARTIN PM, 1990, PLANT CELL, V2, P447; GILMARTIN PM, 1990, PLANT CELL, V2, P369; Gitelson AA, 2003, J PLANT PHYSIOL, V160, P271, DOI 10.1078/0176-1617-00887; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074<0038:OPANEO>2.0.CO;2; GREEN PJ, 1988, EMBO J, V7, P4035; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Hruz T., 2008, ADV BIOINFORMAT, V2008, P420; Jung HS, 2013, P NATL ACAD SCI USA, V110, P14474, DOI 10.1073/pnas.1311632110; Juszczak I, 2012, PHYSIOL PLANTARUM, V146, P53, DOI 10.1111/j.1399-3054.2012.01602.x; Kindgren P, 2012, PLANT J, V70, P279, DOI 10.1111/j.1365-313X.2011.04865.x; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Long AD, 1996, GENETICS, V144, P1497; Mackay TFC, 2004, NAT GENET, V36, P1145, DOI 10.1038/ng1104-1145                                                             ; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Moore CR, 2013, GENETICS, V195, P1077, DOI 10.1534/genetics.113.153346; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Ouwerkerk PBF, 1999, MOL GEN GENET, V261, P610, DOI 10.1007/s004380050003                                                           ; Perez-Perez JM, 2002, GENETICS, V162, P893; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Simkin AJ, 2015, J EXP BOT, V66, P4075, DOI 10.1093/jxb/erv204; van Rooijen R, 2015, PLANT PHYSIOL, V167, P1412, DOI 10.1104/pp.114.252239; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Williams-Carrier R, 2014, PLANT PHYSIOL, V164, P239, DOI 10.1104/pp.113.228726; Wunder T, 2013, PLANTA, V237, P541, DOI 10.1007/s00425-012-1775-y; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	40	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 10	2017	8								1421	10.1038/s41467-017-01576-3				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM2YR	WOS:000414869900007	29123092	gold			2018-01-05	
J	Rauscher, B; Valentini, E; Hardeland, U; Boutros, M				Rauscher, Benedikt; Valentini, Erica; Hardeland, Ulrike; Boutros, Michael			Phenotype databases for genetic screens in human cells	JOURNAL OF BIOTECHNOLOGY			English	Article						Functional genomics; Database; Phenotype; High-throughput biology; de.NBI; ELIXIR	CANCER-CELLS; RNA INTERFERENCE; CAENORHABDITIS-ELEGANS; GUIDE RNA; IDENTIFICATION; RESOURCE; DESIGN; GENOME; TARGET; REPOSITORY	Genetic screens are powerful tools to identify components that make up biological systems. Perturbations introduced by methods such as RNA interference (RNAi) or CRISPR/Cas9-mediated genome editing lead to biological phenotypes that can be examined to understand the molecular function of genes in the cell. Over the years, many of such experiments have been conducted providing a wealth of knowledge about genotype-to-phenotype relationships. These data are a rich source of information and it is in a common interest to make them available in a simplified and integrated format. Thus, an important challenge is that genetic screening data can be stored in databases in standardized ways, allowing users to gain new biological insights through data mining and integrated analyses. Here, we provide an overview of available phenotype databases for human cells. We review in detail two databases for high-throughput screens, GenomeRNAi and GenomeCRISPR, and describe how these resources are integrated into the German Network for Bioinformatics Infrastructure de.NBI as part of the European infrastructure for life-science information ELIXIR.	[Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany; Heidelberg Univ, D-69120 Heidelberg, Germany	Boutros, M (reprint author), German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany.	m.boutros@dkfz.de			BMBF within the German Network for Bioinformatics Infrastructure (de.NBI) [031A537A]	This work was supported by the BMBF-funded Heidelberg Center for Human Bioinformatics (HD-HuB) within the German Network for Bioinformatics Infrastructure (de.NBI) (Grant #031A537A).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Aguirre A.J., 2016, CANC DISCOVERY, V6; Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6                                                   ; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berthold M. R., 2009, SIGKDD EXPLORATIONS, p[11, 26], DOI DOI 10.1145/1656274.1656280; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Boutros M, 2015, CELL, V163, P1314, DOI 10.1016/j.cell.2015.11.007; Breinig M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156400; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107                                                                ; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer B, 2015, ELIFE, V4, DOI 10.7554/eLife.05464; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Heigwer F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0915-2; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horn T, 2007, NUCLEIC ACIDS RES, V35, pD492, DOI 10.1093/nar/gkl906; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jupp S, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0074-0; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kirsanova C, 2015, BIOINFORMATICS, V31, P2736, DOI 10.1093/bioinformatics/btv199; Kitts PA, 2016, NUCLEIC ACIDS RES, V44, pD73, DOI 10.1093/nar/gkv1226; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maeda I., 2001, NUCLEIC ACIDS RES, V33, pD54; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McEntyre J, 2015, MOL SYST BIOL, V11; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Munoz D.M, 2016, CANC DISCOVERY, V6; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pawlowski N, 2016, BIORXIV; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rauscher B, 2017, NUCLEIC ACIDS RES, V45, pD679, DOI 10.1093/nar/gkw997; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shamu CE, 2012, NAT CELL BIOL, V14, P115, DOI 10.1038/ncb2435; SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/nmeth.2655, 10.1038/NMETH.2655]; Stelzer G, 2016, CURRENT PROTOCOLS BI; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Williams E., 2017, BIORXIV; Winter J., 2017, BIORXIV; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	59	0	0	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656	1873-4863		J BIOTECHNOL	J. Biotechnol.	NOV 10	2017	261				SI		63	69		10.1016/j.jbiotec.2017.06.008				7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FK6BB	WOS:000413586900008	28625679	gold			2018-01-05	
J	Kuhn, A; Ackermann, M; Mussolino, C; Cathomen, T; Lachmann, N; Moritz, T				Kuhn, Alexandra; Ackermann, Mania; Mussolino, Claudio; Cathomen, Toni; Lachmann, Nico; Moritz, Thomas			TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis	SCIENTIFIC REPORTS			English	Article							PLURIPOTENT STEM-CELLS; CHRONIC GRANULOMATOUS-DISEASE; SEVERE COMBINED IMMUNODEFICIENCY; CHROMATIN OPENING ELEMENT; GENE-THERAPY; HEMATOPOIETIC DIFFERENTIATION; POINT MUTATION; PATIENT; TRANSPLANTATION; NUCLEASES	Hereditary pulmonary alveolar proteinosis (herPAP) constitutes a rare, life threatening lung disease characterized by the inability of alveolar macrophages to clear the alveolar airspaces from surfactant phospholipids. On a molecular level, the disorder is defined by a defect in the CSF2RA gene coding for the GM-CSF receptor alpha-chain (CD116). As therapeutic options are limited, we currently pursue a cell and gene therapy approach aiming for the intrapulmonary transplantation of gene-corrected macrophages derived from herPAP-specific induced pluripotent stem cells (herPAP-iPSC) employing transcriptional activator-like effector nucleases (TALENs). Targeted insertion of a codon-optimized CSF2RA-cDNA driven by the hybrid cytomegalovirus (CMV) early enhancer/chicken beta actin (CAG) promoter into the AAVS1 locus resulted in robust expression of the CSF2RA gene in gen-edited herPAP-iPSCs as well as thereof derived macrophages. These macrophages displayed typical morphology, surface phenotype, phagocytic and secretory activity, as well as functional CSF2RA expression verified by STAT5 phosphorylation and GM-CSF uptake studies. Thus, our study provides a proof-of-concept, that TALEN-mediated integration of the CSF2RA gene into the AAVS1 safe harbor locus in patient-specific iPSCs represents an efficient strategy to generate functionally corrected monocytes/macrophages, which in the future may serve as a source for an autologous cell-based gene therapy for the treatment of herPAP.	[Kuhn, Alexandra; Ackermann, Mania; Lachmann, Nico; Moritz, Thomas] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Kuhn, Alexandra; Moritz, Thomas] REBIRTH Cluster Excellence, RG Reprogramming & Gene Therapy, Hannover, Germany; [Ackermann, Mania; Lachmann, Nico] REBIRTH Cluster Excellence, JRG Translat Hematol Congenital Dis, Hannover, Germany; [Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Inst Transfus Med & Gene Therapy, Freiburg, Germany; [Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany	Moritz, T (reprint author), Hannover Med Sch, Inst Expt Hematol, Hannover, Germany.; Moritz, T (reprint author), REBIRTH Cluster Excellence, RG Reprogramming & Gene Therapy, Hannover, Germany.	Moritz.thomas@mh-hannover.de		Lachmann, Nico/0000-0002-4245-1497; Cathomen, Toni/0000-0002-7757-4630	Deutsche Forschungsgemeinschaft (Cluster of excellence REBIRTH) [Exc 62/1, LA 3680/2-1]; Else Kroner-Fresenius-Stiftung (EKFS) [2013_A24, 2015_A92]; German Federal Ministry of Education and Research (BMBF) [01EO0803]; MHH (young academy); Cluster of Excellence, REBIRTH; Hannover Biomedical Research School (HBRS) at the MHH	The authors thank Anne-Kathrin Dreyer (Institute of Experimental Hematology, Hannover Medical School (MHH), Hannover, Germany; current: Max-Delbruck-Center for Molecular Medicine, Berlin, Germany) and Sylvia Merkert (Leibniz Forschungslaboratorien fur Biotechnologie und kunstliche Organe (LEBAO), MHH) for providing donor plasmids. We also thank Doreen Luttge and Theresa Buchegger (Institute of Experimental Hematology, MHH) for their excellent technical support. The authors also thank Johann Meyer (Institute of Experimental Hematology, MHH) for his support regarding the Southern Blot technology and Sabine Schild (Fraunhofer-Institut fur Toxikologie und Experimentelle Medizin (ITEM), Hannover, Germany) for her help with the pHRodo Assay. This work was supported by grants from Deutsche Forschungsgemeinschaft (Cluster of excellence REBIRTH Exc 62/1 (T.M. and N.L.), grant LA 3680/2-1 (N.L.)), the Else Kroner-Fresenius-Stiftung (EKFS), grant 2013_A24 (T.M.) and 2015_A92 (N.L.), the German Federal Ministry of Education and Research (BMBF) grant 01EO0803 (C.M. and T.C.). This work was further supported by the MHH (young academy; N.L.) and a stipend from the Cluster of Excellence, REBIRTH and the Hannover Biomedical Research School (HBRS) at the MHH (A.K.).	Ackermann M, 2017, TRANSFUS MED HEMOTH, V44, P135, DOI 10.1159/000477129; Ackermann M, 2014, BIOMATERIALS, V35, P1531, DOI 10.1016/j.biomaterials.2013.11.024; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Brendel C, 2012, GENE THER, V19, P1018, DOI 10.1038/gt.2011.167; Brendel C, 2013, HUM GENE THER METHOD, V24, P151, DOI 10.1089/hgtb.2012.157; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chang CW, 2015, CELL REP, V12, P1668, DOI 10.1016/j.celrep.2015.08.013; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; Dreyer AK, 2015, BIOMATERIALS, V69, P191, DOI 10.1016/j.biomaterials.2015.07.057; Dvorak C, 2008, BONE MARROW TRANSPL, V41, P119, DOI 10.1038/sj.bmt.1705890; Flynn R, 2015, EXP HEMATOL, V43, P838, DOI 10.1016/j.exphem.2015.06.002; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Kustikova OS, 2009, MOL THER, V17, P1537, DOI 10.1038/mt.2009.134; Lachmann N, 2015, STEM CELL REP, V4, P282, DOI 10.1016/j.stemcr.2015.01.005; Lachmann N, 2014, AM J RESP CRIT CARE, V189, P167, DOI 10.1164/rccm.201306-1012OC; Litvack ML, 2016, AM J RESP CRIT CARE, V193, P1219, DOI 10.1164/rccm.201509-1838OC; Luo YQ, 2014, STEM CELL TRANSL MED, V3, P821, DOI 10.5966/sctm.2013-0212; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Matsubara Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05043; Menon T, 2015, CELL STEM CELL, V16, P367, DOI 10.1016/j.stem.2015.02.005; Merling RK, 2015, MOL THER, V23, P147, DOI 10.1038/mt.2014.195; Mucci A, 2016, STEM CELL REP, V7, P292, DOI 10.1016/j.stemcr.2016.06.011; Muller-Kuller U, 2015, NUCL ACIDS RES; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Newrzela S, 2008, BLOOD, V112, P2278, DOI 10.1182/blood-2007-12-128751; Ordovas L, 2015, STEM CELL REP, V5, P918, DOI 10.1016/j.stemcr.2015.09.004; Pfaff N, 2013, STEM CELLS, V31, P488, DOI 10.1002/stem.1316; Schwanke K, 2014, HUM GENE THER METHOD, V25, P136, DOI 10.1089/hgtb.2012.248; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Suzuki T, 2014, AM J RESP CRIT CARE, V189, P183, DOI 10.1164/rccm.201306-1039OC; Suzuki T, 2010, AM J RESP CRIT CARE, V182, P1292, DOI 10.1164/rccm.201002.0271OC; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Vollweiler JL, 2003, BONE MARROW TRANSPL, V32, P1, DOI 10.1038/sj.bmt.1704081; Wang XY, 2017, MOL THER-METH CLIN D, V5, P96, DOI 10.1016/j.omtm.2017.03.003; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Zhang HR, 2015, CIRC RES, V117, P17, DOI 10.1161/CIRCRESAHA.117.305860; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	53	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 9	2017	7								15195	10.1038/s41598-017-14566-8				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FM2JK	WOS:000414810800018	29123113	gold			2018-01-05	
J	Vigentini, I; Gebbia, M; Belotti, A; Foschino, R; Roth, FP				Vigentini, Ileana; Gebbia, Marinella; Belotti, Alessandra; Foschino, Roberto; Roth, Frederick P.			CRISPR/Cas9 System as a Valuable Genome Editing Tool for Wine Yeasts with Application to Decrease Urea Production	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR/Cas9 system; saccharomyces cerevisiae; wine; arginine degradation pathway; urea; ethyl carbamate	ETHYL CARBAMATE; SACCHAROMYCES-CEREVISIAE; EFFICIENT TRANSFORMATION; FERMENTATION; PERSPECTIVES; GLUTATHIONE; MINIMIZE; ETHANOL; FOODS; GENE	An extensive repertoire of molecular tools is available for genetic analysis in laboratory strains of S. cerevisiae. Although this has widely contributed to the interpretation of gene functionality within haploid laboratory isolates, the genetics of metabolism in commercially-relevant polyploid yeast strains is still poorly understood. Genetic engineering in industrial yeasts is undergoing major changes due to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) engineering approaches. Here we apply the CRISPR/Cas9 system to two commercial "starter" strains of S. cerevisiae (EC1118, AWRI796), eliminating the CAN1 arginine permease pathway to generate strains with reduced urea production (18.5 and 35.5% for EC1118 and AWRI796, respectively). In a wine-model environment based on two grape musts obtained from Chardonnay and Cabernet Sauvignon cultivars, both S. cerevisiae starter strains and CAN1 mutants completed the must fermentation in 8-12 days. However, recombinant strains carrying the can1 mutation failed to produce urea, suggesting that the genetic modification successfully impaired the arginine metabolism. In conclusion, the reduction of urea production in a wine-model environment confirms that the CRISPR/Cas9 system has been successfully established in S. cerevisiae wine yeasts.	[Vigentini, Ileana; Belotti, Alessandra; Foschino, Roberto] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy; [Gebbia, Marinella; Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Roth, Frederick P.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON, Canada	Vigentini, I (reprint author), Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy.	ileana.vigentini@unimi.it			YeSVitE consortium [612441]; YeSViTE project; Canada Excellence Research Chairs Program	The authors gratefully acknowledge the YeSVitE consortium (FP7-IRSES-2013-GA no. 612441) for helpful discussion and precious collaboration. IV was supported by the YeSViTE project in her secondment to the University of Toronto. FR and MG were supported by the Canada Excellence Research Chairs Program. The authors thank Dr. Daniela Fracassetti and Mrs. Zhou Shijie for excellent technical assistance.	Amerine M. A., 1980, METHODS ANAL MUSTS W; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brouns SJJ, 2012, SCIENCE, V337, P808, DOI 10.1126/science.1227253; Cheng TH, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.24.e108; Chiva R, 2009, J APPL MICROBIOL, V107, P235, DOI 10.1111/j.1365-2672.2009.04201.x; Coulon J, 2006, AM J ENOL VITICULT, V57, P113; Dahabieh MS, 2010, J APPL MICROBIOL, V109, P963, DOI 10.1111/j.1365-2672.2010.04723.x; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fracassetti D, 2015, AUST J GRAPE WINE R, V21, P389, DOI 10.1111/ajgw.12139; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; GYSLER C, 1990, Biotechnology Techniques, V4, P285, DOI 10.1007/BF00158845; Hayama Y, 2002, J BIOSCI BIOENG, V94, P166, DOI 10.1263/jbb.94.166; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Hryhorowicz M, 2017, ARCH IMMUNOL THER EX, V65, P233, DOI 10.1007/s00005-016-0427-5; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lee JS, 2015, BIOTECHNOL J, V10, P979, DOI 10.1002/biot.201500082; Lee KG, 2013, EUR FOOD RES TECHNOL, V236, P891, DOI 10.1007/s00217-013-1953-6; Lu XX, 2015, ANAL METHODS-UK, V7, P1261, DOI 10.1039/c4ay02693d; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; OUGH CS, 1988, AM J ENOL VITICULT, V39, P239; Pribylova L, 2003, J MICROBIOL METH, V55, P481, DOI 10.1016/S0167-7012(03)00197-0; Ryan OW, 2014, METHOD ENZYMOL, V546, P473, DOI 10.1016/B978-0-12-801185-0.00023-4; Sambrook J, 1989, MOL CLONING LAB MANU; STEVENS DF, 1993, AM J ENOL VITICULT, V44, P309; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vincenzini Massimo, 2009, P167, DOI 10.1007/978-3-540-85463-0_9; Weber JV, 2009, ENVIRON CHEM LETT, V7, P233, DOI 10.1007/s10311-008-0168-8; Wu DH, 2014, INT J FOOD MICROBIOL, V180, P19, DOI 10.1016/j.ijfoodmicro.2014.04.007; Xue J, 2015, S AFR J ENOL VITIC, V36, P277; Zhao XR, 2014, APPL ENVIRON MICROB, V80, P392, DOI 10.1128/AEM.03055-13	33	0	0	12	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 9	2017	8								2194	10.3389/fmicb.2017.02194				11	Microbiology	Microbiology	FM2GP	WOS:000414803500001	29163459	gold			2018-01-05	
J	Huai, C; Li, G; Yao, RJ; Zhang, Y; Cao, M; Kong, LL; Jia, CQ; Yuan, H; Chen, HY; Lu, DR; Huang, Q				Huai, Cong; Li, Gan; Yao, Ruijie; Zhang, Yingyi; Cao, Mi; Kong, Liangliang; Jia, Chenqiang; Yuan, Hui; Chen, Hongyan; Lu, Daru; Huang, Qiang			Structural insights into DNA cleavage activation of CRISPR-Cas9 system	NATURE COMMUNICATIONS			English	Article							PROTEIN-STRUCTURE REFINEMENT; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CRYO-EM; ELECTRON-MICROSCOPY; HOLLIDAY JUNCTION; TARGET DNA; CAS9; ENDONUCLEASE; COMPLEX	CRISPR-Cas9 technology has been widely used for genome engineering. Its RNA-guided endonuclease Cas9 binds specifically to target DNA and then cleaves the two DNA strands with HNH and RuvC nuclease domains. However, structural information regarding the DNA cleavage-activating state of two nuclease domains remains sparse. Here, we report a 5.2 angstrom cryo-EM structure of Cas9 in complex with sgRNA and target DNA. This structure reveals a conformational state of Cas9 in which the HNH domain is closest to the DNA cleavage site. Compared with two known HNH states, our structure shows that the HNH active site moves toward the cleavage site by about 25 and 13 angstrom, respectively. In combination with EM-based molecular dynamics simulations, we show that residues of the nuclease domains in our structure could form cleavage-compatible conformations with the target DNA. Together, these results strongly suggest that our cryo-EM structure resembles a DNA cleavage-activating architecture of Cas9.	[Huai, Cong; Li, Gan; Yao, Ruijie; Jia, Chenqiang; Yuan, Hui; Chen, Hongyan; Lu, Daru; Huang, Qiang] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Zhang, Yingyi; Cao, Mi; Kong, Liangliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai 200031, Peoples R China; [Zhang, Yingyi; Cao, Mi; Kong, Liangliang] Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai 201204, Peoples R China	Lu, DR; Huang, Q (reprint author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.	drlu@fudan.edu.cn; huangqiang@fudan.edu.cn			Natural Science Foundation of China [31671386, 91430112, 31571371]; Shanghai Natural Science Foundation [13ZR1402400]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	We are grateful to Dr Bo Wan for his help in the initial phase of this project, Dr Huaxing Zhu, Yuanping Liao (Novoprotein Co., Ltd.) for their assistance in protein expression, Drs. Peng Nan, Jungang Zhou and Jianping Liu for their assistance in protein purification and sample preparation, Dr Junrui Li for their assistance in the single-particle reconstruction, and to Dandan Zhang (Shanghai Supercomputer Center) for her assistance in MD simulation. The cryo-EM data were collected at the National Center for Protein Science Shanghai (NCPSS), Shanghai Institutes for Biological Sciences/Shanghai Science Research Center, Chinese Academy of Sciences. This work was supported by the grants from the Natural Science Foundation of China (31671386 and 91430112 to Q.H., and 31571371 to D.L.), the Shanghai Natural Science Foundation (13ZR1402400 to Q.H.), and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase, to Q.H.).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Ashworth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp242; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Broo KS, 1997, J AM CHEM SOC, V119, P11362, DOI 10.1021/ja970854s                                                               ; Chen HF, 2014, J BIOL CHEM, V289, P13284, DOI 10.1074/jbc.M113.539726; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gorecka KM, 2013, NUCLEIC ACIDS RES, V41, P9945, DOI 10.1093/nar/gkt769; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869                                                                ; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336; Mirjalili V, 2013, J CHEM THEORY COMPUT, V9, P1294, DOI 10.1021/ct300962x; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palermo G, 2015, ACCOUNTS CHEM RES, V48, P220, DOI 10.1021/ar500314j; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wilkinson Royce, 2014, F1000Prime Rep, V6, P3, DOI 10.12703/P6-3; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	35	0	0	21	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 9	2017	8								1375	10.1038/s41467-017-01496-2				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM2IA	WOS:000414807200003	29123204	gold			2018-01-05	
J	Arora, L; Narula, A				Arora, Leena; Narula, Alka			Gene Editing and Crop Improvement Using CRISPR-Cas9 System	FRONTIERS IN PLANT SCIENCE			English	Review						CRISPR/Cas system; genome editing; nutrition improvement; disease resistance; metabolic engineering; gene expression regulation; CRISPR ribonucleoproteins	CRISPR/CAS9-MEDIATED TARGETED MUTAGENESIS; GUIDED SURVEILLANCE COMPLEX; SITE-DIRECTED MUTAGENESIS; SEQUENCE-SPECIFIC CONTROL; ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; CAS SYSTEM; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE	Advancements in Genome editing technologies have revolutionized the fields of functional genomics and crop improvement. CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat)-Cas9 is a multipurpose technology for genetic engineering that relies on the complementarity of the guideRNA (gRNA) to a specific sequence and the Cas9 endonuclease activity. It has broadened the agricultural research area, bringing in new opportunities to develop novel plant varieties with deletion of detrimental traits or addition of significant characters. This RNA guided genome editing technology is turning out to be a groundbreaking innovation in distinct branches of plant biology. CRISPR technology is constantly advancing including options for various genetic manipulations like generating knockouts; making precise modifications, multiplex genome engineering, and activation and repression of target genes. The review highlights the progression throughout the CRISPR legacy. We have studied the rapid evolution of CRISPR/Cas9 tools with myriad functionalities, capabilities, and specialized applications. Among varied diligences, plant nutritional improvement, enhancement of plant disease resistance and production of drought tolerant plants are reviewed. The review also includes some information on traditional delivery methods of Cas9-gRNA complexes into plant cells and incorporates the advent of CRISPR ribonucleoproteins (RNPs) that came up as a solution to various limitations that prevailed with plasmid-based CRISPR system.	[Arora, Leena; Narula, Alka] Jamia Hamdard, Sch Chem & Life Sci, Dept Biotechnol, New Delhi, India	Narula, A (reprint author), Jamia Hamdard, Sch Chem & Life Sci, Dept Biotechnol, New Delhi, India.	alka.narula@rediffmail.com			Frontiers in Plant Science	The article for publication is supported by Frontiers in Plant Science.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Ahloowalia BS, 2001, EUPHYTICA, V118, P167, DOI 10.1023/A:1004162323428; Ainley WM, 2013, PLANT BIOTECHNOL J, V11, P1126, DOI 10.1111/pbi.12107; Alagoz Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30910; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Andersson M, 2017, PLANT CELL REP, V36, P117, DOI 10.1007/s00299-016-2062-3; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bastet A, 2017, TRENDS PLANT SCI, V22, P411, DOI 10.1016/j.tplants.2017.01.008; Bikard David, 2013, F1000Prime Rep, V5, P47, DOI 10.12703/P5-47; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Chen XG, 2017, SCI REP-UK, V7, DOI 10.1038/srep44304; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Collonnier C, 2017, METHODS, V121, P103, DOI 10.1016/j.ymeth.2017.04.024; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Geisinger JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1542; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Halterman D, 2016, AM J POTATO RES, V93, P1, DOI 10.1007/s12230-015-9485-1; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iqbal Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00475; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WZ, 2017, PLANT BIOTECHNOL J, V15, P648, DOI 10.1111/pbi.12663; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RA, 2015, PLANT MOL BIOL, V87, P143, DOI 10.1007/s11103-014-0266-x; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI [10.1038/nbt0709-671a, 10.1038/nbt.1543]; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Lee YJ, 2016, NUCLEIC ACIDS RES, V44, P2462, DOI 10.1093/nar/gkw056; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep43320; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01483; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Petolino JF, 2013, PLANT SCI, V201, P128, DOI 10.1016/j.plantsci.2012.12.006; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Schaeffer SM, 2016, PLANT CELL REP, V35, P1451, DOI 10.1007/s00299-016-1987-x; Senturk S., 2015, NAT COMMUN, V8, P14370, DOI [10.1101/023366, DOI 10.1101/023366]; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sikora P, 2011, INT J PLANT GENOM, V2011, DOI DOI 10.1155/2011/314829; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; Subburaj S, 2016, PLANT CELL REP, V35, P1535, DOI 10.1007/s00299-016-1937-7; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tieman D, 2017, SCIENCE, V355, P391, DOI 10.1126/science.aal1556; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsutsui H, 2017, PLANT CELL PHYSIOL, V58, P46, DOI 10.1093/pcp/pcw191; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu T, 2014, APPL ENVIRON MICROB, V80, P1544, DOI 10.1128/AEM.03786-13; Yang X, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0038-1; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00177; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	136	0	0	52	52	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	NOV 8	2017	8								1932	10.3389/fpls.2017.01932				21	Plant Sciences	Plant Sciences	FM0CC	WOS:000414625400001	29167680	gold			2018-01-05	
J	Coggins, NB; Stultz, J; O'Geen, H; Carvajal-Carmona, LG; Segal, DJ				Coggins, Nicole B.; Stultz, Jacob; O'Geen, Henriette; Carvajal-Carmona, Luis G.; Segal, David J.			Methods for Scarless, Selection-Free Generation of Human Cells and Allele-Specific Functional Analysis of Disease-Associated SNPs and Variants of Uncertain Significance	SCIENTIFIC REPORTS			English	Article							COLORECTAL-CANCER; HUMAN GENOME; MYC; RECOMBINATION; MUTATIONS; RS6983267; REGIONS; REPAIR; DNA	With the continued emergence of risk loci from Genome-Wide Association studies and variants of uncertain significance identified from patient sequencing, better methods are required to translate these human genetic findings into improvements in public health. Here we combine CRISPR/Cas9 gene editing with an innovative high-throughput genotyping pipeline utilizing KASP (Kompetitive Allele-Specific PCR) genotyping technology to create scarless isogenic cell models of cancer variants in similar to 1 month. We successfully modeled two novel variants previously identified by our lab in the PALB2 gene in HEK239 cells, resulting in isogenic cells representing all three genotypes for both variants. We also modeled a known functional risk SNP of colorectal cancer, rs6983267, in HCT-116 cells. Cells with extremely low levels of gene editing could still be identified and isolated using this approach. We also introduce a novel molecular assay, ChIPnQASO (Chromatin Immunoprecipitation and Quantitative Allele-Specific Occupation), which uses the same technology to reveal allele-specific function of these variants at the DNA-protein interaction level. We demonstrated preferential binding of the transcription factor TCF7L2 to the rs6983267 risk allele over the non-risk. Our pipeline provides a platform for functional variant discovery and validation that is accessible and broadly applicable for the progression of efforts towards precision medicine.	[Carvajal-Carmona, Luis G.; Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Carvajal-Carmona, LG; Segal, DJ (reprint author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	lgcarvajal@ucdavis.edu; djsegal@ucdavis.edu			US National Institutes of Health [R21 CA204563, R21 CA199631, K12 CA138464]; V Foundation from Cancer Research	This work was supported by US National Institutes of Health awards R21 CA204563 to D.J.S and R21 CA199631 and K12 CA138464 to L.G.C.C., and by the V Foundation from Cancer Research to L.G.C.C.	Cavalli M, 2016, HUM GENET, V135, P485, DOI 10.1007/s00439-016-1654-x; Cheon JY, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0121-3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Foley SB, 2015, EBIOMEDICINE, V2, P74, DOI 10.1016/j.ebiom.2014.12.003; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6                                                    ; Jin HJ, 2016, ONCOTARGET, V7, P54616, DOI 10.18632/oncotarget.10520; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; O'Geen H, 2010, METHODS MOL BIOL, V649, P437, DOI 10.1007/978-1-60761-753-2_27; Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richardson CD, 2017, BIORXIV; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sahasrabudhe R, 2017, GASTROENTEROLOGY, V152, P983, DOI 10.1053/j.gastro.2016.12.010; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tak YG, 2016, NUCLEIC ACIDS RES, V44, P4123, DOI 10.1093/nar/gkv1530; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09	25	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 8	2017	7								15044	10.1038/s41598-017-15407-4				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM0JG	WOS:000414648700011	29118424	gold			2018-01-05	
J	Xu, JY; Lian, W; Jia, YN; Li, LY; Huang, Z				Xu, Jianyong; Lian, Wei; Jia, Yuning; Li, Lingyun; Huang, Zhong			Optimized guide RNA structure for genome editing via Cas9	ONCOTARGET			English	Article						RNA guided endonuclease; genome editing; Cas9; guide RNA; gRNA	HUMAN-CELLS; CRISPR-CAS9; CARDIOMYOPATHY; ENDONUCLEASE; NUCLEASES; GENE; ZFN	The genome editing tool Cas9-gRNA (guide RNA) has been successfully applied in different cell types and organisms with high efficiency. However, more efforts need to be made to enhance both efficiency and specificity. In the current study, we optimized the guide RNA structure of Streptococcus pyogenes CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas (CRISPR-associated) system to improve its genome editing efficiency. Comparing with the original functional structure of guide RNA, which is composed of crRNA and tracrRNA, the widely used chimeric gRNA has shorter crRNA and tracrRNA sequence. The deleted RNA sequence could form extra loop structure, which might enhance the stability of the guide RNA structure and subsequently the genome editing efficiency. Thus the genome editing efficiency of different forms of guide RNA was tested. And we found that the chimeric structure of gRNA with original full length of crRNA and tracrRNA showed higher genome editing efficiency than the conventional chimeric structure or other types of gRNA we tested. Therefore our data here uncovered the new type of gRNA structure with higher genome editing efficiency.	[Xu, Jianyong; Lian, Wei; Jia, Yuning; Li, Lingyun; Huang, Zhong] Shenzhen Univ, Inst Biol Therapy, Shenzhen, Peoples R China; [Xu, Jianyong; Lian, Wei; Jia, Yuning; Li, Lingyun; Huang, Zhong] Shenzhen Univ, Sch Med, Dept Pathogen Biol & Immunol, Shenzhen, Peoples R China	Xu, JY; Huang, Z (reprint author), Shenzhen Univ, Inst Biol Therapy, Shenzhen, Peoples R China.; Xu, JY; Huang, Z (reprint author), Shenzhen Univ, Sch Med, Dept Pathogen Biol & Immunol, Shenzhen, Peoples R China.	xujianyong@szu.edu.cn; zhuang809@126.com			Natural Science Foundation of SZU [2017083]; Natural Science Foundation of Shenzhen [JCYJ20170302152735071]; Novel technology development project of Shenzhen [CXZZ2015093105220591]; Special Program of Construction National Innovative City of Shenzhen [JCYJ2015040309143312]	This work was supported by Natural Science Foundation of SZU (2017083), Natural Science Foundation of Shenzhen (JCYJ20170302152735071), Novel technology development project of Shenzhen (CXZZ2015093105220591) and Special Program of Construction National Innovative City of Shenzhen (grant JCYJ2015040309143312).	Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/nmeth.4265, 10.1038/NMETH.4265]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Urnov F, 2016, NATURE, V529, P468, DOI 10.1038/529468a; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084	20	0	0	3	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	NOV 7	2017	8	55					94166	94171		10.18632/oncotarget.21607				6	Oncology; Cell Biology	Oncology; Cell Biology	FL9VQ	WOS:000414608400079	29212218				2018-01-05	
J	Zhao, GN; Wang, QH; Gu, QQ; Qiang, WA; Wei, JJ; Dong, PX; Watari, H; Li, W; Yue, JM				Zhao, Guannan; Wang, Qinghui; Gu, Qingqing; Qiang, Wenan; Wei, Jian-Jun; Dong, Peixin; Watari, Hidemichi; Li, Wei; Yue, Junming			Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells	ONCOTARGET			English	Article						BIRC5 (survivin); CRISPR/Cas9 nickase; lentiviral vector; ovarian cancer; epithelial to mesenchymal transition	SURVIVIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; TUMOR PROGRESSION; CARCINOMA CELLS; APOPTOSIS; CHEMORESISTANCE; CHEMOTHERAPY; PACLITAXEL; KNOCKDOWN; PATHWAY	BIRC5 encodes the protein survivin, a member of the inhibitor of apoptosis family. Survivin is highly expressed in a variety of cancers but has very low expression in the corresponding normal tissues, and its expression is often associated with tumor metastasis and chemoresistance. We report that survivin was highly expressed in ovarian cancer and strongly correlated with patient overall poor survival. For the first time, we provide experimental evidence that survivin is involved in epithelial to mesenchymal transition (EMT) in ovarian cancer cells. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 gene editing led to the inhibition of EMT by upregulating epithelial cell marker, cytokeratin 7 and downregulating mesenchymal markers: snail2, beta-catenin, and vimentin in both ovarian cancer SKOV3 and OVCAR3 cells. Consistent with this molecular approach, pharmacological treatment of ovarian cancer cells using a small molecule survivin inhibitor, YM155 also inhibited EMT in these ovarian cancer cell lines. Overexpression of BIRC5 promoted EMT in SKOV3 cells. Using molecular or pharmacological approaches, we found that cell proliferation, migration, and invasion were significantly inhibited following BIRC5 disruption in both cell lines. Inhibition of BIRC5 expression also sensitized cell responses to paclitaxel treatment. Moreover, loss of BIRC5 expression attenuated TGF beta signaling in both SKOV3 and OVCAR3 cells. Collectively, our studies demonstrated that disruption of BIRC5 expression inhibited EMT by attenuating the TGF beta pathway in ovarian cancer cells.	[Zhao, Guannan; Gu, Qingqing; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Zhao, Guannan; Gu, Qingqing; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Wang, Qinghui; Li, Wei] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Qiang, Wenan; Wei, Jian-Jun] Northwestern Univ, Sch Med, Dept Obstet & Gynecol, Dept Pathol, Chicago, IL 60611 USA; [Qiang, Wenan] Northwestern Univ, Chem Life Proc Inst, Ctr Dev Therapeut, Evanston, IL USA; [Dong, Peixin; Watari, Hidemichi] Hokkaido Univ, Sch Med, Dept Womens Hlth Educ Syst, Sapporo, Hokkaido, Japan; [Dong, Peixin; Watari, Hidemichi] Hokkaido Univ, Sch Med, Dept Gynaecol, Sapporo, Hokkaido, Japan	Yue, JM (reprint author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.; Yue, JM (reprint author), Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA.; Li, W (reprint author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	wli@uthsc.edu; jyue@uthsc.edu		Dong, Peixin/0000-0002-2335-1394	AHA; West Cancer Center; NIH [R01CA193609-01A1]; NU-PSOC [U54 CA193419]; Robert H. Lurie Comprehensive Cancer Center OncoSET initiatives at the Northwestern University	This study was partially supported by a grant from AHA (JY) and West Cancer Center (JY) and NIH grant R01CA193609-01A1 (WL). W. Qiang was partially supported by NU-PSOC (U54 CA193419) and Robert H. Lurie Comprehensive Cancer Center OncoSET initiatives at the Northwestern University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175                                                      ; AHMED N, 2013, FRONT ONCOL, V3; Amankwah EK, 2015, GENET EPIDEMIOL, V39, P689, DOI 10.1002/gepi.21921; Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI [10.1016/j.ygyno.2013.09.034, 10.1016/j.ygyno2013.09.034]; Athanassiadou P, 2008, PATHOL RES PRACT, V204, P241, DOI 10.1016/j.prp.2007.11.004; Azrak RG, 2008, CANCER BIOL THER, V7, P1901, DOI 10.4161/cbt.7.12.6939; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Chen LF, 2013, INT J GYNECOL CANCER, V23, P256, DOI 10.1097/IGC.0b013e31827ad2b8; Chen WL, 2016, MOL NEUROBIOL, V53, P1648, DOI 10.1007/s12035-015-9121-6; Chen Z., 2014, ADV MECH ENG, V2014, P9, DOI DOI 10.1049/IET-SPR.2013.0423; Chou JL, 2010, EXPERT OPIN THER TAR, V14, P1213, DOI 10.1517/14728222.2010.525353; Czyz M, 2010, BRIT J PHARMACOL, V160, P1144, DOI 10.1111/j.1476-5381.2010.00749.x; de Moraes GN, 2015, CELL SIGNAL, V27, P2496, DOI 10.1016/j.cellsig.2015.09.013; Deng JL, 2016, ONCOTARGET, V7, P55771, DOI 10.18632/oncotarget.9908; Dobrzycka B, 2015, TUMOR BIOL, V36, P4157, DOI 10.1007/s13277-015-3050-x; Gasowska-Bodnar A, 2014, INT J GYNECOL CANCER, V24, P687, DOI 10.1097/IGC.0000000000000108; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Jiang L, 2013, MOL MED REP, V7, P425, DOI 10.3892/mmr.2012.1216; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kobayashi M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-4; Lee SC, 2015, ONCOTARGET, V6, P27146, DOI 10.18632/oncotarget.4354; Liguang Z., 2007, Experimental Oncology, V29, P121; Lili LN, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-49; Ma XY, 2005, ONCOL REP, V14, P275; Mir R, 2014, GYNECOL ONCOL, V132, P211, DOI 10.1016/j.ygyno.2013.11.013; NAGAI T, 2015, MEDICINE BALTIMORE, V94; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; No JH, 2011, GYNECOL OBSTET INVES, V71, P136, DOI 10.1159/000316049; Parvani JG, 2015, NEOPLASIA, V17, P317, DOI 10.1016/j.neo.2015.02.003; Scalici JM, 2017, CANCER-AM CANCER SOC, V123, P977, DOI 10.1002/cncr.30415; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Strippoli R, 2015, EMBO MOL MED, V7, P102, DOI 10.15252/emmm.201404127; Tai CJ, 2012, ANN SURG ONCOL, V19, P336, DOI 10.1245/s10434-011-1692-5; Takai M, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-76; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Wang JJ, 2010, INT J GYNECOL CANCER, V20, P500, DOI 10.1111/IGC.0b013e3181c5ddfa; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Xie Li, 2004, Neoplasia (New York), V6, P603, DOI 10.1593/neo.04241; Yan HC, 2014, ONCOL LETT, V8, P426, DOI 10.3892/ol.2014.2063; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Yoshida S, 2009, INT J GYNECOL CANCER, V19, P992, DOI 10.1111/IGC.0b013e3181aaa93a; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047; Zhou LG, 2008, ANTICANCER RES, V28, P1119; Zhou XM, 2014, TUMOR BIOL, V35, P9523, DOI 10.1007/s13277-014-2537-1	46	0	0	3	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	NOV 7	2017	8	55					94666	94680		10.18632/oncotarget.21863				15	Oncology; Cell Biology	Oncology; Cell Biology	FL9VQ	WOS:000414608400118	29212257				2018-01-05	
J	Shi, J; Bi, PP; Pei, JM; Li, H; Grishin, NV; Bassel-Duby, R; Chen, EH; Olson, EN				Shi, Jun; Bi, Pengpeng; Pei, Jimin; Li, Hui; Grishin, Nick V.; Bassel-Duby, Rhonda; Chen, Elizabeth H.; Olson, Eric N.			Requirement of the fusogenic micropeptide myomixer for muscle formation in zebrafish	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						myomaker; fusogenic; zebrafish; myogenesis; micropeptide	CELL-CELL FUSION; MYOBLAST FUSION; EMBRYONIC-DEVELOPMENT; MEDIATES FUSION; IN-VIVO; MYOMAKER; PROTEIN; GENE; HAP2; FERTILIZATION	Skeletal muscle formation requires fusion of mononucleated myoblasts to form multinucleated myofibers. The muscle-specific membrane proteins myomaker and myomixer cooperate to drive mammalian myoblast fusion. Whereas myomaker is highly conserved across diverse vertebrate species, myomixer is a micropeptide that shows relatively weak cross-species conservation. To explore the functional conservation of myomixer, we investigated the expression and function of the zebrafish myomixer ortholog. Here we show that myomixer expression during zebrafish embryogenesis coincides with myoblast fusion, and genetic deletion of myomixer using CRISPR/Cas9 mutagenesis abolishes myoblast fusion in vivo. We also identify myomixer orthologs in other species of fish and reptiles, which can cooperate with myomaker and substitute for the fusogenic activity of mammalian myomixer. Sequence comparison of these diverse myomixer orthologs reveals key amino acid residues and a minimal fusogenic peptide motif that is necessary for promoting cell-cell fusion with myomaker. Our findings highlight the evolutionary conservation of the myomaker-myomixer partnership and provide insights into the molecular basis of myoblast fusion.	[Shi, Jun; Bi, Pengpeng; Li, Hui; Bassel-Duby, Rhonda; Chen, Elizabeth H.; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Shi, Jun; Bi, Pengpeng; Li, Hui; Bassel-Duby, Rhonda; Chen, Elizabeth H.; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Bi, Pengpeng; Li, Hui; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Senator Paul D Wellstone Muscular Dystrophy Coope, Dallas, TX 75390 USA; [Pei, Jimin; Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Chen, EH; Olson, EN (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Chen, EH; Olson, EN (reprint author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.; Olson, EN (reprint author), Univ Texas Southwestern Med Ctr Dallas, Senator Paul D Wellstone Muscular Dystrophy Coope, Dallas, TX 75390 USA.	Elizabeth.Chen@utsouthwestern.edu; Eric.Olson@utsouthwestern.edu			NIH [AR-067294, HL-130253, DK-099653, AR-053173, GM-098816]; Robert A. Welch Foundation [1-0025]; American Heart Association [13EIA14560083]; Howard Hughes Medical Institute	We thank Dr. Xiaoying Bai for sharing the zebrafish facility. We are grateful to Jose Cabrera for graphics and Jennifer Brown for editorial assistance. We thank Alexis Houghton, Andres Ramirez-Martinez, and Akansha Shah for technical assistance and other members of the E.N.O. and E.H.C. laboratories for technical advice and comments. This work was supported by NIH Grants AR-067294, HL-130253, and DK-099653 (to E.N.O. and R.B.-D.) and AR-053173 and GM-098816 (to E.H.C.); Grant 1-0025 from the Robert A. Welch Foundation (to E.N.O.); National Established Investigator Award 13EIA14560083 from the American Heart Association (to E.H.C.); and a Faculty Scholar Award from the Howard Hughes Medical Institute (to E.H.C.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000                                                 ; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Di Gioia SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16077; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0409509102; Fedry J, 2017, CELL, V168, P904, DOI 10.1016/j.cell.2017.01.024; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Kim JH, 2015, DEV CELL, V32, P561, DOI 10.1016/j.devcel.2015.01.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000                                                   ; Landemaine A, 2014, BIOCHEM BIOPH RES CO, V451, P480, DOI 10.1016/j.bbrc.2014.07.093; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Mi S, 2000, NATURE, V403, P785; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Shin NY, 2014, J CELL BIOL, V207, P73, DOI 10.1083/jcb.201401137; Steele RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007680; Stickney HL, 2000, DEV DYNAM, V219, P287; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664; Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019	41	0	0	2	2	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 7	2017	114	45					11950	11955		10.1073/pnas.1715229114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FM0DT	WOS:000414631200068	29078404				2018-01-05	
J	Gu, CF; Nguyen, HN; Ganini, D; Chen, ZW; Jessen, HJ; Gu, Z; Wang, HC; Shears, SB				Gu, Chunfang; Nguyen, Hoai-Nghia; Ganini, Douglas; Chen, Zhaowei; Jessen, Henning J.; Gu, Zhen; Wang, Huanchen; Shears, Stephen B.			KO of 5-InsP(7) kinase activity transforms the HCT116 colon cancer cell line into a hypermetabolic, growth-inhibited phenotype	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						bioenergetics; signaling; inositol pyrophosphates	DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASES; INOSITOL HEXAKISPHOSPHATE KINASE; PHOSPHATE HOMEOSTASIS; METABOLIC-REGULATION; INSULIN SENSITIVITY; PYROPHOSPHATES; PROTEIN; FAMILY; PHOSPHORYLATION; APOPTOSIS	The inositol pyrophosphates 5-InsP(7) (diphosphoinositol pentakisphosphate) and 1,5-InsP(8) (bis-diphosphoinositol tetrakisphosphate) are highly energetic cellular signals interconverted by the diphosphoinositol pentakisphosphate kinases (PPIP5Ks). Here, we used CRISPR to KO PPIP5Ks in the HCT116 colon cancer cell line. This procedure eliminates 1,5-InsP(8) and raises 5-InsP(7) levels threefold. Expression of p53 and p21 was up-regulated; proliferation and G1/S cell-cycle transition slowed. Thus, PPIP5Ks are potential targets for tumor therapy. Deletion of the PPIP5Ks elevated [ATP] by 35%; both [ATP] and [5-InsP(7)] were restored to WT levels by overexpression of PPIP5K1, and a kinase-compromised PPIP5K1 mutant had no effect. This covariance of [ATP] with [5-InsP(7)] provides direct support for an energy-sensing attribute (i.e., 1 mM K-m for ATP) of the 5-InsP(7)-generating inositol hexakisphosphate kinases (IP6Ks). We consolidate this conclusion by showing that 5-InsP(7) levels are elevated on direct delivery of ATP into HCT116 cells using liposomes. Elevated [ATP] in PPIP5K(-/-) HCT116 cells is underpinned by increased mitochondrial oxidative phosphorylation and enhanced glycolysis. To distinguish between 1,5-InsP(8) and 5-InsP(7) as drivers of the hypermetabolic and p53-elevated phenotypes, we used IP6K2 RNAi and the pan-IP6K inhibitor, N2-(m-trifluorobenzyl), N6-(p-nitrobenzyl) purine (TNP), to return 5-InsP(7) levels in PPIP5K(-/-) cells to those of WT cells without rescuing 1,5-InsP8 levels. Attenuation of IP6K restored p53 expression but did not affect the hypermetabolic phenotype. Thus, we conclude that 5-InsP(7) regulates p53 expression, whereas 1,5-InsP(8) regulates ATP levels. These findings attribute hitherto unsuspected functionality for 1,5-InsP(8) to bioenergetic homeostasis.	[Gu, Chunfang; Nguyen, Hoai-Nghia; Wang, Huanchen; Shears, Stephen B.] NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Ganini, Douglas] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Chen, Zhaowei; Gu, Zhen] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Chen, Zhaowei; Gu, Zhen] North Carolina State Univ, Raleigh, NC 27695 USA; [Jessen, Henning J.] Albert Ludwigs Univ, Inst Organ Chem, D-79104 Freiburg, Germany	Shears, SB (reprint author), NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	shears@niehs.nih.gov	Jessen, Henning/F-5108-2014	Jessen, Henning/0000-0002-1025-9484	NIH, NIEHS; Swiss National Science Foundation [PP00P2_157607]; Alfred P. Sloan Foundation	D.G. and S.B.S. thank Dr. Ron Mason [National Institute of Environmental Health Sciences (NIEHS)] for his support. Research was supported by the Intramural Research Program of the NIH, NIEHS. H.J.J. received support from Swiss National Science Foundation Grant PP00P2_157607. Z.G. acknowledges a Sloan Research Fellowship from the Alfred P. Sloan Foundation.	Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Barker CJ, 2013, PHARMACOL REV, V65, P641, DOI 10.1124/pr.112.006775; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Choi K, 2008, MOL PHARMACOL, V74, P527, DOI 10.1124/mol.107.044628; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Fu CL, 2017, P NATL ACAD SCI USA, V114, P2036, DOI 10.1073/pnas.1700165114; Ganini D, 2017, REDOX BIOL, V12, P462, DOI 10.1016/j.redox.2017.03.002; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gu CF, 2017, J BIOL CHEM, V292, P4544, DOI 10.1074/jbc.M116.765743; Gu CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165286; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Lev S, 2015, MBIO, V6, DOI 10.1128/mBio.00531-15; Liang W, 2004, J MICROENCAPSUL, V21, P251, DOI 10.1080/02652040410001673900; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Malbert-Colas L, 2014, MOL CELL, V54, P500, DOI 10.1016/j.molcel.2014.02.035; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; Pulloor NK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004519; Pulloor NK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003981; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao F, 2014, MOL CELL, V54, P119, DOI 10.1016/j.molcel.2014.02.020; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shears SB, 2017, J CELL PHYSL, DOI 10.1002/jcp.26017; Sun DD, 2015, J CELL MOL MED, V19, P1296, DOI 10.1111/jcmm.12501; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Thota SG, 2015, J BIOSCIENCES, V40, P593, DOI 10.1007/s12038-015-9549-x; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5178; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu MX, 2016, P NATL ACAD SCI USA, V113, pE6757, DOI 10.1073/pnas.1606853113; Zhu QZ, 2017, MOL METAB, V6, P73, DOI 10.1016/j.molmet.2016.11.010; Zhu QZ, 2016, J CLIN INVEST, V126, P4273, DOI 10.1172/JCI85510	42	0	0	5	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 7	2017	114	45					11968	11973		10.1073/pnas.1702370114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FM0DT	WOS:000414631200071	29078269				2018-01-05	
J	He, Q; Bouley, R; Liu, Z; Wein, MN; Zhu, Y; Spatz, JM; Wang, CY; Pajevic, PD; Plagge, A; Babitt, JL; Bastepe, M				He, Qing; Bouley, Richard; Liu, Zun; Wein, Marc N.; Zhu, Yan; Spatz, Jordan M.; Wang, Chia-Yu; Pajevic, Paola Divieti; Plagge, Antonius; Babitt, Jodie L.; Bastepe, Murat			Large G protein alpha-subunit XL alpha s limits clathrin-mediated endocytosis and regulates tissue iron levels in vivo	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						heterotrimeric G proteins; stimulatory G protein; GNAS; endocytosis; transferrin	VASOPRESSIN TYPE-2 RECEPTOR; PARATHYROID-HORMONE; ALZHEIMERS-DISEASE; SORTING NEXIN-9; DOWN-REGULATION; GNAS; MUTATIONS; ACTIVATION; VARIANT; DOMAIN	Alterations in the activity/levels of the extralarge G protein alpha-sub-unit (XL alpha s) are implicated in various human disorders, such as perinatal growth retardation. Encoded by GNAS, XL alpha s is partly identical to the alpha-subunit of the stimulatory G protein (Gs alpha), but the cellular actions of XL alpha s remain poorly defined. Following an initial proteomic screen, we identified sorting nexin-9 (SNX9) and dynamins, key components of clathrin-mediated endocytosis, as binding partners of XL alpha s. Overexpression of XL alpha s in HEK293 cells inhibited internalization of transferrin, a process that depends on clathrin-mediated endocytosis, while its ablation by CRISPR/Cas9 in an osteocyte-like cell line (Ocy454) enhanced it. Similarly, primary cardiomyocytes derived from XL alpha s knockout (XLKO) pups showed enhanced transferrin internalization. Early postnatal XLKO mice showed a significantly higher degree of cardiac iron uptake than wild-type littermates following iron dextran injection. In XLKO neonates, iron and ferritin levels were elevated in heart and skeletal muscle, where XL alpha s is normally expressed abundantly. XLKO heart and skeletal muscle, as well as XLKO Ocy454 cells, showed elevated SNX9 protein levels, and siRNA-mediated knockdown of SNX9 in XLKO Ocy454 cells prevented enhanced transferrin internalization. In transfected cells, XL alpha s also inhibited internalization of the parathyroid hormone and type 2 vasopressin receptors. Internalization of transferrin and these G protein-coupled receptors was also inhibited in cells expressing an XL alpha s mutant missing the G alpha portion, but not Gsa or an N-terminally truncated XL alpha s mutant unable to interact with SNX9 or dynamin. Thus, XL alpha s restricts clathrin-mediated endocytosis and plays a critical role in iron/transferrin uptake in vivo.	[He, Qing; Liu, Zun; Wein, Marc N.; Zhu, Yan; Spatz, Jordan M.; Pajevic, Paola Divieti; Bastepe, Murat] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; [He, Qing; Liu, Zun; Wein, Marc N.; Zhu, Yan; Spatz, Jordan M.; Pajevic, Paola Divieti; Bastepe, Murat] Harvard Med Sch, Boston, MA 02114 USA; [Bouley, Richard; Wang, Chia-Yu; Babitt, Jodie L.] Harvard Med Sch, Program Membrane Biol, Dept Med, Boston, MA 02114 USA; [Bouley, Richard; Wang, Chia-Yu; Babitt, Jodie L.] Harvard Med Sch, Div Nephrol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bouley, Richard; Wang, Chia-Yu; Babitt, Jodie L.] Harvard Med Sch, Boston, MA 02114 USA; [Pajevic, Paola Divieti] Boston Univ Henry M Goldman, Dept Mol & Cell Biol, Sch Dent Med, Boston, MA 02118 USA; [Plagge, Antonius] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	Bastepe, M (reprint author), Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA.; Bastepe, M (reprint author), Harvard Med Sch, Boston, MA 02114 USA.	bastepe@helix.mgh.harvard.edu		Plagge, Antonius/0000-0001-6592-1343	NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK073911]; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [5K08AR067285, R01AR05965]; NIH/NIDDK Grant [T32DK007028]; NIH Grant [DK096586]; University of Baltimore Maryland Polycystic Kidney Disease Core Center Grant [P30DK090868]; NIH/NIAMS [P30AR066261]	We thank Dr. Gavin Kelsey (Babraham Institute) for kindly providing the XLKO mice. This work was supported in part by grants from NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R01DK073911 to M.B.) and NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (5K08AR067285 to M.N.W. and R01AR05965 to P.D.P.). Q.H. is supported by NIH/NIDDK Grant T32DK007028. R.B. is supported by NIH Grant DK096586 and University of Baltimore Maryland Polycystic Kidney Disease Core Center Grant P30DK090868. Histology analyses were performed at the Massachusetts General Hospital Endocrine Unit Center for Skeletal Research, Bone Cell and Signaling Core, funded by Grant P30AR066261 from NIH/NIAMS.	Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Aydin C, 2009, ENDOCRINOLOGY, V150, P3567, DOI 10.1210/en.2009-0318; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bendris N, 2017, TRENDS CELL BIOL, V27, P189, DOI 10.1016/j.tcb.2016.11.001; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bouley R, 2013, AM J PHYSIOL-RENAL, V304, pF553, DOI 10.1152/ajprenal.00438.2011; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093130; Chen S, 2011, ENDOCRINOLOGY, V152, P3893, DOI 10.1210/en.2011-1049; Conway RR, 2001, J CELL PHYSIOL, V189, P341; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578                                                           ; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; Enns CA, 2001, TRAFFIC, V2, P167, DOI 10.1034/j.1600-0854.2001.020303.x; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Fernandez-Rebollo E, 2012, P NATL ACAD SCI USA, V109, P6638, DOI 10.1073/pnas.1117608109; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Freson K, 2008, J CLIN ENDOCR METAB, V93, P4851, DOI 10.1210/jc.2008-0883; Garcia-Murillas I, 2014, ONCOGENE, V33, P2478, DOI 10.1038/onc.2013.202; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; He Q, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa9953; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151                                                           ; Izzi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038579; Kay BK, 2000, FASEB J, V14, P231; KEHLENBACH RH, 1994, NATURE, V372, P804; Klemke M, 2000, J BIOL CHEM, V275, P33633, DOI 10.1074/jbc.M006594200; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Krechowec SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029753; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Kundu K, 2014, BIOINFORMATICS, V30, P2668, DOI 10.1093/bioinformatics/btu350; Linglart AS, 2006, ENDOCRINOLOGY, V147, P2253, DOI 10.1210/en.2005-1487; Liu Z, 2011, J BIOL CHEM, V286, P38558, DOI 10.1074/jbc.M111.240150; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Ma MPC, 2012, J CELL SCI, V125, P4372, DOI 10.1242/jcs.105981; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oudit GY, 2004, CIRCULATION, V109, P1877, DOI 10.1161/01.CIR.0000124229.40424.80; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pignolo RJ, 2011, J BONE MINER RES, V26, P2647, DOI 10.1002/jbmr.481; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Richard N, 2013, J CLIN ENDOCR METAB, V98, pE1549, DOI 10.1210/jc.2013-1667; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262                                                            ; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Turan S, 2015, CURR OSTEOPOROS REP, V13, P146, DOI 10.1007/s11914-015-0268-x; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weinstein LS, 2002, ANN NY ACAD SCI, V968, P173, DOI 10.1111/j.1749-6632.2002.tb04335.x                                              ; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514; Zumbrennen-Bullough KB, 2014, J BIOL CHEM, V289, P23796, DOI 10.1074/jbc.M114.577387	66	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 7	2017	114	45					E9559	E9568		10.1073/pnas.1712670114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FM0DT	WOS:000414631200018	29078380				2018-01-05	
J	Zheng, QT; Lin, J; Huang, JJ; Zhang, HY; Zhang, R; Zhang, XY; Cao, CW; Hambly, C; Qin, GS; Yao, J; Song, RG; Jia, QT; Wang, X; Li, YS; Zhang, N; Piao, ZY; Ye, RC; Speakman, JR; Wang, HM; Zhou, Q; Wang, YF; Jin, WZ; Zhao, JG				Zheng, Qiantao; Lin, Jun; Huang, Jiaojiao; Zhang, Hongyong; Zhang, Rui; Zhang, Xueying; Cao, Chunwei; Hambly, Catherine; Qin, Guosong; Yao, Jing; Song, Ruigao; Jia, Qitao; Wang, Xiao; Li, Yongshun; Zhang, Nan; Piao, Zhengyu; Ye, Rongcai; Speakman, John R.; Wang, Hongmei; Zhou, Qi; Wang, Yanfang; Jin, Wanzhu; Zhao, Jianguo			Reconstitution of UCP1 using CRISPR/Cas9 in the white adipose tissue of pigs decreases fat deposition and improves thermogenic capacity	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						UCP1; thermoregulation; fat deposition; pig; CRISPR/Cas9	DOUBLY-LABELED WATER; DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; ONE-STEP GENERATION; ENERGY-EXPENDITURE; ACID-COMPOSITION; LACTATING SOWS; CO2 PRODUCTION; MESSENGER-RNA; ADULT HUMANS	Uncoupling protein 1 (UCP1) is localized on the inner mitochondrial membrane and generates heat by uncoupling ATP synthesis from proton transit across the inner membrane. UCP1 is a key element of nonshivering thermogenesis and is most likely important in the regulation of body adiposity. Pigs (Artiodactyl family Suidae) lack a functional UCP1 gene, resulting in poor thermoregulation and susceptibility to cold, which is an economic and pig welfare issue owing to neonatal mortality. Pigs also have a tendency toward fat accumulation, which may be linked to their lack of UCP1, and thus influences the efficiency of pig production. Here, we report application of a CRISPR/Cas9-mediated, homologous recombination (HR)-independent approach to efficiently insert mouse adiponectin-UCP1 into the porcine endogenous UCP1 locus. The resultant UCP1 knock-in (KI) pigs showed an improved ability to maintain body temperature during acute cold exposure, but they did not have alterations in physical activity levels or total daily energy expenditure (DEE). Furthermore, ectopic UCP1 expression in white adipose tissue (WAT) dramatically decreased fat deposition by 4.89% (P < 0.01), consequently increasing carcass lean percentage (CLP; P < 0.05). Mechanism studies indicated that the loss of fat upon UCP1 activation in WAT was linked to elevated lipolysis. UCP1 KI pigs are a potentially valuable resource for agricultural production through their combination of cold adaptation, which improves pig welfare and reduces economic losses, with reduced fat deposition and increased lean meat production.	[Zheng, Qiantao; Huang, Jiaojiao; Zhang, Hongyong; Zhang, Rui; Cao, Chunwei; Qin, Guosong; Yao, Jing; Song, Ruigao; Jia, Qitao; Wang, Xiao; Li, Yongshun; Zhang, Nan; Wang, Hongmei; Zhou, Qi; Zhao, Jianguo] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zheng, Qiantao; Huang, Jiaojiao; Zhang, Hongyong; Zhang, Rui; Cao, Chunwei; Qin, Guosong; Yao, Jing; Song, Ruigao; Jia, Qitao; Wang, Xiao; Wang, Hongmei; Zhou, Qi; Jin, Wanzhu; Zhao, Jianguo] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China; [Lin, Jun; Song, Ruigao; Ye, Rongcai; Jin, Wanzhu] Chinese Acad Sci, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Lin, Jun; Ye, Rongcai] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Zhang, Xueying; Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Hambly, Catherine; Speakman, John R.] Univ Aberdeen, Zool Dept, Energet Res Grp, Aberdeen AB24 2TZ, Scotland; [Piao, Zhengyu] Yanbian Univ, Dept Anim Sci, Yanji 133002, Jilin, Peoples R China; [Wang, Yanfang] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Zhao, JG (reprint author), Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Jin, WZ; Zhao, JG (reprint author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.; Jin, WZ (reprint author), Chinese Acad Sci, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China.; Wang, YF (reprint author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	wangyanfang@caas.cn; jinw@ioz.ac.cn; zhaojg@ioz.ac.cn			National Transgenic Project of China [2016ZX08009003-006-007]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA08010304, XDB13030000]; National Natural Science Foundation of China [81671274, 31272440]; National Program on Key Basic Research Project (973 Program) [2015CB943100]; Elite Youth Program of the Chinese Academy of Agricultural Sciences [ASTIP-IAS05]	We thank members of the J.Z., W.J., and Y.W. laboratories for helpful discussions; P. Chai, S. Liu, H. Tang, and C. Wei (Institute of High Energy Physics at the Chinese Academy of Sciences and Beijing Engineering Research Center of Radiographic Techniques and Equipment) for their help with the PET scan experiments and analysis; L. Yang (Institute of Genetics and Developmental Biology at the Chinese Academy of Sciences) for help in TEM analysis; and Peter Thomson (University of Aberdeen) for technical assistance with isotope analysis. This study was supported by the National Transgenic Project of China (Grant 2016ZX08009003-006-007), the Strategic Priority Research Programs of the Chinese Academy of Sciences (Grants XDA08010304 and XDB13030000), the National Natural Science Foundation of China (Grants 81671274 and 31272440), and the National Program on Key Basic Research Project (973 Program; Grant 2015CB943100). Y.W. was supported by the Elite Youth Program of the Chinese Academy of Agricultural Sciences (ASTIP-IAS05).	Ai H, 2012, ANIM GENET, V43, P383, DOI 10.1111/j.1365-2052.2011.02282.x; ALGERS B, 1990, LIVEST PROD SCI, V25, P177, DOI 10.1016/0301-6226(90)90051-7; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Baxter EM, 2013, ANIM WELFARE, V22, P219, DOI 10.7120/09627286.22.2.219; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.002019; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Braganca MM, 1998, J ANIM SCI, V76, P2017; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Executive BP, 2011, PIG YB 2011; GARRUTI G, 1992, INT J OBESITY, V16, P383; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hou LJ, 2017, BIOCHEM BIOPH RES CO, V487, P795, DOI 10.1016/j.bbrc.2017.04.118; Jacyno E, 2015, S AFR J ANIM SCI, V45, P122, DOI 10.4314/sajas.v45i2.2; Jastroch M, 2015, MOL METAB, V4, P359, DOI 10.1016/j.molmet.2015.02.005; Jiang YZ, 2012, GENET MOL RES, V11, P4447, DOI 10.4238/2012.September.19.6; Kirkden RD, 2013, J ANIM SCI, V91, P3361, DOI 10.2527/jas.2012-5637; Knecht D, 2016, ARCH ANIM BREED, V59, P51, DOI 10.5194/aab-59-51-2016; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363                                                               ; Krol E, 1999, J EXP BIOL, V202, P2839; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Li B, 2000, NAT MED, V6, P1115; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Lin J, 2017, J MOL CELL BIOL, V9, P364, DOI 10.1093/jmcb/mjx018; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)90036-5; Lowe BK, 2014, J ANIM SCI, V92, P3715, DOI [10.2527/jas2013-7515, 10.2527/jas.2013-7515]; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; McGaugh S, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0749; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Quiniou N, 1999, J ANIM SCI, V77, P2124; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; Ruan JX, 2015, SCI REP, V5, P14253; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Speakman JR, 2016, COMP BIOCHEM PHYS A, V202, P3, DOI 10.1016/j.cbpa.2016.03.017; SPEAKMAN JR, 1987, J THEOR BIOL, V127, P79, DOI 10.1016/S0022-5193(87)80162-5; SPEAKMAN JR, 1993, FUNCT ECOL, V7, P746; SPEAKMAN JR, 1988, COMP BIOCHEM PHYS A, V90, P337, DOI 10.1016/0300-9629(88)91125-5                                                    ; Speakman JR, 1997, DOUBLY LABELLED WATE; SYMONDS ME, 1992, P NUTR SOC, V51, P165, DOI 10.1079/PNS19920026; Takahashi A, 2015, CELL REP, V13, P2756, DOI 10.1016/j.celrep.2015.11.056; Theil PK, 2014, ANIMAL, V8, P1021, DOI 10.1017/S1751731114000950; TRAYHURN P, 1989, CAN J PHYSIOL PHARM, V67, P1480, DOI 10.1139/y89-239                                                                 ; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/nmeth.1806, 10.1038/NMETH.1806]; Vijgen GHEJ, 2012, J CLIN ENDOCR METAB, V97, pE1229, DOI 10.1210/jc.2012-1289; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wang X., 2016, SCI REP, V6, P20620; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Wischner D, 2009, LIVEST SCI, V124, P1, DOI 10.1016/j.livsci.2009.01.015; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06926; Zhou H, 1999, APPL ENG AGRIC, V15, P327; Zhou H, 1998, RESPONSES PIGLETS VA; Zhao J, 2017, People's Republic of China Patent, Patent No. [201710323141.0, 201710323141]	68	1	1	12	12	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 7	2017	114	45					E9474	E9482		10.1073/pnas.1707853114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FM0DT	WOS:000414631200009	29078316				2018-01-05	
J	McAllister, KN; Bouillaut, L; Kahn, JN; Self, WT; Sorg, JA				McAllister, Kathleen N.; Bouillaut, Laurent; Kahn, Jennifer N.; Self, William T.; Sorg, Joseph A.			Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis	SCIENTIFIC REPORTS			English	Article							CLOSTRIDIUM-DIFFICILE; ESCHERICHIA-COLI; SPORE GERMINATION; TOXIN PRODUCTION; RNA-POLYMERASE; IN-VIVO; SEQUENCE; ENDONUCLEASE; METABOLISM; INFECTION	Clostridium difficile is a significant concern as a nosocomial pathogen, and genetic tools are important when analyzing the physiology of such organisms so that the underlying physiology/pathogenesis of the organisms can be studied. Here, we used TargeTron to investigate the role of selenoproteins in C. difficile Stickland metabolism and found that a TargeTron insertion into selD, encoding the selenophosphate synthetase that is essential for the specific incorporation of selenium into selenoproteins, results in a significant growth defect and a global loss of selenium incorporation. However, because of potential polar effects of the TargeTron insertion, we developed a CRISPR-Cas9 mutagenesis system for C. difficile. This system rapidly and efficiently introduces site-specific mutations into the C. difficile genome (20-50% mutation frequency). The selD CRISPR deletion mutant had a growth defect in protein-rich medium and mimicked the phenotype of a generated TargeTron selD mutation. Our findings suggest that Stickland metabolism could be a target for future antibiotic therapies and that the CRISPR-Cas9 system can introduce rapid and efficient modifications into the C. difficile genome.	[McAllister, Kathleen N.; Kahn, Jennifer N.; Sorg, Joseph A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Bouillaut, Laurent] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Self, William T.] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Bouillaut, Laurent] Matrivax R&D Corp, 650 Albany St, Boston, MA USA	Sorg, JA (reprint author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	jsorg@bio.tamu.edu		Sorg, Joseph/0000-0001-7822-2656	National Institute of Allergy and Infectious Diseases [5R01AI116895, 1U01AI124290]; National Institute of General Medical Sciences [R01GM042219]	We would like to thank Dr. Robert Fagan at The University of Sheffield for the generous gift of the plasmid, pRPF215, containing the tetracycline-inducible system and Dr. Linc Sonenshein for helpful advice. We would also like to thank members of the Sorg lab, Dr. Leif Smith, and members from Dr. Leif Smith's lab at Texas A&M University for their helpful comments and suggestions during the preparation of this manuscript. This project was supported by awards 5R01AI116895 and 1U01AI124290 to J.A.S. from the National Institute of Allergy and Infectious Diseases and R01GM042219 from the National Institute of General Medical Sciences to Dr. Abraham L. Sonenshein. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID and NIGMS. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aktories K., 2017, ANN REV MICROBIOLOGY; Allen CA, 2013, ANTIMICROB AGENTS CH, V57, P664, DOI 10.1128/AAC.01611-12; Bakker D, 2014, INFECT IMMUN, V82, P4222, DOI 10.1128/IAI.02336-14; Boudry P., 2015, MBIO, V6; Bouillaut L., 2011, CURR PROTOC MICROBIO, DOI DOI 10.1002/9780471729259.MC09A02S20; Bouillaut L, 2015, RES MICROBIOL, V166, P375, DOI 10.1016/j.resmic.2014.10.002; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Cartman S. T., 2009, APPL ENV MICROBIOL; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Dembek M, 2015, MBIO, V6, DOI [10.1128/mBio.02383-14d, 10.1128/mBio.02383-14]; Dineen S. S., 2007, MOL MICROBIOL, V61, P1335; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Francis MB, 2015, J BACTERIOL, V197, P2276, DOI 10.1128/JB.02575-14; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Ho TD, 2011, INFECT IMMUN, V79, P3229, DOI 10.1128/IAI.00019-11; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson S, 2006, J BACTERIOL, V188, P8487, DOI 10.1128/JB.01370-06; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karlsson S, 1999, MICROBIOL-UK, V145, P1683, DOI 10.1099/13500872-145-7-1683                                                     ; Kelly ML, 2016, ANAEROBE, V39, P51, DOI 10.1016/j.anaerobe.2016.02.011; KIM IY, 1992, J BIOL CHEM, V267, P19650; Kirk JA, 2016, ANAEROBE, V42, P1, DOI 10.1016/j.anaerobe.2016.06.009; Lawson PA, 2016, ANAEROBE, V40, P95, DOI 10.1016/j.anaerobe.2016.06.008; Mani N, 2006, J BACTERIOL, V188, P96, DOI 10.1128/JB.188.1.96-102.2006; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598                                                          ; Martin-Verstraete I., 2016, TOXINS BASEL, V8; McBride S. M., 2010, INFECT IMMUN; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Ng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077575; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Oren Aharon, 2016, Int J Syst Evol Microbiol, V66, P4921, DOI 10.1099/ijsem.0.001620; Paiva AMO, 2016, ACS SYNTH BIOL, V5, P1376, DOI 10.1021/acssynbio.6b00104; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189                                                            ; Power D. A., 2003, DIFCO BBL MANUAL MAN; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Self WT, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P121; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.20; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Srivastava M, 2011, J BACTERIOL, V193, P1643, DOI 10.1128/JB.01063-10; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; WREN BW, 1987, J CLIN MICROBIOL, V25, P2402; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15	54	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 7	2017	7								14672	10.1038/s41598-017-15236-5				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FL9II	WOS:000414566600041	29116155	gold			2018-01-05	
J	Luo, ZF; Rhie, SK; Lay, FD; Farnham, PJ				Luo, Zhifei; Rhie, Suhn Kyong; Lay, Fides D.; Farnham, Peggy J.			A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13	CELL REPORTS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; SUSCEPTIBILITY LOCI; CHROMATIN; DOMAINS; DISEASE; CELLS; PROGRESSION; INTEGRATION	Prostate cancer (PCa) is the leading cancer among men in the United States, with genetic factors contributing to similar to 42% of the susceptibility to PCa. We analyzed a PCa risk region located at 7p15.2 to gain insight into the mechanisms by which this noncoding region may affect gene regulation and contribute to PCa risk. We performed Hi-C analysis and demonstrated that this region has long-range interactions with the HOXA locus, located similar to 873 kb away. Using the CRISPR/Cas9 system, we deleted a 4-kb region encompassing several PCa risk-associated SNPs and performed RNA-seq to investigate transcriptomic changes in prostate cells lacking the regulatory element. Our results suggest that the risk element affects the expression of HOXA13 and HOTTIP, but not other genes in the HOXA locus, via a repressive loop. Forced expression of HOXA13 was performed to gain further insight into the mechanisms by which this risk element affects PCa risk.	[Luo, Zhifei; Rhie, Suhn Kyong; Lay, Fides D.; Farnham, Peggy J.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90089 USA; [Luo, Zhifei; Rhie, Suhn Kyong; Lay, Fides D.; Farnham, Peggy J.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Lay, Fides D.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Farnham, PJ (reprint author), Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90089 USA.; Farnham, PJ (reprint author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	peggy.farnham@med.usc.edu			NIH [R01CA136924, U01MH103346A, P30CA014089]; USC Office of Research; Norris Medical Library	This work was supported in part by grants R01CA136924, U01MH103346A, and P30CA014089 from the NIH. We thank the USC Cancer Center Molecular Genomics Core, the UCLA Technology Center for Genomics and Bioinformatics, Phoebe Guo for the RWPE-1 CTCF ChIP-seq data, and the USC Norris Medical Library Bioinformatics Service for assisting with pathway analysis (the bioinformatics software used in the analysis is funded by the USC Office of Research and the Norris Medical Library). We thank the members of the Farnham, Coetzee, and Hazelett labs for helpful discussions.	Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Chiang YT, 2014, ONCOTARGET, V5, P451, DOI 10.18632/oncotarget.1296                                                        ; Crispino JD, 2017, BLOOD, V129, P2103, DOI 10.1182/blood-2016-09-687889; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Gu ZD, 2009, CANCER RES, V69, P4969, DOI 10.1158/0008-5472.CAN-08-4546; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Han Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0564-1; Han Y, 2015, HUM MOL GENET, V24, P5603, DOI 10.1093/hmg/ddv269; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; He B, 2014, P NATL ACAD SCI USA, V111, P18261, DOI 10.1073/pnas.1421415111; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Huang LW, 2007, ENDOCRINOLOGY, V148, P1235, DOI 10.1210/en.2006-1250; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Kerschner JL, 2014, EPIGENETICS-US, V9, P557, DOI 10.4161/epi.27696; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Larson NB, 2015, AM J HUM GENET, V96, P869, DOI 10.1016/j.ajhg.2015.04.015; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li ZH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0442-z; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Taberlay PC, 2016, GENOME RES, V26, P719, DOI 10.1101/gr.201517.115; Tak YG, 2016, NUCLEIC ACIDS RES, V44, P4123, DOI 10.1093/nar/gkv1530; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Whitington T, 2016, NAT GENET, V48, P387, DOI 10.1038/ng.3523; Xiao LJ, 2016, ONCOTARGET, V7, P47891, DOI 10.18632/oncotarget.10294; Zhang L, 2015, MOL CELL BIOL, V35, P1350, DOI 10.1128/MCB.00102-15; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111	41	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	NOV 7	2017	21	6					1411	1417		10.1016/j.celrep.2017.10.048				7	Cell Biology	Cell Biology	FL9AE	WOS:000414541700001	29117547	gold			2018-01-05	
J	Cho, S; Yu, SI; Park, J; Mao, YF; Zhu, JK; Yun, DJ; Lee, BH				Cho, Sungkyung; Yu, Si-in; Park, Junghoon; Mao, Yanfei; Zhu, Jian-Kang; Yun, Dae-Jin; Lee, Byeong-ha			Accession-Dependent CBF Gene Deletion by CRISPR/Cas System in Arabidopsis	FRONTIERS IN PLANT SCIENCE			English	Article						CRISPR; Cas; CBF; cold stress; cold signaling; accessions	TRANSCRIPTION FACTOR; COLD-ACCLIMATION; GUIDE RNA; PLANTS; THALIANA; CRISPR-CAS9; MUTANTS; REPAIR; CAS9; TOOL	The CRISPR/Cas system became a powerful genome editing tool for basic plant research and crop improvement. Thus far, CRISPR/Cas has been applied to many plants, including Arabidopsis, rice and other crop plants. It has been reported that CRISPR/Cas efficiency is generally high in many plants. In this study, we compared the genome editing efficiency of CRISPR/Cas in three different Arabidopsis accessions [Col-0, Ler, and C24RDLUC (C24 accession harboring the stress-responsive RD29A promoter-driven luciferase reporter)]. For the comparison, we chose to target the cold-responsive C-repeat/DRE-Binding Factor (CBF) genes. CBF1, CBF2, and CBF3 genes are tandemly located on Arabidopsis chromosome 4 with redundant functions as the key transcription factors functioning in cold stress signaling and tolerance. Due to the close proximity of these CBFs on the chromosome, it is impossible to generate cbf1, cbf2, cbf3 triple mutants (cbf123) by traditional genetic crosses. Therefore, using the CRISPR/Cas tool, we aimed to generate cbf123 mutants and compared the genome editing efficiency in different Arabidopsis accessions. Among the accessions, Ler was the most resilient to the CRISPR/Cas deletion with the lowest gene deletion ratio in both T1 and T2 generations. Interestingly, while C24RDLUC showed a high CBF123 deletion frequency in T2 only when the gene deletion was observed in T1 generation, Col-0 displayed high ratios of the CBF123 deletions in T2 regardless of the presence or absence of the CBF123 deletion in T1. Isolated cbf123 mutants in C24RDLUC background showed no expression of CBF1, CBF2, and CBF3 genes and proteins with reduction in the CBF target gene expression under cold stress.	[Cho, Sungkyung; Yu, Si-in; Lee, Byeong-ha] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Park, Junghoon; Yun, Dae-Jin] Konkuk Univ, Dept Biomed Sci & Engn, Seoul, South Korea; [Mao, Yanfei; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Mao, Yanfei; Zhu, Jian-Kang] Chinese Acad Sci, Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Lee, BH (reprint author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	byeongha@sogang.ac.kr			Rural Development Administration, South Korea [PJ011006]; National Research Foundation (NRF) - Ministry of Science and ICT (MSIT), South Korea [2017K1A1A2013146]	This work was supported by Next-Generation BioGreen21 Program (PJ011006) of the Rural Development Administration, South Korea, and also by the Global Research Laboratory Program (2017K1A1A2013146) of the National Research Foundation (NRF) funded by the Ministry of Science and ICT (MSIT), South Korea.	Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7                                                   ; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Daer RM, 2017, ACS SYNTH BIOL, V6, P428, DOI 10.1021/acssynbio.5b00299; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gorbunova V, 1999, TRENDS PLANT SCI, V4, P263, DOI 10.1016/S1360-1385(99)01430-2                                                   ; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jia YX, 2016, NEW PHYTOL, V212, P345, DOI 10.1111/nph.14088; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Lee BH, 2009, J MICROBIOL BIOTECHN, V19, P542, DOI 10.4014/jmb.0901.0082; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liu WS, 2015, SCI BULL, V60, P1332, DOI 10.1007/s11434-015-0848-2; Lozano-Juste J, 2014, TRENDS PLANT SCI, V19, P284, DOI 10.1016/j.tplants.2014.02.014; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Park S, 2015, PLANT J, V82, P193, DOI 10.1111/tpj.12796; Sampson TR, 2014, BIOESSAYS, V36, P34, DOI 10.1002/bies.201300135; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Tucker MR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-809; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Nguyen XC, 2016, J PLANT BIOL, V59, P55, DOI 10.1007/s12374-016-0442-4; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhao CZ, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1215794; Zhao CZ, 2016, PLANT PHYSIOL, V171, P2744, DOI 10.1104/pp.16.00533	31	0	0	18	18	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	NOV 7	2017	8								1910	10.3389/fpls.2017.01910				11	Plant Sciences	Plant Sciences	FL8OZ	WOS:000414510400001	29163623	gold			2018-01-05	
J	Gonzalez-Hernandez, RJ; Jin, K; Hernandez-Chavez, MJ; Diaz-Jimenez, DF; Trujillo-Esquivel, E; Clavijo-Giraldo, DM; Tamez-Castrellon, AK; Franco, B; Gow, NAR; Mora-Montes, HM				Gonzalez-Hernandez, Roberto J.; Jin, Kai; Hernandez-Chavez, Marco J.; Diaz-Jimenez, Diana F.; Trujillo-Esquivel, Elias; Clavijo-Giraldo, Diana M.; Tamez-Castrellon, Alma K.; Franco, Bernardo; Gow, Neil A. R.; Mora-Montes, Hector M.			Phosphomannosylation and the Functional Analysis of the Extended Candida albicans MNN4-Like Gene Family	FRONTIERS IN MICROBIOLOGY			English	Article						cell wall; phosphomannosylation; Candida albicans; phagocytosis; phosphomannosyltransferase; CRISPR-Cas9 system; mini-Ura-blaster	ALBICANS CELL-WALL; ENGINEERED SACCHAROMYCES-CEREVISIAE; N-LINKED OLIGOSACCHARIDES; FLOW-CYTOMETRIC ASSAY; CANDIDA-ALBICANS; TRANSCRIPTIONAL RESPONSE; MANNOSYLPHOSPHATE TRANSFER; ANTIFUNGAL RESISTANCE; EXPRESSION; VIRULENCE	Phosphomannosylation is a modification of cell wall proteins that occurs in some species of yeast-like organisms, including the human pathogen Candida albicans. These modified mannans confer a negative charge to the wall, which is important for the interactions with phagocytic cells of the immune systems and cationic antimicrobial peptides. In Saccharomyces cerevisiae, the synthesis of phosphomannan relies on two enzymes, the phosphomannosyltransferase Ktr6 and its positive regulator Mnn4. However, in C. albicans, at least three phosphomannosyltransferases, Mnn4, Mnt3 and Mnt5, participate in the addition of phosphomannan. In addition to MNN4, C. albicans has a MNN4-like gene family composed of seven other homologous members that have no known function. Here, using the classical mini-Ura-blaster approach and the new gene knockout CRISPR-Cas9 system for gene disruption, we generated mutants lacking single and multiple genes of the MNN4 family; and demonstrate that, although Mnn4 has a major impact on the phosphomannan content, MNN42 was also required for full protein phosphomannosylation. The reintroduction of MNN41, MNN42, MNN46, or MNN47 in a genetic background lacking MNN4 partially restored the phenotype associated with the mnn4 Delta null mutant, suggesting that there is partial redundancy of function between some family members and that the dominant effect of MNN4 over other genes could be due to its relative abundance within the cell. We observed that additional copies of alleles number of any of the other family members, with the exception of MNN46, restored the phosphomannan content in cells lacking both MNT3 and MNT5. We, therefore, suggest that phosphomannosylation is achieved by three groups of proteins: [i] enzymes solely activated by Mnn4, [ii] enzymes activated by the dual action of Mnn4 and any of the products of other MNN4-like genes, with exception of MNN46, and [iii] activation of Mnt3 and Mnt5 by Mnn4 and Mnn46. Therefore, although the MNN4-like genes have the potential to functionally redundant with Mnn4, they apparently do not play a major role in cell wall mannosylation under most in vitro growth conditions. In addition, our phenotypic analyses indicate that several members of this gene family influence the ability of macrophages to phagocytose C. albicans cells.	[Gonzalez-Hernandez, Roberto J.; Hernandez-Chavez, Marco J.; Trujillo-Esquivel, Elias; Clavijo-Giraldo, Diana M.; Tamez-Castrellon, Alma K.; Franco, Bernardo; Mora-Montes, Hector M.] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico; [Jin, Kai; Gow, Neil A. R.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [Jin, Kai] Chongqing Univ, Sch Life Sci, Chongqing, Peoples R China; [Diaz-Jimenez, Diana F.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico	Mora-Montes, HM (reprint author), Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico.; Gow, NAR (reprint author), Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland.	n.gow@abdn.ac.uk; hmora@ugto.mx			Consejo Nacional de Ciencia y Tecnologia [CB2011/166860, PDCPN2014-247109, FC 2015-02-834]; Universidad de Guanajuato [000025/11, 0087/13, 1025/2016]; Universidad de Guanajuato (Convocatoria Institucional para Fortalecer la Excelencia Academica); Universidad de Guanajuato (CIFOREA) [89/2016]; Programa de Mejoramiento de Profesorado [UGTO-PTC-261]; Red Tematica Glicociencia en Salud (CONACYT-Mexico); Wellcome Trust [086827, 075470, 101873, 200208]; MRC Centre for Medical Mycology [N006364/1]; China Scholarship Council (CSC) [201406055024]	We thank Luz A. Lopez-Ramirez (Universidad de Guanajuato) for technical assistance. This work was supported by Consejo Nacional de Ciencia y Tecnologia (ref. CB2011/166860; PDCPN2014-247109, and FC 2015-02-834), Universidad de Guanajuato (ref. 000025/11; 0087/13; ref. 1025/2016; Convocatoria Institucional para Fortalecer la Excelencia Academica 2015; CIFOREA 89/2016), Programa de Mejoramiento de Profesorado (ref. UGTO-PTC-261), and Red Tematica Glicociencia en Salud (CONACYT-Mexico). NG acknowledges the Wellcome Trust (086827, 075470, 101873, and 200208) and MRC Centre for Medical Mycology for funding (N006364/1). KJ was supported by a research visitor grant to Aberdeen from China Scholarship Council (CSC No. 201406055024).	ABRAMS WR, 1983, J HISTOCHEM CYTOCHEM, V31, P737, DOI 10.1177/31.6.6404983                                                            ; Akeboshi H, 2009, GLYCOBIOLOGY, V19, P1002, DOI 10.1093/glycob/cwp080; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Bates Steven, 2013, BMC Res Notes, V6, P294, DOI 10.1186/1756-0500-6-294; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Courjol F, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv116; Diaz-Jimenez DF, 2012, CURR FUNGAL INFECT R, V6, P275, DOI 10.1007/s12281-012-0109-7; Diaz-Jimenez DF, 2012, BIOCHEM BIOPH RES CO, V419, P77, DOI 10.1016/j.bbrc.2012.01.131; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Gil JY, 2015, J BIOTECHNOL, V206, P66, DOI 10.1016/j.jbiotec.2015.04.007; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Harris M, 2009, MICROBIOL-SGM, V155, P1058, DOI 10.1099/mic.0.026120-0; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kim YH, 2017, APPL MICROBIOL BIOT, V101, P2979, DOI 10.1007/s00253-017-8101-3; Klis FM, 2001, MED MYCOL, V39, P1; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lewis LE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002578; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI [10.1128/EC.3.5.1076-1087.2004, 10.1128/EC.3.5.1075-1087.2004]; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Martinez-Alvarez JA, 2014, REV IBEROAM MICOL, V31, P62, DOI 10.1016/j.riam.2013.09.015; Martinez-Duncker I., 2014, INT J MICROBIOL, V2014, DOI [10.1155/2014/267497, DOI 10.1155/2014/267497]; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Miura M, 2004, GENE, V324, P129, DOI 10.1016/j.gene.2003.09.023; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Mora-Montes HM, 2009, FUTURE MICROBIOL, V4, P1167, DOI 10.2217/FMB.09.88; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4<325::AID-YEA538>3.0.CO;2-#; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Odani T, 1996, GLYCOBIOLOGY, V6, P805, DOI 10.1093/glycob/6.8.805; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Park JN, 2011, APPL ENVIRON MICROB, V77, P1187, DOI 10.1128/AEM.02323-10; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Santos EOL, 2015, J PHARMACOL TOX MET, V72, P67, DOI 10.1016/j.vascn.2014.10.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Trujillo-Esquivel E, 2016, NUCLEOS NUCLEOT NUCL, V35, P404, DOI 10.1080/15257770.2016.1184277; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wang XH, 1997, J BIOL CHEM, V272, P18117, DOI 10.1074/jbc.272.29.18117; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1<65::AID-YEA508>3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	59	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 6	2017	8								2156	10.3389/fmicb.2017.02156				13	Microbiology	Microbiology	FL6WV	WOS:000414387800001	29163439	gold			2018-01-05	
J	Anandan, S; Ragupathi, NKD; Sethuvel, DPM; Thangamani, S; Veeraraghavan, B				Anandan, Shalini; Ragupathi, Naveen Kumar Devanga; Sethuvel, Dhiviya Prabaa Muthuirulandi; Thangamani, Suji; Veeraraghavan, Balaji			Prevailing clone (ST69) of Vibrio cholerae O139 in India over 10 years	GUT PATHOGENS			English	Article						Vibrio cholerae O139; ST69; MLST; Antimicrobial resistance	TOOL	Vibrio cholerae is responsible for the cause of severe life-threatening infection known as cholera. The study aimed to analyze the genetic make-up of V. cholerae O139 isolates from India and compare its phylogeny with the global strains. The genome data revealed that all isolates were of same sequence type (ST69) which belongs to seventh pandemic clone, with same virulence gene profile and, antimicrobial resistance gene profile except for two isolates. No known CRISPR repeats were identified in any of these isolates. Three different phages were identified among the isolates. All the isolates were found to harbour intSXT and seventh pandemic-specific gene (VC2346). Results from this study enhance our understanding on the persistence of ST69 V. cholerae O139 over 20 years.	[Anandan, Shalini; Ragupathi, Naveen Kumar Devanga; Sethuvel, Dhiviya Prabaa Muthuirulandi; Thangamani, Suji; Veeraraghavan, Balaji] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore 632004, Tamil Nadu, India	Veeraraghavan, B (reprint author), Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore 632004, Tamil Nadu, India.	vbalaji@cmcvellore.ac.in		Veeraraghavan, Balaji/0000-0002-8662-4257	Indian Council of Medical Research (ICMR), New Delhi [AMR/TF/55/13ECDII]	The study was funded by Indian Council of Medical Research (ICMR), New Delhi (Ref. No: AMR/TF/55/13ECDII dated 23/10/2013).	Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Jesudason MV, 1996, LANCET, V347, P1493, DOI 10.1016/S0140-6736(96)91733-X; Moore S, 2014, CLIN MICROBIOL INFEC, V20, P373, DOI 10.1111/1469-0691.12610; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siriphap A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169324; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Yi Y, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-3; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	11	0	0	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-4749			GUT PATHOG	Gut Pathogens	NOV 6	2017	9								60	10.1186/s13099-017-0210-0				7	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	FL8JT	WOS:000414496800001	29142593	gold			2018-01-05	
J	Li, Y; Kim, J				Li, Yong; Kim, Jimok			DISTINCT ROLES OF NEURONAL AND MICROGLIAL CB2 CANNABINOID RECEPTORS IN THE MOUSE HIPPOCAMPUS	NEUROSCIENCE			English	Article						Cnr2 gene; adeno-associated virus; behavior; memory; microglia; pyramidal neuron	CONTEXTUAL FEAR; SYNAPTIC-TRANSMISSION; DORSAL HIPPOCAMPUS; GENETIC ASSOCIATION; SPATIAL MEMORY; MICE; BRAIN; ACTIVATION; EXPRESSION; PLASTICITY	The effects of cannabinoids are primarily mediated by type-1 cannabinoid receptors in the brain and type-2 cannabinoid receptors (CB2Rs) in the peripheral immune system. However, recent evidence demonstrates that CB2Rs are also expressed in the brain and implicated in neuropsychiatric effects. Diverse types of cells in various regions in the brain express CB2Rs but the cellular loci of CB2Rs that induce specific behavioral effects have not been determined. To manipulate CB2R expression in specific types of cells in the dorsal hippocampus of adult mice, we used Cre-dependent overexpression and CRISPR-Cas9 genome-editing techniques in combination with adeno-associated viruses and transgenic mice. Elevation and disruption of CB2R expression in microglia in the CA1 area increased and decreased, respectively, contextual fear memory. In CA1 pyramidal neurons, disruption of CB2R expression enhanced spatial working memory, whereas their overexpression reduced anxiety levels assessed as an increase in the exploration time in the central area of open field. Interneuronal CB2Rs were not involved in the modulation of cognitive or emotional behaviors tested in this study. The targeted manipulation of CB2R expression in pyramidal neurons and microglia suggests that CB2Rs in different types of cells in the mature hippocampus play distinct roles in the regulation of memory and anxiety. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Li, Yong; Kim, Jimok] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1462 Laney Walker Blvd, Augusta, GA 30912 USA; [Kim, Jimok] Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	Li, Y (reprint author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1462 Laney Walker Blvd, Augusta, GA 30912 USA.	yoli@augusta.edu			Augusta University	The authors thank Drs. Bo-Shiun Chen, L. Phillip Wang, and Xiangdong Sun for technical advice. Cx3cr1-Cre mice were a gift from Dr. Steffen Jung (Weizmann Institute of Science, Israel) via The Jackson Laboratory. The Addgene plasmids 60229 and 42230 were gifts from Dr. Feng Zhang. The Addgene plasmids 35512, 37084, and 61463 were gifts from Drs. Karl Deisseroth, Bernardo Sabatini, and Bong-Kiun Kaang, respectively. This work was supported by Augusta University Extramural Success Award. The funding agency had no role in study design; in the collection and analysis of data; or in the writing and submission of the report for publication.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Alexander SPH, 2016, PROG NEURO-PSYCHOPH, V64, P157, DOI 10.1016/j.pnpbp.2015.07.001; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; Anchan D, 2014, BRAIN BEHAV, V4, P51, DOI 10.1002/brb3.197; Aracil-Fernandez A, 2012, NEUROPSYCHOPHARMACOL, V37, P1749, DOI 10.1038/npp.2012.22; Ashton JC, 2012, HIPPOCAMPUS, V22, P643, DOI 10.1002/hipo.20946; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Bae JS, 2014, PSYCHIAT GENET, V24, P225, DOI 10.1097/YPG.0000000000000047; Baek JH, 2013, J NEUROSCI METH, V216, P87, DOI 10.1016/j.jneumeth.2013.03.021; Bahi A, 2014, PHYSIOL BEHAV, V135, P119, DOI 10.1016/j.physbeh.2014.06.003; BEACH ME, 1995, CELL, V81, P905; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Cecyre B, 2014, N-S ARCH PHARMACOL, V387, P175, DOI 10.1007/s00210-013-0930-8; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Choi JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-17; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; DENAES T, 2016, SCI REP, V6; Duff G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070849; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferbinteanu J, 1999, BEHAV BRAIN RES, V101, P65, DOI 10.1016/S0166-4328(98)00144-2; Forwood SE, 2005, HIPPOCAMPUS, V15, P347, DOI 10.1002/hipo.20059; Garcia-Gutierrez MS, 2010, BRIT J PHARMACOL, V160, P1773, DOI 10.1111/j.1476-5381.2010.00819.x; Garcia-Gutierrez MS, 2013, NEUROPHARMACOLOGY, V73, P388, DOI [10.1016/j.neuropharm.2013.06.034, 10.1016/j.neuropharm.2013.05.034]; Holmdahl R, 2012, EUR J IMMUNOL, V42, P45, DOI 10.1002/eji.201142048; Hu B, 2009, PAIN, V143, P206, DOI 10.1016/j.pain.2009.02.018; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ishiguro H, 2010, BIOL PSYCHIAT, V67, P974, DOI 10.1016/j.biopsych.2009.09.024; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0                                                   ; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kim J, 2015, J PHYSIOL-LONDON, V593, P871, DOI 10.1113/jphysiol.2014.286633; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kubota M, 2001, BIOCHEM BIOPH RES CO, V282, P242, DOI 10.1006/bbrc.2001.4572; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Li Y, 2015, NEUROSCIENCE, V311, P253, DOI 10.1016/j.neuroscience.2015.10.041; Li Y, 2016, HIPPOCAMPUS, V26, P275, DOI 10.1002/hipo.22558; Li Y, 2016, NEURAL PLAST, DOI 10.1155/2016/9817089; Ligresti A, 2009, CURR OPIN CHEM BIOL, V13, P321, DOI 10.1016/j.cbpa.2009.04.615; Marchalant Y, 2014, J HISTOCHEM CYTOCHEM, V62, P395, DOI 10.1369/0022155414530995; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Minocci D, 2011, J AFFECT DISORDERS, V134, P427, DOI 10.1016/j.jad.2011.05.023; Misane I, 2013, BEHAV BRAIN RES, V238, P160, DOI 10.1016/j.bbr.2012.10.027; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0                                                                ; Navarrete F, 2012, BRIT J PHARMACOL, V165, P260, DOI 10.1111/j.1476-5381.2011.01542.x; Onaivi ES, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001640; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Ortega-Alvaro A, 2011, NEUROPSYCHOPHARMACOL, V36, P1489, DOI 10.1038/npp.2011.34; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Romero-Zerbo SY, 2012, J NEUROENDOCRINOL, V24, P1106, DOI 10.1111/j.1365-2826.2012.02325.x; Roughton K, 2012, EUR J NEUROSCI, V36, P2763, DOI 10.1111/j.1460-9568.2012.08197.x; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schmole AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138986; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sierra S, 2015, BRAIN STRUCT FUNCT, V220, P2721, DOI 10.1007/s00429-014-0823-8; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Stempel AV, 2016, NEURON, V90, P795, DOI 10.1016/j.neuron.2016.03.034; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Tong DX, 2013, J MOL NEUROSCI, V51, P454, DOI 10.1007/s12031-013-0062-0; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Walter L, 2003, J NEUROSCI, V23, P1398; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Zhang HY, 2015, NEUROPSYCHOPHARMACOL, V40, P1037, DOI 10.1038/npp.2014.297; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	79	1	1	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 5	2017	363						11	25		10.1016/j.neuroscience.2017.08.053				15	Neurosciences	Neurosciences & Neurology	FK9IN	WOS:000413824900002	28888955				2018-01-05	
J	Huang, LC; Lin, CL; Qiu, JZ; Lin, CY; Hsu, KW; Tam, KW; Lee, JY; Yang, JM; Lee, CH				Huang, Li-Chi; Lin, Ching-Ling; Qiu, Jia-Zheng; Lin, Chun-Yu; Hsu, Kai-Wen; Tam, Ka-Wai; Lee, Jung-Yu; Yang, Jinn-Moon; Lee, Chia-Hwa			Nicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						triple-negative breast cancer; cancer metastasis; gene editing; alpha 9-nAChR; epithelial-mesenchymal transition	EPITHELIAL-MESENCHYMAL TRANSITION; LUNG-CANCER; E-CADHERIN; CELLS; SLUG; PROLIFERATION; CRISPR-CAS9; EXPRESSION; TARGETS; ANGIOGENESIS	Triple-negative breast cancer (TNBC) subtype is associated with poor prognosis and a high risk of recurrence-related death in women. Despite the aggressiveness of TNBCs, targeted TNBC therapy is not yet available in the clinic. To overcome this challenge, we generated highly metastatic TNBC cells (LM) derived from metastasized lung cells via a serial spontaneous pulmonary metastasis animal model to identify targetable molecules for attenuating the progression of TNBC metastasis. Gene analysis of primary tumor (P), first-round (1LM) and second-round (2LM) metastasized lung cells revealed that mesenchymal-related genes were significantly expressed in LM cells, especially in 2LM cells. Interestingly, alpha 9-nAChR gene expression was also dramatically induced in LM cells, confirming our previous finding that alpha 9-nAChR plays important roles in receptor-mediated carcinogenic signals in human breast cancer development. Using alpha 9-nAChR as a biomarker, we transfected 2LM cells with CRISPR/Cas9 lentivirus targeting the alpha 9-nAChR genomic region (2LM-alpha 9-nAChR-null), showing that mesenchymal markers and the migration and invasion abilities of 2LM cells were significantly attenuated in 2LM-alpha 9-nAChR-null cells both in vitro and in vivo. In addition, the high efficiency of editing the alpha 9-nAChR gene using a CRISPR/Cas9 lentivirus was demonstrated by gene sequencing, genomic indel frequency and protein expression analyses. Collectively, these results confirmed those of our previous study that advanced-stage breast tumors are associated with substantially higher levels of alpha 9-nAChR gene expression, indicating that alpha 9-nAChR expression is essential for mediating TNBC metastasis during cancer development and may potentially act as a biomarker for targeted therapy in clinical investigations.	[Huang, Li-Chi; Lin, Ching-Ling] Cathay Gen Hosp, Dept Endocrinol, Taipei, Taiwan; [Qiu, Jia-Zheng; Lee, Chia-Hwa] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Lin, Chun-Yu; Lee, Jung-Yu; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Hsu, Kai-Wen] China Med Univ, Res Ctr Tumor Med Sci, Taichung, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lee, Chia-Hwa] Taipei Med Univ, Shuang Ho Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Chia-Hwa] Taipei Med Univ, Comprehens Canc Ctr, Taipei, Taiwan	Lee, CH (reprint author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.; Lee, CH (reprint author), Taipei Med Univ, Shuang Ho Hosp, Dept Lab Med, Taipei, Taiwan.; Lee, CH (reprint author), Taipei Med Univ, Comprehens Canc Ctr, Taipei, Taiwan.	chlee@tmu.edu.tw			Cathay Medical Center [CGH-MR-A10629]; Ministry of Science and Technology [102-2320-B-038-039-MY3]; Health and Welfare Surcharge of Tobacco Products, Ministry of Health and Welfare [MOHW105-TDU-B-212-134007, MOHW105-TDU-B-212-134001]	This study was supported by Cathay Medical Center, grant CGH-MR-A10629 for L-CH; the Ministry of Science and Technology, grant 102-2320-B-038-039-MY3 for C-HL, and the Health and Welfare Surcharge of Tobacco Products, Ministry of Health and Welfare to the Comprehensive Cancer Center of Taipei Medical University (MOHW105-TDU-B-212-134007, MOHW105-TDU-B-212-134001). None of the funding bodies were involved in the design of the study, the collection, analysis, and interpretation of the data, or the writing of the manuscript.	Alves CC, 2009, FRONT BIOSCI, V14, P3041, DOI 10.2741/4033; Bailey CK, 2012, J BIOL CHEM, V287, P19472, DOI 10.1074/jbc.M112.345728; Barik J, 2006, MOL PHARMACOL, V69, P618, DOI 10.1124/mol.105.018184; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463                                                ; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cooke JP, 2007, LIFE SCI, V80, P2347, DOI 10.1016/j.lfs.2007.01.061; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI [10.1016/j.tips.2007.12.006, 10.1016/j.tips,2007.12.006]; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366                                                   ; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Hajra KM, 2002, CANCER RES, V62, P1613; HENNIG G, 1995, ONCOGENE, V11, P475; Holladay MW, 1997, J MED CHEM, V40, P4169, DOI 10.1021/jm970377o; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lange-Asschenfeldt C, 2016, NEUROPHARMACOLOGY, V107, P100, DOI 10.1016/j.neuropharm.2016.03.025; Lee CH, 2011, BREAST CANCER RES TR, V129, P331, DOI 10.1007/s10549-010-1209-0; Lee CH, 2010, J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Luebke AE, 2005, J COMP NEUROL, V492, P323, DOI 10.1002/cne.20739; Maouche K, 2009, AM J PATHOL, V175, P1868, DOI 10.2353/ajpath.2009.090212; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Marubio LM, 1999, NATURE, V398, P805; Matsubayashi Hiroaki, 2004, Brain Res Mol Brain Res, V129, P1; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2                                                   ; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5                                                   ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JL, 2015, ONCOL REP, V33, P2972, DOI 10.3892/or.2015.3889; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shin SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34134; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Tu SH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3419-x; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Wang Y, 2005, NEUROSCIENCE, V132, P49, DOI 10.1016/j.neuroscience.2004.12.026; Wei PL, 2009, ANN SURG, V249, P978, DOI 10.1097/SLA.0b013e3181a6ce7e; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Yee JK, 2016, FEBS J, V283, P3239, DOI 10.1111/febs.13760	45	0	0	6	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 3	2017	11								336	10.3389/fncel.2017.00336				14	Neurosciences	Neurosciences & Neurology	FL5TS	WOS:000414309200001	29163048	gold			2018-01-05	
J	Rodic, A; Blagojevic, B; Djordjevic, M; Severinov, K; Djordjevic, M				Rodic, Andjela; Blagojevic, Bojana; Djordjevic, Magdalena; Severinov, Konstantin; Djordjevic, Marko			Features of CRISPR-Cas Regulation Key to Highly Efficient and Temporally-Specific crRNA Production	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR-Cas activation; pre-crRNA processing; CRISPR regulation; crRNA generation; biophysical modeling	RESTRICTION-MODIFICATION SYSTEMS; ESCHERICHIA-COLI; H-NS; TRANSCRIPTION REGULATION; ANTIVIRAL DEFENSE; HOST-CELL; PROKARYOTES; ADAPTATION; IMMUNITY; GENE	Bacterial immune systems, such as CRISPR-Cas or restriction-modification (R-M) systems, affect bacterial pathogenicity and antibiotic resistance by modulating horizontal gene flow. A model system for CRISPR-Cas regulation, the Type I-E system from Escherichia coli, is silent under standard laboratory conditions and experimentally observing the dynamics of CRISPR-Cas activation is challenging. Two characteristic features of CRISPR-Cas regulation in E. coli are cooperative transcription repression of cas gene and CRISPR array promoters, and fast non-specific degradation of full length CRISPR transcripts (pre-crRNA). In this work, we use computational modeling to understand how these features affect the system expression dynamics. Signaling which leads to CRISPR-Cas activation is currently unknown, so to bypass this step, we here propose a conceptual setup for cas expression activation, where cas genes are put under transcription control typical for a restriction-modification (R-M) system and then introduced into a cell. Known transcription regulation of an R-M system is used as a proxy for currently unknown CRISPR-Cas transcription control, as both systems are characterized by high cooperativity, which is likely related to similar dynamical constraints of their function. We find that the two characteristic CRISPR-Cas control features are responsible for its temporally-specific dynamical response, so that the system makes a steep (switch-like) transition from OFF to ON state with a time-delay controlled by pre-crRNA degradation rate. We furthermore find that cooperative transcription regulation qualitatively leads to a cross-over to a regime where, at higher pre-crRNA processing rates, crRNA generation approaches the limit of an infinitely abrupt system induction. We propose that these dynamical properties are associated with rapid expression of CRISPR-Cas components and efficient protection of bacterial cells against foreign DNA. In terms of synthetic applications, the setup proposed here should allow highly efficient expression of small RNAs in a narrow time interval, with a specified time-delay with respect to the signal onset.	[Rodic, Andjela; Djordjevic, Marko] Univ Belgrade, Inst Physiol & Biochem, Fac Biol, Belgrade, Serbia; [Rodic, Andjela] Univ Belgrade, Multidisciplinary PhD Program Biophys, Belgrade, Serbia; [Blagojevic, Bojana; Djordjevic, Magdalena] Univ Belgrade, Inst Phys Belgrade, Belgrade, Serbia; [Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA; [Severinov, Konstantin] Skolkovo Inst Sci & Technol, Skolkovo, Russia	Djordjevic, M (reprint author), Univ Belgrade, Inst Physiol & Biochem, Fac Biol, Belgrade, Serbia.	dmarko@bio.bg.ac.rs			Swiss National Science foundation under SCOPES project [IZ73Z0_152297]; Marie Curie International Reintegration Grant within the 7th European community Framework Programme [PIRG08-GA-2010-276996]; Ministry of Education and Science of the Republic of Serbia [ON173052]; NIH [RO1 GM10407]	This work was funded by the Swiss National Science foundation under SCOPES project number IZ73Z0_152297, by Marie Curie International Reintegration Grant within the 7th European community Framework Programme (PIRG08-GA-2010-276996) and by the Ministry of Education and Science of the Republic of Serbia under project number ON173052. KS acknowledges support through NIH grant RO1 GM10407.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bogdanova E, 2008, NUCLEIC ACIDS RES, V36, P1429, DOI 10.1093/nar/gkm1116; Bogdanova E, 2009, NUCLEIC ACIDS RES, V37, P3354, DOI 10.1093/nar/gkp210; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen CC, 2001, J BIOL CHEM, V276, P9478, DOI 10.1074/jbc.M010501200; Djordjevic M, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-24; Hill T. L, 2013, COOPERATIVITY THEORY; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Medina-Aparicio L, 2011, J BACTERIOL, V193, P2396, DOI 10.1128/JB.01480-10; Mojica FJM, 2010, MOL MICROBIOL, V77, P1341, DOI 10.1111/j.1365-2958.2010.07326.x; Morozova N, 2016, NUCLEIC ACIDS RES, V44, P790, DOI 10.1093/nar/gkv1490; Mruk I, 2008, NUCLEIC ACIDS RES, V36, P2581, DOI 10.1093/nar/gkn097; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Musharova O, 2017, NUCLEIC ACIDS RES, V45, P3297, DOI 10.1093/nar/gkx097; Patterson AG, 2017, CURR OPIN MICROBIOL, V37, P1, DOI 10.1016/j.mib.2017.02.004; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Ratner HK, 2015, CURR OPIN INFECT DIS, V28, P267, DOI 10.1097/QCO.0000000000000154; Richter C, 2012, VIRUSES-BASEL, V4, P2291, DOI 10.3390/v4102291; Rodic A, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-016-0377-x; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Severinov K., 2016, FRONT MOL BIOSCI, V3, P45, DOI 10.3389/fmolb.2016.00045; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Stratmann T, 2012, MOL MICROBIOL, V83, P1109, DOI 10.1111/j.1365-2958.2012.07993.x; TAO T, 1991, J BACTERIOL, V173, P1367, DOI 10.1128/jb.173.4.1367-1375.1991                                                 ; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Vijesurier RM, 2000, J BACTERIOL, V182, P477, DOI 10.1128/JB.182.2.477-487.2000; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Yang CD, 2014, MOL MICROBIOL, V92, P1072, DOI 10.1111/mmi.12614	37	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	NOV 3	2017	8								2139	10.3389/fmicb.2017.02139				16	Microbiology	Microbiology	FL5RF	WOS:000414302700002	29163425	gold			2018-01-05	
J	Shen, YF; Xu, KX; Yuan, ZM; Guo, JX; Zhao, H; Zhang, XZ; Zhao, L; Qing, YB; Li, HH; Pan, WR; Jia, BY; Zhao, HY; Wei, HJ				Shen, Youfeng; Xu, Kaixiang; Yuan, Zaimei; Guo, Jianxiong; Zhao, Heng; Zhang, Xuezeng; Zhao, Lu; Qing, Yubo; Li, Honghui; Pan, Weirong; Jia, Baoyu; Zhao, Hong-Ye; Wei, Hong-Jiang			Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						P53; TALENs; SCNT; Diannan miniature pig	ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; MOUSE MODELS; CANCER; MICE; CRISPR-CAS9; MUTATIONS; TUMORIGENESIS; DNA	Background: Pigs have many features that make them attractive as biomedical models for various diseases, including cancer. P53 is an important tumor suppressor gene that exerts a central role in protecting cells from oncogenic transformation and is mutated in a large number of human cancers. P53 mutations occur in almost every type of tumor and in over 50% of all tumors. In a recent publication, pigs with a mutated P53 gene were generated that resulted in lymphoma and renal and osteogenic tumors. However, approximately 80% of human tumors have dysfunctional P53. A P53-deficient pig model is still required to elucidate. Methods: Transcription activator-like effector nucleases (TALENs) were designed to target porcine P53 exon 4. The targeting activity was evaluated using a luciferase SSA recombination assay. P53 biallelic knockout (KO) cell lines were established from single-cell colonies of fetal fibroblasts derived from Diannan miniature pigs followed by electroporation with TALENs plasmids. One cell line was selected as the donor cell line for somatic cell nuclear transfer (SCNT) for the generation of P53 KO pigs. P53 KO stillborn fetuses and living piglets were obtained. Gene typing of the collected cloned individuals was performed by T7EI assay and sequencing. Fibroblast cells from Diannan miniature piglets with a P53 biallelic knockout or wild type were analyzed for the P53 response to doxorubicin treatment by confocal microscopy and western blotting. Results: The luciferase SSA recombination assay revealed that the targeting activities of the designed TALENs were 55.35-fold higher than those of the control. Eight cell lines (8/19) were mutated for P53, and five of them were biallelic knockouts. One of the biallelic knockout cell lines was selected as nuclear donor cells for SCNT. The cloned embryos were transferred into five recipient gilts, three of them becoming pregnant. Five live fetuses were obtained from one surrogate by caesarean section after 38 days of gestation for genotyping. Finally, six live piglets and one stillborn piglet were collected from two recipients by caesarean section. Sequencing analyses of the target site confirmed the P53 biallelic knockout in all fetuses and piglets, consistent with the genotype of the donor cells. The qPCR analysis showed that the expression of the P53 mRNA had significant reduction in various tissues of the knockout piglets. Furthermore, confocal microscopy and western blotting analyses demonstrated that the fibroblast cells of Diannan miniature piglets with a P53 biallelic knockout were defective in mediating DNA damage when incubated with doxorubicin. Conclusion: TALENs combined with SCNT was successfully used to generate P53 KO Diannan miniature pigs. Although these genetically engineered Diannan miniature pigs had no tumorigenic signs, the P53 gene was dysfunctional. We believe that these pigs will provide powerful new resources for preclinical oncology and basic cancer research.	[Shen, Youfeng; Xu, Kaixiang; Yuan, Zaimei; Guo, Jianxiong; Zhao, Heng; Zhang, Xuezeng; Zhao, Lu; Qing, Yubo; Li, Honghui; Jia, Baoyu; Zhao, Hong-Ye; Wei, Hong-Jiang] Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming 650201, Yunnan, Peoples R China; [Shen, Youfeng; Yuan, Zaimei; Zhao, Heng; Qing, Yubo; Li, Honghui; Pan, Weirong; Jia, Baoyu; Wei, Hong-Jiang] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China; [Zhang, Xuezeng; Zhao, Lu; Wei, Hong-Jiang] Yunnan Agr Univ, Key Lab Anim Nutr & Feed Yunnan Prov, Kunming 650201, Yunnan, Peoples R China	Zhao, HY; Wei, HJ (reprint author), Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming 650201, Yunnan, Peoples R China.; Wei, HJ (reprint author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China.; Wei, HJ (reprint author), Yunnan Agr Univ, Key Lab Anim Nutr & Feed Yunnan Prov, Kunming 650201, Yunnan, Peoples R China.	hyzhao2000@126.com; hongjiangwei@126.com			National Natural Science Foundation of China [31360549]; Major Program on Basic Research Projects of Yunnan Province [2014FC006]; Talent Project of Young and Middle-aged Academic Technology Leadership in Yunnan Province [2013HB073]	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31360549 and 31360549), Major Program on Basic Research Projects of Yunnan Province (Grant No. 2014FC006) and the Talent Project of Young and Middle-aged Academic Technology Leadership in Yunnan Province (Grant No. 2013HB073).	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; Cheng WM, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0212-7; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Chiang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050844; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Flisikowska T, 2014, J APPL GENET, V55, P53, DOI 10.1007/s13353-013-0182-9; Flisikowska T, 2013, TRANSGENIC RES, V22, P673, DOI 10.1007/s11248-013-9720-9; Gun G, 2014, BIORESEARCH OPEN ACC, V3, P255, DOI 10.1089/biores.2014.0039; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Horii T, 2016, J REPROD DEVELOP, V62, P7, DOI 10.1262/jrd.2015-151; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Karlan BY, 2003, GYNECOL ONCOL, V88, pS11, DOI 10.1006/gyno.2002.6675; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31616; Liu J, 2014, ACTA BIOCH BIOPH SIN, V46, P170, DOI 10.1093/abbs/gmt144; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757                                                         ; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mou HW, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0178-7; Nowak-Imialek M, 2013, REPROD FERT DEVELOP, V25, P103, DOI 10.1071/RD12265; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Palmero EI, 2010, CURR OPIN ONCOL, V22, P64, DOI 10.1097/CCO.0b013e328333bf00; Christopher S, 2016, TRANSGENIC RES, V25, P345, DOI 10.1007/s11248-016-9928-6; Saalfrank A, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.19; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sieren JC, 2014, J CLIN INVEST, V124, P4052, DOI 10.1172/JCI75447; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Strong LC, 2003, GYNECOL ONCOL, V88, pS4, DOI 10.1006/gyno.2002.6673; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071068; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Zhao P, 2016, CELL RES, V26, P633, DOI 10.1038/cr.2016.46	52	0	0	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1479-5876			J TRANSL MED	J. Transl. Med.	NOV 3	2017	15								224	10.1186/s12967-017-1327-0				11	Medicine, Research & Experimental	Research & Experimental Medicine	FL9BN	WOS:000414545500002	29100547	gold			2018-01-05	
J	Kim, SK; Seong, W; Han, GH; Lee, DH; Lee, SG				Kim, Seong Keun; Seong, Wonjae; Han, Gui Hwan; Lee, Dae-Hee; Lee, Seung-Goo			CRISPR interference-guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli	MICROBIAL CELL FACTORIES			English	Article						CRISPR interference; Escherichia coli; n-Butanol; Multiple gene knockdown; Endogenous gene	MEVALONATE PATHWAY; SMALL RNAS; E. COLI; EXPRESSION; BIOSYNTHESIS; CHEMICALS; PRODUCTS; SYSTEM; EVOLUTION; 1-BUTANOL	Background: Multiplex control of metabolic pathway genes is essential for maximizing product titers and conversion yields of fuels, chemicals, and pharmaceuticals in metabolic engineering. To achieve this goal, artificial transcriptional regulators, such as clustered regularly interspaced short palindromic repeats (CRISPR) interference (CRISPRi), have been developed to specifically repress genes of interest. Results: In this study, we deployed a tunable CRISPRi system for multiplex repression of competing pathway genes and, thus, directed carbon flux toward production of molecules of interest in Escherichia coli. The tunable CRISPRi system with an array of sgRNAs successfully repressed four endogenous genes (pta, frdA, ldhA, and adhE) individually and in double, triple, or quadruple combination that are involved in the formation of byproducts (acetate, succinate, lactate, and ethanol) and the consumption of NADH in E. coli. Single-target CRISPRi effectively reduced the amount of each byproduct and, interestingly, pta repression also decreased ethanol production (41%), whereas ldhA repression increased ethanol production (197%). CRISPRi-mediated multiplex repression of competing pathway genes also resulted in simultaneous reductions of acetate, succinate, lactate, and ethanol production in E. coli. Among 15 conditions repressing byproduct-formation genes, we chose the quadruple-target CRISPRi condition to produce n-butanol in E. coli as a case study. When heterologous n-butanol-pathway enzymes were introduced into E. coli simultaneously repressing the expression of the pta, frdA, ldhA, and adhE genes via CRISPRi, n-butanol yield and productivity increased up to 5.4- and 3.2-fold, respectively. Conclusions: We demonstrated the tunable CRISPRi system to be a robust platform for multiplex modulation of endogenous gene expression that can be used to enhance biosynthetic pathway productivity, with n-butanol as the test case. CRISPRi applications potentially enable the development of microbial "smart cell" factories capable of producing other industrially valuable products.	[Kim, Seong Keun; Seong, Wonjae; Han, Gui Hwan; Lee, Dae-Hee; Lee, Seung-Goo] KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon 34141, South Korea; [Seong, Wonjae; Lee, Dae-Hee; Lee, Seung-Goo] UST, Dept Biosyst & Bioengn, KRIBB Sch Biotechnol, Daejeon 34113, South Korea	Lee, DH; Lee, SG (reprint author), KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon 34141, South Korea.	dhlee@kribb.re.kr; sglee@kribb.re.kr			KRIBB; National Research Foundation (NRF) - Ministry of Science and ICT of the Republic of Korea [NRF-2015M3D3A1A01064875]; Next-Generation BioGreen 21 Program (SSAC) - Rural Development Administration of the Republic of Korea [PJ011118]	This work was supported by the KRIBB Research Initiative Program and a grant from C1 Gas Refinery Program (Grant Number: NRF-2015M3D3A1A01064875) from the National Research Foundation (NRF) funded by the Ministry of Science and ICT of the Republic of Korea. This work was also supported by a grant from the Next-Generation BioGreen 21 Program (SSAC, Grant Number: PJ011118) funded by the Rural Development Administration of the Republic of Korea.	Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Centeno-Leija S, 2014, ANTON LEEUW INT J G, V105, P687, DOI 10.1007/s10482-014-0124-5; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Chen CT, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw020; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cress BF, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-016-0623-3; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dittrich CR, 2005, BIOTECHNOL PROGR, V21, P1062, DOI 10.1021/bp050073s; Dong HJ, 2016, ADV BIOCHEM ENG BIOT, V155, P141, DOI 10.1007/10_2015_306; Du J., 2012, NUCLEIC ACIDS RES, V40, pe142; Elhadi D, 2016, METAB ENG, V38, P358, DOI 10.1016/j.ymben.2016.09.001; Gallagher RR, 2014, NAT PROTOC, V9, P2301, DOI 10.1038/nprot.2014.082; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Han GH, 2017, METAB ENG, V40, P41, DOI 10.1016/j.ymben.2016.12.012; Jones JA, 2015, CURR OPIN BIOTECH, V33, P52, DOI 10.1016/j.copbio.2014.11.013; Kim JH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0612-6; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Li D, 2017, APPL MICROBIOL BIOTE; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liu M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-016-0913-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013; Martinez-Garcia E, 2015, NUCLEIC ACIDS RES, V43, pD1183, DOI 10.1093/nar/gku1114; Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Phue JN, 2010, BIOTECHNOL LETT, V32, P1897, DOI 10.1007/s10529-010-0369-7; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Saini M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0467-4; Sharma V, 2012, ACS SYNTH BIOL, V1, P6, DOI 10.1021/sb200001q; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Solomon KV, 2012, METAB ENG, V14, P661, DOI 10.1016/j.ymben.2012.08.006; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Wen M, 2013, CURR OPIN CHEM BIOL, V17, P472, DOI 10.1016/j.cbpa.2013.03.034; Wu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13477; Wu JJ, 2014, APPL ENVIRON MICROB, V80, P7283, DOI 10.1128/AEM.02411-14; Xu P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2425; Yang YP, 2015, METAB ENG, V29, P217, DOI 10.1016/j.ymben.2015.03.018; Yoo SM, 2013, NAT PROTOC, V8, P1694, DOI 10.1038/nprot.2013.105; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhu JF, 2005, METAB ENG, V7, P104, DOI 10.1016/j.ymben.2004.10.004	51	0	0	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	NOV 3	2017	16								188	10.1186/s12934-017-0802-x				15	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FL6KV	WOS:000414354500001	29100516	gold			2018-01-05	
J	Shen, RX; Wang, L; Liu, XP; Wu, J; Jin, WW; Zhao, XC; Xie, XR; Zhu, QL; Tang, HW; Li, Q; Chen, LT; Liu, YG				Shen, Rongxin; Wang, Lan; Liu, Xupeng; Wu, Jiang; Jin, Weiwei; Zhao, Xiucai; Xie, Xianrong; Zhu, Qinlong; Tang, Huiwu; Li, Qing; Chen, Letian; Liu, Yao-Guang			Genomic structural variation-mediated allelic suppression causes hybrid male sterility in rice	NATURE COMMUNICATIONS			English	Article							ORYZA-SATIVA L.; COPY NUMBER VARIATION; MONOALLELIC EXPRESSION; REPRODUCTIVE BARRIER; GENES; PLANTS; LOCUS; MECHANISMS; SYSTEM; INCOMPATIBILITY	Hybrids between divergent populations commonly show hybrid sterility; this reproductive barrier hinders hybrid breeding of the japonica and indica rice (Oryza sativa L.) subspecies. Here we show that structural changes and copy number variation at the Sc locus confer japonica-indica hybrid male sterility. The japonica allele, Sc-j, contains a pollen-essential gene encoding a DUF1618-domain protein; the indica allele, Sc-i, contains two or three tandem-duplicated similar to 28-kb segments, each carrying an Sc-j-homolog with a distinct promoter. In Sc-j/Sc-i hybrids, the high-expression of Sc-i in sporophytic cells causes suppression of Sc-j expression in pollen and selective abortion of Sc-j-pollen, leading to transmission ratio distortion. Knocking out one or two of the three Sc-i copies by CRISPR/Cas9 rescues Sc-j expression and male fertility. Our results reveal the gene dosage-dependent allelic suppression as a mechanism of hybrid incompatibility, and provide an effective approach to overcome the reproductive barrier for hybrid breeding.	[Shen, Rongxin; Liu, Xupeng; Wu, Jiang; Zhao, Xiucai; Xie, Xianrong; Zhu, Qinlong; Tang, Huiwu; Li, Qing; Chen, Letian; Liu, Yao-Guang] State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Shen, Rongxin; Wang, Lan; Liu, Xupeng; Wu, Jiang; Zhao, Xiucai; Xie, Xianrong; Zhu, Qinlong; Tang, Huiwu; Li, Qing; Chen, Letian; Liu, Yao-Guang] Key Lab Plant Funct Genom & Biotechnol Guangdong, Guangzhou 510642, Guangdong, Peoples R China; [Shen, Rongxin; Wang, Lan; Liu, Xupeng; Wu, Jiang; Zhao, Xiucai; Xie, Xianrong; Zhu, Qinlong; Tang, Huiwu; Li, Qing; Chen, Letian; Liu, Yao-Guang] South China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Jin, Weiwei] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China,Minist Agr, Beijing 100193, Peoples R China	Liu, YG (reprint author), State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China.; Liu, YG (reprint author), Key Lab Plant Funct Genom & Biotechnol Guangdong, Guangzhou 510642, Guangdong, Peoples R China.; Liu, YG (reprint author), South China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China.	ygliu@scau.edu.cn			Ministry of Science and Technology of China [2013CBA01401, 2013CB126904, 2012AA10A303]; National Nature Science Foundation of China [31401449]; Nature Science Foundation of Guangdong Province, China [S2012040007477]	We thank G. Zhang, C. Zhuang and X.D. Liu (South China Agricultural University, SCAU) for providing T65, E5, and some other rice materials. We also thank H. Wang (SCAU), D. Charlesworth (University of Edinburgh), K. Tsunewaki (Kyoto University), H. Ma (Fudan University), Q. Zhang and Y. Ouyang (Huazhong Agricultural University) for comments on the manuscript. This work was supported by grants from the Ministry of Science and Technology of China (2013CBA01401, 2013CB126904 and 2012AA10A303), the National Nature Science Foundation of China (31401449), and the Nature Science Foundation of Guangdong Province, China (S2012040007477).	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Chess A, 2013, NEUROPSYCHOPHARMACOL, V38, P55, DOI 10.1038/npp.2012.85; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Dobzhansky Theodosius, 1937, GENETICS ORIGIN SPEC; Guo JX, 2012, J INTEGR PLANT BIOL, V54, P967, DOI 10.1111/j.1744-7909.2012.01172.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ikehashi H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P119, DOI 10.1142/9789812814265_0011; Jackson SA, 1998, GENOME, V41, P566, DOI 10.1139/gen-41-4-566; KATO SHIGEMOTO, 1928, BULT SCI FAK TERK KJUSU IMP UNIV, V3, P132; Kubo T, 2016, MOL PLANT, V9, P221, DOI 10.1016/j.molp.2015.09.014; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Li YD, 2010, J INTEGR PLANT BIOL, V52, P1036, DOI 10.1111/j.1744-7909.2010.01001.x; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; LIU YG, 1994, NUCLEIC ACIDS RES, V22, P2168, DOI 10.1093/nar/22.11.2168; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; MULLER HJ, 1942, BIOL S, V6, P71; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; OKA HI, 1974, GENETICS, V77, P521; Ouyang YD, 2013, ANNU REV PLANT BIOL, V64, P111, DOI 10.1146/annurev-arplant-050312-120205; Qian Q, 2016, NATL SCI REV, V3, P283, DOI 10.1093/nsr/nww006; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; SANO Y, 1990, GENETICS, V125, P183; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Shi JX, 2015, TRENDS PLANT SCI, V20, P741, DOI 10.1016/j.tplants.2015.07.010; Wang GD, 2003, MOL GENET GENOMICS, V270, P234, DOI 10.1007/s00438-003-0918-z; Wang L, 2014, J INTEGR PLANT BIOL, V56, P151, DOI 10.1111/jipb.12130; Wang XM, 2014, GENETICS, V196, P937, DOI 10.1534/genetics.113.159970; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Xie WB, 2015, P NATL ACAD SCI USA, V112, pE5411, DOI 10.1073/pnas.1515919112; Xie XR, 2017, MOL PLANT, V10, P1246, DOI 10.1016/j.molp.2017.06.004; Xie YY, 2017, J INTEGR PLANT BIOL, V59, P669, DOI 10.1111/jipb.12564; Xie YY, 2017, MOL PLANT, V10, P1137, DOI 10.1016/j.molp.2017.05.005; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; Yang CY, 2004, CHINESE SCI BULL, V49, P1718, DOI 10.1360/04wc0197; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702; Yu Y, 2016, GENETICS, V203, P1439, DOI 10.1534/genetics.115.183848; Yuan LP, 2014, RICE SCI, V21, P1, DOI 10.1016/S1672-6308(13)60167-5; Yuan L. P., 1994, HYBRID RICE TECHNOLO, P1; Zhang Guiquan, 1994, Acta Genetica Sinica, V21, P34; Zhang ZS, 2006, GENETICA, V127, P295, DOI 10.1007/s10709-005-4848-z	53	0	0	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 3	2017	8								1310	10.1038/s41467-017-01400-y				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FL6SQ	WOS:000414376900011	29101356	gold			2018-01-05	
J	Wang, YF; Li, XY; Song, SS; Sun, Y; Zhang, JF; Yu, CM; Chen, W				Wang, Yongfang; Li, Xinyu; Song, Shasha; Sun, Yang; Zhang, Jiafen; Yu, Changming; Chen, Wei			HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-omega on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells	VIROLOGY JOURNAL			English	Article						Condylomata acuminata; Human papillomavirus 11; HaCaT keratinocytes; Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3; Early gene 6; Interferon-omega	HEPATITIS-B-VIRUS; HUMAN-PAPILLOMAVIRUS; CANCER; RISK; DNA; DEAMINASES; PROTEINS; HYPERMUTATION; ONCOPROTEINS; REPLICATION	Background: Condyloma acuminatum, infected by low-risk human papillomaviruses (e.g., HPV6 and HPV11), is one of the most widespread sexually transmitted diseases. Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 proteins (APOBEC3s, A3s) are cellular cytidine deaminases acting as antiviral factors through hypermutation of viral genome. However, it remains unknown whether A3s results in HPV11 gene mutations and interferon-omega (IFN-omega) exhibits antiviral activities through the A3s system. Here we investigated whether enhanced APOBEC3A (A3A) resulted in the E6 gene mutations and explore the effects of recombinant human interferon-omega (rhIFN-omega) on A3s/E6 expression in HaCaT keratinocytes containing the genome of HPV 11 (HPV11. HaCaT cells). Methods: A3A-overexpressed HPV11.HaCaT (A3A-HPV11.HaCaT) cells were established by lentiviral infection and verified by immunofluorescence and western-blotting. Cell cycle, E6 gene mutations, APOBEC3s/E6 gene expression and subcellular localization were detected by FACS, 3D-PCR and sequencing, qRT-PCR and immunofluorescence respectively. Results: The results suggested that A3A-HPV11.HaCaT cells were successfully established. Enhanced A3A induced S-phase arrest, G > A/C > T mutations and obvious reduction of E6 mRNA expression. A3A/A3B mRNA expression was up-regulated at 6 h and 12 h and obvious A3A staining existed throughout HPV11.HaCaT cells after rhIFN-omega treatment. RhIFN-omega could also inhibit mRNA expression of HPV11 E6 significantly. Conclusions: Enhanced A3A repressed HPV11 E6 expression through gene hypermutation, and rhIFN-omega might be an effective agent against HPV11 infection by up-regulation of A3A.	[Wang, Yongfang; Li, Xinyu; Song, Shasha; Sun, Yang; Zhang, Jiafen] Chinese Acad Med Sci, Inst Dermatol, Dept Pharmacol, 12 Jiang Wang Miao St, Nanjing 210042, Jiangsu, Peoples R China; [Wang, Yongfang; Li, Xinyu; Song, Shasha; Sun, Yang; Zhang, Jiafen] Peking Union Med Coll, 12 Jiang Wang Miao St, Nanjing 210042, Jiangsu, Peoples R China; [Yu, Changming; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 100071, Peoples R China	Li, XY (reprint author), Chinese Acad Med Sci, Inst Dermatol, Dept Pharmacol, 12 Jiang Wang Miao St, Nanjing 210042, Jiangsu, Peoples R China.; Li, XY (reprint author), Peking Union Med Coll, 12 Jiang Wang Miao St, Nanjing 210042, Jiangsu, Peoples R China.	xinyusli609@163.com			PUMC Youth Fund; Fundamental Research Funds for the Central Universities in China [33320140050]	This work was supported by PUMC Youth Fund and the Fundamental Research Funds for the Central Universities in China [Grant number 33320140050].	Bennetts LE, 2015, SEX TRANSM DIS, V42, P541, DOI 10.1097/OLQ.0000000000000319; Bracci L, 2017, CYTOKINE GROWTH F R, V36, P89, DOI 10.1016/j.cytogfr.2017.06.008; Buckwold VE, 2007, ANTIVIR RES, V73, P118, DOI 10.1016/j.antiviral.2006.08.005; Buckwold VE, 2006, BASIC CLIN PHARMACOL, V99, P62, DOI 10.1111/j.1742-7843.2006.pto_365.x; Danielewski JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063892; Desimmie BA, 2016, NUCLEIC ACIDS RES, V44, P7848, DOI 10.1093/nar/gkw653; Egawa N, 2017, VIRUS RES, V231, P119, DOI 10.1016/j.virusres.2016.12.017; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Hagelstein J, 1998, ARZNEIMITTEL-FORSCH, V48, P343; He X, 2014, J VIROL, V88, P5444, DOI 10.1128/JVI.03403-13; Janahi EM, 2013, J VIRAL HEPATITIS, V20, P821, DOI 10.1111/jvh.12192; Kondo S, 2017, ONCOGENE, V36, P1687, DOI 10.1038/onc.2016.335; Kukimoto I, 2015, J MED VIROL, V87, P1754, DOI 10.1002/jmv.24215; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lyman RC, 2008, J LOW GENIT TRACT DI, V12, P224, DOI 10.1097/LGT.0b013e318166eff2; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; Marullo R, 2015, CARCINOGENESIS, V36, P1397, DOI 10.1093/carcin/bgv126; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Mirghani H, 2015, CANCER TREAT REV, V41, P844, DOI 10.1016/j.ctrv.2015.10.001; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Patel H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-39; Pizzol Damiano, 2016, VirusDisease, V27, P116, DOI 10.1007/s13337-016-0319-7; Reinson T, 2015, PLOS ONE, V10; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Skorvanova L, 2015, ACTA VIROL, V59, P413, DOI 10.4149/av_2015_04_413; Sun Y, 2016, ONCOTARGET, V7, P37092, DOI 10.18632/oncotarget.9249; Tummers B, 2015, VIRUSES-BASEL, V7, P2485, DOI 10.3390/v7052485; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wallace NA, 2015, ANNU REV VIROL, V2, P403, DOI 10.1146/annurev-virology-100114-055021; [王永芳 Wang Yongfang], 2016, [中华皮肤科杂志, Chinese Journa of Dermatology], V49, P88; Wang YF, 2014, J BIOMOL SCREEN, V19, P1154, DOI 10.1177/1087057114536987; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Westrich JA, 2017, VIRUS RES, V231, P21, DOI 10.1016/j.virusres.2016.11.023; Willems L, 2015, VIRUSES-BASEL, V7, P2999, DOI 10.3390/v7062757	36	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-422X			VIROL J	Virol. J.	NOV 3	2017	14								211	10.1186/s12985-017-0878-2				9	Virology	Virology	FL9MK	WOS:000414579500002	29100527	gold			2018-01-05	
J	Sanna-Cherchi, S; Khan, K; Westland, R; Krithivasan, P; Fievet, L; Rasouly, HM; Ionita-Laza, I; Capone, VP; Fasel, DA; Kiryluk, K; Kamalakaran, S; Bodria, M; Otto, EA; Sampson, MG; Gillies, CE; Vega-Warner, V; Vukojevic, K; Pediaditakis, I; Makar, GS; Mitrotti, A; Verbitsky, M; Martino, J; Liu, QX; Na, YJ; Goj, V; Ardissino, G; Gigante, M; Gesualdo, L; Janezcko, M; Zaniew, M; Mendelsohn, CL; Shril, S; Hildebrandt, F; van Wijk, JAE; Arapovic, A; Saraga, M; Allegri, L; Izzi, C; Scolari, F; Tasic, V; Ghiggeri, GM; Latos-Bielenska, A; Kiryluk, AM; Mane, S; Goldstein, DB; Lifton, RP; Katsanis, N; Davis, EE; Gharavi, AG				Sanna-Cherchi, Simone; Khan, Kamal; Westland, Rik; Krithivasan, Priya; Fievet, Lorraine; Rasouly, Hila Milo; Ionita-Laza, Iuliana; Capone, Valentina P.; Fasel, David A.; Kiryluk, Krzysztof; Kamalakaran, Sitharthan; Bodria, Monica; Otto, Edgar A.; Sampson, Matthew G.; Gillies, Christopher E.; Vega-Warner, Virginia; Vukojevic, Katarina; Pediaditakis, Igor; Makar, Gabriel S.; Mitrotti, Adele; Verbitsky, Miguel; Martino, Jeremiah; Liu, Qingxue; Na, Young-Ji; Goj, Vinicio; Ardissino, Gianluigi; Gigante, Maddalena; Gesualdo, Loreto; Janezcko, Magdalena; Zaniew, Marcin; Mendelsohn, Cathy Lee; Shril, Shirlee; Hildebrandt, Friedhelm; van Wijk, Joanna A. E.; Arapovic, Adela; Saraga, Marijan; Allegri, Landino; Izzi, Claudia; Scolari, Francesco; Tasic, Velibor; Ghiggeri, Gian Marco; Latos-Bielenska, Anna; Kiryluk, Anna-Materna; Mane, Shrikant; Goldstein, David B.; Lifton, Richard P.; Katsanis, Nicholas; Davis, Erica E.; Gharavi, Ali G.			Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOLITARY FUNCTIONING KIDNEY; URINARY-TRACT MALFORMATIONS; BRANCHIOOTORENAL SYNDROME; RENAL HYPODYSPLASIA; GENETIC-VARIATION; CANDIDATE GENES; DISEASE; CHILDREN; VARIANTS; ANOMALIES	Renal agenesis and hypodysplasia (RHD) are major causes of pediatric chronic kidney disease and are highly genetically heterogeneous. We conducted whole-exome sequencing in 202 case subjects with RHD and identified diagnostic mutations in genes known to be associated with RHD in 7/202 case subjects. In an additional affected individual with RHD and a congenital heart defect, we found a homozygous loss-of-function (LOF) variant in SLIT3, recapitulating phenotypes reported with Slit3 inactivation in the mouse. To identify genes associated with RHD, we performed an exome-wide association study with 195 unresolved case subjects and 6,905 control subjects. The top signal resided in GREB1L, a gene implicated previously in Hoxb1 and Shha signaling in zebrafish. The significance of the association, which was p = 2.0 3 10(-5) for novel LOF, increased to p = 4.1 3 10(-6) for LOF and deleterious missense variants combined, and augmented further after accounting for segregation and de novo inheritance of rare variants (joint p = 2.3 3 10(-7)). Finally, CRISPR/Cas9 disruption or knockdown of greb1l in zebrafish caused specific pronephric defects, which were rescued by wild-type human GREB1L mRNA, but not mRNA containing alleles identified in case subjects. Together, our study provides insight into the genetic landscape of kidney malformations in humans, presents multiple candidates, and identifies SLIT3 and GREB1L as genes implicated in the pathogenesis of RHD.	[Sanna-Cherchi, Simone; Westland, Rik; Krithivasan, Priya; Rasouly, Hila Milo; Capone, Valentina P.; Fasel, David A.; Kiryluk, Krzysztof; Makar, Gabriel S.; Mitrotti, Adele; Verbitsky, Miguel; Martino, Jeremiah; Liu, Qingxue; Na, Young-Ji] Columbia Univ, Div Nephrol, New York, NY 10032 USA; [Khan, Kamal; Fievet, Lorraine; Pediaditakis, Igor; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Westland, Rik; van Wijk, Joanna A. E.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Nephrol, NL-1007 MB Amsterdam, Netherlands; [Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Kamalakaran, Sitharthan; Goldstein, David B.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA; [Bodria, Monica; Ghiggeri, Gian Marco] Ist Giannina Gaslini, Div Nephrol Dialysis Transplantat, I-16147 Genoa, Italy; [Bodria, Monica; Ghiggeri, Gian Marco] Ist Giannina Gaslini, Lab Pathophysiol Uremia, I-16147 Genoa, Italy; [Otto, Edgar A.] Univ Michigan, Dept Internal Med Nephrol, Sch Med, Ann Arbor, MI 48109 USA; [Sampson, Matthew G.; Gillies, Christopher E.; Vega-Warner, Virginia] Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA; [Vukojevic, Katarina] Univ Split, Sch Med, Dept Anat Histol & Embryol, Split 21000, Croatia; [Goj, Vinicio] Fatebenefratelli Hosp, Pediat Unit, I-20121 Milan, Italy; [Ardissino, Gianluigi] Fdn Ca Granda IRCCS Osped Maggiore Policlin Milan, Pediatr Nephrol & Dialysis Unit, I-20122 Milan, Italy; [Gigante, Maddalena] Univ Foggia, Dept Med & Surg Sci, I-71121 Foggia, Italy; [Gesualdo, Loreto] Univ Bari, Dept Emergency & Organ Transplantat, Sect Nephrol, I-70121 Bari, Italy; [Janezcko, Magdalena] Jagiellonian Univ, Dept Med Genet, Chair Pediat, Collegium Medicum, PL-31008 Krakow, Poland; [Zaniew, Marcin] Childrens Hosp, PL-61825 Poznan, Poland; [Mendelsohn, Cathy Lee] Columbia Univ, Dept Urol Pathol & Cell Biol Genet & Dev, New York, NY 10032 USA; [Shril, Shirlee; Hildebrandt, Friedhelm] Boston Childrens Hosp, Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Arapovic, Adela; Saraga, Marijan] Univ Hosp Split, Dept Pediat, Nanjing 21000, Peoples R China; [Saraga, Marijan] Univ Split, Sch Med, Split 21000, Croatia; [Allegri, Landino] Univ Parma, Dept Med & Surg, I-43100 Parma, Italy; [Izzi, Claudia; Scolari, Francesco] Univ Brescia, Div 2, Cattedra Nefrol, Nefrol Azienda Osped Spedali Civili Brescia Presi, I-25018 Brescia, Italy; [Izzi, Claudia] Azienda Osped Spedali Civili Brescia, Dipartimento Ostetr Ginecol, I-25018 Brescia, Italy; [Tasic, Velibor] Univ Childrens Hosp, Dept Pediat Nephrol, Med Fac Skopje, Skopje 1000, Macedonia; [Latos-Bielenska, Anna; Kiryluk, Anna-Materna] Poznan Univ Med Sci, Dept Med Genet, PL-61701 Poznan, Poland; [Latos-Bielenska, Anna; Kiryluk, Anna-Materna] Ctr Med Genet GENESIS, PL-61701 Poznan, Poland; [Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Dept Human Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Sanna-Cherchi, S (reprint author), Columbia Univ, Div Nephrol, New York, NY 10032 USA.; Davis, EE (reprint author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27701 USA.	ss2517@cumc.columbia.edu; erica.davis@duke.edu		Sampson, Matthew/0000-0001-9560-076X	National Institutes of Health [R01DK103184, UL1 TR000040, R01DK108805, R01DK088767, P50DK096415, P30DK096493, R01DK080099, U54DK104309, R01DK105124]; American Heart Association [13GRNT14680075]; Joint Italian Ministry of Health; NIH Young Investigators Finalized Research; National Human Genome Research Institute Centers for Mendelian Genomics [HG006504]; Fondazione Malattie Renali nel Bambino; Charles Woodson Clinical Research Fund; Polish Ministry of Health; Dutch Kidney Foundation for the Kolff post-doc abroad gran [15OKK95]	We thank all individuals with RHD and their family members for participating to this study. This work was supported by grants from the National Institutes of Health (R01DK103184 and UL1 TR000040 to S.S.-C.; R01DK108805 to M.G.S.; R01DK088767 to F.H.; P50DK096415 to N.K.; P30DK096493 to N.K. and E.E.D.; R01DK080099 to A.G.G.; U54DK104309 to A.G.G.; R01DK105124 to K. Kiryluk), the American Heart Association grant-in-aid 13GRNT14680075 to S.S.-C., the Joint Italian Ministry of Health and NIH Young Investigators Finalized Research 2012 to S.S.-C. and G.M.G., the National Human Genome Research Institute Centers for Mendelian Genomics (HG006504 to R.P.L.), and the Fondazione Malattie Renali nel Bambino (to G.M.G.). M.G.S. is supported by the Charles Woodson Clinical Research Fund. A.-M. K. and A.L.-B. are funded by the Polish Ministry of Health. We acknowledge the Polish Kidney Genetics Network (POLYGENES), the Polish Registry of Congenital Malformations (PRCM), the NZOZ Center for Medical Genetics (GENESIS) in Poznan, Poland, and the Dutch Kidney Foundation for the Kolff post-doc abroad grant (15OKK95 to R.W.). The list of contributors for the 6,905 exome controls used in this study is available in the Supplemental Data.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2017, LANCET NEUROL, V16, P135, DOI 10.1016/S1474-4422(16)30359-3; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; BARAKAT AJ, 1991, UROLOGY, V38, P347, DOI 10.1016/0090-4295(91)80150-6; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Brophy PD, 2017, GENETICS, V207, P215, DOI 10.1534/genetics.117.1125; Brunskill EW, 2014, DEVELOPMENT, V141, P3093, DOI 10.1242/dev.110601; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Choe SK, 2011, DEV BIOL, V358, P356, DOI 10.1016/j.ydbio.2011.05.676; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Collins Allan J, 2013, Am J Kidney Dis, V61, pe1, DOI 10.1053/j.ajkd.2012.11.031; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Ghosh MG, 2000, CANCER RES, V60, P6367; Gillies CE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1108-4; Goodyer P. R., 2004, PEDIAT NEPHROLOGY, P83; Guo MH, 2016, AM J HUM GENET, V99, P527, DOI 10.1016/j.ajhg.2016.06.031; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Held T, 2006, MOL CELL BIOL, V26, P8099, DOI 10.1128/MCB.01332-06; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Karamanoukian HL, 2003, ANN THORAC SURG, V75, P1059, DOI 10.1016/S0925-4773(03)00161-8; LIVERA LN, 1989, BRIT MED J, V298, P1421, DOI 10.1136/bmj.298.6685.1421                                                       ; Lopez-Rivera E, 2017, NEW ENGL J MED, V376, P742, DOI 10.1056/NEJMoa1609009; Miklovicova D, 2005, PEDIATR NEPHROL, V20, P1136, DOI 10.1007/s00467-005-1896-7; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Nicolaou N, 2016, KIDNEY INT, V89, P476, DOI 10.1038/ki.2015.319; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Pennimpede T, 2012, DEV BIOL, V372, P55, DOI 10.1016/j.ydbio.2012.09.003; Petrovski S, 2017, AM J RESP CRIT CARE, V196, P82, DOI [10.1164/rccm.201610-2088OC, 10.1164/rccm.201610-2088oc]; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Saisawat P, 2014, KIDNEY INT, V85, P1310, DOI 10.1038/ki.2013.417; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sampson MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081062; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2007, AM J HUM GENET, V80, P539, DOI 10.1086/512248; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Thomas R, 2011, PEDIATR NEPHROL, V26, P897, DOI 10.1007/s00467-011-1826-9; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088                                                                ; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Vivante A, 2015, AM J HUM GENET, V97, P291, DOI 10.1016/j.ajhg.2015.07.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Westland R, 2015, KIDNEY INT, V88, P1402, DOI 10.1038/ki.2015.239; Westland R, 2014, J AM SOC NEPHROL, V25, P1408, DOI 10.1681/ASN.2013080886; Westland R, 2014, CLIN J AM SOC NEPHRO, V9, P978, DOI 10.2215/CJN.08900813; Westland R, 2011, NEPHROL DIAL TRANSPL, V26, P1533, DOI 10.1093/ndt/gfq844; Wuhl E, 2013, CLIN J AM SOC NEPHRO, V8, P67, DOI 10.2215/CJN.03310412; Xu J, 2006, GENETICS, V174, P735, DOI 10.1534/genetics.106.061523; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	68	1	1	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					789	802		10.1016/j.ajhg.2017.09.018				14	Genetics & Heredity	Genetics & Heredity	FL5DL	WOS:000414251600010	29100090				2018-01-05	
J	De Tomasi, L; David, P; Humbert, C; Silbermann, F; Arrondel, C; Tores, F; Fouquet, S; Desgrange, A; Niel, O; Bole-Feysot, C; Nitschke, P; Roume, J; Cordier, MP; Pietrement, C; Isidor, B; Van Kien, PK; Gonzales, M; Saint-Frison, MH; Martinovic, J; Novo, R; Piard, J; Cabrol, C; Verma, IC; Puri, R; Journel, H; Aziza, J; Gavard, L; Said-Menthon, MH; Heidet, L; Saunier, S; Jeanpierre, C				De Tomasi, Lara; David, Pierre; Humbert, Camille; Silbermann, Flora; Arrondel, Christelle; Tores, Frederic; Fouquet, Stephane; Desgrange, Audrey; Niel, Olivier; Bole-Feysot, Christine; Nitschke, Patrick; Roume, Joelle; Cordier, Marie-Pierre; Pietrement, Christine; Isidor, Bertrand; Van Kien, Philippe Khau; Gonzales, Marie; Saint-Frison, Marie-Helene; Martinovic, Jelena; Novo, Robert; Piard, Juliette; Cabrol, Christelle; Verma, Ishwar C.; Puri, Ratna; Journel, Hubert; Aziza, Jacqueline; Gavard, Laurent; Said-Menthon, Marie-Helene; Heidet, Laurence; Saunier, Sophie; Jeanpierre, Cecile			Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL-ANOMALIES; URINARY-TRACT; RENAL AGENESIS; GENE; RARE; GENERATION; VARIANTS; FAMILIES; SEQUENCE; SYSTEM	Congenital anomalies of the kidney and urinary tract (CAKUT) constitute a major cause of chronic kidney disease in children and 20% of prenatally detected anomalies. CAKUT encompass a spectrum of developmental kidney defects, including renal agenesis, hypoplasia, and cystic and non-cystic dysplasia. More than 50 genes have been reported as mutated in CAKUT-affected case subjects. However, the pathophysiological mechanisms leading to bilateral kidney agenesis (BKA) remain largely elusive. Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with BKA, led to the identification of 16 heterozygous variants in GREB1L (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling. Four loss-of-function and 12 damaging missense variants, 14 being absent from GnomAD, were identified. Twelve of them were present in familial or simplex BKA-affected case subjects. Female BKA-affected fetuses also displayed uterus agenesis. We demonstrated a significant association between GREB1L variants and BKA. By in situ hybridization, we showed expression of Greb1l in the nephrogenic zone in developing mouse kidney. We generated a Greb1l knock-out mouse model by CRISPR-Cas9. Analysis at E13.5 revealed lack of kidneys and genital tract anomalies in male and female Greb1l(-/-) embryos and a slight decrease in ureteric bud branching in Greb1l(+/-) embryos. We showed that Greb1l invalidation in mIMCD3 cells affected tubulomorphogenesis in 3D-collagen culture, a phenotype rescued by expression of the wild-type human protein. This demonstrates that GREB1L plays a major role in early metanephros and genital development in mice and humans.	[De Tomasi, Lara; Humbert, Camille; Silbermann, Flora; Arrondel, Christelle; Saunier, Sophie; Jeanpierre, Cecile] Imagine Inst, Lab Hereditary Kidney Dis, INSERM UMR 1163, F-75015 Paris, France; [De Tomasi, Lara; Humbert, Camille; Arrondel, Christelle; Desgrange, Audrey; Saunier, Sophie; Jeanpierre, Cecile] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France; [De Tomasi, Lara] Paris Diderot Univ, F-75013 Paris, France; [David, Pierre] Struct Federat Rech Necker INSERM US24 CNRS UMS36, Imagine Inst, LEAT, Transgenesis Platform, F-75015 Paris, France; [Tores, Frederic] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Bioinformat Platform, INSERM UMR 1163, F-75015 Paris, France; [Fouquet, Stephane] Sorbonne Univ, Imaging Platform, UPMC Univ Paris 06, INSERM UMR S968, F-75012 Paris, France; [Fouquet, Stephane] CNRS, UMR7210, Inst Vis, F-75012 Paris, France; [Desgrange, Audrey] Imagine Inst Pasteur Inst, Lab Heart Morphogenesis, INSERM UMR 1163, F-75015 Paris, France; [Niel, Olivier] Hop Robert Debre, AP HP, Pediat Nephrol Dept, F-75019 Paris, France; [Bole-Feysot, Christine] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Genom Platform, INSERM UMR 1163, F-75015 Paris, France; [Roume, Joelle] CHI Poissy St Germain Laye, Unite Genet Med, Ctr Reference Malad Rarer Dev AnD Rare, F-78300 Poissy, France; [Cordier, Marie-Pierre] Grp Hosp Est, Serv Genet, F-69677 Bron, France; [Pietrement, Christine] CHU Reims, Unit Nephrol Pediatr, F-51100 Reims, France; [Isidor, Bertrand] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Van Kien, Philippe Khau] CHU Caremeau, Nimes Hosp Univ, Unite Genet Med, F-30900 Nimes, France; [Gonzales, Marie] Univ Paris 06, Dept Med Genet, AP HP, Hop Armand Trousseau, F-75571 Paris, France; [Gonzales, Marie] Hop Necker Enfants Malad, AP HP, Unite Embryofoetopathol, Serv Histol Embryol Cytogenet, F-75015 Paris, France; [Saint-Frison, Marie-Helene] Hop Robert Debre, AP HP, Unite Foetopathol, Dept Genet, F-75019 Paris, France; [Martinovic, Jelena] Antoine Beclere Hosp, Unit Fetal Pathol, AP HP, F-92140 Clamart, France; [Novo, Robert] Ctr Hosp Univ Lille, Serv Nephrol Pediat, Hop Jeanne Flandre, F-59000 Lille, France; [Piard, Juliette; Cabrol, Christelle] CHU Besancon, Univ Franche Comte, Ctr Human Genet, F-25000 Besancon, France; [Verma, Ishwar C.; Puri, Ratna] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi 110060, India; [Journel, Hubert] Hop Chubert, Serv Genet Med, F-56000 Vannes, France; [Aziza, Jacqueline] IUCT Oncopole, Dept Anatomie & Cytol Patholog, F-31100 Toulouse, France; [Gavard, Laurent] Hop Louis Mourier, Serv Gynecol Obstet, F-92700 Colombes, France; [Said-Menthon, Marie-Helene] Hop Leman, Serv Pediat, F-74203 Thonon Les Bains, France; [Heidet, Laurence] Hop Necker Enfants Malad, AP HP, Ctr Reference Malad Renales Hereditaires Enfant &, F-75015 Paris, France; [Heidet, Laurence] Hop Necker Enfants Malad, AP HP, Serv Nephrol Pediatr, F-75015 Paris, France	Jeanpierre, C (reprint author), Imagine Inst, Lab Hereditary Kidney Dis, INSERM UMR 1163, F-75015 Paris, France.; Jeanpierre, C (reprint author), Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France.	cecile.jeanpierre@inserm.fr	Desgrange, Audrey/I-3295-2017	Desgrange, Audrey/0000-0001-9716-755X	European Union's Seventh Framework Programme (FP7) [305608]; EURenOmics; GIS-Institut des Maladies Rares [AMA11025KSA]; Fondation pour la Recherche Medicale [DEQ20130326532]; Agence Nationale de la Recherche under "Investissements d'avenir'' program [ANR-10-IAHU-01]	We thank affected individuals and families for their participation. We also thank the foetopathologists of the SOcieteFrancaise de FOETopatholgie (SOFFOET) for providing us with fetal tissue samples, and the pediatric nephrologists from the French Society of Pediatric Nephrology and geneticists for referring the patients. We specifically thank Drs. Dominique Gaillard and Martine Doco. We are very grateful to Yuliya Petrov and Anrifati Harouna for providing us with family 5 grandparents' DNAs. We thank Drs. Lorrie le Page and Nicole Joyefor providing us with clinical information for some of the families. We warmly thank Marie-Claire Gubler for her precious help with histology analysis of fetal kidneys as well as Brigitte Lelongt for her help in dissection of mouse embryos. We are grateful to Sophie Berissi and Sophie Bernard (Small Animal Histology and Morphology platform, Necker) for tissue sections and slide scans. We acknowledge Meriem Garfa-Traoreand Nicolas Goudin (Necker Cell Imaging Platform), Emilie Panafieu, Laetitia Duhamel, Alexandra Levostre, Yann Zimmermann, and Cristian Dicu (LEAT, Animal facility) and Lotfi Slimani and Jeremy Sadoine (Platform Imagerie du Vivant, UniversiteParis Descartes) for their excellent technical assistance. We are also grateful to Marion Delous who introduced us to the embryo clearing technique. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) grant 305608 (EURenOmics). C.H. was funded by EURenOmics. This work was also supported by GIS-Institut des Maladies Rares (AMA11025KSA to C.J.), Fondation pour la Recherche Medicale (DEQ20130326532 to S.S.), and state funding from the Agence Nationale de la Recherche under "Investissements d'avenir'' program (ANR-10-IAHU-01 to S.S.).	Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Brophy PD, 2017, GENETICS, V207, P215, DOI 10.1534/genetics.117.1125; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Garne E, 2012, BIRTH DEFECTS RES A, V94, P134, DOI 10.1002/bdra.22886; Guzeltas A, 2013, PEDIATR CARDIOL, V34, P2096, DOI 10.1007/s00246-013-0656-x; Harewood L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012375; Heidet L, 1997, LAB INVEST, V76, P233; Heidet L, 2017, J AM SOC NEPHROL, V28, P2901, DOI 10.1681/ASN.2017010043; Humbert C, 2014, AM J HUM GENET, V94, P288, DOI 10.1016/j.ajhg.2013.12.017; Jeanpierre C, 2011, J MED GENET, V48, P497, DOI 10.1136/jmg.2010.088526; Kanwar YS, 2003, KIDNEY INT, V63, P1658, DOI 10.1046/j.1523-1755.2003.00905.x; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Oram RA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Torres M, 1995, DEVELOPMENT, V121, P4057; Uy N, 2016, J PEDIATR GENET, V5, P51, DOI 10.1055/s-0035-1558423; van Haelst MM, 2008, AM J MED GENET A, V146A, P2252, DOI 10.1002/ajmg.a.32440; Vivante A, 2017, J AM SOC NEPHROL, V28, P2364, DOI 10.1681/ASN.2016060694; Vivante A, 2017, J AM SOC NEPHROL, V28, P69, DOI 10.1681/ASN.2015080962; Vivante A, 2014, PEDIATR NEPHROL, V29, P695, DOI 10.1007/s00467-013-2684-4; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004	39	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					803	814		10.1016/j.ajhg.2017.09.026				12	Genetics & Heredity	Genetics & Heredity	FL5DL	WOS:000414251600011	29100091				2018-01-05	
J	Morgan, RA; Gray, D; Lomova, A; Kohn, DB				Morgan, Richard A.; Gray, David; Lomova, Anastasia; Kohn, Donald B.			Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned	CELL STEM CELL			English	Article							ZINC-FINGER NUCLEASES; X-LINKED ADRENOLEUKODYSTROPHY; STRAND BREAK REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; ADENOSINE-DEAMINASE DEFICIENCY; HOMOLOGY-DIRECTED REPAIR; LONG-TERM ENGRAFTMENT; LENTIVIRAL VECTOR; IN-VIVO	The use of allogeneic hematopoietic stem cells (HSCs) to treat genetic blood cell diseases has become a clinical standard but is limited by the availability of suitable matched donors and potential immunologic complications. Gene therapy using autologous HSCs should avoid these limitations and thus may be safer. Progressive improvements in techniques for genetic correction of HSCs, by either vector gene addition or gene editing, are facilitating successful treatments for an increasing number of diseases. We highlight the progress, successes, and remaining challenges toward the development of HSC gene therapies and discuss lessons they provide for the development of future clinical stem cell therapies.	[Morgan, Richard A.] Charles R Drew Univ Med & Sci, 1621 E 120th St, Los Angeles, CA 90059 USA; [Morgan, Richard A.; Lomova, Anastasia; Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Gray, David] Univ Calif Los Angeles, Mol Biol Inst, Interdept Doctoral Program, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	Kohn, DB (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Kohn, DB (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Kohn, DB (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.; Kohn, DB (reprint author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA.	dkohn1@mednet.ucla.edu			NIH/NHLBI [F31 HL134313, F31 HL134208]; Paul Calabresi Predoctoral Fellowship (PhRMA Foundation); UCLA MSTP [T32 GM00804]; UCLA Virology and Gene Therapy Training Grant Ruth L. Kirschstein National Research Service Award [T32 AI060567]	D.B.K. is a member of the UCLA Broad Stem Cell Center, the Jonsson Comprehensive Cancer Center, and the Children's Discovery and Innovation Institute. D.B.K. is a consultant to Orchard Therapeutics Ltd. and a member of its Scientific Advisory Board. Orchard has licensed a lentiviral vector for gene therapy of ADA SCID from the University of California Regents on which D.B.K. is an inventor. Training grants provided support to R.M. (NIH/NHLBI F31 HL134313; Paul Calabresi Predoctoral Fellowship (PhRMA Foundation); UCLA MSTP T32 GM00804), D.G. (UCLA Virology and Gene Therapy Training Grant Ruth L. Kirschstein National Research Service Award T32 AI060567), and A. L. (NIH/NHLBI F31 HL134208).	Aiuti Alessandro, 2009, Hematology Am Soc Hematol Educ Program, P682, DOI 10.1182/asheducation-2009.1.682; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Cant Barrett K., 2016, BMC RES NOTES, V9, P6; Barrette S, 2000, BLOOD, V96, P3385; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Bjurstrom CF, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.52; Boelens JJ, 2013, BLOOD, V121, P3981, DOI 10.1182/blood-2012-09-455238; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Brave M, 2010, ONCOLOGY-BASEL, V78, P282, DOI 10.1159/000315736; Brennan TA, 2014, NAT BIOTECHNOL, V32, P874, DOI 10.1038/nbt.3003; Brown MP, 1998, NAT MED, V4, P1253, DOI 10.1038/3233; Browning DL, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4010004; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carbonaro DA, 2014, MOL THER, V22, P607, DOI 10.1038/mt.2013.265; Carroll D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0378-9; Cartier N, 2012, METHOD ENZYMOL, V507, P187, DOI 10.1016/B978-0-12-386509-0.00010-7; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chaudhury S, 2017, BIOL BLOOD MARROW TR, V23, P1695, DOI 10.1016/j.bbmt.2017.06.004; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chhabra A., 2016, SCI TRANSL MED, V8; Chiruvella K. K., 2013, COLD SPRING HARB PER, V5; Clough C, 2016, MOL THER, V24, pS54, DOI 10.1016/S1525-0016(16)32941-0                                                   ; Cooke KR, 2017, BIOL BLOOD MARROW TR, V23, P211, DOI 10.1016/j.bbmt.2016.09.023; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; DANESHBODSKIBBA G, 1980, BRIT J HAEMATOL, V44, P33, DOI 10.1111/j.1365-2141.1980.tb01181.x; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; de Sio FRS, 2006, BLOOD, V107, P4257; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; De Ravin S. S., 2016, SCI TRANSL MED, V8; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DiGiusto D. L., 2016, CELLS MOL THER METHO, V3, P16067; Dull T, 1998, J VIROL, V72, P8463; Eichler F., 2017, N ENGL J MED; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery D. W., 2009, SITES MOL THER, V17, pS144; Enssle J, 2010, HUM GENE THER, V21, P397, DOI 10.1089/hum.2009.076; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fuchs EJ, 2015, BONE MARROW TRANSPL, V50, pS31, DOI 10.1038/bmt.2015.92; Gaspar H. B., 2011, SCI TRANSL MED, V3; Gaspar HB, 2014, MOL THER, V22, pS106; Gelsinger P, 2008, HASTINGS CENT REP, V38, P25, DOI 10.1353/hcr.2008.0022                                                           ; Gennari F, 2009, HUM GENE THER, V20, P554, DOI 10.1089/hum.2008.189; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Girard-Gagnepain A, 2014, BLOOD, V124, P1221, DOI 10.1182/blood-2014-02-558163; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616                                                            ; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hope T, 2002, CURR TOP MICROBIOL, V261, P179; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hsieh MM, 2011, HAEMATOL-HEMATOL J, V96, P13, DOI 10.3324/haematol.2010.035576; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Levy C, 2017, BLOOD ADV, V1, P2088, DOI 10.1182/bloodadvances.2017007773; LEWIS PF, 1994, J VIROL, V68, P510; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lis R, 2017, NATURE, V545, P439, DOI 10.1038/nature22326; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Masiuk KE, 2017, MOL THER, V25, P2163, DOI 10.1016/j.ymthe.2017.05.023; Matreyek KA, 2013, VIRUSES-BASEL, V5, P2483, DOI 10.3390/v5102483; May C, 2000, NATURE, V406, P82; METZGER L, 1991, INT J RADIAT BIOL, V59, P1325, DOI 10.1080/09553009114551201                                                       ; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239                                                           ; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Millington M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006461; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Moreno-Carranza B, 2009, GENE THER, V16, P111, DOI 10.1038/gt.2008.143; Morgan RA, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4020009; Muccio L, 2016, HAEMATOLOGICA, V101, P371, DOI 10.3324/haematol.2015.134155; Nakade S., 2014, NAT COMMUN, V5; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ng YY, 2010, LEUKEMIA, V24, P1617, DOI 10.1038/leu.2010.140; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Orkin SH, 2016, SCIENCE, V352, P1059, DOI 10.1126/science.aaf4770; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Palchaudhuri R, 2016, NAT BIOTECHNOL, V34, P738, DOI 10.1038/nbt.3584; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Petrillo C, 2015, MOL THER, V23, P352, DOI 10.1038/mt.2014.193; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ramezani A, 2008, STEM CELLS, V26, P3257, DOI 10.1634/stemcells.2008-0258; Richardson C. D., 2017, EDITING HUMAN CELLS; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Saydaminova Kamola, 2015, Mol Ther Methods Clin Dev, V1, P14057, DOI 10.1038/mtm.2014.57; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191                                                          ; Schiroli G, 2015, MOL THER, V23, pS191, DOI 10.1016/S1525-0016(16)34090-4                                                   ; Shaw KL, 2017, J CLIN INVEST, V127, P1689, DOI 10.1172/JCI90367; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Sutton RE, 1999, J VIROL, V73, P3649; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Throm RE, 2009, BLOOD, V113, P5104, DOI 10.1182/blood-2008-11-191049; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Verhoeyen E, 2005, BLOOD, V106, P3386, DOI 10.1182/blood-2004-12-4736; Vink CA, 2017, MOL THER, V25, P1790, DOI 10.1016/j.ymthe.2017.04.028; Walters MC, 2015, CURR OPIN HEMATOL, V22, P227, DOI 10.1097/MOH.0000000000000136; Wang CX, 2014, BLOOD, V124, P913, DOI 10.1182/blood-2013-12-546218; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; WOYCHIK RP, 1984, P NATL ACAD SCI-BIOL, V81, P3944, DOI 10.1073/pnas.81.13.3944                                                         ; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu HW, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3454767; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Xue XK, 2010, BLOOD, V116, P5419, DOI 10.1182/blood-2010-07-295949; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194                                                         ; Zhou S, 2016, MOL THER, V24, P1090, DOI 10.1038/mt.2016.55; Zonari E, 2017, STEM CELL REP, V8, P977, DOI 10.1016/j.stemcr.2017.02.010; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873	172	0	0	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2017	21	5					574	590		10.1016/j.stem.2017.10.010				17	Cell & Tissue Engineering; Cell Biology	Cell Biology	FL5DH	WOS:000414251200007	29100011				2018-01-05	
J	Brummer, A; Yang, Y; Chan, TW; Xiao, XS				Brummer, Anneke; Yang, Yun; Chan, Tracey W.; Xiao, Xinshu			Structure-mediated modulation of mRNA abundance by A-to-I editing	NATURE COMMUNICATIONS			English	Article							MICRORNA TARGET SITES; HUMAN BRAIN; SYSTEMATIC IDENTIFICATION; NUCLEAR RETENTION; NONCODING RNA; ADAR; TRANSCRIPTOME; EXPRESSION; DATABASE; SEQUENCE	RNA editing introduces single nucleotide changes to RNA, thus potentially diversifying gene expression. Recent studies have reported significant changes in RNA editing profiles in disease and development. The functional consequences of these widespread alterations remain elusive because of the unknown function of most RNA editing sites. Here, we carry out a comprehensive analysis of A-to-I editomes in human populations. Surprisingly, we observe highly similar editing profiles across populations despite striking differences in the expression levels of ADAR genes. Striving to explain this discrepancy, we uncover a functional mechanism of A-to-I editing in regulating mRNA abundance. We show that A-to-I editing stabilizes RNA secondary structures and reduces the accessibility of AGO2-miRNA to target sites in mRNAs. The editing-dependent stabilization of mRNAs in turn alters the observed editing levels in the stable RNA repertoire. Our study provides valuable insights into the functional impact of RNA editing in human cells.	[Brummer, Anneke; Yang, Yun; Chan, Tracey W.; Xiao, Xinshu] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Bioinformat Interdept Program, Mol Biol Inst, Los Angeles, CA 90095 USA	Xiao, XS (reprint author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Bioinformat Interdept Program, Mol Biol Inst, Los Angeles, CA 90095 USA.	gxxiao@ucla.edu		Brummer, Anneke/0000-0002-3576-0750	NIH-NCI National Cancer Institute [T32LM012424]; National Institutes of Health [U01HG009417, U01CA204695]; National Science Foundation [1262134]	We thank Dr. Erez Levanon, Dr. Desmond Smith and members of the Xiao laboratory for helpful discussions and comments on this work. We thank Shan Sabri for assistance in RNA-Seq read mapping and down-stream filtering. We thank the Geuvadis RNA-Sequencing project for generating and releasing the data sets. We thank the ENCODE Project Consortium (specifically Dr. Brenton Graveley's group) for generating the ADAR1 and AGO2 knockdown RNA-Seq data sets. T.W.C. was supported by the NIH-NCI National Cancer Institute T32LM012424. This work was supported in part by grants from the National Institutes of Health (U01HG009417, U01CA204695) and National Science Foundation (1262134) to X.X.	Ahn J, 2015, BIOINFORMATICS, V31, P3906, DOI 10.1093/bioinformatics/btv505; Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Daniel C, 2011, J BIOL CHEM, V286, P2031, DOI 10.1074/jbc.M110.130096; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Ferreira PG, 2016, SCI REP-UK, V6, DOI 10.1038/srep32406; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hoffman Y, 2013, BIOINFORMATICS, V29, P894, DOI 10.1093/bioinformatics/btt044; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Khermesh K, 2016, RNA, V22, P290, DOI 10.1261/rna.054627.115; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kleinberger Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-453; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JH, 2013, RNA, V19, P725, DOI 10.1261/rna.037903.112; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liscovitch N, 2014, RNA BIOL, V11, P1448, DOI 10.4161/15476286.2014.992286; Liu HQ, 2016, GENOME RES, V26, P499, DOI 10.1101/gr.199877.115; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Ramaswami G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9194; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Sapiro AL, 2015, CELL REP, V11, P697, DOI 10.1016/j.celrep.2015.04.005; Schneider MF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku272; Shamay-Ramot A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005702; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Smit AFA, 1996, REPEATMASKER OPEN 3; Solomon O, 2013, RNA, V19, P591, DOI 10.1261/rna.038042.112; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Wang Y, 2017, GENOME RES; Wulff BE, 2012, CURR TOP MICROBIOL, V353, P91, DOI 10.1007/82_2011_151; Zhang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23226; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]	70	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 2	2017	8								1255	10.1038/s41467-017-01459-7				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FL5BE	WOS:000414245000001	29093448	gold			2018-01-05	
J	Periyasamy, M; Singh, AK; Gemma, C; Kranjec, C; Farzan, R; Leach, DA; Navaratnam, N; Palinkas, HL; Vertessy, BG; Fenton, TR; Doorbar, J; Fuller-Pace, F; Meek, DW; Coombes, RC; Buluwela, L; Ali, S				Periyasamy, Manikandan; Singh, Anup K.; Gemma, Carolina; Kranjec, Christian; Farzan, Raed; Leach, Damien A.; Navaratnam, Naveenan; Palinkas, Hajnalka L.; Vertessy, Beata G.; Fenton, Tim R.; Doorbar, John; Fuller-Pace, Frances; Meek, David W.; Coombes, R. Charles; Buluwela, Laki; Ali, Simak			p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells	NUCLEIC ACIDS RESEARCH			English	Article							INDUCED CYTIDINE DEAMINASE; HUMAN EPITHELIAL-CELLS; MULTIPLE HUMAN CANCERS; HUMAN-PAPILLOMAVIRUS; BREAST-CANCER; MUTATIONAL PROCESSES; TUMOR-SUPPRESSOR; E7 ONCOPROTEIN; CYCLE ARREST; PROTEIN	Cancer genome sequencing has implicated the cytosine deaminase activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC) genes as an important source of mutations in diverse cancers, with APOBEC3B (A3B) expression especially correlated with such cancer mutations. To better understand the processes directing A3B overexpression in cancer, and possible therapeutic avenues for targeting A3B, we have investigated the regulation of A3B gene expression. Here, we show that A3B expression is inversely related to p53 status in different cancer types and demonstrate that this is due to a direct and pivotal role for p53 in repressing A3B expression. This occurs through the induction of p21 (CDKN1A) and the recruitment of the repressive DREAM complex to the A3B gene promoter, such that loss of p53 through mutation, or human papilloma virus-mediated inhibition, prevents recruitment of the complex, thereby causing elevated A3B expression and cytosine deaminase activity in cancer cells. As p53 is frequently mutated in cancer, our findings provide a mechanism by which p53 loss can promote cancer mutagenesis.	[Periyasamy, Manikandan; Singh, Anup K.; Gemma, Carolina; Farzan, Raed; Leach, Damien A.; Coombes, R. Charles; Buluwela, Laki; Ali, Simak] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London W12 0NN, England; [Kranjec, Christian; Doorbar, John] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Navaratnam, Naveenan] Imperial Coll London, MRC London Inst Med Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England; [Palinkas, Hajnalka L.; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary; [Navaratnam, Naveenan; Palinkas, Hajnalka L.] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Lab Genome Metab & Repair, H-1117 Budapest, Hungary; [Fenton, Tim R.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Fuller-Pace, Frances; Meek, David W.] Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Dundee DD1 9SY, Scotland	Ali, S (reprint author), Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London W12 0NN, England.	simak.ali@imperial.ac.uk			Cancer Research UK [C37/A18784]; NIHR Biomedical Research Centre funding scheme; Department of Health Imperial College Experimental Cancer Medicine Centre (ECMC); Rosetrees Trust [JS16/M229-CD1]; Breast Cancer Now [2010NovPR16]; Tayside Tissue Bank; National Research, Development and Innovation Office [K119493]; Charity Open Access Fund (COAF) via the Imperial College Open Access Fund; CRUK	Cancer Research UK [C37/A18784]; NIHR Biomedical Research Centre funding scheme; CRUK and Department of Health Imperial College Experimental Cancer Medicine Centre (ECMC); Rosetrees Trust [JS16/M229-CD1 to T.R.F.]; Breast Cancer Now [2010NovPR16 to F.F-P.]; Tayside Tissue Bank; National Research, Development and Innovation Office [K119493 to H.L.P., B.G.V.]. Funding for open access charge: Charity Open Access Fund (COAF) via the Imperial College Open Access Fund.	Akre MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155391; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x                                                ; Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beshiri ML, 2012, P NATL ACAD SCI USA, V109, P18499, DOI 10.1073/pnas.1216724109; Bochtler M, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600178; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chou WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44089; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Du W, 2009, J BIOL CHEM, V284, P26315, DOI 10.1074/jbc.M109.046904; Fischer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02831-9; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Franchini DM, 2014, EPIGENOMICS-UK, V6, P427, DOI 10.2217/epi.14.35; HALBERT CL, 1992, J VIROL, V66, P2125; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Helt AM, 2002, J VIROL, V76, P10559, DOI 10.1128/JVI.76.20.10559-10568.2002; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Kranjec C, 2017, J PATHOL, V242, P448, DOI 10.1002/path.4917; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Lambert PF, 2005, METH MOLEC MED, V119, P141; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Menzies GE, 2015, NUCLEIC ACIDS RES, V43, P9133, DOI 10.1093/nar/gkv910; MIETZ JA, 1992, EMBO J, V11, P5013; Mori S, 2017, J VIROL, V91, DOI 10.1128/JVI.02413-16; Muller GA, 2014, NUCLEIC ACIDS RES, V42, P10331, DOI 10.1093/nar/gku696; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nowarski R, 2012, BLOOD, V120, P366, DOI 10.1182/blood-2012-01-402123; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Ramiro AR, 2015, TRENDS BIOCHEM SCI, V40, P172, DOI 10.1016/j.tibs.2015.01.006; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.205.10.017; Shin MK, 2009, CANCER RES, V69, P5656, DOI 10.1158/0008-5472.CAN-08-3711; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Silwal-Pandit L, 2014, CLIN CANCER RES, V20, P3569, DOI 10.1158/1078-0432.CCR-13-2943; Spangle JM, 2016, CELL REP, V15, P2692, DOI 10.1016/j.celrep.2016.05.046; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; WALDMAN T, 1995, CANCER RES, V55, P5187; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	74	0	0	10	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 2	2017	45	19					11056	11069		10.1093/nar/gkx721				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL9DZ	WOS:000414552300016	28977491	gold			2018-01-05	
J	Shiimori, M; Garrett, SC; Chambers, DP; Glover, CVC; Graveley, BR; Terns, MP				Shiimori, Masami; Garrett, Sandra C.; Chambers, Dwain P.; Glover, Claiborne V. C., III; Graveley, Brenton R.; Terns, Michael P.			Role of free DNA ends and protospacer adjacent motifs for CRISPR DNA uptake in Pyrococcus furiosus	NUCLEIC ACIDS RESEARCH			English	Article							CAS ADAPTIVE IMMUNITY; SPACER ACQUISITION; HYPERTHERMOPHILIC ARCHAEON; MECHANISTIC BASIS; ESCHERICHIA-COLI; FOREIGN DNA; SYSTEMS; ADAPTATION; GENOME; RNA	To acquire CRISPR-Cas immunity against invasive mobile genetic elements, prokaryotes must first integrate fragments of foreign DNA into their genomic CRISPR arrays for use in future invader silencing. Here, we found that the hyperthermophilic archaeaon, Pyrococcus furiosus, actively incorporates DNA fragments (spacers) from both plasmid (foreign) and host genome (self) sequences into its seven CRISPR loci. The majority of new spacers were derived from DNA immediately downstream from a 5'-CCN-3' protospacer adjacent motif (PAM) that is critical for invader targeting. Interestingly, spacers were preferentially acquired from genome or plasmid regions corresponding to active transposons, CRISPR loci, ribosomal RNA genes, rolling circle origins of replication, and areas where plasmids recombined with the host chromosome. A common feature of the highly sampled spacers is that they arise from DNA regions expected to undergo DNA nicking and/or double-strand breaks. Taken together with recent results from bacterial systems, our findings indicate that free DNA termini and PAMs are conserved features important for CRISPR spacer uptake in diverse prokaryotes and CRISPR-Cas systems. Moreover, lethal self-targeting by CRISPR systems may contribute to host genome stability by eliminating cells undergoing active transposon mobility or chromosomal uptake of autonomously replicating foreign mobile genetic elements.	[Shiimori, Masami; Chambers, Dwain P.; Glover, Claiborne V. C., III; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Garrett, Sandra C.; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Terns, MP (reprint author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Graveley, BR (reprint author), Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA.; Terns, MP (reprint author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.; Terns, MP (reprint author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	graveley@uchc.edu; mterns@bmb.uga.edu		Terns, Michael/0000-0001-8330-1789	National Institutes of Health [R35GM118160, R35GM118140]	National Institutes of Health [R35GM118160 to M.P.T., R35GM118140 to B.R.G.]. Funding for open access charge: National Institutes of Health [R35GM118160].	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Bridger SL, 2012, J BACTERIOL, V194, P4097, DOI 10.1128/JB.00439-12; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; DIRUGGIERO J, 1993, FEMS MICROBIOL LETT, V111, P159; Elmore J, 2015, NUCLEIC ACIDS RES, V43, P10353, DOI 10.1093/nar/gkv1140; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Farkas J, 2012, APPL ENVIRON MICROB, V78, P4669, DOI 10.1128/AEM.00936-12; Farkas J, 2011, APPL ENVIRON MICROB, V77, P6343, DOI 10.1128/AEM.05057-11; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jackson RN, 2017, CURR OPIN MICROBIOL, V37, P110, DOI 10.1016/j.mib.2017.05.010; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Liu GN, 2016, NUCLEIC ACIDS RES, V44, P4233, DOI 10.1093/nar/gkw286; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725; Majumdar S, 2015, RNA, V21, P1147, DOI 10.1261/rna.049130.114; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; SHAPIRO JA, 1979, P NATL ACAD SCI USA, V76, P1933, DOI 10.1073/pnas.76.4.1933; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Stachler AE, 2017, NUCLEIC ACIDS RES, V45, P5208, DOI 10.1093/nar/gkx150; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Terns RM, 2013, BIOCHEM SOC T, V41, P1416, DOI 10.1042/BST20130056; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Waege I, 2010, APPL ENVIRON MICROB, V76, P3308, DOI 10.1128/AEM.01951-09; Wagner A, 2017, NAT REV MICROBIOL, V15, P492, DOI 10.1038/nrmicro.2017.41; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Yoon SH, 2011, GENOME RES, V21, P1892, DOI 10.1101/gr.122218.111; Yosef I, 2015, NATURE, V519, P166, DOI 10.1038/nature14204; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108	59	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 2	2017	45	19					11281	11294		10.1093/nar/gkx839				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL9DZ	WOS:000414552300031	29036456	gold			2018-01-05	
J	Tu, MJ; Lin, L; Cheng, YL; He, XB; Sun, HH; Xie, HH; Fu, JH; Liu, CB; Li, J; Chen, D; Xi, HT; Xue, DY; Liu, Q; Zhao, JZ; Gao, CX; Song, ZM; Qu, J; Gu, F				Tu, Mengjun; Lin, Li; Cheng, Yilu; He, Xiubin; Sun, Huihui; Xie, Haihua; Fu, Junhao; Liu, Changbao; Li, Jin; Chen, Ding; Xi, Haitao; Xue, Dongyu; Liu, Qi; Zhao, Junzhao; Gao, Caixia; Song, Zongming; Qu, Jia; Gu, Feng			A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells	NUCLEIC ACIDS RESEARCH			English	Article							CRISPR-CAS SYSTEM; TARGETED MUTAGENESIS; CPF1; RNA; SPECIFICITIES; ENDONUCLEASE; MICE; TOOL	Cpf1 nucleases were recently reported to be highly specific and programmable nucleases with efficiencies comparable to those of SpCas9. AsCpf1 and LbCpf1 require a single crRNA and recognize a 5'-TTTN- 3' protospacer adjacent motif (PAM) at the 5' end of the protospacer for genome editing. For widespread application in precision site-specific human genome editing, the range of sequences that AsCpf1 and LbCpf1 can recognize is limited due to the size of this PAM. To address this limitation, we sought to identify a novel Cpf1 nuclease with simpler PAM requirements. Specifically, here we sought to test and engineer FnCpf1, one reported Cpf1 nuclease (FnCpf1) only requires 5'-TTN-3' as a PAM but does not exhibit detectable levels of nuclease-induced indels at certain locus in human cells. Surprisingly, we found that FnCpf1 possesses DNA cleavage activity in human cells at multiple loci. We also comprehensively and quantitatively examined various FnCpf1 parameters in human cells, including spacer sequence, direct repeat sequence and the PAM sequence. Our study identifies FnCpf1 as a new member of the Cpf1 family for human genome editing with distinctive characteristics, which shows promise as a genome editing tool with the potential for both research and therapeutic applications.	[Tu, Mengjun; Lin, Li; He, Xiubin; Sun, Huihui; Xie, Haihua; Fu, Junhao; Li, Jin; Chen, Ding; Song, Zongming; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou 325027, Zhejiang, Peoples R China; [Tu, Mengjun; Lin, Li; He, Xiubin; Sun, Huihui; Xie, Haihua; Fu, Junhao; Li, Jin; Chen, Ding; Song, Zongming; Qu, Jia; Gu, Feng] Minist Hlth, Key Lab Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China; [Tu, Mengjun; Lin, Li; He, Xiubin; Sun, Huihui; Xie, Haihua; Fu, Junhao; Li, Jin; Chen, Ding; Song, Zongming; Qu, Jia; Gu, Feng] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China; [Liu, Changbao; Xi, Haitao; Zhao, Junzhao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, Zhejiang, Peoples R China; [Liu, Changbao; Xi, Haitao; Zhao, Junzhao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China; [Xue, Dongyu; Liu, Qi] Tongji Univ, Shanghai Peoples Hosp 10, Sch Life Sci & Technol, Dept Cent Lab, Shanghai 200072, Peoples R China; [Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Genome Editing, Beijing 100101, Peoples R China; [Song, Zongming] Zhengzhou Univ, Henan Prov Peoples Hosp, Henan Eye Hosp, Henan Eye Inst, Zhengzhou 450003, Henan, Peoples R China; [Song, Zongming] Zhengzhou Univ, Peoples Hosp, Zhengzhou 450003, Henan, Peoples R China	Gu, F (reprint author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou 325027, Zhejiang, Peoples R China.; Gu, F (reprint author), Minist Hlth, Key Lab Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China.; Gu, F (reprint author), Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China.	gufenguw@gmail.com			Chinese National Program on Key Basic Research Project [973 Program] [2013CB967502]; Natural Science Foundation of China [81201181, 81473295, 81670882, 81670840]; Natural Science Foundation of Zhejiang Province, China [LY13H040013, Q16H040014]; Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences [WKJ2013-2-023, 2016KYA146]; Science Technology Project of Zhejiang Province [2014C33260, 2017C37176]; Wenzhou city [Y20140633, Y20150071]; Wenzhou Medical University [QTJ12011]; Eye Hospital at Wenzhou Medical University [YNZD201602]	Chinese National Program on Key Basic Research Project [973 Program, 2013CB967502 to F.G.]; Natural Science Foundation of China [81201181 to F.G., 81473295, 81670882 to Z.M.S., 81670840 to J.L.]; Natural Science Foundation of Zhejiang Province, China [LY13H040013 to J.Z.Z., Q16H040014 to H.T.X.]; Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences [WKJ2013-2-023 to F.G., 2016KYA146 to D.C.]; Science Technology Project of Zhejiang Province [2014C33260 to Z.M.S., 2017C37176 to F.G.]; Wenzhou city [Y20140633 to F.G., Y20150071 to D.C.]; Wenzhou Medical University [QTJ12011 to F.G.]; Eye Hospital at Wenzhou Medical University [YNZD201602 to F.G.]. Funding for open access charge: Natural Science Foundation of China [81201181 to F.G].	Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Liu N, 2016, MICROBIOL RES, V182, P40, DOI 10.1016/j.micres.2015.09.008; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang FY, 2017, MOL THER-NUCL ACIDS, V7, P378, DOI 10.1016/j.omtn.2017.04.018; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	20	1	1	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 2	2017	45	19					11295	11304		10.1093/nar/gkx783				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL9DZ	WOS:000414552300032	28977650	gold			2018-01-05	
J	Li, YJ; Zhang, Y; Lin, JZ; Pan, SF; Han, WY; Peng, N; Liang, YX; She, QX				Li, Yingjun; Zhang, Yan; Lin, Jinzhong; Pan, Saifu; Han, Wenyuan; Peng, Nan; Liang, Yun Xiang; She, Qunxin			Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR-Cas system by binding to target RNA and crRNA	NUCLEIC ACIDS RESEARCH			English	Article							SWISS-MODEL; SULFOLOBUS-ISLANDICUS; SILENCING COMPLEX; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; EFFECTOR COMPLEX; CLEAVAGE; RECOGNITION; ADAPTATION; ARCHAEAL	CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) systems provide adaptive immunity against invasive nucleic acids guided by CRISPR RNAs (crRNAs) in archaea and bacteria. Type III CRISPR-Cas effector complexes show RNA cleavage and RNA-activated DNA cleavage activity, representing the only known system of dual nucleic acid interference. Here, we investigated the function of Cmr1 by genetic assays of DNA and RNA interference activity in the mutants and biochemical characterization of their mutated Cmr complexes. Three cmr1 alpha mutants were constructed including Delta beta Delta 1 alpha, Delta beta 1 alpha-M1 and Delta beta 1 alpha-M2 among which the last two mutants carried a double and a quadruple mutation in the first alpha-helix region of Cmr1 alpha. Whereas the double mutation of Cmr1 alpha (W58A and F59A) greatly influenced target RNA capture, the quadruple mutation almost abolished crRNA binding to Cmr1 alpha. We found that Cmr2 alpha-6 alpha formed a stable core complex that is active in both RNA and DNA cleavage and that Cmr1 alpha strongly enhances the basal activity of the core complex upon incorporation into the ribonucleoprotein complex. Therefore, Cmr1 functions as an integral activation module in III-B systems, and the unique occurrence of Cmr1 in III-B systems may reflect the adaptive evolution of type III CRISPR-Cas systems in thermophiles.	[Li, Yingjun; Zhang, Yan; Pan, Saifu; Peng, Nan; Liang, Yun Xiang; She, Qunxin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Li, Yingjun; Zhang, Yan; Pan, Saifu; Peng, Nan; Liang, Yun Xiang; She, Qunxin] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Li, Yingjun; Lin, Jinzhong; Han, Wenyuan; She, Qunxin] Univ Copenhagen, Dept Biol, Archaea Ctr, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark	She, QX (reprint author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; She, QX (reprint author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China.; She, QX (reprint author), Univ Copenhagen, Dept Biol, Archaea Ctr, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	qunxin@bio.ku.dk			Danish Council for Independent Research [DFF-0602-02196, DFF-1323-00330]; Natural Science Foundation of China [31128011]; Scientific and Technological Self-Innovation Foundation of Huazhong Agricultural University [2014RC011]; Huazhong Agricultural University	Danish Council for Independent Research [DFF-0602-02196, DFF-1323-00330]; Natural Science Foundation of China [31128011]; Scientific and Technological Self-Innovation Foundation of Huazhong Agricultural University [2014RC011]. Funding for open access charge: Huazhong Agricultural University.	Ao X, 2013, J BACTERIOL, V195, P5216, DOI 10.1128/JB.00768-13; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Contursi P, 2006, EXTREMOPHILES, V10, P615, DOI 10.1007/s00792-006-0017-2; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; LI YJ, 2016, NUCLEIC ACIDS RES, V44; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Peng N, 2017, SCI CHINA LIFE SCI, V60, P370, DOI 10.1007/s11427-016-0355-8; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Peng WF, 2013, RNA BIOL, V10, P738, DOI 10.4161/rna.23798; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sun J, 2014, ACTA CRYSTALLOGR D, V70, P535, DOI 10.1107/S1399004713030290; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhang J, 2016, NUCLEIC ACIDS RES, V44, P1789, DOI 10.1093/nar/gkw020; Zhu X, 2015, NUCLEIC ACIDS RES, V43, P1257, DOI 10.1093/nar/gku1355	42	0	0	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 2	2017	45	19					11305	11314		10.1093/nar/gkx791				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL9DZ	WOS:000414552300033	28977458	gold			2018-01-05	
J	Bennett-Baker, PE; Mueller, JL				Bennett-Baker, Pamela E.; Mueller, Jacob L.			CRISPR-mediated isolation of specific megabase segments of genomic DNA	NUCLEIC ACIDS RESEARCH			English	Article							HUMAN Y-CHROMOSOME; STRUCTURAL VARIATION; GENE ACQUISITION; AMPLIFICATION; SEQUENCE; CANCER; REGION	Megabase-sized, complex, repetitive regions of genomes are poorly studied, due to the technical and computational challenges inherent to both assembling precise reference sequences and accurately assessing structural variation across contiguous megabase DNA regions. Here we describe a strategy to overcome these challenges, CISMR (CRISPR-mediated isolation of specific megabase-sized regions of the genome), which enables us to perform targeted isolation of contiguous megabase-sized segments of the genome. Direct sequencing of the purified DNA segments can have > 100-fold enrichment of the target region, thus enabling the exploration of both DNA sequence and structural diversity of complex genomic regions in any species.	[Bennett-Baker, Pamela E.; Mueller, Jacob L.] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA	Mueller, JL (reprint author), Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA.	jacobmu@umich.edu		Mueller, Jacob L./0000-0003-1232-0303	NICHD of the National Institutes of Health [HD064753]; University of Michigan	Research reported in this publication was supported by NICHD of the National Institutes of Health [HD064753]. Funding for open access charge: University of Michigan.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Burmeister M., 1992, METHOD MOL BIOL, V12, P1; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640                                                         ; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Haldi ML, 1996, MAMM GENOME, V7, P767, DOI 10.1007/s003359900228; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; Hughes JF, 2012, ANNU REV GENOM HUM G, V13, P83, DOI 10.1146/annurev-genom-090711-163855; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Jiang WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9101; Kawaguchi TK, 2001, NAT GENET, V29, P279; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauer P, 1998, P NATL ACAD SCI USA, V95, P11318, DOI 10.1073/pnas.95.19.11318                                                        ; Lee NCO, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv112; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Soh YQS, 2014, CELL, V159, P800, DOI 10.1016/j.cell.2014.09.052; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004	36	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 2	2017	45	19							e165	10.1093/nar/gkx749				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL9DZ	WOS:000414552300004	28977642	gold			2018-01-05	
J	Sarno, R; Vicq, Y; Uematsu, N; Luka, M; Lapierre, C; Carroll, D; Bastianelli, G; Serero, A; Nicolas, A				Sarno, Roberta; Vicq, Yoan; Uematsu, Norio; Luka, Marine; Lapierre, Clement; Carroll, Dana; Bastianelli, Giacomo; Serero, Alexandre; Nicolas, Alain			Programming sites of meiotic crossovers using Spo11 fusion proteins	NUCLEIC ACIDS RESEARCH			English	Article							DOUBLE-STRAND BREAKS; RECOMBINATION INITIATION SITES; DNA-BINDING SPECIFICITY; SACCHAROMYCES-CEREVISIAE; CHROMATIN-STRUCTURE; YEAST MEIOSIS; STIMULATION; RECOGNITION; MECHANISMS; CRISPR/CAS	Meiotic recombination shapes the genetic diversity transmitted upon sexual reproduction. However, its non-random distribution along the chromosomes constrains the landscape of potential genetic combinations. For a variety of purposes, it is desirable to expand the natural repertoire by changing the distribution of crossovers in a wide range of eukaryotes. Toward this end, we report the local stimulation of meiotic recombination at a number of chromosomal sites by tethering the natural Spo11 protein to various DNA-binding modules: full-length DNA binding proteins, zinc fingers (ZFs), transcription activator-like effector (TALE) modules, and the CRISPR-Cas9 system. In the yeast Saccharomyces cerevisiae, each strategy is able to stimulate crossover frequencies in naturally recombination-cold regions. The binding and cleavage efficiency of the targeting Spo11 fusions (TSF) are variable, being dependent on the chromosomal regions and potential competition with endogenous factors. TSF-mediated genome interrogation distinguishes naturally recombination-cold regions that are flexible and can be warmed-up (gene promoters and coding sequences), from those that remain refractory (gene terminators and centromeres). These results describe new generic experimental strategies to increase the genetic diversity of gametes, which should prove useful in plant breeding and other applications.	[Sarno, Roberta; Vicq, Yoan; Uematsu, Norio; Luka, Marine; Lapierre, Clement; Serero, Alexandre; Nicolas, Alain] PSL Res Univ, CNRS UMR3244, Recombinat & Genet Instabil, Inst Curie, F-75005 Paris, France; [Sarno, Roberta; Vicq, Yoan; Uematsu, Norio; Luka, Marine; Lapierre, Clement; Serero, Alexandre; Nicolas, Alain] UPMC Univ Paris 06, Sorbonne Univ, CNRS UMR3244, F-75005 Paris, France; [Carroll, Dana] Univ Utah, Dept Biochem, Sch Med, Salt Lake City, UT 84112 USA; [Bastianelli, Giacomo] Meiogenix, F-75012 Paris, France; [Uematsu, Norio] Shiodome Bldg,1-2-20 Kalgan,Minato Ku, Tokyo 1050022, Japan	Nicolas, A (reprint author), PSL Res Univ, CNRS UMR3244, Recombinat & Genet Instabil, Inst Curie, F-75005 Paris, France.; Nicolas, A (reprint author), UPMC Univ Paris 06, Sorbonne Univ, CNRS UMR3244, F-75005 Paris, France.	alain.nicolas@curie.fr			ANR [BLAN06-3-150811]; ARC; Meiogenix; CNRS; Institut Curie	ANR [BLAN06-3-150811]; ARC and Meiogenix(C); CNRS and the Institut Curie (to N.U.). Funding for open access charge: Institut Curie.	Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crismani W, 2012, SCIENCE, V336, P1588, DOI 10.1126/science.1220381; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Girard C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005369; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6                                                   ; Higgins JD, 2014, ANNU REV GENET, V48, P29, DOI 10.1146/annurev-genet-120213-092509; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KANE SM, 1974, J BACTERIOL, V118, P8; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney S., 2007, RECOMBINATION MEIOSI, V2, P81; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Koehn DR, 2009, GENETICS, V182, P447, DOI 10.1534/genetics.109.102640; Lam I, 2015, SCIENCE, V350, P932, DOI 10.1126/science.aad0814; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Lesecque Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004790; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mercier R, 2015, ANNU REV PLANT BIOL, V66, P297, DOI 10.1146/annurev-arplant-050213-035923; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Nadarajan S, 2017, ELIFE, V6, DOI 10.7554/eLife.23437; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nicolas A, 2009, METHODS MOL BIOL, V557, P27, DOI 10.1007/978-1-59745-527-5_3; OHTA K, 1994, EMBO J, V13, P5754; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; PARTHUN MR, 1990, J BIOL CHEM, V265, P209; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Sasaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003732; Sasanuma H, 2007, NUCLEIC ACIDS RES, V35, P1119, DOI 10.1093/nar/gkl1162; Seguela-Arnaud M, 2015, P NATL ACAD SCI USA, V112, P4713, DOI 10.1073/pnas.1423107112; Si WN, 2015, NEW PHYTOL, V206, P1491, DOI 10.1111/nph.13319; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; Smagulova F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-493; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Szekvolgyi L, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016527; VASHEE S, 1993, J BIOL CHEM, V268, P24699; Vedel M, 1999, GENETICS, V151, P1245; Vincenten N, 2015, ELIFE, V4, DOI 10.7554/eLife.10850; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; ZENVIRTH D, 1992, EMBO J, V11, P3441; Ziolkowski PA, 2017, GENE DEV, V31, P306, DOI 10.1101/gad.295501.116	60	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	NOV 2	2017	45	19							e164	10.1093/nar/gkx739				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL9DZ	WOS:000414552300003	28977556	gold			2018-01-05	
J	Ajima, R; Suzuki, E; Saga, Y				Ajima, Rieko; Suzuki, Emiko; Saga, Yumiko			Pofut1 point-mutations that disrupt O-fucosyltransferase activity destabilize the protein and abolish Notch1 signaling during mouse somitogenesis	PLOS ONE			English	Article							DELTA INTERACTIONS; LIGAND-BINDING; FRINGE; O-FUCOSYL-TRANSFERASE-1; GLYCOSYLATION; SEGMENTATION; ENDOCYTOSIS; DROSOPHILA; RECEPTOR; PATHWAY	The segmental pattern of the vertebrate body is established via the periodic formation of somites from the presomitic mesoderm (PSM). This periodical process is controlled by the cyclic and synchronized activation of Notch signaling in the PSM. Protein O-fucosyltransfer-ase1 (Pofut1), which transfers O-fucose to the EGF domains of the Notch1 receptor, is indispensable for Notch signaling activation. The Drosophila homologue Ofut1 was reported to control Notch localization via two different mechanisms, working as a chaperone for Notch or as a regulator of Notch endocytosis. However, these were found to be independent of O-fucosyltransferase activity because the phenotypes were rescued by Ofut1 mutants lacking O-fucosyltransferase activity. Pofut1 may also be involved in the Notch receptor localization in mice. However, the contribution of enzymatic activity of Pofut1 to the Notch receptor dynamics remains to be elucidated. In order to clarify the importance of the O-fucosyltransferase activity of Pofut1 for Notch signaling activation and the protein localization in the PSM, we established mice carrying point mutations at the 245th a.a. or 370-372th a.a., highly conserved amino-acid sequences whose mutations disrupt the O-fucosyltransferase activity of both Drosophila Ofut1 and mammalian Pofut1, with the CRISPR/Cas9 mediated genome-engineering technique. Both mutants displayed the same severely perturbed somite formation and Notch1 subcellular localization defects as the Pofut1 null mutants. In the mutants, Pofut1 protein, but not RNA, became undetectable by E9.5. Furthermore, both wild-type and mutant Pofut1 proteins were degraded through lysosome dependent machinery. Pofut1 protein loss in the point mutant embryos caused the same phenotypes as those observed in Pofut1 null embryos.	[Ajima, Rieko; Saga, Yumiko] Natl Inst Genet, Genet Strains Res Ctr, Mammalian Dev Lab, Mishima, Shizuoka, Japan; [Ajima, Rieko; Saga, Yumiko] Natl Inst Genet, Mouse Res Supporting Unit, Mishima, Shizuoka, Japan; [Ajima, Rieko; Suzuki, Emiko; Saga, Yumiko] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Gene Network Lab, Mishima, Shizuoka, Japan; [Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	Ajima, R; Saga, Y (reprint author), Natl Inst Genet, Genet Strains Res Ctr, Mammalian Dev Lab, Mishima, Shizuoka, Japan.; Ajima, R; Saga, Y (reprint author), Natl Inst Genet, Mouse Res Supporting Unit, Mishima, Shizuoka, Japan.; Ajima, R; Saga, Y (reprint author), SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan.; Saga, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	rajima@nig.ac.jp; ysaga@nig.ac.jp			Transdisciplinary Research Integration Center of the Research Organization of Information and Systems	This work was supported by Transdisciplinary Research Integration Center of the Research Organization of Information and Systems (YS).r We thank the Mouse Research Supporting Unit at the National Institute of Genetics for establishing all mutant mice in this study. We are particularly thankful to Dr. Yoshiaki Okamura, Makoto Kiso and Akane Ohishi (National Institute of Genetics, Japan) for technical support. We are grateful to Dr. Yasuyuki Kurihara for generating the monoclonal antibodies used in this study. We are grateful to Dr. Hitoshi Niwa and Dr. Ryoichiro Kageyama for providing reagents. We are grateful to Danelle Wright for editing this manuscript. This work was supported by funding from the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Breton C, 1998, J BIOCHEM-TOKYO, V123, P1000; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030                                                           ; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI [10.1095/biolreprod.106.051136, 10.1095/biolreprod.106.05]; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moretti J, 2013, INT J MOL SCI, V14, P6359, DOI 10.3390/ijms14036359; Muller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088571; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Saga Y, 2012, CURR OPIN GENET DEV, V22, P331, DOI 10.1016/j.gde.2012.05.004; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Serth K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123776; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; Suzuki E, 1995, CELL TECHNOLOGY, V14, P456; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200                                                          ; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	56	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187248	10.1371/journal.pone.0187248				24	Multidisciplinary Sciences	Science & Technology - Other Topics	FL6FI	WOS:000414340200061	29095923	gold			2018-01-05	
J	Park, DS; Yoon, M; Kweon, J; Jang, AH; Kim, Y; Choi, SC				Park, Dong-Seok; Yoon, Mijung; Kweon, Jiyeon; Jang, An-Hee; Kim, Yongsub; Choi, Sun-Cheol			Targeted Base Editing via RNA-Guided Cytidine Deaminases in Xenopus laevis Embryos	MOLECULES AND CELLS			English	Article						base editing; CRISPR/Cas9; genome engineering; Xenopus laevis	EFFECTOR NUCLEASES; GENE DISRUPTION; MUTAGENESIS; TROPICALIS; FUSION; SYSTEM; RICE	Genome editing using programmable nucleases such as CRISPR/Cas9 or Cpf1 has emerged as powerful tools for gene knock-out or knock-in in various organisms. While most genetic diseases are caused by point mutations, these genome-editing approaches are inefficient in inducing single-nucleotide substitutions. Recently, Cas9-linked cytidine deaminases, named base editors (BEs), have been shown to convert cytidine to uridine efficiently, leading to targeted single-base pair substitutions in human cells and organisms. Here, we first report on the generation of Xenopus laevis mutants with targeted single-base pair substitutions using this RNA-guided programmable deaminase. Injection of base editor 3 (BE3) ribonucleoprotein targeting the tyrosinase (tyr) gene in early embryos can induce site-specific base conversions with the rates of up to 20.5%, resulting in oculocutaneous albinism phenotypes without off-target mutations. We further test this base-editing system by targeting the tp53 gene with the result that the expected single-base pair substitutions are observed at the target site. Collectively, these data establish that the programmable deaminases are efficient tools for creating targeted point mutations for human disease modeling in Xenopus.	[Park, Dong-Seok; Yoon, Mijung; Kweon, Jiyeon; Jang, An-Hee; Kim, Yongsub; Choi, Sun-Cheol] Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul 05505, South Korea	Kim, Y; Choi, SC (reprint author), Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul 05505, South Korea.	yongsub1.kim@gmail.com; choisc@amc.seoul.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) [2016R1A2B4013355, 2016R1D1A1A02937096, 2017M3A9B4062419]; Asan Institute for Life Sciences, Seoul, Korea [2011-525]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) (2016R1A2B4013355, 2016R1D1A1A02937096, 2017M3A9B4062419) and in part by a grant (2011-525) from the Asan Institute for Life Sciences, Seoul, Korea. We are grateful to S. Ryu for technical help and to members of Genome Engineering and Molecular Laboratory and Developmental Biology Laboratory for helpful discussions and comments on the manuscript. The authors declare no competing for financial interests.	Aslan Y, 2017, DEVELOPMENT, V144, P2852, DOI 10.1242/dev.152967; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liang PP, 2017, PROTEIN CELL, V8, P601, DOI 10.1007/s13238-017-0418-2; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Packer MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01055-9; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	20	0	0	0	0	KOREAN SOC MOLECULAR & CELLULAR  BIOLOGY	SEOUL	635-4, YUCKSAM-DONG, GANGNAM-GU, SEOUL 135-703, SOUTH KOREA	1016-8478	0219-1032		MOL CELLS	Mol. Cells	NOV	2017	40	11					823	827		10.14348/molcells.2017.0262				5	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FQ7FM	WOS:000418528300003	29179261				2018-01-05	
J	Stanley, WJ; Trivedi, PM; Sutherland, AP; Thomas, HE; Gurzov, EN				Stanley, William J.; Trivedi, Prerak M.; Sutherland, Andrew P.; Thomas, Helen E.; Gurzov, Esteban N.			Differential regulation of pro-inflammatory cytokine signalling by protein tyrosine phosphatases in pancreatic beta-cells	JOURNAL OF MOLECULAR ENDOCRINOLOGY			English	Article						pancreatic beta-cells; protein tyrosine phosphatases; PTPN1; PTPN6; cytokines; inflammation	TUMOR-NECROSIS-FACTOR; NONOBESE DIABETIC MICE; N-TERMINAL KINASE; CYTOTOXIC T-CELLS; MOTH-EATEN MICE; FACTOR-KAPPA-B; FACTOR-ALPHA; JNK1-MEDIATED PHOSPHORYLATION; CANDIDATE GENE; IFN-GAMMA	Type 1 diabetes (T1D) is characterized by the destruction of insulin producing beta-cells by immune cells in the pancreas. Pro-inflammatory including TNF-alpha, IFN-gamma and IL-1 beta are released in the islet during the autoimmune assault and signal in beta-cells through phosphorylation cascades, resulting in pro-apoptotic gene expression and eventually beta-cell death. Protein tyrosine phosphatases (PTPs) are a family of enzymes that regulate phosphorylative signalling and are associated with the development of T1D. Here, we observed expression of PTPN6 and PTPN1 in human islets and islets from non-obese diabetic (NOD) mice. To clarify the role of these PTPs in beta-cells/islets, we took advantage of CRISPR/Cas9 technology and pharmacological approaches to inactivate both proteins. We identify PTPN6 as a negative regulator of TNF-alpha-induced alpha-cell death, through JNK-dependent BCL-2 protein degradation. In contrast, PTPN1 acts as a positive regulator of IFN-gamma-induced STAT1-dependent gene expression, which enhanced autoimmune destruction of beta-cells. Importantly, PTPN1 inactivation by pharmacological modulation protects beta-cells and primary mouse islets from cytokine-mediated cell death. Thus, our data point to a non-redundant effect of PTP regulation of cytokine signalling in beta-cells in autoimmune diabetes.	[Stanley, William J.; Trivedi, Prerak M.; Sutherland, Andrew P.; Thomas, Helen E.; Gurzov, Esteban N.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Stanley, William J.; Trivedi, Prerak M.; Thomas, Helen E.; Gurzov, Esteban N.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Gurzov, Esteban N.] Univ Libre Bruxelles, Ctr Diabet Res, Brussels, Belgium	Gurzov, EN (reprint author), St Vincents Inst Med Res, Melbourne, Vic, Australia.; Gurzov, EN (reprint author), Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia.; Gurzov, EN (reprint author), Univ Libre Bruxelles, Ctr Diabet Res, Brussels, Belgium.	esteban.gurzov@unimelb.edu.au			National Health and Medical Research Council of Australia (NHMRC) [APP1071350]; Juvenile Diabetes Research Foundation (JDRF) fellowship; Operational Infrastructure Support Scheme of the Government of Victoria	This work was supported by a National Health and Medical Research Council of Australia (NHMRC) project grant (APP1071350). ENG is supported by a Juvenile Diabetes Research Foundation (JDRF) fellowship. The St Vincent's Institute receives support from the Operational Infrastructure Support Scheme of the Government of Victoria.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Amin S, 2011, MOL CANCER RES, V9, P1112, DOI 10.1158/1541-7786.MCR-11-0097; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77                                                        ; Campbell PD, 2012, CELL TRANSPLANT, V21, P49, DOI 10.3727/096368911X566262; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chong MMW, 2004, J IMMUNOL, V172, P5714, DOI 10.4049/jimmunol.172.9.5714                                                     ; Chong MMW, 2002, J BIOL CHEM, V277, P27945, DOI 10.1074/jbc.M110214200; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Denhez B, 2015, J BIOL CHEM, V290, P350, DOI 10.1074/jbc.M114.612721; Dudek NL, 2006, DIABETES, V55, P2412, DOI 10.2337/db06-0109; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; Fernandez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096617; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625                                           ; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2016, FEBS J, V283, P3002, DOI 10.1111/febs.13709; Gurzov EN, 2015, TRENDS ENDOCRIN MET, V26, P30, DOI 10.1016/j.tem.2014.10.004; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Hamilton-Williams EE, 2003, P NATL ACAD SCI USA, V100, P6688, DOI 10.1073/pnas.1131954100; Herren DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130781; Herren D, 2010, FASEB J, V24; Holmes DA, 2015, J EXP MED, V212, P1081, DOI 10.1084/jem.20142130; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Jofra T, 2017, IMMUNOL CELL BIOL, V95, P121, DOI 10.1038/icb.2016.92; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/nchembio.1528, 10.1038/NCHEMBIO.1528]; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/1.01694; Makino S, 1980, Jikken Dobutsu, V29, P1; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2012, FEBS LETT, V586, P984, DOI 10.1016/j.febslet.2012.02.021; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Rinna A, 2008, AM J RESP CELL MOL, V39, P97, DOI 10.1165/rcmb.2007-0371OC; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Sarkar SA, 2012, DIABETES, V61, P436, DOI 10.2337/db11-0853; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Stanley WJ, 2015, DIABETES, V64, P2489, DOI 10.2337/db14-1575; Su X, 1998, ARTHRITIS RHEUM, V41, P139, DOI 10.1002/1529-0131(199801)41:1<139::AID-ART17>3.0.CO;2-T; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Thomas HE, 2006, IMMUNOL CELL BIOL, V84, P20, DOI 10.1111/j.1440-1711.2005.01397.x; Thrall RS, 1997, AM J PATHOL, V151, P1303; Trivedi P, 2016, IMMUNOL CELL BIOL, V94, P334, DOI 10.1038/icb.2015.89; Trivedi PM, 2017, DIABETES, V66, P1650, DOI 10.2337/db16-1250; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Villate O, 2014, NUCLEIC ACIDS RES, V42, P11818, DOI 10.1093/nar/gku861; Wali JA, 2015, METHODS MOL BIOL, V1292, P165, DOI 10.1007/978-1-4939-2522-3_12; Wang W, 2014, MOL CANCER THER, V13, P1480, DOI 10.1158/1535-7163.MCT-13-0629; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788                                                               ; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Yi ZA, 2012, EUR J IMMUNOL, V42, P2010, DOI 10.1002/eji.201142374; Zhang X, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05014	61	0	0	1	1	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0952-5041	1479-6813		J MOL ENDOCRINOL	J. Mol. Endocrinol.	NOV	2017	59	4					325	337		10.1530/JME-17-0089				13	Endocrinology & Metabolism	Endocrinology & Metabolism	FQ6IK	WOS:000418468000005	28827413				2018-01-05	
J	Kuokkanen, S; Zhu, LY; Pollard, JW				Kuokkanen, Satu; Zhu, Liyin; Pollard, Jeffrey W.			Xenografted tissue models for the study of human endometrial biology	DIFFERENTIATION			English	Review							EPITHELIAL-CELL PROLIFERATION; ESTROGEN-RECEPTOR-ALPHA; NUDE-MICE; PROGESTERONE-RECEPTOR; UTERINE EPITHELIUM; IMMUNODEFICIENT MICE; STEROID-HORMONES; MOUSE MODEL; IN-VIVO; EXPRESSION	The human endometrium undergoes extensive morphological, biochemical and molecular changes under the influence of female sex steroid hormones. Besides the fact that estrogen stimulates endometrial cell proliferation and progesterone inhibits this proliferation and induces differentiation, there is limited knowledge about precise molecular mechanisms underlying human endometrial biology. The importance of paracrine signaling in endometrial physiology explains why in vitro culture of endometrial cells has been challenging. Researchers, therefore, have developed alternative experimental in vivo models for the study of endometrial biology. The objective of this review is to summarize the recent developments and work on these in vivo endometrial research models. The in vivo recombinant tissue models in which wild-type endometrial cells are combined with endometrial cells from a gene-targeted mouse strain followed by xenografting to host mice have been critical in confirming the significance of paracrine signaling between the epithelium and stroma in the growth regulation of the endometrium. Additionally, these studies have uncovered differences between the mouse and human, emphasizing the need for the development of experimental models specifically of the human endometrium. Recently, xenotransplants of human endometrial fragments into the subcutaneous space of host mice and endometrial xenografts of dissociated and recombined epithelial and stromal cells beneath the kidney capsule of immunodeficient host mice have proven to be highly promising tools for in vivo research of endometrial functions. For the first time, the latter approach provides an immense opportunity for the application of genome engineering, such as targeted ablation of endometrial genes for example by using CRISPR/CAS9 system. This research will begin to elucidate the functional role of specific genes in this complex tissue. Another advantage of xenotransplantation and xenograft models of the human endometrium is their use to investigate endometrial effects of new compounds and drugs without needing to give them to women. Underpinning the molecular mechanisms underlying endometrial functions is critical to ultimately advance our understanding of endometrial pathophysiology and develop targeted therapies to prevent and cure endometrial pathologies as well as enhance endometrial function when it is desired for fertility.	[Kuokkanen, Satu; Zhu, Liyin; Pollard, Jeffrey W.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Zhu, Liyin; Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Pollard, Jeffrey W.] Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Kuokkanen, Satu] Global Fertil & Genet, New York, NY USA	Pollard, JW (reprint author), Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	Jeff.Pollard@ed.ac.uk			Eunice Kennedy Shriver NICHD/NIH through Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD058155]; University of Edinburgh Medical Research Council Centre for Reproductive Health [MR/N022556/1]	Research presented in this review was supported by the Eunice Kennedy Shriver NICHD/NIH through cooperative agreement [U54 HD058155] as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and the University of Edinburgh Medical Research Council Centre for Reproductive Health grant MR/N022556/1. The Institutional Review Board of the Albert Einstein College of Medicine and Montefiore Medical Center approved all experiments using human volunteers. All the animals were maintained in the animal maintenance facilities and all animal studies were performed under the guidelines and protocols of the Institutional Animal Care and Use Committee of the Albert Einstein College of Medicine. We thank all the women who generously participated in the studies.	Adams NR, 2015, ADV ANAT EMBRYOL CEL, V216, P27, DOI 10.1007/978-3-319-15856-3_3; Amaya SC, 2014, REPROD SCI, V21, P1362, DOI 10.1177/1933719114525271; AOKI D, 1994, OBSTET GYNECOL, V83, P220; BERGQVIST A, 1985, AM J PATHOL, V119, P336; BIGSBY RM, 1990, ENDOCRINOLOGY, V126, P2592, DOI 10.1210/endo-126-5-2592                                                         ; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/humrep/gag004; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bruner-Tran KL, 2002, ANN NY ACAD SCI, V955, P328, DOI 10.1111/j.1749-6632.2002.tb02793.x                                              ; Bruner-Tran KL, 2002, J CLIN ENDOCR METAB, V87, P4782, DOI 10.1210/jc.2002-020418; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Chen B, 2005, MOL ENDOCRINOL, V19, P1978, DOI 10.1210/me.2004-0274; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; COOKE PS, 1986, P NATL ACAD SCI USA, V83, P2109, DOI 10.1073/pnas.83.7.2109; Coudyzer P, 2015, HUM REPROD, V30, P1156, DOI 10.1093/humrep/dev043; Coudyzer P, 2013, FASEB J, V27, P3711, DOI 10.1096/fj.13-232074; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; CUNHA GR, 1984, STAIN TECHNOL, V59, P7, DOI 10.3109/10520298409113823                                                       ; Diaz-Gimeno P, 2014, INT J DEV BIOL, V58, P127, DOI 10.1387/ijdb.130340pd; Eggermont J, 2005, FERTIL STERIL, V84, P492, DOI 10.1016/j.fertnstret.2005.03.034; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Gonzalez MLA, 2009, HUM REPROD, V24, P697, DOI 10.1093/humrep/den437; Greenberg LH, 2004, AM J OBSTET GYNECOL, V190, P1788, DOI 10.1016/j.ajog.2004.02.047; Grummer R, 2001, HUM REPROD, V16, P1736, DOI 10.1093/humrep/16.8.1736                                                        ; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016840; Hamilton KJ, 2017, CURR TOP DEV BIOL, V125, P109, DOI 10.1016/bs.ctdb.2016.12.005; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kim TH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005537; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/endo.139.11.6317; Kurita T, 2000, BIOL REPROD, V62, P821, DOI 10.1095/biolreprod62.4.831; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Matsuura-Sawada R, 2005, HUM REPROD, V20, P1477, DOI 10.1093/humrep/deh783; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Niklaus AL, 2007, HUM REPROD, V22, P1778, DOI 10.1093/humrep/dem032; Nisolle M, 2000, FERTIL STERIL, V74, P306, DOI 10.1016/S0015-0282(00)00601-4; Nisolle M, 2000, HUM REPROD, V15, P572, DOI 10.1093/humrep/15.3.572; NOYES RW, 1953, FERTIL STERIL, V4, P504; PADYKULA HA, 1991, ANN NY ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Pierro E, 2001, BIOL REPROD, V64, P831, DOI 10.1095/biolreprod64.3.831; Polotsky AJ, 2009, HUM REPROD, V24, P1960, DOI 10.1093/humrep/dep115; Ray S, 2012, P NATL ACAD SCI USA, V109, pE1334, DOI 10.1073/pnas.1118515109; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1075; TOMOOKA Y, 1986, ENDOCRINOLOGY, V118, P1011, DOI 10.1210/endo-118-3-1011                                                         ; Tong W., 2008, ENDOMETRIUM MOL CELL, P99; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Vasquez YM, 2013, SEMIN CELL DEV BIOL, V24, P724, DOI 10.1016/j.semcdb.2013.08.004; Wetendorf M, 2014, INT J DEV BIOL, V58, P95, DOI 10.1387/ijdb.140069mw; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; ZAINO RJ, 1985, HUM PATHOL, V16, P867, DOI 10.1016/S0046-8177(85)80126-X; ZAMAH NM, 1984, AM J OBSTET GYNECOL, V149, P591, DOI 10.1016/0002-9378(84)90240-0                                                    ; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	56	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4681	1432-0436		DIFFERENTIATION	Differentiation	NOV-DEC	2017	98						62	69		10.1016/j.diff.2017.11.004				8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	FP8BI	WOS:000417864500007	29156254	gold			2018-01-05	
J	Zhu, GH; Peng, YC; Zheng, MY; Zhang, XQ; Sun, JB; Huang, YP; Dong, SL				Zhu, Guan-Heng; Peng, Ying-Chuan; Zheng, Mei-Yan; Zhang, Xiao-Qing; Sun, Jia-Bin; Huang, Yongping; Dong, Shuang-Lin			CRISPR/Cas9 mediated BLOS2 knockout resulting in disappearance of yellow strips and white spots on the larval integument in Spodoptera litura	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Spodoptera litura; BLOS2; CRISPR/Cas9; Genome editing	BOMBYX-MORI; LEPIDOPTERA-NOCTUIDAE; TARGETED MUTAGENESIS; GENE; SILKWORM; SYSTEM; RESISTANCE; DROSOPHILA; NUCLEASES; TALENS	The custom-design bacterial CRISPR/Cas9 system has been recently used in some insects, indicating a powerful technique for studies on gene function and transgenic insects. However, its use in lepidopteran pests is scarce. Here, we reported a CRISPR/Cas9 system mediated mutagenesis of biogenesis of lysosome-related organelles cornplexl, subunit 2 (BLOS2) gene in a noctuid pest Spodoptera litura. A fragment of SlitBLOS2 was identified by analyzing a S. litura transcriptome database by local basic BLAST, and the full length cDNA was acquired by RACE strategy. To clarify the function of SlitBLOS2, CRISPR/Cas9 based target mutagenesis of SlitBLOS2 was achieved, displaying a mosaic translucent integument in 62.3-70.6% larvae of GO generation. Further PCR-based genotype analysis demonstrated various mutations occurred at the SlitBLOS2 specific target site. A homozygote mutant individual was obtained in G1 generation, in which the yellow strips and white spots on the larval integument completely disappeared. Our study clearly demonstrates the function of SlitBLOS2 in the integument coloration, and thus provides a useful marker gene for genome editing based gene functional study and pest control strategy in S. litura as well as other lepidopteran pests.	[Zhu, Guan-Heng; Peng, Ying-Chuan; Zheng, Mei-Yan; Sun, Jia-Bin; Dong, Shuang-Lin] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Xiao-Qing] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Anhui Prov Key Lab Microbial Control, Hefei 230036, Anhui, Peoples R China; [Huang, Yongping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China	Dong, SL (reprint author), Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China.	sldong@njau.edu.cn			National Natural Science Foundation of China [31672350, 31601645]; Special Fund for Agro-scientific Research in the Public Interest of China [201203036]	This study was supported by the National Natural Science Foundation of China (31672350; 31601645) and the Special Fund for Agro-scientific Research in the Public Interest of China (201203036).	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Andersson MN, 2010, J EXP BIOL, V213, P3332, DOI 10.1242/jeb.044396; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; Cochran D.G., 1985, P91; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Fujii T, 2008, INSECT BIOCHEM MOLEC, V38, P1072, DOI 10.1016/j.ibmb.2008.03.004; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; [黄春霞 Huang Chunxia], 2002, 昆虫知识, V39, P229; Huang YP, 2016, INSECT BIOCHEM MOLEC, V75, P98, DOI 10.1016/j.ibmb.2016.06.004; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Liu D, 2014, J GENET GENOMICS, V41, P43, DOI 10.1016/j.jgg.2013.11.004; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Meagher RL, 2008, FLA ENTOMOL, V91, P517; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Muthusamy R, 2014, J ASIA-PAC ENTOMOL, V17, P865, DOI 10.1016/j.aspen.2014.09.001; Rehan A, 2014, CROP PROT, V56, P10, DOI 10.1016/j.cropro.2013.10.013; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sajwan S, 2013, INSECT BIOCHEM MOLEC, V43, P17, DOI 10.1016/j.ibmb.2012.10.011; Shad SA, 2010, PEST MANAG SCI, V66, P839, DOI 10.1002/ps.1950; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tamura T., 1983, Bulletin of the Sericultural Experiment Station, V28, P719; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Wang YQ, 2014, INSECT BIOCHEM MOLEC, V55, P26, DOI 10.1016/j.ibmb.2014.10.003; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang ZJ, 2015, J INSECT PHYSIOL, V79, P73, DOI 10.1016/j.jinsphys.2015.06.004; Zhu GH, 2016, INSECT BIOCHEM MOLEC, V75, P1, DOI 10.1016/j.ibmb.2016.05.006	43	0	0	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	NOV-DEC	2017	103						29	35		10.1016/j.jinsphys.2017.09.008				7	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	FP9JQ	WOS:000417963700004	28927827				2018-01-05	
J	Nandal, A; Mallon, B; Telugu, BP				Nandal, Anjali; Mallon, Barbara; Telugu, Bhanu P.			Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Induced pluripotent stem cells (iPSCs); reprogramming; sendai virus; CRISPR/Cas9; footprint-free iPSCs; nucleofection	PLURIPOTENT STEM-CELLS; SENDAI-VIRUS; GENOME	Embryonic and induced pluripotent stem cells can self-renew and differentiate into multiple cell types of the body. The pluripotent cells are thus coveted for research in regenerative medicine and are currently in clinical trials for eye diseases, diabetes, heart diseases, and other disorders. The potential to differentiate into specialized cell types coupled with the recent advances in genome editing technologies including the CRISPR/Cas system have provided additional opportunities for tailoring the genome of iPSC for varied applications including disease modeling, gene therapy, and biasing pathways of differentiation, to name a few. Among the available editing technologies, the CRISPR/Cas9 from Streptococcus pyogenes has emerged as a tool of choice for site-specific editing of the eukaryotic genome. The CRISPRs are easily accessible, inexpensive, and highly efficient in engineering targeted edits. The system requires a Cas9 nuclease and a guide sequence (20-mer) specific to the genomic target abutting a 3-nucleotide "NGG" protospacer-adjacent-motif (PAM) for targeting Cas9 to the desired genomic locus, alongside a universal Cas9 binding tracer RNA (together called single guide RNA or sgRNA). Here we present a step-by-step protocol for efficient generation of feeder-independent and footprint-free iPSC and describe methodologies for genome editing of iPSC using the Cas9 ribonucleoprotein (RNP) complexes. The genome editing protocol is effective and can be easily multiplexed by pre-complexing sgRNAs for more than one target with the Cas9 protein and simultaneously delivering into the cells. Finally, we describe a simplified approach for identification and characterization of iPSCs with desired edits. Taken together, the outlined strategies are expected to streamline generation and editing of iPSC for manifold applications.	[Nandal, Anjali; Telugu, Bhanu P.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Nandal, Anjali; Telugu, Bhanu P.] ARS, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD 20705 USA; [Mallon, Barbara] NIH, Stem Cell Unit, Bldg 10, Bethesda, MD 20892 USA; [Telugu, Bhanu P.] RenOVAte Biosci Inc, Reisterstown, MD 21136 USA	Telugu, BP (reprint author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Telugu, BP (reprint author), ARS, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD 20705 USA.; Telugu, BP (reprint author), RenOVAte Biosci Inc, Reisterstown, MD 21136 USA.	btelugu@umd.edu			Maryland Stem Cell Research Fund	Work in the lab was supported by postdoctoral fellowship grant to Dr. Anjali Nandal, and Exploratory grant from Maryland Stem Cell Research Fund to BT (TEDCO).	Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Macarthur C. C., 2012, STEM CELLS INT, V2012; Malik Nasir, 2013, Methods Mol Biol, V997, P23, DOI 10.1007/978-1-62703-348-0_3; McElroy S. L., 2008, CSH PROTOC, V2008; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]	18	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	NOV	2017		129							e56260	10.3791/56260				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FP5UP	WOS:000417688700039					2018-01-05	
J	Al Abdallah, Q; Ge, WB; Fortwendel, JR				Al Abdallah, Qusai; Ge, Wenbo; Fortwendel, Jarrod R.			A Simple and Universal System for Gene Manipulation in Aspergillus fumigatus: In Vitro-Assembled Cas9-Guide RNA Ribonucleoproteins Coupled with Microhomology Repair Templates	MSPHERE			English	Article						Aspergillus fumigatus; CRISPR-Cas9; gene deletion; genome editing; in vitro assembly; pksP gene	CRISPR RNA; KNOCK-IN; HUMAN-CELLS; RESISTANCE; SEQUENCE; PATHWAY; PROTEIN; CAS9; PATHOGENICITY; ENDONUCLEASE	CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 is a novel genome-editing system that has been successfully established in Aspergillus fumigatus. However, the current state of the technology relies heavily on DNA-based expression cassettes for delivering Cas9 and the guide RNA (gRNA) to the cell. Therefore, the power of the technology is limited to strains that are engineered to express Cas9 and gRNA. To overcome such limitations, we developed a simple and universal CRISPR-Cas9 system for gene deletion that works across different genetic backgrounds of A. fumigatus. The system employs in vitro assembly of dual Cas9 ribonucleoproteins (RNPs) for targeted gene deletion. Additionally, our CRISPR-Cas9 system utilizes 35 to 50 bp of flanking regions for mediating homologous recombination at Cas9 double-strand breaks (DSBs). As a proof of concept, we first tested our system in the.akuB ((Delta akuBku80)) laboratory strain and generated high rates (97%) of gene deletion using 2 mu g of the repair template flanked by homology regions as short as 35 bp. Next, we inspected the portability of our system across other genetic backgrounds of A. fumigatus, namely, the wild-type strain Af293 and a clinical isolate, A. fumigatus DI15-102. In the Af293 strain, 2 mu g of the repair template flanked by 35 and 50 bp of homology resulted in highly efficient gene deletion (46% and 74%, respectively) in comparison to classical gene replacement systems. Similar deletion efficiencies were also obtained in the clinical isolate DI15-102. Taken together, our data show that in vitro-assembled Cas9 RNPs coupled with microhomology repair templates are an efficient and universal system for gene manipulation in A. fumigatus. IMPORTANCE Tackling the multifactorial nature of virulence and antifungal drug resistance in A. fumigatus requires the mechanistic interrogation of a multitude of genes, sometimes across multiple genetic backgrounds. Classical fungal gene replacement systems can be laborious and time-consuming and, in wild-type isolates, are impeded by low rates of homologous recombination. Our simple and universal CRISPR-Cas9 system for gene manipulation generates efficient gene targeting across different genetic backgrounds of A. fumigatus. We anticipate that our system will simplify genome editing in A. fumigatus, allowing for the generation of single-and multigene knockout libraries. In addition, our system will facilitate the delineation of virulence factors and antifungal drug resistance genes in different genetic backgrounds of A. fumigatus.	[Al Abdallah, Qusai; Ge, Wenbo; Fortwendel, Jarrod R.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm & Translat Sci, Memphis, TN 38163 USA	Al Abdallah, Q (reprint author), Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm & Translat Sci, Memphis, TN 38163 USA.	qalabdal@uthsc.edu			NIH grant [R01AI106925]	This work was supported by NIH grant R01AI106925 to J.R.F.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brakhage A, 1999, ASPERGILLUS FUMIGATU; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dapas M, 2017, BRIEF BIOINFORM, V18, P260, DOI 10.1093/bib/bbw016; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fraczek MG, 2013, J ANTIMICROB CHEMOTH, V68, P1486, DOI 10.1093/jac/dkt075; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Garcia-Effron G, 2008, J CLIN MICROBIOL, V46, P1200, DOI 10.1128/JCM.02330-07; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gonzalez-Huici V, 2017, GENETICS, V206, P1853, DOI 10.1534/genetics.117.203414; Grahl N, 2017, MSPHERE, V2, DOI [10.1128/msphere.00218-17, 10.1128/mSphere.00218-17]; Heinekamp T, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00440; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang MNY, 2017, MSPHERE, V2, DOI [10.1128/msphere.00050-17, 10.1128/mSphere.00050-17]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Koonin E, 2003, SEQUENCE EVOLUTION F; Kowalski CH, 2016, MBIO, V7, DOI [10.1128/mbio.01515-16, 10.1128/mBio.01515-16]; Langfelder K, 2001, INFECT IMMUN, V69, P6411, DOI 10.1128/IAI.69.10.6411-6418.2001; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Liu ZH, 2017, ACS SYNTH BIOL, V6, P601, DOI 10.1021/acssynbio.6b00331; Nakamae K, 2017, BIOENGINEERED, V8, P302, DOI 10.1080/21655979.2017.1313645; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishimasu H, 2017, MOL CELL, V67, P139, DOI 10.1016/j.molcel.2017.04.019; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seol JH, 2017, MUTAT RES; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shimizu K, 2001, GENETICS, V157, P591; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Wang HL, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0136-8; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Wiederhold NP, 2016, J CLIN MICROBIOL, V54, P168, DOI 10.1128/JCM.02478-15; Wu Xuebing, 2014, Quant Biol, V2, P59; Yang J, 2017, RNA BIOL; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Zhang Chi, 2017, Methods Mol Biol, V1625, P249, DOI 10.1007/978-1-4939-7104-6_17; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zheng T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40638	57	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	NOV-DEC	2017	2	6							e00446-17	10.1128/mSphere.00446-17				14	Microbiology	Microbiology	FO6TW	WOS:000417000900004		gold			2018-01-05	
J	Bindal, G; Krishnamurthi, R; Seshasayee, ASN; Rath, D				Bindal, Gargi; Krishnamurthi, Revathy; Seshasayee, Aswin Sai Narain; Rath, Devashish			CRISPR-Cas-Mediated Gene Silencing Reveals RacR To Be a Negative Regulator of YdaS and YdaT Toxins in Escherichia coli K-12	MSPHERE			English	Article						CRISPR gene silencing; Escherichia coli; RacR; essential gene; rac prophage; toxin	CHROMOSOMAL GENES; BIOFILM FORMATION; ANTITOXIN SYSTEM; PROPHAGE; EXCISION; GENOMES; FTSZ; SITE; RNAS	Bacterial genomes are rich in horizontally acquired prophages. racR is an essential gene located in the rac prophage that is resident in many Escherichia coli genomes. Employing a clustered regularly interspaced short palindromic repeat (CRISPR)-Cas-based gene silencing approach, we show that RacR is a negative regulator of the divergently transcribed and adjacent ydaS-ydaT operon in Escherichia coli K-12. Overexpression of YdaS and YdaT due to RacR depletion leads to cell division defects and decrease in survival. We further show that both YdaS and YdaT can act independently as toxins and that RacR serves to counteract the toxicity by tightly downregulating the expression of these toxins. IMPORTANCE racR is an essential gene and one of the many poorly studied genes found on the rac prophage element that is present in many Escherichia coli genomes. Employing a CRISPR-based approach, we have silenced racR expression to various levels and elucidated its physiological consequences. We show that the downregulation of racR leads to upregulation of the adjacent ydaS-ydaT operon. Both YdaS and YdaT act as toxins by perturbing the cell division resulting in enhanced cell killing. This work establishes a physiological role for RacR, which is to keep the toxic effects of YdaS and YdaT in check and promote cell survival. We, thus, provide a rationale for the essentiality of racR in Escherichia coli K-12 strains.	[Bindal, Gargi; Rath, Devashish] Bhabha Atom Res Ctr, Mol Biol Div, Bombay, Maharashtra, India; [Bindal, Gargi; Rath, Devashish] Homi Bhabha Natl Inst, Training Sch Complex, Mumbai, Maharashtra, India; [Krishnamurthi, Revathy; Seshasayee, Aswin Sai Narain] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Krishnamurthi, Revathy] Shanmuga Arts Sci Technol & Res Acad, Thanjavur, Tamil Nadu, India	Rath, D (reprint author), Bhabha Atom Res Ctr, Mol Biol Div, Bombay, Maharashtra, India.; Rath, D (reprint author), Homi Bhabha Natl Inst, Training Sch Complex, Mumbai, Maharashtra, India.	devrath@barc.gov.in					Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bellas CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00656; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Conter A, 1996, J BACTERIOL, V178, P5100, DOI 10.1128/jb.178.17.5100-5104.1996                                                ; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Hargreaves KR, 2014, MBIO, V5, DOI 10.1128/mBio.01045-13; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; Koga M, 2011, GENETICS, V187, P123, DOI 10.1534/genetics.110.121798; Krishnamurthi R, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-17; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; Liu XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16074; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Perez-Rueda E, 2004, COMPUT BIOL CHEM, V28, P341, DOI 10.1016/j.compbiolchem.2004.09.004; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Stead MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks680; Thomason LC, 2007, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb0116s78, DOI 10.1002/0471142727.MB0117S79]; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	30	1	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	NOV-DEC	2017	2	6							e00483-17	10.1128/mSphere.00483-17				11	Microbiology	Microbiology	FO6TW	WOS:000417000900005		gold			2018-01-05	
J	Guan, J; Wang, WY; Sun, BL				Guan, Jing; Wang, Wanying; Sun, Baolin			Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in Staphylococcus aureus	MSPHERE			English	Article						CRISPR-Cas system; Staphylococcus aureus; chromosomal targeting; mobile genetic element; staphylococcal cassette chromosome mec	MEDIATED VIRUS DEFENSE; SEED SEQUENCE; RNA; INTERFERENCE; DNA; RESISTANCE; VIRULENCE; IMMUNITY; REPEATS; ELEMENT	CRISPR-Cas (clustered regularly interspaced short palindromic repeat [CRISPR]-CRISPR-associated protein [Cas]) systems can provide protection against invading genetic elements by using CRISPR RNAs (crRNAs) as a guide to locate and degrade the target DNA. CRISPR-Cas systems have been classified into two classes and five types according to the content of cas genes. Previous studies have indicated that CRISPR-Cas systems can avoid viral infection and block plasmid transfer. Here we show that chromosomal targeting by the Staphylococcus aureus type III-A CRISPR-Cas system can drive large-scale genome deletion and alteration within integrated staphylococcal cassette chromosome mec (SCCmec). The targeting activity of the CRISPR-Cas system is associated with the complementarity between crRNAs and protospacers, and 10-to 13-nucleotide truncations of spacers partially block CRISPR attack and more than 13-nucleotide truncation can fully abolish targeting, suggesting that a minimal length is required to license cleavage. Avoiding base pairings in the upstream region of protospacers is also necessary for CRISPR targeting. Successive trinucleotide complementarity between the 5' tag of crRNAs and protospacers can disrupt targeting. Our findings reveal that type III-A CRISPR-Cas systems can modulate bacterial genome stability and may serve as a high-efficiency tool for deleting resistance or virulence genes in bacteria. IMPORTANCE Staphylococcus aureus is a pathogen that can cause a wide range of infections in humans. Studies have suggested that CRISPR-Cas systems can drive the loss of integrated mobile genetic elements (MGEs) by chromosomal targeting. Here we demonstrate that CRISPR-mediated cleavage contributes to the partial deletion of integrated SCCmec in methicillin-resistant S. aureus (MRSA), which provides a strategy for the treatment of MRSA infections. The spacer within artificial CRISPR arrays should contain more than 25 nucleotides for immunity, and consecutive trinucleotide pairings between a selected target and the 5' tag of crRNA can block targeting. These findings add to our understanding of the molecular mechanisms of the type III-A CRISPR-Cas system and provide a novel strategy for the exploitation of engineered CRISPR immunity against integrated MGEs in bacteria for clinical and industrial applications.	[Guan, Jing; Wang, Wanying; Sun, Baolin] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Hefei, Anhui, Peoples R China; [Guan, Jing; Wang, Wanying; Sun, Baolin] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Guan, Jing; Wang, Wanying; Sun, Baolin] Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China; [Sun, Baolin] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Sun, BL (reprint author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Hefei, Anhui, Peoples R China.; Sun, BL (reprint author), Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China.; Sun, BL (reprint author), Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China.; Sun, BL (reprint author), Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.	sunb@ustc.edu.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB03]; National Natural Science Foundation of China [31670133]	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB03) and the National Natural Science Foundation of China (31670133).	Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6                                                   ; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Boundy S, 2012, J CLIN MICROBIOL, V50, P469, DOI 10.1128/JCM.01063-11; Briner AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133661; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cao LY, 2016, INT J MED MICROBIOL, V306, P686, DOI 10.1016/j.ijmm.2016.08.005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heussler GE, 2016, J BACTERIOL, V198, P1481, DOI 10.1128/JB.00086-16; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000                                                 ; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Li RP, 2016, CELL RES, V26, P1273, DOI 10.1038/cr.2016.135; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806                                                     ; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; SONG MD, 1987, FEBS LETT, V221, P167, DOI 10.1016/0014-5793(87)80373-3; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Valihrach L, 2012, J MICROBIOL METH, V90, P214, DOI 10.1016/j.mimet.2012.05.008; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	46	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	NOV-DEC	2017	2	6							e00403-17	10.1128/mSphere.00403-17				18	Microbiology	Microbiology	FO6TW	WOS:000417000900002		gold			2018-01-05	
J	Oksuz, MF; Karkucak, M; Gorukmez, O; Ocakoglu, G; Yildiz, A; Ture, M; Yakut, T; Dilek, K				Oksuz, Mustafa Ferhat; Karkucak, Mutlu; Gorukmez, Orhan; Ocakoglu, Gokhan; Yildiz, Abdulmecit; Ture, Mehmet; Yakut, Tahsin; Dilek, Kamil			Investigation of MEFV gene polymorphisms (G138G and A165A) in adult patients with familial Mediterranean fever	REVISTA BRASILEIRA DE REUMATOLOGIA			English	Article						Familial Mediterranean fever; MEFV gene; Polymorphism	TURKISH POPULATION; MUTATION FREQUENCY; TURKEY; AMYLOIDOSIS; CHILDREN; FMF; MULTICENTER; PHENOTYPE; REGION; RISK	Aim: Various mutations have been identified in the Mediterranean fever (MEFV) gene which is reported to be responsible from Familial Mediterranean fever (FMF). In our study, we aimed to determine the frequency of the MEFV mutations in our region and to investigate the impact of G138G (rs224224, c.414A>G) and A165A (rs224223, c.495C>A) gene polymorphisms on the clinical findings of the disease. Methods: One hundred and sixteen patients diagnosed with FMF and 95 control subjects were included in this study. We used the DNA sequence analysis method to identify the most prevailing 10 mutations located in exon 2 and 10 of MEFV gene. Results: As a result of the MEFV mutation analysis, the most common mutation was the M694V mutation allele with a frequency rate of 41.8%. When the patients group and control group were compared in terms of frequency of both polymorphic alleles (G polymorphic allele, observed in G138G and the A polymorphic allele, observed in A165A), the variation was observed to be statistically significant (p <0.001). It was found that the MEFV mutation types have no relation with clinical findings and amyloidosis (p > 0.05). Conclusions: To our knowledge, our study is the first study in the Southern Marmara region that reports the frequency of MEFV mutations. Our findings imply that the polymorphisms of G138G and A165A may have an impact on progress of the disease. We think that more studies, having higher number of cases and investigating the polymorphisms of MEFV gene, are needed. (C) 2016 Elsevier Editora Ltda.	[Oksuz, Mustafa Ferhat; Dilek, Kamil] Uludag Univ, Fac Med, Dept Internal Med, Div Rheumatol, Bursa, Turkey; [Karkucak, Mutlu] Sakarya Univ, Educ & Res Hosp, Dept Med Genet, Sakarya, Turkey; [Gorukmez, Orhan] Sevket Yilmaz Educ & Res Hosp, Dept Med Genet, Bursa, Turkey; [Ocakoglu, Gokhan] Uludag Univ, Fac Med, Dept Biostat, Bursa, Turkey; [Yildiz, Abdulmecit] Uludag Univ, Fac Med, Dept Internal Med, Div Nephrol, Bursa, Turkey; [Ture, Mehmet; Yakut, Tahsin] Uludag Univ, Fac Med, Dept Med Genet, Bursa, Turkey	Oksuz, MF (reprint author), Uludag Univ, Fac Med, Dept Internal Med, Div Rheumatol, Bursa, Turkey.	dr.mustafaferhatoksuz@gmail.com					Akar E, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<71::AID-HUMU8>3.0.CO;2-3; Akin H, 2010, MOL BIOL REP, V37, P93, DOI 10.1007/s11033-009-9543-1; Akpolat T, 2012, GENE, V492, P285, DOI 10.1016/j.gene.2011.10.012; Basarslan F, 2013, SYMRNA MED J, V2, P1; Caglayan AO, 2010, NEPHROL DIAL TRANSPL, V25, P2520, DOI 10.1093/ndt/gfp632; Ceylan GG, 2012, GENET MOL RES, V11, P1185, DOI 10.4238/2012.May.7.4; Ceylan GG, 2011, TURK KLIN TIP BILIM, V31, P1317, DOI 10.5336/medsci.2009-15868; Dogan HO, 2012, MOL BIOL REP, V39, P6193, DOI 10.1007/s11033-011-1437-3; Dundar M, 2011, MOL BIOL REP, V38, P5065, DOI 10.1007/s11033-010-0652-7; Dusunsel R, 2008, PEDIATR INT, V50, P208, DOI 10.1111/j.1442-200X.2008.02554.x; Ece A, 2014, RHEUMATOL INT, V34, P207, DOI 10.1007/s00296-013-2858-1; Ertekin V, 2005, PEDIATR INT, V47, P640, DOI 10.1111/j.1442-200x.2005.02140.x; Etem Ebru Onalan, 2010, Open Rheumatol J, V4, P1, DOI 10.2174/1874312901004010001; Giancane G, 2015, ANN RHEUM DIS, V74, P635, DOI 10.1136/annrheumdis-2014-206844; Gunesacar R, 2005, GENET TEST, V9, P220, DOI 10.1089/gte.2005.9.220                                                          ; Jarjour RA, 2010, MOL BIOL REP, V37, P1, DOI 10.1007/s11033-009-9475-9; Kasifoglu T, 2014, RHEUMATOLOGY, V53, P741, DOI 10.1093/rheumatology/ket400; Ozalkaya E, 2011, RHEUMATOL INT, V31, P779, DOI 10.1007/s00296-010-1383-8; Ozturk A, 2008, TURK J MED SCI, V38, P205; Saatci U, 1997, EUR J PEDIATR, V156, P619, DOI 10.1007/s004310050677; Topaloglu R, 2005, ANN RHEUM DIS, V64, P750, DOI 10.1136/ard.2004.026963; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658                                                         ; Tunca M, 2005, MEDICINE, V84, P1, DOI 10.1097/01.md.0000152370.84628.0c; Yalcinkaya F, 1997, BRIT J RHEUMATOL, V36, P1228; Yigit S, 2008, J RHEUMATOL, V35, P106; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674	26	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0482-5004			REV BRAS REUMATOL	Rev. Bras. Reumatol.	NOV-DEC	2017	57	6					501	506		10.1016/j.rbre.2016.02.004				6	Rheumatology	Rheumatology	FO8OK	WOS:000417146600001	29173686	gold			2018-01-05	
J	Lopes, FA; de Rezende, J; Silva, DBD; Alves, FDG; de Oliveira, CE; da Costa, IP				Lopes, Fernando Aguilar; de Rezende, Jania; dos Santos Silva, Danielly Beraldo; Goncalves Alves, Fernanda de Cassia; de Oliveira, Carina Elisei; da Costa, Izaias Pereira			Molecular evidence of Borrelia burgdorferi sensu lato in patients in Brazilian central-western region	REVISTA BRASILEIRA DE REUMATOLOGIA			English	Article						Borrelia burgdorferi; Lyme disease; flgE; Baggio-Yoshinari syndrome; Brazil	POLYMERASE CHAIN-REACTION; FLAGELLIN GENE-SEQUENCES; LYME-DISEASE; STATE	We aimed to detect DNA of Borrelia burgdorferi in whole blood and serum samples of patients with clinical symptoms and epidemiology compatible with Brazilian Lyme-like disease. Four patients with positive epidemiological histories were recruited for the study. Blood samples were collected, screened by serologic testing by ELISA and Western blotting and molecular identification of B. burgdorferi by amplifying a fragment of the conserved gene that synthesizes the hook flagellar flgE. The results showed positive serology and for the first time, the presence of B. burgdorferi sensu lato in humans in the Midwest region of Brazil. The resulting sequences were similar to GenBank corresponding sequences of B. burgdorferi flgE gene. By neighbor-joining the phylogenetic analysis, the flgE sequence of the Brazilian strain clustered in a monophyletic group with the sequence of B. burgdorferi sensu lato under 100% bootstrap support. This study opens up promising perspectives and reinforces the need for additional studies to determine the epidemiological characteristics of the disease, as well as the impact of the prevalence of Brazilian borreliosis in Mato Grosso do Sul State, Brazil. (C) 2017 Elsevier Editora Ltda.	[Lopes, Fernando Aguilar; da Costa, Izaias Pereira] Univ Fed Mato Grosso Sul UFMS, Fac Med Famed, Programa Posgrad Saude & Desenvolvimento Reg Ctr, Campo Grande, MS, Brazil; [Lopes, Fernando Aguilar; da Costa, Izaias Pereira] Univ Fed Mato Grosso Sul UFMS, Hosp Univ Maria Aparecida Pedrossian Humap, Campo Grande, MS, Brazil; [de Rezende, Jania; de Oliveira, Carina Elisei] Univ Catolica Dom Bosco, Programa Posgrad Biotecnol, Campo Grande, MS, Brazil; [dos Santos Silva, Danielly Beraldo] Univ Estadual Paulista Unesp, FCAV, Programa Posgrad Genet & Melhoramento Anim, Jaboticabal, SP, Brazil; [Goncalves Alves, Fernanda de Cassia] UCDB, Programa Inst Bolsas Iniciacao Cient PIBIC, Campo Grande, MS USA	Lopes, FA (reprint author), Univ Fed Mato Grosso Sul UFMS, Fac Med Famed, Programa Posgrad Saude & Desenvolvimento Reg Ctr, Campo Grande, MS, Brazil.; Lopes, FA (reprint author), Univ Fed Mato Grosso Sul UFMS, Hosp Univ Maria Aparecida Pedrossian Humap, Campo Grande, MS, Brazil.	fernando.lopes@ufms.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Council for Scientific and Technological Development) (CNPq); Fundacao de Apoio ao Desenvolvimento do Ensino, Cienciae Tecnologia (FUNDECT) (Foundation for Support to the Development of Education, Science, and Technology) of the State of Mato Grosso do Sul	This study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Council for Scientific and Technological Development) (CNPq) and the Fundacao de Apoio ao Desenvolvimento do Ensino, Cienciae Tecnologia (FUNDECT) (Foundation for Support to the Development of Education, Science, and Technology) of the State of Mato Grosso do Sul.	Barros PJL, 2000, THESIS, P163; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Carranza-Tamayo CO, 2012, BRAZ J INFECT DIS, V16, P586, DOI 10.1016/j.bjid.2012.07.013; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; Costa IP, 2001, REV BRAS REUMATOL, V41, P142; Fukunaga M, 1996, INT J SYST BACTERIOL, V46, P898, DOI 10.1099/00207713-46-4-898                                                       ; Gauditano G, 2005, REV PAUL REUMATOL, V4, P16; Goncalves DD, 2015, BRAZ J MICROBIOL, V46, P571, DOI 10.1590/S1517-838246220140097; GOODMAN JL, 1995, AM J MED, V99, P6, DOI 10.1016/S0002-9343(99)80097-7; Mantovani E, 2007, BRAZ J MED BIOL RES, V40, P443, DOI 10.1590/S0100-879X2007000400002; Mantovani E, 2012, REV INST MED TROP SP, V54, P153, DOI 10.1590/S0036-46652012000300007; Naka EN, 2008, REV BRAS REUMATOL, V48, P74; PICKEN RN, 1992, J CLIN MICROBIOL, V30, P99; Qiu WG, 2008, EMERG INFECT DIS, V14, P1097, DOI 10.3201/eid1407.070880; Rezende J, 2016, JSM TROP MED RES, V1, P1003; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Shinjo Samuel Katsuyuki, 2009, Rev. Bras. Reumatol., V49, P492, DOI 10.1590/S0482-50042009000500003; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Talhari S, 2010, ACTA TROP, V115, P200, DOI 10.1016/j.actatropica.2010.02.017; Yoshinari N H, 1993, Rev Hosp Clin Fac Med Sao Paulo, V48, P170; Yoshinari Natalino Hajime, 2009, Rev. Bras. Reumatol., V49, P483, DOI 10.1590/S0482-50042009000500001; Yoshinari NH, 2010, REV ASSOC MED BRAS, V56, P363, DOI 10.1590/S0104-42302010000300025; Yoshinari NH, 1999, REV BRAS REUMATOL, V39, P57	25	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0482-5004			REV BRAS REUMATOL	Rev. Bras. Reumatol.	NOV-DEC	2017	57	6					641	645		10.1016/j.rbre.2017.05.001				5	Rheumatology	Rheumatology	FO8OK	WOS:000417146600024	28579253	gold			2018-01-05	
J	Jiang, X; Feng, LC; Dai, BQ; Li, LP; Lu, WW				Jiang, Xue; Feng, Lichun; Dai, Baoqiang; Li, Liping; Lu, Weiwei			Identification of key genes involved in nasopharyngeal carcinoma	BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY			English	Article						Nasopharyngeal carcinoma; Differentially expressed genes; Enrichment analysis; Regulatory network	LYMPH-NODE METASTASIS; CYCLOOXYGENASE-2 EXPRESSION; CANCER; GROWTH; CELLS; ANGIOGENESIS; SUPPRESSION; ASSOCIATION; CHEMOKINES; PROGNOSIS	Introduction: Nasopharyngeal carcinoma is the most common cancer originating from the nasopharynx. Objective: To study the mechanisms of nasopharyngeal carcinoma, we analyzed GSE12452 microarray data. Methods: GSE12452 was downloaded from the Gene Expression Omnibus database and included 31 nasopharyngeal carcinoma samples and 10 normal nasopharyngeal tissue samples. The differentially expressed genes were screened by ANOVA in the PGS package. Using the BiNGO plugin in Cytoscape and pathway enrichment analysis in the PGS package, functional and pathway enrichment analyses were performed separately to predict potential functions of the differentially expressed genes. Furthermore, Transcription factor-differentially expressed gene pairs were searched, and then the transcription factor-differentially expressed gene regulatory network was visualized using Cytoscape software. Results: A total of 487 genes were screened as differentially expressed genes between the nasopharyngeal carcinoma samples and the normal nasopharyngeal tissue samples. Enrichment analysis indicated that PTGS2 was involved in the regulation of biological process and small cell lung cancer. ZIC2 and OVOL1 may function in nasopharyngeal carcinoma through targeting significantly up-regulated genes (such as PTGS2, FN1, CXCL9 and CXCL10) in the Transcription factor-differentially expressed gene regulatory network (e.g., ZIC2. PTGS2 and OVOL1. CXCL10). Conclusion: PTGS2, FN1, CXCL9, CXCL10, ZIC2 and OVOL1 might play roles in nasopharyngeal carcinoma. (C) 2016 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.	[Jiang, Xue; Feng, Lichun; Dai, Baoqiang; Li, Liping; Lu, Weiwei] Cangzhou Cent Hosp, Dept Otorhinolaryngol, Cangzhou, Hebei, Peoples R China	Lu, WW (reprint author), Cangzhou Cent Hosp, Dept Otorhinolaryngol, Cangzhou, Hebei, Peoples R China.	13933985866@163.com					Ansell SM, 2012, AM J HEMATOL, V87, P865, DOI 10.1002/ajh.23259; Bae YK, 2013, HUM PATHOL, V44, P2028, DOI 10.1016/j.humpath.2013.03.006; Ben Nasr H, 2009, MOL BIOL REP, V36, P193, DOI 10.1007/s11033-007-9166-3; Bidus MA, 2006, CLIN CANCER RES, V12, P83, DOI 10.1158/1078-0432.CCR-05-0835; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang KP, 2011, CLIN CHIM ACTA, V412, P980, DOI 10.1016/j.cca.2011.02.002; Chang KP, 2010, PROTEOMICS, V10, P2644, DOI 10.1002/pmic.200900620; Chen H, 2012, J GENE MED, V14, P231, DOI 10.1002/jgm.2614; Dawson CW, 2012, SEMINARS CANC BIOL; Fernebro J, 2006, INT J CANCER, V118, P1165, DOI 10.1002/ijc.21475; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; Haynes W., 2013, ENCY SYSTEMBIOL, P78; Hsin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080052; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; Jia DX, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-94; Jiang QP, 2016, TUMOR BIOL, V37, P2425, DOI 10.1007/s13277-015-3966-1; Kanehisa M, 2015, NUCLEIC ACIDS RES; Liao K, 2015, THERANOSTICS, V5, P302, DOI 10.7150/thno.8387; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Lo BKK, 2010, AM J PATHOL, V176, P2435, DOI 10.2353/ajpath.2010.081059; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Lung HL, 2008, INT J CANCER, V123, P401, DOI 10.1002/ijc.23528; Ma LJ, 2014, TUMOR BIOL, V35, P1703, DOI 10.1007/s13277-013-1235-8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maiti S., 2012, COMPREHENSIVE ASSESS; O'Neil JD, 2008, J GEN VIROL, V89, P2833, DOI 10.1099/vir.0.2008/003392-0; Pellegrino A, 2004, CANCER LETT, V207, P221, DOI 10.1016/j.canlet.2003.10.036; Persano L, 2007, MOL ASPECTS MED, V28, P87, DOI 10.1016/j.mam.2006.12.005; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shi DB, 2015, ONCOTARGET, V6, P5005, DOI 10.18632/oncotarget.3215                                                        ; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tan KB, 2005, J CLIN PATHOL, V58, P535, DOI 10.1136/jcp.2004.021923; Tay JK, 2016, OTOLARYNG HEAD NECK, V155, P274, DOI 10.1177/0194599816641038; Teichmann M, 2005, J PATHOL, V206, P68, DOI 10.1002/path.1745; Tong JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-253; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsao SW, 2014, ORAL ONCOL, V50, P330, DOI 10.1016/j.oraloncology.2014.02.006; Wang HY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-27; Yang Y, 2000, J BIOL CHEM, V275, P38863, DOI 10.1074/jbc.M007906200; Zhang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088075	46	0	0	0	0	ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL	SAO PAULO	AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL	1808-8694	1808-8686		BRAZ J OTORHINOLAR	Braz. J. Otorhinolaryngol.	NOV-DEC	2017	83	6					670	676		10.1016/j.bjorl.2016.09.003				7	Otorhinolaryngology	Otorhinolaryngology	FP1RQ	WOS:000417392200011	27765529	gold			2018-01-05	
J	Dinarte, VRP; dos Santos, ARD; de Araujo, LF; dos Reis, MGA; Tamashiro, E; Valera, FCP; da Silva, WA; Anselmo-Lima, WT				Pires Dinarte, Vanessa Ramos; Dinarte dos Santos, Anemari Ramos; de Araujo, Luiza Ferreira; Alves dos Reis, Mariah Guieiro; Tamashiro, Edwin; Pereira Valera, Fabiana Cardoso; da Silva Junior, Wilson Arajo; Anselmo-Lima, Wilma Terezinha			Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review	BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY			English	Review						Polymorphism; Rhinosinusitis; Polyps	MATRIX METALLOPROTEINASE-2; GENE POLYMORPHISMS; ASSOCIATION; PREVALENCE	Introduction: Chronic rhinosinusitis with nasal polyps is a multifactorial disease with a complex pathophysiology involving multiple genetic and environmental factors. Objective: The purpose of this work review is to focus on the importance of genetic studies in chronic rhinosinusitis with nasal polyps besides the several barriers that exists for its understanding. Methods: A systematic review on studies of association between single nucleotide polymorphisms and chronic rhinosinusitis with nasal polyps based on a PubMed/Medline and Periodicos CAPES search of all articles published between January 2005 and January 2015 was made. The search was guided on studies containing the terms polymorphisms, rhinosinusitis, and polyps. Results: Two studies found an association of MMP-9 and MMP-2 polymorphisms and chronic rhinosinusitis with nasal polyps, but not in patients with recurrent nasal polyps. Other studies found an association of nasal polyps with MMP-9 polymorphisms, but not with MMP-2 ones. There is evidence of an association of LTC4S, NOS2A, PTGDR, MET, COX-2, OSF-2, and LF polymorphisms and the risk of developing nasal polyps, especially when combined with chronic allergic rhinitis and asthma. Conclusion: Genetic studies on chronic rhinosinusitis with nasal polyps are promising and may offer insights into its pathophysiology, which is likely affected by multiple genetic factors. (C) 2017 Associacao, Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.	[Pires Dinarte, Vanessa Ramos] Escola Med Marilia, Dept Otorrinolaringol, Div Otorrinolaringol, Marilia, SP, Brazil; [Dinarte dos Santos, Anemari Ramos; da Silva Junior, Wilson Arajo] Hemoctr Ribeirao Preto, Ctr Reg Hemoterapia, LGMB, Ribeirao Preto, SP, Brazil; [de Araujo, Luiza Ferreira] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, SP, Brazil; [Alves dos Reis, Mariah Guieiro] Escola Med Marilia, Dept Otorrinolaringol, Marilia, SP, Brazil; [Tamashiro, Edwin; Pereira Valera, Fabiana Cardoso; Anselmo-Lima, Wilma Terezinha] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, Brazil; [da Silva Junior, Wilson Arajo] Fundacao Amparo Pesquisa Estado Sao Paulo Cepid F, Ctr Pesquisa Inovacao & Difusao, Ctr Terapia Celular, Dept Genet, Sao Paulo, SP, Brazil; [da Silva Junior, Wilson Arajo] Univ Sao Paulo HCFMRP USP, Hosp Clin, Fac Med Ribeirao Preto, Ctr Med Genom, Ribeirao Preto, SP, Brazil; [da Silva Junior, Wilson Arajo] Univ Sao Paulo, Lista Nucleos Apoio Pesquisa NAPs, Ctr Integrat Syst Biol CISBi, Sao Paulo, SP, Brazil	dos Reis, MGA (reprint author), Escola Med Marilia, Dept Otorrinolaringol, Marilia, SP, Brazil.	reismariahh@gmail.com		Araujo, Luiza/0000-0002-5199-619X			Anselmo-Lima WT, 2015, BRAZ J OTORHINOLAR, V81, P8, DOI 10.1016/j.bjorl.2014.11.005; Bachert C, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-25; Pilan RRD, 2012, RHINOLOGY, V50, P129, DOI 10.4193/Rhino11.256; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Mfuna-Endam L, 2011, CURR ALLERGY ASTHM R, V11, P236, DOI 10.1007/s11882-011-0189-4; Pescador DB, 2012, J INVEST ALLERG CLIN, V22, P331; Pleis JR, 2010, VITAL HLTH STAT, V249, P1; Sitarek P, 2012, DNA CELL BIOL, V31, P1258, DOI 10.1089/dna.2011.1453; Wang LF, 2008, ARCH OTOLARYNGOL, V134, P852, DOI 10.1001/archotol.134.8.852; Wang LF, 2013, KAOHSIUNG J MED SCI, V29, P26, DOI 10.1016/j.kjms.2012.08.004; Wang LF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-85; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237                                                      ; Zielinska-Blizniewska H, 2012, MOL BIOL REP, V39, P5449, DOI 10.1007/s11033-011-1345-6	15	0	0	0	0	ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL	SAO PAULO	AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL	1808-8694	1808-8686		BRAZ J OTORHINOLAR	Braz. J. Otorhinolaryngol.	NOV-DEC	2017	83	6					705	711		10.1016/j.bjorl.2017.03.002				7	Otorhinolaryngology	Otorhinolaryngology	FP1RQ	WOS:000417392200016	28400178	gold			2018-01-05	
J	Compagnucci, C; Bertini, E				Compagnucci, Claudia; Bertini, Enrico			The Potential of iPSCs for the Treatment of Premature Aging Disorders	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						induced pluripotent stem cells; premature aging syndromes; cell senescence; lamins; stem cell metabolism; mitochondria; nucleoskeleton; CRISPR/Cas9 technology	PLURIPOTENT STEM-CELLS; GILFORD PROGERIA SYNDROME; A-TYPE LAMINS; IN-VIVO; HUMAN FIBROBLASTS; EPIGENETIC REGULATION; WERNERS-SYNDROME; LMNA MUTATIONS; DYSFUNCTION; METABOLISM	Premature aging disorders including Hutchinson-Gilford progeria syndrome (HGPS) and Werner syndrome, are a group of rare monogenic diseases leading to reduced lifespan of the patients. Importantly, these disorders mimic several features of physiological aging. Despite the interest on the study of these diseases, the underlying biological mechanisms remain unknown and no treatment is available. Recent studies on HGPS (due to mutations of the LMNA gene encoding for the nucleoskeletal proteins lamin A/C) have reported disruptions in cellular and molecular mechanisms modulating genomic stability and stem cell populations, thus giving the nuclear lamina a relevant function in nuclear organization, epigenetic regulation and in the maintenance of the stem cell pool. In this context, modeling premature aging with induced pluripotent stem cells (iPSCs) offers the possibility to study these disorders during self-renewal and differentiation into relevant cell types. iPSCs generated by cellular reprogramming from adult somatic cells allows researchers to understand pathophysiological mechanisms and enables the performance of drug screenings. Moreover, the recent development of precision genome editing offers the possibility to study the complex mechanisms underlying senescence and the possibility to correct disease phenotypes, paving the way for future therapeutic interventions.	[Compagnucci, Claudia; Bertini, Enrico] Childrens Res Hosp Bambino Gesu, IRCCS, Unit Neuromuscular & Neurodegenerat Dis, Dept Neurosci, I-00146 Rome, Italy	Compagnucci, C (reprint author), Childrens Res Hosp Bambino Gesu, IRCCS, Unit Neuromuscular & Neurodegenerat Dis, Dept Neurosci, I-00146 Rome, Italy.	claudia.compagnucci@opbg.net.com; enricosilvio.bertini@opbg.net			Italian Ministry of Health Ricerca Finalizzata [GR-2010-2309463]; Fondazione Bambino Gesu [GR-2010-2309463]; Ricerca Corrente of Ministry of Health [GR-2010-2309463]	We sincerely apologize to colleagues whose work has not been included in this review due to space limitations. Claudia Compagnucci was supported by grant GR-2010-2309463 of the Italian Ministry of Health Ricerca Finalizzata, Fondazione Bambino Gesu and Ricerca Corrente of Ministry of Health.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Blondel S, 2014, STEM CELL TRANSL MED, V3, P510, DOI 10.5966/sctm.2013-0168; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Colasuonno F, 2017, AGING-US, V9, P2206, DOI 10.18632/aging.101309; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3                                                           ; Hawkins KE, 2016, CELL REP, V14, P1883, DOI 10.1016/j.celrep.2016.02.003; Ho JCY, 2011, AGING-US, V3, P380, DOI 10.18632/aging.100277                                                           ; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Lee MR, 2016, STEM CELL REP, V7, P1, DOI 10.1016/j.stemcr.2016.05.012; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Masotti A, 2014, AGING-US, V6, P1094, DOI 10.18632/aging.100708                                                           ; Mathieu J, 2014, CELL STEM CELL, V14, P592, DOI 10.1016/j.stem.2014.02.012; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Moulson CL, 2007, HUM MUTAT, V28, P882, DOI 10.1002/humu.20536; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nissan X, 2012, CELL REP, V2, P1, DOI 10.1016/j.celrep.2012.05.015; Nissan X, 2011, BIOCHEM SOC T, V39, P1775, DOI 10.1042/BST20110659; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Ohnishi K, 2014, BIOCHEM BIOPH RES CO, V455, P10, DOI 10.1016/j.bbrc.2014.07.020; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Pekovic V, 2008, J ANAT, V213, P5, DOI 10.1111/j.1469-7580.2008.00928.x; Petrini S, 2017, AGING-US, V9, P1453, DOI 10.18632/aging.101248; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Prolla TA, 2005, MECH AGEING DEV, V126, P461, DOI 10.1016/j.mad.2004.10.003; Questa M, 2016, STEM CELL RES, V16, P300, DOI 10.1016/j.scr.2015.12.026; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Shimamoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112900; Shimamoto A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00010; Suhr S. T., 2010, PLOS ONE, V5, DOI [DOI 10.1371/JOURNAL.PONE.0014095, 10.1371/journal.pone.001409521124794]; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang A., 2012, CURR PROTOC STEM CEL, V23; Wang L, 2015, J IMMUNOL RES, V2015, P10, DOI DOI 10.1016/J; Wu J, 2016, CELL, V166, P1371, DOI 10.1016/j.cell.2016.08.008; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Xiong ZM, 2016, AGING CELL, V15, P279, DOI 10.1111/acel.12434; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	58	0	0	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2017	18	11							2350	10.3390/ijms18112350				11	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FO4KK	WOS:000416811300123		gold			2018-01-05	
J	Fujii, W; Ikeda, A; Sugiura, K; Naito, K				Fujii, Wataru; Ikeda, Arisa; Sugiura, Koji; Naito, Kunihiko			Efficient Generation of Genome-Modified Mice Using Campylobacter jejuni-Derived CRISPR/Cas	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						CRISPR; Cas; genome-modified mouse; Campylobacter jejuni	ONE-STEP GENERATION; CAS9; RNA; SYSTEMS; CRISPR-CAS9; NUCLEASES	Mammalian zygote-mediated genome-engineering by Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas is currently used for the generation of genome-modified animals. Here, we report that a Campylobacter jejuni-derived orthologous CRISPR/Cas system recognizes a 5-NNNVRYAC sequence as a protospacer-adjacent motif in mouse zygotes, and is applicable for efficient generation of knockout mice. Moreover, this novel CRISPR/Cas can be used for zygote-mediated knock-in at a unique locus, suggesting that this system could help to expand the feasibility of the zygote-mediated generation of genome-modified animals.	[Fujii, Wataru; Ikeda, Arisa; Sugiura, Koji; Naito, Kunihiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, 1-1-1 Yayoi, Tokyo 1138657, Japan	Fujii, W; Naito, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, 1-1-1 Yayoi, Tokyo 1138657, Japan.	awtrfj@mail.ecc.u-tokyo.ac.jp; ikeda-arisa228@g.ecc.u-tokyo.ac.jp; aks@mail.ecc.u-tokyo.ac.jp; aknaito@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [26712025, 25252056]	This work was supported by a Grant in-Aid for Scientific Research (26712025 and 25252056) from the Japan Society for the Promotion of Science.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fujii Wataru, 2017, Methods Mol Biol, V1630, P91, DOI 10.1007/978-1-4939-7128-2_8; Fujii W, 2016, BIOCHEM BIOPH RES CO, V477, P473, DOI 10.1016/j.bbrc.2016.06.070; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Fujii W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059801; Geurts A. M., 2009, SCIENCE, P325, DOI 10.1126/science.117244719628861; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047	22	0	0	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2017	18	11							2286	10.3390/ijms18112286				8	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FO4KK	WOS:000416811300060		gold			2018-01-05	
J	Lee, HJ; Kim, YM; Ono, T; Han, JY				Lee, Hong Jo; Kim, Young Min; Ono, Tamao; Han, Jae Yong			Genome Modification Technologies and Their Applications in Avian Species	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						genome modification; avian; transgenic technology; programmable genome editing; CRISPR/Cas9; primordial germ cells	PRIMORDIAL GERM-CELLS; SITE-SPECIFIC RECOMBINATION; MEDIATED CASSETTE EXCHANGE; ZINC-FINGER NUCLEASES; STEM-CELLS; LINE TRANSMISSION; CRE RECOMBINASE; HOMOLOGOUS RECOMBINATION; INFLUENZA TRANSMISSION; TARGETED MUTAGENESIS	The rapid development of genome modification technology has provided many great benefits in diverse areas of research and industry. Genome modification technologies have also been actively used in a variety of research areas and fields of industry in avian species. Transgenic technologies such as lentiviral systems and piggyBac transposition have been used to produce transgenic birds for diverse purposes. In recent years, newly developed programmable genome editing tools such as transcription activator-like effector nuclease (TALEN) and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9) have also been successfully adopted in avian systems with primordial germ cell (PGC)-mediated genome modification. These genome modification technologies are expected to be applied to practical uses beyond system development itself. The technologies could be used to enhance economic traits in poultry such as acquiring a disease resistance or producing functional proteins in eggs. Furthermore, novel avian models of human diseases or embryonic development could also be established for research purposes. In this review, we discuss diverse genome modification technologies used in avian species, and future applications of avian biotechnology.	[Lee, Hong Jo; Kim, Young Min; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea; [Lee, Hong Jo; Kim, Young Min; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Ono, Tamao] Shinshu Univ, Fac Agr, 8304 Minamiminowa, Nagano 3994598, Japan; [Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, 8304 Minamiminowa, Nagano 3994598, Japan	Han, JY (reprint author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea.; Han, JY (reprint author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.; Han, JY (reprint author), Shinshu Univ, Inst Biomed Sci, 8304 Minamiminowa, Nagano 3994598, Japan.	cszjjang@naver.com; ypoc01@snu.ac.kr; tamaoon@shinshu-u.ac.jp; jaehan@snu.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2015R1A3A2033826]; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT) and Future Planning of Korea [NRF-2016K1A3A1A21005676]	This work was supported by a National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIP; No. 2015R1A3A2033826). This research was also supported by the International Research & Development Program of the National Research Foundation of Korea (NRF) funded by Ministry of Science, Information and Communication Technology (ICT) and Future Planning of Korea (NRF-2016K1A3A1A21005676).	ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; Abu-Bonsrah KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34524; Agate RJ, 2009, P NATL ACAD SCI USA, V106, P17963, DOI 10.1073/pnas.0909139106; Ahn J, 2017, POULTRY SCI, V96, P1445, DOI 10.3382/ps/pew435; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bauser C. A., 1999, MOL BIOL, V8, P223, DOI [10.1046/j.1365-2583.1999.820223.x10380106, DOI 10.1046/J.1365-2583.1999.820223.X10380106]; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; BROWN PO, 1990, CURR TOP MICROBIOL, V157, P19; Bucher E, 2012, CURR OPIN PLANT BIOL, V15, P503, DOI 10.1016/j.pbi.2012.08.006; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chai N, 2006, P NATL ACAD SCI USA, V103, P5531, DOI 10.1073/pnas.0509785103; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cooper CA, 2017, TRANSGENIC RES, V26, P331, DOI 10.1007/s11248-016-0003-0; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Glover JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077222; GOFF SP, 1976, CELL, V9, P695, DOI 10.1016/0092-8674(76)90133-1; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; Graham Catriona, 2009, Biotechnology Journal, V4, P108, DOI 10.1002/biot.200800200; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Huss D, 2015, DEVELOPMENT, V142, P2850, DOI 10.1242/dev.121392; Inbar O, 2000, J BIOL CHEM, V275, P30833, DOI 10.1074/jbc.C000133200; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; JAENISCH R, 1974, P NATL ACAD SCI USA, V71, P1250, DOI 10.1073/pnas.71.4.1250; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; June Byun Sung, 2017, Sci Rep, V7, P5938, DOI 10.1038/s41598-017-05270-8; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kamihira M, 2009, J BIOTECHNOL, V141, P18, DOI 10.1016/j.jbiotec.2009.02.022; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Klucking S, 2002, J VIROL, V76, P7918, DOI 10.1128/JVI.76.15.7918-7921.2002; Koga A, 1996, NATURE, V383, P30, DOI 10.1038/383030a0; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kwon SC, 2010, BIOL REPROD, V82, P1057, DOI 10.1095/biolreprod.109.081687; Lambeth LS, 2016, ENDOCRINOLOGY, V157, P83, DOI 10.1210/en.2015-1697; Lee HJ, 2017, DEV COMP IMMUNOL, V77, P340, DOI 10.1016/j.dci.2017.09.006; Lee HJ, 2017, VET RES, V48, DOI 10.1186/s13567-017-0454-1; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Lee HJ, 2015, MOL CELLS, V38, P743, DOI 10.14348/molcells.2015.0225; Lee YM, 2006, BIOL REPROD, V75, P380, DOI 10.1095/biolreprod.106.052084; Leighton PA, 2016, TRANSGENIC RES, V25, P609, DOI 10.1007/s11248-016-9952-6; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mizuarai S, 2001, BIOCHEM BIOPH RES CO, V286, P456, DOI 10.1006/bbrc.2001.5422; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.3.CO;2-2; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ohtsuka M, 2014, METHODS MOL BIOL, V1194, P3, DOI 10.1007/978-1-4939-1215-5_1; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Oishi I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-5; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Pramod RK, 2017, STEM CELLS DEV, V26, P60, DOI 10.1089/scd.2016.0129; Reardon S, 2016, NATURE, V531, P160, DOI 10.1038/531160a; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445                                                              ; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Schusser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080108; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Taylor L, 2017, DEVELOPMENT, V144, P928, DOI 10.1242/dev.145367; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tizard M, 2016, TRANSGENIC RES, V25, P575, DOI 10.1007/s11248-016-9965-1; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Velho Tarciso A F, 2014, Cold Spring Harb Protoc, V2014, P1284, DOI 10.1101/pdb.prot084608; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang YN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172207; Zuo QS, 2017, J CELL BIOCHEM, V118, P2380, DOI 10.1002/jcb.25900	97	0	0	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2017	18	11							2245	10.3390/ijms18112245				13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FO4KK	WOS:000416811300019		gold			2018-01-05	
J	Wang, WB; Yu, H; Wang, JH; Lei, WJ; Gao, JH; Qiu, XP; Wang, JS				Wang, Wenbin; Yu, Huan; Wang, Jiahui; Lei, Wanjun; Gao, Jianhua; Qiu, Xiangpo; Wang, Jinsheng			The Complete Chloroplast Genome Sequences of the Medicinal Plant Forsythia suspensa (Oleaceae)	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						Forsythia suspensa; sequencing; chloroplast genome; comparative genomics; phylogenetic analysis	GENETIC INFORMATION; PLASTID GENOMES; CODON USAGE; EVOLUTION; DNA; ORGANIZATION; MULTIPLE; DIVERGENCE; EXPRESSION; GENERATION	Forsythia suspensa is an important medicinal plant and traditionally applied for the treatment of inflammation, pyrexia, gonorrhea, diabetes, and so on. However, there is limited sequence and genomic information available for F. suspensa. Here, we produced the complete chloroplast genomes of F. suspensa using Illumina sequencing technology. F. suspensa is the first sequenced member within the genus Forsythia (Oleaceae). The gene order and organization of the chloroplast genome of F. suspensa are similar to other Oleaceae chloroplast genomes. The F. suspensa chloroplast genome is 156,404 bp in length, exhibits a conserved quadripartite structure with a large single-copy (LSC; 87,159 bp) region, and a small single-copy (SSC; 17,811 bp) region interspersed between inverted repeat (IRa/b; 25,717 bp) regions. A total of 114 unique genes were annotated, including 80 protein-coding genes, 30 tRNA, and four rRNA. The low GC content (37.8%) and codon usage bias for A- or T-ending codons may largely affect gene codon usage. Sequence analysis identified a total of 26 forward repeats, 23 palindrome repeats with lengths >30 bp (identity >90%), and 54 simple sequence repeats (SSRs) with an average rate of 0.35 SSRs/kb. We predicted 52 RNA editing sites in the chloroplast of F. suspensa, all for C-to-U transitions. IR expansion or contraction and the divergent regions were analyzed among several species including the reported F. suspensa in this study. Phylogenetic analysis based on whole-plastome revealed that F. suspensa, as a member of the Oleaceae family, diverged relatively early from Lamiales. This study will contribute to strengthening medicinal resource conservation, molecular phylogenetic, and genetic engineering research investigations of this species.	[Wang, Wenbin; Yu, Huan; Lei, Wanjun; Gao, Jianhua; Qiu, Xiangpo; Wang, Jinsheng] Shanxi Agr Univ, Coll Life Sci, Taigu 030801, Peoples R China; [Wang, Jiahui] Northwest Agr & Forestry Univ, Coll Plant Protect, Yangling 712100, Peoples R China	Wang, WB; Wang, JS (reprint author), Shanxi Agr Univ, Coll Life Sci, Taigu 030801, Peoples R China.	sxndwwb@sxau.edu.cn; sxndyh@stu.sxau.edu.cn; wjh1014@nwafu.edu.cn; leiwanjunleo@sxau.edu.cn; gaojh_edu@sxau.edu; sxndqiuxiangpo@stu.sxau.edu; wangjinsheng@sxau.edu.cn			Shanxi Scholarship Council of China [2015-066]; Ministry of Human Resources and Social Security of the People's Republic of China; Shanxi Agricultural University [XB2009002, 2016ZZ04]; Health and Family Planning Commission of Shanxi Province; Modernization Base Construction Project of Traditional Chinese Medicine	This work was supported by the Research Project Supported by the Shanxi Scholarship Council of China (2015-066), the Preferential Research Project Supported by Ministry of Human Resources and Social Security of the People's Republic of China, Doctor Research Grant of Shanxi Agricultural University (XB2009002), the Modernization Base Construction Project of Traditional Chinese Medicine Supported by the Health and Family Planning Commission of Shanxi Province, and Doctor Research Grant of Shanxi Agricultural University (2016ZZ04).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6                                                   ; Bu YY, 2011, BIOORG MED CHEM LETT, V21, P874, DOI 10.1016/j.bmcl.2010.11.049; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Du PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-135; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; Fu JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159566; He Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060820; Hu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143765; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jiang Y., 2011, GOSSYPIUM HIRSUTUM C, V23, P3; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kang Wenyi, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1156; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HW, 2016, MITOCHONDRIAL DNA B, V1, P596, DOI 10.1080/23802359.2016.1202741; Kim K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15655; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Vieira Ldo N., 2014, PLOS ONE, V9, DOI [DOI 10.1371/JOURNAL.PONE.0090618, 10.1371/journal.pone.009061824594889]; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Lei WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21669; [李金璐 Li Jinlu], 2013, [植物学报, Chinese Bulletin of Botany], V48, P72; [刘庆坡 Liu Qiangpo], 2004, [作物学报, Acta Agronomica Sinica], V30, P1220; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Morton BR, 2003, J MOL EVOL, V56, P616, DOI 10.1007/s00239-002-2430-1; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Nazareno AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129930; Ni LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158488; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Piao XL, 2008, BIOORG MED CHEM LETT, V18, P1980, DOI 10.1016/j.bmcl.2008.01.115; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHINOZAKI K, 1986, EMBO J, V5, P2043; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang L, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0970-6; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074141; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wong GKS, 2002, GENOME RES, V12, P851, DOI 10.1101/gr.189102; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9                                                    ; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Zedane L, 2016, BIOL J LINN SOC, V117, P44, DOI 10.1111/bij.12509; Zhang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020596; Zhao LM, 2015, MOL MED REP, V11, P871, DOI 10.3892/mmr.2014.2874; Zhou Meng, 2008, Journal of Forestry Research (Harbin), V19, P293, DOI 10.1007/s11676-008-0052-1; Zhou Meng, 2008, Forestry Studies in China, V10, P235, DOI 10.1007/s11632-008-0047-1	63	0	0	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2017	18	11							2288	10.3390/ijms18112288				16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FO4KK	WOS:000416811300062		gold			2018-01-05	
J	Nabih, A; Sobotka, JA; Wu, MZ; Wedeles, CJ; Claycomb, JM				Nabih, Amena; Sobotka, Julia A.; Wu, Monica Z.; Wedeles, Christopher J.; Claycomb, Julie M.			Examining the intersection between splicing, nuclear export and small RNA pathways	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article							PRE-MESSENGER-RNA; EXON JUNCTION COMPLEX; GERMLINE GENE-EXPRESSION; STRAND PIRNA CLUSTERS; C. ELEGANS; CAENORHABDITIS-ELEGANS; ARGONAUTE PROTEINS; EPIGENETIC MEMORY; CRYSTAL-STRUCTURE; GENOME DEFENSE	Background: Nuclear Argonaute/small RNA pathways in a variety of eukaryotic species are generally known to regulate gene expression via chromatin modulation and transcription attenuation in a process known as transcriptional gene silencing (TGS). However, recent data, including genetic screens, phylogenetic profiling, and molecular mechanistic studies, also point to a novel and emerging intersection between the splicing and nuclear export machinery with nuclear Argonaute/small RNA pathways in many organisms. Scope of review: In this review, we summarize the field's current understanding regarding the relationship between splicing, export and small RNA pathways, and consider the biological implications for coordinated regulation of transcripts by these pathways. We also address the importance and available approaches for understanding the RNA regulatory logic generated by the intersection of these particular pathways in the context of synthetic biology. Major conclusions: The interactions between various eukaryotic RNA regulatory pathways, particularly splicing, nuclear export and small RNA pathways provide a type of combinatorial code that informs the identity ("self" versus "non-self") and dictates the fate of each transcript in a cell. Although the molecular mechanisms for how splicing and nuclear export impact small RNA pathways are not entirely clear at this early stage, the links between these pathways are widespread across eukaryotic phyla. General significance: The link between splicing, nuclear export, and small RNA pathways is emerging and establishes a new frontier for understanding the combinatorial logic of gene regulation across species that could someday be harnessed for therapeutic, biotechnology and agricultural applications. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue.	[Nabih, Amena; Sobotka, Julia A.; Wu, Monica Z.; Wedeles, Christopher J.; Claycomb, Julie M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Wedeles, CJ; Claycomb, JM (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	chris.wedeles@mail.utoronto.ca; julie.claycomb@utoronto.ca			Ontario Early Researcher Award; Ontario Graduate Scholarship (OGS); OGS; U. of Toronto Open Fellowships; Canada Research Chair in Small RNA Biology; Canadian Institutes of Health Research [MOP-274660]; Natural Sciences and Engineering Research Council of Canada [RGPIN-418683]	We thank Drs. Eric Miska, Alper Akay, Olivia Rissland, and Andrew Spence for insightful discussions about the interface between splicing factors and small RNA pathways. A.N. was supported by the Ontario Early Researcher Award to J.M.C. and an Ontario Graduate Scholarship (OGS). C.J.W. and M.Z.W. were supported by OGS and U. of Toronto Open Fellowships. J.M.C. is supported by a Canada Research Chair in Small RNA Biology, the Canadian Institutes of Health Research (MOP-274660) and the Natural Sciences and Engineering Research Council of Canada (RGPIN-418683).	Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Barberan-Soler S, 2014, CELL REP, V8, P1609, DOI 10.1016/j.celrep.2014.08.016; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Brenner TJ, 2005, GENETICS, V170, P1063, DOI 10.1534/genetics.105.042044; Buck AH, 2013, BIOCHEM SOC T, V41, P881, DOI 10.1042/BST20130086; Buckley B.A., 2012, NATURE; Burkhart KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002249; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cecere G, 2014, NAT STRUCT MOL BIOL, V21, P358, DOI 10.1038/nsmb.2801; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Claycomb JM, 2014, CURR BIOL, V24, pR703, DOI 10.1016/j.cub.2014.06.009; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Francisco-Mangilet AG, 2015, PLANT J, V82, P1018, DOI 10.1111/tpj.12874; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Furumizu C, 2010, RNA, V16, P1809, DOI 10.1261/rna.2265710; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2                                                   ; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Hur JK, 2016, GENE DEV, V30, P840, DOI 10.1101/gad.276030.115; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Kallgren SP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004334; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Le Hir H, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.7; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lejeune E, 2010, Cold Spring Harb Symp Quant Biol, V75, P275, DOI 10.1101/sqb.2010.75.024; LOCKHART SR, 1994, MOL CELL BIOL, V14, P3623, DOI 10.1128/MCB.14.6.3623                                                           ; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106                                                                ; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2014, GENE DEV, V28, P1786, DOI 10.1101/gad.245829.114; Mao H, 2015, CURR BIOL, V25, P2398, DOI 10.1016/j.cub.2015.07.051; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Matsumoto N, 2016, CELL, V167, P484, DOI 10.1016/j.cell.2016.09.002; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Okamura K, 2011, MOL CELL BIOL, V31, P884, DOI 10.1128/MCB.01141-10; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rissland O.S., 2017, REV RNA, V8; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Singh KK, 2013, RNA BIOL, V10, P1291, DOI 10.4161/rna.25827; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Taliaferro JM, 2013, GENE DEV, V27, P378, DOI 10.1101/gad.210708.112; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Verdel A, 2009, INT J DEV BIOL, V53, P245, DOI 10.1387/ijdb.082691av; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Wedeles C.J., 2014, WORM, V3, DOI [10.4161/worm.28641, DOI 10.4161/WORM.28641]; Wickramasinghe VO, 2015, NAT REV MOL CELL BIO, V16, P431, DOI 10.1038/nrm4010; Will CL, 2011, COLD SPRING HARB PER, V3; Xiong XP, 2013, P NATL ACAD SCI USA, V110, P16520, DOI 10.1073/pnas.1315803110; Youngman EM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00416; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160                                                                	102	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2017	1861	11	B		SI		2948	2955		10.1016/j.bbagen.2017.05.027				8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FN1VG	WOS:000415778700002	28578161				2018-01-05	
J	Kozar, I; Cesi, G; Margue, C; Philippidou, D; Kreis, S				Kozar, Ines; Cesi, Giulia; Margue, Christiane; Philippidou, Demetra; Kreis, Stephanie			Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Melanoma; Drug resistance; miRNA; BRAF inhibitors; Targeted therapy	CANCER	Background: Melanoma is an aggressive skin cancer with increasing incidence worldwide. The development of BRAF kinase inhibitors as targeted treatments for patients with BRAF-mutant tumours contributed profoundly to an improved overall survival of patients with metastatic melanoma. Despite these promising results, the emergence of rapid resistance to targeted therapy remains a serious clinical issue. Methods: To investigate the impact of BRAF inhibitors on miRNomes and transcriptomes, we used in vitro melanoma models consisting of BRAF inhibitor-sensitive and -resistant cell lines generated in our laboratory. Subsequently, microarray analyses were performed followed by RT-qPCR validations. Results: Regarding miRNome and transcriptome changes, the long-term effects of BRAF inhibition differed in a cell line-specific manner with the two different BRAF inhibitors inducing comparable responses in three melanoma cell lines. Despite this heterogeneity, several miRNAs (e.g. miR-92a-1-5p, miR-708-5p) and genes (e.g. DOK5, PCSK2) were distinctly differentially expressed in drug -resistant versus-sensitive cell lines. Analyses of coexpressed miRNAs, as well as inversely correlated miRNA-mRNA pairs, revealed a low MITF/AXL ratio in two drug -resistant cell lines that might be regulated by miRNAs. Conclusion: Several genes and miRNAs were differentially regulated in the drug -resistant and-sensitive cell lines and might be considered as prognostic and/or diagnostic resistance biomarkers in melanoma drug resistance. General significance: Thus far, only little information is available on the significance and role of miRNAs with respect to kinase inhibitor treatments and emergence of drug resistance. In this study, promising miRNAs and genes were identified and associated to BRAF inhibitor-mediated resistance in melanoma. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue.	[Kozar, Ines; Cesi, Giulia; Margue, Christiane; Philippidou, Demetra; Kreis, Stephanie] Univ Luxembourg, Life Sci Res Unit, 6 Ave Swing, L-4367 Belvaux, Luxembourg	Kreis, S (reprint author), Univ Luxembourg, Life Sci Res Unit, 6 Ave Swing, L-4367 Belvaux, Luxembourg.	ines.kozar@uni.lu; giulia.cesi@uni.lu; christiane.margue@uni.lu; demetra.philippidou@uni.lu; stephanie.kreis@uni.lu			Fondation Cancer (Luxembourg); PRIDE Doctoral Research Program by Fond National de la Recherche (Luxembourg)	We thank Dr. Petr Nazarov from the Luxembourg Institute of Health for providing invaluable advice on the microarray and coexpression data analysis. This study was supported by a grant from the Fondation Cancer (Luxembourg). IK is funded by the PRIDE Doctoral Research Program by Fond National de la Recherche (Luxembourg) in the scope of the Doctoral Teaching Unit-"CANBIO".	Agarwal V., 2015, ELIFE; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Ascierto P. A., 2012, J TRANSL MED, V85; Bansal N, 2015, ONCOTARGET, V6, P15321, DOI 10.18632/oncotarget.4148                                                        ; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Broughton J. P., 2016, GENET SEL EVOL, V31; Cao Y., 2013, CANCER RES, P6230; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766                                                             ; Eroglu Z, 2016, THER ADV MED ONCOL, V8, P48, DOI 10.1177/1758834015616934; Fattore L, 2016, P NATL ACAD SCI USA, V113, pE5005, DOI 10.1073/pnas.1607753113; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Flaherty KT, 2010, CANCER, V116, P4, DOI 10.1002/cncr.24688; Galore-Haskel G, 2015, ONCOTARGET, V6, P28999, DOI 10.18632/oncotarget.4905; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hwang J. H., 2010, PLOS ONE; Kim MH, 2016, EMBO J, V35, P462, DOI 10.15252/embj.201592081; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lankenau MA, 2015, P NATL ACAD SCI USA, V112, pE6744, DOI 10.1073/pnas.1520390112; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Liu S., 2015, PIGM CELL MELANOMA R, P431; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Liu SH, 2009, CLIN EXP METASTAS, V26, P739, DOI 10.1007/s10585-009-9273-8; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Manzano J. L., 2016, ANN TRANSL MED, P237; Margue C, 2015, ONCOTARGET, V6, P12110, DOI 10.18632/oncotarget.3661                                                        ; McCoy KD, 1999, IMMUNOL CELL BIOL, V77, P1; Menzies AM, 2014, CLIN CANCER RES, V20, P2035, DOI 10.1158/1078-0432.CCR-13-2054; Menzies AM, 2012, DRUG DES DEV THER, V6, P391, DOI 10.2147/DDDT.S38998; Meza-Sosa K. F., 2014, FRONT CELL NEUROSCI, P175; Millet A., 2016, MED RES REV; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Muller J., 2014, NAT COMMUN, V5712; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pak Brian J., 2006, ROLE DCT TYRP2 RESIS, P577; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pinto R, 2015, EXPERT OPIN THER TAR, V19, P1027, DOI 10.1517/14728222.2015.1065818                                                   ; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Qin Y., 2016, LEUKEMIA; Qin Y, 2016, MOL CANCER THER, V15, P2442, DOI 10.1158/1535-7163.MCT-15-0963; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Saleiban A, 2014, PIGM CELL MELANOMA R, V27, P431, DOI 10.1111/pcmr.12217; Schadendorf D., 2015, NAT REV DIS PRIMERS, P15003, DOI [DOI 10.1038/NRDP.2015.3, 10.1038/nrdp.2015.3]; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Seok H, 2016, MOL CELLS, V39, P375, DOI 10.14348/molcells.2016.0013; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Song X, 2015, CURR MED RES OPIN, V31, P987, DOI 10.1185/03007995.2015.1021904; Stark MS, 2015, EBIOMEDICINE, V2, P671, DOI 10.1016/j.ebiom.2015.05.011; Stark MS, 2015, ONCOTARGET, V6, P17753, DOI 10.18632/oncotarget.3924                                                        ; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Sun X., 2016, ONCOTARGET, DOI 10.18632/oncotarget.10900; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Travis AJ, 2014, METHODS, V65, P263, DOI 10.1016/j.ymeth.2013.10.015; Vandesompele J., 2002, GENOME BIOL; Vergani E, 2016, ONCOTARGET, V7, P4428, DOI 10.18632/oncotarget.6599; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JH, 2015, J INVEST DERMATOL, V135, P532, DOI 10.1038/jid.2014.418; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609                                                        ; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wozniak M, 2015, EXP MOL PATHOL, V99, P707, DOI 10.1016/j.yexmp.2015.11.014; Yan D., 2012, PLOS ONE; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhou LL, 2015, J CANCER, V6, P717, DOI 10.7150/jca.10865	73	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2017	1861	11	B		SI		2980	2992		10.1016/j.bbagen.2017.04.005				13	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FN1VG	WOS:000415778700005	28408301				2018-01-05	
J	Richter, H; Rompf, J; Wiegel, J; Rau, K; Randau, L				Richter, Hagen; Rompf, Judith; Wiegel, Julia; Rau, Kristina; Randau, Lennart			Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						CRISPR-Cas; Cascade; Ribonucleoproteins; DNA interference	PROVIDES ACQUIRED-RESISTANCE; BACTERIAL IMMUNE-SYSTEM; FUNCTIONAL-CHARACTERIZATION; CLOSTRIDIUM-THERMOCELLUM; ANTIVIRAL DEFENSE; STRUCTURAL BASIS; RNA CLEAVAGE; FOREIGN DNA; CASCADE; COMPLEX	Background: CRISPR arrays are transcribed into long precursor RNA species, which are further processed into mature CRISPR RNAs (crRNAs). Cas proteins utilize these crRNAs, which contain spacer sequences that can be derived from mobile genetic elements, to mediate immunity during a reoccurring virus infection. Type I CRISPR-Cas systems are defined by the presence of different Cascade interference complexes containing large and small subunits that play major roles during target DNA selection. Methods: Here, we produce the protein and crRNA components of the Type I-B CRISPR-Cas complex of Clostridium thermocellum and Methanococcus maripaludis. The C. thermocellum Cascade complexes were reconstituted and analyzed via size-exclusion chromatography. Activity of the heterologous M. maripaludis CRISPR-Cas system was followed using phage lambda plaques assays. Results: The reconstituted Type-I-B Cascade complex contains Cas7, Cas5, CasGb and the large subunit Cas8b. CasGb can be omitted from the reconstitution protocol. The large subunit Cas8b was found to be represented by two tightly associated protein fragments and a small C-terminal Cas8b segment was identified in recombinant complexes and C thermocellum cell lysate. Conclusions: Production of Cas8b generates a small C-terminal fragment, which is suggested to fulfill the role of the missing small subunit. A heterologous, synthetic M. maripaludis Type I-B system is active in E. coli against phage lambda, highlighting a potential for genome editing using endogenous Type-I-B CRISPR-Cas machineries. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue. (C) 2017 Elsevier B.V. All rights reserved.	[Richter, Hagen; Rompf, Judith; Wiegel, Julia; Rau, Kristina; Randau, Lennart] Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany	Randau, L (reprint author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	lennart.randau@mpi-marburg.mpg.de			Max Planck Society; Deutsche Forschungsgemeinschaft [DFG FOR 1680]; LOEWE programme of the state of Hessen	Funding was obtained from the Max Planck Society and the Deutsche Forschungsgemeinschaft [DFG FOR 1680] and the LOEWE programme of the state of Hessen.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cass S. D., 2015, BIOSCI REP, V35; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Guy CP, 2004, NUCLEIC ACIDS RES, V32, P6176, DOI 10.1093/nar/gkh960; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; LYND LR, 1989, APPL ENVIRON MICROB, V55, P3131; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Osawa T., 2013, J MOL BIOL; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Richter H, 2013, RNA BIOL, V10, P700, DOI 10.4161/rna.23715; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Shao YM, 2013, STRUCTURE, V21, P376, DOI 10.1016/j.str.2013.01.002; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	57	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2017	1861	11	B		SI		2993	3000		10.1016/j.bbagen.2017.02.026				8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FN1VG	WOS:000415778700006	28238733				2018-01-05	
J	Lee, BS; Kim, S; Ko, BJ; Yoo, TH				Lee, Byeong Sung; Kim, Suyeon; Ko, Byoung Joon; Yoo, Tae Hyeon			An efficient system for incorporation of unnatural amino acids in response to the four-base codon AGGA in Escherichia coli	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Unnatural amino acid; Four-base AGGA codon; Engineered tRNA; ArgW gene; Escherichia coli	TRANSFER-RNA SYNTHETASE; EXPANDED GENETIC-CODE; FUNCTIONAL QUADRUPLET CODON; SITE-SPECIFIC INCORPORATION; MAMMALIAN-CELLS; IN-VIVO; ORTHOGONAL TRANSLATION; RECOMBINANT PROTEINS; FACILE SYSTEM; EVOLUTION	Background: Adding new amino acids to the set of building blocks for protein synthesis expands the scope of protein engineering, and orthogonal pairs of tRNA and aminoacyl-tRNA synthetase have been developed for incorporating unnatural amino acids (UAAs) into proteins. While diverse systems have been developed to incorporate UAAs in response to the amber codon, less research has been focused on four-base codons despites their advantages. In this study, we report an efficient method to incorporate UAA in response to an AGGA codon in Escherichia coli. Results: The Methanococcus jannaschii tyrosyl-tRNA synthetase-tRNA(cuA)(MjTyrRS-MjtRNA(cuA)) orthogonal pair has been engineered to incorporate diverse UAAs in response to the amber codon. To apply the engineered MjTyrRS enzymes for UAAs to a four-base codon suppression, we developed an MjTyrRS-MjtRNA(uccu) Pair system that enabled incorporation of UAAs in response to the AGGA codon in E. coli. Using this system, we demonstrated that several UAAs could be incorporated quantitatively in the AGGA site. In addition, multiple AGGA codons were successfully suppressed in an E. coli strain when the endogenous tRNA(CCU)(Arg) gene was knocked out. Conclusion: An efficient system was developed for the incorporation of UAAs in response to the AGGA four-base codon in E. coil, and the method was successfully demonstrated for several UAAs and for multiple AGGA sites. General significance: The developed system can expand the repertoire of protein engineering tools based on amino acid analogues in combination with other UAA incorporation methods. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue. (C) 2017 Elsevier B.V. All rights reserved.	[Lee, Byeong Sung; Kim, Suyeon; Yoo, Tae Hyeon] Ajou Univ, Dept Mol Sci & Technol, 206 World Cup Ro, Suwon 16499, South Korea; [Yoo, Tae Hyeon] Ajou Univ, Dept Appl Chem & Biol Engn, 206 World Cup Ro, Suwon 16499, South Korea; [Ko, Byoung Joon] Osong Med Innovat Fdn, New Drug Dev Ctr, 123 Osongsaengmyeong Ro, Cheongju 28160, South Korea	Yoo, TH (reprint author), Ajou Univ, Dept Mol Sci & Technol, 206 World Cup Ro, Suwon 16499, South Korea.	taehyeonyoo@ajou.ac.kr			National Research Foundation of Korea [2015R1A1A1A05000898, 2015R1A2A2A09001059, 2014M3C1A3051470, NRF-2009-0093826]	This research was supported by the National Research Foundation of Korea (2015R1A1A1A05000898, 2015R1A2A2A09001059, 2014M3C1A3051470 and NRF-2009-0093826).	Aldinger CA, 2012, FEBS J, V279, P3622, DOI 10.1111/j.1742-4658.2012.08722.x; Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Beatty K. E., 2009, PROTEIN ENG; Chatterjee A, 2014, CHEMBIOCHEM, V15, P1782, DOI 10.1002/cbic.201402104; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2011, EMBO J, V30, P2312, DOI 10.1038/emboj.2011.160; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Dumas A, 2015, CHEM SCI, V6, P50, DOI 10.1039/c4sc01534g; FAULHAMMER HG, 1987, FEBS LETT, V217, P203, DOI 10.1016/0014-5793(87)80664-6; George S, 2016, FEBS LETT, V590, P1530, DOI 10.1002/1873-3468.12182; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hoesl MG, 2012, CURR OPIN BIOTECH, V23, P751, DOI 10.1016/j.copbio.2011.12.027; Hohsaka T, 2001, BIOCHEMISTRY-US, V40, P11060, DOI 10.1021/bi0108204; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Javahishvili T, 2014, ACS CHEM BIOL, V9, P874, DOI 10.1021/cb4005172; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kim CH, 2012, J AM CHEM SOC, V134, P9918, DOI 10.1021/ja303904e; Konno M, 2009, FEBS J, V276, P4763, DOI 10.1111/j.1742-4658.2009.07178.x; Kwon OH, 2010, P NATL ACAD SCI USA, V107, P17101, DOI 10.1073/pnas.1011569107; Lee BS, 2015, ACS CHEM BIOL, V10, P1648, DOI 10.1021/acschembio.5b00230; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Loscha KV, 2012, ANGEW CHEM INT EDIT, V51, P2243, DOI 10.1002/anie.201108275; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; Minnihan EC, 2011, J AM CHEM SOC, V133, P15942, DOI 10.1021/ja207719f; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Niu W, 2013, ACS CHEM BIOL, V8, P1640, DOI 10.1021/cb4001662; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Rodriguez EA, 2006, P NATL ACAD SCI USA, V103, P8650, DOI 10.1073/pnas.0510817103                                                         ; Seo MH, 2011, ANAL CHEM, V83, P2841, DOI 10.1021/ac103334b; Shimada A, 2001, P NATL ACAD SCI USA, V98, P13537, DOI 10.1073/pnas.231267998; Taki M, 2006, CHEMBIOCHEM, V7, P425, DOI 10.1002/cbic.200500360; Umehara T, 2012, FEBS LETT, V586, P729, DOI 10.1016/j.febslet.2012.01.029; Wan W, 2014, BBA-PROTEINS PROTEOM, V1844, P1059, DOI 10.1016/j.bbapap.2014.03.002; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/NCHEM.1919, 10.1038/nchem.1919]; Wang KH, 2012, ANGEW CHEM INT EDIT, V51, P2288, DOI 10.1002/anie.201105016; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1                                                   ; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077                                                         ; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wang ZYU, 2012, BIOCHEMISTRY-US, V51, P5232, DOI 10.1021/bi300535a; Xie JM, 2005, CURR OPIN CHEM BIOL, V9, P548, DOI 10.1016/j.cbpa.2005.10.011; Yao YN, 2003, FEBS LETT, V547, P197, DOI 10.1016/S0014-5793(03)00717-8; Yoo TH, 2007, P NATL ACAD SCI USA, V104, P13887, DOI 10.1073/pnas.0701904104; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231; Zheng S, 2012, BIOTECHNOL J, V7, P47, DOI 10.1002/biot.201100267	54	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2017	1861	11	B		SI		3016	3023		10.1016/j.bbagen.2017.02.017				8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FN1VG	WOS:000415778700009	28212794				2018-01-05	
J	Gan, QL; Fan, CG				Gan, Qinglei; Fan, Chenguang			Increasing the fidelity of noncanonical amino acid incorporation in cell-free protein synthesis	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Noncanonical amino acid; Genetic code expansion; Cell-free protein synthesis; tRNA isoacceptor; Phosphoserine; Near cognate suppression	GENETIC-CODE EXPANSION; ESCHERICHIA-COLI; RELEASE FACTOR-1; ACTIVATES EFFICIENT; MULTIPLE SITES; TRANSLATION; REASSIGNMENT; PHOSPHOSERINE; SPECIFICITY; EVOLUTION	Background: Cell-free protein synthesis provides a robust platform for co-translational incorporation of noncanonical amino acid (ncAA) into proteins to facilitate biological studies and biotechnological applications. Recently, eliminating the activity of release factor 1 has been shown to increase ncAA incorporation in response to amber codons. However, this approach could promote mis-incorporation of canonical amino acids by near cognate suppression. Methods: We performed a facile protocol to remove near cognate tRNA isoacceptors of the amber codon from total tRNAs, and used the phosphoserine (Sep) incorporation system as validation. By manipulating codon usage of target genes and tRNA species introduced into the cell-free protein synthesis system, we increased the fidelity of Sep incorporation at a specific position. Results: By removing three near cognate tRNA isoacceptors of the amber stop codon [tRNA(LYs), tRNA(TYr), and tRNA(GIn)(CUG)] from the total tRNA, the near cognate suppression decreased by 5-fold without impairing normal protein synthesis in the cell-free protein synthesis system. Mass spectrometry analyses indicated that the fidelity of ncAA incorporation was improved. Conclusions: Removal of near cognate tRNA isoacceptors of the amber codon could increase ncAA incorporation fidelity towards the amber stop codon in release factor deficiency systems. General significance: We provide a general strategy to improve fidelity of ncAA incorporation towards stop, quadruplet and sense codons in cell-free protein synthesis systems. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue. (c) 2016 Elsevier B.V. All rights reserved.	[Gan, Qinglei; Fan, Chenguang] Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA	Fan, CG (reprint author), Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA.	cf021@uark.edu			National Institute of Allergy and Infectious Diseases [AI119813]; National Institute of General Medical Sciences [GM22854]; University of Arkansas [FT2017-01131-02]	We thank Professor Dieter Soli at Yale University for generous support. This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI119813), the National Institute of General Medical Sciences (GM22854), and start-up funds from the University of Arkansas (FT2017-01131-02).	Aerni HR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1087; Albayrak C, 2013, NUCLEIC ACIDS RES, V41, P5949, DOI 10.1093/nar/gkt226; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Fan CG, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv800; Fan CG, 2014, CHEMBIOCHEM, V15, P1805, DOI 10.1002/cbic.201402083; George S, 2016, FEBS LETT, V590, P1530, DOI 10.1002/1873-3468.12182; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Henrich E, 2015, FEBS LETT, V589, P1713, DOI 10.1016/j.febslet.2015.04.045; Hoesl MG, 2012, CURR OPIN BIOTECH, V23, P751, DOI 10.1016/j.copbio.2011.12.027; Hong SH, 2015, CHEMBIOCHEM, V16, P844, DOI 10.1002/cbic.201402708; Hong SH, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00034; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Johnson DBF, 2012, ACS CHEM BIOL, V7, P1337, DOI 10.1021/cb300229q; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Johnson JA, 2010, CURR OPIN CHEM BIOL, V14, P774, DOI 10.1016/j.cbpa.2010.09.013; Kanda T, 2000, BIOCHEM BIOPH RES CO, V270, P1136, DOI 10.1006/bbrc.2000.2556; Krishnakumar R, 2014, FEBS LETT, V588, P383, DOI 10.1016/j.febslet.2013.11.039; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Nehring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031992; Neumann H, 2012, FEBS LETT, V586, P2057, DOI 10.1016/j.febslet.2012.02.002; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Ohuchi M, 2007, CURR OPIN CHEM BIOL, V11, P537, DOI 10.1016/j.cbpa.2007.08.011; Oza JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9168; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Quast RB, 2015, FEBS LETT, V589, P1703, DOI 10.1016/j.febslet.2015.04.041; Ramaswamy K, 2004, J AM CHEM SOC, V126, P11454, DOI 10.1021/ja046843y; Rosenblum G, 2014, FEBS LETT, V588, P261, DOI 10.1016/j.febslet.2013.10.016; Sando S, 2007, BIOORG MED CHEM LETT, V17, P1216, DOI 10.1016/j.bmcl.2006.12.013; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768                                                           ; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Worst EG, 2015, BIOORG MED CHEM LETT, V25, P3658, DOI 10.1016/j.bmcl.2015.06.045; Zhang B., 2016, SCI REP, V6, P1	41	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2017	1861	11	B		SI		3047	3052		10.1016/j.bbagen.2016.12.002				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FN1VG	WOS:000415778700013	27919800				2018-01-05	
J	Vigar, JRJ; Wieden, HJ				Vigar, Justin R. J.; Wieden, Hans-Joachim			Engineering bacterial translation initiation - Do we have all the tools we need?	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Review						RNA engineering; Synthetic biology; Translation initiation; Riboregulation; Rational design; Ribosome engineering	RIBOSOMAL-PROTEIN S1; LEADERLESS MESSENGER-RNAS; ESCHERICHIA-COLI RIBOSOMES; 5'-TERMINAL START CODONS; CONTROL GENE-EXPRESSION; SHINE-DALGARNO REGION; BINDING-SITES; IN-VIVO; SYNTHETIC RIBOSWITCHES; GUANOSINE TRIPHOSPHATE	Background: Reliable tools that allow precise and predictable control over gene expression are critical for the success of nearly all bioengineering applications. Translation initiation is the most regulated phase during protein biosynthesis, and is therefore a promising target for exerting control over gene expression. At the translational level, the copy number of a protein can be fine-tuned by altering the interaction between the translation initiation region of an mRNA and the ribosome. These interactions can be controlled by modulating the mRNA structure using numerous approaches, including small molecule ligands, RNAs, or RNA-binding proteins. A variety of naturally occurring regulatory elements have been repurposed, facilitating advances in synthetic gene regulation strategies. The pursuit of a comprehensive understanding of mechanisms governing translation initiation provides the framework for future engineering efforts. Scope of review: Here we outline state-of-the-art strategies used to predictably control translation initiation in bacteria. We also discuss current limitations in the field and future goals. Major conclusions: Due to its function as the rate-determining step, initiation is the ideal point to exert effective translation regulation. Several engineering tools are currently available to rationally design the initiation characteristics of synthetic mRNAs. However, improvements are required to increase the predictability, effectiveness, and portability of these tools. General significance: Predictable and reliable control over translation initiation will allow greater predictability when designing, constructing, and testing genetic circuits. The ability to build more complex circuits predictably will advance synthetic biology and contribute to our fundamental understanding of the underlying principles of these processes. "This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue.	[Vigar, Justin R. J.; Wieden, Hans-Joachim] Univ Lethbridge, Dept Chem & Biochem, Alberta RNA Res & Training Inst, 4401 Univ Dr West, Lethbridge, AB T1K 3M4, Canada	Wieden, HJ (reprint author), Univ Lethbridge, E868,Univ Hall,4401 Univ Dr West, Lethbridge, AB T1K 3M4, Canada.	hj.wieden@uleth.ca			Alberta Innovates Technology Futures [SC60-T2]	This work was supported by Alberta Innovates Technology Futures (SC60-T2).	Auslander S, 2014, NATURE, V516, P333, DOI 10.1038/516333a; BALAKIN AG, 1992, NUCLEIC ACIDS RES, V20, P563, DOI 10.1093/nar/20.3.563; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3                                                   ; Boni IV, 2000, J BACTERIOL, V182, P5872, DOI 10.1128/JB.182.20.5872-5879.2000; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Boni IV, 2001, EMBO J, V20, P4222, DOI 10.1093/emboj/20.15.4222                                                        ; Borujeni AE, 2016, NUCLEIC ACIDS RES, V44, P1, DOI 10.1093/nar/gkv1289; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Button JE, 2011, MOL MICROBIOL, V81, P1474, DOI 10.1111/j.1365-2958.2011.07784.x; Byrgazov K, 2015, NUCLEIC ACIDS RES, V43, P661, DOI 10.1093/nar/gku1314; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Cardinale S, 2013, CELL REP, V4, P231, DOI 10.1016/j.celrep.2013.06.023; Caron MP, 2010, RNA BIOL, V7, P140, DOI 10.4161/rna.7.2.11056                                                           ; Carrera J, 2011, BIOTECHNOL J, V6, P773, DOI 10.1002/biot.201100084; Carrier TA, 1999, BIOTECHNOL PROGR, V15, P58, DOI 10.1021/bp9801143; Chae TU, 2015, SCI REP-UK, V5, DOI 10.1038/srep13040; Chang AL, 2014, ANAL CHEM, V86, P3273, DOI 10.1021/ac5001527; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953                                                          ; Cironi P, 2008, J BIOL CHEM, V283, P8469, DOI 10.1074/jbc.M708502200; Colussi TM, 2015, NATURE, V519, P110, DOI 10.1038/nature14219; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; de Smit MH, 2003, J MOL BIOL, V331, P737, DOI 10.1016/S0022-2836(03)00809-X; Dedkova LM, 2003, J AM CHEM SOC, V125, P6616, DOI 10.1021/ja035141q; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; Delvillani F, 2011, NUCLEIC ACIDS RES, V39, P7702, DOI 10.1093/nar/gkr417; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Duval M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001731; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0                                                                ; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Fried SD, 2015, ANGEW CHEM INT EDIT, V54, P12791, DOI 10.1002/anie.201506311; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9                                                   ; George KW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11128; Gorochowski TE, 2016, ACS SYNTH BIOL, V5, P710, DOI 10.1021/acssynbio.6b00040; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101                                                        ; Grill S, 2001, FEBS LETT, V495, P167, DOI 10.1016/S0014-5793(01)02378-X                                                   ; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Heppell B, 2011, NAT CHEM BIOL, V7, P384, DOI [10.1038/NCHEMBIO.563, 10.1038/nchembio.563]; HIRASHIM.A, 1970, BIOCHEM BIOPH RES CO, V41, P877, DOI 10.1016/0006-291X(70)90165-8; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; HUI A, 1987, METHOD ENZYMOL, V153, P432; HUI AS, 1988, EMBO J, V7, P4383; HUTTENHOFER A, 1992, P NATL ACAD SCI USA, V89, P7851, DOI 10.1073/pnas.89.17.7851                                                         ; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JACOB WF, 1987, P NATL ACAD SCI USA, V84, P4757, DOI 10.1073/pnas.84.14.4757; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Jang CJ, 2009, J MOL BIOL, V387, P42, DOI 10.1016/j.jmb.2009.01.042; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; JONES RL, 1992, J BACTERIOL, V174, P4753; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kim B, 2014, BIOTECHNOL J, V9, P621, DOI 10.1002/biot.201300263; Koh EYC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082100; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lahiry A., 2017, ACS SYNTH BIOL; Lauber MA, 2012, MOL CELL PROTEOMICS, V11, P1965, DOI 10.1074/mcp.M112.019562; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lee K, 1996, RNA, V2, P1270; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; LOCKWOOD AH, 1971, P NATL ACAD SCI USA, V68, P3122, DOI 10.1073/pnas.68.12.3122                                                         ; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203                                                           ; Lynch SA, 2007, CHEM BIOL, V14, P173, DOI 10.1016/j.chembiol.2006.12.008; Maini R, 2013, BIOORGAN MED CHEM, V21, P1088, DOI 10.1016/j.bmc.2013.01.002; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829                                                         ; Marzi S, 2007, CELL, V130, P1019, DOI 10.1016/j.cell.2007.07.008; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Modi SR, 2011, P NATL ACAD SCI USA, V108, P15522, DOI 10.1073/pnas.1104318108; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x                                                ; Moll I, 2001, J BACTERIOL, V183, P3499, DOI 10.1128/JB.183.11.3499-3505.2001; Moll I, 1998, FEBS LETT, V436, P213, DOI 10.1016/S0014-5793(98)01131-4; Moll I, 2012, TRENDS BIOCHEM SCI, V37, P493, DOI 10.1016/j.tibs.2012.07.007; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; Mutalik VK, 2013, NAT METHODS, V10, P347, DOI [10.1038/nmeth.2403, 10.1038/NMETH.2403]; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Nakahira Y, 2013, PLANT CELL PHYSIOL, V54, P1724, DOI 10.1093/pcp/pct115; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Neupert J, 2009, NAT PROTOC, V4, P1262, DOI 10.1038/nprot.2009.112; NISHIZUKA Y, 1966, ARCH BIOCHEM BIOPHYS, V116, P344, DOI 10.1016/0003-9861(66)90040-3                                                    ; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; NOMURA M, 1980, P NATL ACAD SCI-BIOL, V77, P7084, DOI 10.1073/pnas.77.12.7084                                                         ; Omotajo D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1808-6; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; PHILIPPE C, 1990, J MOL BIOL, V211, P415, DOI 10.1016/0022-2836(90)90362-P; Qu XH, 2012, P NATL ACAD SCI USA, V109, P14458, DOI 10.1073/pnas.1208950109; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Reeve B, 2014, SYNTHETIC BIOL, V2, P1, DOI DOI 10.3389/FBI0E.2014.00001); Resch A, 1996, EMBO J, V15, P4740; RINGQUIST S, 1995, BIOCHEMISTRY-US, V34, P3640, DOI 10.1021/bi00011a019; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x                                              ; Robinson-Mosher A, 2013, CHAOS, V23, DOI 10.1063/1.4810915; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SCHAUDER B, 1989, GENE, V78, P59, DOI 10.1016/0378-1119(89)90314-4; SCHURR T, 1993, NUCLEIC ACIDS RES, V21, P4019, DOI 10.1093/nar/21.17.4019; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; SHEAN CS, 1992, CELL, V70, P513, DOI 10.1016/0092-8674(92)90175-C; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Skorski P, 2006, J BACTERIOL, V188, P6277, DOI 10.1128/JB.00591-06; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; STEPHENSON ML, 1956, ARCH BIOCHEM BIOPHYS, V65, P194, DOI 10.1016/0003-9861(56)90187-4                                                    ; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; SUBRAMANIAN AR, 1970, NATURE, V228, P1273, DOI 10.1038/2281273a0                                                               ; Tchufistova LS, 2003, NUCLEIC ACIDS RES, V31, P6996, DOI 10.1093/nar/gkg883; Tedin K, 1999, MOL MICROBIOL, V31, P67, DOI 10.1046/j.1365-2958.1999.01147.x; Tian T, 2015, NUCLEIC ACIDS RES, V43, P7137, DOI 10.1093/nar/gkv635; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; Topp S, 2008, RNA, V14, P2498, DOI 10.1261/rna.1269008; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1046/j.1365-2958.2003.03935.x; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Venkatesan A, 2001, MOL CELL BIOL, V21, P2826, DOI 10.1128/MCB.21.8.2826-2837.2001                                                 ; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Waldminghaus T, 2008, BIOL CHEM, V389, P1319, DOI 10.1515/BC.2008.150; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6                                                   ; WINTERMEYER W, 1983, BIOCHEMISTRY-US, V22, P690, DOI 10.1021/bi00272a025; Wittmann A, 2012, FEBS LETT, V586, P2076, DOI 10.1016/j.febslet.2012.02.038; WOOD TK, 1991, BIOTECHNOL BIOENG, V38, P891, DOI 10.1002/bit.260380811; Yoo SM, 2013, NAT PROTOC, V8, P1694, DOI 10.1038/nprot.2013.105; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; ZHANG JR, 1992, P NATL ACAD SCI USA, V89, P2605, DOI 10.1073/pnas.89.7.2605	153	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2017	1861	11	B		SI		3060	3069		10.1016/j.bbagen.2017.03.008				10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FN1VG	WOS:000415778700015	28315412				2018-01-05	
J	McLaren, PJ; Pulit, SL; Gurdasani, D; Bartha, I; Shea, PR; Pomilla, C; Gupta, N; Gkrania-Klotsas, E; Young, EH; Bannert, N; Del Amo, J; Gill, MJ; Gilmour, J; Kellam, P; Kelleher, AD; Sonnerborg, A; Zangerle, R; Post, FA; Fisher, M; Haas, DW; Walker, BD; Porter, K; Goldstein, DB; Sandhu, MS; Bakker, PIW; Fellay, J				McLaren, Paul J.; Pulit, Sara L.; Gurdasani, Deepti; Bartha, Istvan; Shea, Patrick R.; Pomilla, Cristina; Gupta, Namrata; Gkrania-Klotsas, Effrossyni; Young, Elizabeth H.; Bannert, Norbert; Del Amo, Julia; Gill, M. John; Gilmour, Jill; Kellam, Paul; Kelleher, Anthony D.; Sonnerborg, Anders; Zangerle, Robert; Post, Frank A.; Fisher, Martin; Haas, David W.; Walker, Bruce D.; Porter, Kholoud; Goldstein, David B.; Sandhu, Manjinder S.; de Bakker, Paul I. W.; Fellay, Jacques			Evaluating the Impact of Functional Genetic Variation on HIV-1 Control	JOURNAL OF INFECTIOUS DISEASES			English	Article						HIV-1 control; exome sequencing; HIV-1 progression; host genetics of infection; HIV host dependency factors	AUTISM SPECTRUM DISORDERS; WHOLE-GENOME ASSOCIATION; WIDE ASSOCIATION; RARE VARIANTS; HOST CONTROL; INFECTION; DETERMINANTS; POPULATION; LINKAGE	Background. Previous genetic association studies of human immunodeficiency virus-1 (HIV-1) progression have focused on common human genetic variation ascertained through genome-wide genotyping. Methods. We sought to systematically assess the full spectrum of functional variation in protein coding gene regions on HIV-1 progression through exome sequencing of 1327 individuals. Genetic variants were tested individually and in aggregate across genes and gene sets for an influence on HIV-1 viral load. Results. Multiple single variants within the major histocompatibility complex (MHC) region were observed to be strongly associated with HIV-1 outcome, consistent with the known impact of classical HLA alleles. However, no single variant or gene located outside of the MHC region was significantly associated with HIV progression. Set-based association testing focusing on genes identified as being essential for HIV replication in genome-wide small interfering RNA (siRNA) and clustered regularly interspaced short palindromic repeats (CRISPR) studies did not reveal any novel associations. Conclusions. These results suggest that exonic variants with large effect sizes are unlikely to have a major contribution to host control of HIV infection.	[McLaren, Paul J.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Lab, JC Wilt Infect Dis Res Ctr, Ottawa, ON, Canada; [McLaren, Paul J.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Pulit, Sara L.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, Utrecht, Netherlands; [Gurdasani, Deepti; Pomilla, Cristina; Young, Elizabeth H.; Kellam, Paul; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Human Genet, Hinxton, England; [Gurdasani, Deepti; Pomilla, Cristina; Young, Elizabeth H.; Sandhu, Manjinder S.] Univ Cambridge, Dept Med, Cambridge, England; [Bartha, Istvan; Fellay, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Shea, Patrick R.; Goldstein, David B.] Columbia Univ, Inst Genom Med, New York, NY USA; [Gupta, Namrata] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Gkrania-Klotsas, Effrossyni] Univ Cambridge, Dept Infect Dis, Cambridge, England; [Bannert, Norbert] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany; [Del Amo, Julia] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain; [Gill, M. John] Univ Calgary, Dept Med, Calgary, AB, Canada; [Gilmour, Jill] Imperial Coll, Int AIDS Vaccine Initiat, Human Immunogenet Lab, London, England; [Kellam, Paul] UCL, Res Dept Infect, Div Infect & Immun, London, England; [Kelleher, Anthony D.] Univ New South Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden; [Zangerle, Robert] Med Univ Innsbruck, Dept Dermatol & Venerol, Innsbruck, Austria; [Post, Frank A.] Kings Coll Hosp London, London, England; [Fisher, Martin] Royal Sussex Cty Hosp, Brighton, E Sussex, England; [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Walker, Bruce D.] MIT, Ragon Inst Massachusetts Gen Hosp, Boston, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Porter, Kholoud] UCL, London, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Fellay, Jacques] Swiss Inst Bioinformat, Lausanne, Switzerland	McLaren, PJ (reprint author), Univ Manitoba, Dept Med Microbiol, Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, 745 Logan Ave, Winnipeg, MB R3E 3L5, Canada.	paul.mclaren@phac-aspc.gc.ca		Fellay, Jacques/0000-0002-8240-939X	Swiss HIV Cohort Study project [651]; Swiss National Science Foundation [148522]; Collaboration for AIDS Vaccine Discovery of the Bill; Melinda Gates Foundation; Harvard University Center for AIDS Research [P-30-A1060354]; University of California San Francisco (UCSF) Center for AIDS Research [P-30 AI27763]; UCSF Clinical and Translational Science Institute [UL1 RR024131]; Center for AIDS Research Network of Integrated Clinical Systems [R24 AI067039]; National Institutes for Health [AI030914, AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, A132782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, A1069434, AI46370, AI68634, AI069502, AI069419, AI068636, RR024975, AI077505, AI110527, TR000445]; European Union Seventh Programme (FP7) [260694]; Spanish Network of HIV/AIDS [RD06/006, RD12/0017/0018, RD16CIII/0002/0006]	This study has been financed in part within the framework of the Swiss HIV Cohort Study (www.shcs.ch) project #651 and supported by the Swiss National Science Foundation (www.snf.ch) grant #148522 (J.F.). The International HIV Controllers Study was made possible through a generous donation from the Mark and Lisa Schwartz Foundation and a subsequent award from the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation (www.cavd.org). This work was also supported in part by the Harvard University Center for AIDS Research (cfar.globalhcalth.harvard.edu) grant P-30-A1060354; University of California San Francisco (UCSF) Center for AIDS Research (cfar.ucsf.edu) grant P-30 AI27763; UCSF Clinical and Translational Science Institute (https://ctsi.ucsf.edu) grant UL1 RR024131; Center for AIDS Research Network of Integrated Clinical Systems (http://cfar.globalhcalth.har-vard.edu) grant R24 AI067039; and the National Institutes for Health (www.nih.gov) grants AI28568 and AI030914 (B.D.W.). The AIDS Clinical Trials Group was supported by NIH grants AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, A132782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, A1069434, AI46370, AI68634, AI069502, AI069419, AI068636, RR024975, AI077505, AI110527, and TR000445 (D.W.H.). Tor the CASCADE Consortium, the research leading to these results has received funding from the European Union Seventh Programme (FP7/2007-2013) under EuroCoord (www.euro-coord.net) grant agreement no. 260694 (K.P.) and the Spanish Network of HIV/AIDS grant nos. RD06/006, RD12/0017/0018 and RD16CIII/0002/0006 (J.DA.).	Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Chinn LW, 2010, J INFECT DIS, V202, P1836, DOI 10.1086/657322; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Estrada K, 2014, JAMA-J AM MED ASSOC, V311, P2305, DOI 10.1001/jama.2014.6511; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; McLaren PJ, 2015, P NATL ACAD SCI USA, V112, P14658, DOI 10.1073/pnas.1514867112; McLaren PJ, 2015, NAT IMMUNOL, V16, P577, DOI 10.1038/ni.3147; McLaren PJ, 2012, HUM MOL GENET, V21, P4334, DOI 10.1093/hmg/dds226; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; UNAIDS, 2014, 90 90 90 AMB TREATM; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031	26	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	NOV 1	2017	216	9					1063	1069		10.1093/infdis/jix470				7	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	FP0ZM	WOS:000417338800004	28968755				2018-01-05	
J	Scheben, A; Wolter, F; Batley, J; Puchta, H; Edwards, D				Scheben, Armin; Wolter, Felix; Batley, Jacqueline; Puchta, Holger; Edwards, David			Towards CRISPR/Cas crops - bringing together genomics and genome editing	NEW PHYTOLOGIST			English	Review						breeding; crops; CRISPR; Cas; gene targeting (GT); genome editing; targeted mutagenesis	ZINC-FINGER NUCLEASES; RNA-GUIDED ENDONUCLEASE; DOUBLE-STRAND BREAKS; TARGETED MUTAGENESIS; HIGH-EFFICIENCY; HOMOLOGOUS RECOMBINATION; PLANT GENOMES; DNA CLEAVAGE; INDUCED MUTATIONS; WIDE PREDICTION	With the rapid increase in the global population and the impact of climate change on agriculture, there is a need for crops with higher yields and greater tolerance to abiotic stress. However, traditional crop improvement via genetic recombination or random mutagenesis is a laborious process and cannot keep pace with increasing crop demand. Genome editing technologies such as clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (CRISPR/Cas) allow targeted modification of almost any crop genome sequence to generate novel variation and accelerate breeding efforts. We expect a gradual shift in crop improvement away from traditional breeding towards cycles of targeted genome editing. Crop improvement using genome editing is not constrained by limited existing variation or the requirement to select alleles over multiple breeding generations. However, current applications of crop genome editing are limited by the lack of complete reference genomes, the sparse knowledge of potential modification targets, and the unclear legal status of edited crops. We argue that overcoming technical and social barriers to the application of genome editing will allow this technology to produce a new generation of high-yielding, climate ready crops.	[Scheben, Armin; Batley, Jacqueline; Edwards, David] Univ Western Australia, Sch Biol Sci, Perth, WA 6009, Australia; [Scheben, Armin; Batley, Jacqueline; Edwards, David] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia; [Wolter, Felix; Puchta, Holger] Karlsruhe Inst Technol, Bot Inst 2, D-76131 Karlsruhe, Germany	Edwards, D (reprint author), Univ Western Australia, Sch Biol Sci, Perth, WA 6009, Australia.; Edwards, D (reprint author), Univ Western Australia, Inst Agr, Perth, WA 6009, Australia.	Dave.Edwards@uwa.edu.au		Batley, Jacqueline/0000-0002-5391-5824	IPRS - Australian government; Australian Research Council [LP160100030, LP140100537, LP130100061, LP130100925]	Armin Scheben was supported by an IPRS awarded by the Australian government. This work was supported by the Australian Research Council (project nos. LP160100030, LP140100537, LP130100061 and LP130100925). We thank three anonymous reviewers for comments that helped improve the manuscript. We are also grateful to Maxim Kapralov for comments on Rubisco.	Acquaah G., 2012, PRINCIPLES PLANT GEN; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Andolfo G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01813; Andorf CM, 2016, NUCLEIC ACIDS RES, V44, pD1195, DOI 10.1093/nar/gkv1007; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Blomstedt CK, 2012, PLANT BIOTECHNOL J, V10, P54, DOI 10.1111/j.1467-7652.2011.00646.x; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Canadian Food Inspection Agency, 2016, PLANTS NOV TRAITS; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Demorest ZL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0906-1; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Edwards D, 2016, PLANT GENOMICS CLIMA, P173; Eeckhaut T, 2013, PLANTA, V238, P991, DOI 10.1007/s00425-013-1936-7; Eid A, 2016, PLANT CELL REP, V35, P1555, DOI 10.1007/s00299-016-2000-4; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Golicz AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13390; Golicz AA, 2016, PLANT BIOTECHNOL J, V14, P1099, DOI 10.1111/pbi.12499; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Huang P, 2017, J EXP BOT, V68, P127, DOI 10.1093/jxb/erw256; Iaffaldano B, 2016, IND CROP PROD, V89, P356, DOI 10.1016/j.indcrop.2016.05.029; Ishida Y, 2007, NAT PROTOC, V2, P1614, DOI 10.1038/nprot.2007.241; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Ji X, 2015, NATURE PLANTS, V1, P144; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lambert B, 2015, PROCEDIA ENVIRON SCI, V29, P77, DOI 10.1016/j.proenv.2015.07.167; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mikkelsen MD, 2010, MOL PLANT, V3, P751, DOI 10.1093/mp/ssq020; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Ordon J, 2017, PLANT J, V89, P155, DOI 10.1111/tpj.13319; Osterberg JT, 2017, TRENDS PLANT SCI, V22, P373, DOI 10.1016/j.tplants.2017.01.004; Pacher M, 2007, GENETICS, V175, P21, DOI 10.1534/genetics.106.065185; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Peng A, 2017, PLANT BIOTECHNOLOGY, V10, P1011; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/nmeth.2340, 10.1038/NMETH.2340]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ranganathan V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5516; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Ruprecht C, 2017, TRENDS PLANT SCI, V22, P298, DOI 10.1016/j.tplants.2016.12.011; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Scheben A, 2017, SCIENCE, V355, P1122, DOI 10.1126/science.aal4680; Schiml S, 2016, P NATL ACAD SCI USA, V113, P7266, DOI 10.1073/pnas.1603823113; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Schinkel H, 2016, PLANT CELL REP, V35, P1487, DOI 10.1007/s00299-016-1988-9; Sedbrook JC, 2014, PLANT SCI, V227, P122, DOI 10.1016/j.plantsci.2014.07.008; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shapter FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082641; Sharwood RE, 2017, NEW PHYTOL, V213, P494, DOI 10.1111/nph.14351; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; TANG X, 2017, NAT PLANTS, V3; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Ueta R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00501-4; Waltz E, 2016, NAT BIOTECHNOL, V34, P582, DOI 10.1038/nbt0616-582; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Whitney SM, 2011, P NATL ACAD SCI USA, V108, P14688, DOI 10.1073/pnas.1109503108; Wolter F, 2017, MAYDICA, V62, P1; Wolter F, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1179-1; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yuan YX, 2017, TRENDS BIOTECHNOL, V35, P547, DOI 10.1016/j.tibtech.2017.02.009; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang WL, 2012, GENOME RES, V22, P151, DOI 10.1101/gr.131342.111; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811; ZsOgona A, 2017, PLANT SCI, V256, P120, DOI 10.1016/j.plantsci.2016.12.012	152	2	2	11	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	NOV	2017	216	3					682	698		10.1111/nph.14702				17	Plant Sciences	Plant Sciences	FO9NU	WOS:000417215200010	28762506				2018-01-05	
J	Haworth, KG; Peterson, CW; Kiem, HP				Haworth, Kevin G.; Peterson, Christopher W.; Kiem, Hans-Peter			CCR5-edited gene therapies for HIV cure: Closing the door to viral entry	CYTOTHERAPY			English	Review						CCR5 receptor; genetic therapy; HIV	STEM-CELL TRANSPLANTATION; HUMAN-IMMUNODEFICIENCY-VIRUS; ZINC-FINGER NUCLEASES; CD4(+) T-CELLS; STOPPING ANTIRETROVIRAL THERAPY; BONE-MARROW-TRANSPLANTATION; DEFICIENCY-SYNDROME AIDS; IN-VIVO SELECTION; CORD BLOOD; CCR5 GENE	Human immunodeficiency virus (HIV) was first reported and characterized more than three decades ago. Once thought of as a death sentence, HIV infection has become a chronically manageable disease. However, it is estimated that a staggering 0.8% of the world's population is infected with HIV, with more than 1 million deaths reported in 2015 alone. Despite the development of effective anti-retroviral drugs, a permanent cure has only been documented in one patient to date. In 2007, an HIV-positive patient received a bone marrow transplant to treat his leukemia from an individual who was homozygous for a mutation in the CCR5 gene. This mutation, known as CCR5 Delta 32, prevents HIV replication by inhibiting the early stage of viral entry into cells, resulting in resistance to infection from the majority of HIV isolates. More than 10 years after his last dose of anti-retroviral therapy, the transplant recipient remains free of replication-competent virus. Multiple groups are now attempting to replicate this success through the use of other CCR5-negative donor cell sources. Additionally, developments in the use of lentiviral vectors and targeted nucleases have opened the doors of precision medicine and enabled new treatment methodologies to combat HIV infection through targeted ablation or down-regulation of CCR5 expression. Here, we review historical cases of CCR5-edited cell-based therapies, current clinical trials and future benefits and challenges associated with this technology.	[Haworth, Kevin G.; Peterson, Christopher W.; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Peterson, Christopher W.; Kiem, Hans-Peter] Univ Washington, Dept Med, Seattle, WA USA; [Kiem, Hans-Peter] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Kiem, HP (reprint author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave Nort Mail Stop D1-100,POB 19024, Seattle, WA 98109 USA.	hkiem@fredhutch.org					Adair JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13173; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Bai JR, 2000, MOL THER, V1, P244, DOI 10.1006/mthe.2000.0038; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Barton K, 2016, TRENDS MICROBIOL, V24, P345, DOI 10.1016/j.tim.2016.01.006; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657                                                ; Bogunia-Kubik K, 2006, HAEMATOL-HEMATOL J, V91, P1628; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Brauer F, 2013, ANTIMICROB AGENTS CH, V57, P679, DOI 10.1128/AAC.01152-12; Burtner CR, 2014, BLOOD, V123, P3578, DOI 10.1182/blood-2013-11-538926; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cillo AR, 2013, JAIDS-J ACQ IMM DEF, V63, P438, DOI 10.1097/QAI.0b013e31828e6163; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621                                                           ; CONTU L, 1993, BONE MARROW TRANSPL, V12, P669; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dervillez X, 2006, CHEMMEDCHEM, V1, P330, DOI 10.1002/cmdc.200500062; Duarte RF, 2015, LANCET HIV, V2, pE236, DOI 10.1016/S2352-3018(15)00083-1; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/01.aids.0000042945.95433.4b; Fischereder M, 2001, LANCET, V357, P1758, DOI 10.1016/S0140-6736(00)04898-4; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823                                                         ; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Garg H, 2016, VIROLOGY, V493, P86, DOI 10.1016/j.virol.2016.03.010; Goldrick BA, 2003, AM J NURS, V103, P26; Gonzalez G, 2011, HIV MED, V12, P481, DOI 10.1111/j.1468-1293.2010.00911.x; Gu WG, 2015, TRENDS BIOTECHNOL, V33, P172, DOI 10.1016/j.tibtech.2014.12.006; Hale M, 2017, MOL THER-METH CLIN D, V4, P192, DOI 10.1016/j.omtm.2016.12.008; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2011, CLIN EXP IMMUNOL, V163, P284, DOI 10.1111/j.1365-2249.2010.04312.x; Hutter G, 2015, VIRUSES-BASEL, V7, P4186, DOI 10.3390/v7082816; Hutter G, 2014, NEW ENGL J MED, V371, P2437, DOI [10.1056/NEJMc1412279, 10.1056/NEJMc1412279#SA1]; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Kindberg E, 2008, J INFECT DIS, V197, P266, DOI 10.1086/524709; Kok YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24157; Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805; Kwon M, 2013, BIOL BLOOD MARROW TR, V19, P143, DOI 10.1016/j.bbmt.2012.08.019; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEVY JA, 1993, MICROBIOL REV, V57, P183; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu SL, 2002, J VIROL, V76, P10674, DOI 10.1128/JVI.76.21.10674-10684.2002; Lucotte G, 2001, HUM IMMUNOL, V62, P933, DOI 10.1016/S0198-8859(01)00292-0                                                   ; Ma Q, 2010, BIOL BLOOD MARROW TR, V16, P132, DOI 10.1016/j.bbmt.2009.05.017; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Matrajt L, 2014, J VIROL, V88, P3202, DOI 10.1128/JVI.03428-13; Mavigner M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004406; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Mulanovich VE, 2016, AIDS, V30, P2653, DOI 10.1097/QAD.0000000000001240; Murray AJ, 2016, J IMMUNOL, V197, P407, DOI 10.4049/jimmunol.1600343; Neff T, 2006, BLOOD, V107, P1751, DOI 10.1182/blood-2005-06-2335; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peterson CW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91230; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Peterson CW, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.7; Peterson CW, 2015, AIDS, V29, P1597, DOI 10.1097/QAD.0000000000000702; Petz LD, 2013, BIOL BLOOD MARROW TR, V19, P393, DOI 10.1016/j.bbmt.2012.10.017; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Richter M, 2016, BLOOD, V128, P2206, DOI 10.1182/blood-2016-04-711580; Ru Renli, 2013, Cell Regen (Lond), V2, P5, DOI 10.1186/2045-9769-2-5; Ruiz-Ferrer M, 2004, J VIRAL HEPATITIS, V11, P319, DOI 10.1111/j.1365-2893.2004.00510.x; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Savkovic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038755; Schnickel GT, 2008, J IMMUNOL, V180, P4714, DOI 10.4049/jimmunol.180.7.4714                                                     ; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x; Swamy MN, 2016, ADV DRUG DELIVER REV, V103, P174, DOI 10.1016/j.addr.2016.03.005; Symons J, 2014, CLIN INFECT DIS, V59, P596, DOI 10.1093/cid/ciu284; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Taylor S, 2007, AIDS, V21, P1673, DOI 10.1097/QAD.0b013e3281c61394; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Westby Mike, 2005, Antiviral Chemistry & Chemotherapy, V16, P339; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Yao YC, 2012, HUM GENE THER, V23, P238, DOI 10.1089/hum.2011.126; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Younan PM, 2013, BLOOD, V122, P179, DOI 10.1182/blood-2013-01-482224; Yu KR, 2016, HUM GENE THER; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	89	0	0	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	NOV	2017	19	11			SI		1325	1338		10.1016/j.jcyt.2017.05.013				14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	FO7TU	WOS:000417080600007	28751153				2018-01-05	
J	Anderson, JL; Mulligan, TS; Shen, MC; Wang, H; Scahill, CM; Tan, FJ; Du, SJ; Busch-Nentwich, EM; Farber, SA				Anderson, Jennifer L.; Mulligan, Timothy S.; Shen, Meng-Chieh; Wang, Hui; Scahill, Catherine M.; Tan, Frederick J.; Du, Shao J.; Busch-Nentwich, Elisabeth M.; Farber, Steven A.			mRNA processing in mutant zebrafish lines generated by chemical and CRISPR-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay	PLOS GENETICS			English	Article							SPLICING MUTATIONS; GENE-EXPRESSION; GENOME; IDENTIFICATION; DISEASE; MISSENSE; DATABASE; DESIGN; SITES	As model organism-based research shifts from forward to reverse genetics approaches, largely due to the ease of genome editing technology, a low frequency of abnormal phenotypes is being observed in lines with mutations predicted to lead to deleterious effects on the encoded protein. In zebrafish, this low frequency is in part explained by compensation by genes of redundant or similar function, often resulting from the additional round of teleostspecific whole genome duplication within vertebrates. Here we offer additional explanations for the low frequency of mutant phenotypes. We analyzed mRNA processing in seven zebrafish lines with mutations expected to disrupt gene function, generated by CRISPR/Cas9 or ENU mutagenesis methods. Five of the seven lines showed evidence of altered mRNA processing: one through a skipped exon that did not lead to a frame shift, one through non-sense-associated splicing that did not lead to a frame shift, and three through the use of cryptic splice sites. These results highlight the need for a methodical analysis of the mRNA produced in mutant lines before making conclusions or embarking on studies that assume loss of function as a result of a given genomic change. Furthermore, recognition of the types of adaptations that can occur may inform the strategies of mutant generation.	[Anderson, Jennifer L.; Mulligan, Timothy S.; Shen, Meng-Chieh; Tan, Frederick J.; Farber, Steven A.] Carnegie Inst Sci, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA; [Wang, Hui; Du, Shao J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wang, Hui] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An, Shandong, Peoples R China; [Scahill, Catherine M.; Busch-Nentwich, Elisabeth M.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Busch-Nentwich, Elisabeth M.] Univ Cambridge, Dept Med, Cambridge, England	Farber, SA (reprint author), Carnegie Inst Sci, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	farber@carnegiescience.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R01DK093399]; National Institute of General Medical Sciences [R01GM63904]; Wellcome Trust Sanger Institute [WT098051]; University of Maryland Baltimore; Shandong Provincial Education Association for International Exchanges; Carnegie Institution for Science Endowment; G. Harold and Leila Y. Mathers Charitable Foundation	This work was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/) R01DK093399 (JLA, CMS, EMB, MS, SAF, TSM) and National Institute of General Medical Sciences (https://www.nigms.nih.gov/) R01GM63904 (JLA, MS, SAF). EMB was also funded by the Wellcome Trust Sanger Institute (www.sanger.ac.uk/), grant number WT098051. SJD was supported by a research fund from University of Maryland Baltimore (http://www.medschool.umaryland.ed/). Shandong Provincial Education Association for International Exchanges (http://en.ceaie.edu.cn/) provided a visiting professor fellowship to HW. Additional support for this work was provided by the Carnegie Institution for Science Endowment (https://carnegiescience.edu) and the G. Harold and Leila Y. Mathers Charitable Foundation (www.mathersfoundation.org/) (JLA, MS, SAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Buchner DA, 2003, SCIENCE, V301, P967, DOI 10.1126/science.1086187; Caminsky Natasha, 2014, F1000Res, V3, P282, DOI 10.12688/f1000research.5654.1; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Gonzales APW, 2014, METHOD ENZYMOL, V546, P377, DOI 10.1016/B978-0-12-801185-0.00018-0; Haffter P, 1996, DEVELOPMENT, V123, P1; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5                                                   ; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jagannathan S, 2016, GENOME RES, V26, P1639, DOI 10.1101/gr.205070.116; Kapustin Y, 2011, NUCLEIC ACIDS RES, V39, P5837, DOI 10.1093/nar/gkr203; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lalonde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178700; Lewandowska MA, 2013, INT J CLIN EXP PATHO, V6, P2675; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu HX, 2001, NAT GENET, V27, P55; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Macedo NJ, 2014, ASEE ZON 1 C STUD PA; Magen A, 2005, NUCLEIC ACIDS RES, V33, P5574, DOI 10.1093/nar/gki858; Makino S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39608; Marx A, 2016, GENOM PROTEOM BIOINF, V14, P55, DOI 10.1016/j.gpb.2015.11.004; Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Mou HW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1237-8; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Pagani F, 2003, J BIOL CHEM, V278, P26580, DOI 10.1074/jbc.M212813200; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Prykhozhij SV, 2017, DIS MODEL MECH, V10, P811, DOI 10.1242/dmm.026765; Prykhozhij SV, 2016, ZEBRAFISH, V13, P70, DOI 10.1089/zeb.2015.1158; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schad E, 2013, NUCLEIC ACIDS RES, V41, P4409, DOI 10.1093/nar/gkt110; Sibley CR, 2016, NAT REV GENET, V17, P407, DOI 10.1038/nrg.2016.46; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; White RJ, 2017, BIORXIV	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	NOV	2017	13	11							e1007105	10.1371/journal.pgen.1007105				18	Genetics & Heredity	Genetics & Heredity	FO4SR	WOS:000416836900027	29161261	gold			2018-01-05	
J	Ishak, NSM; Nong, QD; Matsuura, T; Kato, Y; Watanabe, H				Ishak, Nur Syafiqah Mohamad; Quang Dang Nong; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime			Co-option of the bZIP transcription factor Vrille as the activator of Doublesex1 in environmental sex determination of the crustacean Daphnia magna	PLOS GENETICS			English	Article							JUVENILE-HORMONE RESPONSE; DM-DOMAIN GENE; MOLECULAR-CLONING; DROSOPHILA; EXPRESSION; DIMORPHISM; ENHANCER; ENCODES; PROTEIN; FAMILY	Divergence of upstream regulatory pathways of the transcription factor Doublesex (Dsx) serves as a basis for evolution of sex-determining mechanisms in animals. However, little is known about the regulation of Dsx in environmental sex determination. In the crustacean Daphnia magna, environmental sex determination is implemented by male-specific expression of the Dsx ortholog, Dsx1. Transcriptional regulation of Dsx1 comprises at least three phases during embryogenesis: non-sex-specific initiation, male-specific up-regulation, and its maintenance. Herein, we demonstrate that the male-specific up-regulation is controlled by the bZIP transcription factor, Vrille (Vri), an ortholog of the circadian clock genes-Drosophila Vri and mammalian E4BP4/NFIL3. Sequence analysis of the Dsx1 promoter/enhancer revealed a conserved element among two Daphnia species (D. magna and D. pulex), which contains a potential enhancer harboring a consensus Vri binding site overlapped with a consensus Dsx binding site. Besides non-sex-specific expression of Vri in late embryos, we found male-specific expression in early gastrula before the Dsx1 up-regulation phase begins. Knockdown of Vri in male embryos showed reduction of Dsx1 expression. In addition, transient overexpression of Vri in early female embryos up-regulated the expression of Dsx1 and induced male-specific trait. Targeted mutagenesis using CRISPR/Cas9 disrupted the enhancer on genome in males, which led to the reduction of Dsx1 expression. These results indicate that Vri was co-opted as a transcriptional activator of Dsx1 in environmental sex determination of D. magna. The data suggests the remarkably plastic nature of gene regulatory network in sex determination.	[Ishak, Nur Syafiqah Mohamad; Quang Dang Nong; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Ishak, Nur Syafiqah Mohamad; Quang Dang Nong] Osaka Univ, Biotechnol Global Human Resource Dev Program, Div Adv Sci & Biotechnol, Dept Biotechnol,Grad Sch Engn, Suita, Osaka, Japan; [Kato, Yasuhiko] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan	Kato, Y (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.; Kato, Y (reprint author), Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan.	kato_yasuhiko@bio.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [26840105, 26281027]	This work was supported by Japan Society for the Promotion of Science (https://www. jsps.go.jp/) Grant Numbers 26840105 (to YK) and 26281027 (to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN WQ, 1995, GENE DEV, V9, P256, DOI 10.1101/gad.9.2.256; Asada M, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu043; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BULL JJ, 1985, EXPERIENTIA, V41, P1285, DOI 10.1007/BF01952071; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070                                                           ; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; George H, 1997, GENETICS, V146, P1345; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3                                                   ; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Herpin A, 2015, EMBO REP, V16, P1260, DOI 10.15252/embr.201540667; Honda Y, 2017, J CELL SCI, V130, P1652, DOI 10.1242/jcs.200923; Ishak NSM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154636; Kato Y, 2008, GENOMICS, V91, P94, DOI 10.1016/j.ygeno.2007.09.002; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lebo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-80; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990                                                   ; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Naitou A, 2015, BIOL OPEN, V4, P364, DOI 10.1242/bio.20149738; Nakanishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36252; Nakanishi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18312; Nakanishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098363; Nandakumar V, 2013, P NATL ACAD SCI USA, V110, pE3927, DOI 10.1073/pnas.1308888110; Nong Q, 2017, SCI REP IN PRESS; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Orsini L, 2011, BIOL LETTERS, V7, P2, DOI 10.1098/rsbl.2010.0629; Sasakura Y, 2003, GENE, V308, P11, DOI 10.1016/S0378-1119(03)00426-8; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; SUMIYA E, 2016, APPL TOXICOL, V36, P1476; Szuplewski S, 2003, DEVELOPMENT, V130, P3651, DOI 10.1242/dev.00588                                                               ; Szuplewski S, 2010, DEV GROWTH DIFFER, V52, P409, DOI 10.1111/j.1440-169X.2010.01186.x; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; TORNER K, 2014, DAPHNIA MAGNA, V289, P707, DOI DOI 10.1007/S00438-014-0830-8; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622                                                 ; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zhong C, 2017, PROTEIN CELL, V8, P242, DOI 10.1007/s13238-017-0369-7	56	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	NOV	2017	13	11							e1006953	10.1371/journal.pgen.1006953				19	Genetics & Heredity	Genetics & Heredity	FO4SR	WOS:000416836900001		gold			2018-01-05	
J	Jagle, S; Busch, H; Freihen, V; Beyes, S; Schrempp, M; Boerries, M; Hecht, A				Jaegle, Sabine; Busch, Hauke; Freihen, Vivien; Beyes, Sven; Schrempp, Monika; Boerries, Melanie; Hecht, Andreas			SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells	PLOS GENETICS			English	Article							TO-MESENCHYMAL TRANSITION; EPHB3 TUMOR-SUPPRESSOR; E-CADHERIN; PANCREATIC-CANCER; BREAST-CANCER; COMPETITIVE DISPLACEMENT; FEEDBACK LOOP; COLON-CANCER; FACTOR SNAIL; EXPRESSION	Phenotypic conversion of tumor cells through epithelial-mesenchymal transition (EMT) requires massive gene expression changes. How these are brought about is not clear. Here we examined the impact of the EMT master regulator SNAIL1 on the FOXA family of transcription factors which are distinguished by their particular competence to induce chromatin reorganization for the activation of transcriptional enhancer elements. We show that the expression of SNAIL1 and FOXA genes is anticorrelated in transcriptomes of colorectal tumors and cell lines. In cellular EMT models, ectopically expressed Snail1 directly represses FOXA1 and triggers downregulation of all FOXA family members, suggesting that loss of FOXA expression promotes EMT. Indeed, cells with CRISPR/Cas9-induced FOXA-deficiency acquire mesenchymal characteristics. Furthermore, ChIP-seq data analysis of FOXA chromosomal distribution in relation to chromatin structural features which characterize distinct states of transcriptional activity, revealed preferential localization of FOXA factors to transcriptional enhancers at signature genes that distinguish epithelial from mesenchymal colon tumors. To validate the significance of this association, we investigated the impact of FOXA factors on structure and function of enhancers at the CDH1, CDX2 and EPHB3 genes. FOXA-deficiency and expression of dominant negative FOXA2 led to chromatin condensation at these enhancer elements. Site-directed mutagenesis of FOXA binding sites in reporter gene constructs and by genome-editing in situ impaired enhancer activity and completely abolished the active chromatin state of the EPHB3 enhancer. Conversely, expression of FOXA factors in cells with inactive CDX2 and EPHB3 enhancers led to chromatin opening and de novo deposition of the H3K4me1 and H3K27ac marks. These findings establish the pioneer function of FOXA factors at enhancer regions of epithelial genes and demonstrate their essential role in maintaining enhancer structure and function. Thus, by repressing FOXA family members, SNAIL1 targets transcription factors at strategically important positions in gene-regulatory hierarchies, which may facilitate transcriptional reprogramming during EMT.	[Jaegle, Sabine; Busch, Hauke; Freihen, Vivien; Beyes, Sven; Schrempp, Monika; Boerries, Melanie; Hecht, Andreas] Univ Freiburg, Inst Mol Med & Cell Res, Fac Med, Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] German Canc Consortium DKTK, Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] German Canc Res Ctr, Heidelberg, Germany; [Busch, Hauke] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany; [Busch, Hauke] Univ Lubeck, Inst Cardiogenet, Lubeck, Germany; [Freihen, Vivien; Beyes, Sven; Hecht, Andreas] Univ Freiburg, Fac Biol, Freiburg, Germany; [Hecht, Andreas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Jaegle, Sabine] Univ Freiburg, Ctr Chron Immunodeficiency, Med Ctr, Fac Med, Freiburg, Germany	Hecht, A (reprint author), Univ Freiburg, Inst Mol Med & Cell Res, Fac Med, Freiburg, Germany.; Hecht, A (reprint author), Univ Freiburg, Fac Biol, Freiburg, Germany.; Hecht, A (reprint author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	andreas.hecht@mol-med.uni-freiburg.de		Busch, Hauke/0000-0003-4763-4521	Deutsche Forschungsgemeinschaft (DFG) [DFG HE2004/11-1, CRC-850]; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZX1409B]	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de/) (DFG HE2004/11-1; CRC-850 subproject B5) to All, (CRC-850 subproject Z1) to HB and MB, and by the German Federal Ministry of Education and Research (BMBF; www.bmbf.de/) within the framework of the e:Med research and funding concept (FKZ 01ZX1409B) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Alotaibi H, 2015, BBA-GENE REGUL MECH, V1849, P731, DOI 10.1016/j.bbagrm.2015.01.005; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bae JM, 2015, WORLD J GASTROENTERO, V21, P1457, DOI 10.3748/wjg.v21.i5.1457; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bondow BJ, 2012, DEV BIOL, V371, P1, DOI 10.1016/j.ydbio.2012.06.005; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chiu ST, 2009, CARCINOGENESIS, V30, P1475, DOI 10.1093/carcin/bgp133; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913                                                             ; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Herr R, 2015, CANCER RES, V75, P216, DOI 10.1158/0008-5472.CAN-13-3686; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Jagle S, 2014, P NATL ACAD SCI USA, V111, P4886, DOI 10.1073/pnas.1314523111; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245                                                           ; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li H, 2013, ARXIV13033997V1QBIOG; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Miura H, 2009, NUCLEIC ACIDS RES, V37, P778, DOI 10.1093/nar/gkn978; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294; Navas MA, 2000, HUM HERED, V50, P370, DOI 10.1159/000022943                                                               ; PIERROU S, 1994, EMBO J, V13, P5002; Preca BT, 2015, INT J CANCER, V137, P2566, DOI 10.1002/ijc.29642; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson Jessica L L, 2012, Front Endocrinol (Lausanne), V3, P68, DOI 10.3389/fendo.2012.00068; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Ronsch K, 2015, MOL ONCOL, V9, P335, DOI 10.1016/j.molonc.2014.08.016; San Roman AK, 2015, STEM CELL REP, V5, P673, DOI 10.1016/j.stemcr.2015.09.006; Schnappauf O, 2016, BBA-GENE REGUL MECH, V1859, P1353, DOI 10.1016/j.bbagrm.2016.08.002; Schneider, 2010, PLOS ONE, V5; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Suh E, 1996, MOL CELL BIOL, V16, P619; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; VALLET V, 1995, MOL CELL BIOL, V15, P5453; Wang HY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-680; Wang J, 2014, CARCINOGENESIS, V35, P2576, DOI 10.1093/carcin/bgu180; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Welman A, 2006, NAT PROTOC, V1, P803, DOI 10.1038/nprot.2006.117; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang GH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501473; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2015, CANCER LETT, V361, P240, DOI 10.1016/j.canlet.2015.03.008; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	86	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	NOV	2017	13	11							e1007109	10.1371/journal.pgen.1007109				39	Genetics & Heredity	Genetics & Heredity	FO4SR	WOS:000416836900029	29155818	gold			2018-01-05	
J	Hotez, PJ				Hotez, Peter J.			The poverty-related neglected diseases: Why basic research matters	PLOS BIOLOGY			English	Article							STRONGYLOIDES-STERCORALIS; CAENORHABDITIS-ELEGANS; PARASITIC NEMATODES; MIGRATION; GENOMICS; TOOLS; HOST	Together, malaria and the neglected tropical diseases (NTDs) kill more than 800,000 people annually, while creating long-term disability in millions more. International support for mass drug administration, bed nets, and other preventive measures has resulted in huge public health gains, while support for translational research is leading to the development of some new neglected disease drugs, diagnostics, and vaccines. However, funding for basic science research has not kept up, such that we are missing opportunities to create a more innovative pipeline of control tools for parasitic and related diseases. There is an urgent need to expand basic science approaches for neglected diseases, especially in the areas of systems biology and immunology; ecology, evolution, and mathematical biology; functional and comparative OMICs; gene editing; expanded use of model organisms; and a new single-cell combinatorial indexing RNA sequencing approach. The world's poor deserve access to innovation for neglected diseases. It should be considered a fundamental human right.	[Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA; [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Hotez, PJ (reprint author), Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA.; Hotez, PJ (reprint author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	hotez@bcm.edu					ANDERSON RM, 1982, NATURE, V297, P557, DOI 10.1038/297557a0; Britton C, 2016, ADV PARASIT, V93, P599, DOI 10.1016/bs.apar.2016.02.017; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Chaudhury S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08526-5; Davies J, 2015, LANCET, V386, pE59, DOI 10.1016/S0140-6736(15)01119-8; [Anonymous], LANCET, V388, P1603; The Henry J. Kaiser Family Foundation, GLOB HLTH POL US GLO; Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0003895; Hotez Peter J, 2014, Mol Med, V20 Suppl 1, pS31, DOI 10.2119/molmed.2014.00169; Hotez PJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000718; Hotez PJ, 2013, FORGOTTEN PEOPLE FOR; Howe KL, 2017, MOL BIOCHEM PARASIT, V215, P2, DOI 10.1016/j.molbiopara.2016.11.005; Keiser J, 2015, TRENDS PARASITOL, V31, P455, DOI 10.1016/j.pt.2015.08.004; Kumar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00053-1; Li Q, 2015, CURR BIOL, V25, pR120, DOI 10.1016/j.cub.2014.11.044; Lok JB, 2017, PARASITOLOGY, V144, P327, DOI 10.1017/S0031182016000391; Lustigman S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005464; MANSFIELD LS, 1995, AM J TROP MED HYG, V52, P236, DOI 10.4269/ajtmh.1995.52.236                                                       ; Nag S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02724-x; Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113; Penczykowski RM, 2016, EVOL APPL, V9, P37, DOI 10.1111/eva.12294; Policy Cures Research and G-FINDER, 2016, NEGL DIS RES DEV PIV; SCHAD GA, 1989, J PARASITOL, V75, P740, DOI 10.2307/3283059                                                                 ; Singer M, 2017, TRENDS PARASITOL, V33, P202, DOI 10.1016/j.pt.2016.09.012; Swearingen KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005791; Ward JD, 2015, GENETICS, V201, P1279, DOI 10.1534/genetics.115.182717; Wilson RA, 2009, PARASITOLOGY, V136, P1581, DOI 10.1017/S0031182009005708	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1545-7885			PLOS BIOL	PLoS. Biol.	NOV	2017	15	11							e2004186	10.1371/journal.pbio.2004186				6	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	FO4TN	WOS:000416839200021	29121043	gold			2018-01-05	
J	Smith, I; Greenside, PG; Natoli, T; Lahr, DL; Wadden, D; Tirosh, I; Narayan, R; Root, DE; Golub, TR; Subramanian, A; Doench, JG				Smith, Ian; Greenside, Peyton G.; Natoli, Ted; Lahr, David L.; Wadden, David; Tirosh, Itay; Narayan, Rajiv; Root, David E.; Golub, Todd R.; Subramanian, Aravind; Doench, John G.			Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map	PLOS BIOLOGY			English	Article							HUMAN-CELLS; HUMAN GENOME; SCREENS; TARGET; SIGNATURES; DESIGN; IDENTIFICATION; INTERFERENCE; COMPONENTS; MUTATIONS	The application of RNA interference (RNAi) to mammalian cells has provided the means to perform phenotypic screens to determine the functions of genes. Although RNAi has revolutionized loss-of-function genetic experiments, it has been difficult to systematically assess the prevalence and consequences of off-target effects. The Connectivity Map (CMAP) represents an unprecedented resource to study the gene expression consequences of expressing short hairpin RNAs (shRNAs). Analysis of signatures for over 13,000 shRNAs applied in 9 cell lines revealed that microRNA (miRNA)-like off-target effects of RNAi are far stronger and more pervasive than generally appreciated. We show that mitigating off-target effects is feasible in these datasets via computational methodologies to produce a consensus gene signature (CGS). In addition, we compared RNAi technology to clustered regularly interspaced short palindromic repeat (CRISPR)-based knockout by analysis of 373 single guide RNAs (sgRNAs) in 6 cells lines and show that the on-target efficacies are comparable, but CRISPR technology is far less susceptible to systematic off-target effects. These results will help guide the proper use and analysis of loss-of-function reagents for the determination of gene function.	[Smith, Ian; Greenside, Peyton G.; Natoli, Ted; Lahr, David L.; Wadden, David; Tirosh, Itay; Narayan, Rajiv; Root, David E.; Golub, Todd R.; Subramanian, Aravind; Doench, John G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Golub, Todd R.] Harvard Med Sch, Boston, MA USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Subramanian, A; Doench, JG (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	aravind@broadinstitute.org; jdoench@broadinstitute.org			NIH [5U54HG006093, 5U01HG008699, U54HG008699]	NIH (grant number 5U54HG006093). Received by AS and TRG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NIH (grant number 5U01HG008699). Received by AS and TRG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NIH (grant number U54HG008699). Received by AS and TRG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Duan Q, 2016, NPJ SYST BIOL APPL, V2, P257; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guda S, 2015, MOL THER, V23, P1465, DOI 10.1038/mt.2015.113; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Pirhaji L, 2016, NAT METHODS, V13, P770, DOI [10.1038/NMETH.3940, 10.1038/nmeth.3940]; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Singh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131370; Subramanian A, 2017, COLD SPRING HARBOR L; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WANG ZC, 2016, NATURE COMMUNICATION, V7; Watanabe C, 2016, RNA BIOL, V13, P25, DOI 10.1080/15476286.2015.1128062; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1545-7885			PLOS BIOL	PLoS. Biol.	NOV	2017	15	11							e2003213	10.1371/journal.pbio.2003213				23	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	FO4TN	WOS:000416839200008	29190685	gold			2018-01-05	
J	John, D; Weirick, T; Dimmeler, S; Uchida, S				John, David; Weirick, Tyler; Dimmeler, Stefanie; Uchida, Shizuka			RNAEditor: easy detection of RNA editing events and the introduction of editing islands	BRIEFINGS IN BIOINFORMATICS			English	Article						editing island; RNA editing; RNA modification; software	DNA-SEQUENCING DATA; SEQ DATA; ACCURATE IDENTIFICATION; HUMAN TRANSCRIPTOME; BINDING DOMAINS; NONCODING RNAS; DEAMINASE GENE; GENOME; SITES; RECOGNITION	RNA editing of adenosine residues to inosine ('A-to-I editing') is the most common RNA modification event detectible with RNA sequencing (RNA-seq). While not directly detectable, inosine is read by next-generation sequencers as guanine. Therefore, mapping RNA-seq reads to their corresponding reference genome can detect potential editing events by identifying 'A-to-G' conversions. However, one must exercise caution when searching for editing sites, as A-to-G conversions also arise from sequencing errors as well as mutations. To address these complexities, several algorithms and software products have been developed to accurately identify editing events. Here, we survey currently available methods to analyze RNA editing events and introduce a new easy-to-use bioinformatics tool 'RNAEditor' for the detection of RNA editing events. During the development of RNAEditor, we noticed editing often happened in clusters, which we named 'editing islands'. We developed a clustering algorithm to find editing islands and included it in RNAEditor. RNAEditor is freely available at http://rnaeditor.uni-frankfurt.de. We anticipate that RNAEditor will provide biologists with an easy-to-use tool for studying RNA editing events and the newly defined editing islands.	[John, David; Weirick, Tyler] Uchida Lab, Inst Cardiovasc Regenerat, Frankfurt, Germany; [Weirick, Tyler] Univ Louisville, Louisville, KY 40202 USA; [Dimmeler, Stefanie; Uchida, Shizuka] Inst Cardiovasc Regenerat, Frankfurt, Germany; [Uchida, Shizuka] Univ Louisville, Med, Louisville, KY 40202 USA	Uchida, S (reprint author), Univ Louisville, Cardiovasc Innovat Inst, 302 E Muhammad Ali Blvd, Louisville, KY 40202 USA.	heart.lncrna@gmail.com			LOEWE Center for Cell and Gene Therapy (State of Hessen); DFG [SFB834]; German Center for Cardiovascular Research (DZHK); start-up funding from the Mansbach Family; Gheens Foundation; University of Louisville	The study was supported by the LOEWE Center for Cell and Gene Therapy (State of Hessen), the DFG (SFB834), the German Center for Cardiovascular Research (DZHK) and the start-up funding from the Mansbach Family, the Gheens Foundation and other generous supporters at the University of Louisville.	Ahn J, 2015, BIOINFORMATICS, V31, P3906, DOI 10.1093/bioinformatics/btv505; Alon S, 2015, BIOINFORMATICS, V31, P2568, DOI 10.1093/bioinformatics/btv187; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; D'Antonio M, 2015, METHODS MOL BIOL, V1269, P327, DOI 10.1007/978-1-4939-2291-8_20; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Distefano R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S5; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Higuchi M, 2000, NATURE, V406, P78; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Mazloomian A, 2015, RNA BIOL, V12, P1391, DOI 10.1080/15476286.2015.1107703; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nigita Giovanni, 2015, Front Bioeng Biotechnol, V3, P18, DOI 10.3389/fbioe.2015.00018; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2015, CURR PROTOC BIOINFOR, V49; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Picardi E, 2011, BIOINFORMATICS, V27, P1311, DOI 10.1093/bioinformatics/btr117; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Ronan T, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1932; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Solomon O, 2013, RNA, V19, P591, DOI 10.1261/rna.038042.112; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V43, P11, DOI DOI 10.1002/0471250953.BI1110S43; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	57	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1467-5463	1477-4054		BRIEF BIOINFORM	Brief. Bioinform.	NOV	2017	18	6					993	1001		10.1093/bib/bbw087				9	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	FO3PO	WOS:000416744400010	27694136				2018-01-05	
J	de Pablo-Maiso, L; Glaria, I; Crespo, H; Nistal-Villan, E; Andresdottir, V; de Andres, D; Amorena, B; Reina, R				de Pablo-Maiso, Lorena; Glaria, Idoia; Crespo, Helena; Nistal-Villan, Estanislao; Andresdottir, Valgerdur; de Andres, Damian; Amorena, Beatriz; Reina, Ramses			Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs)	VIRUSES-BASEL			English	Article						APOBEC3; small ruminant lentiviruses; restriction factors; deaminase domain; alternative splicing	E3 UBIQUITIN LIGASE; MAEDI-VISNA VIRUS; ENCEPHALITIS-VIRUS; CAPRINE ARTHRITIS; GENOMIC HETEROGENEITY; NUCLEOTIDE-SEQUENCE; APOBEC PROTEINS; ENZYME APOBEC3G; HIV-1 INFECTION; VIF PROTEIN	Intrinsic factors of the innate immune system include the apolipoprotein B editing enzyme catalytic polypeptide-like 3 (APOBEC3) protein family. APOBEC3 inhibits replication of different virus families by cytosine deamination of viral DNA and a not fully characterized cytosine deamination-independent mechanism. Sheep are susceptible to small ruminant lentivirus (SRLVs) infection and contain three APOBEC3 genes encoding four proteins (A3Z1, Z2, Z3 and Z2-Z3) with yet not deeply described antiviral properties. Using sheep blood monocytes and in vitro-derived macrophages, we found that A3Z1 expression is associated with lower viral replication in this cellular type. A3Z1 transcripts may also contain spliced variants (A3Z1Tr) lacking the cytidine deaminase motif. A3Z1 exogenous expression in fully permissive fibroblast-like cells restricted SRLVs infection while A3Z1Tr allowed infection. A3Z1Tr was induced after SRLVs infection or stimulation of blood-derived macrophages with interferon gamma (IFN-). Interaction between truncated isoform and native A3Z1 protein was detected as well as incorporation of both proteins into virions. A3Z1 and A3Z1Tr interacted with SRLVs Vif, but this interaction was not associated with degradative properties. Similar A3Z1 truncated isoforms were also present in human and monkey cells suggesting a conserved alternative splicing regulation in primates. A3Z1-mediated retroviral restriction could be constrained by different means, including gene expression and specific alternative splicing regulation, leading to truncated protein isoforms lacking a cytidine-deaminase motif.	[de Pablo-Maiso, Lorena; Glaria, Idoia; Crespo, Helena; de Andres, Damian; Amorena, Beatriz; Reina, Ramses] UPNA, CSIC, Gobierno Navarra, Inst Agrobiotecnol, Mutilva 31192, Spain; [Nistal-Villan, Estanislao] Univ San Pablo CEU, Fac Farm, Dept Ciencias Farmaceut & Salud, Secc Microbiol, Ctra Boadilla del Monte Km, Madrid 28003, Spain; [Andresdottir, Valgerdur] Univ Iceland, Inst Expt Pathol, IS-112 Reykjavik, Iceland	Reina, R (reprint author), UPNA, CSIC, Gobierno Navarra, Inst Agrobiotecnol, Mutilva 31192, Spain.	lorena.depablo@unavarra.es; idoia.g@unavarra.es; helena.crespo@unavarra.es; estanislao.nistalvillan@ceu.es; valand@hi.is; ancad@unavarra.es; bamorena@unavarra.es; ramses.reina@unavarra.es			CICYT [AGL2010-22341-C04-01]; Navarra's Government [IIQ010449.RI1, IIQ14064.RI1, PI042-LENTIMOL]; Spanish Ministry of Science and Innovation "Ramon y Cajal" contract; Public University of Navarra; CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)	We sincerely acknowledge Sandra Hervas-Stubbs from CIMA for her fruitful help. We also acknowledge Greg Towers, University College London for plasmids and protocols. Funded by CICYT (AGL2010-22341-C04-01) and Navarra's Government (IIQ010449.RI1, IIQ14064.RI1 and PI042-LENTIMOL). Ramses Reina was supported by the Spanish Ministry of Science and Innovation "Ramon y Cajal" contract. We acknowledge support of the publication fee by the Public University of Navarra and CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Ai YW, 2014, J VIROL, V88, P12112, DOI 10.1128/JVI.01924-14; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cassetta L, 2013, AIDS, V27, P1847, DOI 10.1097/QAD.0b013e328361d059; COFFIN JM, 1997, RETROVIRUSES; Crespo H, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-83; GENDELMAN HE, 1986, J VIROL, V58, P67; Glaria I, 2009, VET MICROBIOL, V138, P156, DOI 10.1016/j.vetmic.2009.03.002; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Henry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030036; Hotzel I, 2003, J VIROL, V77, P11578, DOI 10.1128/JVI.77.21.11578-11587.2003; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jauregui P, 2012, J VIROL, V86, P9504, DOI 10.1128/JVI.00440-12; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kane JR, 2015, CELL REP, V11, P1236, DOI 10.1016/j.celrep.2015.04.038; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lassen KG, 2010, J BIOL CHEM, V285, P29326, DOI 10.1074/jbc.M110.154054; Leroux C, 1997, ARCH VIROL, V142, P1125, DOI 10.1007/s007050050147; LEROUX C, 1995, J GEN VIROL, V76, P1533, DOI 10.1099/0022-1317-76-6-1533; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Morin T, 2003, B VET I PULAWY, V47, P275; NARAYAN O, 1983, INFECT IMMUN, V41, P67; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Pepin M, 1998, VET RES, V29, P341; SALTARELLI M, 1990, VIROLOGY, V179, P347, DOI 10.1016/0042-6822(90)90303-9; SARGAN DR, 1991, J GEN VIROL, V72, P1893, DOI 10.1099/0022-1317-72-8-1893; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Stavrou S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004145; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822	44	0	0	2	2	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	NOV	2017	9	11							345	10.3390/v9110345				19	Virology	Virology	FO4KB	WOS:000416810300035		gold			2018-01-05	
J	Zotova, A; Lopatukhina, E; Filatov, A; Khaitov, M; Mazurov, D				Zotova, Anastasia; Lopatukhina, Elena; Filatov, Alexander; Khaitov, Musa; Mazurov, Dmitriy			Gene Editing in Human Lymphoid Cells: Role for Donor DNA, Type of Genomic Nuclease and Cell Selection Method	VIRUSES-BASEL			English	Article						CRISPR-Cas9; ZFN; gene editing; HIV-1; T lymphocytes; knockout; knockin; cell sorting; cell functionality	ZINC-FINGER NUCLEASES; T-CELLS; CLEAVAGE DOMAIN; CAS9; RNA; DELIVERY; HIV; RIBONUCLEOPROTEINS; SPECIFICITY; RESISTANCE	Programmable endonucleases introduce DNA breaks at specific sites, which are repaired by non-homologous end joining (NHEJ) or homology recombination (HDR). Genome editing in human lymphoid cells is challenging as these difficult-to-transfect cells may also inefficiently repair DNA by HDR. Here, we estimated efficiencies and dynamics of knockout (KO) and knockin (KI) generation in human T and B cell lines depending on repair template, target loci and types of genomic endonucleases. Using zinc finger nuclease (ZFN), we have engineered Jurkat and CEM cells with the 8.2 kb human immunodeficiency virus type 1 (HIV-1) Env genome integrated at the adeno-associated virus integration site 1 (AAVS1) locus that stably produce virus particles and mediate infection upon transfection with helper vectors. Knockouts generated by ZFN or clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) double nicking techniques were comparably efficient in lymphoid cells. However, unlike polyclonal sorted cells, gene-edited cells selected by cloning exerted tremendous deviations in functionality as estimated by replication of HIV-1 and human T cell leukemia virus type 1 (HTLV-1) in these cells. Notably, the recently reported high-fidelity eCas9 1.1 when combined to the nickase mutation displayed gene-dependent decrease in on-target activity. Thus, the balance between off-target effects and on-target efficiency of nucleases, as well as choice of the optimal method of edited cell selection should be taken into account for proper gene function validation in lymphoid cells.	[Zotova, Anastasia; Lopatukhina, Elena] Lomonosov Moscow State Univ, Fac Biol, 1-12 Leninskie Gory, Moscow 119991, Russia; [Filatov, Alexander; Khaitov, Musa; Mazurov, Dmitriy] NRC Inst Immunol FMBA Russia, 24 Kashirskoe Shosse, Moscow 115472, Russia; [Mazurov, Dmitriy] Inst Gene Biol RAS, Cell & Gene Technol Grp, 34-5 Vavilova St, Moscow 119334, Russia	Mazurov, D (reprint author), NRC Inst Immunol FMBA Russia, 24 Kashirskoe Shosse, Moscow 115472, Russia.; Mazurov, D (reprint author), Inst Gene Biol RAS, Cell & Gene Technol Grp, 34-5 Vavilova St, Moscow 119334, Russia.	ashunaeva@gmail.com; helena.lopatukhina@mail.ru; avfilat@yandex.ru; mr.khaitov@nrcii.ru; dvmazurov@yandex.ru			Russian Science Foundation [RSF 15-15-00135]; Russian Foundation for Basic Research [RFBR 15-04-04364]	This work has been supported by the grants of the Russian Science Foundation (RSF 15-15-00135), and partially by the Russian Foundation for Basic Research (RFBR 15-04-04364). We are grateful to Alexey Pichugin from the Insitute of Immunology for the assistance in cell sorting, Mikhail Pashenkov from the Institute of Immunology, and William Telford from NIH (Bethesda) for the critical reading of the manuscript.	Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shi BJ, 2017, JAIDS-J ACQ IMM DEF, V74, P229, DOI 10.1097/QAI.0000000000001190; Shunaeva A, 2015, J VIROL, V89, P10591, DOI 10.1128/JVI.01940-15; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tarasevich A, 2015, ACTA VIROL, V59, P247, DOI 10.4149/av_2015_03_247; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111	29	0	0	1	1	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	NOV	2017	9	11							325	10.3390/v9110325				14	Virology	Virology	FO4KB	WOS:000416810300015		gold			2018-01-05	
J	Lee, MC; Tseng, ST; Yang, JC; Hsieh, TJ; Wu, SC; Kuan, SM; Chen, MJ; Chang, MC; Wang, CC; Chen, HL; Fang, GC; Huang, WJ; Ko, TP; Chen, Y				Lee, Ming-Chang; Tseng, Shih-Ting; Yang, Juan-Cheng; Hsieh, Tung-Ju; Wu, Shang-Chuen; Kuan, Shu-Min; Chen, Ming-Jen; Chang, Ming-Chiu; Wang, Chun-Chiu; Chen, Hsiu-Lin; Fang, Guor-Cheng; Huang, Winn-Jung; Ko, Tzu-Ping; Chen, Yeh			Expression, Purification, Crystallization, and X-ray Structural Analysis of CRISPR-Associated Protein Cas6 from Methanocaldococcus jannaschii	CRYSTALS			English	Article						CRISPR; Cas proteins; endoribonuclease; RNA processing; RNAi	ADAPTIVE IMMUNE-SYSTEMS; PYROCOCCUS-FURIOSUS; RNAS; PROKARYOTES; DEFENSE; RECOGNITION; BACTERIA; ARCHAEA; COOT	The CRISPR-associated protein 6, Cas6 protein, is an endoribonuclease that cleaves precursor CRISPR RNAs within the repeat sequence to release specific invader-targeting RNAs. Cas6 protein can recognize different sequences by their specific scaffold. To investigate its binding mode, we purified and crystallized a His-tagged Cas6 protein from Methanocaldococcus jannaschii (MjCas6) using the sitting-drop vapor-diffusion method. The crystals diffracted to a resolution of 1.85 angstrom and belonged to monoclinic space group C2, with unit-cell parameters a = 200.84 angstrom, b = 85.26 angstrom, c = 100.06 angstrom, beta = 118.47 degrees. The crystals of MjCas6 contain four molecules in the asymmetric unit. The protein fold is similar to the other Cas6 homologues, such as Pyrococcus furiosus Cas6, suggesting functional similarity. Moreover, in the C2 crystal the MjCas6 monomers formed a tandem array, which we hypothesize to possibly correlate with repetitive RNA precursors.	[Lee, Ming-Chang] Da Chien Gen Hosp, Dept Nephrol, Miaoli 36052, Taiwan; [Tseng, Shih-Ting] Kuang Tien Gen Hosp, Dept Endocrinol & Metab, Taichung 43303, Taiwan; [Yang, Juan-Cheng] China Med Univ, Coll Pharm, Sch Pharm, Taichung 40402, Taiwan; [Yang, Juan-Cheng] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung 40402, Taiwan; [Hsieh, Tung-Ju; Wu, Shang-Chuen; Kuan, Shu-Min; Chen, Ming-Jen; Chen, Yeh] Hungkuang Univ, Dept Biotechnol, Taichung 43302, Taiwan; [Wu, Shang-Chuen; Chang, Ming-Chiu; Wang, Chun-Chiu; Chen, Hsiu-Lin; Fang, Guor-Cheng; Huang, Winn-Jung] Hungkuang Univ, Dept Safety Hlth & Environm Engn, Taichung 43302, Taiwan; [Ko, Tzu-Ping] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	Chen, Y (reprint author), Hungkuang Univ, Dept Biotechnol, Taichung 43302, Taiwan.; Ko, TP (reprint author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	lmc4025@gmail.com; tsn4830@gmail.com; qq9113054@gmail.com; tjh@tms.cmu.edu.tw; peterscwu@gate.sinica.edu.tw; p26862304@yahoo.com.tw; mjchen@sunrise.hk.edu.tw; chang@sunrise.hk.edu.tw; chunchin@sunrise.hk.edu.tw; hsiulin@sunrise.hk.edu.tw; gcfang@sunrise.hk.edu.tw; huangwj@sunrise.hk.edu.tw; kotping@gate.sinica.edu.tw; chyeah6599@sunrise.hk.edu.tw			National Science Council [NSC99-2313-B-241-001, NSC100-2313-B-241-006]; Taiwan Protein Project [MOST105-0210-01-12-01, MOST106-0210-01-15-04]	We thank the National Synchrotron Radiation Research Center (NSRRC, Taiwan) for assistance during data collection. This work was supported by grants from the National Science Council (NSC99-2313-B-241-001 and NSC100-2313-B-241-006 to Yeh Chen) and by the Taiwan Protein Project (MOST105-0210-01-12-01 and MOST106-0210-01-15-04).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Calvin K, 2008, MOL LIFE SCI, V65, P1176, DOI 10.1007/s00018-008-7393-y; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HM, 2012, PROTEINS, V80, P1895, DOI 10.1002/prot.24061; Sefcikova J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700019; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wang Ruimei, 2010, AGR SCI TECHNOLOGY, V11, P14, DOI DOI 10.1016/J.STR.2010.11.014	28	0	0	1	1	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2073-4352			CRYSTALS	Crystals	NOV	2017	7	11							344	10.3390/cryst7110344				9	Crystallography; Materials Science, Multidisciplinary	Crystallography; Materials Science	FO2JB	WOS:000416601500022		gold			2018-01-05	
J	Lin, BR; Ke, Q; Li, HY; Pheifer, NS; Velliquette, DC; Leaman, DW				Lin, Boren; Ke, Qi; Li, Haiying; Pheifer, Nichole S.; Velliquette, David C.; Leaman, Douglas W.			Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114	CYTOKINE			English	Article						Innate immunity; Antiviral response; Interferon; RLH signaling; Ubiquitination; RING finger protein	PSORIASIS SUSCEPTIBILITY GENE; INNATE IMMUNE-RESPONSES; RIG-I; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; FUNCTIONAL-ANALYSIS; ANTIVIRAL RESPONSE; VIRUS-INFECTION; PROTEIN; RNA	The retinoic acid-inducible gene-I (RIG-I)-like helicases (RLH)s are cytoplasmic pattern recognition receptors expressed in both immune and non-immune cells that are essential for detection of intracellular RNA products, primarily of viral origin. Upon binding to viral RNA, RLHs interact with mitochondrial antiviral signaling protein (MAVS) to activate interferon (IFN)-mediated antiviral responses. The RLH/MAVS signaling pathway is regulated by ubiquitination/deubiquitination, in which several ubiquitin-editing proteins play critical roles. The really interesting new gene (RING) finger protein 114 (RNF114) was originally identified as a psoriasis susceptibility gene broadly expressed in human tissues. Earlier studies implicated RNF114 in regulating cellular dsRNA responses, cell cycle progression, NF-kappa B activity and T-cell activation. We found that RNF114 inhibited cellular dsRNA responses and RLH-mediated IFN production. RNF114 functioned as an E3 ubiquitin ligase, and MAVS was identified as a potential target for RNF114-mediated polyubiquitination and degradation. Splenocytes and blood harvested from RNF114 KO showed increased basal IFN level and sensitized responses to dsRNA. However, RNF114 knockout mice failed to exhibit enhance resistance to infection by two acute RNA viruses. These data suggested the potential physiological function of RNF114 in inflammation and host antiviral responses, but demonstrate complexity in the regulation of innate immunity by ubiquitin ligases.	[Lin, Boren; Ke, Qi; Li, Haiying; Pheifer, Nichole S.; Velliquette, David C.; Leaman, Douglas W.] Univ Toledo, Dept Biol Sci, Toledo, OH 44606 USA; [Leaman, Douglas W.] Wright State Univ, 4035 Colonel Glenn Hwy,Suite 300, Beavercreek, OH 45431 USA; [Ke, Qi] Univ North Carolina Chapel Hill, 6111 Mars Hall,125 Mason Farm Rd,CB 7290, Chapel Hill, NC 27599 USA; [Li, Haiying] Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	Lin, BR; Leaman, DW (reprint author), Univ Toledo, 2801 W Bancroft St, Toledo, OH 44606 USA.; Leaman, DW (reprint author), Wright State Univ, 4035 Colonel Glenn Hwy,Suite 300, Beavercreek, OH 45431 USA.	boren.lin@utoledo.edu; douglas.leaman@wright.edu			National Institutes of Health [R01AI068133, R21AI063014]; University of Toledo Bridge Funds	This work was supported by the National Institutes of Health [R01AI068133, 2006], [R21AI063014, 2009] and University of Toledo Bridge Funds to D.W.L.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876                                                          ; Bijlmakers MJ, 2011, HUM MOL GENET, V20, P3129, DOI 10.1093/hmg/ddr215; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Chattopadhyay S, 2016, IMMUNITY, V44, P1151, DOI 10.1016/j.immuni.2016.04.009; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14770; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Han J, 2013, CELL DEATH DIFFER, V20, P1055, DOI 10.1038/cdd.2013.33; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Johnson ES, 2002, NAT CELL BIOL, V4, pE295, DOI 10.1038/ncb1202-e295; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621                                                ; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li N, 2007, J BIOCHEM MOL BIOL, V40, P270; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986                                                           ; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Ma YX, 2003, ACTA BIOCH BIOPH SIN, V35, P230; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503                                                ; Rodriguez MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.366; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	38	0	0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2017	99						186	193		10.1016/j.cyto.2017.05.002				8	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	FN7GK	WOS:000416186500025	28625874				2018-01-05	
J	Hara, KY; Kobayashi, J; Yamada, R; Sasaki, D; Kuriya, Y; Hirono-Hara, Y; Ishii, J; Araki, M; Kondo, A				Hara, Kiyotaka Y.; Kobayashi, Jyumpei; Yamada, Ryosuke; Sasaki, Daisuke; Kuriya, Yuki; Hirono-Hara, Yoko; Ishii, Jun; Araki, Michihiro; Kondo, Akihiko			Transporter engineering in biomass utilization by yeast	FEMS YEAST RESEARCH			English	Review						transporter; sugar uptake; exporter; synthetic bioengineering; yeast; biomass-utilizing bioprocess	SACCHAROMYCES-CEREVISIAE STRAIN; IMPROVED BIOFUEL PRODUCTION; ALPHA-GLUCOSIDE TRANSPORT; DIRECT ETHANOL-PRODUCTION; MALIC-ACID PRODUCTION; HEXOSE TRANSPORTERS; CELLOBIOSE FERMENTATION; XYLOSE FERMENTATION; DIRECTED EVOLUTION; SUGAR TRANSPORTER	Biomass resources are attractive carbon sources for bioproduction because of their sustainability. Many studies have been performed using biomass resources to produce sugars as carbon sources for cell factories. Expression of biomass hydrolyzing enzymes in cell factories is an important approach for constructing biomass-utilizing bioprocesses because external addition of these enzymes is expensive. In particular, yeasts have been extensively engineered to be cell factories that directly utilize biomass because of their manageable responses to many genetic engineering tools, such as gene expression, deletion and editing. Biomass utilizing bioprocesses have also been developed using these genetic engineering tools to construct metabolic pathways. However, sugar input and product output from these cells are critical factors for improving bioproduction along with biomass utilization and metabolic pathways. Transporters are key components for efficient input and output activities. In this review, we focus on transporter engineering in yeast to enhance bioproduction from biomass resources.	[Hara, Kiyotaka Y.] Univ Shizuoka, Div Environm & Life Sci, Grad Div Nutr & Environm Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Hara, Kiyotaka Y.; Hirono-Hara, Yoko] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Kobayashi, Jyumpei; Sasaki, Daisuke; Kuriya, Yuki; Ishii, Jun; Araki, Michihiro; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Yamada, Ryosuke] Osaka Prefecture Univ, Dept Chem Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan; [Araki, Michihiro] Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan; [Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.; Kondo, A (reprint author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp			Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [16K00616]	This study was supported by the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), and a Grant-in-Aid for Scientific Research (C) (16K00616) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Anjos J, 2013, BBA-BIOMEMBRANES, V1828, P201, DOI 10.1016/j.bbamem.2012.08.011; Apel AR, 2016, SCI REP-UK, V6, DOI 10.1038/srep19512; Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Badotti F, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-4; Bae YH, 2014, J BIOTECHNOL, V169, P34, DOI 10.1016/j.jbiotec.2013.10.030; Basso TO, 2011, METAB ENG, V13, P694, DOI 10.1016/j.ymben.2011.09.005; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Biterova EI, 2010, J BIOL CHEM, V285, P14459, DOI 10.1074/jbc.M110.104802; Biz A, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0544-1; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1111/j.1574-6976.1997.tb00346.x; Cai Z, 2012, BIOTECHNOL J, V7, P34, DOI 10.1002/biot.201100053; Camarasa C, 2001, APPL ENVIRON MICROB, V67, P4144, DOI 10.1128/AEM.67.9.4144-4151.2001; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Chang JJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-19; Chen BB, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-21; Chen R, 2016, BIOTECHNOL LETT, V38, P213, DOI 10.1007/s10529-015-1976-0; Chen XL, 2017, APPL MICROBIOL BIOT, V101, P4041, DOI 10.1007/s00253-017-8141-8; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; de Sales BB, 2015, BIOTECHNOL LETT, V37, P1973, DOI 10.1007/s10529-015-1893-2; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Diderich JA, 2001, YEAST, V18, P1515, DOI 10.1002/yea.779; Duskova M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu041; Emmerstorfer A, 2014, APPL MICROBIOL BIOT, V98, P7671, DOI 10.1007/s00253-014-5948-4; Eriksen DT, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-61; Fan LH, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0554-6; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Franken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077499; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; Ghiaci P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-101; Goncalves P, 2000, J BACTERIOL, V182, P5628, DOI 10.1128/JB.182.19.5628-5630.2000; Guimaraes PMR, 2008, APPL ENVIRON MICROB, V74, P1748, DOI 10.1128/AEM.00186-08; Gutierrez-Lomeli M, 2008, ANTON LEEUW INT J G, V93, P363, DOI 10.1007/s10482-007-9213-z; Ha SJ, 2013, APPL ENVIRON MICROB, V79, P1500, DOI 10.1128/AEM.03253-12; Ha SJ, 2013, METAB ENG, V15, P134, DOI 10.1016/j.ymben.2012.11.005; Ha SJ, 2011, APPL ENVIRON MICROB, V77, P5822, DOI 10.1128/AEM.05228-11; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; HAN EK, 1995, MOL MICROBIOL, V17, P1093, DOI 10.1111/j.1365-2958.1995.mmi_17061093.x; Harner NK, 2015, J IND MICROBIOL BIOT, V42, P1, DOI 10.1007/s10295-014-1535-z; Hasunuma T, 2015, CURR OPIN CHEM BIOL, V29, P1, DOI 10.1016/j.cbpa.2015.06.004; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Hatzixanthis K, 2003, YEAST, V20, P575, DOI 10.1002/yea.981; Hazelwood LA, 2006, FEMS YEAST RES, V6, P937, DOI 10.1111/j.1567-1364.2006.00094.x; Hector RE, 2008, APPL MICROBIOL BIOT, V80, P675, DOI 10.1007/s00253-008-1583-2; Holyoak CD, 1999, J BACTERIOL, V181, P4644; Hu ML, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00241; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ishii J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0600-4; Ito Y, 2014, BIOSCI BIOTECH BIOCH, V78, P151, DOI 10.1080/09168451.2014.877816; Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; Johnson ZL, 2015, METHOD ENZYMOL, V556, P373, DOI 10.1016/bs.mie.2014.11.048; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kerkhoven EJ, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12199; Kim D, 2015, APPL ENVIRON MICROB, V81, P8392, DOI 10.1128/AEM.02056-15; Kim H, 2014, APPL MICROBIOL BIOT, V98, P1087, DOI 10.1007/s00253-013-5339-2; Kim SR, 2013, BIOTECHNOL ADV, V31, P851, DOI 10.1016/j.biotechadv.2013.03.004; Kim SR, 2012, TRENDS BIOTECHNOL, V30, P274, DOI 10.1016/j.tibtech.2012.01.005; Kiriyama K, 2012, APPL MICROBIOL BIOT, V96, P1021, DOI 10.1007/s00253-012-4075-3; Knoshaug EP, 2015, YEAST, V32, P615, DOI 10.1002/yea.3084; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; LAGUNAS R, 1993, FEMS MICROBIOL LETT, V104, P229, DOI 10.1016/0378-1097(93)90598-V; Lane S, 2015, BIOTECHNOL BIOENG, V112, P1012, DOI 10.1002/bit.25499; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Ledesma-Amaro R, 2016, TRENDS BIOTECHNOL, V34, P798, DOI 10.1016/j.tibtech.2016.04.010; Lee DH, 2014, APPL MICROBIOL BIOT, V98, P3569, DOI 10.1007/s00253-013-5225-y; Lee JJL, 2016, APPL MICROBIOL BIOT, V100, P869, DOI 10.1007/s00253-015-7102-3; Lee J, 2013, GENE DEV, V27, P2590, DOI 10.1101/gad.229310.113; Lee WH, 2017, J BIOTECHNOL, V245, P1, DOI 10.1016/j.jbiotec.2017.01.018; Lee WH, 2013, J BIOTECHNOL, V167, P316, DOI 10.1016/j.jbiotec.2013.06.016; LEWIS DA, 1991, MOL CELL BIOL, V11, P3804, DOI 10.1128/MCB.11.7.3804                                                           ; Li HB, 2016, APPL MICROBIOL BIOT, V100, P10215, DOI 10.1007/s00253-016-7879-8; Li JG, 2015, APPL ENVIRON MICROB, V81, P4062, DOI 10.1128/AEM.00165-15; Lian JZ, 2014, BIOTECHNOL BIOENG, V111, P1521, DOI 10.1002/bit.25214; LILJESTROMSUOMINEN PL, 1988, APPL ENVIRON MICROB, V54, P245; Liu Z, 2016, BIORESOURCE TECHNOL, V215, P324, DOI 10.1016/j.biortech.2016.03.132; Lutfiyya LL, 1996, MOL CELL BIOL, V16, P4790; Lyons JA, 2016, CURR OPIN STRUC BIOL, V38, P137, DOI 10.1016/j.sbi.2016.06.011; Malherbe AR, 2014, J IND MICROBIOL BIOT, V41, P1201, DOI 10.1007/s10295-014-1459-7; MARGARITIS A, 1982, APPL ENVIRON MICROB, V44, P1039; McCracken L D, 1983, Adv Biochem Eng Biotechnol, V27, P33; McMillan JD, 1993, XYLOSE FERMENTATION; MICHELS CA, 1984, J BACTERIOL, V157, P949; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Moyses DN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030207; MWESIGYE PK, 1994, J FERMENT BIOENG, V77, P687, DOI 10.1016/0922-338X(94)90154-6; Nan H, 2014, APPL MICROBIOL BIOT, V98, P5757, DOI 10.1007/s00253-014-5683-x; Navarrete C, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0086-z; Nijland JG, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0573-3; Oh EJ, 2016, APPL ENVIRON MICROB, V82, P3631, DOI 10.1128/AEM.00410-16; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Pandey A, 2016, BIOCHEM CELL BIOL, V94, P507, DOI 10.1139/bcb-2015-0143; PERLMAN D, 1984, MOL CELL BIOL, V4, P1682, DOI 10.1128/MCB.4.9.1682                                                            ; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x                                                ; Remize F, 2001, METAB ENG, V3, P301, DOI 10.1006/mben.2001.0197; Reznicek O, 2015, J APPL MICROBIOL, V119, P99, DOI 10.1111/jam.12825; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1016/S1567-1356(02)00046-6; Rossi G, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-15; Routledge SJ, 2016, METHODS, V95, P26, DOI 10.1016/j.ymeth.2015.09.027; Sadie CJ, 2011, APPL MICROBIOL BIOT, V90, P1373, DOI 10.1007/s00253-011-3164-z; Sakamoto T, 2012, J BIOTECHNOL, V158, P203, DOI 10.1016/j.jbiotec.2011.06.025; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shin HY, 2017, BIOTECHNOL BIOENG, V9999, P1; Shin HY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0360-6; Sloothaak J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006468; Stambuk BU, 2008, J SCI IND RES INDIA, V67, P918; Stambuk BU, 2001, FEMS YEAST RES, V1, P73, DOI 10.1016/S1567-1356(01)00007-1; Stambuk BU, 1999, FEMS MICROBIOL LETT, V170, P105, DOI 10.1016/S0378-1097(98)00529-1; Stambuk BU, 2000, J BIOSCI BIOENG, V89, P212, DOI 10.1016/S1389-1723(00)88742-3; Subtil T, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-38; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Toh TH, 2001, FEMS YEAST RES, V1, P205, DOI 10.1111/j.1567-1364.2001.tb00035.x; TSCHOPP JF, 1986, J BACTERIOL, V166, P313, DOI 10.1128/jb.166.1.313-318.1986                                                   ; TSUGE K, 2015, SCI REP, V5; Turner TL, 2016, BIOTECHNOL BIOENG, V113, P1075, DOI 10.1002/bit.25875; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; Ventura JRS, 2013, APPL MICROBIOL BIOT, V97, P7505, DOI 10.1007/s00253-013-5075-7; Verwaal R, 2010, YEAST, V27, P983, DOI 10.1002/yea.1807; Vilela LD, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0102-y; Volschenk H, 1997, NAT BIOTECHNOL, V15, P253, DOI 10.1038/nbt0397-253; Wang CQ, 2015, METAB ENG, V30, P79, DOI 10.1016/j.ymben.2015.04.007; Wang YC, 2011, METAB ENG, V13, P455, DOI 10.1016/j.ymben.2011.04.005; Wei L, 2015, BIORESOURCE TECHNOL, V187, P246, DOI 10.1016/j.biortech.2015.03.122; Wei N, 2013, APPL ENVIRON MICROB, V79, P3193, DOI 10.1128/AEM.00490-13; Wisselink HW, 2010, METAB ENG, V12, P537, DOI 10.1016/j.ymben.2010.08.003; Yamada R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-34; Yamada R, 2013, BIOTECHNOL ADV, V31, P754, DOI 10.1016/j.biotechadv.2013.02.007; Yoshikawa K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144430; Young E, 2011, APPL ENVIRON MICROB, V77, P3311, DOI 10.1128/AEM.02651-10; Young EM, 2014, P NATL ACAD SCI USA, V111, P131, DOI 10.1073/pnas.1311970111; Yu AQ, 2016, METAB ENG, V34, P36, DOI 10.1016/j.ymben.2015.12.005; Yuan YB, 2013, BIOTECHNOL BIOENG, V110, P2874, DOI 10.1002/bit.24946; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zhou JW, 2011, J APPL MICROBIOL, V110, P44, DOI 10.1111/j.1365-2672.2010.04865.x; Zhou YB, 2017, APPL BIOCHEM BIOTECH, V181, P407, DOI 10.1007/s12010-016-2220-7; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	143	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	NOV	2017	17	7							fox061	10.1093/femsyr/fox061				14	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	FO3IJ	WOS:000416721200004					2018-01-05	
J	Krishnan, V; Maddox, JW; Rodriguez, T; Gleason, E				Krishnan, Vijai; Maddox, J. Wesley; Rodriguez, Tyler; Gleason, Evanna			A role for the cystic fibrosis transmembrane conductance regulator in the nitric oxide-dependent release of Cl- from acidic organelles in amacrine cells	JOURNAL OF NEUROPHYSIOLOGY			English	Article						CFTR; cytosolic chloride; amacrine cells; nitric oxide	ACTIVATED PROTEIN-KINASE; CHLORIDE CHANNEL; INTRACELLULAR LOOP; CFTR INHIBITION; PROXIMAL TUBULE; EXPRESSION; SECRETION; ATP; GLIBENCLAMIDE; MECHANISM	gamma-Amino butyric acid (GABA) and glycine typically mediate synaptic inhibition because their ligandgated ion channels support the influx of Cl-. However, the electrochemical gradient for Cl- across the postsynaptic plasma membrane determines the voltage response of the postsynaptic cell. Typically, low cytosolic Cl- levels support inhibition, whereas higher levels of cytosolic Cl- can suppress inhibition or promote depolarization. We previously reported that nitric oxide (NO) releases Cl- from acidic organelles and transiently elevates cytosolic Cl-, making the response to GABA and glycine excitatory. In this study, we test the hypothesis that the cystic fibrosis transmembrane conductance regulator (CFTR) is involved in the NO-dependent efflux of organellar Cl-. We first establish the mRNA and protein expression of CFTR in our model system, cultured chick retinal amacrine cells. Using whole cell voltage- clamp recordings of currents through GABA-gated Cl- channels, we examine the effects of pharmacological inhibition of CFTR on the NO-dependent release of internal Cl-. To interfere with the expression of CFTR, we used clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing. We find that both pharmacological inhibition and CRISPR/Cas9-mediated knockdown of CFTR block the ability of NO to release Cl- from internal stores. These results demonstrate that CFTR is required for the NO-dependent efflux of Cl- from acidic organelles. NEW & NOTEWORTHY Although CFTR function has been studied extensively in the context of epithelia, relatively little is known about its function in neurons. We show that CFTR is involved in an NO-dependent release of Cl- from acidic organelles. This internal function of CFTR is particularly relevant to neuronal physiology because postsynaptic cytosolic Cl- levels determine the outcome of GABA-and glycinergic synaptic signaling. Thus the CFTR may play a role in regulating synaptic transmission.	[Krishnan, Vijai; Maddox, J. Wesley; Rodriguez, Tyler; Gleason, Evanna] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Gleason, E (reprint author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	egleaso@lsu.edu		Maddox, John/0000-0002-1630-2746	National Science Foundation [IOS-1256782]	This work was supported by National Science Foundation Grant IOS-1256782.	ADLER R, 1984, J CELL BIOL, V99, P1173, DOI 10.1083/jcb.99.3.1173; Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Billeta A, 2016, CHANNELS, V10, P247, DOI 10.1080/19336950.2015.1126010; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149; Chalmers JA, 2014, MOL CELL ENDOCRINOL, V382, P262, DOI 10.1016/j.mce.2013.10.013; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279                                                        ; Dahan D, 2001, PFLUG ARCH EUR J PHY, V443, pS92, DOI 10.1007/s004240100652                                                           ; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; GLEASON E, 1993, J NEUROSCI, V13, P2359; Grimes WN, 2015, J NEUROPHYSIOL, V114, P341, DOI 10.1152/jn.00017.2015; Grimes WN, 2010, NEURON, V65, P873, DOI 10.1016/j.neuron.2010.02.028; Guo Y, 2009, J HISTOCHEM CYTOCHEM, V57, P1113, DOI 10.1369/jhc.2009.953455; Guo Y, 2009, J NEUROSCI RES, V87, P3611, DOI 10.1002/jnr.22154; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622                                                                 ; Hoffpauir B, 2006, J NEUROPHYSIOL, V95, P2866, DOI 10.1152/jn.01317.2005; Hoffpauir BK, 2002, J NEUROPHYSIOL, V88, P1766, DOI 10.1152/jn.00174.2002; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978                                                          ; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kanno T, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-72; Kelly M, 2010, J PHARMACOL EXP THER, V333, P60, DOI 10.1124/jpet.109.162032; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Krishnan V, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00213; Kunzelmann K, 2013, FEBS J, V280, P4417, DOI 10.1111/febs.12457; Laverty G, 2003, AM J PHYSIOL-RENAL, V284, pF987, DOI 10.1152/ajprenal.00281.2002; Laverty G, 2012, COMP BIOCHEM PHYS A, V161, P53, DOI 10.1016/j.cbpa.2011.09.005; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/b924455g, 10.1039/B924455G]; Liu J, 2012, AM J PHYSIOL-CELL PH, V303, pC160, DOI 10.1152/ajpcell.00278.2011; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Maddox JW, 2017, J NEUROPHYSIOL, V117, P1185, DOI 10.1152/jn.00803.2016; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; McMains E, 2011, J NEUROPHYSIOL, V106, P641, DOI 10.1152/jn.00057.2011; Melis N, 2014, BRIT J PHARMACOL, V171, P3716, DOI 10.1111/bph.12726; Morales FR, 2011, NEUROSCIENCE, V177, P138, DOI 10.1016/j.neuroscience.2010.12.034; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; MULBERG AE, 1995, J CLIN INVEST, V96, P646, DOI 10.1172/JCI118080; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Ostroumov A, 2011, DEV NEUROBIOL, V71, P253, DOI 10.1002/dneu.20855; Ousingsawat J, 2011, CELL PHYSIOL BIOCHEM, V28, P715, DOI 10.1159/000335765; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reznikov LR, 2013, P NATL ACAD SCI USA, V110, P3083, DOI 10.1073/pnas.1222729110; RIORDAN JR, 1989, SCIENCE, V245, P1066; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x                                                ; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; Shigemori Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni111; Shumaker H, 1999, AM J PHYSIOL-CELL PH, V276, pC16; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Stahl M, 2012, AM J PHYSIOL-CELL PH, V302, pC67, DOI 10.1152/ajpcell.00225.2011; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; STURGESS NC, 1988, BRIT J PHARMACOL, V95, P83, DOI 10.1111/j.1476-5381.1988.tb16551.x                                              ; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037                                                        ; Tang BL, 2011, TRAFFIC, V12, P364, DOI 10.1111/j.1600-0854.2011.01161.x; Tekmen M, 2010, J NEUROPHYSIOL, V104, P1849, DOI 10.1152/jn.00031.2010; TOMINAGA M, 1995, CIRC RES, V77, P417; Tousson A, 1998, AM J PHYSIOL-CELL PH, V275, pC1555; Tu J, 2010, J PHYSIOL-LONDON, V588, P4563, DOI 10.1113/jphysiol.2010.195255; Vandebrouck C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-113; Wang XR, 2014, BIOMOLECULES, V4, P498, DOI 10.3390/biom4020498; Weyler RT, 1999, AM J PHYSIOL-CELL PH, V277, pC563; WILSON M, 1991, VISUAL NEUROSCI, V6, P19, DOI 10.1017/S0952523800000870                                                       ; XIE JX, 1995, J BIOL CHEM, V270, P28084; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200	71	0	0	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	NOV	2017	118	5					2842	2852		10.1152/jn.00511.2017				11	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	FO4AR	WOS:000416782200010	28835528				2018-01-05	
J	Elston, M; Urschitz, J				Elston, Marlee; Urschitz, Johann			Transposase-mediated gene modulation in the placenta	PLACENTA			English	Article; Proceedings Paper	Placenta Satellite Meeting of the Placneta-Association-Americas	MAR 15, 2017	Orlando, FL	Placneta Assoc Americas		Placenta; Gene; Transposon; Transposase; Transgene; Transgenesis; Piggybac; Gene therapy; Gene modulation; Virus; CRISPR/Cas9	FETAL-GROWTH RESTRICTION; IN-VIVO; NUTRIENT TRANSPORT; MOUSE EMBRYO; TROPHOBLAST; EXPRESSION; MICE; CRISPR-CAS9; NANOPARTICLES; SYSTEM	The placenta is an organ vital to fetal development as well as the maintenance of a healthy pregnancy and plays a crucial role in developmental programming of the fetus. The mechanisms that link intrauterine milieu, fetal health and disease development later in life are poorly understood. Placenta-specific gene modulation, both by generating transgenic animals as well as by developing methods for in vivo genetic modifications is a growing area of interest as this approach provides the opportunity to investigate the role of particular genes or gene networks in regulating placental function and fetal growth. Furthermore, in vivo placental gene transfer may be adapted to treat humans in the future and could be used as an early intervention strategy for a wide range of pregnancy complications. This review is an overview of transposase-based methods available for both transgenic animal generation and in vivo placental gene modifications with an emphasis on piggyBac-based systems. (C) 2017 Published by IFPA and Elsevier Ltd.	[Elston, Marlee; Urschitz, Johann] John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA	Urschitz, J (reprint author), Univ Hawaii, John A Burns Sch Med, Dept Anat Biochem & Physiol, Inst Biogenesis Res, 1960 East West Rd, Honolulu, HI 96822 USA.	johann@hawaii.edu			NIH [P20GM103457];  [HD084096]	Presented at the PAA Placental Satellite Symposium 2016, which was supported by HD084096. This work was supported by NIH grant P20GM103457.	Adams D, 2013, DIS MODEL MECH, V6, P571, DOI 10.1242/dmm.011833; Anderson CD, 2013, ULTRASOUND MED BIOL, V39, P2351, DOI 10.1016/j.ultrasmedbio.2013.07.002; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Carr DJ, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.133744; Carroll K.J., 2016, 113 CRISPRCAS9; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Couzin-Frankel J, 2016, SCIENCE, V352, P286, DOI 10.1126/science.352.6283.286; Fan XJ, 2012, ENDOCRINOLOGY, V153, P5637, DOI 10.1210/en.2012-1556; Fant M, 2010, PRENATAL DIAG, V30, P497, DOI 10.1002/pd.2506; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Godfrey K.M., 2001, FETAL PROGRAM ADULT, V4; GONZALEZCRESPO S, 1991, P NATL ACAD SCI USA, V88, P8749, DOI 10.1073/pnas.88.19.8749                                                         ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Jones H, 2014, PLACENTA, V35, P132, DOI 10.1016/j.placenta.2013.11.012; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074632; Kamat A, 2005, ENDOCRINOLOGY, V146, P2481, DOI 10.1210/en.2004-1606; Keswani SG, 2015, HUM GENE THER, V26, P172, DOI 10.1089/hum.2014.065; King A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600349; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kotterman M.A., 2013, ANNU REV BIOMED ENG, P63; Kwon GS, 2007, GENESIS, V45, P208, DOI 10.1002/dvg.20293; Li H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118299; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Liu WT, 2006, J BIOSCI BIOENG, V102, P1, DOI 10.1263/jbb.102.1; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Mehta V, 2016, REPROD SCI, V23, P1087, DOI 10.1177/1933719116630411; Moreau JLM, 2014, DEV BIOL, V392, P62, DOI 10.1016/j.ydbio.2014.04.023; Morioka Y, 2009, GENESIS, V47, P793, DOI 10.1002/dvg.20563; Myllynen PK, 2008, REPROD TOXICOL, V26, P130, DOI 10.1016/j.reprotox.2008.06.008; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Renaud SJ, 2011, PLACENTA, V32, pS130, DOI 10.1016/j.placenta.2010.12.017; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Selby M.J., 1984, ANAL MAJOR HUMAN CHO, P13131; Shearer RF, 2015, GENES CELLS, V20, P1, DOI 10.1111/gtc.12183; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Spencer R, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1226-7; Srinivasan V.S.P., 2015, BIOENG BIOSCI, V3, P1; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Turuneni TAK, 2016, MOL THER, V24, P620, DOI 10.1038/mt.2015.221; Urschitz J., 2017, PLAC ASS AM SAT M AN; Urschitz J., 2013, MOB GENET ELEMENTS, V3; Urschitz J, 2010, P NATL ACAD SCI USA, V107, P8117, DOI 10.1073/pnas.1003674107; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wenzel PL, 2007, GENESIS, V45, P129, DOI 10.1002/dvg.20276; Woodie Lauren, 2017, Nutr Neurosci, P1, DOI 10.1080/1028415X.2017.1287834; Xin KQ, 2007, VACCINE, V25, P3809, DOI 10.1016/j.vaccine.2007.01.117; Young L.S., 2006, VIRAL GENE THERAPY S, P299; Zhao L., 2014, P ASME 2014 12 INT C, P1; Zhou C.C., 2012, PLOS ONE, V7	57	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	NOV	2017	59			1			S32	S36		10.1016/j.placenta.2017.07.016				5	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	FO3HW	WOS:000416717900006	28778732				2018-01-05	
J	Tobita, T; Kiyozumi, D; Ikawa, M				Tobita, Tomohiro; Kiyozumi, Daiji; Ikawa, Masahito			Placenta-specific gene manipulation using lentiviral vector and its application	PLACENTA			English	Article; Proceedings Paper	Placenta Satellite Meeting of the Placneta-Association-Americas	MAR 15, 2017	Orlando, FL	Placneta Assoc Americas		Placenta; Viral vectors; Gene therapy; Preeclampsia; Genome editing; CRISPR/Cas9 system	EMBRYONIC STEM-CELLS; ACTIVATED PROTEIN-KINASE; TRANSGENIC MICE; KNOCKOUT MICE; MAP KINASE; TROPHOBLAST; TRANSCRIPTION; EXPRESSION; DELIVERY; DIFFERENTIATION	The placenta is an essential organ for embryo development in the uterus of eutherian mammals. Large contributions in unveiling molecular mechanisms and physiological functions underlying placental formation were made by analyzing mutant and transgenic animals. However, it had been difficult to elucidate whether the placental defects observed in such animals originate from the placenta itself or from the fetus, as both placental and fetal genomes are modified. Therefore strategies to modify the placental genome without affecting the "fetal genome" had been needed. Through the ingenious use of lentiviral (LV) vectors, placenta-specific modification is now possible. Lentivirus is a genus of retroviruses that use reverse-transcriptase to convert its single-strand RNA genome to double-strand DNA and integrate into the host genome. Previous studies showed that when LV vectors were used to transduce embryos at the 2-cell stage, the viral genome is systemically introduced into host genome. Interestingly, by delaying the timing of transduction to the blastocyst stage, the transgene is expressed specifically in the placenta as a consequence of trophectoderm-specific viral transduction. This review summarizes the development of the LV vector-mediated placenta-specific gene manipulation technology and its application in placental research over the past decade. A perspective for future application of LV vectors to further placenta research, especially in combination with next generation genome editing technologies, is also presented. (C) 2017 Published by IFPA and Elsevier Ltd.	[Tobita, Tomohiro; Kiyozumi, Daiji; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan; [Tobita, Tomohiro; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Osaka, Japan	Ikawa, M (reprint author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ikawa@biken.osaka-u.ac.jp			MEXT/JSPS KAKENHI [JP25112007, JP25112001, 15K06999]; Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R01 HD088412];  [HD084096]	The authors thank Ms. Ferheen Abbasi and Dr. Julio Manuel Castaneda for critical reading of the manuscript. The manuscript was supported by MEXT/JSPS KAKENHI grants (JP25112007, JP25112001 to M.I and 15K06999 to D.K.) and Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant (R01 HD088412 to M.I.). Presented at the PAA Placental Satellite Symposium 2016, which was supported by HD084096.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Backes CH, 2011, J PREGNANCY, V2011, DOI DOI 10.1155/2011/214365; Baeyens L, 2016, DIABETES OBES METAB, V18, P63, DOI 10.1111/dom.12716; Beltowski J, 2004, POL J PHARMACOL, V56, P5; CALZONETTI T, 1995, DEV BIOL, V171, P615, DOI 10.1006/dbio.1995.1309; Chakraborty D, 2016, P NATL ACAD SCI USA, V113, pE7212, DOI 10.1073/pnas.1612626113; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Chhabra A, 2012, DEV CELL, V22, P651, DOI 10.1016/j.devcel.2011.12.022; Cross JC, 2003, CLIN GENET, V64, P96, DOI 10.1034/j.1399-0004.2003.00127.x; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; Dull T, 1998, J VIROL, V72, P8463; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Fan XJ, 2012, ENDOCRINOLOGY, V153, P5637, DOI 10.1210/en.2012-1556; Fan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016348; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Goossens PH, 2002, CLIN EXP RHEUMATOL, V20, P415; Gordon JW, 2002, HUM REPROD, V17, P2380, DOI 10.1093/humrep/17.9.2380; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hertzel AV, 2000, J LIPID RES, V41, P1082; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; JAHNER D, 1985, P NATL ACAD SCI USA, V82, P6927, DOI 10.1073/pnas.82.20.6927; John RM, 2013, BIOCHEM SOC T, V41, P701, DOI 10.1042/BST20130002; Kamat A, 1999, P NATL ACAD SCI USA, V96, P4575, DOI 10.1073/pnas.96.8.4575; Kashif M, 2012, J BIOL CHEM, V287, P5400, DOI 10.1074/jbc.M111.289801; Kent LN, 2011, MOL CELL BIOL, V31, P4801, DOI 10.1128/MCB.05780-11; Kuhnel E., 2016, J CELL BIOCHEM, P1; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Kureishi Y, 2000, NAT MED, V6, P1004; Latos PA, 2015, GENE DEV, V29, P2435, DOI 10.1101/gad.268821.115; Lee DS, 2009, GENESIS, V47, P433, DOI 10.1002/dvg.20518; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Malashicheva A, 2007, GENESIS, V45, P456, DOI 10.1002/dvg.20313; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; Maynard SE, 2003, OBSTET GYNECOL SURV, V58, P564; Mishima T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33345; Miyoshi H, 1998, J VIROL, V72, P8150; Morioka Y, 2009, GENESIS, V47, P793, DOI 10.1002/dvg.20563; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397                                                          ; Muto M, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.133454; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Pan YB, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.28; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Purcell SH, 2009, BIOL REPROD, V81, P1112, DOI 10.1095/biolreprod.109.076190; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570                                                                ; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/nio707-665; Senut MC, 1998, J CLIN INVEST, V101, P1565, DOI 10.1172/JCI1959; SHIDA MM, 1992, P NATL ACAD SCI USA, V89, P3864, DOI 10.1073/pnas.89.9.3864; Sibai B., 2005, PRE ECLAMPSIA, P785; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902                                                         ; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Ueno M, 2013, DEV CELL, V27, P373, DOI [10.1016/j.devce1.2013.10.019, 10.1016/j.devcel.2013.10.019]; Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang Q, 2015, REPRODUCTION, V150, P139, DOI 10.1530/REP-15-0126; Zhou Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.106; Zufferey R, 1998, J VIROL, V72, P9873	76	0	0	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	NOV	2017	59			1			S37	S43		10.1016/j.placenta.2017.09.012				7	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	FO3HW	WOS:000416717900007	28988726				2018-01-05	
J	Kostner, D; Rachinger, M; Liebl, W; Ehrenreich, A				Kostner, David; Rachinger, Michael; Liebl, Wolfgang; Ehrenreich, Arinin			Markerless deletion of putative alanine dehydrogenase genes in &ITBacillus&IT &ITlicheniformis&IT using a &ITcodBA&IT-based counterselection technique	MICROBIOLOGY-SGM			English	Article						markerless deletion; counterselection; Bacillus licheniformis; 5-fluorocytosine; cytosine deaminase; codBA	BACILLUS-SUBTILIS GENOME; ALLELIC REPLACEMENT; CYTOSINE DEAMINASE; SYSTEM; LICHENIFORMIS; BACTERIA; CONSTRUCTION; CRISPR-CAS9; KNOCKOUT; EXCHANGE	Bacillus licheniformis strains are used for the large-scale production of industrial exoenzymes from proteinaceous substrates, but details of the amino acid metabolism involved are largely unknown. In this study, two chromosomal genes putatively involved in amino acid metabolism of B. licheniformis were deleted to clarify their role. For this, a convenient counterselection system for markerless in-frame deletions was developed for B. licheniformis. A deletion plasmid containing up- and downstream DNA segments of the chromosomal deletion target was conjugated to B. licheniformis and integrated into the genome by homologous recombination. Thereafter, the counterselection was done by using a codBA cassette. The presence of cytosine deaminase and cytosine permease exerted a conditionally lethal phenotype on B. licheniformis cells in the presence of the cytosine analogue 5-fluorocytosine. Thereby clones were selected that lost the integrated vector sequence and the anticipated deletion target after a second recombination step. This method allows the construction of markerless mutants in Bacillus strains in iterative cycles. B. licheniformis MW3 derivatives lacking either one of the ORFs BL03009 or BL00190, encoding a putative alanine dehydrogenase and a similar putative enzyme, respectively, retained the ability to grow in minimal medium supplemented with alanine as the carbon source. In the double deletion mutant MW3 Delta BL03009 Delta BL00190, however, growth on alanine was completely abolished. These data Indicate that the two encoded enzymes are paralogues fulfilling mutually replaceable functions In alanine utilization, and suggest that In B. licheniformis MW3 alanine utilization Is Initiated by direct oxidative transamination to pyruvate and ammonium.	[Kostner, David; Rachinger, Michael; Liebl, Wolfgang; Ehrenreich, Arinin] Tech Univ Munich, Dept Microbiol, Freising Weihenstephan, Germany	Ehrenreich, A (reprint author), Tech Univ Munich, Dept Microbiol, Freising Weihenstephan, Germany.	aehrenr@tum.de			GenoMik programme of the German Federal Ministry for Education and Research; Henkel AG and Co. KGaA	This work was funded in part by the GenoMik programme of the German Federal Ministry for Education and Research and Henkel AG and Co. KGaA.	Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Angelov A, 2013, SYST APPL MICROBIOL, V36, P585, DOI 10.1016/j.syapm.2013.06.001; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; DANIELSEN S, 1992, MOL MICROBIOL, V6, P1335, DOI 10.1111/j.1365-2958.1992.tb00854.x; Dubeau MP, 2009, APPL ENVIRON MICROB, V75, P1211, DOI 10.1128/AEM.02139-08; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Feng ZY, 2002, J BACTERIOL, V184, P5001, DOI 10.1128/JB.184.18.5001-5010.2002; GAY P, 1985, J BACTERIOL, V164, P918; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Graf N, 2011, APPL ENVIRON MICROB, V77, P5549, DOI 10.1128/AEM.05055-11; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; Keller KL, 2009, APPL ENVIRON MICROB, V75, P7682, DOI 10.1128/AEM.01839-09; Kostner D, 2013, APPL MICROBIOL BIOT, V97, P8341, DOI 10.1007/s00253-013-5164-7; Kristich CJ, 2005, APPL ENVIRON MICROB, V71, P5837, DOI 10.1128/AEM.71.10.5837-5849.2005; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; MARTINUSSEN J, 1994, J BACTERIOL, V176, P6457; Morimoto T, 2009, GENES GENET SYST, V84, P315, DOI 10.1266/ggs.84.315                                                              ; MULLEN CA, 1992, P NATL ACAD SCI USA, V89, P33, DOI 10.1073/pnas.89.1.33; Neuhard J., 1982, METABOLISM NUCLEOTID, P95; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Peters B, 2013, APPL MICROBIOL BIOT, V97, P2521, DOI 10.1007/s00253-012-4354-z; Pritchett MA, 2004, APPL ENVIRON MICROB, V70, P1425, DOI 10.1128/AEM.70.3.1425-1433.2004; Rachinger M, 2013, J BIOTECHNOL, V167, P365, DOI 10.1016/j.jbiotec.2013.07.026; Redder P, 2012, APPL ENVIRON MICROB, V78, P3846, DOI 10.1128/AEM.00202-12; Sambrook J, 1989, MOL CLONING LAB MANU; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; van der Geize R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn811; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0; Zhang XZ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl358	32	0	0	0	0	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	1350-0872	1465-2080		MICROBIOL-SGM	Microbiology-(UK)	NOV	2017	163	11					1532	1539		10.1099/mic.0.000544				8	Microbiology	Microbiology	FM4BH	WOS:000414955400002	28984230				2018-01-05	
J	Imm, J; Kerrigan, TL; Jeffries, A; Lunnon, K				Imm, Jennifer; Kerrigan, Talitha L.; Jeffries, Aaron; Lunnon, Katie			Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease	EPIGENOMICS			English	Review						Alzheimer's disease; CRISPR-Cas9; DNA methylation	AMYLOID PRECURSOR PROTEIN; GLOBAL DNA METHYLATION; BETA IN-VIVO; MOUSE MODEL; A-BETA; APOLIPOPROTEIN-E; TRANSGENIC MICE; NEURONAL LOSS; NEUROFIBRILLARY CHANGES; EXPRESSION SIGNATURES	It is thought that both genetic and epigenetic variation play a role in Alzheimer's disease initiation and progression. With the advent of somatic cell reprogramming into induced pluripotent stem cells it is now possible to generate patient-derived cells that are able to more accurately model and recapitulate disease. Furthermore, by combining this with recent advances in (epi) genome editing technologies, it is possible to begin to examine the functional consequence of previously nominated genetic variants and infer epigenetic causality from recently identified epigenetic variants. In this review, we explore the role of genetic and epigenetic variation in Alzheimer's disease and how the functional relevance of nominated loci can be investigated using induced pluripotent stem cells and (epi) genome editing techniques.	[Imm, Jennifer; Kerrigan, Talitha L.; Jeffries, Aaron; Lunnon, Katie] Exeter Univ, Inst Clin & Biomed Sci, Univ Exeter Med Sch, Exeter, Devon, England	Lunnon, K (reprint author), Exeter Univ, Inst Clin & Biomed Sci, Univ Exeter Med Sch, Exeter, Devon, England.	k.lunnon@exeter.ac.uk			Alzheimer's Society [AS-PG-14-038]; Alzheimer's Research UK network cooperation [ARUK-NCG2017A-5]; Alzheimer's Association new investigator research grant [NIRG-14-320878]; Alzheimer's Society Doctoral Training Centre in Dementia Research at the University of Exeter [AS-DTC-2014-030]; Garfield Weston Foundation	This work was funded by an Alzheimer's Society project grant to K Lunnon (grant number AS-PG-14-038), an Alzheimer's Research UK network cooperation grant to K Lunnon (grant number ARUK-NCG2017A-5) and an Alzheimer's Association new investigator research grant to K Lunnon (grant number NIRG-14-320878). J Imm is supported by the Alzheimer's Society Doctoral Training Centre in Dementia Research at the University of Exeter (grant number AS-DTC-2014-030) and the Garfield Weston Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Prince M, 2015, WORLD ALZHEIMER REPO, P1; Bernstein DL, 2015, J CLIN INVEST, V125, P1998, DOI 10.1172/JCI77321; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809                                                              ; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Bradley-Whitman MA, 2013, MECH AGEING DEV, V134, P486, DOI 10.1016/j.mad.2013.08.005; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Byrne SM, 2014, METHOD ENZYMOL, V546, P119, DOI 10.1016/B978-0-12-801185-0.00006-4; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan ES, 2016, SCI REP-UK, V6, DOI 10.1038/srep26119; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Condliffe D, 2014, NEUROBIOL AGING, V35, P1850, DOI 10.1016/j.neurobiolaging.2014.02.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRAGG BG, 1958, NATURE, V182, P675, DOI 10.1038/182675a0; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251                                                    ; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Duan LS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-3; Ebbert MTW, 2014, BIOL PSYCHIAT, V75, P732, DOI 10.1016/j.biopsych.2013.07.008; Escott-Price V, 2017, NEUROBIOL AGING, V49, DOI 10.1016/j.neurobiolaging.2016.07.018; Escott-Price V, 2015, BRAIN, V138, P3673, DOI 10.1093/brain/awv268; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Foraker J, 2015, J ALZHEIMERS DIS, V48, P745, DOI 10.3233/JAD-143060; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137                                                           ; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Govindarajan N, 2013, EMBO MOL MED, V5, P52, DOI 10.1002/emmm.201201923; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holler CJ, 2014, J ALZHEIMERS DIS, V42, P1221, DOI 10.3233/JAD-132450; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jakobsdottir J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006327; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; KALUS P, 1989, BRAIN RES, V494, P198, DOI 10.1016/0006-8993(89)90164-9                                                    ; Karch CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148717; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kitazawa M, 2012, CURR PHARM DESIGN, V18, P1131, DOI 10.2174/138161212799315786                                                      ; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lashley T, 2015, NEUROPATH APPL NEURO, V41, P497, DOI 10.1111/nan.12183; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li XZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12393; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XF, 2016, 2016 22ND INTERNATIONAL CONFERENCE ON AUTOMATION AND COMPUTING (ICAC), P233, DOI 10.1109/IConAC.2016.7604924; Livesey MR, 2016, J PHYSIOL-LONDON, V594, P6573, DOI 10.1113/JP270660; Lopez-Coviella I, 2006, BRAIN RES, V1088, P49, DOI 10.1016/j.brainres.2006.02.073; Lord J, 2014, NAT NEUROSCI, V17, P1138, DOI 10.1038/nn.3792; Lord J, 2012, INT J MOL EPIDEMIOL, V3, P262; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Lunnon K, 2013, AM J MED GENET B, V162, P789, DOI 10.1002/ajmg.b.32201; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mallon BS, 2014, STEM CELL RES, V12, P376, DOI 10.1016/j.scr.2013.11.010; Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Mendioroz M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0183-0; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167                                                           ; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Morgen K, 2014, ALZHEIMERS DEMENT, V10, pS269, DOI 10.1016/j.jalz.2013.11.001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342                                                         ; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nieweg K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.72; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Nunna S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087703; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pires C, 2016, STEM CELL RES, V17, P285, DOI 10.1016/j.scr.2016.08.002; Poirier J, 2005, NEUROBIOL AGING, V26, P355, DOI 10.1016/j.neurobiolaging.2004.09.003; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; Ridge PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079771; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; ROGERS J, 1985, J NEUROSCI, V5, P2801; Sacks CA, 2017, NEW ENGL J MED, V376, P1706, DOI 10.1056/NEJMp1701047; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964                                                       ; Smith AR, 2016, NEUROBIOL AGING, V47, P35, DOI 10.1016/j.neurobiolaging.2016.07.008; Smith A.R., 2016, NEUROEPIGENETICS, V6, P32, DOI DOI 10.1016/J.NEPIG.2016.05.001; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Sung HY, 2011, BIOCHEM BIOPH RES CO, V414, P700, DOI 10.1016/j.bbrc.2011.09.136; Taher N, 2014, J ALZHEIMERS DIS, V38, P831, DOI 10.3233/JAD-131061; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tato CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031680; Tehranchi AK, 2016, CELL, V165, P730, DOI 10.1016/j.cell.2016.03.041; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791                                                          ; VANHOESEN GW, 1990, PROG BRAIN RES, V83, P445; Weick JP, 2016, STEM CELLS INT, V2016; Wes PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106050; Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Xu W, 2015, MOL NEUROBIOL, V52, P399, DOI 10.1007/s12035-014-8878-3; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	129	0	0	1	1	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	NOV	2017	9	11					1455	1468		10.2217/epi-2017-0076				14	Genetics & Heredity	Genetics & Heredity	FO0FW	WOS:000416419400010	28969469				2018-01-05	
J	Qiu, GH; Yang, XY; Zheng, XT; Huang, CQ				Qiu, Guo-Hua; Yang, Xiaoyan; Zheng, Xintian; Huang, Cuiqin			The eukaryotic genome is structurally and functionally more like a social insect colony than a book	EPIGENOMICS			English	Review						book of life; genome; metaphor; noncoding DNA; social insect colony	CRISPR-CAS SYSTEMS; INFLUENZA-A VIRUS; TRANSPOSABLE ELEMENTS; NUCLEAR-ORGANIZATION; ADAPTIVE IMMUNITY; GENE-EXPRESSION; NONCODING RNAS; REPETITIVE DNA; INFECTED-CELLS; MICRORNA	Traditionally, the genome has been described as the 'book of life'. However, the metaphor of a book may not reflect the dynamic nature of the structure and function of the genome. In the eukaryotic genome, the number of centrally located protein-coding sequences is relatively constant across species, but the amount of noncoding DNA increases considerably with the increase of organismal evolutional complexity. Therefore, it has been hypothesized that the abundant peripheral noncoding DNA protects the genome and the central protein-coding sequences in the eukaryotic genome. Upon comparison with the habitation, sociality and defense mechanisms of a social insect colony, it is found that the genome is similar to a social insect colony in various aspects. A social insect colony may thus be a better metaphor than a book to describe the spatial organization and physical functions of the genome. The potential implications of the metaphor are also discussed.	[Qiu, Guo-Hua; Yang, Xiaoyan; Zheng, Xintian; Huang, Cuiqin] Longyan Univ, Fujian Prov Key Lab Prevent & Control Anim Infect, Coll Life Sci, Longyan 364012, Fujian, Peoples R China	Qiu, GH (reprint author), Longyan Univ, Fujian Prov Key Lab Prevent & Control Anim Infect, Coll Life Sci, Longyan 364012, Fujian, Peoples R China.	qgh@lyun.edu.cn			Major Project of Fujian Provincial Science and Technology [2014NZ0002-3]	This work was supported by the Major Project of Fujian Provincial Science and Technology (2014NZ0002-3). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Achinger-Kawecka J, 2017, EPIGENOMICS-UK, V9, P47, DOI 10.2217/epi-2016-0111; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Andrulis ED, 1998, NATURE, V394, P592; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Behmer ST, 2009, CURR BIOL, V19, pR366, DOI 10.1016/j.cub.2009.03.033; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bollazzi M, 2010, INSECT SOC, V57, P267, DOI 10.1007/s00040-010-0081-6; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211                                                            ; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cartwright JH, 2016, PHILOS T A, V374; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Copland P, 2005, J MED ETHICS, V31, P278, DOI 10.1136/jme.2003.005173; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075                                                                ; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013; Diez L, 2012, NATURWISSENSCHAFTEN, V99, P833, DOI 10.1007/s00114-012-0965-6; Faguet G., 2015, CONQUEST CANC DISTAN, P35; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Fischman BJ, 2011, P NATL ACAD SCI USA, V108, P10847, DOI 10.1073/pnas.1100301108; Gadagkar R, 2009, P NATL ACAD SCI USA, V106, P10407, DOI 10.1073/pnas.0904317106; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Haeusler RA, 2004, CELL CYCLE, V3, P273; Heun P, 2001, TRENDS CELL BIOL, V11, P519, DOI 10.1016/S0962-8924(01)02174-2                                                   ; Hiller M, 2012, NUCLEIC ACIDS RES, V40, P11463, DOI 10.1093/nar/gks905; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hily JM, 2005, MOL PLANT MICROBE IN, V18, P794, DOI 10.1094/MPMI-18-0794; Holldobler B., 1990, ANTS; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Houzet L, 2012, NUCLEIC ACIDS RES, V40, P11684, DOI 10.1093/nar/gks912; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Hua-Van A, 2005, CYTOGENET GENOME RES, V110, P426, DOI 10.1159/000084975; Hunt GJ, 2007, J INSECT PHYSIOL, V53, P399, DOI 10.1016/j.jinsphys.2007.01.010; Jackson DE, 2006, CURR BIOL, V16, pR570, DOI 10.1016/j.cub.2006.07.015; Johnson BR, 2011, BEHAV ECOL SOCIOBIOL, V65, P935, DOI 10.1007/s00265-010-1094-x; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Karp G., 2013, CELL MOL BIOL CONCEP; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kumar RP, 2010, BIOESSAYS, V32, P165, DOI 10.1002/bies.200900111; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee TC, 2010, BIOCHEM BIOPH RES CO, V396, P596, DOI 10.1016/j.bbrc.2010.04.080; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Libbrecht R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-212; LODISH H., 2003, MOL CELL BIOL; Ma J, 2011, TRANSGENIC RES, V20, P1367, DOI 10.1007/s11248-011-9502-1; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Middleton EJ, 2016, J R SOC INTERFACE, V13; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Misteli T, 2013, CELL, V152, P1209, DOI 10.1016/j.cell.2013.02.048; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Noble D, 2015, J EXP BIOL, V218, P7, DOI 10.1242/jeb.106310; Noble D, 2012, INTERFACE FOCUS, V2, P55, DOI 10.1098/rsfs.2011.0067; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; OBIN MS, 1989, ANIM BEHAV, V38, P430, DOI 10.1016/S0003-3472(89)80036-3; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Palsson G., 2016, SOCIOL REV MONOGR, V64, P100; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Perbal L, 2015, EMBO REP, V16, P777, DOI 10.15252/embr.201540179; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Poynter Sarah, 2015, Biology-Basel, V4, P460, DOI 10.3390/biology4030460; Prins M, 2008, MOL PLANT PATHOL, V9, P73, DOI [10.1111/J.1364-3703.2007.00447.X, 10.1111/j.1364-3703.2007.00447.x]; Qiu GH, 2016, MUTAT RES-REV MUTAT, V767, P31, DOI 10.1016/j.mrrev.2016.01.001; Qiu GH, 2015, MUTAT RES-REV MUTAT, V764, P108, DOI 10.1016/j.mrrev.2015.04.001; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Radoshevich L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00373; Resh VH, 2009, ENCY INSECTS; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Roossinck MJ, 2005, NAT REV MICROBIOL, V3, P917, DOI 10.1038/nrmicro1285; Sana J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-103; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Shorter JR, 2012, INSECT SOC, V59, P1, DOI 10.1007/s00040-011-0210-x; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; STAMATOYANNOPOULOS, 2012, GENOME BIOL, V13, DOI DOI 10.1186/GB-2012-13-8-418; Stratmann SA, 2015, ELIFE, V4, DOI 10.7554/eLife.11721; Sun Q, 2013, INT J BIOL SCI, V9, P313, DOI 10.7150/ijbs.5781; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Vogt H, 2016, MED HEALTH CARE PHIL, V19, P307, DOI 10.1007/s11019-016-9683-8; Wahlestedt C, 2013, NAT REV DRUG DISCOV, V12, P433, DOI 10.1038/nrd4018; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Weigmann K, 2004, EMBO REP, V5, P116, DOI 10.1038/sj.embor.7400069; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Yandell MD, 2002, NAT REV GENET, V3, P601, DOI 10.1038/nrg861; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058	113	0	0	3	3	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	NOV	2017	9	11					1469	1483		10.2217/epi-2017-0059				15	Genetics & Heredity	Genetics & Heredity	FO0FW	WOS:000416419400011	28972397				2018-01-05	
J	Seppala, S; Wilken, SE; Knop, D; Solomon, KV; O'Malley, MA				Seppala, Susanna; Wilken, St. Elmo; Knop, Doriv; Solomon, Kevin V.; O'Malley, Michelle A.			The importance of sourcing enzymes from non-conventional fungi for metabolic engineering and biomass breakdown	METABOLIC ENGINEERING			English	Review						Fungi; Lignocellulose; Enzyme; Cellulase; Cellulosome; Anaerobic fungi	SACCHAROMYCES-CEREVISIAE STRAIN; NEOCALLIMASTIX-PATRICIARUM XYLANASE; EXTRACELLULAR BETA-GLUCOSIDASE; ANAEROBIC XYLOSE FERMENTATION; FAMILY 11 XYLANASE; RICE BLAST FUNGUS; TRICHODERMA-REESEI; ETHANOL-PRODUCTION; GLYCOSIDE HYDROLASE; ESCHERICHIA-COLI	A wealth of fungal enzymes has been identified from nature, which continue to drive strain engineering and bioprocessing for a range of industries. However, while a number of clades have been investigated, the vast majority of the fungal kingdom remains unexplored for industrial applications. Here, we discuss selected classes of fungal enzymes that are currently in biotechnological use, and explore more basal, non-conventional fungi and their underexploited biomass-degrading mechanisms as promising agents in the transition towards a bio-based society. Of special interest are anaerobic fungi like the Neocallimastigomycota, which were recently found to harbor the largest diversity of biomass-degrading enzymes among the fungal kingdom. Enzymes sourced from these basal fungi have been used to metabolically engineer substrate utilization in yeast, and may offer new paths to lignin breakdown and tunneled biocatalysis. We also contrast classic enzymology approaches with emerging 'omics'-based tools to decipher function within novel fungal isolates and identify new promising enzymes. Recent developments in genome editing are expected to accelerate discovery and metabolic engineering within these systems, yet are still limited by a lack of high-resolution genomes, gene regulatory regions, and even appropriate culture conditions. Finally, we present new opportunities to harness the biomass-degrading potential of undercharacterized fungi via heterologous expression and engineered microbial consortia.	[Seppala, Susanna; Wilken, St. Elmo; Knop, Doriv; O'Malley, Michelle A.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Solomon, Kevin V.] Purdue Univ, Agr & Biol Engn, W Lafayette, IN 47907 USA	O'Malley, MA (reprint author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	susse@engineering.ucsb.edu; stelmo@umail.ucsb.edu; dorivknop@engineering.ucsb.edu; kvs@purdue.edu; momalley@engineering.ucsb.edu			VILLUM Foundation's Young Investigator Programme [VKR023128]; California NanoSystems Institute (CNSI); Pioneer Oil; Institute for Collaborative Biotechnologies from U.S. Army Research Office [W911NF-090001]; Office of Science (BER), U.S. Department of Energy [DE-SC0010352]; National Science Foundation [MCB-1553721]; Camille & Henry Dreyfus Foundation	SS is the recipient of VILLUM Foundation's Young Investigator Programme grant VKR023128, and DK is the recipient of an Elings Fellowship administered by the California NanoSystems Institute (CNSI) on the UCSB campus. KVS acknowledges funding support from Pioneer Oil. MAO gratefully acknowledges funding support from the Institute for Collaborative Biotechnologies through grant W911NF-090001 from the U.S. Army Research Office, the Office of Science (BER), U.S. Department of Energy (DE-SC0010352), the National Science Foundation (MCB-1553721), and a Teacher-Scholar Award from the Camille & Henry Dreyfus Foundation. The authors also thank Chuck Smallwood & James Evans (PNNL) for providing helium-ion images of anaerobic fungi.	Adrio JL, 2014, BIOMOLECULES, V4, P117, DOI 10.3390/biom4010117; Allen F, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-22; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P1335, DOI 10.1002/bit.25559; ARIMA K, 1967, AGR BIOL CHEM TOKYO, V31, P540, DOI 10.1080/00021369.1967.10858849                                                  ; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Artzi L, 2017, NAT REV MICROBIOL, V15, P83, DOI 10.1038/nrmicro.2016.164; BAJPAI P, 1993, PROCESS BIOCHEM, V28, P377, DOI 10.1016/0032-9592(93)80024-B                                                    ; Bamba T, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-015-0175-7; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Bhattacharya AS, 2015, BIOTECHNOL LETT, V37, P1117, DOI 10.1007/s10529-015-1779-3; Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blum DL, 1999, APPL ENVIRON MICROB, V65, P3990; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bok J. W., 2015, BMC GENOM, V16; BORNEMAN WS, 1991, APPL ENVIRON MICROB, V57, P2337; Bothast RJ, 2005, APPL MICROBIOL BIOT, V67, P19, DOI 10.1007/s00253-004-1819-8; Brakhage AA, 1998, MICROBIOL MOL BIOL R, V62, P547; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Buchner E., 1907, NOBEL LECT CELL FREE; Buchner E., 1899, BER, V32, P2086; Buchner E., 1897, BER DTSCH CHEM GES, V30, P117, DOI DOI 10.1002/CBER.18970300121; Busse N., 2016, BIOFUEL BIOREFIN TEC, V3, P271; Chakraborty R, 2004, APPL MICROBIOL BIOT, V64, P437, DOI 10.1007/s00253-003-1526-x; Chandel AK, 2015, CRIT REV BIOTECHNOL, V35, P281, DOI 10.3109/07388551.2013.841638; Chandra RP, 2007, ADV BIOCHEM ENG BIOT, V108, P67, DOI 10.1007/10_2007_064; Chang Y, 2015, GENOME BIOL EVOL, V7, P1590, DOI 10.1093/gbe/evv090; Chen YL, 2001, CAN J MICROBIOL, V47, P1088, DOI 10.1139/cjm-47-12-1088; Chen YH, 2012, BIORESOURCE TECHNOL, V123, P682, DOI 10.1016/j.biortech.2012.07.028; Cheng YS, 2015, APPL MICROBIOL BIOT, V99, P9503, DOI 10.1007/s00253-015-6712-0; Cheng YS, 2014, J BIOL CHEM, V289, P11020, DOI 10.1074/jbc.M114.550905; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clark NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001966; Coconi-Linares N, 2014, APPL MICROBIOL BIOT, V98, P9283, DOI 10.1007/s00253-014-6105-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Crous PW, 2012, PERSOONIA, V28, P138, DOI 10.3767/003158512X652633; Curran KA, 2012, METAB ENG, V14, P289, DOI 10.1016/j.ymben.2012.04.006; Cybinski DH, 1999, APPL MICROBIOL BIOT, V52, P221, DOI 10.1007/s002530051512; Dalboge H, 1997, FEMS MICROBIOL REV, V21, P29, DOI 10.1016/S0168-6445(97)00005-3; Dalrymple BP, 1997, MICROBIOL-SGM, V143, P2605, DOI 10.1099/00221287-143-8-2605                                                     ; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578                                                              ; Davis R., 2013, NATL RENEW ENERGY LA; de Souza PM, 2010, BRAZ J MICROBIOL, V41, P850, DOI 10.1590/S1517-83822010000400004; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Denman S, 1996, APPL ENVIRON MICROB, V62, P1889; Diao LY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-110; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dighton J., 2007, P287; Doyle S, 2011, FEMS MICROBIOL LETT, V321, P1, DOI 10.1111/j.1574-6968.2011.02292.x; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Durand R, 1999, APPL MICROBIOL BIOT, V52, P208, DOI 10.1007/s002530051510; Durand R, 1997, CURR GENET, V31, P158, DOI 10.1007/s002940050190; Efroymson R. A., 2017, ENV SUSTAINABILITY E, V2; Elliott AR, 1999, ANAL BIOCHEM, V269, P418, DOI 10.1006/abio.1999.4036                                                          ; Falade AO, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.394; FANUTTI C, 1995, J BIOL CHEM, V270, P29314, DOI 10.1074/jbc.270.49.29314                                                        ; FIELD JA, 1993, TRENDS BIOTECHNOL, V11, P44, DOI 10.1016/0167-7799(93)90121-O; FISCHER M, 1995, CURR GENET, V28, P80, DOI 10.1007/BF00311885; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galbe M, 2012, BIOMASS BIOENERG, V46, P70, DOI 10.1016/j.biombioe.2012.03.026; GARCIACAMPAYO V, 1993, CARBOHYD RES, V242, P229, DOI 10.1016/0008-6215(93)80037-F; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gazis R, 2016, FUNGAL BIOL-UK, V120, P26, DOI 10.1016/j.funbio.2015.10.002; Gessner M. O., 2007, P301; Gianoulis TA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002558; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Gilmore SP, 2015, BIOENGINEERED, V6, P204, DOI 10.1080/21655979.2015.1060379; GLENN JK, 1983, APPL ENVIRON MICROB, V45, P1741; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546                                                    ; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Guerriero G, 2015, PLANT SCI, V234, P180, DOI 10.1016/j.plantsci.2015.02.010; Gunnoo M, 2016, ADV MATER, V28, P5619, DOI 10.1002/adma.201503948; Gupta R, 2015, PROG LIPID RES, V57, P40, DOI 10.1016/j.plipres.2014.12.001; Hadar Y., 2013, AGR APPL, P115; Haefner S, 2005, APPL MICROBIOL BIOT, V68, P588, DOI 10.1007/s00253-005-0005-y; Haitjema CH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.87; Haitjema CH, 2014, BIOTECHNOL BIOENG, V111, P1471, DOI 10.1002/bit.25264; Harhangi HR, 2003, ARCH MICROBIOL, V180, P134, DOI 10.1007/s00203-003-0565-0; Harhangi HR, 2002, BBA-GENE STRUCT EXPR, V1574, P293, DOI 10.1016/S0167-4781(01)00380-3; HEBRAUD M, 1990, FEMS MICROBIOL LETT, V72, P11, DOI 10.1111/j.1574-6968.1990.tb03853.x; HEBRAUD M, 1990, APPL ENVIRON MICROB, V56, P3164; Hess M., 2011, SCIENCE, P331; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Hong J, 2001, J BIOSCI BIOENG, V92, P434, DOI 10.1263/jbb.92.434; Hou J, 2016, J BIOSCI BIOENG, V121, P160, DOI 10.1016/j.jbiosc.2015.05.014; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Hung YJ, 2008, BIORESOURCE TECHNOL, V99, P8662, DOI 10.1016/j.biortech.2008.04.017; Hung YL, 2012, APPL ENVIRON MICROB, V78, P4294, DOI 10.1128/AEM.07473-11; Husain Q, 2010, CRIT REV BIOTECHNOL, V30, P41, DOI 10.3109/07388550903330497; Ilmberger N, 2013, CATALYSTS, V3, P584, DOI 10.3390/catal3020584; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0                                                   ; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kalyani D, 2013, FUEL, V107, P815, DOI 10.1016/j.fuel.2013.01.037; Kanaly RA, 2000, J BACTERIOL, V182, P2059, DOI 10.1128/JB.182.8.2059-2067.2000; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846                                                ; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; KERN HW, 1987, APPL ENVIRON MICROB, V53, P2242; KERR TJ, 1983, APPL ENVIRON MICROB, V46, P1201; KESTER HCM, 1990, BIOTECHNOL APPL BIOC, V12, P150; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Knop D, 2015, APPL MICROBIOL BIOT, V99, P1025, DOI 10.1007/s00253-014-6256-8; Koivuranta KT, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0107-2; Komar AA, 2016, HUM MOL GENET, V25, pR77, DOI 10.1093/hmg/ddw207; Kotwal SM, 2009, BIOTECHNOL ADV, V27, P311, DOI 10.1016/j.biotechadv.2009.01.009; Kuhad R. C., 2011, ENZYME RES, P1, DOI DOI 10.4061/2011/280696; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2003, FEMS YEAST RES, V4, P69, DOI 10.1016/S1567-1356(03)00141-7; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; LAMED R, 1985, ENZYME MICROB TECH, V7, P37, DOI 10.1016/0141-0229(85)90008-0                                                    ; Langholtz M. H., 2016, EC AVAILABILITY FEED, V1; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; LEE JMT, 1993, CAN J MICROBIOL, V39, P134, DOI 10.1139/m93-020                                                                 ; Lee SM, 2012, APPL ENVIRON MICROB, V78, P5708, DOI 10.1128/AEM.01419-12; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li PF, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0206-8; Li XL, 2007, APPL MICROBIOL BIOT, V74, P1264, DOI 10.1007/s00253-006-0787-6; LI XL, 1991, ENZYME MICROB TECH, V13, P622, DOI 10.1016/0141-0229(91)90075-L; Li XL, 2004, APPL BIOCHEM BIOTECH, V113, P233, DOI 10.1385/ABAB:113:1-3:233; Li XL, 1997, APPL ENVIRON MICROB, V63, P4721; Liao JC, 2016, NAT REV MICROBIOL, V14, P288, DOI 10.1038/nrmicro.2016.32; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Liu G, 2016, BIOPROC BIOSYST ENG, V39, P133, DOI 10.1007/s00449-015-1497-1; Liu JR, 2007, APPL MICROBIOL BIOT, V77, P117, DOI 10.1007/s00253-007-1123-5; Liu JH, 1997, MOL BREEDING, V3, P463, DOI 10.1023/A:1009604119618; Liu JR, 2005, APPL ENVIRON MICROB, V71, P6769, DOI 10.1128/AEM.71.11.6769-6775.2005; Liu JR, 2005, FEMS MICROBIOL LETT, V251, P233, DOI 10.1016/j.femsle.2005.08.008; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Lopez-Contreras AM, 2001, APPL ENVIRON MICROB, V67, P5127, DOI 10.1128/AEM.67.11.5127-5133.2001; LOWE SE, 1987, APPL ENVIRON MICROB, V53, P1216; Mendonca Maciel M. J., 2010, ELECT J BIOTECHNOL, V13; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mantovani CF, 2005, FOOD BIOTECHNOL, V19, P173, DOI 10.1080/08905430500316284; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mathew GM, 2008, J SCI IND RES INDIA, V67, P898; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Meerupati T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003909; MillwardSadler SJ, 1996, FEMS MICROBIOL LETT, V141, P183, DOI 10.1111/j.1574-6968.1996.tb08382.x; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P3822, DOI 10.1128/AEM.00398-07; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Monciardini P, 2014, MICROB BIOTECHNOL, V7, P209, DOI 10.1111/1751-7915.12123; Mondo SJ, 2017, NAT GENET, V49, P964, DOI 10.1038/ng.3859; Mood SH, 2013, RENEW SUST ENERG REV, V27, P77, DOI 10.1016/j.rser.2013.06.033; Morrison JM, 2016, PEERJ, V4, DOI 10.7717/peerj.2289; Morrison JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29217; MOUNTFORT DO, 1985, APPL ENVIRON MICROB, V49, P1314; Nicholson MJ, 2005, MICROBIOL-SGM, V151, P121, DOI 10.1099/mic.0.27353-0; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; O'Callaghan J, 2003, MICROBIOL-SGM, V149, P3485, DOI 10.1099/mic.0.26619-0; O'Malley MA, 2012, ENVIRON PROG SUSTAIN, V31, P37, DOI 10.1002/ep.10614; Obembe OO, 2007, J PLANT RES, V120, P605, DOI 10.1007/s10265-007-0099-7; Ohm RA, 2014, FUNGAL GENET BIOL, V72, P82, DOI 10.1016/j.fgb.2014.05.001; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; ORPIN CG, 1977, J GEN MICROBIOL, V99, P215, DOI 10.1099/00221287-99-1-215                                                       ; ORPIN CG, 1975, J GEN MICROBIOL, V91, P249, DOI 10.1099/00221287-91-2-249                                                       ; Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592; Pai CK, 2010, APPL MICROBIOL BIOT, V85, P1451, DOI 10.1007/s00253-009-2175-5; Paloheimo M, 2016, FUNG BIOL-US, P23, DOI 10.1007/978-3-319-27951-0_2; Parachin NS, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-9; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; PEARCE PD, 1985, APPL ENVIRON MICROB, V49, P1265; Peng XF, 2016, CURR OPIN CHEM ENG, V14, P103, DOI 10.1016/j.coche.2016.09.003; Piao HL, 2014, BIOTECHNOL BIOENG, V111, P1550, DOI 10.1002/bit.25250; Poidevin L, 2009, LETT APPL MICROBIOL, V49, P673, DOI 10.1111/j.1472-765X.2009.02734.x; Ponomarova O, 2015, CURR OPIN MICROBIOL, V27, P37, DOI 10.1016/j.mib.2015.06.014; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Qiu X, 2000, GENE, V245, P119, DOI 10.1016/S0378-1119(00)00028-7; Ramanjaneyulu G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01450; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; REYMOND P, 1991, FEMS MICROBIOL LETT, V77, P107; REYMOND P, 1992, GENE, V110, P57, DOI 10.1016/0378-1119(92)90444-T; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rocha-Martin J, 2014, MAR DRUGS, V12, P3516, DOI 10.3390/md12063516; Rogers JN, 2017, BIOFUEL BIOPROD BIOR, V11, P110, DOI 10.1002/bbb.1728; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Saini J. K., 2015, BIO-TECHNOL, V5, P337, DOI DOI 10.1007/S13205-014-0246-5; Salame TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052446; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; Sanderson K, 2011, NATURE, V474, pS12, DOI 10.1038/474S012a; Sarkar N, 2012, RENEW ENERG, V37, P19, DOI 10.1016/j.renene.2011.06.045; Scarlat N, 2015, ENVIRON DEV, V15, P3, DOI 10.1016/j.envdev.2015.03.006; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Seppala S, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0611-7; Shen Y, 2012, APPL MICROBIOL BIOT, V96, P1079, DOI 10.1007/s00253-012-4418-0; Shong J, 2012, CURR OPIN BIOTECH, V23, P798, DOI 10.1016/j.copbio.2012.02.001; So KK, 2012, J MICROBIOL METH, V91, P412, DOI 10.1016/j.mimet.2012.09.014; Solomon KV, 2016, SCIENCE, V351, P1192, DOI 10.1126/science.aad1431; Song H, 2014, CHEM SOC REV, V43, P6954, DOI 10.1039/c4cs00114a; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumaran RK, 2005, J SCI IND RES INDIA, V64, P832; Tako M, 2017, J MICROBIOL BIOTECHN, V27, P277, DOI 10.4014/jmb.1608.08005; Tedersoo L., 2014, SCIENCE, P346; TEUNISSEN MJ, 1992, ARCH MICROBIOL, V158, P276, DOI 10.1007/BF00245245; Thies S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27035; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Traeger S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003820; Tseng CW, 2011, ACTA CRYSTALLOGR F, V67, P1189, DOI 10.1107/S1744309111032428; Uehling J, 2017, ENVIRON MICROBIOL, V19, P2964, DOI 10.1111/1462-2920.13669; Usher J, 2011, G3-GENES GENOM GENET, V1, P247, DOI 10.1534/g3.111.000695; van der Giezen M, 1998, CURR GENET, V33, P131, DOI 10.1007/s002940050318; Winkler AA, 2007, ADV BIOCHEM ENG BIOT, V10, P57, DOI DOI 10.1007/10_; Vardakou M, 2008, J MOL BIOL, V375, P1293, DOI 10.1016/j.jmb.2007.11.007; Wang D., 2013, GENOME ANNOUNC, V1; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang HC, 2014, BIOCHEM BIOPH RES CO, V451, P190, DOI 10.1016/j.bbrc.2014.07.088; Wang RL, 2013, J IND MICROBIOL BIOT, V40, P841, DOI 10.1007/s10295-013-1282-6; Wang TY, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-24; Wheeldon I, 2016, NAT CHEM, V8, P299, DOI [10.1038/NCHEM.2459, 10.1038/nchem.2459]; WILLIAMS AG, 1987, CAN J MICROBIOL, V33, P418, DOI 10.1139/m87-071                                                                 ; WOOD TM, 1986, FEMS MICROBIOL LETT, V34, P37, DOI 10.1016/0378-1097(86)90266-1; WOOD TM, 1978, BIOCHEM J, V171, P61, DOI 10.1042/bj1710061                                                               ; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; Wu I, 2013, BIOTECHNOL BIOENG, V110, P1874, DOI 10.1002/bit.24864; XUE GP, 1992, J GEN MICROBIOL, V138, P2397, DOI 10.1099/00221287-138-11-2397                                                    ; Xue GP, 1997, J BIOTECHNOL, V54, P139, DOI 10.1016/S0168-1656(97)01671-4                                                   ; XUE GP, 1995, J BIOTECHNOL, V38, P269, DOI 10.1016/0168-1656(94)00133-W; XUE GP, 1992, J GEN MICROBIOL, V138, P1413, DOI 10.1099/00221287-138-7-1413                                                     ; You C, 2014, ACS SYNTH BIOL, V3, P380, DOI 10.1021/sb4000993; You C, 2013, ACS SYNTH BIOL, V2, P102, DOI 10.1021/sb300068g; You C, 2012, ANGEW CHEM INT EDIT, V51, P8787, DOI 10.1002/anie.201202441; You C, 2010, BIOTECHNOL BIOENG, V105, P861, DOI 10.1002/bit.22623; Young E, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-24; Youssef NH, 2013, APPL ENVIRON MICROB, V79, P4620, DOI 10.1128/AEM.00821-13; Zhang GX, 2016, J BIOTECHNOL, V234, P35, DOI 10.1016/j.jbiotec.2016.07.017; Zhang HR, 2016, METAB ENG, V37, P114, DOI 10.1016/j.ymben.2016.05.007; Zhang HR, 2015, P NATL ACAD SCI USA, V112, P8266, DOI 10.1073/pnas.1506781112; Zhang JW, 2012, J BIOSCI BIOENG, V113, P697, DOI 10.1016/j.jbiosc.2012.01.016; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011; Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095; ZHOU LQ, 1994, BIOCHEM J, V297, P359, DOI 10.1042/bj2970359                                                               ; Zuroff TR, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-59; Zuroff TR, 2012, APPL MICROBIOL BIOT, V93, P1423, DOI 10.1007/s00253-011-3762-9; Zoltan I. K., 1933, Patent US, Patent No. 1932833A	259	0	0	7	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7176	1096-7184		METAB ENG	Metab. Eng.	NOV	2017	44						45	59		10.1016/j.ymben.2017.09.008				15	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FO1IX	WOS:000416513600006	28943461				2018-01-05	
J	Wang, P; Zhang, LM; Xie, YZY; Wang, NX; Tang, RB; Zheng, WF; Jiang, XY				Wang, Peng; Zhang, Lingmin; Xie, Yangzhouyun; Wang, Nuoxin; Tang, Rongbing; Zheng, Wenfu; Jiang, Xingyu			Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core-Shell Nanocarrier	ADVANCED SCIENCE			English	Article						cancer therapy; CRISPR/Cas9; genome editing; gold nanoclusters	EFFICIENT DELIVERY; MEDIATED DELIVERY; SIRNA DELIVERY; MESSENGER-RNA; HUMAN-CELLS; NANOPARTICLES; CRISPR-CAS9; DNA; SYSTEM	The type II bacterial clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 (CRISPR-associated protein) system (CRISPR-Cas9) is a powerful toolbox for gene-editing, however, the nonviral delivery of CRISPR-Cas9 to cells or tissues remains a key challenge. This paper reports a strategy to deliver Cas9 protein and single guide RNA (sgRNA) plasmid by a nanocarrier with a core of gold nanoclusters (GNs) and a shell of lipids. By modifying the GNs with HIV-1-transactivator of transcription peptide, the cargo (Cas9/sgRNA) can be delivered into cell nuclei. This strategy is utilized to treat melanoma by designing sgRNA targeting Polo-like kinase-1 (Plk1) of the tumor. The nanoparticle (polyethylene glycol-lipid/GNs/Cas9 protein/sgPlk1 plasmid, LGCP) leads to >70% down-regulation of Plk1 protein expression of A375 cells in vitro. Moreover, the LGCP suppresses melanoma progress by 75% on mice. Thus, this strategy can deliver protein-nucleic acid hybrid agents for gene therapy.	[Wang, Peng; Zhang, Lingmin; Xie, Yangzhouyun; Wang, Nuoxin; Tang, Rongbing; Zheng, Wenfu; Jiang, Xingyu] Natl Ctr NanoSci & Technol, CAS Ctr Excellence Nanosci, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing Engn Res Ctr BioNanotechnol, Beijing 100190, Peoples R China; [Jiang, Xingyu] Univ Chinese Acad Sci, Sinodanish Coll, Coll Mat Sci & Optoelect Technol, Beijing 100049, Peoples R China	Zheng, WF; Jiang, XY (reprint author), Natl Ctr NanoSci & Technol, CAS Ctr Excellence Nanosci, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing Engn Res Ctr BioNanotechnol, Beijing 100190, Peoples R China.; Jiang, XY (reprint author), Univ Chinese Acad Sci, Sinodanish Coll, Coll Mat Sci & Optoelect Technol, Beijing 100049, Peoples R China.	zhengwf@nanoctr.cn; xingyujiang@nanoctr.cn			National Nature Science Foundation of China [81361140345, 21535001, 31470911, 81673039]; Chinese Academy of Sciences [XDA09030305, XDA09030307]; CAS/SAFEA International Partnership Program for Creative Research Teams	P.W. and L.Z. contributed equally to this work. This work was supported by the National Nature Science Foundation of China (81361140345, 21535001, 31470911, and 81673039), Chinese Academy of Sciences (XDA09030305 and XDA09030307), and CAS/SAFEA International Partnership Program for Creative Research Teams. The authors would like to acknowledge Prof. Xiaoyuan Chen (National Institutes of Health, USA) and Prof. Yong Chen (Ecole Normale Superieure) for useful discussion.	Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng Q, 2014, BIOMATERIALS, V35, P5028, DOI 10.1016/j.biomaterials.2014.03.012; Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lei YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15130; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rehman ZU, 2013, ACS NANO, V7, P3767, DOI 10.1021/nn3049494; Spankuch-Schmitt B, 2002, J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863                                                         ; Sun JS, 2015, ADV MATER, V27, P1402, DOI 10.1002/adma.201404788; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Tseng YC, 2009, ADV DRUG DELIVER REV, V61, P721, DOI 10.1016/j.addr.2009.03.003; Vankayala R, 2015, ADV FUNCT MATER, V25, P5934, DOI 10.1002/adfm.201502650; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang M, 2014, ANGEW CHEM INT EDIT, V53, P2893, DOI 10.1002/anie.201311245; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xia YQ, 2016, BIOMATERIALS, V79, P56, DOI 10.1016/j.biomaterials.2015.11.056; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang XZ, 2012, ACS NANO, V6, P771, DOI 10.1021/nn204240b; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zhang LM, 2016, BIOMATERIALS, V104, P269, DOI 10.1016/j.biomaterials.2016.07.015; Zhang L, 2015, ANGEW CHEM INT EDIT, V54, P3952, DOI 10.1002/anie.201500096; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	32	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2198-3844			ADV SCI	Adv. Sci.	NOV	2017	4	11							1700175	10.1002/advs.201700175				10	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	FN6VZ	WOS:000416155900007	29201613	gold			2018-01-05	
J	May, M				May, Mike			Cutting-Edge CRISPR Tools New products make gene editing as easy and effective as possible	AMERICAN LABORATORY			English	Article																Mock U, 2016, NAT PROTOC, V11, P598, DOI 10.1038/nprot.2016.027	1	0	0	0	0	AMER LABORATORY-LABCOMPARE	SOUTHPORT	3530 POST ROAD, STE 206A, SOUTHPORT, CT 06890 USA	0044-7749			AM LAB	Am. Lab.	NOV-DEC	2017	49	9					27	29						3	Chemistry, Analytical; Instruments & Instrumentation	Chemistry; Instruments & Instrumentation	FN9XQ	WOS:000416396600007					2018-01-05	
J	de Sousa, GF; Bulhoes, TL; Cabral, LAF; Ochi, LS; Protti, F				de Sousa Filho, Gilberto F.; Bulhoes Junior, Teobaldo L.; Cabral, Lucidio A. F.; Ochi, Luiz Satoru; Protti, Fabio			New heuristics for the Bicluster Editing Problem	ANNALS OF OPERATIONS RESEARCH			English	Article; Proceedings Paper	Joint International Meeting of 17th Conference of the Association-of-Latin-Iberoamerican-Operational-Research-Societies / 3rd Annual Conference of the Mexican-Operations-Research-Society (SMIO)	OCT, 2014	Monterrey, MEXICO	Mexican Operat Res Soc, Assoc Latin Iberoamerican Operat Res Soc		Bicluster Editing Problem; Metaheuristic; Clustering problem	GENE-EXPRESSION DATA; ALGORITHMS	The NP-hard Bicluster Editing Problem (BEP) consists of editing a minimum number of edges of an input bipartite graph G in order to transform it into a vertex-disjoint union of complete bipartite subgraphs. Editing an edge consists of either adding it to the graph or deleting it from the graph. Applications of the BEP include data mining and analysis of gene expression data. In this work, we generate and analyze random bipartite instances for the BEP to perform empirical tests. A new reduction rule for the problem is proposed, based on the concept of critical independent sets, providing an effective reduction in the size of the instances. We also propose a set of heuristics using concepts of the metaheuristics ILS, VNS, and GRASP, including a constructive heuristic based on analyzing vertex neighborhoods, three local search procedures, and an auxiliary data structure to speed up the local search. Computational experiments show that our heuristics outperform other methods from the literature with respect to both solution quality and computational time.	[de Sousa Filho, Gilberto F.; Bulhoes Junior, Teobaldo L.; Cabral, Lucidio A. F.] Univ Fed Paraiba UFPB, Ctr Informat, Joao Pessoa, PB, Brazil; [Ochi, Luiz Satoru; Protti, Fabio] Univ Fed Fluminense, Inst Computacao, Niteroi, RJ, Brazil	de Sousa, GF (reprint author), Univ Fed Paraiba UFPB, Ctr Informat, Joao Pessoa, PB, Brazil.	gilberto@ci.ufpb.br; teobaldoleite@ci.ufpb.br; lucidio@ci.ufpb.br; satoru@ic.uff.br; fabio@ic.uff.br					Ailon N, 2012, SIAM J COMPUT, V41, P1110, DOI 10.1137/110848712; Amit N., 2004, THESIS; Bansal N, 2004, MACH LEARN, V56, P89, DOI 10.1023/B:MACH.0000033116.57574.95; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bastos L. O., 2012, THESIS; Ben-Dor A., 2002, RECOMB 02, P49, DOI 10.1145/565196.565203; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; BOZDAG D, 2009, P 1 INT C BIOINF COM, V5462, P151; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098                                                         ; Guo J, 2008, LECT NOTES COMPUT SC, V4978, P445; Hansen P, 2010, ANN OPER RES, V175, P367, DOI 10.1007/s10479-009-0657-6; Hartigan J., 1975, CLUSTERING ALGORITHM; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710                                                                 ; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Lazzeroni L, 2002, STAT SINICA, V12, P61; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Lourenco H. R., 2003, HDB METAHEURISTICS I, P320, DOI DOI 10.1007/0-306-48056-5_11; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Murali T M, 2003, Pac Symp Biocomput, P77; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Protti F, 2009, THEOR COMPUT SYST, V44, P91, DOI 10.1007/s00224-007-9032-7; Resende M., 2001, ENCY OPTIMIZATION, P913; Shamir R, 2004, DISCRETE APPL MATH, V144, P173, DOI 10.1016/j.dam.2004.01.007; Subhashini R, 2010, Proceedings of the 2010 First International Conference on Integrated Intelligent Computing (ICIIC 2010), P27, DOI 10.1109/ICIIC.2010.42; Sun P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku201; Sun Peng, 2013, BMC Proc, V7, pS9, DOI 10.1186/1753-6561-7-S7-S9; Tanay A., 2006, HDB COMPUTATIONAL MO; Yizong Cheng, 2000, Proceedings. Eighth International Conference on Intelligent Systems for Molecular Biology, P93	30	0	0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0254-5330	1572-9338		ANN OPER RES	Ann. Oper. Res.	NOV	2017	258	2					781	814		10.1007/s10479-016-2261-x				34	Operations Research & Management Science	Operations Research & Management Science	FN1EH	WOS:000415728600026					2018-01-05	
J	Hai, T; Guo, WW; Yao, J; Cao, CW; Luo, AL; Qi, M; Wang, XL; Wang, X; Huang, JJ; Zhang, Y; Zhang, HY; Wang, DY; Shang, HT; Hong, QL; Zhang, R; Jia, QT; Zheng, QT; Qin, GS; Li, YS; Zhang, T; Jin, WW; Chen, ZY; Wang, HM; Zhou, Q; Meng, AM; Wei, H; Yang, SM; Zhao, JG				Hai, Tang; Guo, Weiwei; Yao, Jing; Cao, Chunwei; Luo, Ailing; Qi, Meng; Wang, Xianlong; Wang, Xiao; Huang, Jiaojiao; Zhang, Ying; Zhang, Hongyong; Wang, Dayu; Shang, Haitao; Hong, Qianlong; Zhang, Rui; Jia, Qitao; Zheng, Qiantao; Qin, Guosong; Li, Yongshun; Zhang, Tao; Jin, Weiwu; Chen, Zheng-Yi; Wang, Hongmei; Zhou, Qi; Meng, Anming; Wei, Hong; Yang, Shiming; Zhao, Jianguo			Creation of miniature pig model of human Waardenburg syndrome type 2A by ENU mutagenesis	HUMAN GENETICS			English	Article							DIFFERENTIAL ALLELIC EXPRESSION; TRANSCRIPTION FACTOR MITF; MICROPHTHALMIA GENE; HEARING-LOSS; TIETZ-SYNDROME; HUMAN HOMOLOG; MOUSE; MUTATIONS; ZEBRAFISH; LOCUS	Human Waardenburg syndrome 2A (WS2A) is a dominant hearing loss (HL) syndrome caused by mutations in the microphthalmia-associated transcription factor (MITF) gene. In mouse models with MITF mutations, WS2A is transmitted in a recessive pattern, which limits the study of hearing loss (HL) pathology. In the current study, we performed ENU (ethylnitrosourea) mutagenesis that resulted in substituting a conserved lysine with a serine (p. L247S) in the DNA-binding domain of the MITF gene to generate a novel miniature pig model of WS2A. The heterozygous mutant pig (MITF+/L247S) exhibits a dominant form of profound HL and hypopigmentation in skin, hair, and iris, accompanied by degeneration of stria vascularis (SV), fused hair cells, and the absence of endocochlear potential, which indicate the pathology of human WS2A. Besides hypopigmentation and bilateral HL, the homozygous mutant pig MITFL247S/L247S) and CRISPR/Cas9-mediated MITF biallelic knockout pigs both exhibited anophthalmia. Three WS2 patients carrying MITF mutations adjacent to the corresponding region were also identified. The pig models resemble the clinical symptom and molecular pathology of human WS2A patients perfectly, which will provide new clues for better understanding the etiology and development of novel treatment strategies for human HL.	[Hai, Tang; Yao, Jing; Cao, Chunwei; Luo, Ailing; Qi, Meng; Wang, Xianlong; Wang, Xiao; Huang, Jiaojiao; Zhang, Ying; Zhang, Hongyong; Wang, Dayu; Hong, Qianlong; Zhang, Rui; Jia, Qitao; Zheng, Qiantao; Qin, Guosong; Li, Yongshun; Zhang, Tao; Jin, Weiwu; Wang, Hongmei; Zhou, Qi; Zhao, Jianguo] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Guo, Weiwei; Yang, Shiming] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otolaryngol Head & Neck Surg, Beijing 100853, Peoples R China; [Shang, Haitao; Wei, Hong] Third Mil Med Univ, Dept Lab Anim Sci, Coll Basic Med Sci, Chongqing 400038, Peoples R China; [Chen, Zheng-Yi] Harvard Med Sch, Dept Otolaryngol, Boston, MA 02114 USA; [Wang, Hongmei] Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA; [Meng, Anming] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hai, Tang; Yao, Jing; Cao, Chunwei; Luo, Ailing; Qi, Meng; Wang, Xianlong; Wang, Xiao; Huang, Jiaojiao; Zhang, Ying; Zhang, Hongyong; Wang, Dayu; Shang, Haitao; Hong, Qianlong; Zhang, Rui; Jia, Qitao; Zheng, Qiantao; Qin, Guosong; Li, Yongshun; Zhang, Tao; Jin, Weiwu; Wang, Hongmei; Zhou, Qi; Meng, Anming; Wei, Hong; Zhao, Jianguo] Chinese Swine Mutagenesis Consortium, Beijing, Peoples R China; [Wang, Hongmei; Zhou, Qi; Zhao, Jianguo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Zhao, JG (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Yang, SM (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otolaryngol Head & Neck Surg, Beijing 100853, Peoples R China.; Wei, H (reprint author), Third Mil Med Univ, Dept Lab Anim Sci, Coll Basic Med Sci, Chongqing 400038, Peoples R China.; Wei, H; Zhao, JG (reprint author), Chinese Swine Mutagenesis Consortium, Beijing, Peoples R China.; Zhao, JG (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	weihong63528@163.com; yangsm301@263.net; zhaojg@ioz.ac.cn			National Natural Science Foundation of China [1671274, 31601008, 31402045]; Strategic Priority Research Program of CAS [XDA08000000, XDA01030400]; National Transgenic Project of China [2016ZX08009003-006, 2014ZX0801007B]; National Basic Research Program of China [2011CBA01005, 2011CB944100, 2011BAI15B02, 2012BAI39B04, 2012CB967900]; National High Technology Research and Development Program of China [2012AA020602]; National Institutes of Health [DC006908]	This work was supported by the National Natural Science Foundation of China (1671274, 31601008, and 31402045); the Strategic Priority Research Program of CAS (XDA08000000 and XDA01030400); the National Transgenic Project of China (2016ZX08009003-006 and 2014ZX0801007B); the National Basic Research Program of China (2011CBA01005, 2011CB944100, 2011BAI15B02, 2012BAI39B04, and 2012CB967900); the National High Technology Research and Development Program of China (2012AA020602); and the National Institutes of Health (DC006908 to Z-Y C).	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3                                                   ; BAUER DC, 2015, BMC GENOM, V16; Baxter LL, 2003, GENE EXPR PATTERNS, V3, P703, DOI 10.1016/j.modgep.2003.07.002; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996                                                          ; Capowski EE, 2014, HUM MOL GENET, V23, P6332, DOI 10.1093/hmg/ddu351; Chen HS, 2010, BIOCHEM BIOPH RES CO, V397, P70, DOI 10.1016/j.bbrc.2010.05.066; Chen L, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0273-2; [陈勇 Chen Yong], 2015, [中华医学遗传学杂志, Chinese Journal of Medical Genetics], V32, P810; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7                                                   ; FARRER LA, 1992, AM J HUM GENET, V50, P902; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; Goding CR, 2000, GENE DEV, V14, P1712; Guo WW, 2015, ANAT REC, V298, P494, DOI 10.1002/ar.23095; Gurr A, 2010, EUR ARCH OTO-RHINO-L, V267, P213, DOI 10.1007/s00405-009-1040-6; Hai T, 2017, ELIFE, V6, DOI 10.7554/eLife.26243; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T                                                    ; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509                                                              ; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; Kochhar A, 2007, GENET MED, V9, P393, DOI 10.1097/GIM.0b013e3180980bd0; Lekmine F, 2007, BIOCHEM BIOPH RES CO, V354, P830, DOI 10.1016/j.bbrc.2007.01.075; LIU XZ, 1995, AM J MED GENET, V55, P95, DOI 10.1002/ajmg.1320550123; Lovell JM, 2007, J MICROSC-OXFORD, V228, P345, DOI 10.1111/j.1365-2818.2007.01852.x; Maia AT, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2458; Moncini S, 2015, EUR J HUM GENET, V23, P1531, DOI 10.1038/ejhg.2015.20; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NAKASHIMA S, 1992, LARYNGOSCOPE, V102, P563, DOI 10.1288/00005537-199205000-00016                                                ; NEWTON V, 1990, J LARYNGOL OTOL, V104, P97, DOI 10.1017/S002221510011196X; Ni C, 2013, PIGM CELL MELANOMA R, V26, P78, DOI 10.1111/pcmr.12030; Nobukuni Y, 1996, AM J HUM GENET, V59, P76; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Oliver PL, 2012, HUM MOL GENET, V21, pR72, DOI 10.1093/hmg/dds318; Philipp U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028857; Pracy JP, 1998, J ANAT, V192, P359, DOI 10.1046/j.1469-7580.1998.19230359.x; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; RILEY BB, 1995, P NATL ACAD SCI USA, V92, P5997, DOI 10.1073/pnas.92.13.5997; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Song J, 2016, CLIN GENET, V89, P416, DOI 10.1111/cge.12631; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; Tachibana M, 2003, PIGM CELL RES, V16, P448, DOI 10.1034/j.1600-0749.2003.00066.x                                                ; TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7                                                    ; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251                                                              ; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131                                                           ; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; Walters EM, 2011, ANN NY ACAD SCI, V1245, P63, DOI 10.1111/j.1749-6632.2011.06345.x; Wang X., 2016, SCI REP, V6, P20620; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yang SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077149; Yasumoto K, 1997, J BIOL CHEM, V272, P503; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058                                                          	59	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	NOV	2017	136	11-12					1463	1475		10.1007/s00439-017-1851-2				13	Genetics & Heredity	Genetics & Heredity	FN6VM	WOS:000416154300007	29094203				2018-01-05	
J	Shao, SM; Ren, CH; Liu, ZT; Bai, YC; Chen, ZL; Wei, ZH; Wang, X; Zhang, ZY; Xu, K				Shao, Simin; Ren, Chonghua; Liu, Zhongtian; Bai, Yichun; Chen, Zhilong; Wei, Zehui; Wang, Xin; Zhang, Zhiying; Xu, Kun			Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						CRISPR/Cas9; Rad52; Homology-directed repair; Surrogate reporter; Precise genome editing	STRAND BREAK REPAIR; DNA-REPAIR; YEAST RAD52; IONIZING-RADIATION; STEM-CELLS; RECOMBINATION; GENE; RNA; CAS9; EFFICIENCY	Precise genome editing with desired point mutations can be generated by CRISPR/Cas9-mediated homology directed repair (HDR) and is of great significance for gene function study, gene therapy and animal breeding. However, HDR efficiency is inherently low and improvements are necessitated. Herein, we determined that the HDR efficiency could be enhanced by expressing Rad52, a gene that is involved in the homologous recombination process. Both the Rad52 co-expression and Rad52-Cas9 fusion strategies yielded approximately 3 fold increase in HDR during the surrogate reporter assays in human HEK293T cells, as well as in the genome editing assays. Moreover, the enhancement effects of the Rad52-Cas9 fusion on HDR mediated by different (plasmid, PCR and ssDNA) donor templates were confirmed. We found that the HDR efficiency could be significantly improved to about 40% by the combined usage of Rad52 and Scr7. In addition, we also applied the fusion strategy for modifying the IGF2 gene of porcine PK15 cells, which further demonstrated a 2.2-fold increase in HDR frequency. In conclusion, our data suggests that Rad52-Cas9 fusion is a good option for enhancing CRISPR/Cas9-mediated HDR, which may be of use in future studies involving precise genome editing.	[Shao, Simin; Ren, Chonghua; Liu, Zhongtian; Bai, Yichun; Chen, Zhilong; Wei, Zehui; Wang, Xin; Zhang, Zhiying; Xu, Kun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Ren, Chonghua] South China Normal Univ, Sch Life Sci, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Guangzhou 510631, Guangdong, Peoples R China; [Bai, Yichun] Xinxiang Med Univ, Inst Lung & Mol Therapy, Xinxiang 453003, Henan, Peoples R China	Zhang, ZY; Xu, K (reprint author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	zhangzhy@nwsuaf.edu.cn; xukunas@nwsuaf.edu.cn			Ph.D. Start-up Fund of Northwest A F University [2452015351]; National Science and Technology Major Project of China [2014ZX0801009B]; National Natural Science Foundation of China (NSFC) [31472068]	We thank Miss Ruth Lee (University of California, Davis) and LetPub (www.letpub.com) for the linguistic assistance during the preparation of this manuscript. This work was supported by grants from The Ph.D. Start-up Fund of Northwest A & F University (2452015351), National Science and Technology Major Project of China (2014ZX0801009B) and National Natural Science Foundation of China (NSFC, 31472068).	ARMSTRONG JD, 1994, MUTAT RES-DNA REPAIR, V315, P281, DOI 10.1016/0921-8777(94)90039-6; Bai YC, 2016, G3-GENES GENOM GENET, V6, P917, DOI 10.1534/g3.116.027706; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bi BY, 2004, P NATL ACAD SCI USA, V101, P9568, DOI 10.1073/pnas.0403205101; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Clark DL, 2014, J ANIM SCI, V92, P5778, DOI [10.2527/jas2014-8283, 10.2527/jas.2014-8283]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Primio C, 2005, NUCLEIC ACIDS RES, V33, P4639, DOI 10.1093/nar/gki778; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson BL, 1996, MUTAT RES-DNA REPAIR, V363, P179, DOI 10.1016/0921-8777(96)00007-9                                                    ; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann Sven, 2007, Fungal Biology Reviews, V21, P25, DOI 10.1016/j.fbr.2007.02.004; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500                                          ; LARIONOV V, 1994, NUCLEIC ACIDS RES, V22, P4234, DOI 10.1093/nar/22.20.4234; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/emborep.kvd002; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8                                                   ; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Mortensen UH, 2002, GENETICS, V161, P549; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; PARK MS, 1995, J BIOL CHEM, V270, P15467, DOI 10.1074/jbc.270.26.15467                                                        ; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; RESNICK MA, 1969, GENETICS, V62, P519; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423                                                          ; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; SHEN ZY, 1995, GENOMICS, V25, P199, DOI 10.1016/0888-7543(95)80126-7; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942                                                                   ; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169768; Xu K, 2015, CELL MOL LIFE SCI, V72, P383, DOI 10.1007/s00018-014-1679-z; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430                                                          ; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003	50	0	0	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	NOV	2017	92						43	52		10.1016/j.biocel.2017.09.012				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FN3PX	WOS:000415912400007	28928041				2018-01-05	
J	Clark, AG; Worni-Schudel, IM; Korte, FM; Foster, MH				Clark, Amy G.; Worni-Schudel, Inge M.; Korte, Francesca M.; Foster, Mary H.			A murine Ig light chain transgene reveals IGKV3 gene contributions to anti-collagen types IV and II specificities	MOLECULAR IMMUNOLOGY			English	Article						Collagen; Autoantibody; Kappa light chain; IGKV3	COLLAGEN-INDUCED ARTHRITIS; AUTOREACTIVE B-CELLS; ANTIBODY-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODIES; ALPHA-3(IV) COLLAGEN; GOODPASTURE ANTIGEN; ALLELIC INCLUSION; MICE; EPITOPE	A subset of autoimmune diseases result from autoantibodies targeting epitopes on matrix collagen. The most extensively studied are anti-glomerular basement membrane glomerulonephritis (or its systemic counterpart Goodpasture's disease) that destroys kidneys and lungs, and rheumatoid arthritis that leads to disabling arthritis. Autoantibodies in these disorders bind evolutionarily conserved conformational epitopes on the noncollagenous domain 1 (NC1) of the alpha3 chain of type IV [alpha3(IV)NC1] collagen in glomerular and alveolar basement membranes, and on native or citrullinated type II collagen (CII) in joint cartilage, respectively. The genetic origins of pathogenic anti-collagen B cells in these diseases is unknown, but observations from murine models raise the possibility that they overlap despite distinct in vivo immunopathologies. Monoclonal autoantibodies isolated from mice immunized with alpha3(IV)NC1 collagen or CII show a biased use of Ig light chains (LC) encoded by genes of the IGKV3 subgroup (previously Vk21 family), paired with diverse Ig heavy chains. To further explore this relationship and determine if a single murine IGKV3 LC independently predisposes to both anti-collagen responses, we generated a novel transgenic (Tg) C57BL/6 mouse that expresses a productively rearranged IGKV3-encoded LC, termed mLCV3-Tg, in conjunction with endogenously rearranged Ig heavy chains. Tg mice are also genetically deficient in endogenous kappa chains to permit tracking of the mLCV3 transgene. We show that mLCV3-Tg mice are susceptible to humoral autoimmunity against both collagen chains. Anti-alpha3(IV)NC1 collagen, but not anti-CII, mLCV3-encoded Ig are detected in serum of unmanipulated Tg mice, while Toll-like receptor ligands induce secretion of mLCV3-Tg autoantibodies of both collagen specificities from splenocytes ex vivo. This indicates developmental survival of mLCV3-Tg B cells reactive with each antigen, and is consistent with production of the two anti-collagen autoIg from distinct B cell populations. Reduced B cell numbers, low serum Ig kappa levels, low cell surface Ig kappa density, and abundant endogenous lambda chain expression suggest that subsets of IGKV3-encoded B cells are regulated in vivo by mechanisms that include deletion, anergy, and LC editing. These results support the notion that murine IGKV3 LCs contribute structural fitness to antigen binding sites that support diverse anti-collagen autoimmune responses, that these responses are regulated in vivo, and that these cells can nonetheless readily escape immune regulation.	[Clark, Amy G.; Worni-Schudel, Inge M.; Korte, Francesca M.; Foster, Mary H.] Duke Univ Hlth Syst, Dept Med, Box 103015, Durham, NC 27710 USA; [Clark, Amy G.; Worni-Schudel, Inge M.; Foster, Mary H.] Durham VA Med Ctr, Durham, NC USA	Foster, MH (reprint author), Duke Univ Hlth Syst, Dept Med, Box 103015, Durham, NC 27710 USA.	amy.clark@duke.edu; ingeschudel@gmail.com; fkorte@wellesley.edu; mary.h.foster@dm.duke.edu			National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK088904]; Swiss National Science Foundation; Novartis Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001117]; Wellesley Career Education Internship; Research Service of the DVAMC	Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R01DK088904 (MHF), the Swiss National Science Foundation (IMWS), the Novartis Foundation (IMWS), the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001117 (MHF), a Wellesley Career Education Internship (FMK), and the Research Service of the DVAMC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, nor was the NIH involved in the study design, data collection/interpretation, writing, or submission of this manuscript. We thank the Shared Resources of the Duke Cancer Institute, including the Transgenic and Knockout Mouse Shared Resource, Flow Cytometry Shared Resource, and DNA Analysis Facility, and Julie Fuller of the Duke Surgical Sciences Histopathology Core/Shared Resource Lab. We thank Melissa Weston Boor for technical support.	Borza DB, 2003, SPRINGER SEMIN IMMUN, V24, P345, DOI 10.1007/s00281-002-0103; Brady GF, 2004, J IMMUNOL, V172, P5313, DOI 10.4049/jimmunol.172.9.5313                                                     ; Burkhardt H, 2002, ARTHRITIS RHEUM, V46, P2339, DOI 10.1002/art.10472; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JC128031; Cao DJ, 2011, J IMMUNOL, V187, P4451, DOI 10.4049/jimmunol.1101378; Casellas R, 2007, J EXP MED, V204, P153, DOI 10.1084/jem.20061918; Clark AG, 2011, IMMUNOL LETT, V141, P134, DOI 10.1016/j.imlet.2011.09.004; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; De Re V, 2000, BLOOD, V96, P3578; Forster M, 2012, ARTHRITIS RHEUM-US, V64, P3594, DOI 10.1002/art.34658; Foster MH, 2017, MATRIX BIOL, V57-58, P149, DOI 10.1016/j.matbio.2016.07.008; Foster MH, 2016, MOL IMMUNOL, V76, P123, DOI 10.1016/j.molimm.2016.07.004; Gorny MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027780; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HOLMDAHL R, 1990, SCAND J IMMUNOL, V31, P147, DOI 10.1111/j.1365-3083.1990.tb02754.x; Kalinina O, 2011, P NATL ACAD SCI USA, V108, P7125, DOI 10.1073/pnas.1019389108; KAUSHIK A, 1989, J EXP MED, V169, P1859, DOI 10.1084/jem.169.5.1859; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Liang ZY, 2003, J IMMUNOL, V171, P3886, DOI 10.4049/jimmunol.171.7.3886                                                     ; Lindh I, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4605; Liu S, 2005, J IMMUNOL, V175, P5067, DOI 10.4049/jimmunol.175.8.5067                                                     ; McLean GR, 2006, MOL IMMUNOL, V43, P2012, DOI 10.1016/j.molimm.2005.11.016; Meyers KEC, 1998, KIDNEY INT, V53, P402, DOI 10.1046/j.1523-1755.1998.00827.x; MO JA, 1993, EUR J IMMUNOL, V23, P2503, DOI 10.1002/eji.1830231019                                                          ; Mo JA, 1996, J IMMUNOL, V157, P2440; Nandakumar KS, 2005, J IMMUNOL METHODS, V304, P126, DOI 10.1016/j.jim.2005.06.017; Nandakumar KS, 2003, AM J PATHOL, V163, P1827, DOI 10.1016/S0002-9440(10)63542-0; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Raposo B, 2014, J EXP MED, V211, P405, DOI 10.1084/jem.20130968; RONNELID J, 1994, ARTHRITIS RHEUM, V37, P1023, DOI 10.1002/art.1780370707; Sackey F. N., 2008, AUTOINUNUNITY ROLE R; SAUS J, 1988, J BIOL CHEM, V263, P13374; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; TARKOWSKI A, 1989, ARTHRITIS RHEUM, V32, P1087, DOI 10.1002/anr.1780320906; TERATO K, 1992, J IMMUNOL, V148, P2103; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; Velez MG, 2007, J IMMUNOL, V179, P1049, DOI 10.4049/jimmunol.179.2.1049                                                     ; Watson CT, 2012, GENES IMMUN, V13, P363, DOI 10.1038/gene.2012.12; Wiehe K, 2014, IMMUNITY, V41, P909, DOI 10.1016/j.immuni.2014.11.014; WOODLEY DT, 1984, NEW ENGL J MED, V310, P1007, DOI 10.1056/NEJM198404193101602; Worni-Schudel IM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0539-4; Zhang Y, 2008, J IMMUNOL, V181, P6092, DOI 10.4049/jimmunol.181.9.6092                                                     ; Zhuang XL, 2014, J BIOL CHEM, V289, P20222, DOI 10.1074/jbc.M114.581090; ZOU YR, 1993, EMBO J, V12, P811	48	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0161-5890			MOL IMMUNOL	Mol. Immunol.	NOV	2017	91						49	56		10.1016/j.molimm.2017.08.015				8	Biochemistry & Molecular Biology; Immunology	Biochemistry & Molecular Biology; Immunology	FN1RD	WOS:000415768000007	28886586				2018-01-05	
J	Sluch, VM; Chamling, X; Liu, MM; Berlinicke, CA; Cheng, J; Mitchell, KL; Welsbie, DS; Zack, DJ				Sluch, Valentin M.; Chamling, Xitiz; Liu, Melissa M.; Berlinicke, Cynthia A.; Cheng, Jie; Mitchell, Katherine L.; Welsbie, Derek S.; Zack, Donald J.			Enhanced Stem Cell Differentiation and Immunopurification of Genome Engineered Human Retinal Ganglion Cells	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Stem cells; Retinal ganglion cells; Clustered regularly interspaced short palindromic repeats; Cell differentiation; Biotechnology	LEUCINE-ZIPPER KINASE; RNA-BINDING PROTEIN; PIGMENT EPITHELIUM; HUMAN ESCS; DIRECTED DIFFERENTIATION; TRANSCRIPTION FACTORS; NEURAL CONVERSION; GENE-EXPRESSION; NEURONS; GLAUCOMA	Human pluripotent stem cells have the potential to promote biological studies and accelerate drug discovery efforts by making possible direct experimentation on a variety of human cell types of interest. However, stem cell cultures are generally heterogeneous and efficient differentiation and purification protocols are often lacking. Here, we describe the generation of clustered regularly-interspaced short palindromic repeats(CRISPR)-Cas9 engineered reporter knock-in embryonic stem cell lines in which tdTomato and a unique cell-surface protein, THY1.2, are expressed under the control of the retinal ganglion cell (RGC)-enriched gene BRN3B. Using these reporter cell lines, we greatly improved adherent stem cell differentiation to the RGC lineage by optimizing a novel combination of small molecules and established an anti-THY1.2-based protocol that allows for large-scale RGC immunopurification. RNA-sequencing confirmed the similarity of the stem cell-derived RGCs to their endogenous human counterparts. Additionally, we developed an in vitro axonal injury model suitable for studying signaling pathways and mechanisms of human RGC cell death and for high-throughput screening for neuroprotective compounds. Using this system in combination with RNAi-based knockdown, we show that knockdown of dual leucine kinase (DLK) promotes survival of human RGCs, expanding to the human system prior reports that DLK inhibition is neuroprotective for murine RGCs. These improvements will facilitate the development and use of largescale experimental paradigms that require numbers of pure RGCs that were not previously obtainable.	[Sluch, Valentin M.; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Chamling, Xitiz; Liu, Melissa M.; Berlinicke, Cynthia A.; Cheng, Jie; Mitchell, Katherine L.; Welsbie, Derek S.; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD USA; [Welsbie, Derek S.] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA	Zack, DJ (reprint author), 400 N Broadway,Smith Bldg,Room 3029, Baltimore, MD 21231 USA.; Welsbie, DS (reprint author), 9452 Med Ctr Dr,Lower Level 3E417, La Jolla, CA 92037 USA.	dwelsbie@ucsd.edu; dzack@jhmi.edu			Maryland Stem Cell Research Fund [2014-MSCRFI-0774]; NIH [T32-90040730, 1R01EY02268001, 5T32EY007143, 5P30EY001765, R01EY023754]; BrightFocus Foundation; Research to Prevent Blindness, Inc.	We thank Hans Bjornsson for allowing us to use his MiSeq instrument, Li Zhang for providing training and help with the RNA-sequencing experiment, and Gabrielle Cannon and Loyal Goff for assistance with the RNA-sequencing run. This research was supported by grants from the Maryland Stem Cell Research Fund (2014-MSCRFI-0774), NIH (T32-90040730, 1R01EY02268001, 5T32EY007143, 5P30EY001765, and R01EY023754), BrightFocus Foundation, and unrestricted funds from Research to Prevent Blindness, Inc., and generous gifts from the Guerrieri Family Foundation and from Mr. and Mrs. Robert and Clarice Smith.	Aquino JB, 2006, BRAIN RES, V1117, P80, DOI 10.1016/j.brainres.2006.02.045; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Baranov P, 2013, TISSUE ENG PART C-ME, V19, P265, DOI [10.1089/ten.tec.2012.0217, 10.1089/ten.TEC.2012.0217]; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bayramov AV, 2011, DEVELOPMENT, V138, P5345, DOI 10.1242/dev.068908; Bertacchi M, 2015, STEM CELL REP, V5, P532, DOI 10.1016/j.stemcr.2015.08.011; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bounoutas A, 2011, P NATL ACAD SCI USA, V108, P3982, DOI 10.1073/pnas.1101360108; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chamling X, 2016, INVEST OPHTH VIS SCI, V57; Crombie DE, 2017, SLAS DISCOV, V22, P1016, DOI 10.1177/2472555217696797; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Du Y, 2010, INVEST OPHTH VIS SCI, V51, P3764, DOI 10.1167/iovs.09-4906; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fernandes KA, 2015, EXP EYE RES, V141, P42, DOI 10.1016/j.exer.2015.06.019; Gill KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep30552; Griffin SM, 2013, NEUROREPORT, V24, P1041, DOI 10.1097/WNR.0000000000000071; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Hannus M BM, 1984, NUCLEIC ACIDS RES, V42, P8049; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880; Kim C, 2006, MOL VIS, V12, P1640; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8                                                   ; Kuwahara A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7286; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Levin LA, 2002, PROG RETIN EYE RES, V21, P465, DOI 10.1016/S1350-9462(02)00012-5; Levin Leonard A, 2008, Am J Manag Care, V14, pS11; Lupo G, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120167; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Maruotti J, 2015, P NATL ACAD SCI USA, V112, P10950, DOI 10.1073/pnas.1422818112; Maruotti J, 2013, STEM CELL TRANSL MED, V2, P341, DOI 10.5966/sctm.2012-0106; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Mertens J, 2013, STEM CELL REP, V1, P491, DOI 10.1016/j.stemcr.2013.10.011; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nomura M, 1998, NATURE, V393, P786; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Pennington BO, 2015, STEM CELL TRANSL MED, V4, P165, DOI 10.5966/sctm.2014-0179; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riazifar H, 2014, STEM CELL TRANSL MED, V3, P424, DOI 10.5966/sctm.2013-0147; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sluch VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16595; Sluch VM, 2014, DEV OPHTHALMOL, V53, P111, DOI 10.1159/000358409; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; Tanaka T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08344; Tian K, 2015, CLIN OPHTHALMOL, V9, P2109, DOI 10.2147/OPTH.S80445; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260; Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Westenskow P, 2015, J VIS EXP; Williams RW, 1996, J NEUROSCI, V16, P7193; Xie BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112175; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	78	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	NOV	2017	6	11					1972	1986		10.1002/sctm.17-0059				15	Cell & Tissue Engineering	Cell Biology	FN7QX	WOS:000416214500004	29024560	gold			2018-01-05	
J	Cai, H; Wang, C				Cai, Hua; Wang, Chen			Surviving With Smog and Smoke Precision Interventions?	CHEST			English	Article						genomics; precision medicine; respiratory diseases; secondhand smoke; smog	ABDOMINAL AORTIC-ANEURYSM; NITRIC-OXIDE SYNTHASE; AIR-POLLUTION; LUNG-CANCER; SOMATIC MUTATIONS; HYDROGEN-PEROXIDE; TOBACCO SMOKING; CHINESE HAZE; LONDON FOG; EXPOSURE	Despite continuous efforts of regional governmental agencies, air pollution remains a major threat to public health worldwide. In January 2017, a severe episode of smog similar to the Great Smog of 1952 occurred in London. The longest episode of Chinese haze also developed in Beijing, during which levels of particulate matter < 2.5 mu m rose to 500 mu g/m(3). European smog and Chinese haze are associated with large numbers of premature deaths each year, at 400,000 and 1.2 million, respectively, primarily from respiratory diseases, cerebrovascular diseases, and ischemic heart diseases. In addition to air pollution, some are exposed to other harmful environmental factors, such as secondhand smoke. For countries with large populations of smokers, such as China, India, the United States, and Russia, surviving both smog and smoke is a serious problem. With novel genomic and epigenomic studies revealing air pollution- and smoking-induced mutational signatures and epigenetic editing in diseases such as lung cancer, it has become feasible to develop precision strategies for early intervention in the disease-causing pathways driven by the specific mutations or epigenetic regulations, or both. New therapies guided by gene-drug interactions and genomic biomarkers may also be developed. We discuss both perspectives regarding the urgent need to manage the toxic effects of smog and smoke for the benefit of global health and the novel concept of precision intervention to protect the exposed individuals when exposure to smog and secondhand smoke cannot be voluntarily avoided or easily modified.	[Cai, Hua; Wang, Chen] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Dis, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Cai, Hua] UCLA, David Geffen Sch Med, Div Mol Med,Div Cardiol, Dept Anesthesiol,Dept Med,Cardiovascular Res Lab, Los Angeles, CA 90095 USA	Cai, H (reprint author), 650 Charles E Young Dr,BH550 CHS, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu			NHLBI NIH HHS [R01 HL088975, R01 HL108701, R01 HL077440, R01 HL119968]		AACR Project GENIE, 2017, CANCER DISCOV, V7, P1; Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Badyda AJ, 2017, ADV EXP MED BIOL, V944, P9, DOI 10.1007/5584_2016_55; Bates Jane, 2017, Nurs Stand, V31, P31, DOI [10.7748/ns.31.27.31.s36, 10.7748/ns.31.35.31.s36, 10.7748/ns.31.21.31.s34, 10.7748/ns.31.36.31.s36, 10.7748/ns.31.22.31.s36, 10.7748/ns.31.50.31.s38, 10.7748/ns.31.51.31.s36, 10.7748/ns.31.44.31.s37, 10.7748/ns.31.25.31.s37, 10.7748/ns.31.19.31.s34, 10.7748/ns.31.24.31.s35, 10.7748/ns.31.23.31.s35, 10.7748/ns.31.41.31.s36, 10.7748/ns.31.52.31.s34, 10.7748/ns.31.34.31.s35]; Bekki K, 2016, ENVIRON TOXICOL PHAR, V45, P362, DOI 10.1016/j.etap.2016.06.022; Bell ML, 2001, ENVIRON HEALTH PERSP, V109, P389, DOI 10.2307/3434786                                                                 ; Bharadwaj P, 2016, AM J RESP CRIT CARE, V194, P1475, DOI 10.1164/rccm.201603-0451OC; Bosse Y, CANC EPIDEMIOL BIOMA; Cadet J, 2017, FREE RADIC BIOL MED, V28, P30184; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Cai H, 2000, CIRC RES, V87, P840; Cai H, 2005, CIRC RES, V96, P818, DOI 10.1161/01.RES.0000163631.07205.fb; Camarena V, 2016, CELL MOL LIFE SCI, V73, P1645, DOI 10.1007/s00018-016-2145-x; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Cohen AJ, 2017, LANCET, V10, P30505; Coyne GO, 2017, CURR PROB CANCER, V11, P30016; Daily China, 2013, CHINA DAILY; Di Francia R, CURR CANC DRUG TARGE; Dong OM, 2017, PHYSIOL GENOMICS, V49, P346, DOI 10.1152/physiolgenomics.00029.2017; Fleck AD, 2016, ENVIRON SCI POLLUT R, V23, P21187, DOI 10.1007/s11356-015-5878-4; Gao JH, 2017, SCI TOTAL ENVIRON, V578, P148, DOI 10.1016/j.scitotenv.2016.10.231; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; GBD, 2017, LANCET, V5, P30819; Gilmour M, 2006, ENVIRON HEALTH PERSP, V114, P627, DOI 10.1289/ehp.8380; Gref A, 2017, AM J RESP CRIT CARE, V195, P1373, DOI 10.1164/rccm.201605-1026OC; Guo XQ, 2011, MUTAGENESIS, V26, P273, DOI 10.1093/mutage/geq083; Holcomb N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158858; Hosgood HD, 2015, HUM GENET, V134, P333, DOI 10.1007/s00439-014-1528-z; Hu GP, 2015, J THORAC DIS, V7, P59, DOI 10.3978/j.issn.2072-1439.2014.12.47; Jensen MA, BLOOD; JIN C, 2016, J AM HEART ASSOC, V5; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Liu D, 2016, J NUTR BIOCHEM, V28, P164, DOI 10.1016/j.jnutbio.2015.10.003; Liu D, 2017, CANCER DISCOV, V7, P555, DOI 10.1158/2159-8290.CD-17-0355; Liu SW, 2017, J EPIDEMIOL COMMUN H, V71, P154, DOI 10.1136/jech-2016-207805; Maga M, 2017, ENVIRON RES, V152, P496, DOI 10.1016/j.envres.2016.09.004; Miao YC, 2015, J ENVIRON SCI-CHINA, V30, P9, DOI 10.1016/j.jes.2014.08.025; Millar L., 2017, ABC NEWS; Moreira AL, 2014, CHEST, V146, P1649, DOI 10.1378/chest.14-0713; MUSTAFA MG, 1990, FREE RADICAL BIO MED, V9, P245, DOI 10.1016/0891-5849(90)90035-H; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Rodgman A, 2013, CHEM COMPONENTS TOBA; Shankar E, 2016, SEMIN CANCER BIOL, V40-41, P82, DOI 10.1016/j.semcancer.2016.04.002; Shorter JH, 2006, SPECTROCHIM ACTA A, V63, P994, DOI 10.1016/j.saa.2005.11.005; Simon R, 2011, EMBO MOL MED, V3, P429, DOI 10.1002/emmm.201100153; Siu KL, 2017, REDOX BIOL, V11, P118, DOI 10.1016/j.redox.2016.11.002; Su KJ, 2017, CHEMOSPHERE, V167, P444, DOI 10.1016/j.chemosphere.2016.10.024; Sun Y, 2011, SCI TOTAL ENVIRON, V409, P933, DOI 10.1016/j.scitotenv.2010.11.007; Wang GH, 2016, P NATL ACAD SCI USA, V113, P13630, DOI 10.1073/pnas.1616540113; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Xie R, 2016, ENVIRON INT, V97, P180, DOI 10.1016/j.envint.2016.09.003; Youn JY, 2013, SYSTEM BIOL OXIDATIV, P849; Yu XJ, 2015, EBIOMEDICINE, V2, P583, DOI 10.1016/j.ebiom.2015.04.003; Zhang B, 2017, NATURE, V542, P31, DOI 10.1038/542031a; Zhang JF, 2015, J THORAC DIS, V7, P3, DOI 10.3978/j.issn.2072-1439.2014.12.06; Zhong J, 2017, P NATL ACAD SCI USA, V114, P3503, DOI 10.1073/pnas.1618545114; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010; [Anonymous], 2016, PREC MED CHIN; [Anonymous], 2017, S CHINA MORNING POST	61	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-3692			CHEST	Chest	NOV	2017	152	5					925	929		10.1016/j.chest.2017.06.030				5	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	FM8UM	WOS:000415365700013	28694198				2018-01-05	
J	Fonseca, LHM; Lohmann, LG				Fonseca, Luiz H. M.; Lohmann, Lucia G.			Plastome Rearrangements in the "Adenocalymma-Neojobertia" Clade (Bignonieae, Bignoniaceae) and Its Phylogenetic Implications	FRONTIERS IN PLANT SCIENCE			English	Article						cp genome; genomic rearrangments; DNA sequence alignment; phylogenomics; plastid primers	COMPLETE CHLOROPLAST GENOME; MULTIPLE SEQUENCE ALIGNMENT; NONCODING REGIONS; HIGHER-PLANTS; EVOLUTION; TOOL; TORTOISE; RESOLVE; HARE; CLASSIFICATION	The chloroplast is one of the most important organelles of plants. This organelle has a circular DNA with approximately 130 genes. The use of plastid genomic data in phylogenetic and evolutionary studies became possible with high-throughput sequencing methods, which allowed us to rapidly obtain complete genomes at a reasonable cost. Here, we use high-throughput sequencing to study the "Adenocalymma-Neojobertia" clade (Bignonieae, Bignoniaceae). More specifically, we use Hi-Seq Illumina technology to sequence 10 complete plastid genomes. Plastomes were assembled using selected plastid reads and de novo approach with SPAdes. The 10 assembled genomes were analyzed in a phylogenetic context using five different partition schemes: (1) 91 protein-coding genes ("coding"); (2) 76 introns and spacers with alignment manually edited ("non-coding edited"); (3) 76 non-coding regions with poorly aligned regions removed using T-Coffee ("non-coding filtered"); (4) 91 coding regions plus 76 non-coding regions edited ("coding + non-coding edited"); and, (5) 91 protein-coding regions plus the 76 filtered non-coding regions ("coding + non-coding filtered"). Fragmented regions were aligned using Mafft. Phylogenetic analyses were conducted using Maximum Likelihood (ML) and Bayesian Criteria (BC). The analyses of the individual plastomes consistently recovered an expansion of the Inverted Repeated (IRs) regions and a compression of the Small Single Copy (SSC) region. Major genomic translocations were observed at the Large Single Copy (LSC) and IRs. ML phylogenetic analyses of the individual datasets led to the same topology, with the exception of the analysis of the "non-coding filtered" dataset. Overall, relationships were strongly supported, with the highest support values obtained through the analysis of the "coding + non-coding edited" dataset. Four regions at the LSC, SSC, and IR were selected for primer development. The "Adenocalymma-Neojobertia" clade shows an unusual pattern of plastid structure variation, including four major genomic translocations. These rearrangements challenge the current view of conserved plastid genome architecture in terms of gene order. It also complicates both genomic assemblies using reference genomes and sequence alignments using whole plastomes. Therefore, strategies that employ de novo assemblies and manual evaluation of sequence alignments are required to prevent assembly and alignment errors.	[Fonseca, Luiz H. M.; Lohmann, Lucia G.] Univ Sao Paulo, Inst Biocencias, Dept Bot, Lab Sistemat Vegetal, Sao Paulo, Brazil	Fonseca, LHM; Lohmann, LG (reprint author), Univ Sao Paulo, Inst Biocencias, Dept Bot, Lab Sistemat Vegetal, Sao Paulo, Brazil.	luizhmf@gmail.com; llohmann@usp.br			CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); ASPT (American Society of Plant Taxonomists); BSA (Botanical Society of America); IAPT (International Association of Plant Taxonomists); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [307781/2013-5]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/50859-2]; FAPESP-NSF-NASA grant [2012/50260-6]	The authors thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), ASPT (American Society of Plant Taxonomists), BSA (Botanical Society of America), and IAPT (International Association of Plant Taxonomists) for graduate fellowships or research grants to LF as well as CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for a Pq-1C grant to LL (307781/2013-5), and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) for a regular research grant to LL (2011/50859-2), and a collaborative FAPESP-NSF-NASA grant to LL (2012/50260-6). We also thank Monica Carlsen for assistance with library preparation, Michael McKain for allowing us to use the unpublished Fast-Plast pipeline, and the Core Facility for Scientific Research from the Universidade de Sao Paulo (CEFAP-USP/GENIAL) for allowing us to use the Covaris S2 sonicator, Qubit and SEAL server.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asaf S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00843; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334                                           ; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; de Medeiros MCMP, 2015, MOL PHYLOGENET EVOL, V85, P32, DOI 10.1016/j.ympev.2015.01.010; Downie SR, 2015, SYST BOT, V40, P336, DOI 10.1600/036364415X686620; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Gardner AG, 2016, MOL PHYLOGENET EVOL, V94, P605, DOI 10.1016/j.ympev.2015.10.003; Gentry A. H., 1980, FLORA NEOTROPICA MON, V25; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Harrison N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153248; Hu SL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1498-0; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kendall M, 2016, MOL BIOL EVOL, V33, P2735, DOI 10.1093/molbev/msw124; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247                                                         ; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu TJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2101; Lohmann LG, 2006, AM J BOT, V93, P304, DOI 10.3732/ajb.93.2.304; Lohmann LG, 2014, ANN MO BOT GARD, V99, P348, DOI 10.3417/2003187; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; LYNCH M, 2007, ORIGINS GENOME ARCHI; Ma PF, 2014, SYST BIOL, V63, P933, DOI 10.1093/sysbio/syu054; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Fonseca LHM, 2015, BOT J LINN SOC, V179, P403, DOI 10.1111/boj.12338; Misof B, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/s13015-014-0022-4; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Moreira PA, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600048; Nazareno AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129930; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Odintsova MS, 2003, MOL BIOL+, V37, P649, DOI 10.1023/A:1026020623631; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; R Development Core Team, 2017, R LANG ENV STAT COMP; Reginato M, 2016, PEERJ, V4, DOI 10.7717/peerj.2715; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Smith DR, 2015, P NATL ACAD SCI USA, V112, P10177, DOI 10.1073/pnas.1422049112; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Sugiura M, 1995, ESSAYS BIOCHEM, V30, P49; Sugiura M, 1998, ANNU REV GENET, V32, P437, DOI 10.1146/annurev.genet.32.1.437                                                  ; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Vallejo-Marin M, 2016, AM J BOT, V103, P1272, DOI 10.3732/ajb.1500471; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wise R, 2006, STRUCTURE FUNCTION P, P2; Wu CS, 2016, GENOME BIOL EVOL, V8, P3740, DOI 10.1093/gbe/evw278; Wu CS, 2015, GENOME BIOL EVOL, V7, P2000, DOI 10.1093/gbe/evv125; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wysocki WP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0321-5; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3                                                   ; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zhang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00306	68	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	NOV 1	2017	8								1875	10.3389/fpls.2017.01875				13	Plant Sciences	Plant Sciences	FL3ON	WOS:000414132900001	29163600	gold			2018-01-05	
J	Goryunov, DV; Logacheva, MD; Ignatov, MS; Milyutina, IA; Fedorova, AV; Troitsky, AV				Goryunov, D. V.; Logacheva, M. D.; Ignatov, M. S.; Milyutina, I. A.; Fedorova, A. V.; Troitsky, A. V.			The Mitochondrial Genome of the Moss Brachythecium rivulare (Hypnales, Brachytheciaceae)	BIOCHEMISTRY-MOSCOW			English	Article						mitochondrial genome; Brachythecium rivulare; Bryophyta; mosses	LAND PLANTS; SEQUENCE DATA; GENE; LINEAGE; VISUALIZATION; ANNOTATION; LIVERWORT; EVOLUTION; TOOL	The mitochondrial genome of the pleurocarpous moss Brachythecium rivulare has been sequenced and annotated. The genome consists of 104,460 base pairs and has approximately the same gene set and organization as other bryophyte mitogenomes. Whole mitochondrial genome comparison between B. rivulare and Physcomitrella patens, Tetraphis pellucida, Anomodon rugelii, and Anomodon attenuatus was performed. The primary cause of bryophyte mitochondrial gene length variation was found to be numerous indels in the introns. Bryophyte mitochondrial gene conservation level was estimated, and it was in a good congruence with the overall phylogeny of bryophytes with the percentage of mitogenome similarity being proportional to the age estimated by phylochronologic analysis. Annotation discrepancies in the analyzed mitogenome sequences were identified. The simple sequence repeat (SSR) content was evaluated, and candidate sites of RNA editing were predicted in the B. rivulare mitochondrial genome.	[Goryunov, D. V.; Logacheva, M. D.; Milyutina, I. A.; Fedorova, A. V.; Troitsky, A. V.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Logacheva, M. D.] Kazan Fed Univ, Inst Fundamental Med & Biol, Extreme Biol Lab, Kazan 420012, Russia; [Ignatov, M. S.] Russian Acad Sci, Main Bot Garden, Moscow 127276, Russia	Troitsky, AV (reprint author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia.	bobr@belozersky.msu.ru			Russian Foundation for Basic Research [15-04-06027]; Russian Science Foundation [14-50-00029]	This study was funded by the Russian Foundation for Basic Research (project No. 15-04-06027) and the Russian Science Foundation (project No. 14-50-00029, construction and sequencing the DNA libraries).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bell NE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-383; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Groth-Malonek M, 2007, MOL BIOL EVOL, V24, P1068, DOI 10.1093/molbev/msm026; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KNOOP V, 2011, PLANT MIT ADV PLANT, V1, P3; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lenz H, 2013, BIOINFORM BIOL INSIG, V7, P1, DOI 10.4137/BBI.S11059; Lewis LA, 1997, MOL PHYLOGENET EVOL, V7, P377, DOI 10.1006/mpev.1996.0395; Liu Y, 2014, SYST BIOL, V63, P862, DOI 10.1093/sysbio/syu049; Liu Y, 2014, MOL BIOL EVOL, V31, P2586, DOI 10.1093/molbev/msu199; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Hilu K. W., 2009, TIMETREE LIFE, P133; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mudunuri SB, 2007, BIOINFORMATICS, V23, P1181, DOI 10.1093/bioinformatics/btm097; NEWTON AE, 2007, PLEUROCARPOUS MOSSES, V71, P337; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; BOBROVA V. K., 2002, ARCTOA, V11, P31; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Wang Xuewen, 2013, Bioinformation, V9, P541, DOI 10.6026/97320630009541; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	0	0	3	3	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0006-2979	0320-9725		BIOCHEMISTRY-MOSCOW+	Biochem.-Moscow	NOV	2017	82	11					1373	1379		10.1134/S0006297917110153				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FM6XZ	WOS:000415208200015	29223164				2018-01-05	
J	Hensel, KO; Rendon, JC; Navas, MC; Rots, MG; Postberg, J				Hensel, Kai O.; Rendon, Julio C.; Navas, Maria-Cristina; Rots, Marianne G.; Postberg, Jan			Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies	FEBS JOURNAL			English	Review						cccDNA; CRISPR/Cas; DNA methylation; epidrugs; epigenome; epigenome editing; HBV; HBx; virus-host interaction	HEPATOCELLULAR-CARCINOMA CELLS; SURFACE-ANTIGEN PROMOTER; HEPATOCYTE NUCLEAR FACTOR-3; ZINC-FINGER NUCLEASES; ARTIFICIAL TRANSCRIPTION FACTORS; SMALL HETERODIMER PARTNER; OCCULT HBV INFECTION; IMPLANTED NUDE-MICE; IN-VIVO; DNA METHYLATION	Worldwide, chronic hepatitis B virus (HBV) infection is a major health problem and no cure exists. Importantly, hepatocyte intrusion by HBV particles results in a complex deregulation of both viral and host cellular genetic and epigenetic processes. Among the attempts to develop novel therapeutic approaches against HBV infection, several options targeting the epigenomic regulation of HBV replication are gaining attention. These include the experimental treatment with 'epidrugs'. Moreover, as a targeted approach, the principle of 'epigenetic editing' recently is being exploited to control viral replication. Silencing of HBV by specific rewriting of epigenetic marks might diminish viral replication, viremia, and infectivity, eventually controlling the disease and its complications. Additionally, epigenetic editing can be used as an experimental tool to increase our limited understanding regarding the role of epigenetic modifications in viral infections. Aiming for permanent epigenetic reprogramming of the viral genome without unspecific side effects, this breakthrough may pave the roads for an ambitious technological pursuit: to start designing a curative approach utilizing manipulative molecular therapies for viral infections in vivo.	[Hensel, Kai O.; Postberg, Jan] Witten Herdecke Univ, Ctr Biomed Educ & Res ZBAF, Fac Hlth, HELIOS Med Ctr Wuppertal,Paediat Ctr,Ctr Clin & T, Witten, Germany; [Rendon, Julio C.; Rots, Marianne G.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Epigenet Editing, Groningen, Netherlands; [Rendon, Julio C.; Navas, Maria-Cristina] Univ Antioquia UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia	Postberg, J (reprint author), Witten Herdecke Univ, HELIOS Med Ctr Wuppertal, Dept Pediat, Heusnerstr 40, D-42283 Wuppertal, Germany.; Rots, MG (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands.	m.g.rots@umcg.nl; jan.postberg@uni-wh.de			UMCG; DGPI (Deutsche Gesellschaft fur padiatrische Infektiologie)	JCR was financially supported by the UMCG. No further relevant financial support was dedicated to the preparation of this manuscript. KOH was supported by a research grand of the DGPI (Deutsche Gesellschaft fur padiatrische Infektiologie).	ARAKI K, 1989, JPN J CANCER RES, V80, P295, DOI 10.1111/j.1349-7006.1989.tb02308.x                                              ; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Benhenda S, 2013, J VIROL, V87, P4360, DOI 10.1128/JVI.02574-12; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; BILLET O, 1995, J VIROL, V69, P5912; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Bock CT, 2000, J VIROL, V74, P2193, DOI 10.1128/JVI.74.5.2193-2202.2000                                                 ; Bock CT, 1999, HEPATOLOGY, V29, P1236, DOI 10.1002/hep.510290426; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2001.4481; BogomolskiYahalom V, 1997, VIRUS RES, V49, P1, DOI 10.1016/S0168-1702(96)01429-3; BREUGEL PC, 2012, HEPATOLOGY BALTIMORE, V56, P2116, DOI DOI 10.1002/HEP.25928; Cano-Rodriguez D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12284; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cao J, 2006, TOXICOL SCI, V91, P476, DOI 10.1093/toxsci/kfj153; Cao J, 2007, FREE RADICAL BIO MED, V43, P968, DOI 10.1016/j.freeradbiomed.2007.06.006; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Carroll D, 2011, CURR GENE THER, V11, P2, DOI 10.2174/156652311794520076; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chen H, 2014, NUCLEIC ACIDS RES, V42, P1563, DOI 10.1093/nar/gkt1019; CHEN IH, 1995, J VIROL, V69, P3647; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; CHEN M, 1994, VIROLOGY, V205, P127, DOI 10.1006/viro.1994.1627                                                          ; Choi BH, 1998, DNA CELL BIOL, V17, P951, DOI 10.1089/dna.1998.17.951; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; Chong CL, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-96; Chuang SE, 2000, CARCINOGENESIS, V21, P331, DOI 10.1093/carcin/21.2.331; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Cui SX, 2006, INT J MOL MED, V18, P227; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Falahi F, 2013, MOL CANCER RES, V11, P1029, DOI 10.1158/1541-7786.MCR-12-0567; Fang S, 2013, CLIN EXP MED, V13, P127, DOI 10.1007/s10238-012-0182-9; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; FU L, 1996, SHENG WU HUA XUE YU, V28, P590; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukai K, 1997, VIROLOGY, V236, P279, DOI 10.1006/viro.1997.8750                                                          ; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gearhart TL, 2010, VIROLOGY, V407, P14, DOI 10.1016/j.virol.2010.07.042; Gearhart TL, 2010, J VIROL, V84, P2675, DOI 10.1128/JVI.02196-09; Gunther S, 1996, J VIROL, V70, P8318; Guo YH, 2011, EPIGENETICS-US, V6, P720, DOI 10.4161/eip.6.6.15815; Gurard-Levin Zachary A, 2014, F1000Prime Rep, V6, P76, DOI 10.12703/P6-76; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001; Hodgson AJ, 2012, VIROLOGY, V426, P73, DOI 10.1016/j.virol.2012.01.021; Hsieh YH, 2013, CARCINOGENESIS, V34, P475, DOI 10.1093/carcin/bgs365; Hu YY, 2013, J ETHNOPHARMACOL, V149, P601, DOI 10.1016/j.jep.2013.07.030; HUAN BF, 1995, J VIROL, V69, P547; Huisman C, 2016, MOL THER, V24, P536, DOI 10.1038/mt.2015.226; Huisman C, 2015, EPIGENETICS-US, V10, P384, DOI 10.1080/15592294.2015.1034415; Huisman C, 2013, MOL ONCOL, V7, P669, DOI 10.1016/j.molonc.2013.02.017; Ishida H, 2000, J VIROL, V74, P1241, DOI 10.1128/JVI.74.3.1241-1251.2000                                                 ; Jabalameli HR, 2015, GENE, V558, P1, DOI 10.1016/j.gene.2014.12.044; Jain S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10478; Jenke ACW, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-26; Jurkowski TP, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0044-x; Kaneto H, 2001, GUT, V48, P372, DOI 10.1136/gut.48.3.372; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kaur P, 2010, J INFECT DIS, V202, P700, DOI 10.1086/655398; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2015, VIROLOGY, V479, P213, DOI 10.1016/j.virol.2015.02.024; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kim BK, 2008, HEPATOLOGY, V48, P361, DOI 10.1002/hep.22359; Knipe DM, 2007, FIELDS VIROLOGY; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kosovsky MJ, 1996, J BIOL CHEM, V271, P21859, DOI 10.1074/jbc.271.36.21859                                                        ; Koumbi Lemonica, 2015, Front Microbiol, V6, P1491, DOI 10.3389/fmicb.2015.01491; Kumar Ashish, 2005, Indian J Gastroenterol, V24, P19; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Laufer BI, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0023-7; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li J, 2001, J VIROL, V75, P8400, DOI 10.1128/JVI.75.18.8400-8406.2001                                                ; Li M, 1995, VIROLOGY, V214, P371, DOI 10.1006/viro.1995.0046; Li X, 2004, CLIN CANCER RES, V10, P7484, DOI 10.1158/1078-0432.CCR-04-1715                                                   ; Lin HC, 2012, CANCER PREV RES, V5, P952, DOI 10.1158/1940-6207.CAPR-12-0001; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lin TJ, 2008, HEPATOL RES, V38, P79, DOI 10.1111/j.1872-034X.2007.00208.x; Lin WJ, 2003, J BIOL CHEM, V278, P9353, DOI 10.1074/jbc.M205944200; Lin YC, 2009, CELL MICROBIOL, V11, P645, DOI 10.1111/j.1462-5822.2008.01280.x; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; LOPEZCABRERA M, 1991, VIROLOGY, V183, P825, DOI 10.1016/0042-6822(91)91019-D; LOPEZCABRERA M, 1990, P NATL ACAD SCI USA, V87, P5069, DOI 10.1073/pnas.87.13.5069                                                         ; Lucifora J, 2016, J HEPATOL, V64, pS41, DOI 10.1016/j.jhep.2016.02.009; Luo L, 2013, INT J MOL MED, V31, P197, DOI 10.3892/ijmm.2012.1165; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74                                                           ; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Mefferd AL, 2015, RNA, V21, P1683, DOI 10.1261/rna.051631.115; MICHALAK TI, 1994, J CLIN INVEST, V94, P907, DOI 10.1172/JCI116950C1; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; MIYOSHI E, 1992, INT J CANCER, V52, P137, DOI 10.1002/ijc.2910520124; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x                                                ; Nakabori T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27782; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2; NEWBOLD JE, 1995, J VIROL, V69, P3350; Ning L, 2009, AM J TRANSL RES, V1, P358; Notarbartolo M, 2005, CANCER LETT, V224, P53, DOI 10.1016/j.canlet.2004.10.051; Notas G, 2006, BBA-GEN SUBJECTS, V1760, P1657, DOI 10.1016/j.bbagen.2006.09.010; Ohashi Y, 2003, ONCOLOGY-BASEL, V65, P250, DOI 10.1159/000074478; Okamoto Y, 2014, GASTROENTEROLOGY, V146, P562, DOI 10.1053/j.gastro.2013.10.056; ORI A, 1995, VIROLOGY, V207, P98, DOI 10.1006/viro.1995.1055; ORI A, 1994, VIROLOGY, V204, P600, DOI 10.1006/viro.1994.1574; Oropeza CE, 2008, J VIROL, V82, P3814, DOI 10.1128/JVI.02507-07; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Park SG, 2003, EUR J BIOCHEM, V270, P2929, DOI 10.1046/j.1432-1033.2003.03650.x; Petersen J, 1997, J VIROL, V71, P5455; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Ponde RAA, 2015, EUR J CLIN MICROBIOL, V34, P1709, DOI 10.1007/s10096-015-2422-x; Qian GH, 2015, DNA CELL BIOL, V34, P327, DOI 10.1089/dna.2014.2714; Qin J, 2009, J GEN VIROL, V90, P1246, DOI 10.1099/vir.0.006007-0; Quarleri J, 2014, WORLD J GASTROENTERO, V20, P425, DOI 10.3748/wjg.v20.i2.425; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; RANEY AK, 1995, J VIROL, V69, P3265; RANEY AK, 1995, VIROLOGY, V208, P399, DOI 10.1006/viro.1995.1167; RANEY AK, 1994, J GEN VIROL, V75, P2671, DOI 10.1099/0022-1317-75-10-2671; RANEY AK, 1992, J VIROL, V66, P6912; Raney AK, 2001, VIROLOGY, V289, P239, DOI 10.1006/viro.2001.1169; Raney AK, 1997, J GEN VIROL, V78, P3029, DOI 10.1099/0022-1317-78-11-3029                                                    ; Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067; Reese VC, 2012, J VIROL, V86, P2760, DOI 10.1128/JVI.06742-11; Ren JH, 2014, J VIROL, V88, P2442, DOI 10.1128/JVI.02861-13; Ritchie D, 2009, HAEMATOL-HEMATOL J, V94, P1618, DOI 10.3324/haematol.2009.008607; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Riviere L, 2015, J HEPATOL, V63, P1093, DOI 10.1016/j.jhep.2015.06.023; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; SHAUL Y, 1986, EMBO J, V5, P1967; Shim YH, 2003, CANCER LETT, V190, P213, DOI 10.1016/S0304-3835(02)00613-4; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Song CL, 2014, VIROLOGY, V462, P149, DOI 10.1016/j.virol.2014.05.027; Srisuttee R, 2012, BIOCHEM BIOPH RES CO, V429, P45, DOI 10.1016/j.bbrc.2012.10.102; Srisuttee R, 2012, ONCOL REP, V28, P276, DOI 10.3892/or.2012.1798; STANDRING DN, 1984, J VIROL, V50, P563; Stehle IM, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-33; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075; Takada S, 1996, VIROLOGY, V216, P80, DOI 10.1006/viro.1996.0036                                                          ; Tavis JE, 2015, ANTIVIR RES, V118, P132, DOI 10.1016/j.antiviral.2015.04.002; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Tong AP, 2009, J PROTEOME RES, V8, P1037, DOI 10.1021/pr8008622; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Tost J, 2016, EPIGENOMICS-UK, V8, P153, DOI 10.2217/epi.15.112; Tropberger P, 2015, P NATL ACAD SCI USA, V112, pE5715, DOI 10.1073/pnas.1518090112; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Vivekanandan P, 2009, J INFECT DIS, V199, P1286, DOI 10.1086/597614; Wachter E, 2014, ELIFE, V3, DOI 10.7554/eLife.03397; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Wang WZ, 2008, FEBS LETT, V582, P2689, DOI 10.1016/j.febslet.2008.06.048; Wang YC, 2013, WORLD J GASTROENTERO, V19, P5159, DOI 10.3748/wjg.v19.i31.5159; Waris G, 2003, J BIOSCIENCES, V28, P311, DOI 10.1007/BF02970150; Weber ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097579; World Health Organization W, 2015, HEP B FACT SHEET N 2; Xiao J, 2010, ONCOL REP, V23, P1435, DOI 10.3892/or_00000781; Xirong L, 2014, BIOCHEMISTRY-MOSCOW+, V79, P111, DOI 10.1134/S0006297914020047; YAGINUMA K, 1989, J VIROL, V63, P2914; Yang HC, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.64; Yeh CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056661; Yoysungnoen P, 2006, CLIN HEMORHEOL MICRO, V34, P109; Yoysungnoen P, 2005, CLIN HEMORHEOL MICRO, V33, P127; Yoysungnoen P, 2008, WORLD J GASTROENTERO, V14, P2003, DOI 10.3748/wjg.14.2003; Yu HB, 2010, HEPATO-GASTROENTEROL, V57, P1241; Yu XM, 1997, J VIROL, V71, P9366; Yu XM, 2001, J VIROL, V75, P11354, DOI 10.1128/JVI.75.23.11354-11364.2001; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; YUH CH, 1992, J VIROL, V66, P4073; Zhang CS, 2013, CELL BIOCHEM BIOPHYS, V65, P187, DOI 10.1007/s12013-012-9417-3; ZHANG P, 1992, VIROLOGY, V191, P31, DOI 10.1016/0042-6822(92)90163-J; Zhang QZ, 2005, MOL CANCER THER, V4, P1465, DOI 10.1158/1535-7163.MCT-05-0198; Zhang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110442; Zhang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056711; Zhao XH, 2013, J BIOMOL SCREEN, V18, P378, DOI 10.1177/1087057112463066; Zheng DL, 2009, J HEPATOL, V50, P377, DOI 10.1016/j.jhep.2008.10.019; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004; Zhong S, 2002, CLIN CANCER RES, V8, P1087; ZHOU DX, 1991, MOL CELL BIOL, V11, P1353, DOI 10.1128/MCB.11.3.1353                                                           ; ZHOU DX, 1990, J BIOL CHEM, V265, P20731; Zhu W, 2016, VIRUS RES, V217, P125, DOI 10.1016/j.virusres.2016.04.003	194	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	NOV	2017	284	21					3550	3572		10.1111/febs.14094				23	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FM3PA	WOS:000414918100002	28457020				2018-01-05	
J	Yamaguchi, YL; Ishida, T; Yoshimura, M; Imamura, Y; Shimaoka, C; Sawa, S				Yamaguchi, Yasuka L.; Ishida, Takashi; Yoshimura, Mika; Imamura, Yuko; Shimaoka, Chie; Sawa, Shinichiro			A Collection of Mutants for CLE-Peptide-Encoding Genes in Arabidopsis Generated by CRISPR/Cas9-Mediated Gene Targeting	PLANT AND CELL PHYSIOLOGY			English	Article						Cell-to-cell communication; CLE peptides; CRISPR/Cas9; loss of function; mutant collection	STEM-CELL PROLIFERATION; FUNCTIONAL DISSECTION; GUIDE RNA; MERISTEM; RECEPTOR; SHOOT; CLAVATA; PLANTS; MUTAGENESIS; TECHNOLOGY	The ligand-receptor-mediated intercellular communication system plays important roles in coordinating developmental and physiological events in multicellular organisms. In plants, CLAVATA3/EMBRYO SURROUNDING REGION (CLE) peptides and their cognate receptors are thought to be involved in various aspects of the plant life cycle. Although the importance of this communication is broadly recognized, most CLE peptides are yet to be functionally characterized. A major problem in research on small signaling peptide-encoding genes is the limited number of loss-of-function mutants available due to their small gene size. CRISPR/Cas9-mediated gene targeting has the potential to overcome this problem, as it can be used to generate targeted mutations in essentially any gene, regardless of size. Here we generated a series of mutants of CLE-peptide-encoding genes. Newly generated clv3 and cle40 mutants reproduced the expected mutant phenotypes in the shoot apical meristem and root meristem, respectively. Our results show that CRISPR/Cas9-mediated gene targeting is a powerful tool for genetic analyses, even of small genes. We also report a novel mutant for CLE44 [which is thought to encode a tracheary elements differentiation inhibitory factor (TDIF)] and show that CLE44 contributes to vascular development. The bioresources presented here will be a powerful tool for further characterization of CLE peptides.	[Yamaguchi, Yasuka L.; Imamura, Yuko; Shimaoka, Chie; Sawa, Shinichiro] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Ishida, Takashi; Yoshimura, Mika] Kumamoto Univ, IROAST, Kumamoto 8608555, Japan; [Yamaguchi, Yasuka L.] Kumamoto Hlth Sci Univ, Kumamoto 8615598, Japan	Ishida, T (reprint author), Kumamoto Univ, IROAST, Kumamoto 8608555, Japan.	ishida-takashi@kumamoto-u.ac.jp	Ishida, Takashi/D-1072-2010	Ishida, Takashi/0000-0001-5167-9971	Japan Society for the Promotion of Science (JSPS) KAKENHI [26440151, 14J40052, 25440134, 25119713, 24114009, 24370024]	Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 26440151, 14J40052, 25440134, 25119713, 24114009 and 24370024).	Aalen RB, 2013, J EXP BOT, V64, P5253, DOI 10.1093/jxb/ert338; Betsuyaku S, 2011, PLANT CELL PHYSIOL, V52, P14, DOI 10.1093/pcp/pcq157; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Czyzewicz N, 2015, J EXP BOT, V66, P5367, DOI 10.1093/jxb/erv284; Depuydt S, 2013, P NATL ACAD SCI USA, V110, P7074, DOI 10.1073/pnas.1222314110; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Doblas VG, 2017, SCIENCE, V355, P280, DOI 10.1126/science.aaj1562; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Ishida T, 2014, EMBO REP, V15, P1202, DOI 10.15252/embr.201438660; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Makino S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39608; Matsubayashi Yoshikatsu, 2011, Arabidopsis Book, V9, pe0150, DOI 10.1199/tab.0150; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Miwa H, 2009, PLANT SIGNAL BEHAV, V4, P477, DOI 10.4161/psb.4.6.8391                                                            ; Motomitsu A, 2015, ESSAYS BIOCHEM, V58, P115, DOI [10.1042/BSE0580115, 10.1042/bse0580115]; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakayama T, 2017, SCIENCE, V355, P284, DOI 10.1126/science.aai9057; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Rodriguez-Villalon A, 2014, P NATL ACAD SCI USA, V111, P11551, DOI 10.1073/pnas.1407337111; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Song XF, 2013, PLANT PHYSIOL, V161, P1076, DOI 10.1104/pp.112.211029; Stahl Y, 2009, CURR BIOL, V19, P909, DOI 10.1016/j.cub.2009.03.060; Tabata R, 2014, SCIENCE, V346, P343, DOI 10.1126/science.1257800; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Xu TT, 2015, J EXP BOT, V66, P5217, DOI 10.1093/jxb/erv293; Yamaguchi YL, 2016, J EXP BOT, V67, P4813, DOI 10.1093/jxb/erw208	33	0	0	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	NOV	2017	58	11					1848	1856		10.1093/pcp/pcx139				9	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	FM5RQ	WOS:000415096300004	29036337				2018-01-05	
J	Mikami, M; Toki, S; Endo, M				Mikami, Masafumi; Toki, Seiichi; Endo, Masaki			In Planta Processing of the SpCas9-gRNA Complex	PLANT AND CELL PHYSIOLOGY			English	Article						CRISPR; Cas9; Ribozyme; Targeted mutagenesis	RNA-GUIDED ENDONUCLEASE; CRISPR-CAS SYSTEMS; TARGETED MUTAGENESIS; PAIRED NICKASES; HUMAN-CELLS; IN-VITRO; GENOME; RICE; ARABIDOPSIS; EXPRESSION	CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/CRISPR-associated protein 9)-mediated genome editing in plants, Streptococcus pyogenes Cas9 (SpCas9) protein and the required guide RNA (gRNA) are, in most cases, expressed from a stably integrated transgene. Generally, SpCas9 protein is expressed from an RNA polymerase (pol) II promoter, while gRNA is expressed from a pol III promoter. However, pol III promoters have not been much characterized other than in model plants, making it difficult to select appropriate promoters for specific applications, while pol II transcripts have to be processed to generate functional gRNAs. Recently, successful processing of a pol II transcript into functional gRNAs using ribozyme or Csy4-RNA cleavage systems has been demonstrated. Here, we show that functional gRNAs can be efficiently processed using SpCas9 protein and plant endogenous RNA cleavage systems without the need for a specific RNA processing system. In our system, SpCas9 RNA and gRNA are both transcribed as a single RNA using a single pol II promoter; translated SpCas9 protein can be bound to this RNA and, finally, extra RNA sequences are trimmed by plant RNA processing systems to form a functional SpCas9-gRNA complex. The efficiency of targeted mutagenesis using our novel SpCas9-gRNA fused system was comparable with that of the SpCas9-gRNA system with ribozyme sequence, achieving rates of up to 100% in rice. Our results could be useful in developing stable SpCas9-gRNA expression systems and in RNA virus vector-mediated genome editing systems in plants.	[Mikami, Masafumi; Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan; [Mikami, Masafumi; Toki, Seiichi; Endo, Masaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan	Endo, M (reprint author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	mendo@affrc.go.jp			Bio-oriented Technology Research Advancement Institution, NARO - Cross-ministerial Strategic Innovation Promotion Program (SIP); Bio-oriented Technology Research Advancement Institution, NARO - Technologies for creating next-generation agriculture, forestry and fisheries; Japan Society for the Promotion of Science [16J06425]	This research was supported by the Bio-oriented Technology Research Advancement Institution, NARO [a grant from the Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries] and the Japan Society for the Promotion of Science [Research Fellowship for Young Scientists (grant No. 16J06425 to M.M.]	Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Barbezier N, 2009, PLANT PHYSIOL, V150, P1598, DOI 10.1104/pp.109.137968; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Canino G, 2009, PLANT PHYSIOL, V150, P1494, DOI 10.1104/pp.109.137950; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cody WB, 2017, PLANT PHYSIOL, V175, P23, DOI 10.1104/pp.17.00411; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kaya H, 2017, PLANT CELL PHYSIOL, V58, P643, DOI 10.1093/pcp/pcx034; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lowder L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2076.07683; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Minkenberg B, 2017, PLANT J, V89, P636, DOI 10.1111/tpj.13399; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1111/j.1574-6976.1999.tb00405.x; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Raitskin O, 2016, CURR OPIN BIOTECH, V37, P69, DOI 10.1016/j.copbio.2015.11.008; Sakane I, 2008, NUCLEIC ACIDS RES, V36, P4266, DOI 10.1093/nar/gkn405; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769                                                        ; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; TAKIMOTO I, 1994, PLANT MOL BIOL, V26, P1007, DOI 10.1007/BF00028868; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109                                                              ; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341	58	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	NOV	2017	58	11					1857	1867		10.1093/pcp/pcx154				11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	FM5RQ	WOS:000415096300005	29040704				2018-01-05	
J	Mari-Alexandre, J; Diaz-Lagares, A; Villalba, M; Juan, O; Crujeiras, AB; Calvo, A; Sandoval, J				Mari-Alexandre, Josep; Diaz-Lagares, Angel; Villalba, Maria; Juan, Oscar; Crujeiras, Ana B.; Calvo, Alfonso; Sandoval, Juan			Translating cancer epigenomics into the clinic: focus on lung cancer	TRANSLATIONAL RESEARCH			English	Review							TARGETED DNA METHYLATION; CIGARETTE-SMOKE EXTRACT; HISTONE DEACETYLASE INHIBITORS; OBSTRUCTIVE PULMONARY-DISEASE; MICRORNA EXPRESSION PROFILE; LONG NONCODING RNA; T-CELL LYMPHOMA; PROSTATE-CANCER; MALIGNANT-TRANSFORMATION; COLORECTAL-CANCER	Epigenetic deregulation is increasingly being recognized as a hallmark of cancer. Recent studies have identified many new epigenetic biomarkers, some of which are being introduced into clinical practice for diagnosis, molecular classification, prognosis or prediction of response to therapies. O-6-methylguanine-DNA methyl-transferase gene is the most clinically advanced epigenetic biomarker as it predicts the response to temozolomide and carmustine in gliomas. Therefore, epigenomics may represent a novel and promising tool for precision medicine, and in particular, the detection of epigenomic biomarkers in liquid biopsies will be of great interest for monitoring diseases in patients. Of particular relevance is the identification of epigenetic biomarkers in lung cancer, one of the most prevalent and deadly types of cancer. DNA methylation of SHOX2 and RASSF1A could be used as diagnostic markers to differentiate between normal and tumor samples. MicroRNA and long noncoding RNA signatures associated with lung cancer development or tobacco smoke have also been identified. In addition to the field of biomarkers, therapeutic approaches using DNA methylation and histone deacetylation inhibitors are being tested in clinical trials for several cancer types. Moreover, new DNA editing techniques based on zinc finger and CRISPR/Cas9 technologies allow specific modification of aberrant methylation found in oncogenes or tumor suppressor genes. We envision that epigenomics will translate into the clinical field and will have an impact on lung cancer diagnosis/prognosis and treatment.	Hlth Res Inst La Fe, Unit Inherited Cardiovasc Dis Sudden Death & Mech, Valencia, Spain; Univ Clin Hosp Santiago CHUS, Translat Med Oncol Oncomet, Hlth Res Inst Santiago IDIS, CIBERONC, Santiago De Compostela, Spain; Univ Navarra, Sch Med, Dept Histol & Pathol, Pamplona, Navarra, Spain; [Calvo, Alfonso] Univ Navarra, CIBERONC, IDISNA, Avda Pio 12,55, Pamplona 31008, Navarra, Spain; [Calvo, Alfonso] Univ Navarra, Program Solid Tumors & Biomarkers, Ctr Appl Med Res CIMA, Avda Pio 12,55, Pamplona 31008, Navarra, Spain; [Sandoval, Juan] Hlth Res Inst La Fe, Biomarkers & Precis Med Unit, 6th Floor,Avda Fernando Abril Martorell 106, Valencia 46026, Spain; CHUS, Lab Mol & Cellular Endocrinol, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; Santiago de Compostela Univ USC, Santiago De Compostela, Spain; CIBER Physiopathol Obes & Nutr CIBERobn, Madrid, Spain	Calvo, A (reprint author), Univ Navarra, CIBERONC, IDISNA, Avda Pio 12,55, Pamplona 31008, Navarra, Spain.; Calvo, A (reprint author), Univ Navarra, Program Solid Tumors & Biomarkers, Ctr Appl Med Res CIMA, Avda Pio 12,55, Pamplona 31008, Navarra, Spain.; Sandoval, J (reprint author), Hlth Res Inst La Fe, Biomarkers & Precis Med Unit, 6th Floor,Avda Fernando Abril Martorell 106, Valencia 46026, Spain.; Crujeiras, AB (reprint author), CHUS, Mol & Cellular Endocrinol Area, Hlth Res Inst Santiago de Compostela IDIS, C Choupana S-N, Santiago De Compostela 15706, Spain.	anabelencrujeiras@hotmail.com; acalvo@unay.es; epigenomica@iislafe.es	Calvo, Alfonso/V-7945-2017	Calvo, Alfonso/0000-0003-4074-4242	Fondo de Investigacion Sanitaria [CP13/00055, PE13/00024, PI14/01012, PI16/00295, PI13/00093, PI16/01352]; CIBERobn [CB06/003]; CIBER-ONC from Instituto de Salud Carlos III (ISM); FEDER; RTICC [RD12/0036/0040]; MINECO [BIO2013-50458-EXP]; AECC Scientific Foundation [GCB 14-2170]; Fondo Europeo de Desarrollo Regional (FEDER); FSE; Xunta de Galicia, Spain [GRC2014/034]; FMV; Corte de Honor de Valencia (Spain); contract "Rio Hortega" [CM14/00067]; "Miguel Servet" by the ISCIII [MS13/00055]; FPU [FPU-14/03247]; La Fundacion Espanola de Trombosis y Hemostasia	This work was supported by grants from the "Fondo de Investigacion Sanitaria", CP13/00055, PE13/00024, PI14/01012, PI16/00295, PI13/00093, and PI16/01352) research projects, CIBERobn (CB06/003) and CIBER-ONC (co-funded with FEDER) from the Instituto de Salud Carlos III (ISM), RTICC (RD12/0036/0040), MINECO (BIO2013-50458-EXP), and AECC Scientific Foundation (GCB 14-2170), Fondo Europeo de Desarrollo Regional (FEDER), FSE and the Xunta de Galicia, Spain (GRC2014/034). In addition, it was funded by a donation from the FMV and Corte de Honor 2011 de Valencia (Spain). Diaz-Lagares, A. and Sandoval J. are funded through a research contract "Rio Hortega" (CM14/00067) and "Miguel Servet" (MS13/00055) by the ISCIII, respectively. Villalba, M. was supported by an FPU fellowship (FPU-14/03247) and Mari-Alexandre J. by "La Fundacion Espanola de Trombosis y Hemostasia".	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alelu-Paz R, 2012, J SIGNAL TRANSDUCT, V2012; Alzoubi S, 2016, ONCOTARGET, V7, P44505, DOI 10.18632/oncotarget.9887; Badrnya S, 2014, THROMB HAEMOSTASIS, V112, P128, DOI 10.1160/TH13-11-0977; Banerjee A, 2015, BIOMARKERS, V20, P123, DOI 10.3109/1354750X.2014.1000970; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436; Bin Lee B, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boeri M, 2012, CANCER J, V18, P268, DOI 10.1097/PPO.0b013e318258b743; Booth MJ, 2014, NAT CHEM, V6, P435, DOI [10.1038/NCHEM.1893, 10.1038/nchem.1893]; Braza-Boils A, 2014, HUM REPROD, V29, P978, DOI 10.1093/humrep/deu019; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brzezianska E, 2013, MOL BIOL REP, V40, P309, DOI 10.1007/s11033-012-2063-4; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Crea F, 2014, CANCER METAST REV, V33, P1, DOI 10.1007/s10555-013-9455-3; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Daskalos A, 2011, CANCER LETT, V300, P79, DOI 10.1016/j.canlet.2010.09.009; Del Bufalo D, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-230; Diaz-Lagares A, 2016, P NATL ACAD SCI USA, V113, pE7535, DOI 10.1073/pnas.1608585113; Diaz-Lagares A, 2016, CLIN CANCER RES, V22, P3361, DOI 10.1158/1078-0432.CCR-15-2346; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084225; DOAMARAL NS, 2017, GENES, V8; Du D, 2016, COLD SPRING HARB PRO, V2016; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Falahi F, 2013, MOL CANCER RES, V11, P1029, DOI 10.1158/1541-7786.MCR-12-0567; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Ferracin M, 2011, J PATHOL, V225, P43, DOI 10.1002/path.2915; Finelli C, 2016, CURR PHARM DESIGN, V22, P2349, DOI 10.2174/1381612822666160310145040; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gallipoli P, 2015, THER ADV HEMATOL, V6, P103, DOI 10.1177/2040620715577614; Gao X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0148-3; Garcia-Bloj B, 2016, ONCOTARGET, V7, P60535, DOI 10.18632/oncotarget.11142; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Graca I, 2014, CURR PHARM DESIGN, V20, P1803, DOI 10.2174/13816128113199990516                                                    ; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Guo SW, 2015, FERTIL STERIL, V104, P813, DOI 10.1016/j.fertnstert.2015.08.006; Gyoba J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040494; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352                                                   ; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Hideshima T, 2011, MOL CANCER THER, V10, P2034, DOI 10.1158/1535-7163.MCT-11-0433; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Huang J, 2015, J THORAC ONCOL, V10, P28, DOI 10.1097/JTO.0000000000000394; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Huisman C, 2015, EPIGENETICS-US, V10, P384, DOI 10.1080/15592294.2015.1034415; Husni RE, 2016, LUNG CANCER, V97, P59, DOI 10.1016/j.lungcan.2016.04.018; Ilse P, 2014, CANCER GENOM PROTEOM, V11, P251; Jarry J, 2014, MOL ONCOL, V8, P819, DOI 10.1016/j.molonc.2014.02.009; Jiang M, 2013, MOL CELL BIOCHEM, V383, P67, DOI 10.1007/s11010-013-1755-y; Jiao F, 2014, INT J ONCOL, V45, P1523, DOI 10.3892/ijo.2014.2568; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Jurkowski TP, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0044-x; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Lan HY, 2015, BIOMED RES INT, DOI 10.1155/2015/125094; Lavelle D, 2012, BLOOD, V119, P1240, DOI 10.1182/blood-2011-08-371690; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li GL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S11; Liu Y, 2015, TOXICOL APPL PHARM, V282, P9, DOI 10.1016/j.taap.2014.10.022; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Lu L, 2017, ONCOTARGET, V8, P19285, DOI 10.18632/oncotarget.15195; Lu L, 2016, TOXICOL APPL PHARM, V304, P30, DOI 10.1016/j.taap.2016.05.012; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mari-Alexandre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010093; Marshall HM, 2013, J THORAC DIS, V5, pS524, DOI 10.3978/j.issn.2072-1439.2013.09.06; Martens-Uzunova ES, 2013, CANCER LETT, V340, P201, DOI 10.1016/j.canlet.2012.11.058; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Nagathihalli NS, 2012, MOL CANCER THER, V11, P2362, DOI 10.1158/1535-7163.MCT-12-0107; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054036; Nunna S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087703; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Oronsky B, 2014, ANTI-CANCER AGENT ME, V14, P1121, DOI 10.2174/1871520614666140418144610                                               ; Ostrow KL, 2010, CLIN CANCER RES, V16, P3463, DOI 10.1158/1078-0432.CCR-09-3304; Parbin S, 2014, J HISTOCHEM CYTOCHEM, V62, P11, DOI 10.1369/0022155413506582; Perkins G, 2017, ADV CLIN CHEM, V79, P43, DOI 10.1016/bs.acc.2016.10.001; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Ponomaryova AA, 2013, LUNG CANCER, V81, P397, DOI 10.1016/j.lungcan.2013.05.016; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qi P, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0524-4; Ramon LA, 2012, HUM REPROD, V27, P3036, DOI 10.1093/humrep/des292; Rapisuwon S, 2016, COMPUT STRUCT BIOTEC, V14, P211, DOI 10.1016/j.csbj.2016.05.004; Ren J, 2014, CURR PHARM DESIGN, V20, P1847, DOI 10.2174/13816128113199990528                                                    ; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Roychowdhury S, 2016, CA-CANCER J CLIN, V66, P75, DOI 10.3322/caac.21329; Ruiz R, 2015, EXPERT OPIN INV DRUG, V24, P1101, DOI 10.1517/13543784.2015.1056779; Samuel N, 2016, J CLIN ONCOL; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Semaan A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0267-5; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Sheaffer KL, 2016, CANCER PREV RES, V9, P534, DOI 10.1158/1940-6207.CAPR-15-0349; Shi B, 2016, ONCOTARGET, V7, P21676, DOI 10.18632/oncotarget.7866; Shrager J, 2014, NAT REV CLIN ONCOL, V11, P109, DOI 10.1038/nrclinonc.2013.244; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh R, 2016, CANCER LETT, V381, P113, DOI 10.1016/j.canlet.2016.07.002; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Soto J, 2016, TRANSL RES, V169, P1, DOI 10.1016/j.trsl.2015.11.003; Sozzi G, 2014, J CLIN ONCOL, V32, P768, DOI 10.1200/JCO.2013.50.4357; Strahl B. D., 2000, NATURE, V403, P41, DOI DOI 10.1038/47412); Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; Sunami E, 2009, CLIN CHEM, V55, P559, DOI 10.1373/clinchem.2008.108498; Sundar IK, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0335-5; Sundar IK, 2014, J PROTEOME RES, V13, P982, DOI 10.1021/pr400998n; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Sundar IK, 2011, CURR OPIN PULM MED, V17, P279, DOI 10.1097/MCP.0b013e3283477533; Takahashi K, 2013, TOXICOL APPL PHARM, V272, P154, DOI 10.1016/j.taap.2013.05.018; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vendetti FP, 2013, EXPERT OPIN BIOL TH, V13, P1273, DOI 10.1517/14712598.2013.819337; Villalba M, 2016, ONCOTARGET, V7, P22752, DOI 10.18632/oncotarget.8045; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Walter JE, 2016, LANCET ONCOL, V17, P907, DOI 10.1016/S1470-2045(16)30069-9; Wang P, 2015, CLIN LUNG CANCER, V16, P313, DOI 10.1016/j.cllc.2014.12.006; Warton K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-476; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Weiss G, 2017, J THORAC ONCOL, V12, P77, DOI 10.1016/j.jtho.2016.08.123; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183                                                ; Wrangle J, 2014, CLIN CANCER RES, V20, P1856, DOI 10.1158/1078-0432.CCR-13-2109; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xie H, 2015, INT J CLIN EXP PATHO, V8, P1790; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; You BR, 2014, MOL CARCINOGEN, V53, P847, DOI 10.1002/mc.22042; Zhao QT, 2015, ONCOTARGETS THER, V8, P3433, DOI 10.2147/OTT.S94300; Ziller MJ, 2015, NAT METHODS, V12, P230, DOI [10.1038/NMETH.3152, 10.1038/nmeth.3152]; Zochbauer-Muller S, 2002, ONCOLOGIST, V7, P451, DOI 10.1634/theoncologist.7-5-451; Zuco V, 2015, BIOCHEM PHARMACOL, V94, P79, DOI 10.1016/j.bcp.2015.01.002	152	0	0	9	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	NOV	2017	189						76	92		10.1016/j.trsl.2017.05.008				17	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	FM3FA	WOS:000414888500006	28644958				2018-01-05	
J	Serikawa, T; Eberle, J; Kurreck, J				Serikawa, Tatsuo; Eberle, Juergen; Kurreck, Jens			Effects of genomic disruption of a guanine quadruplex in the 5 ' UTR of the Bcl-2 mRNA in melanoma cells	FEBS LETTERS			English	Article						apoptosis; Bcl-2; cancer; melanoma; post-transcriptional regulation; RNA G-quadruplexes; translational regulation	REPRESSES TRANSLATION; EUKARYOTIC CELLS; APOPTOSIS; PROTEIN; EXPRESSION; 5'-UTR; MOTIF; OVEREXPRESSION; LEUKEMIA; BIOLOGY	G-quadruplex structures in the 5' UTR of mRNAs have been shown to suppress translation. However, all experiments published so far made use of artificial reporter systems. Here, we investigate for the first time the biological effects of the genomic disruption of a G-quadruplex by CRISPR/Cas9. In melanoma cells lacking the G-quadruplex-forming sequence in the mRNA of the apoptosis inhibitor Bcl-2, the protein level of Bcl-2 remains virtually unchanged. Consequently, sensitivity to an inducer of apoptosis is not reduced. Thus, it is likely that the inhibitory effects of G-quadruplexes observed to date were more pronounced due to the use of the strong overexpression in transfection experiments, whereas G-quadruplexes in endogenous mRNAs, expressed at moderate levels, are widely resolved by cellular RNA helicases.	[Serikawa, Tatsuo; Kurreck, Jens] Berlin Univ Technol, Inst Biotechnol, Dept Appl Biochem, TIB 4-3-2,Gustav Meyer Allee 25, D-13355 Berlin, Germany; [Eberle, Juergen] Charite, Dept Dermatol Venerol & Allergol, Canc Ctr Charite, Berlin, Germany	Kurreck, J (reprint author), Berlin Univ Technol, Inst Biotechnol, Dept Appl Biochem, TIB 4-3-2,Gustav Meyer Allee 25, D-13355 Berlin, Germany.	jens.kurreck@tu-berlin.de			Deutsche Forschungsgemeinschaft [DFG Ku 1436/7-1]	The authors are thankful to Erik Wade for valuable comments and careful proofreading of the manuscript and to Toni Cathomen, Florian Heydt and Regina Kanski for initial support with the design of CRISPR/Cas9 experiments. Furthermore, they want to thank Bernd Krostitz for technical assistance. Financial support by the Deutsche Forschungsgemeinschaft (DFG Ku 1436/7-1) is gratefully acknowledged.	Agarwala P, 2015, ORG BIOMOL CHEM, V13, P5570, DOI 10.1039/c4ob02681k; Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Balkwill GD, 2009, BIOCHEMISTRY-US, V48, P11487, DOI 10.1021/bi901420k; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; BECK F, 1982, KIDNEY INT, V22, P250, DOI 10.1038/ki.1982.162; Bensaid M, 2009, NUCLEIC ACIDS RES, V37, P1269, DOI 10.1093/nar/gkn1058; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chen SB, 2016, J AM CHEM SOC, V138, P10382, DOI 10.1021/jacs.6b04799; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; CoustanSmith E, 1996, BLOOD, V87, P1140; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177                                                           ; Gomez D, 2010, NUCLEIC ACIDS RES, V38, P7187, DOI 10.1093/nar/gkq563; Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371; Halder K, 2012, METHODS, V57, P115, DOI 10.1016/j.ymeth.2012.02.005; Halder K, 2011, METAL IONS LIFE SCI, V9, P125, DOI 10.1039/978184973251200125; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Krajewska M, 1996, AM J PATHOL, V148, P1567; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Monni O, 1997, BLOOD, V90, P1168; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Ocker M, 2005, GUT, V54, P1298, DOI 10.1136/gut.2004.056192; Olejniczak ET, 2007, MOL CANCER RES, V5, P331, DOI 10.1158/1541-7786.MCR-06-0367; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; von Hacht A, 2014, NUCLEIC ACIDS RES, V42, P6630, DOI 10.1093/nar/gku290; Wang XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.95; Zaja F, 1998, LEUKEMIA LYMPHOMA, V28, P567, DOI 10.3109/10428199809058365                                                       	42	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	NOV	2017	591	21					3649	3659		10.1002/1873-3468.12855				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FM5DT	WOS:000415051300016	28940390				2018-01-05	
J	Prior, H; Jawad, AK; MacConnachie, L; Beg, AA				Prior, Harriet; Jawad, Ali K.; MacConnachie, Lauren; Beg, Asim A.			Highly Efficient, Rapid and Co-CRISPR-Independent Genome Editing in Caenorhabditis elegans	G3-GENES GENOMES GENETICS			English	Article						CRISPR; Cas9; ribonucleoprotein; Caenorhabditis elegans; disease variants	INTEGRATION; KNOCKOUT; TARGET	We describe a rapid and highly efficient method to generate point mutations in Caenorhabditis elegans using direct injection of CRISPR-Cas9 ribonucleoproteins. This versatile method does not require sensitized genetic backgrounds or co-CRISPR selection-based methods, and represents a single strategy that can be used for creating genomic point mutations, regardless of location. As proof of principle, we show that knock-in mutants more faithfully report variant-associated phenotypes as compared to transgenic overexpression. Data for nine knock-in mutants across five genes are presented that demonstrate high editing efficiencies (60%), a reduced screening workload (24 F1 progeny), and a rapid timescale (4-5 d). This optimized method simplifies genome engineering and is readily adaptable to other model systems.	[Prior, Harriet; Jawad, Ali K.; Beg, Asim A.] Univ Michigan, Neurosci Program, 1150 W Med Ctr Dr,1220D MSRB 3, Ann Arbor, MI 48109 USA; [MacConnachie, Lauren; Beg, Asim A.] Univ Michigan, Dept Pharmacol, 1150 W Med Ctr Dr,1220D MSRB 3, Ann Arbor, MI 48109 USA	Beg, AA (reprint author), Univ Michigan, 1150 W Med Ctr Dr,1220D MSRB 3, Ann Arbor, MI 48109 USA.	asimbeg@umich.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; Muscular Dystrophy Association [MDA382300]; National Institute of Neurological Disease and Stroke [NS094678]	We thank Georgina Nicholl for critical reading of the manuscript, expert technical assistance and suggestions. We thank Kevin Holden (Synthego, Inc.) for generously sharing unpublished data. Strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). A.A.B. is supported by grants from the Muscular Dystrophy Association (MDA382300) and the National Institute of Neurological Disease and Stroke (NS094678). The authors declare no competing financial interests.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Boyd SD, 2014, GENES-BASEL, V5, P748, DOI 10.3390/genes5030748; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Evans T. C, 2006, TRANSFORMATION MICRO, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1]; Frokjaer-Jensen C, 2013, GENETICS, V195, P635, DOI 10.1534/genetics.113.156521; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Jobson MA, 2015, J NEUROSCI, V35, P2803, DOI 10.1523/JNEUROSCI.4557-14.2015; Ma DY, 2015, GENOM PROTEOM BIOINF, V13, P336, DOI 10.1016/j.gpb.2015.12.001; MELLO CC, 1991, EMBO J, V10, P3959; Minikel EV, 2016, NEURON, V92, P336, DOI 10.1016/j.neuron.2016.09.054; Nicholl GCB, 2017, BRIT J PHARMACOL, V174, P781, DOI 10.1111/bph.13736; Paix A, 2017, METHODS, V121, P86, DOI 10.1016/j.ymeth.2017.03.023; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sugi T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030295	20	0	0	5	5	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	NOV	2017	7	11					3693	3698		10.1534/g3.117.300216				6	Genetics & Heredity	Genetics & Heredity	FL7ZI	WOS:000414469000012	28893845	gold			2018-01-05	
J	Numamoto, M; Maekawa, H; Kaneko, Y				Numamoto, Minori; Maekawa, Hiromi; Kaneko, Yoshinobu			Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast &ITOgataea polymorpha&IT	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						CRISPR/Cas9; Genome editing; Ogataea polymorpha; tRNA processing; Methylotrophic yeast	HANSENULA-POLYMORPHA; CAS SYSTEMS; MULTIPLEX; ENDONUCLEASE; GENES	The methylotrophic yeast Ogataea polymorpha (syn. Hansenula polymorpha) is an attractive industrial non-conventional yeast showing high thermo-tolerance (up to 50 degrees C) and xylose assimilation. However, genetic manipulation of O. polymorpha is often laborious and time-consuming because it has lower homologous recombination efficiency relative to Saccharomyces cerevisiae. To overcome this disadvantage, we applied the CRISPR/Cas9 system as a powerful genome editing tool in O. polymorpha. In this system, both single guide RNA (sgRNA) and endonuclease Cas9 were expressed by a single autonomously-replicable plasmid and the sgRNA portion could be easily changed by using PCR and In-Fusion cloning techniques. Because the mutation efficiency of the CRISPR/Cas9 system was relatively low when the sgRNA was expressed under the control of the OpSNR6 promoter, the tRNA(CUG) gene was used for sgRNA expression. The editing efficiency of this system ranged from 17% to 71% of transformants in several target genes tested (ADE12, PHO1, PHO11, and PHO84). These findings indicate that genetic manipulation of O. polymorpha will be more convenient and accelerated by using this CRISPR/Cas9 system. (C) 2017, The Society for Biotechnology, Japan. All rights reserved.	[Numamoto, Minori; Maekawa, Hiromi; Kaneko, Yoshinobu] Osaka Univ, Grad Sch Engn, Yeast Genet Resources Lab, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan	Kaneko, Y (reprint author), Osaka Univ, Grad Sch Engn, Yeast Genet Resources Lab, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kaneko@bio.eng.osaka-u.ac.jp			Endowed Chair Funding of the Institute for Fermentation, Osaka (IFO), Japan	This work was financially supported by the Endowed Chair Funding (2011) of the Institute for Fermentation, Osaka (IFO), Japan. The authors thank the National BioResource Project Japan (YGRC/NBRP) for yeast strains and Addgene for primary CRISPR/Cas9 plasmids of S. cerevisiae.	BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229                                                           ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; GLEESON MA, 1988, YEAST, V4, P293, DOI 10.1002/yea.320040407                                                           ; Gonzalez C, 1999, YEAST, V15, P1323, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1323::AID-YEA459>3.0.CO;2-1; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kimura Y., 2014, SCI REP, V4, P1; Kurtzman CP, 2011, ANTON LEEUW INT J G, V100, P455, DOI 10.1007/s10482-011-9603-0; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maekawa H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004796; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ravin NV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-837; Ryabova EB, 2003, FEMS YEAST RES, V4, P157, DOI 10.1016/S1567-1356(03)00146-6; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Saraya R, 2012, FEMS YEAST RES, V12, P271, DOI 10.1111/j.1567-1364.2011.00772.x; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Stockmann C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-22; VANDERKLEI IJ, 1991, ARCH MICROBIOL, V156, P15, DOI 10.1007/BF00418181                                                              ; Weninger A, 2016, J BIOTECHNOL, V235, P139, DOI 10.1016/j.jbiotec.2016.03.027; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhou Y, 2016, CURR GENET, V62, P595, DOI 10.1007/s00294-016-0565-7	30	0	0	15	15	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2017	124	5					487	492		10.1016/j.jbiosc.2017.06.001				6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	FM0AD	WOS:000414620300001	28666889				2018-01-05	
J	Patel, SB; Kadi, W; Walts, AE; Marchevsky, AM; Pao, A; Aguiluz, A; Mudalige, T; Liu, ZQ; Deng, N; Lopategui, J				Patel, Snehal B.; Kadi, Wendy; Walts, Ann E.; Marchevsky, Alberto M.; Pao, Andy; Aguiluz, Angela; Mudalige, Tudor; Liu, Zhenqui; Deng, Nan; Lopategui, Jean			Next-Generation Sequencing A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases	JOURNAL OF MOLECULAR DIAGNOSTICS			English	Article							FORTHCOMING 8TH EDITION; PROJECT BACKGROUND DATA; TNM CLASSIFICATION; INTRATUMORAL HETEROGENEITY; MULTIPLE FOCI; CANCER; MUTATIONS; PROPOSALS; CARCINOMA; TUMORS	Distinguishing between multiple Lung primary tumors and intrapulmonary metastases is imperative for accurate staging. The American Joint Committee on Cancer (AJCC) criteria are routinely used for this purpose but can yield equivocal conclusions. This study evaluated whether next-generation sequencing (NGS) using the 50-gene AmpliSeq Cancer Hotspot Panel version 2 can help facilitate this distinction. NGS was performed on known primary-metastatic pairs (8 patients) and multiple lung adenocarcinomas (11 patients). Primary-metastatic pairs had high mutational concordance. Seven pairs shared mutations, and 1 was concordant for having no mutations. Driver mutations in KRAS (n = 4), EGFR (n = 2), and BRAF (n = 1) were always concordant. Multiple lung tumors from 3 patients were completely concordant and predicted by NGS to be intrapulmonary metastases, whereas 8 had completely discordant mutations and were predicted to be independent primary tumors. The NGS prediction correlated with the AJCC (eighth edition) prediction in all patients for whom the latter was unequivocal (8 of 11). Furthermore, it separated patients by overall survival. Patients with predicted multiple independent primary tumors by NGS had better survival than those with distant metastases (P = 0.016, log-rank test), whereas those with predicted intrapulmonary metastases had no difference (P = 0.527). With further validation, the 50-gene panel has the potential to serve as an adjunct to the AJCC criteria.	[Patel, Snehal B.; Kadi, Wendy; Walts, Ann E.; Marchevsky, Alberto M.; Pao, Andy; Aguiluz, Angela; Mudalige, Tudor; Lopategui, Jean] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Pathol & Lab Med, 8700 Beverly Blvd,SSB 362, Los Angeles, CA 90048 USA; [Liu, Zhenqui; Deng, Nan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Res Ctr, 8700 Beverly Blvd,SSB 362, Los Angeles, CA 90048 USA; NCI, Pathol Lab, Mol Diagnost Sect, NIH, Bldg 10, Bethesda, MD 20892 USA	Lopategui, J (reprint author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Pathol & Lab Med, 8700 Beverly Blvd,SSB 362, Los Angeles, CA 90048 USA.	jean.lopategui@cshs.org			Cedars-Sinai Medical Center Department of Pathology and Laboratory Medicine	Supported by the Cedars-Sinai Medical Center Department of Pathology and Laboratory Medicine. License for use of the lung and trachea clipart was purchased from the Florida Center for Instructional Technology.	Alsdorf WH, 2013, EXP MOL PATHOL, V94, P155, DOI 10.1016/j.yexmp.2012.09.016; Arai J, 2012, LUNG CANCER, V77, P281, DOI 10.1016/j.lungcan.2012.04.003; Bauml J, 2013, LUNG CANCER, V81, P347, DOI 10.1016/j.lungcan.2013.05.011; Chen DL, 2015, ONCOL LETT, V9, P1081, DOI 10.3892/ol.2015.2880; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dacic S, 2012, ARCH PATHOL LAB MED, V136, P1194, DOI 10.5858/arpa.2012-0282-CC; Desmedt C, 2015, J PATHOL, V236, P457, DOI 10.1002/path.4540; Detterbeck FC, 2016, J THORAC ONCOL, V11, P681, DOI 10.1016/j.jtho.2015.12.114; Detterbeck FC, 2016, J THORAC ONCOL, V11, P666, DOI 10.1016/j.jtho.2015.12.113; Detterbeck FC, 2016, J THORAC ONCOL, V11, P651, DOI 10.1016/j.jtho.2016.01.025; Detterbeck FC, 2016, J THORAC ONCOL, V11, P639, DOI 10.1016/j.jtho.2016.01.024; Fonseca A, 2014, LUNG CANCER, V85, P7, DOI 10.1016/j.lungcan.2014.02.014; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gazdar AF, 2009, J NATL CANCER I, V101, P541, DOI 10.1093/jnci/djp059; Geurts-Giele WRR, 2013, VIRCHOWS ARCH, V462, P249, DOI 10.1007/s00428-012-1346-4; Girard N, 2009, CLIN CANCER RES, V15, P5184, DOI 10.1158/1078-0432.CCR-09-0594; Henschke CI, 2001, ONCOLOGIST, V6, P147, DOI 10.1634/theoncologist.6-2-147                                                   ; Homer RJ, 2015, AM J CLIN PATHOL, V143, P701, DOI 10.1309/AJCPNBWF55VGKOIW; Huang J, 2001, Ann Diagn Pathol, V5, P321, DOI 10.1053/adpa.2001.29338; Improta G, 2016, ONCOL LETT, V11, P393, DOI 10.3892/ol.2015.3863; Johnson BE, 1998, J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; Johnson BE, 1997, SEMIN ONCOL, V24, P492; Kim HK, 2014, ANTICANCER RES, V34, P707; Kinsey CM, 2014, LUNG CANCER, V84, P145, DOI 10.1016/j.lungcan.2014.02.002; Kunze K, 2014, HISTOPATHOLOGY, V64, P1041, DOI 10.1111/his.12352; Lee B, 2016, ONCOTARGET, V7, P23874, DOI 10.18632/oncotarget.8074; LI ZH, 1994, AM J PATHOL, V144, P303; Lou F, 2013, J THORAC CARDIOV SUR, V145, P75, DOI 10.1016/j.jtcvs.2012.09.030; Lou Yanyan, 2016, Clin Lung Cancer, V17, pe5, DOI 10.1016/j.cllc.2015.11.003; Loukeri AA, 2015, CLIN LUNG CANCER, V16, P15, DOI 10.1016/j.cllc.2014.07.001; Lu ZM, 2016, J PATHOL, V239, P72, DOI 10.1002/path.4696; Mattsson JSM, 2012, HISTOPATHOLOGY, V61, P744, DOI 10.1111/j.1365-2559.2012.04245.x; Murphy SJ, 2014, J CLIN ONCOL, V32, P4050, DOI 10.1200/JCO.2014.56.7644; Picozzi G, 2005, RADIOL MED, V109, P17; Rami-Porta R, 2017, AJCC CANC STAGING MA, P431; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; Shen C, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0109-5; Sherwood J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0207-9; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9                                                   ; SOZZI G, 1995, CANCER RES, V55, P135; Torre Lindsey A, 2016, Adv Exp Med Biol, V893, P1, DOI 10.1007/978-3-319-24223-1_1; van Rens MTM, 2002, CANCER-AM CANCER SOC, V94, P188, DOI 10.1002/cncr.10001; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Waits AE, 2016, AM J CLIN PATHOL, V145, P244, DOI 10.1093/ajcp/aqv025; Wang XY, 2009, J NATL CANCER I, V101, P560, DOI 10.1093/jnci/djp054; Warrick JI, 2015, VIRCHOWS ARCH, V466, P297, DOI 10.1007/s00428-014-1699-y; Warth A, 2012, EUR RESPIR J, V39, P1437, DOI 10.1183/09031936.00105911; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Yu HA, 2014, J THORAC ONCOL, V9, P554, DOI 10.1097/JTO.0000000000000052	51	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-1578	1943-7811		J MOL DIAGN	J. Mol. Diagn.	NOV	2017	19	6					870	880		10.1016/j.jmoldx.2017.07.006				11	Pathology	Pathology	FL5KO	WOS:000414275900009	28866070				2018-01-05	
J	Zheng, QF; Bai, L; Zheng, SJ; Liu, M; Zhang, JY; Wang, T; Xu, ZW; Chen, Y; Li, JS; Duan, ZP				Zheng, Qingfen; Bai, Li; Zheng, Sujun; Liu, Mei; Zhang, Jinyan; Wang, Ting; Xu, Zhongwei; Chen, Yu; Li, Jiansheng; Duan, Zhongping			Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system	MOLECULAR MEDICINE REPORTS			English	Article						CRISPR/cas9; duck hepatitis B virus; hepatitis B virus; covalently closed circular DNA; antivirus	GUIDED CAS9 NUCLEASE; GENOME; INFECTION; CCCDNA; ENDONUCLEASE; REPLICATION; CRISPR-CAS9; CLEAVAGE; LATENT; STEP	Current therapeutic strategies cannot eradicate hepatitis B virus covalently closed circular DNA (HBV cccDNA), which accounts for the persistence of HBV infection. Very recently, the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system has been used as an efficient and powerful tool for viral genome editing. Given that the primary duck hepatocyte (PDH) infected with duck hepatitis B virus (DHBV) has been widely used to study human HBV infection in vitro, the present study aimed to demonstrate the targeted inhibition of DHBV DNA, especially cccDNA, by the CRISPR/Cas9 system using this model. We designed six single-guide RNAs (sgRNA1-6) targeting the DHBV genome. The sgRNA/Cas9 plasmid was transfected into DHBV-infected PDHs, and then DHBV total DNA (in culture medium and PDHs) and cccDNA were quantified by reverse transcription-quantitative polymerase chain reaction. The combined inhibition of CRISPR/Cas9 system and entecavir (ETV) was also assessed. Two sgRNAs, sgRNA4 and sgRNA6, exhibited efficient inhibition on DHBV total DNA (77.23 and 86.51%, respectively), cccDNA (75.67 and 85.34%, respectively) in PDHs, as well as DHBV total DNA in the culture medium (62.17 and 59.52%, respectively). The inhibition remained or enhanced from day 5 to day 9 following transfection. The combination of the CRISPR/Cas9 system and ETV further increased the inhibitory effect on DHBV total DNA in PDHs and culture medium, but not cccDNA. The CRISPR/Cas9 system has the potential to be a useful tool for the suppression of DHBV DNA.	[Zheng, Qingfen; Bai, Li; Zheng, Sujun; Liu, Mei; Zhang, Jinyan; Wang, Ting; Chen, Yu; Duan, Zhongping] Capital Med Univ, Beijing Youan Hosp, Artificial Liver Ctr, 8 Xitoutiao Rd, Beijing 100069, Peoples R China; [Zheng, Qingfen; Li, Jiansheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, 1 Jianshe E Rd, Zhengzhou 450052, Henan, Peoples R China; [Zheng, Qingfen] Xinxiang Med Coll, Affiliated Hosp 1, Dept Gastroenterol, Weihui 410781, Henan, Peoples R China; [Xu, Zhongwei] Univ Penn, Penn Hosp, Dept Gastroenterol, Philadelphia, PA 19104 USA	Duan, ZP (reprint author), Capital Med Univ, Beijing Youan Hosp, Artificial Liver Ctr, 8 Xitoutiao Rd, Beijing 100069, Peoples R China.; Li, JS (reprint author), Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, 1 Jianshe E Rd, Zhengzhou 450052, Henan, Peoples R China.	lijiansheng@medmail.com.cn; duan2517@163.com			National Science and Technology Key Project [2017ZX10201201, 2017ZX10203201-005, 2017ZX10202203-006-001, 2017ZX10302201-004-002]; Beijing Municipal Administration of Hospital's Ascent Plan [DFL20151601]; Beijing Municipal Science and Technology Commission [Z151100004015066]; Capital Medical University [15JL67, 17JL47]; YouAn Fund for Liver Diseases and AIDS [YNKT20160012]	The present study was supported by the National Science and Technology Key Project (grant nos. 2017ZX10201201, 2017ZX10203201-005, 2017ZX10202203-006-001 and 2017ZX10302201-004-002), the Beijing Municipal Administration of Hospital's Ascent Plan (grant no. DFL20151601), the Beijing Municipal Science and Technology Commission (grant no. Z151100004015066), the Basic-Clinical Cooperation Project of Capital Medical University (grant nos. 15JL67 and 17JL47) and the YouAn Fund for Liver Diseases and AIDS (grant no. YNKT20160012).	Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, NAT BIOTECHNOL, V30, P836, DOI 10.1038/nbt.2357; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Jilbert AR, 1998, VIROLOGY, V244, P273, DOI 10.1006/viro.1998.9095                                                          ; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Komatsu H, 2014, WORLD J GASTROENTERO, V20, P8998, DOI 10.3748/wjg.v20.i27.8998; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Marion PL, 2002, ANTIMICROB AGENTS CH, V46, P82, DOI 10.1128/AAC.46.1.82-88.2002; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Shen H, 2014, BIOMED RES INT; TUTTLEMAN JS, 1986, J VIROL, V58, P17; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang YY, 2005, J VIROL, V79, P9896, DOI 10.1128/JVI.79.15.9896-9903.2005; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2	30	0	0	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2017	16	5					7199	7204		10.3892/mmr.2017.7518				6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	FM0ZU	WOS:000414698900191	28944845				2018-01-05	
J	Borel, F; Tang, QS; Gernoux, G; Greer, C; Wang, ZQ; Barzel, A; Kay, MA; Shultz, LD; Greiner, DL; Flotte, TR; Brehm, MA; Mueller, C				Borel, Florie; Tang, Qiushi; Gernoux, Gwladys; Greer, Cynthia; Wang, Ziqiong; Barzel, Adi; Kay, Mark A.; Shultz, Leonard D.; Greiner, Dale L.; Flotte, Terence R.; Brehm, Michael A.; Mueller, Christian			Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of alpha-1 Antitrypsin Deficiency	MOLECULAR THERAPY			English	Article							ALPHA1-ANTITRYPSIN DEFICIENCY; TRANSGENIC MICE; LIVER; DISEASE; TRIAL; AUGMENTATION; ACCUMULATION; INDIVIDUALS; INHIBITOR; MECHANISM	Hepatocytes represent an important target for gene therapy and editing of single-gene disorders. In alpha-1 antitrypsin (AAT) deficiency, one missense mutation results in impaired secretion of AAT. In most patients, lung damage occurs due to a lack of AAT-mediated protection of lung elastin from neutrophil elastase. In some patients, accumulation of misfolded PiZ mutant AAT protein triggers hepatocyte injury, leading to inflammation and cirrhosis. We hypothesized that correcting the Z mutant defect in hepatocytes would confer a selective advantage for repopulation of hepatocytes within an intact liver. A human PiZ allele was crossed onto an immune-deficient (NSG) strain to create a recipient strain (NSG-PiZ) for human hepatocyte xenotransplantation. Results indicate that NSG-PiZ recipients support heightened engraftment of normal human primary hepatocytes as compared with NSG recipients. This model can therefore be used to test hepatocyte cell therapies for AATD, but more broadly it serves as a simple, highly reproducible liver xenograft model. Finally, a promoterless adeno-associated virus (AAV) vector, expressing a wild-type AAT and a synthetic miRNA to silence the endogenous allele, was integrated into the albumin locus: This gene-editing approach leads to a selective advantage of edited hepatocytes, by silencing the mutant protein and augmenting normal AAT production, and improvement of the liver pathology.	[Borel, Florie; Tang, Qiushi; Gernoux, Gwladys; Greer, Cynthia; Wang, Ziqiong; Flotte, Terence R.; Mueller, Christian] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; [Borel, Florie; Tang, Qiushi; Gernoux, Gwladys; Greer, Cynthia; Wang, Ziqiong; Flotte, Terence R.; Mueller, Christian] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA 01605 USA; [Barzel, Adi] LogicBio Therapeut Inc, Cambridge, MA 02139 USA; [Barzel, Adi] Tel Aviv Univ, Dept Biochem & Mol Biol, George S Wise Fac Life Sci, IL-6997801 Tel Aviv, Israel; [Barzel, Adi; Kay, Mark A.] Stanford Med Sch, Dept Pediat, Stanford, CA 94305 USA; [Barzel, Adi; Kay, Mark A.] Stanford Med Sch, Dept Genet, Stanford, CA 94305 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Brehm, MA; Mueller, C (reprint author), Univ Massachusetts, Sch Med, 368 Plantat St, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu; chris.mueller@umassmed.edu		Borel, Florie/0000-0002-8171-6195	Office of the Director of the NIH [1R240D018259-01]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH [1R01DK098252-01]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [1P01HL131471-01, R01 HL064274]; Alpha-1 Foundation; Cancer Core grant [CA034196]	We thank Ann Fu at the University of Florida Molecular Pathology Core for her assistance with histology and the UMMS Flow Cytometry Core Facility, David Perlmutter, and Ira Fox for providing L.D.S. with the STOCK-PiZ mice. This research was supported by the Office of the Director of the NIH (1R240D018259-01 to D.L.G., C.M., M.A.B., and L.D.S.), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH (1R01DK098252-01 to C.M. and T.R.F.), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH (1P01HL131471-01 and 1P01HL131471-01 to C.M. and R01 HL064274 to M.K.), and an Alpha-1 Foundation postdoctoral fellowship (to F.B.) and research grant (to C.M.). L.D.S. was supported by a Cancer Core grant (CA034196) to The Jackson Laboratory. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of this work was funded by LogicBio Therapeutics.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Baligar P, 2017, HEPATOLOGY, V65, P1319, DOI [10.1002/hep.29027/suppinfo, 10.1002/hep.29027]; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; BRANTLY M, 1988, AM J MED, V84, P13; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; Chapman KR, 2015, LANCET, V386, P360, DOI 10.1016/S0140-6736(15)60860-1; Chiuchiolo MJ, 2014, HUM GENE THER CL DEV, V25, P112, DOI 10.1089/humc.2014.2513; Chiuchiolo MJ, 2013, HUM GENE THER CL DEV, V24, P161, DOI 10.1089/humc.2013.168; Dawwas MF, 2013, AM J RESP CRIT CARE, V187, P502, DOI 10.1164/rccm.201204-0739OC; de Serres FJ, 2002, CHEST, V122, P1818, DOI 10.1378/chest.122.5.1818; Ding JQ, 2011, J CLIN INVEST, V121, P1930, DOI 10.1172/JCI45260; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x                                              ; Li SY, 2015, MOL THER, V23, P1867, DOI 10.1038/mt.2015.174; Lindblad D, 2007, HEPATOLOGY, V46, P1228, DOI 10.1002/hep.21822; Ling C, 2010, HUM GENE THER, V21, P1741, DOI 10.1089/hum.2010.075; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; McElvaney NG, 2017, LANCET RESP MED, V5, P51, DOI 10.1016/S2213-2600(16)30430-1; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mueller C, 2013, J CLIN INVEST, V123, P5310, DOI 10.1172/JCI70314; Mueller C, 2013, COPD, V10, P44, DOI 10.3109/15412555.2013.764978; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; NEMETH A, 1982, ACTA PAEDIATR SCAND, V71, P1001, DOI 10.1111/j.1651-2227.1982.tb09563.x; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Piccolo P, 2017, HEPATOLOGY, V66, P124, DOI 10.1002/hep.29160; Shah M, 2005, AM J PHYSIOL-CELL PH, V288, pC850, DOI 10.1152/ajpcell.00327.2004; SHARP HL, 1976, GASTROENTEROLOGY, V70, P611; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477                                                    ; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	32	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	NOV 1	2017	25	11					2477	2489		10.1016/j.ymthe.2017.09.020				13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FM1GZ	WOS:000414723500008	29032169	gold			2018-01-05	
J	Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; Del Rio, M; Duarte, B; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U				Hainzl, Stefan; Peking, Patricia; Kocher, Thomas; Murauer, Eva M.; Larcher, Fernando; Del Rio, Marcela; Duarte, Blanca; Steiner, Markus; Klausegger, Alfred; Bauer, Johann W.; Reichelt, Julia; Koller, Ulrich			COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa	MOLECULAR THERAPY			English	Article							PLURIPOTENT STEM-CELLS; IN-VIVO; GENE-THERAPY; MINICIRCLE DNA; MOUSE MODEL; REPAIR; DISEASE; TRANSPLANTATION; CRISPR-CAS9; MECHANISMS	Designer nucleases allow specific and precise genomic modifications and represent versatile molecular tools for the correction of disease-associated mutations. In this study, we have exploited an ex vivo CRISPR/Cas9-mediated homology-directed repair approach for the correction of a frequent inherited mutation in exon 80 of COL7A1, which impairs type VII collagen expression, causing the severe blistering skin disease recessive dystrophic epidermolysis bullosa. Upon CRISPR/Cas9 treatment of patient-derived keratinocytes, using either the wild-type Cas9 or DIOA nickase, corrected single-cell clones expressed and secreted similar levels of type VII collagen as control keratinocytes. Transplantation of skin equivalents grown from corrected keratinocytes onto immunodeficient mice showed phenotypic reversion with normal localization of type VII collagen at the basement membrane zone, compared with uncorrected keratinocytes, as well as fully stratified and differentiated skin layers without indication of blister development. Next-generation sequencing revealed on-target efficiency of up to 30%, whereas nuclease-mediated off-target site modifications at predicted genomic loci were not detected. These data demonstrate the potential of the CRISPR/Cas9 technology as a possible ex vivo treatment option for genetic skin diseases in the future.	[Hainzl, Stefan; Peking, Patricia; Kocher, Thomas; Murauer, Eva M.; Klausegger, Alfred; Reichelt, Julia; Koller, Ulrich] Paracelsus Med Univ, Univ Hosp, Res Program Mol Therapy Genodermatoses, EB House Austria,Dept Dermatol, A-5020 Salzburg, Austria; [Larcher, Fernando; Del Rio, Marcela; Duarte, Blanca] Fdn Jimenez Diaz, Inst Invest Sanitaria, UC3M, Epithelial Biomed Div,CIEMAT CIBERER,Dept Bioengn, E-28040 Madrid, Spain; [Steiner, Markus] Paracelsus Med Univ, Oncol Ctr, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Infect Dis, A-5020 Salzburg, Austria; [Bauer, Johann W.] Paracelsus Med Univ, Univ Hosp, Dept Dermatol, A-5020 Salzburg, Austria	Koller, U (reprint author), Paracelstis Med Univ Salzburg, Dept Dermatol, Univ Hosp, EB House Austria, Strubergasse 22, A-5020 Salzburg, Austria.	u.koller@salk.at		Koller, Ulrich/0000-0002-6285-1789	DEBRA Austria; Spanish MINECO [PI14/00931, SAF2013-43475-R]	We thank Dr. Andrea Zurl from the University Clinic of Ophthalmology and Optometry (Salzburg, Austria) for offering microscopy analysis. Special thanks to Univ.-Prof. Dr. Eva Rohde and Karin Roider, MSc, of the Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS) for providing their Core Facility for Microscopy. Furthermore, we thank Dr. Alexander Nystrom from the Department of Dermatology, University Medical Center (Freiburg, Germany), for providing the anti-type VII collagen antibody, as well as Dr. Langbein from DKFZ (Heidelberg, Germany) for providing the anti-human K16 antibody. The work was supported by DEBRA Austria. F.L. and M.D.R. were supported by grants PI14/00931 and SAF2013-43475-R, respectively, from the Spanish MINECO.	Bauer JW, 2017, J INVEST DERMATOL, V137, P778, DOI 10.1016/j.jid.2016.10.038; Biffi A, 2015, CELL STEM CELL, V16, P348, DOI 10.1016/j.stem.2015.03.009; Chamorro C, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.19; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Cuadrado-Corrales N, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-139; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garcia M, 2011, J INVEST DERMATOL, V131, P1053, DOI 10.1038/jid.2010.353; Garcia M, 2010, AM J PATHOL, V177, P865, DOI 10.2353/ajpath.2010.091096; Guitart JR, 2016, J INVEST DERMATOL, V136, pE87, DOI 10.1016/j.jid.2016.06.007; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hung SSC, 2016, PROG RETIN EYE RES, V53, P1, DOI 10.1016/j.preteyeres.2016.05.001; Kern JS, 2009, MOL THER, V17, P1605, DOI 10.1038/mt.2009.144; Lwin S.M., 2017, GENE THERAPY INHERIT; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; March O. P., 2017, EXP PHYSL; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Murauer EM, 2011, J INVEST DERMATOL, V131, P74, DOI 10.1038/jid.2010.249; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Peking P, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.3; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rashidghamat E, 2017, INTRACTABLE RARE DIS, V6, P6, DOI 10.5582/irdr.2017.01005; Rio P, 2014, EMBO MOL MED, V6, P835, DOI 10.15252/emmm.201303374; Schwieger-Briel A, 2015, BRIT J DERMATOL, V173, P1308, DOI 10.1111/bjd.13945; Sebastiano V, 2014, SCI TRANSL MED, V6; Shinkuma S, 2016, P NATL ACAD SCI USA, V113, P5676, DOI 10.1073/pnas.1512028113; Siprashvili Z, 2016, JAMA-J AM MED ASSOC, V316, P1808, DOI 10.1001/jama.2016.15588; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Titeux M, 2010, MOL THER, V18, P1509, DOI 10.1038/mt.2010.91; Tockner B, 2016, GENE THER, V23, P775, DOI 10.1038/gt.2016.57; Valletta S, 2015, ONCOTARGET, V6, P44061, DOI 10.18632/oncotarget.6392; Wang QT, 2014, J VIROL, V88, P1924, DOI 10.1128/JVI.02757-13; Webber BR, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.14; Wertheim-Tysarowska K, 2012, HUM MUTAT, V33, P327, DOI 10.1002/humu.21651; Wu WB, 2017, P NATL ACAD SCI USA, V114, P1660, DOI 10.1073/pnas.1614775114; [郑武 Zheng Wu], 2015, [遗传, Hereditas(Beijing)], V37, P1003, DOI 10.16288/j.yczz.15-070	46	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	NOV 1	2017	25	11					2573	2584		10.1016/j.ymthe.2017.07.005				12	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FM1GZ	WOS:000414723500016	28800953				2018-01-05	
J	Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U				Kocher, Thomas; Peking, Patricia; Klausegger, Alfred; Murauer, Eva Maria; Hofbauer, Josefina Pinon; Wally, Verena; Lettner, Thomas; Hainzl, Stefan; Ablinger, Michael; Bauer, Johann Wolfgang; Reichelt, Julia; Koller, Ulrich			Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases	MOLECULAR THERAPY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; EPIDERMAL STEM-CELLS; GENE-THERAPY; KERATINOCYTES; TRANSPLANTATION; ENDONUCLEASE; KERATIN-14; DISORDERS; FAMILY; SAFETY	With the ability to induce rapid and efficient repair of disease causing mutations, CRISPR/Cas9 technology is ideally suited for gene therapy approaches for recessively and dominantly inherited monogenic disorders. In this study, we have corrected a causal hotspot mutation in exon 6 of the keratin 14 gene (KRT14) that results in generalized severe epidermolysis bullosa simplex (EBS-gen sev), using a double-nicking strategy targeting intron 7, followed by homology-directed repair (HDR). Co-delivery into EBS keratinocytes of a Cas9 D10A nickase (Cas9n), a predicted single guide RNA pair specific for intron 7, and a minicircle donor vector harboring the homology donor template resulted in a recombination efficiency of >30% and correction of the mutant KRT14 allele. Phenotypic correction of EBS-gen sev keratinocytes was demonstrated by immunofluorescence analysis, revealing the absence of disease-associated K14 aggregates within the cytoplasm. We achieved a promising safety profile for the CRISPR/Cas9 double-nicking approach, with no detectable off-target activity for a set of predicted off-target genes as confirmed by next generation sequencing. In conclusion, we demonstrate a highly efficient and specific gene-editing approach for KRT14, offering a causal treatment option for EBS.	[Kocher, Thomas; Peking, Patricia; Klausegger, Alfred; Murauer, Eva Maria; Hofbauer, Josefina Pinon; Wally, Verena; Lettner, Thomas; Hainzl, Stefan; Ablinger, Michael; Reichelt, Julia; Koller, Ulrich] Paracelsus Med Univ Salzburg, Univ Hosp, Res Program Mol Therapy Genodermatoses, EB House Austria,Dept Dermatol, A-5020 Salzburg, Austria; [Bauer, Johann Wolfgang] Paracelsus Med Univ Salzburg, Univ Hosp, Dept Dermatol, A-5020 Salzburg, Austria	Koller, U (reprint author), Paracelsus Med Univ Salzburg, Univ Hosp, Dept Dermatol, EB House Austria, Strubergasse 22, A-5020 Salzburg, Austria.	u.koller@salk.at		Koller, Ulrich/0000-0002-6285-1789	DEBRA Austria	The authors thank Franz Zimmermann for his suggestions and critical scientific input. Special thanks to Univ.-Prof. Dr. Eva Rohde and Karin Roider, MSc, of the Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS) for providing their Core Facility for Microscopy. This work was supported by DEBRA Austria.	Abitbol RJ, 2009, ARCH DERMATOL, V145, P13, DOI 10.1001/archdermatol.2008.546; Aushev M, 2017, MOL THER-METH CLIN D, V6, P112, DOI 10.1016/j.omtm.2017.06.008; Bauer JW, 2017, J INVEST DERMATOL, V137, P778, DOI 10.1016/j.jid.2016.10.038; Bloom K, 2017, METHODS MOL BIOL, V1540, P85, DOI 10.1007/978-1-4939-6700-1_8; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; Chamcheu JC, 2011, J INVEST DERMATOL, V131, P1684, DOI 10.1038/jid.2011.93; Chiaverini C, 2015, BRIT J DERMATOL, V173, P563, DOI 10.1111/bjd.13672; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Duarte B, 2014, MOL THER, V22, P1878, DOI 10.1038/mt.2014.187; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Glasz-Bona A, 2009, J INVEST DERMATOL, V129, P229, DOI 10.1038/jid.2008.223; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hainzl S., 2017, MOL THER; Horn HM, 2000, BRIT J DERMATOL, V142, P468, DOI 10.1046/j.1365-2133.2000.03358.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko S, 2011, INT J DERMATOL, V50, P436, DOI 10.1111/j.1365-4632.2010.04702.x; Kerns ML, 2017, J AM ACAD DERMATOL, V76, P449, DOI 10.1016/j.jaad.2016.10.009; Larcher F, 2007, MOL THER, V15, P1670, DOI 10.1038/sj.mt.6300238; Malkinson FD, 1999, ARCH DERMATOL, V135, P997, DOI 10.1001/archderm.135.8.997; March O. P., 2017, EXP PHYSL; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; NeufeldKaiser W, 1997, ARCH DERMATOL, V133, P251, DOI 10.1001/archderm.133.2.251                                                      ; Peking P, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.3; Petek LM, 2010, MOL THER, V18, P1624, DOI 10.1038/mt.2010.102; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Siprashvili Z, 2016, JAMA-J AM MED ASSOC, V316, P1808, DOI 10.1001/jama.2016.15588; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tockner B, 2016, GENE THER, V23, P775, DOI 10.1038/gt.2016.57; Veien NK, 2000, ARCH DERMATOL, V136, P424, DOI 10.1001/archderm.136.3.424-a                                                    ; Wally V, 2013, J INVEST DERMATOL, V133, P1901, DOI 10.1038/jid.2013.31; Wally V, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-69; Wally V, 2010, HUM MOL GENET, V19, P4715, DOI 10.1093/hmg/ddq405; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; [郑武 Zheng Wu], 2015, [遗传, Hereditas(Beijing)], V37, P1003, DOI 10.16288/j.yczz.15-070	41	0	0	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	NOV 1	2017	25	11					2585	2598		10.1016/j.ymthe.2017.08.015				14	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FM1GZ	WOS:000414723500017	28888469	gold			2018-01-05	
J	Ito, Y; Nishizawa-Yokoi, A; Endo, M; Mikami, M; Shima, Y; Nakamura, N; Kotake-Nara, E; Kawasaki, S; Toki, S				Ito, Yasuhiro; Nishizawa-Yokoi, Ayako; Endo, Masaki; Mikami, Masafumi; Shima, Yoko; Nakamura, Nobutaka; Kotake-Nara, Eiichi; Kawasaki, Susumu; Toki, Seiichi			Re-evaluation of the rin mutation and the role of RIN in the induction of tomato ripening	NATURE PLANTS			English	Article							BOX TRANSCRIPTION FACTOR; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASE; FRUIT-DEVELOPMENT; GENE-EXPRESSION; ETHYLENE CONTROL; ABSCISSION ZONE; FLORAL ORGAN; HOMOLOGS; REGULATOR; COMPLEXES	Tomato (Solanum lycopersicum) rin mutants completely fail to ripen: they do not produce red pigmentation, soften or induce an ethylene burst. Therefore, RIN has long been believed to function as a major regulator that is essential for the induction of ripening. Here, we provide evidence contradicting this concept of RIN function, showing induction of fruit ripening in the absence of RIN. A CRISPR/Cas9-mediated RIN-knockout mutation did not repress initiation of ripening and the mutant fruits showed moderate red colouring. Moreover, inactivation of the rin mutant allele partially restored the induction of ripening. Therefore, RIN is not required for the initiation of ripening and rin is not a null mutation, but rather is a gain-of-function mutation that produces a protein that actively represses ripening. Since the discovery of the rin mutant a half-century ago, many models have depicted RIN as indispensable for the induction of ripening; these models should be reconsidered in light of these results.	[Ito, Yasuhiro; Shima, Yoko; Nakamura, Nobutaka; Kotake-Nara, Eiichi; Kawasaki, Susumu] Natl Agr & Food Res Org NARO, Food Res Inst, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan; [Nishizawa-Yokoi, Ayako; Endo, Masaki; Mikami, Masafumi; Toki, Seiichi] NARO, Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Mikami, Masafumi; Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan	Ito, Y (reprint author), Natl Agr & Food Res Org NARO, Food Res Inst, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	yasuito@affrc.go.jp			Cross-ministerial Strategic Innovation Promotion Program (SIP); Japan Society for Bioscience, Biotechnology, and Agrochemistry	The authors thank A. Koma for technical assistance. This work was supported by the Cross-ministerial Strategic Innovation Promotion Program (SIP) and the Japan Society for Bioscience, Biotechnology, and Agrochemistry.	Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Dong TT, 2013, PLANT PHYSIOL, V163, P1026, DOI 10.1104/pp.113.224436; Elitzur T, 2016, PLANT PHYSIOL, V171, P380, DOI 10.1104/pp.15.01866; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; EXPOSITORODRIGUEZ, 2008, BMC PLANT BIOL, V8, DOI DOI 10.1186/1471-2229-8-131; Fujisawa M, 2014, PLANT CELL, V26, P89, DOI 10.1105/tpc.113.119453; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Fujisawa M, 2012, PLANTA, V235, P1107, DOI 10.1007/s00425-011-1561-2; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; Gimenez E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014427; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Kamiyoshihara Y, 2010, PLANT J, V64, P140, DOI 10.1111/j.1365-313X.2010.04316.x; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kitagawa M, 2005, PHYSIOL PLANTARUM, V123, P331, DOI 10.1111/j.1399-3054.2005.00460.x; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; KNAPP J, 1989, PLANT MOL BIOL, V12, P105, DOI 10.1007/BF00017453; Lelievre JM, 1997, PHYSIOL PLANTARUM, V101, P727, DOI [10.1034/j.1399-3054.1997.1010408.x, 10.1111/j.1399-3054.1997.tb01057.x]; Liu DM, 2014, PLANT J, V77, P284, DOI 10.1111/tpj.12387; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Liu RE, 2015, P NATL ACAD SCI USA, V112, P10804, DOI 10.1073/pnas.1503362112; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Qin GZ, 2012, PLANT J, V70, P243, DOI 10.1111/j.1365-313X.2011.04861.x; Robinson R., 1968, REP TOMATO GENET COO, V18, P36; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shima Y, 2014, BIOSCI BIOTECH BIOCH, V78, P231, DOI 10.1080/09168451.2014.878221; Shima Y, 2013, PLANT MOL BIOL, V82, P427, DOI 10.1007/s11103-013-0071-y; TIGCHELAAR EC, 1978, HORTSCIENCE, V13, P508; Uluisik S, 2016, NAT BIOTECHNOL, V34, P950, DOI 10.1038/nbt.3602; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Wang SF, 2014, J EXP BOT, V65, P3005, DOI 10.1093/jxb/eru137; Yokotani N, 2004, POSTHARVEST BIOL TEC, V32, P247, DOI 10.1016/j.postharvbio.2004.01.001; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	50	0	0	23	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2055-026X	2055-0278		NAT PLANTS	Nat. Plants	NOV	2017	3	11					866	874		10.1038/s41477-017-0041-5				9	Plant Sciences	Plant Sciences	FL8PW	WOS:000414512800012	29085071				2018-01-05	
J	Stella, S; Alcon, P; Montoya, G				Stella, Stefano; Alcon, Pablo; Montoya, Guillermo			Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing	NATURE STRUCTURAL & MOLECULAR BIOLOGY			English	Review							TARGET DNA RECOGNITION; ALTERED PAM SPECIFICITIES; R-LOOP COMPLEX; ADAPTIVE IMMUNITY; STRUCTURAL BASIS; CPF1 ENDONUCLEASE; WIDE SPECIFICITIES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SEED SEQUENCE	CRISPR-Cas is a bacterial defense system against phage infection and nucleic acid invasion. Class 2 type II CRISPR-Cas9 has also been widely used for genome engineering. Here, we review novel insights into the CRISPR class 2 type V enzymes, specifically Cpf1 and C2c1, which display different DNA-recognition and cleavage characteristics than those of Cas9, the best-characterized member of class 2. Recent structures of these ribonucleoprotein complexes that capture several stages of the endonuclease reaction have provided molecular details of recognition, unzipping and cleavage of the target DNA, allowing their comparison with Cas9. A detailed understanding of these mechanisms is crucial for improving these genome engineering tools and expanding the genomic space that can be targeted.	[Stella, Stefano; Alcon, Pablo; Montoya, Guillermo] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme, Struct Mol Biol Grp,Fac Hlth & Med Sci, Copenhagen, Denmark	Stella, S; Montoya, G (reprint author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme, Struct Mol Biol Grp,Fac Hlth & Med Sci, Copenhagen, Denmark.	stefano.stella@cpr.ku.dk; guillermo.montoya@cpr.ku.dk			Novo Nordisk Foundation [NNF14CC0001]; Danish Cancer Society; Swiss Light Source (PSI, Switzerland); Computerome, the Danish National Computer for Life Sciences	The Novo Nordisk Foundation Center for Protein Research is financially supported by the Novo Nordisk Foundation (Grant NNF14CC0001). This work was also supported by a grant from the Danish Cancer Society to G.M. We thank the Swiss Light Source (PSI, Switzerland) and the Computerome, the Danish National Computer for Life Sciences, for supporting our research.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Alcon P, 2017, ACTA CRYSTALLOGR F, V73, P409, DOI 10.1107/S2053230X1700838X; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carroll D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0378-9; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; HERMANS PWM, 1991, INFECT IMMUN, V59, P2695; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson RN, 2017, CURR OPIN MICROBIOL, V37, P110, DOI 10.1016/j.mib.2017.05.010; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim SK, 2017, ACS SYNTH BIOL, V6, P1273, DOI 10.1021/acssynbio.6b00368; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knott J.K., 2017, NAT STRUCT MOL BIOL; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Molina R, 2015, NAT STRUCT MOL BIOL, V22, P65, DOI 10.1038/nsmb.2932; Nishimasu H, 2017, MOL CELL, V67, P139, DOI 10.1016/j.molcel.2017.04.019; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Palermo G, 2017, P NATL ACAD SCI USA, V114, P7260, DOI 10.1073/pnas.1707645114; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Stella S, 2016, BIOESSAYS, V38, pS4, DOI 10.1002/bies.201670903; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; TANG X, 2017, NAT PLANTS, V3; THOMAS M, 1976, P NATL ACAD SCI USA, V73, P2294, DOI 10.1073/pnas.73.7.2294; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2017, MOL CELL, V67, P633, DOI 10.1016/j.molcel.2017.06.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zaidi SSEA, 2017, TRENDS PLANT SCI, V22, P550, DOI 10.1016/j.tplants.2017.05.001; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814	91	0	0	19	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1545-9993	1545-9985		NAT STRUCT MOL BIOL	Nat. Struct. Mol. Biol.	NOV	2017	24	11					882	892		10.1038/nsmb.3486				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FL9CG	WOS:000414547600002	29035385				2018-01-05	
J	Tang, JP; Zhang, WW; Wen, K; Chen, GM; Sun, J; Tian, YL; Tang, WJ; Yu, J; An, HZ; Wu, TT; Kong, F; Terzaghi, W; Wang, CM; Wan, JM				Tang, Jianpeng; Zhang, Wenwei; Wen, Kai; Chen, Gaoming; Sun, Juan; Tian, Yunlu; Tang, Weijie; Yu, Jun; An, Hongzhou; Wu, Tingting; Kong, Fei; Terzaghi, William; Wang, Chunming; Wan, Jianmin			OsPPR6, a pentatricopeptide repeat protein involved in editing and splicing chloroplast RNA, is required for chloroplast biogenesis in rice	PLANT MOLECULAR BIOLOGY			English	Article						Rice; PPR; Chloroplast biogenesis; RNA editing; RNA splicing	GROUP-II INTRONS; ARABIDOPSIS-THALIANA; MAIZE CHLOROPLASTS; GENE-EXPRESSION; BINDING DOMAIN; ORYZA-SATIVA; PLANTS; REVEALS; PROMOTES; STRESS	The chloroplast has its own genetic material and genetic system, but it is also regulated by nuclear-encoded genes. However, little is known about nuclear-plastid regulatory mechanisms underlying early chloroplast biogenesis in rice. In this study, we isolated and characterized a mutant, osppr6, that showed early chloroplast developmental defects leading to albino leaves and seedling death. We found that the osppr6 mutant failed to form thylakoid membranes. Using map-based cloning and complementation tests, we determined that OsPPR6 encoded a new Pentatricopeptide Repeat (PPR) protein localized in plastids. In the osppr6 mutants, mRNA levels of plastidic genes transcribed by the plastid-encoded RNA polymerase decreased, while those of genes transcribed by the nuclear-encoded RNA polymerase increased. Western blot analyses validated these expression results. We further investigated plastidic RNA editing and splicing in the osppr6 mutants and found that the ndhB transcript was mis-edited and the ycf3 transcript was misspliced. Therefore, we demonstrate that OsPPR6, a PPR protein, regulates early chloroplast biogenesis and participates in editing of ndhB and splicing of ycf3 transcripts in rice.	[Tang, Jianpeng; Zhang, Wenwei; Wen, Kai; Chen, Gaoming; Sun, Juan; Tian, Yunlu; Tang, Weijie; Yu, Jun; An, Hongzhou; Wu, Tingting; Kong, Fei; Wang, Chunming; Wan, Jianmin] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Tang, Jianpeng; Wang, Chunming] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China; [Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Terzaghi, William] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA	Wang, CM; Wan, JM (reprint author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	wangchm@njau.edu.cn; wanjianmin@caas.cn			National Key Research and Development Project, China [2016YFD0101107, 2016YFD0100700]; National Key Technology Support Program project, China [2015BAD01B02-7]; "Shuangchuang", Project, Jiangsu Province, China; "Innovation Team Core Member", Jiangsu Province, China	The National Key Research and Development Project (2016YFD0101107, 2016YFD0100700), and National Key Technology Support Program project (2015BAD01B02-7), China supported this study. CW was supported by the "Shuangchuang", Project (2012), and "Innovation Team Core Member" (2013) 140, Jiangsu Province, China. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1                                                               ; Asakura Y, 2007, PLANT CELL, V19, P3864, DOI 10.1105/tpc.107.055160; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Asano T, 2013, PLANT BIOTECHNOL-NAR, V30, P57, DOI 10.5511/plantbiotechnology.12.1217a; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cao ZL, 2011, J INTEGR PLANT BIOL, V53, P258, DOI 10.1111/j.1744-7909.2011.01030.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Hanaoka M, 2005, EMBO REP, V6, P545, DOI 10.1038/sj.embor.7400411; Jiang Y, 2012, GENET MOL RES, V11, P987, DOI 10.4238/2012.April.19.4; Kaminaka H, 1999, BIOSCI BIOTECH BIOCH, V63, P302, DOI 10.1271/bbb.63.302; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; Li H, 2013, NEW PHYTOL, V200, P1076, DOI 10.1111/nph.12427; Liere K, 1999, EMBO J, V18, P249, DOI 10.1093/emboj/18.1.249; Liu P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Naver H, 2001, PLANT CELL, V13, P2731; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Ostersetzer O, 2005, PLANT CELL, V17, P241, DOI 10.1105/tpc.104.027516; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ren YL, 2014, PLANT CELL, V26, P410, DOI 10.1105/tpc.113.121376; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Sasaki Y, 2001, J BIOL CHEM, V276, P3937, DOI 10.1074/jbc.M008166200; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Sun J, 2017, NEW PHYTOL, V215, P240, DOI 10.1111/nph.14482; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tan JJ, 2014, MOL PLANT, V7, P1329, DOI 10.1093/mp/ssu054; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Wang LW, 2016, PLANT MOL BIOL, V92, P581, DOI 10.1007/s11103-016-0533-0; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Watkins KP, 2011, PLANT CELL, V23, P1082, DOI 10.1105/tpc.111.084335; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Yap A, 2015, PLANT J, V81, P661, DOI 10.1111/tpj.12756; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zhang HD, 2015, PHOTOSYNTH RES, V126, P311, DOI 10.1007/s11120-015-0171-4	53	0	0	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	NOV	2017	95	4-5					345	357		10.1007/s11103-017-0654-0				13	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	FM7BG	WOS:000415222500002	28856519				2018-01-05	
J	Srivastava, D; Shamim, M; Kumar, M; Mishra, A; Pandey, P; Kumar, D; Yadav, P; Siddiqui, MH; Singh, KN				Srivastava, Deepti; Shamim, Md; Kumar, Mahesh; Mishra, Anurag; Pandey, Pramila; Kumar, Deepak; Yadav, Prashant; Siddiqui, Mohammed Harrish; Singh, Kapildeo Narayan			Current Status of Conventional and Molecular Interventions for Blast Resistance in Rice	RICE SCIENCE			English	Review						backcross breeding; gene pyramiding; allele mining; transgenic technology; rice; blast resistance; CRISPR/Cas9; molecular breeding; bioinformatics approach	ORYZA-SATIVA L.; FUNGUS MAGNAPORTHE-ORYZAE; QUANTITATIVE TRAIT LOCI; CONFERRING PARTIAL RESISTANCE; MARKER-ASSISTED SELECTION; BROAD-SPECTRUM RESISTANCE; JAPANESE UPLAND RICE; NEAR-ISOGENIC LINES; BACTERIAL-BLIGHT RESISTANCE; ANTIFUNGAL AFP PROTEIN	Pyricularia oryzae anamorph of Magnaporthe oryzae is one of the most notorious fungal pathogens causing severe economic loss in rice production worldwide. Various methods, viz. cultural, biological and molecular approaches, are utilized to counteract this pathogen. Moreover, some tolerant or resistant rice varieties have been developed with the help of breeding programmes. Isolation and molecular characterization of different blast resistance genes now open the gate for new possibilities to elucidate the actual allelic variants of these genes via various molecular breeding and transgenic approaches. However, the behavioral pattern of this fungus breakups the resistance barriers in the resistant or tolerant rice varieties. This host-pathogen barrier will be possibly countered in future research by comparative genomics data from available genome sequence data of rice and M. oryzae for durable resistance. Present review emphasized fascinating recent updates, new molecular breeding approaches, transgenic and genomics approaches (i.e. miRNA and genome editing) for the management of blast disease in rice. The updated information will be helpful for the durable, resistance breeding programme in rice against blast pathogen.	[Srivastava, Deepti; Siddiqui, Mohammed Harrish] Integral Univ, Integral Inst Agr Sci & Technol, Lucknow 226021, Uttar Pradesh, India; [Shamim, Md; Kumar, Mahesh] Bihar Agr Univ, Dept Mol Biol & Genet Engn, Dr Kalam Agr Coll, Bhagalpur 813210, Bihar, India; [Mishra, Anurag] Sardar Vallabhbhai Patel Univ Agr & Technol, Dept Agr Biotechnol, Meerut 250110, Uttar Pradesh, India; [Pandey, Pramila; Kumar, Deepak; Singh, Kapildeo Narayan] Narendra Deva Univ Agr & Technol, Dept Plant Mol Biol & Genet Engn, Faizabad 224229, Uttar Pradesh, India; [Yadav, Prashant] Indian Council Agr Res, Directerate Rapeseed Mustard Res, Bharatpur 321303, Rajasthan, India	Singh, KN (reprint author), Narendra Deva Univ Agr & Technol, Dept Plant Mol Biol & Genet Engn, Faizabad 224229, Uttar Pradesh, India.	kapildeos@hotmail.com					Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Ahn SN, 2000, EUPHYTICA, V116, P17, DOI 10.1023/A:1004045812357; Ahn S., 1996, RICE GENET NEWSL, V13, P74; Allard R.W., 1999, PRINCIPLES PLANT BRE; AMANTEBORDEOS A, 1992, THEOR APPL GENET, V84, P345, DOI 10.1007/BF00229493; Anupam A, 2017, RICE SCI, V24, P10, DOI 10.1016/j.rsci.2016.07.003; Anwar Ali, 2005, Agricultural Science Digest, V25, P293; Arunakumari K, 2016, RICE SCI, V23, P306, DOI 10.1016/j.rsci.2016.04.005; Asghar A, 2007, PAK J BOT, V39, P1277; Ashkani S, 2016, CRIT REV BIOTECHNOL, V36, P353, DOI 10.3109/07388551.2014.961403; Ashkani S, 2013, BIOTECHNOL LETT, V35, P799, DOI 10.1007/s10529-012-1130-1; Ashkani S, 2013, MOL BIOL REP, V40, P2503, DOI 10.1007/s11033-012-2331-3; Ashkani S, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00886, 10.3389/fols.2015.00886]; Ashkani S, 2012, PLANT MOL BIOL REP, V30, P79, DOI 10.1007/s11105-011-0315-4; Azizi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00773; Baldrich P, 2015, RNA BIOL, V12, P847, DOI 10.1080/15476286.2015.1050577; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Barman SR, 2004, PLANT BREEDING, V123, P300, DOI 10.1111/j.1439-0523.2004.00982.x; Berruyer R, 2003, THEOR APPL GENET, V107, P1139, DOI 10.1007/s00122-003-1349-2; Beser N, 2016, MOL PLANT BREEDING, V7, P1; Bevitori R, 2014, J RICE RES, V3, pe111; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Bundo M, 2016, PLANT BIOTECHNOL J, V14, P1357, DOI 10.1111/pbi.12500; Calvero SB, 1996, PLANT PATHOL, V45, P667, DOI 10.1046/j.1365-3059.1996.d01-168.x; CAUSSE MA, 1994, GENETICS, V138, P1251; Chen DH, 1999, THEOR APPL GENET, V98, P1046, DOI 10.1007/s001220051166; [陈红旗 CHEN Hongqi], 2008, [中国水稻科学, Chinese Journal of Rice Science], V22, P23; [陈学伟 Chen Xuewei], 2004, [生物工程学报, Chinese Journal of Biotechnology], V20, P708; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Cho Young-Chan, 2008, Journal of Crop Science and Biotechnology, V11, P269; Choi W. J., 1988, Korean Journal of Plant Pathology, V4, P25; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Coca M, 2004, PLANT MOL BIOL, V54, P245, DOI 10.1023/B:PLAN.0000028791.34706.80; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Costanzo S, 2010, PLANT SCI, V178, P523, DOI 10.1016/j.plantsci.2010.02.014; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; Das G, 2015, FRONT PLANT SCI, V6, P1, DOI [10.3389/fpls.2015.00698, DOI 10.3389/FPLS.2015.00698]; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deng YW, 2006, THEOR APPL GENET, V113, P705, DOI 10.1007/s00122-006-0338-7; Divya B, 2014, EUPHYTICA, V200, P61, DOI 10.1007/s10681-014-1146-9; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI [10.1073/pnas.1222783110, 10.1073/pnas.1222783110/-/DCSupplemental]; Fang NY, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0603-7; Filippi MC, 1997, PLANT DIS, V81, P351, DOI 10.1094/PDIS.1997.81.4.351                                                      ; Fjellstrom R, 2006, MOL BREEDING, V17, P149, DOI 10.1007/s11032-005-4735-4; Fu C, 2012, AFR J BIOTECHNOL, V11, P13104; Fuentes JL, 2008, EUPHYTICA, V160, P295, DOI 10.1007/s10681-007-9497-0; Fujii K, 2000, BREEDING SCI, V50, P183, DOI 10.1270/jsbbs.50.183                                                            ; FUJIMAKI H, 1979, JARQ-JPN AGR RES Q, V13, P153; Fujita D, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P315, DOI 10.1007/978-1-4020-9500-9_31; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; Fukuoka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07773; Fukuta Y, 2004, RICE BLAST INTERACTI, P229; Gandikota M, 2001, MOL BREEDING, V7, P73, DOI 10.1023/A:1009657923408; [耿显胜 GENG XianSheng], 2008, [遗传, Hereditas(Beijing)], V30, P109, DOI 10.3724/SP.J.1005.2008.00109; Ghazanfar M. U., 2009, Mycopath, V7, P29; Gohel N. M., 2015, African Journal of Agricultural Research, V10, P2038; Goto I., 1970, ANN PHYTOPATH SOC JA, V36, P304; GOTO I, 1988, Annals of the Phytopathological Society of Japan, V54, P460; Gouda PK, 2013, PLANT BREEDING, V132, P61, DOI 10.1111/pbr.12017; Gowda M, 2006, PLANT BREEDING, V125, P596, DOI 10.1111/j.1439-0523.2006.01248.x; Gowda M, 2015, GENOM DATA, V5, P284, DOI 10.1016/j.gdata.2015.06.018; Guimaraes E P, 1997, ADV RICE POPULATION, P165; Guo LY, 2015, PLANT BREEDING, V134, P646, DOI 10.1111/pbr.12310; Hasan MM, 2015, BIOTECHNOL BIOTEC EQ, V29, P237, DOI 10.1080/13102818.2014.995920; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hayashi N, 1998, PHYTOPATHOLOGY, V88, P822, DOI 10.1094/PHYTO.1998.88.8.822; He WW, 2017, PHYTOPATHOLOGY, V107, P84, DOI 10.1094/PHYTO-03-16-0151-R; He XY, 2012, SCI CHINA LIFE SCI, V55, P141, DOI 10.1007/s11427-012-4282-2; Hegde S. S., 2016, Journal of Farm Sciences, V29, P327; Helliwell EE, 2013, PLANT BIOTECHNOL J, V11, P33, DOI 10.1111/pbi.12004; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hua LX, 2015, BIOTECHNOL BIOTEC EQ, V29, P448, DOI 10.1080/13102818.2015.1011894; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; Huang HM, 2011, PHYTOPATHOLOGY, V101, P620, DOI 10.1094/PHYTO-08-10-0209; Hubert J., 2015, American Journal of Plant Sciences, V6, P602, DOI 10.4236/ajps.2015.65065; Imam J, 2016, FRONT PLANT SCI, V10, P1846; Imamura T, 2010, TRANSGENIC RES, V19, P415, DOI 10.1007/s11248-009-9320-x; Nelson R, 1994, REP HOKKAIDO BR CROP, V35, P54; Jain P, 2017, FRONT PLANT SCI, V8, P1, DOI 10.3389/fpls.2017.00093; Jena K K, 2000, RICE BREEDING GENETI, P269; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jeung JU, 2007, THEOR APPL GENET, V115, P1163, DOI 10.1007/s00122-007-0642-x; Ji ZJ, 2016, J INTEGR AGR, V15, P1432, DOI 10.1016/S2095-3119(15)61165-0; Jiang JF, 2015, RICE, V8, DOI 10.1186/s12284-015-0048-3; Jiang JF, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0282-9; Jiang N, 2012, RICE, V5, DOI 10.1186/1939-8433-5-29; Kadotani N, 2003, MOL PLANT MICROBE IN, V16, P769, DOI 10.1094/MPMI.2003.16.9.769; Kapoor A S, 1982, IND PHYTOPATH, V53, P283; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Kaur S, 1975, P IAEA RES COORD GEO, P141; Khanna A, 2015, THEOR APPL GENET, V128, P1243, DOI 10.1007/s00122-015-2502-4; KIM CK, 1993, SYST APPR S, V2, P309; Kim JA, 2009, MOL CELLS, V28, P431, DOI 10.1007/s10059-009-0161-5; Kinoshita T., 1997, RICE GENET NEWSLETT, V14, P57; Koide Y, 2010, PLANT BREEDING, V129, P670, DOI 10.1111/j.1439-0523.2010.01781.x; Koide Y, 2013, MOL BREEDING, V32, P241, DOI 10.1007/s11032-013-9865-5; Koide Y, 2011, FIELD CROP RES, V123, P19, DOI 10.1016/j.fcr.2011.04.005; Koide Y, 2009, JARQ-JPN AGR RES Q, V43, P255, DOI 10.6090/jarq.43.255                                                             ; Kontargyri V T, 2008, 9 WSEAS INT C NEUR N, P225; Korinsak S, 2011, FIELD CROP RES, V122, P32, DOI 10.1016/j.fcr.2011.02.005; Krishnamurthy K, 2001, MOL PLANT MICROBE IN, V14, P1255, DOI 10.1094/MPMI.2001.14.10.1255; Kumar M K P, 2013, FUNGICIDES SHOWCASES, P77; Kumar P, 2010, MOL BREEDING, V25, P217, DOI 10.1007/s11032-009-9320-9; Kumar Mac Siddegowda DK, 2011, PESTOLOGY, V35, P34; Kumar MKP, 2014, J EXP BIOL AGRIC SCI, V2, P49; Kumar VA, 2016, J GENET, V95, P895, DOI 10.1007/s12041-016-0711-5; Kumari A, 2013, EUR J PLANT PATHOL, V137, P55, DOI 10.1007/s10658-013-0216-5; Kurahashi Y., 2001, Pesticide Outlook, V12, P32, DOI 10.1039/b100806o; Kwon SW, 2008, MOL CELLS, V25, P407; Lee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026260; Lee S, 2009, GENETICS, V183, P1315, DOI 10.1534/genetics.109.108266; Lei C., 2005, RICE GENET NEWSL, V22, P76; Li LY, 2007, MOL BREEDING, V20, P179, DOI 10.1007/s11032-007-9118-6; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00002; Li Y, 2014, PLANT PHYSIOL, V164, P1077, DOI 10.1104/pp.113.230052; Liang Y, 2017, RICE SCI, V24, P41, DOI 10.1016/j.rsci.2016.07.004; Liang ZJ, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0120-7; Lin F, 2007, PLANT BREEDING, V126, P287, DOI 10.1111/j.1439-0523.2007.01352.x; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Liu B, 2004, MOL PLANT MICROBE IN, V17, P1146, DOI 10.1094/MPMI.2004.17.10.1146                                                    ; Liu SP, 2003, ACTA BOT SIN, V45, P1346; Liu XQ, 2007, GENETICS, V176, P2541, DOI 10.1534/genetics.107.075465; Liu XQ, 2005, MOL GENET GENOMICS, V274, P394, DOI 10.1007/s00438-005-0032-5; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Liu Y, 2011, THEOR APPL GENET, V122, P341, DOI 10.1007/s00122-010-1450-2; Liu ZY, 2010, COMPUT ELECTRON AGR, V72, P99, DOI 10.1016/j.compag.2010.03.003; Luo WL, 2017, PLANT BREEDING, V136, P67, DOI 10.1111/pbr.12447; Luo YC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0695-8; Lv QM, 2013, PHYTOPATHOLOGY, V103, P594, DOI 10.1094/PHYTO-10-12-0260-R; LV QM, 2017, SCI REP, V7; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; MACKILL DJ, 1992, PHYTOPATHOLOGY, V82, P746, DOI 10.1094/Phyto-82-746; Mahdian S., 2013, SEED PLANT IMPROV J, V29, P391; Mahesh HB, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2523-7; Malzahn A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0148-4; Mandal L, 2017, BIOTECHNOL J INTER, V19, P1; MANIBHUSHANRAO K, 1991, RICE BLAST MODELING AND FORECASTING, P31; Mao SJ, 2003, CHINESE SCI BULL, V48, P1753, DOI 10.1360/03wc0049; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mgonja EM, 2017, PHYTOPATHOLOGY, V107, P1039, DOI [10.1094/PHYTO-12-16-0421-R, 10.1094/phyto-12-16-0421-r]; Miah G, 2013, MOL BIOL REP, V40, P2369, DOI 10.1007/s11033-012-2318-0; Miyamoto M, 2001, BREEDING SCI, V51, P257, DOI 10.1270/jsbbs.51.257; Moreno AB, 2005, MOL PLANT MICROBE IN, V18, P960, DOI 10.1094/MPMI-18-0960; Motoyama T, 1999, MODERN FUNGICIDES AND ANTIFUNGAL COMPOUNDS II, P111; Nagaoka I, 2017, BREEDING SCI, V67, P159, DOI 10.1270/jsbbs.16099; Nagato Y., 1998, RICE GENET NEWSLETT, V15, P13; Nakata Y, 2008, CROP PROT, V27, P865, DOI 10.1016/j.cropro.2007.08.016; Naqvi NI, 1996, GENOME, V39, P26, DOI 10.1139/g96-004; Narayanan NN, 2002, CROP SCI, V42, P2072, DOI 10.2135/cropsci2002.2072                                                        ; Neelakanth Sidde Gowda D K, 2017, INT J PURE APP BIOSC, V5, P259; Nguyen TTT, 2006, THEOR APPL GENET, V113, P697, DOI 10.1007/s00122-006-0337-8; Ni DH, 2015, FIELD CROP RES, V184, P1, DOI 10.1016/j.fcr.2015.07.018; Nishimura A, 2002, AGROCHEM JPN, V81, P13; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Ou SH, 1985, RICE DIS; Pan QH, 1996, PHYTOPATHOLOGY, V86, P1071, DOI 10.1094/Phyto-86-1071; Pan QH, 1998, PLANT BREEDING, V117, P27, DOI 10.1111/j.1439-0523.1998.tb01443.x                                              ; Pan QH, 2003, ACTA BOT SIN, V45, P871; Petit-Houdenot Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01072; Pinta W., 2013, African Journal of Biotechnology, V12, P4432; Prasad MS, 2009, WORLD J MICROB BIOT, V25, P1765, DOI 10.1007/s11274-009-0074-7; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Raboin LM, 2016, RICE, V9, DOI 10.1186/s12284-016-0131-4; Rahim HA, 2012, GENET MOL RES, V11, P3277, DOI 10.4238/2012.September.12.11; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Ramkumar G, 2010, INT RICE RES NOTES, V117, P185; Ramsey F, 1993, STAT SLEUTH INTERMED, P177; Rani R, 2016, BIOTECHNOL LETT, V11, P1; Rao G. V., 1983, Indian Phytopathology, V36, P355; Sachin U, 2011, PLANT DIS RES, V26, P196; Sadek S., 2013, WSEAS T INFORM SCI A, V10, P116; Sadumpati V, 2013, J BIOTECHNOL, V166, P114, DOI 10.1016/j.jbiotec.2013.04.016; Sallaud C, 2003, THEOR APPL GENET, V106, P794, DOI 10.1007/s00122-002-1088-9; Sato H, 2006, BREEDING SCI, V56, P415, DOI 10.1270/jsbbs.56.415; Schaffrath U, 2000, PLANT MOL BIOL, V43, P59, DOI 10.1023/A:1006423232753; Selin C, 2016, FRONT MICROBIOL, V7, P967; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shang JJ, 2009, GENETICS, V182, P1303, DOI [10.1534/genetics.108.102871, 10.1534/genetics.109.102871]; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Sharma TR, 2010, J PLANT BIOCHEM BIOT, V19, P87, DOI 10.1007/BF03323441                                                              ; Sharma T. R., 2005, GENOMICS, V274, P569, DOI [10.1007/s00438-005-0035-2, DOI 10.1007/S00438-005-0035-2]; Shi BH, 2012, MOL BREEDING, V30, P1089, DOI 10.1007/s11032-011-9695-2; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shinoda Toriyama H, 1971, B CHUGOKU AGR EXP A, V20, P1; Shu G Y., 2009, INDUCED PLANT MUTATI, P425; Singh A, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls029; Singh VK, 2013, PLANT BREEDING, V132, P486, DOI 10.1111/pbr.12077; Singh VK, 2012, FIELD CROP RES, V128, P8, DOI 10.1016/j.fcr.2011.12.003; Siregar A. F., 2016, Journal of Agricultural Science (Toronto), V8, P86, DOI 10.5539/jas.v8n12p86; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Song FM, 2001, PHYSIOL MOL PLANT P, V59, P1, DOI 10.1006/pmpp.2001.0353; Spence C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-130; Sreewongchai T, 2010, PLANT BREEDING, V129, P176, DOI 10.1111/j.1439-0523.2009.01669.x; Sun PY, 2013, EUPHYTICA, V192, P45, DOI 10.1007/s10681-012-0829-3; Sundaram Raman M., 2009, Biotechnology Journal, V4, P400, DOI 10.1002/biot.200800310; Suwannual T, 2017, CZECH J GENET PLANT, V53, P1, DOI 10.17221/51/2016-CJGPB; Tabien RE, 2000, THEOR APPL GENET, V101, P1215, DOI 10.1007/s001220051600; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; Tanweer FA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01002; Terashima T, 2008, PLANT BREEDING, V127, P485, DOI 10.1111/j.1439-0523.2007.01451.x; Thakur S, 2013, FUNCT INTEGR GENOMIC, V13, P309, DOI 10.1007/s10142-013-0325-4; Thakur S, 2013, J PLANT INTERACT, V8, P34, DOI 10.1080/17429145.2012.721523; Tian DG, 2016, RICE, V9, DOI 10.1186/s12284-016-0091-8; Toojinda T, 2005, PLANT PROD SCI, V8, P330, DOI 10.1626/pps.8.330; Tsuda M, 1998, J PESTIC SCI, V23, P230; Urso S, 2013, P 57 IT SOC AGR GEN; Usatov AV, 2016, INDIAN J GENET PL BR, V76, P18, DOI 10.5958/0975-6906.2016.00003.1; Wang D, 2014, BIOCHEM BIOPH RES CO, V446, P1085, DOI 10.1016/j.bbrc.2014.03.056; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; WANG GL, 1994, GENETICS, V136, P1421; Wang XY, 2014, RICE - GERMPLASM, GENETICS AND IMPROVEMENT, P195, DOI 10.5772/56824; Wang Z, 2007, PLANT BREEDING, V126, P36, DOI 10.1111/j.1439-0523.2007.01304.x; Wang ZZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175734; Wen S., 2011, RICE GENOMICS GENET, V2, P31, DOI DOI 10.5376/RGG.2011.02.0004; Wongsaprom C, 2010, FIELD CROP RES, V119, P245, DOI 10.1016/j.fcr.2010.07.013; Wu JL, 2005, THEOR APPL GENET, V111, P50, DOI 10.1007/s00122-005-1971-2; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; Wu YY, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0433-7; Wu YY, 2013, PHYTOPATHOLOGY, V103, P1162, DOI 10.1094/PHYTO-02-13-0044-R; Xi ZY, 2006, GENOME, V49, P476, DOI 10.1139/G06-005; Xiao N, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01918; Xiao WM, 2016, J INTEGR AGR, V15, P2290, DOI 10.1016/S2095-3119(16)61415-6; Xu JC, 2004, CHINESE SCI BULL, V49, P337, DOI 10.1360/03wc0017; Xu XR, 2014, BIOMED RES INT, DOI 10.1155/2014/623509; Yang Q Z, 2001, P GEN M RIC BLAST CH, P49; Yasuda N, 2015, PLANT DIS, V99, P904, DOI 10.1094/PDIS-02-14-0214-RE; Yoshida K, 2009, GENES GENET SYST, V84, P121, DOI 10.1266/ggs.84.121; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479                                                  ; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; YU ZH, 1991, THEOR APPL GENET, V81, P471, DOI 10.1007/BF00219436; YUNOKI T, 1970, Bulletin of the Chugoku National Agricultural Experiment Station Series E (Environment Division), V6, P21; Zenbayashi K, 2002, THEOR APPL GENET, V104, P547, DOI 10.1007/s00122-001-0779-y; Zhang HJ, 2009, AFR J BIOTECHNOL, V8, P1750; Zhang J, 2006, PLANT BREEDING, V125, P600, DOI 10.1111/j.1439-0523.2006.01281.x; Zhang MX, 2003, EUPHYTICA, V130, P71, DOI 10.1023/A:1022380626371; Zhang YX, 2012, EUPHYTICA, V184, P141, DOI 10.1007/s10681-011-0601-0; Zheng WJ, 2016, THEOR APPL GENET, V129, P1035, DOI 10.1007/s00122-016-2681-7; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Zhou JH, 2004, PLANT PATHOL, V53, P191, DOI 10.1111/j.1365-3059.2004.00986.x; Zhu L-H, 1993, RICE GENET NEWSL, V10, P132; Zhu ML, 2004, PHYTOPATHOLOGY, V94, P515, DOI 10.1094/PHYTO.2004.94.5.515; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhuang JY, 2002, EUPHYTICA, V128, P363, DOI 10.1023/A:1021272710294; Fukuoka S, 2007, Patent No. [WO/2007/000880., 2007000880]; [Anonymous], 1992, STAT AGROCHEMICALS J	253	0	0	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1672-6308	1876-4762		RICE SCI	Rice Sci.	NOV	2017	24	6					299	321		10.1016/j.rsci.2017.08.001				23	Agronomy; Plant Sciences	Agriculture; Plant Sciences	FM5RW	WOS:000415097300001		gold			2018-01-05	
J	Smith, KJ; Boyer, JA; Muku, GE; Murray, IA; Gowda, K; Desai, D; Amin, SG; Glick, AB; Perdew, GH				Smith, Kayla J.; Boyer, Jacob A.; Muku, Gulsum E.; Murray, Iain A.; Gowda, Krishne; Desai, Dhimant; Amin, Shantu G.; Glick, Adam B.; Perdew, Gary H.			Editor's Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin	TOXICOLOGICAL SCIENCES			English	Article						aryl hydrocarbon receptor; Cxcl5; inflammation; TCDD; Ah receptor	ARYL-HYDROCARBON RECEPTOR; ULTRAVIOLET-B; EPIDERMAL DIFFERENTIATION; SYNERGISTIC INDUCTION; THERAPEUTIC TARGETS; CHEMOKINE RECEPTORS; CYTOCHROMES P450; HOST-DEFENSE; TNF-ALPHA; COAL-TAR	Chemokines are components of the skin microenvironment, which enable immune cell chemotaxis. Traditionally, transcription factors involved in inflammatory signaling (eg, NF kappa B) are important mediators of chemokine expression. To what extent xenobiotics and their associated receptors control chemokine expression is poorly understood. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor known to mediate physiological responses in the skin through the regulation of genes involved in xenobiotic metabolism, epidermal differentiation, and immunity. Here, we demonstrate that AHR activation within primary mouse keratinocytes regulates the expression of a neutrophil directing chemokine (C-X-C motif) ligand 5 (Cxcl5). AHR-mediated regulation of Cxcl5 is because of direct transcriptional activity upon treatment with AHR agonists such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Additionally, AHR mediates enhanced induction of Cxcl5 upon exposure to an agonist and the inflammatory cytokine interleukin 1 beta. This synergy is confined primarily to keratinocytes, as dermal fibroblasts did not achieve the same level of combinatorial induction. AHR-specific antagonists were able to reduce basal and induced levels of Cxcl5, demonstrating the potential for pharmacological intervention. Exposure of C57BL/6 J mice to ultraviolet (UV) light followed by topical treatment with the AHR agonist formylindolo(3,2-b)carbazole (FICZ) significantly induced Cxcl5 expression in skin compared with UV alone, and this response was absent in Ahr(-/-) mice. These results establish AHR as an important mediator of Cxcl5, with implications for the treatment of inflammatory skin diseases.	[Smith, Kayla J.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Biochem & Mol Biol, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Boyer, Jacob A.; Muku, Gulsum E.; Murray, Iain A.; Glick, Adam B.; Perdew, Gary H.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, 309A Life Sci Bldg, University Pk, PA 16802 USA; [Gowda, Krishne; Desai, Dhimant; Amin, Shantu G.] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Perdew, GH (reprint author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, 309A Life Sci Bldg, University Pk, PA 16802 USA.	ghp2@psu.edu			National Institutes of Health [ES004869, ES019964, T32Al074551]	National Institutes of Health (ES004869 and ES019964 to G.H.P. and T32Al074551 to K.J.S.).	BARKER CW, 1992, J BIOL CHEM, V267, P8050; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20                                          ; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Brink N, 2000, INFLAMM RES, V49, P290, DOI 10.1007/PL00000209                                                              ; Chiaro CR, 2008, MOL PHARMACOL, V74, P1649, DOI 10.1124/mol.108.049379; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; Denison MS, 1998, TARG ORG T, P3; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Haarmann-Stemmann T, 2015, J INVEST DERMATOL, V135, P2572, DOI 10.1038/jid.2015.285; Haas K, 2016, J INVEST DERMATOL, V136, P2260, DOI 10.1016/j.jid.2016.06.627; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; Kim EJ, 2010, MOL CARCINOGEN, V49, P672, DOI 10.1002/mc.20640; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kostyuk V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044472; Lahoti TS, 2015, TOXICOL SCI, V148, P229, DOI 10.1093/toxsci/kfv178; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Ming M, 2015, ONCOGENE, V34, P281, DOI 10.1038/onc.2013.583; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246                                                       ; MUKHTAR H, 1986, J INVEST DERMATOL, V87, P348, DOI 10.1111/1523-1747.ep12524446; Murray Iain A, 2017, Curr Opin Toxicol, V2, P15, DOI 10.1016/j.cotox.2017.01.003; Murray IA, 2010, CHEM RES TOXICOL, V23, P955, DOI 10.1021/tx100045h; Narayanan GA, 2012, J PHARMACOL EXP THER, V342, P345, DOI 10.1124/jpet.112.193482; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; PERDEW GH, 1995, HYBRIDOMA, V14, P279, DOI 10.1089/hyb.1995.14.279                                                         ; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; REINERS JJ, 1993, ARCH BIOCHEM BIOPHYS, V301, P449, DOI 10.1006/abbi.1993.1170; Smith JB, 2002, IMMUNOGENETICS, V54, P599, DOI 10.1007/s00251-002-0501-5; Smith KJ, 2011, J PHARMACOL EXP THER, V338, P318, DOI 10.1124/jpet.110.178392; Song J, 2013, J IMMUNOL, V190, P401, DOI 10.4049/jimmunol.1202286; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sutter CH, 2011, TOXICOL SCI, V124, P128, DOI 10.1093/toxsci/kfr205; Tauchi M, 2005, MOL CELL BIOL, V25, P9360, DOI 10.1128/MCB.25.21.9360-9368.2005; Teske S, 2005, AM J PHYSIOL-LUNG C, V289, pL111, DOI 10.1152/ajplung.00318.2004; Teske S, 2008, TOXICOL SCI, V102, P89, DOI 10.1093/toxsci/kfm282; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tigges J, 2014, J INVEST DERMATOL, V134, P556, DOI 10.1038/jid.2013.362; van den Bogaard EH, 2015, J INVEST DERMATOL, V135, P1320, DOI 10.1038/jid.2015.6; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; Yang F, 2004, J BIOL CHEM, V279, P35403, DOI 10.1074/jbc.M404055200	51	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	NOV	2017	160	1					83	94		10.1093/toxsci/kfx160				12	Toxicology	Toxicology	FL6XX	WOS:000414390700009	28973351				2018-01-05	
J	De La Rosa, VY; Asfaha, J; Fasullo, M; Loguinov, A; Li, P; Moore, LE; Rothman, N; Nakamura, J; Swenberg, JA; Scelo, G; Zhang, LP; Smith, MT; Vulpe, CD				De La Rosa, Vanessa Y.; Asfaha, Jonathan; Fasullo, Michael; Loguinov, Alex; Li, Peng; Moore, Lee E.; Rothman, Nathaniel; Nakamura, Jun; Swenberg, James A.; Scelo, Ghislaine; Zhang, Luoping; Smith, Martyn T.; Vulpe, Chris D.			Editor's Highlight: High-Throughput Functional Genomics Identifies Modulators of TCE Metabolite Genotoxicity and Candidate Susceptibility Genes	TOXICOLOGICAL SCIENCES			English	Article						DNA repair; genotoxicity; high-throughput testing; susceptibility genes; toxicogenomics; trichloroethylene	OCCUPATIONAL TRICHLOROETHYLENE EXPOSURE; GLUTATHIONE-DEPENDENT BIOACTIVATION; REPAIR PATHWAY CHOICE; SACCHAROMYCES-CEREVISIAE; TRICHLOROACETIC-ACID; DICHLOROACETIC ACID; SCIENTIFIC ISSUES; DNA-DAMAGE; TOXICITY; CELL	Trichloroethylene (TCE), an industrial chemical and environmental contaminant, is a human carcinogen. Reactive metabolites are implicated in renal carcinogenesis associated with TCE exposure, yet the toxicity mechanisms of these metabolites and their contribution to cancer and other adverse effects remain unclear. We employed an integrated functional genomics approach that combined functional profiling studies in yeast and avian DT40 cell models to provide new insights into the specific mechanisms contributing to toxicity associated with TCE metabolites. Genome-wide profiling studies in yeast identified the error-prone translesion synthesis (TLS) pathway as an import mechanism in response to TCE metabolites. The role of TLS DNA repair was further confirmed by functional profiling in DT40 avian cell lines, but also revealed that TLS and homologous recombination DNA repair likely play competing roles in cellular susceptibility to TCE metabolites in higher eukaryotes. These DNA repair pathways are highly conserved between yeast, DT40, and humans. We propose that in humans, mutagenic TLS is favored over homologous recombination repair in response to TCE metabolites. The results of these studies contribute to the body of evidence supporting a mutagenic mode of action for TCE-induced renal carcinogenesis mediated by reactive metabolites in humans. Our approach illustrates the potential for high-throughput in vitro functional profiling in yeast to elucidate toxicity pathways (molecular initiating events, key events) and candidate susceptibility genes for focused study.	[De La Rosa, Vanessa Y.; Asfaha, Jonathan; Loguinov, Alex; Vulpe, Chris D.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Fasullo, Michael] State Univ New York Polytech Inst, Coll Nanoscale Sci, Albany, NY 12205 USA; [Fasullo, Michael] State Univ New York Polytech Inst, Coll Engn, Albany, NY 12205 USA; [Li, Peng; Scelo, Ghislaine] IARC, Lyon, France; [Moore, Lee E.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD USA; [Nakamura, Jun] Univ N Carolina, Gillings Sch Global Publ Hlth, Environm Sci & Engn, Chapel Hill, NC USA; [Zhang, Luoping; Smith, Martyn T.] Univ Calif Berkeley, Div Environm Hlth Sci, Sch Publ Hlth, Berkeley, CA 94720 USA	Vulpe, CD (reprint author), Univ Florida, Ctr Environm & Human Toxicol, Dept Physiol Sci, 2187 Mowry Dr,Bldg 470,Room 113,POB 110885, Gainesville, FL 32611 USA.	cvulpe@ufl.edu			National Institute of Environmental Health Sciences Superfund Research Program [P42ES004705]; National Institute of General Medical Sciences [R25GM090110]; NIH [S10RR029668, S10RR027303]	This work was supported, in part, by grants from National Institute of Environmental Health Sciences Superfund Research Program (P42ES004705 to M.T.S.), and by award number R25GM090110 from the National Institute of General Medical Sciences to V.Y.D. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303 V.Y.D was a trainee in the Superfund Research Program (University of California, Berkeley). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences, the National Institute of General Medical Sciences or the National Institutes of Health.	Anders MW, 2008, CHEM RES TOXICOL, V21, P145, DOI 10.1021/tx700202w; Anders MW, 2004, DRUG METAB REV, V36, P583, DOI 10.1081/DMR-200033451; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Bakke B, 2007, J OCCUP ENVIRON HYG, V4, P375, DOI 10.1080/15459620701301763; Brauch H, 2004, TOXICOL LETT, V151, P301, DOI 10.1016/j.toxlet.2003.12.074; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; CASPARY WJ, 1988, MUTAT RES, V196, P61, DOI 10.1016/0165-1110(88)90028-0; Charbotel Barbara, 2007, J Occup Med Toxicol, V2, P13, DOI 10.1186/1745-6673-2-13; Chiu WA, 2006, ENVIRON HEALTH PERSP, V114, P1445, DOI 10.1289/ehp.8690; Chiu WHA, 2013, ENVIRON HEALTH PERSP, V121, P303, DOI 10.1289/ehp.1205879; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; De La Rosa V. Y., 2017, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.p8k18, DOI 10.5061/DRYAD.P8K18]; Evans TJ, 2010, DNA REPAIR, V9, P1292, DOI 10.1016/j.dnarep.2010.09.017; Gaytan BD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00110; Gaytan Brandon D., 2013, Frontiers in Genetics, V4, P154, DOI 10.3389/fgene.2013.00154; Gaytan BD, 2013, TOXICOL SCI, V132, P347, DOI 10.1093/toxsci/kft018; GOEPTAR AR, 1995, CHEM RES TOXICOL, V8, P3, DOI 10.1021/tx00043a001                                                             ; Guha N, 2012, LANCET ONCOL, V13, P1192, DOI 10.1016/S1470-2045(12)70485-0; Huang DQ, 2013, MOL CELL BIOL, V33, P1515, DOI 10.1128/MCB.01392-12; Irving RM, 2013, TOXICOLOGY, V306, P157, DOI 10.1016/j.tox.2013.02.003; Ji K, 2009, ENVIRON HEALTH PERSP, V117, P1737, DOI 10.1289/ehp.0900842; Jo WJ, 2009, TOXICOL SCI, V111, P424, DOI 10.1093/toxsci/kfp162; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Karami S, 2013, OCCUP ENVIRON MED, V70, P591, DOI 10.1136/oemed-2012-101212; Karami S, 2012, OCCUP ENVIRON MED, V69, P858, DOI 10.1136/oemed-2012-100932; Kawabe YI, 2006, DNA REPAIR, V5, P816, DOI 10.1016/j.dnarep.2006.04.006; Kim S, 2009, TOXICOLOGY, V262, P230, DOI 10.1016/j.tox.2009.06.013; Kim S, 2009, TOXICOL APPL PHARM, V238, P90, DOI 10.1016/j.taap.2009.04.019; Lash LH, 2007, TOXICOLOGY, V235, P11, DOI 10.1016/j.tox.2007.03.001; Lash LH, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.1289/ehp.00108s2177                                                          ; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Loguinov AV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r18                                                         ; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Mao FJ, 2010, CANCER RES, V70, P6548, DOI 10.1158/0008-5472.CAN-10-0475; McGoldrick TA, 2003, ARCH TOXICOL, V77, P365, DOI 10.1007/s00204-003-0459-6; McHugh PJ, 2000, MOL CELL BIOL, V20, P3425, DOI 10.1128/MCB.20.10.3425-3433.2000; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Moore LE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002312; Moore LE, 2010, CANCER RES, V70, P6527, DOI 10.1158/0008-5472.CAN-09-4167; Munari FM, 2013, FUNGAL GENET BIOL, V60, P122, DOI 10.1016/j.fgb.2013.09.003; North M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024205; North M, 2010, INT J MOL SCI, V11, P4796, DOI 10.3390/ijms11124796; North M, 2009, TOXICOL LETT, V189, pS93, DOI 10.1016/j.toxlet.2009.06.281; O'Connor Sean Timothy Francis, 2012, Front Genet, V3, P316, DOI 10.3389/fgene.2012.00316; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Ren XF, 2013, ARCH TOXICOL, V87, P189, DOI 10.1007/s00204-012-0911-6; Ridpath JR, 2011, ENVIRON MOL MUTAGEN, V52, P153, DOI 10.1002/em.20595; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rusyn I, 2014, PHARMACOL THERAPEUT, V141, P55, DOI 10.1016/j.pharmthera.2013.08.004; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Vermeulen R, 2012, CARCINOGENESIS, V33, P1538, DOI 10.1093/carcin/bgs191; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539	55	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	NOV	2017	160	1					111	120		10.1093/toxsci/kfx159				10	Toxicology	Toxicology	FL6XX	WOS:000414390700011	28973557				2018-01-05	
J	Sriwattanapong, K; Slocum, SL; Chawanthayatham, S; Fedeles, BI; Egner, PA; Groopman, JD; Satayavivad, J; Croy, RG; Essigmann, JM				Sriwattanapong, Kanokwan; Slocum, Stephen L.; Chawanthayatham, Supawadee; Fedeles, Bogdan I.; Egner, Patricia A.; Groopman, John D.; Satayavivad, Jutamaad; Croy, Robert G.; Essigmann, John M.			Editor's Highlight: Pregnancy Alters Aflatoxin B-1 Metabolism and Increases DNA Damage in Mouse Liver	TOXICOLOGICAL SCIENCES			English	Article						Aflatoxin B1; DNA adducts; early life exposure; maternal exposure; maternal fetal health axis	GLUTATHIONE-S-TRANSFERASE; DEVELOPING-COUNTRIES; GENE-EXPRESSION; KNOCKOUT MICE; EXPOSURE; QUANTIFICATION; HEALTH; MUTAGENESIS; MECHANISMS; MYCOTOXINS	Pregnancy is a complex physiological state, in which the metabolism of endogenous as well as exogenous agents is ostensibly altered. One exogenous agent of concern is the hepatocarcinogen aflatoxin B-1 (AFB(1)), a foodborne fungal toxin, that requires phase I metabolic oxidation for conversion to its toxic and carcinogenic form, the AFB(1)-8,9-exo-epoxide. The epoxide interacts with cellular targets causing toxicity and cell death; these targets include the covalent modification of DNA leading to mutations that can initiate malignant transformation. The main detoxification pathway of the AFB(1)-epoxide involves phase II metabolic enzymes including the glutathione-S-transferase (GST) family. Pregnancy can modulate both phase I and II metabolism and alter the biological potency of AFB(1). The present work investigated the impact of pregnancy on AFB(1) exposure in mice. A single IP dose of 6 mg/kg AFB(1) was administered to pregnant C57BL/6 J mice at gestation day 14 and matched non-pregnant controls. Pregnant mice accumulated 2-fold higher AFB(1)-N-7-guanine DNA adducts in the liver when compared with nonpregnant controls 6 h post-exposure. Enhanced DNA adduct formation in pregnant animals paralleled elevated hepatic protein expression of mouse CYP1A2 and mouse homologs of human CYP3A4, phase I enzymes capable of bioactivating AFB(1). Although phase II enzymes GSTA1/2 showed decreased protein expression, GSTA3, the primary enzymatic protection against the AFB(1)-epoxide, was unaffected at the protein level. Taken together, our results reveal that pregnancy may constitute a critical window of susceptibility for maternal health, and provide insight into the biochemical factors that could explain the underlying risks.	[Sriwattanapong, Kanokwan; Slocum, Stephen L.; Chawanthayatham, Supawadee; Fedeles, Bogdan I.; Croy, Robert G.; Essigmann, John M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Sriwattanapong, Kanokwan; Slocum, Stephen L.; Chawanthayatham, Supawadee; Fedeles, Bogdan I.; Croy, Robert G.; Essigmann, John M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Sriwattanapong, Kanokwan; Slocum, Stephen L.; Chawanthayatham, Supawadee; Fedeles, Bogdan I.; Croy, Robert G.; Essigmann, John M.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Sriwattanapong, Kanokwan; Satayavivad, Jutamaad] Chulabhorn Grad Inst, Grad Program Environm Toxicol, Bangkok 10210, Thailand; [Egner, Patricia A.; Groopman, John D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Essigmann, JM (reprint author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.; Essigmann, JM (reprint author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Essigmann, JM (reprint author), MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA.	jessig@mit.edu			National Institutes of Health [T32-ES007020, P30-ES002109, R01-ES016313, R01-CA080024, P30-CA006973]	This work was supported by the National Institutes of Health (T32-ES007020, P30-ES002109, R01-ES016313, R01-CA080024, P30-CA006973).	Abdulrazzaq YM, 2002, ANN TROP PAEDIATR, V22, P3, DOI 10.1170/9027249302125000094; BENNETT RA, 1981, CANCER RES, V41, P650; Chawanthayatham S, 2017, P NATL ACAD SCI USA, V114, pE3101, DOI 10.1073/pnas.1700759114; Chawanthayatham S, 2015, INT J CANCER, V136, P1254, DOI 10.1002/ijc.29102; Choi SY, 2013, DRUG METAB DISPOS, V41, P263, DOI 10.1124/dmd.112.046276; Choi SY, 2011, BIOCHEM PHARMACOL, V81, P777, DOI 10.1016/j.bcp.2010.12.019; CROY RG, 1981, CANCER RES, V41, P197; DENNING DW, 1990, CARCINOGENESIS, V11, P1033, DOI 10.1093/carcin/11.6.1033; Dohnal V, 2014, ARCH TOXICOL, V88, P1635, DOI 10.1007/s00204-014-1312-9; EDWARDS GS, 1971, CANCER RES, V31, P1943; Egner PA, 2006, CHEM RES TOXICOL, V19, P1191, DOI 10.1021/tx060108d; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; GALLAGHER EP, 1994, CANCER RES, V54, P101; GROOPMAN JD, 1981, P NATL ACAD SCI-BIOL, V78, P5445, DOI 10.1073/pnas.78.9.5445; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.09089; Hernandez-Vargas H, 2015, INT J EPIDEMIOL, V44, P1238, DOI 10.1093/ije/dyv027; HSIEH LL, 1993, CANCER RES, V53, P1278; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V56, P245; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Kensler KH, 2014, TOXICOL SCI, V139, P293, DOI 10.1093/toxsci/kfu056; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Koh KH, 2011, DRUG METAB DISPOS, V39, P165, DOI 10.1124/dmd.110.035790; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Moss MO, 1998, J APPL MICROBIOL, V84, p62S, DOI 10.1046/j.1365-2672.1998.0840s162S.x; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x                                              ; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/01.fpc.0000054151.92680.31; Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sakuma T, 2004, BIOCHEM BIOPH RES CO, V314, P495, DOI 10.1016/j.bbrc.2003.12.114; Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536                                                                 ; Shupe T, 2004, TOXICOL LETT, V148, P1, DOI 10.1016/j.toxlet.2003.11.008; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Turner PC, 2007, INT J EPIDEMIOL, V36, P1119, DOI 10.1093/ije/dym122; Van Ness KP, 1998, TOXICOL APPL PHARM, V152, P166, DOI 10.1006/taap.1998.8493                                                          ; VESSELINOVITCH SD, 1972, CANCER RES, V32, P2289; Wattanawaraporn R, 2012, TOXICOL SCI, V128, P326, DOI 10.1093/toxsci/kfs151; Wen X, 2013, J PHARMACOL EXP THER, V344, P244, DOI 10.1124/jpet.112.199034; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; WOGAN GN, 1971, CANCER RES, V31, P1936; Wogan G. N., 1969, AFLATOXIN SCIENTIFIC, P151; Woo LL, 2011, TOXICOL SCI, V122, P38, DOI 10.1093/toxsci/kfr087; Zhang HX, 2008, MOL PHARMACOL, V74, P714, DOI 10.1124/mol.107.043851	46	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	NOV	2017	160	1					173	179		10.1093/toxsci/kfx171				7	Toxicology	Toxicology	FL6XX	WOS:000414390700016	28973694				2018-01-05	
J	Song, X; Huang, H; Xiong, ZQ; Ai, LZ; Yang, S				Song, Xin; Huang, He; Xiong, Zhiqiang; Ai, Lianzhong; Yang, Sheng			CRISPR-Cas9(D10A) Nickase-Assisted Genome Editing in Lactobacillus casei	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						Lactobacillus casei; CRISPR; gene editing; nickase	LACTOCOCCUS-LACTIS; CRISPR/CAS9 SYSTEM; BACTERIA; CONSTRUCTION; CHROMOSOMES; REPLACEMENT; BULGARICUS; BIOSENSOR; DELETION; PLASMID	Lactobacillus casei has drawn increasing attention as a health-promoting probiotic, while effective genetic manipulation tools are often not available, e.g., the single-gene knockout in L. casei still depends on the classic homologous recombination-dependent double-crossover strategy, which is quite labor-intensive and timeconsuming. In the present study, a rapid and precise genome editing plasmid, pLCNICK, was established for L. casei genome engineering based on CRISPR-Cas9(D10A). In addition to the P-23-Cas9(D10A) and P-ldh-sgRNA (single guide RNA) expression cassettes, pLCNICK includes the homologous arms of the target gene as repair templates. The ability and efficiency of chromosomal engineering using pLCNICK were evaluated by in-frame deletions of four independent genes and chromosomal insertion of an enhanced green fluorescent protein (eGFP) expression cassette at the LC2W_1628 locus. The efficiencies associated with in-frame deletions and chromosomal insertion is 25 to 62%. pLCNICK has been proved to be an effective, rapid, and precise tool for genome editing in L. casei, and its potential application in other lactic acid bacteria (LAB) is also discussed in this study. IMPORTANCE The lack of efficient genetic tools has limited the investigation and biotechnological application of many LAB. The CRISPR-Cas9(D10A) nickase-based genome editing in Lactobacillus casei, an important food industrial microorganism, was demonstrated in this study. This genetic tool allows efficient single-gene deletion and insertion to be accomplished by one-step transformation, and the cycle time is reduced to 9 days. It facilitates a rapid and precise chromosomal manipulation in L. casei and overcomes some limitations of previous methods. This editing system can serve as a basic technological platform and offers the possibility to start a comprehensive investigation on L. casei. As a broad-host-range plasmid, pLCNICK has the potential to be adapted to other Lactobacillus species for genome editing.	[Song, Xin; Xiong, Zhiqiang; Ai, Lianzhong] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai Engn Res Ctr Food Microbiol, Shanghai, Peoples R China; [Huang, He; Yang, Sheng] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Sheng] SICAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing, Jiangsu, Peoples R China; [Yang, Sheng] Shanghai Res & Dev Ctr Ind Biotechnol, Shanghai, Peoples R China	Ai, LZ (reprint author), Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai Engn Res Ctr Food Microbiol, Shanghai, Peoples R China.; Yang, S (reprint author), Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.; Yang, S (reprint author), SICAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing, Jiangsu, Peoples R China.; Yang, S (reprint author), Shanghai Res & Dev Ctr Ind Biotechnol, Shanghai, Peoples R China.	ailianzhong@hotmail.com; syang@sibs.ac.cn			National Basic Research Program of China [2014CB745101]; National Natural Science Foundation of China [31470209, 31371809]; Program of Shanghai Subject Chief Scientist [14XD1424900]; Ministry of Education of China [NCET-13-0901]; Shanghai Science and Technology Commission [14390711700]; Shuguang Program; Shanghai Education Development Foundation; Shanghai Municipal Education Commission [15SG42]	This work was financially supported by the National Basic Research Program of China (2014CB745101), National Natural Science Foundation of China (31470209), and Program of Shanghai Subject Chief Scientist (14XD1424900). It was also funded by the National Natural Science Foundation of China (31371809), New Century Excellent Talents Project of Ministry of Education of China (no. NCET-13-0901), International Cooperation Project of Shanghai Science and Technology Commission (no. 14390711700), and the Shuguang Program, supported by the Shanghai Education Development Foundation and Shanghai Municipal Education Commission (no. 15SG42).	Aktas B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156374; Bidart GN, 2014, MOL MICROBIOL, V93, P521, DOI 10.1111/mmi.12678; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/jb.175.11.3628-3635.1993                                                ; Bron Peter A, 2011, Bioeng Bugs, V2, P80, DOI 10.4161/bbug.2.2.13910; Chen C, 2011, J BACTERIOL, V193, P3419, DOI 10.1128/JB.05017-11; Chen ZJ, 2014, APPL MICROBIOL BIOT, V98, P5977, DOI 10.1007/s00253-014-5649-z; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fang F, 2009, FRONT BIOSCI-LANDMRK, V14, P3111, DOI 10.2741/4039; Gleeson M, 2016, EUR J APPL PHYSIOL, V116, P1555, DOI 10.1007/s00421-016-3415-x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato-Kataoka A, 2016, APPL ENVIRON MICROB, V82, P3649, DOI 10.1128/AEM.04134-15; Kimmel SA, 1998, INT J FOOD MICROBIOL, V40, P87, DOI 10.1016/S0168-1605(98)00023-3; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995                                                ; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Lokman BC, 1997, J BACTERIOL, V179, P5391, DOI 10.1128/jb.179.17.5391-5397.1997                                                ; Lucena BTL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-298; Munoz-Provencio D, 2012, APPL ENVIRON MICROB, V78, P8684, DOI 10.1128/AEM.02287-12; Mustafi N, 2012, METAB ENG, V14, P449, DOI 10.1016/j.ymben.2012.02.002; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruas-Madiedo P, 2005, J DAIRY SCI, V88, P843, DOI 10.3168/jds.S0022-0302(05)72750-8                                               ; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Serror P, 2003, MICROBIOL-SGM, V149, P1503, DOI 10.1099/mic.0.25827-0; Song L, 2014, J MICROBIOL METH, V102, P37, DOI 10.1016/j.mimet.2014.04.011; Sybesma W, 2004, METAB ENG, V6, P109, DOI 10.1016/j.ymben.2003.11.002; van Pijkeren JP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S10; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Vinay-Lara E, 2016, J IND MICROBIOL BIOT, V43, P1205, DOI 10.1007/s10295-016-1797-8; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Yang P, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0344-z; Yasuda E, 2008, APPL ENVIRON MICROB, V74, P4746, DOI 10.1128/AEM.00412-08; Yi Jiang, 2015, ICIC Express Letters, V9, P81	43	0	0	15	15	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	NOV	2017	83	22							UNSP e01259-17	10.1128/AEM.01259-17				13	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FL1UX	WOS:000414001000001					2018-01-05	
J	Wang, SX; Chen, HQ; Tang, X; Zhang, H; Chen, W; Chen, YQ				Wang, Shunxian; Chen, Haiqin; Tang, Xin; Zhang, Hao; Chen, Wei; Chen, Yong Q.			Molecular tools for gene manipulation in filamentous fungi	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Filamentous fungi; Molecular tools; Gene manipulation; CRISPR/Cas9	TUMEFACIENS-MEDIATED TRANSFORMATION; CRISPR INTERFERENCE CRISPRI; GENOME-EDITING SPECIFICITY; SEQUENCE-SPECIFIC CONTROL; AGROBACTERIUM-TUMEFACIENS; HIGHLY EFFICIENT; HUMAN-CELLS; INSERTIONAL MUTAGENESIS; MAGNAPORTHE-GRISEA; PLASMID DNA	Functional genomics of filamentous fungi has gradually uncovered gene information for constructing 'cell factories' and controlling pathogens. Available gene manipulation methods of filamentous fungi include random integration methods, gene targeting technology, gene editing with artificial nucleases and RNA technology. This review describes random gene integration constructed by restriction enzyme-mediated integration (REMI); Agrobacterium-mediated transformation (AMT); transposon-arrayed gene knockout (TAGKO); gene targeting technology, mainly about homologous recombination; and modern gene editing strategies containing transcription activator-like effector nucleases (TALENs) and a clustered regularly interspaced short palindromic repeat/associated protein system (CRISPR/Cas) developed in filamentous fungi and RNA technology including RNA interference (RNAi) and ribozymes. This review describes historical and modern gene manipulation methods in filamentous fungi and presents the molecular tools available to researchers investigating filamentous fungi. The biggest difference of this review from the previous ones is the addition of successful application and details of the promising gene editing tool CRISPR/Cas9 system in filamentous fungi.	[Wang, Shunxian; Chen, Haiqin; Tang, Xin; Zhang, Hao; Chen, Wei; Chen, Yong Q.] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Wang, Shunxian; Chen, Haiqin; Tang, Xin; Zhang, Hao; Chen, Wei; Chen, Yong Q.] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Chen, Wei; Chen, Yong Q.] Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi 214122, Jiangsu, Peoples R China; [Chen, Wei] Beijing Technol & Business Univ BTBU, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China; [Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA	Chen, HQ (reprint author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.; Chen, HQ (reprint author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.	haiqinchen@jiangnan.edu.cn			National Science Foundation of China (NSFC) [31722041, 31530056]; Fundamental Research Funds for the Central Universities [JUSRP51702A]; program of 'Collaborative innovation center of food safety and quality control in Jiangsu Province'	This study was supported by the National Science Foundation of China (NSFC) (31722041, 31530056), the Fundamental Research Funds for the Central Universities (JUSRP51702A) and the program of 'Collaborative innovation center of food safety and quality control in Jiangsu Province'.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adachi K, 2002, CURR GENET, V42, P123, DOI 10.1007/s00294-002-0339-2; Ando A, 2009, APPL ENVIRON MICROB, V75, P5529, DOI 10.1128/AEM.00648-09; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BHAIRI SM, 1992, PHYTOPATHOLOGY, V82, P986, DOI 10.1094/Phyto-82-986; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; CASE ME, 1979, P NATL ACAD SCI USA, V76, P5259, DOI 10.1073/pnas.76.10.5259                                                         ; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chen HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11247; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Combier JP, 2003, FEMS MICROBIOL LETT, V220, P141, DOI 10.1016/S0378-1097(03)00089-2; Daboussi MJ, 1997, CONT ISSUES GENETICS, P253; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; de Queiroz MV, 2003, FEMS MICROBIOL LETT, V218, P317, DOI 10.1016/S0378-1097(02)01171-0; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; FINCHAM JRS, 1989, MICROBIOL REV, V53, P148; Firon A, 2003, EUKARYOT CELL, V2, P247, DOI 10.1128/EC.2.2.247-255.2003; Florea S, 2009, FUNGAL GENET BIOL, V46, P721, DOI 10.1016/j.fgb.2009.06.010; Forment JV, 2006, CURR GENET, V50, P217, DOI 10.1007/s00294-006-0081-2; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hamer L, 2001, P NATL ACAD SCI USA, V98, P5110, DOI 10.1073/pnas.091094198; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hao GF, 2014, APPL ENVIRON MICROB, V80, P2672, DOI 10.1128/AEM.00140-14; Hihlal E, 2011, APPL ENVIRON MICROB, V77, P2332, DOI 10.1128/AEM.02688-10; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; HOOYKAAS PJJ, 1994, ANNU REV PHYTOPATHOL, V32, P157, DOI 10.1146/annurev.py.32.090194.001105                                             ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305                                                          ; Imazaki I, 2007, MOL MICROBIOL, V63, P737, DOI 10.1111/j.1365-2958.2006.05554.x; Jiang DW, 2013, BIOTECHNOL ADV, V31, P1562, DOI 10.1016/j.biotechadv.2013.08.005; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kahmann R, 1999, EUR J PLANT PATHOL, V105, P221, DOI 10.1023/A:1008757414036; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; KUCK U, 1989, APPL MICROBIOL BIOT, V31, P358; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Kupfer DM, 1997, FUNGAL GENET BIOL, V21, P364, DOI 10.1006/fgbi.1997.0982; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li LD, 2010, CELL MOL LIFE SCI, V67, P3849, DOI 10.1007/s00018-010-0471-y; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Magnuson JK, 2004, ADV FUNGAL BIOTECHNO; Manivasakam P, 1998, MOL CELL BIOL, V18, P1736, DOI 10.1128/MCB.18.3.1736                                                           ; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2011, BIOTECHNOL LETT, V33, P469, DOI 10.1007/s10529-010-0473-8; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Mueller D, 2006, J MICROBIOL METH, V65, P585, DOI 10.1016/j.mimet.2005.10.003; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Noh W, 2010, J MICROBIOL, V48, P253, DOI 10.1007/s12275-010-9278-7; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613                                                          ; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; PUNT PJ, 1992, METHOD ENZYMOL, V216, P447; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin YY, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; RICHEY MG, 1989, PHYTOPATHOLOGY, V79, P844, DOI 10.1094/Phyto-79-844; Rogers CW, 2004, FEMS MICROBIOL LETT, V241, P207, DOI 10.1016/j.femsle.2004.10.022; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; SCHIESTL RH, 1991, P NATL ACAD SCI USA, V88, P7585, DOI 10.1073/pnas.88.17.7585; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHI Z, 1995, PHYTOPATHOLOGY, V85, P329, DOI 10.1094/Phyto-85-329; Shi ZX, 1995, MOL PLANT MICROBE IN, V8, P949, DOI 10.1094/MPMI-8-0949; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sorensen LM, 2008, INT J FOOD MICROBIOL, V124, P58, DOI 10.1016/j.ijfoodmicro.2008.02.019; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sweigard JA, 1998, MOL PLANT MICROBE IN, V11, P404, DOI 10.1094/MPMI.1998.11.5.404; Tang X, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0428-4; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsuji Gento, 2003, Journal of General Plant Pathology, V69, P230, DOI 10.1007/s10327-003-0040-4; Turgeon BG, 2010, METHODS MOL BIOL, V638, P3, DOI 10.1007/978-1-60761-611-5_1; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P823, DOI 10.1631/jzus.B0860006; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xu J, 2005, J MICROBIOL, V43, P417	100	0	0	37	37	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	NOV	2017	101	22					8063	8075		10.1007/s00253-017-8486-z				13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FK7KP	WOS:000413685300001	28965220				2018-01-05	
J	Chen, J; Li, TC; Zhou, XD; Cheng, L; Huo, YY; Zou, J; Li, YQ				Chen, Jing; Li, Tiancheng; Zhou, Xuedong; Cheng, Lei; Huo, Yuanyuan; Zou, Jing; Li, Yuqing			Characterization of the clustered regularly interspaced short palindromic repeats sites in Streptococcus mutans isolated from early childhood caries patients	ARCHIVES OF ORAL BIOLOGY			English	Article						CRISPR; Streptococcus mutans; Biofilm; Early childhood caries; Cariogenic virulence	CRISPR-CAS SYSTEMS; BIOFILM FORMATION; POLYSACCHARIDE SYNTHESIS; INHIBITION; VIRULENCE; CHILDREN; NICOTINE; FLUORIDE; IMMUNITY; MATRIX	Objective: The aim of this study was to analyze the characteristics of the clustered regularly interspaced short palindromic repeats (CRISPR) sites in 45 clinical Streptococcus mutans strains and their relationship to the clinical manifestations of early childhood caries (ECC). Methods: Forty-five S. mutans strains were isolated from the plaque samples taken from sixty-three children. CRISPR sites were sequenced and BLAST was used to compare these sites to those in the CRISPRTarget database. The association between the distribution of CRISPR sites and the manifestation of caries was analyzed by Chi-Square test. Further, biofilm formation (by crystal violet staining) and the synthesis of polysaccharide (by an throne -sulfuric method) of all clinical isolated S. mutans strains with both CRISPR sites and no CRISPR site were comapared. Finally, acidogenicity and acidurity of two typical strains were determined using pH drop and acid tolerance assays. Biofilm formation and EPS synthesis by two typical strains were compared by 3D CLSM (Confocal Laser Scanning Microscope) assays and the expression of gtf genes were evaluated using qPCR. Results: We found that most of the spacers in the clinical S. mutans strains were derived from Streptococcus phages APCM01 and M102. The number of CRISPR sites in these strains was associated with the clinical manifestations of ECC. Moreover, we found that the biofilm formation and EPS synthesis ability of the S. mutans strains with both CRISPR sites was significant improved. Conclusions: An association was found between the distribution of CRISPR sites and the clinical manifestations of caries. The CRISPR sites might contribute to the cariogenic potential of S. mutans.	[Chen, Jing; Li, Tiancheng; Zhou, Xuedong; Li, Yuqing] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Chen, Jing; Zhou, Xuedong; Cheng, Lei] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu, Sichuan, Peoples R China; [Huo, Yuanyuan; Zou, Jing] Sichuan Univ, West China Hosp Stomatol, Dept Pediat Dent, Chengdu, Sichuan, Peoples R China; [Li, Tiancheng] Sichuan Univ, West China Hosp Stomatol, Dept Orthodont, Chengdu, Sichuan, Peoples R China	Li, YQ (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	liyuqing@scu.edu.cn			National Natural Science Foundation of China [31200985, 81430011, 81470035]; State Key Laboratory of Oral Diseases [SKLOD201609]	This work was supported by grants from National Natural Science Foundation of China (grant numbers 31200985, 81430011 and 81470035); and State Key Laboratory of Oral Diseases (grant number SKLOD201609).	American Academy of Pedodontics & American Academy of Pediatrics, 2011, PEDIAT DENT S, V30, P40; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250                                                 ; Chen LL, 2016, APPL MICROBIOL BIOT, V100, P857, DOI 10.1007/s00253-015-7092-1; Cheng XQ, 2016, ENVIRON MICROBIOL, V18, P904, DOI 10.1111/1462-2920.13123; Divaris K, 2016, J DENT RES, V95, P248, DOI 10.1177/0022034515620779; Endo A, 2015, ISME J, V9, P629, DOI 10.1038/ismej.2014.155; Saravia ME, 2013, ARCH ORAL BIOL, V58, P311, DOI 10.1016/j.archoralbio.2012.10.010; Ferreira L, 2013, AM J DENT, V26, P207; Fu Qiang, 2015, Weishengwu Xuebao, V55, P251; Garcia S. S., 2017, J DENT RES; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395                                                    ; Huang RJ, 2012, EUR J ORAL SCI, V120, P319, DOI 10.1111/j.1600-0722.2012.00971.x; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Li MY, 2013, INT J ORAL SCI, V5, P206, DOI 10.1038/ijos.2013.86; Loo CY, 2003, J BACTERIOL, V185, P2887, DOI 10.1128/JB.185.9.2887-2900.2003; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003765; Nomura R, 2009, J MED MICROBIOL, V58, P469, DOI 10.1099/jmm.0.007559-0; Qiu W, 2017, ARCH ORAL BIOL, V73, P113, DOI 10.1016/j.archoralbio.2016.10.011; Ren Z, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.31095; Serbanescu MA, 2015, J BACTERIOL, V197, P749, DOI 10.1128/JB.02333-14; Teng F, 2015, CELL HOST MICROBE, V18, P296, DOI 10.1016/j.chom.2015.08.005; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Wake Nanako, 2016, NPJ Biofilms Microbiomes, V2, P16018, DOI 10.1038/npjbiofilms.2016.18; Wang P., 2016, WORLD J MICROB BIOT, V32, P1; Wang SP, 2016, INT J ORAL SCI, V8, P76, DOI 10.1038/ijos.2015.55; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; Zhao W, 2014, NUTRIENTS, V6, P3572, DOI 10.3390/nu6093572; Zheng X, 2015, J DENT RES, V94, P344, DOI 10.1177/0022034514561259	34	0	0	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	NOV	2017	83						174	180		10.1016/j.archoralbio.2017.07.023				7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	FK1ZA	WOS:000413280900026	28783550				2018-01-05	
J	Marino-Puertas, L; Goulas, T; Gomis-Ruth, FX				Marino-Puertas, Laura; Goulas, Theodoros; Xavier Gomis-Ruth, F.			Matrix metalloproteinases outside vertebrates	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Zinc metalloproteinase; Metzincin; MMP; Invertebrates; Catalytic domain; Structure-based sequence motif	SOYBEAN LEAF METALLOPROTEINASE; X-RAY-STRUCTURE; CATALYTIC DOMAIN; TANNERELLA-FORSYTHIA; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BACTEROIDES-FRAGILIS; CAENORHABDITIS-ELEGANS; BIOCHEMICAL-PROPERTIES; ARABIDOPSIS-THALIANA	The matrix metalloproteinase (MMP) family belongs to the metzincin clan of zinc-dependent metallopeptidases. Due to their enormous implications in physiology and disease, MMPs have mainly been studied in vertebrates. They are engaged in extracellular protein processing and degradation, and present extensive paralogy, with 23 forms in humans. One characteristic of MMPs is a similar to 165-residue catalytic domain (CD), which has been structurally studied for 14 MMPs from human, mouse, rat, pig and the oral-microbiome bacterium Tannerella forsythia. These studies revealed close overall coincidence and characteristic structural features, which distinguish MMPs from other metzincins and give rise to a sequence pattern for their identification. Here, we reviewed the literature available on MMPs outside vertebrates and performed database searches for potential MMP CDs in invertebrates, plants, fungi, viruses, protists, archaea and bacteria. These and previous results revealed that MMPs are widely present in several copies in Eumetazoa and higher plants (Tracheophyta), but have just token presence in eukaryotic algae. A few dozen sequences were found in Ascomycota (within fungi) and in double-stranded DNA viruses infecting invertebrates (within viruses). In contrast, a few hundred sequences were found in archaea and > 1000 in bacteria, with several copies for some species. Most of the archaeal and bacterial phyla containing potential MMPs are present in human oral and gut microbiomes. Overall, MMP-like sequences are present across all kingdoms of life, but their asymmetric distribution contradicts the vertical descent model from a eubacterial or archaeal ancestor. This article is part of a Special Issue entitled: Matrix Metalloproteinases edited by Rafael Fridman.	[Marino-Puertas, Laura; Goulas, Theodoros; Xavier Gomis-Ruth, F.] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, Barcelona Sci Pk,C Baldiri Reixac 15-21, E-08028 Barcelona, Spain	Goulas, T; Gomis-Ruth, FX (reprint author), CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, Barcelona Sci Pk,C Baldiri Reixac 15-21, E-08028 Barcelona, Spain.	thgcri@ibmb.csic.es; xgrcri@ibmb.csic.es	Goulas, Theodoros/H-1951-2015		European Agency; Spanish Agency; Catalan Agency [FP7-HEALTH-2012-306029-2, BFU2015-64487R, MDM-2014-0435, BIO2013-49320-EXP, BIO2015-64216-P, BIO2013-49604-EXP, 2014SGR9]	This study was supported in part by grants from European, Spanish, and Catalan Agencies (grant references FP7-HEALTH-2012-306029-2 "TRIGGER"; BFU2015-64487R, MDM-2014-0435; BIO2013-49320-EXP; BIO2015-64216-P; BIO2013-49604-EXP; and 2014SGR9). The Structural Biology Unit (www.sbu.csic.es) of IBMB is a "Maria de Maeztu" Unit of Excellence from the Spanish Ministry of Economy, Industry and Competitiveness.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P400, DOI 10.1016/j.dci.2007.08.001; Altincicek B, 2010, DEV COMP IMMUNOL, V34, P1160, DOI 10.1016/j.dci.2010.06.010; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Antoni C, 2013, J STRUCT BIOL, V182, P246, DOI 10.1016/j.jsb.2013.03.015; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Aravind L, 1999, CURR OPIN GENET DEV, V9, P688, DOI 10.1016/S0959-437X(99)00028-3; Axelsson P, 2002, PERIODONTOL 2000, V29, P235, DOI 10.1034/j.1600-0757.2002.290112.x                                               ; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Broccanello C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0300-2; BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004                                                             ; Bryzek D, 2014, MOL ORAL MICROBIOL, V29, P294, DOI 10.1111/omi.12080; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38                                                         ; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Cho CW, 2009, BIOL PLANTARUM, V53, P461, DOI 10.1007/s10535-009-0086-z; Chovar-Vera O, 2015, FISH SHELLFISH IMMUN, V42, P241, DOI 10.1016/j.fsi.2014.11.007; CLAES H, 1971, ARCH MIKROBIOL, V78, P180, DOI 10.1007/BF00424874; Clark I. M., 2013, HDB PROTEOLYTIC ENZY, V1, P854; Coates D, 2000, BIOCHEM SOC T, V28, P464, DOI 10.1042/0300-5127:0280464; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Delorme VGR, 2000, PLANT PHYSIOL, V123, P917, DOI 10.1104/pp.123.3.917; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; DOOLITTLE RF, 1990, J MOL EVOL, V31, P383, DOI 10.1007/BF02106053; Eswar N, 2006, CURR PROTOC BIOINFOR, V5, P6, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Flinn BS, 2008, FUNCT PLANT BIOL, V35, P1183, DOI 10.1071/FP08182; Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Garcia-Ferrer I, 2015, P NATL ACAD SCI USA, V112, P8290, DOI 10.1073/pnas.1506538112; GHIGLIONE C, 1994, EUR J BIOCHEM, V219, P845, DOI 10.1111/j.1432-1033.1994.tb18566.x; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gomis-Rtith F. X., 2004, HDB METALLOPROTEINS, V3, P631; GOMISRUTH FX, 1993, EMBO J, V12, P4151; Gongalves R. N., 2016, BIOTECHNOL RES INT, V2016; Goulas T, 2017, BIOL CHEM, V398, P975, DOI 10.1515/hsz-2016-0329; Goulas T, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P887, DOI 10.1016/B978-0-12-382219-2.00186-1; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Goulielmaki E, 2014, INFECT IMMUN, V82, P4865, DOI 10.1128/IAI.02080-14; GRAHAM JS, 1991, PLANT PHYSIOL, V97, P786, DOI 10.1104/pp.97.2.786; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; [管京敏 GUAN Jing-Min], 2009, [昆虫学报, Acta Entomologica Sinica], V52, P353; Guevara T, 2013, ACTA CRYSTALLOGR F, V69, P472, DOI 10.1107/S1744309113007392; Hallmann A, 2001, PLANT J, V26, P583, DOI 10.1046/j.1365-313x.2001.01059.x                                                ; Heitzer M, 2002, J BIOL CHEM, V277, P28280, DOI 10.1074/jbc.M203925200; Huxley-Jones J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-63; Indra D, 2005, COMP BIOCHEM PHYS B, V142, P1, DOI 10.1016/j.cbpc.2005.02.004; Ishimwe E, 2015, VIROLOGY, V481, P166, DOI 10.1016/j.virol.2015.02.022; Isolani ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055649; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Kang C, 2014, TOXICON, V86, P116, DOI 10.1016/j.toxicon.2014.04.005; Kantor AM, 2017, INSECT MOL BIOL, V26, P113, DOI 10.1111/imb.12275; Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009; KINOSHITA T, 1992, P NATL ACAD SCI USA, V89, P4693, DOI 10.1073/pnas.89.10.4693; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Ko R, 2000, J VIROL, V74, P11240, DOI 10.1128/JVI.74.23.11240-11246.2000; Kohno T, 2006, BIOCHEM BIOPH RES CO, V344, P315, DOI 10.1016/j.bbrc.2006.03.098; Kotnik T, 2016, J MEMBRANE BIOL, V249, P623, DOI 10.1007/s00232-016-9897-y; Kovaleva ES, 2004, MOL BIOCHEM PARASIT, V136, P109, DOI 10.1016/j.molbiopara.2004.03.001; Koziel J, 2010, J INNATE IMMUN, V2, P288, DOI 10.1159/000281881; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; Ksiazek M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00312; Kubo T, 2001, CURR GENET, V40, P136, DOI 10.1007/s002940100239; Lang R, 2004, J MOL BIOL, V336, P213, DOI 10.1016/j.jmb.2003.12.022; Leontovich AA, 2000, DEVELOPMENT, V127, P907; Li DY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0536-z; LIBSON AM, 1995, NAT STRUCT BIOL, V2, P938, DOI 10.1038/nsb1195-938; Liu C. Y., 1998, PLANT PHYSIOL, V117, P1127; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.127.4.1788; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956                                                            ; Lopez-Pelegrin M, 2015, J BIOL CHEM, V290, P4728, DOI 10.1074/jbc.M114.605956; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Maidment JM, 1999, J BIOL CHEM, V274, P34706, DOI 10.1074/jbc.274.49.34706; Mandal MK, 2010, PLANTA, V232, P899, DOI 10.1007/s00425-010-1221-y; Mannello F, 2001, COMP BIOCHEM PHYS B, V128, P507, DOI 10.1016/S1096-4959(00)00352-3; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Marino G, 2012, PHYSIOL PLANTARUM, V145, P196, DOI 10.1111/j.1399-3054.2011.01544.x; MARTIN W, 1986, EUR J BIOCHEM, V159, P323, DOI 10.1111/j.1432-1033.1986.tb09871.x; Massova I, 1998, FASEB J, V12, P1075; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Matsuda Y., 2013, HDB PROTEOLYTIC ENZY, V1, P891; MCGEEHAN G, 1992, PLANT PHYSIOL, V99, P1179, DOI 10.1104/pp.99.3.1179; McHenry JZ, 1996, PLANT PATHOL, V45, P552, DOI 10.1046/j.1365-3059.1996.d01-142.x; Means JC, 2010, P NATL ACAD SCI USA, V107, P9825, DOI 10.1073/pnas.0913582107; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; Miyamoto N, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-016-0844-4; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MURPHY GJP, 1991, FEBS LETT, V289, P4, DOI 10.1016/0014-5793(91)80895-A; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491                                                        ; Nikapitiya C, 2014, FISH SHELLFISH IMMUN, V41, P27, DOI 10.1016/j.fsi.2014.06.015; Nomura K, 1997, BIOCHEMISTRY-US, V36, P7225, DOI 10.1021/bi9629790; Obiso R. J. J., 1997, CLIN INFECT DIS, V25; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pak JH, 1997, FEBS LETT, V404, P283, DOI 10.1016/S0014-5793(97)00141-5; Pal LR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-91; Passarelli AL, 2011, VIROLOGY, V411, P383, DOI 10.1016/j.virol.2011.01.009; Pavlovsky AG, 1999, PROTEIN SCI, V8, P1455, DOI 10.1110/ps.8.7.1455                                                             ; Pavlukova EB, 1998, BIOCHEMISTRY-MOSCOW+, V63, P899; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Potempa J., 2013, HDB PROTEOLYTIC ENZY, V1, P883; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Quesada V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-220; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; RAGSTER L, 1979, PLANT PHYSIOL, V64, P857, DOI 10.1104/pp.64.5.857; Ramos OHP, 2001, GENET MOL BIOL, V24, P285, DOI 10.1590/S1415-47572001000100037; Ratnaparkhe SM, 2009, PLANTA, V230, P339, DOI 10.1007/s00425-009-0949-8; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Rhee JS, 2012, FISH SHELLFISH IMMUN, V32, P700, DOI 10.1016/j.fsi.2012.01.017; Roskov Y., 2017, SPECIES 2000 ITIS CA, V2000; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; Schiermeyer A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-83; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Shimizu H, 2002, DEVELOPMENT, V129, P1521; Shimizu T, 2002, GENE, V284, P179, DOI 10.1016/S0378-1119(01)00899-X; Shiryaev SA, 2014, FEBS J, V281, P2487, DOI 10.1111/febs.12804; Siddiqi A, 2016, CLIN ORAL IMPLAN RES, V27, P288, DOI 10.1111/clr.12536; Skottrup PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048537; Small CD, 2016, NEURAL REGEN RES, V11, P357, DOI 10.4103/1673-5374.179030; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STOCKER W, 1995, PROTEIN SCI, V4, P823; Stocker W., 2013, PROTEASES STRUCTURE, P235; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Sun R, 2012, PARASITOL RES, V110, P2001, DOI 10.1007/s00436-011-2729-1; Tallant C, 2010, J BIOL CHEM, V285, P13951, DOI 10.1074/jbc.M109.083378; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; TERASHITA T, 1985, AGR BIOL CHEM TOKYO, V49, P2293, DOI 10.1080/00021369.1985.10867077                                                  ; Terauchi M, 2017, MAR GENOM, V32, P49, DOI 10.1016/j.margen.2016.12.002; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Ueno T, 2009, ZOOL SCI, V26, P557, DOI 10.2108/zsj.26.557; Uparanukraw P, 2001, PARASITOL RES, V87, P751, DOI 10.1007/s004360100440; van der Hoorn RAL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00089; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578                                                         ; Vishnuvardhan S, 2013, J EXP ZOOL PART B, V320B, P105, DOI 10.1002/jez.b.22487; Wada K, 1998, GENE, V211, P57, DOI 10.1016/S0378-1119(98)00076-6; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yoshino TP, 2014, INT J PARASITOL, V44, P551, DOI 10.1016/j.ijpara.2014.04.002; Zhang Y, 2012, DEV COMP IMMUNOL, V37, P371, DOI 10.1016/j.dci.2012.02.015; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zimmermann D, 2016, PLANT PHYSIOL, V171, P1456, DOI 10.1104/pp.16.00513	157	0	0	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	NOV	2017	1864	11	A		SI		2026	2035		10.1016/j.bbamcr.2017.04.003				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK6JN	WOS:000413610100010	28392403				2018-01-05	
J	Jobin, PG; Butler, GS; Overall, CM				Jobin, Parker G.; Butler, Georgina S.; Overall, Christopher M.			New intracellular activities of matrix metalloproteinases shine in the moonlight	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Moonlighting protein; Multifunctional protein; Matrix metalloproteinase; Proteolysis; Signal transduction; Transcription factor	ISCHEMIA-REPERFUSION INJURY; HUMAN GELATINASE-A; CEREBRAL-ARTERY OCCLUSION; SITE-DIRECTED MUTAGENESIS; ACUTE MYOCARDIAL-ISCHEMIA; TIMP-2 BINDING-SITE; ISOLATED RAT HEARTS; HEMOPEXIN-C-DOMAIN; II-LIKE MODULES; EXTRACELLULAR-MATRIX	Adaption of a single protein to perform multiple independent functions facilitates functional plasticity of the proteome allowing a limited number of protein-coding genes to perform a multitude of cellular processes. Multifunctionality is achievable by post-translational modifications and by modulating subcellular localization. Matrix metalloproteinases (MMPs), classically viewed as degraders of the extracellular matrix (ECM) responsible for matrix protein turnover, are more recently recognized as regulators of a range of extracellular bioactive molecules including chemokines, cytokines, and their binders. However, growing evidence has convincingly identified select MMPs in intracellular compartments with unexpected physiological and pathological roles. Intracellular MMPs have both proteolytic and non-proteolytic functions, including signal transduction and transcription factor activity thereby challenging their traditional designation as extracellular proteases. This review highlights current knowledge of subcellular location and activity of these "moonlighting" MMPs. Intracellular roles herald a new era of MMP research, rejuvenating interest in targeting these proteases in therapeutic strategies. This article is part of a Special Issue entitled: Matrix Metalloproteinases edited by Rafael Fridman.	[Jobin, Parker G.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Jobin, Parker G.; Butler, Georgina S.; Overall, Christopher M.] Univ British Columbia, Life Sci Inst, Ctr Blood Res, Vancouver, BC, Canada; [Butler, Georgina S.; Overall, Christopher M.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC, Canada	Overall, CM (reprint author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	chris.overall@ubc.ca					Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Benmerah A, 2003, TRAFFIC, V4, P503, DOI 10.1034/j.1600-0854.2003.00102.x                                                ; Berton A, 2007, CELL MOL LIFE SCI, V64, P610, DOI 10.1007/s00018-007-6415-5; Bigg HF, 2001, CANCER RES, V61, P3610; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cauwe B, 2009, INTEGR BIOL, V1, P404, DOI 10.1039/b904701h; Cho WJ, 2007, J CELL MOL MED, V11, P1069, DOI 10.1111/j.1582-4934.2007.00113.x; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; Chow AK, 2007, J MOL CELL CARDIOL, V42, P896, DOI 10.1016/j.yjmcc.2007.01.008; Coker M. L., 1999, AM J PHYS, V277; Cuadrado E, 2009, J CEREBR BLOOD F MET, V29, P398, DOI 10.1038/jcbfm.2008.130; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; De Bock M, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/257471; DeCoux A, 2014, J MOL CELL CARDIOL, V77, P64, DOI 10.1016/j.yjmcc.2014.09.016; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Galt SW, 2002, CIRC RES, V90, P1093, DOI 10.1161/01.RES.0000019241.12929.EB; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Ganguly B, 2007, FEBS LETT, V581, P5723, DOI 10.1016/j.febslet.2007.11.042; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003                                                ; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2005, J BIOL CHEM, V280, P42237, DOI 10.1074/jbc.M510139200; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hadler-Olsen E, 2015, J CELL PHYSIOL, V230, P160, DOI 10.1002/jcp.24694; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Henderson B, 2014, BIOCHEM SOC T, V42, P1671, DOI 10.1042/BST20140273; Hernandez S, 2014, NUCLEIC ACIDS RES, V42, pD517, DOI 10.1093/nar/gkt1153; Hill JW, 2012, NEUROSCIENCE, V220, P277, DOI 10.1016/j.neuroscience.2012.06.019; Hoffner G, 2002, J CELL SCI, V115, P941; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Hughes BG, 2014, AM J PHYSIOL-HEART C, V306, pH764, DOI 10.1152/ajpheart.00909.2013; Hynes RO, 2012, COLD SPRING HARB PER, V4, P4903, DOI DOI 10.1101/CSHPERSPECT.A004903; Ip YC, 2007, MOL CANCER THER, V6, P2858, DOI 10.1158/1535-7163.MCT-07-0453; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2005, MASS SPECTROM REV, V24, P772, DOI 10.1002/mas.20041; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7                                                   ; Jeffery CJ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00211; Jeffery CJ, 2014, BIOCHEM SOC T, V42, P1679, DOI 10.1042/BST20140226; Jeffery CJ, 2011, IUBMB LIFE, V63, P489, DOI 10.1002/iub.504; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jurasz P, 2002, CIRC RES, V90, P1041, DOI 10.1161/01.RES.0000021398.28936.1D; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kandasamy AD, 2009, CARDIOVASC RES, V83, P698, DOI 10.1093/cvr/cvp175; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Kimura-Ohba S., 2016, OXID MED CELL LONGEV, V2016; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; Koppisetti RK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6552; Kowluru RA, 2012, EXPERT OPIN INV DRUG, V21, P797, DOI 10.1517/13543784.2012.681043; Kowluru RA, 2011, DIABETES, V60, P3023, DOI 10.2337/db11-0816; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Li CKF, 2004, J IMMUNOL, V173, P5171, DOI 10.4049/jimmunol.173.8.5171                                                     ; Linask KK, 2005, DEV DYNAM, V233, P739, DOI 10.1002/dvdy.20377; Lindsey ML, 2006, CIRCULATION, V113, P2919, DOI 10.1161/CIRCULATIONAHA.106.612960; Linke WA, 2010, CIRCULATION, V122, P2002, DOI 10.1161/CIRCULATIONAHA.110.985317; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Marchenko ND, 2002, J BIOL CHEM, V277, P18967, DOI 10.1074/jbc.M201197200; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Mohammad G, 2012, J CELL PHYSIOL, V227, P1052, DOI 10.1002/jcp.22822; Mohammad G, 2011, INVEST OPHTH VIS SCI, V52, P3832, DOI 10.1167/iovs.10-6368; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Moshal KS, 2008, AM J PHYSIOL-HEART C, V295, pH890, DOI 10.1152/ajpheart.00099.2008; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491                                                        ; Nagase H, 1997, BIOL CHEM, V378, P151; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Ohtaki H, 2007, NEUROSCI RES, V58, P349, DOI 10.1016/j.neures.2007.04.005; Omenn GS, 2016, J PROTEOME RES, V15, P3951, DOI 10.1021/acs.jproteome.6b00511; Overall C M, 2001, Methods Mol Biol, V151, P79; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 1999, J BIOL CHEM, V274, P4421, DOI 10.1074/jbc.274.7.4421                                                          ; Overall CM, 1999, ANN NY ACAD SCI, V878, P747, DOI 10.1111/j.1749-6632.1999.tb07780.x                                              ; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pal S, 2012, PHARMACOL THERAPEUT, V136, P283, DOI 10.1016/j.pharmthera.2012.08.005; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Rouet-Benzineb P, 1999, EUR J HEART FAIL, V1, P337, DOI 10.1016/S1388-9842(99)00048-3                                                   ; Ruta A, 2009, EXP LUNG RES, V35, P59, DOI 10.1080/01902140802406059; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Fons MGS, 2010, AM J PATHOL, V177, P2870, DOI 10.2353/ajpath.2010.090050; Santos JM, 2013, BIOCHEM BIOPH RES CO, V438, P760, DOI 10.1016/j.bbrc.2013.07.066; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Savinov AY, 2006, CANCER RES, V66, P2716, DOI 10.1158/0008-5472.CAN-05-3592; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694                                                          ; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Schulze CJ, 2003, CIRCULATION, V107, P2487, DOI 10.1161/01.CIR.0000065603.09430.58; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Shanahan MT, 2010, J BIOL CHEM, V285, P7493, DOI 10.1074/jbc.M109.083220; Sheu JR, 2004, BRIT J PHARMACOL, V143, P193, DOI 10.1038/sj.bjp.0705917; Shimizu-Hirota R, 2012, GENE DEV, V26, P395, DOI 10.1101/gad.178749.111; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Solli AI, 2013, J HISTOCHEM CYTOCHEM, V61, P444, DOI 10.1369/0022155413484765; Soslau G, 2014, THROMB HAEMOSTASIS, V111, P140, DOI 10.1160/TH13-03-0248; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Sung MM, 2007, J MOL CELL CARDIOL, V43, P429, DOI 10.1016/j.yjmcc.2007.07.055; Szklarczyk A, 2007, J NEUROCHEM, V102, P1256, DOI 10.1111/j.1471-4159.2007.04625.x; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112                                                           ; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Vincenti M P, 2001, Methods Mol Biol, V151, P121; Waelter S, 2001, HUM MOL GENET, V10, P1807, DOI 10.1093/hmg/10.17.1807                                                          ; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473                                                         ; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113                                                    ; Woo MS, 2008, J NEUROCHEM, V106, P770, DOI 10.1111/j.1471-4159.2008.05430.x; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yamamoto K, 2016, MATRIX BIOL, V56, P57, DOI 10.1016/j.matbio.2016.03.007; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yasmin W, 1997, CARDIOVASC RES, V33, P422, DOI 10.1016/S0008-6363(96)00254-4; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhang ZY, 2015, J IMMUNOL, V195, P2452, DOI 10.4049/jimmunol.1500944; Zhao YG, 2003, J BIOL CHEM, V278, P15056, DOI 10.1074/jbc.M210975200; Zhou HZ, 2007, BIOCHEM BIOPH RES CO, V358, P189, DOI 10.1016/j.bbrc.2007.04.094; Zuo XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084748	160	1	1	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	NOV	2017	1864	11	A		SI		2043	2055		10.1016/j.bbamcr.2017.05.013				13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK6JN	WOS:000413610100012	28526562				2018-01-05	
J	Stengel, S; Messner, B; Falk-Paulsen, M; Sommer, N; Rosenstiel, P				Stengel, Stephanie; Messner, Berith; Falk-Paulsen, Maren; Sommer, Nina; Rosenstiel, Philip			Regulated proteolysis as an element of ER stress and autophagy: Implications for intestinal inflammation	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Autophagy; Inflammatory bowel disease; Er stress; Cell death; Proteolysis; Proteasome; Necroptosis	UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE ASSOCIATION; SELECTIVE AUTOPHAGY; CROHNS-DISEASE; MOLECULAR-BASIS; CELL-DEATH; DEGRADATION SYSTEMS; BOWEL-DISEASE; GENE ATG16L1	Endoplasmic reticulum (ER) stress and autophagy are tightly controlled cellular processes, which are responsible for maintaining protein homeostasis in a cell. Impairment of the interlinking pathways have been implicated in a number of human diseases, prominently in inflammatory bowel disease, where genetic variants in several independent autophagy and ER stress related loci have been associated to increased disease risk. Autophagy is a selective quality control process, which governs the integrity of the cell by removal of aged organelles and proteins via the lysosome, but recently has been shown to actively license the outcome of other signaling pathways by guiding the proteolytic removal of signaling protein complexes (adaptophagy). In this review, we summarize our knowledge on regulated proteolytic events involved in ER stress responses and autophagy, their interplay and potential regulatory effects with a particular focus on intestinal inflammation. This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiology edited by Stefan Rose-John.	[Stengel, Stephanie; Messner, Berith; Falk-Paulsen, Maren; Sommer, Nina; Rosenstiel, Philip] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany	Rosenstiel, P (reprint author), Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany.	p.rosenstiel@mucosa.de			Deutsche Forschungsgemeinschaft (DFG) [SFB877 B9]; Cluster of Excellence Inflammation at Interfaces [ExC 306]	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) under contract numbers SFB877 B9 and the Cluster of Excellence Inflammation at Interfaces (ExC 306) to P.R. We thank all members of the SFB877 for discussion. We want to point out that this article is an opinionated view rather than a systematic review and thus apologize to those researchers whose important contributions to the field were unintentionally not cited.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Deuring JJ, 2014, GUT, V63, P1081, DOI 10.1136/gutjnl-2012-303527; Diamanti M.A., 2017, J EXP MED; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ellinghaus D, 2013, GASTROENTEROLOGY, V145, P339, DOI 10.1053/j.gastro.2013.04.040; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Goodall ML, 2016, DEV CELL, V37, P337, DOI 10.1016/j.devcel.2016.04.018; Goode A, 2010, J CLIN PATHOL, V63, P199, DOI 10.1136/jcp.2009.064428; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guo HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6276; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Harding HP, 1999, NATURE, V397, P271; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8                                                   ; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787                                                          ; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nakamura K, 2010, J BIOL CHEM, V285, P2077, DOI 10.1074/jbc.M109.065102; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park SW, 2011, HEPATOLOGY, V53, P1662, DOI 10.1002/hep.24253; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901                                                         ; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Sternsdorf T, 1997, J CELL BIOL, V138, P435, DOI 10.1083/jcb.138.2.435; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tomkinson B, 2005, INT J BIOCHEM CELL B, V37, P1933, DOI 10.1016/j.biocel.2005.02.009; Tschurtschenthaler M, 2017, J EXP MED, V214, P401, DOI 10.1084/jem.20160791; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235                                                        ; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wu WKK, 2008, BIOCHEM BIOPH RES CO, V374, P258, DOI 10.1016/j.bbrc.2008.07.031; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Xie XQ, 2015, AUTOPHAGY, V11, P1775, DOI 10.1080/15548627.2015.1082025; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7                                                   ; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zheng W, 2006, GENES IMMUN, V7, P11, DOI 10.1038/sj.gene.6364263; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	96	1	1	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	NOV	2017	1864	11	B		SI		2183	2190		10.1016/j.bbamcr.2017.07.008				8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK3LB	WOS:000413385500014	28736290				2018-01-05	
J	Harkness, VRW; Mittermaier, AK				Harkness, Robert W., V; Mittermaier, Anthony K.			G-quadruplex dynamics	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						G-quadruplex; Dynamics; Conformational exchange; Folding; Ensemble; Nuclear magnetic resonance; Thermodynamics; Kinetics	TELOMERIC G-QUADRUPLEX; STATISTICAL-MECHANICAL DECONVOLUTION; C-KIT PROMOTER; DIFFERENTIAL SCANNING CALORIMETRY; STRANDED G-QUADRUPLEXES; TRIPLET REPEAT DNA; RNA G-QUADRUPLEX; NUCLEIC-ACIDS; THERMAL TRANSITIONS; CRYSTAL-STRUCTURE	G-quadruplexes (GQs) are four-stranded nucleic acid secondary structures formed by guanosine (G)-rich DNA and RNA sequences. It is becoming increasingly clear that cellular processes including gene expression and mRNA translation are regulated by GQs. GQ structures have been extensively characterized, however little attention to date has been paid to their conformational dynamics, despite the fact that many biological GQ sequences populate multiple structures of similar free energies, leading to an ensemble of exchanging conformations. The impact of these dynamics on biological function is currently not well understood. Recently, structural dynamics have been demonstrated to entropically stabilize GQ ensembles, potentially modulating gene expression. Transient, low-populated states in GQ ensembles may additionally regulate nucleic acid interactions and function. This review will underscore the interplay of GQ dynamics and biological function, focusing on several dynamic processes for biological GQs and the characterization of GQ dynamics by nuclear magnetic resonance (NMR) spectroscopy in conjunction with other biophysical techniques. This article is part of a Special Issue entitled: Biophysics in Canada, edited by Lewis Kay, John Baenziger, Albert Berghuis and Peter Tieleman.	[Harkness, Robert W., V; Mittermaier, Anthony K.] McGill Univ, Dept Chem, 801 Sherbrooke St W, Montreal, PQ H3A 0B8, Canada	Mittermaier, AK (reprint author), McGill Univ, Dept Chem, 801 Sherbrooke St W, Montreal, PQ H3A 0B8, Canada.	anthony.mittermaier@mcgill.ca	Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225	Natural Sciences and Engineering Research Council (NSERC) of Canada CREATE training program in Bionanomachines; NSERC [327028-09]	R. W. H. V. is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada CREATE training program in Bionanomachines. A. K. M. is supported by NSERC grant number 327028-09.	Adrian M, 2014, J AM CHEM SOC, V136, P6297, DOI 10.1021/ja4125274; Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; Agrawal P, 2013, NUCLEIC ACIDS RES, V41, P10584, DOI 10.1093/nar/gkt784; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Amrane S, 2009, NUCLEIC ACIDS RES, V37, P931, DOI 10.1093/nar/gkn990; Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Arora A, 2011, RNA BIOL, V8, P802, DOI 10.4161/rna.8.5.16038; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Bessi I, 2015, ANGEW CHEM INT EDIT, V54, P8444, DOI 10.1002/anie.201502286; Boncina M, 2012, J AM CHEM SOC, V134, P9657, DOI 10.1021/ja300605n; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Buscaglia R, 2013, NUCLEIC ACIDS RES, V41, P7934, DOI 10.1093/nar/gkt440; Campbell NH, 2012, METAL IONS LIFE SCI, V10, P119, DOI 10.1007/978-94-007-2172-2_4; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; CHEN FM, 1992, BIOCHEMISTRY-US, V31, P3769, DOI 10.1021/bi00130a006; Chung WJ, 2015, P NATL ACAD SCI USA, V112, P2729, DOI 10.1073/pnas.1418718112; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Deng H, 1996, J MOL BIOL, V255, P476, DOI 10.1006/jmbi.1996.0039                                                          ; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; Dettler JM, 2011, BIOPHYS J, V100, P1517, DOI 10.1016/j.bpj.2011.01.068; Endoh T, 2013, NUCLEIC ACIDS RES, V41, P6222, DOI 10.1093/nar/gkt286; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X                                                   ; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Fitter J, 2003, BIOPHYS J, V84, P3924, DOI 10.1016/S0006-3495(03)75120-0                                                   ; Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202; FREIRE E, 1978, BIOPOLYMERS, V17, P481, DOI 10.1002/bip.1978.360170213; FREIRE E, 1978, BIOPOLYMERS, V17, P497, DOI 10.1002/bip.1978.360170214; FREIRE E, 1978, BIOPOLYMERS, V17, P463, DOI 10.1002/bip.1978.360170212                                                      ; Fu BS, 2016, CHEM COMMUN, V52, P10052, DOI 10.1039/c6cc04866h; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640                                                      ; Ghimire C, 2014, J AM CHEM SOC, V136, P15537, DOI 10.1021/ja503585h; Gray R.D., 2011, CURR PROTOC NUCL ACI; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Gray RD, 2012, J AM CHEM SOC, V134, P16834, DOI 10.1021/ja307543z; Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X; Hardin CC, 2001, BIOPOLYMERS, V56, P147; Harkness RW, 2016, NUCLEIC ACIDS RES, V44, P3481, DOI 10.1093/nar/gkw190; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Hud NV, 2006, RSC BIOMOL SCI, P100; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ilc T, 2013, J PHYS CHEM C, V117, P23208, DOI 10.1021/jp4019348; Islam B, 2015, NUCLEIC ACIDS RES, V43, P8673, DOI 10.1093/nar/gkv785; Jiang HX, 2014, BIOSENS BIOELECTRON, V55, P133, DOI 10.1016/j.bios.2013.12.001; Katsuda Y, 2016, J AM CHEM SOC, V138, P9037, DOI 10.1021/jacs.6b04506; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Koirala D, 2013, J AM CHEM SOC, V135, P2235, DOI 10.1021/ja309668t; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Latham MP, 2014, P NATL ACAD SCI USA, V111, P5532, DOI 10.1073/pnas.1322079111; Lee MPH, 2007, J AM CHEM SOC, V129, P10106, DOI 10.1021/ja0740869; Li XM, 2015, P NATL ACAD SCI USA, V112, P14581, DOI 10.1073/pnas.1516925112; Lim KW, 2010, J AM CHEM SOC, V132, P12331, DOI 10.1021/ja101252n; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Limongelli V, 2013, ANGEW CHEM INT EDIT, V52, P2269, DOI 10.1002/anie.201206522; Liu W, 2012, NUCLEIC ACIDS RES, V40, P4229, DOI 10.1093/nar/gkr1310; LIVOLANT F, 1991, MOL CELL BIOL, V176, P117; Marchand A, 2016, NUCLEIC ACIDS RES, V44, P10999, DOI 10.1093/nar/gkw970; Martadinata H, 2013, BIOCHEMISTRY-US, V52, P2176, DOI 10.1021/bi301606u; Mashimo T, 2010, J AM CHEM SOC, V132, P14910, DOI 10.1021/ja105806u; Matsugami A, 2003, J BIOL CHEM, V278, P28147, DOI 10.1074/jbc.M303694200; Matsugami A, 2001, J MOL BIOL, V313, P255, DOI 10.1006/jmbi.2001.5047; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Miller MC, 2011, ORG BIOMOL CHEM, V9, P7633, DOI 10.1039/c1ob05891f; Moye AL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8643; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Mullen MA, 2010, NUCLEIC ACIDS RES, V38, P8149, DOI 10.1093/nar/gkq804; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Do NQ, 2012, CHEM-EUR J, V18, P14752, DOI 10.1002/chem.201103295; Ou TM, 2008, CHEMMEDCHEM, V3, P690, DOI 10.1002/cmdc.200700300; Pagano B, 2013, METHODS, V64, P43, DOI 10.1016/j.ymeth.2013.02.018; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Petraccone L, 2011, J AM CHEM SOC, V133, P20951, DOI 10.1021/ja209192a; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phan AT, 2005, P NATL ACAD SCI USA, V102, P634, DOI 10.1073/pnas.0406278102; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Phan AT, 2004, J MOL BIOL, V338, P93, DOI 10.1016/j.jmb.2004.02.042; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Phan AT, 2002, J AM CHEM SOC, V124, P1160, DOI 10.1021/ja011977m; Phan AT, 2001, METHOD ENZYMOL, V338, P341; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Podbevsek P, 2007, NUCLEIC ACIDS RES, V35, P2554, DOI 10.1093/nar/gkm138; Privalov PL, 2015, J SOLUTION CHEM, V44, P1141, DOI 10.1007/s10953-015-0337-x; PRIVALOV PL, 1980, PURE APPL CHEM, V52, P479, DOI 10.1351/pac198052020479                                                         ; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Randazzo A, 2013, TOP CURR CHEM, V330, P67, DOI 10.1007/128_2012_331; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; RODER H, 1985, BIOCHEMISTRY-US, V24, P7396, DOI 10.1021/bi00346a055; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Shastri A, 2015, NAT CHEM, V7, P447, DOI [10.1038/nchem.2203, 10.1038/NCHEM.2203]; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Sket P, 2005, NUCLEIC ACIDS RES, V33, P3691, DOI 10.1093/nar/gki690; Sket P, 2012, NUCLEIC ACIDS RES, V40, P11047, DOI 10.1093/nar/gks851; Smirnov I, 2000, BIOCHEMISTRY-US, V39, P1462, DOI 10.1021/bi9919044; Song JW, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1244031; Spink CH, 2015, METHODS, V76, P78, DOI 10.1016/j.ymeth.2014.12.001; Stadlbauer P, 2013, NUCLEIC ACIDS RES, V41, P7128, DOI 10.1093/nar/gkt412; Su DGT, 2009, P NATL ACAD SCI USA, V106, P12861, DOI 10.1073/pnas.0902386106; Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5; Wallimann P, 2003, J AM CHEM SOC, V125, P1203, DOI 10.1021/ja0275360; Wang CH, 2012, ANGEW CHEM INT EDIT, V51, P9352, DOI 10.1002/anie.201204850; Wang ZF, 2016, NUCLEIC ACIDS RES, V44, P3958, DOI 10.1093/nar/gkw145; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	112	0	0	18	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	NOV	2017	1865	11	B		SI		1544	1554		10.1016/j.bbapap.2017.06.012				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FL3GN	WOS:000414111000008	28642152				2018-01-05	
J	Bloudoff, K; Schmeing, TM				Bloudoff, Kristjan; Schmeing, T. Martin			Structural and functional aspects of the nonribosomal peptide synthetase condensation domain superfamily: discovery, dissection and diversity	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Condensation domain; Nonribosomal peptide synthetase; Natural products; Megaenzyme; C domain superfamily; Antibiotics	BIOSYNTHETIC GENE-CLUSTER; GLYCOPEPTIDE ANTIBIOTIC BIOSYNTHESIS; STREPTOMYCES-VERTICILLUS ATCC15003; DEPENDENT PHENYLALANINE RACEMASE; TERMINAL THIOESTERASE DOMAIN; INITIATION MODULE PHEATE; GRAMICIDIN-S SYNTHETASE; BACILLUS-BREVIS NAGANO; CRYSTAL-STRUCTURE; CARRIER PROTEIN	Nonribosomal peptide synthetases (NRPSs) are incredible macromolecular machines that produce a wide range of biologically- and therapeutically-relevant molecules. During synthesis, peptide elongation is performed by the condensation (C) domain, as it catalyzes amide bond formation between the nascent peptide and the amino acid it adds to the chain. Since their discovery more than two decades ago, C domains have been subject to extensive biochemical, bioinformatic, mutagenic, and structural analyses. They are composed of two lobes, each with homology to chloramphenicol acetyltransferase, have two binding sites for their two peptidyl carrier protein bound ligands, and have an active site with conserved motif HHxxxDG located between the two lobes. This review discusses some of the important insights into the structure, catalytic mechanism, specificity, and gatekeeping functions of C domains revealed since their discovery. In addition, C domains are the archetypal members of the C domain superfamily, which includes several other members that also function as NRPS domains. The other family members can replace the C domain in NRP synthesis, can work in concert with a C domain, or can fulfill diverse and novel functions. These domains include the epimerization (E) domain, the heterocyclization (Cy) domain, the ester-bond forming C domain, the fungal NRPS terminal C domain (C-T), the beta-lactam ring forming C domain, and the X domain. We also discuss structural and function insight into C, E, Cy, C-T and X domains, to present a holistic overview of historical and current knowledge of the C domain superfamily. This article is part of a Special Issue entitled: Biophysics in Canada, edited by Lewis Kay, John Baenziger, Albert Berghuis and Peter Tieleman.	[Bloudoff, Kristjan; Schmeing, T. Martin] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	Schmeing, TM (reprint author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	martin.schmeing@mcgill.ca			Canadian Institutes of Health Research [FDN-148472]; Canada Research Chairs	We thank members of the Schmeing laboratory for advice and critique, Janice Reimer and Nancy Rogerson for editing help and Adrian Keatinge-Clay for interesting discussions. Funding support is thankfully acknowledged from Canadian Institutes of Health Research (FDN-148472) and the Canada Research Chairs to T.M.S.	Ackerley DF, 2004, CHEM BIOL, V11, P971, DOI 10.1016/j.chembiol.2004.04.014; AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Alonzo DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128569; ANDERSON RF, 1974, INT J RADIAT PHYS CH, V6, P33, DOI 10.1016/0020-7055(74)90033-3                                                    ; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Balibar CJ, 2005, CHEM BIOL, V12, P1189, DOI 10.1016/j.chembiol.2005.08.010; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x                                                ; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N; Bischoff D, 2005, CHEMBIOCHEM, V6, P267, DOI 10.1002/cbic.200400328; Bloudoff K, 2017, P NATL ACAD SCI USA, V114, P95, DOI 10.1073/pnas.1614191114; Bloudoff K, 2016, CELL CHEM BIOL, V23, P331, DOI 10.1016/j.chembiol.2016.02.012; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5                                                   ; Calcott MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0496-3; Calcott MJ, 2014, APPL ENVIRON MICROB, V80, P5723, DOI 10.1128/AEM.01453-14; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0                                                   ; Chen HW, 2001, CHEM BIOL, V8, P899, DOI 10.1016/S1074-5521(01)00064-3; Chen WH, 2016, ACS CHEM BIOL, V11, P2293, DOI 10.1021/acschembio.6b00332; Cheng YQ, 2006, CHEMBIOCHEM, V7, P471, DOI 10.1002/cbic.200500425; Clugston SL, 2003, BIOCHEMISTRY-US, V42, P12095, DOI 10.1021/bi035090+                                                               ; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cramer RA, 2006, GENE, V383, P24, DOI 10.1016/j.gene.2006.07.008; DECRECYLAGARD V, 1995, CR ACAD SCI III-VIE, V318, P927; Di Lorenzo M, 2004, J BACTERIOL, V186, P7327, DOI 10.1128/JB.186.21.7327-7336.2004; Di Lorenzo M, 2008, BIOMETALS, V21, P635, DOI 10.1007/s10534-008-9149-4; Ding YS, 2011, J AM CHEM SOC, V133, P14492, DOI 10.1021/ja204716f; DITTMANN J, 1994, J BIOL CHEM, V269, P2841; Dorrestein PC, 2005, P NATL ACAD SCI USA, V102, P13843, DOI 10.1073/pnas.0506964102; Dowling DP, 2016, P NATL ACAD SCI USA, V113, P12432, DOI 10.1073/pnas.1608615113; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Duerfahrt T, 2004, CHEM BIOL, V11, P261, DOI 10.1016/j.chembiol.2004.01.013; Ehmann DE, 2000, CHEM BIOL, V7, P765, DOI 10.1016/S1074-5521(00)00022-3; Evans BS, 2011, CHEM BIOL, V18, P601, DOI 10.1016/j.chembiol.2011.03.008; Felnagle EA, 2008, MOL PHARM, V5, P191, DOI 10.1021/mp700137g; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; Gatto GJ, 2005, BIOCHEMISTRY-US, V44, P5993, DOI 10.1021/bi050230w; Gaudelli NM, 2015, NATURE, V520, P383, DOI 10.1038/nature14100; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P17104, DOI 10.1021/bi9850524                                                               ; Gokhale RS, 1999, CHEM BIOL, V6, P117, DOI 10.1016/S1074-5521(99)80008-8; Goodrich AC, 2015, J AM CHEM SOC, V137, P12100, DOI 10.1021/jacs.5b07772; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Green R, 2002, CELL, V110, P665, DOI 10.1016/S0092-8674(02)00965-0                                                   ; GUEST JR, 1987, FEMS MICROBIOL LETT, V44, P417, DOI 10.1016/0378-1097(87)90358-2; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gunsior M, 2004, CHEM BIOL, V11, P927, DOI 10.1016/j.chembiol.2004.04.012; Harden BJ, 2015, J MAGN RESON, V260, P83, DOI 10.1016/j.jmr.2015.09.007; Haslinger K, 2015, NATURE, V521, P105, DOI 10.1038/nature14141; Haynes SW, 2011, BIOCHEMISTRY-US, V50, P5668, DOI 10.1021/bi2004922; Holzbaur IE, 1999, CHEM BIOL, V6, P189, DOI 10.1016/S1074-5521(99)80035-0; Hoyer KM, 2007, CHEM BIOL, V14, P13, DOI 10.1016/j.chembiol.2006.10.011; Jaitzig J, 2014, ACS SYNTH BIOL, V3, P432, DOI [10.1021/sb400882j, 10.1021/sb400082j]; Jaremko MJ, 2015, J AM CHEM SOC, V137, P11546, DOI 10.1021/jacs.5b04525; [Anonymous], 1969, CATALYSIS CHEM ENZYM; Kallow W, 1997, FEBS LETT, V414, P74, DOI 10.1016/S0014-5793(97)00977-0; Kawai Y, 2004, APPL ENVIRON MICROB, V70, P2906, DOI 10.1128/AEM.70.5.2906-2911.2004; Keating TA, 2000, BIOCHEMISTRY-US, V39, P4729, DOI 10.1021/bi992923g                                                               ; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; Kelly WL, 2005, BIOCHEMISTRY-US, V44, P13385, DOI 10.1021/bi051124x; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X                                                   ; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Kraas FI, 2012, FEBS LETT, V586, P283, DOI 10.1016/j.febslet.2012.01.003; Kries H, 2015, CHEM BIOL, V22, P640, DOI 10.1016/j.chembiol.2015.04.015; Kuhlenkoetter S, 2011, NATURE, V476, P351, DOI 10.1038/nature10247; Labby KJ, 2015, NAT PROD REP, V32, P641, DOI 10.1039/c4np00120f; Lai JR, 2006, J AM CHEM SOC, V128, P11002, DOI 10.1021/ja063238h; Lai JR, 2006, P NATL ACAD SCI USA, V103, P5314, DOI 10.1073/pnas.0601038103; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LAWEN A, 1990, J BIOL CHEM, V265, P11355; Leduc D, 2007, J BACTERIOL, V189, P7112, DOI 10.1128/JB.00755-07; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; LEWENDON A, 1994, BIOCHEMISTRY-US, V33, P1944, DOI 10.1021/bi00173a043; Li R., 2016, CELL CHEM BIOL; Lin SJ, 2012, ORG LETT, V14, P2300, DOI 10.1021/ol300720s; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; Linne U, 2001, BIOCHEMISTRY-US, V40, P15824, DOI 10.1021/bi011595t; Lohman JR, 2014, PROTEINS, V82, P1210, DOI 10.1002/prot.24485; Luo LS, 2001, J AM CHEM SOC, V123, P11208, DOI 10.1021/ja0166646; Luo LS, 2002, BIOCHEMISTRY-US, V41, P9184, DOI 10.1021/bi026047+; Magarvey NA, 2006, J AM CHEM SOC, V128, P10698, DOI 10.1021/ja0640187; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e                                                               ; Marshall CG, 2002, BIOCHEMISTRY-US, V41, P244, DOI 10.1021/bi011852u; Marshall CG, 2001, BIOCHEMISTRY-US, V40, P10655, DOI 10.1021/bi010937s; Marxen S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10637; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Meyer S, 2016, CELL CHEM BIOL, V23, P462, DOI 10.1016/j.chembiol.2016.03.011; Miller BR, 2016, J BIOL CHEM, V291, P22559, DOI 10.1074/jbc.M116.746297; Miller BR, 2016, METHODS MOL BIOL, V1401, P3, DOI 10.1007/978-1-4939-3375-4_1; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mishra SH, 2015, J BIOMOL NMR, V62, P281, DOI 10.1007/s10858-015-9943-6; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997                                                ; Nguyen KT, 2006, P NATL ACAD SCI USA, V103, P17462, DOI 10.1073/pnas.0608589103; Patel HM, 2001, BIOCHEMISTRY-US, V40, P9023, DOI 10.1021/bi010519n; Payne JAE, 2017, MOL BIOSYST, V13, P9, DOI 10.1039/c6mb00675b; Peschke M, 2016, CURR OPIN STRUC BIOL, V41, P46, DOI 10.1016/j.sbi.2016.05.018; Peschke M, 2016, J AM CHEM SOC, V138, P6746, DOI 10.1021/jacs.6b00307; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reimer JM, 2016, NATURE, V529, P239, DOI 10.1038/nature16503; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; Roche ED, 2003, BIOCHEMISTRY-US, V42, P1334, DOI 10.1021/BI026867m; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Roongsawang N, 2005, FEMS MICROBIOL LETT, V252, P143, DOI 10.1016/j.femsle.2005.08.041; Roy RS, 1999, NAT PROD REP, V16, P249, DOI 10.1039/a806930a                                                                ; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Samel SA, 2014, ACTA CRYSTALLOGR D, V70, P1442, DOI 10.1107/S1399004714004398; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Schneider TL, 2003, BIOCHEMISTRY-US, V42, P9722, DOI 10.1021/bi034792w; Schoenafinger G, 2006, J AM CHEM SOC, V128, P7406, DOI 10.1021/ja0611240; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; STACHELHAUS T, 1995, J BIOL CHEM, V270, P6163, DOI 10.1074/jbc.270.11.6163                                                         ; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773                                                        ; Stachelhaus T, 2000, BIOCHEMISTRY-US, V39, P5775, DOI 10.1021/bi9929002; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stegmann E, 2010, CURR OPIN MICROBIOL, V13, P595, DOI 10.1016/j.mib.2010.08.011; Stein DB, 2005, FEBS J, V272, P4506, DOI 10.1111/j.1743-4658.2005.04871.x; STEIN T, 1995, BIOCHEMISTRY-US, V34, P4633, DOI 10.1021/bi00014a017; STINDL A, 1994, BIOCHEMISTRY-US, V33, P9358, DOI 10.1021/bi00197a041; TAKAHASHI H, 1971, J BIOCHEM, V69, P973, DOI 10.1093/oxfordjournals.jbchem.a129548                                           ; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tarry MJ, 2017, STRUCTURE, V25, P783, DOI 10.1016/j.str.2017.03.014; Townsend CA, 2016, CURR OPIN CHEM BIOL, V35, P97, DOI 10.1016/j.cbpa.2016.09.013; Trauger JW, 2000, NATURE, V407, P215; Tseng CC, 2002, BIOCHEMISTRY-US, V41, P13350, DOI 10.1021/bi026592a; Ulrich V., 2016, MOL BIOSYST; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6                                                   ; Vater J, 1997, J PROTEIN CHEM, V16, P557, DOI 10.1023/A:1026386100259                                                         ; Veatch W., 1976, J SUPRAMOL STRUCT, V5; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Vollbrecht L, 2002, J ANTIBIOT, V55, P715, DOI 10.7164/antibiotics.55.715                                                      ; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; von Dohren H, 1999, CHEM BIOL, V6, pR273, DOI 10.1016/S1074-5521(00)80014-9; Wallin G, 2010, P NATL ACAD SCI USA, V107, P1888, DOI 10.1073/pnas.0914192107; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Weissman KJ, 2015, NAT CHEM BIOL, V11, P660, DOI [10.1038/NCHEMBIO.1883, 10.1038/nchembio.1883]; YAMADA M, 1968, J BIOCHEM, V63, P59, DOI 10.1093/oxfordjournals.jbchem.a128748                                           ; Yang W, 2000, ORG LETT, V2, P4133, DOI 10.1021/ol006691l; Yim G, 2014, J ANTIBIOT, V67, P31, DOI 10.1038/ja.2013.117; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Zerbe K, 2004, ANGEW CHEM INT EDIT, V43, P6709, DOI 10.1002/anie.200461278; Zhang J., 2016, NAT CHEM BIOL; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	163	1	1	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	NOV	2017	1865	11	B		SI		1587	1604		10.1016/j.bbapap.2017.05.010				18	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FL3GN	WOS:000414111000012	28526268	gold			2018-01-05	
J	Setiaputra, DT; Yip, CK				Setiaputra, Dheva T.; Yip, Calvin K.			Characterizing the molecular architectures of chromatin-modifying complexes	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Chromatin-modifying complex; Nucleosome; Post-translational modifications; Electron microscopy; X-ray crystallography; Nuclear magnetic resonance spectroscopy	ACUTE MYELOID-LEUKEMIA; CREB-BINDING-PROTEIN; HISTONE METHYLTRANSFERASE ACTIVITY; UBIQUITIN LIGASE COMPLEX; NUCLEOSOME CORE PARTICLE; ACTIN-RELATED PROTEINS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; KIX DOMAIN; TRANSCRIPTIONAL COACTIVATOR	Eukaryotic cells package their genome in the form of a DNA-protein complex known as chromatin. This organization not only condenses the genome to fit within the confines of the nucleus, but also provides a platform for a cell to regulate accessibility to different gene sequences. The basic packaging element of chromatin is the nucleosome, which consists of 146 base pairs of DNA wrapped around histone proteins. One major means that a cell regulates chromatin structure is by depositing post-translational modifications on nucleosomal histone proteins, and thereby altering internucleosomal interactions and/or binding to different chromatin associated factors. These chromatin modifications are often catalyzed by multi-subunit enzyme complexes, whose large size, sophisticated composition, and inherent conformational flexibility pose significant technical challenges to their biochemical and structural characterization. Multiple structural approaches including nuclear magnetic resonance spectroscopy, X-ray crystallography, single-particle electron microscopy, and crosslinking coupled to mass spectrometry are often used synergistically to probe the overall architecture, subunit organization, and catalytic mechanisms of these macromolecular assemblies. In this review, we highlight several recent chromatin modifying complexes studies that embodies this multipronged structural approach, and explore common themes amongst them. This article is part of a Special Issue entitled: Biophysics in Canada, edited by Lewis Kay, John Baenziger, Albert Berghuis and Peter Tieleman.	[Setiaputra, Dheva T.; Yip, Calvin K.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	Yip, CK (reprint author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	calvin.yip@ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [418157-2012]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation (CFI); NSERC CGS	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (418157-2012), a Michael Smith Foundation for Health Research Career Investigator Award, a Canadian Institutes of Health Research (CIHR) New Investigator Award, and an infrastructure grant from the Canadian Foundation for Innovation (CFI) to CY and a NSERC CGS fellowship to DS.	ALBERTS B, 2002, MOL BIOL CELL; Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bash R, 2001, PROG NUCLEIC ACID RE, V65, P197; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Bruschweiler S, 2013, ACS CHEM BIOL, V8, P1600, DOI 10.1021/cb4002188; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020                                                    ; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cao TT, 2016, P NATL ACAD SCI USA, V113, P8985, DOI 10.1073/pnas.1602818113; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399                                                          ; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005                                                    ; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Diehl C, 2016, J BIOL CHEM, V291, P12658, DOI 10.1074/jbc.M115.711325; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Durand A., 1993, STRUCT LOND ENGL, P1553; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Fritsch C, 2003, MECH DEVELOP, V120, P949, DOI 10.1016/S0925-4773(03)00083-2; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; He J, 2011, NUCLEIC ACIDS RES, V39, P4464, DOI 10.1093/nar/gkr030; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Ida K, 1997, BLOOD, V90, P4699; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981                                                                   ; Lin YX, 1999, NATURE, V400, P86; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Luger K, 1997, NATURE, V389, P251; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Nelson DL, 2013, LEHNINGER PRINCIPLES; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3                                                   ; Rojas JR, 1999, NATURE, V401, P93; Rosenzweig R, 2014, ANNU REV BIOCHEM, V83, P291, DOI 10.1146/annurev-biochem-060713-035829; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Schlichting I, 2015, IUCRJ, V2, P246, DOI 10.1107/S205225251402702X; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; Shimojo H, 2008, J MOL BIOL, V378, P987, DOI 10.1016/j.jmb.2008.03.021; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561                                                          ; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Steunou A.-L., 2014, FUNDAMENTALS CHROMAT, P147, DOI DOI 10.1007/978-1-4614-8624-4_4; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Taherbhoy AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8621; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Vinothkumar KR, 2016, Q REV BIOPHYS, V49, P1, DOI 10.1017/S0033583516000068; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wang F, 2012, P NATL ACAD SCI USA, V109, P6078, DOI 10.1073/pnas.1119073109; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Ward AB, 2013, SCIENCE, V339, P913, DOI 10.1126/science.1228565; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Xu P, 2016, MOL CELL, V63, P965, DOI 10.1016/j.molcel.2016.07.024; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7                                                   ; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang Q., 2016, STRUCTURE; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	125	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	NOV	2017	1865	11	B		SI		1613	1622		10.1016/j.bbapap.2017.06.018				10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FL3GN	WOS:000414111000014	28652207				2018-01-05	
J	Fradin, C				Fradin, Cecile			On the importance of protein diffusion in biological systems: The example of the Bicoid morphogen gradient	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Review						Morphogen gradients; Bicoid; Hunchback; Diffusion; Fluorescence correlation spectroscopy; Fluorescence recovery after photobleaching	FLUORESCENCE CORRELATION SPECTROSCOPY; COOPERATIVE DNA-BINDING; EARLY DROSOPHILA EMBRYO; POSITIONAL INFORMATION; MESSENGER-RNA; TRANSLATIONAL DIFFUSION; GENE-EXPRESSION; FINGER PROTEIN; LIPID-BILAYERS; HUNCHBACK	Morphogens are proteins that form concentration gradients in embryos and developing tissues, where they act as postal codes, providing cells with positional information and allowing them to behave accordingly. Bicoid was the first discovered morphogen, and remains one of the most studied. It regulates segmentation in flies, forming a striking exponential gradient along the anterior-posterior axis of early Drosophila embryos, and activating the transcription of multiple target genes in a concentration-dependent manner. In this review, the work done by us and by others to characterize the mobility of Bicoid in D. melanogaster embryos is presented. The central role played by the diffusion of Bicoid in both the establishment of the gradient and the activation of target genes is discussed, and placed in the context of the need for these processes to be all at once rapid, precise and robust. The Bicoid system, and morphogen gradients in general, remain amongst the most amazing examples of the coexistence, often observed in living systems, of small-scale disorder and large-scale spatial order. This article is part of a Special Issue entitled: Biophysics in Canada, edited by Lewis Kay, John Baenziger, Albert Berghuis and Peter Tieleman.	[Fradin, Cecile] McMaster Univ, Dept Phys & Astron, 1280 Main St W, Hamilton, ON L8S 4M1, Canada	Fradin, C (reprint author), McMaster Univ, Dept Phys & Astron, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.				Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/250205-10, RGPIN/06362-15, PGPAS/396071-10]	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC, grants RGPIN/250205-10, RGPIN/06362-15 and PGPAS/396071-10). The author thanks her collaborators Nathalie Dostatni, Aleksandra Walczak, Matthieu Coppey and Huy Tran, as well as former and current students, in particular Asmahan Abu-Arish, Daniel Banks and Carmina Perez-Romero, for their help, advice and many stimulating discussions.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; Abu-Arish A, 2009, BIOPHYS J, V97, P2164, DOI 10.1016/j.bpj.2009.07.055; Abu-Arish A., 2008, THESIS; Adam G., 1968, STRUCT CHEM MOL BIOL, V198; Adhikary R., 2017, BIOCHEM; Akiyama T, 2015, WIRES DEV BIOL, V4, P99, DOI 10.1002/wdev.167; Arrio-Dupont M, 2000, BIOPHYS J, V78, P901, DOI 10.1016/S0006-3495(00)76647-1                                                   ; Baird-Titus JM, 2006, J MOL BIOL, V356, P1137, DOI 10.1016/j.jmb.2005.12.007; Banks DS, 2016, SOFT MATTER, V12, P4190, DOI 10.1039/c5sm01213a; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Berezhkovskii AM, 2010, BIOPHYS J, V99, pL59, DOI 10.1016/j.bpj.2010.07.045; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6                                                   ; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; BERLETH T, 1988, EMBO J, V7, P1749; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Brown R., 1827, PHILOS MAG, V4, P161, DOI DOI 10.1080/14786442808674769; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Castle BT, 2011, CELL MOL BIOENG, V4, P116, DOI 10.1007/s12195-010-0157-4; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652                                                   ; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Daniels BR, 2012, P NATL ACAD SCI USA, V109, P8588, DOI 10.1073/pnas.1204270109; DEGENNES PG, 1992, ANGEW CHEM INT EDIT, V31, P842, DOI 10.1002/anie.199208421                                                          ; Desponds J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005256; DEUCHAR EM, 1970, NATURE, V225, P671, DOI 10.1038/225671b0                                                                ; Di Rienzo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6891; DRIEVER W, 1989, NATURE, V342, P149, DOI 10.1038/342149a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3                                                    ; Drocco JA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055004; Drocco JA, 2011, BIOPHYS J, V101, P1807, DOI 10.1016/j.bpj.2011.07.025; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2                                                   ; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Ferraro T, 2016, WIRES DEV BIOL, V5, P296, DOI 10.1002/wdev.221; Ferraro T, 2016, CURR BIOL, V26, P212, DOI 10.1016/j.cub.2015.11.058; Fried P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6077; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Grimm O, 2010, DEVELOPMENT, V137, P2857, DOI 10.1242/dev.052589; Grimm O, 2010, DEVELOPMENT, V137, P2253, DOI 10.1242/dev.032409; Guo L, 2008, CHEMPHYSCHEM, V9, P721, DOI 10.1002/cphc.200700611; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Hornung G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041916; Houchmandzadeh B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061920; Houchmandzadeh B, 2002, NATURE, V415, P798; Kaizu K, 2014, BIOPHYS J, V106, P976, DOI 10.1016/j.bpj.2013.12.030; Kastrup L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178104; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kicheva A, 2012, CURR OPIN GENET DEV, V22, P527, DOI 10.1016/j.gde.2012.08.004; Krieger JW, 2015, NAT PROTOC, V10, P1948, DOI 10.1038/nprot.2015.100; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X                                                   ; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; LEWIS J, 1977, J THEOR BIOL, V65, P579, DOI 10.1016/0022-5193(77)90216-8; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lopes FJP, 2012, DEV BIOL, V370, P165, DOI 10.1016/j.ydbio.2012.07.020; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Ma XG, 1996, DEVELOPMENT, V122, P1195; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; McHale P, 2006, PHYS BIOL, V3, P107, DOI 10.1088/1478-3975/3/2/003; Mir M., 2017, BIORXIV; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Niessing D, 1999, EMBO J, V18, P1966, DOI 10.1093/emboj/18.7.1966; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pearson K, 1905, NATURE, V72, P294, DOI 10.1038/072294b0                                                                ; Ipina EP, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa56d9; Ipina EP, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022706; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Phillips R, 2006, PHYS TODAY, V59, P38, DOI 10.1063/1.2216960                                                               ; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971                                                          ; Reingruber J, 2014, SEMIN CELL DEV BIOL, V35, P189, DOI 10.1016/j.semcdb.2014.08.015; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0                                                                ; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Rose M, 2015, MEMBRANES, V5, P702, DOI 10.3390/membranes5040702; Roth S, 2012, CELL, V149, P511, DOI 10.1016/j.cell.2012.04.007; Satsoura D, 2007, CHEMPHYSCHEM, V8, P834, DOI 10.1002/cphc.200600589; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131                                                           ; Shivakumar S, 2014, BIOPHYS J, V106, P2085, DOI 10.1016/j.bpj.2014.03.049; Shusterman R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.048303; Sigaut L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003629; Sigaut L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051912; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X                                                   ; Smoluchowski M. v., 1917, COLLOID POLYM SCI, V21, P98; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7                                                    ; Stumpf H., 1966, J INSECT PHYSL, V12; Stumpf H., 1967, DEV GENES EVOL, V158, P315; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Waharte F, 2005, BIOPHYS J, V88, P1467, DOI 10.1529/biophysj.104.049619; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Weiss M, 2004, TRAFFIC, V5, P662, DOI 10.1111/j.1600-0854.2004.00215.x; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Wolff C, 1998, DEVELOPMENT, V125, P3645; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0                                                   ; Xu H, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.128101; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Yeung C, 2007, BIOPHYS J, V92, P2271, DOI 10.1529/biophysj.106.081794; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Yuan D, 1996, J BIOL CHEM, V271, P21660, DOI 10.1074/jbc.271.35.21660                                                        ; Yuste SB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061123; Zhao C, 2002, DEVELOPMENT, V129, P1669; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065	133	1	1	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	NOV	2017	1865	11	B		SI		1676	1686		10.1016/j.bbapap.2017.09.002				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FL3GN	WOS:000414111000020	28919007				2018-01-05	
J	Wang, MFZ; Fernandez-Gonzalez, R				Wang, Michael F. Z.; Fernandez-Gonzalez, Rodrigo			(Machine-)Learning to analyze in vivo microscopy: Support vector machines	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Machine learning; Image analysis; In vivo microscopy; Model organisms	LIGHT-SHEET MICROSCOPY; CAENORHABDITIS-ELEGANS; IMAGE-ANALYSIS; FLUORESCENCE MICROSCOPY; PROTEIN LOCALIZATION; DEVELOPMENTAL-STAGES; GLOBAL ANALYSIS; BUDDING YEAST; CELL LINEAGES; C. ELEGANS	The development of new microscopy techniques for super-resolved, long-term monitoring of cellular and sub cellular dynamics in living organisms is revealing new fundamental aspects of tissue development and repair. However, new microscopy approaches present several challenges. In addition to unprecedented requirements for data storage, the analysis of high resolution, time-lapse images is too complex to be done manually. Machine learning techniques are ideally suited for the (semi-)automated analysis of multidimensional image data. In particular, support vector machines (SVMs), have emerged as an efficient method to analyze microscopy images obtained from animals. Here, we discuss the use of SVMs to analyze in vivo microscopy data. We introduce the mathematical framework behind SVMs, and we describe the metrics used by SVMs and other machine learning approaches to classify image data. We discuss the influence of different SVM parameters in the context of an algorithm for cell segmentation and tracking. Finally, we describe how the application of SVMs has been critical to study protein localization in yeast screens, for lineage tracing in C. elegans, or to determine the developmental stage of Drosophila embryos to investigate gene expression dynamics. We propose that SVMs will become central tools in the analysis of the complex image data that novel microscopy modalities have made possible. This article is part of a Special Issue entitled: Biophysics in Canada, edited by Lewis Kay, John Baenziger, Albert Berghuis and Peter Tieleman.	[Wang, Michael F. Z.; Fernandez-Gonzalez, Rodrigo] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Wang, Michael F. Z.; Fernandez-Gonzalez, Rodrigo] Univ Toronto, Ted Rogers Ctr Heart Res, Toronto, ON M5G 1M1, Canada; [Fernandez-Gonzalez, Rodrigo] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Fernandez-Gonzalez, Rodrigo] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada	Fernandez-Gonzalez, R (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.	rodrigo.fernandez.gonzalez@utoronto.ca			Canada Foundation for Innovation [30279]; Natural Sciences and Engineering Research Council of Canada [418438-13]; Ted Rogers Centre for Heart Research; Canada First Research Excellence Fund for the Medicine by Design Initiative of the University of Toronto; Ontario Ministry of Research and Innovation [ER14-10-170]	Work in our laboratory is supported by grants from the Canada Foundation for Innovation (#30279), the Natural Sciences and Engineering Research Council of Canada (#418438-13), the Translational Biology and Engineering Program of the Ted Rogers Centre for Heart Research, the Canada First Research Excellence Fund for the Medicine by Design Initiative of the University of Toronto, and an Early Researcher Award to RFG from the Ontario Ministry of Research and Innovation (#ER14-10-170). RFG is the Canada Research Chair (Tier II) in Quantitative Cell Biology and Morphogenesis.	Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Aydin Z, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-84; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Beucher S., 1992, P 10 PFEFF C SIGN IM, V6, P299; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Chang C-C., 2011, ACM T INTELL SYST TE, V2, P27; Chen SC, 2007, BIOINFORMATICS, V23, pI66, DOI 10.1093/bioinformatics/btm206; Chong YT, 2015, CELL, V161, P1413, DOI 10.1016/j.cell.2015.04.051; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705                                                          ; Fernandez-Gonzalez R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045005; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314                                                       ; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/TIT.1962.1057692; Huang K, 2004, J BIOMED OPT, V9, P893, DOI 10.1117/1.1779233; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jain AK, 1997, PATTERN RECOGN, V30, P295, DOI 10.1016/S0031-3203(96)00068-4; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Le HH, 2016, J CELL BIOL, V214, P319, DOI 10.1083/jcb.201601050; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leung CYB, 2015, METHODS MOL BIOL, V1189, P99, DOI 10.1007/978-1-4939-1164-6_7; Li YX, 2012, IEEE ACM T COMPUT BI, V9, P98, DOI 10.1109/TCBB.2011.73; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Loo LH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003504; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; LOWE D. G, 1999, P IEEE INT C COMP VI, V1999, P1150, DOI DOI 10.1109/ICCV.1999.790410; Maji S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036973; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565                                                            ; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Power RM, 2017, NAT METHODS, V14, P360, DOI 10.1038/nmeth.4224; Schnorrenberg S, 2016, ELIFE, V5, DOI 10.7554/eLife.15567; Strnad P, 2016, NAT METHODS, V13, P139, DOI [10.1038/nmeth.3690, 10.1038/NMETH.3690]; Styles EB, 2016, CELL SYST, V3, P264, DOI 10.1016/j.cels.2016.08.008; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sydor AM, 2015, TRENDS CELL BIOL, V25, P730, DOI 10.1016/j.tcb.2015.10.004; TEAGUE MR, 1980, J OPT SOC AM, V70, P920, DOI 10.1364/JOSA.70.000920; TOMANCAK P, 2002, GENOME BIOL, V3, pH88, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; WALTON WH, 1948, NATURE, V162, P329, DOI 10.1038/162329b0                                                                ; Wang MFZ, 2017, DEVELOPMENT, V144, P1350, DOI 10.1242/dev.141473; Weldon TP, 1996, OPT ENG, V35, P2852, DOI 10.1117/1.600971; White AG, 2013, IEEE T MED IMAGING, V32, P1791, DOI 10.1109/TMI.2013.2265092; Yuan L, 2014, BIOINFORMATICS, V30, P266, DOI 10.1093/bioinformatics/btt648; Zernike F, 1934, PHYSICA, V1, P689; Zhan H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5974	52	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	NOV	2017	1865	11	B		SI		1719	1727		10.1016/j.bbapap.2017.09.013				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FL3GN	WOS:000414111000024	28974388				2018-01-05	
J	Licht, K; Jantsch, MF				Licht, Konstantin; Jantsch, Michael F.			The Other Face of an Editor: ADAR1 Functions in Editing-Independent Ways	BIOESSAYS			English	Article						ADAR1; RNA editing; double-stranded RNA; RNA-processing; adenosine deaminase; Staufen-mediated decay; interferon response	DOUBLE-STRANDED-RNA; ENZYME ADAR1; ADENOSINE-DEAMINASE; Z-DNA; BINDING DOMAINS; INTERFERON; GENE; APOPTOSIS; DECAY; EXPORTIN-5	The RNA editing enzyme ADAR1 seemingly has more functions besides RNA editing. Mouse models lacking ADAR1 and sensors of foreign RNA show that RNA editing by ADAR1 plays a crucial role in the innate immune response. Still, RNA editing alone cannot explain all observed phenotypes. Thus, additional roles for ADAR1 must exist. Binding of ADAR1 to RNA is independent of its RNA editing function. Thus, ADAR1 may compete with other RNA-binding proteins. A very recent manuscript elaborates on this and reports competition of ADAR1 with STAUFEN1, thereby modulating RNA-degradation. ADAR1 is also known to recruit proteins such as DROSHA to nascent transcripts. Still, many open questions remain. For instance, the biological role of the Z-DNA binding domains in ADAR1 is not defined. Moreover, the impact of ADAR1 on the RNA-folding landscape is unclear. In sum, moonlighting functions of ADAR1 may be manifold and have a great impact on the transcriptome.	[Licht, Konstantin; Jantsch, Michael F.] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell & Dev Biol, Schwarzspanierstr 17, A-1090 Vienna, Austria	Jantsch, MF (reprint author), Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell & Dev Biol, Schwarzspanierstr 17, A-1090 Vienna, Austria.	michael.jantsch@meduniwien.ac.at			Austrian Science Fund (FWF) [F4313, P26845, P30505]	We thank Thomas Nardelli for the design of the graphical abstract and Prajakta Bajad for critically reading the manuscript. This work was supported by grants from the Austrian Science Fund (FWF). Grant numbers F4313 and P26845 to MFJ and P30505 to KL.	Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Barraud P, 2014, P NATL ACAD SCI USA, V111, pE1852, DOI 10.1073/pnas.1323698111; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421                                                         ; Higuchi M, 2000, NATURE, V406, P78; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li X, 2015, MOL SYST BIOL, V11; Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050                                                         ; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Park E, 2013, P NATL ACAD SCI USA, V110, P405, DOI 10.1073/pnas.1213508110; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286                                                           ; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rodriguez J, 2012, MOL CELL, V47, P27, DOI 10.1016/j.molcel.2012.05.002; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Strehblow A, 2002, MOL BIOL CELL, V13, P3822, DOI 10.1091/mbc.E02-03-0161; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Whipple JM, 2015, RNA, V21, P786, DOI 10.1261/rna.048801.114; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	NOV	2017	39	11							1700129	10.1002/bies.201700129				6	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	FK7DX	WOS:000413666000010		gold			2018-01-05	
J	Sidiropoulos, K; Viteri, G; Sevilla, C; Jupe, S; Webber, M; Orlic-Milacic, M; Jassal, B; May, B; Shamovsky, V; Duenas, C; Rothfels, K; Matthews, L; Song, H; Stein, L; Haw, R; D'Eustachio, P; Ping, PP; Hermjakob, H; Fabregat, A				Sidiropoulos, Konstantinos; Viteri, Guilherme; Sevilla, Cristoffer; Jupe, Steve; Webber, Marissa; Orlic-Milacic, Marija; Jassal, Bijay; May, Bruce; Shamovsky, Veronica; Duenas, Corina; Rothfels, Karen; Matthews, Lisa; Song, Heeyeon; Stein, Lincoln; Haw, Robin; D'Eustachio, Peter; Ping, Peipei; Hermjakob, Henning; Fabregat, Antonio			Reactome enhanced pathway visualization	BIOINFORMATICS			English	Article							GENE ONTOLOGY; KNOWLEDGE; BIOLOGY	Motivation: Reactome is a free, open-source, open-data, curated and peer-reviewed knowledge base of biomolecular pathways. Pathways are arranged in a hierarchical structure that largely corresponds to the GO biological process hierarchy, allowing the user to navigate from high level concepts like immune system to detailed pathway diagrams showing biomolecular events like membrane transport or phosphorylation. Here, we present new developments in the Reactome visualization system that facilitate navigation through the pathway hierarchy and enable efficient reuse of Reactome visualizations for users' own research presentations and publications. Results: For the higher levels of the hierarchy, Reactome now provides scalable, interactive textbook-style diagrams in SVG format, which are also freely downloadable and editable. Repeated diagram elements like 'mitochondrion' or 'receptor' are available as a library of graphic elements. Detailed lower-level diagrams are now downloadable in editable PPTX format as sets of interconnected objects.	[Sidiropoulos, Konstantinos; Viteri, Guilherme; Sevilla, Cristoffer; Jupe, Steve; Duenas, Corina; Hermjakob, Henning; Fabregat, Antonio] EBI, EMBL, Wellcome Genome Campus, Hinxton CB10 1SD, England; [Webber, Marissa; Orlic-Milacic, Marija; Jassal, Bijay; May, Bruce; Rothfels, Karen; Song, Heeyeon; Stein, Lincoln; Haw, Robin] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Shamovsky, Veronica; Matthews, Lisa; D'Eustachio, Peter] NYU, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Stein, Lincoln] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A3, Canada; [Ping, Peipei] Univ Calif Los Angeles, Dept Physiol Med & Bioinformat, NIH Ctr Excellence BD2K, Los Angeles, CA 90095 USA; [Hermjakob, Henning] Natl Ctr Prot Sci Beijing, Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China; [Fabregat, Antonio] OpenTargets, Wellcome Genome Campus, Hinxton CB10 1SD, England	Hermjakob, H; Fabregat, A (reprint author), EBI, EMBL, Wellcome Genome Campus, Hinxton CB10 1SD, England.; Hermjakob, H (reprint author), Natl Ctr Prot Sci Beijing, Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China.; Fabregat, A (reprint author), OpenTargets, Wellcome Genome Campus, Hinxton CB10 1SD, England.	hhe@ebi.ac.uk; fabregat@ebi.ac.uk		Jupe, Steven/0000-0001-5807-0069; D'Eustachio, Peter/0000-0002-5494-626X	National Institutes of Health BD2K grant [U54 GM114833]; National Human Genome Research Institute at the National Institutes of Health [U41 HG003751]; European Bioinformatics Institute (EMBL-EBI); Open Targets (The target validation platform); Medicine by Design (University of Toronto); National Institutes of Health [U54 GM114833]	National Institutes of Health BD2K grant (U54 GM114833); National Human Genome Research Institute at the National Institutes of Health (U41 HG003751); European Bioinformatics Institute (EMBL-EBI); Open Targets (The target validation platform); Medicine by Design (University of Toronto). Funding for open access charge: National Institutes of Health (U54 GM114833).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Battiato S, 2005, CAMP 2005: Seventh International Workshop on Computer Architecture for Machine Perception , Proceedings, P333; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Gawron Piotr, 2016, NPJ Syst Biol Appl, V2, P16020, DOI 10.1038/npjsba.2016.20; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kuperstein I, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-100; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Miller CA, 2013, BIOINFORMATICS, V29, P381, DOI 10.1093/bioinformatics/bts677; Perini L, 2013, KNOWL ENG REV, V28, P273, DOI 10.1017/S0269888913000246; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401	13	0	0	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	NOV 1	2017	33	21					3461	3467		10.1093/bioinformatics/btx441				7	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FK6WL	WOS:000413645800017	29077811				2018-01-05	
J	Millette, K; Georgia, S				Millette, Katelyn; Georgia, Senta			Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development	CURRENT DIABETES REPORTS			English	Review						Diabetes; Gene editing; CRISPR/Cas9; Pluripotent stem cells; Cellular therapy; Disease modeling; Beta cells; Insulin	ZINC-FINGER NUCLEASES; HOMOLOGY-DIRECTED REPAIR; HUMAN HEMATOPOIETIC STEM; GENOME-WIDE-ASSOCIATION; INSULIN-PRODUCING CELLS; CRISPR-CAS NUCLEASES; IN-VITRO; DNA CLEAVAGE; PANCREATIC PROGENITORS; SUSCEPTIBILITY LOCI	Purpose of Review This review will focus on the multiple approaches to gene editing and address the potential use of genetically modified human pluripotent stem cell-derived beta cells (SC-beta) as a tool to study human beta-cell development and model their function in diabetes. We will explore how new variations of CRISPR/Cas9 gene editing may accelerate our understanding of beta-cell developmental biology, elucidate novel mechanisms that establish and regulate beta-cell function, and assist in pioneering new therapeutic modalities for treating diabetes. Recent Findings Improvements in CRISPR/Cas9 target specificity and homology-directed recombination continue to advance its use in engineering stem cells to model and potentially treat disease. We will review how CRISPR/Cas9 gene editing is informing our understanding of beta-cell development and expanding the therapeutic possibilities for treating diabetes and other diseases. Summary Here we focus on the emerging use of gene editing technology, specifically CRISPR/Cas9, as a means of manipulating human gene expression to gain novel insights into the roles of key factors in beta-cell development and function. Taken together, the combined use of SC-beta cells and CRISPR/Cas9 gene editing will shed new light on human beta-cell development and function and accelerate our progress towards developing new therapies for patients with diabetes.	[Millette, Katelyn; Georgia, Senta] Childrens Hosp Los Angeles, Ctr Endocrinol Diabet & Metab, Dept Pediat, Los Angeles, CA 90027 USA; [Georgia, Senta] Univ Southern Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Georgia, Senta] Univ Southern Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90007 USA; [Georgia, Senta] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA	Georgia, S (reprint author), Childrens Hosp Los Angeles, Ctr Endocrinol Diabet & Metab, Dept Pediat, Los Angeles, CA 90027 USA.; Georgia, S (reprint author), Univ Southern Calif, Dept Pediat, Los Angeles, CA 90089 USA.; Georgia, S (reprint author), Univ Southern Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90007 USA.; Georgia, S (reprint author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	sgeorgia@chla.usc.edu			Larry L. Hillblom Foundation [2015-D-006-SUP]; California Institute for Regenerative Medicine [DISC1-088680]	We thank Cristy Lytal for her help in editing the manuscript. SG was supported by a Larry L. Hillblom Foundation grant (2015-D-006-SUP) and a California Institute for Regenerative Medicine Discovery grant (DISC1-088680).	Agulnick AD, 2015, STEM CELL TRANSL MED, V4, P1214, DOI 10.5966/sctm.2015-0079; Balboa D, 2015, BEST PRACT RES CL EN, V29, P899, DOI 10.1016/j.beem.2015.10.012; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102                                                       ; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chen HD, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0051-6, 10.1186/S40659-015-0051-6]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Desai T, 2017, NAT REV DRUG DISCOV, V16, P338, DOI 10.1038/nrd.2016.232; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Feng Q, 2014, STEM CELL REP, V3, P817, DOI 10.1016/j.stemcr.2014.09.010; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gimenez CA, 2016, GENE THER, V23, P543, DOI 10.1038/gt.2016.28; Gjelberg HK, 2017, CLIN CASE REP; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gornalusse GG, 2017, NAT BIOTECHNOL; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hayek Alberto, 2016, Clin Diabetes Endocrinol, V2, P4, DOI 10.1186/s40842-016-0023-y; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hofer U, 2013, J INFECT DIS, V208, pS160, DOI 10.1093/infdis/jit382; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649                                                            ; Jensen KT, 2017, FEBS LETT, V591, P1892, DOI 10.1002/1873-3468.12707; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; KLOPPEL G, 1984, VIRCHOWS ARCH A, V403, P441, DOI 10.1007/BF00737292; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lu PF, 2013, STEM CELL REV REP, V9, P806, DOI 10.1007/s12015-013-9457-0; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McGrath PS, 2015, DIABETES, V64, P2497, DOI 10.2337/db14-1412; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301                                                       ; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nair G, 2015, CURR OPIN GENET DEV, V32, P171, DOI 10.1016/j.gde.2015.03.004; Nakade S, 2017, BIOENGINEERED, V8, P265, DOI 10.1080/21655979.2017.1282018; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quiskamp N, 2015, BEST PRACT RES CL EN, V29, P833, DOI 10.1016/j.beem.2015.10.011; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB1215S100, 10.1002/0471142727.mb1215s100]; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rubio-Cabezas O, 2011, DIABETES, V60, P1349, DOI 10.2337/db10-1008; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Rutter GA, 2014, DIABETIC MED, V31, P1480, DOI 10.1111/dme.12579; Sayar E, 2013, PEDIATR INT, V55, P661, DOI 10.1111/ped.12169; Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shi ZD, 2017, CELL STEM CELL; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tan G, 2014, J MOL ENDOCRINOL, V53, pR119, DOI 10.1530/JME-14-0188; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thatava T, 2013, MOL THER, V21, P228, DOI 10.1038/mt.2012.245; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomeit AA, 2015, EXPERT OPIN BIOL TH, V15, P1321, DOI 10.1517/14712598.2015.1055242; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tse HM, 2015, MOL ENDOCRINOL, V29, P1388, DOI 10.1210/me.2015-1085; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vaithilingam Vijayaganapathy, 2017, Rev Diabet Stud, V14, P51, DOI 10.1900/RDS.2017.14.51; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yang YY, 2016, STEM CELL TRANSL MED, V5, P8, DOI 10.5966/sctm.2015-0157; Zeng H, 2016, CELL STEM CELL, V19, P326, DOI 10.1016/j.stem.2016.07.002; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814; Zhao LM, 2014, STEM CELL RES, V13, P342, DOI 10.1016/j.scr.2014.08.004; Zhu ZR, 2016, CELL STEM CELL, V18, P755, DOI 10.1016/j.stem.2016.03.015	123	0	0	24	24	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1534-4827	1539-0829		CURR DIABETES REP	Curr. Diabetes Rep.	NOV	2017	17	11							116	10.1007/s11892-017-0947-3				10	Endocrinology & Metabolism	Endocrinology & Metabolism	FJ9BZ	WOS:000413064200016	28980194				2018-01-05	
J	Dever, DP; Porteus, MH				Dever, Daniel P.; Porteus, Matthew H.			The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation	CURRENT OPINION IN HEMATOLOGY			English	Review						Cas9; clustered regularly interspace short palindromic repeats; genome editing; hematopoietic stem cells; homologous recombination	CHRONIC GRANULOMATOUS-DISEASE; FETAL-HEMOGLOBIN; PROGENITOR CELLS; MARROW TRANSPLANTATION; STEM/PROGENITOR CELLS; BCL11A; CRISPR/CAS9; THERAPY; MUTATION; IMMUNODEFICIENCY	Purpose of review Since the discovery two decades ago that programmable endonucleases can be engineered to modify human cells at single nucleotide resolution, the concept of genome editing was born. Now these technologies are being applied to therapeutically relevant cell types, including hematopoietic stem cells (HSC), which possess the power to repopulate an entire blood and immune system. The purpose of this review is to discuss the changing landscape of genome editing in hematopoietic stem cells (GE-HSC) from the discovery stage to the preclinical stage, with the imminent goal of clinical translation for the treatment of serious genetic diseases of the blood and immune system. Recent findings With the discovery that the RNA-programmable (sgRNA) clustered regularly interspace short palindromic repeats (CRISPR)-Cas9 nuclease (Cas9/sgRNA) systems can be easily used to precisely modify the human genome in 2012, a genome-editing revolution of hematopoietic stem cells (HSC) has bloomed. We have observed that over the last 2 years, academic institutions and small biotech companies are developing HSC-based Cas9/sgRNA genome-editing curative strategies to treat monogenic disorders, including beta-hemoglobinopathies and primary immunodeficiencies. We will focus on recent publications (within the past 2 years) that employ different genome-editing strategies to 'hijack' the cell's endogenous double-strand repair pathways to confer a disease-specific therapeutic advantage. Summary The number of genome-editing strategies in HSCs that could offer therapeutic potential for diseases of the blood and immune system have dramatically risen over the past 2 years. The HSC-based genome-editing field is primed to enter clinical trials in the subsequent years. We will summarize the major advancements for the development of novel autologous GE-HSC cell and gene therapy strategies for hematopoietic diseases that are candidates for curative allogeneic bone marrow transplantation.	[Dever, Daniel P.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Porteus, MH (reprint author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	mporteus@stanford.edu			Stanford Child Health Research Institute (CHRI); Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; NIH [R01-AI097320, R01-AI120766]	D.P.D. was supported through the Stanford Child Health Research Institute (CHRI) Grant and Postdoctoral Award. M.H.P. gratefully acknowledges the support of the Amon Carter Foundation, the Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research and NIH grant support R01-AI097320 and R01-AI120766.	Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/nmeth.4265, 10.1038/NMETH.4265]; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Bahal R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13304; Bak RO, 2017, CELL REP, V20, P750, DOI 10.1016/j.celrep.2017.06.064; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bjurstrom CF, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.52; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DiGiusto DL, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.67; DOVER GJ, 1992, NEW ENGL J MED, V327, P569; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; GATTI RA, 1968, LANCET, V2, P1366; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; JOHNSON FL, 1984, NEW ENGL J MED, V311, P780, DOI 10.1056/NEJM198409203111207; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; LUCARELLI G, 1984, EXP HEMATOL, V12, P676; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marciano BE, 2015, CLIN INFECT DIS, V60, P1176, DOI 10.1093/cid/ciu1154; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307                                                     ; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113	41	0	0	43	43	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1065-6251	1531-7048		CURR OPIN HEMATOL	Curr. Opin. Hematol.	NOV	2017	24	6					481	488		10.1097/MOH.0000000000000385				8	Hematology	Hematology	FJ0QX	WOS:000412415200002	28806273				2018-01-05	
J	Banerji, R; Skibbens, RV; Iovine, MK				Banerji, Rajeswari; Skibbens, Robert V.; Iovine, M. Kathryn			How many roads lead to cohesinopathies?	DEVELOPMENTAL DYNAMICS			English	Review						Roberts Syndrome (RBS); Cornelia de Lange Syndrome (CdLS); DNA tethering; cohesin; ESCO2; NIPBL	SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; MAMMALIAN MEDIATOR COMPLEX; CCCTC-BINDING FACTOR; CRISPR-CAS SYSTEM; ROBERTS-SYNDROME; NIPPED-B; ACETYLATION CYCLE; GENE-EXPRESSION; ACETYLTRANSFERASE ACTIVITY	Genetic mapping studies reveal that mutations in cohesion pathways are responsible for multispectrum developmental abnormalities termed cohesinopathies. These include Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome (WABS). The cohesinopathies are characterized by overlapping phenotypes ranging from craniofacial deformities, limb defects, and mental retardation. Though these syndromes share a similar suite of phenotypes and arise due to mutations in a common cohesion pathway, the underlying mechanisms are currently believed to be distinct. Defects in mitotic failure and apoptosis i.e. trans DNA tethering events are believed to be the underlying cause of RBS, whereas the underlying cause of CdLS is largely modeled as occurring through defects in transcriptional processes i.e. cis DNA tethering events. Here, we review recent findings described primarily in zebrafish, paired with additional studies in other model systems, including human patient cells, which challenge the notion that cohesinopathies represent separate syndromes. We highlight numerous studies that illustrate the utility of zebrafish to provide novel insights into the phenotypes, genes affected and the possible mechanisms underlying cohesinopathies. We propose that transcriptional deregulation is the predominant mechanism through which cohesinopathies arise. Developmental Dynamics 246:881-888, 2017. (c) 2017 Wiley Periodicals, Inc.	[Banerji, Rajeswari; Skibbens, Robert V.; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Iovine, MK (reprint author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	mki3@lehigh.edu			Faculty Innovation Grant (Lehigh); National Institutes of Health [R15GM110631]	The authors thank Iovine and Skibbens lab members. Research by the Iovine and Skibbens lab was supported by a Faculty Innovation Grant (Lehigh, to M.K.I.), and by an award from the National Institutes of Health (R15GM110631 to R.V.S.). Any opinions expressed in this review are those of the authors and do not reflect the views of the National Institutes of General Medicine.	Ball AR, 2014, BBA-GENE REGUL MECH, V1839, P191, DOI 10.1016/j.bbagrm.2013.11.002; Banerji R, 2016, DEV DYNAM, V245, P7, DOI [10.1002/DVDY.24354, 10.1002/dvdy.24354]; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; Choi HK, 2010, BIOCHEM BIOPH RES CO, V394, P1063, DOI 10.1016/j.bbrc.2010.03.125; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7                                                   ; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cucco F, 2016, AM J MED GENET C, V172, P171, DOI 10.1002/ajmg.c.31492; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dorsett D, 2016, AM J MED GENET C, V172, P129, DOI 10.1002/ajmg.c.31490; Dorsett D, 2009, ANN NY ACAD SCI, V1151, P22, DOI 10.1111/j.1749-6632.2008.03450.x; Fazio G, 2016, J CELL PHYSIOL, V231, P613, DOI 10.1002/jcp.25106; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Ghiselli G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-52; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Horsfield Julia A., 2012, Frontiers in Genetics, V3, P171, DOI 10.3389/fgene.2012.00171; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411                                                            ; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4                                                   ; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaur M, 2005, AM J MED GENET A, V138A, P27, DOI 10.1002/ajmg.a.30919; Kim BJ, 2008, BIOCHEM BIOPH RES CO, V372, P298, DOI 10.1016/j.bbrc.2008.05.056; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Leem YE, 2011, CELL SIGNAL, V23, P1876, DOI 10.1016/j.cellsig.2011.07.006; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Majumder P, 2011, J IMMUNOL, V187, P4236, DOI 10.4049/jimmunol.1100688; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mannini L, 2010, HUM MUTAT, V31, P5, DOI 10.1002/humu.21129; Marsman J, 2014, BBA-GENE REGUL MECH, V1839, P50, DOI 10.1016/j.bbagrm.2013.11.007; Marston AL, 2014, GENETICS, V196, P31, DOI 10.1534/genetics.112.145144; Minamino M, 2015, CURR BIOL, V25, P1694, DOI 10.1016/j.cub.2015.05.017; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Morita A, 2012, DEV GROWTH DIFFER, V54, P588, DOI 10.1111/j.1440-169X.2012.01362.x; Mourad R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004908; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Muto A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004671; Muto A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001181; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nativio R, 2011, HUM MOL GENET, V20, P1363, DOI 10.1093/hmg/ddr018; OPITZ JM, 1985, AM J MED GENET, V22, P89, DOI 10.1002/ajmg.1320220110; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devce1.2007.12.009; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Percival SM, 2015, DIS MODEL MECH, V8, P941, DOI 10.1242/dmm.019059; Pistocchi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.371; Rahman S, 2015, P NATL ACAD SCI USA, V112, P11270, DOI 10.1073/pnas.1505323112; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201                                                         ; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Schuster K, 2015, HUM MOL GENET, V24, P7005, DOI 10.1093/hmg/ddv402; Seitan VC, 2006, PLOS BIOL, V4, P1411, DOI 10.1371/journal.pbio.0040242; Seruggia D, 2014, TRANSGENIC RES, V23, P707, DOI 10.1007/s11248-014-9823-y; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Skibbens RV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006337; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann K, 1999, ELECTROPHORESIS, V20, P1748, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1748::AID-ELPS1748>3.0.CO;2-1; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; van der Lelij P, 2009, PLOS ONE, V4, DOI [10.1371/joumal.pone.0006936, 10.1371/journal.pone.0006936]; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; VANDENBERG DJ, 1993, SOMAT CELL MOLEC GEN, V19, P377; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Whelan G, 2012, EMBO J, V31, P71, DOI 10.1038/emboj.2011.381; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Xu BS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2354-y; Xu BS, 2015, HUM MOL GENET, V24, P1540, DOI 10.1093/hmg/ddu565; Yuan B, 2015, J CLIN INVEST, V125, P636, DOI 10.1172/JCI77435; Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	98	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	NOV	2017	246	11			SI		881	888		10.1002/dvdy.24510				8	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	FK0CZ	WOS:000413149200012	28422453				2018-01-05	
J	Duncan, KM; Mukherjee, K; Cornell, RA; Liao, EC				Duncan, Kaylia M.; Mukherjee, Kusumika; Cornell, Robert A.; Liao, Eric C.			Zebrafish models of orofacial clefts	DEVELOPMENTAL DYNAMICS			English	Review							TREACHER-COLLINS-SYNDROME; ARHINIA MICROPHTHALMIA SYNDROME; PIERRE-ROBIN-SEQUENCE; POPLITEAL PTERYGIUM SYNDROMES; GENOME-WIDE ASSOCIATION; ACTIN CAPPING PROTEIN; NEURAL CREST; CRANIOFACIAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; PALATE MORPHOGENESIS	Zebrafish is a model organism that affords experimental advantages toward investigating the normal function of genes associated with congenital birth defects. Here we summarize zebrafish studies of genes implicated in orofacial cleft (OFC). The most common use of zebrafish in this context has been to explore the normal function an OFC-associated gene product in craniofacial morphogenesis by inhibiting expression of its zebrafish ortholog. The most frequently deployed method has been to inject embryos with antisense morpholino oligonucleotides targeting the desired transcript. However, improvements in targeted mutagenesis strategies have led to widespread adoption of CRISPR/Cas9 technology. A second application of zebrafish has been for functional assays of gene variants found in OFC patients; such in vivo assays are valuable because the success of in silico methods for testing allele severity has been mixed. Finally, zebrafish have been used to test the tissue specificity of enhancers that harbor single nucleotide polymorphisms associated with risk for OFC. We review examples of each of these approaches in the context of genes that are implicated in syndromic and non-syndromic OFC. Developmental Dynamics 246:897-914, 2017. (c) 2017 Wiley Periodicals, Inc.	[Duncan, Kaylia M.; Cornell, Robert A.] Univ Iowa, Dept Anat & Cell Biol, Mol & Cell Biol Grad Program, Iowa City, IA USA; [Mukherjee, Kusumika; Liao, Eric C.] Harvard Med Sch, Massachusetts Gen Hosp, Div Plast & Reconstruct Surg, Ctr Regenerat Med, Boston, MA USA	Cornell, RA (reprint author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.; Liao, EC (reprint author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	robert-cornell@uiowa.edu; cliao@partners.org		Cornell, Robert/0000-0003-4207-9100; Mukherjee, Kusumika/0000-0002-2183-4552	National Institutes of Health [NIDCR HD073107, NIGMS PO1GM061354]	Grant sponsor: National Institutes of Health; Grant numbers: NIDCR HD073107 (Cornell), NIGMS PO1GM061354 (Liao).	Ahn HJ, 2010, MOL CELLS, V30, P377, DOI 10.1007/s10059-010-0128-6; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713                                                          ; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Baris I, 2006, J CLIN ENDOCR METAB, V91, P4183, DOI 10.1210/jc.2006-0405; Beaty Terri H, 2016, F1000Res, V5, P2800; Ben J, 2005, GENE EXPR PATTERNS, V5, P629, DOI 10.1016/j.modgep.2005.03.002; Bhoj EJ, 2015, AM J MED GENET A, V167, P2497, DOI 10.1002/ajmg.a.37217; Biggs LC, 2014, J CELL SCI, V127, P2840, DOI 10.1242/jcs.139246; Bogershausen N, 2013, CLIN GENET, V83, P201, DOI 10.1111/cge.12051; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; BOSMA JF, 1981, J CRAN GENET DEV BIO, V1, P153; Brown KK, 2010, HUM GENET, V127, P19, DOI 10.1007/s00439-009-0736-4; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; Castanet M, 2002, HUM MOL GENET, V11, P2051, DOI 10.1093/hmg/11.17.2051; Chiquet BT, 2008, HUM MOL GENET, V17, P2212, DOI 10.1093/hmg/ddn121; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Cox AA, 2010, GENE EXPR PATTERNS, V10, P251, DOI 10.1016/j.gep.2010.05.005; Curtin E, 2011, MECH DEVELOP, V128, P104, DOI 10.1016/j.mod.2010.11.003; Cvjetkovic N, 2015, MOL GENET GENOM MED, V3, P440, DOI 10.1002/mgg3.155; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; DeLaurier A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-16; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dixon MJ, 1996, HUM MOL GENET, V5, P1391, DOI 10.1093/hmg/5.Supplement_1.1391                                                 ; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Docker D, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.280; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dougherty M, 2013, DEVELOPMENT, V140, P76, DOI 10.1242/dev.080473; Dougherty M, 2012, J CRANIOFAC SURG, V23, P1333, DOI 10.1097/SCS.0b013e318260f20b; Driever W, 1996, DEVELOPMENT, V123, P37; Dworkin S, 2014, MECH DEVELOP, V133, P77, DOI 10.1016/j.mod.2014.05.005; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Eppley BL, 2005, PLAST RECONSTR SURG, V115, p101E, DOI 10.1097/01.PRS.0000164494.45986.91; Field LL, 2004, AM J MED GENET A, V130A, P265, DOI 10.1002/ajmg.a.30252; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Gfrerer L, 2014, PLAST RECONSTR SURG, V134, P748, DOI 10.1097/PRS.0000000000000517; Ghassibe-Sabbagh M, 2011, AM J HUM GENET, V88, P150, DOI 10.1016/j.ajhg.2011.01.003; Gladwin AJ, 1996, HUM MOL GENET, V5, P1533, DOI 10.1093/hmg/5.10.1533; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Gordon CT, 2017, NAT GENET, V49, P249, DOI 10.1038/ng.3765; Gordon CT, 2010, EVOL DEV, V12, P459, DOI 10.1111/j.1525-142X.2010.00432.x; GORLIN RJ, 1968, PEDIATRICS, V41, P503; Graham JM, 2006, AM J MED GENET A, V140A, P189, DOI 10.1002/ajmg.a.31039; Grosen D, 2011, EPIDEMIOLOGY, V22, P313, DOI 10.1097/EDE.0b013e3182125f9c; Haffter P, 1996, INT J DEV BIOL, V40, P221; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Isrie M, 2015, AM J HUM GENET, V97, P790, DOI 10.1016/j.ajhg.2015.10.014; Ittiwut R, 2016, GENET TEST MOL BIOMA, V20, P406, DOI 10.1089/gtmb.2015.0325; Jackson H. W., 2015, AM J MOL BIOL, V05, P57; Jezewski PA, 2008, ZEBRAFISH, V5, P169, DOI 10.1089/zeb.2007.0517; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Juriloff DM, 2006, BIRTH DEFECTS RES A, V76, P574, DOI 10.1002/bdra.20302; Kadakia S, 2014, INT J PEDIATR OTORHI, V78, P893, DOI 10.1016/j.ijporl.2014.03.006; Kaplan F, 1999, AM J PHYSIOL-LUNG C, V276, pL1027; Kerr ID, 2017, J COMMUN GENET, V8, P87, DOI 10.1007/s12687-016-0289-x; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Kousa YA, 2017, BIRTH DEFECTS RES, V109, P169, DOI 10.1002/bdra.23598; Kruszka P, 2015, J MED GENET, V52, P104, DOI 10.1136/jmedgenet-2014-102677; KUNZE J, 1982, EUR J PEDIATR, V138, P301, DOI 10.1007/BF00442501                                                              ; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lan J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-83; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Larbuisson A, 2013, DIFFERENTIATION, V86, P192, DOI 10.1016/j.diff.2013.07.006; Lau MCC, 2016, BBA-MOL BASIS DIS, V1862, P1147, DOI 10.1016/j.bbadis.2016.03.005; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee SJ, 2014, BIOCHEM BIOPH RES CO, V452, P1, DOI 10.1016/j.bbrc.2014.08.005; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Leslie EJ, 2017, HUM GENET, V136, P275, DOI 10.1007/s00439-016-1754-7; Leslie EJ, 2016, AM J HUM GENET, V98, P744, DOI 10.1016/j.ajhg.2016.02.014; Leslie EJ, 2015, AM J HUM GENET, V96, P397, DOI 10.1016/j.ajhg.2015.01.004; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li L, 2010, AM J MED GENET A, V152A, P856, DOI 10.1002/ajmg.a.33236; Lidral AC, 2015, HUM MOL GENET, V24, P3895, DOI 10.1093/hmg/ddv047; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; Liu H, 2016, BIRTH DEFECTS RES A; Liu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14759; Liu H, 2016, HUM MOL GENET, V25, P766, DOI 10.1093/hmg/ddv614; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; Mangold E, 2016, AM J HUM GENET, V98, P755, DOI 10.1016/j.ajhg.2016.02.013; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2004, AM J MED GENET A, V126A, P111, DOI 10.1002/ajmg.a.20564; McCarthy N, 2016, DEV DYNAM, V245, P641, DOI [10.1002/DVDY.24403, 10.1002/dvdy.24403]; McGurk PD, 2014, JOVE-J VIS EXP, DOI 10.3791/51190; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8                                                   ; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; Miyake N, 2013, HUM MUTAT, V34, P108, DOI 10.1002/humu.22229; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Mukherjee K, 2016, HUM MOL GENET, V25, P1255, DOI 10.1093/hmg/ddw006; Nakada C, 2009, J EXP ZOOL PART B, V312B, P827, DOI 10.1002/jez.b.21298; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Peyrard-Janvid M, 2014, AM J HUM GENET, V94, P23, DOI 10.1016/j.ajhg.2013.11.009; Printzlau A, 2004, CLEFT PALATE-CRAN J, V41, P47, DOI 10.1597/02-055                                                                  ; Rainger JK, 2014, HUM MOL GENET, V23, P2569, DOI 10.1093/hmg/ddt647; Rattanasopha S, 2012, EUR J HUM GENET, V20, P1058, DOI 10.1038/ejhg.2012.55; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Richardson RJ, 2014, J CLIN INVEST, V124, P3891, DOI 10.1172/JCI71946; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Rochard L, 2016, DEVELOPMENT, V143, P2541, DOI 10.1242/dev.137000; Rochard LJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52935; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; ROSS CM, 1969, ARCH DERMATOL, V100, P320, DOI 10.1001/archderm.100.3.320; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Saadi I, 2011, AM J HUM GENET, V89, P44, DOI 10.1016/j.ajhg.2011.05.023; Sabel JL, 2009, DEV BIOL, V325, P249, DOI 10.1016/j.ydbio.2008.10.031; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Sheehan-Rooney K, 2010, DEV DYNAM, V239, P3481, DOI 10.1002/dvdy.22483; Shen X, 2011, BIRTH DEFECTS RES A, V91, P918, DOI 10.1002/bdra.20840; Shi JN, 2010, EUR J ORAL SCI, V118, P430, DOI 10.1111/j.1600-0722.2010.00743.x; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; SONG HQ, 2017, MEDICINE, V96; Soriano P, 1997, DEVELOPMENT, V124, P2691; Swartz ME, 2011, DEV DYNAM, V240, P2204, DOI 10.1002/dvdy.22713; Swindell EC, 2015, GENESIS, V53, P660, DOI 10.1002/dvg.22897; Tan TY, 2013, AM J MED GENET C, V163, P295, DOI 10.1002/ajmg.c.31374; Thisse B, 2001, EXPRESSION ZEBRAFISH; Thisse B, 2004, FAST RELEASE CLONES; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Titomanlio L, 2005, AM J MED GENET A, V137A, P332, DOI 10.1002/ajmg.a.30878; Urquhart J, 2016, AM J MED GENET A, V170, P1216, DOI 10.1002/ajmg.a.37564; Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Wang SQ, 2012, CURR TOP DEV BIOL, V98, P35, DOI 10.1016/B978-0-12-386499-4.00002-1; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Watt KEN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006187; Weiner AMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029574; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Wilson NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep17735; Wolf ZT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004257; Wouters L, 2011, EUR J MED GENET, V54, P236, DOI 10.1016/j.ejmg.2011.01.003; Wu D, 2015, HUM MOL GENET, V24, P4340, DOI 10.1093/hmg/ddv167; Wyszynski DF, 2003, AM J MED GENET A, V123A, P140, DOI 10.1002/ajmg.a.20283; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yu YQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14364; Yuan QP, 2012, GENESIS, V50, P871, DOI 10.1002/dvg.22051; Zarate YA, 2015, AM J MED GENET A, V167, P1026, DOI 10.1002/ajmg.a.36849; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039	161	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	NOV	2017	246	11			SI		897	914		10.1002/dvdy.24566				18	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	FK0CZ	WOS:000413149200014	28795449				2018-01-05	
J	Moravec, CE; Yousef, H; Kinney, BA; Salerno-Eichenholz, R; Monestime, CM; Martin, BL; Sirotkin, HI				Moravec, Cara E.; Yousef, Hakeem; Kinney, Brian A.; Salerno-Eichenholz, Ryan; Monestime, Camillia M.; Martin, Benjamin L.; Sirotkin, Howard I.			Zebrafish sin3b mutants are viable but have size, skeletal, and locomotor defects	DEVELOPMENTAL DYNAMICS			English	Article						Sin3b; zebrafish; behavior; CRISPR; early development	HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; PROTEIN; YEAST; COREPRESSOR; REGULATOR; CELLS; MSIN3A; DIFFERENTIATION	Background: The transcriptional co-repressor Sin3 is highly conserved from yeast to vertebrates and has multiple roles controlling cell fate, cell cycle progression, and senescence programming. Sin3 proteins recruit histone deacetylases and other chromatin modifying factors to specific loci through interactions with transcription factors including Myc, Rest, p53 and E2F. Most vertebrates have two Sin3 family members (sin3a and sin3b), but zebrafish have a second sin3a paralogue. In mice, sin3a and sin3b are essential for embryonic development. Sin3b knockout mice show defects in growth as well as bone and blood differentiation. Results: To study the requirement for Sin3b during development, we disrupted zebrafish sin3b using CRISPR-Cas9, and studied the effects on early development and locomotor behavior. Conclusions: Surprisingly, Sin3b is not essential in zebrafish. sin3b mutants show a decrease in fitness, small size, changes to locomotor behavior, and delayed bone development. We did not detect a role for Sin3b in cell proliferation. Our analysis of the sin3b mutant revealed a more nuanced requirement for zebrafish Sin3b than would be predicted from analysis of mutants in other species. Developmental Dynamics 246:946-955, 2017. (c) 2017 Wiley Periodicals, Inc.	[Moravec, Cara E.; Yousef, Hakeem; Salerno-Eichenholz, Ryan; Monestime, Camillia M.; Sirotkin, Howard I.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Moravec, Cara E.; Kinney, Brian A.; Sirotkin, Howard I.] SUNY Stony Brook, Genet Gradate Program, Stony Brook, NY 11794 USA; [Kinney, Brian A.; Salerno-Eichenholz, Ryan; Martin, Benjamin L.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Sirotkin, HI (reprint author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	howard.sirotkin@stonybrook.edu					AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Bansal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026156; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cantor DJ, 2017, BLOOD, V129, P60, DOI [10.1182/blood-2016-06721746., 10.1182/blood-2016-06-721746]; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Garcia-Sanz P, 2014, J BIOL CHEM, V289, P22221, DOI 10.1074/jbc.M113.538744; Granato M, 1996, DEVELOPMENT, V123, P399; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Gyda M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003106; Halder D, 2017, SCI REP-UK, V7, DOI 10.1038/srep44818; HALLECK MS, 1995, GENOMICS, V26, P403, DOI 10.1016/0888-7543(95)80229-F; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852                                                           ; Kok FO, 2012, DEVELOPMENT, V139, P3838, DOI 10.1242/dev.080994; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Low SE, 2010, DEV NEUROBIOL, V70, P508, DOI [10.1002/dneu.2079, 10.1002/dneu.20791]; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Moravec CE, 2016, J NEUROSCI, V36, P9407, DOI 10.1523/JNEUROSCI.1246-16.2016; Moravec CE, 2015, BEHAV BRAIN RES, V284, P238, DOI 10.1016/j.bbr.2015.02.026; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764                                                                   ; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004                                                ; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Pellegrino J, 2012, DEV BIOL, V369, P349, DOI 10.1016/j.ydbio.2012.07.006; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pietri T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00118; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202                                                              ; Rielland M, 2014, J CLIN INVEST, V124, P2125, DOI 10.1172/JC172619; Sharma V, 2008, DEV DYNAM, V237, P3040, DOI 10.1002/dvdy.21706; Shi XZ, 2012, MOL CELL BIOCHEM, V366, P251, DOI 10.1007/s11010-012-1302-2; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Stadhouders R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9893; STERNBERG PW, 1987, CELL, V48, P567, DOI 10.1016/0092-8674(87)90235-2; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Vega AV, 2013, SCI REP-UK, V3, DOI 10.1038/srep02809; WANG HM, 1990, MOL CELL BIOL, V10, P5927, DOI 10.1128/MCB.10.11.5927                                                          ; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057080; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7                                                   ; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Yang Q, 2000, BIOCHEM J, V345, P335, DOI 10.1042/0264-6021:3450335                                                       ; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0                                                   ; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	56	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	NOV	2017	246	11			SI		946	955		10.1002/dvdy.24581				10	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	FK0CZ	WOS:000413149200017	28850761				2018-01-05	
J	Milani, M; Annoni, A; Bartolaccini, S; Biffi, M; Russo, F; Di Tomaso, T; Raimondi, A; Lengler, J; Holmes, MC; Scheiflinger, F; Lombardo, A; Cantore, A; Naldini, L				Milani, Michela; Annoni, Andrea; Bartolaccini, Sara; Biffi, Mauro; Russo, Fabio; Di Tomaso, Tiziano; Raimondi, Andrea; Lengler, Johannes; Holmes, Michael C.; Scheiflinger, Friedrich; Lombardo, Angelo; Cantore, Alessio; Naldini, Luigi			Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy	EMBO MOLECULAR MEDICINE			English	Article						gene therapy; hemophilia; lentiviral vectors; MHC-I; stable producer cell line	PACKAGING CELL-LINE; COMPLEMENT INHIBITOR ECULIZUMAB; LONG-TERM SAFETY; TRANSGENE EXPRESSION; MAMMALIAN-CELLS; HEMOPHILIA-B; SERUM; DISEASE; INACTIVATION; PARTICLES	Lentiviral vectors (LV) are powerful and versatile vehicles for gene therapy. However, their complex biological composition challenges large-scale manufacturing and raises concerns for in vivo applications, because particle components and contaminants may trigger immune responses. Here, we show that producer cell-derived polymorphic class-I major histocompatibility complexes (MHC-I) are incorporated into the LV surface and trigger allogeneic T-cell responses. By disrupting the beta-2 microglobulin gene in producer cells, we obtained MHC-free LV with substantially reduced immunogenicity. We introduce this targeted editing into a novel stable LV packaging cell line, carrying single-copy inducible vector components, which can be reproducibly converted into high-yield LV producers upon site-specific integration of the LV genome of interest. These LV efficiently transfer genes into relevant targets and are more resistant to complement-mediated inactivation, because of reduced content of the vesicular stomatitis virus envelope glycoprotein G compared to vectors produced by transient transfection. Altogether, these advances support scalable manufacturing of alloantigen-free LV with higher purity and increased complement resistance that are better suited for in vivo gene therapy.	[Milani, Michela; Annoni, Andrea; Bartolaccini, Sara; Biffi, Mauro; Russo, Fabio; Di Tomaso, Tiziano; Lombardo, Angelo; Cantore, Alessio; Naldini, Luigi] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Milani, Michela; Lombardo, Angelo; Naldini, Luigi] Univ Vita Salute San Raffaele, Milan, Italy; [Raimondi, Andrea] IRCCS San Raffaele Sci Inst, Milan, Italy; [Lengler, Johannes; Scheiflinger, Friedrich] Baxalta Innovat GmbH, Baxter, Vienna, Austria; [Holmes, Michael C.] Sangamo Therapeut Inc, Richmond, CA USA	Naldini, L (reprint author), IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Milan, Italy.; Naldini, L (reprint author), Univ Vita Salute San Raffaele, Milan, Italy.	luigi.naldini@hsr.it			Telethon; Bioverativ	We thank S. Marktel (San Raffaele Hematology and Bone Marrow Transplantation Unit) for serum samples from allo-immunized patients; T. Plati and A. Migliara for help with some experiments; MolMed S.p.A. for large-scale production using the LV producer cell line; A. Nonis, A. Pramov, and C. Di Serio for statistical consulting. T. Liu and R. Peters (Bioverativ) and all other members of the Naldini, Lombardo, and Gentner laboratories for helpful discussions. We thank the ALEMBIC facility at the San Raffaele Scientific Institute for help with electron microscopy analysis. M.M. conducted this study as partial fulfillment of her International Ph.D. Course in Molecular Medicine at San Raffaele University, Milan. This work was supported by Telethon (SR-Tiget Core Grant 2011-2016), and Bioverativ sponsored research agreement.	Adiko AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00335; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Annoni A, 2013, TRANSL RES, V161, P230, DOI 10.1016/j.trsl.2012.12.018; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Broussau S, 2008, MOL THER, V16, P500, DOI 10.1038/sj.mt.6300383; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cantore A, 2015, SCI TRANSL MED, V7, DOI DOI 10.1126/SCITRANSLMED.AAA1405; Cantore A, 2012, BLOOD, V120, P4517, DOI 10.1182/blood-2012-05-432591; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; DePolo NJ, 2000, MOL THER, V2, P218, DOI 10.1006/mthe.2000.0116; Dull T, 1998, J VIROL, V72, P8463; Escobar G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006353; Farson D, 2001, HUM GENE THER, V12, P981, DOI 10.1089/104303401750195935; Follenzi A, 2000, NAT GENET, V25, P217; Garcia BL, 2016, J IMMUNOL, V197, P2051, DOI 10.4049/jimmunol.1600863; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hwang BY, 2013, GENE THER, V20, P807, DOI 10.1038/gt.2013.1; Jones J, 2005, BIOTECHNOL BIOENG, V91, P722, DOI 10.1002/bit.20566; Kafri T, 1999, J VIROL, V73, P576; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Schauber CA, 2004, GENE THER, V11, P266, DOI 10.1038/sj.gt.3302170; Schauber-Plewa C, 2005, GENE THER, V12, P238, DOI 10.1038/sj.gt.3302399; Serena M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40037; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Stewart HJ, 2009, GENE THER, V16, P805, DOI 10.1038/gt.2009.20; Stornaiuolo A, 2013, HUM GENE THER METHOD, V24, P228, DOI 10.1089/hgtb.2012.190; Throm RE, 2009, BLOOD, V113, P5104, DOI 10.1182/blood-2008-11-191049; Trobridge GD, 2010, MOL THER, V18, P725, DOI 10.1038/mt.2009.282; Wang LL, 1997, P NATL ACAD SCI USA, V94, P11563, DOI 10.1073/pnas.94.21.11563; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939                                                      ; Zanta-Boussif MA, 2009, GENE THER, V16, P605, DOI 10.1038/gt.2009.3; Zufferey R, 1998, J VIROL, V72, P9873; Zufferey R, 1999, J VIROL, V73, P2886	45	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	NOV	2017	9	11					1558	1573		10.15252/emmm.201708148				16	Medicine, Research & Experimental	Research & Experimental Medicine	FL6FD	WOS:000414339700008	28835507	gold			2018-01-05	
J	Diez, B; Genovese, P; Roman-Rodriguez, FJ; Alvarez, L; Schiroli, G; Ugalde, L; Rodriguez-Perales, S; Sevilla, J; de Heredia, CD; Holmes, MC; Lombardo, A; Naldini, L; Bueren, JA; Rio, P				Diez, Begona; Genovese, Pietro; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Schiroli, Giulia; Ugalde, Laura; Rodriguez-Perales, Sandra; Sevilla, Julian; Diaz de Heredia, Cristina; Holmes, Michael C.; Lombardo, Angelo; Naldini, Luigi; Antonio Bueren, Juan; Rio, Paula			Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients	EMBO MOLECULAR MEDICINE			English	Article						CD34(+) cells; Fanconi anemia; gene editing; hematopoietic stem and progenitor cells; zinc finger nucleases	ZINC-FINGER NUCLEASES; STEM-CELLS; LENTIVIRAL VECTOR; REVERSE MOSAICISM; DISEASE; COMPLEMENTATION; TECHNOLOGIES; REPAIR	Gene targeting constitutes a new step in the development of gene therapy for inherited diseases. Although previous studies have shown the feasibility of editing fibroblasts from Fanconi anemia (FA) patients, here we aimed at conducting therapeutic gene editing in clinically relevant cells, such as hematopoietic stem cells (HSCs). In our first experiments, we showed that zinc finger nuclease (ZFN)-mediated insertion of a non-therapeutic EGFP-reporter donor in the AAVS1 "safe harbor" locus of FA-A lymphoblastic cell lines (LCLs), indicating that FANCA is not essential for the editing of human cells. When the same approach was conducted with therapeutic FANCA donors, an efficient phenotypic correction of FA-A LCLs was obtained. Using primary cord blood CD34(+) cells from healthy donors, gene targeting was confirmed not only in in vitro cultured cells, but also in hematopoietic precursors responsible for the repopulation of primary and secondary immunodeficient mice. Moreover, when similar experiments were conducted with mobilized peripheral blood CD34(+) cells from FA-A patients, we could demonstrate for the first time that gene targeting in primary hematopoietic precursors from FA patients is feasible and compatible with the phenotypic correction of these clinically relevant cells.	[Diez, Begona; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Ugalde, Laura; Antonio Bueren, Juan; Rio, Paula] Ctr Invest Energet Medioambientales & Tecnol, Div Hematopoiet Innovat Therapies, Madrid, Spain; [Diez, Begona; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Ugalde, Laura; Antonio Bueren, Juan; Rio, Paula] Fdn Jimenez Diaz, Adv Therapies Unit, Inst Invest Sanitaria, Madrid, Spain; [Diez, Begona; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Ugalde, Laura; Sevilla, Julian; Antonio Bueren, Juan; Rio, Paula] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Genovese, Pietro; Schiroli, Giulia; Lombardo, Angelo; Naldini, Luigi] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Schiroli, Giulia; Lombardo, Angelo; Naldini, Luigi] Univ Vita Salute San Raffaele, Milan, Italy; [Rodriguez-Perales, Sandra] CINIO, Mol Cytogenet Grp, Human Canc Genet Program, Madrid, Spain; [Sevilla, Julian] Hosp Infantil Univ Nino Jesus, Serv Hematooncol Pediat, Madrid, Spain; [Sevilla, Julian] Hosp Infantil Univ Nino Jesus, Fdn Invest Biomed, Madrid, Spain; [Diaz de Heredia, Cristina] Hosp Univ Vall dHebron, Serv Oncol & Hematol Pediat, Barcelona, Spain; [Holmes, Michael C.] Sangamo Therapeut Inc, Richmond, CA USA	Bueren, JA; Rio, P (reprint author), Ctr Invest Energet Medioambientales & Tecnol, Div Hematopoiet Innovat Therapies, Madrid, Spain.; Bueren, JA; Rio, P (reprint author), Fdn Jimenez Diaz, Adv Therapies Unit, Inst Invest Sanitaria, Madrid, Spain.; Bueren, JA; Rio, P (reprint author), Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain.	juan.bueren@ciemat.es; paula.rio@ciemat.es	Rio, Paula/G-8681-2015	Rio, Paula/0000-0002-5424-5543	7th Framework Program European Commission (EUROFAN-COLEN) [HEALTH-FS-2012-305421]; Ministerio de Sanidad, Servicios Sociales e Igualdad [EC11/060, EC11/550]; Ministerio de Economia, Comercio y Competitividad y Fondo Europeo de Desarrollo Regional (FEDER) [SAF2015-68073-R]; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III [RD12/0019/0023]	The authors would like to thank Aurora de la Cal for her assistance with the coordination in the delivery of the samples from the patients. Rebeca Sanchez-Dominguez for her expertise in flow cytometry and Centro de Transfusiones de la Comunidad de Madrid for providing cord blood samples. The authors are also indebted to the FA patients, families, and clinicians from the FA spanish network, This work was supported by grants from the "7th Framework Program European Commission (HEALTH-FS-2012-305421; EUROFAN-COLEN)", "Ministerio de Sanidad, Servicios Sociales e Igualdad" (EC11/060 and EC11/550), "Ministerio de Economia, Comercio y Competitividad y Fondo Europeo de Desarrollo Regional (FEDER)" (SAF2015-68073-R), and "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III" (RD12/0019/0023). The authors also thank the Fundacion Marcelino Botin for promoting translational research at the Hematopoietic Innovative Therapies Division of the CIEMAT. CIBERER is an initiative of the Instituto de Salud Carlos III, Spain.	Adair JE, 2016, CURR GENE THER, V16, P338, DOI 10.2174/1566523217666170119113029; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Becker PS, 2010, GENE THER, V17, P1244, DOI 10.1038/gt.2010.62; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Bluteau D, 2016, J CLIN INVEST, V126, P3580, DOI 10.1172/JCI88010; Bogliolo M, 2015, CURR OPIN GENET DEV, V33, P32, DOI 10.1016/j.gde.2015.07.002; BUTTURINI A, 1994, BLOOD, V84, P1650; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Castella M, 2011, BLOOD, V117, P3759, DOI 10.1182/blood-2010-08-299917; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Charrier S, 2011, GENE THER, V18, P479, DOI 10.1038/gt.2010.163; Corrigan-Curay J, 2015, MOL THER, V23, P796, DOI 10.1038/mt.2015.54; Daniel MG, 2016, TRENDS CELL BIOL, V26, P202, DOI 10.1016/j.tcb.2015.10.002; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gonzalez-Murillo A, 2010, HUM GENE THER, V21, P623, DOI 10.1089/hum.2009.141; Gregory JJ, 2001, P NATL ACAD SCI USA, V98, P2532, DOI 10.1073/pnas.051609898; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hoban MD, 2016, BLOOD, V127, P2525, DOI 10.1182/blood-2016-01-678151; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb21912; Jacome A, 2009, MOL THER, V17, P1083, DOI 10.1038/mt.2009.26; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; Knies K, 2017, J CLIN INVEST, V127, P3013, DOI 10.1172/JCI92069; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Osborn MJ, 2016, INT J HEMATOL, V104, P18, DOI 10.1007/s12185-016-2017-z; Park JY, 2016, J MED GENET, V53, P672, DOI 10.1136/jmedgenet-2016-103847; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Rio P, 2014, EMBO MOL MED, V6, P835, DOI 10.15252/emmm.201303374; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tolar J, 2012, HUM GENE THER, V23, P141, DOI 10.1089/hum.2011.237; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Waisfisz Q, 1999, NAT GENET, V22, P379; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Zhang HJ, 2016, CELL STEM CELL, V18, P668, DOI 10.1016/j.stem.2016.03.002	45	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	NOV	2017	9	11					1574	1588		10.15252/emmm.201707540				15	Medicine, Research & Experimental	Research & Experimental Medicine	FL6FD	WOS:000414339700009	28899930	gold			2018-01-05	
J	Gholizadeh, P; Aghazadeh, M; Asgharzadeh, M; Kafil, HS				Gholizadeh, P.; Aghazadeh, M.; Asgharzadeh, M.; Kafil, H. S.			Suppressing the CRISPR/Cas adaptive immune system in bacterial infections	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Review							SHORT PALINDROMIC REPEATS; RESISTANT STAPHYLOCOCCUS-AUREUS; PROVIDES ACQUIRED-RESISTANCE; PSEUDOMONAS-AERUGINOSA PAO1; GUIDED SURVEILLANCE COMPLEX; GUILLAIN-BARRE-SYNDROME; REAL-TIME PCR; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; STREPTOCOCCUS-THERMOPHILUS	Clustered regularly interspaced short palindromic repeats (CRISPR) coupled with CRISPR-associated (Cas) proteins (CRISPR/Cas) are the adaptive immune system of eubacteria and archaebacteria. This system provides protection of bacteria against invading foreign DNA, such as transposons, bacteriophages and plasmids. Three-stage processes in this system for immunity against foreign DNAs are defined as adaptation, expression and interference. Recent studies suggested a correlation between the interfering of the CRISPR/Cas locus, acquisition of antibiotic resistance and pathogenicity island. In this review article, we demonstrate and discuss the CRISPR/Cas system's roles in interference with acquisition of antibiotic resistance and pathogenicity island in some eubacteria. Totally, these systems function as the adaptive immune system of bacteria against invading foreign DNA, blocking the acquisition of antibiotic resistance and virulence factor, detecting serotypes, indirect effects of CRISPR self-targeting, associating with physiological functions, associating with infections in humans at the transmission stage, interfering with natural transformation, a tool for genome editing in genome engineering, monitoring foodborne pathogens etc. These results showed that the CRISPR/Cas system might prevent the emergence of virulence both in vitro and in vivo. Moreover, this system was shown to be a strong selective pressure for the acquisition of antibiotic resistance and virulence factor in bacterial pathogens.	[Gholizadeh, P.] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran; [Gholizadeh, P.] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran; [Aghazadeh, M.] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran; [Asgharzadeh, M.] Tabriz Univ Med Sci, Infect & Trop Dis Res Ctr, Tabriz, Iran; [Kafil, H. S.] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran	Kafil, HS (reprint author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.	Kafilhs@tbzmed.ac.ir	Samadi Kafil, Hossein/B-5855-2012	Samadi Kafil, Hossein/0000-0001-6026-8795	Drug Applied Research Center, Tabriz University of Medical Sciences; National Institute for Medical Research Development (NIMAD)	This work was supported by the Drug Applied Research Center, Tabriz University of Medical Sciences and National Institute for Medical Research Development (NIMAD).	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736                                                    ; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Cymerman IA, 2006, PROTEINS, V65, P867, DOI 10.1002/prot.21156; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Delannoy S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Faucher SP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00098; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879                                                       ; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Gunderson FF, 2013, MBIO, V4, DOI 10.1128/mBio.00074-13; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heussler GE, 2015, MBIO, V6, DOI 10.1128/mBio.00129-15; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jakubauskas A, 2007, J MOL BIOL, V370, P157, DOI 10.1016/j.jmb.2007.04.049; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kleanthous C, 1999, NAT STRUCT BIOL, V6, P243, DOI 10.1038/6683                                                                    ; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Labbate M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36891; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; McLeod SM, 2005, MOL MICROBIOL, V57, P347, DOI 10.1111/j.1365-2958.04676.x; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Newton GJ, 2001, MOL MICROBIOL, V39, P1237, DOI 10.1046/j.1365-2958.2001.02311.x; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997                                                ; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995                                                   ; Sontheimer EJ, 2010, NATURE, V468, P45, DOI 10.1038/468045a; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sun HH, 2015, FOODBORNE PATHOG DIS, V12, P68, DOI 10.1089/fpd.2014.1792; Toro M, 2014, APPL ENVIRON MICROB, V80, P1411, DOI 10.1128/AEM.03018-13; Touchon M, 2012, MICROBIOL-SGM, V158, P2997, DOI 10.1099/mic.0.060814-0; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Vaca-Pacheco S, 1999, CURR MICROBIOL, V38, P239, DOI 10.1007/PL00006794; van Belkum A, 2001, NAT MED, V7, P752, DOI 10.1038/89831                                                                   ; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wiedenheft B, 2013, RNA BIOL, V10, P886, DOI 10.4161/rna.23591; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yin Shuang, 2013, Appl Environ Microbiol, V79, P5710, DOI 10.1128/AEM.00950-13; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	87	0	0	12	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	NOV	2017	36	11					2043	2051		10.1007/s10096-017-3036-2				9	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	FK6NH	WOS:000413620200007	28601970				2018-01-05	
J	Wang, Q; Pronin, AN; Levay, K; Almaca, J; Fornoni, A; Caicedo, A; Slepak, VZ				Wang, Qiang; Pronin, Alexey N.; Levay, Konstantin; Almaca, Joana; Fornoni, Alessia; Caicedo, Alejandro; Slepak, Vladlen Z.			Regulator of G-protein signaling G beta 5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion	FASEB JOURNAL			English	Article						islet of Langerhans; pupil sphincter; CRISPR-Cas9; UBO-QIC; fluorescent biosensor	PANCREATIC BETA-CELL; RGS PROTEINS; COUPLED RECEPTORS; SUBUNIT G-BETA-5; IN-VITRO; COMPLEX; DOMAIN; RELEASE; BINDING; PHOSPHORYLATION	In pancreatic beta cells, muscarinic cholinergic receptor M3 (M3R) stimulates glucose-induced secretion of insulin. Regulator of G-protein signaling (RGS) proteins are critical modulators of GPCR activity, yet their role in cells remains largely unknown. R7 subfamily RGS proteins are stabilized by the G-protein subunit G beta 5, such that the knockout of the Gnb5 gene results in degradation of all R7 subunits. We found that Gnb5 knockout in mice or in the insulin-secreting MIN6 cell line almost completely eliminates insulinotropic activity of M3R. Moreover, overexpression of G beta 5-RGS7 strongly promotes M3R-stimulated insulin secretion. Examination of this noncanonical mechanism in Gnb5(-/-) MIN6 cells showed that cAMP, diacylglycerol, or Ca2+ levels were not significantly affected. There was no reduction in the amplitude of free Ca2+ responses in islets from the Gnb5(-/-) mice, but the frequency of Ca2+ oscillations induced by cholinergic agonist was lowered by more than 30%. Ablation of Gnb5 impaired M3R-stimulated phosphorylation of ERK1/2. Stimulation of the ERK pathway in Gnb5(-/-) cells by epidermal growth factor restored M3R-stimulated insulin release to near normal levels. Identification of the novel role of G beta 5-R7 in insulin secretion may lead to a new therapeutic approach for improving pancreatic beta-cell function.	[Wang, Qiang; Pronin, Alexey N.; Levay, Konstantin; Slepak, Vladlen Z.] Univ Miami, Leonard M Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Almaca, Joana; Fornoni, Alessia; Caicedo, Alejandro] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL 33136 USA	Slepak, VZ (reprint author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rosenstiel Med Sci Bldg 6130, Miami, FL 33136 USA.	vslepak@med.miami.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK105427, R01DK0090316, R01DK104753, R01DK111538]	The authors thank Jongmin Jeon and Junior Tayou (Leonard M. Miller School of Medicine, University of Miami) for sharing technical expertise. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01DK105427 (to V.Z.S.), R01DK0090316 and R01DK104753 (to A.F.), and R01DK111538 (to A.C.). The authors declare no conflicts of interest.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alejandro EU, 2011, FASEB J, V25, P3884, DOI 10.1096/fj.10-180349; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; de Azua IR, 2012, LIFE SCI, V91, P986, DOI 10.1016/j.lfs.2012.04.010; de Azua IR, 2012, FASEB J, V26, P4275, DOI 10.1096/fj.12-204644; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Gylfe E, 2014, DIABETES OBES METAB, V16, P102, DOI 10.1111/dom.12345; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hunt RA, 2003, BIOCHEM BIOPH RES CO, V303, P594, DOI 10.1016/S0006-291X(03)00400-5; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; KATADA T, 1984, J BIOL CHEM, V259, P3568; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Leitner MG, 2016, BRIT J PHARMACOL, V173, P2555, DOI 10.1111/bph.13538; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Malmersjo S, 2016, EMBO J, V35, P1810, DOI 10.15252/embj.201694071; Moran BM, 2016, ACTA DIABETOL, V53, P177, DOI 10.1007/s00592-015-0826-9; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Osei-Owusu P, 2015, PROG MOL BIOL TRANSL, V133, P77, DOI 10.1016/bs.pmbts.2015.02.001; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Pronin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096435; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795                                                ; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Selway J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033004; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tewson PH, 2016, J BIOMOL SCREEN, V21, P298, DOI 10.1177/1087057115618608; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Xie KQ, 2012, PSYCHOPHARMACOLOGY, V219, P823, DOI 10.1007/s00213-011-2409-y; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0	48	0	0	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4734	4744		10.1096/fj.201700197RR				11	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	WOS:000413398500007	28687610				2018-01-05	
J	Voloshanenko, O; Gmach, P; Winter, J; Kranz, D; Boutros, M				Voloshanenko, Oksana; Gmach, Philipp; Winter, Jan; Kranz, Dominique; Boutros, Michael			Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families	FASEB JOURNAL			English	Article						multiplex sgRNA; canonical Wnt signaling; FZD receptors; Cas9	CHROMOSOMAL REARRANGEMENTS; PROTEIN; POLARITY; CELLS; MEMBRANE; WINGLESS; PATHWAY; CANCER; GROWTH; RECOGNITION	Signaling pathway modules are often encoded by several closely related paralogous genes that can have redundant roles and are therefore difficult to analyze by loss-of-function analysis. A typical example is the Wnt signaling pathway, which in mammals is mediated by 19 Wnt ligands that can bind to 10 Frizzled (FZD) receptors. Although significant progress in understanding Wnt-FZD receptor interactions has been made in recent years, tools to generate systematic interaction maps have been largely lacking. Here we generated cell lines with multiplex mutant alleles of FZD1, FZD2, and FZD7 and demonstrate that these cells are unresponsive to canonical Wnt ligands. Subsequently, we performed genetic rescue experiments with combinations of FZDs and canonical Wnts to create a functional ligand-receptor interaction map. These experiments showed that whereas several Wnt ligands, such as Wnt3a, induce signaling through a broad spectrum of FZD receptors, others, such as Wnt8a, act through a restricted set of FZD genes. Together, our results map functional interactions of FZDs and 10 Wnt ligands and demonstrate how multiplex targeting by clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 can be used to systematically elucidate the functions of multigene families.	German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; Heidelberg Univ, Dept Cell & Mol Biol, Med Fac Mannheim, Heidelberg, Germany	Voloshanenko, O; Boutros, M (reprint author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	o.voloshanenko@dkfz.de; m.boutros@dkfz.de			German Research Foundation (DFG)	The authors thank members of the M.B. group for helpful discussions and F. Reuter [German Cancer Research Center (DKFZ)] for help with experiments. The authors are particularly grateful to B. Rauscher for help with computational analysis and F. Heigwer (both from the DKFZ) for the help with E-CRISP and the design of sgRNAs. The authors thank M. Waterman (University of California, Irvine, Irvine, CA USA), D. Virshup (Duke-National University of Singapore Medical School, Singapore), and F. Zhang (Broad Institute, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.) for plasmids received through Addgene. Work in the laboratory of M.B. was in part supported by the German Research Foundation (DFG). The authors declare no conflicts of interest.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Chang H, 2013, P NATL ACAD SCI USA, V110, pE908, DOI 10.1073/pnas.1301430110; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601                                                                ; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; He ZY, 2015, BIOTECHNOL BIOENG, V112, P1060, DOI 10.1002/bit.25490; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spanjer AIR, 2016, FASEB J, V30, P1823, DOI 10.1096/fj.201500129; Stanganello E, 2016, J CELL SCI, V129, P665, DOI 10.1242/jcs.182469; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang Y, 2012, CELL SIGNAL, V24, P2389, DOI 10.1016/j.cellsig.2012.08.009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	60	0	0	3	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4832	4844		10.1096/fj.201700144R				13	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	WOS:000413398500015	28733458				2018-01-05	
J	Lin, QH; Mei, J; Li, Z; Zhang, XM; Zhou, L; Gui, JF				Lin, Qiaohong; Mei, Jie; Li, Zhi; Zhang, Xuemei; Zhou, Li; Gui, Jian-Fang			Distinct and Cooperative Roles of amh and dmrt1 in Self-Renewal and Differentiation of Male Germ Cells in Zebrafish	GENETICS			English	Article						amh; dmrt1; germ cells; self-renewal; differentiation; Genetics of Sex	ANTI-MULLERIAN HORMONE; SEX REVERSAL; ADULT ZEBRAFISH; SERTOLI-CELLS; DANIO-RERIO; GIBEL CARP; TESTIS DIFFERENTIATION; SPERMATOGENIC CELLS; EXPRESSION ANALYSIS; STEM-CELLS	Spermatogenesis is a fundamental process in male reproductive biology and depends on precise balance between self-renewal and differentiation of male germ cells. However, the regulative factors for controlling the balance are poorly understood. In this study, we examined the roles of amh and dmrt1 in male germ cell development by generating their mutants with Crispr/Cas9 technology in zebrafish. Amh mutant zebrafish displayed a female-biased sex ratio, and both male and female amh mutants developed hypertrophic gonads due to uncontrolled proliferation and impaired differentiation of germ cells. A large number of proliferating spermatogonium-like cells were observed within testicular lobules of the amh-mutated testes, and they were demonstrated to be both Vasa-and PH3-positive. Moreover, the average number of Sycp3- and Vasa-positive cells in the amh mutants was significantly lower than in wild-type testes, suggesting a severely impaired differentiation of male germ cells. Conversely, all the dmrt1-mutated testes displayed severe testicular developmental defects and gradual loss of all Vasa-positive germ cells by inhibiting their self-renewal and inducing apoptosis. In addition, several germ cell and Sertoli cell marker genes were significantly downregulated, whereas a prominent increase of Insl3-positive Leydig cells was revealed by immunohistochemical analysis in the disorganized dmrt1-mutated testes. Our data suggest that amh might act as a guardian to control the balance between proliferation and differentiation of male germ cells, whereas dmrt1 might be required for the maintenance, self-renewal, and differentiation of male germ cells. Significantly, this study unravels novel functions of amh gene in fish.	[Lin, Qiaohong; Mei, Jie; Zhang, Xuemei; Gui, Jian-Fang] Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan 430070, Hubei, Peoples R China; [Li, Zhi; Zhou, Li; Gui, Jian-Fang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei, Peoples R China	Gui, JF (reprint author), Huazhong Agr Univ, Coll Fisheries, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.; Gui, JF (reprint author), Chinese Acad Sci, Inst Hydrobiol, 7 Donghu South Rd, Wuhan 430072, Hubei, Peoples R China.	jfgui@ihb.ac.cn			National Natural Science Foundation of China [31672635]; Key Program of Frontier Sciences of the Chinese Academy of Sciences (CAS) [QYZDY-SSW-SMC025]; Strategic Priority Research Program of CAS [XDA08030201]; Autonomous Project of State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ22]; Autonomous Projects of the Institute of Hydrobiology, CAS [Y25A17, Y45A171301]	This work was supported by the National Natural Science Foundation of China (31672635), the Key Program of Frontier Sciences of the Chinese Academy of Sciences (CAS) (QYZDY-SSW-SMC025), the Strategic Priority Research Program of CAS (XDA08030201), the Autonomous Project of State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ22), and the Autonomous Projects of the Institute of Hydrobiology, CAS (Y25A17 and Y45A171301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare that they have no conflict of interest.	Agbor VA, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103135; Arukwe A, 2008, CELL BIOL TOXICOL, V24, P527, DOI 10.1007/s10565-008-9069-7; Assis LHC, 2016, CELL TISSUE RES, V363, P579, DOI 10.1007/s00441-015-2213-9; Baudiffier D, 2012, TOXICOLOGY, V298, P30, DOI 10.1016/j.tox.2012.04.012; Beer RL, 2013, DEV BIOL, V374, P308, DOI 10.1016/j.ydbio.2012.12.003; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brion F, 2004, AQUAT TOXICOL, V68, P193, DOI 10.1016/j.aquatox.2004.01.022; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chen SX, 2013, GEN COMP ENDOCR, V185, P1, DOI 10.1016/j.ygcen.2013.01.005; Chen SJ, 2016, MOL CELL ENDOCRINOL, V433, P105, DOI 10.1016/j.mce.2016.06.005; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; Dimitriadis F, 2015, HORM-INT J ENDOCRINO, V14, P479, DOI 10.14310/horm.2002.1633; Dranow DB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006323; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892; Good-Avila SV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-293; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Herpin A, 2015, EMBO REP, V16, P1260, DOI 10.15252/embr.201540667; Hinfray N, 2011, GEN COMP ENDOCR, V174, P309, DOI 10.1016/j.ygcen.2011.09.008; Kim S, 2007, DEV BIOL, V307, P314, DOI 10.1016/j.ydbio.2007.04.046; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kobayashi A, 2011, DEVELOPMENT, V138, P1967, DOI 10.1242/dev.056143; Leal MC, 2009, BIOL REPROD, V81, P177, DOI 10.1095/biolreprod.109.076299; Li MH, 2017, SCI BULL, V62, P165, DOI 10.1016/j.scib.2017.01.003; Li XY, 2017, SCI BULL, V62, P528, DOI 10.1016/j.scib.2017.04.002; Li XY, 2014, MOL PHYLOGENET EVOL, V78, P96, DOI 10.1016/j.ympev.2014.05.005; Li XY, 2014, GENE, V548, P119, DOI 10.1016/j.gene.2014.07.031; Liu W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2130-z; MARSHALL GR, 1995, ENDOCRINOLOGY, V136, P3504, DOI 10.1210/en.136.8.3504; Masuyama H, 2012, CHROMOSOME RES, V20, P163, DOI 10.1007/s10577-011-9264-x; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morinaga C, 2007, P NATL ACAD SCI USA, V104, P9691, DOI 10.1073/pnas.0611379104; Nakamura S, 2006, DEV BIOL, V295, P678, DOI 10.1016/j.ydbio.2006.03.052; Nakamura S, 2012, DEVELOPMENT, V139, P2283, DOI 10.1242/dev.076307; Neumann JC, 2011, P NATL ACAD SCI USA, V108, P13153, DOI 10.1073/pnas.1102311108; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Ozaki Y, 2011, GENE EXPR PATTERNS, V11, P309, DOI 10.1016/j.gep.2011.03.002; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; Rocha A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137547; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Skaar KS, 2011, ENDOCRINOLOGY, V152, P3527, DOI 10.1210/en.2010-1469; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Sun D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.456; Sun HY, 2014, CELL REPROGRAM, V16, P196, DOI 10.1089/cell.2013.0083; Sweeney Sean T, 2012, Cold Spring Harb Protoc, V2012, P1013, DOI 10.1101/pdb.prot068379; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang H, 2016, REPRODUCTION, V152, pR31, DOI 10.1530/REP-15-0546; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Wang Y, 2013, SCI CHINA LIFE SCI, V56, P975, DOI 10.1007/s11427-013-4563-4; Webster KA, 2017, DEV BIOL, V422, P33, DOI 10.1016/j.ydbio.2016.12.008; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-S0960-9822(03)00537-2; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xiong ST, 2017, SCI BULL, V62, P185, DOI 10.1016/j.scib.2017.01.008; Xu HY, 2010, SCI CHINA LIFE SCI, V53, P435, DOI 10.1007/s11427-010-0058-8; Yang YJ, 2017, GENETICS, V205, P1551, DOI 10.1534/genetics.116.199133; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang LJ, 2015, P NATL ACAD SCI USA, V112, P4003, DOI 10.1073/pnas.1422371112; Zhang T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006293; Zhang ZW, 2015, ENDOCRINOLOGY, V156, P3747, DOI 10.1210/en.2015-1039	70	0	0	4	4	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	2017	207	3					1007	1022		10.1534/genetics.117.300274				16	Genetics & Heredity	Genetics & Heredity	FL5HR	WOS:000414265000014	28893856				2018-01-05	
J	Xiong, G; Tong, XL; Gai, TT; Li, CL; Qiao, L; Monteiro, A; Hu, H; Han, MJ; Ding, X; Wu, SY; Xiang, ZH; Lu, C; Dai, FY				Xiong, Gao; Tong, Xiaoling; Gai, Tingting; Li, Chunlin; Qiao, Liang; Monteiro, Antonia; Hu, Hai; Han, Minjin; Ding, Xin; Wu, Songyuan; Xiang, Zhonghuai; Lu, Cheng; Dai, Fangyin			Body Shape and Coloration of Silkworm Larvae Are Influenced by a Novel Cuticular Protein	GENETICS			English	Article						body shape; color patterns; cuticular protein; apoptosis; novel gene	BOMBYX-MORI; CUTICLE PROTEIN; PAPILIO-XUTHUS; GENES; PATTERN; EXPRESSION; EVOLUTION; APOPTOSIS; EXOSKELETON; DROSOPHILA	The genetic basis of body shape and coloration patterns on caterpillars is often assumed to be regulated separately, but it is possible that common molecules affect both types of trait simultaneously. Here we examine the genetic basis of a spontaneous cuticle defect in silkworm, where larvae exhibit a bamboo-like body shape and decreased pigmentation. We performed linkage mapping and mutation screening to determine the gene product that affects body shape and coloration simultaneously. In these mutant larvae we identified a null mutation in BmorCPH24, a gene encoding a cuticular protein with low complexity sequence. Spatiotemporal expression analyses showed that BmorCPH24 is expressed in the larval epidermis postecdysis. RNAi-mediated knock-down and CRISPR/Cas9-mediated knockout of BmorCPH24 produced the abnormal body shape and the inhibited pigment typical of the mutant phenotype. In addition, our results showed that BmorCPH24 may be involved in the synthesis of endocuticle and its disruption-induced apoptosis of epidermal cells that accompanied the reduced expression of R&R-type larval cuticle protein genes and pigmentation gene Wnt1. Strikingly, BmorCPH24, a fast-evolving gene, has evolved a new function responsible for the assembly of silkworm larval cuticle and has evolved to be an indispensable factor maintaining the larval body shape and its coloration pattern. This is the first study to identify a molecule whose pleiotropic function affects the development of body shape and color patterns in insect larvae.	[Xiong, Gao; Tong, Xiaoling; Gai, Tingting; Li, Chunlin; Hu, Hai; Han, Minjin; Ding, Xin; Wu, Songyuan; Xiang, Zhonghuai; Lu, Cheng; Dai, Fangyin] Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Tong, Xiaoling; Han, Minjin; Xiang, Zhonghuai; Lu, Cheng; Dai, Fangyin] Southwest Univ, Coll Biotechnol, Minist Agr, Key Lab Sericultural Biol & Genet Breeding, Chongqing 400715, Peoples R China; [Qiao, Liang] Chongqing Normal Univ, Coll Life Sci, Inst Entomol & Mol Biol, Chongqing 401331, Peoples R China; [Monteiro, Antonia] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Monteiro, Antonia] Yale NUS Coll, Singapore 138614, Singapore	Dai, FY (reprint author), Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericultural Biol & Genet Breeding, Minist Agr,Coll Biotechnol, 1 Tiansheng Rd, Chongqing 400715, Peoples R China.	fydai@swu.edu.cn	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X	Hi-Tech Research and Development 863 Program of China [2013AA102507]; National Natural Science Foundation of China [31372379, 31472153]; China Agriculture Research System [CARS-18-ZJ0102]; Chongqing Youth Science and Technology Talent Training Project [cstc2014kjrc-qnrc80001]; municipal graduate student research innovation project of Chongqing [CYB2015066]	We thank Haruhiko Fujiwara and Junichi Yamaguchi for the advice on in situ hybridization, and Zhengwen Yan and Chenxing Peng on cuticle dissection. We also thank Duan Tan, Songzhen He, and Jiangbo Song for helpful comments. This work was supported by the Hi-Tech Research and Development 863 Program of China (grant no. 2013AA102507), the National Natural Science Foundation of China (no. 31372379, no. 31472153), China Agriculture Research System (CARS-18-ZJ0102), Chongqing Youth Science and Technology Talent Training Project (cstc2014kjrc-qnrc80001), and the municipal graduate student research innovation project of Chongqing (no. CYB2015066).	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; Arakane Y, 2012, PLOS GENET, V8, P612, DOI 10.1371/journal.pgen.1002682; Brackenbury J, 1997, NATURE, V390, P453, DOI 10.1038/37253                                                                   ; Chaudhari SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003268; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Chen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134694; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dittmer NT, 2015, INSECT BIOCHEM MOLEC, V62, P100, DOI 10.1016/j.ibmb.2014.12.010; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Futahashi R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-46; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hossie TJ, 2015, P NATL ACAD SCI USA, V112, P6664, DOI 10.1073/pnas.1415121112; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Janssen JM, 2001, EVOL DEV, V3, P415, DOI 10.1046/j.1525-142X.2001.01046.x                                                ; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; KANEKATSU R, 1988, Journal of Sericultural Science of Japan, V57, P151; Kawahara AY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0970; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Soares MPM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-576; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Moussian B., 2016, EXTRACELLULAR COMPOS; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Nakato H, 1997, INSECT BIOCHEM MOLEC, V27, P701, DOI 10.1016/S0965-1748(97)00048-9; NAKATO H, 1994, BBA-GENE STRUCT EXPR, V1218, P64, DOI 10.1016/0167-4781(94)90101-5; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; O''Hanlon JC, 2014, AM NAT, V183, P126, DOI 10.1086/673858; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Oota Keisuke, 1993, Journal of Sericultural Science of Japan, V62, P448; Osanai-Futahashi M, 2016, HEREDITY, V116, P135, DOI 10.1038/hdy.2015.74; Osanai-Futahashi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2312; Ozsu N, 2017, DEV BIOL, V429, P177, DOI 10.1016/j.ydbio.2017.06.030; Pan C, 2014, BIOCHEM BIOPH RES CO, V447, P237, DOI 10.1016/j.bbrc.2014.03.093; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Prudic KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1531; Qiao L, 2014, GENETICS, V196, P1103, DOI 10.1534/genetics.113.158766; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Shirataki H, 2010, EVOL DEV, V12, P305, DOI 10.1111/j.1525-142X.2010.00416.x; Shofuda K, 1999, COMP BIOCHEM PHYS B, V122, P105, DOI 10.1016/S0305-0491(98)10151-7; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Tajiri R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006548; Tan D, 2016, INSECT MOL BIOL, V25, P93, DOI 10.1111/imb.12205; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Wu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26114; Yamaguchi Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3063; Yang CH, 2017, INSECT BIOCHEM MOLEC, V83, P94, DOI 10.1016/j.ibmb.2017.03.003; Yi HS, 2014, BIOCHEM BIOPH RES CO, V445, P100, DOI 10.1016/j.bbrc.2014.01.139; Yoda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5936; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	61	0	0	8	8	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	2017	207	3					1053	1066		10.1534/genetics.117.300300				14	Genetics & Heredity	Genetics & Heredity	FL5HR	WOS:000414265000017	28923848				2018-01-05	
J	McCaffrey, J; Young, E; Lassahn, K; Sibert, J; Pastor, S; Riethman, H; Xiao, M				McCaffrey, Jennifer; Young, Eleanor; Lassahn, Katy; Sibert, Justin; Pastor, Steven; Riethman, Harold; Xiao, Ming			High-throughput single-molecule telomere characterization	GENOME RESEARCH			English	Article							HUMAN-CELLS; NANOCHANNEL ARRAYS; LENGTH; SYSTEM; CHROMOSOMES; INSTABILITY; LEUKEMIA; DISEASE; FUSION	We have developed a novel method that enables global subtelomere and haplotype-resolved analysis of telomere lengths at the single-molecule level. An in vitro CRISPR/Cas9 RNA-directed nickase system directs the specific labeling of human (TTAGGG) n DNA tracts in genomes that have also been barcoded using a separate nickase enzyme that recognizes a 7bp motif genome-wide. High-throughput imaging and analysis of large DNA single molecules from genomes labeled in this fashion using a nanochannel array system permits mapping through subtelomere repeat element (SRE) regions to unique chromosomal DNA while simultaneously measuring the (TTAGGG) n tract length at the end of each large telomere- terminal DNA segment. The methodology also permits subtelomere and haplotype-resolved analyses of SRE organization and variation, providing a window into the population dynamics and potential functions of these complex and structurally variant telomere-adjacent DNA regions. At its current stage of development, the assay can be used to identify and characterize telomere length distributions of 30-35 discrete telomeres simultaneously and accurately. The assay's utility is demonstrated using early versus late passage and senescent human diploid fibroblasts, documenting the anticipated telomere attrition on a global telomere-by-telomere basis as well as identifying subtelomere-specific biases for critically short telomeres. Similarly, we present the first global single-telomere-resolved analyses of two cancer cell lines.	[McCaffrey, Jennifer; Young, Eleanor; Sibert, Justin; Pastor, Steven; Xiao, Ming] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Lassahn, Katy; Riethman, Harold] Old Dominion Univ, Med Diagnost & Translat Sci, Norfolk, VA 23529 USA; [Xiao, Ming] Drexel Univ, Inst Mol Med & Infect Dis, Sch Med, Philadelphia, PA 19129 USA	Xiao, M (reprint author), Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.; Riethman, H (reprint author), Old Dominion Univ, Med Diagnost & Translat Sci, Norfolk, VA 23529 USA.; Xiao, M (reprint author), Drexel Univ, Inst Mol Med & Infect Dis, Sch Med, Philadelphia, PA 19129 USA.	hriethma@odu.edu; ming.xiao@drexel.edu			FV7[L;]9; US National Institutes of Health (NIH) [R21HG007205, R21CA177395]; Drexel's University Research Computing Facility	This research is supported in part by US National Institutes of Health (NIH) grants to H.R. and M.X. (R21HG007205 and R21CA177395). Part of the informatics analysis was run on hardware supported by Drexel's University Research Computing Facility.	Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Britt-Compton B, 2006, HUM MOL GENET, V15, P725, DOI 10.1093/hmg/ddi486; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47                                                           ; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Gutierrez-Rodrigues F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113747; INGLEHEARN CF, 1990, NUCLEIC ACIDS RES, V18, P471, DOI 10.1093/nar/18.3.471                                                            ; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Kageyama Y, 1997, Int J Urol, V4, P407, DOI 10.1111/j.1442-2042.1997.tb00216.x; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Lin TT, 2014, BRIT J HAEMATOL, V167, P214, DOI 10.1111/bjh.13023; Lynch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146723; Mak ACY, 2016, GENETICS, V202, P351, DOI 10.1534/genetics.115.183483; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1749, DOI 10.1093/ije/dyv171; McCaffrey J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv878; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; Perner S, 2003, AM J PATHOL, V163, P1751, DOI 10.1016/S0002-9440(10)63534-1; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roger L, 2013, JNCI-J NATL CANCER I, V105, P1202, DOI 10.1093/jnci/djt191; Sabatier L, 2005, MOL CANCER RES, V3, P139, DOI 10.1158/1541-7786.MCR-04-0194                                                   ; Samassekou O, 2010, ANN ANAT, V192, P284, DOI 10.1016/j.aanat.2010.07.005; Samassekou O, 2009, NEOPLASIA, V11, P1146, DOI 10.1593/neo.09836; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Simpson K, 2015, MOL ONCOL, V9, P1186, DOI 10.1016/j.molonc.2015.02.003; Stong N, 2014, GENOME RES, V24, P1039, DOI 10.1101/gr.166983.113; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462                                                           ; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; YOUNGMAN S, 1992, GENOMICS, V14, P350, DOI 10.1016/S0888-7543(05)80225-3; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	45	0	0	6	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2017	27	11					1904	1915		10.1101/gr.222422.117				12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FL3ZP	WOS:000414165900011	29025896				2018-01-05	
J	VandenDriessche, T; Chuah, MK				VandenDriessche, Thierry; Chuah, Marinee K.			Hemophilia Gene Therapy: Ready for Prime Time?	HUMAN GENE THERAPY			English	Review						factor IX; factor VIII; coagulation; hemophilia; AAV; lentiviral; CRISPR; ZFN; factor IX Padua	COAGULATION-FACTOR-IX; ADENOASSOCIATED VIRAL VECTORS; HUMAN-FACTOR-VIII; SUSTAINED PHENOTYPIC CORRECTION; HIGH-LEVEL EXPRESSION; LONG-TERM EXPRESSION; REGULATORY T-CELLS; IN-VIVO; LENTIVIRAL VECTORS; B DOGS	Hemophilia A and B are congenital, X-linked bleeding disorders caused by mutations in the genes encoding for the blood clotting factor VIII (FVIII) or factor IX (FIX), respectively. Since the beginning of gene therapy, hemophilia has been considered an attractive disease target that served as a trailblazer for the field at large. Different technologies have been explored to efficiently and safely deliver the therapeutic FVIII and FIX genes into the patients' cells. Currently, the most promising vectors for hemophilia gene therapy are adeno-associated viral vectors (AAVs) and lentiviral vectors. More recently, gene editing approaches based on designer nucleases or CRISPR/Cas, have also been considered to minimize risks associated with random vector integration and insertional mutagenesis though off-target issues would have to be carefully and comprehensively assessed. In the past two decades, several phase 1 hemophilia gene therapy clinical trials have been initiated with varying success. In particular, the early gene therapy clinical trials in hemophilia B patients based on AAV showed either transient or subtherapeutic clotting factor expression levels. This could be ascribed, at least in part, to suboptimal vector design and/or inadvertent immune consequences triggering hepatic inflammation. Hence, there was an unmet need to further increase vector safety and efficacy in future trials, preferably by using lower vector doses. It is particularly encouraging that sustained therapeutic FVIII and FIX expression levels have recently been attained after gene therapy in patients with severe hemophilia paving the way towards pivotal trials and commercialization. Nevertheless, transient liver toxicity still occurs and the use of transient immunosuppression was still required to curtail inadvertent immune responses, especially at high vector doses. To further boost clotting factor expression levels, codon-usage optimized synthetic FVIII or FIX transgenes have been employed. Alternatively, we and others have shown that the incorporation of hyperactive gain-of-function R338L mutation in the FIX gene substantially increased the overall efficacy. It is inevitable that the continued improvements in vector engineering and new insights in the vector-patient interactions will further benefit the development of a safe and effective cure for hemophilia A and B.	[VandenDriessche, Thierry; Chuah, Marinee K.] Free Univ Brussels VUB, Dept Gene Therapy & Regenerat Med, Brussels, Belgium; [VandenDriessche, Thierry; Chuah, Marinee K.] Univ Leuven, Dept Cardiovasc Sci, Ctr Mol & Vasc Biol, Leuven, Belgium	VandenDriessche, T; Chuah, MK (reprint author), Free Univ Brussels, Dept Gene Therapy & Regenerat Med, Fac Med & Pharm, Bldg D,Room D306,Laarbeeklaan 103, B-1090 Brussels, Belgium.	thierry.vandendriessche@vub.ac.be; marinee.chuah@vub.ac.be			Fonds voor Wetenschappelijk Onderzoek (FWO); Shire; Bayer; Pfizer; Agentschap voor Innovatie door Wetenschap en Technologie (IWT); Vrije Universiteit Brussel Industrieel Onderzoeksfonds Groups of Excellence in Applied Research (VUB-IOF-GEAR) (GENEFIX); Strategic Research Program (SRP)-Groeier; Willy Gepts Fund	We thank the members of the Department of Gene Therapy and Regenerative Medicine and all of our collaborators for their various contributions to portions of the work presented in this review. We also wish to thank Fonds voor Wetenschappelijk Onderzoek (FWO), Shire, Bayer, Pfizer, Agentschap voor Innovatie door Wetenschap en Technologie (IWT), Vrije Universiteit Brussel Industrieel Onderzoeksfonds Groups of Excellence in Applied Research (VUB-IOF-GEAR) (GENEFIX), Strategic Research Program (SRP)-Groeier, and the Willy Gepts Fund for providing financial support.	Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Annoni A, 2013, EMBO MOL MED, V5, P1684, DOI 10.1002/emmm.201302857; Annoni A, 2009, BLOOD, V114, P5152, DOI 10.1182/blood-2009-04-214569; Arruda VR, 2010, BLOOD, V115, P4678, DOI 10.1182/blood-2009-12-261156; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Berns KI, 2015, HUM GENE THER, V26, P779, DOI 10.1089/hum.2015.29014.kib; Brown BD, 2004, BLOOD, V103, P804, DOI 10.1182/blood-2003-05-1426; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown HC, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.36; Brunetti-Pierri N, 2009, MOL THER, V17, P327, DOI 10.1038/mt.2008.257; Buchlis G, 2012, BLOOD, V119, P3038, DOI 10.1182/blood-2011-09-382317; Buning H, 2015, MOL THER, V23, P1673, DOI 10.1038/mt.2015.182; Cantore A, 2015, SCI TRANSL MED, V7, DOI DOI 10.1126/SCITRANSLMED.AAA1405; Cantore A, 2012, BLOOD, V120, P4517, DOI 10.1182/blood-2012-05-432591; Cao O, 2009, J THROMB HAEMOST, V7, P88, DOI 10.1111/j.1538-7836.2009.03417.x; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chuah MK, 2014, MOL THER, V22, P1605, DOI 10.1038/mt.2014.114; Chuah MK, 2012, HUM GENE THER, V23, P557, DOI 10.1089/hum.2012.088; CHUAH MKL, 1995, HUM GENE THER, V6, P1363, DOI 10.1089/hum.1995.6.11-1363                                                      ; Chuah MKL, 2003, BLOOD, V101, P1734, DOI 10.1182/blood-2002-03-0823; Chuah MKL, 2001, J GENE MED, V3, P3, DOI 10.1002/1521-2254(200101/02)3:1<3::AID-JGM167>3.0.CO;2-H                        ; Crudele JM, 2015, BLOOD, V125, P1553, DOI 10.1182/blood-2014-07-588194; Di Matteo M, 2014, MOL THER, V22, P1614, DOI 10.1038/mt.2014.131; Dobrzynski E, 2006, P NATL ACAD SCI USA, V103, P4592, DOI 10.1073/pnas.0508685103; Doering CB, 2009, MOL THER, V17, P1145, DOI 10.1038/mt.2009.35; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Du LM, 2013, NAT COMMUN, V4, P2773; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Finn JD, 2012, BLOOD, V120, P4521, DOI 10.1182/blood-2012-06-440123; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Hartmann J, 2016, AM J HEMATOL, V91, P1252, DOI 10.1002/ajh.24543; Herzog RW, 1999, NAT MED, V5, P56; Herzog RW, 2001, MOL THER, V4, P192, DOI 10.1006/mthe.2001.0442; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804                                                         ; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; Kaufman RJ, 1997, BLOOD COAGUL FIBRIN, V8, pS3; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kren BT, 2009, J CLIN INVEST, V119, P2086, DOI 10.1172/JCI34332; Kuether EL, 2012, J THROMB HAEMOST, V10, P1570, DOI 10.1111/j.1538-7836.2012.04791.x; Lange AM, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.64; Levy C, 2016, J THROMB HAEMOST, V14, P2478, DOI 10.1111/jth.13520; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Lillicrap D, 2006, HAEMOPHILIA, V12, P36, DOI 10.1111/j.1365-2516.2006.01259.x; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Logan GJ, 2017, NAT GENET, V49, P1267, DOI 10.1038/ng.3893; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Markusic DM, 2013, EMBO MOL MED, V5, P1698, DOI 10.1002/emmm.201302859; Martino AT, 2013, BLOOD, V121, P2224, DOI 10.1182/blood-2012-10-460733; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Matrai J, 2010, CURR OPIN HEMATOL, V17, P387, DOI 10.1097/MOH.0b013e32833cd4bd; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Matsui H, 2009, BLOOD, V114, P677, DOI 10.1182/blood-2009-03-202267; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McIntosh J, 2013, BLOOD, V121, P3335, DOI 10.1182/blood-2012-10-462200; Merlin S, 2017, MOL THER, V25, P1815, DOI 10.1016/j.ymthe.2017.04.029; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Monahan PE, 2015, HUM GENE THER, V26, P69, DOI 10.1089/hum.2014.106; Montgomery RR, 2012, THROMB RES, V129, pS46, DOI 10.1016/j.thromres.2012.02.031; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Nair N, 2014, BLOOD, V123, P3195, DOI 10.1182/blood-2013-10-534032; Nathwani AC, 2002, BLOOD, V100, P1662, DOI 10.1182/blood-2002-02-0589; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Nguyen GN, 2017, J THROMB HAEMOST, V15, P110, DOI 10.1111/jth.13543; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Pien GC, 2009, J CLIN INVEST, V119, P1688, DOI 10.1172/JCI36891; Pierce GF, 2007, J THROMB HAEMOST, V5, P901, DOI 10.1111/j.1538-7836.2007.02410.x                                                ; PITTMAN DD, 1993, BLOOD, V81, P2925; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301; Sabatino DE, 2011, MOL THER, V19, P442, DOI 10.1038/mt.2010.240; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; Sarkar R, 2003, J THROMB HAEMOST, V1, P220, DOI 10.1046/j.1538-7836.2003.00096.x; Scallan CD, 2003, BLOOD, V102, P2031, DOI 10.1182/blood-2003-01-0292; Schuettrumpf J, 2005, BLOOD, V105, P2316, DOI 10.1182/blood-2004-08-2990; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shi Q, 2007, J THROMB HAEMOST, V5, P352, DOI 10.1111/j.1538-7836.2007.02346.x                                                ; Shi Q, 2015, J THROMB HAEMOST, V13, P1301, DOI 10.1111/jth.13001; Simioni P, 2009, NEW ENGL J MED, V361, P1671, DOI 10.1056/NEJMoa0904377; Siner JI, 2013, BLOOD, V121, P4396, DOI 10.1182/blood-2012-10-464164; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Snyder RO, 1999, NAT MED, V5, P64; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; VandenDriessche T, 2012, HUM GENE THER, V23, P4, DOI 10.1089/hum.2011.221; VandenDriessche T, 2003, BLOOD, V102, P1938; VandenDriessche T, 1999, P NATL ACAD SCI USA, V96, P10379, DOI 10.1073/pnas.96.18.10379; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813                                                        ; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x                                                ; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; Wang L, 2005, GENE THER, V12, P1453, DOI 10.1038/sj.gt.3302539; Wang LL, 2000, MOL THER, V1, P154, DOI 10.1006/mthe.2000.0031; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; Wang LX, 2005, CURR GENE THER, V5, P349, DOI 10.2174/1566523054065048; Wang XF, 2015, MOL THER, V23, P617, DOI 10.1038/mt.2015.20; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Wu Z, 2008, MOL THER, V16, P280, DOI 10.1038/sj.mt.6300355; Xu LF, 2005, P NATL ACAD SCI USA, V102, P6080, DOI 10.1073/pnas.0409249102; Xu LF, 2003, BLOOD, V101, P3924, DOI 10.1182/blood-2002-10-3050; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	112	0	0	12	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV	2017	28	11					1013	1023		10.1089/hum.2017.116				11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FJ8XS	WOS:000413052500014	28793786				2018-01-05	
J	Mussolino, C; Alzubi, J; Pennucci, V; Turchiano, G; Cathomen, T				Mussolino, Claudio; Alzubi, Jamal; Pennucci, Valentina; Turchiano, Giandomenico; Cathomen, Toni			Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System	HUMAN GENE THERAPY			English	Review						designer nucleases; SCID; sickle cell anemia; thalassemia; CAR T cells	SICKLE-CELL-DISEASE; ENGINEERED T-CELLS; GENE-THERAPY; BETA-HEMOGLOBINOPATHIES; FETAL-HEMOGLOBIN; PRIMARY IMMUNODEFICIENCY; DNA METHYLATION; STEM-CELLS; CAR; EXPRESSION	The possibility of editing complex genomes in a targeted fashion has revolutionized basic research as well as biomedical and biotechnological applications in the last 5 years. The targeted introduction of genetic changes has allowed researchers to create smart model systems for basic research, bio-engineers to modify crops and farm animals, and translational scientists to develop novel treatment approaches for inherited and acquired disorders for which curative treatment options are not yet available. With the rapid development of genome editing tools, in particular zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the CRISPR-Cas system, a wide range of therapeutic options have beenand will bedeveloped at an unprecedented speed, which will change the clinical routine of various disciplines in a revolutionary way. This review summarizes the fundamentals of genome editing and the current state of research. It particularly focuses on the advances made in employing engineered nucleases in hematopoietic stem cells for the treatment of primary immunodeficiencies and hemoglobinopathies, provides a perspective of combining gene editing with the chimeric antigen receptor T cell technology, and concludes by presenting targeted epigenome editing as a novel potential treatment option.	[Mussolino, Claudio; Alzubi, Jamal; Pennucci, Valentina; Turchiano, Giandomenico; Cathomen, Toni] Univ Freiburg, Inst Transfus Med & Gene Therapy, Med Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany; [Mussolino, Claudio; Alzubi, Jamal; Pennucci, Valentina; Turchiano, Giandomenico; Cathomen, Toni] Univ Freiburg, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany	Cathomen, T (reprint author), Univ Freiburg, Inst Transfus Med & Gene Therapy, Med Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany.	toni.cathomen@uniklinik-freiburg.de		Cathomen, Toni/0000-0002-7757-4630	Federal Ministry of Education and Research [IFB-01EO0803, iMACnet-01EK1602B, HBV-TALE-01DG15005]; German Research Foundation [SFB1160-TP17]; European Commission [SCIDNET-666908, CARAT-667980]; Marie Sklodowska-Curie Innovative Training Networks [IMGENE-765269]; Casebia Therapeutics [CAU-950-20140702]; Cellectis [ZVS20170614]; German Academic Exchange Service	We thank the members of the laboratory for helpful discussions. Current research in the lab is supported by the Federal Ministry of Education and Research (IFB-01EO0803; iMACnet-01EK1602B; HBV-TALE-01DG15005), the German Research Foundation (SFB1160-TP17), the European Commission's Horizon 2020 Program (SCIDNET-666908; CARAT-667980), the Marie Sklodowska-Curie Innovative Training Networks (IMGENE-765269), Casebia Therapeutics (CAU-950-20140702), Cellectis (ZVS20170614), and the German Academic Exchange Service.	Abken H, 2015, IMMUNOTHERAPY-UK, V7, P535, DOI [10.2217/IMT.15.15, 10.2217/imt.15.15]; Aiuti A, 2017, EMBO MOL MED, V9, P737, DOI 10.15252/emmm.201707573; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Booth C, 2016, TRENDS MOL MED, V22, P317, DOI 10.1016/j.molmed.2016.02.002; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Breda L, 2016, BLOOD, V128, P1139, DOI 10.1182/blood-2016-01-691089; Brendel C, 2016, J CLIN INVEST, V126, P3868, DOI 10.1172/JCI87885; Brown MP, 1998, NAT MED, V4, P1253, DOI 10.1038/3233; Cavazzana M, 2017, MOL THER, V25, P1142, DOI 10.1016/j.ymthe.2017.03.024; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; Dawson MA, 2017, SCIENCE, V355, P1147, DOI 10.1126/science.aam7304; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Esteller Manel, 2011, F1000 Biol Rep, V3, P9, DOI 10.3410/B3-9; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Falahi F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00022; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Haas SA, 2017, HAMOSTASEOLOGIE, V37, P45, DOI 10.5482/HAMO-16-09-0035; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hale M, 2017, MOL THER, V25, P570, DOI 10.1016/j.ymthe.2016.12.023; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Horsthemke B, 2008, ADV GENET, V61, P225, DOI 10.1016/S0065-2660(07)00008-9; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kohne E, 2011, DTSCH ARZTEBL INT, V108, P532, DOI 10.3238/arztebl.2011.0532; Kubota T, 2013, EPIGENOMICS-UK, V5, P583, DOI 10.2217/epi.13.54; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl035; MacLeod DT, 2017, MOL THER, V25, P949, DOI 10.1016/j.ymthe.2017.02.005; Mastaglio S, 2017, BLOOD, V130, P606, DOI 10.1182/blood-2016-08-732636; Menger L, 2016, CANCER RES, V76, P2087, DOI 10.1158/0008-5472.CAN-15-3352; Mlambo T, 2017, MOL THER, V25, P297; Mussolino C, 2015, CURR OPIN PHARMACOL, V24, P105, DOI 10.1016/j.coph.2015.08.008; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Ren JT, 2017, ONCOTARGET, V8, P17002, DOI 10.18632/oncotarget.15218; Sadelain M, 2016, CURR OPIN IMMUNOL, V41, P68, DOI 10.1016/j.coi.2016.06.004; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thrasher AJ, 2017, MOL THER, V25, P1132, DOI 10.1016/j.ymthe.2017.03.018; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Urnov FD, 2001, J MAMMARY GLAND BIOL, V6, P153, DOI 10.1023/A:1011304606604; WAINSCOAT JS, 1985, ANN NY ACAD SCI, V445, P20, DOI 10.1111/j.1749-6632.1985.tb17171.x; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529                                                 ; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Yamanaka YJ, 2013, TRENDS IMMUNOL, V34, P59, DOI 10.1016/j.it.2012.10.006; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YP, 2017, FRONT MED-PRC, V11, P554, DOI 10.1007/s11684-017-0543-6	79	0	0	18	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV	2017	28	11					1105	1115		10.1089/hum.2017.149				11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FJ8XS	WOS:000413052500021	28806883				2018-01-05	
J	Wills, ES; te Morsche, RHM; van Reeuwijk, J; Horn, N; Geomini, I; van de Laarschot, LFM; Mans, DA; Ueffing, M; Boldt, K; Drenth, JPH; Roepman, R				Wills, Edgar S.; te Morsche, Rene H. M.; van Reeuwijk, Jeroen; Horn, Nicola; Geomini, Iris; van de laarschot, Liyanne F. M.; Mans, Dorus A.; Ueffing, Marius; Boldt, Karsten; Drenth, Joost P. H.; Roepman, Ronald			Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling	HUMAN MOLECULAR GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; BETA-CATENIN; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; MEMBRANE-PROTEINS; PKD2 MUTATIONS; 2-HIT MODEL; GLYCOSYLATION; NUCLEOREDOXIN; CYSTOGENESIS	Mutations in the PRKCSH, SEC63 and LRP5 genes cause autosomal dominant polycystic liver disease (ADPLD). The proteins products of PRKCSH (alias GIIB) and SEC63 function in protein quality control and processing in the endoplasmic reticulum(ER), while LRP5 is implicated inWnt/beta-catenin signaling. To identify common denominators in the PLD pathogenesis, we mapped the PLD interactome by affinity proteomics, employing both HEK293T cells and H69 cholangiocytes. Identification of known complex members, such as glucosidase IIA (GIIA) for PRKCSH, and SEC61A1 and SEC61B for SEC63, confirmed the specificity of the analysis. GANAB, encoding GIIA, was very recently identified as an ADPLD gene. The presence of GIIA in the LRP5 complex pinpoints a potential functional connection with PRKCSH. Interestingly, all three PLD-associated protein complexes included filamin A (FLNA), amultifunctional protein described to play a role in ciliogenesis as well as canonical Wnt signalling. As ciliary dysfunction may also contribute to hereditary liver cyst formation, we evaluated the requirement of PRKCSH and SEC63 for ciliogenesis and Wnt signaling. By CRISPR/Cas9 induced knockdown of both ADPLD genes in HEK293T cells and H69 cholangiocytes, we identified that their depletion results in defective ciliogenesis. However, only H69 knockouts displayed reduced Wnt3a activation. Our results suggest that loss of PRKCSH and SEC63 leads to general defects in ciliogenesis, while quenching of the Wnt signaling cascade is cholangiocyte-restricted. Interactions of all three PLD-associated protein complexes with FLNA may mark a common link between the ADPLD proteins and the cystogenic processes driving this disease.	[Wills, Edgar S.; te Morsche, Rene H. M.; Geomini, Iris; van de laarschot, Liyanne F. M.; Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands; [van Reeuwijk, Jeroen; Mans, Dorus A.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [van Reeuwijk, Jeroen; Mans, Dorus A.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Insitute Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Horn, Nicola; Ueffing, Marius; Boldt, Karsten] Eberhard Karls Univ Tubingen, Ctr Ophthalmol, Div Expt Ophthalmol & Med Bioanalyt, D-72076 Tubingen, Germany	Drenth, JPH (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands.	joost.drenth@radboudumc.nl			Radboud University Medical Center; Netherlands Organisation for Scientific Research [Vici-865.12.005]; European Community's Seventh Framework Programme, SYSCILIA [241955]	This work was supported by an institutional grant of the Radboud University Medical Center (to J.P.H.D. and R.R.), by the Netherlands Organisation for Scientific Research (Vici-865.12.005 to R.R.) and by the European Community's Seventh Framework Programme FP7/2009 under grant agreement no: 241955, SYSCILIA (to R.R.).	Adams M, 2012, HUM MOL GENET, V21, P1272, DOI 10.1093/hmg/ddr557; Ahn VE, 2011, DEV CELL, V21, P862, DOI [10.1016/j.devce1.2011.09.003, 10.1016/j.devcel.2011.09.003]; Alvaro D, 2008, MOL ASPECTS MED, V29, P50, DOI 10.1016/j.mam.2007.09.007; Alvaro D, 2008, AM J PATHOL, V172, P321, DOI 10.2353/ajpath.2008.070293; Besse W, 2017, J CLIN INVEST, V127, P1772, DOI 10.1172/JCI90129; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Boldt K, 2009, METHOD CELL BIOL, V91, P143, DOI 10.1016/S0091-679X(08)91009-8; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267; Cnossen WR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-69; Cnossen WR, 2014, P NATL ACAD SCI USA, V111, P5343, DOI 10.1073/pnas.1309438111; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Fedeles SV, 2014, TRENDS MOL MED, V20, P251, DOI 10.1016/j.molmed.2014.01.004; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fischer E, 2004, NEPHROL DIAL TRANSPL, V19, P2700, DOI 10.1093/ndt/gfh533                                                              ; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gloeckner C. J., 2009, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS1920S57; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025                                                      ; Janssen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050324; Janssen MJ, 2011, GASTROENTEROLOGY, V141, P2056, DOI 10.1053/j.gastro.2011.08.004; Janssen MJ, 2010, J HEPATOL, V52, P432, DOI 10.1016/j.jhep.2009.12.011; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Jung H, 2011, BIOCHEM J, V436, P263, DOI 10.1042/BJ20101512; Jung SJ, 2014, J CELL SCI, V127, P4270, DOI 10.1242/jcs.153650; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Mades A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049243; Masyuk AI, 2008, DEV DYNAM, V237, P2007, DOI 10.1002/dvdy.21530; Masyuk T, 2009, CURR OPIN GASTROEN, V25, P265, DOI 10.1097/MOG.0b013e328328f4ff; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Muller L, 2011, FEBS LETT, V585, P596, DOI 10.1016/j.febslet.2011.01.024; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0                                                   ; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2                                                   ; Porath B, 2016, AM J HUM GENET, V98, P1193, DOI 10.1016/j.ajhg.2016.05.004; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sengupta PK, 2013, J CELL SCI, V126, P484, DOI 10.1242/jcs.113035; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steinberg S. J., 2003, GENE REV, P1993; Texier Y, 2014, MOL CELL PROTEOMICS, V13, P1382, DOI 10.1074/mcp.O113.033233; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Waanders E, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9441; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123018; Watnick T, 2000, NAT GENET, V25, P143; Wills ES, 2014, TRENDS MOL MED, V20, P261, DOI 10.1016/j.molmed.2014.01.003; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538	57	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	NOV 1	2017	26	21					4190	4202		10.1093/hmg/ddx308				13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FK4HU	WOS:000413453900009	28973524				2018-01-05	
J	Gao, WJ; Chen, C; Zhou, TF; Yang, SL; Gao, B; Zhou, H; Lian, CJ; Wu, ZZ; Qiu, XJ; Yang, XM; Alattar, E; Liu, WT; Su, DY; Sun, SL; Chen, YL; Cheung, KMC; Song, YQ; Luk, KKD; Chan, D; Sham, PC; Xing, C; Khor, CC; Liu, G; Yang, JL; Deng, YB; Hao, DJ; Huang, DS; Li, QZ; Xu, CX; Su, PQ				Gao, Wenjie; Chen, Chong; Zhou, Taifeng; Yang, Shulan; Gao, Bo; Zhou, Hang; Lian, Chengjie; Wu, Zizhao; Qiu, Xianjian; Yang, Xiaoming; Alattar, Esam; Liu, Wentao; Su, Deying; Sun, Silong; Chen, Yulan; Cheung, Kenneth M. C.; Song, Youqiang; Luk, Keith K. D.; Chan, Danny; Sham, Pak Chung; Xing, Chao; Khor, Chiea Chuen; Liu, Gabriel; Yang, Junlin; Deng, Yubin; Hao, Dingjun; Huang, Dongsheng; Li, Quan-Zhen; Xu, Caixia; Su, Peiqiang			Rare coding variants in MAPK7 predispose to adolescent idiopathic scoliosis	HUMAN MUTATION			English	Article						adolescent idiopathic scoliosis; CRISPR/Cas9; MAPK7; whole-exome sequencing; zebrafish	GENOME-WIDE ASSOCIATION; GENE; ASSIGNMENT; LOCATION; LOCI	Adolescent idiopathic scoliosis (AIS) is a complex genetic disorder characterized by three-dimensional spinal curvatures, affecting 2%-3% of school age children, yet the causes underlying AIS are not well understood. Here, we first conducted a whole-exome sequencing and linkage analysis on a three-generation Chinese family with autosomal-dominant (AD) AIS, and then performed targeted sequencing in a discovery cohort comprising 20 AD AIS families and 86 simplex patients, and finally identified three disease-associated missense variants (c.886G>A, c.1943C>T, and c.1760C>T) in the MAPK7 gene (encoding mitogen-activated protein kinase 7). Genotyping of the three rare variants in a Chinese replication cohort comprising 1,038 simplex patients and 1,841 controls showed that their combined allele frequency was significantly over-represented in patients as compared with controls (2.0% [41/2,076] vs. 0.7% [27/3,682]; odds ratio = 2.7; P=2.8 x 10(-5)). In vitro, we demonstrated that the three MAPK7 mutants disrupted nuclear translocation in cellular models, which is necessary for the normal function of MAPK7. In vivo, we also conducted CRISPR/Cas9-mediated deletion of mapk7 in zebrafish recapitulating the characteristic phenotype of idiopathic scoliosis. Taken together, our findings suggest that rare coding variants in MAPK7 predispose to AIS, providing clues to understanding the mechanisms of AIS.	[Gao, Wenjie; Chen, Chong; Zhou, Taifeng; Zhou, Hang; Yang, Xiaoming; Alattar, Esam; Liu, Wentao; Su, Deying; Yang, Junlin; Su, Peiqiang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Gao, Wenjie; Chen, Chong; Zhou, Taifeng; Zhou, Hang; Yang, Xiaoming; Alattar, Esam; Liu, Wentao; Su, Deying; Yang, Junlin; Su, Peiqiang] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab ofOrthoped & Traumatol, Guangzhou, Guangdong, Peoples R China; [Xu, Caixia] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Gao, Wenjie; Hao, Dingjun] Xi An Jiao Tong Univ, Xian Honghui Hosp, Dept Spine Surg, Xian, Shaanxi, Peoples R China; [Chen, Chong] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing, Peoples R China; [Chen, Chong] Chinese Acad Med Sci, Beijing, Peoples R China; [Gao, Bo; Lian, Chengjie; Wu, Zizhao; Qiu, Xianjian; Huang, Dongsheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Spine Surg, Guangzhou, Guangdong, Peoples R China; [Sun, Silong; Chen, Yulan] BGI Shenzhen, Shenzhen, Peoples R China; [Cheung, Kenneth M. C.; Luk, Keith K. D.] Univ Hong Kong, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Chan, Danny] Univ Hong Kong, Dept Biochem, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Khor, Chiea Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Liu, Gabriel] Natl Univ Singapore Hosp, Univ Spine Ctr, Dept Orthopaed Surg, Singapore, Singapore; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX USA; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core& Genom Facil, Dallas, TX 75390 USA	Su, PQ (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	xucx3@mail.sysu.edu.cn; supq@mail.sysu.edu.cn		Xing, Chao/0000-0002-1838-0502	National Natural Science Foundation of China [81371908, 81472039, 81572091, 81601898]; China Postdoctoral Science Foundation [2017M613177]; Program for New Century Excellent Talents in University [NCET-12-0564]; Fundamental Research Funds for the Central Universities; Sun Yat-Sen University [13YKPY23]	National Natural Science Foundation of China (Nos. 81371908, 81472039, 81572091, 81601898); the China Postdoctoral Science Foundation (No. 2017M613177); the Program for New Century Excellent Talents in University (NCET-12-0564); Fundamental Research Funds for the Central Universities; Young Teachers Fund of the Sun Yat-Sen University (13YKPY23).	Altaf F, 2013, BMJ-BRIT MED J, V346, pf2508; Borges J, 2007, CELL SIGNAL, V19, P1473, DOI 10.1016/j.cellsig.2007.01.023; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Cheng JC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.30; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Edery P, 2011, EUR J HUM GENET, V19, P865, DOI 10.1038/ejhg.2011.31; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588                                                        ; Gao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053234; Grimes DT, 2016, SCIENCE, V352, P1341, DOI 10.1126/science.aaf6419; Gurnett CA, 2009, SPINE, V34, pE94, DOI 10.1097/BRS.0b013e31818b88a5; Hresko MT, 2013, NEW ENGL J MED, V368, P834, DOI 10.1056/NEJMcp1209063; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kesling K. L., 1997, SPINE, V22; Kim HKW, 2013, SPINE, V38, pE1307, DOI 10.1097/BRS.0b013e3182a3d370; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Lennartsson J, 2010, CELL SIGNAL, V22, P955, DOI 10.1016/j.cellsig.2010.01.020; Li W, 2016, J MED GENET, V53, P488, DOI 10.1136/jmedgenet-2015-103684; Lian CJ, 2016, J PINEAL RES, V61, P317, DOI 10.1111/jpi.12349; Miller NH, 2005, SPINE, V30, P1181, DOI 10.1097/01.brs.0000162282.46160.0a                                              ; Miyake A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072802; Ocaka L, 2008, J MED GENET, V45, P87, DOI 10.1136/jmg.2007.051896; Oestreich AE, 1998, SKELETAL RADIOL, V27, P591, DOI 10.1007/s002560050445                                                           ; Ogura Y, 2015, AM J HUM GENET, V97, P337, DOI 10.1016/j.ajhg.2015.06.012; Patten SA, 2015, J CLIN INVEST, V125, P1124, DOI 10.1172/JCI77262; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006                                                ; Salehi LB, 2002, HUM GENET, V111, P401, DOI 10.1007/s00439-002-0785-4; Stevenson DA, 2011, AM J MED GENET C, V157C, P90, DOI 10.1002/ajmg.c.30296; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Ward K, 2010, AM J MED GENET A, V152A, P1178, DOI 10.1002/ajmg.a.33145; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24; Zhu ZZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9355	34	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	NOV	2017	38	11					1500	1510		10.1002/humu.23296				11	Genetics & Heredity	Genetics & Heredity	FJ6AL	WOS:000412835700008	28714182				2018-01-05	
J	Imran, A; Qamar, HY; Ali, Q; Naeem, H; Riaz, M; Amin, S; Kanwal, N; Ali, F; Sabar, MF; Nasir, IA				Imran, Aman; Qamar, Hafiza Yasara; Ali, Qurban; Naeem, Hafsa; Riaz, Mariam; Amin, Saima; Kanwal, Naila; Ali, Fawad; Sabar, Muhammad Farooq; Nasir, Idrees Ahmad			Role of Molecular Biology in Cancer Treatment: A Review Article	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Review						Cancer; Oncogenes; Proto-oncogenes; Mutagenesis; Viral infection; Tumor; CRISPR	ZINC-FINGER NUCLEASES; SIMIAN FOAMY VIRUS; TUMOR-SUPPRESSOR GENES; RETROVIRAL VECTORS; GENOME; THERAPY; ONCOGENES; CLEAVAGE; MICE; POPULATION	Background: Cancer is a genetic disease and mainly arises due to a number of reasons include activation of oncogenes, malfunction of tumor suppressor genes or mutagenesis due to external factors. Methods: This article was written from the data collected from PubMed, Nature, Science Direct, Springer and Elsevier groups of journals. Results: Oncogenes are deregulated form of normal proto-oncogenes required for cell division, differentiation and regulation. The conversion of proto-oncogene to oncogene is caused due to translocation, rearrangement of chromosomes or mutation in gene due to addition, deletion, duplication or viral infection. These oncogenes are targeted by drugs or RNAi system to prevent proliferation of cancerous cells. There have been developed different techniques of molecular biology used to diagnose and treat cancer, including retroviral therapy, silencing of oncogenes and mutations in tumor suppressor genes. Conclusion: Among all the techniques used, RNAi, zinc finger nucleases and CRISPR hold a brighter future towards creating a Cancer Free World.	[Imran, Aman; Qamar, Hafiza Yasara; Ali, Qurban; Naeem, Hafsa; Riaz, Mariam; Amin, Saima; Nasir, Idrees Ahmad] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; [Ali, Qurban] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan; [Kanwal, Naila; Ali, Fawad] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Ali, Fawad] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia; [Sabar, Muhammad Farooq] Univ Punjab, Ctr Appl Mol Biol, Lahore, Pakistan	Ali, Q (reprint author), Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan.; Ali, Q (reprint author), Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan.; Sabar, MF (reprint author), Univ Punjab, Ctr Appl Mol Biol, Lahore, Pakistan.	qurban.ali@cemb.edu.pk					Ahmed T, 2014, ADVAN LIFE SCI, V1, P96; Barquinero J, 2004, GENE THER, V11, pS3, DOI 10.1038/sj.gt.3302363; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Callahan ME, 1999, J VIROL, V73, P9619; Campbell JM, 2013, CIRC RES, V113, P571, DOI 10.1161/CIRCRESAHA.113.301765; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Diamandis EP, 1997, CLIN CHIM ACTA, V257, P157, DOI 10.1016/S0009-8981(96)06442-X; DIAMANDIS EP, 1992, CRIT REV CL LAB SCI, V29, P269, DOI 10.3109/10408369209114603; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Dudley JP, 2003, TRENDS MOL MED, V9, P43, DOI 10.1016/S1471-4914(03)00003-0; ENGLERT C, 1995, EMBO J, V14, P4662; Flintoft L, 2011, NAT REV GENET, V12, P380, DOI 10.1038/nrg3004; Gorga F, 1998, BRIDGEWATER REV, V17, P3; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Javed S, 2015, ADVAN LIFE SCI, V2, P115; Khan MT, 2015, ADVAN LIFE SCI, V2, P67; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Lopez-Chavez A, 2015, J CLIN ONCOL, V33, P1000, DOI 10.1200/JCO.2014.58.2007; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mao XY, 2016, ONCOTARGET, V7, P33461, DOI 10.18632/oncotarget.8075; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mergia A, 2001, VIROLOGY, V280, P243, DOI 10.1006/viro.2000.0773; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5                                                   ; Mikkers H, 2002, NAT GENET, V32, P153, DOI 10.1038/ng950; Ottolino-Perry K, 2010, MOL THER, V18, P251, DOI 10.1038/mt.2009.283; Park BH, 2003, CANC MED, V6, P87; Perry AR, 2001, NOSTRANDS SCI ENCY; Pierotti MA, 2003, HOLLAND FREI CANC ME; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Rethwilm A, 2007, CURR GENE THER, V7, P261; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schweizer M, 1997, J VIROL, V71, P4821; Sevik M, 2012, TURK J VET ANIM SCI, V36, P323, DOI 10.3906/vet-1104-2; Solly SK, 2003, CANCER GENE THER, V10, P30, DOI 10.1038/sj.cgt.7700521; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Sudhakar Akulapalli, 2009, J Cancer Sci Ther, V1, P1; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9                                                   ; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039; Wu X, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.32; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yi Y, 2011, CURR GENE THER, V11, P218	55	0	0	8	8	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	NOV	2017	46	11					1475	1485						11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	FL5MY	WOS:000414291100003	29167765				2018-01-05	
J	Tungadi, EA; Ito, A; Kiyomitsu, T; Goshima, G				Tungadi, Elsa A.; Ito, Ami; Kiyomitsu, Tomomi; Goshima, Gohta			Human microcephaly ASPM protein is a spindle pole-focusing factor that functions redundantly with CDK5RAP2	JOURNAL OF CELL SCIENCE			English	Article						Microcephaly; ASPM; CDK5RAP2; CEP215; Spindle pole focusing; Mitosis; Centrosome	CEREBRAL CORTICAL SIZE; TUBULIN RING COMPLEX; ABNORMAL-SPINDLE; MITOTIC SPINDLE; NEUROEPITHELIAL CELLS; BRAIN SIZE; CENTROSOME; MICROTUBULES; DROSOPHILA; ORGANIZATION	Nonsense mutations in the ASPM gene have been most frequently identified among familial microcephaly patients. Depletion of the Drosophila orthologue (asp) causes spindle pole unfocusing during mitosis in multiple cell types. However, it remains unknown whether human ASPM has a similar function. Here, by performing CRISPR-based gene knockout (KO) and RNA interference combined with auxin-inducible degron, we show that ASPM functions in spindle pole organisation during mitotic metaphase redundantly with another microcephaly protein, CDK5RAP2 (also called CEP215), in human tissue culture cells. Deletion of the ASPM gene alone did not affect spindle morphology or mitotic progression. However, when the pericentriolar material protein CDK5RAP2 was depleted in ASPM KO cells, spindle poles were unfocused during prometaphase, and anaphase onset was significantly delayed. The phenotypic analysis of CDK5RAP2-depleted cells suggested that the pole-focusing function of CDK5RAP2 is independent of its known function to localise the kinesin-14 motor HSET (also known as KIFC1) or activate the.-tubulin complex. Finally, a hypomorphic mutation identified in ASPM microcephaly patients similarly caused spindle pole unfocusing in the absence of CDK5RAP2, suggesting a possible link between spindle pole disorganisation and microcephaly.	[Tungadi, Elsa A.; Ito, Ami; Kiyomitsu, Tomomi; Goshima, Gohta] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Goshima, G (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	goshima@bio.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [17H01431]; Uehara Memorial Foundation; Takeda Science Foundation; JSPS	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (17H01431), the Uehara Memorial Foundation and Takeda Science Foundation (to G.G.). A. I. was a recipient of a JSPS pre-doctoral fellowship.	Abdel-Hamid MS, 2016, AM J MED GENET A, V170, P2133, DOI 10.1002/ajmg.a.37724; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Baumbach J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005261; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085                                                                  ; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Chavali PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11005; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fujimori A, 2014, BRAIN DEV-JPN, V36, P661, DOI 10.1016/j.braindev.2013.10.006; Gai M, 2016, EMBO REP, V17, P1396, DOI 10.15252/embr.201541823; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831; Ito A, 2015, J CELL BIOL, V211, P999, DOI 10.1083/jcb.201507001; Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056; Jiang K, 2017, NAT CELL BIOL, V19, P480, DOI 10.1038/ncb3511; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356                                                            ; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Rujano MA, 2013, NAT CELL BIOL, V15, P1294, DOI 10.1038/ncb2858; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881                                                           ; Schoborg T, 2015, J CELL BIOL, V211, P987, DOI 10.1083/jcb.201509054; Seldin L, 2016, ELIFE, V5, DOI 10.7554/eLife.12504; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Tan C, 2014, CLIN GENET, V85, P353, DOI 10.1111/cge.12172; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637                                                           ; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029                                                             	49	0	0	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	NOV 1	2017	130	21					3676	3684		10.1242/jcs.203703				9	Cell Biology	Cell Biology	FL3UF	WOS:000414149400010	28883092				2018-01-05	
J	Ghosh, S; Wallerath, C; Covarrubias, S; Hornung, V; Carpenter, S; Fitzgerald, KA				Ghosh, Sreya; Wallerath, Christina; Covarrubias, Sergio; Hornung, Veit; Carpenter, Susan; Fitzgerald, Katherine A.			The PYHIN Protein p205 Regulates the Inflammasome by Controlling Asc Expression	JOURNAL OF IMMUNOLOGY			English	Article							NF-KAPPA-B; MYELOID CELL-DIFFERENTIATION; DOUBLE-STRANDED-RNA; AIM2-LIKE RECEPTORS; COLORECTAL-CANCER; AIM2 INFLAMMASOME; INTRACELLULAR DNA; CYTOPLASMIC DNA; INNATE IMMUNITY; BREAST-CANCER	Members of the IFN-inducible PYHIN protein family, such as absent in melanoma-2 and IFN-gamma-inducible protein (IFI) 16, bind dsDNA and form caspase-1-activating inflammasomes that are important in immunity to cytosolic bacteria, DNA viruses, or HIV. IFI16 has also been shown to regulate transcription of type I IFNs during HSV infection. The role of other members of the PYHIN protein family in the regulation of immune responses is much less clear. In this study, we identified an immune-regulatory function for a member of the murine PYHIN protein family, p205 (also called Ifi205). Examination of immune responses induced by dsDNA and other microbial ligands in bone marrow-derived macrophages lacking p205 revealed that inflammasome activation by dsDNA, as well as ligands that engage the NLRP3 inflammasome, was severely compromised in these cells. Further analysis revealed that p205-knockdown cells showed reduced expression of apoptosis-associated speck-like molecule containing CARD domain (Asc) at the protein and RNA levels. p205 knockdown resulted in reduced binding of actively transcribing RNA polymerase II to the endogenous Asc gene, resulting in decreased transcription and processing of Asc pre-mRNA. Deletion of p205 in B16 melanoma cells using CRISPR/Cas9 showed a similar loss of Asc expression. Ectopic expression of p205 induced expression of an Asc promoter-luciferase reporter gene. Together, these findings suggest that p205 controls expression of Asc mRNA to regulate inflammasome responses. These findings expand on our understanding of immune-regulatory roles for the PYHIN protein family.	[Ghosh, Sreya; Fitzgerald, Katherine A.] Univ Massachusetts, Med Sch, Dept Med, Program Innate Immun, Worcester, MA 01605 USA; [Wallerath, Christina; Hornung, Veit] Ludwig Maximilian Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Wallerath, Christina; Hornung, Veit] Ludwig Maximilian Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Covarrubias, Sergio; Carpenter, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Fitzgerald, KA (reprint author), Univ Massachusetts, Med Sch, Program Innate Immun, Dept Med,LRB, Room 308,364 Plantation St, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu			National Institutes of Health [AI093752, AI083713, AI067497]	This work was supported by National Institutes of Health Grants AI093752, AI083713, and AI067497.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Baum R, 2015, J IMMUNOL, V194, P873, DOI 10.4049/jimmunol.1402573; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Collard RL, 2006, PROSTATE, V66, P687, DOI 10.1002/pros.20371; Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031; Conrady CD, 2012, MUCOSAL IMMUNOL, V5, P173, DOI 10.1038/mi.2011.63; Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Datta B, 1996, J BIOL CHEM, V271, P27544, DOI 10.1074/jbc.271.44.27544                                                        ; Datta B, 1998, MOL CELL BIOL, V18, P1074, DOI 10.1128/MCB.18.2.1074                                                           ; Dermott JM, 2004, STEM CELLS, V22, P832, DOI 10.1634/stemcells.22-5-832                                                      ; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234                                                          ; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Lembo M, 1998, ONCOGENE, V16, P1543, DOI 10.1038/sj.onc.1201677                                                          ; Levine JJ, 2003, ONCOGENE, V22, P3475, DOI 10.1038/sj.onc.1206430; Li H, 2016, TRANSPORT RES REC, P92, DOI 10.3141/2575-10; Liu CJ, 2000, MOL CELL BIOL, V20, P7024, DOI 10.1128/MCB.20.18.7024-7036.2000; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu FH, 2014, MOL CELL ENDOCRINOL, V392, P80, DOI 10.1016/j.mce.2014.05.009; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Machida EO, 2006, CANCER RES, V66, P6210, DOI 10.1158/0008-5472.CAN-05-4447; Min W, 1996, MOL CELL BIOL, V16, P359; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Moriai R, 2002, ANTICANCER RES, V22, P4163; Ohtsuka T, 2006, ONCOGENE, V25, P1807, DOI 10.1038/sj.onc.1209204; Parsons MJ, 2006, ONCOGENE, V25, P6948, DOI 10.1038/sj.onc.1209684; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Riojas MA, 2007, CANCER BIOL THER, V6, P1710, DOI 10.4161/cbt.6.11.4829                                                           ; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Virmani A, 2003, INT J CANCER, V106, P198, DOI 10.1002/ijc.11206; Weiler SR, 1999, BLOOD, V93, P527; Wu L, 2016, CLIN TRANSL ONCOL, V18, P296, DOI 10.1007/s12094-015-1367-y; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	58	0	0	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2017	199	9					3249	3260		10.4049/jimmunol.1700823				12	Immunology	Immunology	FK4LT	WOS:000413466400024	28931603				2018-01-05	
J	Liu, FL; Niu, QL; Fan, XZ; Liu, CN; Zhang, J; Wei, Z; Hou, W; Kanneganti, TD; Robb, ML; Kim, JH; Michael, NL; Sun, JR; Soong, L; Hu, HT				Liu, Fengliang; Niu, Qingli; Fan, Xiuzhen; Liu, Connie; Zhang, Jie; Wei, Zhi; Hou, Wei; Kanneganti, Thirumala-Devi; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.; Sun, Jiaren; Soong, Lynn; Hu, Haitao			Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16-STING-Type I IFN Pathway and AIM2 Sensor	JOURNAL OF IMMUNOLOGY			English	Article							T-CELL RESPONSES; INNATE IMMUNE RECOGNITION; DENDRITIC CELLS; ADENOVIRUS VECTOR; RHESUS-MONKEYS; DNA VIRUSES; HIV-1; VACCINE; INFECTION; GENE	Viral vectors derived from different virus families, including poxvirus (canarypox virus vector ALVAC) and adenovirus (human Ad5 vector), have been widely used in vaccine development for a range of human diseases including HIV/AIDS. Less is known about the mechanisms underlying the host innate response to these vectors. Increasing evidence from clinical vaccine trials testing different viral vectors has suggested the importance of understanding basic elements of host-viral vector interactions. In this study, we investigated the innate interactions of APCs with two commonly used HIV vaccine vectors, ALVAC and Ad5, and identified AIM2 as an innate sensor for ALVAC, triggering strong inflammasome activation in both human and mouse APCs. Microarray and comprehensive gene-knockout analyses (CRISPR/Cas9) identified that ALVAC stimulated the cGAS/IFI16-STING-type I IFN pathway to prime AIM2, which was functionally required for ALVAC-induced inflammasome activation. We also provided evidence that, in contrast to ALVAC, the Ad5 vector itself was unable to induce inflammasome activation, which was related to its inability to stimulate the STING-type I IFN pathway and to provide inflammasome-priming signals. In preconditioned APCs, the Ad5 vector could stimulate inflammasome activation through an AIM2-independent mechanism. Therefore, our study identifies the AIM2 inflammasome and cGAS/IFI16-STING-type I IFN pathway as a novel mechanism for host innate immunity to the ALVAC vaccine vector.	[Liu, Fengliang; Niu, Qingli; Fan, Xiuzhen; Liu, Connie; Sun, Jiaren; Soong, Lynn; Hu, Haitao] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Zhang, Jie; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Hou, Wei] Wuhan Univ, Sch Basic Med Sci, Wuhan 430070, Hubei, Peoples R China; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Immunol Dept, Memphis, TN 38105 USA; [Robb, Merlin L.; Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul 08826, South Korea; [Sun, Jiaren; Soong, Lynn; Hu, Haitao] Univ Texas Med Branch, Inst Human Infect & Immun, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	Hu, HT (reprint author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	haihu@UTMB.edu		Kim, Jerome/0000-0003-0461-6438; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Liu, Feng-Liang/0000-0002-5038-5012; Michael, Nelson/0000-0001-5882-5548; Robb, Merlin/0000-0003-3949-9649	National Institutes of Health [R21AI110214]; Robert Mapplethorpe Foundation	This work was supported by the National Institutes of Health (R21AI110214 to H.H.) and the Robert Mapplethorpe Foundation (to H.H.).	Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Barouch DH, 2014, NAT REV MICROBIOL, V12, P765, DOI 10.1038/nrmicro3360; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258                                                                  ; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Cui WG, 2014, J IMMUNOL, V192, P4221, DOI 10.4049/jimmunol.1302569; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dostert C, 2013, CURR OPIN IMMUNOL, V25, P359, DOI 10.1016/j.coi.2013.02.008; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichholz K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005871; Engelmayer J, 2001, J VIROL, V75, P2142, DOI 10.1128/JVI.75.5.2142-2153.2001; Ewer KJ, 2016, CURR OPIN IMMUNOL, V41, P47, DOI 10.1016/j.coi.2016.05.014; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchini Genoveffa, 2004, Expert Rev Vaccines, V3, pS75, DOI 10.1586/14760584.3.4.S75; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harenberg A, 2008, VACCINE, V26, P5004, DOI 10.1016/j.vaccine.2008.07.050; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721                                                     ; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakae S, 2001, IMMUNOLOGY, V104, P402, DOI 10.1046/j.1365-2567.2001.01337.x; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112; Panchanathan R, 2010, J IMMUNOL, V185, P7385, DOI 10.4049/jimmunol.1002468; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Perreau M, 2005, J VIROL, V79, P14595, DOI 10.1128/JVI.79.23.14595-14605.2005; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Ponomareva L, 2013, MOL CANCER RES, V11, P1193, DOI 10.1158/1541-7786.MCR-13-0145; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt T, 2016, METHODS MOL BIOL, V1338, P261, DOI 10.1007/978-1-4939-2932-0_19; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suschak JJ, 2015, J IMMUNOL, V194, P630, DOI 10.4049/jimmunol.1402530; Teigler JE, 2014, J VIROL, V88, P1809, DOI 10.1128/JVI.02386-13; Ura T, 2014, VACCINES, V2, P624, DOI 10.3390/vaccines2030624; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Webster SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006383; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153                                                         ; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024	58	0	0	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2017	199	9					3293	3305		10.4049/jimmunol.1700698				13	Immunology	Immunology	FK4LT	WOS:000413466400028	28947539				2018-01-05	
J	Spielmann, M; Hernandez-Miranda, LR; Ceccherini, I; Weese-Mayer, DE; Kragesteen, BK; Harabula, I; Krawitz, P; Birchmeier, C; Leonard, N; Mundlos, S				Spielmann, Malte; Hernandez-Miranda, Luis R.; Ceccherini, Isabella; Weese-Mayer, Debra E.; Kragesteen, Bjort K.; Harabula, Izabela; Krawitz, Peter; Birchmeier, Carmen; Leonard, Norma; Mundlos, Stefan			Mutations in MYO1H cause a recessive form of central hypoventilation with autonomic dysfunction	JOURNAL OF MEDICAL GENETICS			English	Article							NERVOUS-SYSTEM DYSFUNCTION; TBX4 GENE; PHOX2B; CHEMOSENSITIVITY; MOUSE; GENERATION; ELEMENTS; FAMILY; MICE	Background Congenital central hypoventilation syndrome (CCHS) is a rare life-threatening disorder of respiratory and autonomic regulation. It is classically caused by dominant mutations in the transcription factor PHOX2B. The objective of the present study was to identify the molecular cause of a recessive form of central hypoventilation with autonomic dysfunction. Methods Here, we used homozygosity mapping and whole-genome sequencing in a consanguineous family with CCHS in combination with functional analyses in CRISPR/Cas9 engineered mice. Results We report on a consanguineous family with three affected children, all tested PHOX2B mutation negative, presenting with alveolar hypoventilation and symptoms of autonomic dysregulation. Whole-genome sequencing revealed a homozygous frameshift mutation in exon 25 of the MYO1H gene (c.2524_2524delA) segregating with the phenotype in the family. MYO1H encodes for the unconventional myosin IH, which is thought to function as a motor protein in intracellular transport and vesicle trafficking. We show that Myo1h is broadly expressed in the mouse lower medulla, including the CO2-sensitive Phox2b+ retrotrapezoid neurons. To test the pathogenicity of the variant, we engineered two Myo1h mutant mouse strains: the first strain (Myo1h*) resembling the human mutation and the second being a full knock-out (Myo1hFS). Whole-body plethysmography studies in Myo1h* newborns with the re-engineered human mutation revealed hypoventilation and a blunted response to CO2, recapitulating the breathing phenotype observed in the kindred. Conclusions Our results identify MYO1H as an important gene in CO2 sensitivity and respiratory control and as the cause of a rare recessive form of congenital central hypoventilation.	[Spielmann, Malte; Kragesteen, Bjort K.; Harabula, Izabela; Mundlos, Stefan] Max Planck Inst Mol Genet, Ihnestr 63-73, D-14195 Berlin, Germany; [Spielmann, Malte; Krawitz, Peter; Mundlos, Stefan] Charite, Inst Med Genet & Human Genet, Berlin, Germany; [Hernandez-Miranda, Luis R.; Birchmeier, Carmen] Max Delbruck Ctr Mol Med Helmholtz Gemeinschaft, Berlin, Germany; [Ceccherini, Isabella] Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Weese-Mayer, Debra E.] Ann & Robert H Lurie Childrens Hosp Chicago, CAMP, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Weese-Mayer, Debra E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Leonard, Norma] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	Mundlos, S (reprint author), Max Planck Inst Mol Genet, Ihnestr 63-73, D-14195 Berlin, Germany.	mundlos@molgen.mpg.de			Deutsche Forschungsgemeinschaft (DFG); DFG [SP1532/2-1]; Berlin-Brandenburg School for Regenerative Therapies, Berlin, Germany; European Commission under the scheme of Marie Sklodowska-Curie Intra-European fellowship [302477]	This project was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to SM and CB. MS was supported by a grant from the DFG (SP1532/2-1) and by a fellowship of the Berlin-Brandenburg School for Regenerative Therapies, Berlin, Germany. LRH-M was supported by a grant from the European Commission under the scheme of Marie Sklodowska-Curie Intra-European fellowship (302477).	Adamek N, 2011, CELL MOL LIFE SCI, V68, P139, DOI 10.1007/s00018-010-0448-x; Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Bachetti T, 2011, J MOL MED, V89, P505, DOI 10.1007/s00109-010-0718-y; Berry-Kravis EM, 2006, AM J RESP CRIT CARE, V174, P1139, DOI 10.1164/rccm.200602-305OC; Bongers EMHF, 2004, AM J HUM GENET, V74, P1239, DOI 10.1086/421331; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Carroll MS, 2014, J APPL PHYSIOL, V116, P439, DOI 10.1152/japplphysiol.01310.2013; Chatonnet F, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-19; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374; Kerstjens-Frederikse WS, 2013, J MED GENET, V50, P500, DOI 10.1136/jmedgenet-2012-101152; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lin TM, 2011, BIOCHEMISTRY-US, V50, P1831, DOI 10.1021/bi1016777; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Marazita ML, 2001, AM J MED GENET, V100, P229, DOI 10.1002/ajmg.1284                                                               ; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Nimmakayalu M, 2011, AM J MED GENET A, V155A, P418, DOI 10.1002/ajmg.a.33827; Rand CM, 2012, AM J MED GENET A, V158A, P2297, DOI 10.1002/ajmg.a.35499; Spielmann M, 2016, GENOME RES, V26, P183, DOI 10.1101/gr.199430.115; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Tassopoulou-Fishell M, 2012, AM J ORTHOD DENTOFAC, V141, P51, DOI 10.1016/j.ajodo.2011.06.033; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Weese-Mayer DE, 2001, AM J MED GENET, V100, P237, DOI 10.1002/ajmg.1249                                                               ; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; Weese-Mayer DE, 1993, GENEREVIEWS R	32	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-2593	1468-6244		J MED GENET	J. Med. Genet.	NOV	2017	54	11					754	761		10.1136/jmedgenet-2017-104765				8	Genetics & Heredity	Genetics & Heredity	FK4VT	WOS:000413495600005	28779001				2018-01-05	
J	Gulchina, Y; Xu, SJ; Snyder, MA; Elefant, F; Gao, WJ				Gulchina, Yelena; Xu, Song-Jun; Snyder, Melissa A.; Elefant, Felice; Gao, Wen-Jun			Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia	JOURNAL OF NEUROCHEMISTRY			English	Article						animal model; ChIP; histone modification H3K27me3; juvenile; NMDA receptors; repressor protein REST/NRSF; schizophrenia	WORKING-MEMORY DEFICITS; SUBUNIT GENE GRIN2B; METHYLAZOXYMETHANOL ACETATE; SYNAPTIC PLASTICITY; NR2B SUBUNIT; ADULT RATS; DEVELOPMENTAL REGULATION; VENTRAL HIPPOCAMPUS; PRENATAL DISRUPTION; UNAFFECTED SIBLINGS	Schizophrenia (SCZ) is characterized not only by psychosis, but also by working memory and executive functioning deficiencies, processes that rely on the prefrontal cortex (PFC). Because these cognitive impairments emerge prior to psychosis onset, we investigated synaptic function during development in the neurodevelopmental methylazoxymethanol (MAM) model for SCZ. Specifically, we hypothesize that N-methyl-D-aspartate receptor (NMDAR) hypofunction is attributable to reductions in the NR2B subunit through aberrant epigenetic regulation of gene expression, resulting in deficient synaptic physiology and PFC-dependent cognitive dysfunction, a hallmark of SCZ. Using western blot and whole-cell patch-clamp electrophysiology, we found that the levels of synaptic NR2B protein are significantly decreased in juvenile MAM animals, and the function of NMDARs is substantially compromised. Both NMDA-mEPSCs and synaptic NMDA-eEPSCs are significantly reduced in prelimbic PFC (plPFC). This protein loss during the juvenile period is correlated with an aberrant increase in enrichment of the epigenetic transcriptional repressor RE1-silencing transcription factor (REST) and the repressive histone marker H3K27me3 at the Grin2b promoter, as assayed by ChIP-quantitative polymerase chain reaction. Glutamate hypofunction has been a prominent hypothesis in the understanding of SCZ pathology; however, little attention has been given to the NMDAR system in the developing PFC in models for SCZ. Our work is the first to confirm that NMDAR hypofunction is a feature of early postnatal development, with epigenetic hyper-repression of the Grin2b promoter being a contributing factor. The selective loss of NR2B protein and subsequent synaptic dysfunction weakens plPFC function during development and may underlie early cognitive impairments in SCZ models and patients. Read the Editorial Highlight for this article on page 264.	[Gulchina, Yelena; Snyder, Melissa A.; Gao, Wen-Jun] Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane,Room 243, Philadelphia, PA 19104 USA; [Xu, Song-Jun; Elefant, Felice] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Xu, Song-Jun] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Snyder, Melissa A.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada	Gao, WJ (reprint author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane,Room 243, Philadelphia, PA 19104 USA.	fe22@drexel.edu; wgao@drexelmed.edu			NIH [R01MH085666]; NARSAD Independent Investigator Award	The authors acknowledge Yan-Chun Li, Bo Xing, and Brielle R. Ferguson for assistance with electrophysiology experiments, and Sarah A. Monaco for helpful comments on the manuscript. Funding for this study was provided by the NIH R01MH085666 and NARSAD Independent Investigator Award 2015 to W.J. Gao. The authors report no biomedical financial interests or potential conflicts of interest. We reaffirm that the content of this manuscript is not under consideration for publication elsewhere nor has the information been previously published. All of the authors have fulfilled all conditions required for authorship and have approved the submission.	Akbarian S, 2014, DIALOGUES CLIN NEURO, V16, P405; Akbarian S, 2010, CURR TOP BEHAV NEURO, V4, P611, DOI 10.1007/7854_2010_38; Akbarian S, 2010, BRAIN RES BULL, V83, P103, DOI [10.1016/j.brainresbull.2010.08.018, 10.1016/j.brainresbull.2009.08.018]; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Beneyto M, 2008, NEUROPSYCHOPHARMACOL, V33, P2175, DOI 10.1038/sj.npp.1301604; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Bowie Christopher R, 2006, Neuropsychiatr Dis Treat, V2, P531, DOI 10.2147/nedt.2006.2.4.531; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P379, DOI 10.1093/oxfordjournals.schbul.a033460                                           ; Coyle Joseph T., 2002, Current Drug Targets - CNS and Neurological Disorders, V1, P183, DOI 10.2174/1568007024606212; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Dumas TC, 2005, PROG NEUROBIOL, V76, P189, DOI 10.1016/j.pneurobio.2005.08.002; ELLIOTT R, 1995, PSYCHOL MED, V25, P619, DOI 10.1017/S0033291700033523                                                       ; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Flagstad P, 2005, NEUROPSYCHOPHARMACOL, V30, P250, DOI 10.1038/sj.npp.1300625; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gilmour G, 2012, NEUROPHARMACOLOGY, V62, P1401, DOI 10.1016/j.neuropharm.2011.03.015; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gourevitch R, 2004, BEHAV PHARMACOL, V15, P287, DOI 10.1097/01.fbp.0000135703.48799.71; Hradetzky E, 2012, NEUROPSYCHOPHARMACOL, V37, P364, DOI 10.1038/npp.2011.219; Jeevakumar V, 2015, BEHAV BRAIN RES, V282, P165, DOI 10.1016/j.bbr.2015.01.010; Jia PL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002587; Jiang Y, 2010, J NEUROSCI, V30, P7152, DOI 10.1523/JNEUROSCI.1314-10.2010; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Kano S, 2013, MOL PSYCHIATR, V18, P740, DOI 10.1038/mp.2012.120; Kantrowitz J, 2012, CURR OPIN PSYCHIATR, V25, P96, DOI 10.1097/YCO.0b013e32835035b2; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI [10.1016/j.brainresbull.2010.06.006, 10.1016/j.brainresbull.2010.04.006]; Kim J, 2012, ILAR J, V53, P232, DOI 10.1093/ilar.53.3-4.232; Kristiansen LV, 2010, SCHIZOPHR RES, V119, P198, DOI 10.1016/j.schres.2010.02.1069; Laruelle M, 2000, BRAIN RES REV, V31, P371, DOI 10.1016/S0165-0173(99)00054-5                                                   ; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavin A, 2005, NEUROPSYCHOPHARMACOL, V30, P1426, DOI 10.1038/sj.npp.1300696; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Li ML, 2017, NEUROBIOL LEARN MEM, V140, P52, DOI 10.1016/j.nlm.2017.02.004; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Lodge DJ, 2009, BEHAV BRAIN RES, V204, P306, DOI 10.1016/j.bbr.2009.01.031; Mackowiak M, 2014, EUR NEUROPSYCHOPHARM, V24, P271, DOI 10.1016/j.euroneuro.2013.05.013; Marquis JP, 2008, NEUROBIOL LEARN MEM, V90, P339, DOI 10.1016/j.nlm.2008.04.005; Marquis JP, 2006, NEUROSCIENCE, V140, P759, DOI 10.1016/j.neuroscience.2006.02.048; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; Meador-Woodruff JH, 2000, BRAIN RES REV, V31, P288, DOI 10.1016/S0165-0173(99)00044-2; Monaco SA, 2015, NEUROSCI BIOBEHAV R, V56, P127, DOI 10.1016/j.neubiorev.2015.06.022; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Nestler EJ, 2016, NEUROSCIENTIST, V22, P447, DOI 10.1177/1073858415608147; Numata S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00280; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Rosso IM, 2000, SCHIZOPHRENIA BULL, V26, P367, DOI 10.1093/oxfordjournals.schbul.a033459                                           ; Snyder MA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00031; Snyder MA, 2013, NEUROPSYCHOPHARMACOL, V38, P328, DOI 10.1038/npp.2012.180; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Tamminga A, 2015, NEUROSCIENCE, V309, P233, DOI 10.1016/j.neuroscience.2015.07.038; Tang YP, 1999, NATURE, V401, P63; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591; Wang HX, 2009, NEUROPSYCHOPHARMACOL, V34, P2028, DOI 10.1038/npp.2009.20; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Xing B, 2016, NEUROPSYCHOPHARMACOL, V41, P3003, DOI 10.1038/npp.2016.110	65	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2017	143	3					320	333		10.1111/jnc.14101				14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FK5OQ	WOS:000413550000006	28628228				2018-01-05	
J	Takamochi, K; Oh, S; Matsunaga, T; Suzuki, K				Takamochi, Kazuya; Oh, Shiaki; Matsunaga, Takeshi; Suzuki, Kenji			Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						lung adenocarcinoma; epidermal growth facter receptor; gene mutation; prognosis	GROWTH-FACTOR RECEPTOR; TNM STAGE GROUPINGS; CANCER; GEFITINIB; PLACEBO; CLASSIFICATION; RECURRENCE; PROPOSALS; REVISION; EDITION	Objective: Epidermal growth factor receptor (EGFR) gene mutation status is a well-established predictor of the efficacy of EGFR tyrosine-kinase inhibitor (TKI) therapy in patients with non-small cell lung cancer. Recently, differences in EGFR mutation subtypes have been reported to be associated with the efficacy of EGFR-TKI therapy. The prognostic impact of EGFR mutation status and subtypes remains controversial, however. Methods: We retrospectively reviewed 939 patients with surgically resected adenocarcinomas who underwent EGFR mutation status analysis between January 2010 and December 2014. Overall survival (OS) and recurrence-free survival (RFS) were compared according to pathological stage, EGFR mutation status, and EGFR mutation subtype using the log-rank test. Independent prognostic factors for OS and RFS were identified by multivariate analysis using the Cox proportional hazards model. Results: The median duration of follow-up was 48 months. We found that positive EGFR mutation status was significantly associated with longer OS and RFS in all patients and was associated with longer OS in patients in pathological stage I; however, therewere no significant differences inOS and RFS between patients with exon 21 L858Rmutations and those with exon 19 deletions. In a Cox regression model for OS, EGFR mutation status was a significant prognostic factor that was independent of well-established prognostic factors, including age, pathological stage, vascular invasion, lymphatic permeation, and serum carcinoembryonic antigen level. Conclusions: Positive EGFR mutation status is a favorable prognostic factor in patients with surgically resected lung adenocarcinomas; however, EGFR mutation subtype (exon 21 L858R mutation or exon 19 deletion) exhibits no prognostic impact.	[Takamochi, Kazuya; Oh, Shiaki; Matsunaga, Takeshi; Suzuki, Kenji] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo, Japan	Takamochi, K (reprint author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, 1-3,Hongo 3 Chome, Tokyo 1138431, Japan.	ktakamo@juntendo.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan and the Smoking Research Foundation.	D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Goss GD, 2013, J CLIN ONCOL, V31, P3320, DOI 10.1200/JCO.2013.51.1816; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Kelly K, 2015, J CLIN ONCOL, V33, P4007, DOI 10.1200/JCO.2015.61.8918; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238                                                            ; Kudo Y, 2015, CLIN LUNG CANCER, V16, pE213, DOI 10.1016/j.cllc.2015.04.005; Lee YJ, 2009, J CANCER RES CLIN, V135, P1647, DOI 10.1007/s00432-009-0611-7; Li N, 2014, ANN SURG ONCOL, V21, P2091, DOI 10.1245/s10434-014-3586-9; Liu WS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0771-9; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938                                                            ; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Okamoto T, 2016, ANTICANCER RES, V36, P3057; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Steuer CE, 2015, CANCER-AM CANCER SOC, V121, pE1, DOI 10.1002/cncr.29139; Zhang YC, 2014, IEEE INT CONF ELECTR, P9; Zhang ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106053	22	2	2	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	NOV	2017	154	5					1768	+		10.1016/j.jtcvs.2017.06.062				8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	FJ8QA	WOS:000413032500078	28826599				2018-01-05	
J	Weidenbach, K; Nickel, L; Neve, H; Alkhnbashi, OS; Kunzel, S; Kupczok, A; Bauersachs, T; Cassidy, L; Tholey, A; Backofen, R; Schmitz, RA				Weidenbach, Katrin; Nickel, Lisa; Neve, Horst; Alkhnbashi, Omer S.; Kuenzel, Sven; Kupczok, Anne; Bauersachs, Thorsten; Cassidy, Liam; Tholey, Andreas; Backofen, Rolf; Schmitz, Ruth A.			Methanosarcina Spherical Virus, a Novel Archaeal Lytic Virus Targeting Methanosarcina Strains	JOURNAL OF VIROLOGY			English	Article						Methanosarcina mazei strain Go1; virus; methanoarchaea; CRISPR/Cas; virus for methanoarchaea	CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; METHANOBREVIBACTER-SMITHII; SULFOLOBUS-SOLFATARICUS; HALOARCULA-HISPANICA; BORDETELLA-PERTUSSIS; GENOME ORGANIZATION; DNA-REPLICATION; HUMAN GUT; MAZEI	A novel archaeal lytic virus targeting species of the genus Methanosarcina was isolated using Methanosarcina mazei strain Go1 as the host. Due to its spherical morphology, the virus was designated Methanosarcina spherical virus (MetSV). Molecular analysis demonstrated that MetSV contains double-stranded linear DNA with a genome size of 10,567 bp containing 22 open reading frames (ORFs), all oriented in the same direction. Functions were predicted for some of these ORFs, i.e., such as DNA polymerase, ATPase, and DNA-binding protein as well as envelope (structural) protein. MetSV-derived spacers in CRISPR loci were detected in several published Methanosarcina draft genomes using bioinformatic tools, revealing a potential protospacer-adjacent motif (PAM) motif (TTA/T). Transcription and expression of several predicted viral ORFs were validated by reverse transcription-PCR (RT-PCR), PAGE analysis, and liquid chromatography-mass spectrometry (LC-MS)-based proteomics. Analysis of core lipids by atmospheric pressure chemical ionization (APCI) mass spectrometry showed that MetSV and Methanosarcina mazei both contain archaeol and glycerol dialkyl glycerol tetraether without a cyclopentane moiety (GDGT-0). The MetSV host range is limited to Methanosarcina strains growing as single cells (M. mazei, Methanosarcina barkeri and Methanosarcina soligelidi). In contrast, strains growing as sarcina-like aggregates were apparently protected from infection. Heterogeneity related to morphology phases in M. mazei cultures allowed acquisition of resistance to MetSV after challenge by growing cultures as sarcina-like aggregates. CRISPR/Cas-mediated resistance was excluded since neither of the two CRISPR arrays showed MetSV-derived spacer acquisition. Based on these findings, we propose that changing the morphology from single cells to sarcina-like aggregates upon rearrangement of the envelope structure prevents infection and subsequent lysis by MetSV. IMPORTANCE Methanoarchaea are among the most abundant organisms on the planet since they are present in high numbers in major anaerobic environments. They convert various carbon sources, e.g., acetate, methylamines, or methanol, to methane and carbon dioxide; thus, they have a significant impact on the emission of major greenhouse gases. Today, very little is known about viruses specifically infecting methanoarchaea that most probably impact the abundance of methanoarchaea in microbial consortia. Here, we characterize the first identified Methanosarcina-infecting virus (MetSV) and show a mechanism for acquiring resistance against MetSV. Based on our results, we propose that growth as sarcina-like aggregates prevents infection and subsequent lysis. These findings allow new in-sights into the virus-host relationship in methanogenic community structures, their dynamics, and their phase heterogeneity. Moreover, the availability of a specific virus provides new possibilities to deepen our knowledge of the defense mechanisms of potential hosts and offers tools for genetic manipulation.	[Weidenbach, Katrin; Nickel, Lisa; Kupczok, Anne; Schmitz, Ruth A.] Christian Abrechts Univ, Inst Gen Microbiol, Kiel, Germany; [Neve, Horst] Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany; [Alkhnbashi, Omer S.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany; [Kuenzel, Sven] MPI Evolutionary Biol, Plon, Germany; [Bauersachs, Thorsten] Univ Kiel, Inst Geosci, Dept Organ Geochem, Kiel, Germany; [Cassidy, Liam; Tholey, Andreas] Univ Kiel, Inst Expt Med, Dept Systemat Prote & Bioanalyt, Kiel, Germany; [Backofen, Rolf] Univ Freiburg, Cluster Excellence, Ctr Biol Signalling Studies, Freiburg, Germany	Schmitz, RA (reprint author), Christian Abrechts Univ, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de		Bauersachs, Thorsten/0000-0003-4858-9443	DFG [FOR1680, SCHM1052/12-1, SCHM1052/12-2]	This study was supported by the DFG (FOR1680 and SCHM1052/12-1 and 2).	Alkhnbashi OS, 2014, BIOINFORMATICS, V30, pI489, DOI 10.1093/bioinformatics/btu459; Bamford DH, 2005, J VIROL, V79, P9097, DOI 10.1128/JVI.79.14.9097-9107.2005; Bath C, 2006, VIROLOGY, V350, P228, DOI 10.1016/j.virol.2006.02.005; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; Borrel G, 2012, ISME J, V6, P2119, DOI 10.1038/ismej.2012.49; Brard M, 2007, J ORG CHEM, V72, P8267, DOI 10.1021/jo071181r; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Casey E, 2015, APPL ENVIRON MICROB, V81, P1319, DOI 10.1128/AEM.03413-14; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45; Chien IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081040; Colombet J, 2007, J MICROBIOL METH, V71, P212, DOI 10.1016/j.mimet.2007.08.012; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; DEPPENMEIER U, 1990, P NATL ACAD SCI USA, V87, P9449, DOI 10.1073/pnas.87.23.9449; DiMaio D, 2014, ANNU REV MICROBIOL, V68, P21, DOI 10.1146/annurev-micro-091313-103727; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Ehlers Claudia, 2002, Archaea, V1, P143, DOI 10.1155/2002/362813; Erez Z, 2017, NATURE, V541, DOI 10.1038/nature21049; Frols S, 2012, ENVIRON MICROBIOL, V14, P3159, DOI 10.1111/j.1462-2920.2012.02895.x; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P40547, DOI 10.1074/jbc.M007170200; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Haring M, 2004, VIROLOGY, V323, P233, DOI 10.1016/j.virol.2004.03.002; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.0.CO;2-N; Hung CW, 2016, MOL CELL PROTEOMICS, V15, P3090, DOI 10.1074/mcp.M115.051474; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Jaakkola ST, 2012, J VIROL, V86, P4734, DOI 10.1128/JVI.06666-11; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; JORDAN M, 1989, MOL GEN GENET, V220, P161; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kessler A, 2004, J BACTERIOL, V186, P7745, DOI 10.1128/JB.186.22.7745-7745.2004; Krupovic M, 2008, VIROLOGY, V375, P292, DOI 10.1016/j.virot.2008.01.043; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai MC, 2001, INT J SYST EVOL MICR, V51, P1873, DOI 10.1099/00207713-51-5-1873                                                      ; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Liu XL, 2012, RAPID COMMUN MASS SP, V26, P2295, DOI 10.1002/rcm.6355; Luo YN, 2001, J BACTERIOL, V183, P5788, DOI 10.1128/JB.183.19.5788-5792.2001; Maaty WS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00411; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makino S, 1999, P JPN ACAD B-PHYS, V75, P166, DOI 10.2183/pjab.75.166                                                             ; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MEILE L, 1989, ARCH MICROBIOL, V152, P105, DOI 10.1007/BF00456085; Nickel L, 2013, RNA BIOL, V10, P779, DOI 10.4161/rna.23928; NOLLING J, 1993, J GEN MICROBIOL, V139, P2511, DOI 10.1099/00221287-139-10-2511                                                    ; Okutan E, 2013, RNA BIOL, V10, P875, DOI 10.4161/rna.24537; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; Ortmann AC, 2008, J VIROL, V82, P4874, DOI 10.1128/JVI.02583-07; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444                                                          ; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; Pietila MK, 2014, TRENDS MICROBIOL, V22, P334, DOI 10.1016/j.tim.2014.02.007; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Porter K, 2008, MICROBIOL-SGM, V154, P3599, DOI 10.1099/mic.0.2008/019422-0; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; Rensen EI, 2016, P NATL ACAD SCI USA, V113, P2478, DOI 10.1073/pnas.1518929113; [Anonymous], 2010, RAP LIB PREP METH MA; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Saunders NFW, 2006, J PROTEOME RES, V5, P2457, DOI 10.1021/pr060220x; SAVILAHTI H, 1993, J VIROL, V67, P4696; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Snyder JC, 2015, VIROLOGY, V479, P369, DOI 10.1016/j.virol.2015.03.031; Sowers KR, 1995, ARCHAEA LAB MANUAL; STIBITZ S, 1989, NATURE, V338, P266, DOI 10.1038/338266a0; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Veit K, 2006, MOL GENET GENOMICS, V276, P41, DOI 10.1007/s00438-006-0117-9; Veit K, 2005, J BACTERIOL, V187, P6147, DOI 10.1128/JB.187.17.6147-6154.2005; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wang HN, 2015, MICROBIOL MOL BIOL R, V79, P117, DOI 10.1128/MMBR.00042-14; Weidenbach K, 2008, MOL MICROBIOL, V67, P662, DOI 10.1111/j.1365-2958.2007.06076.x; WOOD AG, 1989, J BACTERIOL, V171, P93, DOI 10.1128/jb.171.1.93-98.1989                                                     ; Youngblut ND, 2015, ISME J, V9, P2191, DOI 10.1038/ismej.2015.31	75	0	0	4	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	NOV	2017	91	22							UNSP e00955-17	10.1128/JVI.00955-17				17	Virology	Virology	FL1WP	WOS:000414005400014					2018-01-05	
J	Juhas, M; Ajioka, JW				Juhas, Mario; Ajioka, James W.			T7 RNA polymerase-driven inducible cell lysis for DNA transfer from Escherichia coli to Bacillus subtilis	MICROBIAL BIOTECHNOLOGY			English	Article							GENE-EXPRESSION SYSTEM; CHROMOSOMAL INTEGRATION; PATHWAY; LEVEL; STEP; OVEREXPRESSION; BIOSYNTHESIS; CONSTRUCTION; STREPTOMYCES; GENERATION	The majority of the good DNA editing techniques have been developed in Escherichia coli; however, Bacillus subtilis is better host for a plethora of synthetic biology and biotechnology applications. Reliable and efficient systems for the transfer of synthetic DNA between E.coli and B.subtilis are therefore of the highest importance. Using synthetic biology approaches, such as streamlined lambda Red recombineering and Gibson Isothermal Assembly, we integrated genetic circuits pT7L123, Repr-ts-1 and pLT7pol encoding the lysis genes of bacteriophages MS2, phi X174 and lambda, the thermosensitive repressor and the T7 RNA polymerase into the E.coli chromosome. In this system, T7 RNA polymerase regulated by the thermosensitive repressor drives the expression of the phage lysis genes. We showed that T7 RNA polymerase significantly increases efficiency of cell lysis and transfer of the plasmid and bacterial artificial chromosome-encoded DNA from the lysed E.coli into B.subtilis. The T7 RNA polymerase-driven inducible cell lysis system is suitable for the efficient cell lysis and transfer of the DNA engineered in E.coli to other naturally competent hosts, such as B.subtilis.	[Juhas, Mario; Ajioka, James W.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England	Juhas, M (reprint author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mj417@cam.ac.uk			OpenPlant Fund; SynBio Fund; Engineering and Physical Sciences Research Council	OpenPlant Fund, SynBio Fund, Engineering and Physical Sciences Research Council.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvani S, 2012, J BIOTECHNOL, V159, P162, DOI 10.1016/j.jbiotec.2012.01.004; Barnard GC, 2004, PROTEIN EXPRES PURIF, V38, P264, DOI 10.1016/j.pep.2004.09.001; Berry J, 2008, MOL MICROBIOL, V70, P341, DOI 10.1111/j.1365-2958.2008.06408.x; BRUNSCHWIG E, 1992, GENE, V111, P35, DOI 10.1016/0378-1119(92)90600-T; Catalao MJ, 2013, FEMS MICROBIOL REV, V37, P554, DOI 10.1111/1574-6976.12006; Commichau FM, 2014, METAB ENG, V25, P38, DOI 10.1016/j.ymben.2014.06.007; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; Corchero JL, 2001, MICROBIOL RES, V156, P13, DOI 10.1078/0944-5013-00066; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662; deRuyter PGGA, 1997, NAT BIOTECHNOL, V15, P976, DOI 10.1038/nbt1097-976                                                             ; Equbal MJ, 2013, APPL MICROBIOL BIOT, V97, P7755, DOI 10.1007/s00253-013-4900-3; Gamer M, 2009, APPL MICROBIOL BIOT, V82, P1195, DOI 10.1007/s00253-009-1952-5; Gandon S, 2016, TRENDS MICROBIOL, V24, P356, DOI 10.1016/j.tim.2016.02.008; Gao YQ, 2013, APPL MICROBIOL BIOT, V97, P7121, DOI 10.1007/s00253-013-5100-x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grundling A, 2001, P NATL ACAD SCI USA, V98, P9348, DOI 10.1073/pnas.151247598; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hao T, 2013, MOL BIOSYST, V9, P2034, DOI 10.1039/c3mb25568a; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; HERRERO M, 1993, GENE, V134, P103, DOI 10.1016/0378-1119(93)90181-2; Itaya M, 2010, NUCLEIC ACIDS RES, V38, P2551, DOI 10.1093/nar/gkq142; Juhas M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165778; Juhas M, 2017, CRIT REV BIOTECHNOL, V37, P277, DOI 10.3109/07388551.2016.1141394; Juhas M, 2016, CRIT REV BIOTECHNOL, V36, P416, DOI 10.3109/07388551.2014.989423; Juhas M, 2015, MICROB BIOTECHNOL, V8, P726, DOI 10.1111/1751-7915.12296; Juhas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123007; Juhas M, 2014, MICROBIOL-SGM, V160, P2341, DOI 10.1099/mic.0.079376-0; Juhas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111451; Kaneko S, 2010, J BIOCHEM, V147, P819, DOI 10.1093/jb/mvq012; Kortmann M, 2015, MICROB BIOTECHNOL, V8, P253, DOI 10.1111/1751-7915.12236; J-H Lee, 2013, J ANTENNAS PROPAG, V2013, P8, DOI DOI 10.1371/J0URNAL; Lussier FX, 2010, APPL ENVIRON MICROB, V76, P967, DOI 10.1128/AEM.02186-09; Manabe K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-18; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; Miller E M, 1995, Methods Mol Biol, V47, P105; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11                                                          ; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; Richhardt J, 2010, APPL MICROBIOL BIOT, V86, P1959, DOI 10.1007/s00253-010-2503-9; Shi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081370; Shulman LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039455; Song J, 1999, ANAL BIOCHEM, V271, P89, DOI 10.1006/abio.1999.4106                                                          ; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI [10.1021/s400021j, 10.1021/sb400021j]; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2                                                    ; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; Wei JH, 2017, BIOTECHNOL LETT, V39, P857, DOI 10.1007/s10529-017-2309-2; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Yadav T, 2014, J BIOL CHEM, V289, P27640, DOI 10.1074/jbc.M114.577924; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; YOUNG RY, 1992, MICROBIOL REV, V56, P430; Zhang XM, 2009, J MICROBIOL METH, V79, P199, DOI 10.1016/j.mimet.2009.09.001; Zhou L, 2012, METAB ENG, V14, P560, DOI 10.1016/j.ymben.2012.05.004	57	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-7915			MICROB BIOTECHNOL	Microb. Biotechnol.	NOV	2017	10	6			SI		1797	1808		10.1111/1751-7915.12843				12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FL0LX	WOS:000413904000052	28815907	gold			2018-01-05	
J	Akdemir, B; Nakajima, Y; Inazawa, J; Inoue, J				Akdemir, Burak; Nakajima, Yasuaki; Inazawa, Johji; Inoue, Jun			miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1	MOLECULAR CANCER RESEARCH			English	Article							CARCINOMA CELL-LINES; CANCER-CELLS; DNA HYPERMETHYLATION; ENDOMETRIAL CANCER; MICRORNAS; PATHWAY; DIFFERENTIATION; ACTIVATION; MUTATIONS; AUTOPHAGY	NF-E2-related factor 2 (NRF2) is a master transcriptional regulator that integrates cellular stress responses and is negatively regulated by Kelch-like ECH-associated protein 1 (KEAP1) at the post-translational level. In human cancers, aberrantly stabilized NRF2, by the mutation of either NRF2 or KEAP1 or by the potential inhibition of autophagy, plays a vital role in tumor growth and chemoresistance through the activation of target genes. MicroRNAs (miRNA) are endogenous small noncoding RNAs that can negatively regulate gene expression by interfering with translation and/or stability of target transcripts. However, miRNA-mediated regulation of the NRF2-KEAP1 pathway under physiological conditions is poorly understood. Here, miR-432-3p positively regulates NRF2 activity through the downregulation of KEAP1 by a direct-binding mechanism to the coding region of KEAP1. Overexpression of miR-432-3p resulted in a decreased sensitivity of esophageal squamous cell carcinoma (ESCC) cells to chemotherapy drugs including cisplatin (CDDP). Conversely, the inhibition of miR-432-3p expression by the CRISPR/Cas9 system resulted in an increased sensitivity of ESCC cells to CDDP. Furthermore, miR-432-3p was overexpressed in primary ESCC tumors (55 of 84, 65.5%) and a negative correlation between the expression level of KEAP1 and miR-432-3p in primary ESCC tumors was observed.	[Akdemir, Burak; Inazawa, Johji; Inoue, Jun] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Nakajima, Yasuaki] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Gastroenterol, Tokyo, Japan; [Inazawa, Johji; Inoue, Jun] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan	Inazawa, J; Inoue, J (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp; jun.cgen@mri.tmd.ac.jp			JSPS [C: 15K08301, 15H05908]; MEXT, a research program of the Project for Cancer Research and Therapeutic Evolution (P-CREATE); Tailor-Made Medical Treatment; BioBank Japan Project (BBJ) from the Japan Agency for Medical Research and Development (AMED); MRI, TMDU	This work was supported in part by Grant-in-Aid for Scientific Research (C: 15K08301; to Jun Inoue), Grant-in-Aid for Scientific Research on Innovative Areas "Conquering cancer through NEO-dimensional systems understandings" (15H05908; to Johji Inazawa) from JSPS and MEXT, a research program of the Project for Cancer Research and Therapeutic Evolution (P-CREATE), the Tailor-Made Medical Treatment with the BioBank Japan Project (BBJ) from the Japan Agency for Medical Research and Development (AMED), and the Joint Usage/Research Program of MRI, TMDU.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Eades G, 2011, J BIOL CHEM, V286, P40725, DOI 10.1074/jbc.M111.275495; Fujiwara N, 2015, CANCER RES, V75, P3890, DOI 10.1158/0008-5472.CAN-15-0257; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kozaki K, 2012, CANCER SCI, V103, P837, DOI 10.1111/j.1349-7006.2012.02236.x; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Leinonen HM, 2015, BIOCHEM SOC T, V43, P645, DOI 10.1042/BST20150048; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Macari ER, 2011, BLOOD, V117, P5987, DOI 10.1182/blood-2010-10-314096; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rothschild Sacha I, 2014, Mol Cell Ther, V2, P7, DOI 10.1186/2052-8426-2-7; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tanaka H, 1997, INT J CANCER, V70, P437, DOI 10.1002/(SICI)1097-0215(19970207)70:4<437::AID-IJC11>3.3.CO;2-I; Tanaka H, 1996, INT J CANCER, V65, P372, DOI 10.1002/(SICI)1097-0215(19960126)65:3<372::AID-IJC16>3.3.CO;2-3; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Yamamoto S, 2014, MOL CANCER RES, V12, P58, DOI 10.1158/1541-7786.MCR-13-0246-T; Yang DK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11916; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	42	0	0	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1541-7786	1557-3125		MOL CANCER RES	Mol. Cancer Res.	NOV	2017	15	11					1570	1578		10.1158/1541-7786.MCR-17-0232				9	Oncology; Cell Biology	Oncology; Cell Biology	FL5CC	WOS:000414247700010	28760781				2018-01-05	
J	Yang, Z; Maciejowski, J; de Lange, T				Yang, Zhe; Maciejowski, John; de lange, Titia			Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb	MOLECULAR CANCER RESEARCH			English	Article							CELL-MIGRATION; RETINOBLASTOMA PROTEIN; DNA-DAMAGE; LAMINS; LINES; CHROMOTHRIPSIS; LAMINOPATHIES; CONFINEMENT; MICRONUCLEI; INVASION	The mammalian nuclear envelope (NE) forms a stable physical barrier between the nucleus and the cytoplasm, normally breaking down only during mitosis. However, spontaneous transient NE rupture in interphase can occur when NE integrity is compromised, such as when the nucleus experiences mechanical stress. For instance, deficiencies in the nuclear lamins and their associated proteins can cause NE rupture that is promoted by forces exerted by actin filaments. NE rupture can allow cytoplasmic nucleases to access chromatin, potentially compromising genome integrity. Importantly, spontaneous NE rupture was noted in several human cancer cell lines, but the cause of this defect is not known. Here, we investigated the mechanistic contributions of two major tumor suppressors, p53 (TP53) and Rb (RB1), to the repression of NE rupture. NE rupture was induced in normal human epithelial RPE-1 cells upon impairment of either Rb or p53 achieved by shRNA knockdown and CRISPR/Cas9 gene editing. NE rupture did not involve diminished expression of NE components or greater cell motility. However, cells that underwent NE rupture displayed a larger nuclear projection area. In conclusion, the data indicate that NE rupture in cancer cells is likely due to loss of either the Rb or the p53 pathway. (C)2017 AACR.	[Yang, Zhe; Maciejowski, John; de lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, Box 159,1230 York Ave, New York, NY 10065 USA	de Lange, T (reprint author), Rockefeller Univ, Lab Cell Biol & Genet, Box 159,1230 York Ave, New York, NY 10065 USA.	delange@rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [K99CA212290]; NCI [R35CA210036]; BCRF; Starr Foundation Cancer Consortium [I9-A9-047]; National Center For Research Resources [S10RR031855]	J. Maciejowski is supported by a grant from the NIH (K99CA212290). Research reported in this publication was supported by an OIA to T. de Lange from the NCI (R35CA210036) and grants to T. de Lange from the BCRF and the Starr Foundation Cancer Consortium (I9-A9-047). T. de Lange is an American Cancer Society Rose Zarucki Trust Research Professor. Bio-Imaging Center at RU is supported by a grant (S10RR031855) from the National Center For Research Resources to the Bio-Imaging Center at RU.	Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Broceno C, 2002, P NATL ACAD SCI USA, V99, P14200, DOI 10.1073/pnas.212519499                                                          ; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Hatch EM, 2016, J CELL BIOL, V215, P27, DOI 10.1083/jcb.201603053; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kim KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080590; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6                                                   ; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nili E, 2001, J CELL SCI, V114, P3297; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Porwal M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003671; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Skau CT, 2016, CELL, V167, P1571, DOI 10.1016/j.cell.2016.10.023; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tamiello C., 2014, NUCLEUS, V4, P61; Vargas JD, 2014, NUCLEUS, V3, P88; Yamada K, 2013, MOL CELL, V49, P922, DOI 10.1016/j.molcel.2012.12.023; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	35	0	0	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1541-7786	1557-3125		MOL CANCER RES	Mol. Cancer Res.	NOV	2017	15	11					1579	1586		10.1158/1541-7786.MCR-17-0084				8	Oncology; Cell Biology	Oncology; Cell Biology	FL5CC	WOS:000414247700011	28811362				2018-01-05	
J	Tran, VM; Wade, A; McKinney, A; Chen, K; Lindberg, OR; Engler, JR; Persson, AI; Phillips, JJ				Tran, Vy M.; Wade, Anna; McKinney, Andrew; Chen, Katharine; Lindberg, Olle R.; Engler, Jane R.; Persson, Anders I.; Phillips, Joanna J.			Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion	MOLECULAR CANCER RESEARCH			English	Article							GROWTH-FACTOR RECEPTOR; XENOGRAFT MODEL; STEM-CELL; EXPRESSION; CANCER; GLIOMA; PROTEOGLYCANS; ANGIOGENESIS; MELANOMA; DIFFERENTIATION	Glioblastoma (GBM) is the most common primary malignant brain tumor of adults and confers a poor prognosis due, in part, to diffuse invasion of tumor cells. Heparan sulfate (HS) glycosaminoglycans, present on the cell surface and in the extracellular matrix, regulate cell signaling pathways and cell-microenvironment interactions. In GBM, the expression of HS glycosaminoglycans and the enzymes that regulate their function are altered, but the actual HS content and structure are unknown. However, inhibition of HS glycosaminoglycan function is emerging as a promising therapeutic strategy for some cancers. In this study, we use liquid chromatography-mass spectrometry analysis to demonstrate differences in HS disaccharide content and structure across four patient-derived tumorsphere lines (GBM1, 5, 6, 43) and between two murine tumorsphere lines derived from murine GBM with enrichment of mesenchymal and proneural gene expression (mMES and mPN, respectively) markers. In GBM, the heterogeneous HS content and structure across patient-derived tumorsphere lines suggested diverse functions in the GBM tumor microenvironment. In GBM5 and mPN, elevated expression of sulfatase 2 (SULF2), an extracellular enzyme that alters ligand binding to HS, was associated with low trisulfated HS disaccharides, a substrate of SULF2. In contrast, other primary tumorsphere lines had elevated expression of the HS-modifying enzyme heparanase (HPSE). Using gene editing strategies to inhibit HPSE, a role for HPSE in promoting tumor cell adhesion and invasion was identified. These studies characterize the heterogeneity in HS glycosaminoglycan content and structure across GBM and reveal their role in tumor cell invasion.	[Tran, Vy M.; Wade, Anna; McKinney, Andrew; Chen, Katharine; Lindberg, Olle R.; Engler, Jane R.; Persson, Anders I.; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, Brain Tumor Ctr, San Francisco, CA 94158 USA; [Persson, Anders I.; Phillips, Joanna J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Persson, Anders I.] Univ Calif San Francisco, Dept Neurol, Sandler Neurosci Ctr, San Francisco, CA 94158 USA; [Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, Div Neuropathol, San Francisco, CA 94158 USA	Phillips, JJ (reprint author), Univ Calif San Francisco, 1450 Third St,Room HD492B,Box 0520, San Francisco, CA 94158 USA.	Joanna.phillips@ucsf.edu		Lindberg, Olle/0000-0001-5646-2501	NIH/NINDS [R01 NS081117]; NIH/NCI [U01 CA168878]; NIH [PO1-HL107152]	This study was funded by NIH/NINDS R01 NS081117 and NIH/NCI U01 CA168878 (to J.J. Phillips), and resources were provided by NIH Grant PO1-HL107152 (to BK). Mass spectrometry was performed at the UCSF Mass Spec Facility (NIH NCRR P41RR001614). The UCSF Brain Tumor SPORE Tissue Core (P50CA097257) provided deidentified GBM tissue for establishment of GBM1 tumorspheres.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6                                                   ; BARNER M, 1987, BLOOD, V70, P551; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; Edovitsky E, 2004, J NATL CANCER I, V96, P1219, DOI 10.1093/jnci.djh230; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Hadigal SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7985; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hong X, 2010, J NEUROSURG, V113, P261, DOI 10.3171/2009.9.JNS09682; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Joyce JA, 2005, ONCOGENE, V24, P4037, DOI 10.1038/sj.onc.1208602; Jung O, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.5; Kelly T, 2005, CANCER RES, V65, P5778, DOI 10.1158/0008-5472.CAN-05-0749                                                   ; Kundu S, 2016, MOL CANCER RES, V14, P1243, DOI 10.1158/1541-7786.MCR-16-0223; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li BYZ, 2011, METHODS MOL BIOL, V690, P285, DOI 10.1007/978-1-60761-962-8_19; Li GY, 2015, ACS CHEM BIOL, V10, P1303, DOI 10.1021/acschembio.5b00011; Lindberg OR, 2016, ONCOTARGET, V7, P79087, DOI 10.18632/oncotarget.12600; Marchetti D, 1997, J CELL PHYSIOL, V172, P334, DOI 10.1002/(SICI)1097-4652(199709)172:3<334::AID-JCP7>3.0.CO;2-P; Marchetti D, 2000, CANCER RES, V60, P4767; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2012, J BIOL CHEM, V287, P41288, DOI 10.1074/jbc.M112.391417; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ridgway LD, 2011, EXP THER MED, V2, P229, DOI 10.3892/etm.2010.189; Roy M, 2005, NEOPLASIA, V7, P253, DOI 10.1593/neo.04493; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Shao C, 2013, ANAL CHEM, V85, P10984, DOI 10.1021/ac402517s; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; Ueno Y, 2005, J NEUROSURG, V102, P513, DOI 10.3171/jns.2005.102.3.0513; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vicente CM, 2015, MOL CANCER RES, V13, P510, DOI 10.1158/1541-7786.MCR-14-0372; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Wade A, 2015, METHODS MOL BIOL, V1229, P507, DOI 10.1007/978-1-4939-1714-3_39; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wood MD, 2016, J NEUROPATHOL EXP NE; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Yang B, 2011, ANAL BIOCHEM, V415, P59, DOI 10.1016/j.ab.2011.04.003; Zetser A, 2003, CANCER RES, V63, P7733; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021106	63	0	0	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1541-7786	1557-3125		MOL CANCER RES	Mol. Cancer Res.	NOV	2017	15	11					1623	1633		10.1158/1541-7786.MCR-17-0352				11	Oncology; Cell Biology	Oncology; Cell Biology	FL5CC	WOS:000414247700015	28778876				2018-01-05	
J	Arang, N; Kain, HS; Glennon, EK; Bello, T; Dudgeon, DR; Walter, ENF; Gujral, TS; Kaushansky, A				Arang, Nadia; Kain, Heather S.; Glennon, Elizabeth K.; Bello, Thomas; Dudgeon, Denali R.; Walter, Emily N. F.; Gujral, Taranjit S.; Kaushansky, Alexis			Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles	NATURE COMMUNICATIONS			English	Article							DAVID BIOINFORMATICS RESOURCES; HEPATOCYTE GROWTH-FACTOR; LARGE GENE LISTS; PLASMODIUM-FALCIPARUM; DRUG-RESISTANCE; HUMAN GENOME; HUMAN-CELLS; RECEPTOR; PARASITES; CRISPR-CAS9	Plasmodium parasites have extensive needs from their host hepatocytes during the obligate liver stage of infection, yet there remains sparse knowledge of specific host regulators. Here we assess 34 host-targeted kinase inhibitors for their capacity to eliminate Plasmodium yoeliiinfected hepatocytes. Using pre-existing activity profiles of each inhibitor, we generate a predictive computational model that identifies host kinases, which facilitate Plasmodium yoelii liver stage infection. We predict 47 kinases, including novel and previously described kinases that impact infection. The impact of a subset of kinases is experimentally validated, including Receptor Tyrosine Kinases, members of the MAP Kinase cascade, and WEE1. Our approach also predicts host-targeted kinase inhibitors of infection, including compounds already used in humans. Three of these compounds, VX-680, Roscovitine and Sunitinib, each eliminate > 85% of infection. Our approach is well-suited to uncover key host determinants of infection in difficult model systems, including field-isolated parasites and/or emerging pathogens.	[Arang, Nadia; Kain, Heather S.; Glennon, Elizabeth K.; Dudgeon, Denali R.; Walter, Emily N. F.; Kaushansky, Alexis] Ctr Infect Dis Res, 307 Westlake Ave N 500, Seattle, WA 98109 USA; [Bello, Thomas; Gujral, Taranjit S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Bello, Thomas; Gujral, Taranjit S.] Univ Washington, Program Mol & Cellular Biol, 1959 NE Pacific St,HSB T 466,Box 357275, Seattle, WA 98195 USA; [Kaushansky, Alexis] Univ Washington, Dept Global Hlth, Harris Hydraul Lab, Box 357965, Seattle, WA 98195 USA; [Arang, Nadia] Univ Calif San Diego, Dept Biomed Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA	Kaushansky, A (reprint author), Ctr Infect Dis Res, 307 Westlake Ave N 500, Seattle, WA 98109 USA.; Kaushansky, A (reprint author), Univ Washington, Dept Global Hlth, Harris Hydraul Lab, Box 357965, Seattle, WA 98195 USA.	alexis.kaushansky@cidresearch.org			 [1R01GM101183];  [1K99/R00AI111785];  [K22CA201229];  [P50CA097186]	We are grateful to Myles Hollowed for technical assistance. We thank Stefan Kappe for the gift of the P. falciparum GFP-Luc strain. We thank Photini Sinnis and Fidel Zavala for the P. yoelii Hsp70 antisera. We thank the Center for Infectious Disease Research vivarium staff for their work with mice. All work was done according to IACUC procedures and protocols. This work was funded by 1R01GM101183 (A.K.), 1K99/R00AI111785 (A.K.),K22CA201229 (T.S.G.), and P50CA097186 (T.S.G.).	Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947; Chen XA, 2006, MOL CELL, V22, P489, DOI 10.1016/j.molcel.2006.04.021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Douglass AN, 2015, MOL THER, V23, P857, DOI 10.1038/mt.2015.18; Ruivo MTG, 2016, CELL REP, V16, P2539, DOI 10.1016/j.celrep.2016.08.001; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Hora R, 2009, J BIOL CHEM, V284, P6260, DOI 10.1074/jbc.M809756200; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inacio P, 2015, EMBO REP, V16, P955, DOI 10.15252/embr.201439979; Kaushansky A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.286; Kaushansky A, 2015, SCIENCE, V350, P1089, DOI 10.1126/science.aad3318; Kaushansky A, 2011, NAT MED, V17, P1180, DOI 10.1038/nm.2456; KROTOSKI WA, 1982, AM J TROP MED HYG, V31, P1291, DOI 10.4269/ajtmh.1982.31.1291                                                      ; Lindner SE, 2012, CELL MICROBIOL, V14, P316, DOI 10.1111/j.1462-5822.2011.01734.x; Luder CGK, 2009, INT J PARASITOL, V39, P163, DOI 10.1016/j.ijpara.2008.09.013; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mast FD, 2014, J CELL BIOL, V206, P695, DOI 10.1083/jcb.201405027; Meireles P., 2016, CELL MICROBIOL, V19; Mikolajczak SA, 2015, CELL HOST MICROBE, V17, P526, DOI 10.1016/j.chom.2015.02.011; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; RODHAIN J., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P287, DOI 10.1016/0035-9203(56)90036-0; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; RYALL KA, 2015, BMC GENOMICS S12, V16; Ryall KA, 2015, BIOINFORMATICS, V31, P3799, DOI 10.1093/bioinformatics/btv427; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sibley CH, 2014, MOL BIOCHEM PARASIT, V195, P107, DOI 10.1016/j.molbiopara.2014.06.001; Sicard A, 2011, CELL MICROBIOL, V13, P836, DOI 10.1111/j.1462-5822.2011.01582.x; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Thieleke-Matos C, 2016, CELL MICROBIOL, V18, P437, DOI 10.1111/cmi.12524; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1                                                   ; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013	46	1	1	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 1	2017	8								1232	10.1038/s41467-017-01345-2				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4VE	WOS:000414228800003	29089541	gold			2018-01-05	
J	Moder, M; Velimezi, G; Owusu, M; Mazouzi, A; Wiedner, M; da Silva, JF; Robinson-Garcia, L; Schischlik, F; Slavkovsky, R; Kralovics, R; Schuster, M; Bock, C; Ideker, T; Jackson, SP; Menche, J; Loizou, JI				Moder, Martin; Velimezi, Georgia; Owusu, Michel; Mazouzi, Abdelghani; Wiedner, Marc; da Silva, Joana Ferreira; Robinson-Garcia, Lydia; Schischlik, Fiorella; Slavkovsky, Rastislav; Kralovics, Robert; Schuster, Michael; Bock, Christoph; Ideker, Trey; Jackson, Stephen P.; Menche, Joerg; Loizou, Joanna I.			Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia	NATURE COMMUNICATIONS			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; HEMATOPOIETIC STEM; BLOOMS-SYNDROME; REPAIR PATHWAY; FANCD2; SENSITIVITY; INSTABILITY; ALDEHYDES	Maintenance of genome integrity via repair of DNA damage is a key biological process required to suppress diseases, including Fanconi anemia (FA). We generated loss-of-function human haploid cells for FA complementation group C (FANCC), a gene encoding a component of the FA core complex, and used genome-wide CRISPR libraries as well as insertional mutagenesis to identify synthetic viable (genetic suppressor) interactions for FA. Here we show that loss of the BLM helicase complex suppresses FANCC phenotypes and we confirm this interaction in cells deficient for FA complementation group I and D2 (FANCI and FANCD2) that function as part of the FA I-D2 complex, indicating that this interaction is not limited to the FA core complex, hence demonstrating that systematic genome-wide screening approaches can be used to reveal genetic viable interactions for DNA repair defects.	[Moder, Martin; Velimezi, Georgia; Owusu, Michel; Mazouzi, Abdelghani; Wiedner, Marc; da Silva, Joana Ferreira; Robinson-Garcia, Lydia; Schischlik, Fiorella; Slavkovsky, Rastislav; Kralovics, Robert; Schuster, Michael; Bock, Christoph; Menche, Joerg; Loizou, Joanna I.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14,AKH BT 25-3, A-1090 Vienna, Austria; [Ideker, Trey] Univ Calif San Diego, Dept Med, Div Genet, La Jolla, CA 92093 USA; [Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ideker, Trey] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ideker, Trey] Canc Cell Map Initiat, La Jolla, CA 92093 USA; [Jackson, Stephen P.] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Wellcome Trust Res Labs, Sanger Inst, Cambridge CB10 1SA, England; [Slavkovsky, Rastislav] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic	Loizou, JI (reprint author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14,AKH BT 25-3, A-1090 Vienna, Austria.	jloizou@cemm.oeaw.ac.at		Menche, Jorg/0000-0002-1583-6404; Bock, Christoph/0000-0001-6091-3088; Jackson, Stephen Philip/0000-0001-9317-7937; Loizou, Joanna/0000-0003-1853-0424	FWF stand-alone grant [FWF29763, FWF29555]; EMBO long-term fellowship [ALTF 730 2014]; Boehringer Ingelheim Fonds PhD fellowship; DOC fellowship [OAW24102]; Austrian Academy of Sciences; US National Institutes of Health [ES014811]; WWTF career grant [VRG15-005]	We thank the Biomedical Sequencing Facility (BSF) at CeMM for all next generation sequencing and related bioinformatics analyses. We thank Thijn Brummelkamp (NKI, The Netherlands) for providing protocols and the WT HAP1 insertional mutagenesis data. Delta FANCD2 cells were kindly provided by Ketan J. Patel (LMB, Cambridge, UK). The FANCM antibody was generously provided by Weidong Wang (NIH, USA). The shRNA constructs for BRCA1 were kindly provided by Sebastian M. Nijman (Ludwig Institute for Cancer Research Ltd, UK). We thank Ian Hickson (University of Copenhagen, Denmark) for providing experimental advice and suggestions. We thank Oscar Fernandez-Capetillo (Spanish National Cancer Research Center, Spain) for discussions and input. M. M. was partially funded by an FWF stand-alone grant to J.I.L. (FWF29763). G.V. was funded by an EMBO long-term fellowship (Grant number: ALTF 730 2014) and an FWF stand-alone grant to J.I.L. (FWF29555). L.G.R. was funded by a Boehringer Ingelheim Fonds PhD fellowship. A. M. was funded by a DOC fellowship (OAW24102). CeMM is funded by the Austrian Academy of Sciences. T.I. was supported by grant ES014811 from the US National Institutes of Health. J. M. was supported by a WWTF career grant (VRG15-005).	Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Forment JV, 2017, NAT CHEM BIOL, V13, P12, DOI [10.1038/NCHEMBIO.2226, 10.1038/nchembio.2226]; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Grabarz A, 2013, CELL REP, V5, P21, DOI 10.1016/j.celrep.2013.08.034; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232                                                                ; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kais Z, 2016, CELL REP, V15, P2488, DOI 10.1016/j.celrep.2016.05.031; Kim TM, 2015, NUCLEIC ACIDS RES, V43, P893, DOI 10.1093/nar/gku1334; Kim TM, 2011, MUTAT RES-FUND MOL M, V712, P20, DOI 10.1016/j.mrfmmm.2011.03.010; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Michl J, 2016, EMBO J, V35, P909, DOI 10.15252/embj.201693860; Mikami K, 1996, CANCER RES, V56, P2823; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Murina O, 2014, CELL REP, V7, P1030, DOI 10.1016/j.celrep.2014.03.069; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	36	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 1	2017	8								1238	10.1038/s41467-017-01439-x				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4VG	WOS:000414229000002	29089570	gold			2018-01-05	
J	Mumbach, MR; Satpathy, AT; Boyle, EA; Dai, C; Gowen, BG; Cho, SW; Nguyen, ML; Rubin, AJ; Granja, JM; Kazane, KR; Wei, YN; Nguyen, T; Greenside, PG; Corces, MR; Tycko, J; Simeonov, DR; Suliman, N; Li, R; Xu, J; Flynn, RA; Kundaje, A; Khavari, PA; Marson, A; Corn, JE; Quertermous, T; Greenleaf, WJ; Chang, HY				Mumbach, Maxwell R.; Satpathy, Ansuman T.; Boyle, Evan A.; Dai, Chao; Gowen, Benjamin G.; Cho, Seung Woo; Nguyen, Michelle L.; Rubin, Adam J.; Granja, Jeffrey M.; Kazane, Katelynn R.; Wei, Yuning; Nguyen, Trieu; Greenside, Peyton G.; Corces, M. Ryan; Tycko, Josh; Simeonov, Dimitre R.; Suliman, Nabeela; Li, Rui; Xu, Jin; Flynn, Ryan A.; Kundaje, Anshul; Khavari, Paul A.; Marson, Alexander; Corn, Jacob E.; Quertermous, Thomas; Greenleaf, William J.; Chang, Howard Y.			Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements	NATURE GENETICS			English	Article							HUMAN GENOME; CHROMATIN ARCHITECTURE; HI-C; VARIANTS; RESOLUTION; PROMOTERS; LOCI; SPECIFICITY; DIFFERENTIATION; TRANSCRIPTION	The challenge of linking intergenic mutations to target genes has limited molecular understanding of human diseases. Here we show that H3K27ac HiChIP generates high-resolution contact maps of active enhancers and target genes in rare primary human T cell subtypes and coronary artery smooth muscle cells. Differentiation of naive T cells into T helper 17 cells or regulatory T cells creates subtype-specific enhancer-promoter interactions, specifically at regions of shared DNA accessibility. These data provide a principled means of assigning molecular functions to autoimmune and cardiovascular disease risk variants, linking hundreds of noncoding variants to putative gene targets. Target genes identified with HiChIP are further supported by CRISPR interference and activation at linked enhancers, by the presence of expression quantitative trait loci, and by allele-specific enhancer loops in patient-derived primary cells. The majority of disease-associated enhancers contact genes beyond the nearest gene in the linear genome, leading to a fourfold increase in the number of potential target genes for autoimmune and cardiovascular diseases.	[Mumbach, Maxwell R.; Satpathy, Ansuman T.; Boyle, Evan A.; Dai, Chao; Cho, Seung Woo; Granja, Jeffrey M.; Wei, Yuning; Corces, M. Ryan; Li, Rui; Xu, Jin; Flynn, Ryan A.; Greenleaf, William J.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Mumbach, Maxwell R.; Boyle, Evan A.; Granja, Jeffrey M.; Greenside, Peyton G.; Tycko, Josh; Suliman, Nabeela; Kundaje, Anshul; Greenleaf, William J.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Gowen, Benjamin G.; Kazane, Katelynn R.; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Gowen, Benjamin G.; Kazane, Katelynn R.; Marson, Alexander; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Nguyen, Michelle L.; Simeonov, Dimitre R.; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Rubin, Adam J.; Khavari, Paul A.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Nguyen, Trieu; Quertermous, Thomas] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Simeonov, Dimitre R.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Marson, Alexander; Greenleaf, William J.] Chan Zuckerberg Biohub, San Francisco, CA 94143 USA; [Marson, Alexander; Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Greenleaf, WJ; Chang, HY (reprint author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Greenleaf, WJ (reprint author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Chang, HY (reprint author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.; Greenleaf, WJ (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94143 USA.; Greenleaf, WJ (reprint author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	wjg@stanford.edu; howchang@stanford.edu		Kundaje, Anshul/0000-0003-3084-2287; Satpathy, Ansuman/0000-0002-5167-537X; Boyle, Evan/0000-0003-4494-9771; Corn, Jacob/0000-0002-7798-5309	US National Institutes of Health (NIH) [P50HG007735, U19AI057266, 1UM1HG009436]; Human Frontier Science Program; Rita Allen Foundation; Scleroderma Research Foundation; National Science Foundation; Cancer Research Institute; IGI-AstraZeneca Postdoctoral Fellowship; Leukemia & Lymphoma Society; Li Ka Shing Foundation; Heritage Medical Research Institute	We thank members of the Chang and Greenleaf laboratories for helpful discussions and J. Tumey for artwork. We thank J. Engreitz, M. Pjanic, and C. Miller for assistance interpreting their published data sets. We thank X. Ji and J. Coller at the Stanford Functional Genomics Facility. We thank Agilent Technologies for generating oligonucleotide pools for cloning of the CRISPRa gRNAs. We thank the UC Berkeley High-Throughput Screening Facility and Flow Cytometry Facility. This work was supported by US National Institutes of Health (NIH) grants P50HG007735 (H.Y.C. and W.J.G.) U19AI057266 (W.J.G.), and 1UM1HG009436 (W.J.G.), the Human Frontier Science Program (W.J.G.), the Rita Allen Foundation (W.J.G.), and the Scleroderma Research Foundation (H.Y.C.). M.R.M. and E.A.B. acknowledge support from the National Science Foundation Graduate Research Fellowship. A.T.S. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. B.G.G. was supported by an IGI-AstraZeneca Postdoctoral Fellowship. M.R.C. is supported by a grant from the Leukemia & Lymphoma Society Career Development Program. J.E.C. was supported by the Li Ka Shing Foundation and the Heritage Medical Research Institute. W.J.G. and A. M. are Chan Zuckerberg Biohub investigators. Sequencing was performed by the Stanford Functional Genomics Facility (NIH S10OD018220).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bonnal RJP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.51; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dao LTM, 2017, NAT GENET, V49, P1073, DOI 10.1038/ng.3884; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Franzen O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Miller CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12092; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI [10.1038/NMTH.3999, 10.1038/nmeth.3999]; Nurnberg ST, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005155; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Sinha R., 2017, 4000 DNA; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; van Arensbergen J, 2014, TRENDS CELL BIOL, V24, P695, DOI 10.1016/j.tcb.2014.07.004; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	60	1	1	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2017	49	11					1602	+		10.1038/ng.3963				14	Genetics & Heredity	Genetics & Heredity	FL0OD	WOS:000413909800009	28945252				2018-01-05	
J	Romero, R; Sayin, VI; Davidson, SM; Bauer, MR; Singh, SX; LeBoeuf, SE; Karakousi, TR; Ellis, DC; Bhutkar, A; Sanchez-Rivera, FJ; Subbaraj, L; Martinez, B; Bronson, RT; Prigge, JR; Schmidt, EE; Thomas, CJ; Goparaju, C; Davies, A; Dolgaley, I; Heguy, A; Allaj, V; Poirier, JT; Moreira, AL; Rudin, CM; Pass, HI; Vander Heiden, MG; Jacks, T; Papagiannakopoulos, T				Romero, Rodrigo; Sayin, Volkan I.; Davidson, Shawn M.; Bauer, Matthew R.; Singh, Simranjit X.; LeBoeuf, Sarah E.; Karakousi, Triantafyllia R.; Ellis, Donald C.; Bhutkar, Arjun; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Martinez, Britney; Bronson, Roderick T.; Prigge, Justin R.; Schmidt, Edward E.; Thomas, Craig J.; Goparaju, Chandra; Davies, Angela; Dolgaley, Igor; Heguy, Adriana; Allaj, Viola; Poirier, John T.; Moreira, Andre L.; Rudin, Charles M.; Pass, Harvey I.; Vander Heiden, Matthew G.; Jacks, Tyler; Papagiannakopoulos, Thales			Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis	NATURE MEDICINE			English	Article							RENAL-CELL CARCINOMA; SIGNALING PATHWAY; TUMOR INITIATION; SEQUENCING DATA; NRF2; EXPRESSION; ADENOCARCINOMA; PROGRESSION; METABOLISM; ACTIVATION	Treating KRAS-mutant lung adenocarcinoma (LUAD) remains a major challenge in cancer treatment given the difficulties associated with directly inhibiting the KRAS oncoprotein(1). One approach to addressing this challenge is to define mutations that frequently co-occur with those in KRAS, which themselves may lead to therapeutic vulnerabilities in tumors. Approximately 20% of KRAS-mutant LUAD tumors carry loss-of-function mutations in the KEAP1 gene encoding Kelch-like ECH-associated protein 1 (refs. 2-4), a negative regulator of nuclear factor erythroid 2-like 2 (NFE2L2; hereafter NRF2), which is the master transcriptional regulator of the endogenous antioxidant response5-10. The high frequency of mutations in KEAP1 suggests an important role for the oxidative stress response in lung tumorigenesis. Using a CRISPR-Cas9-based approach in a mouse model of KRAS-driven LUAD, we examined the effects of Keap1 loss in lung cancer progression. We show that loss of Keap1 hyperactivates NRF2 and promotes KRAS-driven LUAD in mice. Through a combination of CRISPR-Cas9-based genetic screening and metabolomic analyses, we show that Keap1-or Nrf2-mutant cancers are dependent on increased glutaminolysis, and this property can be therapeutically exploited through the pharmacological inhibition of glutaminase. Finally, we provide a rationale for stratification of human patients with lung cancer harboring KRAS/KEAP1-or KRAS/ NRF2-mutant lung tumors as likely to respond to glutaminase inhibition.	[Romero, Rodrigo; Davidson, Shawn M.; Bauer, Matthew R.; Ellis, Donald C.; Bhutkar, Arjun; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Vander Heiden, Matthew G.; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Romero, Rodrigo; Davidson, Shawn M.; Ellis, Donald C.; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Vander Heiden, Matthew G.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sayin, Volkan I.; Singh, Simranjit X.; LeBoeuf, Sarah E.; Karakousi, Triantafyllia R.; Martinez, Britney; Moreira, Andre L.; Papagiannakopoulos, Thales] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Bronson, Roderick T.] Tufts Univ, Boston, MA 02111 USA; [Bronson, Roderick T.] Harvard Med Sch, Boston, MA USA; [Prigge, Justin R.; Schmidt, Edward E.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Thomas, Craig J.] US Natl Inst Hlth, NIH, Chem Genom Ctr, Div Preclin Innovat,Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Goparaju, Chandra; Pass, Harvey I.] NYU, Dept Cardiothorac Surg, Langone Med Ctr, New York, NY USA; [Davies, Angela] Champ Oncol, Hackensack, NJ USA; [Heguy, Adriana] NYU, Sch Med, Genome Technol Ctr, New York, NY USA; [Poirier, John T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Poirier, John T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Papagiannakopoulos, Thales] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10003 USA	Jacks, T (reprint author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jacks, T (reprint author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Papagiannakopoulos, T (reprint author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.; Jacks, T (reprint author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Papagiannakopoulos, T (reprint author), NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10003 USA.	tjacks@mit.edu; papagt01@nyumc.org		Pass, Harvey/0000-0003-3222-3471; Sayin, Volkan/0000-0002-5225-8260; Rudin, Charles/0000-0001-5204-3465; Dolgalev, Igor/0000-0003-4451-126X; Poirier, John/0000-0001-9795-5644	National Institutes of Health (NIH); National Cancer Institute [P30-CA14051]; American Cancer Society; Hope Funds for Cancer Research; NIH [K22CA201088-01, 5T32HL007151-38]; New York University Department of Pathology Bridge Grant; National Science Foundation Graduate Research Fellowship [1122374]; Swedish Medical Research Council; AG Fond; Wenner-Gren Foundations; EMBO long-term fellowship - European Commission [ALTF 1451-2015, LTCOFUND2013, GA-2013-609409]; National Cancer Institute Early Detection Research Network grant [2U01CA 111295-04]; Cancer Center Support Grant [P30-CA14051]; Howard Hughes Medical Institute; Laura and Isaac Perlmutter Cancer Support Grant	We thank D. McFadden, R. Possemato, S. Sayin, and T. Gonzalez-Robles for critical reading of the manuscript; T. Tammela, L. Sullivan, G. DeNicola, and I. Harris for scientific discussions and feedback; S. Levine and T. Mason for massively parallel sequencing expertise; M. Griffin, M. Jennings, and G. Paradis for fluorescence-activated cell sorting (FACS) support; K. Cormier and the Hope Babette Tang (1983) Histology Facility for histology support; I. Baptista, A. Deconinck, J. Teixeira, and K. Yee for administrative support; and the Swanson Biotechnology Center for excellent core facilities. This work was supported in part by the Laura and Isaac Perlmutter Cancer Support Grant, National Institutes of Health (NIH) S10 awards, and Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute. T.P. was supported by the American Cancer Society and Hope Funds for Cancer Research. The laboratory of T. P. is supported by the NIH (K22CA201088-01) and the New York University Department of Pathology Bridge Grant. R. R. was supported by the National Science Foundation Graduate Research Fellowship under grant number 1122374. V.I.S. received support from the Swedish Medical Research Council, the AG Fond, and the Wenner-Gren Foundations and is the recipient of EMBO long-term fellowship ALTF 1451-2015 that is co-funded by the European Commission (LTCOFUND2013, GA-2013-609409) with support from Marie Curie Actions. S.E.L. is supported by an NIH training grant (5T32HL007151-38). Human tumor collection by H.I.P. was supported by a National Cancer Institute Early Detection Research Network grant (2U01CA 111295-04). Research in the laboratory of T. J. was supported by Cancer Center Support Grant P30-CA14051 and the Howard Hughes Medical Institute.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bauer AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026590; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimitrova N, 2016, CANCER DISCOV, V6, P188, DOI 10.1158/2159-8290.CD-15-0854; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fabrizio FP, 2017, ONCOTARGET, V8, P11187, DOI 10.18632/oncotarget.14492; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3                  ; Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006; Goldstein LD, 2016, CELL REP, V16, P2605, DOI 10.1016/j.celrep.2016.08.010; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Krall E. B., 2017, ELIFE, V1, P6; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Muscarella LA, 2011, EPIGENETICS-US, V6, P317, DOI 10.4161/epi.6.3.14408                                                           ; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Satoh H, 2016, CANCER RES, V76, P3088, DOI 10.1158/0008-5472.CAN-15-1584; Satoh H, 2013, CANCER RES, V73, P4158, DOI 10.1158/0008-5472.CAN-12-4499; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schneeberger VE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160587; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5                                                    ; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632	70	0	0	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1362	+		10.1038/nm.4407				11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	WOS:000414548300018	28967920				2018-01-05	
J	Westra, ER; Sunderhauf, D; Landsberger, M; Buckling, A				Westra, Edze R.; Sunderhauf, David; Landsberger, Mariann; Buckling, Angus			Mechanisms and consequences of diversity-generating immune strategies	NATURE REVIEWS IMMUNOLOGY			English	Article							CRISPR-CAS SYSTEMS; ZEBRAFISH ANTIBODY REPERTOIRE; RED QUEEN HYPOTHESIS; HIGH MUTATION-RATES; ESCHERICHIA-COLI; RNA INTERFERENCE; ADAPTIVE IMMUNITY; GERMINAL CENTER; SEXUAL REPRODUCTION; ANTIVIRAL IMMUNITY	Species from all five kingdoms of life have evolved sophisticated mechanisms to generate diversity in genes that are involved in host-pathogen interactions, conferring reduced levels of parasitism to both individuals and populations. Here, we highlight unifying concepts that underpin these evolutionarily unrelated diversity-generating mechanisms (DGMs). We discuss the mechanisms of and selective forces acting on these diversity-generating immune strategies, as well as their epidemiological and co-evolutionary consequences. We propose that DGMs can be broadly classified into two classes -targeted and untargeted DGMs -which generate different levels of diversity with important consequences for host-parasite co-evolution.	[Westra, Edze R.; Sunderhauf, David; Landsberger, Mariann; Buckling, Angus] Univ Exeter, Biosci, Exeter TR10 9EZ, Devon, England	Westra, ER (reprint author), Univ Exeter, Biosci, Exeter TR10 9EZ, Devon, England.	E.R.Westra@exeter.ac.uk			Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; Royal Society; Leverhulme Trust; Wellcome Trust; European Research Council; AXA research fund	E.R.W. and A.B. acknowledge the Natural Environment Research Council, the Biotechnology and Biological Sciences Research Council, the Royal Society, the Leverhulme Trust, the Wellcome Trust, the European Research Council and the AXA research fund for funding.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Ashby B, 2015, J EVOLUTION BIOL, V28, P511, DOI 10.1111/jeb.12590; Atanasiu C, 2002, NUCLEIC ACIDS RES, V30, P3936, DOI 10.1093/nar/gkf518                                                              ; Baer B, 2001, EVOLUTION, V55, P1639; Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; Baer B, 2003, ECOL LETT, V6, P106, DOI 10.1046/j.1461-0248.2003.00411.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Chabas H, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0721; Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elton CS, 1958, ECOLOGY INVASIONS AN; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Forsberg LA, 2017, NAT REV GENET, V18, P128, DOI 10.1038/nrg.2016.145; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gemmill AW, 1997, EVOLUTION, V51, P393, DOI 10.1111/j.1558-5646.1997.tb02426.x; Gerber M, 2014, TRENDS MICROBIOL, V22, P446, DOI 10.1016/j.tim.2014.04.001; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879                                                       ; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238                                                         ; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; HERMAN RK, 1971, J BACTERIOL, V106, P543; Holz CL, 2012, J VIROL, V86, P786, DOI 10.1128/JVI.06210-11; Horns F, 2016, ELIFE, V5, DOI 10.7554/eLife.16578; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; Kamiya T, 2014, MOL ECOL, V23, P5151, DOI 10.1111/mec.12934; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; King KC, 2009, OIKOS, V118, P1416, DOI 10.1111/j.1600-0706.2009.17476.x; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; KORONA R, 1993, EVOLUTION, V47, P556, DOI 10.1111/j.1558-5646.1993.tb02113.x; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Lafforgue G, 2011, J VIROL, V85, P9686, DOI 10.1128/JVI.05326-11; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818                                                         ; LEVIN BR, 1988, PHILOS T ROY SOC B, V319, P459, DOI 10.1098/rstb.1988.0059                                                          ; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0                                                                ; Lively CM, 2010, J HERED, V101, pS13, DOI 10.1093/jhered/esq010; Lively CM, 2010, AM NAT, V175, pE149, DOI 10.1086/652430; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Luijckx P, 2013, CURR BIOL, V23, P1085, DOI 10.1016/j.cub.2013.04.064; Luijckx P, 2011, ECOL LETT, V14, P125, DOI 10.1111/j.1461-0248.2010.01561.x; Lumley AJ, 2015, NATURE, V522, P470, DOI 10.1038/nature14419; Lynch M, 2016, NAT REV GENET, V17, P704, DOI 10.1038/nrg.2016.104; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; MAIZELS N, 1987, CELL, V48, P359, DOI 10.1016/0092-8674(87)90182-6; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Martinez F, 2012, MOL BIOL EVOL, V29, P3297, DOI 10.1093/molbev/mss135; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833                                                   ; McDonald MJ, 2016, NATURE, V531, P233, DOI 10.1038/nature17143; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Morgan AD, 2010, EVOLUTION, V64, P2980, DOI 10.1111/j.1558-5646.2010.01037.x; Morley D, 2017, MOL ECOL, V26, P1756, DOI 10.1111/mec.13917; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Paul BG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7585; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pleska M, 2016, CURR BIOL, V26, P404, DOI 10.1016/j.cub.2015.12.041; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0                                                                ; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5                                                    ; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97                                                     ; Schwede A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005259; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Maynard Smith J., 1978, EVOLUTION SEX; Maynard Smith J., 1971, GROUP SELECTION, P163; Sneppen K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00528; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1                                                    ; Swaney S, 1995, MOL PLANT MICROBE IN, V8, P1004, DOI 10.1094/MPMI-8-1004                                                             ; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tubbs A, 2017, CELL, V168, P644, DOI 10.1016/j.cell.2017.01.002; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vergara D, 2014, AM NAT, V184, pS22, DOI 10.1086/676886; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wielgoss S, 2016, MOL BIOL EVOL, V33, P770, DOI 10.1093/molbev/msv270; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026                                                             ; Zaman L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002023; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	150	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2017	17	11					719	728		10.1038/nri.2017.78				10	Immunology	Immunology	FL1LO	WOS:000413976600010	28787398				2018-01-05	
J	Nelson, CE; Robinson-Hamm, JN; Gersbach, CA				Nelson, Christopher E.; Robinson-Hamm, Jacqueline N.; Gersbach, Charles A.			Genome engineering: a new approach to gene therapy for neuromuscular disorders	NATURE REVIEWS NEUROLOGY			English	Review							DUCHENNE MUSCULAR-DYSTROPHY; ZINC-FINGER NUCLEASES; PLURIPOTENT STEM-CELLS; ADENOASSOCIATED VIRUS AAV; HOMOLOGY-DIRECTED-REPAIR; IMPROVES MUSCLE FUNCTION; DOUBLE-STRAND BREAKS; MOUSE MODEL; IN-VIVO; MYOTONIC-DYSTROPHY	For many neuromuscular disorders, including Duchenne muscular dystrophy, spinal muscular atrophy and myotonic dystrophy, the genetic causes are well known. Gene therapy holds promise for the treatment of these monogenic neuromuscular diseases, and many such therapies have made substantial strides toward clinical translation. Recently, genome engineering tools, including targeted gene editing and gene regulation, have become available to correct the underlying genetic mutations that cause these diseases. In particular, meganucleases, zinc finger nucleases, TALENs, and the CRISPR-Cas9 system have been harnessed to make targeted and specific modifications to the genome. However, for most gene therapy applications, including genome engineering, gene delivery remains the primary hurdle to clinical translation. In preclinical models, genome engineering tools have been delivered via gene-modified cells or by non-viral or viral vectors to correct a diverse array of genetic diseases. In light of the positive results of these studies, genome engineering therapies are being enthusiastically explored for several genetic neuromuscular disorders. This Review summarizes the genome engineering strategies that are currently under preclinical evaluation for the treatment of degenerative neuromuscular disorders, with a focus on the molecular tools that show the greatest potential for clinical translation of these therapies.	[Nelson, Christopher E.; Robinson-Hamm, Jacqueline N.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, 101 Sci Dr,FCIEMAS Bldg,Box 90281, Durham, NC 27708 USA; [Nelson, Christopher E.; Robinson-Hamm, Jacqueline N.; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, 101 Sci Dr,DUMC Box 3382, Durham, NC 27708 USA; [Gersbach, Charles A.] Duke Univ, Dept Orthopaed Surg, Med Ctr, 200 Trent Dr, Durham, NC 27710 USA	Gersbach, CA (reprint author), Duke Univ, Dept Biomed Engn, 101 Sci Dr,FCIEMAS Bldg,Box 90281, Durham, NC 27708 USA.; Gersbach, CA (reprint author), Duke Univ, Ctr Genom & Computat Biol, 101 Sci Dr,DUMC Box 3382, Durham, NC 27708 USA.; Gersbach, CA (reprint author), Duke Univ, Dept Orthopaed Surg, Med Ctr, 200 Trent Dr, Durham, NC 27710 USA.	charles.gersbach@duke.edu			Muscular Dystrophy Association [MDA277360]; Duke-Coulter Translational Partnership Grant; Duke/UNC-Chapel Hill CTSA Consortium; Hartwell Foundation; March of Dimes Foundation; NIH [R01AR069085, UH3TR000505, DP2-OD008586]; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0469, W81XWH-16-1-0221]; Thorek Memorial Foundation; Paul G. Allen Frontiers Group; National Science Foundation; American Heart Association	The authors' work has been supported by the Muscular Dystrophy Association (grant MDA277360), a Duke-Coulter Translational Partnership Grant, a Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award, a Hartwell Foundation Individual Biomedical Research Award, a March of Dimes Foundation Basil O'Connor Starter Scholar Award, NIH grants R01AR069085 and UH3TR000505, an NIH Director's New Innovator Award (DP2-OD008586), the Office of the Assistant Secretary of Defense for Health Affairs, through the Duchenne Muscular Dystrophy Research Program under awards W81XWH-15-1-0469 and W81XWH-16-1-0221, the Thorek Memorial Foundation, and the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the NIH or Department of Defense. C.E.N. is supported by a Hartwell Foundation Postdoctoral Fellowship and J.R.H. is supported by a National Science Foundation Graduate Research Fellowship and American Heart Association Predoctoral Fellowship.	Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Abu-Baker A, 2007, BBA-MOL BASIS DIS, V1772, P173, DOI 10.1016/j.bbadis.2006.10.003; Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100; Al-Zaidy S, 2014, PEDIATR NEUROL, V51, P607, DOI 10.1016/j.pediatrneurol.2014.08.002; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Arnett ALH, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.38; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arruda VR, 2004, BLOOD, V103, P85, DOI 10.1182/blood-2003-05-1446; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Benabdallah BF, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.55; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bortolanza S, 2011, MOL THER, V19, P2055, DOI 10.1038/mt.2011.153; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164                                                              ; BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429                                                             ; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckland KF, 2014, ADV DRUG DELIVER REV, V73, P162, DOI 10.1016/j.addr.2014.02.010; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cai YJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01911; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chapdelaine P, 2010, GENE THER, V17, P846, DOI 10.1038/gt.2010.26; Chapdelaine P, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.41; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Corbi N, 2000, GENE THER, V7, P1076, DOI 10.1038/sj.gt.3301204; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; DAVIE AM, 1978, J MED GENET, V15, P339, DOI 10.1136/jmg.15.5.339; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; De Michele G, 2015, NAT REV NEUROL, V11, P188, DOI 10.1038/nrneurol.2015.33; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; DiMatteo D, 2008, EXP CELL RES, V314, P878, DOI 10.1016/j.yexcr.2007.10.012; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja0575191; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Faust SM, 2013, J CLIN INVEST, V123, P2994, DOI 10.1172/JCI68205; Feeney SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117665; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Foster H, 2012, HUM GENE THER, V23, P676, DOI 10.1089/hum.2012.099; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gerard C, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.44; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Geutskens SB, 2000, GENE THER, V7, P1410, DOI 10.1038/sj.gt.3301251; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Godinho BMDC, 2015, DRUG DISCOV TODAY, V20, P50, DOI 10.1016/j.drudis.2014.09.011; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Gordley RM, 2009, P NATL ACAD SCI USA, V106, P5053, DOI 10.1073/pnas.0812502106; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Goyenvalle A, 2015, NAT MED, V21, P270, DOI 10.1038/nm.3765; Gruber K, 2012, LANCET, V380, pE10, DOI 10.1016/S0140-6736(12)61992-8                                                   ; Harish P, 2015, HUM GENE THER, V26, P286, DOI 10.1089/hum.2015.014; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Hartmann J, 2016, AM J HEMATOL, V91, P1252, DOI 10.1002/ajh.24543; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Izmiryan A, 2011, NUCLEIC ACIDS RES, V39, P7610, DOI 10.1093/nar/gkr524; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kasparek P, 2014, FEBS LETT, V588, P3982, DOI 10.1016/j.febslet.2014.09.014; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kemaladewi DU, 2017, NAT MED, V23, P984, DOI 10.1038/nm.4367; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kimura E, 2010, MOL THER, V18, P206, DOI 10.1038/mt.2009.253; Klein AF, 2015, CURR GENE THER, V15, P329, DOI 10.2174/1566523215666150630120537                                               ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Larkindale J, 2014, MUSCLE NERVE, V49, P431, DOI 10.1002/mus.23942; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lek A, 2015, TRENDS MOL MED, V21, P295, DOI 10.1016/j.molmed.2015.02.011; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Li YJ, 2015, MOL THER, V23, P1055, DOI 10.1038/mt.2015.41; Liu J, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.13; Liu J, 2012, CURR GENE THER, V12, P307, DOI 10.2174/156652312802083585                                                      ; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525                                                         ; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long CZ, 2016, JAMA NEUROL, V73, P1349, DOI 10.1001/jamaneurol.2016.3388; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Lu QL, 2003, GENE THER, V10, P131, DOI 10.1038/sj.gt.3301874; Madsen D, 2009, J GEN VIROL, V90, P2622, DOI 10.1099/vir.0.014175-0; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maggio I, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0316-x; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; McNeer NA, 2013, GENE THER, V20, P658, DOI 10.1038/gt.2012.82; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Moore R, 2014, ACS SYNTH BIOL, V3, P708, DOI 10.1021/sb400137b; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; Onori A, 2007, BIOCHEM CELL BIOL, V85, P358, DOI 10.1139/O07-015; Onori A, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-3; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Palmieri B, 2010, SURG TODAY, V40, P902, DOI 10.1007/s00595-009-4242-z; Pandey SN, 2014, MOL THER, V22, P390, DOI 10.1038/mt.2013.263; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Perie S, 2014, MOL THER, V22, P219, DOI 10.1038/mt.2013.155; Persons DA, 2010, MOL THER, V18, P861, DOI 10.1038/mt.2010.70; Popplewell L, 2013, HUM GENE THER, V24, P692, DOI 10.1089/hum.2013.081; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Quadros RM, 2015, FEBS OPEN BIO, V5, P191, DOI 10.1016/j.fob.2015.03.003; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rando TA, 2007, BBA-MOL BASIS DIS, V1772, P263, DOI 10.1016/j.bbadis.2006.07.009; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Remy S, 2014, GENOME RES, V24, P1371, DOI 10.1101/gr.171538.113; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031                                                           ; Richard GF, 2015, TRENDS GENET, V31, P177, DOI 10.1016/j.tig.2015.02.003; Richard GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095611; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; Robinson-Hamm JN, 2016, HUM GENET, V135, P1029, DOI 10.1007/s00439-016-1725-z; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Sato T, 2015, STEM CELL REP, V5, P75, DOI 10.1016/j.stemcr.2015.05.011; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Seto Jane T, 2014, Curr Pediatr Rep, V2, P102; Seto J. T., CURR GENE THER, V12; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shelbourne Peggy, 1992, Human Mutation, V1, P183, DOI 10.1002/humu.1380010302; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shen S, 2013, J BIOL CHEM, V288, P28814, DOI 10.1074/jbc.M113.482380; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Sondergaard PC, 2015, ANN CLIN TRANSL NEUR, V2, P256, DOI 10.1002/acn3.172; STITELMAN DH, 2014, MOL THER METHODS CLI, V1; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Strimpakos G, 2014, J CELL PHYSIOL, V229, P1283, DOI 10.1002/jcp.24567; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Tinsley J, 2015, J CLIN PHARMACOL, V55, P698, DOI 10.1002/jcph.468; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366                                                            ; Turan S, 2016, MOL THER, V24, P685, DOI 10.1038/mt.2016.40; Udd B, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0434-4; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Vannoy CH, 2014, HUM GENE THER METHOD, V25, P187, DOI 10.1089/hgtb.2013.151; Verhaart IEC, 2012, CURR OPIN NEUROL, V25, P588, DOI 10.1097/WCO.0b013e328357b0be; VICTOR M, 1962, NEW ENGL J MED, V267, P1267, DOI 10.1056/NEJM196212202672501; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183                                                ; Wooddell CI, 2011, HUM GENE THER, V22, P889, DOI 10.1089/hum.2010.160; Wu TL, 2014, MOL THER, V22, P42, DOI 10.1038/mt.2013.218; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xia GB, 2015, STEM CELLS, V33, P1829, DOI 10.1002/stem.1970; Xu L., 2013, MOL THERAPY NUCL ACI, V2, P112; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yu HH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101668; Yu M, 2013, HUM GENE THER, V24, P317, DOI 10.1089/hum.2012.084; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang GF, 2010, HUM GENE THER, V21, P221, DOI 10.1089/hum.2009.133; Zhang W., MOL THER; Zhang YD, 2012, HUM GENE THER, V23, P98, DOI 10.1089/hum.2011.131; Zhao CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096279; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	247	0	0	25	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	NOV	2017	13	11					647	661		10.1038/nrneurol.2017.126				15	Clinical Neurology	Neurosciences & Neurology	FL1LI	WOS:000413975900010	28960187				2018-01-05	
J	Roesch, EA; Drumm, ML				Roesch, Erica A.; Drumm, Mitchell L.			Powerful tools for genetic modification: Advances in gene editing	PEDIATRIC PULMONOLOGY			English	Review						cystic fibrosis; DNA repair; mutation	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; AIRWAY EPITHELIAL-CELLS; STEM-CELLS; CFTR; EXPRESSION; IDENTIFICATION; DEFECT; CAS9; CRISPR/CAS9	Recent discoveries and technical advances in genetic engineering, methods called gene or genome editing, provide hope for repairing genes that cause diseases like cystic fibrosis (CF) or otherwise altering a gene for therapeutic benefit. There are both hopes and hurdles with these technologies, with new ideas emerging almost daily. Initial studies using intestinal organoid cultures carrying the common, F508del mutation have shown that gene editing by CRISPR/Cas9 can convert cells lacking CFTR function to cells with normal channel function, providing a precedent that this technology can be harnessed for CF. While this is an important precedent, the challenges that remain are not trivial. A logistical issue for this and many other genetic diseases is genetic heterogeneity. Approximately, 2000 mutations associated with CF have been found in CFTR, the gene responsible for CF, and thus a feasible strategy that would encompass all individuals affected by the disease is particularly difficult to envision. However, single strategies that would be applicable to all subjects affected by CF have been conceived and are being investigated. With all of these approaches, efficiency (the proportion of cells edited), accuracy (how often other sites in the genome are affected), and delivery of the gene editing components to the desired cells are perhaps the most significant, impending hurdles. Our understanding of each of these areas is increasing rapidly, and while it is impossible to predict when a successful strategy will reach the clinic, there is every reason to believe it is a question of when and not if.	[Roesch, Erica A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Dept Genet & Genome Sci, Res Inst Childrens Hlth, Biomed Res Bldg,Room 733, Cleveland, OH 44106 USA	Drumm, ML (reprint author), Case Western Reserve Univ, Dept Pediat, Dept Genet & Genome Sci, Res Inst Childrens Hlth, Biomed Res Bldg,Room 733, Cleveland, OH 44106 USA.	mitchell.drumm@case.edu					Alton EWFW, 2016, PEDIATR PULM, V51, pS5, DOI 10.1002/ppul.23543; ALTON EWFW, 1993, NAT GENET, V5, P135, DOI 10.1038/ng1093-135; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; FERKOL T, 1993, J CLIN INVEST, V92, P2394, DOI 10.1172/JCI116845; FLOTTE TR, 1992, AM J RESP CELL MOL, V7, P349, DOI 10.1165/ajrcmb/7.3.349                                                          ; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Gruet M, 2017, J CYST FRIB IN PRESS; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Milla CE, 2017, AM J RESP CRIT CARE, V195, P912, DOI 10.1164/rccm.201608-1754OC; Ollero M, 2004, J CELL PHYSIOL, V200, P235, DOI 10.1002/jcp.20020; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2005, J PHYSIOL-LONDON, V568, P483, DOI 10.1113/jphysiol.2005.085019; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shoseyov D, 2016, EXPERT REV RESP MED, P1; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Turan S, 2016, MOL THER, V24, P685, DOI 10.1038/mt.2016.40; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417                                                          	38	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-6863	1099-0496		PEDIATR PULM	Pediatr. Pulmonol.	NOV	2017	52			48			S15	S20		10.1002/ppul.23791				6	Pediatrics; Respiratory System	Pediatrics; Respiratory System	FL2HC	WOS:000414035000002	28960896				2018-01-05	
J	Geng, CH; Wang, C; Yang, J; Wang, H; Ma, RQ; Liu, X; Wang, CH				Geng, Cai-Hong; Wang, Chao; Yang, Jun; Wang, Hua; Ma, Rui-Qing; Liu, Xu; Wang, Chang-Hong			Arginine vasopressin improves the memory deficits in Han Chinese patients with first-episode schizophrenia	PEPTIDES			English	Article						Schizophrenia; Arginine vasopressin; Cognition; Memory; P-300 potential; A randomized controlled trial	HAMSTERS MESOCRICETUS-AURATUS; NEGATIVE SYNDROME SCALE; AGGRESSIVE-BEHAVIOR; CEREBROSPINAL-FLUID; BRATTLEBORO RATS; WORKING-MEMORY; RECEPTOR GENE; OXYTOCIN; MICE; SYMPTOMS	The memory impairment is a core deficit in the first-episode schizophrenia patients. Arginine vasopressin (AVP) in the brain can improve learning and memory. We performed multicentre, randomized, double-blind, placebo-controlled, parallel-group clinical trial to study the cognitive functioning in Han Chinese first-episode schizophrenic patients in a 12-week treatment regime with the intranasal administration of AVP (128 cases) or placebo (131 cases) in addition to the conventional treatment. The methods of positive and negative syndrome scale (PANSS), Wechsler memory scale-4th edition (WMS-IV) and event-related potential (ERP) were used to study the effects of AVP on the cognitive function. The results showed that (1) AVP concentration decreased in cerebrospinal fluid (CSF) of the right-handed Han Chinese first-episode schizophrenic patients comparing with that of the health volunteers (7.1 +/- 1.5 pg/ml vs 13.3 +/- 1.9 pg/ml, p < 0.01), and did not change in plasma; (2) AVP significantly improved PANSS scores including total scores, positive symptoms, negative symptoms and general psychopathology comparing with those of the placebo group; (3) AVP elevated WMS-IV scores including the long-term memory (accumulation), short-term memory (recognition, comprehension), immediate memory (number recitation) and memory quotient 4, 8 and 12 weeks after treatment; and (4) AVP did not influence the latency and wave amplitude of target stimulus of P-300 of right-handed Han Chinese first-episode schizophrenic patients. The data suggested that AVP might improve cognitive process, such as memorizing and extraction of the information although there were many changes of cognitive functions in the right-handed Han Chinese first-episode schizophrenic patients.	[Geng, Cai-Hong; Wang, Chao; Liu, Xu; Wang, Chang-Hong] Xinxiang Med Univ, Affiliated Hosp 2, Xinxiang 453002, Henan, Peoples R China; [Geng, Cai-Hong; Wang, Chao; Liu, Xu; Wang, Chang-Hong] Henan Prov Mental Hosp, Xinxiang 453002, Henan, Peoples R China; [Yang, Jun; Wang, Hua; Ma, Rui-Qing] Xinxiang Inst New Med, Xinxing 453003, Henan, Peoples R China; [Yang, Jun; Wang, Hua] Xinjiang Hongda Food & Beverage Ltd, Xinjiang 043110, Shanxi, Peoples R China	Yang, J (reprint author), Xinxiang Inst New Med, Xinxing 453003, Henan, Peoples R China.	bcd2009@126.com			National Natural Science Foundation of China [87671346]	This work was supported by the grants from National Natural Science Foundation of China (87671346).	Albers HE, 1998, PROG BRAIN RES, V119, P395; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441                                                      ; ANTUNES JL, 1978, J COMP NEUROL, V181, P539; Bao LL, 2014, NEUROPEPTIDES, V48, P361, DOI 10.1016/j.npep.2014.09.006; Barak Y, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-108; Barak Y, 2010, COMPR PSYCHIAT, V51, P94, DOI 10.1016/j.comppsych.2008.11.013; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; BECKMANN H, 1985, PSYCHONEUROENDOCRINO, V10, P187, DOI 10.1016/0306-4530(85)90056-3; Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Blanchard RJ, 2005, PHARMACOL BIOCHEM BE, V80, P189, DOI 10.1016/j.pbb.2004.10.024; Bleuler E., 1911, HDB PSYCHIAT; BLUTHE RM, 1993, PSYCHONEUROENDOCRINO, V18, P323, DOI 10.1016/0306-4530(93)90028-J; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Busnelli M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12359; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Caldwell Heather K, 2016, Curr Top Behav Neurosci, V27, P51; Cilia J, 2010, J PSYCHOPHARMACOL, V24, P407, DOI 10.1177/0269881108098787; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sb1029; Demeter K, 2016, BEHAV BRAIN RES, V300, P123, DOI 10.1016/j.bbr.2015.12.007; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Engelmann M, 2008, PROG BRAIN RES, V170, P389, DOI 10.1016/S0079-6123(08)00432-9; Ferris CF, 2006, PHARMACOL BIOCHEM BE, V83, P169, DOI 10.1016/j.pbb.2006.01.001; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Fervaha G, 2015, J CLIN PSYCHOPHARM, V35, P128, DOI 10.1097/JCP.0000000000000286; Goldman MB, 1996, CLIN ENDOCRINOL, V44, P31, DOI 10.1046/j.1365-2265.1996.641463.x; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636                                                      ; Guillon G, 2004, J NEUROENDOCRINOL, V16, P356, DOI 10.1111/j.0953-8194.2004.01163.x; Guy W, 1976, ECDEU ASSESSMENT MAN; Harvey PD, 1998, AM J PSYCHIAT, V155, P1080, DOI 10.1176/ajp.155.8.1080                                                          ; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hosseini SMR, 2014, EUR NEUROPSYCHOPHARM, V24, P846, DOI 10.1016/j.euroneuro.2014.02.001; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; Jobst A, 2014, ACTA NEUROPSYCHIATR, V26, P347, DOI 10.1017/neu.2014.20; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261                                                         ; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Liberman RP, 2002, INT REV PSYCHIATR, V14, P256, DOI 10.1080/0954026021000016905; LIU Z, 1987, ACTA ZOOL SINICA, V33, P309; LOLAIT SJ, 1995, P NATL ACAD SCI USA, V92, P6783, DOI 10.1073/pnas.92.15.6783; McEwen B. B., 2004, ROLE VASOPRESSIN OXY, V50; McGurk SR, 2000, SCHIZOPHR RES, V45, P175, DOI 10.1016/S0920-9964(99)00198-X; Molina V, 2004, NEUROPSYCHOBIOLOGY, V50, P182, DOI 10.1159/000079112; MOREL A, 1993, REGUL PEPTIDES, V45, P53, DOI 10.1016/0167-0115(93)90182-8; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Petrulis A, 2009, BEHAV BRAIN RES, V200, P260, DOI 10.1016/j.bbr.2008.10.027; RASKIND MA, 1987, BIOL PSYCHIAT, V22, P453, DOI 10.1016/0006-3223(87)90167-3; Rubin LH, 2014, SCHIZOPHRENIA BULL, V40, P1374, DOI 10.1093/schbul/sbu027; Rubin LH, 2013, SCHIZOPHR RES, V146, P138, DOI 10.1016/j.schres.2013.01.019; Tremeau Fabien, 2006, Dialogues Clin Neurosci, V8, P59; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8; van Raalten TR, 2008, SCHIZOPHR RES, V100, P161, DOI 10.1016/j.schres.2007.10.035; Weickert TW, 2003, NEUROPSYCHOPHARMACOL, V28, P1491, DOI 10.1038/sj.npp.1300216; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P653, DOI 10.1111/j.1601-183X.2006.00294.x; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; White L, 1997, PSYCHOPATHOLOGY, V30, P263, DOI 10.1159/000285058                                                               ; Wu X, 2007, NEUROIMAGE, V35, P1654, DOI 10.1016/j.neuroimage.2007.02.011; Yang J, 2012, PEPTIDES, V38, P100, DOI 10.1016/j.peptides.2012.07.029; Yang J, 2012, NEUROPEPTIDES, V46, P141, DOI 10.1016/j.npep.2012.03.003; Yang J, 2009, PEPTIDES, V30, P241, DOI 10.1016/j.peptides.2008.10.013; Yang J, 2006, PEPTIDES, V27, P3341, DOI 10.1016/j.peptides.2006.08.019; Zhao XY, 2015, NEUROPEPTIDES, V52, P61, DOI 10.1016/j.npep.2015.06.002; Zhao XY, 2015, NEUROPEPTIDES, V51, P55, DOI 10.1016/j.npep.2015.01.003	66	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	NOV	2017	97						8	15		10.1016/j.peptides.2017.09.002				8	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	FK3OS	WOS:000413396000002	28882471				2018-01-05	
J	Collins, PJ; Hale, CM; Xu, H				Collins, Patrick J.; Hale, Christopher M.; Xu, Han			Edited course of biomedical research: leaping forward with CRISPR	PHARMACOLOGICAL RESEARCH			English	Review						CRISPR; Cas9; Cas13a; Gene modification; Gene modulation; CRISPR imaging; CRISPRi; CRISPRa; dCas9	PLURIPOTENT STEM-CELLS; HUMAN GENOME; IN-VIVO; DNA METHYLATION; GENE DRIVE; GUIDE RNAS; CAS9; ELEMENTS; SCREENS; DISEASE	Within the short few years since the report of its application in precise genome editing, CRISPR technology has become the method of choice to modify and modulate gene expression in biomedical research and therapeutic development. Subsequently, a variety of research, diagnostic, and therapeutic tools have been developed based upon CRISPR's mechanism of action. Such tools have helped to deepen the understanding of fundamental biology and broaden the horizon in the search for treatments for diseases that have been considered hard or impossible to cure. As CRISPR technology advances closer to clinical applications, its short comings are becoming more apparent, thus creating opportunities to improve the technology's efficacy, specificity, and safety profile in this setting. We will summarize the current status of CRISPR technology and discuss its future impact in this review. (C) 2017 Elsevier Ltd. All rights reserved.	[Collins, Patrick J.; Hale, Christopher M.; Xu, Han] Amgen Inc, Cell & Gene Therapy Unit, 1120 Vet Blvd, San Francisco, CA 94080 USA	Xu, H (reprint author), Amgen Inc, Cell & Gene Therapy Unit, 1120 Vet Blvd, San Francisco, CA 94080 USA.	hanx@amgen.com					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chen Bin, 2013, J HIGH ENERGY PHYS, V2013, P1, DOI DOI 10.1109/NSSMIC.2013.6829356; Chen BH, 2014, METHOD ENZYMOL, V546, P337, DOI 10.1016/B978-0-12-801185-0.00016-7; CHEN BH, 2016, NUCL ACIDS RES, V44; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doerflinger M, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12693; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Freiermuth J. L., 2017, J CELL BIOCH; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; HE XJ, 2016, NUCL ACIDS RES, V44; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Horlbeck M. A., 2016, ELIFE, V5, P1; Huang Z, 2017, GENE THER, V24, P377, DOI 10.1038/gt.2017.35; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson JZ, 2015, CURR OPIN CELL BIOL, V37, P84, DOI 10.1016/j.ceb.2015.10.007; Kaiser J., 2017, SCIENCE, P1; Kamb A, 2013, NAT BIOTECHNOL, V31, P975, DOI 10.1038/nbt.2732; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; Kennedy EM, 2017, ANNU REV MED, V68, P401, DOI 10.1146/annurev-med-051215-031129; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V61, P5985, DOI DOI 10.1038/NATUREL7946; Kungulovski G, 2016, TRENDS GENET, V32, P101, DOI 10.1016/j.tig.2015.12.001; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Metzakopian A., 2017, SCI REP, V7, P1; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Moreno AM, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1380; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nishida K., 2016, SCIENCE, V353; Niu D., 2017, SCIENCE, V4187, P1; Nowak CM, 2016, NUCLEIC ACIDS RES, V44, P9555, DOI 10.1093/nar/gkw908; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Park R.J., 2016, NAT GENET, V49, P1; Prabhu V., 2016, TODAY TECHNOL, V21, P17; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Regalado A., 2015, MIT TECHNOL REV, P1; Regalado A., 2015, MIT TECHNOL REV, V118, P26; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen JP, 2017, NAT METHODS, V14, P573, DOI [10.1036/NMETH.4225, 10.1038/nmeth.4225]; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Takei Y, 2017, BIOPHYS J, V112, P1773, DOI 10.1016/j.bpj.2017.03.024; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Vassena R, 2016, HUM REPROD UPDATE, V22, P411, DOI 10.1093/humupd/dmw005; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Zhou YX, 2017, CELL RES, V27, P298, DOI 10.1038/cr.2017.9	83	0	0	14	14	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	NOV	2017	125		B				258	265		10.1016/j.phrs.2017.09.008				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FL3GH	WOS:000414110400015	28918173				2018-01-05	
J	Murao, N; Yokoi, N; Honda, K; Han, GR; Hayami, T; Gheni, G; Takahashi, H; Minami, K; Seino, S				Murao, Naoya; Yokoi, Norihide; Honda, Kohei; Han, Guirong; Hayami, Tomohide; Gheni, Ghupurjan; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu			Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in beta-cell glutamate signaling for incretin-induced insulin secretion	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PHOSPHATE TRANSPORTER; RELEASE; ISLETS; TARGET; ACTS	Incretins (GLP-1 and GIP) potentiate insulin secretion through cAMP signaling in pancreatic beta-cells in a glucose-dependent manner. We recently proposed a mechanistic model of incretin-induced insulin secretion (IIIS) that requires two critical processes: 1) generation of cytosolic glutamate through the malate-aspartate (MA) shuttle in glucose metabolism and 2) glutamate transport into insulin granules by cAMP signaling to promote insulin granule exocytosis. To directly prove the model, we have established and characterized CRISPR/Cas9-engineered clonal mouse beta-cell lines deficient for the genes critical in these two processes: aspartate aminotransferase 1 (AST1, gene symbol Got1), a key enzyme in the MA shuttle, which generates cytosolic glutamate, and the vesicular glutamate transporters (VGLUT1, VGLUT2, and VGLUT3, gene symbol Slc17a7, Slc17a6, and Slc17a8, respectively), which participate in glutamate transport into secretory vesicles. Got1 knockout (KO) (3 -cell lines were defective in cytosolic glutamate production from glucose and showed impaired IIIS. Unexpectedly, different from the previous finding that global Slc17a7K0 mice exhibited impaired IIIS from pancreatic islets, beta-cell specific Slc17a7 KO mice showed no significant impairment in IIIS, as assessed by pancreas perfusion experiment. Single Slc17a7 KO 13 cell lines also retained IIIS, probably due to compensatory upregulation of Slc17a6. Interestingly, triple KO of Slc17a7, Slc17a6, and Slc17a8 diminished IIIS, which was rescued by exogenously introduced wild-type Slc17a7 or Slc17a6 genes. The present study provides direct evidence for the essential roles of AST1 and VGLUTs in beta-cell glutamate signaling for IIIS and also shows the usefulness of the CRISPR/Cas9 system for studying beta-cells by simultaneous disruption of multiple genes.	[Murao, Naoya; Yokoi, Norihide; Honda, Kohei; Han, Guirong; Hayami, Tomohide; Gheni, Ghupurjan; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan; [Han, Guirong; Hayami, Tomohide] Kansai Elect Power Med Res Inst, Kobe, Hyogo, Japan; [Han, Guirong] Kobe Univ, Div Med Chem, Dept Biophys, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Hayami, Tomohide] Aichi Med Univ, Div Diabet, Dept Internal Med, Nagakute, Aichi, Japan	Yokoi, N; Seino, S (reprint author), Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan.	yokoi@med.kobe-u.ac.jp; seino@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; MSD K.K.; Japan Diabetes Foundation	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by a research grant from MSD K.K. and a research grant from Japan Diabetes Foundation.	Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957                                                    ; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gras C, 2002, J NEUROSCI, V22, P5442; Hayashi M, 2003, J HISTOCHEM CYTOCHEM, V51, P1375, DOI 10.1177/002215540305101014                                                      ; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280                                                                   ; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Naylor J, 2016, BIOCHEM J, V473, P2881, DOI 10.1042/BCJ20160476; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; PRENTKI M, 1987, PHYSIOL REV, V67, P1185; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; SIEGEL EG, 1985, DIABETOLOGIA, V28, P857, DOI 10.1007/BF00291078; Takamori S, 2001, J NEUROSCI, V21; Tamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126003; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; Yokoi N, 2016, J DIABETES INVEST, V7, P38, DOI 10.1111/jdi.12468	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187213	10.1371/journal.pone.0187213				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4VN	WOS:000414229700046	29091932	gold			2018-01-05	
J	Paliwal, D; Joshi, P; Panda, SK				Paliwal, Daizy; Joshi, Prashant; Panda, Subrat Kumar			Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non coding RNA (IncRNA) BISPR	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ORF3 PROTEIN; CELL-LINES; IN-VIVO; EXPRESSION; RELEASE; BST-2/TETHERIN; GLYCOSYLATION; LOCALIZATION; CYTOSKELETON	Background The biology of Hepatitis E Virus (HEV), a common cause of epidemic and sporadic hepatitis, is still being explored. HEV exits liver through bile, a process which is essential for its natural transmission by feco-oral route. Though the process of this polarised HEV egress is not known in detail, HEV pORF3 and hepatocyte actin cytoskeleton have been shown to play a role. Methods Our transcriptome analysis in Hepatitis E virus (HEV) replicon transfected Huh7 cells at 24 and 72 hrs indicated that at 24hrs, both LncBISPR and BST2, expressed by a bidirectional promoter were highly upregulated whereas at 72 hrs, BST2 expression was comparatively reduced accompanied by normal levels of BISPR. These findings were confirmed by qPCR analysis. Co-localisation of BST2 and HEV pORF2 was confirmed in HEV transfected Huh7 by confocal microscopy. To investigate the role of BISPR/BST2 in HEV life cycle, particularly virus egress, we generated Huh7 cells with-8kb deletion in BISPR gene using Crispr-Cas9 system. The deletion was confirmed by PCR screening, Sanger sequencing and Real time PCR. Virus egress in BISPR Huh7 and Huh7 cells was compared by measuring HEV positive strand RNA copy numbers in cell lysates and culture supernatants at 24 and 72 hrs post HEV replicon transfection and further validated by western blot for HEV pORF2 capsid protein. Results BISPR Huh7 cells showed-8 fold increase in virus egress at 24 hrs compared to Huh7 cells. No significant difference in virus egress was observed at 72hrs. Immunohistochemistry in histologically normal liver and HEV associated acute liver failure revealed BST2 over expression in HEV infected hepatocytes and a dominant canalicular BST2 distribution in normal liver in addition to the cytoplasmic localisation reported in literature. Conclusions These findings lead us to believe that BISPR and BST2 may regulate egress of HEV virions into bile in vivo. This system may also be used to scale up virus production in vitro.	[Paliwal, Daizy; Joshi, Prashant; Panda, Subrat Kumar] All India Inst Med Sci, Dept Pathol, New Delhi, India	Panda, SK (reprint author), All India Inst Med Sci, Dept Pathol, New Delhi, India.	subrat@gmail.com		Panda, Subrat Kumar/0000-0003-0761-8631	Department of Biotechnology [BT/PR13335/MED/29/959/2015]; J.C. Bose fellowship granted form Department of Science and Technology, Govt. of India [SR/S2/JCB-05/2007]	The present work has been funded by Department of Biotechnology (www.dbtindia.nic.in) (BT/PR13335/MED/29/959/2015) and J.C. Bose fellowship (SR/S2/JCB-05/2007) granted form Department of Science and Technology, Govt. of India (www.dstgov.in) to SKP. Both the funding agencies had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Dave VP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-128; Devhare PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26827; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Emerson SU, 2004, J VIROL, V78, P4838, DOI 10.1128/JVI.78.9.4838-4846.2004; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Fujita H, 2012, CURR HIV RES, V10, P321, DOI 10.2174/157016212800792522; GOTO T, 1994, BLOOD, V84, P1922; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Gupta P, 2012, J VIRAL HEPATITIS, V19, pE177, DOI 10.1111/j.1365-2893.2011.01498.x; Homann S, 2011, J VIROL, V85, P10659, DOI 10.1128/JVI.05524-11; Jagya N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087835; Kambara H, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00676; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; Kenney SP, 2015, VIROLOGY, V486, P198, DOI 10.1016/j.virol.2015.09.012; Lei QS, 2016, VIRAL IMMUNOL, V29, P105, DOI 10.1089/vim.2015.0107; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Nagashima S, 2011, J GEN VIROL, V92, P2838, DOI 10.1099/vir.0.035378-0; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pan XB, 2013, ANTIVIR RES, V98, P54, DOI 10.1016/j.antiviral.2013.01.009; Panda SK, 2000, J VIROL, V74, P2430, DOI 10.1128/JVI.74.5.2430-2437.2000; Qi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132503; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Torresi J, 1999, J GEN VIROL, V80, P1185, DOI 10.1099/0022-1317-80-5-1185                                                     ; Varma SPK, 2011, J GEN VIROL, V92, P572, DOI 10.1099/vir.0.027714-0; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yin X, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080229; Zafrullah M, 1997, J VIROL, V71, P9045; Zafrullah M, 1999, J VIROL, V73, P4074	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187334	10.1371/journal.pone.0187334				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4VN	WOS:000414229700057	29091957	gold			2018-01-05	
J	Kanayama, M; Hayano, T; Koebis, M; Maeda, T; Tabe, Y; Horie, S; Aiba, A				Kanayama, Mayuko; Hayano, Toshiya; Koebis, Michinori; Maeda, Tatsuya; Tabe, Yoko; Horie, Shigeo; Aiba, Atsu			Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1	PROSTATE			English	Article						hyperactive mTOR; interferon regulatory factor 1; LNCaP; NED	TRANSCRIPTION FACTORS; MAMMALIAN TARGET; TUMOR-CELLS; RAPAMYCIN; PATHWAY; PROGRESSION; ACTIVATION; EXPRESSION; CARCINOMA; GROWTH	BackgroundNeuroendocrine-differentiated prostate cancer (NEPCa) is refractory to androgen deprivation therapy and shows a poor prognosis. The underlying mechanisms responsible for neuroendocrine differentiation (NED) are yet to be clarified. In this study, we investigated the role of mammalian target of rapamycin (mTOR) in NEPCa. MethodsWe utilized a gain-of-function analysis by establishing a human PCa LNCaP stable line that expresses hyperactive mTOR (LNCaP-mTOR). Then, we employed a comprehensive mass spectrometric analysis to identify a key transcription factor in LNCaP-mTOR, followed by a loss-of-function analysis using CRISPR/Cas system. ResultsThe activation of mTOR induced NED. We observed significant cell growth arrest in NED of LNCaP-mTOR, which accompanied increased expression of p21(WAF1/CIP1). A comprehensive mass spectrometric analysis identified interferon regulatory factor 1 (IRF1) as a key transcription factor in growth arrest of LNCaP-mTOR. The disruption of IRF1 gene in LNCaP-mTOR reversed cell growth arrest along with the suppression of its target p21(WAF1/CIP1). These results indicate that the growth arrest in NED is at least in part dependent on IRF1 through the induction of p21(WAF1/CIP1). ConclusionsWe identified active mTOR as a novel inducer of NED, and elucidated a mechanism underlying the malignant transformation of NEPCa by recapitulating NED in vitro.	[Kanayama, Mayuko; Horie, Shigeo] Juntendo Univ, Dept Urol, Grad Sch Med, Tokyo, Japan; [Kanayama, Mayuko; Koebis, Michinori; Aiba, Atsu] Univ Tokyo, Grad Sch Med, Lab Anim Resources, Ctr Dis Biol & Integrated Med, Tokyo, Japan; [Hayano, Toshiya] Ritsumeikan Univ, Dept Biomed Sci, Coll Life Sci, Shiga, Japan; [Maeda, Tatsuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Tabe, Yoko] Juntendo Univ, Dept Clin Lab Med, Grad Sch Med, Tokyo, Japan	Aiba, A (reprint author), Univ Tokyo, Lab Anim Resources, Ctr Dis Biol & Integrated Med, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	aiba@m.u-tokyo.ac.jp			JSPS KAKENHI [25291042, 17H03802]; Comprehensive Brain Science Network [221S0003]	JSPS KAKENHI, Grant number: 25291042 and 17H03802; Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network), Grant number: 221S0003	Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO;2-S                 ; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Amorino GP, 2004, CRIT REV EUKAR GENE, V14, P287, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.40; Andersen P, 2008, INT J CANCER, V122, P342, DOI 10.1002/ijc.23109; Armstrong MJ, 2006, THESIS; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Berenguer C, 2008, ONCOGENE, V27, P506, DOI 10.1038/sj.onc.1210656; Bonkhoff H, 1998, PROSTATE, P18; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox ME, 1999, CANCER RES, V59, P3821; Deeble PD, 2007, CANCER RES, V67, P3663, DOI 10.1158/0008-5472.CAN-06-2616; DISANTAGNESE PA, 1987, HUM PATHOL, V18, P849; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; Nelson EC, 2007, PROSTATE CANCER P D, V10, P6, DOI 10.1038/sj.pcan.4500922; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Shida T, 2010, CANCER CHEMOTH PHARM, V65, P889, DOI 10.1007/s00280-009-1094-6; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Sudhakar C, 2013, BIOCHEM BIOPH RES CO, V437, P179, DOI 10.1016/j.bbrc.2013.06.065; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623                                                ; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tohsato Y, 2012, J PROTEOMICS, V75, P4792, DOI 10.1016/j.jprot.2012.04.038; Vaarala MH, 2000, LAB INVEST, V80, P1259, DOI 10.1038/labinvest.3780134                                                       ; Venkatesh D, 2013, IMMUNITY, V38, P1025, DOI 10.1016/j.immuni.2013.01.012; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316                                                            ; Wu CY, 2007, J BIOL CHEM, V282, P3571, DOI 10.1074/jbc.M608487200; Wu TH, 2011, CANC IMMUN, V11, P2; Yang XH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2465-0; Yang XZ, 2005, CANCER RES, V65, P5263, DOI 10.1158/0008-5472.CAN-05-0162; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	42	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-4137	1097-0045		PROSTATE	Prostate	NOV 1	2017	77	15					1489	1498		10.1002/pros.23425				10	Endocrinology & Metabolism; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	FJ4AQ	WOS:000412676200004	28905415				2018-01-05	
J	Liang, PP; Ding, CH; Sun, HW; Xie, XW; Xu, YW; Zhang, XY; Sun, Y; Xiong, YY; Ma, WB; Liu, YX; Wang, YL; Fang, JP; Liu, D; Zhou, SY; Zhou, CQ; Huang, JJ				Liang, Puping; Ding, Chenhui; Sun, Hongwei; Xie, Xiaowei; Xu, Yanwen; Zhang, Xiya; Sun, Ying; Xiong, Yuanyan; Ma, Wenbin; Liu, Yongxiang; Wang, Yali; Fang, Jianpei; Liu, Dan; Zhou Songyang; Zhou, Canquan; Huang, Junjiu			Correction of beta-thalassemia mutant by base editor in human embryos	PROTEIN & CELL			English	Article						beta-thalassemia; HBB-28 (A > G); base editor; human embryo	MODIFIED CRISPR/CAS9 SYSTEM; CAS9 PROTEIN; TARGET BASE; ZYGOTES; RICE; MOUSE; SURVIVAL; MUTATION; TAIWAN; DNA	beta-Thalassemia is a global health issue, caused by mutations in the HBB gene. Among these mutations, HBB -28 (A > G) mutations is one of the three most common mutations in China and Southeast Asia patients with beta-thalassemia. Correcting this mutation in human embryos may prevent the disease being passed onto future generations and cure anemia. Here we report the first study using base editor (BE) system to correct disease mutant in human embryos. Firstly, we produced a 293T cell line with an exogenous HBB -28 (A > G) mutant fragment for gRNAs and targeting efficiency evaluation. Then we collected primary skin fibroblast cells from a beta-thalassemia patient with HBB -28 (A>G) homozygous mutation. Data showed that base editor could precisely correct HBB -28 (A > G) mutation in the patient's primary cells. To model homozygous mutation disease embryos, we constructed nuclear transfer embryos by fusing the lymphocyte or skin fibroblast cells with enucleated in vitro matured (IVM) oocytes. Notably, the gene correction efficiency was over 23.0% in these embryos by base editor. Although these embryos were still mosaic, the percentage of repaired blastomeres was over 20.0%. In addition, we found that base editor variants, with narrowed deamination window, could promote G-to-A conversion at HBB -28 site precisely in human embryos. Collectively, this study demonstrated the feasibility of curing genetic disease in human somatic cells and embryos by base editor system.	[Liang, Puping; Sun, Hongwei; Xie, Xiaowei; Zhang, Xiya; Sun, Ying; Xiong, Yuanyan; Ma, Wenbin; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou Key Lab Healthy Aging Res, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Sun, Hongwei; Xie, Xiaowei; Zhang, Xiya; Sun, Ying; Xiong, Yuanyan; Ma, Wenbin; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, State Key Lab Biocontrol, SYSU BCM Joint Res Ctr, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Ding, Chenhui; Xu, Yanwen; Liu, Yongxiang; Wang, Yali; Zhou Songyang; Zhou, Canquan; Huang, Junjiu] Sun Yat Sen Univ, Key Lab Reprod Med Guangdong Prov, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Ding, Chenhui; Xu, Yanwen; Liu, Yongxiang; Wang, Yali; Zhou Songyang; Zhou, Canquan; Huang, Junjiu] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Jianpei] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Pediat, Guangzhou 510120, Guangdong, Peoples R China; [Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA	Zhou, SY; Huang, JJ (reprint author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou Key Lab Healthy Aging Res, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, SY; Huang, JJ (reprint author), Sun Yat Sen Univ, State Key Lab Biocontrol, SYSU BCM Joint Res Ctr, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, SY; Zhou, CQ; Huang, JJ (reprint author), Sun Yat Sen Univ, Key Lab Reprod Med Guangdong Prov, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, SY; Zhou, CQ; Huang, JJ (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, SY (reprint author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA.	songyanz@mail.sysu.edu.cn; zhoucanquan@hotmail.com; hjunjiu@mail.sysu.edu.cn			National Key R&D Program of China [2017YFC1001901, 2017YFC1001600]; Science and Technology Planning Project of Guangdong Province [2015B020228002]; Guangzhou Science and Technology Project [201707010085]; National Natural Science Foundation of China [81771579]	We are grateful to Dr. Qi Zhou for helpful suggestions. This work was supported by National Key R&D Program of China (2017YFC1001901 and 2017YFC1001600), the Science and Technology Planning Project of Guangdong Province (2015B020228002), the Guangzhou Science and Technology Project (201707010085) and the National Natural Science Foundation of China (Grant No. 81771579).	Cao A, 2010, GENET MED, V12, P61, DOI 10.1097/GIM.0b013e3181cd68ed; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; Chern JPS, 2007, PEDIATR BLOOD CANCER, V48, P550, DOI 10.1002/pbc.21028; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ding CH, 2015, STEM CELLS DEV, V24, P2307, DOI 10.1089/scd.2015.0031; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hohmann S, 2017, MOL GENET GENOMICS, V292, P535, DOI 10.1007/s00438-017-1300-x; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li GL, 2017, PROTEIN CELL, V8, P776, DOI 10.1007/s13238-017-0458-7; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Liang PP, 2017, PROTEIN CELL, V8, P601, DOI 10.1007/s13238-017-0418-2; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727                                                          ; Ren B, 2017, SCI CHINA LIFE SCI, V60, P516, DOI 10.1007/s11427-016-0406-x; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Wang LJ, 2017, CELL RES, V27, P1289, DOI 10.1038/cr.2017.111; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Wu HP, 2017, PEDIATR BLOOD CANCER, V64, P135, DOI 10.1002/pbc.26181; ZHANG XF, 2016, SCI REP UK, V6; Zhou CY, 2017, PROTEIN CELL, V8, P772, DOI 10.1007/s13238-017-0459-6; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	28	2	2	4	4	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	NOV	2017	8	11					811	822		10.1007/s13238-017-0475-6				12	Cell Biology	Cell Biology	FL9DD	WOS:000414549900006	28942539	gold			2018-01-05	
J	Radtke, S; Adair, JE; Giese, MA; Chan, YY; Norgaard, ZK; Enstrom, M; Haworth, KG; Schefter, LE; Kiem, HP				Radtke, Stefan; Adair, Jennifer E.; Giese, Morgan A.; Chan, Yan-Yi; Norgaard, Zachary K.; Enstrom, Mark; Haworth, Kevin G.; Schefter, Lauren E.; Kiem, Hans-Peter			A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates	SCIENCE TRANSLATIONAL MEDICINE			English	Article							VECTOR INTEGRATION SITES; DELTA-LIKE-1 IN-VITRO; HUMAN CORD BLOOD; PROGENITOR CELLS; GENE-THERAPY; MYELOID PROGENITORS; REPOPULATING CELLS; PERIPHERAL-BLOOD; IRRADIATED MICE; CLONAL-TRACKING	Hematopoietic reconstitution after bone marrow transplantation is thought to be driven by committed multipotent progenitor cells followed by long-term engrafting hematopoietic stem cells (HSCs). We observed a population of early-engrafting cells displaying HSC-like behavior, which persisted long-term in vivo in an autologous myeloablative transplant model in nonhuman primates. To identify this population, we characterized the phenotype and function of defined nonhuman primate hematopoietic stem and progenitor cell (HSPC) subsets and compared these to human HSPCs. We demonstrated that the CD34(+) CD45RA(-)CD90(+) cell phenotype is highly enriched for HSCs. This population fully supported rapid short-term recovery and robust multilineage hematopoiesis in the nonhuman primate transplant model and quantitatively predicted transplant success and time to neutrophil and platelet recovery. Application of this cell population has potential in the setting of HSC transplantation and gene therapy/ editing approaches.	[Radtke, Stefan; Adair, Jennifer E.; Giese, Morgan A.; Chan, Yan-Yi; Norgaard, Zachary K.; Enstrom, Mark; Haworth, Kevin G.; Schefter, Lauren E.; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA; [Radtke, Stefan] Univ Duisburg Essen, Univ Hosp Essen, Inst Transfus Med, D-45147 Essen, Germany; [Adair, Jennifer E.; Kiem, Hans-Peter] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Kiem, Hans-Peter] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Kiem, HP (reprint author), Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA.; Kiem, HP (reprint author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.; Kiem, HP (reprint author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.	hkiem@fredhutch.org		Radtke, Stefan/0000-0002-2842-4820	NIH [HL115128, HL098489, AI096111]; Fred Hutchinson Cancer Research Center; Cuyamaca Foundation; Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research; Fred Hutchinson Cancer Research Center Endowed Chair for Cell and Gene Therapy	This work was supported, in part, by grants to H.-P.K. from the NIH (HL115128, HL098489, and AI096111) and by funds to J.E.A. from the Fred Hutchinson Cancer Research Center and the Cuyamaca Foundation. H.-P.K. is a Markey Molecular Medicine Investigator and received support as the inaugural recipient of the Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research and the Fred Hutchinson Cancer Research Center Endowed Chair for Cell and Gene Therapy.	Adair JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13173; Beard BC, 2007, MOL THER, V15, P1356, DOI 10.1038/sj.mt.6300159; Beard BC, 2014, METHODS MOL BIOL, V1185, P321, DOI 10.1007/978-1-4939-1133-2_22; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chandrasekaran D, 2014, HUM GENE THER, V25, P1013, DOI 10.1089/hum.2014.031; CIVIN CI, 1984, J IMMUNOL, V133, P157; Crisan M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9040; de Kruijf EJFM, 2010, HAEMATOL-HEMATOL J, V95, P1061, DOI 10.3324/haematol.2009.016691; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Drize N, 1997, BLOOD, V89, P1811; Drize NJ, 2001, EXP HEMATOL, V29, P786, DOI 10.1016/S0301-472X(01)00634-8; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Hocum JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0653-6; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; ITOH K, 1989, EXP HEMATOL, V17, P145; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KATZ FE, 1985, LEUKEMIA RES, V9, P191, DOI 10.1016/0145-2126(85)90082-7; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kiem HP, 2004, MOL THER, V9, P389, DOI 10.1016/j.ymthe.2003.12.006; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358                                                    ; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lansdorp PM, 1990, CYTOMETRY, V172, P363; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Notta F., 2015, SCIENCE, V351; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Peterson CW, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.7; PLOEMACHER RE, 1989, BLOOD, V74, P2755; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schmidt M, 2001, ANN NY ACAD SCI, V938, P146; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shepherd BE, 2007, BLOOD, V110, P1806, DOI 10.1182/blood-2007-02-075382; SNODGRASS R, 1987, EMBO J, V6, P3955; Tang Leilei, 2010, BMC Pharmacology, V10, P12, DOI 10.1186/1471-2210-10-12; Trobridge GD, 2008, BLOOD, V111, P5537, DOI 10.1182/blood-2007-09-115022; Vitali C, 2015, CANCER RES, V75, P2387, DOI 10.1158/0008-5472.CAN-14-3625; Wang JCY, 1997, BLOOD, V89, P3919; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Younan PM, 2015, MOL THER, V23, P943, DOI 10.1038/mt.2015.19; Younan PM, 2013, BLOOD, V122, P179, DOI 10.1182/blood-2013-01-482224; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zonari E, 2017, STEM CELL REP, V8, P977, DOI 10.1016/j.stemcr.2017.02.010	54	0	0	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	NOV 1	2017	9	414							eaan1145	10.1126/scitranslmed.aan1145				10	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FL3MZ	WOS:000414128500002					2018-01-05	
J	Bin Naser, I; Hoque, MM; Nahid, MA; Tareq, TM; Rocky, MK; Faruque, SM				Bin Naser, Iftekhar; Hoque, M. Mozammel; Nahid, M. Ausrafuggaman; Tareq, Tokee M.; Rocky, M. Kamruzzaman; Faruque, Shah M.			Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh	SCIENTIFIC REPORTS			English	Article							PATHOGENICITY ISLAND INTERFERENCE; PHAGE; BACTERIA; ARCHAEA; HOST; EVOLUTION; DATASETS; DEFENSE; TOOL	CRISPR-Cas (clustered regularly interspersed short palindromic repeats-CRISPR-associated proteins) are microbial nuclease systems involved in defense against phages. Bacteria also resist phages by hosting phage-inducible chromosomal islands (PICI) which prevent phage reproduction. Vibrio cholerae which causes cholera epidemics, interacts with numerous phages in the environment and in cholera patients. Although CRISPR-Cas systems are usually carried by bacteria and archea, recently V. cholerae specific ICP1 phages were found to host a CRISPR-Cas system that inactivates PICI-like elements (PLE) in V. cholerae. We analyzed a collection of phages and V. cholerae isolated during seasonal cholera epidemics in Bangladesh, to study the distribution, and recent evolution of the phage-encoded CRISPRCas system. Five distinct but related phages carrying the CRISPR-Cas system, and possible CRISPR-Cas negative progenitor phages were identified. Furthermore, CRISPR arrays in the phages were found to have evolved by acquisition of new spacers targeting diverse regions of PLEs carried by the V. cholerae strains, enabling the phages to efficiently grow on PLE positive strains. Our results demonstrate a continuing arms-race involving genetic determinants of phage-resistance in V. cholerae, and the phageencoded CRISPR-Cas system in the co-evolution of V. cholerae and its phages, presumably fostered by their enhanced interactions during seasonal epidemics of cholera.	[Bin Naser, Iftekhar; Hoque, M. Mozammel; Nahid, M. Ausrafuggaman; Tareq, Tokee M.; Rocky, M. Kamruzzaman; Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka 1212, Bangladesh	Faruque, SM (reprint author), Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka 1212, Bangladesh.	faruque@icddrb.org			Wellcome Trust [WT-105927/Z/14/Z]; Swedish International Development Cooperation Agency (SIDA)	This research was funded in part by the Wellcome Trust through a senior investigator award WT-105927/Z/14/Z to Shah Faruque, and the Swedish International Development Cooperation Agency (SIDA). The icddr,b receives core support from the Governments of Bangladesh, Canada, Sweden and the UK. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Carpenter MR, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00842-16; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chakraborty Sajib, 2009, In Silico Biology, V9, P245, DOI 10.3233/ISB-2009-0402; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Faruque SM, 2012, VIRULENCE, V3, P556, DOI 10.4161/viru.22351; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kamruzzaman M, 2010, P NATL ACAD SCI USA, V107, P1588, DOI 10.1073/pnas.0913404107; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Labbate M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36891; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maniatis T., 1982, MOL CLONING LAB MANU; Marraffini L. A., NAT REV GENET; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; O'Hara BJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006838; Ram G, 2014, P NATL ACAD SCI USA, V111, P14536, DOI 10.1073/pnas.1406749111; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seed K. D., 2011, PLOS PATHOG, V11; Seed KD, 2014, ELIFE, V3, DOI 10.7554/eLife.03497; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	0	0	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 1	2017	7								14880	10.1038/s41598-017-14839-2				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4XD	WOS:000414233900025		gold			2018-01-05	
J	Bohaciakova, D; Renzova, T; Fedorova, V; Barak, M; Barak, M; Hampl, A; Cajanek, L				Bohaciakova, Dasa; Renzova, Tereza; Fedorova, Veronika; Barak, Martin; Bosakova, Michaela Kunova; Hampl, Ales; Cajanek, Lukas			An Efficient Method for Generation of Knockout Human Embryonic Stem Cells Using CRISPR/Cas9 System	STEM CELLS AND DEVELOPMENT			English	Article						human embryonic stem cells; CRISPR/Cas9; gene engineering; knockout	CENTROSOME LOSS; SPECIFICITY; GENES; CAS9	Human embryonic stem cells (hESCs) represent a promising tool to study functions of genes during development, to model diseases, and to even develop therapies when combined with gene editing techniques such as CRISPR/CRISPR-associated protein-9 nuclease (Cas9) system. However, the process of disruption of gene expression by generation of null alleles is often inefficient and tedious. To circumvent these limitations, we developed a simple and efficient protocol to permanently downregulate expression of a gene of interest in hESCs using CRISPR/Cas9. We selected p53 for our proof of concept experiments. The methodology is based on series of hESC transfection, which leads to efficient downregulation of p53 expression even in polyclonal population (p53 Low cells), here proven by a loss of regulation of the expression of p53 target gene, microRNA miR-34a. We demonstrate that our approach achieves over 80% efficiency in generating hESC clonal sublines that do not express p53 protein. Importantly, we document by a set of functional experiments that such genetically modified hESCs do retain typical stem cells characteristics. In summary, we provide a simple and robust protocol to efficiently target expression of gene of interest in hESCs that can be useful for laboratories aiming to employ gene editing in their hESC applications/protocols.	[Bohaciakova, Dasa; Renzova, Tereza; Fedorova, Veronika; Barak, Martin; Hampl, Ales; Cajanek, Lukas] Masaryk Univ, Fac Med, Dept Histol & Embryol, Kamenice 3, Brno 62500, Czech Republic; [Bosakova, Michaela Kunova] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Hampl, Ales] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic	Bohaciakova, D; Cajanek, L (reprint author), Masaryk Univ, Fac Med, Dept Histol & Embryol, Kamenice 3, Brno 62500, Czech Republic.	dolezal@med.muni.cz; cajanek@med.muni.cz	Hampl, Ales/N-1632-2016	Hampl, Ales/0000-0002-8963-9235; Bohaciakova, Dasa/0000-0002-9538-6668	Faculty of Medicine MU [ROZV/24/LF/2016, ROZV/25/LF/2017]; Masaryk University [7, MUNI/A/1369/2016, MUNI/C/1709/2016]; Czech Science Foundation [15-18316Y, 1603269Y]; Federation of European Biochemical Societies (FEBS); Swiss National Science Foundation [IZ11Z0_166533]	N Authors would like to acknowledge Oscar Fernandez-Capetillo, Peter Andrews, Lumir Krejci, Stjepan Uldrijan, Borivoj Vojtesek, and Karel Soucek for sharing various reagents, Hana Kotasova for assistance with cell sorting, Milan Esner for assistance with microscopy, and Ondrej Bernatik, Michaela Klouckova, Klara Koudelkova, Katerina Mareckova, Veronika Sedlakova, and Katerina Vasickova for technical support. This work was supported by funds from the Faculty of Medicine MU to junior researcher D.B. and L.C. (ROZV/24/LF/2016, ROZV/25/LF/2017), funds from Masaryk University to A.H. (Tissue Engineering 7; MUNI/A/1369/2016) and M.B. (MUNI/C/1709/2016), grants from Czech Science Foundation to D.B. (15-18316Y) and L.C. (1603269Y), Follow-up research fund from Federation of European Biochemical Societies (FEBS), and grant from Swiss National Science Foundation (IZ11Z0_166533) to L.C.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Byrne SM, 2014, METHOD ENZYMOL, V546, P119, DOI 10.1016/B978-0-12-801185-0.00006-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fong CS, 2016, ELIFE, V5, DOI 10.7554/eLite.16270; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kunova M, 2013, STEM CELL TRANSL MED, V2, P246, DOI 10.5966/sctm.2012-0081; Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKinley KL, 2017, DEV CELL, V40, P405, DOI 10.1016/j.devcel.2017.01.012; Meitinger F, 2016, J CELL BIOL, V214, P155, DOI 10.1083/jcb.201604081; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555	19	0	0	6	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	NOV 1	2017	26	21					1521	1527		10.1089/scd.2017.0058				7	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	FK6UE	WOS:000413639900001	28835165				2018-01-05	
J	Jangam, D; Feschotte, C; Betran, E				Jangam, Diwash; Feschotte, Cedric; Betran, Esther			Transposable Element Domestication As an Adaptation to Evolutionary Conflicts	TRENDS IN GENETICS			English	Review							CRISPR-CAS SYSTEMS; POGO-LIKE TRANSPOSASES; CENP-B; V(D)J RECOMBINATION; DNA TRANSPOSONS; SCHIZOSACCHAROMYCES-POMBE; TETRAHYMENA-THERMOPHILA; EXOGENOUS RETROVIRUSES; PIGGYBAC TRANSPOSON; MAMMALIAN PLACENTA	Transposable elements (TEs) are selfish genetic units that typically encode proteins that enable their proliferation in the genome and spread across individual hosts. Here we review a growing number of studies that suggest that TE proteins have often been co-opted or 'domesticated' by their host as adaptations to a variety of evolutionary conflicts. In particular, TE-derived proteins have been recurrently repurposed as part of defense systems that protect prokaryotes and eukaryotes against the proliferation of infectious or invasive agents, including viruses and TEs themselves. We argue that the domestication of TE proteins may often be the only evolutionary path toward the mitigation of the cost incurred by their own selfish activities.	[Jangam, Diwash; Betran, Esther] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Feschotte, Cedric] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Feschotte, Cedric] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Betran, E (reprint author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.; Feschotte, C (reprint author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.; Feschotte, C (reprint author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	cf458@cornell.edu; betran@uta.edu			National Institute of General Medical Sciences of the National Institutes of Health [GM071813]; National Institutes of Health [GM112972, GM059290, HG009391]	E.B. would like to acknowledge the support from the National Institute of General Medical Sciences of the National Institutes of Health (GM071813). C.F. is supported by grants GM112972, GM059290, HG009391 from the National Institutes of Health. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Blanco-Melo D, 2017, ELIFE, V6, DOI 10.7554/eLife.22519; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Burt A, 2006, GENES CONFLICT BIOL; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Carmona LM, 2017, FEBS J, V284, P1590, DOI 10.1111/febs.13990; Carr M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050978; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; Chen X, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0057-9; Chen X, 2014, CELL, V158, P1187, DOI 10.1016/j.cell.2014.07.034; Cheng CY, 2016, GENE DEV, V30, P2724, DOI 10.1101/gad.290460.116; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Chuong EB, 2013, BIOESSAYS, V35, P853, DOI 10.1002/bies.201300059; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Chuong EB, 2010, MOL BIOL EVOL, V27, P1221, DOI 10.1093/molbev/msq034; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; Cornelis G, 2014, P NATL ACAD SCI USA, V111, pE4332, DOI 10.1073/pnas.1412268111; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; d'Alencon E, 2011, GENE, V485, P91, DOI 10.1016/j.gene.2011.06.007; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Dlakic M, 2011, RNA, V17, P799, DOI 10.1261/rna.2396011; Dubois E, 2017, NUCLEIC ACIDS RES, V45, P3204, DOI 10.1093/nar/gkw1359; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Esnault C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003400; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gogol-Doring A, 2016, MOL THER, V24, P592, DOI 10.1038/mt.2016.11; Guerin F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3713-7; Haig D, 2008, PLACENTA, V29, pS36, DOI 10.1016/j.placenta.2007.09.010; Haig D, 2016, BIOESSAYS, V38, P1158, DOI 10.1002/bies.201600125; Haig D, 2015, BIOESSAYS, V37, P1154, DOI 10.1002/bies.201500114; Hamilton EP, 2016, ELIFE, V5, DOI 10.7554/eLife.19090; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Ikeda Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15122; Ito J, 2013, J VIROL, V87, P12029, DOI 10.1128/JVI.01267-13; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Johansen P, 2015, GENETICS, V201, P897, DOI 10.1534/genetics.115.179465; Joly-Lopez Z, 2016, MOL BIOL EVOL, V33, P1937, DOI 10.1093/molbev/msw067; Joly-Lopez Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002931; Kapitonov VV, 2016, J BACTERIOL, V198, P797, DOI 10.1128/JB.00783-15; Kapitonov VV, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0055-8; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Kozak Christine A, 2014, Viruses, V7, P1, DOI 10.3390/v7010001; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507; Lee YCG, 2017, MOL BIOL EVOL, V34, P467, DOI 10.1093/molbev/msw248; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Liang SC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005660; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LYNCH M, 2007, ORIGINS GENOME ARCHI; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Malfavon-Borja R, 2015, J VIROL, V89, P4047, DOI 10.1128/JVI.03653-14; Malik HS, 2005, TRENDS ECOL EVOL, V20, P151, DOI 10.1016/j.tree.2005.01.014; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mateo L, 2014, GENOME BIOL EVOL, V6, P2008, DOI 10.1093/gbe/evu153; McLaughlin RN, 2017, J EXP BIOL, V220, P6, DOI 10.1242/jeb.148148; McLaughlin RN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004531; Miller WJ, 1997, GENETICA, V100, P261, DOI 10.1023/A:1018306317836; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90040-W; Murton HE, 2016, GENETICS, V203, P1669, DOI 10.1534/genetics.116.189118; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Pardue Mary-Lou, 2011, Mob Genet Elements, V1, P128; Pardue ML, 2011, P NATL ACAD SCI USA, V108, P20317, DOI 10.1073/pnas.1100278108; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Rice WR, 1998, ENDLESS FORMS, P261; Roach KC, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P83; Schroeder DI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005442; Servant G, 2016, FRONT GENET, V6, DOI 10.3339/fgene.2015.00353; Shieh AWY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075337; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Spencer TE, 2003, J VIROL, V77, P749, DOI 10.1128/JVI.77.1.749-753.2003; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Sun C, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0145-1; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004032; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003659; Wacholder AC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004482; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809                                           ; Wu TY, 2005, J VIROL, V79, P9677, DOI 10.1128/JVI.79.15.9677-9684.2005; Yap MW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003968	108	0	0	9	9	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0168-9525	1362-4555		TRENDS GENET	Trends Genet.	NOV	2017	33	11					817	831		10.1016/j.tig.2017.07.011				15	Genetics & Heredity	Genetics & Heredity	FK9JP	WOS:000413827800005	28844698				2018-01-05	
J	Farboud, B				Farboud, Behnom			Targeted genome editing in Caenorhabditis elegans using CRISPR/Cas9	WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY			English	Article							RNA-GUIDED ENDONUCLEASE; C. ELEGANS; GENE-EXPRESSION; OFF-TARGET; CRISPR-CAS9 SYSTEM; DNA RECOGNITION; HUMAN-CELLS; CAS SYSTEM; IN-VITRO; TRANSCRIPTION TERMINATION	Utilization of programmable nucleases to generate DNA lesions at precise endogenous sequences has transformed the ability to edit genomes from microbes to plants and animals. This is especially true in organisms that previously lacked the means to engineer precise genomic changes, like Caenorhabditis elegans. C. elegans is a 1mm long free-living, nonparasitic, nematode worm, which is easily cultivated in a laboratory. Its detailed genetic map and relatively compact genome (similar to 100 megabases) helped make it the first metazoan to have its entire genome sequenced. With detailed sequence information came development of numerous molecular tools to dissect gene function. Initially absent from this toolbox, however, were methods to make precise edits at chosen endogenous loci. Adapting site-specific nucleases for use in C. elegans, revolutionized studies of C. elegans biology. Zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and then CRISPR-associated protein 9 (Cas9) were used to target specific endogenous DNA sequences to make double-strand DNA breaks (DSBs). Precise changes could be engineered by providing repair templates targeting the DSBin trans. The ease of programming Cas9 to bind and cleave DNA sequences with few limitations has led to its widespread use in C. elegans research and sped the development of strategies to facilitate mutant recovery. Numerous innovative CRISPR/Cas9 methodologies are now primed for use in C. elegans. (C) 2017 Wiley Periodicals, Inc.	[Farboud, Behnom] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Farboud, B (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	farboud@berkeley.edu			NIH [5R01-GM030702]	I apologize to researchers whose work I was unable to cite owing to space constraints. I thank B.S. Wheeler, N. Fuda, A.F. Severson, M.M Jow, and C.M. Schartner for comments on the manuscript. This work was supported in part by NIH grant 5R01-GM030702 to Barbara J. Meyer.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Bell RT, 2016, GENETICS, V202, P381, DOI 10.1534/genetics.115.185041; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Bothmer A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13905; BRENNER S, 1974, GENETICS, V77, P71; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Chen XY, 2015, GENETICS, V201, P1295, DOI 10.1534/genetics.115.181883; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das A, 2015, MOL BIOL CELL, V26, P4248, DOI 10.1091/mbc.E15-08-0603; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Du D, 2016, COLD SPRING HARB PRO, V2016; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/nmeth.1454, 10.1038/NMETH.1454]; FRUSCOLONI P, 1995, NUCLEIC ACIDS RES, V23, P2914, DOI 10.1093/nar/23.15.2914                                                          ; Fu BXH, 2016, NUCLEIC ACIDS RES, V44, P5365, DOI 10.1093/nar/gkw417; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11707; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gilleland CL, 2015, GENETICS, V201, P39, DOI 10.1534/genetics.115.179648; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; IWATA S, 2016, SCI REP, V6; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katic I, 2015, G3-GENES GENOM GENET, V5, P1649, DOI 10.1534/g3.115.019273; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Li WJ, 2015, J CELL BIOL, V208, P683, DOI 10.1083/jcb.201411041; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Liu PP, 2014, CELL RES, V24, P886, DOI 10.1038/cr.2014.73; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Long LJ, 2015, CELL RES, V25, P638, DOI 10.1038/cr.2015.35; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Markov GV, 2016, MOL BIOL EVOL, V33, P2506, DOI 10.1093/molbev/msw090; Martin A, 2016, CURR BIOL, V26, P14, DOI 10.1016/j.cub.2015.11.021; MELLO CC, 1991, EMBO J, V10, P3959; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Norris AD, 2015, GENETICS, V201, P449, DOI 10.1534/genetics.115.180679; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; PAIX A, 2016, NUCL ACIDS RES, V44; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Praitis V, 2001, GENETICS, V157, P1217; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thyme SB, 2016, CELL REPORTS POLQ ME; Tian D, 2015, CURR BIOL, V25, P1135, DOI 10.1016/j.cub.2015.02.072; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Schendel R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8394; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ward JD, 2015, GENETICS, V199, P363, DOI 10.1534/genetics.114.172361; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu L., 2016, NUCLEIC ACIDS RES, V45, pe28; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao P, 2016, CELL RES, V26, P633, DOI 10.1038/cr.2016.46; Zhao P, 2014, CELL RES, V24, P247, DOI 10.1038/cr.2014.9	118	1	1	32	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7684	1759-7692		WIRES DEV BIOL	Wiley Interdiscip. Rev.-Dev. Biol.	NOV-DEC	2017	6	6							e287	10.1002/wdev.287				14	Developmental Biology	Developmental Biology	FJ5XP	WOS:000412827400004					2018-01-05	
J	Zhang, WF; Xiao, D; Shan, LL; Zhao, JL; Mao, QW; Xia, HB				Zhang, Weifeng; Xiao, Dan; Shan, Linlin; Zhao, Junli; Mao, Qinwen; Xia, Haibin			Generation of apoptosis-resistant HEK293 cells with CRISPR/Cas mediated quadruple gene knockout for improved protein and virus production	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						adenovirus; apoptosis; CRISPR/Cas; gene therapy; genome editing	MAMMALIAN-CELLS; DEATH; BCL-2; CAS9; ENDONUCLEASE; SURVIVAL; SYSTEM; LINE; AIF; BAX	Apoptosis has important functions during pathophysiologic processes. However, from a biopharmaceutical point of view, active apoptosis of host cells is undesirable during viral packaging or protein expression, because it decreases the efficiency of viral or protein production. Here we used the CRISPR/Cas technique to knock out four pro-apoptotic genes, Caspase3, Caspase6, Caspase7 and AIF1, in HEK293 cells, and successfully produced an apoptosis-resistant cell line. Furthermore, this cell line showed higher expression levels of pro-apoptotic proteins and higher packaging efficiency for the virus carrying these proteins than control HEK293 cells. This study not only produced an apoptosis-resistant cell line that is useful in producing apoptosis-inducing proteins or viruses expressing these proteins, but also provides a methodology to build other apoptosis-resistant cell lines.	[Zhang, Weifeng; Shan, Linlin; Zhao, Junli; Xia, Haibin] Shaanxi Normal Univ, Dept Biochem, Coll Life Sci, Lab Gene Therapy, 199 South Changan Rd, Xian 710062, Shaanxi, Peoples R China; [Xiao, Dan] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian, Shaanxi, Peoples R China; [Mao, Qinwen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Xia, HB (reprint author), Shaanxi Normal Univ, Dept Biochem, Coll Life Sci, Lab Gene Therapy, 199 South Changan Rd, Xian 710062, Shaanxi, Peoples R China.	hbxia2001@163.com		Mao, Qinwen/0000-0001-7876-2046	National Natural Science Foundation of China [31601086, 81471772]; Natural Science Foundation of Shaanxi Province [2014JZ005]; China Postdoctoral Science Foundation [2015M570809]; Fundamental Research Funds for the Central Universities [GK201603113]	National Natural Science Foundation of China, Grant numbers: 31601086, 81471772; Natural Science Foundation of Shaanxi Province, Grant number: 2014JZ005; China Postdoctoral Science Foundation, Grant number: 2015M570809; Fundamental Research Funds for the Central Universities, Grant number: GK201603113	Bandaranayake AD, 2014, FEBS LETT, V588, P253, DOI 10.1016/j.febslet.2013.11.035; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Coco-Martin JM, 2008, BIOPROCESS INT, V6, P28; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Cuconati A, 2002, J VIROL, V76, P4547, DOI 10.1128/JVI.76.9.4547-4558.2002; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Figueroa B, 2004, BIOTECHNOL BIOENG, V85, P589, DOI 10.1002/bit.10913; Gibson EM, 2002, CANCER RES, V62, P488; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kagawa S, 2000, GENE THER, V7, P75, DOI 10.1038/sj.gt.3301048; Kim NS, 2001, BIOTECHNOL BIOENG, V71, P184; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mastrangelo AJ, 2000, BIOTECHNOL BIOENG, V67, P544, DOI 10.1002/(SICI)1097-0290(20000305)67:5<544::AID-BIT5>3.3.CO;2-R; Mastrangelo AJ, 2000, BIOTECHNOL BIOENG, V67, P555, DOI 10.1002/(SICI)1097-0290(20000305)67:5<555::AID-BIT6>3.0.CO;2-T                  ; Meents H, 2002, BIOTECHNOL BIOENG, V80, P706, DOI 10.1002/bit.10449; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200                                                          ; Tey BT, 2000, BIOTECHNOL BIOENG, V68, P31, DOI 10.1002/(SICI)1097-0290(20000405)68:1<31::AID-BIT4>3.0.CO;2-L; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xiao D, 2016, J BIOTECHNOL, V219, P110, DOI 10.1016/j.jbiotec.2015.12.026	32	0	0	23	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	NOV	2017	114	11					2539	2549		10.1002/bit.26382				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FI1MY	WOS:000411699200012	28710851				2018-01-05	
J	Sredni, ST; Suzuki, M; Yang, JP; Topczewski, J; Bailey, AW; Gokirmak, T; Gross, JN; de Andrade, A; Kondo, A; Piper, DR; Tomita, T				Sredni, Simone Treiger; Suzuki, Mario; Yang, Jian-Ping; Topczewski, Jacek; Bailey, Anders W.; Gokirmak, Tufan; Gross, Jeffrey N.; de Andrade, Alexandre; Kondo, Akihide; Piper, David R.; Tomita, Tadanori			A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain	PEDIATRIC BLOOD & CANCER			English	Article						AT/RT; CFI-400495; CRISPR/Cas9; gene editing; inhibitor; kinase; kinome; Lentivirus; MRT; PLK4; PLK4i; rhabdoid; RTK; treatment	ATYPICAL TERATOID/RHABDOID TUMORS; HUMAN-CELLS; GENE-EXPRESSION; RADIATION SENSITIVITY; CENTRIOLE DUPLICATION; AURORA KINASE; HUMAN GENOME; INHIBITION; CFI-400945; CANCER	Purpose: Malignant rhabdoid tumors (MRTs) are deadly embryonal tumors of the infancy. With poor survival and modest response to available therapies, more effective and less toxic treatments are needed. We hypothesized that a systematic screening of the kinome will reveal kinases that drive rhabdoid tumors and can be targeted by specific inhibitors. Methods: We individually mutated 160 kinases in a well-characterized rhabdoid tumor cell line (MON) using lentiviral clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9). The kinase that most significantly impaired cell growth was further validated. Its expression was evaluated by microarray gene expression (GE) within 111 pediatric tumors, and functional assays were performed. A small molecule inhibitor was tested in multiple rhabdoid tumor cell lines and its toxicity evaluated in zebrafish larvae. Results: The Polo-like kinase 4 (PLK4) was identified as the kinase that resulted in higher impairment of cell proliferation when mutated by CRISPR/Cas9. PLK4 CRISPR-mutated rhabdoid cells demonstrated significant decrease in proliferation, viability, and survival. GE showed upregulation of PLK4 in rhabdoid tumors and other embryonal tumors of the brain. The PLK4 inhibitor CFI-400945 showed cytotoxic effects on rhabdoid tumor cell lines while sparing non-neoplastic human fibroblasts and developing zebrafish larvae. Conclusions: Our findings indicate that rhabdoid tumor cell proliferation is highly dependent on PLK4 and suggest that targetingPLK4with small-molecule inhibitors may hold a novel strategy for the treatment of MRT and possibly other embryonal tumors of the brain. This is the first time that PLK4 has been described as a potential target for both brain and pediatric tumors.	[Sredni, Simone Treiger; Suzuki, Mario; Bailey, Anders W.; Tomita, Tadanori] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Neurosurg, Chicago, IL 60611 USA; [Sredni, Simone Treiger; Tomita, Tadanori] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Sredni, Simone Treiger; Suzuki, Mario; Bailey, Anders W.; Gross, Jeffrey N.] Stanley Manne Childrens Res Inst, Dept Canc Biol & Epigen, Chicago, IL USA; [Suzuki, Mario; Kondo, Akihide] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; [Yang, Jian-Ping; Gokirmak, Tufan; de Andrade, Alexandre; Piper, David R.] Thermo Fisher Sci, Biosci Div, Res & Dev, Carlsbad, CA USA; [Topczewski, Jacek] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Topczewski, Jacek] Stanley Manne Childrens Res Inst, Dept Dev Biol, Chicago, IL USA	Sredni, ST (reprint author), 225 E Chicago Ave,Box 28, Chicago, IL 60611 USA.	ssredni@luriechildrens.org			Rally Foundation for Childhood Cancer Research [925597]; Voices Against Brain Cancer Foundation [925432]; Lurie Children'sHospital Faculty Practice Plan Development Funding [931220]; Rally Foundation for Childhood Cancer Research; Voices Against Brain Cancer Foundation; Lurie Children's Hospital Faculty Practice Plan Development Funding (FPP)	Rally Foundation for Childhood Cancer Research in memory of Hailey Trainer (Fund#925597), The Voices Against Brain Cancer Foundation (Fund#925432) and the Lurie Children'sHospital Faculty Practice Plan Development Funding (Fund#931220).; Funded by The Rally Foundation for Childhood Cancer Research in memory of Hailey Trainer, The Voices Against Brain Cancer Foundation and the Lurie Children's Hospital Faculty Practice Plan Development Funding (FPP).	Albanese P, 2006, EUR J CANCER, V42, P2326, DOI 10.1016/j.ejca.2006.03.028; Alimova I, 2013, NEURO-ONCOLOGY, V15, P149, DOI 10.1093/neuonc/nos285; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Birks DK, 2013, PEDIATR BLOOD CANCER, V60, P1095, DOI 10.1002/pbc.24481; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297                                                            ; Fleuren EDG, 2016, NAT REV CANCER, V16, P83, DOI 10.1038/nrc.2015.18; Fruhwald MC, 2016, NEURO-ONCOLOGY, V18, P764, DOI 10.1093/neuonc/nov264; Gadd S, 2010, LAB INVEST, V90, P724, DOI 10.1038/labinvest.2010.66; Ginn KF, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00114; Grupenmacher AT, 2013, CHILD NERV SYST, V29, P1977, DOI 10.1007/s00381-013-2268-4; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hashizume R, 2016, NEURO-ONCOLOGY, V18, P1519, DOI 10.1093/neuonc/now106; Hashizume R, 2010, NEURO-ONCOLOGY, V12, P366, DOI 10.1093/neuonc/nop033; Holland AJ, 2014, CANCER CELL, V26, P151, DOI 10.1016/j.ccr.2014.07.017; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lee S, 2011, CANCER RES, V71, P3225, DOI 10.1158/0008-5472.CAN-10-2167; Liu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041293; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; Morozov A, 2007, CLIN CANCER RES, V13, P4721, DOI 10.1158/1078-0432.CCR-07-0054; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Rosario CO, 2015, ONCOGENE, V34, P3441, DOI 10.1038/onc.2014.275; Sampson PB, 2015, J MED CHEM, V58, P147, DOI 10.1021/jm5005336; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Singh A, 2013, MOL ONCOL, V7, P497, DOI 10.1016/j.molonc.2013.01.001; Sredni ST, 2015, PEDIATR DEVEL PATHOL, V18, P49, DOI 10.2350/14-07-1531-MISC.1; Sredni ST, 2014, CANCER GENET-NY, V207, P420, DOI 10.1016/j.cancergen.2014.05.009; Sredni ST, 2014, J NEURO-ONCOL, V118, P201, DOI 10.1007/s11060-014-1406-5; Suzuki M, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26398; Torchia J, 2015, LANCET ONCOL, V16, P569, DOI 10.1016/S1470-2045(15)70114-2; Venkataraman S, 2012, J NEURO-ONCOL, V107, P517, DOI 10.1007/s11060-011-0795-y; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wetmore C, 2015, NEURO-ONCOLOGY, V17, P882, DOI 10.1093/neuonc/nov017; Yu B, 2015, EUR J MED CHEM, V95, P35, DOI 10.1016/j.ejmech.2015.03.020; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	54	0	0	12	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2017	64	11							e26551	10.1002/pbc.26551				10	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	FH3OO	WOS:000411059000008		gold			2018-01-05	
J	White, MK; Kaminski, R; Young, WB; Roehm, PC; Khalili, K				White, Martyn K.; Kaminski, Rafal; Young, Won-Bin; Roehm, Pamela C.; Khalili, Kamel			CRISPR Editing Technology in Biological and Biomedical Investigation	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						CRISPR; Cas9; GENOME EDITING	INHIBIT HIV-1 REPLICATION; PLURIPOTENT STEM-CELLS; IN-VIVO; FUNCTIONAL GENOMICS; CAS9 PROTEIN; GUIDE RNAS; NUCLEASES; TARGET; INFECTION; SYSTEM	The CRISPR or clustered regularly interspaced short palindromic repeats system is currently the most advanced approach to genome editing and is notable for providing an unprecedented degree of specificity, effectiveness, and versatility in genetic manipulation. CRISPR evolved as a prokaryotic immune system to provide an acquired immunity and resistance to foreign genetic elements such as bacteriophages. It has recently been developed into a tool for the specific targeting of nucleotide sequences within complex eukaryotic genomes for the purpose of genetic manipulation. The power of CRISPR lies in its simplicity and ease of use, its flexibility to be targeted to any given nucleotide sequence by the choice of an easily synthesized guide RNA, and its ready ability to continue to undergo technical improvements. Applications for CRISPR are numerous including creation of novel transgenic cell animals for research, high-throughput screening of gene function, potential clinical gene therapy, and nongene-editing approaches such as modulating gene activity and fluorescent tagging. In this prospect article, we will describe the salient features of the CRISPR system with an emphasis on important drawbacks and considerations with respect to eliminating off-target events and obtaining efficient CRISPR delivery. We will discuss recent technical developments to the system and we will illustrate some of the most recent applications with an emphasis on approaches to eliminate human viruses including HIV-1, JCV and HSV-1 and prospects for the future. J. Cell. Biochem. 118: 3586-3594, 2017. (c) 2017 Wiley Periodicals, Inc.	[Khalili, Kamel] Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, 3500 N Broad St, Philadelphia, PA 19140 USA; [Khalili, Kamel] Temple Univ, Lewis Katz Sch Med, Comprehens NeuroAIDS Ctr, Dept Neurosci, 3500 N Broad St, Philadelphia, PA 19140 USA	Khalili, K (reprint author), Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, 3500 N Broad St, Philadelphia, PA 19140 USA.; Khalili, K (reprint author), Temple Univ, Lewis Katz Sch Med, Comprehens NeuroAIDS Ctr, Dept Neurosci, 3500 N Broad St, Philadelphia, PA 19140 USA.	kamel.kalili@temple.edu			NIMH NIH HHS [P30 MH092177, R21 MH100949]; NINDS NIH HHS [R21 NS094084]		Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Cano-Rodriguez David, 2016, Curr Genet Med Rep, V4, P170; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chou YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36921; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Doerflinger M, 2017, CELL MICROB IN PRESS; Doetschman T, 2017, CIRC RES, V120, P876, DOI 10.1161/CIRCRESAHA.116.309727; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Gaj T., 2016, COLD SPRING HARB PER, V8; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jo YI, 2015, CELL MOL LIFE SCI, V72, P3819, DOI 10.1007/s00018-015-1956-5; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; KAMINSKI R, 2016, SCI REP UK, V6; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kennedy EM, 2017, ANNU REV MED, V68, P401, DOI 10.1146/annurev-med-051215-031129; Khalili K, 2017, CELL MOL LI IN PRESS; Khalili K, 2015, J NEUROVIROL, V21, P310, DOI 10.1007/s13365-014-0308-9; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Li Z, 2017, VIRUS RES; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Liu J, 2016, J CONTROL RELEASE, V244, P83, DOI 10.1016/j.jconrel.2016.11.014; Lotti SN, 2017, ANIM BIOTECHNOL, V19, P1; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Moyo B, 2017, VIRUS RES; Nakade S, 2017, BIOENGINEERED, V8, P265, DOI 10.1080/21655979.2017.1282018; Nishida K, 2016, SCIENCE, V353, P8729; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2016, ANAL BIOCH; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Seth K, 2016, BIOCHEM BIOPH RES CO, V480, P499, DOI 10.1016/j.bbrc.2016.10.130; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Singh V, 2017, GENE, V599, P1, DOI 10.1016/j.gene.2016.11.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tschaharganeh DF, 2016, FEBS J, V283, P3194, DOI 10.1111/febs.13750; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang L, 2016, INT J MOL SCI, V17; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.95; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; White MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005953; White MK, 2016, NEUROTHERAPEUTICS, V13, P547, DOI 10.1007/s13311-016-0439-1; White MK, 2016, ONCOTARGET, V7, P12305, DOI 10.18632/oncotarget.7104; White MK, 2015, DISCOV MED, V19, P255; Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046; Wollebo HS, 2015, ANN NEUROL, V77, P560, DOI 10.1002/ana.24371; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wright DA, 2014, BIOCHEM J, V462, P15, DOI 10.1042/BJ20140295; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yee JK, 2016, FEBS J, V283, P3239, DOI 10.1111/febs.13760; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Yuen KS, 2017, METHODS MOL BIOL, V1498, P23, DOI 10.1007/978-1-4939-6472-7_2; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; ZHANG YG, 2015, SCI REP UK, V5; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	82	0	0	70	70	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	NOV	2017	118	11					3586	3594		10.1002/jcb.26099				9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FH3QV	WOS:000411065300006	28460414				2018-01-05	
J	Pratt, CP; Kuljis, DA; Homanics, GE; He, JJ; Kolodieznyi, D; Dudem, S; Hollywood, MA; Barth, AL; Bruchez, MP				Pratt, Christopher P.; Kuljis, Dika A.; Homanics, Gregg E.; He, Jianjun; Kolodieznyi, Dmytro; Dudem, Srikanth; Hollywood, Mark A.; Barth, Alison L.; Bruchez, Marcel P.			Tagging of Endogenous BK Channels with a Fluorogen-Activating Peptide Reveals beta 4-Mediated Control of Channel Clustering in Cerebellum	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						BK channels; CRISPR/Cas9; fluorogen-activating peptides; knock-in; Purkinje cells; fluorescent dyes; trafficking	CA2+-ACTIVATED K+ CHANNEL; ENDOCYTIC TRAFFICKING SIGNALS; NEOCORTICAL PYRAMIDAL NEURONS; REGULATES SURFACE EXPRESSION; CENTRAL-NERVOUS-SYSTEM; LARGE-CONDUCTANCE; POTASSIUM CHANNELS; TRANSMITTER RELEASE; ETHANOL SENSITIVITY; PROTEIN-KINASE	BK channels are critical regulators of neuronal activity, controlling firing, neurotransmitter release, cerebellar function, and BK channel mutations have been linked to seizure disorders. Modulation of BK channel gating is well characterized, regulated by accessory subunit interactions, intracellular signaling pathways, and membrane potential. In contrast, the role of intracellular trafficking mechanisms in controlling BK channel function, especially in live cells, has been less studied. Fluorogen-activating peptides (FAPs) are well-suited for trafficking and physiological studies due to the binding of malachite green (MG)-based dyes with sub-nanomolar affinity to the FAP, resulting in bright, photostable, far-red fluorescence. Cell-excluded MG dyes enable the selective tagging of surface protein and tracking through endocytic pathways. We used CRISPR to insert the FAP at the extracellular N-terminus of BK a in the first exon of its native locus, enabling regulation by the native promoter elements and tag incorporation into multiple splice isoforms. Motor coordination was found to be normal; however, BK channel expression seems to be reduced in some locations. Alternate start site selection or post-translational proteolytic processing resulted in incomplete FAP tagging of the BK a proteins in brain tissues. In Purkinje cell somata, FAP revealed BK channel clustering previously only observed by electron microscopy. Measurement of these clusters in beta 4(+/-) and beta 4(-/-) mice showed that puncta number and cluster fluorescence intensity on the soma are reduced in beta 4(-/-) knockout animals. This novel mouse line provides a versatile fluorescent platform for studying endogenous BK channels in living and fixed tissues. Future studies could apply this line to ex vivo neuronal cultures to study live-cell channel trafficking.	[Pratt, Christopher P.; Kuljis, Dika A.; Barth, Alison L.; Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Pratt, Christopher P.; He, Jianjun; Kolodieznyi, Dmytro; Bruchez, Marcel P.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Pratt, Christopher P.; Barth, Alison L.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [He, Jianjun; Kolodieznyi, Dmytro; Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Dudem, Srikanth; Hollywood, Mark A.] Dundalk Inst Technol, Smooth Muscle Res Ctr, Dundalk, Ireland	Bruchez, MP (reprint author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.; Bruchez, MP (reprint author), Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA.; Bruchez, MP (reprint author), Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA.	bruchez@cmu.edu			National Institutes of Health [T32 NS07433, R21MH100612, R21NS092109, AA020889]; European Union InterReg VA (Health & Life Sciences) Program	This work was supported by the National Institutes of Health (T32 NS07433: CP; R21MH100612: MB, CP, and AB; R21NS092109: DAK and AB; AA020889: GH) and European Union InterReg VA (Health & Life Sciences) Program: SD and MH.	Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Benton MD, 2013, J NEUROPHYSIOL, V109, P2528, DOI 10.1152/jn.00127.2012; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Chen XW, 2010, P NATL ACAD SCI USA, V107, P12323, DOI 10.1073/pnas.1001745107; Cheron G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007991; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; Connors EC, 2008, J BIOL CHEM, V283, P3445, DOI 10.1074/jbc.M708875200; Contet C, 2016, INT REV NEUROBIOL, V128, P281, DOI 10.1016/bs.irn.2016.04.001; Cox N, 2014, BRAIN RES, V1553, P12, DOI 10.1016/j.brainres.2014.01.028; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x                                                ; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; Gabriel L, 2012, J BIOL CHEM, V287, P32354, DOI 10.1074/jbc.M112.391458; Gonzalez-Perez V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9341; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Griguoli M, 2016, J PHYSIOL-LONDON, V594, P3489, DOI 10.1113/JP271841; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hagen BM, 2006, AM J PHYSIOL-CELL PH, V291, pC750, DOI 10.1152/ajpcell..00116.2006; He JJ, 2016, NAT METHODS, V13, P263, DOI [10.1038/NMETH.3735, 10.1038/nmeth.3735]; Hu H, 2001, J NEUROSCI, V21, P9585; Indriati DW, 2013, J NEUROSCI, V33, P3668, DOI 10.1523/JNEUROSCI.2921-12.2013; Kang J, 1996, J NEUROPHYSIOL, V76, P188; Kaufmann WA, 2010, NEUROSCIENCE, V169, P974, DOI 10.1016/j.neuroscience.2010.05.070; Kaufmann WA, 2009, J COMP NEUROL, V515, P215, DOI 10.1002/cne.22066; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kim JE, 2007, INTEST RES, V5, P26; Korovkina VP, 2006, J PHYSIOL-LONDON, V573, P329, DOI 10.1113/jphysiol.2006.106922; Kyle BD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00316; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Ly C, 2011, J COMPUT NEUROSCI, V30, P211, DOI 10.1007/s10827-010-0246-3; Ma DH, 2007, FEBS LETT, V581, P1000, DOI 10.1016/j.febslet.2007.01.077; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Martire M, 2010, J NEUROCHEM, V115, P411, DOI 10.1111/j.1471-4159.2010.06938.x; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X                                                   ; Poulsen AN, 2011, PFLUG ARCH EUR J PHY, V461, P65, DOI 10.1007/s00424-010-0887-0; Poulsen AN, 2009, BBA-BIOMEMBRANES, V1788, P380, DOI 10.1016/j.bbamem.2008.10.001; Pratt CP, 2015, BIOCONJUGATE CHEM, V26, P1963, DOI 10.1021/acs.bioconjchem.5b00409; Roy S, 2014, EUR J MED CHEM, V75, P426, DOI 10.1016/j.ejmech.2014.01.035; Roy S, 2012, CHEMMEDCHEM, V7, P1763, DOI 10.1002/cmdc.201200321; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Saurabh S, 2016, J AM CHEM SOC, V138, P10398, DOI 10.1021/jacs.6b05943; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101                                                         ; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728                                                           ; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Soom M, 2008, CHANNELS, V2, P278, DOI 10.4161/chan.2.4.6571                                                           ; Szent-Gyorgyi C, 2013, J MOL BIOL, V425, P4595, DOI 10.1016/j.jmb.2013.08.014; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tabarki B, 2016, HUM GENET, V135, P1295, DOI 10.1007/s00439-016-1726-y; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Toro L, 2014, PFLUG ARCH EUR J PHY, V466, P875, DOI 10.1007/s00424-013-1359-0; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9                                                    ; van Welie I, 2011, J NEUROPHYSIOL, V105, P1651, DOI 10.1152/jn.00058.2011; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922                                                        ; Wang B, 2016, J NEUROPHYSIOL, V116, P456, DOI 10.1152/jn.00857.2015; Wang Y, 2017, CHEM COMMUN, V53, P2001, DOI 10.1039/c6cc09137g; Wang Y, 2015, BIOCONJUGATE CHEM, V26, P137, DOI 10.1021/bc500525b; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7; Webb TI, 2015, P NATL ACAD SCI USA, V112, P2064, DOI 10.1073/pnas.1400555112; Wen DH, 2013, AM J PHYSIOL-RENAL, V305, pF463, DOI 10.1152/ajprenal.00171.2013; Wynne PM, 2009, J PHARMACOL EXP THER, V329, P978, DOI 10.1124/jpet.108.146175; Yan Q, 2015, ORG BIOMOL CHEM, V13, P2078, DOI 10.1039/c4ob02309a; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019; Zhang M, 2015, J CLIN INVEST, V125, P3915, DOI 10.1172/JCI81086; Zhang ZB, 2015, MOVEMENT DISORD, V30, P1290, DOI 10.1002/mds.26216	76	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	OCT 31	2017	11								337	10.3389/fncel.2017.00337				18	Neurosciences	Neurosciences & Neurology	FL1VJ	WOS:000414002200001	29163049	gold			2018-01-05	
J	Jordi, M; Marty, J; Mordasini, V; Lunemann, A; McComb, S; Bernasconi, M; Nadal, D				Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David			IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; NF-KAPPA-B; LYTIC CYCLE; HISTONE MODIFICATION; SIGNAL-TRANSDUCTION; CROSS-LINKING; LATENCY; EBV; REACTIVATION; ACTIVATION	Burkitt's lymphoma (BL) is the most common childhood cancer in equatorial Africa, and is endemic to areas where people are chronically co-infected with Epstein-Barr virus (EBV) and the malaria pathogen Plasmodium falciparum. The contribution of these pathogens in the oncogenic process remains poorly understood. We showed earlier that the activation of Toll-like receptor (TLR) 9 by hemozoin, a disposal product formed from the digestion of blood by P. falciparum, suppresses the lytic reactivation of EBV in BL cells. EBV lytic reactivation is regulated by the expression of transcription factor Zta (ZEBRA), encoded by the EBV gene BZLF1. Here, we explore in the BL cell line Akata, the mechanism involved in repression by TLR9 of expression of BZLF1. We show that BZLF1 repression is mediated upon TLR9 engagement by a mechanism that is largely independent of de novo protein synthesis. By CRISPR/Cas9-induced inactivation of TLR9, MyD88, IRAK4 and IRAK1 we confirm that BZLF1 repression is dependent on functional TLR9 and MyD88 signaling, and identify IRAK4 as an essential element for TLR9-induced repression of BZLF1 expression upon BCR cross-linking. Our results unprecedentedly show that TLR9-mediated inhibition of lytic EBV is largely independent of new protein synthesis and demonstrate the central roles of MyD88 and IRAK4 in this process contributing to EBV's persistence in the host's B-cell pool.	[Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Lab Expt Infect Dis & Canc Res, Div Infect Dis, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Nadal, David] Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	Nadal, D (reprint author), Univ Zurich, Univ Childrens Hosp Zurich, Lab Expt Infect Dis & Canc Res, Div Infect Dis, Zurich, Switzerland.; Nadal, D (reprint author), Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland.; Nadal, D (reprint author), Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland.; Nadal, D (reprint author), Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.; Nadal, D (reprint author), Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	david.nadal@kispi.uzh.ch			Swiss National Foundation [310040-568 114118]; Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; OPO Foundation; Wolfermann-Nageli Foundation	This work was supported by grants from the Swiss National Foundation (#310040-568 114118), Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation, OPO Foundation, and Wolfermann-Nageli Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYA T, 1991, LANCET, V337, P1190, DOI 10.1016/0140-6736(91)92861-U; Brady G, 2008, POSTGRAD MED J, V84, P372, DOI 10.1136/jcp.2007.047977; Bryant H, 2002, J VIROL, V76, P10290, DOI 10.1128/JVI.76.20.10290-10298.2002; Callan MFC, 2004, MICROBES INFECT, V6, P937, DOI 10.1016/j.micinf.2004.04.014; COUNTRYMAN J, 1987, J VIROL, V61, P3672; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; DIRENZO L, 1994, INT J CANCER, V57, P914, DOI 10.1002/ijc.2910570623; Chene A, 2007, PLOS PATHOG, V3, pe80; Duellman SJ, 2009, J GEN VIROL, V90, P2251, DOI 10.1099/vir.0.012260-0; FLEMINGTON EK, 1991, J VIROL, V65, P7073; Haas F, 2014, J VIROL, V88, P10002, DOI 10.1128/JVI.01486-14; Heeg K, 2008, INT J MED MICROBIOL, V298, P33, DOI 10.1016/j.ijmm.2007.07.007; Hislop AD, 2015, CURR TOP MICROBIOL, V391, P325, DOI 10.1007/978-3-319-22834-1_11; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000                                                   ; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KLEIN G, 1994, CELL, V77, P791, DOI 10.1016/0092-8674(94)90125-2; Ladell K, 2007, CELL MICROBIOL, V9, P2055, DOI 10.1111/j.1462-5822.2007.00937.x; Lunemann A, 2015, CURR TOP MICROBIOL, V391, P265, DOI 10.1007/978-3-319-22834-1_9; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Middeldorp JM, 2015, CURR TOP MICROBIOL, V391, P289, DOI 10.1007/978-3-319-22834-1_10; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; NEMEROW GR, 1987, J VIROL, V61, P1416; Ramasubramanyan S, 2012, J VIROL, V86, P1809, DOI 10.1128/JVI.06334-11; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; ROWE DT, 1986, EMBO J, V5, P2599; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0                                                                ; Ye JJ, 2010, J VIROL, V84, P12405, DOI 10.1128/JVI.01415-10; Yin QY, 2004, VIROLOGY, V327, P134, DOI 10.1016/j.virol.2004.06.026; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zauner L, 2010, ONCOGENE, V29, P4588, DOI 10.1038/onc.2010.203; ZURHAUSEN H, 1978, NATURE, V272, P373	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186614	10.1371/journal.pone.0186614				21	Multidisciplinary Sciences	Science & Technology - Other Topics	FL2ZD	WOS:000414088900018	29088270	gold			2018-01-05	
J	Dampier, W; Sullivan, NT; Chung, CH; Mell, JC; Nonnemacher, MR; Wigdahl, B				Dampier, Will; Sullivan, Neil T.; Chung, Cheng-Han; Mell, Joshua Chang; Nonnemacher, Michael R.; Wigdahl, Brian			Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants	SCIENTIFIC REPORTS			English	Article							INHIBIT HIV-1 REPLICATION; LATENT HIV-1; CRISPR/CAS9 SYSTEM; VIRAL ESCAPE; GUIDE RNAS; IN-VIVO; DNA; GENOME; CAS9; ACTIVATION	Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (Cas9), including specific guide RNAs (gRNAs), can excise integrated human immunodeficiency virus type 1 (HIV-1) provirus from host chromosomes. To date, anti-HIV-1 gRNAs have been designed to account for off-target activity, however, they seldom account for genetic variation in the HIV-1 genome within and between patients, which will be crucial for therapeutic application of this technology. This analysis tests the ability of published anti-HIV-1 gRNAs to cleave publicly available patient-derived HIV-1 sequences to inform gRNA design and provides basic computational tools to researchers in the field.	[Dampier, Will; Sullivan, Neil T.; Chung, Cheng-Han; Mell, Joshua Chang; Nonnemacher, Michael R.; Wigdahl, Brian] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Dampier, Will; Sullivan, Neil T.; Chung, Cheng-Han; Nonnemacher, Michael R.; Wigdahl, Brian] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Mol Virol & Translat Neurosci, Philadelphia, PA 19104 USA; [Dampier, Will] Drexel Univ, Sch Biomed Engn & Hlth Syst, Philadelphia, PA 19104 USA; [Mell, Joshua Chang] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Genom Sci, Philadelphia, PA 19104 USA; [Mell, Joshua Chang] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Adv Microbial Proc, Philadelphia, PA 19104 USA; [Wigdahl, Brian] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Wigdahl, B (reprint author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.; Wigdahl, B (reprint author), Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Mol Virol & Translat Neurosci, Philadelphia, PA 19104 USA.; Wigdahl, B (reprint author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	bw45@drexel.edu			Public Health Service, National Institutes of Health, through grants from the National Institute of Mental Health (NIMH) [R01 MH110360]; NIMH Comprehensive NeuroAIDS Center (CNAC) [P30 MH092177]; Ruth L. Kirschstein National Research Service Award [T32 MH079785]	These studies were funded in part by the Public Health Service, National Institutes of Health, through grants from the National Institute of Mental Health (NIMH) R01 MH110360 (Contact PI, BW), the NIMH Comprehensive NeuroAIDS Center (CNAC) P30 MH092177 (Kamel Khalili, PI; Brian Wigdahl, PI of the Drexel subcontract involving the Clinical and Translational Research Support Core) and under the Ruth L. Kirschstein National Research Service Award T32 MH079785 (Dr. Brian Wigdahl, Principal Investigator of the Drexel University College of Medicine component and Dr. Olimpia Meucci as Co-Director). The contents of the paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Aiamkitsumrit B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107389; Antell GC, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0266-9; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Dampier W., 2014, MOJ IMMUNOLOGY, V1; Dampier W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155382; Ebina H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120047; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Herrera-Carrillo E, 2016, BIOCHEM SOC T, V44, P1355, DOI 10.1042/BST20160060; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; HUANG ZH, 2017, SCI REPORTS, V7; Ji HYY, 2016, MOL THER, V24, P508, DOI 10.1038/mt.2016.7; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31527; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kim V., 2017, MATTERS, V2017; Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Nonnemacher MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150835; Qu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34532; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395; Wang G, 2016, CELL REP, V17, P2819, DOI 10.1016/j.celrep.2016.11.057; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127986; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	37	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 31	2017	7								14413	10.1038/s41598-017-12612-z				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4WA	WOS:000414231000014	29089503	gold			2018-01-05	
J	Tang, L; Mao, BG; Li, YK; Lv, QM; Zhang, LP; Chen, CY; He, HJ; Wang, WP; Zeng, XF; Shao, Y; Pan, YL; Hu, YY; Peng, Y; Fu, XQ; Li, HQ; Xia, ST; Zhao, BR				Tang, Li; Mao, Bigang; Li, Yaokui; Lv, Qiming; Zhang, LiPing; Chen, Caiyan; He, Hanjie; Wang, Weiping; Zeng, Xiongfeng; Shao, Ye; Pan, Yinlin; Hu, Yuanyi; Peng, Yan; Fu, Xiqin; Li, Hongqing; Xia, Shitou; Zhao, Bingran			Knockout of OsNramp5 using the CRISPR/Cas9 system produces low Cd-accumulating indica rice without compromising yield	SCIENTIFIC REPORTS			English	Article							CADMIUM ACCUMULATION; TARGETED MUTAGENESIS; RESISTANT RICE; TRANSLOCATION; PLANTS; TRANSPORTER; MANGANESE; GRAIN; ZINC; MUTATIONS	Rice grain with excessive cadmium (Cd) is a major source of dietary Cd intake and a serious threat to health for people who consume rice as a staple food. The development of elite rice cultivars with consistently low Cd content is challenging for conventional breeding approaches, and new strategies urgently need to be developed. Here, we report the development of new indica rice lines with low Cd accumulation and no transgenes by knocking out the metal transporter gene OsNramp5 using CRISPR/Cas9 system. Hydroponic culture showed that Cd concentrations in shoots and roots of osnramp5 mutants were dramatically decreased, resulting in rescue of impaired growth in high Cd condition. Cd-contaminated paddy field trials demonstrated that Cd concentration in osnramp5 grains was consistently less than 0.05 mg/kg, in contrast to high Cd concentrations from 0.33 mg/kg to 2.90 mg/kg in grains of Huazhan (the wild-type indica rice). In particular, the plant yield was not significantly affected in osnramp5 mutants. Furthermore, we developed promising hybrid rice lines with extremely low Cd content in grains. Our work supplies a practical approach to developing Cd pollution-safe indica rice cultivars that minimizes Cd contamination risk in grains.	[Tang, Li; Zeng, Xiongfeng; Xia, Shitou] Hunan Agr Univ, Coll Biosci & Biotechnol, Hunan Prov Key Lab Phytohormones & Growth Dev, Changsha 410128, Hunan, Peoples R China; [Tang, Li; Mao, Bigang; Li, Yaokui; Lv, Qiming; He, Hanjie; Wang, Weiping; Shao, Ye; Pan, Yinlin; Hu, Yuanyi; Peng, Yan; Fu, Xiqin; Zhao, Bingran] Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha 410125, Hunan, Peoples R China; [Zhang, LiPing; Chen, Caiyan] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China; [He, Hanjie] Cent South Univ Forestry & Technol, Hunan Prov Key Lab Forestry Biotechnol, Changsha 410004, Hunan, Peoples R China; [Li, Hongqing] South China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou 510631, Guangdong, Peoples R China	Xia, ST (reprint author), Hunan Agr Univ, Coll Biosci & Biotechnol, Hunan Prov Key Lab Phytohormones & Growth Dev, Changsha 410128, Hunan, Peoples R China.; Zhao, BR (reprint author), Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha 410125, Hunan, Peoples R China.; Li, HQ (reprint author), South China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou 510631, Guangdong, Peoples R China.	hqli@scnu.edu.cn; xstone0505@hunau.net; brzhaorice@163.com			Major Scientific Research Project of Hunan Province [XCNZ [2014] 180]; Hunan Provincial Natural Science Fund for Distinguished Young Scholars [11JJ1007]; Natural Science Foundation of Hunan Province [14JJ7084]; Earmarked Fund for Modern Agro-Industry Technology System of China [CARS-01-04B]	We thank Prof. Yao-Guang Liu (South China Agricultural University, Guangzhou) for kindly providing the plant binary vector pYLCRISPR/Cas9Pubi-H and the pYLgRNA plasmids. This work was supported by the Major Scientific Research Project of Hunan Province (Grant No. XCNZ [2014] 180), Hunan Provincial Natural Science Fund for Distinguished Young Scholars (Grant No. 11JJ1007), the Natural Science Foundation of Hunan Province (Grant No. 14JJ7084) and the Earmarked Fund for Modern Agro-Industry Technology System of China (Grant No. CARS-01-04B).	Arao T, 2006, JARQ-JPN AGR RES Q, V40, P21, DOI 10.6090/jarq.40.21                                                              ; Arao T, 2003, SOIL SCI PLANT NUTR, V49, P473, DOI 10.1080/00380768.2003.10410035                                                  ; Arao T, 2010, PADDY WATER ENVIRON, V8, P247, DOI 10.1007/s10333-010-0205-7; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Ebbs SD, 1997, J ENVIRON QUAL, V26, P1424, DOI 10.2134/jeq1997.00472425002600050032x                                           ; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fujimaki S, 2010, PLANT PHYSIOL, V152, P1796, DOI 10.1104/pp.109.151035; Grant CA, 2008, SCI TOTAL ENVIRON, V390, P301, DOI 10.1016/j.scitotenv.2007.10.038; Honda R, 2010, TOXICOL LETT, V198, P26, DOI 10.1016/j.toxlet.2010.04.023; Hu YN, 2016, ENVIRON INT, V92-93, P515, DOI 10.1016/j.envint.2016.04.042; Huang S., 2016, B ENVIRON CONTAM TOX, P1; Huang SW, 2016, NAT GENET, V48, P109, DOI 10.1038/ng.3484; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Jallad KN, 2015, ENVIRON SCI POLLUT R, V22, P15449, DOI 10.1007/s11356-015-4753-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Meharg AA, 2013, ENVIRON SCI TECHNOL, V47, P5613, DOI 10.1021/es400521h; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; ROWLAND LJ, 1993, BIOTECHNIQUES, V14, P734; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Sasaki A, 2011, PLANT PHYSIOL, V157, P1832, DOI 10.1104/pp.111.186031; Satoh-Nagasawa N, 2012, PLANT CELL PHYSIOL, V53, P213, DOI 10.1093/pcp/pcr166; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shraim A. M., 2014, ARAB J CHEM, P1; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Sun L, 2016, FRONT PLANT SCI, V7, DOI 10.3339/fpls.2016.01407; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Takahashi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098816; Takahashi R, 2012, PLANT CELL ENVIRON, V35, P1948, DOI 10.1111/j.1365-3040.2012.02527.x; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Ueno D, 2011, J EXP BOT, V62, P2265, DOI 10.1093/jxb/erq383; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Uraguchi S, 2013, CURR OPIN PLANT BIOL, V16, P328, DOI 10.1016/j.pbi.2013.03.012; Uraguchi S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-5; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; Uraguchi S, 2009, J EXP BOT, V60, P2677, DOI 10.1093/jxb/erp119; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Watanabe T, 1996, SCI TOTAL ENVIRON, V184, P191, DOI 10.1016/0048-9697(96)05100-5; Xu RF, 2016, J GENET GENOMICS, V43, P529, DOI 10.1016/j.jgg.2016.07.003; Xu XY, 2008, ENVIRON SCI TECHNOL, V42, P5574, DOI 10.1021/es800324u; Yang M, 2014, J EXP BOT, V65, P4849, DOI 10.1093/jxb/eru259; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yuan LP, 2014, RICE SCI, V21, P1, DOI 10.1016/S1672-6308(13)60167-5; Zhao FJ, 2015, ENVIRON SCI TECHNOL, V49, P750, DOI 10.1021/es5047099; Zhou H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37395	57	1	1	19	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 31	2017	7								14438	10.1038/s41598-017-14832-9				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FL4WA	WOS:000414231000039	29089547	gold			2018-01-05	
J	Wu, Y; Hao, YQ; Wei, X; Shen, Q; Ding, XW; Wang, LY; Zhao, HX; Lu, Y				Wu, Yan; Hao, Yaqiao; Wei, Xuan; Shen, Qi; Ding, Xuanwei; Wang, Liyan; Zhao, Hongxin; Lu, Yuan			Impairment of NADH dehydrogenase and regulation of anaerobic metabolism by the small RNA RyhB and NadE for improved biohydrogen production in Enterobacter aerogenes	BIOTECHNOLOGY FOR BIOFUELS			English	Article						Enterobacter aerogenes; Biohydrogen; NADH dehydrogenase; CRISPR-Cas9; Small RNA RyhB	INCREASED HYDROGEN-PRODUCTION; ESCHERICHIA-COLI; FLUX REDISTRIBUTION; FERMENTATION; EVOLUTION; COMPLEX; POOL	Background: Enterobacter aerogenes is a facultative anaerobe and is one of the most widely studied bacterial strains because of its ability to use a variety of substrates, to produce hydrogen at a high rate, and its high growth rate during dark fermentation. However, the rate of hydrogen production has not been optimized. In this present study, three strategies to improve hydrogen production in E. aerogenes, namely the disruption of nuoCDE, overexpression of the small RNA RyhB and of NadE to regulate global anaerobic metabolism, and the redistribution of metabolic flux. The goal of this study was to clarify the effect of nuoCDE, RyhB, and NadE on hydrogen production and how the perturbation of NADH influences the yield of hydrogen gas from E. aerogenes. Results: NADH dehydrogenase activity was impaired by knocking out nuoCD or nuoCDE in E. aerogenes IAM1183 using the CRISPR-Cas9 system to explore the consequent effect on hydrogen production. The hydrogen yields from IAM1183-CD(Delta nuoC/Delta nuoD) and IAM1183-CDE (Delta nuoC/Delta nuoD/Delta nuoE) increased, respectively, by 24.5 and 45.6% in batch culture (100 mL serum bottles). The hydrogen produced via the NADH pathway increased significantly in IAM1183-CDE, suggesting that nuoE plays an important role in regulating NADH concentration in E. aerogenes. Batch-cultivating experiments showed that by the overexpression of NadE (N), the hydrogen yields of IAM1183/N, IAM1183CD/N, and IAM1183-CDE/N increased 1.06-, 1.35-, and 1.55-folds, respectively, compared with IAM1183. Particularly worth mentioning is that the strain IAM118-CDE/N reached 2.28 mol in H-2 yield, per mole of glucose consumed. IAN1183/R, IAM1183-CD/R, and IAM1183-CDE/R showed increasing H-2 yields in batch culture. Metabolic flux analysis indicated that increased expression of RyhB led to a significant shift in metabolic patterns. We further investigated IAM1183-CDE/N, which had the best hydrogen-producing traits, as a potential candidate for industry applications using a 5-L fermenter; hydrogen production reached up to 1.95 times greater than that measured for IAM1183. Conclusions: Knockout of nuoCD or nuoCDE and the overexpression of nadE in E. aerogenes resulted in a redistribution of metabolic flux and improved the hydrogen yield. Overexpression of RyhB had an significant change on the hydrogen production via NADH pathway. A combination of strategies would be a novel approach for developing a more economic and efficient bioprocess for hydrogen production in E. aerogenes. Finally, the latest CRISPR-Cas9 technology was successful for editing genes in E. aerogenes to develop our engineered strain for hydrogen production.	[Wu, Yan; Hao, Yaqiao; Wei, Xuan; Shen, Qi; Ding, Xuanwei; Zhao, Hongxin] Zhejiang Sci Tech Univ, Coll Life Sci, Zhejiang Prov Key Lab Plant Metab & Regulat 2, Hangzhou 310018, Zhejiang, Peoples R China; [Ding, Xuanwei; Lu, Yuan] Tsinghua Univ, Dept Chem Engn, Key Lab Ind Biocatalysis, Minist Educ, Beijing 100084, Peoples R China; [Ding, Xuanwei; Wang, Liyan; Lu, Yuan] Tsinghua Univ, Inst Biochem Engn, Dept Chem Engn, Beijing 100084, Peoples R China; [Hao, Yaqiao; Wei, Xuan; Ding, Xuanwei] Shenyang Normal Univ, Coll Life Sci, Shenyang 110034, Liaoning, Peoples R China	Zhao, HX (reprint author), Zhejiang Sci Tech Univ, Coll Life Sci, Zhejiang Prov Key Lab Plant Metab & Regulat 2, Hangzhou 310018, Zhejiang, Peoples R China.; Lu, Y (reprint author), Tsinghua Univ, Dept Chem Engn, Key Lab Ind Biocatalysis, Minist Educ, Beijing 100084, Peoples R China.; Lu, Y (reprint author), Tsinghua Univ, Inst Biochem Engn, Dept Chem Engn, Beijing 100084, Peoples R China.	bxxbj2003@gmail.com; yuanlu@tsinghua.edu.cn			National Natural Science Foundation of China [31601671]; Science Public Welfare Fund Projects of Zhejiang Province [2017C32050]; Talent Fund Projects of Zhejiang Sci-tech University [116129326 11513]	This work was supported by grants from the National Natural Science Foundation of China (31601671), the Science Public Welfare Fund Projects of Zhejiang Province (2017C32050), and Talent Fund Projects of Zhejiang Sci-tech University (116129326 11513).	Azwar MY, 2014, RENEW SUST ENERG REV, V31, P158, DOI 10.1016/j.rser.2013.11.022; Beauchene NA, 2015, MBIO, V6, DOI 10.1128/mBio.01947-15; Boboescu IZ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0139-1; Cha M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-85; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Ghimire A, 2015, APPL ENERG, V144, P73, DOI 10.1016/j.apenergy.2015.01.045; Ghosh D, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-122; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hallenbeck PC, 2005, WATER SCI TECHNOL, V52, P21; Heuser F, 2007, ENG LIFE SCI, V7, P343, DOI 10.1002/elsc.200720203; Huang SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-148; Jauch R, 2005, J BIOL CHEM, V280, P15131, DOI 10.1074/jbc.M413195200; Miller Jeffrey H, 1972, EXPT MOL GENETICS; Kang Z, 2012, BIOTECHNOL LETT, V34, P527, DOI 10.1007/s10529-011-0794-2; Khan MA, 2017, RENEW ENERG, DOI [10.1016/j.renene.2017.04.029, DOI 10.1016/J.RENENE.2017.04.029]; Liang LY, 2012, ENZYME MICROB TECH, V51, P286, DOI 10.1016/j.enzmictec.2012.07.011; Lu Y, 2010, APPL MICROBIOL BIOT, V86, P255, DOI 10.1007/s00253-009-2274-3; Lu Y, 2009, BIORESOURCE TECHNOL, V100, P2889, DOI 10.1016/j.biortech.2009.01.023; Ma K, 2012, INT J HYDROGEN ENERG, V37, P15875, DOI 10.1016/j.ijhydene.2012.08.017; Machner MP, 2016, NATURE, V529, P472, DOI 10.1038/nature16872; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McDowall JS, 2014, P NATL ACAD SCI USA, V111, pE3948, DOI 10.1073/pnas.1407927111; Passos F, 2014, BIORESOURCE TECHNOL, V172, P403, DOI 10.1016/j.biortech.2014.08.114; Rachman MA, 1998, APPL MICROBIOL BIOT, V49, P450, DOI 10.1007/s002530051197                                                           ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sinha P, 2011, INT J HYDROGEN ENERG, V36, P7460, DOI 10.1016/j.ijhydene.2011.03.077; TANISHO S, 1989, BIOCHIM BIOPHYS ACTA, V973, P1, DOI 10.1016/S0005-2728(89)80393-7; Wang J, 2013, INT J HYDROGEN ENERG, V38, P13204, DOI 10.1016/j.ijhydene.2013.07.121; Xu N, 2017, J BIOTECHNOL, V251, P1, DOI 10.1016/j.jbiotec.2017.04.004; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Zhang C, 2009, INT J HYDROGEN ENERG, V34, P1226, DOI 10.1016/j.ijhydene.2008.11.070; Zhao HX, 2015, BIORESOURCE TECHNOL, V194, P99, DOI 10.1016/j.biortech.2015.06.149; Zhao HX, 2009, INT J HYDROGEN ENERG, V34, P186, DOI 10.1016/j.ijhydene.2008.10.025	35	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-6834			BIOTECHNOL BIOFUELS	Biotechnol. Biofuels	OCT 30	2017	10								248	10.1186/s13068-017-0938-2				15	Biotechnology & Applied Microbiology; Energy & Fuels	Biotechnology & Applied Microbiology; Energy & Fuels	FL1KL	WOS:000413973500003	29093752	gold			2018-01-05	
J	Pelosse, M; Crocker, H; Gorda, B; Lemaire, P; Rauch, J; Berger, I				Pelosse, Martin; Crocker, Hannah; Gorda, Barbara; Lemaire, Paul; Rauch, Jens; Berger, Imre			MultiBac: from protein complex structures to synthetic viral nanosystems	BMC BIOLOGY			English	Review							BACULOVIRUS EXPRESSION SYSTEM; GENETIC-CODE EXPANSION; MULTIPROTEIN COMPLEXES; INSECT CELLS; INFLUENZA POLYMERASE; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; VECTOR SYSTEM; VIRUS; BIOLOGY	The MultiBac baculovirus/insect cell expression vector system was conceived as a user-friendly, modular tool-kit for producing multiprotein complexes for structural biology applications. MultiBac has allowed the structure and function of many molecular machines to be elucidated, including previously inaccessible high-value drug targets. More recently, MultiBac developments have shifted to customized baculoviral genomes that are tailored for a range of applications, including synthesizing artificial proteins by genetic code expansion. We review some of these developments, including the ongoing rewiring of the MultiBac system for mammalian applications, notably CRISPR/Cas9-mediated gene editing.	[Pelosse, Martin; Crocker, Hannah; Gorda, Barbara; Berger, Imre] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Pelosse, Martin; Crocker, Hannah; Gorda, Barbara; Berger, Imre] Univ Bristol, Bristol Synthet Biol Ctr BrisSynBio, Bristol BS8 1TD, Avon, England; [Lemaire, Paul] Geneva Biotech SARL, Ave Roseraie 64, CH-1205 Geneva, Switzerland; [Rauch, Jens] Univ Coll Dublin, Syst Biol Ireland, Belfield Dublin 4, Ireland	Berger, I (reprint author), Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England.; Berger, I (reprint author), Univ Bristol, Bristol Synthet Biol Ctr BrisSynBio, Bristol BS8 1TD, Avon, England.	imre.berger@bristol.ac.uk		Rauch, Jens/0000-0002-5120-9547	Science Foundation Ireland [14/IA/3295]; European Commission Framework Programme 7 project SynSignal [613879]; European Commission Framework Programme 7 project ComplexINC [279039]	We thank all members of the Berger laboratory, in particular Deepak Balaji Govinda Raj, for helpful discussions. Kapil Gupta is acknowledged for help with structure representations. Kari Airenne (University of Eastern Finland) kindly provided the schematic drawing of the bacuvirion. We thank Daniel Fitzgerald (Geneva Biotech, Switzerland) and Ismail Moarefi (Crelux GmbH, Germany) for useful comments on the manuscript, and Tim Richmond (FTH Zurich, Switzerland) for encouragement and support at the early stages of the project. This work was supported by the Science Foundation Ireland (grant number 14/IA/3295, to JR) and the European Commission Framework Programme 7 projects SynSignal (contract number 613879, to JR and IB) and ComplexINC (contract number 279039, to IB). The authors acknowledge	Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114; Ames RS, 2007, EXPERT OPIN DRUG DIS, V2, P1669, DOI 10.1517/17460441.2.12.1669; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Barsoum J, 1997, HUM GENE THER, V8, P2011, DOI 10.1089/hum.1997.8.17-2011                                                      ; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Berger I, 2013, JOVE-J VIS EXP, V77; Berger I, 2015, BIOENGINEERED, V6, P316, DOI 10.1080/21655979.2015.1104433; Bertipaglia C, 2016, EMBO REP, V17, P1044, DOI 10.15252/embr.201541960; Bieniossek C, 2008, CURR PROTOC PROTEIN; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Chao WCH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13952; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Crepin T, 2015, CURR OPIN STRUC BIOL, V32, P139, DOI 10.1016/j.sbi.2015.04.007; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Gorelik A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12196; Gupta K, 2016, J MOL BIOL, V428, P2581, DOI 10.1016/j.jmb.2016.04.003; Haase S, 2015, VIRUSES-BASEL, V7, P2230, DOI 10.3390/v7052230; Haffke M, 2013, METHODS MOL BIOL, V1073, P131, DOI 10.1007/978-1-62703-625-2_11; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Hons MT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12523; Hunkeler M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11196; Jeong H, 2017, J MICROBIOL, V55, P220, DOI 10.1007/s12275-017-7058-3; Koehler C, 2016, NAT METHODS, V13, P997, DOI [10.1038/NMETH.4032, 10.1038/nmeth.4032]; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Lemke EA, 2014, CHEMBIOCHEM, V15, P1691, DOI 10.1002/cbic.201402362; Leveque D, 2008, CURR CLIN PHARMACOL, V3, P51, DOI 10.2174/157488408783329931; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu JL, 2016, VIROL SIN, V31, P279, DOI 10.1007/s12250-016-3756-y; LUCKOW VA, 1993, J VIROL, V67, P4566; Luckow Verne A., 1993, Current Opinion in Biotechnology, V4, P564, DOI 10.1016/0958-1669(93)90078-B; Lukarska M, 2017, NATURE, V541, P117, DOI 10.1038/nature20594; Luo S, 2017, NATURE, V542, P255, DOI 10.1038/nature21061; Malyshev DA, 2015, ANGEW CHEM INT EDIT, V54, P11930, DOI 10.1002/anie.201502890; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; Mietzsch M, 2017, HUM GENE THER METHOD, V28, P15, DOI 10.1089/hgtb.2016.164; Mietzsch M, 2014, HUM GENE THER, V25, P212, DOI 10.1089/hum.2013.184; Neumann-Staubitz P, 2016, CURR OPIN STRUC BIOL, V38, P119, DOI 10.1016/j.sbi.2016.06.006; Nie Y, 2014, METHODS MOL BIOL, V1091, P131, DOI 10.1007/978-1-62703-691-7_8; Nie Y, 2009, CURR GENOMICS, V10, P558, DOI 10.2174/138920209789503923; Nikic I, 2015, CURR OPIN CHEM BIOL, V28, P164, DOI 10.1016/j.cbpa.2015.07.021; Palmberger D, 2015, METHODS MOL BIOL, V1321, P153, DOI 10.1007/978-1-4939-2760-9_11; Palmberger D, 2013, BIOENGINEERED, V4, P78, DOI 10.4161/bioe.22327; Palmberger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034226; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Pijlman GP, 2003, J GEN VIROL, V84, P2669, DOI 10.1099/vir.0.19438-0; Pijlman GP, 2002, J VIROL, V76, P5605, DOI 10.1128/JVI.76.11.5605-5611.2002; Pijlman GP, 2001, VIROLOGY, V283, P132, DOI 10.1006/viro.2001.0854; Potter M, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.34; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Sari D, 2016, ADV EXP MED BIOL, V896, P199, DOI 10.1007/978-3-319-27216-0_13; Sari-Ak D, METHODS MOL IN PRESS; Shang Y, 2017, ACS SYNTH BIOL; Shapiro A, 2008, DIABETES, V57, P614, DOI 10.2337/db07-0863; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Temchura V, 2017, CURR OPIN HIV AIDS, V12, P272, DOI [10.1097/COH.0000000000000358, 10.1097/coh.0000000000000358]; Trowitzsch S, 2012, EXPERT REV PROTEOMIC, V9, P363, DOI [10.1586/EPR.12.32, 10.1586/epr.12.32]; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; van Beek N, 2016, METHODS MOL BIOL, V1350, P393, DOI 10.1007/978-1-4939-3043-2_20; van Oers MM, 2015, J GEN VIROL, V96, P6, DOI 10.1099/vir.0.067108-0; Vijayachandran LS, 2013, BIOENGINEERED, V4, P279, DOI 10.4161/bioe.22966; Vijayachandran LS, 2011, J STRUCT BIOL, V175, P198, DOI 10.1016/j.jsb.2011.03.007; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Weissmann F, 2016, P NATL ACAD SCI USA, V113, pE2564, DOI 10.1073/pnas.1604935113; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang ZG, 2016, METHODS, V95, P13, DOI 10.1016/j.ymeth.2015.10.003	69	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1741-7007			BMC BIOL	BMC Biol.	OCT 30	2017	15								99	10.1186/s12915-017-0447-6				10	Biology	Life Sciences & Biomedicine - Other Topics	FL1KC	WOS:000413972400002	29084535	gold			2018-01-05	
J	Hayakawa, K; Hirosawa, M; Tani, R; Yoneda, C; Tanaka, S; Shiota, K				Hayakawa, Koji; Hirosawa, Mitsuko; Tani, Ruiko; Yoneda, Chikako; Tanaka, Satoshi; Shiota, Kunio			H2A O-GlcNAcylation at serine 40 functions genomic protection in association with acetylated H2AZ or gamma H2AX	EPIGENETICS & CHROMATIN			English	Article						O-GlcNAcylation; Histone modification; Canonical histone; Histone variant; DNA damage; DNA repair	DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; NUCLEOSOME CORE PARTICLE; EMBRYONIC STEM-CELLS; HISTONE H2AX; SACCHAROMYCES-CEREVISIAE; GLCNAC TRANSFERASE; CRYSTAL-STRUCTURE; MESSENGER-RNA; CHROMATIN	Background: We have previously reported a novel O-GlcNAc modification at serine 40 (S40) of H2A (H2AS40Gc). S40-type H2A isoforms susceptible to O-GlcNAcylation are evolutionarily new and restricted to the viviparous animals; however, the biological function of H2AS40Gc is largely unknown. H2A isoforms are consisted of S40 and alanine 40 (A40) type and this residue on H2A is located in the L1 of the globular domain, which is also known as a variable portion that distinguishes between the canonical and non-canonical H2A variants. In this study, by considering the similarity between the S40-type H2A and histone H2A variants, we explored the function of H2AS40Gc in mouse embryonic stem cells (mESCs). Results: We found several similarities between the S40-type H2A isoforms and histone H2A variants such H2AZ and H2AX. mRNA of S40-type H2A isoforms (H2A1 N and H2A3) had a poly(A) tail and was produced throughout the cell cycle in contrast to that of A40-type. Importantly, H2AS40Gc level increased owing to chemical-induced DNA damage, similar to phosphorylated H2AX (gamma H2AX) and acetylated H2AZ (AcH2AZ). H2AS40Gc was accumulated at the restricted area (+/- 1.5 kb) of DNA damage sites induced by CRISPR/CAS9 system in contrast to accumulation of gamma H2AX, which was widely scattered. Overexpression of the wild-type (WT) H2A3, but not the S40 to A40 mutation (S40A-mutant), protected the mESC genome against chemical-induced DNA damage. Furthermore, 3 h after the DNA damage treatment, the genome was almost recovered in WT mESCs, whereas the damage advanced further in the S40A-mutant mESCs, suggesting functions of H2AS40Gc in the DNA repair mechanism. Furthermore, the S40A mutant prevented the accumulation of the DNA repair apparatus such as DNA-PKcs and Rad51 at the damage site. Co-immunoprecipitation experiment in WT and S40A-mutant mESCs revealed that H2AS40Gc physiologically bound to AcH2AZ at the initial phase upon DNA damage, followed by binding with gamma H2AX during the DNA damage repair process. Conclusions: These data suggest that H2AS40Gc functions to maintain genome integrity through the DNA repair mechanism in association with AcH2AZ and gamma H2AX.	[Hayakawa, Koji; Hirosawa, Mitsuko; Tani, Ruiko; Yoneda, Chikako; Tanaka, Satoshi; Shiota, Kunio] Univ Tokyo, Lab Cellular Biochem, Dept Anim Resource Sci Vet Med Sci, Tokyo 1138657, Japan; [Shiota, Kunio] Waseda Univ, Waseda Res Inst Sci & Engn, Tokyo 1698555, Japan	Shiota, K (reprint author), Univ Tokyo, Lab Cellular Biochem, Dept Anim Resource Sci Vet Med Sci, Tokyo 1138657, Japan.	ashiota@mail.ecc.u-tokyo.ac.jp		Hayakawa, Koji/0000-0003-0453-1303	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan; Bio-oriented Technology Research Advancement Institute (BRAIN), Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26252052]; Lotte Shigemitsu Prize, Japan; Mizutani Foundation for Glycoscience	This study was supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan (to K.S.), and Bio-oriented Technology Research Advancement Institute (BRAIN), Japan (to K.S.), and a Grant-in-Aid for Scientific Research A from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (No. 26252052, to K.S.), and Lotte Shigemitsu Prize, Japan (to K.H.), and Mizutani Foundation for Glycoscience (to K.S.).	Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bakkenist CJ, 2015, DNA REPAIR, V36, P8, DOI 10.1016/j.dnarep.2015.09.002; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen Q, 2016, NUCLEIC ACIDS RES, V44, P9266, DOI 10.1093/nar/gkw663; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; DELISLE AJ, 1983, MOL CELL BIOL, V3, P1920, DOI 10.1128/MCB.3.11.1920                                                           ; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Gursoy-Yuzugullu O, 2015, P NATL ACAD SCI USA, V112, P7507, DOI 10.1073/pnas.1504868112; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Hayakawa K, 2013, J BIOL CHEM, V288, P17099, DOI 10.1074/jbc.M113.455899; Hayakawa K, 2012, EPIGENETICS-US, V7, P1029, DOI 10.4161/epi.21492; Henikoff S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019364; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hirosawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31785; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li A, 2010, J BIOL CHEM, V285, P17778, DOI 10.1074/jbc.M110.116426; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Luger K, 1997, NATURE, V389, P251; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reitsema T, 2005, DNA REPAIR, V4, P1172, DOI 10.1016/j.dnarep.2005.06.005; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858                                                         ; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schouppe D, 2011, PLANT PHYSIOL, V155, P1091, DOI 10.1104/pp.110.170134; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207                                                   ; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/bjc.C100569200; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Xu Y, 2012, MOL CELL, V48, P723, DOI 10.1016/j.molcel.2012.09.026; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	54	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-8935			EPIGENET CHROMATIN	Epigenetics Chromatin	OCT 30	2017	10								51	10.1186/s13072-017-0157-x				14	Genetics & Heredity	Genetics & Heredity	FL1FI	WOS:000413959700001	29084613	gold			2018-01-05	
J	Wang, FZ; Chen, MX; Yu, LJ; Xie, LJ; Yuan, LB; Qi, H; Xiao, M; Guo, WX; Chen, Z; Yi, KK; Zhang, JH; Qiu, RL; Shu, WS; Xiao, S; Chen, QF				Wang, Feng-Zhu; Chen, Mo-Xian; Yu, Lu-Jun; Xie, Li-Juan; Yuan, Li-Bing; Qi, Hua; Xiao, Ming; Guo, Wuxiu; Chen, Zhe; Yi, Keke; Zhang, Jianhua; Qiu, Rongliang; Shu, Wensheng; Xiao, Shi; Chen, Qin-Fang			OsARM1, an R2R3 MYB Transcription Factor, Is Involved in Regulation of the Response to Arsenic Stress in Rice	FRONTIERS IN PLANT SCIENCE			English	Article						arsenic; As transport; As uptake; MYB transcription factor; OsARM1; Oryza sativa	AGROBACTERIUM-MEDIATED TRANSFORMATION; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; TRACE-ELEMENTS; GENE; TRANSPORTER; TOLERANCE; PLANTS; EXPRESSION; SILICON	Bioaccumulation of arsenic (As) in rice (Oryza sativa) increases human exposure to this toxic, carcinogenic element. Recent studies identified several As transporters, but the regulation of these transporters remains unclear. Here, we show that the rice R2R3 MYB transcription factor OsARM1 (ARSENITE-RESPONSIVE MYB1) regulates As-associated transporters genes. Treatment with As(III) induced OsARM1 transcript accumulation and an OsARM1-GFP fusion localized to the nucleus. Histochemical analysis of OsARM1pro::GUS lines indicated that OsARM1 was expressed in the phloem of vascular bundles in basal and upper nodes. Knockout of OsARM1 (OsARM1-KO CRISPR/Cas9-generated mutants) improved tolerance to As(III) and overexpression of OsARM1 (OsARM1-OE lines) increased sensitivity to As(III). Measurement of As in As(III)-treated plants showed that under low As(III) conditions (2 mu M), more As was transported from the roots to the shoots in OsARM1-KOs. By contrast, more As accumulated in the roots in OsARM1-OEs in response to high As(III) exposure (25 mu M). In particular, the As(III) levels in node I were significantly higher in OsARM1-KOs, but significantly lower in OsARM1-OEs, compared to wild-type plants, implying that OsARM1 is important for the regulation of root-to-shoot translocation of As. Moreover, OsLsi1, OsLsi2, and OsLsi6, which encode key As transporters, were significantly downregulated in OsARM1-OEs and upregulated in OsARM1-KOs compared to wild type. Chromatin immunoprecipitation-quantitative PCR of OsARM1-OEs indicated that OsARM1 binds to the conserved MYB-binding sites in the promoters or genomic regions of OsLsi1, OsLsi2, and OsLsi6 in rice. Our findings suggest that the OsARM1 transcription factor has essential functions in regulating As uptake and root-to-shoot translocation in rice.	[Wang, Feng-Zhu; Yu, Lu-Jun; Xie, Li-Juan; Yuan, Li-Bing; Qi, Hua; Xiao, Ming; Guo, Wuxiu; Shu, Wensheng; Xiao, Shi; Chen, Qin-Fang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Plant Resources, Collaborat Innovat Ctr Genet & Dev,Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Mo-Xian; Zhang, Jianhua] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Chen, Zhe; Qiu, Rongliang] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Yi, Keke] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing, Peoples R China; [Zhang, Jianhua] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chen, QF (reprint author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Plant Resources, Collaborat Innovat Ctr Genet & Dev,Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	chenqf3@mail.sysu.edu.cn	QIU, Rong-Liang/F-9450-2012		National Natural Science Foundation of China [31200200, 31400219]; Research Fund for the Doctoral Program of Higher Education of China [20120171120004]; Pearl River S&T Nova Program of Guangzhou [201610010070]; Natural Science Foundation of Guangdong Province [2015A030313075]; Foundation of Guangzhou Science and Technology [201504010021]; Sun Yat-sen University	This work was supported by the National Natural Science Foundation of China (Projects 31200200 and 31400219), Research Fund for the Doctoral Program of Higher Education of China (Project 20120171120004), the Pearl River S&T Nova Program of Guangzhou (201610010070), the Natural Science Foundation of Guangdong Province (2015A030313075), the Foundation of Guangzhou Science and Technology (Project 201504010021), and Sun Yat-sen University (Start-up fund to QC).	Abedin MJ, 2002, PLANT PHYSIOL, V128, P1120, DOI 10.1104/pp.010733; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Ali W, 2009, CELL MOL LIFE SCI, V66, P2329, DOI 10.1007/s00018-009-0021-7; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Brammer H, 2009, ENVIRON INT, V35, P647, DOI 10.1016/j.envint.2008.10.004; Carey AM, 2010, PLANT PHYSIOL, V152, P309, DOI 10.1104/pp.109.146126; Castrillo G, 2013, PLANT CELL, V25, P2944, DOI 10.1105/tpc.113.114009; Chen J, 2016, PLANT PHYSIOL, V171, P707, DOI 10.1104/pp.15.01882; Chen MX, 2013, J AGR FOOD CHEM, V61, P6423, DOI 10.1021/jf401537q; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen Y, 2015, J EXP BOT, V66, P3717, DOI 10.1093/jxb/erv164; Chen Z, 2005, NEW PHYTOL, V165, P91, DOI 10.1111/j.1469-8137.2004.01241.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Gao J, 2015, BIOCHEM BIOPH RES CO, V458, P287, DOI 10.1016/j.bbrc.2015.01.101; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Kusaba M, 1996, PLANT PHYSIOL, V111, P1161, DOI 10.1104/pp.111.4.1161                                                           ; Li CX, 2007, J ENVIRON SCI-CHINA, V19, P725, DOI 10.1016/S1001-0742(07)60121-1; Li G, 2011, ENVIRON INT, V37, P1219, DOI 10.1016/j.envint.2011.05.007; Li NN, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv143; Li RY, 2009, PLANT PHYSIOL, V150, P2071, DOI 10.1104/pp.109.140350; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Meharg AA, 2002, NEW PHYTOL, V154, P29, DOI 10.1046/j.1469-8137.2002.00363.x; Meharg AA, 2009, ENVIRON SCI TECHNOL, V43, P1612, DOI 10.1021/es802612a; Mirlean N, 2014, SCI TOTAL ENVIRON, V482, P148, DOI 10.1016/j.scitotenv.2014.02.138; Moore KL, 2014, NEW PHYTOL, V201, P104, DOI 10.1111/nph.12497; Nagae M, 2008, PLANT PHYSIOL, V146, P1687, DOI 10.1104/pp.107.114868; Nicolli HB, 2012, SCI TOTAL ENVIRON, V429, P36, DOI 10.1016/j.scitotenv.2012.04.048; Pabuayon IM, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0104-7; Piya S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00744; QUINN JM, 1995, PLANT CELL, V7, P623; Rahman MA, 2007, CHEMOSPHERE, V67, P1072, DOI 10.1016/j.chemosphere.2006.11.061; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shri M, 2009, ECOTOX ENVIRON SAFE, V72, P1102, DOI 10.1016/j.ecoenv.2008.09.022; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896                                                         ; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Stoeva N, 2003, BIOL PLANTARUM, V47, P449, DOI 10.1023/B:BIOP.0000023893.12939.48; Sun N, 2015, PLANT PHYSIOL, V167, P1136, DOI 10.1104/pp.114.253096; Sytar O, 2013, ACTA PHYSIOL PLANT, V35, P985, DOI 10.1007/s11738-012-1169-6; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109                                                              ; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Wang HP, 2017, MOL PLANT, V10, P1461, DOI 10.1016/j.molp.2017.08.007; Wang Y, 2016, PLANT CELL, V28, P1094, DOI 10.1105/tpc.16.00100; Wang YH, 2012, PLANT MOL BIOL, V78, P275, DOI 10.1007/s11103-011-9861-2; Xiao S, 2008, PLANT MOL BIOL, V68, P571, DOI 10.1007/s11103-008-9392-7; Xu WZ, 2015, MOL PLANT, V8, P722, DOI 10.1016/j.molp.2015.01.005; Yamaguchi Nobutoshi, 2014, Arabidopsis Book, V12, pe0170, DOI 10.1199/tab.0170; Yamaji N, 2008, PLANT CELL, V20, P1381, DOI 10.1105/tpc.108.059311; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007; Yamaji N, 2009, PLANT CELL, V21, P2878, DOI 10.1105/tpc.109.069831; Yang GY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18752; Yu LJ, 2012, NEW PHYTOL, V195, P97, DOI 10.1111/j.1469-8137.2012.04154.x; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zheng SX, 2012, J EXP BOT, V63, P2985, DOI 10.1093/jxb/ers009; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185	69	0	0	12	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	OCT 30	2017	8								1868	10.3389/fpls.2017.01868				16	Plant Sciences	Plant Sciences	FL0VM	WOS:000413929600001	29163593	gold			2018-01-05	
J	Walkley, CR; Li, JB				Walkley, Carl R.; Li, Jin Billy			Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs	GENOME BIOLOGY			English	Review							DOUBLE-STRANDED-RNA; DYSCHROMATOSIS SYMMETRICA HEREDITARIA; AICARDI-GOUTIERES SYNDROME; HUMAN-BRAIN; UNWINDING ACTIVITY; DEAMINASE GENE; ENZYME ADAR1; SYSTEMATIC IDENTIFICATION; HEPATOCELLULAR-CARCINOMA; ACCURATE IDENTIFICATION	One of the most prevalent forms of post-transcritpional RNA modification is the conversion of adenosine nucleosides to inosine (A-to-I), mediated by the ADAR family of enzymes. The functional requirement and regulatory landscape for the majority of A-to-I editing events are, at present, uncertain. Recent studies have identified key in vivo functions of ADAR enzymes, informing our understanding of the biological importance of A-to-I editing. Large-scale studies have revealed how editing is regulated both in cis and in trans. This review will explore these recent studies and how they broaden our understanding of the functions and regulation of ADAR-mediated RNA editing.	[Walkley, Carl R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Walkley, Carl R.] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Walkley, CR (reprint author), St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia.; Li, JB (reprint author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cwalkley@svi.edu.au; jin.billy.li@stanford.edu		Walkley, Carl/0000-0002-4784-9031	NHMRC [1102006]; Cancer Council Victoria; Victorian Cancer Agency Mid Career Research Fellowship; Victorian State Government OIS; NIH [R01GM102484, R01GM104215, R01MH115080]; Ellison Medical Foundation; Stanford University Department of Genetics	Work in CRW's laboratory is supported by grants from the NHMRC (1102006), Cancer Council Victoria, and a Victorian Cancer Agency Mid Career Research Fellowship, in part by the Victorian State Government OIS (to St Vincent's Institute). Work in JBL's laboratory is supported by the NIH (R01GM102484, R01GM104215, and R01MH115080), Ellison Medical Foundation, and Stanford University Department of Genetics.	Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Ben-Shoshan SO, 2017, RNA BIOL, V14, P587, DOI 10.1080/15476286.2016.1203501; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Blango MG, 2016, GENOME RES, V26, P852, DOI 10.1101/gr.203992.116; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Carmi S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002317; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Cattenoz PB, 2013, RNA, V19, P257, DOI 10.1261/rna.036202.112; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Deffit SN, 2017, ELIFE, V6, DOI 10.7554/eLife.28625; Dominissini D, 2014, SCIENCE, V346, P1192, DOI 10.1126/science.aaa1807; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Eisenberg E, 2005, NUCLEIC ACIDS RES, V33, P4612, DOI 10.1093/nar/gki771; Eisenberg E, 2010, RNA BIOL, V7, P248, DOI 10.4161/rna.7.2.11565                                                           ; Feng S, 2011, NAT STRUCT MOL BIOL, V18, P169, DOI 10.1038/nsmb.1962; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Figueroa T, 2016, J GEN VIROL, V97, P2973, DOI 10.1099/jgv.0.000606; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gaisler-Salomon I, 2014, NEUROBIOL AGING, V35, P1785, DOI 10.1016/j.neurobiolaging.2014.02.018; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2010, J INTERFERON CYTOKIN, V31, P99; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; Heraud-Farlow JE, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1301-4; Higuchi M, 2000, NATURE, V406, P78; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298                                                            ; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Keegan L, 2017, RNA, V23, P1317, DOI [10.1261/rna.060921, 10.1261/rna.060921.117]; Keegan LP, 2011, NUCLEIC ACIDS RES, V39, P7249, DOI 10.1093/nar/gkr423; Khermesh K, 2016, RNA, V22, P290, DOI 10.1261/rna.054627.115; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Kleinman CL, 2012, SCIENCE, V335, DOI 10.1126/science.1209658; Ko NL, 2012, J GEN VIROL, V93, P2646, DOI 10.1099/vir.0.045146-0; Krestel H, 2013, NEUROBIOL DIS, V56, P66, DOI 10.1016/j.nbd.2013.04.006; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Kurmangaliyev Yerbol Z, 2015, G3 (Bethesda), V6, P391, DOI 10.1534/g3.115.024471; Kwak S, 2005, J MOL MED-JMM, V83, P110, DOI 10.1007/s00109-004-0599-z; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914                                                          ; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li YZ, 2017, ELIFE, V6, DOI 10.7554/eLife.25687; Liddicoat BJ, 2016, EXP HEMATOL, V44, P947, DOI 10.1016/j.exphem.2016.06.250; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; Miyamura Y, 2003, AM J HUM GENET, V73, P693, DOI 10.1086/378209; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oakes E, 2017, J BIOL CHEM, V292, P4326, DOI 10.1074/jbc.M117.779868; OCONNELL MA, 1994, P NATL ACAD SCI USA, V91, P10596, DOI 10.1073/pnas.91.22.10596                                                        ; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Park E, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1270-7; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Picardi E, 2017, RNA, V23, P860, DOI 10.1261/rna.058271.116; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; POLSON AG, 1994, EMBO J, V13, P5701; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Porath HT, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1315-y; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Qi LH, 2017, NUCLEIC ACIDS RES, V45, P10436, DOI 10.1093/nar/gkx667; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9194; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rice GI, 2017, NEUROPEDIATRICS, V48, P166, DOI 10.1055/s-0037-1601449; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Robinson JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10512; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI [10.1038/nchembio.434, 10.1038/.NCHEMBIO.434]; Sapiro AL, 2015, CELL REP, V11, P697, DOI 10.1016/j.celrep.2015.04.005; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Snyder EM, 2017, BIOL REPROD, V96, P244, DOI 10.1095/biolreprod.116.145151; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Terajima H, 2017, NAT GENET, V49, P146, DOI 10.1038/ng.3731; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Whipple JM, 2015, RNA, V21, P786, DOI 10.1261/rna.048801.114; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107; Zhang R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006563; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736; Zhang S, 2017, CANCER CELL, V31; Zhang XJ, 2004, HUM MUTAT, V23, P629, DOI 10.1002/humu.9246; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhu SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-206; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	157	1	1	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	OCT 30	2017	18								205	10.1186/s13059-017-1347-3				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FL1JH	WOS:000413970200001	29084589	gold			2018-01-05	
J	Kleinjan, DA; Wardrope, C; Sou, SN; Rosser, SJ				Kleinjan, Dirk A.; Wardrope, Caroline; Sou, Si Nga; Rosser, Susan J.			Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors	NATURE COMMUNICATIONS			English	Article							HUMAN-CELLS; CRISPR-CAS9; ACTIVATION; SYSTEM; TRANSCRIPTION; CAS9; DEGRADATION; REPRESSION; DEPLETION; PROTEINS	The nuclease-deactivated variant of CRISPR-Cas9 proteins (dCas9) fused to heterologous transactivation domains can act as a potent guide RNA sequence-directed inducer or repressor of gene expression in mammalian cells. In such a system the long-term presence of a stable dCas9 effector can be a draw-back precluding the ability to switch rapidly between repressed and activated target gene expression states, imposing a static environment on the synthetic regulatory circuits in the cell. To address this issue we have generated a toolkit of conditionally degradable or stabilisable orthologous dCas9 or Cpf1 effector proteins, thus opening options for multidimensional control of functional activities through combinations of orthogonal, drug-tunable artificial transcription factors.	[Kleinjan, Dirk A.; Wardrope, Caroline; Sou, Si Nga; Rosser, Susan J.] Univ Edinburgh, Inst Quantitat Biol Biochem & Biotechnol, Sch Biol Sci, UK Ctr Mammalian Synthet Biol,SynthSys, Edinburgh EH9 3BF, Midlothian, Scotland; [Rosser, Susan J.] Univ Edinburgh, Inst Bioengn, Faraday Bldg,Kings Bldg, Edinburgh EH9 3DW 2, Midlothian, Scotland	Rosser, SJ (reprint author), Univ Edinburgh, Inst Quantitat Biol Biochem & Biotechnol, Sch Biol Sci, UK Ctr Mammalian Synthet Biol,SynthSys, Edinburgh EH9 3BF, Midlothian, Scotland.; Rosser, SJ (reprint author), Univ Edinburgh, Inst Bioengn, Faraday Bldg,Kings Bldg, Edinburgh EH9 3DW 2, Midlothian, Scotland.	Susan.Rosser@ed.ac.uk			BBSRC [BB/M018040/1, BB/M018229/1]	This work was supported by grants from the BBSRC (BB/M018040/1 and BB/M018229/1) to S.J.R.	Brown AJ, 2016, BIOTECHNOL ADV, V34, P492, DOI 10.1016/j.biotechadv.2015.12.012; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Maji B, 2017, NAT CHEM BIOL, V13, P9, DOI 10.1038/nchembio.2224; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Samejima K, 2014, J BIOL CHEM, V289, P31617, DOI 10.1074/jbc.M114.583542; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	21	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT 30	2017	8								1191	10.1038/s41467-017-01222-y				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FL0ID	WOS:000413894100013	29084946	gold			2018-01-05	
J	Johansen, AK; Molenaar, B; Versteeg, D; Leitoguinho, AR; Demkes, C; Spanjaard, B; de Ruiter, H; Moqadam, FA; Kooijman, L; Zentilin, L; Giacca, M; van Rooij, E				Johansen, Anne Katrine; Molenaar, Bas; Versteeg, Danielle; Leitoguinho, Ana Rita; Demkes, Charlotte; Spanjaard, Bastiaan; de Ruiter, Hesther; Moqadam, Farhad Akbari; Kooijman, Lieneke; Zentilin, Lorena; Giacca, Mauro; van Rooij, Eva			Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption	CIRCULATION RESEARCH			English	Article						clustered regularly interspaced short palindromic repeats; gene editing; molecular biology; myocytes, cardiac; sequence analysis, DNA	IN-VIVO; MOUSE MODEL; MUSCULAR-DYSTROPHY; GENOME; HEART; MICE; CANCER; CAS9; ENDONUCLEASE; PROTEINS	Rationale: CRISPR/Cas9 (clustered regularly interspaced palindromic repeats/CRISPR-associated protein 9)-based DNA editing has rapidly evolved as an attractive tool to modify the genome. Although CRISPR/Cas9 has been extensively used to manipulate the germline in zygotes, its application in postnatal gene editing remains incompletely characterized. Objective: To evaluate the feasibility of CRISPR/Cas9-based cardiac genome editing in vivo in postnatal mice. Methods and Results: We generated cardiomyocyte-specific Cas9 mice and demonstrated that Cas9 expression does not affect cardiac function or gene expression. As a proof-of-concept, we delivered short guide RNAs targeting 3 genes critical for cardiac physiology, Myh6, Sav1, and Tbx20, using a cardiotropic adeno-associated viral vector 9. Despite a similar degree of DNA disruption and subsequent mRNA downregulation, only disruption of Myh6 was sufficient to induce a cardiac phenotype, irrespective of short guide RNA exposure or the level of Cas9 expression. DNA sequencing analysis revealed target-dependent mutations that were highly reproducible across mice resulting in differential rates of in-and out-of-frame mutations. Finally, we applied a dual short guide RNA approach to effectively delete an important coding region of Sav1, which increased the editing efficiency. Conclusions: Our results indicate that the effect of postnatal CRISPR/Cas9-based cardiac gene editing using adeno-associated virus serotype 9 to deliver a single short guide RNA is target dependent. We demonstrate a mosaic pattern of gene disruption, which hinders the application of the technology to study gene function. Further studies are required to expand the versatility of CRISPR/Cas9 as a robust tool to study novel cardiac gene functions in vivo.	[Johansen, Anne Katrine; Molenaar, Bas; Versteeg, Danielle; Leitoguinho, Ana Rita; Demkes, Charlotte; Spanjaard, Bastiaan; de Ruiter, Hesther; Moqadam, Farhad Akbari; Kooijman, Lieneke; van Rooij, Eva] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Versteeg, Danielle; Demkes, Charlotte; van Rooij, Eva] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Zentilin, Lorena; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Trieste, Italy	van Rooij, E (reprint author), Royal Netherlands Acad Arts & Sci KNAW, Mol Cardiol, Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands.	e.vanrooij@hubrecht.eu			Foundation Leducq [14CVD04]; European Research Council [ERC CoG 615708 MICARUS]	This study was funded by the Foundation Leducq (14CVD04) and the European Research Council (ERC CoG 615708 MICARUS).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S525-0016(03)00034-0; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doetschman T, 2012, CIRC RES, V110, P1498, DOI 10.1161/CIRCRESAHA.112.265066; Doyle A, 2012, TRANSGENIC RES, V21, P327, DOI 10.1007/s11248-011-9537-3; Franklin S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000703; Guo YX, 2017, CIRC RES, V120, P1874, DOI 10.1161/CIRCRESAHA.116.310283; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lovric J, 2012, MOL THER, V20, P2087, DOI 10.1038/mt.2012.144; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Xie C, 2016, CELL RES, V26, P1099, DOI 10.1038/cr.2016.101; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zacchigna S, 2014, CIRC RES, V114, P1827, DOI 10.1161/CIRCRESAHA.114.302331; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001	38	2	2	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7330	1524-4571		CIRC RES	Circ.Res.	OCT 27	2017	121	10					1168	+		10.1161/CIRCRESAHA.116.310370				40	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	FO6SJ	WOS:000416996100015	28851809				2018-01-05	
J	Fan, QP; Cai, QC; Li, PF; Wang, WY; Wang, J; Gerry, E; Wang, TL; Shih, IM; Nephew, KP; Xu, Y				Fan, Qipeng; Cai, Qingchun; Li, Pengfei; Wang, Wenyan; Wang, Jing; Gerry, Emily; Wang, Tian-Li; Shih, Ie-Ming; Nephew, Kenneth P.; Xu, Yan			The novel ZIP4 regulation and its role in ovarian cancer	ONCOTARGET			English	Article						ZIP4; LPA; ovarian cancer; cancer stem cells (CSC)	ACTIVATED RECEPTOR-GAMMA; LYSOPHOSPHATIDIC ACID; STEM-CELLS; PPAR-GAMMA; BREAST-CANCER; MESSENGER-RNA; PROGRESSION; LYSOPHOSPHOLIPIDS; SUPPLEMENTATION; IDENTIFICATION	Our RNAseq analyses revealed that ZIP4 is a top gene up-regulated in more aggressive ovarian cancer cells. ZIP4's role in cancer stem cells has not been reported in any type of cancer. In addition, the role and regulation of ZIP4, a zinc transporter, have been studied in the context of extracellular zinc transporting. Factors other than zinc with ZIP4 regulatory effects are essentially unknown. ZIP4 expression and its regulation in epithelial ovarian cancer cells was assessed by immunoblotting, quantitative PCR, or immunohistochemistry staining in human ovarian tissues. Cancer stem cell-related activities were examined to evaluate the role of ZIP4 in human high-grade serous ovarian cancer cells in vitro and in vivo. RNAi and CRISPR techniques were used to knockdown or knockout ZIP4 and related genes. Ovarian cancer tissues overexpressed ZIP4 when compared with normal and benign tissues. ZIP4 knockout significantly reduced several cancer stem cell-related activities in EOC cells, including proliferation, anoikis-resistance, colony-formation, spheroid-formation, drug-resistance, and side-population in vitro. ZIP4-expressing side-population highly expressed known CSC markers ALDH1 and OCT4. ZIP4 knockout dramatically reduced tumorigenesis and ZIP4 overexpression increased tumorigenesis in vivo. In addition, the ZIP4-expressing side-population had the tumor initiating activity. Moreover, the oncolipid lysophosphatic acid effectively up-regulated ZIP4 expression via the nuclear receptor peroxisome proliferator-activated receptor gamma and lysophosphatic acid 's promoting effects in cancer stem cell-related activities in HGSOC cells was at least partially mediated by ZIP4 in an extracellular zinc-independent manner. Our critical data imply that ZIP4 is a new and important cancer stem cell regulator in ovarian cancer. Our data also provide an innovative interpretation for the apparent disconnection between low levels of zinc and up-regulation of ZIP4 in ovarian cancer tissues.	[Fan, Qipeng; Cai, Qingchun; Li, Pengfei; Wang, Wenyan; Wang, Jing; Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Li, Pengfei] Capital Med Univ, Beijing Chao Yang Hosp, Pharmaceut Res Ctr, Beijing 100020, Peoples R China; [Wang, Wenyan] Anhui Med Univ, Hosp 2, Dept Obstet & Gynecol, Hefei 230601, Anhui, Peoples R China; [Wang, Jing] MASDINO Beijing Med Res Co Ltd, Beijing 100123, Peoples R China; [Gerry, Emily; Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Med Sci, Jordan Hall 302, Bloomington, IN 47405 USA	Xu, Y (reprint author), Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA.	xu2@iupui.edu			National Institutes of Health [RO1 155145, CA13001]; Mary Fendrich-Hulman Charitable Trust	This work is supported in part by the National Institutes of Health (RO1 155145 to YX and CA13001 to KPN) and the Mary Fendrich-Hulman Charitable Trust Fund to YX.	Alam S, 2012, NUTRIENTS, V4, P875, DOI 10.3390/nu4080875; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Balch C, 2010, CANCER BIOMARK, V8, P203, DOI 10.3233/CBM-2011-0214; Bapat SA, 2010, EPIGENETICS-US, V5, P716, DOI 10.4161/epi.5.8.13014; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Belloni-Olivi L, 2009, J NEUROSCI RES, V87, P3221, DOI 10.1002/jnr.22144; Bogale A, 2015, NUTR METAB INSIGHTS, V8, P7, DOI 10.4137/NMI.S23233; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Chandra M, 2017, PPAR RES, V2017; Chen QG, 2012, UROL ONCOL-SEMIN ORI, V30, P906, DOI 10.1016/j.urolonc.2010.11.010; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Engelken J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004128; Fischer T, 2015, ORVOSI HETILAP, V156, P1847, DOI 10.1556/650.2015.30207; Frohlich E, 2015, BIOMED RES INT, DOI 10.1155/2015/845340; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gefeller EM, 2015, J PHYSIOL SCI, V65, P317, DOI 10.1007/s12576-015-0369-4; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Ivan C, 2013, GYNECOL ONCOL, V128, P506, DOI 10.1016/j.ygyno.2012.11.029; Kang Xing, 2015, Asian Pac J Cancer Prev, V16, P3355; Karki R, 2017, CANCER IMMUNOL RES, V5, P94, DOI 10.1158/2326-6066.CIR-16-0269; Kim S, 2011, BIOCHEM BIOPH RES CO, V406, P389, DOI 10.1016/j.bbrc.2011.02.052; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; LEWIS AD, 1988, CARCINOGENESIS, V9, P1283, DOI 10.1093/carcin/9.7.1283; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Liu J, 2015, COCHRANE DB SYST REV, V10; Llona-Minguez S, 2015, PROG LIPID RES, V58, P51, DOI 10.1016/j.plipres.2015.01.004; Lupia M, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0638-3; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Miller DFB, 2013, METHODS, V63, P126, DOI 10.1016/j.ymeth.2013.03.023; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mughal A, 2015, EUR J PHARMACOL, V768, P217, DOI 10.1016/j.ejphar.2015.10.057; Munn LL, 2017, WILEY INTERDISCIP RE, V9, P9; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Seo EJ, 2016, STEM CELLS, V34, P551, DOI 10.1002/stem.2279; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Stoddard NC, 2015, BIOMOL THER, V23, P1, DOI 10.4062/biomolther.2014.109; Stuckey A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-308; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Tsukahara T, 2013, J LIPIDS, DOI 10.1155/2013/246597; Tsukahara T, 2013, BIOCHEM BIOPH RES CO, V433, P281, DOI 10.1016/j.bbrc.2013.02.101; Tsukahara T, 2012, PPAR RES, DOI 10.1155/2012/362361; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Vermeersch KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118262; Wang XH, 2015, CURR PROTEIN PEPT SC, V16, P270, DOI 10.2174/138920371604150429151457                                                ; Wei ZT, 2016, ONCOL LETT, V12, P41, DOI 10.3892/ol.2016.4565; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu X, 2014, INT J BIOL SCI, V10, P245, DOI 10.7150/ijbs.7401; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933                                                               ; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Xue J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109180; Yang JG, 2009, BIOL TRACE ELEM RES, V131, P298, DOI 10.1007/s12011-009-8362-5; Yokoyama Y, 2011, J CANCER RES CLIN, V137, P1219, DOI 10.1007/s00432-011-0993-1; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405; Zheng DL, 2014, METALLOMICS, V6, P154, DOI 10.1039/c3mt00212h	62	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 27	2017	8	52					90090	90107		10.18632/oncotarget.21435				18	Oncology; Cell Biology	Oncology; Cell Biology	FL3BP	WOS:000414097100057	29163813				2018-01-05	
J	Ortiz-Virumbrales, M; Moreno, CL; Kruglikov, I; Marazuela, P; Sproul, A; Jacob, S; Zimmer, M; Paull, D; Zhang, B; Schadt, EE; Ehrlich, ME; Tanzi, RE; Arancio, O; Noggle, S; Gandy, S				Ortiz-Virumbrales, Maitane; Moreno, Cesar L.; Kruglikov, Ilya; Marazuela, Paula; Sproul, Andrew; Jacob, Samson; Zimmer, Matthew; Paull, Daniel; Zhang, Bin; Schadt, Eric E.; Ehrlich, Michelle E.; Tanzi, Rudolph E.; Arancio, Ottavio; Noggle, Scott; Gandy, Sam			CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2(N141I) neurons	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Alzheimer's disease; iPSC; BFCN; CRISPR/Cas9; Electrophysiology; Basal forebrain; Cholinergic; Presenilin; PSEN2	PLURIPOTENT STEM-CELLS; FOREBRAIN CHOLINERGIC NEURONS; AMYLOID-BETA; BASAL FOREBRAIN; A-BETA; DIRECTED DIFFERENTIATION; TRANSGENIC MICE; MOUSE MODEL; SYNAPTIC-TRANSMISSION; ORAL PHYSOSTIGMINE	Basal forebrain cholinergic neurons (BFCNs) are believed to be one of the first cell types to be affected in all forms of AD, and their dysfunction is clinically correlated with impaired short- term memory formation and retrieval. We present an optimized in vitro protocol to generate human BFCNs from iPSCs, using cell lines from presenilin 2 (PSEN2) mutation carriers and controls. As expected, cell lines harboring the PSEN2(N141I) mutation displayed an increase in the A beta 42/40 in iPSC-derived BFCNs. Neurons derived from PSEN2(N141I) lines generated fewer maximum number of spikes in response to a square depolarizing current injection. The height of the first action potential at rheobase current injection was also significantly decreased in PSEN2(N141I) BFCNs. CRISPR/Cas9 correction of the PSEN2 point mutation abolished the electrophysiological deficit, restoring both the maximal number of spikes and spike height to the levels recorded in controls. Increased A beta 42/40 was also normalized following CRISPR/Casmediated correction of the PSEN2(N141I) mutation. The genome editing data confirms the robust consistency of mutation-related changes in A beta 42/40 ratio while also showing a PSEN2-mutation-related alteration in electrophysiology.	[Ortiz-Virumbrales, Maitane; Moreno, Cesar L.; Ehrlich, Michelle E.; Gandy, Sam] Icahn Sch Med Mt Sinai, NFL Neurol Care Ctr, Dept Neurol, New York, NY 10029 USA; [Moreno, Cesar L.; Gandy, Sam] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, Dept Psychiat, New York, NY 10029 USA; [Kruglikov, Ilya; Sproul, Andrew; Jacob, Samson; Zimmer, Matthew; Paull, Daniel; Noggle, Scott] New York Stem Cell Fdn Res Inst, New York, NY USA; [Marazuela, Paula] Univ Francisco Vitoria, Madrid 28223, Spain; [Sproul, Andrew] Taub Inst, New York, NY 10032 USA; [Sproul, Andrew] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Zhang, Bin; Schadt, Eric E.; Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Icahn Inst Multi Scale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Unit, Boston, MA 02114 USA; [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Gandy, S (reprint author), Icahn Sch Med Mt Sinai, NFL Neurol Care Ctr, Dept Neurol, New York, NY 10029 USA.; Gandy, S (reprint author), Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, Dept Psychiat, New York, NY 10029 USA.; Noggle, S (reprint author), New York Stem Cell Fdn Res Inst, New York, NY USA.	snoggle@nyscf.org; samuel.gandy@mssm.edu			Charles Evans Foundation; Alzheimer's Drug Discovery Foundation; The NY Community Trust; Cure Alzheimer's Fund [R21AG042965, U01AG046170]; National Institutes of Health (NIH) [R21AG042965, U01AG046170]; Werber Family Foundation; Scott and Jennifer Moskowitz Foundation; Stuart Katz and Dr Jane Martin Foundation; Louis B. Mayer Foundation; Georgianne and Dr. Reza Khatib Foundation; Sarah and Gideon Gartner Foundation; NIH [NS049442]; Mount Sinai Alzheimer's Disease Research Center [P50 AG05138]	This work is generously supported by grants to Scott Noggle by the Charles Evans Foundation, the Alzheimer's Drug Discovery Foundation, and The NY Community Trust. Scott Noggle and Sam Gandy were jointly supported by the Cure Alzheimer's Fund and by National Institutes of Health (NIH) grants R21AG042965 and U01AG046170 (to Eric Schadt, Bin Zhang, Sam Gandy, and Michelle Ehrlich). Sam Gandy was also supported by The Werber Family Foundation, the Scott and Jennifer Moskowitz Foundation, the Stuart Katz and Dr Jane Martin Foundation, the Louis B. Mayer Foundation, the Georgianne and Dr. Reza Khatib Foundation, and the Sarah and Gideon Gartner Foundation. Bin Zhang, Michelle Ehrlich, and Eric Schadt were supported by U01AG046170 (to Eric Schadt, Bin Zhang, Sam Gandy, and Michelle Ehrlich). Ottavio Arancio was supported by NIH grant NS049442. Rudolph Tanzi was supported by Cure Alzheimer's Fund. Maitane OrtizVirumbrales was supported by The Werber Family Foundation and U01AG046170. Cesar Moreno was supported by Mount Sinai Alzheimer's Disease Research Center P50 AG05138 to Mary Sano.	ARENDT T, 1983, ACTA NEUROPATHOL, V61, P101, DOI 10.1007/BF00697388                                                              ; Armijo E, 2017, NEUROSCI LETT, V639, P74, DOI 10.1016/j.neulet.2016.12.060; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5                                                   ; BOWEN DM, 1976, BRAIN, V99, P459, DOI 10.1093/brain/99.3.459                                                          ; Bragina O, 2010, NEUROSCI LETT, V482, P81, DOI 10.1016/j.neulet.2010.06.068; Briggs CA, 2013, NEUROBIOL AGING, V34, P1632, DOI 10.1016/j.neurobiolaging.2012.12.013; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Brueggen K, 2015, J ALZHEIMERS DIS, V48, P197, DOI 10.3233/JAD-150063; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crompton LA, 2013, STEM CELL RES, V11, P1206, DOI 10.1016/j.scr.2013.08.002; Cummings DM, 2015, BRAIN, V138, P1992, DOI 10.1093/brain/awv127; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; DAVIES P, 1976, LANCET, V2, P1403; DAVIS KL, 1983, PSYCHOPHARMACOL BULL, V19, P451; De Strooper B, 2017, SOLANEZUMAB SHOULD A; Echeverria V, 2007, CURR ALZHEIMER RES, V4, P518, DOI 10.2174/156720507783018190; Epelbaum S, 2017, ALZHEIMERS DEMENT, V13, P454, DOI 10.1016/j.jalz.2016.12.003; ETCHEBERRIGARAY R, 1994, SCIENCE, V264, P276, DOI 10.1126/science.8146663; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137                                                           ; Gamzu E R, 1990, Adv Neurol, V51, P241; Gandy S, 2006, NAT MED, V12, P1121, DOI 10.1038/nm1006-1121; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Guo Q, 1999, J NEUROSCI RES, V56, P457, DOI 10.1002/(SICI)1097-4547(19990601)56:5<457::AID-JNR2>3.3.CO;2-G; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Hager K, 2014, NEUROPSYCH DIS TREAT, V10, P391, DOI 10.2147/NDT.S57909; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heine VM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002731; HIXSON JE, 1990, J LIPID RES, V31, P545; Hoxha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034726; Hu Y, 2016, J NEUROSCI METH, V266, P42, DOI 10.1016/j.jneumeth.2016.03.017; Hunsberger JG, 2016, LANCET NEUROL, V15, P219, DOI 10.1016/S1474-4422(15)00332-4; Jack CR, 2013, NEUROLOGY, V81, P1732, DOI 10.1212/01.wnl.0000435556.21319.e4; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200                                                          ; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622                                                         ; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Liu L, 2014, AGEING RES REV, V15, P6, DOI 10.1016/j.arr.2013.12.007; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Mahairaki V, 2014, STEM CELLS DEV, V23, P2996, DOI 10.1089/scd.2013.0511; Marcantoni A, 2014, PFLUG ARCH EUR J PHY, V466, P1437, DOI 10.1007/s00424-013-1368-z; Marchani EE, 2010, AM J MED GENET B, V153B, P1031, DOI 10.1002/ajmg.b.31072; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Muller U, 2011, ARCH NEUROL-CHICAGO, V68, P1210, DOI 10.1001/archneurol.2011.218; Nava-Mesa MO, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00117; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; Nieweg K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.72; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3                                                   ; Onos KD, 2016, BRAIN RES BULL, V122, P1, DOI 10.1016/j.brainresbull.2015.12.003; Oyama F, 1998, J NEUROCHEM, V71, P313; Paull D, 2015, NAT METHODS, V12, P885, DOI [10.1038/NMETH.3507, 10.1038/nmeth.3507]; PERRY EK, 1977, J NEUROL SCI, V34, P247, DOI 10.1016/0022-510X(77)90073-9; Pini L, 2016, AGEING RES REV, V30, P25, DOI 10.1016/j.arr.2016.01.002; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461                                                  ; Proulx E, 2015, J NEUROSCI, V35, P12779, DOI 10.1523/JNEUROSCI.4501-14.2015; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren SC, 2015, AMYLOID, V22, P36, DOI 10.3109/13506129.2014.990558; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Roder S, 2003, NEUROSCIENCE, V120, P705, DOI 10.1016/S0306-4522(03)00381-6; RYLETT RJ, 1983, BRAIN RES, V289, P169, DOI 10.1016/0006-8993(83)90017-3; Sachse CC, 2013, FASEB J, V27, P2458, DOI 10.1096/fj.12-214056; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Sepulveda-Falla D, 2014, J CLIN INVEST, V124, P1552, DOI 10.1172/JCI66407; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Smilansky A, 2015, J BIOL CHEM, V290, P30670, DOI 10.1074/jbc.M115.691493; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Supnet C, 2011, CELL CALCIUM, V50, P303, DOI 10.1016/j.ceca.2011.05.013; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; THAL LJ, 1983, ANN NEUROL, V13, P491, DOI 10.1002/ana.410130504; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tucker ES, 2008, J NEUROSCI, V28, P9504, DOI 10.1523/JNEUROSCI.2341-08.2008; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Varga E, 2014, NEURAL PLAST, DOI 10.1155/2014/584314; Verdile G, 2007, NEUROCHEM RES, V32, P609, DOI 10.1007/s11064-006-9131-x; Wang X, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.2016.00094, 10.3389/fncel.2016.00094]; Wicklund L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015600; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu H, 2015, STEM CELLS DEV, V24, P2723, DOI 10.1089/scd.2015.0122; Xu W, 2015, EXP NEUROL, V264, P82, DOI 10.1016/j.expneurol.2014.12.008; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yue W, 2015, STEM CELL REP, V5, P776, DOI 10.1016/j.stemcr.2015.09.010	94	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	OCT 27	2017	5								77	10.1186/s40478-017-0475-z				20	Neurosciences	Neurosciences & Neurology	FL2AR	WOS:000414016700002	29078805	gold			2018-01-05	
J	Campanello, GC; Lofgren, M; Yokom, AL; Southworth, DR; Banerjee, R				Campanello, Gregory C.; Lofgren, Michael; Yokom, Adam L.; Southworth, Daniel R.; Banerjee, Ruma			Switch I-dependent allosteric signaling in a G-protein chaperone-B-12 enzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; RADICAL B-12 ENZYME; COENZYME B-12; VITAMIN-B-12 METABOLISM; COMPLEMENTATION GROUP; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GTP HYDROLYSIS; RAS PROTEIN; MMAA GENE	G-proteins regulate various processes ranging from DNA replication and protein synthesis to cytoskeletal dynamics and cofactor assimilation and serve as models for uncovering strategies deployed for allosteric signal transduction. MeaB is a multifunctional G-protein chaperone, which gates loading of the active 5 '-deoxyadenosylcobalamin cofactor onto methylmalonyl-CoA mutase (MCM) and precludes loading of inactive cofactor forms. MeaB also safeguards MCM, which uses radical chemistry, against inactivation and rescues MCM inactivated during catalytic turnover by using the GTP-binding energy to offload inactive cofactor. The conserved switch I and II signaling motifs used by G-proteins are predicted to mediate allosteric regulation in response to nucleotide binding and hydrolysis in MeaB. Herein, we targeted conserved residues in the MeaB switch I motif to interrogate the function of this loop. Unexpectedly, the switch I mutations had only modest effects on GTP binding and on GTPase activity and did not perturb stability of the MCM-MeaB complex. However, these mutations disrupted multiple MeaB chaperone functions, including cofactor editing, loading, and offloading. Hence, although residues in the switch I motif are not essential for catalysis, they are important for allosteric regulation. Furthermore, single-particle EM analysis revealed, for the first time, the overall architecture of the MCM MeaB complex, which exhibits a 2:1 stoichiometry. These EM studies also demonstrate that the complex exhibits considerable conformational flexibility. In conclusion, the switch I element does not significantly stabilize the MCM-MeaB complex or influence the affinity of MeaB for GTP but is required for transducing signals between MeaB and MCM.	[Campanello, Gregory C.; Lofgren, Michael; Yokom, Adam L.; Southworth, Daniel R.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Med Ctr, Life Sci Inst, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yokom, Adam L.] Univ Michigan, Med Ctr, Life Sci Inst, Grad Program Chem Biol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	Banerjee, R (reprint author), Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, 5 F32 GM113405, GM110001]	This work was supported by National Institutes of Health Grants DK45776 (to to R. B.), 5 F32 GM113405 (to G. C. C.), and GM110001 (to D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jost M, 2015, J BIOL CHEM, V290, P26882, DOI 10.1074/jbc.M115.676890; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157                                                          ; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2006, MOL GENET METAB, V87, P219, DOI 10.1016/j.ymgme.2005.11.011; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; Li Z, 2017, J BIOL CHEM, V292, P3977, DOI 10.1074/jbc.M117.775957; Lofgren M, 2013, J BIOL CHEM, V288, P30980, DOI 10.1074/jbc.M113.499970; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tanpaiboon P, 2005, MOL GENET METAB, V85, P2; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001                                                             ; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P                                                    ; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zhang J, 2006, MOL GENET METAB, V87, P315, DOI 10.1016/j.ymgme.22005.12.003	42	0	0	3	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17617	17625		10.1074/jbc.M117.786095				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FL1ZL	WOS:000414013000005	28882898				2018-01-05	
J	Zhang, LM; Wang, P; Feng, Q; Wang, NX; Chen, ZT; Huang, YY; Zheng, WF; Jiang, XY				Zhang, Lingmin; Wang, Peng; Feng, Qiang; Wang, Nuoxin; Chen, Zitian; Huang, Yanyi; Zheng, Wenfu; Jiang, Xingyu			Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy	NPG ASIA MATERIALS			English	Article							MICROFLUIDIC SYNTHESIS; CANCER-THERAPY; HUMAN-CELLS; IN-VIVO; CRISPR-CAS9; SIRNA; CAS9; PACLITAXEL; LIPOSOMES; PLATFORM	The emerging CRISPR/Cas9 system represents a promising platform for genome editing. However, its low transfection efficiency is a major problem hampering the application of the gene-editing potential of CRISPR/Cas9. Herein, by screening a pool of more than 56 kinds of agents, we constructed a novel polyethylene glycol phospholipid-modified cationic lipid nanoparticle (PLNP)-based delivery system that can condense and encapsulate a Cas9/single-guide RNA (sgRNA) plasmid (DNA) to form a core-shell structure (PLNP/DNA) that mediated up to 47.4% successful transfection of Cas9/sgPLK-1 plasmids in A375 cells in vitro. An intratumor injection of Cas9/sgPLK-1 plasmids into melanoma tumor-bearing mice resulted in significant downregulation of Polo-like kinase 1 (PLK-1) protein and suppression of the tumor growth (> 67%) in vivo. This approach provides a versatile method that could be used for delivering the CRISPR/Cas9 system with high efficiency and safety both in vitro and in vivo.	[Zhang, Lingmin; Wang, Peng; Feng, Qiang; Wang, Nuoxin; Zheng, Wenfu; Jiang, Xingyu] Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing Engn Res Ctr BioNanotechnol, CAS Ctr Excellence Nanosci, Beijing, Peoples R China; [Zhang, Lingmin; Jiang, Xingyu] Guangzhou Med Univ, Affiliated Hosp 3, Sch Pharmaceut Sci, Key Lab Mol Clin Pharmacol, Guangzhou, Guangdong, Peoples R China; [Zhang, Lingmin; Jiang, Xingyu] Guangzhou Med Univ, Affiliated Hosp 5, Guangzhou, Guangdong, Peoples R China; [Chen, Zitian; Huang, Yanyi] Peking Univ, Coll Engn, Mat Sci & Engn, Beijing, Peoples R China; [Jiang, Xingyu] Univ Chinese Acad Sci, Beijing, Peoples R China	Zheng, WF; Jiang, XY (reprint author), Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, 11 BeiYiTiao, Beijing 100190, Peoples R China.	zhengwf@nanoctr.cn; xingyujiang@nanoctr.cn			National Nature Science Foundation of China [81361140345, 31470911, 81673039]; Chinese Academy of Sciences [XDA09030305, XDA09030307]; CAS/SAFEA International Partnership Program for Creative Research Teams	We appreciate the support of National Nature Science Foundation of China (81361140345, 31470911, 81673039), Chinese Academy of Sciences (XDA09030305, XDA09030307) and the CAS/SAFEA International Partnership Program for Creative Research Teams.	Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Feng Q, 2014, BIOMATERIALS, V35, P5028, DOI 10.1016/j.biomaterials.2014.03.012; Gao WW, 2014, ACS NANO, V8, P2900, DOI 10.1021/nn500110a; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Heintze Jacob, 2013, Frontiers in Genetics, V4, P193, DOI 10.3389/fgene.2013.00193; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Immordino ML, 2006, INT J NANOMED, V1, P297; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng H, 2015, ACS NANO, V9, P3540, DOI 10.1021/acsnano.5b00510; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slingerland M, 2012, DRUG DISCOV TODAY, V17, P160, DOI 10.1016/j.drudis.2011.09.015; Spankuch-Schmitt B, 2002, J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863                                                         ; Sun JS, 2015, ADV MATER, V27, P1402, DOI 10.1002/adma.201404788; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Tseng YC, 2009, ADV DRUG DELIVER REV, V61, P721, DOI 10.1016/j.addr.2009.03.003; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao A, 2013, NUCLEIC ACIDS RES, V41, pD415, DOI 10.1093/nar/gks1144; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang LM, 2016, BIOMATERIALS, V104, P269, DOI 10.1016/j.biomaterials.2016.07.015; Zhang L, 2015, ACS NANO, V9, P9912, DOI 10.1021/acsnano.5b05792; Zhang L, 2015, ANGEW CHEM INT EDIT, V54, P3952, DOI 10.1002/anie.201500096; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	28	0	0	33	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	OCT 27	2017	9								e441	10.1038/am.2017.185				8	Materials Science, Multidisciplinary	Materials Science	FL0MW	WOS:000413906500003		gold			2018-01-05	
J	Miliu, A; Lebrun, M; Braun-Breton, C; Lamarque, MH				Miliu, Alexandra; Lebrun, Maryse; Braun-Breton, Catherine; Lamarque, Mauld H.			Shelph2, a bacterial-like phosphatase of the malaria parasite Plasmodium falciparum, is dispensable during asexual blood stage	PLOS ONE			English	Article							PROTEIN-KINASE; CELL INVASION; ERYTHROCYTES; TYROSINE; PHOSPHORYLATION; CULTURE; ANTIGEN; EGRESS; BAND-3; GROWTH	During the erythrocytic cycle of the malaria parasite Plasmodium falciparum, egress and invasion are essential steps finely controlled by reversible phosphorylation. In contrast to the growing number of kinases identified as key regulators, phosphatases have been poorly studied, and calcineurin is the only one identified so far to play a role in invasion. PfShelph2, a bacterial-like phosphatase, is a promising candidate to participate in the invasion process, as it was reported to be expressed late during the asexual blood stage and to reside within an apical compartment, yet distinct from rhoptry bulb, micronemes, or dense granules. It was also proposed to play a role in the control of the red blood cell membrane deformability at the end of the invasion process. However, genetic studies are still lacking to support this hypothesis. Here, we take advantage of the CRISPR-Cas9 technology to tag shelph2 genomic locus while retaining its endogenous regulatory regions. This new strain allows us to follow the endogenous PfShelph2 protein expression and location during asexual blood stages. We show that PfShelph2 apical location is also distinct from the rhoptry neck or exonemes. We further demonstrate PfShelph2 dispensability during the asexual blood stage by generating PfShelph2-KO parasites using CRISPR-Cas9 machinery. Analyses of the mutant during the course of the erythrocytic development indicate that there are no detectable phenotypic consequences of Pfshelph2 genomic deletion. As this lack of phenotype might be due to functional redundancy, we also explore the likelihood of PfShelph1 (PfShelph2 paralog) being a compensatory phosphatase. We conclude that despite its cyclic expression profile, PfShelph2 is a dispensable phosphatase during the Plasmodium falciparum asexual blood stage, whose function is unlikely substituted by PfShelph1.	[Miliu, Alexandra; Lebrun, Maryse; Braun-Breton, Catherine; Lamarque, Mauld H.] Univ Montpellier, CNRS, DIMNP, Montpellier, France	Lamarque, MH (reprint author), Univ Montpellier, CNRS, DIMNP, Montpellier, France.	mauld.lamarque@umontpellier.fr			Laboratoire d'Excellence (LabEx) (ParaFrap) [ANR-11-LABX-0024, ANR-10-LABX-12-01]	This research was supported by the Laboratoire d'Excellence (LabEx) (ParaFrap ANR-11-LABX-0024 and ANR-10-LABX-12-01)-ML and CBB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Andreeva AV, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-47; Aniweh Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12747; Anonymous, 2016, WORLD MALARIA REPORT; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169                                                     ; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Fernandez-Pol S, 2013, EUKARYOT CELL, V12, P1179, DOI 10.1128/EC.00027-13; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Koch M, 2017, P NATL ACAD SCI USA, V114, P4225, DOI 10.1073/pnas.1620843114; Kutuzov MA, 2012, FUNCT INTEGR GENOMIC, V12, P11, DOI 10.1007/s10142-011-0254-z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283                                                  ; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; ROGER N, 1988, MOL BIOCHEM PARASIT, V27, P135, DOI 10.1016/0166-6851(88)90033-3; Santos JM, 2017, CELL HOST MICROBE, V21, P731, DOI 10.1016/j.chom.2017.05.006; SAUL A, 1982, B WORLD HEALTH ORGAN, V60, P755; Sisquella X, 2017, ELIFE, V6, DOI 10.7554/eLife.21083; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tsuruta H, 1999, J BIOCHEM-TOKYO, V125, P690, DOI 10.1093/oxfordjournals.jbchem.a022338                                           ; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-490; Zuccala ES, 2016, SCI REP, V6	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187073	10.1371/journal.pone.0187073				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FK9QH	WOS:000413845400108	29073264	gold			2018-01-05	
J	Valach, M; Moreira, S; Hoffmann, S; Stadler, PF; Burger, G				Valach, Matus; Moreira, Sandrine; Hoffmann, Steve; Stadler, Peter F.; Burger, Gertraud			Keeping it complicated: Mitochondrial genome plasticity across diplonemids	SCIENTIFIC REPORTS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CYTOCHROME-C; RNA; EVOLUTION; DNA; GENERATION; GENES; TOOL; RECONSTRUCTION; ORGANIZATION	Chromosome rearrangements are important drivers in genome and gene evolution, with implications ranging from speciation to development to disease. In the flagellate Diplonema papillatum (Euglenozoa), mitochondrial genome rearrangements have resulted in nearly hundred chromosomes and a systematic dispersal of gene fragments across the multipartite genome. Maturation into functional RNAs involves separate transcription of gene pieces, joining of precursor RNAs via transsplicing, and RNA editing by substitution and uridine additions both reconstituting crucial coding sequence. How widespread these unusual features are across diplonemids is unclear. We have analyzed the mitochondrial genomes and transcriptomes of four species from the Diplonema/Rhynchopus clade, revealing a considerable genomic plasticity. Although gene breakpoints, and thus the total number of gene pieces (similar to 80), are essentially conserved across this group, the number of distinct chromosomes varies by a factor of two, with certain chromosomes combining up to eight unrelated gene fragments. Several internal protein-coding gene pieces overlap substantially, resulting, for example, in a stretch of 22 identical amino acids in cytochrome c oxidase subunit 1 and NADH dehydrogenase subunit 5. Finally, the variation of post-transcriptional editing patterns across diplonemids indicates compensation of two adverse trends: rapid sequence evolution and loss of genetic information through unequal chromosome segregation.	[Valach, Matus; Moreira, Sandrine; Burger, Gertraud] Univ Montreal, Dept Biochem, 2900 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada; [Valach, Matus; Moreira, Sandrine; Burger, Gertraud] Univ Montreal, Robert Cedergren Ctr Bioinformat & Genom, 2900 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada; [Hoffmann, Steve] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Haertelstr 16-18, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Bioinformat Grp, Dept Comp Sci, Hartelstr 16-18, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Hartelstr 16-18, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, German Ctr Integrat Biodivers Res iDiv Halle Jena, Competence Ctr Scalable Data Serv & Solut, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04107 Leipzig, Germany; [Stadler, Peter F.] Max Planck Inst Math Sci, Inselstr 22, D-04103 Leipzig, Germany; [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, Perlickstr 1, D-04103 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, Wahringerstr 17, A-1090 Vienna, Austria; [Stadler, Peter F.] Univ Copenhagen, Ctr RNA Technol & Hlth, Gronnegardsvej 3, DK-1870 Frederiksberg C, Denmark; [Stadler, Peter F.] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA; [Moreira, Sandrine] Columbia Univ, Dept Biochem & Mol Biophys, Hammer Hlth Sci Ctr, 701 W 168th St, New York, NY 10031 USA	Valach, M; Burger, G (reprint author), Univ Montreal, Dept Biochem, 2900 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.; Valach, M; Burger, G (reprint author), Univ Montreal, Robert Cedergren Ctr Bioinformat & Genom, 2900 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	matus.a.valach@gmail.com; gertraud.burger@umontreal.ca		Stadler, Peter F./0000-0002-5016-5191; Moreira, Sandrine/0000-0002-4580-3566; Valach, Matus/0000-0001-8689-0080	Canadian Institute of Health Research (CIHR) [MOP-79309]; Gordon and Betty Moore Foundation [GBMF-4983]; NSERC [RGPIN-2014-05286]	We acknowledge G. N. Kiethega and S. Teijeiro for culturing diplonemids and extracting DNA and RNA. We thank B. F. Lang for assistance in phylogenetic analyses, B. F. Lang and M. Sarrasin for critically reading the manuscript, and M. Aoulad Aissa for excellent technical assistance (all at the Universite de Montreal, Montreal, Canada). We also thank A. Yabuki (JAMSTEC, Yokosuka, Japan) for sharing Hemistasia data prior to their release in GenBank. This work was supported by Canadian Institute of Health Research (CIHR, operating grant number MOP-79309); Gordon and Betty Moore Foundation (grant number GBMF-4983); and NSERC (grant number RGPIN-2014-05286).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bracht JR, 2013, CELL, V152, P406, DOI 10.1016/j.cell.2013.01.005; Brown JD, 2010, ANNU REV GENOM HUM G, V11, P291, DOI 10.1146/annurev-genom-082509-141554; Bryant SA, 2016, MOL BIOL EVOL, V33, P2337, DOI 10.1093/molbev/msw104; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Burger G, 2016, TRENDS GENET, V32, P553, DOI 10.1016/j.tig.2016.06.005; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; de Vargas C., 2015, SCIENCE, V348; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Flegontova O, 2016, CURR BIOL, V26, P3060, DOI 10.1016/j.cub.2016.09.031; Gawryluk RMR, 2016, CURR BIOL, V26, P3053, DOI 10.1016/j.cub.2016.09.013; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hou J, 2014, CURR BIOL, V24, P1153, DOI 10.1016/j.cub.2014.03.063; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Jackson CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056777; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kieleczawa Jan, 2006, J Biomol Tech, V17, P207; Kiethega GN, 2013, RNA BIOL, V10, P301, DOI 10.4161/rna.23340; Kiethega GN, 2011, MOL BIOL EVOL, V28, P2425, DOI 10.1093/molbev/msr075; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara E, 2009, ENVIRON MICROBIOL, V11, P47, DOI 10.1111/j.1462-2920.2008.01737.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Lavrov DV, 2016, GENOME BIOL EVOL, V8, P2896, DOI 10.1093/gbe/evw195; Lei Q, 2016, GENOME BIOL EVOL, V8, P562, DOI 10.1093/gbe/evw025; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Moreira S, 2016, NUCLEIC ACIDS RES, V44, P4907, DOI 10.1093/nar/gkw188; Mungpakdee S, 2014, GENOME BIOL EVOL, V6, P1408, DOI 10.1093/gbe/evu109; Otto C, 2012, BIOINFORMATICS, V28, P1698, DOI 10.1093/bioinformatics/bts254; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rammelt C, 2016, RNA BIOL, V13, P1182, DOI 10.1080/15476286.2016.1239007; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; RODRIGUEZEZPELETA, 2009, METH MOL B, V533, P33, DOI DOI 10.1007/978-1-60327-136-3_3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy J, 2007, PROTIST, V158, P385, DOI 10.1016/j.protis.2007.03.002; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith DR, 2010, CURR GENET, V56, P427, DOI 10.1007/s00294-010-0311-5; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Tomita K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00036; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Valach M, 2016, RNA BIOL, V13, P1204, DOI 10.1080/15476286.2016.1240143; Valach M, 2014, NUCLEIC ACIDS RES, V42, P2660, DOI 10.1093/nar/gkt1152; Valach M, 2011, NUCLEIC ACIDS RES, V39, P4202, DOI 10.1093/nar/gkq1345; Vlcek C, 2011, NUCLEIC ACIDS RES, V39, P979, DOI 10.1093/nar/gkq883; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Wang JB, 2014, CURR OPIN GENET DEV, V27, P26, DOI 10.1016/j.gde.2014.03.012; Yabuki A., 2016, GENOME BIOL EVOL, V8, P2870; Yabuki A, 2015, J EUKARYOT MICROBIOL, V62, P426, DOI 10.1111/jeu.12191; YOKOBORI S, 1995, P NATL ACAD SCI USA, V92, P10432, DOI 10.1073/pnas.92.22.10432                                                        ; Zhang ZD, 1999, NATURE, V400, P155	71	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 26	2017	7								14166	10.1038/s41598-017-14286-z				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FK9FI	WOS:000413816600025	29074957	gold			2018-01-05	
J	Poon, A; Zhang, Y; Chandrasekaran, A; Phanthong, P; Schmid, B; Nielsen, TT; Freude, KK				Poon, Anna; Zhang, Yu; Chandrasekaran, Abinaya; Phanthong, Phetcharat; Schmid, Benjamin; Nielsen, Troels T.; Freude, Kristine K.			Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges	NEW BIOTECHNOLOGY			English	Review						IPSC; Neurodegeneration; Disease models; Alzheimer's disease; Frontotemporal dementia; Ataxia; 3D neural cultures; 2D neural cultures	FAMILIAL ALZHEIMERS-DISEASE; PROTEIN-TAU MAPT; CORRECTED IPSC LINE; HUMAN TRISOMY-21 IPSCS; EMBRYONIC STEM-CELLS; FRONTOTEMPORAL DEMENTIA; SPINOCEREBELLAR ATAXIA; R406W MUTATION; DOWN-SYNDROME; 3D CULTURE	The rising prevalence of progressive neurodegenerative diseases coupled with increasing longevity poses an economic burden at individual and societal levels. There is currently no effective cure for the majority of neurodegenerative diseases and disease-affected tissues from patients have been difficult to obtain for research and drug discovery in pre-clinical settings. While the use of animal models has contributed invaluable mechanistic insights and potential therapeutic targets, the translational value of animal models could be further enhanced when combined with in vitro models derived from patient-specific induced pluripotent stem cells (iPSCs) and isogenic controls generated using CRISPR-Cas9 mediated genome editing. The iPSCs are self-renewable and capable of being differentiated into the cell types affected by the diseases. These in vitro models based on patient-derived iPSCs provide the opportunity to model disease development, uncover novel mechanisms and test potential therapeutics. Here we review findings from iPSC-based modeling of selected neurodegenerative diseases, including Alzheimer's disease, frontotemporal dementia and spinocerebellar ataxia. Furthermore, we discuss the possibilities of generating three-dimensional (3D) models using the iPSCs-derived cells and compare their advantages and disadvantages to conventional two-dimensional (2D) models. (C) 2017 Elsevier B.V. All rights reserved.	[Poon, Anna; Zhang, Yu; Freude, Kristine K.] Univ Copenhagen, Fac Hlth & Med Sci, Gronnegaardsvej 7, DK-1870 Frederiksberg C, Denmark; [Chandrasekaran, Abinaya] BioTalentum Ltd, Godollo, Hungary; [Phanthong, Phetcharat] Mahidol Univ, Inst Mol Biosci, Stem Cell Res Grp, Bangkok 10400, Thailand; [Phanthong, Phetcharat] Mahidol Univ, Deparment Anat, Fac Sci, Bangkok 10400, Thailand; [Schmid, Benjamin] Bioneer AS, Kogle Alle 2, DK-2970 Horsholm, Denmark; [Nielsen, Troels T.] Univ Copenhagen, Rigshosp, Danish Dementia Res Ctr, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark	Freude, KK (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Gronnegaardsvej 7, DK-1870 Frederiksberg C, Denmark.	kkf@sund.ku.dk			China Scholarship Council; Mahidol University; European Union [PIAP-GA-2012-324451-STEMMAD]; Innovation Fund Denmark [4108-00008B, 4096-00001B]	The China Scholarship Council supported Yu Zhang and the Mahidol University research fund supported Phetcharat Phanthong. The European Union 7th Framework Program (PIAP-GA-2012-324451-STEMMAD), The Innovation Fund Denmark (BrainStem (4108-00008B) and NeuroStem 4096-00001B) supported our research activities. Tamas Bellak, Annamaria Teglasi and Abinaya Chandrasekaran performed the experiments in the laboratory of BioTalentum Ltd. and provided the pictures presented in Fig. 3.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241                                                              ; Apostolova Liana G, 2016, Continuum (Minneap Minn), V22, P419, DOI 10.1212/CON.0000000000000307; Asim A, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0138-y; Balez R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31450; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Bellak TO, 19 C HUNG AN SOC; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Biswas MHU, 2016, STEM CELL REP, V7, P316, DOI 10.1016/j.stemcr.2016.08.006; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Capell A, 2014, J BIOL CHEM, V289, P25879, DOI 10.1074/jbc.M114.560128; Cataldo A, 2001, ANN NEUROL, V50, P661, DOI 10.1002/ana.1254; Chandrasekaran ANR, 15 BIANN C HUNG NEUR; CHANG CY, 2015, SCI REP UK, V5; Chaudhari AA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121974; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Cui X, 2017, J R SOC INTERFACE, V14; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Duan LS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-3; Ehrlich M, 2015, STEM CELL REP, V5, P83, DOI 10.1016/j.stemcr.2015.06.001; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4                                                   ; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Hansen SK, 2016, STEM CELL RES, V17, P306, DOI 10.1016/j.scr.2016.07.004; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Hu WT, 2009, CURR NEUROL NEUROSCI, V9, P353, DOI 10.1007/s11910-009-0052-3; Hu YH, 2016, ACS APPL MATER INTER, V8, P21939, DOI 10.1021/acsami.5b12268; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Ivanov DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103817; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jang M, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4922863; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044                                                         ; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lee WC, 2014, HUM MOL GENET, V23, P1467, DOI 10.1093/hmg/ddt534; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622                                                         ; Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marthaler AG, 2016, STEM CELL RES, V16, P199, DOI 10.1016/j.scr.2015.12.049; Marthaler AG, 2016, STEM CELL RES, V16, P159, DOI 10.1016/j.scr.2015.12.027; Marthaler AG, 2016, STEM CELL RES, V16, P166, DOI 10.1016/j.scr.2015.12.029; Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Morino H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0180-4; Mufson EJ, 2002, J COMP NEUROL, V443, P136, DOI 10.1002/cne.10122; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Nimsanor N, 2016, STEM CELL RES, V17, P576, DOI 10.1016/j.scr.2016.09.020; Nimsanor N, 2016, STEM CELL RES, V17, P600, DOI 10.1016/j.scr.2016.09.024; Nimsanor N, 2016, STEM CELL RES, V17, P556, DOI 10.1016/j.scr.2016.09.021; Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Preynat-Seauve O, 2009, STEM CELLS, V27, P509, DOI 10.1634/stemcells.2008-0600; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Raghavan S, 2015, GYNECOL ONCOL, V138, P181, DOI 10.1016/j.ygyno.2015.04.014; Raitano S, 2015, STEM CELL REP, V4, P16, DOI 10.1016/j.stemcr.2014.12.001; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Rasmussen MA, 2016, STEM CELL RES, V16, P75, DOI 10.1016/j.scr.2015.12.006; Rasmussen MA, 2016, STEM CELL RES, V16, P70, DOI 10.1016/j.scr.2015.12.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0                                                                ; Roman VK, INFAR C; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203                                                     ; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; Schizas N, 2014, J BIOMATER APPL, V28, P825, DOI 10.1177/0885328213483636; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi Y., 2012, SCI TRANSL MED, V4, P124, DOI DOI 10.1126/SCITRANSLMED.3003771; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tieng V, 2014, STEM CELLS DEV, V23, P1535, DOI 10.1089/scd.2013.0442; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; WANG SY, 2015, SCI REP UK, V5; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Weick JP, 2016, METHODS MOL BIOL, V1303, P247, DOI 10.1007/978-1-4939-2627-5_15; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yegambaram M, 2015, CURR ALZHEIMER RES, V12, P116, DOI 10.2174/1567205012666150204121719                                               ; Zhang Y, 2017, STEM CELL REP, V8, P648, DOI 10.1016/j.stemcr.2017.01.012; Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113; Zhang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076055	102	0	0	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1871-6784	1876-4347		NEW BIOTECHNOL	New Biotech.	OCT 25	2017	39		B				190	198		10.1016/j.nbt.2017.05.009				9	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FM6QI	WOS:000415180100005	28579476				2018-01-05	
J	Gutierrez-Guerrero, A; Sanchez-Hernandez, S; Galvani, G; Pinedo-Gomez, J; Martin-Guerra, R; Sanchez-Gilabert, A; Aguilar-Gonzalez, A; Cobo, M; Gregory, P; Holmes, M; Benabdellah, K; Martin, F				Gutierrez-Guerrero, Alejandra; Sanchez-Hernandez, Sabina; Galvani, Giuseppe; Pinedo-Gomez, Javier; Martin-Guerra, Rocio; Sanchez-Gilabert, Almudena; Aguilar-Gonzalez, Araceli; Cobo, Marien; Gregory, Philip; Holmes, Michael; Benabdellah, Karim; Martin, Francisco			Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus	HUMAN GENE THERAPY			English	Article; Early Access						genome editing; Wiskott-Aldrich syndrome; integrative deficient lentiviral vectors (IDLV); zinc finger nucleases (ZFN); CRISPR/Cas9; K562	OFF-TARGET CLEAVAGE; DEFECTIVE LENTIVIRAL VECTORS; DOUBLE-STRAND BREAKS; GENE-THERAPY; STEM-CELLS; HEMATOPOIETIC STEM; WIDE ANALYSIS; DNA; DELIVERY; CAS9	Primary immunodeficiencies, including Wiskott-Aldrich syndrome (WAS), are a main target for genome-editing strategies using specific nucleases (SNs) because a small number of corrected hematopoietic stem cells could cure patients. In this work, we have designed various WAS gene-specific CRISPR/Cas9 systems and compared their efficiency and specificity with homodimeric and heterodimeric WAS-specific zinc finger nucleases (ZFNs), using K-562 cells as a cellular model and plasmid nucleofection or integration-deficient lentiviral vectors (IDLVs) for delivery. The various CRISPR/Cas9 and ZFN SNs showed similar efficiency when using plasmid nucleofection for delivery. However, dual IDLVs expressing ZFNs were more efficient than dual IDLVs expressing Cas9 and guide RNA or all-in-one IDLVs, expressing Cas9 and guide RNA in the same vector. The specificity of heterodimeric ZFNs and CRISPR/Cas9, measured by increments in gamma-H2AX focus formation in WAS-edited cells, was similar for both, and both outperformed homodimeric ZFNs independently of the delivery system used. Interestingly, we show that delivery of SNs, using IDLVs, is more efficient and less genotoxic than plasmid nucleofection. We also show the similar behavior of heterodimeric ZFNs and CRISPR/Cas9 for homology-directed gene knock-in strategies, with 88 and 83% of the donors inserted in the WAS locus, respectively, whereas when using homodimeric ZFNs only 45% of the insertions were on target. In summary, our data indicate that CRISPR/Cas9 and heterodimeric ZFNs are both good alternatives to further develop SN-based gene therapy strategies for WAS. However, IDLV delivery of WAS-specific heterodimeric ZFNs was the best option of all systems compared in this study.	[Gutierrez-Guerrero, Alejandra; Sanchez-Hernandez, Sabina; Galvani, Giuseppe; Pinedo-Gomez, Javier; Martin-Guerra, Rocio; Sanchez-Gilabert, Almudena; Aguilar-Gonzalez, Araceli; Cobo, Marien; Benabdellah, Karim; Martin, Francisco] Pfizer Univ Granada Andalusian Reg Govt, Genom Med Dept, Ctr Genom & Oncol Res GENYO, Granada, Spain; [Cobo, Marien; Benabdellah, Karim; Martin, Francisco] LentiStem Biotech, Granada, Spain; [Gregory, Philip; Holmes, Michael] Point Richmond Tech Ctr, Sangamo BioSci, Richmond, CA USA; [Galvani, Giuseppe] RCCS San Raffaele Sci Inst, DRI, Milan, Italy; [Gregory, Philip] Bluebird Bio Inc, Cambridge, MA USA	Martin, F (reprint author), Pfizer Univ Granada Andalusian Reg Govt, Genom Med Dept, GENYO, Ave Ilustrac 114, Granada 18016, Spain.	francisco.martin@genyo.es			Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI12/01097, PI15/02015]; ISCIII Red de Terapia Celular [TerCel: RD12/0019/0006]; CICE; CS de la Junta de Andalucia FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia [P09-CTS-04532, PI-57069, PI-0001/2009, PAIDI-Bio-326]; Plan de Empleo Juvenil (MINECO);  [PI-0160/2012];  [PI-0014-2016];  [PI-0407/2012];  [PI-0318/2014]	This work has been financed by Fondo de Investigaciones Sanitarias ISCIII (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union, through research grants PI12/01097, PI15/02015 (F.M.), and ISCIII Red de Terapia Celular (TerCel: RD12/0019/0006) (F.M.); by the CICE and CS de la Junta de Andalucia FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia 2007-2013 through research grants P09-CTS-04532, PI-57069, PI-0001/2009, and PAIDI-Bio-326 (F.M.); PI-0160/2012, PI-0014-2016 (K.B.), and PI-0407/2012, PI-0318/2014 (M.C.). A.G.-G. and S.S.-H. are doctoral students from the Biomedicine Doctorate Program from Granada University (Spain). S.S.-H. is funded by Plan de Empleo Juvenil (MINECO).	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benabdellah K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084268; Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Cornu TI, 2010, METHODS MOL BIOL, V649, P237, DOI 10.1007/978-1-60761-753-2_14; Cottle RN, 2016, HUM GENET, V135, P993, DOI 10.1007/s00439-016-1696-0; Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joglekar AV, 2013, MOL THER, V21, P1705, DOI 10.1038/mt.2013.106; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kirchhausen T, 1998, MOL MED TODAY, V4, P300, DOI 10.1016/S1357-4310(98)01268-4                                                   ; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Ling C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35495; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Martin F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091507; Massaad MJ, 2013, ANN NY ACAD SCI, V1285, P26, DOI 10.1111/nyas.12049; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Ochs HD, 1998, SPRINGER SEMIN IMMUN, V19, P435, DOI 10.1007/BF00792601                                                              ; Olsen PA, 2009, DNA REPAIR, V8, P298, DOI 10.1016/j.dnarep.2008.11.011; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Toscano MG, 2004, GENE THER, V11, P956, DOI 10.1038/sj.gt.3302259; Toscano MG, 2013, DIS MODEL MECH, V6, P544, DOI 10.1242/dmm.010652; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Worth AJJ, 2015, EXPERT REV CLIN IMMU, V11, P1015, DOI 10.1586/1744666X.2015.1062366; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113	63	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	OCT 25	2017										10.1089/hum.2017.047		OCT	2017	15	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FL7GT	WOS:000414415700001					2018-01-05	
J	Wilkinson, AC; Nakauchi, H; Gottgens, B				Wilkinson, Adam C.; Nakauchi, Hiromitsu; Gottgens, Berthold			Mammalian Transcription Factor Networks: Recent Advances in Interrogating Biological Complexity	CELL SYSTEMS			English	Article							GENE REGULATORY NETWORKS; HEMATOPOIETIC STEM-CELLS; PROTEIN-DNA INTERACTIONS; SINGLE-CELL; HUMAN GENOME; IN-VIVO; CHROMATIN ACCESSIBILITY; BLOOD STEM; EXPRESSION ANALYSIS; ENHANCER ACTIVITY	Transcription factor (TF) networks are a key determinant of cell fate decisions in mammalian development and adult tissue homeostasis and are frequently corrupted in disease. However, our inability to experimentally resolve and interrogate the complexity of mammalian TF networks has hampered the progress in this field. Recent technological advances, in particular large-scale genome-wide approaches, single-cell methodologies, live-cell imaging, and genome editing, are emerging as important technologies in TF network biology. Several recent studies even suggest a need to re-evaluate established models of mammalian TF networks. Here, we provide a brief overview of current and emerging methods to define mammalian TF networks. We also discuss how these emerging technologies facilitate new ways to interrogate complex TF networks, consider the current open questions in the field, and comment on potential future directions and biomedical applications.	[Wilkinson, Adam C.; Nakauchi, Hiromitsu] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA; [Nakauchi, Hiromitsu] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Gottgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Gottgens, Berthold] Univ Cambridge, Wellcome Trust, Cambridge CB2 0XY, England; [Gottgens, Berthold] Univ Cambridge, MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England	Gottgens, B (reprint author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England.; Gottgens, B (reprint author), Univ Cambridge, Wellcome Trust, Cambridge CB2 0XY, England.; Gottgens, B (reprint author), Univ Cambridge, MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England.	bg200@cam.ac.uk			Bloodwise Visiting Fellowship [15050]; NIH-NCATS [UL1 TR001085]; Japan Science and Technology Agency; California Institute of Regenerative Medicine [LA1-06917, DISC2-08874]; Ludwig Foundation; Bloodwise [12029]; Cancer Research UK [C1163/A12765, C1163/A21762]; Wellcome Trust [105031/D/14/Z, 097922/Z/11/Z]; MRC [MR/M008975/1]; NIH-NIDDK [R24 DK106766-01]	We apologize to those authors whose work could not be cited due to space constraints. We thank Dr. Hannah Long and Dr. Craig Mak for helpful discussion and feedback on the manuscript. A.C.W. is funded by a Bloodwise Visiting Fellowship (15050) and the NIH-NCATS (UL1 TR001085). H.N. is funded by the Japan Science and Technology Agency, the California Institute of Regenerative Medicine (LA1-06917 and DISC2-08874), and Ludwig Foundation. B.G. is funded by Bloodwise (12029), Cancer Research UK (C1163/A12765 and C1163/A21762), the Wellcome Trust (105031/D/14/Z), the MRC (MR/M008975/1), NIH-NIDDK (R24 DK106766-01), and core funding from the Wellcome Trust to the Cambridge Stem Cell Institute (097922/Z/11/Z). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bass JIF, 2015, CELL, V161, P661, DOI 10.1016/j.cell.2015.03.003; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Bonzanni N, 2013, BIOINFORMATICS, V29, P80, DOI 10.1093/bioinformatics/btt243; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Brent MR, 2016, TRENDS GENET, V32, P736, DOI 10.1016/j.tig.2016.08.009; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dogan N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0009-5; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dowell KG, 2014, STEM CELLS, V32, P1161, DOI 10.1002/stem.1612; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Filipczyk A, 2015, NAT CELL BIOL, V17, P1235, DOI 10.1038/ncb3237; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Gottgens B, 2015, BLOOD, V125, P2614, DOI 10.1182/blood-2014-08-570226; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Horlbeck MA, 2016, ELIFE, P5; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Ma YQ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00019; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; MacNeil LT, 2015, CELL SYST, V1, P152, DOI 10.1016/j.cels.2015.08.003; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mak K. S., 2011, INT J CELL BIOL, V2011, DOI DOI 10.1155/2011/808524; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ng SWK, 2016, NATURE, V540, P433, DOI 10.1038/nature20598; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satija R, 2014, TRENDS IMMUNOL, V35, P219, DOI 10.1016/j.it.2014.03.004; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schutte J, 2016, ELIFE, V5, DOI 10.7554/eLife.11469; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Sigvardsson M, 2012, BLOOD, V120, P3630, DOI 10.1182/blood-2012-09-455113; Sive JI, 2014, EXP CELL RES, V329, P255, DOI 10.1016/j.yexcr.2014.06.021; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662                                                         ; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007                                                              ; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilkinson AC, 2014, DEVELOPMENT, V141, P4018, DOI 10.1242/dev.115709; Wilkinson AC, 2013, ADV EXP MED BIOL, V786, P187, DOI 10.1007/978-94-007-6621-1_11; Wilson NK, 2016, BLOOD, V127, pE12, DOI 10.1182/blood-2015-10-677393; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Woodhouse S, 2016, IMMUNOL CELL BIOL, V94, P256, DOI 10.1038/icb.2015.102; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003777; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yamazaki H, 2014, CANCER CELL, V25, P415, DOI 10.1016/j.ccr.2014.02.008	128	0	0	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2405-4712	2405-4720		CELL SYST	Cell Syst.	OCT 25	2017	5	4					319	331		10.1016/j.cels.2017.07.004				13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK7BT	WOS:000413659600006	29073372				2018-01-05	
J	Carleton, JB; Berrett, KC; Gertz, J				Carleton, Julia B.; Berrett, Kristofer C.; Gertz, Jason			Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor alpha-Bound Enhancers	CELL SYSTEMS			English	Article							SEQUENCE-SPECIFIC CONTROL; BETA-GLOBIN GENE; SHADOW ENHANCERS; BINDING-SITES; HUMAN GENOME; CRISPR INTERFERENCE; DROSOPHILA-EMBRYO; SUPER-ENHANCER; BREAST-CANCER; EXPRESSION	Multiple regulatory regions have the potential to regulate a single gene, yet how these elements combine to affect gene expression remains unclear. To uncover the combinatorial relationships between enhancers, we developed Enhancer-interference (Enhancer-i), a CRISPR interference-based approach that uses 2 different repressive domains, KRAB and SID, to prevent enhancer activation simultaneously at multiple regulatory regions. We applied Enhancer-i to promoter-distal estrogen receptor a binding sites (ERBS), which cluster around estradiol-responsive genes and therefore may collaborate to regulate gene expression. Targeting individual sites revealed predominant ERBS that are completely required for the transcriptional response, indicating a lack of redundancy. Simultaneous interference of different ERBS combinations identified supportive ERBS that contribute only when predominant sites are active. Using mathematical modeling, we find strong evidence for collaboration between predominant and supportive ERBS. Overall, our findings expose a complex functional hierarchy of enhancers, where multiple loci bound by the same transcription factor combine to fine-tune the expression of target genes.	[Carleton, Julia B.; Berrett, Kristofer C.; Gertz, Jason] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Gertz, J (reprint author), Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	jay.gertz@hci.utah.edu			NIH/NHGRI [R00 HG006922, R01 HG008974]; Huntsman Cancer Institute; NIH/NCI [P30 CA042014]; NIH/NIGMS [T32 GM007464]	This work was supported by NIH/NHGRI R00 HG006922 and NIH/NHGRI R01 HG008974 to J.G., and the Huntsman Cancer Institute. Research reported in this publication utilized the High-Throughput Genomics Shared Resource at the University of Utah and was supported by NIH/NCI award P30 CA042014. J.B.C. was supported by NIH/NIGMS Training Program in Genetics T32 GM007464. We thank Don Ayer for reagents and advice, and K-T Varley and Edward Chuong for their helpful comments on the manuscript.	Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6                                                    ; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; BLASQUEZ VC, 1992, J BIOL CHEM, V267, P23888; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405                                                              ; DEVILLIERS J, 1981, NUCLEIC ACIDS RES, V9, P6251, DOI 10.1093/nar/9.23.6251; Droog M, 2016, MOL ENDOCRINOL, V30, P1046, DOI 10.1210/me.2016-1062; Dukler N, 2017, NAT GENET, V49, P2, DOI 10.1038/ng.3759; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; FULTON R, 1994, NUCLEIC ACIDS RES, V22, P4216, DOI 10.1093/nar/22.20.4216                                                          ; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563                                                 ; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kehayova P, 2011, P NATL ACAD SCI USA, V108, P17195, DOI 10.1073/pnas.1114357108; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lam DD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004935; Langmead B, 2009, GENOME BIOL, V10, P2009; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rennoll SA, 2014, BIOCHEM BIOPH RES CO, V446, P1120, DOI 10.1016/j.bbrc.2014.03.077; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Savic D, 2015, GENOME RES, V25, P1791, DOI 10.1101/gr.191593.115; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; SMALL S, 1992, EMBO J, V11, P4047; Stern DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0028; Stine ZE, 2011, HUM MOL GENET, V20, P3746, DOI 10.1093/hmg/ddr291; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yuh CH, 1996, DEVELOPMENT, V122, P1069; Zhang Y, 2008, GENOME BIOL, V9, pR137, DOI DOI 10.1186/GB-2008-9-9-R137	68	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2405-4712	2405-4720		CELL SYST	Cell Syst.	OCT 25	2017	5	4					333	+		10.1016/j.cels.2017.08.011				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FK7BT	WOS:000413659600007	28964699				2018-01-05	
J	Lee, J; Jefcoate, C				Lee, Jinwoo; Jefcoate, Colin			Monitoring of Dual crisPr/cas9Mediated steroidogenic acute regulatory Protein gene Deletion and cholesterol accumulation Using high-resolution Fluorescence In Situ hybridization in a single cell	FRONTIERS IN ENDOCRINOLOGY			English	Article						steroidogenic acute regulatory protein; CRIS PR; fluorescence in situ hybridization; cholesterol; lipid droplets	HORMONE-SENSITIVE LIPASE; LEYDIG TUMOR-CELLS; LIPOID ADRENAL-HYPERPLASIA; STAR EXPRESSION; CONTACT SITES; STIMULATION; MECHANISMS; CAS9; RNA; PROKARYOTES	Recent advances in fluorescence microscopy, coupled with CRISPR/Cas9 gene editing technology, provide opportunities for understanding gene regulation at the single-cell level. The application of direct imaging shown here provides an in situ side-by-side comparison of CRISPR/Cas9-edited cells and adjacent unedited cells. We apply this methodology to the steroidogenic acute regulatory protein (StAR) gene in Y-1 adrenal cells and MA-10 testis cells. StAR is a gatekeeper protein that controls the access of cholesterol from the cytoplasm to the inner mitochondria. The loss of this mitochondrial cholesterol transfer mediator rapidly increases lipid droplets in cells, as seen in StAR-/-mice. Here, we describe a dual CRISPR/Cas9 strategy marked by GFP/mCherry expression that deletes StAR activity within 12 h. We used single-molecule fluorescence in situ hybridization (sm-FISH) imaging to directly monitor the time course of gene editing in single cells. We achieved StAR gene deletion at high efficiency dual gRNA targeting to the proximal promoter and exon 2. Seventy percent of transfected cells showed a slow DNA deletion as measured by PCR, and loss of Br-cAMP stimulated transcription. This DNA deletion was seen by sm-FISH in both loci of individual cells relative to non-target Cyp11a1 and StAR exon 7. sm-FISH also distinguishes two effects on stimulated StAR expression without this deletion. Br-cAMP stimulation of primary and spliced StAR RNA at the gene loci were removed within 4 h in this dual CRISPR/Cas9 strategy before any effect on cytoplasmic mRNA and protein occurred. StAR mRNA disappeared between 12 and 24 h in parallel with this deletion, while cholesterol ester droplets increased fourfold. These alternative changes match distinct StAR expression processes. This dual gRNA and sm-FISH approach to CRISPR/Cas9 editing facilitates rapid testing of editing strategies and immediate assessment of single-cell adaptation responses without the perturbation of clonal expansion procedures.	[Lee, Jinwoo; Jefcoate, Colin] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Lee, Jinwoo; Jefcoate, Colin] Univ Wisconsin, Endocrinol & Reprod Physiol Program, Madison, WI 53706 USA; [Jefcoate, Colin] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Jefcoate, Colin] Univ Wisconsin, Mol & Cellular Pharmacol, Madison, WI 53706 USA	Lee, J; Jefcoate, C (reprint author), Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.; Lee, J; Jefcoate, C (reprint author), Univ Wisconsin, Endocrinol & Reprod Physiol Program, Madison, WI 53706 USA.; Jefcoate, C (reprint author), Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.; Jefcoate, C (reprint author), Univ Wisconsin, Mol & Cellular Pharmacol, Madison, WI 53706 USA.	jwlee7@wisc.edu; jefcoate@wisc.edu			NIH [RO1 DK074819, RO1 DK090249]; University of Wisconsin School of Medicine and Public Health Department of Cell and Regenerative Biology	This study was financially supported by NIH (RO1 DK074819, RO1 DK090249). This research was also supported by funding from the University of Wisconsin School of Medicine and Public Health Department of Cell and Regenerative Biology.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Anuka E, 2013, MOL CELL ENDOCRINOL, V371, P47, DOI 10.1016/j.mce.2013.02.003; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88                                                           ; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Borthwick F, 2010, CLIN SCI, V119, P265, DOI 10.1042/CS20100266; Borthwick F, 2009, FEBS LETT, V583, P1147, DOI 10.1016/j.febslet.2009.02.042; Bose HS, 2000, J CLIN ENDOCR METAB, V85, P3636, DOI 10.1210/jc.85.10.3636; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Castillo AF, 2015, MOL CELL ENDOCRINOL, V408, P73, DOI 10.1016/j.mce.2014.12.011; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; DIBARTOLOMEIS MJ, 1984, J BIOL CHEM, V259, P159; Duan H, 2009, MOL ENDOCRINOL, V23, P497, DOI 10.1210/me.2008-0296; Findlay SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153901; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hasegawa T, 2000, MOL ENDOCRINOL, V14, P1462, DOI 10.1210/me.14.9.1462; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Lee J, 2017, MOL CELL ENDOCRINOL, V441, P22, DOI 10.1016/j.mce.2016.08.015; Lee JW, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00107; Lee J, 2016, MOL CELL ENDOCRINOL, V429, P93, DOI 10.1016/j.mce.2016.04.001; Lee J, 2015, MOL CELL ENDOCRINOL, V408, P80, DOI 10.1016/j.mce.2015.01.022; Li H, 2002, ENDOCRINOLOGY, V143, P3333, DOI 10.1210/en.2002-220341; Luo J, 2017, TRAFFIC, V18, P209, DOI 10.1111/tra.12471; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Manna PR, 2001, ENDOCRINOLOGY, V142, P319, DOI 10.1210/endo.142.1.7900; Manna PR, 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/821615, DOI 10.1155/2011/821615]; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Paz C, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00060; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao RM, 2002, ENDOCR RES, V28, P387, DOI 10.1081/ERC-120016813; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; Ronen-Fuhrmann T, 1998, ENDOCRINOLOGY, V139, P303, DOI 10.1210/en.139.1.303                                                            ; Rose JC, 2017, NAT METHODS, V14, P891, DOI [10.1038/NMETH.4368, 10.1038/nmeth.4368]; Schimmer B P, 1979, Methods Enzymol, V58, P570; Shen WJ, 2016, EXP CELL RES, V340, P209, DOI 10.1016/j.yexcr.2015.11.024; Shy BR, 2016, NUCLEIC ACIDS RES, V44, P7997, DOI 10.1093/nar/gkw685; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tremblay JJ, 2002, ENDOCRINOLOGY, V143, P3935, DOI 10.1210/en.2002-220413; Venugopal S, 2016, J BIOL CHEM, V291, P26109, DOI 10.1074/jbc.M116.740928; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wilhelm LP, 2017, EMBO J, V36, P1412, DOI 10.15252/embj.201695917; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126	56	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	OCT 25	2017	8								289	10.3389/fendo.2017.00289				18	Endocrinology & Metabolism	Endocrinology & Metabolism	FK6SB	WOS:000413634400001	29118738	gold			2018-01-05	
J	Yan, Q; Fong, SS				Yan, Qiang; Fong, Stephen S.			Challenges and Advances for Genetic Engineering of Non-model Bacteria and Uses in Consolidated Bioprocessing	FRONTIERS IN MICROBIOLOGY			English	Review						non-model organism; shuttle vector; promoter; genome-scale metabolic models; homologous recombination; CRISPR/Cas9; consolidated bioprocessing	FREE PLASMID SELECTION; CRISPR-CAS SYSTEMS; METABOLIC FLUX ANALYSIS; LACTIC-ACID BACTERIA; N-BUTANOL PRODUCTION; FOOD-GRADE CLONING; CLOSTRIDIUM-THERMOCELLUM; ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; CONSTITUTIVE PROMOTERS	Metabolic diversity in microorganisms can provide the basis for creating novel biochemical products. However, most metabolic engineering projects utilize a handful of established model organisms and thus, a challenge for harnessing the potential of novel microbial functions is the ability to either heterologously express novel genes or directly utilize non-model organisms. Genetic manipulation of non-model microorganisms is still challenging due to organism-specific nuances that hinder universal molecular genetic tools and translatable knowledge of intracellular biochemical pathways and regulatory mechanisms. However, in the past several years, unprecedented progress has been made in synthetic biology, molecular genetics tools development, applications of omics data techniques, and computational tools that can aid in developing non-model hosts in a systematic manner. In this review, we focus on concerns and approaches related to working with non-model microorganisms including developing molecular genetics tools such as shuttle vectors, selectable markers, and expression systems. In addition, we will discuss: (1) current techniques in controlling gene expression (transcriptional/translational level), (2) advances in site-specific genome engineering tools [homologous recombination (HR) and clustered regularly interspaced short palindromic repeats (CRISPR)], and (3) advances in genome-scale metabolic models (GSMMs) in guiding design of non-model species. Application of these principles to metabolic engineering strategies for consolidated bioprocessing (CBP) will be discussed along with some brief comments on foreseeable future prospects.	[Yan, Qiang; Fong, Stephen S.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Fong, Stephen S.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA	Yan, Q; Fong, SS (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Fong, SS (reprint author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA.	yanq2@vcu.edu; ssfong@vcu.edu					Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Allison GE, 1996, APPL ENVIRON MICROB, V62, P4450; Angermayr SA, 2015, TRENDS BIOTECHNOL, V33, P352, DOI 10.1016/j.tibtech.2015.03.009; Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P973, DOI 10.1016/j.copbio.2013.03.018; BAKER TA, 1992, ANNU REV GENET, V26, P447; Banerjee C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00432; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Bhandiwad A, 2014, METAB ENG, V21, P17, DOI 10.1016/j.ymben.2013.10.012; Biswas R, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0204-4; Book AJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002475; Bormann S, 2014, METAB ENG, V25, P124, DOI 10.1016/j.ymben.2014.07.003; Boucher I, 2002, APPL ENVIRON MICROB, V68, P6152, DOI 10.1128/AEM.68.12.6152-6161.2002; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Choi HS, 2010, APPL ENVIRON MICROB, V76, P3097, DOI 10.1128/AEM.00115-10; Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111; Chung D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062881; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Cranenburgh RM, 2004, J MOL MICROB BIOTECH, V7, P197, DOI 10.1159/000079828; Cress BF, 2016, NUCLEIC ACIDS RES, V44, P4472, DOI 10.1093/nar/gkw231; Crown SB, 2013, METAB ENG, V20, P42, DOI 10.1016/j.ymben.2013.08.005; Dai ZJ, 2015, CURR OPIN BIOTECH, V36, P8, DOI 10.1016/j.copbio.2015.08.006; Dash S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0144-4; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng Y, 2017, APPL MICROBIOL BIOT, V101, P2217, DOI 10.1007/s00253-017-8156-1; Deng Y, 2013, METAB ENG, V15, P151, DOI 10.1016/j.ymben.2012.11.006; Deng Y, 2010, APPL ENVIRON MICROB, V76, P2098, DOI 10.1128/AEM.02626-09; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09; Dusseaux S, 2013, METAB ENG, V18, P1, DOI 10.1016/j.ymben.2013.03.003; El Demerdash HAM, 2003, APPL ENVIRON MICROB, V69, P4408, DOI 10.1128/AEM.69.8.4408-4412.2003; Elmore J. R., 2017, METAB ENG COMMUN, V5, P1, DOI 10.1016/j.meteno.2017.04.001; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fogg PCM, 2014, J MOL BIOL, V426, P2703, DOI 10.1016/j.jmb.2014.05.014; FRISBY D, 1991, J BACTERIOL, V173, P7557, DOI 10.1128/jb.173.23.7557-7564.1991                                                ; Gowen CM, 2010, BIOTECHNOL J, V5, P759, DOI 10.1002/biot.201000084; Guss AM, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-30; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Herrmann S, 2012, APPL ENVIRON MICROB, V78, P1804, DOI 10.1128/AEM.06054-11; Holwerda EK, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0155-1; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu B, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0156-0; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Khodakaramian G, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj019; KIESER T, 1991, METHOD ENZYMOL, V204, P430; Kim JM, 2008, FEMS MICROBIOL LETT, V278, P78, DOI 10.1111/j.1574-6968.2007.00981.x; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Klapatch TR, 1996, APPL MICROBIOL BIOT, V45, P127, DOI 10.1007/s002530050659; Lambertz C, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0135-5; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Li SS, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0351-0; Liao C, 2015, P NATL ACAD SCI USA, V112, P8505, DOI 10.1073/pnas.1423143112; Liao JC, 2016, NAT REV MICROBIOL, V14, P288, DOI 10.1038/nrmicro.2016.32; Lin PP, 2015, METAB ENG, V31, P44, DOI 10.1016/j.ymben.2015.07.001; Lindenkamp N, 2012, APPL ENVIRON MICROB, V78, P5375, DOI 10.1128/AEM.00824-12; Lo J, 2017, METAB ENG, V39, P71, DOI 10.1016/j.ymben.2016.10.018; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Luo YZ, 2015, ACS SYNTH BIOL, V4, P1001, DOI 10.1021/acssynbio.5b00016; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MACALUSO A, 1991, J BACTERIOL, V173, P1353, DOI 10.1128/jb.173.3.1353-1356.1991                                                 ; MACCORMICK CA, 1995, FEMS MICROBIOL LETT, V127, P105, DOI 10.1016/0378-1097(95)00045-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Nakayama S, 2011, APPL ENVIRON MICROB, V77, P6470, DOI 10.1128/AEM.00706-11; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Oliver NJ, 2016, CURR OPIN CHEM BIOL, V35, P43, DOI 10.1016/j.cbpa.2016.08.023; Olson Daniel G., 2015, Metabolic Engineering Communications, V2, P23, DOI 10.1016/j.meteno.2015.03.002; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Papanek B, 2015, METAB ENG, V32, P49, DOI 10.1016/j.ymben.2015.09.002; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Platteeuw C, 1996, APPL ENVIRON MICROB, V62, P1008; Pogrebnyakov I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171313; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RADDING CM, 1982, COLD SPRING HARB SYM, V47, P821; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sasaki Y, 2004, APPL ENVIRON MICROB, V70, P1858, DOI 10.1128/AEM.70.3.1858-1864.2004; Savijoki K, 1997, GENE, V186, P255, DOI 10.1016/S0378-1119(96)00717-2; Schneider JC, 2005, BIOTECHNOL PROGR, V21, P343, DOI 10.1021/bp049696g; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Selle K, 2015, TRENDS MICROBIOL, V23, P225, DOI 10.1016/j.tim.2015.01.008; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Song CW, 2015, BIOTECHNOL J, V10, P56, DOI 10.1002/biot.201400057; Spath K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-141; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P3069, DOI 10.1128/AEM.69.6.3069-3076.2003; Takala TM, 2002, APPL MICROBIOL BIOT, V59, P467, DOI 10.1007/s00253-002-1034-4; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thompson RA, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0607-x; Nguyen T, 2011, J AGR FOOD CHEM, V59, P5617, DOI 10.1021/jf104755r; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Tummala SB, 2003, J BACTERIOL, V185, P3644, DOI 10.1128/JB.185.12.3644-3653.2003; Vanee N, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0086-2; Vidal L, 2008, J BIOTECHNOL, V134, P127, DOI 10.1016/j.jbiotec.2008.01.011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang HH, 2012, ACS SYNTH BIOL, V1, P43, DOI 10.1021/sb3000029; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/nmeth.1971, 10.1038/NMETH.1971]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang SH, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00233-17; Wang SW, 2013, J IND MICROBIOL BIOT, V40, P633, DOI 10.1007/s10295-013-1253-y; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039; Wen ZQ, 2017, METAB ENG, V39, P38, DOI 10.1016/j.ymben.2016.10.013; Wen ZQ, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0092-5; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; Xiao H, 2012, METAB ENG, V14, P569, DOI 10.1016/j.ymben.2012.05.003; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Yan N, 2015, NATURE, V524, P155, DOI 10.1038/524155a; Yan Q, 2015, BIORESOUR BIOPROCESS, V2, P31; Yan Q., 2016, SYSTEMS BIOL APPL SY, P53, DOI [10.1007/978-81-322-2809-7_5, DOI 10.1007/978-81-322-2809-7_5]; Yan Q, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0075-2; Yan Q, 2017, APPL MICROBIOL BIOT, V101, P7567, DOI 10.1007/s00253-017-8488-x; Yang XR, 2015, METAB ENG, V32, P39, DOI 10.1016/j.ymben.2015.09.001; Yang YP, 2015, METAB ENG, V29, P217, DOI 10.1016/j.ymben.2015.03.018; Yang YP, 2016, METAB ENG, V35, P121, DOI 10.1016/j.ymben.2016.02.006; Yao GS, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0253-8; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yu L, 2015, BIOTECHNOL BIOENG, V112, P2134, DOI 10.1002/bit.25613; Yu MR, 2011, METAB ENG, V13, P373, DOI 10.1016/j.ymben.2011.04.002; Zeldes BM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01209; Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095	157	0	0	13	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	OCT 24	2017	8								2060	10.3389/fmicb.2017.02060				16	Microbiology	Microbiology	FK5FJ	WOS:000413522900001	29123506	gold			2018-01-05	
J	Wei, YL; Deng, PP; Mohsin, A; Yang, Y; Zhou, HY; Guo, MJ; Fang, HQ				Wei, Yanlong; Deng, Pingping; Mohsin, Ali; Yang, Yan; Zhou, Huayan; Guo, Meijin; Fang, Hongqing			An electroporation-free method based on Red recombineering for markerless deletion and genomic replacement in the Escherichia coli DH1 genome	PLOS ONE			English	Article							REDUCED-GENOME; MEVALONATE; K-12	The lambda-Red recombination system is a popular method for gene editing. However, its applications are limited due to restricted electroporation of DNA fragments. Here, we present an electroporation-free lambda-Red recombination method in which target DNA fragments are excised by I-CreI endonuclease in vivo from the landing pad plasmid. Subsequently, the I-SceI endonuclease-cutting chromosome and DNA double-strand break repair were required. Markerless deletion and genomic replacement were successfully accomplished by this novel approach. Eight nonessential regions of 2.4-104.4 kb in the Escherichia coli DH1 genome were deleted separately with selection efficiencies of 5.3-100%. Additionally, the recombination efficiencies were 2.5-45%, representing an order of magnitude improvement over the electroporation method. For example, for genomic replacement, lycopene expression flux (3.5 kb) was efficiently and precisely integrated into the chromosome, accompanied by replacement of nonessential regions separately into four differently oriented loci. The lycopene production level varied approximately by 5- and 10-fold, corresponding to the integrated position and expression direction, respectively, in the E. coli chromosome.	[Wei, Yanlong; Mohsin, Ali; Guo, Meijin; Fang, Hongqing] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Deng, Pingping; Fang, Hongqing] Anhui Univ, Econ & Technol Dev Zone, Inst Hlth Sci, Hefei, Anhui, Peoples R China; [Yang, Yan] Luoyang Vocat & Tech Coll, Luoyang, Henan, Peoples R China; [Yang, Yan; Zhou, Huayan; Fang, Hongqing] Acad Mil Med Sci, Inst Biotechnol, Beijing, Peoples R China	Guo, MJ; Fang, HQ (reprint author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.; Fang, HQ (reprint author), Anhui Univ, Econ & Technol Dev Zone, Inst Hlth Sci, Hefei, Anhui, Peoples R China.; Fang, HQ (reprint author), Acad Mil Med Sci, Inst Biotechnol, Beijing, Peoples R China.	guo_mj@ecust.edu.cn; fanghongqing@vip.sina.com			National Natural Science Foundation of China [81373286]; National Basic Research Program of China [2011CBA00800]; State Key Laboratory of Bioreactor Engineering	This research was supported by grants from the National Natural Science Foundation of China (81373286), National Basic Research Program of China (2011CBA00800), and Open Funding Project of the State Key Laboratory of Bioreactor Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant JA, 2014, NUCLEIC ACIDS RES, V42, P11383, DOI 10.1093/nar/gku828; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mizoguchi H, 2008, DNA RES, V15, P277, DOI 10.1093/dnares/dsn019; Mizoguchi H, 2007, BIOTECHNOL APPL BIOC, V46, P157, DOI 10.1042/BA200650107; Murphy K. C., 1998, BACTERIOL, V180, P2063; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Tas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136963; Wang JF, 2014, BIOTECHNOL LETT, V36, P1021, DOI 10.1007/s10529-014-1460-2; Yin J, 2015, APPL MICROBIOL BIOT, V99, P5523, DOI 10.1007/s00253-015-6510-8; Ying BW, 2014, MOL BIOSYST, V10, P375, DOI 10.1039/c3mb70254e; Yoon SH, 2006, BIOTECHNOL BIOENG, V94, P1025, DOI 10.1002/bit.20912; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Zhang J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0439-1	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186891	10.1371/journal.pone.0186891				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FK5VD	WOS:000413568900052	29065183	gold			2018-01-05	
